PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Saito, K; Sakaguchi, M; Iioka, H; Matsui, M; Nakanishi, H; Huh, NH; Kondo, E				Saito, K.; Sakaguchi, M.; Iioka, H.; Matsui, M.; Nakanishi, H.; Huh, N. H.; Kondo, E.			Coxsackie and adenovirus receptor is a critical regulator for the survival and growth of oral squamous carcinoma cells	ONCOGENE			English	Article						CAR; ROCK; anoikis; SCC	RHO-KINASE; BLADDER-CANCER; TIGHT JUNCTION; E-CADHERIN; CAR; EXPRESSION; ANOIKIS; DOMAIN; KERATINOCYTES; ACTIVATION	Coxsackie and adenovirus receptor (CAR) is essential for adenovirus infection to target cells, and its constitutive expression in various cancerous and normal tissues has been reported. Recently, the biological role of CAR in human cancers of several different origins has been investigated with respect to tumor progression, metastasis and tumorigenesis. However, its biological function in tumor cells remains controversial. Here we report the critical role of CAR in growth regulation of oral squamous cell carcinomas (SCCs) in vitro and in vivo via the specific interaction with Rho-associated protein kinase (ROCK). Loss of endogenous CAR expression by knockdown using specific small interfering RNA (siRNA) against CAR facilitates growth suppression of SCC cells due to cell dissociation, followed by apoptosis. The consequent morphological reaction was reminiscent of anoikis, rather than epithelial-mesenchymal transition, and the dissociation of oral SCC cells was triggered not by lack of contact with extracellular matrix, but by loss of cell-to-cell contact caused by abnormal translocation of E-cadherin from surface membrane to cytoplasm. Immunoprecipitation assays of the CAR-transfected oral SCC cell line, HSC-2, with or without ROCK inhibitor (Y-27632) revealed that CAR directly associates with ROCK! and ROCKII, which results in inhibition of ROCK activity and contributes to maintenance of cell-to-cell adhesion for their growth and survival. Based on these findings, in vivo behavior of CAR-downregulated HSC-2 cells from siRNA knockdown was compared with that of normally CAR-expressing cells in intraperitoneally xenografted mouse models. The mice engrafted with CAR siRNA-pretreated HSC-2 cells showed poor formation of metastatic foci in contrast to those implanted with the control siRNA-pretreated cells. Thus, CAR substantially has an impact on growth and survival of oral SCC cells as a negative regulator of ROCK in vitro and in vivo.	[Saito, K.; Iioka, H.; Matsui, M.; Nakanishi, H.; Kondo, E.] Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Nagoya, Aichi 4648681, Japan; [Sakaguchi, M.; Huh, N. H.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008530, Japan; [Iioka, H.] Aichi Med Univ, Adv Med Res Ctr, Div Translat Res, Nagakute, Aichi 48011, Japan; [Kondo, E.] Nagoya Univ, Grad Sch Med, Dept Epidemiol, Program Hlth & Community Med, Nagoya, Aichi 4648601, Japan	Aichi Cancer Center; Okayama University; Aichi Medical University; Nagoya University	Kondo, E (corresponding author), Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ekondo@aichi-cc.jp	Sakaguchi, Masakiyo/B-2280-2011; Iioka, Hidekazu/AAB-1424-2021	Iioka, Hidekazu/0000-0002-2639-8315	Grants-in-Aid for Scientific Research [23650625] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Anders M, 2009, CANCER GENE THER, V16, P508, DOI 10.1038/cgt.2008.103; Anders M, 2009, BRIT J CANCER, V100, P352, DOI 10.1038/sj.bjc.6604876; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bruning A, 2005, CLIN CANCER RES, V11, P4316, DOI 10.1158/1078-0432.CCR-04-2370; Cheng HL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-126; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Fok PT, 2007, J BIOL CHEM, V282, P7512, DOI 10.1074/jbc.M607230200; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giaginis C, 2010, APMIS, V118, P210, DOI 10.1111/j.1600-0463.2009.02582.x; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Huang KC, 2005, INT J CANCER, V113, P738, DOI 10.1002/ijc.20623; Lai JM, 2003, J CELL SCI, V116, P3491, DOI 10.1242/jcs.00660; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Maseki S, 2012, BRIT J CANCER, V106, P1196, DOI 10.1038/bjc.2012.24; Matsumoto K, 2005, UROLOGY, V66, P441, DOI 10.1016/j.urology.2005.02.033; Mayr GA, 1997, J VIROL, V71, P412, DOI 10.1128/JVI.71.1.412-418.1997; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Okegawa T, 2000, CANCER RES, V60, P5031; Okegawa T, 2001, CANCER RES, V61, P6592; Qin M, 2004, CANCER RES, V64, P6377, DOI 10.1158/0008-5472.CAN-04-1490; Sakaguchi M, 2003, J CELL BIOL, V163, P825, DOI 10.1083/jcb.200304017; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Stecker K, 2011, BRIT J CANCER, V104, P1426, DOI 10.1038/bjc.2011.116; Stoff A, 2006, WOUND REPAIR REGEN, V14, P608, DOI 10.1111/j.1743-6109.2006.00168.x; Street CA, 2011, ANTICANCER RES, V31, P3645; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Vigl B, 2009, EXP CELL RES, V315, P336, DOI 10.1016/j.yexcr.2008.10.020; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Xiao LQ, 2009, J BIOL CHEM, V284, P29365, DOI 10.1074/jbc.M109.007971; Yamashita M, 2007, INT J CANCER, V121, P1690, DOI 10.1002/ijc.22852; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001	42	16	18	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1274	1286		10.1038/onc.2013.66	http://dx.doi.org/10.1038/onc.2013.66			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23503462				2022-12-25	WOS:000332631100008
J	Xie, X; Piao, L; Bullock, BN; Smith, A; Su, T; Zhang, M; Teknos, TN; Arora, PS; Pan, Q				Xie, X.; Piao, L.; Bullock, B. N.; Smith, A.; Su, T.; Zhang, M.; Teknos, T. N.; Arora, P. S.; Pan, Q.			Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma	ONCOGENE			English	Article						human papillomavirus; anticancer therapeutics; p53; p300; head and neck cancer	HUMAN-PAPILLOMAVIRUS TYPE-16; E6 ONCOPROTEIN; CERVICAL-CANCER; STRUCTURAL BASIS; STEM-CELLS; PROTEIN; ACETYLATION; ACTIVATION; UBIQUITINATION; IDENTIFICATION	The incidence of human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) has rapidly increased over the past 30 years, prompting the suggestion that an epidemic maybe on the horizon. Therefore, there is a clinical need to develop alternate therapeutic strategies to manage the growing number of HPV-positive HNSCC patients. High-risk HPV E6 inactivates p53 through two distinct mechanisms; association with E6AP to degrade p53 and association with p300 to block p300-mediated p53 acetylation and activation. In this study, we determined if targeting the E6-p300 interaction is an effective approach to reactivate p53 in HPV-positive HNSCC. Ectopic expression of the CH1 domain of p300 in HPV-positive HNSCC blocks the association between E6 and p300, increases total and acetylated p53 levels and enhances p53 transcriptional activity. Moreover, expression of p21, miR-34a and miR-200c are increased, demonstrating functional p53 reactivation. CH1 overexpression in HPV-positive HNSCC has a global anticancer effect resulting in a decrease in cell proliferation and clonogenic survival and an increase in apoptosis. The in vivo tumor-initiating ability of HPV-positive HNSCC is severely compromised with CH1 overexpression, in part through a reduction in the cancer-initiating cell population. A novel small-molecule CH1 inhibitor, CH1iB, reactivates p53 and potentiates the anticancer activity of cis-platinum in HPV-positive HNSCC cells. Our work shows that CH1-domain inhibitors represent a novel class of p53-reactivation therapeutics for managing HPV-positive HNSCC patients.	[Xie, X.; Piao, L.; Smith, A.; Su, T.; Zhang, M.; Teknos, T. N.; Pan, Q.] Ohio State Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Xie, X.; Piao, L.; Smith, A.; Su, T.; Zhang, M.; Teknos, T. N.; Pan, Q.] Arthur G James Canc Hosp, Columbus, OH USA; [Xie, X.; Piao, L.; Smith, A.; Su, T.; Zhang, M.; Teknos, T. N.; Pan, Q.] Ohio State Univ, Ctr Comprehens Canc, Richard J Solove Res Inst, Columbus, OH 43210 USA; [Bullock, B. N.; Arora, P. S.] NYU, Dept Chem, New York, NY 10003 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; New York University	Pan, Q (corresponding author), Ohio State Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 442 Tzagournis Med Res,420 West 12th Ave, Columbus, OH 43210 USA.	Quintin.Pan@osumc.edu	Pan, Quintin/E-3808-2011; Reever, Larson/H-9685-2019; Arora, Paramjit/AAR-3086-2020	Reever, Larson/0000-0002-5692-4793; 	National Institutes of Health [R01CA135096, R01GM073943]; Mary E. and John W. Alford Cancer Research Endowment Fund; Joan Bisesi Fund for Head and Neck Oncology Research; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA135096, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary E. and John W. Alford Cancer Research Endowment Fund; Joan Bisesi Fund for Head and Neck Oncology Research; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants R01CA135096 (to QP) and R01GM073943 (to PSA); Mary E. and John W. Alford Cancer Research Endowment Fund; The Michelle Theado Memorial Grant from the Joan Bisesi Fund for Head and Neck Oncology Research; and Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University Comprehensive Cancer Center.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Balz V, 2003, CANCER RES, V63, P1188; Beerheide W, 2000, BIOORGAN MED CHEM, V8, P2549, DOI 10.1016/S0968-0896(00)00193-0; Beerheide W, 1999, J NATL CANCER I, V91, P1211, DOI 10.1093/jnci/91.14.1211; BeerRomero P, 1997, ONCOGENE, V14, P595, DOI 10.1038/sj.onc.1200872; Chang CJ, NAT CELL BIOL MAR, p[13, 317]; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Choi YJ, NAT CELL BIOL, P1353; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Courtete J, 2007, MOL CANCER THER, V6, P1728, DOI 10.1158/1535-7163.MCT-06-0808; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Henchey LK, 2010, J AM CHEM SOC, V132, P941, DOI 10.1021/ja9082864; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Koivusalo R, 2006, CANCER RES, V66, P11817, DOI 10.1158/0008-5472.CAN-06-2185; Laz TH, 2012, VACCINE, V30, P3534, DOI 10.1016/j.vaccine.2012.03.067; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Licitra Lisa, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P95, DOI 10.1097/01.moo.0000193170.23956.5f; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Pan Q, 2009, EXPERT OPIN PHARMACO, V10, P2291, DOI 10.1517/14656560903136754; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Patgiri A, 2010, NAT PROTOC, V5, P1857, DOI 10.1038/nprot.2010.146; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reiter PL, 2011, VACCINE, V29, P5595, DOI 10.1016/j.vaccine.2011.06.020; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Sigurdsson K, 2009, ACTA OBSTET GYN SCAN, V88, P27, DOI 10.1080/00016340802566770; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; White JS, 2007, ORAL ONCOL, V43, P701, DOI 10.1016/j.oraloncology.2006.09.001; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zimmermann H, 1999, J VIROL, V73, P6209, DOI 10.1128/JVI.73.8.6209-6219.1999	49	48	52	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					1037	1046		10.1038/onc.2013.25	http://dx.doi.org/10.1038/onc.2013.25			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23474763	Green Accepted			2022-12-25	WOS:000331933200011
J	Matos, PM; Marin, M; Ahn, B; Lam, W; Santos, NC; Melikyan, GB				Matos, Pedro M.; Marin, Mariana; Ahn, Byungwook; Lam, Wilbur; Santos, Nuno C.; Melikyan, Gregory B.			Anionic Lipids Are Required for Vesicular Stomatitis Virus G Protein-mediated Single Particle Fusion with Supported Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL MEMBRANE-FUSION; PH-DEPENDENT FUSION; INFLUENZA HEMAGGLUTININ; CONFORMATIONAL-CHANGES; PLANAR MEMBRANES; PORE FORMATION; CELLS; GLYCOPROTEIN; ENDOCYTOSIS; ENTRY	Viral glycoproteins mediate fusion between viral and cellular membranes upon binding to cognate receptors and/or experiencing low pH. Although activation of viral glycoproteins is thought to be necessary and sufficient for fusion, accumulating evidence suggests that additional cellular factors, including lipids, can modulate the fusion process. Understanding the role of lipids in virus entry via endocytosis is impeded by poor accessibility and the highly diverse nature of endosomes. Here we imaged fusion of single retroviral particles pseudotyped with the vesicular stomatitis virus (VSV) G protein with dextran-supported lipid bilayers. Incorporation of diffusible fluorescent labels into the viral membrane and the viral interior enabled detection of the lipid mixing (hemifusion) and content transfer (full fusion) steps of VSV G-mediated fusion at low pH. Although single virus fusion with supported bilayers made of zwitterionic lipids could not be detected, inclusion of anionic lipids, phosphatidylserine, and bis(monoacylglycero) phosphate (BMP), greatly enhanced the efficiency of hemifusion and permitted full fusion. Importantly, lipid mixing always preceded the opening of a fusion pore, demonstrating that VSV G-mediated fusion proceeds through a long-lived hemifusion intermediate. Kinetic analysis of lipid and content transfer showed that the lags between lipid and content mixing defining the lifetime of a hemifusion intermediate were significantly shorter for BMP-containing compared with PS-containing bilayers. The strong fusion-enhancing effect of BMP, a late endosome-resident lipid, is consistent with the model that VSV initiates fusion in early endosomes but releases its core into the cytosol after reaching late endosomal compartments.	[Matos, Pedro M.; Marin, Mariana; Ahn, Byungwook; Lam, Wilbur; Melikyan, Gregory B.] Emory Univ, Sch Med, Dept Pediat, Emory Childrens Ctr, Atlanta, GA 30322 USA; [Matos, Pedro M.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; Universidade de Lisboa; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat Infect Dis, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Matos, Pedro/B-4718-2010; Santos, Nuno/N-7248-2013	Matos, Pedro/0000-0002-8386-6613; Santos, Nuno/0000-0002-0580-0475	National Institutes of Health [R01 AI053668]; Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia (FCT-MEC, Portugal) [PTDC/QUI-BIQ/104787/2008];  [SFRH/BD/42205/2007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia (FCT-MEC, Portugal); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI053668 (to G. B. M.). This work was also supported by Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia (FCT-MEC, Portugal) Project Grant PTDC/QUI-BIQ/104787/2008 (to N. C. S.) and by Fellowship SFRH/BD/42205/2007 (to P. M. M.).	Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; BLUMENTHAL R, 1987, J BIOL CHEM, V262, P13614; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Carneiro FA, 2002, J VIROL, V76, P3756, DOI 10.1128/JVI.76.8.3756-3764.2002; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Coil DA, 2004, J VIROL, V78, P10920, DOI 10.1128/JVI.78.20.10920-10926.2004; Costello DA, 2012, ANAL CHEM, V84, P8480, DOI 10.1021/ac3006473; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; EIDELMAN O, 1984, J BIOL CHEM, V259, P4622; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Fredericksen BL, 1996, VIROLOGY, V217, P49, DOI 10.1006/viro.1996.0092; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; Gaudin Y, 2000, Subcell Biochem, V34, P379; Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Karatekin E, 2012, NAT PROTOC, V7, P903, DOI 10.1038/nprot.2012.019; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Koch P, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-84; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; Luyet PP, 2008, TRAFFIC, V9, P2279, DOI 10.1111/j.1600-0854.2008.00820.x; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Markosyan RM, 2000, MOL BIOL CELL, V11, P1143, DOI 10.1091/mbc.11.4.1143; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; MELIKYAN GB, 1993, J GEN PHYSIOL, V102, P1131, DOI 10.1085/jgp.102.6.1131; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mire CE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000994; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Padilla-Parra S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002694; PURI A, 1992, BIOCHEMISTRY-US, V31, P10108, DOI 10.1021/bi00156a034; PURI A, 1988, J BIOL CHEM, V263, P4749; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roth SL, 2011, FEBS LETT, V585, P865, DOI 10.1016/j.febslet.2011.02.015; SCHLEGEL R, 1983, CELL, V32, P639, DOI 10.1016/0092-8674(83)90483-X; SCHLEGEL R, 1983, BIOCHEM BIOPH RES CO, V114, P774, DOI 10.1016/0006-291X(83)90848-3; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shokralla S, 1998, VIROLOGY, V242, P39, DOI 10.1006/viro.1997.8986; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Smith MB, 2011, BIOPHYS J, V101, P1794, DOI 10.1016/j.bpj.2011.09.007; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; SPRUCE AE, 1989, NATURE, V342, P555, DOI 10.1038/342555a0; SPRUCE AE, 1991, P NATL ACAD SCI USA, V88, P3623, DOI 10.1073/pnas.88.9.3623; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Wessels L, 2007, BIOPHYS J, V93, P526, DOI 10.1529/biophysj.106.097485; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	70	34	34	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12416	12425		10.1074/jbc.M113.462028	http://dx.doi.org/10.1074/jbc.M113.462028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493401	hybrid, Green Published			2022-12-25	WOS:000318555100001
J	Fils-Aime, N; Dai, MO; Guo, JM; El-Mousawi, M; Kahramangil, B; Neel, JC; Lebrun, JJ				Fils-Aime, Nadege; Dai, Meiou; Guo, Jimin; El-Mousawi, Mayada; Kahramangil, Bora; Neel, Jean-Charles; Lebrun, Jean-Jacques			MicroRNA-584 and the Protein Phosphatase and Actin Regulator 1 (PHACTR1), a New Signaling Route through Which Transforming Growth Factor-beta Mediates the Migration and Actin Dynamics of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MESENCHYMAL TRANSITION; TUMOR-SUPPRESSION; BINDING-PROTEIN; TARGET GENES; IN-VITRO; METASTASIS; PROLIFERATION; INHIBITION; FAMILY	TGF-beta plays an important role in breast cancer progression as a prometastatic factor, notably through enhancement of cell migration. It is becoming clear that microRNAs, a new class of small regulatory molecules, also play crucial roles in mediating tumor formation and progression. We found TGF-beta to downregulate the expression of the microRNA miR-584 in breast cancer cells. Furthermore, we identified PHACTR1, an actin-binding protein, to be positively regulated by TGF-beta in a miR584- dependent manner. Moreover, we found TGF-beta-mediated down-regulation of miR-584 and increased expression of PHACTR1 to be required for TGF-beta-induced cell migration of breast cancer cells. Indeed, both overexpression of miR-584 and knockdown of PHACTR1 resulted in a drastic reorganization of the actin cytoskeleton and reduced TGF-beta-induced cell migration. Our data highlight a novel signaling route whereby TGF-beta silences the expression of miR-584, resulting in enhanced PHACTR1 expression, and further leading to actin rearrangement and breast cancer cell migration.	[Fils-Aime, Nadege; Dai, Meiou; Guo, Jimin; El-Mousawi, Mayada; Kahramangil, Bora; Neel, Jean-Charles; Lebrun, Jean-Jacques] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Med Oncol,Dept Med, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Lebrun, JJ (corresponding author), McGill Univ, Fac Med, Div Expt Med, 687 Pine Ave W,Rm H7-66, Montreal, PQ H3A 1A1, Canada.	jj.lebrun@mcgill.ca	Lebrun, Jean-Jacques/GNP-5222-2022	Guo, Jimin/0000-0003-4008-2285	Canadian Institutes of Health Research (CIHR) [MOP-114904]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR) Grant MOP-114904 (to J.J.L.).	Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen WJ, 1999, MICROBES INFECT, V1, P1367, DOI 10.1016/S1286-4579(99)00249-X; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Drummond A, 2006, REPRODUCTION, V132, P177, DOI 10.1530/rep.1.01238; Eisenmann KM, 2009, ONCOGENE, V28, P3429, DOI 10.1038/onc.2009.207; Enright AJ, 2004, GENOME BIOL, V5; Favot L, 2005, FEBS LETT, V579, P100, DOI 10.1016/j.febslet.2004.11.054; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo JM, 2009, CELL SIGNAL, V21, P899, DOI 10.1016/j.cellsig.2009.01.037; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Humbert L, 2010, TRENDS CELL MOL BIOL, V5, P69; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ivanovic V, 2006, CLIN CHIM ACTA, V371, P191, DOI 10.1016/j.cca.2006.02.027; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; KONG FM, 1995, ANN SURG, V222, P155, DOI 10.1097/00000658-199508000-00007; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lebrun JJ, 2012, ISRN MOL BIOL, V2012, DOI [DOI 10.5402/2012/381428, 10.5402/2012/381428]; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lehmann S, 2007, LEUKEMIA, V21, P1931, DOI 10.1038/sj.leu.2404852; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutherborrow M, 2011, AM J HEMATOL, V86, P2, DOI 10.1002/ajh.21864; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Moore LD, 2008, CLIN CANCER RES, V14, P4961, DOI 10.1158/1078-0432.CCR-07-4604; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Neel J. C., 2012, MED SCI AM NUMERO GR, V1, P1; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rodriguez Luis G., 2004, V294, P23; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Sanborn JZ, 2011, NUCLEIC ACIDS RES, V39, pD951, DOI 10.1093/nar/gkq1113; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tobin SW, 2001, CELL GROWTH DIFFER, V12, P109; Ueno K, 2011, BRIT J CANCER, V104, P308, DOI 10.1038/sj.bjc.6606028; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zhang BX, 2009, CANCER LETT, V277, P114, DOI 10.1016/j.canlet.2008.11.035	81	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11807	11823		10.1074/jbc.M112.430934	http://dx.doi.org/10.1074/jbc.M112.430934			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479725	Green Published, hybrid			2022-12-25	WOS:000318157600017
J	Malmgren, S; Spegel, P; Danielsson, APH; Nagorny, CL; Andersson, LE; Nitert, MD; Ridderstrale, M; Mulder, H; Ling, C				Malmgren, Siri; Spegel, Peter; Danielsson, Anders P. H.; Nagorny, Cecilia L.; Andersson, Lotta E.; Nitert, Marloes Dekker; Ridderstrale, Martin; Mulder, Hindrik; Ling, Charlotte			Coordinate Changes in Histone Modifications, mRNA Levels, and Metabolite Profiles in Clonal INS-1 832/13 beta-Cells Accompany Functional Adaptations to Lipotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-SECRETION; RAT PANCREATIC-ISLETS; FREE FATTY-ACIDS; DNA METHYLATION; MITOCHONDRIAL DYSFUNCTION; CHROMATIN MODIFICATIONS; GLUCOSE-METABOLISM; MALONYL-COA; EXPRESSION; GENES	Lipotoxicity is a presumed pathogenetic process whereby elevated circulating and stored lipids in type 2 diabetes cause pancreatic beta-cell failure. To resolve the underlying molecular mechanisms, we exposed clonal INS-1 832/13 beta-cells to palmitate for 48 h. We observed elevated basal insulin secretion but impaired glucose-stimulated insulin secretion in palmitate-exposed cells. Glucose utilization was unchanged, palmitate oxidation was increased, and oxygen consumption was impaired. Halting exposure of the clonal INS-1 832/13 beta-cells to palmitate largely recovered all of the lipid-induced functional changes. Metabolite profiling revealed profound but reversible increases in cellular lipids. Glucose-induced increases in tricarboxylic acid cycle intermediates were attenuated by exposure to palmitate. Analysis of gene expression by microarray showed increased expression of 982 genes and decreased expression of 1032 genes after exposure to palmitate. Increases were seen in pathways for steroid biosynthesis, cell cycle, fatty acid metabolism, DNA replication, and biosynthesis of unsaturated fatty acids; decreases occurred in the aminoacyl-tRNA synthesis pathway. The activity of histone-modifying enzymes and histone modifications of differentially expressed genes were reversibly altered upon exposure to palmitate. Thus, Insig1, Lss, Peci, Idi1, Hmgcs1, and Casr were subject to epigenetic regulation. Our analyses demonstrate that coordinate changes in histone modifications, mRNA levels, and metabolite profiles accompanied functional adaptations of clonal beta-cells to lipotoxicity. It is highly likely that these changes are pathogenetic, accounting for loss of glucose responsiveness and perturbed insulin secretion.	[Malmgren, Siri; Spegel, Peter; Danielsson, Anders P. H.; Nagorny, Cecilia L.; Andersson, Lotta E.; Mulder, Hindrik] Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Mol Metab,CRC, S-20502 Malmo, Sweden; [Malmgren, Siri; Ling, Charlotte] Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Epigenet & Diabet,CRC, S-20502 Malmo, Sweden; [Danielsson, Anders P. H.; Ridderstrale, Martin] Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Clin Obes,CRC, S-20502 Malmo, Sweden; [Nitert, Marloes Dekker] Univ Queensland, Sch Med, Clin Res Ctr, Herston, Qld 4029, Australia	Lund University; Lund University; Lund University; University of Queensland	Malmgren, S (corresponding author), Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Mol Metab,CRC, S-20502 Malmo, Sweden.	siri.malmgren@med.lu.se	Mulder, Hindrik/E-1045-2012; Nitert, Marloes D/A-8822-2011; Spégel, Peter/G-9947-2018; Ling, Charlotte/Q-2432-2015	Nitert, Marloes D/0000-0002-1909-8920; Spégel, Peter/0000-0002-6092-2387; Ling, Charlotte/0000-0003-0587-7154; Malmgren, Siri/0000-0002-4540-1102; Mulder, Hindrik/0000-0002-6593-8417	Magnus Bergvalls Foundation; Crafoordska Foundation; Direktor Albert Pahlssons Foundation; Fredrik och Ingrid Thurings Foundation; Ake Wibergs Foundation; O.E. och Edla Johanssons Foundation; Knut och Alice Wallenbergs Foundation; Lars Hiertas Minne; Swedish Research Council; Region Skane Foundation; Novo Nordisk Foundation; Soderberg; Diabetes Fonden; Linne Grant [B31 5631/2006]; Exodiab; Novo Nordisk Fonden [NNF11OC1014660] Funding Source: researchfish	Magnus Bergvalls Foundation; Crafoordska Foundation; Direktor Albert Pahlssons Foundation; Fredrik och Ingrid Thurings Foundation; Ake Wibergs Foundation; O.E. och Edla Johanssons Foundation; Knut och Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation); Lars Hiertas Minne; Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Soderberg; Diabetes Fonden; Linne Grant; Exodiab; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Magnus Bergvalls, Crafoordska, Direktor Albert Pahlssons, Fredrik och Ingrid Thurings, Ake Wibergs, O.E. och Edla Johanssons, Knut och Alice Wallenbergs Foundations, Lars Hiertas Minne, the Swedish Research Council, Region Skane Foundation, Novo Nordisk Foundation, Soderberg, Diabetes Fonden, Linne Grant B31 5631/2006, and Exodiab.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen K, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-57; Danielsson APH, 2012, METABOLOMICS, V8, P50, DOI 10.1007/s11306-011-0283-6; Danielsson APH, 2010, ANAL BIOCHEM, V404, P30, DOI 10.1016/j.ab.2010.04.013; Deering TG, 2009, DIABETES, V58, P185, DOI 10.2337/db08-1150; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; El-Osta A, 2012, CURR OPIN LIPIDOL, V23, P24, DOI 10.1097/MOL.0b013e32834f319d; Eto K, 2002, DIABETES, V51, pS414, DOI 10.2337/diabetes.51.2007.S414; Falchetti A, 2012, EUR J ENDOCRINOL, V166, P933, DOI 10.1530/EJE-11-0953; Ferrannini E, 2003, DIABETOLOGIA, V46, P1211, DOI 10.1007/s00125-003-1169-6; Fex M, 2004, ENDOCRINOLOGY, V145, P3746, DOI 10.1210/en.2003-1673; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; GILON P, 1991, ENDOCRINOLOGY, V129, P2521, DOI 10.1210/endo-129-5-2521; GU XH, 1993, LIFE SCI, V52, P687, DOI 10.1016/0024-3205(93)90229-V; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishikawa M, 2008, J LIPID RES, V49, P2524, DOI 10.1194/jlr.M800238-JLR200; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Keating ST, 2012, J CARDIOVASC TRANSL, V5, P399, DOI 10.1007/s12265-012-9380-9; KELLY RP, 1991, J PHYSIOL-LONDON, V443, P175, DOI 10.1113/jphysiol.1991.sp018829; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; LeRoith D, 2005, DIABETES-METAB RES, V21, P85, DOI 10.1002/dmrr.530; Liang Y, 1997, DIABETOLOGIA, V40, P1018, DOI 10.1007/s001250050783; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Moran A, 1997, J CLIN INVEST, V99, P534, DOI 10.1172/JCI119190; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Ogihara T, 2009, ISLETS, V1, P269, DOI 10.4161/isl.1.3.9779; Olson LK, 1998, MOL ENDOCRINOL, V12, P207, DOI 10.1210/me.12.2.207; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Quintens R, 2008, BIOCHEM SOC T, V36, P300, DOI 10.1042/BST0360300; RANDLE PJ, 1963, LANCET, V1, P785; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; Shi YG, 2000, AM J PHYSIOL-ENDOC M, V279, pE684, DOI 10.1152/ajpendo.2000.279.3.E684; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; van Weeghel M, 2012, FASEB J, V26, P4316, DOI 10.1096/fj.12-206326; Vock C, 2008, CELL PHYSIOL BIOCHEM, V22, P515, DOI 10.1159/000185525; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Weishaupt H, 2010, BIOL PROCED ONLINE, V12, P1, DOI 10.1007/s12575-010-9031-y; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	79	51	53	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11973	11987		10.1074/jbc.M112.422527	http://dx.doi.org/10.1074/jbc.M112.422527			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23476019	hybrid, Green Published			2022-12-25	WOS:000318157600032
J	Kay, NE; Bainbridge, TW; Condit, RC; Bubb, MR; Judd, RE; Venkatakrishnan, B; McKenna, R; D'Costa, SM				Kay, Nicole E.; Bainbridge, Travis W.; Condit, Richard C.; Bubb, Michael R.; Judd, Reuben E.; Venkatakrishnan, Balasubramanian; McKenna, Robert; D'Costa, Susan M.			Biochemical and Biophysical Properties of a Putative Hub Protein Expressed by Vaccinia Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANTS; TRANSCRIPTION TERMINATION FACTOR; TRIPHOSPHATE PHOSPHOHYDROLASE I; RNA-POLYMERASE; MESSENGER-RNA; REPLICATION COMPLEX; INTRINSIC DISORDER; ELONGATION-FACTOR; DNA-REPLICATION; A20R PROTEIN	H5 is a constitutively expressed, phosphorylated vaccinia virus protein that has been implicated in viral DNA replication, post-replicative gene expression, and virus assembly. For the purpose of understanding the role of H5 in vaccinia biology, we have characterized its biochemical and biophysical properties. Previously, we have demonstrated that H5 is associated with an endoribonucleolytic activity. In this study, we have shown that this cleavage results in a 3'-OH end suitable for polyadenylation of the nascent transcript, corroborating a role for H5 in vaccinia transcription termination. Furthermore, we have shown that H5 is intrinsically disordered, with an elongated rod-shaped structure that preferentially binds double-stranded nucleic acids in a sequence nonspecific manner. The dynamic phosphorylation status of H5 influences this structure and has implications for the role of H5 in multiple processes during virus replication.	[Kay, Nicole E.; Bainbridge, Travis W.; Condit, Richard C.; D'Costa, Susan M.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Bubb, Michael R.; Judd, Reuben E.] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Venkatakrishnan, Balasubramanian; McKenna, Robert] Univ Florida, Dept Biochem, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	D'Costa, SM (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, J Hillis Miller Hlth Ctr, POB 100266, Gainesville, FL 32610 USA.	ihssd@ufl.edu			National Institutes of Health [RO1 18094]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RO1 18094 (to R. C. C.).	ANTCZAK JB, 1992, P NATL ACAD SCI USA, V89, P12033, DOI 10.1073/pnas.89.24.12033; BAYLISS CD, 1995, J BIOL CHEM, V270, P1550, DOI 10.1074/jbc.270.4.1550; BEAUD G, 1995, J VIROL, V69, P1819, DOI 10.1128/JVI.69.3.1819-1826.1995; Beaud G, 1997, J GEN VIROL, V78, P3297, DOI 10.1099/0022-1317-78-12-3297; Black EP, 1996, J VIROL, V70, P47, DOI 10.1128/JVI.70.1.47-54.1996; Black EP, 1998, VIROLOGY, V245, P313, DOI 10.1006/viro.1998.9166; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; BUBB MR, 1995, J BIOL CHEM, V270, P3463, DOI 10.1074/jbc.270.8.3463; BUBB MR, 1991, J BIOL CHEM, V266, P3820; Christen LM, 1998, VIROLOGY, V245, P360, DOI 10.1006/viro.1998.9177; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; CONDIT RC, 1981, VIROLOGY, V113, P224, DOI 10.1016/0042-6822(81)90150-1; Condit RC, 1996, VIROLOGY, V218, P169, DOI 10.1006/viro.1996.0177; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cresawn SG, 2007, VIROLOGY, V363, P333, DOI 10.1016/j.virol.2007.02.016; D'Costa SM, 2004, VIROLOGY, V319, P1, DOI 10.1016/j.virol.2003.09.041; D'Costa SM, 2008, J BIOL CHEM, V283, P5267, DOI 10.1074/jbc.M709258200; D'Costa SM, 2010, VIROLOGY, V401, P49, DOI 10.1016/j.virol.2010.01.020; De Silva FS, 2007, P NATL ACAD SCI USA, V104, P18724, DOI 10.1073/pnas.0709276104; Dellis S, 2004, VIROLOGY, V329, P328, DOI 10.1016/j.virol.2004.08.017; DeMasi J, 2000, J VIROL, V74, P2393, DOI 10.1128/JVI.74.5.2393-2405.2000; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Domi A, 2000, J GEN VIROL, V81, P1231, DOI 10.1099/0022-1317-81-5-1231; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Eckert D, 2005, J VIROL, V79, P15084, DOI 10.1128/JVI.79.24.15084-15090.2005; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; GORDON J, 1991, VIROLOGY, V181, P671, DOI 10.1016/0042-6822(91)90901-M; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Ishii K, 2002, VIROLOGY, V303, P232, DOI 10.1006/viro.2002.1721; Ishii K, 2001, J VIROL, V75, P1656, DOI 10.1128/JVI.75.4.1656-1663.2001; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kovacs GR, 1996, J VIROL, V70, P6796, DOI 10.1128/JVI.70.10.6796-6802.1996; Lackner CA, 2000, J BIOL CHEM, V275, P1485, DOI 10.1074/jbc.275.2.1485; Latner DR, 2000, VIROLOGY, V269, P345, DOI 10.1006/viro.2000.0243; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MAHR A, 1984, J VIROL, V49, P510, DOI 10.1128/JVI.49.2.510-520.1984; Mayer M, 2000, BIOCHEMISTRY-US, V39, P2096, DOI 10.1021/bi992253e; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Mohamed MR, 2000, J BIOL CHEM, V275, P25798, DOI 10.1074/jbc.M002250200; MOHANDAS AR, 1994, VIROLOGY, V200, P207, DOI 10.1006/viro.1994.1179; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Moss B, 2007, FIELDS VIROLOGY, P2906; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; NOWAKOWSKI M, 1978, VIROLOGY, V86, P217, DOI 10.1016/0042-6822(78)90022-3; PARSONS BL, 1990, VIROLOGY, V175, P69, DOI 10.1016/0042-6822(90)90187-V; PATEL DD, 1989, J VIROL, V63, P1076, DOI 10.1128/JVI.63.3.1076-1086.1989; PATEL DD, 1988, P NATL ACAD SCI USA, V85, P9431, DOI 10.1073/pnas.85.24.9431; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Silva MD, 2006, BIOINFORMATICS, V22, P2846, DOI 10.1093/bioinformatics/btl506; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI 10.1586/EPR.10.36; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; WINTERSBERGER U, 1990, PHARMACOL THERAPEUT, V48, P259, DOI 10.1016/0163-7258(90)90083-E; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2012, CELL MOL LIFE SCI, V69, P1211, DOI 10.1007/s00018-011-0859-3; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang ZL, 2012, J BIOL CHEM, V287, P31050, DOI 10.1074/jbc.M112.390054; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	69	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11470	11481		10.1074/jbc.M112.442012	http://dx.doi.org/10.1074/jbc.M112.442012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23476017	hybrid, Green Published			2022-12-25	WOS:000317915500048
J	Aronson, D; Kapeliovich, M; Hammerman, H; Dragu, R				Aronson, Doron; Kapeliovich, Michael; Hammerman, Haim; Dragu, Robert			The Relation between Serum Phosphorus Levels and Clinical Outcomes after Acute Myocardial Infarction	PLOS ONE			English	Article							DEPENDENT PHOSPHATE COTRANSPORTER; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; MATRIX GLA PROTEIN; GROWTH-FACTOR 23; CARDIOVASCULAR-DISEASE; VASCULAR CALCIFICATION; PARATHYROID-HORMONE; HEART-FAILURE; HEMODIALYSIS-PATIENTS	Background: Elevated serum phosphorus levels have been linked with cardiovascular disease and mortality with conflicting results, especially in the presence of normal renal function. Methods: We studied the association between serum phosphorus levels and clinical outcomes in 1663 patients with acute myocardial infarction (AMI). Patients were categorized into 4 groups based on serum phosphorus levels (<2.50, 2.51-3.5, 3.51-4.50 and >4.50 mg/dL). Cox proportional-hazards models were used to examine the association between serum phosphorus and clinical outcomes after adjustment for potential confounders. Results: The mean follow up was 45 months. The lowest mortality occurred in patients with serum phosphorus between 2.5-3.5 mg/dL, with a multivariable-adjusted hazard ratio of 1.24 (95% CI 0.85-1.80), 1.35 (95% CI 1.05-1.74), and 1.75 (95% CI 1.27-2.40) in patients with serum phosphorus of <2.50, 3.51-4.50 and >4.50 mg/dL, respectively. Higher phosphorus levels were also associated with increased risk of heart failure, but not the risk of myocardial infarction or stroke. The effect of elevated phosphorus was more pronounced in patients with chronic kidney disease (CKD). The hazard ratio for mortality in patients with serum phosphorus >4.5 mg/dL compared to patients with serum phosphorus 2.50-3.50 mg/dL was 2.34 (95% CI 1.55-3.54) with CKD and 1.53 (95% CI 0.87-2.69) without CKD. Conclusion: We found a graded, independent association between serum phosphorus and all-cause mortality and heart failure in patients after AMI. The risk for mortality appears to increase with serum phosphorus levels within the normal range and is more prominent in the presence of CKD.	[Aronson, Doron; Kapeliovich, Michael; Hammerman, Haim; Dragu, Robert] Rambam Med Ctr, Dept Cardiol, Haifa, Israel; [Aronson, Doron; Hammerman, Haim] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Aronson, Doron; Hammerman, Haim] Technion Israel Inst Technol, Res Inst, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Aronson, D (corresponding author), Rambam Med Ctr, Dept Cardiol, Haifa, Israel.	daronson@tx.technion.ac.il	Aronson, Doron/F-3390-2010					Aronson D, 2011, AM J CARDIOL, V107, P1738, DOI 10.1016/j.amjcard.2011.02.334; Aronson D, 2010, CIRC-HEART FAIL, V3, P125, DOI 10.1161/CIRCHEARTFAILURE.109.877340; Ayus JC, 2005, J AM SOC NEPHROL, V16, P2778, DOI 10.1681/ASN.2005040392; Bishara R, 2011, THROMB HAEMOSTASIS, V106, P877, DOI 10.1160/TH11-05-0343; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Bushinsky DA, 1998, LANCET, V352, P306, DOI 10.1016/S0140-6736(97)12331-5; de Boer IH, 2009, AM J KIDNEY DIS, V53, P399, DOI 10.1053/j.ajkd.2008.07.036; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Dhingra R, 2010, EUR J HEART FAIL, V12, P812, DOI 10.1093/eurjhf/hfq106; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hruska KA, 2008, KIDNEY INT, V74, P148, DOI 10.1038/ki.2008.130; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Kendrick J, 2011, AM J KIDNEY DIS, V58, P826, DOI 10.1053/j.ajkd.2011.07.020; Kestenbaum B, 2007, SEMIN DIALYSIS, V20, P286, DOI 10.1111/j.1525-139X.2007.00303.x; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Lau WL, 2010, THROMB HAEMOSTASIS, V104, P464, DOI 10.1160/TH09-12-0814; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; OCONNOR LR, 1977, NEW ENGL J MED, V297, P901, DOI 10.1056/NEJM197710272971702; OGNIBENE A, 1994, SOUTHERN MED J, V87, P65, DOI 10.1097/00007611-199401000-00014; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Ritz E, 2008, CLIN J AM SOC NEPHRO, V3, P920, DOI 10.2215/CJN.04571007; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schurgers LJ, 2010, CLIN J AM SOC NEPHRO, V5, P568, DOI 10.2215/CJN.07081009; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Slinin Y, 2011, INT J CARDIOL, V149, P335, DOI 10.1016/j.ijcard.2010.02.013; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Suleiman M, 2006, J AM COLL CARDIOL, V47, P962, DOI 10.1016/j.jacc.2005.10.055; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Taddei S, 2011, HEART FAIL REV, V16, P615, DOI 10.1007/s10741-010-9197-z; Taylor EN, 2011, AM HEART J, V161, P956, DOI 10.1016/j.ahj.2011.02.012; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198	47	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58348	10.1371/journal.pone.0058348	http://dx.doi.org/10.1371/journal.pone.0058348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505492	Green Submitted, gold, Green Published			2022-12-25	WOS:000316251100047
J	Kalantari-Dehaghi, M; Anhalt, GJ; Camilleri, MJ; Chernyavsky, AI; Chun, S; Felgner, PL; Jasinskas, A; Leiferman, KM; Liang, L; Marchenko, S; Nakajima-Sasaki, R; Pittelkow, MR; Zone, JJ; Grando, SA				Kalantari-Dehaghi, Mina; Anhalt, Grant J.; Camilleri, Michael J.; Chernyavsky, Alex I.; Chun, Sookhee; Felgner, Philip L.; Jasinskas, Algis; Leiferman, Kristin M.; Liang, Li; Marchenko, Steve; Nakajima-Sasaki, Rie; Pittelkow, Mark R.; Zone, John J.; Grando, Sergei A.			Pemphigus Vulgaris Autoantibody Profiling by Proteomic Technique	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; INDIRECT IMMUNOFLUORESCENCE; PATHOGENIC AUTOANTIBODIES; DESMOGLEIN 3; CONFORMATIONAL EPITOPES; ANNEXIN A8; ANTIBODIES; ANTIGEN; AUTOIMMUNITY; CALCIUM	Pemphigus vulgaris (PV) is a mucocutaneous blistering disease characterized by IgG autoantibodies against the stratified squamous epithelium. Current understanding of PV pathophysiology does not explain the mechanism of acantholysis in patients lacking desmoglein antibodies, which justifies a search for novel targets of pemphigus autoimmunity. We tested 264 pemphigus and 138 normal control sera on the multiplexed protein array platform containing 701 human genes encompassing many known keratinocyte cell-surface molecules and members of protein families targeted by organ-nonspecific PV antibodies. The top 10 antigens recognized by the majority of test patients' sera were proteins encoded by the DSC1, DSC3, ATP2C1, PKP3, CHRM3, COL21A1, ANXA8L1, CD88 and CHRNE genes. The most common combinations of target antigens included at least one of the adhesion molecules DSC1, DSC3 or PKP3 and/or the acetylcholine receptor CHRM3 or CHRNE with or without the MHC class II antigen DRA. To identify the PV antibodies most specific to the disease process, we sorted the data based on the ratio of patient to control frequencies of antigen recognition. The frequency of antigen recognition by patients that exceeded that of control by 10 and more times were the molecules encoded by the CD33, GP1BA, CHRND, SLC36A4, CD1B, CD32, CDH8, CDH9, PMP22 and HLA-E genes as well as mitochondrial proteins encoded by the NDUFS1, CYB5B, SOD2, PDHA1 and FH genes. The highest specificity to PV showed combinations of autoantibodies to the calcium pump encoded by ATP2C1 with C5a receptor plus DSC1 or DSC3 or HLA-DRA. The results identified new targets of pemphigus autoimmunity. Novel autoantibody signatures may help explain individual variations in disease severity and treatment response, and serve as sensitive and specific biomarkers for new diagnostic assays in PV patients.	[Kalantari-Dehaghi, Mina; Chernyavsky, Alex I.; Marchenko, Steve; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA; [Anhalt, Grant J.] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD 21218 USA; [Camilleri, Michael J.; Pittelkow, Mark R.] Mayo Clin, Dept Dermatol, Rochester, MN USA; [Chun, Sookhee; Felgner, Philip L.; Jasinskas, Algis; Liang, Li; Nakajima-Sasaki, Rie] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Leiferman, Kristin M.; Zone, John J.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Grando, Sergei A.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Irvine, CA USA	University of California System; University of California Irvine; Johns Hopkins University; Mayo Clinic; University of California System; University of California Irvine; Utah System of Higher Education; University of Utah; University of California System; University of California Irvine; University of California System; University of California Irvine	Kalantari-Dehaghi, M (corresponding author), Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA.	mkalanta@uci.edu; sgrando@uci.edu	Liang, Li/AGH-5380-2022; liang, li/I-3972-2013	Liang, Li/0000-0001-6185-2651				Abasq C, 2009, ARCH DERMATOL, V145, P529, DOI 10.1001/archdermatol.2009.9; AHMED AR, 1982, J AM ACAD DERMATOL, V7, P221; Akman Ayse, 2010, Skinmed, V8, P12; AMAGAI M, 1995, J INVEST DERMATOL, V105, P243, DOI 10.1111/1523-1747.ep12317587; AMAGAI M, 1995, J INVEST DERMATOL, V104, P895, DOI 10.1111/1523-1747.ep12606168; Amagai M, 2006, EXP DERMATOL, V15, P815, DOI 10.1111/j.1600-0625.2006.00499.x; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; AMAGAI M, 1994, J CLIN INVEST, V94, P59, DOI 10.1172/JCI117349; Amagai M, 1998, J CLIN INVEST, V102, P775, DOI 10.1172/JCI3647; Amagai M, 1996, J INVEST DERMATOL, V107, P539, DOI 10.1111/1523-1747.ep12582796; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; ANDERSON HJ, 1970, ARCH DERMATOL, V101, P538, DOI 10.1001/archderm.101.5.538; Arin MJ, 2005, BRIT J DERMATOL, V153, P620, DOI 10.1111/j.1365-2133.2005.06651.x; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Bastian Boris C., 1994, Journal of Dermatological Science, V8, P194, DOI 10.1016/0923-1811(94)90054-X; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Belloni-Fortina A, 2009, CLIN DEV IMMUNOL, P1, DOI 10.1155/2009/187864; BEUTNER EH, 1965, J AMER MED ASSOC, V192, P682, DOI 10.1001/jama.1965.03080210026006; Botelho-Nogueira L, 2011, REV BRAS PSIQUIATR, V33, P412, DOI 10.1590/S1516-44462011000400017; Brandsen R, 1997, J AM ACAD DERMATOL, V36, P44, DOI 10.1016/S0190-9622(97)70324-4; Carson PJ, 1996, J AM ACAD DERMATOL, V34, P645, DOI 10.1016/S0190-9622(96)80066-1; Chams-Davatchi C, 2005, INT J DERMATOL, V44, P470, DOI 10.1111/j.1365-4632.2004.02501.x; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Chernyavsky AI, 2008, J BIOL CHEM, V283, P3401, DOI 10.1074/jbc.M704956200; Cozzani E, 2010, ARCH DERMATOLOGICAL; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Davies L, 2009, J CELL MOL MED, V13, P1995, DOI 10.1111/j.1582-4934.2008.00590.x; Desai BV, 2009, J CELL SCI, V122, P4401, DOI 10.1242/jcs.037457; Di Zenzo G, 2012, J CLIN INVEST, DOI 10.1172/JCI64413; DMOCHOWSKI M, 1995, BRIT J DERMATOL, V133, P519, DOI 10.1111/j.1365-2133.1995.tb02698.x; DMOCHOWSKI M, 1993, J INVEST DERMATOL, V100, P380, DOI 10.1111/1523-1747.ep12471934; Evangelista F, 2008, J INVEST DERMATOL, V128, P1710, DOI 10.1038/sj.jid.5701260; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Flores G, 2012, J INVEST DERMATOL; Gallo R, 2002, CONTACT DERMATITIS, V46, P364, DOI 10.1034/j.1600-0536.2002.460614.x; GEOGHEGAN W, 1992, J INVEST DERMATOL, V98, P589; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Gil MP, 2012, EXP DERMATOL, V21, P254, DOI 10.1111/j.1600-0625.2012.01441.x; Goebeler V, 2008, MOL BIOL CELL, V19, P5267, DOI 10.1091/mbc.E08-04-0383; Grando SA, 2000, DERMATOLOGY, V201, P290, DOI 10.1159/000051540; Grando Sergei A, 2006, Autoimmunity, V39, P521, DOI 10.1080/08916930600971414; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Hilario-Vargas J, 2006, J INVEST DERMATOL, V126, P2044, DOI 10.1038/sj.jid.5700388; Horvath B, 2012, BRIT J DERMATOL, V166, P405, DOI 10.1111/j.1365-2133.2011.10663.x; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Hueber W, 2002, ARTHRITIS RES, V4, P290, DOI 10.1186/ar426; Hueber W, 2006, PROTEOMICS, V6, P4100, DOI 10.1002/pmic.200600017; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jiao D, 1997, J AM ACAD DERMATOL, V37, P211, DOI 10.1016/S0190-9622(97)80127-2; JORDON RE, 1985, J INVEST DERMATOL, V85, pS72, DOI 10.1111/1523-1747.ep12275497; JUDD KP, 1979, J INVEST DERMATOL, V72, P314, DOI 10.1111/1523-1747.ep12531752; Kalantari-Dehaghi M, 2011, EXP DERMATOL, V20, P154, DOI 10.1111/j.1600-0625.2010.01193.x; Kamiya K, 2012, BRIT J DERMATOL, V167, P252, DOI 10.1111/j.1365-2133.2012.10929.x; KAWANA S, 1989, J INVEST DERMATOL, V92, P588, DOI 10.1111/1523-1747.ep12709624; Khandpur S, 2010, INDIAN J DERMATOL VE, V76, P27, DOI 10.4103/0378-6323.58675; Kitajima Y, 2002, CLIN EXP DERMATOL, V27, P684, DOI 10.1046/j.1365-2230.2002.01116.x; Kricheli D, 2000, BRIT J DERMATOL, V143, P337, DOI 10.1046/j.1365-2133.2000.03659.x; Kwon EJ, 2008, J EUR ACAD DERMATOL, V22, P1070, DOI 10.1111/j.1468-3083.2008.02715.x; Lambert JL, 2006, J INVEST DERMATOL, V126, P11; Lessey E, 2008, IMMUNOL RES, V41, P223, DOI 10.1007/s12026-008-8028-y; Liang L, 2011, J PROTEOME RES, V10, P4813, DOI 10.1021/pr200619r; Lim PL, 2006, IMMUNOL LETT, V103, P17, DOI 10.1016/j.imlet.2005.10.023; Luevano M, 2010, VIROLOGY; Mao XM, 2010, AM J PATHOL, V177, P2724, DOI 10.2353/ajpath.2010.100483; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Naziroglu Mustafa, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P31; Nguyen VT, 2000, J BIOL CHEM, V275, P29466, DOI 10.1074/jbc.M003174200; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; PISANTI S, 1974, ORAL SURG ORAL MED O, V38, P382, DOI 10.1016/0030-4220(74)90365-X; Plebani M, 2009, AUTOIMMUN REV, V8, P238, DOI 10.1016/j.autrev.2008.07.032; RAINTEAU D, 1995, FEBS LETT, V360, P80, DOI 10.1016/0014-5793(95)00087-P; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; ROSENBERG FR, 1976, ARCH DERMATOL, V112, P962, DOI 10.1001/archderm.112.7.962; Runkel F, 2006, J MOL HISTOL, V37, P353, DOI 10.1007/s10735-006-9063-4; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Sharma VK, 2006, INT J DERMATOL, V45, P518, DOI 10.1111/j.1365-4632.2006.02593.x; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Sinha AA, 2012, AUTOIMMUNITY, V45, P36, DOI 10.3109/08916934.2011.606445; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; Thwaites DT, 2011, BRIT J PHARMACOL, V164, P1802, DOI 10.1111/j.1476-5381.2011.01438.x; TIGALONOWA M, 1990, ACTA DERM-VENEREOL, V70, P385; Tirado-Sanchez Andres, 2012, Dermatol Online J, V18, P14; Torzecka Jolanta D, 2003, Med Sci Monit, V9, pCR528; Torzecka JD, 2007, ARCH DERMATOL RES, V299, P239, DOI 10.1007/s00403-007-0760-y; Tozzoli R, 2008, CLIN CHEM LAB MED, V46, P577, DOI 10.1515/CCLM.2008.138; VERMEER BJ, 1985, BRIT J DERMATOL, V113, P118, DOI 10.1111/j.1365-2133.1985.tb15639.x; Vigil A, 2010, FUTURE MICROBIOL, V5, P241, DOI 10.2217/FMB.09.127; Ware J, 1997, BLOOD CELL MOL DIS, V23, P292, DOI 10.1006/bcmd.1997.0146; Yamagami J, 2008, J DERMATOL SCI, V52, P98, DOI 10.1016/j.jdermsci.2008.05.002; Yazdanpanah MJ, 2011, INT J DERMATOL, V50, P1343, DOI 10.1111/j.1365-4632.2011.04968.x; Yesilova Y, 2012, J EUR ACAD DERMATOL; Yoshimura T, 2001, CLIN EXP DERMATOL, V26, P441, DOI 10.1046/j.1365-2230.2001.00854.x; Zagorodniuk I, 2005, INT J DERMATOL, V44, P541, DOI 10.1111/j.1365-4632.2004.02541.x; ZIMMERMAN UJP, 1995, BIOCHEM MOL BIOL INT, V35, P307	99	72	73	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57587	10.1371/journal.pone.0057587	http://dx.doi.org/10.1371/journal.pone.0057587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505434	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500026
J	Kendjo, E; Agbenyega, T; Bojang, K; Newton, CRJC; Bouyou-Akotet, M; Pedross, F; Kombila, M; Helbok, R; Kremsner, PG				Kendjo, Eric; Agbenyega, Tsiri; Bojang, Kalifa; Newton, Charles R. J. C.; Bouyou-Akotet, Marielle; Pedross, Florian; Kombila, Maryvonne; Helbok, Raimund; Kremsner, Peter Gottfried			Mortality Patterns and Site Heterogeneity of Severe Malaria in African Children	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TRANSMISSION INTENSITY; MALAWIAN CHILDREN; PROGNOSTIC INDICATORS; FALCIPARUM-MALARIA; CLINICAL-FEATURES; AGE-PATTERNS; SEASONALITY; MANAGEMENT; INFECTION	Background: In this study we aimed to assess site heterogeneity of early, intermediate, and late mortality prediction in children with severe Plasmodium falciparum malaria in sub-Saharan Africa. Methods: Medical records of 26,036 children admitted with severe Plasmodium falciparum malaria in six hospital research centers between December 2000 to May 2005 were analyzed. Demographic, clinical and laboratory data of children who died within 24 hours (early), between 24 and 47 hours (intermediate) and thereafter (48 hours or later, late mortality) were compared between groups and survivors. Results: Overall mortality was 4.3% (N = 1,129). Median time to death varied across sites (P<0.001), ranging from 8h (3h-2h) in Lambarene to 40h (10h-100h) in Kilifi. Fifty-eight percent of deaths occurred within 24 hours and intermediate and late mortality rate were 19% and 23%, respectively. Combining all sites, deep breathing, prostration and hypoglycemia were independent predictors for early, intermediate and late mortality (P<0.01). Site specific independent predictors for early death included prostration, coma and deep breathing at all sites (P<0.001). Site specific independent predictors for intermediate and late death largely varied between sites (P<0.001) and included between 1 and 7 different clinical and laboratory variables. Conclusion: Site heterogeneity for mortality prediction is evident in African children with severe malaria. Prediction for early mortality has the highest consistency between sites.	[Kendjo, Eric; Helbok, Raimund; Kremsner, Peter Gottfried] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Kendjo, Eric; Kremsner, Peter Gottfried] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Kendjo, Eric; Bouyou-Akotet, Marielle; Kombila, Maryvonne] Univ Hlth Sci, Fac Med, Dept Parasitol Mycol & Trop Med, Libreville, Gabon; [Kendjo, Eric] Univ Paris 06, CNR Paludisme, Paris, France; [Agbenyega, Tsiri] Univ Sci & Technol Kumasi, Sch Med Sci, Kumasi, Ghana; [Bojang, Kalifa] MRC Labs, Banjul, Gambia; [Newton, Charles R. J. C.] KEMRI Ctr Geog Med Res Coast, Kilifi, Kenya; [Newton, Charles R. J. C.] UCL, Inst Child Hlth, London, England; [Pedross, Florian] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Helbok, Raimund] Med Univ Innsbruck, Dept Clin Neurol, A-6020 Innsbruck, Austria	Eberhard Karls University of Tubingen; UDICE-French Research Universities; Sorbonne Universite; Kwame Nkrumah University Science & Technology; MRC Laboratory Molecular Biology; University of London; University College London; Medical University of Innsbruck; Medical University of Innsbruck	Helbok, R (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.	raimund.helbok@uki.at	Newton, Charles/V-7872-2019; Newton, Charles RJC/B-7578-2014; Helbok, Raimund/AAA-8361-2021; KENDJO, Eric/AAI-7830-2021	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; KENDJO, Eric/0000-0002-2632-0964; Bojang, Kalifa/0000-0001-7506-0938	US National Institutes of Health, Institute of Allergy and Infectious Diseases [AI45955]; MRC [MC_UP_A900_1118] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI045955, U01AI045955] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A900_1118] Funding Source: researchfish	US National Institutes of Health, Institute of Allergy and Infectious Diseases; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by a grant from the US National Institutes of Health, Institute of Allergy and Infectious Diseases, AI45955. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbenyega T, 2000, J CLIN ENDOCR METAB, V85, P1569, DOI 10.1210/jc.85.4.1569; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; Branca F, 2002, ANN NUTR METAB, V46, P8, DOI 10.1159/000066397; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; ENGLISH M, 1995, ARCH DIS CHILD, V72, P334, DOI 10.1136/adc.72.4.334; Fernando D, 2003, T ROY SOC TROP MED H, V97, P161, DOI 10.1016/S0035-9203(03)90107-6; Helbok R, 2009, J INFECT DIS, V200, P1834, DOI 10.1086/648409; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93; Kremsner PG, 2009, J INFECT DIS, V199, P142, DOI 10.1086/595295; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; MOLYNEUX ME, 1989, Q J MED, V71, P441; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Roca-Feltrer A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-282; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; WHO, 2011, WORLD MALARIA REPORT 2011, P1	28	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58686	10.1371/journal.pone.0058686	http://dx.doi.org/10.1371/journal.pone.0058686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505549	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500113
J	Rice, WL; Van Hoek, AN; Paunescu, TG; Huynh, C; Goetze, B; Singh, B; Scipioni, L; Stern, LA; Brown, D				Rice, William L.; Van Hoek, Alfred N.; Paunescu, Teodor G.; Huynh, Chuong; Goetze, Bernhard; Singh, Bipin; Scipioni, Larry; Stern, Lewis A.; Brown, Dennis			High Resolution Helium Ion Scanning Microscopy of the Rat Kidney	PLOS ONE			English	Article							ACUTE RESPIRATORY-ACIDOSIS; ELECTRON-MICROSCOPY; INTERCALATED CELLS; COATED PITS; ULTRASTRUCTURE; IDENTIFICATION; LOCALIZATION; MICROVILLI; NEURONS; SURFACE	Helium ion scanning microscopy is a novel imaging technology with the potential to provide sub-nanometer resolution images of uncoated biological tissues. So far, however, it has been used mainly in materials science applications. Here, we took advantage of helium ion microscopy to explore the epithelium of the rat kidney with unsurpassed image quality and detail. In addition, we evaluated different tissue preparation methods for their ability to preserve tissue architecture. We found that high contrast, high resolution imaging of the renal tubule surface is possible with a relatively simple processing procedure that consists of transcardial perfusion with aldehyde fixatives, vibratome tissue sectioning, tissue dehydration with graded methanol solutions and careful critical point drying. Coupled with the helium ion system, fine details such as membrane texture and membranous nanoprojections on the glomerular podocytes were visualized, and pores within the filtration slit diaphragm could be seen in much greater detail than in previous scanning EM studies. In the collecting duct, the extensive and striking apical microplicae of the intercalated cells were imaged without the shrunken or distorted appearance that is typical with conventional sample processing and scanning electron microscopy. Membrane depressions visible on principal cells suggest possible endo- or exocytotic events, and central cilia on these cells were imaged with remarkable preservation and clarity. We also demonstrate the use of colloidal gold probes for highlighting specific cell-surface proteins and find that 15 nm gold labels are practical and easily distinguishable, indicating that external labels of various sizes can be used to detect multiple targets in the same tissue. We conclude that this technology represents a technical breakthrough in imaging the topographical ultrastructure of animal tissues. Its use in future studies should allow the study of fine cellular details and provide significant advances in our understanding of cell surface structures and membrane organization.	[Rice, William L.; Van Hoek, Alfred N.; Paunescu, Teodor G.; Brown, Dennis] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA; [Rice, William L.; Van Hoek, Alfred N.; Paunescu, Teodor G.; Brown, Dennis] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Rice, William L.; Van Hoek, Alfred N.; Paunescu, Teodor G.; Brown, Dennis] Harvard Univ, Sch Med, Boston, MA USA; [Huynh, Chuong; Goetze, Bernhard; Singh, Bipin; Scipioni, Larry; Stern, Lewis A.] Carl Zeiss Microscopy, Peabody, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Carl Zeiss AG	Brown, D (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA.	brown.dennis@mgh.harvard.edu	Paunescu, Teodor/AAX-7533-2020	Van Hoek, Alfred/0000-0003-2724-6855; Paunescu, Teodor/0000-0003-0227-9028	NIH [DK42956]; Zeiss Corporation; Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R37DK042956, R01DK042956, R01DK096586, P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zeiss Corporation; Massachusetts General Hospital(General Electric); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was in part from an NIH grant to D. Brown to examine the role of renal intercalated cell cells in kidney function (DK42956). Additional funding was provided by a sponsored research agreement to Dr. Brown from the Zeiss Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The work was performed partially with a sponsored research agreement between the Massachusetts General Hospital and the Zeiss Corporation. Four of the authors are employed by the Zeiss Corporation in the Helium Ion Microscopy Facility in Peabody, MA. The corresponding author D. Brown is the PI of the sponsored research agreement from the Zeiss Corporation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ANDREWS P M, 1980, Scanning Electron Microscopy, P179; ANDREWS PM, 1974, AM J ANAT, V140, P81, DOI 10.1002/aja.1001400107; BACHINSKY DR, 1993, AM J PATHOL, V143, P598; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; Bazou D, 2011, J MICROSC-OXFORD, V242, P290, DOI 10.1111/j.1365-2818.2010.03467.x; Bazou D, 2011, BRIT J PHARMACOL, V162, P1577, DOI 10.1111/j.1476-5381.2010.01182.x; BEARER EL, 1985, J CELL BIOL, V100, P418, DOI 10.1083/jcb.100.2.418; Bell DC, 2009, MICROSC MICROANAL, V15, P147, DOI 10.1017/S1431927609090138; BHAN AK, 1985, LAB INVEST, V53, P421; BRETTON R, 1976, J HISTOCHEM CYTOCHEM, V24, P1093, DOI 10.1177/24.10.977938; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Chen X, 2011, BIOPHYS J, V101, P1788, DOI 10.1016/j.bpj.2011.08.028; CONNOLLY JL, 1981, J CELL BIOL, V90, P176, DOI 10.1083/jcb.90.1.176; DEHARVEN E, 1984, J CELL BIOL, V99, P53, DOI 10.1083/jcb.99.1.53; ESKELINEN S, 1988, SCANNING MICROSCOPY, V2, P1765; EVERHART TE, 1960, J SCI INSTRUM, V37, P246, DOI 10.1088/0950-7671/37/7/307; FAN JY, 1982, P NATL ACAD SCI-BIOL, V79, P7788, DOI 10.1073/pnas.79.24.7788; Gagliardini E, 2010, J AM SOC NEPHROL, V21, P2081, DOI 10.1681/ASN.2010020199; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; GROSS DK, 1990, J HISTOCHEM CYTOCHEM, V38, P775, DOI 10.1177/38.6.2139886; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; KERJASCHKI D, 1984, J CELL BIOL, V98, P1505, DOI 10.1083/jcb.98.4.1505; Kiernan J.A., 2018, MICROSC TODAY, V8, P8, DOI [10.1017/S1551929500057060, DOI 10.1017/S1551929500057060]; MADSEN KM, 1983, AM J PHYSIOL, V245, pF670, DOI 10.1152/ajprenal.1983.245.6.F670; MADSEN KM, 1986, AM J PHYSIOL, V250, pF1, DOI 10.1152/ajprenal.1986.250.1.F1; ORCI L, 1981, INT REV CYTOL, V73, P183, DOI 10.1016/S0074-7696(08)61289-9; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; RODMAN JS, 1986, J CELL BIOL, V102, P77, DOI 10.1083/jcb.102.1.77; Schatten H, 2011, MICRON, V42, P175, DOI 10.1016/j.micron.2010.08.008; STUMP RF, 1988, J HISTOCHEM CYTOCHEM, V36, P493, DOI 10.1177/36.5.2965720; Vanden Berg-Foels W, 2011, MICROSC MICROANAL, V17, P282; VERLANDER JW, 1987, AM J PHYSIOL, V253, pF1142, DOI 10.1152/ajprenal.1987.253.6.F1142; Ward B, 2007, PHOTONIC SPECTRA, V41, P68; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011; Yabuki A, 2012, RES VET SCI, V93, P560, DOI 10.1016/j.rvsc.2011.12.001	37	56	56	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57051	10.1371/journal.pone.0057051	http://dx.doi.org/10.1371/journal.pone.0057051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505418	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500010
J	Druzhkova, AS; Thalmann, O; Trifonov, VA; Leonard, JA; Vorobieva, NV; Ovodov, ND; Graphodatsky, AS; Wayne, RK				Druzhkova, Anna S.; Thalmann, Olaf; Trifonov, Vladimir A.; Leonard, Jennifer A.; Vorobieva, Nadezhda V.; Ovodov, Nikolai D.; Graphodatsky, Alexander S.; Wayne, Robert K.			Ancient DNA Analysis Affirms the Canid from Altai as a Primitive Dog	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; WOLF; DOMESTICATION; PATTERNS; ORIGIN	The origin of domestic dogs remains controversial, with genetic data indicating a separation between modern dogs and wolves in the Late Pleistocene. However, only a few dog-like fossils are found prior to the Last Glacial Maximum, and it is widely accepted that the dog domestication predates the beginning of agriculture about 10,000 years ago. In order to evaluate the genetic relationship of one of the oldest dogs, we have isolated ancient DNA from the recently described putative 33,000-year old Pleistocene dog from Altai and analysed 413 nucleotides of the mitochondrial control region. Our analyses reveal that the unique haplotype of the Altai dog is more closely related to modern dogs and prehistoric New World canids than it is to contemporary wolves. Further genetic analyses of ancient canids may reveal a more exact date and centre of domestication.	[Druzhkova, Anna S.; Trifonov, Vladimir A.; Vorobieva, Nadezhda V.; Graphodatsky, Alexander S.] Russian Acad Sci, Dept Genom Div & Evolut, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia; [Thalmann, Olaf] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland; [Leonard, Jennifer A.] CSIC, Conservat & Evolutionary Genet Grp, Estn Biol Donana, Seville, Spain; [Ovodov, Nikolai D.] Russian Acad Sci, Inst Archaeol & Ethnog, Siberian Branch, Novosibirsk, Russia; [Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Russian Academy of Sciences; University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; University of California System; University of California Los Angeles	Trifonov, VA (corresponding author), Russian Acad Sci, Dept Genom Div & Evolut, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia.	vlad@mcb.nsc.ru	Druzhkova, Anna/N-2011-2015; Trifonov, Vladimir/E-4907-2012; Graphodatsky, Alexander/B-4922-2010; Vorobieva, Nadezhda/N-6461-2015; Leonard, Jennifer/A-7894-2010	Trifonov, Vladimir/0000-0003-0454-8359; Graphodatsky, Alexander/0000-0002-8282-1085; Leonard, Jennifer/0000-0003-0291-7819; Thalmann, Olaf/0000-0003-1700-0130	Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research; Emil Aaltonen grant; Division Of Environmental Biology [1021397] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0910272] Funding Source: National Science Foundation	Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Emil Aaltonen grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences and Russian Foundation for Basic Research grants to ASD, VAT, NVV, NO, ASG; Emil Aaltonen grant to OT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Crockford SJ, 2012, J ARCHAEOL SCI, V39, P2797, DOI 10.1016/j.jas.2012.04.033; Germonpre M, 2013, J ARCHAEOL SCI, V40, P786, DOI 10.1016/j.jas.2012.06.016; Germonpre M, 2012, J ARCHAEOL SCI, V39, P184, DOI 10.1016/j.jas.2011.09.022; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Poulakakis N, 2006, BIOL LETTERS, V2, P451, DOI 10.1098/rsbl.2006.0467; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchernov E, 1997, J ARCHAEOL SCI, V24, P65, DOI 10.1006/jasc.1995.0096; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	30	69	73	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57754	10.1371/journal.pone.0057754	http://dx.doi.org/10.1371/journal.pone.0057754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483925	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100041
J	Maeda, Y; Fukushima, K; Omichi, R; Kariya, S; Nishizaki, K				Maeda, Yukihide; Fukushima, Kunihiro; Omichi, Ryotaro; Kariya, Shin; Nishizaki, Kazunori			Time Courses of Changes in Phospho- and Total- MAP Kinases in the Cochlea after Intense Noise Exposure	PLOS ONE			English	Article							PROTEIN-KINASES; ACOUSTIC INJURY; HEARING-LOSS; PATHWAY; ACTIVATION; OTOTOXICITY; MECHANISMS; PROTECTION; TRAUMA; AM-111	Mitogen-activated protein kinases (MAP kinases) are intracellular signaling kinases activated by phosphorylation in response to a variety of extracellular stimuli. Mammalian MAP kinase pathways are composed of three major pathways: MEK1 (mitogen-activated protein kinase kinase 1)/ERK 1/2 (extracellular signal-regulated kinases 1/2)/p90 RSK (p90 ribosomal S6 kinase), JNK (c-Jun amino (N)-terminal kinase)/c-Jun, and p38 MAPK pathways. These pathways coordinately mediate physiological processes such as cell survival, protein synthesis, cell proliferation, growth, migration, and apoptosis. The involvement of MAP kinase in noise-induced hearing loss (NIHL) has been implicated in the cochlea; however, it is unknown how expression levels of MAP kinase change after the onset of NIHL and whether they are regulated by transient phosphorylation or protein synthesis. CBA/J mice were exposed to 120-dB octave band noise for 2 h. Auditory brainstem response confirmed a component of temporary threshold shift within 0-24 h and significant permanent threshold shift at 14 days after noise exposure. Levels and localizations of phospho-and total-MEK1/ERK1/2/p90 RSK, JNK/c-Jun, and p38 MAPK were comprehensively analyzed by the Bio-Plex (R) Suspension Array System and immunohistochemistry at 0, 3, 6, 12, 24 and 48 h after noise exposure. The phospho-MEK1/ERK1/2/p90 RSK signaling pathway was activated in the spiral ligament and the sensory and supporting cells of the organ of Corti, with peaks at 3-6 h and independently of regulations of total-MEK1/ERK1/2/p90 RSK. The expression of phospho-JNK and p38 MAPK showed late upregulation in spiral neurons at 48 h, in addition to early upregulations with peaks at 3 h after noise trauma. Phospho-p38 MAPK activation was dependent on upregulation of total-p38 MAPK. At present, comprehensive data on MAP kinase expression provide significant insight into understanding the molecular mechanism of NIHL, and for developing therapeutic models for acute sensorineural hearing loss.	[Maeda, Yukihide; Fukushima, Kunihiro; Omichi, Ryotaro; Kariya, Shin; Nishizaki, Kazunori] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharm, Okayama 7008530, Japan	Okayama University	Maeda, Y (corresponding author), Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharm, Okayama 7008530, Japan.	maedayj@yahoo.co.jp	Omichi, Ryotaro/AAN-9037-2021	Omichi, Ryotaro/0000-0001-5441-9796	Japanese Ministry of Health, Labour and Welfare [H23-NANCHI-IPPAN-021]; Japanese Ministry of Education, Culture, Sports, Science and Technology [KAKEN 22591880]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Japanese Ministry of Health, Labour and Welfare (H23-NANCHI-IPPAN-021; http://www.mhlw.go.jp/) and Japanese Ministry of Education, Culture, Sports, Science and Technology (KAKEN 22591880; http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Coleman JKM, 2007, HEARING RES, V226, P70, DOI 10.1016/j.heares.2006.05.006; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cui Y, 2011, EUR ARCH OTO-RHINO-L, V268, P973, DOI 10.1007/s00405-011-1484-3; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; Eshraghi AA, 2007, HEARING RES, V226, P168, DOI 10.1016/j.heares.2006.09.008; Jamesdaniel S, 2011, J PROTEOMICS, V75, P410, DOI 10.1016/j.jprot.2011.08.007; Meltser I, 2010, NEUROSCIENCE, V165, P1439, DOI 10.1016/j.neuroscience.2009.11.025; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Nagashima R, 2010, J PHARMACOL SCI, V114, P50, DOI 10.1254/jphs.10113FP; Omotehara Y, 2011, OTOL NEUROTOL, V32, P1422, DOI 10.1097/MAO.0b013e3182355658; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Tabuchi K, 2010, NEUROSCIENCE, V166, P665, DOI 10.1016/j.neuroscience.2009.12.038; Wang J, 2007, MOL PHARMACOL, V71, P654, DOI 10.1124/mol.106.028936; Wei X, 2005, NEUROSCIENCE, V131, P513, DOI 10.1016/j.neuroscience.2004.11.014; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104	21	37	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58775	10.1371/journal.pone.0058775	http://dx.doi.org/10.1371/journal.pone.0058775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484051	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100137
J	Scherer, KR; Meuleman, B				Scherer, Klaus R.; Meuleman, Ben			Human Emotion Experiences Can Be Predicted on Theoretical Grounds: Evidence from Verbal Labeling	PLOS ONE			English	Article							ANTECEDENT APPRAISAL; SPECIFICITY; PATTERNS	In an effort to demonstrate that the verbal labeling of emotional experiences obeys lawful principles, we tested the feasibility of using an expert system called the Geneva Emotion Analyst (GEA), which generates predictions based on an appraisal theory of emotion. Several thousand respondents participated in an Internet survey that applied GEA to self-reported emotion experiences. Users recalled appraisals of emotion-eliciting events and labeled the experienced emotion with one or two words, generating a massive data set on realistic, intense emotions in everyday life. For a final sample of 5969 respondents we show that GEA achieves a high degree of predictive accuracy by matching a user's appraisal input to one of 13 theoretically predefined emotion prototypes. The first prediction was correct in 51% of the cases and the overall diagnosis was considered as at least partially correct or appropriate in more than 90% of all cases. These results support a component process model that encourages focused, hypothesis-guided research on elicitation and differentiation, memory storage and retrieval, and categorization and labeling of emotion episodes. We discuss the implications of these results for the study of emotion terms in natural language semantics.	[Scherer, Klaus R.; Meuleman, Ben] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland	University of Geneva	Scherer, KR (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	Klaus.scherer@unige.ch			National Center of Competence in Research (NCCR) Affective Sciences; Swiss National Science Foundation [51NF40-104897]; European Research Council (ERC) [230331-PROPEREMO]	National Center of Competence in Research (NCCR) Affective Sciences; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was funded by the National Center of Competence in Research (NCCR) Affective Sciences financed by the Swiss National Science Foundation (no 51NF40-104897) (http://www.snf.ch/E/Pages/default.aspx) and a European Research Council (ERC) Advanced Grant (no 230331-PROPEREMO) to KRS (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; DAVIDSON RJ, 2003, HDB AFFECTIVE SCI; de Sousa R., 1987, RATIONALITY EMOTION; Dixon Thomas, 2003, PASSIONS EMOTIONS CR; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Fischer A.H., 2001, APPRAISAL PROCESSES, P221; Fontaine J. R. J., COMPONENTS IN PRESS; Frijda N. H., 2007, LAWS EMOTION; Frijda NH, 2009, SERIES AFFECTIVE SCI, P142; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; James W., 1890, PRINCIPLES PSYCHOL; Kuppens P, 2003, EMOTION, V3, P254, DOI 10.1037/1528-3542.3.3.254; LANG PJ, 1979, PSYCHOPHYSIOLOGY, V16, P495, DOI 10.1111/j.1469-8986.1979.tb01511.x; Leventhal H., 1987, COGNITION EMOTION, V1, P3, DOI [DOI 10.1080/02699938708408361, 10.1080/02699938708408361]; Moors A., HDB COGNITI IN PRESS; Romney AK, 2000, P NATL ACAD SCI USA, V97, P518, DOI 10.1073/pnas.97.1.518; Roseman IJ, 2004, COGNITION EMOTION, V18, P1, DOI 10.1080/02699930244000390; Russell JA, 2009, COGNITION EMOTION, V23, P1259, DOI 10.1080/02699930902809375; Sander D.E., 2009, OXFORD COMPANION EMO; Scherer K. R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Scherer KR, 2011, INT J PSYCHOL, V46, P401, DOI 10.1080/00207594.2011.626049; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; Scherer KR, 2004, SOC SCI INFORM, V43, P499, DOI 10.1177/0539018404047701; Scherer KR, 1997, MOTIV EMOTION, V21, P211, DOI 10.1023/A:1024498629430; SCHERER KR, 1993, COGNITION EMOTION, V7, P325, DOI 10.1080/02699939308409192; Scherer KR, 2013, COMPONENTS IN PRESS; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; Siemer M, 2007, EMOTION, V7, P592, DOI 10.1037/1528-3542.7.3.592; SMITH CA, 1987, J PERS SOC PSYCHOL, V52, P475, DOI 10.1037/0022-3514.52.3.475	31	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58166	10.1371/journal.pone.0058166	http://dx.doi.org/10.1371/journal.pone.0058166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483988	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100083
J	Young, B; Dunstone, RL; Senden, TJ; Young, GC				Young, Ben; Dunstone, Robert L.; Senden, Timothy J.; Young, Gavin C.			A Gigantic Sarcopterygian (Tetrapodomorph Lobe-Finned Fish) from the Upper Devonian of Gondwana (Eden, New South Wales, Australia)	PLOS ONE			English	Article							FAMENNIAN EVIEUX FORMATION; TRISTICHOPTERID SARCOPTERYGII; NORTH-AMERICA; EAST GONDWANA; VICTORIA; OSTEOLEPIFORMES; RHIZODONTIDS; CANOWINDRA; BELGIUM; ANATOMY	Edenopteron keithcrooki gen. et sp. nov. is described from the Famennian Worange Point Formation; the holotype is amongst the largest tristichopterids and sarcopterygians documented by semi-articulated remains from the Devonian Period. The new taxon has dentary fangs and premaxillary tusks, features assumed to be derived for large Northern Hemisphere tristichopterids (Eusthenodon, Hyneria, Langlieria). It resembles Eusthenodon in ornament, but is distinguished by longer proportions of the parietal compared to the post-parietal shield, and numerous differences in shape and proportions of other bones. Several characters (accessory vomers in the palate, submandibulars overlapping ventral jaw margin, scales ornamented with widely-spaced deep grooves) are recorded only in tristichopterids from East Gondwana (Australia-Antarctica). On this evidence Edenopteron gen. nov. is placed in an endemic Gondwanan subfamily Mandageriinae within the Tristichopteridae; it differs from the nominal genotype Mandageria in its larger size, less pointed skull, shape of the orbits and other skull characters. The hypothesis that tristichopterids evolved in Laurussia and later dispersed into Gondwana, and a derived subgroup of large Late Devonian genera dispersed from Gondwana, is inconsistent with the evidence of the new taxon. Using oldest fossil and most primitive clade criteria the most recent phylogeny resolves South China and Gondwana as areas of origin for all tetrapodomorphs. The immediate outgroup to tristichopterids remains unresolved - either Spodichthys from Greenland as recently proposed, or Marsdenichthys from Gondwana, earlier suggested to be the sister group to all tristichopterids. Both taxa combine two characters that do not co-occur in other tetrapodomorphs (extratemporal bone in the skull; non-cosmoid round scales with an internal boss). Recently both 'primitive' and 'derived' tristichopterids have been discovered in the late Middle Devonian of both hemispheres, implying extensive ghost lineages within the group. Resolving their phylogeny and biogeography will depend on a comprehensive new phylogenetic analysis.	[Young, Ben] Lithicon Australia Pty Ltd, Canberra, ACT, Australia; [Young, Ben; Dunstone, Robert L.; Young, Gavin C.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Senden, Timothy J.] Australian Natl Univ, Res Sch Phys & Engn, Canberra, ACT, Australia	Australian National University; Australian National University	Young, GC (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	Gavin.Young@anu.edu.au	Senden, Tim J/A-7319-2008	Senden, Tim J/0000-0001-6808-7219	Australian Research Council [DP0558499, DP0772138]; Australian National University [10MEC15]	Australian Research Council(Australian Research Council); Australian National University(Australian National University)	This research was supported by Australian Research Council [www.arc.gov.au] Discovery Grants DP0558499 ('Australia's exceptional Palaeozoic fossil fishes, and a Gondwana origin for land vertebrates') and DP0772138 ('Old brains, new data-early evolution of structural complexity in the vertebrate head'). Surface scanning and 3D printing equipment was partly financed by an Australian National University [www.anu.edu.au] Major Equipment Grant (10MEC15). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Ahlberg PE, 2001, J VERTEBR PALEONTOL, V21, P1, DOI 10.1671/0272-4634(2001)021[0001:TLDLSS]2.0.CO;2; Ahlberg PE, 1997, J VERTEBR PALEONTOL, V17, P653, DOI 10.1080/02724634.1997.10011015; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P391; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; [Anonymous], AM MUS NOVIT; Bishop P, 2012, MEMOIRS QUE IN PRESS, V56; Clement G, 2002, PALAEONTOLOGY, V45, P577, DOI 10.1111/1475-4983.00250; Clement G, 2009, PALAEONTOLOGY, V52, P823, DOI 10.1111/j.1475-4983.2009.00876.x; Cope E. D., 1889, AM NAT, V23, P849, DOI DOI 10.1086/275018; Daeschler E, 2007, J VERTEBR PALEONTOL, V27, p65A; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Holland Timothy, 2010, Memoirs of Museum Victoria, V67, P35; Holland T, 2010, J VERTEBR PALEONTOL, V30, P68, DOI 10.1080/02724630903409105; HUXLEY T. H., 1880, P ZOOL SOC LOND, P649; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jarvik E., 1985, GEOSCIENCE, V13, P1; Jarvik E., 1942, ZOOL BIDR UPPS, V21, P235; Jarvik E., 1980, BASIC STRUCTURE EVOL, DOI [10.1126/science.214.4519.431.b, DOI 10.1126/SCIENCE.214.4519.431.B]; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; JARVIK ERIK, 1948, K SVENSKA VETENSKAPSAKAD HANDL, V25, P1; Jarvik E., 1944, K SVENSKA VETENSKAPSAKAD HANDL, V21, P1; Jarvik Erik, 1996, P285; Jeffery JE, 2003, T ROY SOC EDIN-EARTH, V93, P255, DOI 10.1017/S0263593300000432; Johanson Z, 2003, PALAEONTOLOGY, V46, P271, DOI 10.1111/1475-4983.00298; Johanson Z, 2001, T ROY SOC EDIN-EARTH, V92, P43, DOI 10.1017/S0263593300000043; Johanson Z, 1997, T ROY SOC EDIN-EARTH, V88, P39, DOI 10.1017/S0263593300002303; Johanson Z, 2004, RECENT ADV ORIGIN EA, P287; JOHANSON Z, 2000, GEOWISSENSCHAFTLICHE, V3, P111; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; LONG JA, 1990, LETHAIA, V23, P157, DOI 10.1111/j.1502-3931.1990.tb01357.x; LONG JA, 1985, ALCHERINGA, V9, P1, DOI 10.1080/03115518508618955; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; ROMER AS, 1955, NATURE, V176, P126, DOI 10.1038/176126a0; Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055; Schultze HP, 2012, HIST BIOL, V24, P425, DOI 10.1080/08912963.2012.673599; SCHULTZE HP, 1969, PALAEONTOGRAPHIA ITA, V65, P63; Snitting D, 2008, J VERTEBR PALEONTOL, V28, P637, DOI 10.1671/0272-4634(2008)28[637:AROTAO]2.0.CO;2; Snitting D, 2009, ACTA ZOOL-STOCKHOLM, V90, P273, DOI 10.1111/j.1463-6395.2008.00376.x; Swartz B, 2012, PLOS ONE, V7, P1; Thomson K. S., 1968, Postilla, VNo. 124, P1; Thomson K. S., 1967, ZOOL J LINN SOC-LOND, V46, P223; Vorobeva E.I., 1977, Trudy Paleontologicheskogo Instituta, V163, P1; Vorobyeva E. I., 1962, T PALEONTOLOGICHESKO, V94, P1; VOROBYEVA EI, 1959, T PALEONTOLOGISCHESK, V3, P95; Young GC, 2008, ALCHERINGA, V32, P321, DOI 10.1080/03115510802104368; Young GC, 2007, AUST J EARTH SCI, V54, P991, DOI 10.1080/08120090701488313; Young G.C., 2003, Records of the Western Australian Museum Supplement, V65, P1; Young G. C., 1992, REC AUST MUS, V14, P1, DOI [10.3853/j.0812-7387.14.1992.90, DOI 10.3853/J.0812-7387.14.1992.90]; Young Gavin C., 2003, Courier Forschungsinstitut Senckenberg, V242, P169; Young Gavin C., 2010, P85; Young Gavin C., 2010, Palaeoworld, V19, P160, DOI 10.1016/j.palwor.2009.10.001; Young Gavin C., 2010, Palaeoworld, V19, P55, DOI 10.1016/j.palwor.2009.11.005; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; YOUNG GC, 2006, ALCHERINGA S, V30, P409	58	13	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e53871	10.1371/journal.pone.0053871	http://dx.doi.org/10.1371/journal.pone.0053871			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483884	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100002
J	Malan-Muller, S; Hemmings, SMJ; Spies, G; Kidd, M; Fennema-Notestine, C; Seedat, S				Malan-Mueller, Stefanie; Hemmings, Sian Megan Joanna; Spies, Georgina; Kidd, Martin; Fennema-Notestine, Christine; Seedat, Soraya			Shorter Telomere Length - A Potential Susceptibility Factor for HIV-Associated Neurocognitive Impairments in South African Woman	PLOS ONE			English	Article							CHILDHOOD TRAUMA QUESTIONNAIRE; OXIDATIVE DNA-DAMAGE; REVERSE-TRANSCRIPTASE; NUCLEAR EXPORT; T-CELLS; BLOOD; DISORDERS; DISEASE; STRESS; OLDER	The neuropathogenesis of the human immunodeficiency virus (HIV) may manifest as various neurocognitive impairments (NCI). HIV-positive individuals also have significantly shorter telomere length (TL) in peripheral blood mononuclear cells (PBMCs) and CD8+ T cells compared to HIV-negative individuals. Additionally, reduced TL has been found to be associated with chronic psychological stress. This study focused on the effects of HIV-infection and chronic stress associated with childhood trauma on telomere length, and investigated whether leukocyte TL (LTL), in particular, represents a risk factor for NCI. Eighty-three HIV-positive and 45 HIV-negative women were assessed for childhood trauma and were subjected to detailed neurocognitive testing. Blood from each participant was used to extract Deoxyribonucleic acid (DNA). Relative LTL were determined by performing real time quantitative PCR reactions as described by Cawthon et al. (2002). As expected, relative LTL in the HIV-positive individuals was significantly shorter than that of HIV-negative individuals (F = 51.56, p= <0.01). Notably, a significant positive correlation was evident between relative LTL and learning performance in the HIV-positive group. In addition, a significant negative correlation was observed between relative LTL and verbal fluency, but this association was only evident in HIV-positive individuals who had experienced trauma. Our results suggest that reduced LTL is associated with worse learning performance in HIV-positive individuals, indicating that TL could act as a susceptibility factor in increasing neurocognitive decline in HIV-infected individuals.	[Malan-Mueller, Stefanie; Hemmings, Sian Megan Joanna; Spies, Georgina; Seedat, Soraya] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Psychiat, Cape Town, South Africa; [Hemmings, Sian Megan Joanna] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Med Res Council,South Africa Ctr Mol & Cellular B, Cape Town, South Africa; [Kidd, Martin] Univ Stellenbosch, Dept Stat & Actuarial Sci, Ctr Stat Consultat, ZA-7600 Stellenbosch, South Africa; [Fennema-Notestine, Christine] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Fennema-Notestine, Christine] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA	Stellenbosch University; South African Medical Research Council; Stellenbosch University; Stellenbosch University; University of California System; University of California San Diego; University of California System; University of California San Diego	Malan-Muller, S (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Psychiat, Cape Town, South Africa.	smalan@sun.ac.za		Seedat, Soraya/0000-0002-5118-786X; Malan-Muller, Stefanie/0000-0003-0639-0129; Fennema-Notestine, Christine/0000-0002-6527-6361; Hemmings, Sian/0000-0001-8461-1017	Harry Crossley Foundation; National Institutes of Health CFAR Developmental Award [10316485]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER	Harry Crossley Foundation; National Institutes of Health CFAR Developmental Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	1. Harry Crossley Foundation (http://www.afterschoolafrica.com/2011/09/harry-crossley-foundation-research.html). 2. National Institutes of Health CFAR Developmental Award, Grant no: PO# 10316485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Bremner J Douglas, 2002, Semin Clin Neuropsychiatry, V7, P104, DOI 10.1053/scnp.2002.31787; Callen E, 2004, MUTAT RES-REV MUTAT, V567, P85, DOI 10.1016/j.mrrev.2004.06.003; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Effros RB, 2000, MICROBES INFECT, V2, P69, DOI 10.1016/S1286-4579(00)00283-5; Epel ES, 2009, AGING-US, V1, P81; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Glass Daniel, 2010, Biol Psychiatry, V68, pe21, DOI 10.1016/j.biopsych.2010.02.026; Gleissner U, 2001, CORTEX, V37, P55, DOI 10.1016/S0010-9452(08)70557-4; Grant I, 2008, INT REV PSYCHIATR, V20, P33, DOI 10.1080/09540260701877894; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Irie M, 2003, BIOCHEM BIOPH RES CO, V311, P1014, DOI 10.1016/j.bbrc.2003.10.105; Irie M, 2002, PSYCHOTHER PSYCHOSOM, V71, P90, DOI 10.1159/000049351; Joska JA, 2010, AIDS BEHAV, V14, P371, DOI 10.1007/s10461-009-9538-x; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kurosaka D, 2006, J RHEUMATOL, V33, P1102; Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078; Nakamura KI, 2007, EXP GERONTOL, V42, P944, DOI 10.1016/j.exger.2007.05.003; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; Obana N, 2003, INTERNAL MED, V42, P150, DOI 10.2169/internalmedicine.42.150; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Thurnher D, 2001, HEAD NECK-J SCI SPEC, V23, P1049, DOI 10.1002/hed.1150; Tsuboi H, 2004, J PSYCHOSOM RES, V56, P53, DOI 10.1016/S0022-3999(03)00567-1; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; Wu KD, 2001, EXP DERMATOL, V10, P329, DOI 10.1034/j.1600-0625.2001.100505.x	45	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58351	10.1371/journal.pone.0058351	http://dx.doi.org/10.1371/journal.pone.0058351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472184	gold, Green Published			2022-12-25	WOS:000315637900130
J	Ewers, RM; Banks-Leite, C				Ewers, Robert M.; Banks-Leite, Cristina			Fragmentation Impairs the Microclimate Buffering Effect of Tropical Forests	PLOS ONE			English	Article							ATLANTIC FOREST; SOIL-MOISTURE; EDGE; GRADIENTS; IMPACTS; VARIABILITY; RESPONSES; ECOSYSTEM; DYNAMICS; HABITAT	Background: Tropical forest species are among the most sensitive to changing climatic conditions, and the forest they inhabit helps to buffer their microclimate from the variable climatic conditions outside the forest. However, habitat fragmentation and edge effects exposes vegetation to outside microclimatic conditions, thereby reducing the ability of the forest to buffer climatic variation. In this paper, we ask what proportion of forest in a fragmented ecosystem is impacted by altered microclimate conditions driven by edge effects, and extrapolate these results to the whole Atlantic Forest biome, one of the most disturbed biodiversity hotspots. To address these questions, we collected above and below ground temperature for a full year using temperature sensors placed in forest fragments of different sizes, and at different distances from the forest edge. Principal Findings: In the Atlantic forests of Brazil, we found that the buffering effect of forests reduced maximum outside temperatures by one third or more at ground level within a forest, with the buffering effect being stronger below-ground than one metre above-ground. The temperature buffering effect of forests was, however, reduced near forest edges with the edge effect extending up to 20 m inside the forest. The heavily fragmented nature of the Brazilian Atlantic forest means that 12% of the remaining biome experiences altered microclimate conditions. Conclusions: Our results add further information about the extent of edge effects in the Atlantic Forest, and we suggest that maintaining a low perimeter-to-area ratio may be a judicious method for minimizing the amount of forest area that experiences altered microclimatic conditions in this ecosystem.	[Ewers, Robert M.; Banks-Leite, Cristina] Imperial Coll London, Ascot, Berks, England	Imperial College London	Ewers, RM (corresponding author), Imperial Coll London, Silwood Pk Campus, Ascot, Berks, England.	r.ewers@imperial.ac.uk	Banks-Leite, Cristina/D-3075-2011	Banks-Leite, Cristina/0000-0002-0091-2857	Royal Society of London [RG080214]; Natural Environment Research Council [NE/H016228/1]; NERC [NE/H016228/1] Funding Source: UKRI	Royal Society of London(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Fieldwork was funded by the Royal Society of London (Research Grant RG080214, http://royalsociety.org/), and CBL was funded by the Natural Environment Research Council (Grant Number NE/H016228/1, http://www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Banks-Leite C, ECOLOGICAL IN PRESS; Banks-Leite C, 2012, ECOLOGY, V93, P2560, DOI 10.1890/11-2054.1; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Bennie JJ, 2010, AGR FOREST METEOROL, V150, P12, DOI 10.1016/j.agrformet.2009.07.014; Billings SA, 2008, LANDSCAPE ECOL, V23, P581, DOI 10.1007/s10980-008-9218-7; Cadenasso ML, 1997, CAN J FOREST RES, V27, P774, DOI 10.1139/cjfr-27-5-774; CAMARGO JLC, 1995, J TROP ECOL, V11, P205, DOI 10.1017/S026646740000866X; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Davies-Colley RJ, 2000, NEW ZEAL J ECOL, V24, P111; Didham RK, 2012, BIOL CONSERV, V155, P104, DOI 10.1016/j.biocon.2012.06.019; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Ewers RM, 2010, TRENDS ECOL EVOL, V25, P699, DOI 10.1016/j.tree.2010.09.008; Fletcher RJ, 2005, J ANIM ECOL, V74, P342, DOI 10.1111/j.1365-2656.2005.00930.x; Guan XD, 2009, ADV ATMOS SCI, V26, P692, DOI 10.1007/s00376-009-8198-0; Harper KA, 2001, ECOLOGY, V82, P649, DOI 10.1890/0012-9658(2001)082[0649:SACORB]2.0.CO;2; Hennenberg KJ, 2008, BASIC APPL ECOL, V9, P275, DOI 10.1016/j.baae.2007.02.004; Honnay O, 2002, FOREST ECOL MANAG, V161, P109, DOI 10.1016/S0378-1127(01)00490-X; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kitoh A, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014920; Lafortezza R, 2010, GLOBAL ECOL BIOGEOGR, V19, P741, DOI 10.1111/j.1466-8238.2010.00542.x; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Lira PK, 2012, FOREST ECOL MANAG, V278, P80, DOI 10.1016/j.foreco.2012.05.008; Malcolm JR, 1998, CLIMATIC CHANGE, V39, P487, DOI 10.1023/A:1005376603186; MALCOLM JR, 1994, ECOLOGY, V75, P2438, DOI 10.2307/1940897; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Pincebourde S, 2007, J ANIM ECOL, V76, P424, DOI 10.1111/j.1365-2656.2007.01231.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Smith DL, 2004, ECOLOGY, V85, P3348, DOI 10.1890/03-0576; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart KJ, 2006, ECOL APPL, V16, P1474, DOI 10.1890/1051-0761(2006)016[1474:BRTMEE]2.0.CO;2; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Temple S.A., 1986, P301; Williams-Linera G, 1998, CONSERV BIOL, V12, P1091, DOI 10.1046/j.1523-1739.1998.97262.x	46	136	139	10	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58093	10.1371/journal.pone.0058093	http://dx.doi.org/10.1371/journal.pone.0058093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483976	Green Published, Green Submitted, gold			2022-12-25	WOS:000315634900069
J	Nofiele, JT; Cheng, HLM				Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret			Ultrashort Echo Time for Improved Positive-Contrast Manganese-Enhanced MRI of Cancer	PLOS ONE			English	Article							LABELED CELLS; QUANTIFICATION; NANOPARTICLES	Objective: Manganese (Mn) is a positive magnetic resonance imaging (MRI) contrast agent that has been used to obtain physiological, biochemical, and molecular biological information. There is great interest to broaden its applications, but a major challenge is to increase detection sensitivity. Another challenge is distinguishing regions of Mn-related signal enhancement from background tissue with inherently similar contrast. To overcome these limitations, this study investigates the use of ultrashort echo time (UTE) and subtraction UTE (SubUTE) imaging for more sensitive and specific determination of Mn accumulation. Materials and Methods: Simulations were performed to investigate the feasibility of UTE and SubUTE for Mn-enhanced MRI and to optimize imaging parameters. Phantoms containing aqueous Mn solutions were imaged on a MRI scanner to validate simulations predictions. Breast cancer cells that are very aggressive (MDA-MB-231 and a more aggressive variant LM2) and a less aggressive cell line (MCF7) were labeled with Mn and imaged on MRI. All imaging was performed on a 3 Tesla scanner and compared UTE and SubUTE against conventional T-1-weighted spoiled gradient echo (SPGR) imaging. Results: Simulations and phantom imaging demonstrated that UTE and SubUTE provided sustained and linearly increasing positive contrast over a wide range of Mn concentrations, whereas conventional SPGR displayed signal plateau and eventual decrease. Higher flip angles are optimal for imaging higher Mn concentrations. Breast cancer cell imaging demonstrated that UTE and SubUTE provided high sensitivity, with SubUTE providing background suppression for improved specificity and eliminating the need for a pre-contrast baseline image. The SubUTE sequence allowed the best distinction of aggressive breast cancer cells. Conclusions: UTE and SubUTE allow more sensitive and specific positive-contrast detection of Mn enhancement. This imaging capability can potentially open many new doors for Mn-enhanced MRI in vascular, cellular, and molecular imaging.	[Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Cheng, HLM (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	Hai-Ling.Cheng@sickkids.ca	Cheng, Hai-Ling Margaret/E-5551-2011	Cheng, Hai-Ling Margaret/0000-0002-0733-9512	The SickKids Foundation; The Garron Family Cancer Centre Small Grant Competition	The SickKids Foundation; The Garron Family Cancer Centre Small Grant Competition	This study was supported by funding from The SickKids Foundation and The Garron Family Cancer Centre Small Grant Competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baio G, 2012, EUR RADIOL, V22, P551, DOI 10.1007/s00330-011-2285-1; BERGIN CJ, 1991, RADIOLOGY, V179, P777, DOI 10.1148/radiology.179.3.2027991; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Braga HJV, 2002, RADIOLOGY, V223, P525, DOI 10.1148/radiol.2232010908; Brismar TB, 2012, EUR RADIOL, V22, P633, DOI 10.1007/s00330-011-2288-y; Brurok H, 1999, NMR BIOMED, V12, P364, DOI 10.1002/(SICI)1099-1492(199910)12:6<364::AID-NBM585>3.3.CO;2-Q; Bulte JWM, 1999, MAGN RESON MED, V42, P379, DOI 10.1002/(SICI)1522-2594(199908)42:2<379::AID-MRM20>3.0.CO;2-L; Crowe LA, 2011, AM J TRANSPLANT, V11, P1158, DOI 10.1111/j.1600-6143.2011.03559.x; Girard OM, 2012, CONTRAST MEDIA MOL I, V7, P411, DOI 10.1002/cmmi.1467; Girard OM, 2011, MAGN RESON MED, V65, P1649, DOI 10.1002/mrm.22755; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Kotek G, 2012, CONTRAST MEDIA MOL I, V7, P195, DOI 10.1002/cmmi.481; Lauterbur PC., 1978, FRONTIERS BIOL ENERG, V1978, P752; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; MENDONCADIAS MH, 1983, SEMIN NUCL MED, V13, P364, DOI 10.1016/S0001-2998(83)80048-8; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140; Zhang LJ, 2011, J MAGN RESON IMAGING, V33, P194, DOI 10.1002/jmri.22412	18	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58617	10.1371/journal.pone.0058617	http://dx.doi.org/10.1371/journal.pone.0058617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484042	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900094
J	Armacki, M; Joodi, G; Nimmagadda, SC; de Kimpe, L; Pusapati, GV; Vandoninck, S; Van Lint, J; Illing, A; Seufferlein, T				Armacki, M.; Joodi, G.; Nimmagadda, S. C.; de Kimpe, L.; Pusapati, G. V.; Vandoninck, S.; Van Lint, J.; Illing, A.; Seufferlein, T.			A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growth by regulating angiogenesis	ONCOGENE			English	Article						PKD2; CIB1; angiogenesis; carcinogenesis	FOCAL ADHESION KINASE; ENDOTHELIAL-CELLS; CIB1; PHOSPHORYLATION; INVASION; D2; ACTIVATION; INHIBITION; EXPORT; IDENTIFICATION	Protein kinase D2 (PKD2) is a member of the PKD family of serine/threonine kinases, a subfamily of the CAMK super-family. PKDs have a critical role in cell motility, migration and invasion of cancer cells. Expression of PKD isoforms is deregulated in various tumours and PKDs, in particular PKD2, have been implicated in the regulation of tumour angiogenesis. In order to further elucidate the role of PKD2 in tumours, we investigated the signalling context of this kinase by performing an extensive substrate screen by in vitro expression cloning (IVEC). We identified a novel splice variant of calcium and integrin-binding protein 1, termed CIB1a, as a potential substrate of PKD2. CIB1 is a widely expressed protein that has been implicated in angiogenesis, cell migration and proliferation, all important hallmarks of cancer, and CIB1a was found to be highly expressed in various cancer cell lines. We identify Ser(118) as the major PKD2 phosphorylation site in CIB1a and show that PKD2 interacts with CIB1a via its alanine and proline-rich domain. Furthermore, we confirm that CIB1a is indeed a substrate of PKD2 also in intact cells using a phosphorylation-specific antibody against CIB1a-Ser(118). Functional analysis of PKD2-mediated CIB1a phosphorylation revealed that on phosphorylation, CIB1a mediates tumour cell invasion, tumour growth and angiogenesis by mediating PKD-induced vascular endothelial growth factor secretion by the tumour cells. Thus, CIB1a is a novel mediator of PKD2-driven carcinogenesis and a potentially interesting therapeutic target.	[Armacki, M.; Illing, A.; Seufferlein, T.] Univ Ulm, Dept Internal Med 1, D-89081 Baden Baden, Germany; [Armacki, M.; Joodi, G.; Nimmagadda, S. C.; Seufferlein, T.] Univ Halle Wittenberg, Dept Internal Med 1, D-06108 Halle, Saale, Germany; [de Kimpe, L.] Univ Amsterdam, AMC, Amsterdam, Netherlands; [de Kimpe, L.; Vandoninck, S.; Van Lint, J.] Katholieke Univ Leuven, Fac Med, Dept Cellular & Mol Med, Louvain, Belgium; [Pusapati, G. V.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Ulm University; Martin Luther University Halle Wittenberg; University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; Stanford University	Seufferlein, T (corresponding author), Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, D-89081 Ulm, Germany.	Thomas.seufferlein@uniklinik-ulm.de	Van Lint, Johan/P-9073-2019; Seufferlein, Thomas TW/P-7147-2018	Pusapati, Ganesh/0000-0002-1406-2566; Van Lint, Johan/0000-0002-0275-571X; Joodi, Golsa/0000-0002-6371-433X	German Federal Ministry of Education and Research (BMBF) [PKB-01GS08209-4]; German Cancer Aid [109373]; Research Programme of the Research Foundation-Flanders (FWO);  [G.0612.07]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Aid(Deutsche Krebshilfe); Research Programme of the Research Foundation-Flanders (FWO)(FWO); 	This project was funded in part by the German Federal Ministry of Education and Research (BMBF) grant no. PKB-01GS08209-4 and the German Cancer Aid grant no. 109373 (both to TS) and in part by the Research Programme of the Research Foundation-Flanders (FWO) (PhD fellowship to LDK and grant G.0612.07 to JVL). We thank Holger Reim and Claudia Ruhland for expert technical assistance.	Albini A, 2004, INT J DEV BIOL, V48, P563, DOI 10.1387/ijdb.041822aa; ALBINI A, 1987, CANCER RES, V47, P3239; Albini A, 1998, Pathol Oncol Res, V4, P230; Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Azoitei N, 2011, NEURO-ONCOLOGY, V13, P710, DOI 10.1093/neuonc/nor084; Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Cells J., 1998, CELL BIOL LAB HDB; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Evans IM, 2011, IUBMB LIFE, V63, P258, DOI 10.1002/iub.456; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Gao ZH, 2000, BIOCHEM BIOPH RES CO, V268, P562, DOI 10.1006/bbrc.2000.2168; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guha S, 2010, BIOCHEM PHARMACOL, V80, P1946, DOI 10.1016/j.bcp.2010.07.002; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Haataja L, 2002, J BIOL CHEM, V277, P8321, DOI 10.1074/jbc.M105363200; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Hollenbach AD, 2002, BBA-GENE STRUCT EXPR, V1574, P321, DOI 10.1016/S0167-4781(02)00230-0; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Jackson LN, 2006, BIOCHEM BIOPH RES CO, V348, P945, DOI 10.1016/j.bbrc.2006.07.142; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Lacal PM, 2005, INT J ONCOL, V27, P1625; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Malhotra V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005280; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Naik MU, 2011, J CELL BIOCHEM, V112, P3289, DOI 10.1002/jcb.23255; Naik MU, 2011, INT J CANCER, V128, P587, DOI 10.1002/ijc.25388; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Obenauer John C, 2004, Methods Mol Biol, V261, P445; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Qazi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020348; Qin LL, 2006, J BIOL CHEM, V281, P32550, DOI 10.1074/jbc.M604853200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Ruifrok AC, 1997, ANAL QUANT CYTOL, V19, P107; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Vempati P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011860; Vogler M, 2005, ONCOGENE, V24, P7190, DOI 10.1038/sj.onc.1208876; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zayed MA, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-17; Zhang C, 2004, METHODS, V33, P144, DOI 10.1016/j.ymeth.2003.11.004	66	13	19	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1167	1180		10.1038/onc.2013.43	http://dx.doi.org/10.1038/onc.2013.43			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23503467				2022-12-25	WOS:000331933800010
J	Serrano-Bueno, G; Hernandez, A; Lopez-Lluch, G; Perez-Castineira, JR; Navas, P; Serrano, A				Serrano-Bueno, Gloria; Hernandez, Agustin; Lopez-Lluch, Guillermo; Roman Perez-Castineira, Jose; Navas, Placido; Serrano, Aurelio			Inorganic Pyrophosphatase Defects Lead to Cell Cycle Arrest and Autophagic Cell Death through NAD(+) Depletion in Fermenting Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; ESCHERICHIA-COLI; EXPRESSION; APOPTOSIS; GLUCOSE; IDENTIFICATION; DEGRADATION; MECHANISMS; INHIBITORS	Inorganic pyrophosphatases are required for anabolism to take place in all living organisms. Defects in genes encoding these hydrolytic enzymes are considered inviable, although their exact nature has not been studied at the cellular and molecular physiology levels. Using a conditional mutant in IPP1, the Saccharomyces cerevisiae gene encoding the cytosolic soluble pyrophosphatase, we show that respiring cells arrest in S phase upon Ipp1p deficiency, but they remain viable and resume growth if accumulated pyrophosphate is removed. However, fermenting cells arrest in G(1)/G(0) phase and suffer massive vacuolization and eventual cell death by autophagy. Impaired NAD(+) metabolism is a major determinant of cell death in this scenario because demise can be avoided under conditions favoring accumulation of the oxidized pyridine coenzyme. These results posit that the mechanisms related to excess pyrophosphate toxicity in eukaryotes are dependent on the energy metabolism of the cell.	[Serrano-Bueno, Gloria; Hernandez, Agustin; Roman Perez-Castineira, Jose; Serrano, Aurelio] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; [Hernandez, Agustin] Univ Pablo de Olavide, Dept Physiol Anat & Cell Biol, Seville 41013, Spain; [Lopez-Lluch, Guillermo; Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Lopez-Lluch, Guillermo; Navas, Placido] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville 41013, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Hernandez, A (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Avda Americo Vespucio 49, Seville 41092, Spain.	agustin.hernandez@ibvf.csic.es; aurelio@ibvf.csic.es	Lopez-Lluch, Guillermo/N-4742-2014; Serrano, Aurelio/K-3004-2014; Hernandez, Agustin/E-4544-2010; Pérez-Castiñeira, José R/F-2811-2010; NAVAS, PLACIDO/R-5943-2019	Lopez-Lluch, Guillermo/0000-0001-9830-8502; Serrano, Aurelio/0000-0002-8077-9098; Hernandez, Agustin/0000-0002-7884-8023; Pérez-Castiñeira, José R/0000-0002-4749-6897; NAVAS, PLACIDO/0000-0002-4115-7966; Serrano-Bueno, Gloria/0000-0002-8518-9038	Andalusian Regional Government; Spanish Ministries of Science and Innovation and of Health, Social Policies, and Equality [BIO-261, BIO-177, P07-CVI-3082, BFU2007-61887, BFU2010-15622, FIS-PI080500, P08-CTS-3988]; European Regional Development Fund program	Andalusian Regional Government; Spanish Ministries of Science and Innovation and of Health, Social Policies, and Equality; European Regional Development Fund program	This work was supported by grants from the Andalusian Regional Government and the Spanish Ministries of Science and Innovation and of Health, Social Policies, and Equality (to Plan Andaluz de Investigacion, Desarrollo e Innovacion Groups BIO-261 and BIO-177) and Grants P07-CVI-3082, BFU2007-61887, BFU2010-15622, FIS-PI080500, and P08-CTS-3988, all of them partially funded by European Regional Development Fund program.	Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Chen GA, 2002, CLIN CANCER RES, V8, P2298; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Drake R, 2010, BIOCHEM J, V426, P147, DOI 10.1042/BJ20091491; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; George GM, 2010, PLANT PHYSIOL, V154, P55, DOI 10.1104/pp.110.157776; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gomez-Garcia MR, 2006, BIOCHEM J, V395, P211, DOI 10.1042/BJ20051657; Heinonen J. K., 2001, BIOL ROLE INORGANIC; Hernandez A, 2009, GENE CHROMOSOME CANC, V48, P194, DOI 10.1002/gcc.20630; Jimenez-Hidalgo M, 2009, AGING CELL, V8, P140, DOI 10.1111/j.1474-9726.2009.00461.x; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Journo D, 2008, METHOD ENZYMOL, V451, P79, DOI 10.1016/S0076-6879(08)03207-2; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirkland JB, 2010, EXP BIOL MED, V235, P561, DOI 10.1258/ebm.2010.009280; KORNBERG A, 1950, J BIOL CHEM, V182, P763; KUKKOKALSKE E, 1989, J BACTERIOL, V171, P4498, DOI 10.1128/JB.171.8.4498-4500.1989; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Nakamura N, 1997, J BIOCHEM, V121, P338; Perez-Castineira Jose R., 2001, International Microbiology, V4, P135; Perez-Castineira JR, 2002, P NATL ACAD SCI USA, V99, P15914, DOI 10.1073/pnas.242625399; Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; RATHBUN WB, 1969, ANAL BIOCHEM, V28, P436, DOI 10.1016/0003-2697(69)90198-5; Ruckenstuhl C, 2010, AGING-US, V2, P643, DOI 10.18632/aging.100223; SAZER S, 1990, J CELL SCI, V97, P509; Serrano A, 2007, IUBMB LIFE, V59, P76, DOI 10.1080/15216540701258132; SONNEWALD U, 1992, PLANT J, V2, P571; Takahashi R, 2010, J BIOCHEM, V147, P95, DOI 10.1093/jb/mvp152; Tomonaga T, 2004, CLIN CANCER RES, V10, P2007, DOI 10.1158/1078-0432.CCR-03-0321; Verstrepen KJ, 2004, TRENDS BIOTECHNOL, V22, P531, DOI 10.1016/j.tibtech.2004.08.001; Weissen-Plenz G, 2008, ADV CLIN CHEM, V46, P263, DOI 10.1016/S0065-2423(08)00407-1; Wilkinson S, 2010, CURR OPIN GENET DEV, V20, P57, DOI 10.1016/j.gde.2009.12.004; Wlodkowic D, 2009, METHODS MOL BIOL, V559, P19, DOI 10.1007/978-1-60327-017-5_2; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Zuin A, 2010, AGING-US, V2, P231, DOI 10.18632/aging.100133	46	28	30	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13082	13092		10.1074/jbc.M112.439349	http://dx.doi.org/10.1074/jbc.M112.439349			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23479727	hybrid, Green Published			2022-12-25	WOS:000318555100059
J	Hix, LM; Karavitis, J; Khan, MW; Shi, YH; Khazaie, K; Zhang, M				Hix, Laura M.; Karavitis, John; Khan, Mohammad W.; Shi, Yihui H.; Khazaie, Khashayarsha; Zhang, Ming			Tumor STAT1 Transcription Factor Activity Enhances Breast Tumor Growth and Immune Suppression Mediated by Myeloid-derived Suppressor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IFN-GAMMA; INFILTRATING LYMPHOCYTES; TARGETED DISRUPTION; MAMMARY CARCINOMAS; SIGNAL TRANSDUCER; ADAPTIVE IMMUNITY; NECROSIS-FACTOR; CANCER-CELLS; BEARING MICE	Previous studies had implicated the IFN-gamma transcription factor signal transducer and activator of transcription 1 (STAT1) as a tumor suppressor. However, accumulating evidence has correlated increased STAT1 activation with increased tumor progression in multiple types of cancer, including breast cancer. Indeed, we present evidence that tumor up-regulation of STAT1 activity in human and mouse mammary tumors correlates with increasing disease progression to invasive carcinoma. A microarray analysis comparing low aggressive TM40D and highly aggressive TM40D-MB mouse mammary carcinoma cells revealed significantly higher STAT1 activity in the TM40D-MB cells. Ectopic overexpression of constitutively active STAT1 in TM40D cells promoted mobilization of myeloid-derived suppressor cells (MDSCs) and inhibition of antitumor T cells, resulting in aggressive tumor growth in tumor-transplanted, immunocompetent mice. Conversely, gene knockdown of STAT1 in the metastatic TM40D-MB cells reversed these events and attenuated tumor progression. Importantly, we demonstrate that in human breast cancer, the presence of tumor STAT1 activity and tumor-recruited CD33(+) myeloid cells correlates with increasing disease progression from ductal carcinoma in situ to invasive carcinoma. We conclude that STAT1 activity in breast cancer cells is responsible for shaping an immunosuppressive tumor microenvironment, and inhibiting STAT1 activity is a promising immune therapeutic approach.	[Hix, Laura M.; Karavitis, John; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol, Chicago, IL 60611 USA; [Hix, Laura M.; Karavitis, John; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem, Chicago, IL 60611 USA; [Hix, Laura M.; Karavitis, John; Khan, Mohammad W.; Shi, Yihui H.; Khazaie, Khashayarsha; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol, Chicago, IL 60611 USA.	m-zhang@northwestern.edu			Department of Defense [W81XWH-10-1-0200, W81XWH-10-1-0685]; Susan G. Komen for the Cure Foundation [KG 080231]	Department of Defense(United States Department of Defense); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by Department of Defense Predoctoral Fellowship W81XWH-10-1-0200 (to L. M. H.), Department of Defense Idea Award W81XWH-10-1-0685 (to K. K. and M. Z.), and Susan G. Komen for the Cure Foundation Grant KG 080231 (to M. Z.).	AALTOMAA S, 1992, EUR J CANCER, V28A, P859, DOI 10.1016/0959-8049(92)90134-N; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; American Cancer Society Inc, BREAST CANC FACTS FI; Brooks B, 1997, INT J CANCER, V73, P690, DOI 10.1002/(SICI)1097-0215(19971127)73:5<690::AID-IJC13>3.0.CO;2-A; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Cheon EC, 2011, CANCER RES, V71, P1627, DOI 10.1158/0008-5472.CAN-10-1923; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; de Prati AC, 2005, CURR MED CHEM, V12, P1819, DOI 10.2174/0929867054546645; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Demaria S, 2001, CLIN CANCER RES, V7, P3025; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gross S, 2008, IMMUNOL LETT, V116, P7, DOI 10.1016/j.imlet.2007.11.012; Handel-Fernandez ME, 2009, ANTICANCER RES, V29, P2051; Hix LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020702; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Karavitis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046342; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Khazaie K, 2006, SEMIN CANCER BIOL, V16, P124, DOI 10.1016/j.semcancer.2005.11.006; Khodarev N, 2010, ONCOGENE, V29, P920, DOI 10.1038/onc.2009.391; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Khodarev NN, 2012, CLIN CANCER RES, V18, P3015, DOI 10.1158/1078-0432.CCR-11-3225; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Li JN, 2007, J INTERF CYTOK RES, V27, P209, DOI 10.1089/jir.2006.0111; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Lynch RA, 2007, CANCER RES, V67, P1254, DOI 10.1158/0008-5472.CAN-06-2439; Manavi M, 2007, GYNECOL ONCOL, V105, P418, DOI 10.1016/j.ygyno.2006.12.032; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mocellin S, 2005, CYTOKINE GROWTH F R, V16, P35, DOI 10.1016/j.cytogfr.2004.11.001; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Schultz J, 2010, CLIN EXP METASTAS, V27, P133, DOI 10.1007/s10585-010-9310-7; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shi HY, 2003, HISTOL HISTOPATHOL, V18, P201, DOI 10.14670/HH-18.201; Shi HY, 2001, CANCER RES, V61, P6945; Simons DL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-52; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; TANAKA K, 1986, CANCER IMMUNOL IMMUN, V22, P37; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Xuan YT, 2003, J MOL CELL CARDIOL, V35, P525, DOI 10.1016/S0022-2828(03)00076-2; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	64	92	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11676	11688		10.1074/jbc.M112.441402	http://dx.doi.org/10.1074/jbc.M112.441402			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486482	Green Published, hybrid			2022-12-25	WOS:000318157600006
J	Kandouz, M; Zhao, J; Bier, A; Di Marco, S; Oviedo-Landaverde, I; Gallouzi, IE; Batist, G				Kandouz, Mustapha; Zhao, Jing; Bier, Andrew; Di Marco, Sergio; Oviedo-Landaverde, Irene; Gallouzi, Imed-Eddine; Batist, Gerald			Post-Transcriptional Regulation of Connexin43 in H-Ras-Transformed Cells	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA DECAY; HUMAN BREAST-CANCER; GAP-JUNCTIONS; GROWTH-FACTOR; GLIOMA-CELLS; POLY(C)-BINDING PROTEINS; ADENOCARCINOMA CELLS; SIGNALING PATHWAY	Connexin43 (Cx43) expression is lost in cancer cells and many studies have reported that Cx43 is a tumor suppressor gene. Paradoxically, in a cellular NIH3T3 model, we have previously shown that Ha-Ras-mediated oncogenic transformation results in increased Cx43 expression. Although the examination of transcriptional regulation revealed essential regulatory elements, it could not solve this paradox. Here we studied post-transcriptional regulation of Cx43 expression in cancer using the same model in search of novel gene regulatory elements. Upon Ras transformation, both Cx43 mRNA stability and translation efficiency were increased. We investigated the role of Cx43 mRNA 3' and 5'Untranslated regions (UTRs) and found an opposing effect; a 5'UTR-driven positive regulation is observed in Ras-transformed cells (NIH-3T3(Ras)), while the 3'UTR is active only in normal NIH-3T3(Neo) cells and completely silenced in NIH-3T3(Ras) cells. Most importantly, we identified a previously unknown regulatory element within the 3'UTR, named S1516, which accounts for this 3'UTR-mediated regulation. We also examined the effect of other oncogenes and found that Ras- and Src-transformed cells show a different Cx43 UTRs post-transcriptional regulation than ErbB2-transformed cells, suggesting distinct regulatory pathways. Next, we detected different patterns of S1516 RNA-protein complexes in NIH-3T3(Neo) compared to NIH-3T3(Ras) cells. A proteomic approach identified most of the S1516-binding proteins as factors involved in post-transcriptional regulation. Building on our new findings, we propose a model to explain the discrepancy between the Cx43 expression in Ras-transformed NIH3T3 cells and the data in clinical specimens.	[Kandouz, Mustapha] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Kandouz, Mustapha] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Zhao, Jing; Bier, Andrew; Oviedo-Landaverde, Irene; Batist, Gerald] McGill Univ, Montreal Ctr Expt Therapeut Canc, Segal Canc Ctr, Lady Davis Inst Med Res,Dept Oncol, Montreal, PQ, Canada; [Di Marco, Sergio; Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Lady Davis Institute; McGill University; McGill University	Kandouz, M (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA.	ag1764@wayne.edu; gerald.batist@mcgill.ca		Di Marco, Sergio/0000-0002-4039-0600	Canadian Breast Cancer Research Alliance/National Cancer Institute; Wayne State University School of Medicine, Department of Pathology	Canadian Breast Cancer Research Alliance/National Cancer Institute; Wayne State University School of Medicine, Department of Pathology	This work was supported by a Canadian Breast Cancer Research Alliance/National Cancer Institute grant to G. B. and a start-up fund from Wayne State University School of Medicine, Department of Pathology, to M. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT CD, 1990, TOXICOL PATHOL, V18, P324, DOI 10.1177/019262339001800211; Alldredge B, 2008, J CLIN PATHOL, V61, P885, DOI 10.1136/jcp.2008.055699; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Auboeuf D, 2005, MOL CELL BIOL, V25, P5307, DOI 10.1128/MCB.25.13.5307-5316.2005; Bao XP, 2000, AM J PHYSIOL-HEART C, V278, pH1598, DOI 10.1152/ajpheart.2000.278.5.H1598; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bier A, 2009, MOL CANCER THER, V8, P786, DOI 10.1158/1535-7163.MCT-08-0930; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; BOS JL, 1989, CANCER RES, V49, P4682; BRISSETTE JL, 1991, MOL CELL BIOL, V11, P5364, DOI 10.1128/MCB.11.10.5364; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Carystinos GD, 2003, MOL PHARMACOL, V63, P821, DOI 10.1124/mol.63.4.821; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2012, METHOD ENZYMOL, V511, P347, DOI 10.1016/B978-0-12-396546-2.00016-4; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Greco SJ, 2012, REPORTER ASSAY DETEC; Gregory LA, 2011, CURR CANCER THER REV, V7, P176, DOI 10.2174/157339411796234915; Hofer A, 1996, J NEUROSCI, V16, P4311; Holden PR, 1997, CARCINOGENESIS, V18, P15, DOI 10.1093/carcin/18.1.15; Hossain MZ, 1999, J BIOL CHEM, V274, P10489, DOI 10.1074/jbc.274.15.10489; Hossain MZ, 1998, J CELL PHYSIOL, V176, P332, DOI 10.1002/(SICI)1097-4652(199808)176:2<332::AID-JCP11>3.3.CO;2-O; Hossain MZ, 1999, J CELL PHYSIOL, V179, P87, DOI 10.1002/(SICI)1097-4652(199904)179:1<87::AID-JCP11>3.0.CO;2-K; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.3.CO;2-S; Inose H, 2009, MICRORNA REGULATORY; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Jagatheesan G, 1999, J CELL SCI, V112, P4651; Ji XJ, 2007, MOL CELL BIOL, V27, P3290, DOI 10.1128/MCB.02289-05; Kandouz M, 2004, ONCOGENE, V23, P4763, DOI 10.1038/sj.onc.1207506; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Klotz LO, 2012, ARCH BIOCHEM BIOPHYS, V524, P23, DOI 10.1016/j.abb.2012.03.012; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Lahlou H, 2005, MOL CELL BIOL, V25, P4034, DOI 10.1128/MCB.25.10.4034-4045.2005; Laird DW, 1999, CANCER RES, V59, P4104; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lee CG, 2002, J BIOL CHEM, V277, P39679, DOI 10.1074/jbc.C200337200; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Lim PK, 2011, GAP JUNCTION MEDIATE; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Macaluso M, 2002, J CELL PHYSIOL, V192, P125, DOI 10.1002/jcp.10109; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; NICOLSON GL, 1988, P NATL ACAD SCI USA, V85, P473, DOI 10.1073/pnas.85.2.473; Pesole G, 2002, NUCLEIC ACIDS RES, V30, P335, DOI 10.1093/nar/30.1.335; Pfeifer I, 2004, NUCLEIC ACIDS RES, V32, P4550, DOI 10.1093/nar/gkh792; Prendergast GC, 1996, CANCER RES, V56, P2626; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Raponi M, 2008, CURR OPIN PHARMACOL, V8, P413, DOI 10.1016/j.coph.2008.06.006; RAYTER SI, 1989, ONCOGENES, P113; RINKERSCHAEFFER CW, 1993, INT J CANCER, V55, P841, DOI 10.1002/ijc.2910550525; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; Schiavi A, 1999, FEBS LETT, V464, P118, DOI 10.1016/S0014-5793(99)01699-3; Tomakidi P, 2000, CELL TISSUE RES, V301, P323, DOI 10.1007/s004410000231; Tsai H, 1996, BIOCHEM BIOPH RES CO, V227, P64, DOI 10.1006/bbrc.1996.1468; Umhauer S, 2000, AM J OBSTET GYNECOL, V182, P999, DOI 10.1016/S0002-9378(00)70135-9; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wong RCB, 2008, STEM CELL REV, V4, P283, DOI 10.1007/s12015-008-9038-9; YAMASAKI H, 1990, CARCINOGENESIS, V11, P1051, DOI 10.1093/carcin/11.7.1051; Yamasaki H, 1995, MUTAT RES-FUND MOL M, V333, P181, DOI 10.1016/0027-5107(95)00144-1; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883; ZHU DG, 1992, P NATL ACAD SCI USA, V89, P10218, DOI 10.1073/pnas.89.21.10218	77	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58500	10.1371/journal.pone.0058500	http://dx.doi.org/10.1371/journal.pone.0058500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505521	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100056
J	Kang, AD; Cosenza, SC; Bonagura, M; Manair, M; Reddy, MVR; Reddy, EP				Kang, Anthony D.; Cosenza, Stephen C.; Bonagura, Marie; Manair, Manoj; Reddy, M. V. Ramana; Reddy, E. Premkumar			ON01210.Na (Ex-RAD (R)) Mitigates Radiation Damage through Activation of the AKT Pathway	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ENDOTHELIAL APOPTOSIS; IN-VIVO; AGENTS; AMIFOSTINE; PROGENITORS; RESISTANCE; STABILITY; SURVIVAL	Development of radio-protective agents that are non-toxic is critical in light of ever increasing threats associated with proliferation of nuclear materials, terrorism and occupational risks associated with medical and space exploration. In this communication, we describe the discovery, characterization and mechanism of action of ON01210.Na, which effectively protects mouse and human bone marrow cells from radiation-induced damage both in vitro and in vivo. Our results show that treatment of normal fibroblasts with ON01210.Na before and after exposure to ionizing radiation provides dose dependent protection against radiation-induced damage. Treatment of mice with ON01210.Na prior to radiation exposure was found to result in a more rapid recovery of their hematopoietic system. The mechanistic studies described here show that ON01210.Na manifests its protective effects through the up-regulation of PI3-Kinase/AKT pathways in cells exposed to radiation. These results suggest that ON01210.Na is a safe and effective radioprotectant and could be a novel agent for use in radiobiological disasters.	[Kang, Anthony D.; Cosenza, Stephen C.; Bonagura, Marie; Reddy, M. V. Ramana; Reddy, E. Premkumar] Fels Inst Canc Res & Mol Biol, Philadelphia, PA USA; [Manair, Manoj] Onconova Therapeut Inc, Newtown, PA USA		Reddy, EP (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	ep.reddy@mssm.edu	Reddy, E. Premkumar/F-6233-2011		Onconova Therapeutics Inc.	Onconova Therapeutics Inc.	This work was supported by Onconova Therapeutics Inc. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bonnaud S, 2010, CANCER RES, V70, P9905, DOI 10.1158/0008-5472.CAN-10-2043; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DENEKAMP J, 1986, INT J RADIAT BIOL, V49, P357, DOI 10.1080/09553008514552591; Dumont F, 2010, EXPERT OPIN THER PAT, V20, P73, DOI 10.1517/13543770903490429; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Ghosh SP, 2009, RADIAT RES, V171, P173, DOI 10.1667/RR1367.1; Gumireddy K, 2005, P NATL ACAD SCI USA, V102, P1992, DOI 10.1073/pnas.0408283102; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Gupta AK, 2001, METHOD ENZYMOL, V333, P284; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hosseinimehr SJ, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Lancell J, 2008, AVIAT SPACE ENVIR MD, V79, P651, DOI 10.3357/ASEM.2113.2008; List AF, 1998, LEUKEMIA, V12, P1596, DOI 10.1038/sj.leu.2401151; Moulder JE, 2007, SEMIN RADIAT ONCOL, V17, P141, DOI 10.1016/j.semradonc.2006.11.010; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Porta C, 2000, HAEMATOLOGICA, V85, P820; Ramdas J, 2003, J PEDIAT HEMATOL ONC, V25, P19, DOI 10.1097/00043426-200301000-00006; Reddy EP, 2004, E STYRYL SULFONE ANT; Reddy EP, 2002, METHOD PROTECTING CE; Reddy MVR, 2008, J MED CHEM, V51, P86, DOI 10.1021/jm701077b; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stone HB, 2004, RADIAT RES, V162, P711, DOI 10.1667/RR3276; Suman S, 2012, J RADIAT RES, V53, P368, DOI 10.1269/jrr.11191; Thotala DK, 2008, CANCER RES, V68, P5859, DOI 10.1158/0008-5472.CAN-07-6327; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Yazlovitskaya EM, 2006, LITHIUM TREATMENT PR; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	35	24	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58355	10.1371/journal.pone.0058355	http://dx.doi.org/10.1371/journal.pone.0058355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505494	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500073
J	Karachanak, S; Grugni, V; Fornarino, S; Nesheva, D; Al-Zahery, N; Battaglia, V; Carossa, V; Yordanov, Y; Torroni, A; Galabov, AS; Toncheva, D; Semino, O				Karachanak, Sena; Grugni, Viola; Fornarino, Simona; Nesheva, Desislava; Al-Zahery, Nadia; Battaglia, Vincenza; Carossa, Valeria; Yordanov, Yordan; Torroni, Antonio; Galabov, Angel S.; Toncheva, Draga; Semino, Ornella			Y-Chromosome Diversity in Modern Bulgarians: New Clues about Their Ancestry	PLOS ONE			English	Article							MUTATION-RATE; GENE FLOW; HAPLOGROUPS; DIFFUSION; ASIA	To better define the structure and origin of the Bulgarian paternal gene pool, we have examined the Y-chromosome variation in 808 Bulgarian males. The analysis was performed by high-resolution genotyping of biallelic markers and by analyzing the STR variation within the most informative haplogroups. We found that the Y-chromosome gene pool in modern Bulgarians is primarily represented by Western Eurasian haplogroups with, similar to 40% belonging to haplogroups E-V13 and I-M423, and 20% to R-M17. Haplogroups common in the Middle East (J and G) and in South Western Asia (R-L23*) occur at frequencies of 19% and 5%, respectively. Haplogroups C, N and Q, distinctive for Altaic and Central Asian Turkic-speaking populations, occur at the negligible frequency of only 1.5%. Principal Component analyses group Bulgarians with European populations, apart from Central Asian Turkic-speaking groups and South Western Asia populations. Within the country, the genetic variation is structured in Western, Central and Eastern Bulgaria indicating that the Balkan Mountains have been permeable to human movements. The lineage analysis provided the following interesting results: (i) R-L23* is present in Eastern Bulgaria since the post glacial period; (ii) haplogroup E-V13 has a Mesolithic age in Bulgaria from where it expanded after the arrival of farming; (iii) haplogroup J-M241 probably reflects the Neolithic westward expansion of farmers from the earliest sites along the Black Sea. On the whole, in light of the most recent historical studies, which indicate a substantial proto-Bulgarian input to the contemporary Bulgarian people, our data suggest that a common paternal ancestry between the proto-Bulgarians and the Altaic and Central Asian Turkic-speaking populations either did not exist or was negligible.	[Karachanak, Sena; Nesheva, Desislava; Toncheva, Draga] Med Univ Sofia, Dept Med Genet, Sofia, Bulgaria; [Karachanak, Sena; Grugni, Viola; Fornarino, Simona; Al-Zahery, Nadia; Battaglia, Vincenza; Carossa, Valeria; Torroni, Antonio; Semino, Ornella] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Yordanov, Yordan] Bulgarian Acad Sci, Inst Expt Morphol & Anthropol Museum, Sofia, Bulgaria; [Galabov, Angel S.] Bulgarian Acad Sci, Stephan Angeloff Inst Microbiol, Sofia, Bulgaria	Medical University Sofia; University of Pavia; Bulgarian Academy of Sciences; Bulgarian Academy of Sciences; Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences	Toncheva, D (corresponding author), Med Univ Sofia, Dept Med Genet, Sofia, Bulgaria.	dragatoncheva@gmail.com; ornella.semino@unipv.it	Torroni, Antonio/E-1557-2011; Battaglia, Vincenza/F-6950-2017; Yordanov, Yordan/M-4526-2016; Al-Zahery, Nadia/AAV-5878-2020; Karachanak-Yankova, Sena/AAL-2721-2021	Torroni, Antonio/0000-0002-4163-4478; Karachanak-Yankova, Sena/0000-0001-6441-629X; Nesheva, Desislava/0000-0002-8574-8477; Toncheva, Draga/0000-0002-7451-6363; SEMINO, Ornella/0000-0002-9675-9403	National Science Fund of Bulgaria [DOO 2-110/22.05.2009]; Fondazione Alma Mater Ticinensis; Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; Institute of International Education	National Science Fund of Bulgaria(National Science Fund of Bulgaria); Fondazione Alma Mater Ticinensis; Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; Institute of International Education	This study was supported by the National Science Fund of Bulgaria, project "Characterization of the anthropo-genetic identity of Bulgarians", contract number DOO 2-110/22.05.2009, and Fondazione Alma Mater Ticinensis (to OS and AT), the Italian Ministry of the University: Progetti Ricerca Interesse Nazionale 2009 (to OS and AT). NA-Z was supported by a fellowship from the Institute of International Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Bazin L, 1974, THESIS PARIS U LILLE; Beshevliev V, 1993, 1 BULGARIAN INSCRIPT; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cholov P, 2008, VOLGA BULGARIA 7 16; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Daskalov R, 2011, AMAZING WORLD PROTOB; Dimitrov B, 2005, 12 MYTHS BULGARIAN H, P38; DOBREV P, 2005, GOLDEN CORE BULGARIA; Dobrev P, 1998, CRUCIFIED HIST 1; Dobrev P, 1994, WORLD PROTOBULGARIAN; Dobrev PD, 1991, PROTOBULGARIANS ORIG; Dujchev I, 1963, MEDIEVAL TRANSLATION; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fol A, 2000, BULGARIANS; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Gimbutas M., 1970, INDOEUROPEAN INDOEUR, P155; Haefs H, 2009, GOLDENE REICH PAMIR; Karachanak S, 2012, INT J LEGAL MED; Kozlowski JK, 2007, DIOGENES, V54, P134, DOI 10.1177/0392192107077648; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Malyarchuk B, 2011, J HUM GENET, V56, P583, DOI 10.1038/jhg.2011.64; Manchen-Helfen O, 1973, WORLD HUNS STUDIES T; Marjanovic D, 2005, ANN HUM GENET, V69, P757, DOI 10.1111/j.1529-8817.2005.00190.x; Menges K.H., 1995, VER FFENTLICHUNGEN S; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nitecki M.H., 1994, ORIGINS ANATOMICALLY; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Petrov P, 1979, CHRESTOMATHY BULGARI, VI, P88; Pritsak O., 1955, BULGARISCHE FURSTENL; Rashev R, 1993, ORIGIN PROTOBULGARIA; Ray N., 2001, INTERNET ARCHAEOL, V11; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Stamatov A, 1997, TEMPORA INCOGNITA EA; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Wozniak M, 2010, AM J PHYS ANTHROPOL, V142, P540, DOI 10.1002/ajpa.21253; Yordanov Yordan Al, 2006, ANTHR BULGARIAN POPU; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	49	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56779	10.1371/journal.pone.0056779	http://dx.doi.org/10.1371/journal.pone.0056779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483890	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100008
J	Liu, TA; Jan, YJ; Ko, BS; Liang, SM; Chen, SC; Wang, J; Hsu, C; Wu, YM; Liou, JY				Liu, Tzu-An; Jan, Yee-Jee; Ko, Bor-Sheng; Liang, Shu-Man; Chen, Shyh-Chang; Wang, John; Hsu, Chiun; Wu, Yao-Ming; Liou, Jun-Yang			14-3-3 epsilon Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma	PLOS ONE			English	Article							ISOFORM-SPECIFIC EXPRESSION; TUMOR PROGRESSION; BREAST-CANCER; 14-3-3 PROTEINS; LUNG-CANCER; E-CADHERIN; EXTRAHEPATIC METASTASIS; DOWN-REGULATION; KAPPA-B; SNAIL	Background: 14-3-3 epsilon is implicated in regulating tumor progression, including hepatocellular carcinoma (HCC). Our earlier study indicated that elevated 14-3-3 epsilon expression is significantly associated with higher risk of metastasis and lower survival rates of HCC patients. However, the molecular mechanisms of how 14-3-3 epsilon regulates HCC tumor metastasis are still unclear. Methodology and Principal Findings: In this study, we show that increased 14-3-3 epsilon expression induces HCC cell migration and promotes epithelial-mesenchymal transition (EMT), which is determined by the reduction of E-cadherin expression and induction of N-cadherin and vimentin expression. Knockdown with specific siRNA abolished 14-3-3 epsilon-induced cell migration and EMT. Furthermore, 14-3-3 epsilon selectively induced Zeb-1 and Snail expression, and 14-3-3 epsilon-induced cell migration was abrogated by Zeb-1 or Snail siRNA. In addition, the effect of 14-3-3 epsilon-reduced E-cadherin was specifically restored by Zeb-1 siRNA. Positive 14-3-3 epsilon expression was significantly correlated with negative E-cadherin expression, as determined by immunohistochemistry analysis in HCC tumors. Analysis of 14-3-3 epsilon/E-cadherin expression associated with clinicopathological characteristics revealed that the combination of positive 14-3-3 epsilon and negative E-cadherin expression is significantly correlated with higher incidence of HCC metastasis and poor 5-year overall survival. In contrast, patients with positive 14-3-3 epsilon and positive E-cadherin expression had better prognostic outcomes than did those with negative E-cadherin expression. Significance: Our findings show for the first time that E-cadherin is one of the downstream targets of 14-3-3 epsilon in modulating HCC tumor progression. Thus, 14-3-3 epsilon may act as an important regulator in modulating tumor metastasis by promoting EMT as well as cell migration, and it may serve as a novel prognostic biomarker or therapeutic target for HCC.	[Liu, Tzu-An; Ko, Bor-Sheng; Liang, Shu-Man; Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Jan, Yee-Jee; Chen, Shyh-Chang; Wang, John] Taichung Vet Gen Hosp, Dept Pathol & Lab Med, Taichung, Taiwan; [Ko, Bor-Sheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hsu, Chiun] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Wu, Yao-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Liou, Jun-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan	Liou, JY (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	jliou@nhri.org.tw	Liou, Jun-Yang/B-1065-2010	KO, BOR-SHENG/0000-0002-7965-7579; Hsu, Chiun/0000-0002-1122-0055; WU, YAO-MING/0000-0002-1720-7863	National Health Research Institutes [01A1-CSPP07-014]; National Science Council [98-2320-B-400-008-MY3]; Taichung Veterans General Hospital [TCVGH-1005801B]; Department of Health of Taiwan [DOH-100-TD-C-111-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital; Department of Health of Taiwan	This work was supported by the National Health Research Institutes (01A1-CSPP07-014), the National Science Council (98-2320-B-400-008-MY3), the Taichung Veterans General Hospital (TCVGH-1005801B) and the Department of Health (DOH-100-TD-C-111-001) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Barnes DM, 1996, BRIT J CANCER, V74, P1445, DOI 10.1038/bjc.1996.563; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jan YJ, 2009, HUM PATHOL, V40, P1384, DOI 10.1016/j.humpath.2009.03.006; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kanai Y, 1997, INT J CANCER, V71, P355; Ko BS, 2011, HISTOPATHOLOGY, V58, P705, DOI 10.1111/j.1365-2559.2011.03789.x; Ko BS, 2011, HUM PATHOL, V42, P129, DOI 10.1016/j.humpath.2010.01.028; Ko BS, 2010, LIFE SCI, V86, P199, DOI 10.1016/j.lfs.2009.12.003; Ko BS, 2013, UPREGULATIO IN PRESS; Leal MF, 2012, WORLD J GASTROENTERO, V18, P1531, DOI 10.3748/wjg.v18.i13.1531; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Liang SF, 2009, PROTEOM CLIN APPL, V3, P743, DOI 10.1002/prca.200800198; Liou JY, 2008, MOL PHARMACOL, V74, P1399, DOI 10.1124/mol.108.049569; Liou JY, 2007, CANCER RES, V67, P3185, DOI 10.1158/0008-5472.CAN-06-3431; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Liu TA, 2011, AM J PATHOL, V179, P2698, DOI 10.1016/j.ajpath.2011.08.010; Liu Y, 2010, BRAIN RES, V1336, P98, DOI 10.1016/j.brainres.2010.04.009; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Matsumura T, 2001, CLIN CANCER RES, V7, P594; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Neal CL, 2012, ONCOGENE, V31, P897, DOI 10.1038/onc.2011.284; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Sofiadis A, 2012, EUR J ENDOCRINOL, V166, P657, DOI 10.1530/EJE-11-0856; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024843; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yang XL, 2009, J NEUROL SCI, V276, P54, DOI 10.1016/j.jns.2008.08.040; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhou YM, 2012, ANN SURG ONCOL, V19, P1700, DOI 10.1245/s10434-011-1772-6	44	46	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57968	10.1371/journal.pone.0057968	http://dx.doi.org/10.1371/journal.pone.0057968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483955	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100061
J	Wang, YR; Zhu, J; Li, Q; Li, W; Wu, N; Zheng, Y; Chang, HF; Chen, JJ; Wang, W				Wang, Yarong; Zhu, Jia; Li, Qiang; Li, Wei; Wu, Ning; Zheng, Ying; Chang, Haifeng; Chen, Jiajie; Wang, Wei			Altered Fronto-Striatal and Fronto-Cerebellar Circuits in Heroin-Dependent Individuals: A Resting-State fMRI Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; ABSTINENT COCAINE ABUSERS; ANTERIOR CINGULATE CORTEX; LOW-FREQUENCY FLUCTUATION; WORKING-MEMORY TASK; DORSAL STRIATUM; BRAIN ACTIVITY; DECISION-MAKING; FUNCTIONAL MRI	Background: The formation of compulsive pattern of drug use is related to abnormal regional neural activity and functional reorganization in the heroin addicts' brain, but the relationship between heroin-use-induced disrupted local neural activity and its functional organization pattern in resting-state is unknown. Methodology/Principal Findings: With fMRI data acquired during resting state from 17 male heroin dependent individuals (HD) and 15 matched normal controls (NC), we analyzed the changes of amplitude of low frequency fluctuation (ALFF) in brain areas, and its relationship with history of heroin use. Then we investigated the addiction related alteration in functional connectivity of the brain regions with changed ALFF using seed-based correlation analysis. Compared with NC, the ALFF of HD was obviously decreased in the right caudate, right dorsal anterior cingulate cortex (dACC), right superior medial frontal cortex and increased in the bilateral cerebellum, left superior temporal gyrus and left superior occipital gyrus. Of the six regions, only the ALFF value of right caudate had a negative correlation with heroin use. Setting the six regions as "seeds'', we found the functional connectivity between the right caudate and dorsolateral prefrontal cortex (dlPFC) was reduced but that between the right caudate and cerebellum was enhanced. Besides, an abnormal lateral PFC-dACC connection was also observed in HD. Conclusions: The observations of dysfunction of fronto-striatal and fronto-cerebellar circuit in HD implicate an altered balance between local neuronal assemblies activity and their integrated network organization pattern which may be involved in the process from voluntary to habitual and compulsive drug use.	[Wang, Yarong; Zhu, Jia; Li, Qiang; Li, Wei; Wu, Ning; Zheng, Ying; Chang, Haifeng; Chen, Jiajie; Wang, Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Radiol, Xian 710032, Peoples R China	Air Force Military Medical University	Wang, W (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Radiol, Xian 710032, Peoples R China.	m_d_wang@hotmail.com			National Natural Science Foundation of China [30870685, 81071143, 81071142]; Shaanxi Province Science and Technology Development Projection [2008k12-02, 2009K01-65, 2010k16-03-01, 2010K16-03-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Development Projection	This work was supported by the grants from National Natural Science Foundation of China (NO: 30870685, 81071143 and 81071142; http://www.nsfc.gov.cn) and Shaanxi Province Science and Technology Development Projection (NO: 2008k12-02, 2009K01-65, 2010k16-03-01 and 2010K16-03-02; http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2000, ALCOHOL CLIN EXP RES, V24, P1850, DOI 10.1097/00000374-200012000-00014; Amiaz R, 2009, ADDICTION, V104, P653, DOI 10.1111/j.1360-0443.2008.02448.x; Anderson CM, 2006, NEUROPSYCHOPHARMACOL, V31, P1318, DOI 10.1038/sj.npp.1300937; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Banich MT, 2009, NEUROPSYCHOLOGIA, V47, P3095, DOI 10.1016/j.neuropsychologia.2009.07.005; Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; BECK CHM, 1995, J PSYCHIATR NEUROSCI, V20, P25; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Bora E, 2010, ADDICT BIOL; Botta P, 2007, ALCOHOL, V41, P187, DOI 10.1016/j.alcohol.2007.04.004; BROTHERS L, 1990, BEHAV BRAIN RES, V41, P199, DOI 10.1016/0166-4328(90)90108-Q; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cox WM, 2006, PSYCHOL BULL, V132, P443, DOI 10.1037/0033-2909.132.3.443; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; Daglish MRC, 2003, NEUROIMAGE, V20, P1964, DOI 10.1016/j.neuroimage.2003.07.025; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fingelkurts AA, 2004, INT J NEUROSCI, V114, P843, DOI 10.1080/00207450490450046; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.3.CO;2-A; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Gruol DL, 1997, BRAIN RES, V773, P82, DOI 10.1016/S0006-8993(97)00912-8; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Jimenez-Rivera CA, 2000, EUR J PHARMACOL, V407, P91, DOI 10.1016/S0014-2999(00)00711-1; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Liu HH, 2008, AM J DRUG ALCOHOL AB, V34, P562, DOI 10.1080/00952990802295238; Liu HH, 2009, PSYCHIAT CLIN NEUROS, V63, P563, DOI 10.1111/j.1440-1819.2009.01989.x; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Lu L, 2008, CELL MOL NEUROBIOL, V28, P479, DOI 10.1007/s10571-007-9225-2; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; Martin-Solch C, 2001, EXP BRAIN RES, V139, P278, DOI 10.1007/s002210100751; Miquel Marta, 2009, Curr Drug Abuse Rev, V2, P26; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Oscar-Berman M, 1987, Recent Dev Alcohol, V5, P59; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubino T, 2003, EUR J NEUROSCI, V17, P325, DOI 10.1046/j.1460-9568.2003.02452.x; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; Shi J, 2008, EUR J PHARMACOL, V579, P160, DOI 10.1016/j.ejphar.2007.09.042; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8; Skidmore FM, 2011, NEUROIMAGE; Tavares P, 2008, CEREB CORTEX, V18, P1876, DOI 10.1093/cercor/bhm212; Thanos PK, 2005, BEHAV BRAIN RES, V164, P206, DOI 10.1016/j.bbr.2005.06.021; Van den Eynde F, 2010, BIOL PSYCHIAT, V67, P793, DOI 10.1016/j.biopsych.2009.11.023; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Volkow ND, 2003, J NEUROSCI, V23, P11461; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Vollstadt-Klein S, 2010, ADDICTION, V105, P1741, DOI 10.1111/j.1360-0443.2010.03022.x; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Wang Xuyi, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P728, DOI 10.3969/j.issn.1672-7347.2011.08.005; Weissman DH, 2002, NEUROIMAGE, V17, P1266, DOI 10.1006/nimg.2002.1284; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Xiao ZW, 2006, DRUG ALCOHOL DEPEN, V83, P157, DOI 10.1016/j.drugalcdep.2005.11.012; Xu JS, 2005, BIOL PSYCHIAT, V58, P143, DOI 10.1016/j.biopsych.2005.03.028; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang Zhi-Qiang, 2008, Zhonghua Yi Xue Za Zhi, V88, P1594; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982	74	41	45	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58098	10.1371/journal.pone.0058098	http://dx.doi.org/10.1371/journal.pone.0058098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483978	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100076
J	Wilkinson, M; Sherratt, E; Starace, F; Gower, DJ				Wilkinson, Mark; Sherratt, Emma; Starace, Fausto; Gower, David J.			A New Species of Skin-Feeding Caecilian and the First Report of Reproductive Mode in Microcaecilia (Amphibia: Gymnophiona: Siphonopidae)	PLOS ONE			English	Article							ICHTHYOPHIS	A new species of siphonopid caecilian, Microcaecilia dermatophaga sp. nov., is described based on nine specimens from French Guiana. The new species is the first new caecilian to be described from French Guiana for more than 150 years. It differs from all other Microcaecilia in having fewer secondary annular grooves and/or in lacking a transverse groove on the dorsum of the first collar. Observations of oviparity and of extended parental care in M. dermatophaga are the first reproductive mode data for any species of the genus. Microcaecilia dermatophaga is the third species, and represents the third genus, for which there has been direct observation of young animals feeding on the skin of their attending mother. The species is named for this maternal dermatophagy, which is hypothesised to be characteristic of the Siphonopidae.	[Wilkinson, Mark; Sherratt, Emma; Gower, David J.] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Sherratt, Emma] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sherratt, Emma] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Natural History Museum London; Harvard University; Harvard University	Sherratt, E (corresponding author), Nat Hist Museum, Dept Zool, Cromwell Rd, London SW7 5BD, England.	emma.sherratt@gmail.com	Wilkinson, Mark/J-2026-2014; Sherratt, Emma/A-9931-2011	Wilkinson, Mark/0000-0002-9459-8976; Sherratt, Emma/0000-0003-2164-7877	Centre national de la recherche scientifique; Biotechnology and Biological Sciences Research Council Syntax scheme; Natural Environment Research Council CASE Studentship [NE/F009011/1]	Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Biotechnology and Biological Sciences Research Council Syntax scheme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council CASE Studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported in part by funding from Centre national de la recherche scientifique, from the Biotechnology and Biological Sciences Research Council Syntax scheme, and from a Natural Environment Research Council CASE Studentship NE/F009011/1 to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Pires Teresa Cristina Sauer, 2010, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V5, P13; Dubbin W, 2001, SOILS; Dumeril A, 1864, MEMOIRES SOC IMPERIA, V1, P307; Kamei RG, 2009, ZOOTAXA, P26, DOI 10.11646/zootaxa.2267.1.2; Kouete TM, 2012, ISRN ZOOL, V2012, P7; Kupfer A, 2006, NATURE, V440, P926, DOI 10.1038/nature04403; Kupfer A, 2005, ACTA OECOL, V28, P95, DOI 10.1016/j.actao.2005.03.002; Lescure J., 2000, COLLECTION PATRIMOIN, V45; Maciel AO, 2011, ZOOTAXA, P1; Maciel Adriano Oliveira, 2011, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V6, P67; NUSSBAUM R A, 1979, Zoologische Mededelingen (Leiden), V54, P217; Renous S., 1990, Gegenbaurs Morphologisches Jahrbuch, V136, P781; Taylor E.H., 1968, CAECILIANS WORLD TAX; Teodecki EE, 1998, HERPETOLOGICA, V54, P154; Wilkinson M, 2008, BIOL LETTERS, V4, P358, DOI 10.1098/rsbl.2008.0217; Wilkinson M, 2010, ZOOTAXA, P35; Wilkinson M, 2011, ZOOTAXA, P41; Wilkinson M, 2009, HERPETOLOGICA, V65, P413, DOI 10.1655/08-030.1	18	32	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57756	10.1371/journal.pone.0057756	http://dx.doi.org/10.1371/journal.pone.0057756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483926	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100042
J	Jin, M; He, YQ; Li, HY; Huang, PW; Zhong, WM; Yang, H; Zhang, HL; Tan, M; Duan, ZJ				Jin, Miao; He, Yaqing; Li, Huiying; Huang, Pengwei; Zhong, Weiming; Yang, Hong; Zhang, Hailong; Tan, Ming; Duan, Zhao-jun			Two Gastroenteritis Outbreaks Caused by GII Noroviruses: Host Susceptibility and HBGA Phenotypes	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; NORWALK VIRUS-INFECTION; CAPSID PROTEIN FORMS; VIRAL GASTROENTERITIS; BINDING SPECIFICITY; NONSENSE MUTATION; STRUCTURAL BASIS; UNITED-STATES; P-DOMAIN; STRAIN	Noroviruses (NoVs) cause epidemic acute gastroenteritis, in which histo-blood group antigens (HBGAs) may play an important role in the host susceptibility. To further explore this issue, two outbreaks of acute gastroenteritis caused by a GII.4 and a GII.3 NoV, respectively, in China in 2009 were studied. Stool and saliva samples from symptomatic patients and water samples from the outbreak facilities were collected. RT-PCR showed that 23 out of 33 (GII.4 outbreak) and 12 out of 13 (GII.3outbreak) stool samples were NoV positive. For the GII.4 outbreak the NoV sequences of stool and water samples were from an identical GII.4 strain, while the same GII.3 NoV sequences were found in five stool samples from the GII.3 outbreak. The HBGA phenotypes (A, B, Le(a), Le(b), Le(x), and Le(y)) of all saliva samples were determined, which revealed both secretors and nonsecretors in the symptomatic groups of the two outbreaks. In the GII.3 outbreak, type O individuals appeared less susceptible, while the type A may be more at risk of infection. However, No preference of HBGAs was observed in the GII. 4 outbreak. The observation that nonsecretors were infected in both outbreaks differed from the previous results that nonsecretors are resistant to these two GII NoVs.	[Jin, Miao; Li, Huiying; Duan, Zhao-jun] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Jin, Miao; Huang, Pengwei; Zhong, Weiming; Tan, Ming] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Tan, Ming] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [He, Yaqing; Yang, Hong; Zhang, Hailong] Shenzhen Ctr Dis Control & Prevent, Major Infect Dis Control Key Lab, Shenzhen, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Shenzhen Center for Disease Control & Prevention (SZCDC)	Tan, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA.	Ming.Tan@cchmc.org; zhaojund@126.com			National Institute of Allergy and Infectious Diseases [R21 AI092434-01A1]; Institutional Clinical and Translational Science Award (NIH/NCRR) [1UL1RR026314-01]; National Natural Science Foundation of China [81000727]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092434] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institutional Clinical and Translational Science Award (NIH/NCRR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this article was supported by the National Institute of Allergy and Infectious Diseases (R21 AI092434-01A1), Institutional Clinical and Translational Science Award (NIH/NCRR Grant Number 1UL1RR026314-01) and National Natural Science Foundation of China (Grant number: 81000727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Bucardo F, 2009, J MED VIROL, V81, P728, DOI 10.1002/jmv.21426; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Chan MCW, 2008, J INFECT DIS, V198, P940, DOI 10.1086/588707; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514; GREEN KY, 2001, FIELDS VIROLOGY, P841; Halperin T, 2008, J INFECT DIS, V197, P63, DOI 10.1086/524145; Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; Jin M, 2008, J MED VIROL, V80, P1997, DOI 10.1002/jmv.21308; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Kindberg E, 2007, J CLIN MICROBIOL, V45, P2720, DOI 10.1128/JCM.00162-07; Le Guyader FS, 2010, J CLIN MICROBIOL, V48, P915, DOI 10.1128/JCM.01664-09; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Nordgren J, 2010, EMERG INFECT DIS, V16, P81, DOI 10.3201/eid1601.090633; Rockx BHG, 2005, J INFECT DIS, V191, P749, DOI 10.1086/427779; Rydell GE, 2009, GLYCOBIOLOGY, V19, P309, DOI 10.1093/glycob/cwn139; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2004, J MED VIROL, V74, P641, DOI 10.1002/jmv.20228; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2008, VIROLOGY, V379, P324, DOI 10.1016/j.virol.2008.06.041; Tan M, 2008, J INFECT DIS, V198, P940, DOI 10.1086/589810; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Tan M, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P111; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005058; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	55	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58605	10.1371/journal.pone.0058605	http://dx.doi.org/10.1371/journal.pone.0058605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472212	Green Submitted, Green Published, gold			2022-12-25	WOS:000315637900158
J	Nitta, M; Imamura, M; Inoue, Y; Kunitomo, Y; Lin, ZYC; Ogawa, T; Yogo, K; Ishida-Kitagawa, N; Fukunaga, N; Okano, H; Sato, E; Takeya, T; Miyoshi, J				Nitta, Mai; Imamura, Masanori; Inoue, Yu; Kunitomo, Yasuo; Lin, Zachary Yu-Ching; Ogawa, Takuya; Yogo, Keiichiro; Ishida-Kitagawa, Norihiro; Fukunaga, Noritaka; Okano, Hideyuki; Sato, Eimei; Takeya, Tatsuo; Miyoshi, Jun			Aberrant Gene Expression and Sexually Incompatible Genomic Imprinting in Oocytes Derived from XY Mouse Embryonic Stem Cells In Vitro	PLOS ONE			English	Article							FETAL GERM-CELLS; FOLLICLE DEVELOPMENT; PRIMORDIAL FOLLICLES; OVARIAN STRUCTURES; GRANULOSA-CELLS; Y-CHROMOSOME; MATURATION; MICE; GROWTH; DIFFERENTIATION	Mouse embryonic stem cells (ESCs) have the potential to differentiate into germ cells (GCs) in vivo and in vitro. Interestingly, XY ESCs can give rise to both male and female GCs in culture, irrespective of the genetic sex. Recent studies showed that ESC-derived primordial GCs contributed to functional gametogenesis in vivo; however, in vitro differentiation techniques have never succeeded in generating mature oocytes from ESCs due to cryptogenic growth arrest during the preantral follicle stages of development. To address this issue, a mouse ESC line, capable of producing follicle-like structures (FLSs) efficiently, was established to investigate their properties using conventional molecular biological methods. The results revealed that the ESC-derived FLSs were morphologically similar to ovarian primary-to-secondary follicles but never formed an antrum; instead, the FLSs eventually underwent abnormal development or cell death in culture, or formed teratomas when transplanted under the kidney capsule in mice. Gene expression analyses demonstrated that the FLSs lacked transcripts for genes essential to late folliculogenesis, including gonadotropin receptors and steroidogenic enzymes, whereas some other genes were overexpressed in FLSs compared to the adult ovary. The E-Cadherin protein, which is involved in cell-to-cell interactions, was also expressed ectopically. Remarkably, it was seen that oocyte-like cells in the FLSs exhibited androgenetic genomic imprinting, which is ordinarily indicative of male GCs. Although the FLSs did not express male GC marker genes, the DNA methyltransferase, Dnmt3L, was expressed at an abnormally high level. Furthermore, the expression of sex determination factors was ambiguous in FLSs as both male and female determinants were expressed weakly. These data suggest that the developmental dysfunction of the ESC-derived FLSs may be attributable to aberrant gene expression and genomic imprinting, possibly associated with uncertain sex determination in culture.	[Nitta, Mai; Inoue, Yu; Kunitomo, Yasuo; Ogawa, Takuya; Ishida-Kitagawa, Norihiro; Takeya, Tatsuo] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan; [Nitta, Mai; Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan; [Imamura, Masanori; Lin, Zachary Yu-Ching; Okano, Hideyuki] Keio Univ, Dept Physiol, Tokyo, Japan; [Yogo, Keiichiro] Shizuoka Univ, Lab Anim Reprod & Physiol, Shizuoka, Japan; [Fukunaga, Noritaka; Sato, Eimei] Tohoku Univ, Lab Anim Reprod, Sendai, Miyagi 980, Japan	Nara Institute of Science & Technology; Osaka Medical Center for Cancer & Cardiovascular Diseases; Keio University; Shizuoka University; Tohoku University	Imamura, M (corresponding author), Keio Univ, Dept Physiol, Tokyo, Japan.	imamura@a5.keio.jp; ttakeya@bs.naist.jp	Okano, Hideyuki/I-7584-2019; Ogawa, Takuya/ABC-9628-2020; Imamura, Masanori/AAV-5743-2021	Ogawa, Takuya/0000-0001-9194-3079; Imamura, Masanori/0000-0001-7609-2026; Inoue, Yu/0000-0002-7540-6940; Yogo, Keiichiro/0000-0003-2051-6891	Japan Society for the Promotion of Science [JSPS-16108003]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for World-leading Innovative R&D in Science and Technology (FIRST); Keio University; Grants-in-Aid for Scientific Research [25860222] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-leading Innovative R&D in Science and Technology (FIRST); Keio University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS-16108003); grant-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to J.M., for period 2004-2010); the Funding Program for World-leading Innovative R&D in Science and Technology (FIRST); and Keio University Grant-in-Aid for Encouragement of Young Medical Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian B, 2006, REPRODUCTION, V132, P699, DOI 10.1530/REP-06-0022; Alton M, 2008, REPRODUCTION, V135, P241, DOI 10.1530/REP-07-0383; Arnaud P, 2010, REPRODUCTION, V140, P411, DOI 10.1530/REP-10-0173; Binelli M, 2010, REPROD FERT DEVELOP, V22, P1, DOI 10.1071/RD09218; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Bowles J, 2010, REPRODUCTION, V139, P943, DOI 10.1530/REP-10-0075; Britt KL, 2002, J ENDOCRINOL, V175, P269, DOI 10.1677/joe.0.1750269; Durcova-Hills G, 2004, DEV BIOL, V268, P105, DOI 10.1016/j.ydbio.2003.12.018; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; EVANS EP, 1977, NATURE, V267, P430, DOI 10.1038/267430a0; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Isotani A, 2005, P NATL ACAD SCI USA, V102, P4039, DOI 10.1073/pnas.0406769102; Kageyama S, 2007, REPRODUCTION, V133, P85, DOI 10.1530/REP-06-0025; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kerjean A, 2003, EUR J HUM GENET, V11, P493, DOI 10.1038/sj.ejhg.5200990; Kidder GM, 2002, REPRODUCTION, V123, P613, DOI 10.1530/rep.0.1230613; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kumar TR, 2005, REPRODUCTION, V130, P293, DOI 10.1530/rep.1.00660; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lavagnolli TMC, 2009, DIFFERENTIATION, V78, P124, DOI 10.1016/j.diff.2009.07.003; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; MCLAREN A, 1981, J REPROD FERTIL, V61, P461, DOI 10.1530/jrf.0.0610461; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Nicholas CR, 2009, ENDOCR REV, V30, P264, DOI 10.1210/er.2008-0034; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Picton HM, 2008, REPRODUCTION, V136, P703, DOI 10.1530/REP-08-0290; Psathaki OE, 2011, STEM CELLS DEV, V20, P2205, DOI 10.1089/scd.2010.0575; Qing TT, 2007, DIFFERENTIATION, V75, P902, DOI 10.1111/j.1432-0436.2007.00181.x; Salha O, 1998, HUM REPROD UPDATE, V4, P816, DOI 10.1093/humupd/4.6.816; Salvador LM, 2008, METHODS, V45, P172, DOI 10.1016/j.ymeth.2008.03.004; Shen W, 2007, REPRODUCTION, V134, P223, DOI 10.1530/REP-06-0378; Shen W, 2006, BIOL REPROD, V75, P615, DOI 10.1095/biolreprod.106.051482; Soyal SM, 2000, DEVELOPMENT, V127, P4645; SPEARS N, 1994, HUM REPROD, V9, P527, DOI 10.1093/oxfordjournals.humrep.a138539; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Tedesco M, 2011, INT J DEV BIOL, V55, P215, DOI 10.1387/ijdb.103108mt; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vanderhyden BC, 1997, BIOL REPROD, V57, P641, DOI 10.1095/biolreprod57.3.641; Villemure M, 2007, DEV BIOL, V301, P1, DOI 10.1016/j.ydbio.2006.10.034; West FD, 2010, HUM REPROD, V25, P168, DOI 10.1093/humrep/dep338; Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739; Young JC, 2010, BIOL REPROD, V82, P390, DOI 10.1095/biolreprod.109.078493; Yu Z, 2009, J MOL CELL BIOL, V1, P93, DOI 10.1093/jmcb/mjp026; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	59	5	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58555	10.1371/journal.pone.0058555	http://dx.doi.org/10.1371/journal.pone.0058555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472205	Green Submitted, gold, Green Published			2022-12-25	WOS:000315637900151
J	Costello, MJ; Bouchet, P; Boxshall, G; Fauchald, K; Gordon, D; Hoeksema, BW; Poore, GCB; van Soest, RWM; Stohr, S; Walter, TC; Vanhoorne, B; Decock, W; Appeltans, W				Costello, Mark J.; Bouchet, Philippe; Boxshall, Geoff; Fauchald, Kristian; Gordon, Dennis; Hoeksema, Bert W.; Poore, Gary C. B.; van Soest, Rob W. M.; Stohr, Sabine; Walter, T. Chad; Vanhoorne, Bart; Decock, Wim; Appeltans, Ward			Global Coordination and Standardisation in Marine Biodiversity through the World Register of Marine Species (WoRMS) and Related Databases	PLOS ONE			English	Article							CLIMATE-CHANGE; TAXONOMY; COLLECTIONS; INFORMATION; CONSERVATION; PUBLICATION; RICHNESS; IMPACT; OCEAN; RATES	The World Register of Marine Species is an over 90% complete open-access inventory of all marine species names. Here we illustrate the scale of the problems with species names, synonyms, and their classification, and describe how WoRMS publishes online quality assured information on marine species. Within WoRMS, over 100 global, 12 regional and 4 thematic species databases are integrated with a common taxonomy. Over 240 editors from 133 institutions and 31 countries manage the content. To avoid duplication of effort, content is exchanged with 10 external databases. At present WoRMS contains 460,000 taxonomic names (from Kingdom to subspecies), 368,000 species level combinations of which 215,000 are currently accepted marine species names, and 26,000 related but non-marine species. Associated information includes 150,000 literature sources, 20,000 images, and locations of 44,000 specimens. Usage has grown linearly since its launch in 2007, with about 600,000 unique visitors to the website in 2011, and at least 90 organisations from 12 countries using WoRMS for their data management. By providing easy access to expert-validated content, WoRMS improves quality control in the use of species names, with consequent benefits to taxonomy, ecology, conservation and marine biodiversity research and management. The service manages information on species names that would otherwise be overly costly for individuals, and thus minimises errors in the application of nomenclature standards. WoRMS' content is expanding to include host-parasite relationships, additional literature sources, locations of specimens, images, distribution range, ecological, and biological data. Species are being categorised as introduced (alien, invasive), of conservation importance, and on other attributes. These developments have a multiplier effect on its potential as a resource for biodiversity research and management. As a consequence of WoRMS, we are witnessing improved communication within the scientific community, and anticipate increased taxonomic efficiency and quality control in marine biodiversity research and management.	[Costello, Mark J.] Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand; [Bouchet, Philippe] Museum Natl Hist Nat, F-75231 Paris, France; [Boxshall, Geoff] Nat Hist Museum, London SW7 5BD, England; [Fauchald, Kristian; Walter, T. Chad] Smithsonian Inst, Washington, DC 20560 USA; [Gordon, Dennis] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Hoeksema, Bert W.; van Soest, Rob W. M.] Nat Biodivers Ctr, Leiden, Netherlands; [Poore, Gary C. B.] Museum Victoria, Melbourne, Vic, Australia; [Stohr, Sabine] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; [Vanhoorne, Bart; Decock, Wim; Appeltans, Ward] Flanders Marine Inst, Oostende, Belgium; [Appeltans, Ward] Intergovt Oceanog Commiss UNESCO, IOC Project Off IODE, Oostende, Belgium	University of Auckland; Museum National d'Histoire Naturelle (MNHN); Natural History Museum London; Smithsonian Institution; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Naturalis Biodiversity Center; Museum Victoria; Swedish Museum of Natural History	Costello, MJ (corresponding author), Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand.	m.costello@auckland.ac.nz	Costello, Mark/C-9267-2013; Hoeksema, Bert W/B-2973-2010; Stöhr, Sabine/B-8629-2011; Hoeksema, Bert W./U-8530-2019	Costello, Mark/0000-0003-2362-0328; Hoeksema, Bert W/0000-0001-8259-3783; Stöhr, Sabine/0000-0002-2586-7239; Hoeksema, Bert W./0000-0001-8259-3783; Boxshall, Geoffrey/0000-0001-8170-7734	European commission research programme: FP4 Marine Science and Technology programme for ERMS [MAS3-CT97-0146]; Species 2000 europa; FP6 Marine biodiversity and Ecosystem Function (MarBEF) network of excellence; FP6 PESI; FP7 4D4 life; National Science Foundation CORONA project; Ocean Biogeographic Information system; Census of Marine Life Synthesis project; Global Biodiversity Information Facility; Musee Cantonal de Zoologie (Switzerland); Universite Pierre AMP; Marie Curie(France); School of computer Science AMP; Statitics, Lloyds Institute; Trinity College, Dublin(Ireland); Academia Sinica; Biodiversity Research Centre (Taiwan); Future of Marine Animal Program, Department of Biological Sciences, Dalhousie University (Canada); University of Aucklan's Leigh Marine Laboratory (New Zealand)	European commission research programme: FP4 Marine Science and Technology programme for ERMS; Species 2000 europa; FP6 Marine biodiversity and Ecosystem Function (MarBEF) network of excellence; FP6 PESI; FP7 4D4 life; National Science Foundation CORONA project; Ocean Biogeographic Information system; Census of Marine Life Synthesis project; Global Biodiversity Information Facility; Musee Cantonal de Zoologie (Switzerland); Universite Pierre AMP; Marie Curie(France); School of computer Science AMP; Statitics, Lloyds Institute; Trinity College, Dublin(Ireland); Academia Sinica(Academia Sinica - Taiwan); Biodiversity Research Centre (Taiwan); Future of Marine Animal Program, Department of Biological Sciences, Dalhousie University (Canada); University of Aucklan's Leigh Marine Laboratory (New Zealand)	The development of WoRMS has benefited from major funding from the European commission research programme: FP4 Marine Science and Technology programme for ERMS(MAS3-CT97-0146), Species 2000 europa, FP6 Marine biodiversity and Ecosystem Function (MarBEF) network of excellence, FP6 PESI and FP7 4D4 life. Funding has also been provided by the National Science Foundation CORONA project, Ocean Biogeographic Information system, Census of Marine Life Synthesis project and Global Biodiversity Information Facility. SMEBD acknowledges financial contributions from Musee Cantonal de Zoologie (Switzerland); Universite Pierre & Marie Curie(France); School of computer Science & Statitics, Lloyds Institute; Trinity College, Dublin(Ireland), Academia Sinica, Biodiversity Research Centre (Taiwan); Future of Marine Animal Program, Department of Biological Sciences, Dalhousie University (Canada); and the University of Aucklan's Leigh Marine Laboratory (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRS, 2009, AUSTR FAUN DIR; Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Agatha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022466; Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; Appeltans W, 2012, WORLD REGISTER MARIN; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Arizona State University International Institute for Species Exploration, 2012, TOP 10 NEW SPEC 2012; Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Bisby FA, 2010, SPECIES 2000 ITIS CA; Blazewicz-Paszkowycz Magdalena, 2012, PLoS One, V7, pe33068, DOI 10.1371/journal.pone.0033068; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Bouchet P, 1997, VELIGER, V40, P1; Bouchet Philippe, 2006, P31; Bowman DD, 2005, TRENDS PARASITOL, V21, P267, DOI 10.1016/j.pt.2005.04.008; Cairns SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021670; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2001, MYCOTA, V7, P3; Costello, 2001, OCEANIS, V24, P25; Costello M, 2001, EUROPEAN REGISTER MA; Costello MJ, 2006, MAR ECOL PROG SER, V316, P203, DOI 10.3354/meps316203; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Costello Mark J., 2000, Oceanography, V13, P48; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Costello MJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P319, DOI 10.1111/j.1466-8238.2010.00603.x; Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Costello MJ, 2005, MARBEF NEWSLETTER, V2, P20; Costello MJ, 2004, MARBEF NEWSLETTER, V1, P22; Costello MJ, 2010, GLOSSARY TERMINOLOGY; Cuvelier D, 2006, MARBEF NEWSL, V4, P14; Drew J, 2011, CONSERV BIOL, V25, P1250, DOI 10.1111/j.1523-1739.2011.01725.x; Edwards JL, 2000, SCIENCE, V289, P2312, DOI 10.1126/science.289.5488.2312; Eitel M, PLOS ONE UNPUB; Eschmeyer WN, 2010, ZOOTAXA, P19; Essl F, 2012, GLOBAL ECOL IN PRESS; Euzeby JP, 2012, LPSN LIST PROKARYOTI; Felder DL, 2009, BIODIVERSITY, V1; Fisher R, 2012, ENVIRON MODELL SOFTW, V30, P1, DOI 10.1016/j.envsoft.2011.11.011; Fisher R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026556; Fontaine B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036881; GASTON KJ, 1993, P ROY SOC B-BIOL SCI, V251, P139, DOI 10.1098/rspb.1993.0020; Godfray HCJ, 2007, NATURE, V446, P259, DOI 10.1038/446259a; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Gollner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009801; Gordon D., 2009, NZ INVENTORY BIODIVE, V1; Gordon DP, 2010, NZ INVENTORY BIODIVE, V2; Gordon DP, 2009, SPEC 2000 ITIS CAT L; Gordon DP, 2012, NZ INVENTORY BIODIVE; Gordon DP, 2012, NZ INVENTORY BIODIVE, V3, P17; Govaerts R, 2003, TAXON, V52, P583, DOI 10.2307/3647457; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hawksworth DL, 2011, IMA FUNGUS, V2, P55; Hoeksema BW, 2011, MAR ECOL-EVOL PERSP, V32, P135, DOI 10.1111/j.1439-0485.2011.00434.x; Hoeksema BW, 2009, RAFFLES B ZOOL, P91; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; *ICZN, 1999, INT COD ZOOL NOM; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; International Commission on Zoological Nomenclature, 2012, ZOOTAXA, V3450, P1, DOI DOI 10.11646/zootaxa.3450.1.1; Johnson GD, 2009, BIOL LETTERS, V5, P235, DOI 10.1098/rsbl.2008.0722; Johnson KG, 2011, BIOSCIENCE, V61, P147, DOI 10.1525/bio.2011.61.2.10; Kennedy MK, 2011, CANADIAN TECHNICAL R, V2933, P1; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; Knapp S, 2007, NATURE, V446, P261, DOI 10.1038/446261a; Knapp Sandra, 2011, PhytoKeys, V6, P5, DOI [10.1111/j.1469-8137.2011.03914.x, 10.3897/phytokeys.6.1960, 10.1111/j.1096-0031.2011.00378.x]; Kottelat M, 1997, BIOLOGIA, V52, P1; Lapage SP, 1992, INT CODE NOMENCLATUR; Linnaeus G, 1758, ANIMALIA, V1; Lleonart J, 2006, MAR ECOL PROG SER, V316, P231, DOI 10.3354/meps316231; Ludwig A, 2002, NATURE, V419, P447, DOI 10.1038/419447a; Mah CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035644; Mallet J, 2003, TRENDS ECOL EVOL, V18, P57, DOI 10.1016/S0169-5347(02)00061-7; McNeill J., 2006, V146, P1; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moretzsohn F, 2002, SPEC 2000 AS OC P 2, V171, P142; Mozzherin D, 2012, SCI NAMES PARSER; Munilla T, 2009, ANTARCT SCI, V21, P99, DOI 10.1017/S095410200800151X; Neiber MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019627; Nic Donnacha E, 2002, BIOL ENVIRON, V102, P185; Patterson DJ, 2010, TRENDS ECOL EVOL, V1297, P1; Pennisi E, 2000, SCIENCE, V289, P2306, DOI 10.1126/science.289.5488.2306; Perrin WF, 2012, WORLD CETACEA DATABA; Polaszek A, 2005, NATURE, V437, P477, DOI 10.1038/437477a; Poore GCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043529; Pyle RL, 2008, ZOOTAXA, P39, DOI 10.11646/zootaxa.1950.1.6; Rainbow PS, 2009, ZOOL SCR, V38, P33, DOI 10.1111/j.1463-6409.2007.00313.x; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Rees T, 2012, IRMNG HOMONYMS LIST; Rees T, 2011, TAXAMATCH FUZZY MATC; Ruggiero M, 2012, SPEC 2000 ITIS CAT L; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Scotland RW, 2003, TAXON, V52, P101, DOI 10.2307/3647306; Segers Hendrik, 2012, Zootaxa, V3179, P61; Shenkar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020657; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Stork Nigel E., 1997, P41; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Suarez-Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022915; Thomas James D., 1997, P357; van Bruggen A.C., 2001, Zoologische Verhandelingen (Leiden), V334, P7; van der Land J, 1994, UNESCO IOC REGISTER; van der Meij SET, 2009, MAR POLLUT BULL, V59, P101, DOI 10.1016/j.marpolbul.2009.02.021; van der Meij SET, 2010, MAR POLLUT BULL, V60, P1442, DOI 10.1016/j.marpolbul.2010.05.011; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; van Soest RWM, 2012, WORLD PORIFERA DATAB; Vandepitte L, 2011, HYDROBIOLOGIA, V667, P1, DOI 10.1007/s10750-011-0656-x; Wheeler QD, 2010, STATE OBSERVED SPECI; Wheeler QD, 2007, NATURE, V447, P142, DOI 10.1038/447142c; Williams GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022747; Williams JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035350; Wilson EO, 2000, SCIENCE, V289, P2279; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Wilson SP, 2005, J R STAT SOC C-APPL, V54, P897, DOI 10.1111/j.1467-9876.2005.00513.x	113	126	131	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51629	10.1371/journal.pone.0051629	http://dx.doi.org/10.1371/journal.pone.0051629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23505408	Green Published, gold, Green Submitted			2022-12-25	WOS:000313551500006
J	Joseph, K; Kulik, L; Coughlin, B; Kunchithapautham, K; Bandyopadhyay, M; Thiel, S; Thielens, NM; Holers, VM; Rohrer, B				Joseph, Kusumam; Kulik, Liudmila; Coughlin, Beth; Kunchithapautham, Kannan; Bandyopadhyay, Mausumi; Thiel, Steffen; Thielens, Nicole M.; Holers, V. Michael; Rohrer, Baerbel			Oxidative Stress Sensitizes Retinal Pigmented Epithelial (RPE) Cells to Complement-mediated Injury in a Natural Antibody-, Lectin Pathway-, and Phospholipid Epitope-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CHOROIDAL NEOVASCULARIZATION; LIPID-PEROXIDATION PRODUCTS; MACULAR DEGENERATION AMD; MEMBRANE-ATTACK-COMPLEX; MANNOSE-BINDING LECTIN; FACTOR-H; ISCHEMIA/REPERFUSION INJURY; SERINE-PROTEASE; ALTERNATIVE PATHWAY; REPERFUSION INJURY	Uncontrolled activation of the alternative complement pathway (AP) is thought to be associated with age-related macular degeneration. Previously, we have shown that in retinal pigmented epithelial (RPE) monolayers, oxidative stress reduced complement inhibition on the cell surface, resulting in sublytic complement activation and loss of transepithelial resistance (TER), but the potential ligand and pathway involved are unknown. ARPE-19 cells were grown as monolayers on transwell plates, and sublytic complement activation was induced with H2O2 and normal human serum. TER deteriorated rapidly in H2O2-exposed monolayers upon adding normal human serum. Although the effect required AP activation, AP was not sufficient, because elimination of MASP, but not C1q, prevented TER reduction. Reconstitution experiments to unravel essential components of the lectin pathway (LP) showed that both ficolin and mannan-binding lectin can activate the LP through natural IgM antibodies (IgM-C2) that recognize phospholipid cell surface modifications on oxidatively stressed RPE cells. The same epitopes were found on human primary embryonic RPE monolayers. Likewise, mouse laser-induced choroidal neovascularization, an injury that involves LP activation, could be increased in antibody-deficient rag1(-/-) mice using the phospholipid-specific IgM-C2. In summary, using a combination of depletion and reconstitution strategies, we have shown that the LP is required to initiate the complement cascade following natural antibody recognition of neoepitopes, which is then further amplified by the AP. LP activation is triggered by IgM bound to phospholipids. Taken together, we have defined novel mechanisms of complement activation in oxidatively stressed RPE, linking molecular events involved in age-related macular degeneration, including the presence of natural antibodies and neoepitopes.	[Joseph, Kusumam; Coughlin, Beth; Kunchithapautham, Kannan; Bandyopadhyay, Mausumi; Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Kulik, Liudmila; Holers, V. Michael] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA; [Thiel, Steffen] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Thielens, Nicole M.] Univ Grenoble 1, CNRS, Inst Biol Struct, UMR 5075 CEA, F-38027 Grenoble 1, France; [Rohrer, Baerbel] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; University of Colorado System; University of Colorado Anschutz Medical Campus; Aarhus University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Rohrer, B (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave,SEI 511, Charleston, SC 29425 USA.	rohrer@musc.edu	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302; Thiel, Steffen/0000-0002-4817-155X	National Institutes of Health Grant [R01EY019320, C06 RR015455]; Department of Veterans Affairs Grant [I01 RX000444]; Foundation Fighting Blindness; Research to Prevent Blindness, Inc. (New York); NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Grant(US Department of Veterans Affairs); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness, Inc. (New York)(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY019320. This work was also supported by Department of Veterans Affairs Grant I01 RX000444, Foundation Fighting Blindness, and an unrestricted grant to the Medical University of South Carolina from Research to Prevent Blindness, Inc. (New York). Animal studies were conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Banda NK, 2011, MOL IMMUNOL, V49, P281, DOI 10.1016/j.molimm.2011.08.021; Bandyopadhyay M, 2012, INVEST OPHTH VIS SCI, V53, P1953, DOI 10.1167/iovs.11-8638; Bergmann M, 2011, GRAEF ARCH CLIN EXP, V249, P1477, DOI 10.1007/s00417-011-1682-0; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Bhutto IA, 2011, BRIT J OPHTHALMOL, V95, P1323, DOI 10.1136/bjo.2010.199216; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Campa C, 2008, INVEST OPHTH VIS SCI, V49, P1178, DOI 10.1167/iovs.07-1194; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dhillon B, 2010, INVEST OPHTH VIS SCI, V51, P5858, DOI 10.1167/iovs.09-5124; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Edwards Albert O., 2007, Angiogenesis, V10, P119, DOI 10.1007/s10456-007-9064-2; Elvington A, 2012, J IMMUNOL, V188, P1460, DOI 10.4049/jimmunol.1102132; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Faro J, 2008, CLIN EXP IMMUNOL, V151, P275, DOI 10.1111/j.1365-2249.2007.03538.x; Fett AL, 2012, HISTOL HISTOPATHOL, V27, P357, DOI 10.14670/HH-27.357; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Gounopoulos P, 2007, Minerva Cardioangiol, V55, P821; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Issa PC, 2011, GRAEF ARCH CLIN EXP, V249, P163, DOI 10.1007/s00417-010-1568-6; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Jensenius JC, 2003, BIOCHEM SOC T, V31, P763, DOI 10.1042/BST0310763; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kaemmerer E, 2007, INVEST OPHTH VIS SCI, V48, P1342, DOI 10.1167/iovs.06-0549; Kijlstra A, 2005, OCUL IMMUNOL INFLAMM, V13, P3, DOI 10.1080/09273940590909185; Krohne TU, 2010, EXP EYE RES, V90, P261, DOI 10.1016/j.exer.2009.10.014; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; Kunchithapautham K, 2011, J BIOL CHEM, V286, P23717, DOI 10.1074/jbc.M110.214593; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; Morohoshi K, 2009, J AUTOIMMUN, V33, P247, DOI 10.1016/j.jaut.2009.09.003; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; National Advisory Eye Council, 1999, VIS RES NAT PLAN 199; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Nowak M, 2003, EUR J OPHTHALMOL, V13, P281, DOI 10.1177/112067210301300307; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Rajagopalan R, 2009, IMMUNOL LETT, V123, P114, DOI 10.1016/j.imlet.2009.02.013; Rayborn ME, 2006, ADV EXP MED BIOL, V572, P75; Rohrer B, 2012, OXID STRESS APPL BAS, P47, DOI 10.1007/978-1-61779-606-7_2; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Rohrer Barbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016; Rutar M, 2012, ADV EXP MED BIOL, V723, P31, DOI 10.1007/978-1-4614-0631-0_5; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; Takahashi M, 2007, ADV EXP MED BIOL, V598, P93; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Tateishi K, 2011, MICROBIOL IMMUNOL, V55, P817, DOI 10.1111/j.1348-0421.2011.00378.x; Thiel S, 2009, J IMMUNOL, V182, P2939, DOI 10.4049/jimmunol.0802053; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005304; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zeiss CJ, 2010, VET PATHOL, V47, P396, DOI 10.1177/0300985809359598; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727	69	50	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12753	12765		10.1074/jbc.M112.421891	http://dx.doi.org/10.1074/jbc.M112.421891			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493397	hybrid, Green Published			2022-12-25	WOS:000318555100032
J	Kawasaki, H; Doi, R; Ito, K; Shimoda, M; Ishida, N				Kawasaki, Haruhisa; Doi, Ryosuke; Ito, Kumpei; Shimoda, Masami; Ishida, Norio			The Circadian Binding of CLOCK Protein to the Promoter of C/ebp alpha Gene in Mouse Cells	PLOS ONE			English	Article							MUTANT MICE; MOLECULAR ANALYSIS; MYELOID-LEUKEMIA; EXPRESSION; TRANSCRIPTION; LIVER; DIFFERENTIATION; HOMEOSTASIS; RHYTHMS; ELEMENT	C/ebp alpha plays important roles in metabolism as well as in the maintenance of energy homeostasis. Here we describe loss of the circadian oscillation of C/ebp alpha expression in liver of Clock mutant mice. Reporter assays indicate Clock and Bmal significantly induced C/ebp alpha gene expression whereas Cry suppressed. Real time reporter assays showed that two mutated E-boxes disrupted C/ebp alpha promoter dependent-oscillation. Chromatin immunoprecipitation suggests Clock can bind to two E-boxes in the C/ebp alpha promoter with a circadian manner in vivo. Thus, C/ebp alpha gene transcription is under circadian control of a core clock component, Clock. The data suggests that circadian disturbances may affect metabolic abnormalities through the C/ebp alpha pathway in liver.	[Kawasaki, Haruhisa; Doi, Ryosuke; Ito, Kumpei; Ishida, Norio] Natl Inst Adv Sci & Technol AIST, Biomed Res Inst, Ishida Grp Clock Gene, Tsukuba, Ibaraki, Japan; [Doi, Ryosuke; Ito, Kumpei; Ishida, Norio] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Doi, Ryosuke] Kobe Univ, Div Cell Physiol, Dept Physiol & Cell Biol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Shimoda, Masami] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Kobe University; National Institute of Agrobiological Sciences - Japan	Ishida, N (corresponding author), Natl Inst Adv Sci & Technol AIST, Biomed Res Inst, Ishida Grp Clock Gene, 6-5 Cent, Tsukuba, Ibaraki, Japan.	n.ishida@aist.go.jp		DOI, RYOSUKE/0000-0002-1725-2082				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Ando H, 2009, CLIN EXP HYPERTENS, V31, P201, DOI 10.1080/10641960902822450; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Delgado-Lista J, 2012, NUTR METAB CARDIOVAS; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Friedman AD, 2003, BLOOD CELL MOL DIS, V31, P338, DOI 10.1016/S1079-9796(03)00135-9; Gery S, 2005, BLOOD, V106, P2827, DOI 10.1182/blood-2005-01-0358; Gery S, 2009, INTEGR CANCER THER, V8, P317, DOI 10.1177/1534735409352084; Ishida N, 2007, NEUROSCI RES, V57, P483, DOI 10.1016/j.neures.2006.12.012; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lu Y, 2010, AM J HEMATOL, V85, P426, DOI 10.1002/ajh.21706; Mongrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026622; Nakahata Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-1; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2001, NATURE, V410, P311, DOI 10.1038/35066655; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JA, 2000, GENE DEV, V14, P679; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Westmacott A, 2006, INT J DEV BIOL, V50, P653, DOI 10.1387/ijdb.062146aw	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58221	10.1371/journal.pone.0058221	http://dx.doi.org/10.1371/journal.pone.0058221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505471	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100036
J	Cravo, RM; Frazao, R; Perello, M; Osborne-Lawrence, S; Williams, KW; Zigman, JM; Vianna, C; Elias, CF				Cravo, Roberta M.; Frazao, Renata; Perello, Mario; Osborne-Lawrence, Sherri; Williams, Kevin W.; Zigman, Jeffery M.; Vianna, Claudia; Elias, Carol F.			Leptin Signaling in Kiss1 Neurons Arises after Pubertal Development	PLOS ONE			English	Article							PROOPIOMELANOCORTIN NEURONS; BODY-WEIGHT; ONSET; MICE; HYPOGONADISM; PEPTIDE; TARGETS	The adipocyte-derived hormone leptin is required for normal pubertal maturation in mice and humans and, therefore, leptin has been recognized as a crucial metabolic cue linking energy stores and the onset of puberty. Several lines of evidence have suggested that leptin acts via kisspeptin expressing neurons of the arcuate nucleus to exert its effects. Using conditional knockout mice, we have previously demonstrated that deletion of leptin receptors (LepR) from kisspeptin cells cause no puberty or fertility deficits. However, developmental adaptations and system redundancies may have obscured the physiologic relevance of direct leptin signaling in kisspeptin neurons. To overcome these putative effects, we re-expressed endogenous LepR selectively in kisspeptin cells of mice otherwise null for LepR, using the Cre-loxP system. Kiss1-Cre LepR null mice showed no pubertal development and no improvement of the metabolic phenotype, remaining obese, diabetic and infertile. These mice displayed decreased numbers of neurons expressing Kiss1 gene, similar to prepubertal control mice, and an unexpected lack of re-expression of functional LepR. To further assess the temporal coexpression of Kiss1 and Lepr genes, we generated mice with the human renilla green fluorescent protein (hrGFP) driven by Kiss1 regulatory elements and crossed them with mice that express Cre recombinase from the Lepr locus and the R26-tdTomato reporter gene. No coexpression of Kiss1 and LepR was observed in prepubertal mice. Our findings unequivocally demonstrate that kisspeptin neurons are not the direct target of leptin in the onset of puberty. Leptin signaling in kisspeptin neurons arises only after completion of sexual maturation.	[Cravo, Roberta M.; Frazao, Renata; Perello, Mario; Osborne-Lawrence, Sherri; Williams, Kevin W.; Zigman, Jeffery M.; Vianna, Claudia; Elias, Carol F.] Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA; [Frazao, Renata] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Perello, Mario] CONICET CICPBA, Multidisciplinary Inst Cell Biol, Neurophysiol Lab, La Plata, Buenos Aires, Argentina; [Elias, Carol F.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Michigan System; University of Michigan	Elias, CF (corresponding author), Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA.	cfelias@umich.edu	Frazao, Renata/D-1374-2012; Williams, Kevin W/ABD-5818-2021; Williams, Kevin W/AAA-4243-2020	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; Frazao, Renata/0000-0002-0877-8453; Elias, Carol F/0000-0001-9878-9203; Zigman, Jeffrey/0000-0003-3477-1295; Perello, Mario/0000-0003-2114-6765	National Institutes of Health [R01HD061539, R01HD69702, R01DA024680, R01MH085298, K01DK087780];  [c DK081182-01];  [UL1RR024923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061539, R01HD069702] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK087780, PL1DK081182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (grants R01HD061539 and R01HD69702 to C. F. E.; R01DA024680 and R01MH085298 to J.M.Z.; K01DK087780 to K.W.W.), and by c DK081182-01 and UL1RR024923, for the metabolic core at UTSW Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bentsen AH, 2010, PEPTIDES, V31, P275, DOI 10.1016/j.peptides.2009.11.017; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Colledge WH, 2009, TRENDS ENDOCRIN MET, V20, P115, DOI 10.1016/j.tem.2008.10.005; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Desroziers E, 2012, J NEUROENDOCRINOL, V24, P1154, DOI 10.1111/j.1365-2826.2012.02317.x; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Elias CF, 2012, TRENDS ENDOCRIN MET, V23, P9, DOI 10.1016/j.tem.2011.09.002; Elias CF, 2000, J COMP NEUROL, V423, P261; Elias CF, 2012, CELL MOL LIFE SCI; FRISCH RE, 1985, PERSPECT BIOL MED, V28, P611; Fu LY, 2010, J NEUROSCI, V30, P10205, DOI 10.1523/JNEUROSCI.2098-10.2010; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P408, DOI 10.1113/jphysiol.1963.sp007112; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Qiu JA, 2011, ENDOCRINOLOGY, V152, P1503, DOI 10.1210/en.2010-1285; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; Roa J, 2010, MOL CELL ENDOCRINOL, V324, P87, DOI 10.1016/j.mce.2009.12.018; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Smith JT, 2006, J NEUROENDOCRINOL, V18, P298, DOI 10.1111/j.1365-2826.2006.01417.x; Terasawa E, 2012, ENDOCRINOLOGY, V153, P1696, DOI 10.1210/en.2011-1970; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; VANDENBERGH JG, 1989, J ANIM SCI, V67, P1841; Williams KW, 2011, J NEUROSCI, V31, P13147, DOI 10.1523/JNEUROSCI.2602-11.2011; ZHANG YY, 1995, NATURE, V374, P479, DOI 10.1038/374479a0; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885	40	100	103	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58698	10.1371/journal.pone.0058698	http://dx.doi.org/10.1371/journal.pone.0058698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505551	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500116
J	Farmer, JR; Altschaefl, KM; O'Shea, KS; Miller, DJ				Farmer, Jocelyn R.; Altschaefl, Kate M.; O'Shea, K. Sue; Miller, David J.			Activation of the Type I Interferon Pathway Is Enhanced in Response to Human Neuronal Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NEURAL PROGENITOR CELLS; SINDBIS VIRUS-INFECTION; CENTRAL-NERVOUS-SYSTEM; HUMAN CYTOMEGALOVIRUS-INFECTION; EQUINE ENCEPHALITIS VIRUSES; AGE-DEPENDENT RESISTANCE; TOLL-LIKE RECEPTORS; ALPHA/BETA-INTERFERON; EXPRESSION LEVELS	Despite the crucial role of innate immunity in preventing or controlling pathogen-induced damage in most, if not all, cell types, very little is known about the activity of this essential defense system in central nervous system neurons, especially in humans. In this report we use both an established neuronal cell line model and an embryonic stem cell-based system to examine human neuronal innate immunity and responses to neurotropic alphavirus infection in cultured cells. We demonstrate that neuronal differentiation is associated with increased expression of crucial type I interferon signaling pathway components, including interferon regulatory factor-9 and an interferon receptor heterodimer subunit, which results in enhanced interferon stimulation and subsequent heightened antiviral activity and cytoprotective responses against neurotropic alphaviruses such as western equine encephalitis virus. These results identify important differentiation-dependent changes in innate immune system function that control cell-autonomous neuronal responses. Furthermore, this work demonstrates the utility of human embryonic stem cell-derived cultures as a platform to study the interactions between innate immunity, virus infection, and pathogenesis in central nervous system neurons.	[Farmer, Jocelyn R.; Miller, David J.] Univ Michigan, Sch Med, Dept Microbiol, Ann Arbor, MI 48109 USA; [Farmer, Jocelyn R.; Miller, David J.] Univ Michigan, Sch Med, Dept Immunol, Ann Arbor, MI 48109 USA; [Altschaefl, Kate M.] Univ Michigan, Sch Med, Dept Epidemiol, Ann Arbor, MI 48109 USA; [O'Shea, K. Sue] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Miller, David J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Miller, DJ (corresponding author), Univ Michigan, Sch Med, Dept Microbiol, Ann Arbor, MI 48109 USA.	milldavi@umich.edu		Farmer, Jocelyn/0000-0003-4901-9848	National Institute of Allergy and Infectious Diseases [U54 AI057153, R21 A1076975]; National Institute of General Medical Sciences [T32 GM007863, GM069985]; National Institute of Neurological Disorders and Stroke [F30 NS065566]; A. Alfred Taubman Consortium for Stem Cell Therapies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069985, T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS065566] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); A. Alfred Taubman Consortium for Stem Cell Therapies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institute of Allergy and Infectious Diseases grants U54 AI057153 (Region V "Great Lakes" Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research Career Development Award to D.J.M), R21 A1076975 (to D.J.M.), National Institute of General Medical Sciences grant T32 GM007863 (to J.R.F.) and GM069985 (to K.S.O.), National Institute of Neurological Disorders and Stroke grant F30 NS065566 (to J.R.F.), and the A. Alfred Taubman Consortium for Stem Cell Therapies. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 1998, J IMMUNOL, V161, P5016; Bianchi TI, 1997, ACTA VIROL, V41, P13; Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11; Burdeinick-Kerr R, 2005, J VIROL, V79, P5374, DOI 10.1128/JVI.79.9.5374-5385.2005; Castorena KM, 2008, VIROLOGY, V372, P208, DOI 10.1016/j.virol.2007.10.025; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; COHEN B, 1995, MOL CELL BIOL, V15, P4208; Cohen M. A., 2007, CURR PROTOC CELL BIO; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; DICKERSON RB, 1952, AM J MED, V12, P277, DOI 10.1016/0002-9343(52)90356-2; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Dukhovny A, 2012, J VIROL, V86, P3211, DOI 10.1128/JVI.06810-11; Fantuzzi L, 1997, EUR J IMMUNOL, V27, P1075, DOI 10.1002/eji.1830270506; FAZAKERLEY JK, 1993, VIROLOGY, V195, P627, DOI 10.1006/viro.1993.1414; Feuer R, 2005, J NEUROSCI, V25, P2434, DOI 10.1523/JNEUROSCI.4517-04.2005; Gaspard N, 2011, DEV MED CHILD NEUROL, V53, P13, DOI 10.1111/j.1469-8749.2010.03827.x; Gazziola C, 2005, INT J ONCOL, V26, P129; GRIFFIN DE, 1976, J INFECT DIS, V133, P456, DOI 10.1093/infdis/133.4.456; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hardy MP, 2001, BLOOD, V97, P473, DOI 10.1182/blood.V97.2.473; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; Kosugi I, 2000, LAB INVEST, V80, P1373, DOI 10.1038/labinvest.3780145; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Lawrence DMP, 2004, J VIROL, V78, P7319, DOI 10.1128/JVI.78.14.7319-7328.2004; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lowry PW, 1997, J LAB CLIN MED, V129, P405, DOI 10.1016/S0022-2143(97)90073-1; Luo MH, 2008, J VIROL, V82, P9994, DOI 10.1128/JVI.00943-08; Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09; LUTFALLA G, 1995, EMBO J, V14, P5100, DOI 10.1002/j.1460-2075.1995.tb00192.x; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; PATTYN SR, 1975, ARCH VIROL, V49, P33, DOI 10.1007/BF02175593; Pekosz A, 1996, J VIROL, V70, P5329, DOI 10.1128/JVI.70.8.5329-5335.1996; Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133; Peng WP, 2009, J INFECT DIS, V199, P950, DOI 10.1086/597275; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Porret Andree, 2006, V337, P185; Reed DS, 2005, J INFECT DIS, V192, P1173, DOI 10.1086/444397; REHBERG E, 1982, J BIOL CHEM, V257, P1497; REINARZ ABG, 1971, INFECT IMMUN, V3, P268, DOI 10.1128/IAI.3.2.268-273.1971; Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000; SABIN AB, 1947, JAMA-J AM MED ASSOC, V133, P281, DOI 10.1001/jama.1947.02880050001001; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Schoepp RJ, 2002, VIROLOGY, V302, P299, DOI 10.1006/viro.2002.1677; SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Tsueng G, 2011, J VIROL, V85, P5718, DOI 10.1128/JVI.02261-10; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Vernon PS, 2005, J VIROL, V79, P3438, DOI 10.1128/JVI.79.6.3438-3447.2005; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wellen J, 2009, NEUROPHARMACOLOGY, V56, P386, DOI 10.1016/j.neuropharm.2008.09.011; Wen YJ, 2011, EXPERT OPIN BIOL TH, V11, P41, DOI 10.1517/14712598.2011.540235; White LJ, 2001, J VIROL, V75, P3706, DOI 10.1128/JVI.75.8.3706-3718.2001; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou Y, 2009, J NEUROSCI RES, V87, P2916, DOI 10.1002/jnr.22110; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	73	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58813	10.1371/journal.pone.0058813	http://dx.doi.org/10.1371/journal.pone.0058813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505563	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500128
J	Nguyen, EV; Gharib, SA; Palazzo, SJ; Chow, YH; Goodlett, DR; Schnapp, LM				Nguyen, Elizabeth V.; Gharib, Sina A.; Palazzo, Steven J.; Chow, Yu-hua; Goodlett, David R.; Schnapp, Lynn M.			Proteomic Profiling of Bronchoalveolar Lavage Fluid in Critically Ill Patients with Ventilator-Associated Pneumonia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; C-REACTIVE PROTEIN; MASS-SPECTROMETRY; ANTIMICROBIAL PROTEINS; MICROARRAY DATA; INFLAMMATION; DIAGNOSIS; RECEPTOR; FIBRONECTIN; EXPRESSION	Rationale: Ventilator-associated pneumonia (VAP) is a common complication in patients with acute lung injury (ALI) and can lead to increased morbidity and mortality. Identifying protein profiles specific to VAP in bronchoalveolar lavage fluid (BALF) may aid in earlier diagnosis, elucidate mechanisms of disease, and identify putative targets for therapeutic intervention. Methods: BALF was obtained from 5 normal subjects and 30 ALI patients: 14 with VAP (VAP(+)) and 16 without VAP (VAP(-)). Each sample underwent shotgun proteomic analysis based on tandem mass spectrometry. Differentially expressed proteins between the groups were identified using statistical methods based on spectral counting. Mechanisms of disease were explored using functional annotation and protein interaction network analysis. Supervised classification algorithms were implemented to discover a proteomic classifier for identifying critically ill patients with VAP. Results: ALI patients had distinct BALF proteomic profiles compared to normal controls. Within the ALI group, we identified 76 differentially expressed proteins between VAP(+) and VAP(-). Functional analysis of these proteins suggested activation of pro-inflammatory pathways during VAP. We identified and validated a limited proteomic signature that discriminated VAP(+) from VAP(-) patients comprised of three proteins: S100A8, lactotransferrin (LTF), and actinin 1 (ACTN1). Conclusions: Combining proteomic with computational analyses is a powerful approach to study the BALF proteome during lung injury and development of VAP. This integrative methodology is a promising strategy to differentiate clinically relevant subsets of ALI patients, including those suffering from VAP.	[Nguyen, Elizabeth V.; Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Gharib, Sina A.; Chow, Yu-hua; Schnapp, Lynn M.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Ctr Lung Biol, Seattle, WA 98195 USA; [Palazzo, Steven J.] Seattle Univ, Coll Nursing, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle University	Gharib, SA (corresponding author), Univ Washington, Dept Med, Div Pulm & Crit Care Med, Ctr Lung Biol, Seattle, WA 98195 USA.	sagharib@u.washington.edu; goodlett@u.washington.edu	Palazzo, Steven/V-4571-2019	Nguyen, Elizabeth/0000-0002-6495-7827; GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health (NIH) Institute of Translational Health Sciences award [UL1RR025014]; American Heart Association; NIH [HL083481, K24HL068796, 1U54 447 AI57141]; National Center for Research Resources [1S10RR-449017262]; Washington State Life Sciences Discovery Fund [2496490]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Institute of Translational Health Sciences award; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Washington State Life Sciences Discovery Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health (NIH) UL1RR025014 Institute of Translational Health Sciences award (SAG), American Heart Association grant-in-aid (LMS), NIH HL083481 (LMS), K24HL068796 (LMS), NIH 1U54 447 AI57141 (DRG), National Center for Research Resources Grant 1S10RR-449017262 (DRG), and Grant #2496490 from the Washington State Life Sciences Discovery Fund to the Center for Intracellular Drug Delivery (LMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Determann RM, 2005, INTENS CARE MED, V31, P1495, DOI 10.1007/s00134-005-2818-7; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; Fagon JY, 2011, CRIT CARE, V15, DOI 10.1186/cc10050; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Fu X, 2008, J PROTEOME RES, V7, P845, DOI 10.1021/pr070271+; Ghio AJ, 2003, CRIT CARE MED, V31, P395, DOI 10.1097/01.CCM.0000050284.35609.97; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Herard AL, 1996, AM J PHYSIOL-LUNG C, V271, pL726, DOI 10.1152/ajplung.1996.271.5.L726; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lu YT, 2008, PROTEOM CLIN APPL, V2, P1208, DOI 10.1002/prca.200800069; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oppert M, 2002, RESUSCITATION, V53, P167, DOI 10.1016/S0300-9572(02)00008-4; Oudhuis GJ, 2009, INTENS CARE MED, V35, P1265, DOI 10.1007/s00134-009-1463-y; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Povoa P, 2005, EUR RESPIR J, V25, P804, DOI 10.1183/09031936.05.00071704; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Rasband W.S., 1997, IMAGE J; Rea-Neto A, 2008, CRIT CARE, V12, DOI 10.1186/cc6877; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sagel SD, 2009, PEDIATR PULM, V44, P402, DOI 10.1002/ppul.21028; Scherl A, 2008, ANAL CHEM, V80, P1182, DOI 10.1021/ac701680f; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; THOMPSON AB, 1990, J LAB CLIN MED, V115, P148; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016	34	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58782	10.1371/journal.pone.0058782	http://dx.doi.org/10.1371/journal.pone.0058782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505561	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500126
J	Saussereau, EL; Roussel, D; Diallo, S; Debarbieux, L; Edelman, A; Sermet-Gaudelus, I				Saussereau, Emilie Lyne; Roussel, Delphine; Diallo, Siradiou; Debarbieux, Laurent; Edelman, Aleksander; Sermet-Gaudelus, Isabelle			Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ION-TRANSPORT; CHLORIDE TRANSPORT; TRAFFICKING; COEFFICIENT; VALIDATION; EPITHELIUM; CHILDREN; CHANNELS	Background: Treatments designed to correct cystic fibrosis transmembrane conductance regulator (CFTR) defects must first be evaluated in preclinical experiments in the mouse model of cystic fibrosis (CF). Mice nasal mucosa mimics the bioelectric defect seen in humans. The use of nasal potential difference (V-TE) to assess ionic transport is a powerful test evaluating the restoration of CFTR function. Nasal V-TE in CF mice must be well characterized for correct interpretation. Methods: We performed V-TE measurements in large-scale studies of two mouse models of CF-B6; 129 cftr knockout and FVB F508del-CFTR-and their respective wild-type (WT) littermates. We assessed the repeatability of the test for cftr knockout mice and defined cutoff points distinguishing between WT and F508del-CFTR mice. Results: We determined the typical V-TE values for CF and WT mice and demonstrated the existence of residual CFTR activity in F508del-CFTR mice. We characterized intra-animal variability in B6;129 mice and defined the cutoff points for F508del-CFTR chloride secretion rescue. Hyperpolarization of more than -2.15 mV after perfusion with a low-concentration Cl solution was considered to indicate a normal response. Conclusions: These data will make it possible to interpret changes in nasal V-TE in mouse models of CF, in future preclinical studies.	[Saussereau, Emilie Lyne; Debarbieux, Laurent] Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France; [Saussereau, Emilie Lyne; Roussel, Delphine; Diallo, Siradiou; Edelman, Aleksander; Sermet-Gaudelus, Isabelle] Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, U845, Paris, France; [Saussereau, Emilie Lyne] Univ Paris 06, Cellule Pasteur UPMC, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Saussereau, EL (corresponding author), Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France.	sauss72@hotmail.fr		Roussel, Delphine/0000-0003-4644-7679; Debarbieux, Laurent/0000-0001-6875-5758	Vaincre la Mucoviscidose [IC0704]	Vaincre la Mucoviscidose	E. Saussereau received a PhD grant from Vaincre la Mucoviscidose (IC0704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Barker PM, 2005, AM J RESP CRIT CARE, V171, P868, DOI 10.1164/rccm.200311-1508OC; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brady KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1173, DOI 10.1152/ajplung.2001.281.5.L1173; Bruscia EM, 2006, P NATL ACAD SCI USA, V103, P2965, DOI 10.1073/pnas.0510758103; Cartiera MS, 2010, MOL PHARMACEUT, V7, P86, DOI 10.1021/mp900138a; Colas J, 2011, HUMAN MOL GENETICS; Egli M, 2004, J PHYSIOL-LONDON, V560, P857, DOI 10.1113/jphysiol.2004.066704; Goubau C, 2009, THORAX, V64, P683, DOI 10.1136/thx.2008.104752; Griesenbach U, 2008, AM J RESP CELL MOL, V39, P490, DOI 10.1165/rcmb.2007-0385OC; Grubb BR, 2009, AM J PHYSIOL-CELL PH, V296, pC1301, DOI 10.1152/ajpcell.00578.2008; Grubb BR, 2006, AM J RESP CELL MOL, V34, P355, DOI 10.1165/rcmb.2005-0286OC; Grubb BR, 1999, PHYSIOL REV, V79, P193; Lubamba B, 2008, AM J RESP CRIT CARE, V177, P506, DOI 10.1164/rccm.200703-344OC; Lubamba B, 2009, AM J RESP CRIT CARE, V179, P1022, DOI 10.1164/rccm.200901-0049OC; Middleton PG, 2010, PEDIATR PULM, V45, P789, DOI 10.1002/ppul.21253; Parsons DW, 2000, GENE THER, V7, P1810, DOI 10.1038/sj.gt.3301317; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Salinas DB, 2004, AM J PHYSIOL-LUNG C, V287, pL936, DOI 10.1152/ajplung.00354.2003; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; SCHWIEBERT EM, 1994, AM J PHYSIOL, V266, pC1464, DOI 10.1152/ajpcell.1994.266.5.C1464; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Sermet-Gaudelus I, 2010, THORAX, V65, P539, DOI 10.1136/thx.2009.123422; Sorensen JB, 2002, SOCIOL METHOD RES, V30, P475, DOI 10.1177/0049124102030004001; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tamanini A, 2011, AM J PHYSIOL-LUNG C, V300, pL380, DOI 10.1152/ajplung.00129.2010; Taylor SL, 1999, COMMUN SOIL SCI PLAN, V30, P1439, DOI 10.1080/00103629909370298; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053	31	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57317	10.1371/journal.pone.0057317	http://dx.doi.org/10.1371/journal.pone.0057317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505426	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500018
J	Sproull, M; Avondoglio, D; Kramp, T; Shankavaram, U; Camphausen, K				Sproull, Mary; Avondoglio, Dane; Kramp, Tamalee; Shankavaram, Uma; Camphausen, Kevin			Correlation of Plasma FL Expression with Bone Marrow Irradiation Dose	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE-RADIATION-SYNDROME; LIGAND CONCENTRATION; URINE BIOSPECIMENS; HEMATOPOIESIS; MICE; TRANSPLANTATION; CHEMOTHERAPY; BIODOSIMETRY	Purpose: Ablative bone marrow irradiation is an integral part of hematopoietic stem cell transplantation. These treatment regimens are based on classically held models of radiation dose and the bone marrow response. Flt-3 ligand (FL) has been suggested as a marker of hematopoiesis and bone marrow status but the kinetics of its response to bone marrow irradiation has yet to be fully characterized. In the current study, we examine plasma FL response to total body and partial body irradiation in mice and its relationship with irradiation dose, time of collection and pattern of bone marrow exposure. Materials/Methods: C57BL6 mice received a single whole body or partial body irradiation dose of 1-8 Gy. Plasma was collected by mandibular or cardiac puncture at 24, 48 and 72 hr post-irradiation as well as 1-3 weeks post-irradiation. FL levels were determined via ELISA assay and used to generate two models: a linear regression model and a gated values model correlating plasma FL levels with radiation dose. Results: At all doses between 1-8 Gy, plasma FL levels were greater than control and the level of FL increased proportionally to the total body irradiation dose. Differences in FL levels were statistically significant at each dose and at all time points. Partial body irradiation of the trunk areas, encompassing the bulk of the hematopoietically active bone marrow, resulted in significantly increased FL levels over control but irradiation of only the head or extremities did not. FL levels were used to generate a dose prediction model for total body irradiation. In a blinded study, the model differentiated mice into dose received cohorts of 1, 4 or 8 Gy based on plasma FL levels at 24 or 72 hrs post-irradiation. Conclusion: Our findings indicate that plasma FL levels might be used as a marker of hematopoietically active bone marrow and radiation exposure in mice.	[Sproull, Mary; Avondoglio, Dane; Kramp, Tamalee; Shankavaram, Uma; Camphausen, Kevin] NCI, Radiat Oncol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Camphausen, K (corresponding author), NCI, Radiat Oncol Branch, Bldg 10, Bethesda, MD 20892 USA.	camphauk@mail.nih.gov						Adkins DR, 2008, CURR OPIN HEMATOL, V15, P555, DOI 10.1097/MOH.0b013e32831188f5; Bertho JM, 2008, RADIAT RES, V169, P543, DOI 10.1667/RR1259.1; Bertho JM, 2009, BRIT J RADIOL, V82, P764, DOI 10.1259/bjr/49063618; Bertho JM, 2009, BIOMARKERS, V14, P94, DOI 10.1080/13547500902773904; Bertho JM, 2001, INT J RADIAT BIOL, V77, P703, DOI 10.1080/09553000110043711; Bieri S, 2001, INT J RADIAT ONCOL, V49, P1071, DOI 10.1016/S0360-3016(00)01491-7; Blakely WF, 2011, RADIAT MEAS, V46, P898, DOI 10.1016/j.radmeas.2011.05.006; Blumenthal RD, 2000, CANCER, V88, P333, DOI 10.1002/(SICI)1097-0142(20000115)88:2<333::AID-CNCR13>3.0.CO;2-D; Bourland J, 2007, CLIN RAD ONCOLOGY, P111; Chklovskaia E, 1999, BLOOD, V93, P2595, DOI 10.1182/blood.V93.8.2595.408k16_2595_2604; Corvo R, 1999, INT J RADIAT ONCOL, V43, P497, DOI 10.1016/S0360-3016(98)00441-6; Dainiak N, 2007, EXP HEMATOL, V35, P17, DOI 10.1016/j.exphem.2007.01.007; Davies SM, 2000, J CLIN ONCOL, V18, P340, DOI 10.1200/JCO.2000.18.2.340; DOWN JD, 1991, BLOOD, V77, P661; Fichelson S, 1998, EUR CYTOKINE NETW, V9, P7; Fish J, 2012, LONG TERM EFFECTS BO; Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204; Forman S, 2008, CANC MANAGEMENT MULT, P877; Gourmelon P, 2010, HEALTH PHYS, V98, P825, DOI 10.1097/HP.0b013e3181ce64d4; Gratwohl A, 1998, BLOOD, V92, P765; Harden SV, 2001, BRIT J RADIOL, V74, P1041, DOI 10.1259/bjr.74.887.741041; Hayward RM, 2008, J CELL MOL MED, V12, P343, DOI 10.1111/j.1582-4934.2007.00135.x; Huchet A, 2003, INT J RADIAT ONCOL, V57, P508, DOI 10.1016/S0360-3016(03)00584-4; Iversen PO, 2002, AM J PHYSIOL-REG I, V282, pR166, DOI 10.1152/ajpregu.2002.282.1.R166; Ivey RG, 2009, RADIAT RES, V171, P549, DOI 10.1667/RR1638.1; Iwashita T, 2003, J NEURO-ONCOL, V64, P265, DOI 10.1023/A:1025684903137; Kirk MJ, 2008, J CELL MOL MED, V12, P1250, DOI 10.1111/j.1582-4934.2008.00182.x; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; KRICUN ME, 1985, SKELETAL RADIOL, V14, P10, DOI 10.1007/BF00361188; Kun L, 2005, PEDIAT RAD ONCOLOGY, P15; Ljungman P, 2006, BONE MARROW TRANSPL, V37, P439, DOI 10.1038/sj.bmt.1705265; LYMAN SD, 1995, ONCOGENE, V11, P1165; LYMAN SD, 1994, STEM CELLS, V12, P99; Lyman SD, 1994, STEM CELLS S1, V12, P108; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; McClanahan T, 1996, BLOOD, V88, P3371, DOI 10.1182/blood.V88.9.3371.bloodjournal8893371; Meineke V., 2005, BR J RADIOL S, P196, DOI DOI 10.1259/BJR/25654769; Partridge MA, 2010, INT J RADIAT BIOL, V86, P321, DOI 10.3109/09553000903564034; Poujol C, 1998, BLOOD, V92, P2012, DOI 10.1182/blood.V92.6.2012.418k28_2012_2023; Prat M, 2006, LEUKEMIA LYMPHOMA, V47, P77, DOI 10.1080/10428190500175122; Prat M, 2005, RADIAT RES, V163, P408, DOI 10.1667/RR3340; Prat M, 2006, RADIAT RES, V166, P504, DOI 10.1667/RR0568.1; Shank B, 2007, CLIN RAD ONCOLOGY, P343; Shaposhnikov V, 1979, B EXP BIOL MED, P510; Siegel JA, 2003, J NUCL MED, V44, P67; Snyder WS, 1975, REPORT TASK GROUP RE; Waller E, 2009, HEALTH PHYS, V97, P145, DOI 10.1097/01.HP.0000348464.78396.23; Williams W, 1995, HEMATOLOGY, P15; Wodnar-Filipowicz A, 2003, NEWS PHYSIOL SCI, V18, P247, DOI 10.1152/nips.01452.2003; WodnarFilipowicz A, 1996, BLOOD, V88, P4493, DOI 10.1182/blood.V88.12.4493.bloodjournal88124493	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58558	10.1371/journal.pone.0058558	http://dx.doi.org/10.1371/journal.pone.0058558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505536	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500101
J	Jablonsky, J; Hagemann, M; Schwarz, D; Wolkenhauer, O				Jablonsky, Jiri; Hagemann, Martin; Schwarz, Doreen; Wolkenhauer, Olaf			Phosphoglycerate Mutases Function as Reverse Regulated Isoenzymes in Synechococcus elongatus PCC 7942	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; CARBON ACCLIMATION; METABOLISM; MUTANTS; SERINE	Phosphoglycerate-mutase (PGM) is an ubiquitous glycolytic enzyme, which in eukaryotic cells can be found in different compartments. In prokaryotic cells, several PGMs are annotated/localized in one compartment. The identification and functional characterization of PGMs in prokaryotes is therefore important for better understanding of metabolic regulation. Here we introduce a method, based on a multi-level kinetic model of the primary carbon metabolism in cyanobacterium Synechococcus elongatus PCC 7942, that allows the identification of a specific function for a particular PGM. The strategy employs multiple parameter estimation runs in high CO2, combined with simulations testing a broad range of kinetic parameters against the changes in transcript levels of annotated PGMs. Simulations are evaluated for a match in metabolic level in low CO2, to reveal trends that can be linked to the function of a particular PGM. A one-isoenzyme scenario shows that PGM2 is a major regulator of glycolysis, while PGM1 and PGM4 make the system robust against environmental changes. Strikingly, combining two PGMs with reverse transcriptional regulation allows both features. A conclusion arising from our analysis is that a two-enzyme PGM system is required to regulate the flux between glycolysis and the Calvin-Benson cycle, while an additional PGM increases the robustness of the system.	[Jablonsky, Jiri; Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany; [Hagemann, Martin; Schwarz, Doreen] Univ Rostock, Dept Plant Physiol, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Jablonsky, J (corresponding author), Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany.	jiri.jablonsky@gmail.com	Jablonsky, Jiri/F-7958-2015	Wolkenhauer, Olaf/0000-0001-6105-2937; Schwarz, Doreen/0000-0002-1071-5865	German Research Foundation (DFG) as part of PROMICS research group 1186	German Research Foundation (DFG) as part of PROMICS research group 1186(German Research Foundation (DFG))	The work presented here has been supported by the German Research Foundation (DFG) as part of PROMICS research group 1186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi S, 2012, BIOINFORMATICS, V28, P3203, DOI 10.1093/bioinformatics/bts608; BORKENHAGEN LF, 1959, J BIOL CHEM, V234, P849; CARRERAS J, 1982, COMP BIOCHEM PHYS B, V71, P591, DOI 10.1016/0305-0491(82)90467-9; Chiba Y, 2012, J BIOL CHEM, V287, P11934, DOI 10.1074/jbc.M111.330621; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Foster JM, 2010, PLOS ONE, V5; Fraser HI, 1999, FEBS LETT, V455, P344, DOI 10.1016/S0014-5793(99)00910-2; Hackenberg C, 2012, MICROBIOL-SGM, V158, P398, DOI 10.1099/mic.0.054544-0; Heinrich R., 1996, REGULATION CELLULAR; Huege J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016278; Jablonsky J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-185; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; PONCEDELEON MM, 1972, J BACTERIOL, V110, P895, DOI 10.1128/JB.110.3.895-904.1972; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Steuer R, 2012, J EXP BOT, V63, P2259, DOI 10.1093/jxb/ers018; Tabei Y, 2007, BIOCHEM BIOPH RES CO, V355, P1045, DOI 10.1016/j.bbrc.2007.02.065; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zaretsky Joseph Z, 2008, Transl Oncogenomics, V3, P99; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; Zhu XG, 2007, PLANT PHYSIOL, V145, P513, DOI 10.1104/pp.107.103713	22	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58281	10.1371/journal.pone.0058281	http://dx.doi.org/10.1371/journal.pone.0058281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484009	Green Published, gold			2022-12-25	WOS:000316936100099
J	Jiang, Y; Tang, JJ; Wu, BQ; Yuan, B; Qu, Z				Jiang, Yong; Tang, Jian Jun; Wu, Bao Qiang; Yuan, Bo; Qu, Zhen			The Protective Effects of Different-Time-Ischemic Preconditioning on the Reperfusion Injury in Fatty Livers in Rats	PLOS ONE			English	Article								Background: The present study was aimed to investigate the protective effects of different-time-ischemic preconditioning on the reperfusion injury in fatty livers in rats, and to elucidate the mechanisms underlying the protective effects and the optimal safe ischemic preconditioning time on the hepatic IR injury in steatotic livers. Methodology/Principal Findings: A rat fatty liver model was established by high-fat diet feeding. We investigated the changes in the concentration of AST, ALT, LDH and NO in the serum, and of MDA, SOD, and MPO in the liver samples in response to different ischemic preconditioning times and ischemia-reperfusion injury. Histological analysis was performed to evaluate the results of the hepatic fatty infiltration. 1) At 24 h after 15 min ischemic preconditioning with 10 min reperfusion (15 min +10 min IP), the extent and area of the necrosis was markedly higher in the fatty liver samples with respect to IR, compared to the normal liver samples. 2) In response to the treatment of 5/8 min + 10 min IP, the fatty liver group showed lower levels of serological indicators and liver MDA and MPO compared to the other groups, while the SOD activity of the fatty liver group was significantly higher than the other groups (p<.05). Compared to the corresponding IR group, all IP groups showed a significantly higher serum NO concentration (p<.05). Among the fatty liver groups, the 5/8 min+10 min IP group showed the highest NO concentration (p<.05). Conclusions/Significance: Fat infiltration could aggravate the ischemia-reperfusion injury in the rat liver. Furthermore, ischemic preconditioning could increase the tolerance of the fatty liver, which was induced by the high-fat diet, to hepatic ischemia-reperfusion injury in rats. The protocol of 5/8 min +10 min IP was the optimal regimen for the treatment of moderate and severe fatty livers.	[Jiang, Yong; Wu, Bao Qiang; Yuan, Bo; Qu, Zhen] 1st Peoples Hosp Changzhou, Dept Hepatobiliary Surg, Changzhou, Jiangsu, Peoples R China; [Tang, Jian Jun] Peoples Hosp Wujin, Dept Hepatobiliary Surg, Changzhou, Jiangsu, Peoples R China		Jiang, Y (corresponding author), 1st Peoples Hosp Changzhou, Dept Hepatobiliary Surg, Changzhou, Jiangsu, Peoples R China.	yjiang8888@hotmail.com			General Project of Jiangsu Province Department of Health [H200870]; Bidding Project of Changzhou Bureau of Health [ZD200811]; Social Development Project of Changzhou [CS2008912]	General Project of Jiangsu Province Department of Health; Bidding Project of Changzhou Bureau of Health; Social Development Project of Changzhou	The General Project of Jiangsu Province Department of Health (H200870), the Bidding Project of Changzhou Bureau of Health (ZD200811), the Social Development Project of Changzhou (CS2008912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Federico A, 2006, DIGEST LIVER DIS, V38, P789, DOI 10.1016/j.dld.2006.04.009; Iniguez Maria, 2008, Recent Pat Cardiovasc Drug Discov, V3, P9; Lehmann TG, 2003, TRANSPLANTATION, V76, P28, DOI 10.1097/01.TP.0000065299.29900.17; Nakano H, 1997, HEPATOLOGY, V26, P670, DOI 10.1002/hep.510260320; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Camara-Lemarroy CR, 2009, EUR J PHARMACOL, V621, P78, DOI 10.1016/j.ejphar.2009.08.038; Romanque P, 2010, TRANSPL P, V42, P1569, DOI 10.1016/j.transproceed.2009.11.052; Rutherford A, 2006, CLIN GASTROENTEROL H, V4, P1544, DOI 10.1016/j.cgh.2006.07.014	8	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58086	10.1371/journal.pone.0058086	http://dx.doi.org/10.1371/journal.pone.0058086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483973	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100074
J	Martin, JA; Parekh, P; Kim, Y; Morey, TE; Sefah, K; Gravenstein, N; Dennis, DM; Tan, WH				Martin, Jennifer A.; Parekh, Parag; Kim, Youngmi; Morey, Timothy E.; Sefah, Kwame; Gravenstein, Nikolaus; Dennis, Donn M.; Tan, Weihong			Selection of an Aptamer Antidote to the Anticoagulant Drug Bivalirudin	PLOS ONE			English	Article							DIRECT THROMBIN INHIBITORS; RNA APTAMERS; MOLECULES; SELEX; DNA; CHROMATOGRAPHY; PHARMACOLOGY; COAGULATION; LIGANDS; BINDS	Adverse drug reactions, including severe patient bleeding, may occur following the administration of anticoagulant drugs. Bivalirudin is a synthetic anticoagulant drug sometimes employed as a substitute for heparin, a commonly used anticoagulant that can cause a condition called heparin-induced thrombocytopenia (HIT). Although bivalrudin has the advantage of not causing HIT, a major concern is lack of an antidote for this drug. In contrast, medical professionals can quickly reverse the effects of heparin using protamine. This report details the selection of an aptamer to bivalirudin that functions as an antidote in buffer. This was accomplished by immobilizing the drug on a monolithic column to partition binding sequences from nonbinding sequences using a low-pressure chromatography system and salt gradient elution. The elution profile of binding sequences was compared to that of a blank column (no drug), and fractions with a chromatographic difference were analyzed via real-time PCR (polymerase chain reaction) and used for further selection. Sequences were identified by 454 sequencing and demonstrated low micromolar dissociation constants through fluorescence anisotropy after only two rounds of selection. One aptamer, JPB5, displayed a dose-dependent reduction of the clotting time in buffer, with a 20 mu M aptamer achieving a nearly complete antidote effect. This work is expected to result in a superior safety profile for bivalirudin, resulting in enhanced patient care.	[Martin, Jennifer A.; Parekh, Parag; Kim, Youngmi; Sefah, Kwame; Tan, Weihong] Univ Florida, Dept Chem, Shands Canc Ctr, Gainesville, FL 32611 USA; [Martin, Jennifer A.; Parekh, Parag; Kim, Youngmi; Sefah, Kwame; Tan, Weihong] Univ Florida, Dept Physiol & Funct Genom, Shands Canc Ctr, Gainesville, FL USA; [Martin, Jennifer A.; Parekh, Parag; Kim, Youngmi; Sefah, Kwame; Tan, Weihong] Univ Florida, Ctr Res Bio Nano Interface, Gainesville, FL USA; [Morey, Timothy E.; Gravenstein, Nikolaus; Dennis, Donn M.] Univ Florida, Dept Anesthesiol & Pharmacol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tan, WH (corresponding author), Univ Florida, Dept Chem, Shands Canc Ctr, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Tan, Weihong/AAA-4536-2020; Parekh, Parag/ABE-2100-2021; Tan, Weihong/A-5412-2008	Tan, Weihong/0000-0002-8066-1524; Morey, Timothy/0000-0003-2922-8984	National Institutes of Health; National Science Foundation; State of Florida Board of Governors	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); State of Florida Board of Governors	This work was supported by grants through the National Institutes of Health, National Science Foundation, and the State of Florida Board of Governors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker RC, 2005, THROMB HAEMOSTASIS, V93, P1014, DOI 10.1160/TH04-12-0790; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fanikos J, 2007, AM J CARDIOL, V100, P1465, DOI 10.1016/j.amjcard.2007.06.041; Gal SW, 1998, EUR J BIOCHEM, V252, P553, DOI 10.1046/j.1432-1327.1998.2520553.x; Giovannini R, 1998, ANAL CHEM, V70, P3348, DOI 10.1021/ac980390w; Glickman JF, 2002, J BIOMOL SCREEN, V7, P3, DOI 10.1177/108705710200700102; Gopinath SCB, 2008, THROMB RES, V122, P838, DOI 10.1016/j.thromres.2007.10.022; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Heckel A, 2006, ANGEW CHEM INT EDIT, V45, P6748, DOI 10.1002/anie.200602346; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Ishizuka N, 2002, J CHROMATOGR A, V960, P85, DOI 10.1016/S0021-9673(01)01580-1; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Joachimi A, 2007, J AM CHEM SOC, V129, P3036, DOI 10.1021/ja0677822; Kam PCA, 2005, ANAESTHESIA, V60, P565, DOI 10.1111/j.1365-2044.2005.04192.x; Kim YM, 2009, P NATL ACAD SCI USA, V106, P6489, DOI 10.1073/pnas.0812402106; Oney S, 2007, OLIGONUCLEOTIDES, V17, P265, DOI 10.1089/oli.2007.0089; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Roberts MWH, 2009, J SEP SCI, V32, P2485, DOI 10.1002/jssc.200900309; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2000, THROMB HAEMOSTASIS, V84, P841; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Sciulli TM, 2002, ANN PHARMACOTHER, V36, P1028; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; Tok JBH, 2008, CHEM COMMUN, P1883, DOI 10.1039/b717936g; Weitz JI, 2002, THROMB RES, V106, pV275, DOI 10.1016/S0049-3848(02)00093-2; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275	31	9	12	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57341	10.1371/journal.pone.0057341	http://dx.doi.org/10.1371/journal.pone.0057341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483901	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100018
J	Shimizu, C; Kim, J; Stepanowsky, P; Trinh, C; Lau, HD; Akers, JC; Chen, C; Kanegaye, JT; Tremoulet, A; Ohno-Machado, L; Burns, JC				Shimizu, Chisato; Kim, Jihoon; Stepanowsky, Petra; Trinh, Christine; Lau, Hubert D.; Akers, Johnny C.; Chen, Clark; Kanegaye, John T.; Tremoulet, Adriana; Ohno-Machado, Lucila; Burns, Jane C.			Differential Expression of miR-145 in Children with Kawasaki Disease	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CONVERTING-ENZYME GENE; GENOME-WIDE ASSOCIATION; CIRCULATING MICRORNAS; INSERTION/DELETION POLYMORPHISM; CARDIOVASCULAR-DISEASE; VASCULAR HOMEOSTASIS; SUSCEPTIBILITY; ACTIVATION; POPULATION	Background: Kawasaki disease is an acute, self-limited vasculitis of childhood that can result in structural damage to the coronary arteries. Previous studies have implicated the TGF-beta pathway in disease pathogenesis and generation of myofibroblasts in the arterial wall. microRNAs are small non-coding RNAs that modulate gene expression at the post-transcriptional level and can be transported between cells in extracellular vesicles. To understand the role that microRNAs play in modifying gene expression in Kawasaki disease, we studied microRNAs from whole blood during the acute and convalescent stages of the illness. Methodology/Principal Findings: RNA isolated from the matched whole blood of 12 patients with acute and convalescent Kawasaki disease were analyzed by sequencing of small RNA. This analysis revealed six microRNAs (miRs-143, -199b-5p, -618, -223, -145 and -145* (complementary strand)) whose levels were significantly elevated during the acute phase of Kawasaki disease. The result was validated using targeted qRT-PCR using an independent cohort (n = 16). miR-145, which plays a critical role in the differentiation of neutrophils and vascular smooth muscle cells, was expressed at high levels in blood samples from acute Kawasaki disease but not adenovirus-infected control patients (p = 0.005). miR-145 was also detected in small extracellular vesicles isolated from acute Kawasaki disease plasma samples. Pathway analysis of the predicted targets of the 6 differentially expressed microRNAs identified the TGF-beta pathway as the top pathway regulated by microRNAs in Kawasaki disease. Conclusion: Sequencing of small RNA species allowed discovery of microRNAs that may participate in Kawasaki disease pathogenesis. miR-145 may participate, along with other differentially expressed microRNAs, in regulating expression of genes in the TGF-beta pathway during the acute illness. If the predicted target genes are confirmed, our findings suggest a model of Kawasaki disease pathogenesis whereby miR-145 modulates TGF-beta signaling in the arterial wall.	[Shimizu, Chisato; Trinh, Christine; Lau, Hubert D.; Kanegaye, John T.; Tremoulet, Adriana; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kim, Jihoon; Stepanowsky, Petra; Ohno-Machado, Lucila] Univ Calif San Diego, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA; [Akers, Johnny C.; Chen, Clark] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA; [Kanegaye, John T.; Tremoulet, Adriana; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Shimizu, C (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	c1shimizu@ucsd.edu	Burns, Jane C/J-6167-2015; Shimizu, Chisato/J-6516-2015; Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277; Ohno-Machado, Lucila/0000-0002-8005-7327; Shimizu, Chisato/0000-0002-3149-2699	 [NIH U54 HL108460];  [NIH NHLBI 69413]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL108460, T35HL007491] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH U54 HL108460, NIH NHLBI 69413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Batliner J, 2012, LEUKEMIA RES, V36, P237, DOI 10.1016/j.leukres.2011.10.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fukazawa R, 2004, PEDIATR RES, V56, P597, DOI 10.1203/01.PDR.0000139426.16381.C8; Gatsiou A, 2012, CURR VASC PHARMACOL, V10, P524, DOI 10.2174/157016112801784611; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Orenstein JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038998; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rowley AH, 2011, ANNU REV MED, V62, P69, DOI 10.1146/annurev-med-042409-151944; Shim YH, 2006, J KOREAN MED SCI, V21, P208, DOI 10.3346/jkms.2006.21.2.208; Shimizu C, 2012, HUM PATHOL; Shimizu C, 2011, CIRC-CARDIOVASC GENE, V4, P16, DOI 10.1161/CIRCGENETICS.110.940858; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; SUZUKI A, 1986, PEDIATR CARDIOL, V7, P3, DOI 10.1007/BF02315475; Takahashi K, 2005, PEDIATR INT, V47, P305, DOI 10.1111/j.1442-200x.2005.02049.x; Takeuchi K, 1997, EUR J PEDIATR, V156, P266, DOI 10.1007/s004310050597; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wu SF, 2004, PEDIATR CARDIOL, V25, P529, DOI 10.1007/s00246-003-0662-5; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; YONESAKA S, 1989, Acta Paediatrica Japonica, V31, P706; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhu HL, 2012, J CLIN IMMUNOL, V32, P514, DOI 10.1007/s10875-011-9647-y	55	51	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58159	10.1371/journal.pone.0058159	http://dx.doi.org/10.1371/journal.pone.0058159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483985	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100081
J	van Meegen, MA; Terheggen-Lagro, SWJ; Koymans, KJ; van der Ent, CK; Beekman, JM				van Meegen, Marit Arianne; Terheggen-Lagro, Suzanne Willemina Julia; Koymans, Kirsten Judith; van der Ent, Cornelis Korstiaan; Beekman, Jeffrey Matthijn			Apical CFTR Expression in Human Nasal Epithelium Correlates with Lung Disease in Cystic Fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-KINASE-A; PSEUDOMONAS-AERUGINOSA; RESPIRATORY EPITHELIA; POTENTIAL DIFFERENCE; DELTA-F508 MUTATION; AIRWAY CELLS; WILD-TYPE; PHENOTYPE; SEVERITY	Introduction: Although most individuals with cystic fibrosis (CF) develop progressive obstructive lung disease, disease severity is highly variable, even for individuals with similar CFTR mutations. Measurements of chloride transport as expression of CFTR function in nasal epithelial cells correlate with pulmonary function and suggest that F508del-CFTR is expressed at the apical membrane. However, an association between quantitative apical CFTR expression in nasal epithelium and CF disease severity is still missing. Methods and Materials: Nasal epithelial cells from healthy individuals and individuals with CF between 12-18 years were obtained by nasal brushing. Apical CFTR expression was measured by confocal microscopy using CFTR mAb 596. Expression was compared between both groups and expression in CF nasal epithelial cells was associated with standardized pulmonary function (FEV1%). Results: The proportion of cells expressing apical CFTR in columnar epithelium is lower in CF compared to non-CF. The apical CFTR expression level was significantly correlated with FEV1% in F508del homozygous subjects (r = 0.63, p = 0.012). Conclusion: CFTR expression in nasal epithelial cells is lower in subjects with CF compared to healthy subjects. The proportion of cells expressing F508del-CFTR at the apical membrane is variable between subjects and is positively correlated with FEV1% in F508del-CFTR homozygous subjects.	[van Meegen, Marit Arianne; Terheggen-Lagro, Suzanne Willemina Julia; Koymans, Kirsten Judith; van der Ent, Cornelis Korstiaan; Beekman, Jeffrey Matthijn] Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands; [van Meegen, Marit Arianne; Koymans, Kirsten Judith; Beekman, Jeffrey Matthijn] Univ Med Ctr Utrecht, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [van Meegen, Marit Arianne; Koymans, Kirsten Judith; Beekman, Jeffrey Matthijn] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Beekman, JM (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands.	J.Beekman@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014	Beekman, Jeffrey M/0000-0003-4886-3756; Van der Ent, Cornelis/0000-0002-2501-4121	Grunenthal; Glaxo Smith Kline; Wilhelmina Children's Hospital (WKZ) Foundation, The Netherlands	Grunenthal(HAL Allergy Group); Glaxo Smith Kline(GlaxoSmithKline); Wilhelmina Children's Hospital (WKZ) Foundation, The Netherlands	C.K. van der Ent has received unrestricted research grants from Grunenthal and Glaxo Smith Kline. This work was supported by the Wilhelmina Children's Hospital (WKZ) Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; BERRYMAN M, 1993, J CELL SCI, V105, P1025; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borthwick LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023226; BREZILLON S, 1995, LAB INVEST, V72, P191; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Carvalho-Oliveira I, 2004, J HISTOCHEM CYTOCHEM, V52, P193, DOI 10.1177/002215540405200207; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; DUPUIT F, 1995, J CLIN INVEST, V96, P1601, DOI 10.1172/JCI118199; Fanellli T, 2008, BIOL CELL, V100, P399, DOI 10.1042/BC20070095; Flume PA, 2012, CHEST; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Koopman M, 2011, RESP MED, V105, P15, DOI 10.1016/j.rmed.2010.07.020; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Kunzelmann K, 1999, J MEMBRANE BIOL, V168, P1, DOI 10.1007/s002329900492; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Penque D, 2000, LAB INVEST, V80, P857, DOI 10.1038/labinvest.3780090; Quanjer PH, 2012, EUR RESP J; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Sermet-Gaudelus I, 2002, PEDIATR RES, V52, P628, DOI 10.1203/01.PDR.0000032981.64413.AD; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Sweezey NB, 2007, PEDIATR PULM, V42, P519, DOI 10.1002/ppul.20624; Taouil K, 2003, J BIOL CHEM, V278, P17320, DOI 10.1074/jbc.M212227200; Thomas SR, 1999, LANCET, V353, P984, DOI 10.1016/S0140-6736(98)05447-6; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; van Meegen MA, 2013, J CYST FIBR IN PRESS; van Meegen MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027658; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57617	10.1371/journal.pone.0057617	http://dx.doi.org/10.1371/journal.pone.0057617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483918	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100034
J	Alkerwi, A; Pagny, S; Lair, ML; Delagardelle, C; Beissel, J				Alkerwi, Ala'a; Pagny, Sybil; Lair, Marie-Lise; Delagardelle, Charles; Beissel, Jean			Level of Unawareness and Management of Diabetes, Hypertension, and Dyslipidemia among Adults in Luxembourg: Findings from ORISCAV-LUX Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; GENERAL-POPULATION; TASK-FORCE; PREVALENCE; AWARENESS; GUIDELINES	Background: In the absence of evidence-based information, assessment of population awareness and management of diabetes, hypertension and dyslipidemia (treatable and preventable cardiovascular risk factors) are important to halt coronary and cerebrovascular diseases and to improve public health. Methods: The analysis was based on a nationally representative sample of 1432 adult subjects, recruited for the ORISCAV-LUX survey (2007-2008). Descriptive and multivariable logistic regression analyses were performed. The 10-year Framingham risk score was calculated for each participant who classified at low, intermediate and high risk. Results: Among the diagnosed cases, 32%, 60%, and 85% were respectively unaware of their diabetes, hypertension and dyslipidemia. Increasing age and BMI were the strongest protective factors against unawareness of hypertension and dyslipidemia. Having a family history decreased the risk of unawareness of hypertension (OR = 0.57; 95% CI 0.36, 0.92; P = 0.021), whereas, not having a family doctor increased double-fold the odd of being unaware of hypertension (P = 0.048). Poor health perception reduced significantly the risk of unawareness of dyslipidemia (OR = 0.27; 95% CI 0.11, 0.68). Concerning the management, diabetes was markedly better treated than hypertension and dyslipidemia. Among diabetic subjects (constituting 4% of the population), 3% were treated vs. 1% not treated. In contrast, 22% of the hypertensive participants (35% of the population) were not treated vs. 13% treated. Concerning dyslipidemia, only 9% of those with lipid disorder (70% of the population) were under medication vs. 61% not treated. For the treated cases of these pathologies, almost only one-third was under control. Framingham risk of developing CHD within 10 years was moderate to high among 62%, 27%, and 17% of the unaware/untreated diabetic, hypertensive, and dyslipidemic participants, respectively. Conclusion: The considerable lack of awareness and insufficient management underscore the urgent need for intensive efforts to reduce the gap in prevention strategies, and control of cases according to explicit clinical guidelines.	[Alkerwi, Ala'a; Pagny, Sybil; Lair, Marie-Lise] Ctr Rech Publ Sante CRP Sante, Dept Publ Hlth, Strassen, Grand Duchy Of, Luxembourg; [Delagardelle, Charles; Beissel, Jean] Ctr Hosp Luxembourg, Serv Cardiol, Luxembourg, Grand Duchy Of, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center	Alkerwi, A (corresponding author), Ctr Rech Publ Sante CRP Sante, Dept Publ Hlth, Strassen, Grand Duchy Of, Luxembourg.	alaa.alkerwi@crp-sante.lu	Alkerwi, Ala'a/M-3435-2014	Alkerwi, Ala'a/0000-0002-7448-3936	National Fund of Research (Fond National de Recherche; project MSF) [784844]; Ministry of Health and Ministry of Research	National Fund of Research (Fond National de Recherche; project MSF); Ministry of Health and Ministry of Research	The present study was supported by a research grant from the National Fund of Research (Fond National de Recherche; project MSF, 784844, BM). The authors acknowledge the financial support of the Ministry of Health and Ministry of Research for the financial support of the ORISCAV-LUX study. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.	Alkerwi A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-80; Alkerwi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-468; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2009, BMC GERIATR, V9, P16, DOI DOI 10.1186/1471-2318-9-16; Braun M, 2012, EUR J PREV CARDIOL; Cai L, 2012, J ATHEROSCLER THROMB, V19, P159, DOI 10.5551/jat.10116; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Costanzo S, 2008, J HYPERTENS, V26, P2303, DOI 10.1097/HJH.0b013e328311ce04; Danon-Hersch N, 2009, EUR J CARDIOV PREV R, V16, P66, DOI 10.1097/HJR.0b013e32831e9511; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; El Assaad MA, 2002, BLOOD PRESS MONIT, V7, P237, DOI 10.1097/00126097-200208000-00006; Goff DC, 2006, CIRCULATION, V113, P647, DOI 10.1161/CIRCULATIONAHA.105.552737; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Macedo ME, 2005, J HYPERTENS, V23, P1661, DOI 10.1097/01.hjh.0000179908.51187.de; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Ministry of Health, 2010, NAT STAT ALL CAUS DE; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Psaltopoulou T, 2004, INT J EPIDEMIOL, V33, P1345, DOI 10.1093/ije/dyh249; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Thoenes M, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/925046; Verberk WJ, 2006, J HYPERTENS, V24, P1541, DOI 10.1097/01.hjh.0000239289.87141.b6; Volpe M, 2007, J HYPERTENS, V25, P1491, DOI 10.1097/HJH.0b013e3280fa83a6; Wang SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017326; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	26	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57920	10.1371/journal.pone.0057920	http://dx.doi.org/10.1371/journal.pone.0057920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483942	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900054
J	Sun, D; Layer, R; Mueller, AC; Cichewicz, MA; Negishi, M; Paschal, BM; Dutta, A				Sun, D.; Layer, R.; Mueller, A. C.; Cichewicz, M. A.; Negishi, M.; Paschal, B. M.; Dutta, A.			Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells	ONCOGENE			English	Article						miRNA cluster; androgen regulation; prostate cancer proliferation	GROWTH-FACTOR-I; CHROMATIN IMMUNOPRECIPITATION; RECEPTOR EXPRESSION; BREAST-CANCER; UP-REGULATION; POLYCOMB; NETWORK; PROTEIN; FAMILY; JMJD3	The androgen receptor (AR) stimulates and represses gene expression to promote the initiation and progression of prostate cancer. Here, we report that androgen represses the miR-99a/let7c/125b-2 cluster through AR and anti-androgen drugs block the androgen-repression of the miRNA cluster. AR directly binds to the host gene of the miR-99a/let7c/125b-2 cluster, LINC00478. Expression of the cluster is repressed or activated by chromatin remodelers EZH2 or JMJD3 in the presence or absence of androgen, respectively. Bioinformatics analysis reveals a significant enrichment of targets of miR-99a, let-7c and miR-125b in androgen-induced gene sets, suggesting that downregulation of the miR-99a/let7c/125b-2 cluster by androgen protects many of their target mRNAs from degradation and indirectly assists in the gene induction. We validated the hypothesis with 12 potential targets of the miR-99a/let7c/125b-2 cluster induced by androgen: 9 out of the 12 mRNAs are downregulated by the microRNA cluster. To ascertain the biological significance of this hypothesis, we focused on IGF1R, a known prostate cancer growth factor that is induced by androgen and directly targeted by the miR-99a/let7c/125b-2 cluster. The androgen-induced cell proliferation is ameliorated to a similar extent as anti-androgen drugs by preventing the repression of the microRNAs or induction of IGF1R in androgen-dependent prostate cancer cells. Expression of a microRNA-resistant form of IGF1R protects these cells from inhibition by the miR-99a/let7c/125b-2 cluster. These results indicate that a thorough understanding of how androgen stimulates prostate cancer growth requires not only an understanding of genes directly induced/repressed by AR, but also of genes indirectly induced by AR through the repression of key microRNAs.	[Sun, D.; Layer, R.; Mueller, A. C.; Cichewicz, M. A.; Negishi, M.; Paschal, B. M.; Dutta, A.] Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Layer, R.] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22908 USA; [Paschal, B. M.] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Dutta, A (corresponding author), Univ Virginia, Hlth Sci Ctr, Jordan Hall 1240,Box 800733, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073; Mueller, Adam/0000-0003-2678-0159	NIH [P01CA104106]; DOD from the US Army DOD [PC094499]; NATIONAL CANCER INSTITUTE [T32CA009109, P01CA104106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD from the US Army DOD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by P01CA104106 from NIH to AD and BMP and DOD PC094499 from the US Army DOD to DS. We thank members of the Prostate Cancer Research Working group at UVA for helpful discussions.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Antonarakis ES, 2010, CANCER LETT, V291, P1, DOI 10.1016/j.canlet.2009.08.012; Baniwal SK, 2009, MOL ENDOCRINOL, V23, P1203, DOI 10.1210/me.2008-0470; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cardillo MR, 2003, ANTICANCER RES, V23, P3825; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Chlenski A, 2001, PROSTATE, V47, P66; Curtin D, 2001, MOL ENDOCRINOL, V15, P1906, DOI 10.1210/me.15.11.1906; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Gennigens C, 2006, CRIT REV ONCOL HEMAT, V58, P124, DOI 10.1016/j.critrevonc.2005.10.003; Gommans Willemijn M, 2012, Methods Mol Biol, V822, P1, DOI 10.1007/978-1-61779-427-8_1; Gonit M, 2011, MOL ENDOCRINOL, V25, P621, DOI 10.1210/me.2010-0409; Grad JM, 1999, MOL ENDOCRINOL, V13, P1896, DOI 10.1210/me.13.11.1896; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Jalava SE, 2012, ONCOGENE, V31, P4460, DOI 10.1038/onc.2011.624; Jiang JT, 2012, PROSTATE, V72, P225, DOI 10.1002/pros.21430; Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kojima S, 2009, INT J UROL, V16, P161, DOI 10.1111/j.1442-2042.2008.02224.x; Lanzino M, 2010, NUCLEIC ACIDS RES, V38, P5351, DOI 10.1093/nar/gkq278; Lee JG, 2009, MOL CARCINOGEN, V48, P141, DOI 10.1002/mc.20462; Liao YD, 2005, HUM PATHOL, V36, P1186, DOI 10.1016/j.humpath.2005.07.023; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nelius T, 2007, INT J CANCER, V121, P999, DOI 10.1002/ijc.22802; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ozkan EE, 2011, MOL CELL ENDOCRINOL, V344, P1, DOI 10.1016/j.mce.2011.07.002; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Pandini G, 2009, ANN NY ACAD SCI, V1155, P263, DOI 10.1111/j.1749-6632.2009.04361.x; Papatsoris AG, 2005, TRENDS MOL MED, V11, P52, DOI 10.1016/j.molmed.2004.12.005; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Richter E, 2007, PROSTATE CANCER P D, V10, P114, DOI 10.1038/sj.pcan.4500936; Rubinstein M, 2004, ENDOCRINOLOGY, V145, P3769, DOI 10.1210/en.2004-0173; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Wang Y, 2011, GENOMICS, V98, P445, DOI 10.1016/j.ygeno.2011.09.004; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhao JC, 2012, GENOME RES, V22, P322, DOI 10.1101/gr.131508.111; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	72	77	82	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1448	1457		10.1038/onc.2013.77	http://dx.doi.org/10.1038/onc.2013.77			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23503464	Green Accepted			2022-12-25	WOS:000332943500012
J	Padmanabhan, A; Li, X; Bieberich, CJ				Padmanabhan, Achuth; Li, Xiang; Bieberich, Charles J.			Protein Kinase A Regulates MYC Protein through Transcriptional and Post-translational Mechanisms in a Catalytic Subunit Isoform-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; TUMOR-SUPPRESSOR NKX3.1; CREB-BINDING PROTEIN; C-MYC; MESSENGER-RNA; GENE; DEGRADATION; ACTIVATION; DIFFERENTIATION; TRANSFORMATION	MYC levels are tightly regulated in cells, and deregulation is associated with many cancers. In this report, we describe the existence of a MYC-protein kinase A (PKA)-polo-like kinase 1 (PLK1) signaling loop in cells. We report that sequential MYC phosphorylation by PKA and PLK1 protects MYC from proteasome-mediated degradation. Interestingly, short term pan-PKA inhibition diminishes MYC level, whereas prolonged PKA catalytic subunit alpha (PKAC alpha) knockdown, but not PKA catalytic subunit beta (PKAC beta) knockdown, increases MYC. We show that the short term effect of pan-PKA inhibition on MYC is post-translational and the PKAC alpha-specific long term effect on MYC is transcriptional. These data also reveal distinct functional roles among PKA catalytic isoforms in MYC regulation. We attribute this effect to differential phosphorylation selectivity among PKA catalytic subunits, which we demonstrate for multiple substrates. Further, we also show that MYC up-regulates PKAC beta, transcriptionally forming a proximate positive feedback loop. These results establish PKA as a regulator of MYC and highlight the distinct biological roles of the different PKA catalytic subunits.	[Padmanabhan, Achuth; Li, Xiang; Bieberich, Charles J.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; [Bieberich, Charles J.] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	Bieberich, CJ (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA.	bieberic@umbc.edu		Bieberich, Charles/0000-0002-9208-5077	National Institutes of Health [RCA155568A]; NATIONAL CANCER INSTITUTE [R21CA155568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RCA155568A (to C. J. B.).	Amarzguioui M, 2004, BIOTECHNIQUES, V36, P766, DOI 10.2144/04365BM03; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Baluchamy S, 2007, ONCOGENE, V26, P781, DOI 10.1038/sj.onc.1209825; Bernard Sandra, 2006, V42, P329, DOI 10.1007/004; CHAUDHARY D, 1995, BIOCHEMISTRY-US, V34, P3438, DOI 10.1021/bi00010a036; Dang CV, 1999, MOL CELL BIOL, V19, P1; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guan B, 2008, J BIOL CHEM, V283, P4834, DOI 10.1074/jbc.M708630200; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Jiang GS, 2008, LEUKEMIA RES, V32, P297, DOI 10.1016/j.leukres.2007.06.021; Kolli S, 2001, P NATL ACAD SCI USA, V98, P4646, DOI 10.1073/pnas.081141998; Kvissel AK, 2007, CELL SIGNAL, V19, P401, DOI 10.1016/j.cellsig.2006.07.011; Lee CM, 1999, ONCOGENE, V18, P2997, DOI 10.1038/sj.onc.1202786; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; Li X, 2007, NAT METHODS, V4, P957, DOI 10.1038/NMETH1106; Li X, 2012, J PROTEOME RES, V11, P3637, DOI 10.1021/pr3000514; Liu J, 2004, FEBS LETT, V577, P175, DOI 10.1016/j.febslet.2004.09.079; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Padmanabhan A, 2013, J CELL BIOCHEM, V114, P1050, DOI 10.1002/jcb.24444; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Rajabi HN, 2005, J BIOL CHEM, V280, P361, DOI 10.1074/jbc.M408633200; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; RAMSAY GM, 1990, P NATL ACAD SCI USA, V87, P2102, DOI 10.1073/pnas.87.6.2102; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Su AI, 2001, CANCER RES, V61, P7388; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wall M, 2008, BLOOD, V112, P2305, DOI 10.1182/blood-2007-09-111856; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu KJ, 2002, ONCOGENE, V21, P7872, DOI 10.1038/sj.onc.1205986; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	43	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14158	14169		10.1074/jbc.M112.432377	http://dx.doi.org/10.1074/jbc.M112.432377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23504319	Green Published, hybrid			2022-12-25	WOS:000319253500020
J	Gastebois, A; Aimanianda, V; Bachellier-Bassi, S; Nesseir, A; Firon, A; Beauvais, A; Schmitt, C; England, P; Beau, R; Prevost, MC; d'Enfert, C; Latge, JP; Mouyna, I				Gastebois, Amandine; Aimanianda, Vishukumar; Bachellier-Bassi, Sophie; Nesseir, Audrey; Firon, Arnaud; Beauvais, Anne; Schmitt, Christine; England, Patrick; Beau, Remi; Prevost, Marie-Christine; d'Enfert, Christophe; Latge, Jean-Paul; Mouyna, Isabelle			SUN Proteins Belong to a Novel Family of beta-(1,3)-Glucan-modifying Enzymes Involved in Fungal Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL BIOGENESIS; MOTOR-LIKE DOMAIN; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; BIOFILM FORMATION; BETA-GLUCOSIDASE; CHITIN SYNTHASES; GENE	In yeasts, the family of SUN proteins has been involved in cell wall biogenesis. Here, we report the characterization of SUN proteins in a filamentous fungus, Aspergillus fumigatus. The function of the two A. fumigatus SUN genes was investigated by combining reverse genetics and biochemistry. During conidial swelling and mycelial growth, the expression of AfSUN1 was strongly induced, whereas the expression of AfSUN2 was not detectable. Deletion of AfSUN1 negatively affected hyphal growth and conidiation. A closer examination of the morphological defects revealed swollen hyphae, leaky tips, intrahyphal growth, and double cell wall, suggesting that, like in yeast, AfSun1p is associated with cell wall biogenesis. In contrast to AfSUN1, deletion of AfSUN2 either in the parental strain or in the AfSUN1 single mutant strain did not affect colony and hyphal morphology. Biochemical characterization of the recombinant AfSun1p and Candida albicans Sun41p showed that both proteins had a unique hydrolysis pattern: acting on beta-(1,3)-oligomers from dimer up to insoluble beta-(1,3)-glucan. Referring to the CAZy database, it is clear that fungal SUN proteins represent a new family of glucan hydrolases (GH132) and play an important morphogenetic role in fungal cell wall biogenesis and septation.	[Gastebois, Amandine; Aimanianda, Vishukumar; Beauvais, Anne; Beau, Remi; Latge, Jean-Paul; Mouyna, Isabelle] Inst Pasteur, Unite Aspergillus, Dept Parasitol & Mycol, F-75015 Paris, France; [Bachellier-Bassi, Sophie; Nesseir, Audrey; Firon, Arnaud; d'Enfert, Christophe] Inst Pasteur, Unite Biol & Pathogenicite Fong, Dept Genomes & Genet, F-75015 Paris, France; [Bachellier-Bassi, Sophie; Nesseir, Audrey; Firon, Arnaud; d'Enfert, Christophe] INRA, USC2019, F-75015 Paris, France; [Schmitt, Christine; Prevost, Marie-Christine] Inst Pasteur, Dept Biol Cellulaire & Infect, F-75015 Paris, France; [England, Patrick] Inst Pasteur, Dept Biol Struct & Chim, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Latge, JP (corresponding author), Inst Pasteur, Unite Aspergillus, Dept Parasitol & Mycol, 25 Rue Dr Roux, F-75015 Paris, France.	jplatge@pasteur.fr	Mouyna, Isabelle/O-7697-2018; Beauvais, Anne/A-6358-2012; Bachellier-Bassi, Sophie/AAB-7981-2020; Aimanianda, Vishukumar/E-9204-2011; Latge, Jean Paul/C-9846-2014	Mouyna, Isabelle/0000-0003-3140-5927; Bachellier-Bassi, Sophie/0000-0003-3970-4825; Aimanianda, Vishukumar/0000-0001-5813-7497; ENGLAND, Patrick/0000-0001-6410-5918; d'Enfert, Christophe/0000-0002-6235-3886; FIRON, Arnaud/0000-0002-5323-5212	European Commission [MRTN-CT-2003-504148, PITN-GA-2008-214004]; European Science Foundation (ESF) Fuminomics; Partenariat Sanofi-aventis-Aviesan (ITMO Maladies Infectieuses, Sanofi Aventis Research & Development TSU ID (SAR&D) TSU ID/Sanofi-Pasteur); Agence Nationale de Recherches (ANR) [09-BLAN-0287]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation (ESF) Fuminomics(European Science Foundation (ESF)); Partenariat Sanofi-aventis-Aviesan (ITMO Maladies Infectieuses, Sanofi Aventis Research & Development TSU ID (SAR&D) TSU ID/Sanofi-Pasteur); Agence Nationale de Recherches (ANR)(French National Research Agency (ANR))	This work was supported by grants from the European Commission (Galar Fungail 2, MRTN-CT-2003-504148; FINSysB, PITN-GA-2008-214004) (to C. d. E.) and the European Science Foundation (ESF) Fuminomics, Partenariat Sanofi-aventis-Aviesan (ITMO Maladies Infectieuses, Sanofi Aventis Research & Development TSU ID (SAR&D) TSU ID/Sanofi-Pasteur), and Agence Nationale de Recherches (ANR) (Grant 09-BLAN-0287) (to J. P. L.).	Alonso-Nunez ML, 2005, MOL BIOL CELL, V16, P2003, DOI 10.1091/mbc.E04-06-0442; Bandara PDS, 1998, CURR GENET, V34, P259, DOI 10.1007/s002940050395; Camougrand N, 2004, FEMS YEAST RES, V5, P133, DOI 10.1016/j.femsyr.2004.05.001; Camougrand NM, 2000, ARCH BIOCHEM BIOPHYS, V375, P154, DOI 10.1006/abbi.1999.1655; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DESAI NN, 1983, BIOCHEM J, V211, P273, DOI 10.1042/bj2110273; Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Firon A, 2007, MOL MICROBIOL, V66, P1256, DOI 10.1111/j.1365-2958.2007.06011.x; Fontaine T, 1997, J BACTERIOL, V179, P3154, DOI 10.1128/jb.179.10.3154-3163.1997; GIRARDIN H, 1993, J CLIN MICROBIOL, V31, P1547, DOI 10.1128/JCM.31.6.1547-1554.1993; Guyard C, 2002, J ANTIMICROB CHEMOTH, V49, P961, DOI 10.1093/jac/dkf040; Guyard C, 2002, YEAST, V19, P1127, DOI 10.1002/yea.898; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Jimenez-Ortigosa C, 2012, ANTIMICROB AGENTS CH, V56, P6121, DOI 10.1128/AAC.00752-12; Lamarre C, 2007, FUNGAL GENET BIOL, V44, P682, DOI 10.1016/j.fgb.2007.01.009; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Mouassite M, 2000, YEAST, V16, P905, DOI 10.1002/1097-0061(200007)16:10<905::AID-YEA584>3.0.CO;2-1; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Norice CT, 2007, EUKARYOT CELL, V6, P2046, DOI 10.1128/EC.00314-07; Omi K, 1999, BIOCHEM BIOPH RES CO, V262, P368, DOI 10.1006/bbrc.1999.1209; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; RAU U, 1992, J IND MICROBIOL, V9, P19, DOI 10.1007/BF01576364; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Ritch JJ, 2010, FEMS YEAST RES, V10, P168, DOI 10.1111/j.1567-1364.2009.00601.x; Roncero C, 2010, YEAST, V27, P521, DOI 10.1002/yea.1779; SANCHEZ M, 1993, APPL ENVIRON MICROB, V59, P2087; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; SKORY CD, 1995, APPL ENVIRON MICROB, V61, P518, DOI 10.1128/AEM.61.2.518-525.1995; Sorgo AG, 2010, YEAST, V27, P661, DOI 10.1002/yea.1775; Sosinska GJ, 2008, MICROBIOL-SGM, V154, P510, DOI 10.1099/mic.0.2007/012617-0; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; Wang HX, 2011, EUKARYOT CELL, V10, P72, DOI 10.1128/EC.00167-10; Wei Y, 2011, ACTA BIOCH BIOPH SIN, V43, P226, DOI 10.1093/abbs/gmr001; Weidner G, 1998, CURR GENET, V33, P378, DOI 10.1007/s002940050350; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu ZW, 2006, PROTEIN EXPRES PURIF, V47, P118, DOI 10.1016/j.pep.2005.11.025; Zverlov VV, 1997, MICROBIOL-SGM, V143, P3537, DOI 10.1099/00221287-143-11-3537	45	21	23	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13387	13396		10.1074/jbc.M112.440172	http://dx.doi.org/10.1074/jbc.M112.440172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23508952	Green Published, hybrid			2022-12-25	WOS:000318850300024
J	Bu, LT; Crowley, MF; Himmel, ME; Beckham, GT				Bu, Lintao; Crowley, Michael F.; Himmel, Michael E.; Beckham, Gregg T.			Computational Investigation of the pH Dependence of Loop Flexibility and Catalytic Function in Glycoside Hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; TRICHODERMA-REESEI; MOLECULAR-DYNAMICS; CELLOBIOHYDROLASE-I; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; PROCESSIVE CELLULASE; CELLULOMONAS-FIMI; ACTIVITY PROFILE; ENDOGLUCANASE I	Cellulase enzymes cleave glycosidic bonds in cellulose to produce cellobiose via either retaining or inverting hydrolysis mechanisms, which are significantly pH-dependent. Many fungal cellulases function optimally at pH similar to 5, and their activities decrease dramatically at higher or lower pH. To understand the molecular-level implications of pH in cellulase structure, we use a hybrid, solvent-based, constant pH molecular dynamics method combined with pH-based replica exchange to determine the pK(a) values of titratable residues of a glycoside hydrolase (GH) family 6 cellobiohydrolase (Cel6A) and a GH family 7 cellobiohydrolase (Cel7A) from the fungus Hypocrea jecorina. For both enzymes, we demonstrate that a bound substrate significantly affects the pK(a) values of the acid residues at the catalytic center. The calculated pK(a) values of catalytic residues confirm their proposed roles from structural studies and are consistent with the experimentally measured apparent pK(a) values. Additionally, GHs are known to impart a strained pucker conformation in carbohydrate substrates in active sites for catalysis, and results from free energy calculations combined with constant pH molecular dynamics suggest that the correct ring pucker is stable near the optimal pH for both Cel6A and Cel7A. Much longer molecular dynamics simulations of Cel6A and Cel7A with fixed protonation states based on the calculated pK(a) values suggest that pH affects the flexibility of tunnel loops, which likely affects processivity and substrate complexation. Taken together, this work demonstrates several molecular-level effects of pH on GH enzymes important for cellulose turnover in the biosphere and relevant to biomass conversion processes.	[Bu, Lintao; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Crowley, Michael F.; Himmel, Michael E.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines	Bu, LT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd,MS 3322, Golden, CO 80401 USA.	lintao.bu@nrel.gov; gregg.beckham@nrel.gov	crowley, michael F/A-4852-2013	crowley, michael F/0000-0001-5163-9398	United States Department of Energy Bioenergy Technologies Office; United States Department of Energy Office of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]; National Science Foundation TeraGrid Grant via Texas Advanced Computing Center Ranger Cluster [TG-MCB090159]; National Institute for Computational Sciences Kraken Cluster	United States Department of Energy Bioenergy Technologies Office(United States Department of Energy (DOE)); United States Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); National Science Foundation TeraGrid Grant via Texas Advanced Computing Center Ranger Cluster(National Science Foundation (NSF)); National Institute for Computational Sciences Kraken Cluster	This work was supported by the United States Department of Energy Bioenergy Technologies Office. Computational time for this research was provided by the National Renewable Energy Laboratory Computational Sciences Center supported by the United States Department of Energy Office of Energy Efficiency and Renewable Energy under Contract DE-AC36-08GO28308 and by National Science Foundation TeraGrid Grant TG-MCB090159 via the Texas Advanced Computing Center Ranger Cluster and the National Institute for Computational Sciences Kraken Cluster.	Barnett CB, 2010, J AM CHEM SOC, V132, P12800, DOI 10.1021/ja103766w; BARROWS SE, 1995, CARBOHYD RES, V276, P219, DOI 10.1016/0008-6215(95)00175-S; Becker D, 2001, BIOCHEM J, V356, P19, DOI 10.1042/0264-6021:3560019; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Boer H, 2003, EUR J BIOCHEM, V270, P841, DOI 10.1046/j.1432-1033.2003.03431.x; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castaneda CA, 2009, PROTEINS, V77, P570, DOI 10.1002/prot.22470; CHANZY H, 1983, FEBS LETT, V153, P113, DOI 10.1016/0014-5793(83)80129-X; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cockburn DW, 2011, PROTEIN ENG DES SEL, V24, P429, DOI 10.1093/protein/gzr004; Cockburn DW, 2010, BIOCHEMISTRY-US, V49, P2042, DOI 10.1021/bi1000596; Colussi F, 2012, EUR BIOPHYS J BIOPHY, V41, P89, DOI 10.1007/s00249-011-0762-8; Cox EG, 1939, NATURE, V143, P894, DOI 10.1038/143894b0; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Damude HG, 1996, BIOCHEM J, V315, P467, DOI 10.1042/bj3150467; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Hill AD, 2007, J CHEM INF MODEL, V47, P1031, DOI 10.1021/ci600492e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Khandogin J, 2006, BIOCHEMISTRY-US, V45, P9363, DOI 10.1021/bi060706r; KNOWLES JKC, 1988, J CHEM SOC CHEM COMM, P1401, DOI 10.1039/c39880001401; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Koivula A, 1996, PROTEIN ENG, V9, P691, DOI 10.1093/protein/9.8.691; Kong XJ, 1996, J CHEM PHYS, V105, P2414, DOI 10.1063/1.472109; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lee MS, 2004, PROTEINS, V56, P738, DOI 10.1002/prot.20128; Li JH, 2010, J PHYS CHEM B, V114, P15261, DOI 10.1021/jp1064177; Linder M, 1999, FEBS LETT, V447, P13, DOI 10.1016/S0014-5793(99)00253-7; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Pingali SV, 2011, J BIOL CHEM, V286, P32801, DOI 10.1074/jbc.M111.263004; Qin YQ, 2008, J BIOTECHNOL, V135, P190, DOI 10.1016/j.jbiotec.2008.03.016; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; REEVES RE, 1950, J AM CHEM SOC, V72, P1499, DOI 10.1021/ja01160a021; Rosgaard L, 2007, BIOTECHNOL PROGR, V23, P1270, DOI 10.1021/bp070329p; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Stahlberg J, 2001, J MOL BIOL, V305, P79, DOI 10.1006/jmbi.2000.4237; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Sulzenbacher G, 1997, BIOCHEMISTRY-US, V36, P5902, DOI 10.1021/bi962963+; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Swails JM, 2012, J CHEM THEORY COMPUT, V8, P4393, DOI 10.1021/ct300512h; Taylor CB, 2012, J BIOL CHEM, V287, P3147, DOI 10.1074/jbc.M111.270389; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Wallace JA, 2011, J CHEM THEORY COMPUT, V7, P2617, DOI 10.1021/ct200146j; Wohlfahrt G, 2003, BIOCHEMISTRY-US, V42, P10095, DOI 10.1021/bi034954o; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	80	28	28	0	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12175	12186		10.1074/jbc.M113.462465	http://dx.doi.org/10.1074/jbc.M113.462465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504310	Green Published, hybrid			2022-12-25	WOS:000318157600049
J	Lo, YY; Hsu, SH; Ko, YC; Hung, CC; Chang, MY; Hsu, HH; Pan, MJ; Chen, YW; Lee, CH; Tseng, FG; Sun, YJ; Yang, CW; Pan, RL				Lo, Yueh-Yu; Hsu, Shen-Hsing; Ko, Yi-Ching; Hung, Cheng-Chieh; Chang, Ming-Yang; Hsu, Hsiang-Hao; Pan, Ming-Jeng; Chen, Yen-Wei; Lee, Ching-Hung; Tseng, Fan-Gang; Sun, Yuh-Ju; Yang, Chih-Wei; Pan, Rong-Long			Essential Calcium-binding Cluster of Leptospira LipL32 Protein for Inflammatory Responses through the Toll-like Receptor 2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATES FIBRONECTIN-BINDING; ATOMIC-FORCE MICROSCOPE; OUTER-MEMBRANE PROTEINS; TUBULE EPITHELIAL-CELLS; PATHOGENIC LEPTOSPIRA; RENAL-DISEASE; SURFACE; LIPOPROTEIN; ANTIGEN; GENES	Leptospirosis is the most widespread zoonosis caused by the pathogenic Leptospira worldwide. LipL32, a 32-kDa lipoprotein, is the most abundant protein on the outer membrane of Leptospira and has an atypical poly(Asp) motif ((161)DDDDDGDD(168)). The x-ray crystallographic structure of LipL32 revealed that the calcium-binding cluster of LipL32 includes several essential residues Asp(132), Thr(133), Asp(164), Asp(165), and Tyr(178). The goals of this study were to determine possible roles of the Ca2+-binding cluster for the interaction of LipL32 and Toll-like receptor 2 (TLR2) in induced inflammatory responses of human kidney cells. Site-directed mutagenesis was employed to individually mutate Ca2+-binding residues of LipL32 to Ala, and their effects subsequently were observed. These mutations abolished primarily the structural integrity of the calcium-binding cluster in LipL32. The binding assay and atomic force microscopy analysis further demonstrated the decreased binding capability of LipL32 mutants to TLR2. Inflammatory responses induced by LipL32 variants, as determined by TLR2 pathway intermediates hCXCL8/IL-8, hCCL2/MCP-1, hMMP7, and hTNF-alpha, were also lessened. In conclusion, the calcium-binding cluster of LipL32 plays essential roles in presumably sustaining LipL32 conformation for its proper association with TLR2 to elicit inflammatory responses in human renal cells.	[Lo, Yueh-Yu; Chen, Yen-Wei; Lee, Ching-Hung; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Coll Life Sci, Dept Life Sci, Hsinchu 30013, Taiwan; [Lo, Yueh-Yu; Chen, Yen-Wei; Lee, Ching-Hung; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Coll Life Sci, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Hsu, Shen-Hsing; Ko, Yi-Ching; Hung, Cheng-Chieh; Chang, Ming-Yang; Hsu, Hsiang-Hao; Yang, Chih-Wei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Tao Yuan 33333, Taiwan; [Pan, Ming-Jeng] Cent Taiwan Univ Sci & Technol, Coll Hlth Sci, Inst Biotechnol, Taichung 40601, Taiwan; [Tseng, Fan-Gang] Natl Tsing Hua Univ, Coll Nucl Sci, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University; Central Taiwan University Science & Technology; National Tsing Hua University	Yang, CW (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Tao Yuan 33333, Taiwan.	cwyang@ms1.hinet.net; rlpan@life.nthu.edu.tw	Chang, Ming-Yang/AGH-5397-2022	Chang, Ming-Yang/0000-0001-8899-0376; Tseng, Fan-Gang/0000-0001-7654-6905	Chang Gung Memorial Hospital-National Tsing Hua University [101N2748E1]; National Science Council, Republic of China [NSC 101-2627-M-007-008, NSC 100-2311-B-007-001-MY3, NSC100-2314-B-182-031-MY3, NSC 101-2120-M-007-001, NSC 101-2627-M-007-009]	Chang Gung Memorial Hospital-National Tsing Hua University(Chang Gung Memorial Hospital); National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grant 101N2748E1 (to R.-L. P.) and National Science Council, Republic of China, Grants NSC 101-2627-M-007-008 and NSC 100-2311-B-007-001-MY3 (to R.-L. P.), NSC100-2314-B-182-031-MY3 (to C.-W. Y.), and NSC 101-2120-M-007-001 and NSC 101-2627-M-007-009 (to F.-G. T.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Hsu SH, 2010, BIOCHEMISTRY-US, V49, P5408, DOI 10.1021/bi100058w; Hsu SH, 2009, BOT STUD, V50, P291; Hung CC, 2006, KIDNEY INT, V69, P1814, DOI 10.1038/sj.ki.5000362; Hung CC, 2006, NEPHROL DIAL TRANSPL, V21, P898, DOI 10.1093/ndt/gfi316; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Kim H, 2006, ULTRAMICROSCOPY, V106, P652, DOI 10.1016/j.ultramic.2005.12.007; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Lee SH, 2000, GENE, V254, P19, DOI 10.1016/S0378-1119(00)00293-6; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Stroh C, 2004, P NATL ACAD SCI USA, V101, P12503, DOI 10.1073/pnas.0403538101; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; Yang CW, 2000, J AM SOC NEPHROL, V11, P2017, DOI 10.1681/ASN.V11112017; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2001, NEPHROL DIAL TRANSPL, V16, P73, DOI 10.1093/ndt/16.suppl_5.73	37	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12335	12344		10.1074/jbc.M112.418699	http://dx.doi.org/10.1074/jbc.M112.418699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486465	Green Published, hybrid			2022-12-25	WOS:000318157600064
J	Mundkur, L; Mukhopadhyay, R; Samson, S; Varma, M; Kale, D; Chen, DX; Shivaprasad, S; Sivanandan, H; Soman, V; Lu, XJ; Kakkar, VV				Mundkur, Lakshmi; Mukhopadhyay, Rupak; Samson, Sonia; Varma, Meenakshi; Kale, Dnyaneswar; Chen, Daxin; Shivaprasad, Sneha; Sivanandan, Hemapriya; Soman, Vinod; Lu, Xinjie; Kakkar, Vijay V.			Mucosal Tolerance to a Combination of ApoB and HSP60 Peptides Controls Plaque Progression and Stabilizes Vulnerable Plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; ATHEROSCLEROTIC LESIONS; MACROPHAGE APOPTOSIS; ORAL TOLERANCE; MECHANISMS; SUPPRESSION; INFLAMMATION; AUTOIMMUNITY; INDUCTION	Oral tolerance to auto antigens reduces the development of atherosclerosis in mouse models. However, the effect of immune tolerance to multiple self antigenic peptides in plaque progression and stabilization is not known. We studied the protective effect of mucosal tolerance to peptides from apolipoprotein B (ApoB; 661-680) and heat shock protein 60 (HSP60; 153-163), in combination with diet, in the prevention of atherosclerotic lesion progression and plaque stabilization in ApoB(tm25gy)LDLr(tm1Her) mice. We found that oral administration of five doses of a combination of ApoB and HSP60 peptides (20 mu g/mice/dose) induced tolerance to both the peptides and reduced early plaque development by 39.9% better than the individual peptides (ApoB = 28.7%; HSP60 = 26.8%)(P<0.001). Oral tolerance to combination of peptides along with diet modification arrested plaque progression by 37.6% which was associated with increases in T-regulatory cell and transforming growth factor-beta expression in the plaque and peripheral circulation. Reduced macrophage infiltration and tumor necrosis factor-alpha expression in the plaque was also observed. Tolerance with continued hypercholesterolemia resulted in 60.8% reduction in necrotic core area suggesting plaque stabilization, which was supported by reduction in apoptosis and increased efferocytosis demonstrated by greater expression of receptor tyrosine kinase Mer (MerTK) in the plaque. Tolerance to the two peptides also reduced the expression of matrix metalloproteinase 9, tissue factor, calprotectin, and increased its collagen content. Our study suggests that oral tolerance to ApoB and HSP60 peptide combination induces CD4(+) CTLA4(+) Tregs and CD4(+) CD25(+) Foxp3(+) Tregs secreting TGF-beta, which inhibit pathogenic T cell response to both peptides thus reducing the development and progression of atherosclerosis and provides evidence for plaque stabilization in ApoB(tm25gy)LDLr(tm1Her) mice.	[Mundkur, Lakshmi; Mukhopadhyay, Rupak; Samson, Sonia; Varma, Meenakshi; Kale, Dnyaneswar; Shivaprasad, Sneha; Sivanandan, Hemapriya; Soman, Vinod; Kakkar, Vijay V.] Thrombosis Res Inst, Mary & Gary Western & Tata Mol Immunol Unit, Bangalore, Karnataka, India; [Chen, Daxin; Lu, Xinjie; Kakkar, Vijay V.] Thrombosis Res Inst, Mol Immunol Unit, London SW3 6LR, England	Thrombosis Research Institute; University of London; University College London	Kakkar, VV (corresponding author), Thrombosis Res Inst, Mary & Gary Western & Tata Mol Immunol Unit, Bangalore, Karnataka, India.	vijay@tri-london.ac.uk	Mukhopadhyay, Rupak/Q-9168-2017; Mundkur, Lakshmi/ABI-8141-2020	Mukhopadhyay, Rupak/0000-0001-5211-1413; Mundkur, Lakshmi/0000-0003-2928-1726	Thrombosis Research Institute, London; Thrombosis Research Institute, Bangalore,; Tata Social Welfare Trust, India (TSWT/IG/SNB/JP/Sdm); Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/CDE/08/07]	Thrombosis Research Institute, London; Thrombosis Research Institute, Bangalore,; Tata Social Welfare Trust, India (TSWT/IG/SNB/JP/Sdm); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grants from the trustees of Thrombosis Research Institute, London and Bangalore, Tata Social Welfare Trust, India (TSWT/IG/SNB/JP/Sdm) and Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/01/CDE/08/07). The sponsors did not participate in the design, conduct, analysis and interpretation of the data or in the preparation, review or approval of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Almanzar G, 2012, J AUTOIMMUN; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Binder CJ, 2007, J AM COLL CARDIOL, V50, P547, DOI 10.1016/j.jacc.2007.04.054; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bjorkerud S, 1996, AM J PATHOL, V149, P367; Boks MA, 2010, SCAND J IMMUNOL, V72, P158, DOI 10.1111/j.1365-3083.2010.02414.x; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Fredrikson GN, 2007, ATHEROSCLEROSIS, V194, pE188, DOI 10.1016/j.atherosclerosis.2006.12.014; George J, 2004, CARDIOVASC RES, V62, P603, DOI 10.1016/j.cardiores.2004.01.028; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Grundtman C, 2011, CURR OPIN LIPIDOL, V22, P327, DOI 10.1097/MOL.0b013e32834aa0c2; Grundtman C, 2011, ARTERIOSCL THROM VAS, V31, P960, DOI 10.1161/ATVBAHA.110.217877; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Herbin O, 2012, ARTERIOSCL THROM VAS, V32, P605, DOI 10.1161/ATVBAHA.111.242800; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Lu XJ, 2010, ATHEROSCLEROSIS, V212, P472, DOI 10.1016/j.atherosclerosis.2010.06.007; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Mallat Z, 2004, EXPERT OPIN BIOL TH, V4, P1387, DOI 10.1517/14712598.4.9.1387; Mallat Z, 2007, TRENDS CARDIOVAS MED, V17, P113, DOI 10.1016/j.tcm.2007.03.001; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Milovanova TN, 2007, CYTOM PART B-CLIN CY, V72B, P265, DOI 10.1002/cyto.b.20166; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mundkur L, 2013, J VACCIN, V2013, P13; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Nilsson J, 2009, J INTERN MED, V266, P221, DOI 10.1111/j.1365-2796.2009.02150.x; Nilsson J, 2012, CURR OPIN LIPIDOL, V23, P422, DOI 10.1097/MOL.0b013e328356ec7c; Qi GF, 2005, LIFE SCI, V77, P2690, DOI 10.1016/j.lfs.2005.05.037; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Tabas I, 2009, ANN NY ACAD SCI, V1173, pE40, DOI 10.1111/j.1749-6632.2009.04957.x; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; van Puijvelde GHM, 2006, CIRCULATION, V114, P1968, DOI 10.1161/CIRCULATIONAHA.106.615609; van Puijvelde HM, 2007, ARTERIOSCL THROM VAS, V27, P2677, DOI 10.1161/ATVBAHA.107.151274; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644	55	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58364	10.1371/journal.pone.0058364	http://dx.doi.org/10.1371/journal.pone.0058364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505495	gold, Green Submitted, Green Published			2022-12-25	WOS:000316251100048
J	Zerbato, M; Holic, N; Moniot-Frin, S; Ingrao, D; Galy, A; Perea, J				Zerbato, Madeleine; Holic, Nathalie; Moniot-Frin, Sophie; Ingrao, Dina; Galy, Anne; Perea, Javier			The Brown Algae Pl.LSU/2 Group II Intron-Encoded Protein Has Functional Reverse Transcriptase and Maturase Activities	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; SELF-SPLICING INTRON; SEVERE COMBINED IMMUNODEFICIENCY; SECONDARY STRUCTURE PREDICTION; CHRONIC GRANULOMATOUS-DISEASE; MITOCHONDRIAL GROUP-I; GENE-THERAPY; DNA ENDONUCLEASE; PYLAIELLA-LITTORALIS; YEAST MITOCHONDRIA	Group II introns are self-splicing mobile elements found in prokaryotes and eukaryotic organelles. These introns propagate by homing into precise genomic locations, following assembly of a ribonucleoprotein complex containing the intron-encoded protein (IEP) and the spliced intron RNA. Engineered group II introns are now commonly used tools for targeted genomic modifications in prokaryotes but not in eukaryotes. We speculate that the catalytic activation of currently known group II introns is limited in eukaryotic cells. The brown algae Pylaiella littoralis Pl.LSU/2 group II intron is uniquely capable of in vitro ribozyme activity at physiological level of magnesium but this intron remains poorly characterized. We purified and characterized recombinant Pl.LSU/2 IEP. Unlike most IEPs, Pl.LSU/2 IEP displayed a reverse transcriptase activity without intronic RNA. The Pl.LSU/2 intron could be engineered to splice accurately in Saccharomyces cerevisiae and splicing efficiency was increased by the maturase activity of the IEP. However, spliced transcripts were not expressed. Furthermore, intron splicing was not detected in human cells. While further tool development is needed, these data provide the first functional characterization of the Pl.LSU/2 IEP and the first evidence that the Pl.LSU/2 group II intron splicing occurs in vivo in eukaryotes in an IEP-dependent manner.	[Zerbato, Madeleine; Holic, Nathalie; Moniot-Frin, Sophie; Ingrao, Dina; Galy, Anne; Perea, Javier] INSERM, U951, Evry, France; [Zerbato, Madeleine; Holic, Nathalie; Moniot-Frin, Sophie; Ingrao, Dina; Galy, Anne; Perea, Javier] Univ Evry Val dEssonne, UMR S 951, Evry, France; [Zerbato, Madeleine; Holic, Nathalie; Moniot-Frin, Sophie; Ingrao, Dina; Galy, Anne; Perea, Javier] Genethon, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Perea, J (corresponding author), INSERM, U951, Evry, France.	perea@genethon.fr	Holic, Nathalie/U-8979-2018; Galy, Anne HM/J-4439-2013; Holic, Nathalie/J-6886-2013	Holic, Nathalie/0000-0001-9869-1388; Galy, Anne HM/0000-0002-0153-4392; Holic, Nathalie/0000-0001-9869-1388	Association Francaise contre les myopathies (AFM); Institut national de la sante et de la recherche medicale (INSERM); University of Evry Val d'Essonne; 7th European Commission Framework Program (FP7) "PERSIST" [222878]	Association Francaise contre les myopathies (AFM)(Association Francaise contre les Myopathies); Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Evry Val d'Essonne; 7th European Commission Framework Program (FP7) "PERSIST"	This work was supported by the Association Francaise contre les myopathies (AFM, http://www.afm-telethon.fr/); the Institut national de la sante et de la recherche medicale (INSERM http://www.inserm.fr); the University of Evry Val d'Essonne (www.univ-evry.fr); and by the 7th European Commission Framework Program (FP7) "PERSIST" (agreement 222878). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Barzel A, 2011, NUCLEIC ACIDS RES, V39, P6646, DOI 10.1093/nar/gkr242; Belfort M, 2003, GENE DEV, V17, P2860, DOI 10.1101/gad.1162503; Bibikova M, 2002, GENETICS, V161, P1169; Brachmann CB, 1998, YEAST, V14, P115; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chalamcharla VR, 2010, GENE DEV, V24, P827, DOI 10.1101/gad.1905010; Charrier S, 2007, GENE THER, V14, P415, DOI 10.1038/sj.gt.3302863; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Costa M, 1999, EMBO J, V18, P1025, DOI 10.1093/emboj/18.4.1025; Costa M, 2000, EMBO J, V19, P5007, DOI 10.1093/emboj/19.18.5007; Costa M, 1998, RNA, V4, P1055, DOI 10.1017/S1355838298980670; Costa M, 1997, J MOL BIOL, V274, P353, DOI 10.1006/jmbi.1997.1416; Cui XX, 2004, J MOL BIOL, V340, P211, DOI 10.1016/j.jmb.2004.05.004; DELAHODDE A, 1989, CELL, V56, P431, DOI 10.1016/0092-8674(89)90246-8; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; FONTAINE JM, 1995, J MOL BIOL, V251, P378, DOI 10.1006/jmbi.1995.0441; Fontaine JM, 1997, J MOL EVOL, V44, P33, DOI 10.1007/PL00006119; Frazier CL, 2003, APPL ENVIRON MICROB, V69, P1121, DOI 10.1128/AEM.69.2.1121-1128.2003; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; Guo HT, 1997, EMBO J, V16, P6835, DOI 10.1093/emboj/16.22.6835; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Ho Y, 1997, P NATL ACAD SCI USA, V94, P8994, DOI 10.1073/pnas.94.17.8994; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Huang HR, 2003, MOL CELL BIOL, V23, P8809, DOI 10.1128/MCB.23.23.8809-8819.2003; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; KENNELL JC, 1993, CELL, V73, P133, DOI 10.1016/0092-8674(93)90166-N; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; Matsuura M, 2001, EMBO J, V20, P7259, DOI 10.1093/emboj/20.24.7259; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Mohr G, 2000, GENE DEV, V14, P559; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Olszewska M, 2012, CELL BIOCHEM FUNCT, V30, P177, DOI 10.1002/cbf.2804; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Porteus MH, 2009, NATURE, V459, P337, DOI 10.1038/459337a; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Rambo RP, 2004, BIOCHEMISTRY-US, V43, P6486, DOI 10.1021/bi049912u; Romani AMP, 2002, BIOMETALS, V15, P271, DOI 10.1023/A:1016082900838; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; SCHAFER B, 1994, CURR GENET, V25, P336, DOI 10.1007/BF00351487; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Singh NN, 2001, J MOL BIOL, V309, P361, DOI 10.1006/jmbi.2001.4658; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Szczepanek T, 2000, MOL GEN GENET, V264, P137, DOI 10.1007/s004380000297; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toor N, 2009, CURR OPIN STRUC BIOL, V19, P260, DOI 10.1016/j.sbi.2009.04.002; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vellore J, 2004, APPL ENVIRON MICROB, V70, P7140, DOI 10.1128/AEM.70.12.7140-7147.2004; Wank H, 1999, MOL CELL, V4, P239, DOI 10.1016/S1097-2765(00)80371-8; WENZLAU JM, 1989, CELL, V56, P421, DOI 10.1016/0092-8674(89)90245-6; White TB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002534; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706; Zarschler K, 2009, APPL ENVIRON MICROB, V75, P3077, DOI 10.1128/AEM.00087-09; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248; Zhuang FL, 2009, RNA, V15, P432, DOI 10.1261/rna.1378909	80	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58263	10.1371/journal.pone.0058263	http://dx.doi.org/10.1371/journal.pone.0058263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505475	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100039
J	Katragadda, U; Fan, W; Wang, YZ; Teng, Q; Tan, C				Katragadda, Usha; Fan, Wei; Wang, Yingzhe; Teng, Quincy; Tan, Chalet			Combined Delivery of Paclitaxel and Tanespimycin via Micellar Nanocarriers: Pharmacokinetics, Efficacy and Metabolomic Analysis	PLOS ONE			English	Article							IN-VIVO; INDOCYANINE GREEN; CELL METABOLISM; PHASE-I; CANCER; DRUG; TUMORS; THERAPEUTICS; CHEMOTHERAPY; MALIGNANCIES	Background: Despite the promising anticancer efficacy observed in preclinical studies, paclitaxel and tanespimycin (17-AAG) combination therapy has yielded meager responses in a phase I clinical trial. One serious problem associated with paclitaxel/17-AAG combination therapy is the employment of large quantities of toxic organic surfactants and solvents for drug solubilization. The goal of this study was to evaluate a micellar formulation for the concurrent delivery of paclitaxel and 17-AAG in vivo. Methodology/Principal Findings: Paclitaxel/17-AAG-loaded micelles were assessed in mice bearing human ovarian tumor xenografts. Compared with the free drugs at equivalent doses, intravenous administration of paclitaxel/17-AAG-loaded micelles led to 3.5- and 1.7-fold increase in the tumor concentrations of paclitaxel and 17-AAG, respectively, without significant altering drug levels in normal organs. The enhanced tumor accumulation of the micellar drugs was further confirmed by the whole-body near infrared imaging using indocyanine green-labeled micelles. Subsequently, the anticancer efficacy of paclitaxel/17-AAG-loaded micelles was examined in comparison with the free drugs (weekly 20 mg/kg paclitaxel, twice-weekly 37.5 mg/kg 17-AAG). We found that paclitaxel/17-AAG-loaded micelles caused near-complete arrest of tumor growth, whereas the free drug-treated tumors experienced rapid growth shortly after the 3-week treatment period ended. Furthermore, comparative metabolomic profiling by proton nuclear magnetic resonance revealed significant decrease in glucose, lactate and alanine with simultaneous increase in glutamine, glutamate, aspartate, choline, creatine and acetate levels in the tumors of mice treated with paclitaxel/17-AAG-loaded micelles. Conclusions/Significance: We have demonstrated in the current wok a safe and efficacious nano-sized formulation for the combined delivery of paclitaxel and 17-AAG, and uncovered unique metabolomic signatures in the tumor that correlate with the favorable therapeutic response to paclitaxel/17-AAG combination therapy.	[Katragadda, Usha; Fan, Wei; Wang, Yingzhe; Tan, Chalet] Mercer Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Canc Nanomed Lab, Atlanta, GA USA; [Teng, Quincy] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	Mercer University; University System of Georgia; University of Georgia	Tan, C (corresponding author), Mercer Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Canc Nanomed Lab, Atlanta, GA USA.	tan_c@mercer.edu	Wang, Yingzhe/AAA-4340-2020	Wang, Yingzhe/0000-0002-7382-9683; Fan, Wei/0000-0001-5893-6045	National Institutes of Health [R15CA152860]; Georgia Cancer Coalition Cancer Research Award; NATIONAL CANCER INSTITUTE [R15CA152860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Cancer Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R15CA152860 (CT) and the Georgia Cancer Coalition Cancer Research Award (CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal S, 2010, SMALL, V6, P1442, DOI 10.1002/smll.201000631; Chen H, 2008, LANGMUIR, V24, P5213, DOI 10.1021/la703570m; Collette TW, 2010, ENVIRON SCI TECHNOL, V44, P6881, DOI 10.1021/es1011884; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dicko A, 2010, EXPERT OPIN DRUG DEL, V7, P1329, DOI 10.1517/17425247.2010.538678; Egorin MJ, 2001, CANCER CHEMOTH PHARM, V47, P291, DOI 10.1007/s002800000242; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Katragadda U, 2011, INT J PHARMACEUT, V419, P281, DOI 10.1016/j.ijpharm.2011.07.033; Kim SC, 2001, J CONTROL RELEASE, V72, P191, DOI 10.1016/S0168-3659(01)00275-9; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068; Munster PN, 2001, CLIN CANCER RES, V7, P2228; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006; Ramalingam SS, 2008, CLIN CANCER RES, V14, P3456, DOI 10.1158/1078-0432.CCR-07-5088; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Shin HC, 2009, J CONTROL RELEASE, V140, P294, DOI 10.1016/j.jconrel.2009.04.024; Solit DB, 2003, CANCER RES, V63, P2139; Spaareboom A, 1996, CANCER RES, V56, P2112; Tang N, 2007, JNCI-J NATL CANCER I, V99, P1004, DOI 10.1093/jnci/djm027; Teng Q, 2012, ANALYST, V137, P2226, DOI 10.1039/c2an16251b; Teng Q, 2009, METABOLOMICS, V5, P199, DOI 10.1007/s11306-008-0137-z; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WHEELER HO, 1958, P SOC EXP BIOL MED, V99, P11	30	36	38	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58619	10.1371/journal.pone.0058619	http://dx.doi.org/10.1371/journal.pone.0058619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505544	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500108
J	Blok, DC; van der Sluijs, KF; Florquin, S; de Boer, OJ; van 't Veer, C; de Vos, AF; van der Poll, T				Blok, Dana C.; van der Sluijs, Koenraad F.; Florquin, Sandrine; de Boer, Onno J.; van 't Veer, Cornelis; de Vos, Alex F.; van der Poll, Tom			Limited Anti-Inflammatory Role for Interleukin-1 Receptor Like 1 (ST2) in the Host Response to Murine Postinfluenza Pneumococcal Pneumonia	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; INNATE LYMPHOID-CELLS; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL PNEUMONIA; KINASE-M; INFLAMMATORY RESPONSE; MICE DEMONSTRATE; INFLUENZA-VIRUS; DEFENSE; INFECTION	Interleukin-1 receptor like 1 (ST2) is a negative regulator of Toll-like receptor (TLR) signaling. TLRs are important for host defense during respiratory tract infections by both influenza and Streptococcus (S.) pneumoniae. Enhanced susceptibility to pneumococcal pneumonia is an important complication following influenza virus infection. We here sought to determine the role of ST2 in primary influenza A infection and secondary pneumococcal pneumonia. ST2 knockout (st2(-/-)) and wildtype (WT) mice were intranasally infected with influenza A virus; in some experiments mice were infected 2 weeks later with S. pneumoniae. Both mouse strains cleared the virus similarly during the first 14 days of influenza infection and had recovered their weights equally at day 14. Overall st2(-/-) mice tended to have a stronger pulmonary inflammatory response upon infection with influenza; especially 14 days after infection modest but statistically significant elevations were seen in lung IL-6, IL-1 beta, KC, IL-10, and IL-33 concentrations and myeloperoxidase levels, indicative of enhanced neutrophil activity. Interestingly, bacterial lung loads were higher in st2(-/-) mice during the later stages of secondary pneumococcal pneumonia, which was associated with relatively increased lung IFN-gamma levels. ST2 deficiency did not impact on gross lung pathology in either influenza or secondary S. pneumoniae pneumonia. These data show that ST2 plays a limited anti-inflammatory role during both primary influenza and postinfluenza pneumococcal pneumonia.	[Blok, Dana C.; van 't Veer, Cornelis; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [van der Sluijs, Koenraad F.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine; de Boer, Onno J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Blok, DC (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.c.blok@amc.uva.nl		Florquin, Sandrine/0000-0002-9676-1722; de Boer, Onno/0000-0001-8844-1326				Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Alicino C, 2011, J Prev Med Hyg, V52, P102; Ballinger MN, 2010, J INTERF CYTOK RES, V30, P643, DOI 10.1089/jir.2010.0049; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Dessing MC, 2007, AM J RESP CELL MOL, V36, P609, DOI 10.1165/rcmb.2006-0166OC; Dessing MC, 2009, J INNATE IMMUN, V1, P366, DOI 10.1159/000167961; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Grabowska K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-58; Hoogerwerf JJ, 2012, MOL MED, V18, P1067, DOI 10.2119/molmed.2011.00450; Hoogerwerf JJ, 2011, AM J RESP CRIT CARE, V183, P932, DOI 10.1164/rccm.201006-0934OC; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Irizarry-Acosta M, 2010, MED HLTH R I, V93, P211; Irizarry-Acosta Melina, 2010, Med Health R I, V93, P204; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kager LM, 2011, J THROMB HAEMOST, V9, P2020, DOI 10.1111/j.1538-7836.2011.04473.x; Karlstrom A, 2011, J INFECT DIS, V204, P1358, DOI 10.1093/infdis/jir522; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kozak W, 1997, AM J PHYSIOL-REG I, V272, pR621, DOI 10.1152/ajpregu.1997.272.2.R621; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; LeVine AM, 2001, J VIROL METHODS, V94, P173, DOI 10.1016/S0166-0934(01)00287-7; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Paterson GK, 2010, RESPIROLOGY, V15, P1057, DOI 10.1111/j.1440-1843.2010.01814.x; Rijneveld AW, 2002, J IMMUNOL, V168, P3507, DOI 10.4049/jimmunol.168.7.3507; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seki M, 2010, J IMMUNOL, V184, P1410, DOI 10.4049/jimmunol.0901709; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; Shinya K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-97; Smith MW, 2007, COMPARATIVE MED, V57, P82; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Tuvim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030596; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; van der Sluijs KF, 2006, AM J PHYSIOL-LUNG C, V290, pL194, DOI 10.1152/ajplung.00050.2005; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; van der Sluijs KF, 2003, IMMUNOL LETT, V89, P201, DOI 10.1016/S0165-2478(03)00138-X; van der Sluijs KF, 2010, CRIT CARE, V14, DOI 10.1186/cc8893; van der Windt GJW, 2012, J INFECT DIS, V205, P1849, DOI 10.1093/infdis/jis290; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048	62	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58191	10.1371/journal.pone.0058191	http://dx.doi.org/10.1371/journal.pone.0058191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483993	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100086
J	Eremenko, E; Ben-Zvi, A; Morozova-Roche, LA; Raveh, D				Eremenko, Ekaterina; Ben-Zvi, Anat; Morozova-Roche, Ludmilla A.; Raveh, Dina			Aggregation of Human S100A8 and S100A9 Amyloidogenic Proteins Perturbs Proteostasis in a Yeast Model	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; URE3 PRION PROPAGATION; EF-HAND PROTEINS; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; NEURODEGENERATIVE DISEASE; MOLECULAR CHAPERONES; HUNTINGTIN TOXICITY; MUTANT HUNTINGTIN; GENE-EXPRESSION	Amyloid aggregates of the calcium-binding EF-hand proteins, S100A8 and S100A9, have been found in the corpora amylacea of patients with prostate cancer and may play a role in carcinogenesis. Here we present a novel model system using the yeast Saccharomyces cerevisiae to study human S100A8 and S100A9 aggregation and toxicity. We found that S100A8, S100A9 and S100A8/9 cotransfomants form SDS-resistant non-toxic aggregates in yeast cells. Using fluorescently tagged proteins, we showed that S100A8 and S100A9 accumulate in foci. After prolonged induction, S100A8 foci localized to the cell vacuole, whereas the S100A9 foci remained in the cytoplasm when present alone, but entered the vacuole in cotransformants. Biochemical analysis of the proteins indicated that S100A8 and S100A9 alone or coexpressed together form amyloid-like aggregates in yeast. Expression of S100A8 and S100A9 in wild type yeast did not affect cell viability, but these proteins were toxic when expressed on a background of unrelated metastable temperature-sensitive mutant proteins, Cdc53-1p, Cdc34-2p, Srp1-31p and Sec27-1p. This finding suggests that the expression and aggregation of S100A8 and S100A9 may limit the capacity of the cellular proteostasis machinery. To test this hypothesis, we screened a set of chaperone deletion mutants and found that reducing the levels of the heat-shock proteins Hsp104p and Hsp70p was sufficient to induce S100A8 and S100A9 toxicity. This result indicates that the chaperone activity of the Hsp104/Hsp70 bi-chaperone system in wild type cells is sufficient to reduce S100A8 and S100A9 amyloid toxicity and preserve cellular proteostasis. Expression of human S100A8 and S100A9 in yeast thus provides a novel model system for the study of the interaction of amyloid deposits with the proteostasis machinery.	[Eremenko, Ekaterina; Ben-Zvi, Anat; Raveh, Dina] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ben-Zvi, Anat] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden	Ben Gurion University; Ben Gurion University; Umea University	Ben-Zvi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	anatbz@bgu.ac.il; raveh@bgu.ac.il	BEN-ZVI, ANAT/F-1674-2012; Morozova-Roche, Ludmilla A./AAU-9044-2021; Morozova-Roche, Ludmilla/AAV-9983-2021	BEN-ZVI, ANAT/0000-0003-2477-6519; Morozova-Roche, Ludmilla/0000-0001-5886-2023; Eremenko, Ekaterina/0000-0001-5520-9416	EU [PITN-GA-2008-215148]	EU(European Commission)	This work was supported by FP7 EU contract PITN-GA-2008-215148, http://cordis.europa.eu/fp7/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bates GP, 2006, SCIENCE, V311, P1385, DOI 10.1126/science.1125246; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Derkatch IL, 1997, GENETICS, V147, P507; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; Giorgini F, 2009, METHODS MOL BIOL, V548, P161, DOI 10.1007/978-1-59745-540-4_9; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hood JK, 2000, J CELL SCI, V113, P1471; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Ivantsiv Y, 2006, MOL CELL BIOL, V26, P1579, DOI 10.1128/MCB.26.5.1579-1588.2006; Kaplun L, 2003, J BIOL CHEM, V278, P48727, DOI 10.1074/jbc.M308671200; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kryndushkin DS, 2011, GENETICS, V188, P339, DOI 10.1534/genetics.111.127779; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Miller-Fleming Leonor, 2008, Biotechnol J, V3, P325, DOI 10.1002/biot.200700217; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroi D, 2012, J BIOL CHEM, V287, P27567, DOI 10.1074/jbc.M112.361865; Prendergast JA, 1996, MOL CELL BIOL, V16, P677; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Su HB, 2010, CARDIOVASC RES, V85, P253, DOI 10.1093/cvr/cvp287; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Tauber E, 2011, J BIOL CHEM, V286, P410, DOI 10.1074/jbc.M110.101527; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002; Wolfe KJ, 2011, SEMIN CELL DEV BIOL, V22, P476, DOI 10.1016/j.semcdb.2011.03.011; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562	75	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58218	10.1371/journal.pone.0058218	http://dx.doi.org/10.1371/journal.pone.0058218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483999	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100091
J	Kang, FX; Wang, H; Gao, YZ; Long, J; Wang, Q				Kang, Fuxing; Wang, Hong; Gao, Yanzheng; Long, Jian; Wang, Qian			Ca2+ Promoted the Low Transformation Efficiency of Plasmid DNA Exposed to PAH Contaminants	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; STRUCTURAL-ANALYSIS; ESCHERICHIA-COLI; ORGANIC-MATTER; GENE-TRANSFER; DEGRADATION; WATER; FTIR; CD	The effects of interactions between genetic materials and polycyclic aromatic hydrocarbons (PAHs) on gene expression in the extracellular environment remain to be elucidated and little information is currently available on the effect of ionic strength on the transformation of plasmid DNA exposed to PAHs. Phenanthrene and pyrene were used as representative PAHs to evaluate the transformation of plasmid DNA after PAH exposure and to determine the role of Ca2+ during the transformation. Plasmid DNA exposed to the test PAHs demonstrated low transformation efficiency. In the absence of PAHs, the transformation efficiency was 4.7 log units; however, the efficiency decreased to 3.72-3.14 log units with phenanthrene/pyrene exposures of 50 mu g.L-1. The addition of Ca2+ enhanced the low transformation efficiency of DNA exposed to PAHs. Based on the co-sorption of Ca2+ and phenanthrene/pyrene by DNA, we employed Fourier-transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), and mass spectrometry (MS) to determine the mechanisms involved in PAH-induced DNA transformation. The observed low transformation efficiency of DNA exposed to either phenanthrene or pyrene can be attributed to a broken hydrogen bond in the double helix caused by planar PAHs. Added Ca2+ formed strong electrovalent bonds with "-POO-'' groups in the DNA, weakening the interaction between PAHs and DNA based on weak molecular forces. This decreased the damage of PAHs to hydrogen bonds in double-stranded DNA by isolating DNA molecules from PAHs and consequently enhanced the transformation efficiency of DNA exposed to PAH contaminants. The findings provide insight into the effects of anthropogenic trace PAHs on DNA transfer in natural environments.	[Kang, Fuxing; Wang, Hong; Gao, Yanzheng] Nanjing Agr Univ, Coll Resource & Environm Sci, Inst Organ Contaminant Control & Soil Remediat, Nanjing, Jiangsu, Peoples R China; [Kang, Fuxing; Long, Jian] Guizhou Normal Univ, Key Lab Informat Syst Mountainous Areas & Protect, Guiyang, Peoples R China; [Wang, Qian] Nanjing Univ, Sch Earth Sci & Engn, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Agricultural University; Guizhou Normal University; Nanjing University	Gao, YZ (corresponding author), Nanjing Agr Univ, Coll Resource & Environm Sci, Inst Organ Contaminant Control & Soil Remediat, Nanjing, Jiangsu, Peoples R China.	gaoyanzheng@njau.edu.cn	Gao, Yanzheng/G-6391-2010	Gao, Yanzheng/0000-0002-3814-3555	National Natural Science Foundation of China [41171193, 51278252, 21077056]; Key Technology R&D Program of Jiangsu Province [BE2011780]; Fundamental Research Funds for the Central Universities of China [KYZ201109]; Foundation of State Key Laboratory of Pollution Control and Resources Reuse, China [PCRRF11034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology R&D Program of Jiangsu Province; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Foundation of State Key Laboratory of Pollution Control and Resources Reuse, China	The work was supported by the National Natural Science Foundation of China (41171193, 51278252, 21077056), the Key Technology R&D Program of Jiangsu Province (BE2011780), the Fundamental Research Funds for the Central Universities of China (KYZ201109), and the Foundation of State Key Laboratory of Pollution Control and Resources Reuse, China (PCRRF11034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MP, 2005, WORLD J MICROB BIOT, V21, P1157, DOI 10.1007/s11274-005-0381-6; ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Banyay E, 1990, SPECTROCHIM ACTA A, V46A, P107; Banyay M, 2002, J MOL BIOL, V324, P667, DOI 10.1016/S0022-2836(02)01104-X; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; Cai P, 2006, ENVIRON SCI TECHNOL, V40, P2971, DOI 10.1021/es0522985; Cai P, 2007, THESIS HUAZHONG AGR, P1; Cajthaml T, 2002, J CHROMATOGR A, V974, P213, DOI 10.1016/S0021-9673(02)00904-4; Chauhan A, 2008, INDIAN J MICROBIOL, V48, P95, DOI 10.1007/s12088-008-0010-9; FERGUSON LR, 1991, MUTAT RES, V258, P123, DOI 10.1016/0165-1110(91)90006-H; Gao YZ, 2008, PLANT SOIL, V311, P201, DOI 10.1007/s11104-008-9671-8; Gao YZ, 2008, CHEMOSPHERE, V72, P636, DOI 10.1016/j.chemosphere.2008.02.032; Gao YZ, 2007, J HAZARD MATER, V140, P138, DOI 10.1016/j.jhazmat.2006.06.053; Gao YZ, 2009, ENVIRON SCI TECHNOL, V43, P6190, DOI 10.1021/es900662d; Hamdi H, 2007, CHEMOSPHERE, V70, P135, DOI 10.1016/j.chemosphere.2007.06.043; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Inbaraj BS, 2008, BIORESOURCE TECHNOL, V99, P1026, DOI 10.1016/j.biortech.2007.03.008; JEFFREY AM, 1985, PHARMACOL THERAPEUT, V28, P237, DOI 10.1016/0163-7258(85)90013-0; Kang FX, 2010, ENVIRON SCI TECHNOL, V44, P8891, DOI 10.1021/es103215b; Kang FX, 2010, FUND APPL LIMNOL, V176, P173, DOI 10.1127/1863-9135/2010/0176-0173; KASTNER M, 1994, APPL MICROBIOL BIOT, V41, P267, DOI 10.1007/BF00186971; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Ledford HA, 2010, NATURE, DOI [10.1038/news.2010.169, DOI 10.1038/NEWS.2010.169]; Lindqvist M, 2001, J MOL BIOL, V314, P423, DOI 10.1006/jmbi.2001.5164; Liquier J, 1996, INFRARED SPECTROSCOP; LOPRETE DM, 1993, BIOCHEMISTRY-US, V32, P4077, DOI 10.1021/bi00066a032; Lou SL, 2002, GENE INTRO CELL ACCE; MAO Y, 1994, ENVIRON HEALTH PERSP, V102, P165, DOI 10.2307/3432234; Mott HV, 2002, ADV ENVIRON RES, V6, P577, DOI 10.1016/S1093-0191(01)00104-6; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Raber B, 1997, EUR J SOIL SCI, V48, P443, DOI 10.1046/j.1365-2389.1997.00101.x; Rensing C, 2002, SOIL BIOL BIOCHEM, V34, P285, DOI 10.1016/S0038-0717(01)00183-3; Seiichi Kondo, 2005, ADSORPTION SCI; Shimanouchi T, 1964, ADV CHEM PHYS; Stephens TD, 2000, BIOCHEM PHARMACOL, V59, P1489, DOI 10.1016/S0006-2952(99)00388-3; TAILLANDIER E, 1992, METHOD ENZYMOL, V211, P307; Tajmir-Riahi HA, 2009, SPECTROSC-INT J, V23, P81, DOI 10.1155/2009/587956; TAJMIRRIAHI HA, 1995, FEBS LETT, V370, P105, DOI 10.1016/0014-5793(95)00802-G; TSUBOI M, 1969, APPL SPECTROSC REV, V3, P45; Veronico P, 2001, FEBS LETT, V508, P470, DOI 10.1016/S0014-5793(01)03132-5; Wang X.R., 1993, ENVIRON CHEM, V2nd; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454	45	8	10	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58238	10.1371/journal.pone.0058238	http://dx.doi.org/10.1371/journal.pone.0058238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484001	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100092
J	Marchi, N; Bazarian, JJ; Puvenna, V; Janigro, M; Ghosh, C; Zhong, JH; Zhu, T; Blackman, E; Stewart, D; Ellis, J; Butler, R; Janigro, D				Marchi, Nicola; Bazarian, Jeffrey J.; Puvenna, Vikram; Janigro, Mattia; Ghosh, Chaitali; Zhong, Jianhui; Zhu, Tong; Blackman, Eric; Stewart, Desiree; Ellis, Jasmina; Butler, Robert; Janigro, Damir			Consequences of Repeated Blood-Brain Barrier Disruption in Football Players	PLOS ONE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; NEUROLOGICAL DISORDERS; PROFESSIONAL FOOTBALL; IMPACT BIOMECHANICS; ALZHEIMERS-DISEASE; SERUM S100-BETA; AUTOANTIBODIES; CONCUSSION	The acknowledgement of risks for traumatic brain injury in American football players has prompted studies for sideline concussion diagnosis and testing for neurological deficits. While concussions are recognized etiological factors for a spectrum of neurological sequelae, the consequences of sub-concussive events are unclear. We tested the hypothesis that blood-brain barrier disruption (BBBD) and the accompanying surge of the astrocytic protein S100B in blood may cause an immune response associated with production of auto-antibodies. We also wished to determine whether these events result in disrupted white matter on diffusion tensor imaging (DT) scans. Players from three college football teams were enrolled (total of 67 volunteers). None of the players experienced a concussion. Blood samples were collected before and after games (n = 57); the number of head hits in all players was monitored by movie review and post-game interviews. S100B serum levels and auto-antibodies against S100B were measured and correlated by direct and reverse immunoassays (n = 15 players; 5 games). A subset of players underwent DTI scans pre- and post-season and after a 6-month interval (n = 10). Cognitive and functional assessments were also performed. After a game, transient BBB damage measured by serum S100B was detected only in players experiencing the greatest number of sub-concussive head hits. Elevated levels of auto-antibodies against S100B were elevated only after repeated sub-concussive events characterized by BBBD. Serum levels of S100B auto-antibodies also predicted persistence of MRI-DTI abnormalities which in turn correlated with cognitive changes. Even in the absence of concussion, football players may experience repeated BBBD and serum surges of the potential autoantigen S100B. The correlation of serum S100B, auto-antibodies and DTI changes support a link between repeated BBBD and future risk for cognitive changes.	[Marchi, Nicola; Puvenna, Vikram; Ghosh, Chaitali; Stewart, Desiree; Ellis, Jasmina; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Puvenna, Vikram; Ghosh, Chaitali; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Puvenna, Vikram; Ghosh, Chaitali; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Cell & Mol Med, Cleveland, OH 44106 USA; [Janigro, Mattia; Janigro, Damir] Flocel Inc, Cleveland, OH USA; [Ellis, Jasmina] Baldwin Wallace Coll, Berea, OH USA; [Butler, Robert] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Bazarian, Jeffrey J.; Zhong, Jianhui; Zhu, Tong; Blackman, Eric] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Baldwin Wallace University; Cleveland Clinic Foundation; University of Rochester	Janigro, D (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	janigrd@ccf.org	Marchi, Nicola/J-8607-2016; Zhu, Tong/A-9402-2011; Zhong, Jianhui/AAE-6061-2020	Marchi, Nicola/0000-0001-9124-0226; Ghosh, Chaitali/0000-0003-4078-0278; Blackman, Eric/0000-0002-9405-8435; Zhu, Tong/0000-0002-0012-0091; Janigro, Damir/0000-0003-2165-5826	NINDS [R21HD057256]; Flocel, Inc; National Football League-Charities Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078307] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Flocel, Inc; National Football League-Charities Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was received from: NINDS R21HD057256; Salary for MJ supported by Flocel, Inc; National Football League-Charities Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankeny DP, 2010, TRENDS IMMUNOL, V31, P332, DOI 10.1016/j.it.2010.06.006; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Maetzler W, 2011, J ALZHEIMERS DIS, V26, P171, DOI 10.3233/JAD-2011-110221; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-34; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Pardini J, 2011, YOUMANS NEUROLOGICAL, P3380; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Sorokina EG, 2010, ZH NEVROL PSIKHIATR, V110, P30; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Storace D, 2010, ARCH NEUROL-CHICAGO, V67, P867, DOI 10.1001/archneurol.2010.137; Taira BR, 2012, ANN EMERG MED, V60, P236, DOI 10.1016/j.annemergmed.2012.04.004; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	47	185	190	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56805	10.1371/journal.pone.0056805	http://dx.doi.org/10.1371/journal.pone.0056805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483891	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100009
J	Santoni, D; Castiglione, F; Paci, P				Santoni, Daniele; Castiglione, Filippo; Paci, Paola			Identifying Correlations between Chromosomal Proximity of Genes and Distance of Their Products in Protein-Protein Interaction Networks of Yeast	PLOS ONE			English	Article							ORGANIZATION; NUCLEOSOME	In this article we present evidence for a relationship between chromosome gene loci and the topological properties of the protein-protein interaction network corresponding to the set of genes under consideration. Specifically, for each chromosome of the Saccharomyces cerevisiae genome, the distribution of the intra-chromosome inter-gene distances was analyzed and a positive correlation with the distance among the corresponding proteins of the protein-protein interaction network was found. In order to study this relationship we used concepts based on non-parametric statistics and information theory. We provide statistical evidence that if two genes are closely located, then it is likely that their protein products are closely located in the protein-protein interaction network, or in other words, that they are involved in the same biological process.	[Santoni, Daniele; Paci, Paola] Natl Res Council Italy, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy; [Castiglione, Filippo] Natl Res Council Italy, Inst Comp Applicat Mauro Picone, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR)	Santoni, D (corresponding author), Natl Res Council Italy, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy.	daniele.santoni@iasi.cnr.it	santoni, daniele/E-8853-2010; Castiglione, Filippo/B-1366-2010	Castiglione, Filippo/0000-0002-1442-3552; SANTONI, DANIELE/0000-0003-1898-5285	"Consorzio interuniversitario per le Applicazioni di Supercalcolo Per Universita e Ricerca" (CASPUR)	"Consorzio interuniversitario per le Applicazioni di Supercalcolo Per Universita e Ricerca" (CASPUR)	We thank the "Consorzio interuniversitario per le Applicazioni di Supercalcolo Per Universita e Ricerca" (CASPUR) for computing resources and support. We thank Professor G. Cesareni for illuminating discussion and for providing MINT data network.	Batada NN, 2007, TRENDS GENET, V23, P480, DOI 10.1016/j.tig.2007.08.003; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Duan Z, 2010, NATURE; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; Goetze S, 2007, SEMIN CELL DEV BIOL, V18, P707, DOI 10.1016/j.semcdb.2007.08.007; Hill T., 2006, STAT METHODS APPL; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Lee J, 2003, GENOME RES; Lehmann E. L., 2006, NONPARAMETRICS STAT; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; MacKay D. J. C., 2003, INFORM THEORY INFERE; Numata Jorge, 2008, Genome Inform, V20, P112; Park K, 2009, PROTEOMICS, V9, P5143, DOI 10.1002/pmic.200900357; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204; Yanai I, 2002, TRENDS GENET, V18, P176, DOI 10.1016/S0168-9525(01)02621-X	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57707	10.1371/journal.pone.0057707	http://dx.doi.org/10.1371/journal.pone.0057707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483922	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100038
J	Padilla-Torres, SD; Ferraz, G; Luz, SLB; Zamora-Perea, E; Abad-Franch, F				Padilla-Torres, Samael D.; Ferraz, Goncalo; Luz, Sergio L. B.; Zamora-Perea, Elvira; Abad-Franch, Fernando			Modeling Dengue Vector Dynamics under Imperfect Detection: Three Years of Site-Occupancy by Aedes aegypti and Aedes albopictus in Urban Amazonia	PLOS ONE			English	Article							POPULATION-DYNAMICS; PUERTO-RICO; TRANSMISSION; MOSQUITOS; CULICIDAE; DIPTERA; OVITRAP; BRAZIL; FEVER; INFESTATION	Aedes aegypti and Ae. albopictus are the vectors of dengue, the most important arboviral disease of humans. To date, Aedes ecology studies have assumed that the vectors are truly absent from sites where they are not detected; since no perfect detection method exists, this assumption is questionable. Imperfect detection may bias estimates of key vector surveillance/control parameters, including site-occupancy (infestation) rates and control intervention effects. We used a modeling approach that explicitly accounts for imperfect detection and a 38-month, 55-site detection/non-detection dataset to quantify the effects of municipality/state control interventions on Aedes site-occupancy dynamics, considering meteorological and dwelling-level covariates. Ae. aegypti site-occupancy estimates (mean 0.91; range 0.79-0.97) were much higher than reported by routine surveillance based on ` rapid larval surveys' (0.03; 0.02-0.11) and moderately higher than directly ascertained with oviposition traps (0.68; 0.50-0.91). Regular control campaigns based on breeding-site elimination had no measurable effects on the probabilities of dwelling infestation by dengue vectors. Site-occupancy fluctuated seasonally, mainly due to the negative effects of high maximum (Ae. aegypti) and minimum (Ae. albopictus) summer temperatures (June-September). Rainfall and dwelling-level covariates were poor predictors of occupancy. The marked contrast between our estimates of adult vector presence and the results from ` rapid larval surveys' suggests, together with the lack of effect of local control campaigns on infestation, that many Aedes breeding sites were overlooked by vector control agents in our study setting. Better sampling strategies are urgently needed, particularly for the reliable assessment of infestation rates in the context of control program management. The approach we present here, combining oviposition traps and site-occupancy models, could greatly contribute to that crucial aim.	[Padilla-Torres, Samael D.; Ferraz, Goncalo] Inst Nacl de Pesquisas da Amazonia, Grad Program Ecol, Manaus, Amazonas, Brazil; [Ferraz, Goncalo] Inst Nacl de Pesquisas da Amazonia, Smithsonian Trop Res Inst, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Luz, Sergio L. B.; Zamora-Perea, Elvira; Abad-Franch, Fernando] Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute; Fundacao Oswaldo Cruz	Abad-Franch, F (corresponding author), Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil.	fernando@amazonia.fiocruz.br	Abad-Franch, Fernando/AAB-6729-2021; Abad-Franch, Fernando/L-4741-2013; Ferraz, Gonçalo/C-3860-2008; Abad-Franch, Fernando/AAG-2432-2020	Ferraz, Gonçalo/0000-0001-8748-0462; Abad-Franch, Fernando/0000-0002-7715-0328	PDTSP-Dengue Program (Fiocruz-CNPq); Instituto Leonidas e Maria Deane; Fiocruz-Fapeam agreement; Brazilian National Research Council (CAPES/CNPq) [190023/10-4]; Research Program on Infectious Disease Ecology in the Amazon (RP-IDEA) of the Instituto Leonidas e Maria Deane - Fiocruz Amazonia [17]	PDTSP-Dengue Program (Fiocruz-CNPq); Instituto Leonidas e Maria Deane; Fiocruz-Fapeam agreement; Brazilian National Research Council (CAPES/CNPq); Research Program on Infectious Disease Ecology in the Amazon (RP-IDEA) of the Instituto Leonidas e Maria Deane - Fiocruz Amazonia	Research partially funded by the PDTSP-Dengue Program (Fiocruz-CNPq), the Instituto Leonidas e Maria Deane, the Fiocruz-Fapeam agreement, and the Brazilian National Research Council (CAPES/CNPq; scholarship 190023/10-4 to SDP-T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank RM Mota, DLN Leite, and AC Barbosa for field assistance. RS Rocha and the Manaus municipal and state Health Departments provided data on routine control-surveillance activities. We particularly thank the residents who participated in the study - and patiently let us keep running our vector monitoring system. SA Juliano, LL Bailey, RE Gurtler, and BW Nelson provided insightful comments on earlier versions of this manuscript. This work is contribution number 17 of the Research Program on Infectious Disease Ecology in the Amazon (RP-IDEA) of the Instituto Leonidas e Maria Deane - Fiocruz Amazonia.	Abad-Franch F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000620; Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; CHADEE D D, 1986, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V24, P199; Chadee DD, 2009, ACTA TROP, V109, P236, DOI 10.1016/j.actatropica.2008.12.001; da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x; Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942; Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Donatti JE, 2007, REV BRAS ENTOMOL, V51, P255, DOI 10.1590/S0085-56262007000200019; Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x; Favier C, 2006, TROP MED INT HEALTH, V11, P1104, DOI 10.1111/j.1365-3156.2006.01653.x; Fe NF, 2003, REV SAUDE PUBL, V37, P674, DOI 10.1590/S0034-89102003000500020; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; FUNASA, 2001, DENG INSTR PESS COMB; *FUNASA, 2002, PROGR NAC CONTR DENG; Fundacao de Vigilancia em Saude do Estado do Amazonas, 2008, REL FIN OP IMP CONTR; Fundacao de Vigilancia em Saude do Estado do Amazonas, 2009, REL FIN OP IMP 2 CON; FURLOW BM, 1970, MOSQ NEWS, V30, P468; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Gubler D. J., 1988, The arboviruses: epidemiology and ecology. Volume II., P223; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000427; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Hines, 2017, OCCUPANCY ESTIMATION; Hines J. E., 2006, PRESENCE 4 0 SOFTWAR; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Leisnham PT, 2009, OECOLOGIA, V160, P343, DOI 10.1007/s00442-009-1305-1; Lourenco-de-Oliveira R, 2008, J AM MOSQUITO CONTR, V24, P387, DOI 10.2987/5585.1; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; MacKenzie DI, 2005, AUST NZ J STAT, V47, P65, DOI 10.1111/j.1467-842X.2005.00372.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MINISTERIO DA SAUDE, 2005, DIAGN RAP NOS MUN VI; MOGI M, 1990, J MED ENTOMOL, V27, P509, DOI 10.1093/jmedent/27.4.509; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Pilger D, 2011, TROP MED INT HEALTH, V16, P1143, DOI 10.1111/j.1365-3156.2011.02818.x; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; REITER P, 1991, J AM MOSQUITO CONTR, V7, P52; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Reiter Paul, 1997, P425; Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076; Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77; Taliberti H, 2010, REV PANAM SALUD PUBL, V27, P175, DOI 10.1590/S1020-49892010000300004; Tukey JW, 1977, EXPLORATORY DATA ANA; TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543; TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591; Who, 2006, SCI WORK GROUP REP D; WHO, 2012, GLOB AL RESP IMP DEN	60	12	13	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58420	10.1371/journal.pone.0058420	http://dx.doi.org/10.1371/journal.pone.0058420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472194	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900140
J	Eker, B; Meissner, R; Bertsch, A; Mehta, K; Renaud, P				Eker, Bilge; Meissner, Robert; Bertsch, Arnaud; Mehta, Kapil; Renaud, Philippe			Label-Free Recognition of Drug Resistance via Impedimetric Screening of Breast Cancer Cells	PLOS ONE			English	Article							MODEL; EXPRESSION; BIOMECHANICS; DOXORUBICIN; ADHESION; CADHERIN; MONITOR; KINASE	We present a novel study on label-free recognition and distinction of drug resistant breast cancer cells (MCF-7 DOX) from their parental cells (MCF-7 WT) via impedimetric measurements. Drug resistant cells exhibited significant differences in their dielectric properties compared to wild-type cells, exerting much higher extracellular resistance (R-extra). Immunostaining revealed that MCF-7 DOX cells gained a much denser F-actin network upon acquiring drug resistance indicating that remodeling of actin cytoskeleton is probably the reason behind higher R-extra, providing stronger cell architecture. Moreover, having exposed both cell types to doxorubicin, we were able to distinguish these two phenotypes based on their substantially different drug response. Interestingly, impedimetric measurements identified a concentration-dependent and reversible increase in cell stiffness in the presence of low non-lethal drug doses. Combined with a profound frequency analysis, these findings enabled distinguishing distinct cellular responses during drug exposure within four concentration ranges without using any labeling. Overall, this study highlights the possibility to differentiate drug resistant phenotypes from their parental cells and to assess their drug response by using microelectrodes, offering direct, real-time and noninvasive measurements of cell dependent parameters under drug exposure, hence providing a promising step for personalized medicine applications such as evaluation of the disease progress and optimization of the drug treatment of a patient during chemotherapy.	[Eker, Bilge; Meissner, Robert; Bertsch, Arnaud; Renaud, Philippe] Ecole Polytech Fed Lausanne, Lab Microsyst LMIS4, Stn 17, CH-1015 Lausanne, Switzerland; [Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Texas System; UTMD Anderson Cancer Center	Eker, B (corresponding author), Ecole Polytech Fed Lausanne, Lab Microsyst LMIS4, Stn 17, CH-1015 Lausanne, Switzerland.	bilge.eker@epfl.ch	Renaud, Philippe/AAQ-6205-2021; Bertsch, Arnaud/U-5753-2017; Renaud, P/A-6994-2011; Bertsch, Arnaud/AAA-7279-2020	Renaud, Philippe/0000-0001-5199-1252; Bertsch, Arnaud/0000-0002-1044-0478; Renaud, P/0000-0001-5199-1252; Bertsch, Arnaud/0000-0002-1044-0478	NanoTera Livesense project [20NAN1-123593]	NanoTera Livesense project	This study was financially supported by the NanoTera Livesense project no. 20NAN1-123593, http://www.nano-tera.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias L, 2010, BIOSENSORS BIOELECTR; Bagnaninchi PO, 2011, P NATL ACAD SCI USA, V108, P6462, DOI 10.1073/pnas.1018260108; Bartholoma P, 2005, J BIOMOL SCREEN, V10, P705, DOI 10.1177/1087057105277841; Besser A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/425; Bijman M, 2006, MOL CANC; BLOBE GC, 1993, J BIOL CHEM, V268, P10627; Chen J, 2011, LAB CHIP, V11, P3174, DOI 10.1039/c1lc20473d; Chen JSK, 2004, J CELL PHYSIOL, V200, P223, DOI 10.1002/jcp.20014; Chen JSK, 2002, BREAST CANCER RES TR, V71, P237, DOI 10.1023/A:1014461832403; Cole K. S., 1940, Cold Spring Harbor Symposia on Quantitative Biology, V8, P110; Coley HM, 2007, BBA-GEN SUBJECTS, V1770, P601, DOI 10.1016/j.bbagen.2006.12.002; Cross SE, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/215101; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; Debye PJW, 1929, POLAR MOL; Devarajan E, 2002, INT J ONCOL, V20, P913; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Gawad S, 2004, THESIS ECOLE POLYTEC; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Grimnes S, 2005, IEEE T BIO-MED ENG, V52, P132, DOI 10.1109/TBME.2004.836499; Grzanka A, 2005, NEOPLASMA; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Isambert H, 1998, PHYS REV LETT, V80, P3404, DOI 10.1103/PhysRevLett.80.3404; ITAKURA Y, 1989, BIOMATERIALS, V10, P489, DOI 10.1016/0142-9612(89)90091-4; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kitada S, 2002, ONCOGENE, V21, P3459, DOI 10.1038/sj.onc.1205327; Kols A., 2002, OUTLOOK, V19, P1; Lin SP, 2009, BIOMATERIALS, V30, P3110, DOI 10.1016/j.biomaterials.2009.03.017; Linderholm P, 2006, THESIS ECOLE POLYTEC; MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316; Meissner R, 2011, LAB CHIP, V11, P2352, DOI 10.1039/c1lc20212j; Mercanzini A, 2009, IEEE T BIO-MED ENG, V56, P1909, DOI 10.1109/TBME.2009.2018457; MITRA P, 1991, BIOTECHNIQUES, V11, P504; MOSCOW JA, 1993, CYTOTECHNOLOGY, V12, P155, DOI 10.1007/BF00744663; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; PAULY H, 1959, Z NATURFORSCH PT B, V14, P125; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PESSINA A, 1993, CYTOTECHNOLOGY, V12, P127, DOI 10.1007/BF00744661; Pierce RH, 2002, BIOCHEM PHARMACOL, V64, P413, DOI 10.1016/S0006-2952(02)01180-2; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rao J, 2004, CURRENT CANC DRUG TA; Satcher RL, 1996, BIOPHYS J, V71, P109, DOI 10.1016/S0006-3495(96)79206-8; Schwan HP, 1985, ANAL DIELECTRIC DATA, P913; Sharma SK, 2011, E-ADOPTION AND SOCIO-ECONOMIC IMPACTS: EMERGING INFRASTRUCTURAL EFFECTS, P1, DOI [10.4018/978-1-60960-597-1, 10.1057/9780230119208]; Stieglitz T, 2004, NEUROPROSTHETICS THE, P475; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Tu YP, 1996, BLOOD, V88, P1805, DOI 10.1182/blood.V88.5.1805.bloodjournal8851805; UEDA K, 1987, J BIOL CHEM, V262, P505; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Weldon C, 2012, EXPT BIOL MED CANC; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Winograd-Katz SE, 2011, EUR J CELL BIOL, V90, P143, DOI 10.1016/j.ejcb.2010.07.006; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	54	31	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57423	10.1371/journal.pone.0057423	http://dx.doi.org/10.1371/journal.pone.0057423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483910	Green Published, Green Submitted, gold			2022-12-25	WOS:000315634900018
J	Wang, J; Tian, X; Han, R; Zhang, X; Wang, X; Shen, H; Xue, L; Liu, Y; Yan, X; Shen, J; Mannoor, K; Deepak, J; Donahue, JM; Stass, SA; Xing, L; Jiang, F				Wang, J.; Tian, X.; Han, R.; Zhang, X.; Wang, X.; Shen, H.; Xue, L.; Liu, Y.; Yan, X.; Shen, J.; Mannoor, K.; Deepak, J.; Donahue, J. M.; Stass, S. A.; Xing, L.; Jiang, F.			Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer	ONCOGENE			English	Article						miR-486-5p; tumor-suppressor gene; lung cancer; ARHGAP5; therapy	MICRORNA MARKERS; P190B RHOGAP; CELL; SUPPRESSOR; CARCINOMA; IDENTIFICATION; TUMORIGENESIS; ACTIVATION; BIOMARKERS; DIAGNOSIS	We have previously shown that miR-486-5p is one of the most downregulated micro RNAs in lung cancer. The objective of the study was to investigate the role of miR-486-5p in the progression and metastasis of non-small-cell lung cancer (NSCLC). We evaluated miR-486-5p expression status on 76 frozen and 33 formalin-fixed paraffin-embedded tissues of NSCLC by quantitative reverse transcriptase PCR to determine its clinicopathologic significance. We then performed function analysis of miR-486-5p to determine its potential roles on cancer cell migration and invasion in vitro and metastasis in vivo. We also investigated the target genes of miR-486-5p in lung tumorigenesis. miR-486-5p expression level was significantly lower in lung tumors compared with their corresponding normal tissues (P<0.0001), and associated with stage (P = 0.0001) and lymph node metastasis of NSCLC (P = 0.0019). Forced expression of miR-486-5p inhibited NSCLC cell migration and invasion in vitro and metastasis in mice by inhibiting cell proliferation. Furthermore, ectopic expression of miR-486-5p in cancer cells reduced ARHGAP5 expression level, whereas miR-486-5p silencing increased its expression. Luciferase assay demonstrated that miR-486-5p could directly bind to the 30-untranslated region of ARHGAP5. The expression level of miR-486-5p was inversely correlated with that of ARHGAP5 in lung tumor tissues (P = 0.0156). Reduced expression of ARHGAP5 considerably inhibited lung cancer cell migration and invasion, resembling that of miR-486-5p overexpression. miR-486-5p may act as a tumor-suppressor contributing to the progression and metastasis of NSCLC by targeting ARHGAP5. miR-486-5p would provide potential diagnostic and therapeutic targets for the disease.	[Wang, J.; Tian, X.; Han, R.; Shen, H.; Xue, L.; Yan, X.; Xing, L.] Hebei Med Univ, Dept Pathol, Shijiazhuang 050017, Peoples R China; [Zhang, X.] Hebei Med Univ, Hosp 2, Dept Pathol, Shijiazhuang 050017, Peoples R China; [Wang, X.; Liu, Y.] Hebei Med Univ, Tumor Hosp, Dept Pathol, Shijiazhuang 050017, Peoples R China; [Shen, J.; Mannoor, K.; Stass, S. A.; Jiang, F.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Deepak, J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Donahue, J. M.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	Hebei Medical University; Hebei Medical University; Hebei Medical University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Xing, L (corresponding author), Hebei Med Univ, Dept Pathol, 361 East Zhongshan Rd, Shijiazhuang 050017, Peoples R China.	xinglingxiao@hotmail.com; fjiang@som.umaryland.edu			National Natural Science Foundation of China [81101482]; Natural Science Foundation of Hebei province, China [C2011206001]; American Cancer Society-Research Scholar Grant in Basic, Preclinical, Clinical and Epidemiology Research [115154AF109040]; National Cancer Institute (NCI) [R01CA161837-01]; Maryland Stem Cell Research Fund; VA-Merit grant [I01 CX000512-01]; NATIONAL CANCER INSTITUTE [R01CA161837] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000512] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei province, China(Natural Science Foundation of Hebei Province); American Cancer Society-Research Scholar Grant in Basic, Preclinical, Clinical and Epidemiology Research; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maryland Stem Cell Research Fund; VA-Merit grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Grants 81101482 from the National Natural Science Foundation of China and Grants C2011206001 from the Natural Science Foundation of Hebei province, China (to LX) and American Cancer Society-Research Scholar Grant in Basic, Preclinical, Clinical and Epidemiology Research-115154AF109040, National Cancer Institute (NCI)-R01CA161837-01, an exploratory research grant from the Maryland Stem Cell Research Fund, and VA-Merit grant-I01 CX000512-01 (to FJ).	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bansal A, 2011, AM J GASTROENTEROL, V106, P1055, DOI 10.1038/ajg.2011.37; Chakravarty G, 2003, MOL ENDOCRINOL, V17, P1054, DOI 10.1210/me.2002-0428; Fan T, CANC RES; Feng J, 2004, NEOPLASIA, V6, P623, DOI 10.1593/neo.04142; Gao SM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-110; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gen Y, 2009, CANCER LETT, V275, P27, DOI 10.1016/j.canlet.2008.09.036; Heckman-Stoddard BM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2352; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McHenry PR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2643; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Ragusa M, 2010, MOL CANCER THER, V9, P3396, DOI 10.1158/1535-7163.MCT-10-0137; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Shen J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-374; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Teng DHF, 1997, CANCER RES, V57, P5221; Wang HJ, 2005, INT J CANCER, V116, P285, DOI 10.1002/ijc.21035; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xing LX, 2010, MODERN PATHOL, V23, P1157, DOI 10.1038/modpathol.2010.111; Yu L, 2010, INT J CANCER, V127, P2870, DOI 10.1002/ijc.25289	32	188	198	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1181	1189		10.1038/onc.2013.42	http://dx.doi.org/10.1038/onc.2013.42			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23474761	Green Accepted			2022-12-25	WOS:000331933800011
J	Calzada, C; Vericel, E; Colas, R; Guillot, N; El Khoury, G; Drai, J; Sassolas, A; Peretti, N; Ponsin, G; Lagarde, M; Moulin, P				Calzada, Catherine; Vericel, Evelyne; Colas, Romain; Guillot, Nicolas; El Khoury, Graziella; Drai, Jocelyne; Sassolas, Agnes; Peretti, Noel; Ponsin, Gabriel; Lagarde, Michel; Moulin, Philippe			Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia	FASEB JOURNAL			English	Article						metabolic disease; vitamin E; lipid peroxidation; hydroxylated fatty acids	APOLIPOPROTEIN-A-I; FAMILIAL HYPOBETALIPOPROTEINEMIA; OXIDATIVE STRESS; TRANSFER PROTEIN; ACTIVATION; ATHEROSCLEROSIS; DISEASE; HDL; EXPRESSION; TARGET	There is evidence that high-density lipoproteins (HDLs) may regulate platelet function, but disparate results exist regarding the effects of oxidized HDLs on platelets. The objective of our study was to determine the role of in vivo oxidized HDLs on platelet aggregation. Platelet aggregation and redox status were investigated in 5 patients with abetalipoproteinemia (ABLP) or homozygous hypobetalipoproteinemia, two rare metabolic diseases characterized by the absence of apolipoprotein B-containing lipoproteins, compared to 5 control subjects. Platelets isolated from plasma of patients with ABLP aggregated 4 to 10 times more than control platelets, depending on the agonist. By contrast, no differences in the extent of platelet aggregation were observed between ABLP platelet-rich plasma (PRP) and control PRP, suggesting the presence of a protective factor in ABLP plasma. ABLP HDLs inhibited agonist-induced platelet aggregation by binding to SR-BI, while control HDLs had no effect. On the other hand, lipoprotein-deficient plasma from patients with ABLP did not inhibit platelet aggregation. Severe oxidative stress was evidenced in patients with ABLP. Compared to control HDLs, ABLP HDLs showed a 40% decrease of -tocopherol and an 11-fold increased malondialdehyde concentration. These results demonstrate that in vivo oxidized HDLs do not lose their antiaggregatory properties despite oxidation.Calzada, C., Vericel, E., Colas, R., Guillot, N., El Khoury, G., Drai, J., Sassolas, A., Peretti, N., Ponsin, G., Lagarde, M., Moulin, P. Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia.	[Calzada, Catherine; Vericel, Evelyne; Colas, Romain; Guillot, Nicolas; El Khoury, Graziella; Drai, Jocelyne; Sassolas, Agnes; Peretti, Noel; Ponsin, Gabriel; Lagarde, Michel; Moulin, Philippe] Univ Lyon 1, INSERM, Cardiovasc Metab Diabetol & Nutr CarMeN Lab, Inst Natl Sci Appl Lyon INSA Lyon,IMBL,UMR 1060, F-69622 Villeurbanne, France; [Moulin, Philippe] Hosp Civils Lyon, Lyon Bron, France; [Peretti, Noel] Hosp Civils Lyon, Serv Gastroenterol & Nutr, Lyon Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon	Calzada, C (corresponding author), Univ Lyon, INSERM, UMR 1060, INSA Lyon,IMBL, Bat Louis Pasteur,20 Av Albert Einstein, F-69621 Villeurbanne, France.	catherine.calzada@insa-lyon.fr	Vericel, Evelyne/M-4187-2018	Calzada, Catherine/0000-0001-8858-6752; Guillot, Nicolas/0000-0003-1096-6960; El Khoury, Graziella/0000-0003-1902-390X	Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche (ANR) [ANR-05-COD-D019-01]; Centre National de la Recherche Scientifique	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	The authors are grateful to the patients for their reliable cooperation, to the control subjects for their participation, and to the nurses from Hospices Civils de Lyon for their expert blood drawing. The authors greatly thank Prof. Alain Lachaux for medical cooperation and Mathilde Di Filippo for scientific contribution. This work was supported by Institut National de la Sante et de la Recherche Medicale and Agence Nationale de la Recherche (ANR; grant ANR-05-COD-D019-01). C.C. is supported by the Centre National de la Recherche Scientifique.	ARDLIE NG, 1989, ATHEROSCLEROSIS, V76, P117, DOI 10.1016/0021-9150(89)90094-4; Assinger A, 2008, FEBS LETT, V582, P778, DOI 10.1016/j.febslet.2008.02.001; AVIRAM M, 1985, ATHEROSCLEROSIS, V57, P313, DOI 10.1016/0021-9150(85)90043-7; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; BOUKHCHACHE D, 1982, BIOCHIM BIOPHYS ACTA, V713, P386, DOI 10.1016/0005-2760(82)90257-0; BOWYER DE, 1963, BIOCHIM BIOPHYS ACTA, V70, P423, DOI 10.1016/0926-6542(63)90061-1; Brodde MF, 2011, ATHEROSCLEROSIS, V215, P374, DOI 10.1016/j.atherosclerosis.2010.12.026; Calkin AC, 2009, CIRCULATION, V120, P2095, DOI 10.1161/CIRCULATIONAHA.109.870709; Calzada C, 2007, J CLIN ENDOCR METAB, V92, P1961, DOI 10.1210/jc.2006-2045; Clarke MW, 2006, CLIN CHEM, V52, P1339, DOI 10.1373/clinchem.2006.068692; Colas R, 2011, DIABETOLOGIA, V54, P2931, DOI 10.1007/s00125-011-2272-8; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Di Leo E, 2008, CLIN GENET, V74, P267, DOI 10.1111/j.1399-0004.2008.01023.x; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; Granot E, 2004, AM J CLIN NUTR, V79, P226; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Imachi H, 2003, ARTERIOSCL THROM VAS, V23, P898, DOI 10.1161/01.ATV.0000067429.46333.7B; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; LAGARDE M, 1980, THROMB RES, V17, P581, DOI 10.1016/0049-3848(80)90098-5; LINTON MF, 1993, J LIPID RES, V34, P521; Macdonald DL, 2003, ARTERIOSCL THROM VAS, V23, P1583, DOI 10.1161/01.ATV.0000085840.67498.00; Nakano T, 2003, J LAB CLIN MED, V141, P378, DOI 10.1016/S0022-2143(03)00026-X; Nofer JR, 2011, CURR OPIN LIPIDOL, V22, P277, DOI 10.1097/MOL.0b013e32834701de; Nofer JR, 2010, CLIN EXP PHARMACOL P, V37, P726, DOI 10.1111/j.1440-1681.2010.05377.x; Patrono C, 1997, ARTERIOSCL THROM VAS, V17, P2309, DOI 10.1161/01.ATV.17.11.2309; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; SHASTRI KM, 1980, J LIPID RES, V21, P467; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; SURYA II, 1991, THROMB HAEMOSTASIS, V65, P306; Takahashi Y, 1996, BIOCHEM BIOPH RES CO, V222, P453, DOI 10.1006/bbrc.1996.0765; Valiyaveettil M, 2008, BLOOD, V111, P1962, DOI 10.1182/blood-2007-08-107813; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	33	12	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2855	2861		10.1096/fj.12-225169	http://dx.doi.org/10.1096/fj.12-225169			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23507868				2022-12-25	WOS:000328841000033
J	Dalli, J; Zhu, M; Vlasenko, NA; Deng, B; Haeggstrom, JZ; Petasis, NA; Serhan, CN				Dalli, Jesmond; Zhu, Min; Vlasenko, Nikita A.; Deng, Bin; Haeggstrom, Jesper Z.; Petasis, Nicos A.; Serhan, Charles N.			The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A(4) hydrolase (LTA(4)H), and shifts macrophage phenotype	FASEB JOURNAL			English	Article						inflammation resolution; leukocytes; n-3 omega essential fatty acids; proresolving mediators; DHA	PRO-RESOLVING MEDIATORS; FATTY-ACIDS; INFLAMMATION; RESOLUTION; ENZYME; D1; INACTIVATION; LEUKOCYTES; DISEASE; INJURY	Maresins are produced by macrophages from docosahexaenoic acid (DHA) and exert potent proresolving and tissue homeostatic actions. Maresin 1 (MaR1; 7R,14S-dihydroxy-docosa-4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid) is the first identified maresin. Here, we investigate formation, stereochemistry, and precursor role of 13,14-epoxy-docosahexaenoic acid, an intermediate in MaR1 biosynthesis. The 14-lipoxygenation of DHA by human macrophage 12-lipoxygenase (hm12-LOX) gave 14-hydro(peroxy)-docosahexaenoic acid (14-HpDHA), as well as several dihydroxy-docosahexaenoic acids, implicating an epoxide intermediate formation by this enzyme. Using a stereo-controlled synthesis, enantiomerically pure 13S,14S-epoxy-docosa-4Z,7Z,9E,11E,16Z,19Z-hexaenoic acid (13S,14S-epoxy-DHA) was prepared, and its stereochemistry was confirmed by NMR spectroscopy. When this 13S,14S-epoxide was incubated with human macrophages, it was converted to MaR1. The synthetic 13S,14S-epoxide inhibited leukotriene B-4 (LTB4) formation by human leukotriene A(4) hydrolase (LTA(4)H) approximate to 40% (P<0.05) to a similar extent as LTA(4) (approximate to 50%, P<0.05) but was not converted to MaR1 by this enzyme. 13S,14S-epoxy-DHA also reduced (approximate to 60%; P<0.05) arachidonic acid conversion by hm12-LOX and promoted conversion of M1 macrophages to M2 phenotype, which produced more MaR1 from the epoxide than M1. Together, these findings establish the biosynthesis of the 13S,14S-epoxide, its absolute stereochemistry, its precursor role in MaR1 biosynthesis, and its own intrinsic bioactivity. Given its actions and role in MaR1 biosynthesis, this epoxide is now termed 13,14-epoxy-maresin (13,14-eMaR) and exhibits new mechanisms in resolution of inflammation in its ability to inhibit proinflammatory mediator production by LTA(4) hydrolase and to block arachidonate conversion by human 12-LOX rather than merely terminating phagocyte involvement.Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggstrom, J. Z., Petasis, N. A., Serhan, C. N. The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A(4) hydrolase (LTA(4)H) and shifts macrophage phenotype.	[Dalli, Jesmond; Deng, Bin; Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Dalli, Jesmond; Deng, Bin; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA USA; [Zhu, Min; Vlasenko, Nikita A.; Petasis, Nicos A.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Zhu, Min; Vlasenko, Nikita A.; Petasis, Nicos A.] Univ So Calif, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA; [Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Southern California; University of Southern California; Karolinska Institutet	Serhan, CN (corresponding author), Harvard Inst Med, 77 Ave Louis Pasteur,HIM 829, Boston, MA 02115 USA.	petasis@usc.edu; cnserhan@zeus.bwh.harvard.edu	Petasis, Nicos/B-3162-2009	Petasis, Nicos/0000-0002-8864-4446; Dalli, Jesmond/0000-0001-6328-3640	U.S. National Institutes of Health [P01GM095467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Mary Halm Small for expert assistance in manuscript preparation. This study was supported by U.S. National Institutes of Health grant P01GM095467. The C.N.S. and N.A.P. laboratories contributed equally to this study.	Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Giera M, 2012, BBA-MOL CELL BIOL L, V1821, P1415, DOI 10.1016/j.bbalip.2012.07.011; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; IZUMI T, 1990, P NATL ACAD SCI USA, V87, P7477, DOI 10.1073/pnas.87.19.7477; Lu Y, 2010, J LIPID RES, V51, P923, DOI 10.1194/jlr.M000059; MUELLER MJ, 1995, P NATL ACAD SCI USA, V92, P8383, DOI 10.1073/pnas.92.18.8383; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; OHISHI N, 1987, J BIOL CHEM, V262, P10200; Rudberg PC, 2002, J BIOL CHEM, V277, P1398, DOI 10.1074/jbc.M106577200; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN., 2010, FUNDAMENTALS INFLAMM, DOI 10.1017/CBO9781139195737; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Tian HB, 2012, STEM CELLS DEV, V21, P1187, DOI 10.1089/scd.2011.0220; Tian HB, 2011, J BIOL CHEM, V286, P4443, DOI 10.1074/jbc.M110.100388; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; WEISSMANN G, 1978, HOSP PRACT, V13, P53, DOI 10.1080/21548331.1978.11707397; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yang R, 2011, CURR PROTOC IMMUNOL, V95, P14261; Zhang MJ, 2012, ANNU REV NUTR, V32, P203, DOI 10.1146/annurev-nutr-071811-150726	31	185	194	4	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2573	2583		10.1096/fj.13-227728	http://dx.doi.org/10.1096/fj.13-227728			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23504711	Green Published			2022-12-25	WOS:000328841000007
J	Gameiro, PA; Laviolette, LA; Kelleher, JK; Iliopoulos, O; Stephanopoulos, G				Gameiro, Paulo A.; Laviolette, Laura A.; Kelleher, Joanne K.; Iliopoulos, Othon; Stephanopoulos, Gregory			Cofactor Balance by Nicotinamide Nucleotide Transhydrogenase (NNT) Coordinates Reductive Carboxylation and Glucose Catabolism in the Tricarboxylic Acid (TCA) Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE DINUCLEOTIDE PHOSPHATE; MALATE-ASPARTATE SHUTTLE; ISOCITRATE DEHYDROGENASE; CELL-GROWTH; GLUTAMINE-METABOLISM; INSULIN-SECRETION; MALIC ENZYME; TUMOR-CELLS; REDOX STATE; RAT LIVER	Cancer and proliferating cells exhibit an increased demand for glutamine-derived carbons to support anabolic processes. In addition, reductive carboxylation of alpha-ketoglutarate by isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) was recently shown to be a major source of citrate synthesis from glutamine. The role of NAD(P)H/NAD(P)(+) cofactors in coordinating glucose and glutamine utilization in the tricarboxylic acid (TCA) cycle is not well understood, with the source(s) of NADPH for the reductive carboxylation reaction remaining unexplored. Nicotinamide nucleotide transhydrogenase (NNT) is a mitochondrial enzyme that transfers reducing equivalents from NADH to NADPH. Here, we show that knockdown of NNT inhibits the contribution of glutamine to the TCA cycle and activates glucose catabolism in SkMel5 melanoma cells. The increase in glucose oxidation partially occurred through pyruvate carboxylase and rendered NNT knockdown cells more sensitive to glucose deprivation. Importantly, knocking down NNT inhibits reductive carboxylation in SkMel5 and 786-O renal carcinoma cells. Overexpression of NNT is sufficient to stimulate glutamine oxidation and reductive carboxylation, whereas it inhibits glucose catabolism in the TCA cycle. These observations are supported by an impairment of the NAD(P) H/NAD(P)+ ratios. Our findings underscore the role of NNT in regulating central carbon metabolism via redox balance, calling for other mechanisms that coordinate substrate preference to maintain a functional TCA cycle.	[Gameiro, Paulo A.; Kelleher, Joanne K.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Gameiro, Paulo A.; Laviolette, Laura A.; Iliopoulos, Othon] Massachusetts Gen Hosp Canc Ctr, Ctr Canc Res, Charlestown, MA 02129 USA; [Gameiro, Paulo A.; Laviolette, Laura A.; Iliopoulos, Othon] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; [Laviolette, Laura A.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02139 USA; [Gameiro, Paulo A.] Univ Coimbra, Dept Life Sci, P-3004517 Coimbra, Portugal	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Universidade de Coimbra	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Gameiro, Paulo A/AAD-9324-2021	Gameiro, Paulo A./0000-0001-8176-4237	Massachusetts General Hospital (MGH) ProtonBeam Federal Share Project; National Institutes of Health [R01 DK075850, R01 CA122591]; Astra-Zeneca; Foundation for Science and Technology (FCT), Portugal; NATIONAL CANCER INSTITUTE [R01CA160458, R01CA122591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075850] Funding Source: NIH RePORTER	Massachusetts General Hospital (MGH) ProtonBeam Federal Share Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astra-Zeneca(AstraZeneca); Foundation for Science and Technology (FCT), Portugal(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Ana M. Metelo for insights on the xenograft experiments, Eric L. Bell for help with the NNT cDNA plasmid, Taylor Murphy for help on extracellular flux analyses, Thomas Wasylenko for feedback on cofactor measurements, and Christian M. Metallo for scientific discussions. This work was also supported by the Massachusetts General Hospital (MGH) ProtonBeam Federal Share Project.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK075850 (to G.S.) and R01 CA122591 (to O.I.). This work was also supported by an Award from Astra-Zeneca (to O.I.) and the Foundation for Science and Technology (FCT), Portugal (to P.A.G.).	Alberts B, 2002, MOL BIOL CELL; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; BRAND K, 1985, BIOCHEM J, V228, P353, DOI 10.1042/bj2280353; CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; DALZIEL K, 1968, BIOCHEM J, V110, P223, DOI 10.1042/bj1100223; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; GREENHOUSE WVV, 1976, CANCER RES, V36, P1392; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; MORENOSANCHEZ R, 1990, BIOCHEM J, V268, P421, DOI 10.1042/bj2680421; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; NEWSHOLME EA, 1985, BIOSCIENCE REP, V5, P393, DOI 10.1007/BF01116556; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Parker N, 2009, BBA-BIOENERGETICS, V1787, P1451, DOI 10.1016/j.bbabio.2009.06.005; Ripoll VM, 2012, FASEB J, V26, P3550, DOI 10.1096/fj.11-199935; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; SAUER LA, 1980, J BIOL CHEM, V255, P3844; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; SIEBERT G, 1957, J BIOL CHEM, V226, P977; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	46	84	85	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12967	12977		10.1074/jbc.M112.396796	http://dx.doi.org/10.1074/jbc.M112.396796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504317	Green Published, hybrid			2022-12-25	WOS:000318555100050
J	Kohzuma, K; Dal Bosco, C; Meurer, J; Kramer, DM				Kohzuma, Kaori; Dal Bosco, Cristina; Meurer, Joerg; Kramer, David M.			Light- and Metabolism-related Regulation of the Chloroplast ATP Synthase Has Distinct Mechanisms and Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR ACTIVITY; CYCLIC ELECTRON FLOW; GAMMA-SUBUNIT; ARABIDOPSIS-THALIANA; INVERSE REGULATION; THIOL MODULATION; IN-VIVO; PHOTOSYNTHESIS; MUTATION; PLANTS	The chloroplast CF0-CF1-ATP synthase (ATP synthase) is activated in the light and inactivated in the dark by thioredoxin-mediated redox modulation of a disulfide bridge on its gamma subunit. The activity of the ATP synthase is also fine-tuned during steady-state photosynthesis in response to metabolic changes, e.g. altering CO2 levels to adjust the thylakoid proton gradient and thus the regulation of light harvesting and electron transfer. The mechanism of this fine-tuning is unknown. We test here the possibility that it also involves redox modulation. We found that modifying the Arabidopsis thaliana gamma subunit by mutating three highly conserved acidic amino acids, D211V, E212L, and E226L, resulted in a mutant, termed mothra, in which ATP synthase which lacked light-dark regulation had relatively small effects on maximal activity in vivo. In situ equilibrium redox titrations and thiol redox-sensitive labeling studies showed that the gamma subunit disulfide/sulfhydryl couple in the modified ATP synthase has a more reducing redox potential and thus remains predominantly oxidized under physiological conditions, implying that the highly conserved acidic residues in the gamma subunit influence thiol redox potential. In contrast to its altered light-dark regulation, mothra retained wild-type fine-tuning of ATP synthase activity in response to changes in ambient CO2 concentrations, indicating that the light-dark- and metabolic-related regulation occur through different mechanisms, possibly via small molecule allosteric effectors or covalent modification.	[Kohzuma, Kaori; Kramer, David M.] Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA; [Dal Bosco, Cristina; Meurer, Joerg] Univ Munich, Dept Biol 1, D-82152 Planegg Martinsried, Germany; [Dal Bosco, Cristina] Univ Freiburg, Fac Biol, Inst Biol Bot 2, D-79104 Freiburg, Germany	Michigan State University; United States Department of Energy (DOE); University of Munich; University of Freiburg	Kramer, DM (corresponding author), Michigan State Univ, MSU DOE Plant Res Lab, 612 Wilson Rd,Rm S220, E Lansing, MI 48824 USA.	kramerd8@msu.edu	Kramer, David M/B-9588-2016; Meurer, Jörg/F-8479-2010; Kohzuma, Kaori/N-6161-2014	Kramer, David M/0000-0003-2181-6888; Meurer, Jörg/0000-0003-2973-9514; Dal Bosco, Cristina/0000-0002-0280-5369; Kohzuma, Kaori/0000-0003-3899-543X	United States Department of Energy, Office of Science, Basic Energy Sciences Program [DE-FG02-91ER20021]; Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft [SFB TR1]	United States Department of Energy, Office of Science, Basic Energy Sciences Program(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by United States Department of Energy, Office of Science, Basic Energy Sciences Program DE-FG02-91ER20021 (to K. K. and D. M. K.), the Deutsche Forschungsgemeinschaft (to C. D. B.), and Deutsche Forschungsgemeinschaft (SFB TR1) (to J. M.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CROSS RL, 1982, J BIOL CHEM, V257, P2874; Cruz JA, 2005, J EXP BOT, V56, P395, DOI 10.1093/jxb/eri022; Dal Bosco C, 2004, J BIOL CHEM, V279, P1060, DOI 10.1074/jbc.M308435200; del Riego G, 2006, PHOTOSYNTH RES, V89, P11, DOI 10.1007/s11120-006-9078-4; Evron Y, 2000, J BIOENERG BIOMEMBR, V32, P501, DOI 10.1023/A:1005669008974; GABRYS H, 1994, PLANT PHYSIOL, V104, P769, DOI 10.1104/pp.104.2.769; Groth G, 1999, PHYSIOL PLANTARUM, V106, P142, DOI 10.1034/j.1399-3054.1999.106120.x; Hisabori T, 2003, FEBS LETT, V545, P71, DOI 10.1016/S0014-5793(03)00395-8; Hisabori T, 2002, BBA-BIOENERGETICS, V1555, P140, DOI 10.1016/S0005-2728(02)00269-4; Hisabori T., 2013, ANTIOXID RE IN PRESS; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; JUNESCH U, 1991, FEBS LETT, V294, P275, DOI 10.1016/0014-5793(91)81447-G; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; Kiirats O, 2010, PHOTOSYNTH RES, V105, P89, DOI 10.1007/s11120-010-9561-9; Kohzuma K, 2009, PLANT CELL ENVIRON, V32, P209, DOI 10.1111/j.1365-3040.2008.01912.x; Kohzuma K, 2012, P NATL ACAD SCI USA, V109, P3293, DOI 10.1073/pnas.1115728109; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Konno H, 2012, PLANT CELL PHYSIOL, V53, P626, DOI 10.1093/pcp/pcs018; KRAMER DM, 1990, PHOTOSYNTH RES, V26, P213, DOI 10.1007/BF00033134; KRAMER DM, 1989, BIOCHIM BIOPHYS ACTA, V976, P28, DOI 10.1016/S0005-2728(89)80186-0; Livingston AK, 2010, PLANT CELL ENVIRON, V33, P1779, DOI 10.1111/j.1365-3040.2010.02183.x; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; MILLS JD, 1982, BIOCHIM BIOPHYS ACTA, V679, P75, DOI 10.1016/0005-2728(82)90257-2; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; Seelert H, 2003, J MOL BIOL, V333, P337, DOI 10.1016/j.jmb.2003.08.046; SHARKEY TD, 1989, PLANT PHYSIOL, V91, P679, DOI 10.1104/pp.91.2.679; SHARKEY TD, 1989, PLANT PHYSIOL, V90, P385, DOI 10.1104/pp.90.2.385; Takizawa K, 2008, PLANT CELL ENVIRON, V31, P235, DOI 10.1111/j.1365-3040.2007.01753.x; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; Wu G, 2008, PHOTOSYNTH RES, V97, P185, DOI 10.1007/s11120-008-9315-0; Wu G, 2007, J BIOL CHEM, V282, P36782, DOI 10.1074/jbc.M707007200	42	36	36	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13156	13163		10.1074/jbc.M113.453225	http://dx.doi.org/10.1074/jbc.M113.453225			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486473	hybrid, Green Published			2022-12-25	WOS:000318555100065
J	McNeill, DR; Paramasivam, M; Baldwin, J; Huang, J; Vyjayanti, VN; Seidman, MM; Wilson, DM				McNeill, Daniel R.; Paramasivam, Manikandan; Baldwin, Jakita; Huang, Jing; Vyjayanti, Vaddadi N.; Seidman, Michael M.; Wilson, David M., III			NEIL1 Responds and Binds to Psoralen-induced DNA Interstrand Crosslinks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DAMAGE RESPONSE; HUMAN-CELLS; GLYCOSYLASE; DISEASE; BIOLOGY; CANCER	Recent evidence suggests a role for base excision repair (BER) proteins in the response to DNA interstrand crosslinks, which block replication and transcription, and lead to cell death and genetic instability. Employing fluorescently tagged fusion proteins and laser microirradiation coupled with confocal microscopy, we observed that the endonuclease VIII-like DNA glycosylase, NEIL1, accumulates at sites of oxidative DNA damage, as well as trioxsalen (psoralen)-induced DNA interstrand crosslinks, but not to angelicin monoadducts. While recruitment to the oxidative DNA lesions was abrogated by the anti-oxidant N-acetylcysteine, this treatment did not alter the accumulation of NEIL1 at sites of interstrand crosslinks, suggesting distinct recognition mechanisms. Consistent with this conclusion, recruitment of the NEIL1 population variants, G83D, C136R, and E181K, to oxidative DNA damage and psoralen-induced interstrand crosslinks was differentially affected by the mutation. NEIL1 recruitment to psoralen crosslinks was independent of the nucleotide excision repair recognition factor, XPC. Knockdown of NEIL1 in LN428 glioblastoma cells resulted in enhanced recruitment of XPC, a more rapid removal of digoxigenin-tagged psoralen adducts, and decreased cellular sensitivity to trioxsalen plus UVA, implying that NEIL1 and BER may interfere with normal cellular processing of interstrand crosslinks. While exhibiting no enzymatic activity, purified NEIL1 protein bound stably to psoralen interstrand crosslink-containing synthetic oligonucleotide substrates in vitro. Our results indicate that NEIL1 recognizes specifically and distinctly interstrand crosslinks in DNA, and can obstruct the efficient removal of lethal crosslink adducts.	[McNeill, Daniel R.; Paramasivam, Manikandan; Huang, Jing; Vyjayanti, Vaddadi N.; Seidman, Michael M.; Wilson, David M., III] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Baldwin, Jakita] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Northwestern University; Feinberg School of Medicine	Wilson, DM (corresponding author), NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA.	wilsonda@mail.nih.gov	Huang, Jing/J-8282-2018; Wilson, David M/AAK-5409-2021	Huang, Jing/0000-0002-5494-378X; Wilson, David M/0000-0002-8945-0395	National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000743, ZIAAG000746] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in whole by the Intramural Research Program at the National Institutes of Health, National Institute on Aging.	Allan JM, 1998, CANCER RES, V58, P3965; Chaisaingmongkol J, 2012, ONCOGENE, V31, P5108, DOI 10.1038/onc.2011.660; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Couve S, 2009, J BIOL CHEM, V284, P11963, DOI 10.1074/jbc.M900746200; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; Forsbring M, 2009, CARCINOGENESIS, V30, P1147, DOI 10.1093/carcin/bgp118; Hoogstraten D, 2008, J CELL SCI, V121, P2850, DOI 10.1242/jcs.031708; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kothandapani A, 2011, J BIOL CHEM, V286, P14564, DOI 10.1074/jbc.M111.225375; Lai CF, 2008, ANAL CHEM, V80, P8790, DOI 10.1021/ac801520m; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maor-Shoshani A, 2008, DNA REPAIR, V7, P1399, DOI 10.1016/j.dnarep.2008.04.017; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Muniandy PA, 2009, J BIOL CHEM, V284, P27908, DOI 10.1074/jbc.M109.029025; Roy LM, 2007, J BIOL CHEM, V282, P15790, DOI 10.1074/jbc.M610626200; Shinmura K, 2004, CARCINOGENESIS, V25, P2311, DOI 10.1093/carcin/bgh267; SPIELMANN HP, 1995, BIOCHEMISTRY-US, V34, P12937, DOI 10.1021/bi00040a004; Stone MP, 2011, CHEM BIODIVERS, V8, P1571, DOI 10.1002/cbdv.201100033; Thazhathveetil AK, 2007, BIOCONJUGATE CHEM, V18, P431, DOI 10.1021/bc060309t; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Wilson DM, 2010, TRENDS BIOCHEM SCI, V35, P247, DOI 10.1016/j.tibs.2010.01.003	24	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12426	12436		10.1074/jbc.M113.456087	http://dx.doi.org/10.1074/jbc.M113.456087			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508956	Green Published, hybrid			2022-12-25	WOS:000318555100002
J	Chen, J; Fu, R; Cui, Y; Li, YS; Pan, JR; Liu, JL; Luo, HS; Yin, JD; Li, DF; Cui, S				Chen, Juan; Fu, Rui; Cui, Yan; Li, Yu-shan; Pan, Ji-rong; Liu, Jia-li; Luo, Hao-shu; Yin, Jing-dong; Li, De-fa; Cui, Sheng			LIM-homeodomain Transcription Factor Isl-1 Mediates the Effect of Leptin on Insulin Secretion in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET BETA-CELLS; HIGH-FAT DIET; GENE-EXPRESSION; PANCREATIC-ISLETS; MESSENGER-RNA; DNA-BINDING; ENDOCRINE PANCREAS; DIABETES-MELLITUS; TERMINAL DOMAIN; DEFICIENT MICE	In addition to the well known regulating effects of leptin on energy balance and glucose homeostasis through the central nervous system, circulating leptin has a direct effect on pancreatic islet and insulin secretion through its receptor (OBRb). The LIM-homeodomain transcription factor Isl-1 is expressed in all classes of pancreatic endocrine cells and is involved in regulating both islet development and insulin secretion. Both OBRb and Isl-1 mutations result in obesity-related diabetes. However, the interactions and physiological significance of leptin and Isl-1 in pancreatic islets remain to be established. Here, we show that most of leptin target cells in pancreatic islets and NIT beta cells express Isl-1. Both in vivo and in vitro results demonstrate that leptin suppresses Isl-1 expression and insulin secretion in islet in physiological and pathophysiological conditions, e. g. high fat diet. This effect of leptin on insulin secretion is lost in leptin receptor-defective db/db and Isl-1-inducible knock-out mice. We conclude that the action of leptin on insulin secretion is at least partly mediated by Isl-1. Another new finding of this study is that Isl-1 acts as a direct downstream target of leptin signaling molecule STAT3 to influence the effect of leptin on insulin secretion, whereas inversely, insulin has feedback regulating effects on Isl-1 expression through JAK-STAT3 pathway. These findings are crucial for understanding the mechanisms regulating insulin secretion and metabolism in related diseases, such as obesity and type 2 diabetes.	[Chen, Juan; Fu, Rui; Li, Yu-shan; Pan, Ji-rong; Liu, Jia-li; Luo, Hao-shu; Cui, Sheng] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Cui, Yan] 306th Hosp PLA, Beijing 100101, Peoples R China; [Yin, Jing-dong; Li, De-fa] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University	Li, DF (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	defali@public2.bta.net.cn; cuisheng@cau.edu.cn		Yin, Jingdong/0000-0003-4623-0568	National Basic Research Program of China [2012CB124702]; Natural Science Foundation of China [31172287, 30630011]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB124702) and the Natural Science Foundation of China (31172287 and 30630011).	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Barat-Houari M, 2002, DIABETES, V51, P1640, DOI 10.2337/diabetes.51.5.1640; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Campbell SC, 1999, FEBS LETT, V463, P53, DOI 10.1016/S0014-5793(99)01584-7; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Emilsson V, 1997, DIABETES, V46, P313, DOI 10.2337/diabetes.46.2.313; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fruhbeck G, 1999, PHYSIOL RES, V48, P189; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Hao AJ, 2005, MOL BIOL CELL, V16, P1569, DOI 10.1091/mbc.e04-08-0664; Iacobazzi V, 2009, BIOCHEM BIOPH RES CO, V385, P220, DOI 10.1016/j.bbrc.2009.05.030; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; KORANYI L, 1992, J CLIN INVEST, V89, P432, DOI 10.1172/JCI115602; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lin X, 1998, J NUTR, V128, P1606, DOI 10.1093/jn/128.10.1606; Liu JX, 2011, J BIOL CHEM, V286, P15352, DOI 10.1074/jbc.M111.231670; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; May CL, 2010, ISLETS, V2, P121, DOI 10.4161/isl.2.2.10908; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Morton NM, 1999, J MOL ENDOCRINOL, V22, P173, DOI 10.1677/jme.0.0220173; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pallett AL, 1997, BIOCHEM BIOPH RES CO, V238, P267, DOI 10.1006/bbrc.1997.7274; Pande M, 2011, DIABETES, V60, P1981, DOI 10.2337/db10-1541; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Sander M, 2000, DEVELOPMENT, V127, P5533; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; Seufert J, 1999, J CLIN ENDOCR METAB, V84, P670, DOI 10.1210/jc.84.2.670; Shimomura H, 2000, DIABETES, V49, P1597, DOI 10.2337/diabetes.49.9.1597; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stepanova OI, 2007, B EXP BIOL MED+, V144, P813, DOI 10.1007/s10517-007-0438-7; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; Wu HL, 2011, J BIOTECHNOL, V151, P231, DOI 10.1016/j.jbiotec.2010.12.003; Wu YJ, 2010, ENDOCRINOLOGY, V151, P4787, DOI 10.1210/en.2010-0208; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yu J, 2007, MOL ENDOCRINOL, V21, P2775, DOI 10.1210/me.2006-0473; Zhang H, 2009, J MOL BIOL, V392, P566, DOI 10.1016/j.jmb.2009.07.036	50	11	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12395	12405		10.1074/jbc.M113.450536	http://dx.doi.org/10.1074/jbc.M113.450536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504315	hybrid, Green Published			2022-12-25	WOS:000318157600070
J	Kim, SC; Guo, L; Wang, XM				Kim, Sang-Chul; Guo, Liang; Wang, Xuemin			Phosphatidic Acid Binds to Cytosolic Glyceraldehyde-3-phosphate Dehydrogenase and Promotes Its Cleavage in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-STRESS-RESPONSE; PHOSPHOLIPASE-D; FUNCTIONAL DIVERSITY; SIGNAL-TRANSDUCTION; TOMATO CELLS; PROTEIN; DELTA; IDENTIFICATION; MODULATION; ACTIVATION	Phosphatidic acid (PA) is a class of lipid messengers involved in a variety of physiological processes. To understand how PA mediates cell functions in plants, we used a PA affinity membrane assay to isolate PA-binding proteins from Camelina sativa followed by mass spectrometric sequencing. A cytosolic glyceraldehyde-3-phosphate dehydrogenase (GAPC) was identified to bind to PA, and detailed analysis was carried out subsequently using GAPC1 and GAPC1 from Arabidopsis. The PA and GAPC binding was abolished by the cation zinc whereas oxidation of GAPCs promoted the PA binding. PA had little impact on the GAPC catalytic activity in vitro, but the PA treatment of Arabidopsis seedlings induced proteolytic cleavage of GAPC2 and inhibited Arabidopsis seedling growth. The extent of PA inhibition was greater in GAPC-overexpressing than wildtype seedlings, but the greater PA inhibition was abolished by application of zinc to the seedling. The PA treatment also reduced the expression of genes involved in PA synthesis and utilization, and the PA-reduced gene expression was partially recovered by zinc treatment. These data suggest that PA binds to oxidized GAPDH and promotes its cleavage and that the PA and GAPC interaction may provide a signaling link coordinating carbohydrate and lipid metabolism.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Wang, Xuemin] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center	Wang, XM (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	wangxue@umsl.edu	Guo, Liang/AAW-4739-2021; Wang, Xuemin/M-2853-2013	Guo, Liang/0000-0001-7191-5062; wang, xuemin/0000-0002-6251-6745	Center for Advanced Biofuels Systems, an Energy Frontier Research Center; United States Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001295]; National Science Foundation [0818740]	Center for Advanced Biofuels Systems, an Energy Frontier Research Center; United States Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported primarily by the Center for Advanced Biofuels Systems, an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Basic Energy Sciences, under Award DE-SC0001295 (lipid-protein interactions) and by National Science Foundation Award 0818740 (mutant isolation).	Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Barr FA, 2000, CURR BIOL, V10, pR141, DOI 10.1016/S0960-9822(00)00326-2; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Cotelle V, 2000, EMBO J, V19, P2869, DOI 10.1093/emboj/19.12.2869; Demarse NA, 2009, J MOL BIOL, V394, P789, DOI 10.1016/j.jmb.2009.09.062; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Gardiner J, 2003, PLANT CELL PHYSIOL, V44, P687, DOI 10.1093/pcp/pcg095; Guo L, 2012, PLANT CELL, V24, P2200, DOI 10.1105/tpc.111.094946; Guo L, 2011, J BIOL CHEM, V286, P13336, DOI 10.1074/jbc.M110.190892; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Hutcheon C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-233; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Jost R, 2009, J BIOL CHEM, V284, P31962, DOI 10.1074/jbc.M109.022657; Katagiri T, 2001, PLANT J, V26, P595, DOI 10.1046/j.1365-313x.2001.01060.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; McLoughlin F, 2013, BIOCHEM J, V450, P573, DOI 10.1042/BJ20121639; Monteiro D, 2005, J EXP BOT, V56, P1665, DOI 10.1093/jxb/eri163; Munnik T, 2000, PLANT J, V22, P147, DOI 10.1046/j.1365-313x.2000.00725.x; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Ohashi Y, 2003, SCIENCE, V300, P1427, DOI 10.1126/science.1083695; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Potocky M, 2003, PLANTA, V217, P122, DOI 10.1007/s00425-002-0965-4; Raho N, 2011, J PLANT PHYSIOL, V168, P534, DOI 10.1016/j.jplph.2010.09.004; Rius SP, 2008, PLANT PHYSIOL, V148, P1655, DOI 10.1104/pp.108.128769; Ruelland E, 2002, PLANT PHYSIOL, V130, P999, DOI 10.1104/pp.006080; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Wang Q, 1997, PROTOPLASMA, V198, P155, DOI 10.1007/BF01287564; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yu LJ, 2010, NEW PHYTOL, V188, P762, DOI 10.1111/j.1469-8137.2010.03422.x; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang WH, 2003, PLANT CELL, V15, P2285, DOI 10.1105/tpc.013961; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170	49	51	55	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11834	11844		10.1074/jbc.M112.427229	http://dx.doi.org/10.1074/jbc.M112.427229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504314	Green Published, hybrid			2022-12-25	WOS:000318157600019
J	Tan, E; Rao, F; Pasunooti, S; Pham, TH; Soehano, I; Turner, MS; Liew, CW; Lescar, J; Pervushin, K; Liang, ZX				Tan, Edward; Rao, Feng; Pasunooti, Swathi; Thi Huong Pham; Soehano, Ishin; Turner, Mark S.; Liew, Chong Wai; Lescar, Julien; Pervushin, Konstantin; Liang, Zhao-Xun			Solution Structure of the PAS Domain of a Thermophilic YybT Protein Homolog Reveals a Potential Ligand-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-AMP; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; LACTOCOCCUS-LACTIS; OXYGEN SENSOR; BACILLUS-SUBTILIS; HISTIDINE KINASES; NMR-SPECTROSCOPY; MECHANISM; LIGHT	The Bacillus subtilis protein YybT (or GdpP) and its homologs were recently established as stress signaling proteins that exert their biological effect by degrading the bacterial messenger cyclic di-AMP. YybT homologs contain a small Per-ARNT-Sim (PAS) domain (similar to 80 amino acids) that can bind b-type heme with 1:1 stoichiometry despite the small size of the domain and the lack of a conserved heme iron-coordinating residue. We determined the solution structure of the PAS domain of GtYybT from Geobacillus thermodenitrificans by NMR spectroscopy to further probe its function. The solution structure confirms that PAS(GtYybT) adopts the characteristic PAS fold composed of a five-stranded antiparallel beta sheet and a few short alpha-helices. One alpha-helix and three central beta-strands of PAS(GtYybT) are noticeably shorter than those of the typical PAS domains. Despite the small size of the protein domain, a hydrophobic pocket is formed by the side chains of nonpolar residues stemming from the beta-strands and alpha-helices. A set of residues in the vicinity of the pocket and in the C-terminal region at the dimeric interface exhibits perturbed NMR parameters in the presence of heme or zinc protoporphyrin. Together, the results unveil a compact PAS domain with a potential ligand-binding pocket and reinforce the view that the PAS(YybT) domains function as regulatory domains in the modulation of cellular cyclic di-AMP concentration.	[Tan, Edward; Rao, Feng; Pasunooti, Swathi; Soehano, Ishin; Liew, Chong Wai; Lescar, Julien; Pervushin, Konstantin; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637551, Singapore; [Thi Huong Pham; Turner, Mark S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia; [Turner, Mark S.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Queensland; University of Queensland	Pervushin, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, 60 Nanyang Dr, Singapore 637551, Singapore.	kpervushin@ntu.edu.sg; zxliang@ntu.edu.sg	RAO, FENG/G-4529-2011; Rao, Feng/AAD-4712-2019; Turner, Mark/L-3798-2013; Pervushin, Konstantin/AAJ-6580-2020; Turner, Mark/K-9365-2013; Liang, Zhao-Xun/A-2191-2011; Tan, Edward/W-8611-2019	RAO, FENG/0000-0002-6038-6406; Rao, Feng/0000-0002-6038-6406; Pervushin, Konstantin/0000-0002-6393-4340; Turner, Mark/0000-0003-2770-852X; Pham, Huong Thi/0000-0003-1769-6713; Liang, Zhao-Xun/0000-0002-3128-1330	Tier II Academic Research Council (ARC) grant, Ministry of Education (MOE) of the Republic of Singapore; Australian Research Council [LP1210282]; Dairy Innovation Australia Limited	Tier II Academic Research Council (ARC) grant, Ministry of Education (MOE) of the Republic of Singapore(Ministry of Education, Singapore); Australian Research Council(Australian Research Council); Dairy Innovation Australia Limited	This work was supported by a Tier II Academic Research Council (ARC) grant (to Z.-X.L.) from the Ministry of Education (MOE) of the Republic of Singapore and grants from the Australian Research Council (LP1210282) and Dairy Innovation Australia Limited (to M. S. T.).	Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Jensen MR, 2006, MAGN RESON CHEM, V44, P294, DOI 10.1002/mrc.1771; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pedersen MB, 2008, J BACTERIOL, V190, P4903, DOI 10.1128/JB.00447-08; PETROS AM, 1990, BIOCHEMISTRY-US, V29, P10041, DOI 10.1021/bi00495a005; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Qi YN, 2009, BIOCHEMISTRY-US, V48, P10275, DOI 10.1021/bi901121w; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rao F, 2011, J BACTERIOL, V193, P1543, DOI 10.1128/JB.01364-10; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Soderback E, 1998, MOL MICROBIOL, V28, P179, DOI 10.1046/j.1365-2958.1998.00788.x; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Ukaegbu UE, 2006, BIOCHEMISTRY-US, V45, P10191, DOI 10.1021/bi060693h; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	56	17	21	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11949	11959		10.1074/jbc.M112.437764	http://dx.doi.org/10.1074/jbc.M112.437764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504327	Green Published, hybrid			2022-12-25	WOS:000318157600030
J	Wang, L; Suzuki, T				Wang, Li; Suzuki, Tadashi			Dual Functions for Cytosolic alpha-Mannosidase (Man2C1) ITS DOWN-REGULATION CAUSES MITOCHONDRIA-DEPENDENT APOPTOSIS INDEPENDENTLY OF ITS alpha-MANNOSIDASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; FREE OLIGOSACCHARIDES; PROTEASOME INHIBITOR; CANCER-CELLS; DEATH; DEGRADATION; MECHANISMS; ROLES; GLYCOSYLATION	Cytosolic alpha-mannosidase (Man2C1) trims free oligosaccharides in mammalian cells, and its down-regulation reportedly delays cancer growth by inducing mitotic arrest or apoptosis. However, the mechanism by which Man2C1 down-regulation induces apoptosis is unknown. Here, we demonstrated that silencing of Man2C1 via small hairpin RNAs induced mitochondria-dependent apoptosis in HeLa cells. Expression of CHOP (C/EBP homologous protein), a transcription factor critical to endoplasmic reticulum stress-induced apoptosis, was significantly up-regulated in Man2C1 knockdown cells. However, this enhanced CHOP expression was not caused by endoplasmic reticulum stress. Interestingly, Man2C1 catalytic activity was not required for this regulation of apoptosis; introduction of mutant, enzymatically inactive Man2C1 rescued apoptotic phenotypes of Man2C1 knockdown cells. These results show that Man2C1 has dual functions: one in glycan catabolism and another in apoptotic signaling.	[Wang, Li; Suzuki, Tadashi] RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama 3510198, Japan	RIKEN	Suzuki, T (corresponding author), RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Glycometabolome Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021	Suzuki, Tadashi/0000-0003-1030-7631	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Foundation for Applied Enzymology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology	The work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a research grant from Japan Foundation for Applied Enzymology (to T. S.).	Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bernon C, 2011, GLYCOBIOLOGY, V21, P363, DOI 10.1093/glycob/cwq169; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Butters TD, 2009, GLYCOCONJUGATE J, V26, P1109, DOI 10.1007/s10719-009-9231-3; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Funakoshi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010545; Funakoshi Y, 2009, BBA-GEN SUBJECTS, V1790, P81, DOI 10.1016/j.bbagen.2008.09.009; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Han YH, 2010, ANTICANCER RES, V30, P879; He LZ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1309; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Howard S, 1998, J BIOL CHEM, V273, P2067, DOI 10.1074/jbc.273.4.2067; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kato A, 2011, J BIOCHEM, V149, P415, DOI 10.1093/jb/mvq153; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lozon TI, 2011, AM J PHYSIOL-LUNG C, V300, pL422, DOI 10.1152/ajplung.00166.2010; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Peric D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011675; Qu L, 2006, CELL RES, V16, P622, DOI 10.1038/sj.cr.7310065; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; Sartorius U, 2001, CHEMBIOCHEM, V2, P20, DOI 10.1002/1439-7633(20010105)2:1<20::AID-CBIC20>3.3.CO;2-O; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Suzuki T, 2009, TRENDS GLYCOSCI GLYC, V21, P219, DOI 10.4052/tigg.21.219; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tang QH, 2011, VIRUS GENES, V42, P355, DOI 10.1007/s11262-011-0582-z; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Tian Y, 2008, CANCER SCI, V99, P2428, DOI 10.1111/j.1349-7006.2008.01019.x; Uddin M, 2011, DIS MARKERS, V30, P111, DOI [10.1155/2011/513659, 10.3233/DMA-2011-0750]; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Vleugels W, 2011, BIOCHIMIE, V93, P823, DOI 10.1016/j.biochi.2011.01.016; Xiang ZG, 2010, TRANSGENIC RES, V19, P67, DOI 10.1007/s11248-009-9299-3; Yue W, 2004, INT J CANCER, V108, P189, DOI 10.1002/ijc.11536	47	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11887	11896		10.1074/jbc.M112.425702	http://dx.doi.org/10.1074/jbc.M112.425702			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486476	Green Published, hybrid			2022-12-25	WOS:000318157600024
J	Yu, HG; Dong, J; Gu, YH; Liu, HY; Xin, AJ; Shi, HJ; Sun, F; Zhang, YL; Lin, DH; Diao, H				Yu, Heguo; Dong, Jing; Gu, Yihua; Liu, Haiyan; Xin, Aijie; Shi, Huijuan; Sun, Fei; Zhang, Yonglian; Lin, Donghai; Diao, Hua			The Novel Human beta-Defensin 114 Regulates Lipopolysaccharide (LPS)-mediated Inflammation and Protects Sperm from Motility Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; DISULFIDE BONDS; GENE CLUSTERS; TNF-ALPHA; IN-VITRO; EXPRESSION; EPIDIDYMIS; ENDOTOXIN; LPS; IMPROVES	Lipopolysaccharide (LPS) is an important pathological factor involved in serious inflammatory diseases and male reproductive impairments. Emerging evidence demonstrates that antimicrobial peptides possess protective activity in response to LPS-induced inflammation. However, the LPS-binding and/or immunosuppressive activity of beta-defensins (DEFBs) has been underestimated. In the present work, we characterized a novel human defensin, DEFB114, which was expressed predominantly in the epididymis and gingival cells at the RNA level. Homogenous recombinant DEFB114 peptides were prepared and characterized using mass spectrometry. DEFB114 protein exhibited a broad spectrum of antimicrobial activity with salt sensitivity against typical pathogenic microbes (i.e. Escherichia coli, Staphylococcus aureus, and Candida albicans). Interestingly, DEFB114 demonstrated novel LPS-binding activity in vitro and inhibited TNF-alpha release in RAW264.7 cultures through the inhibition of MAPK p42/44 when challenged with LPS. Moreover, DEFB114 could also rescue the LPS-induced reduction of human sperm motility in vitro and protect D-galactosamine-sensitized C57BL/6 mice from LPS-induced lethality in vivo. The protective activity of DEFB114 on RAW264.7, human sperm, and the D-galactosamine-sensitized mice was disulfide bond-dependent because alkylated DEFB114 lost its activity. The low cytotoxicity of the DEFB114 peptide toward human erythrocytes is indicative of its potential therapeutic use in the treatment of LPS-induced inflammation, LPS contamination, and potentially septic shock.	[Yu, Heguo; Gu, Yihua; Xin, Aijie; Shi, Huijuan; Zhang, Yonglian; Diao, Hua] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Commiss, Key Lab Contracept & Devices, Shanghai 200032, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Peoples R China; [Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China; [Sun, Fei] Univ Sci & Technol China, Reprod Biol Lab, Sch Life Sci, Hefei 230027, Peoples R China; [Dong, Jing] NW Univ Xian, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China; [Liu, Haiyan] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Peoples R China; [Xin, Aijie] E China Univ Sci & Technol, Shanghai 200237, Peoples R China	Xiamen University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Northwest University Xi'an; China Pharmaceutical University; East China University of Science & Technology	Zhang, YL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China.	ylzhang@sibs.ac.cn; dhlin@xmu.edu.cn; diaohua@gmail.com	Sun, Fei/N-2850-2013		National Basic Research Program of China [2007CB914304, 2009CB941702]; Natural Science Foundation of China [31101030, 31170717, 30900233, 91129713]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2007CB914304 and 2009CB941702 and Natural Science Foundation of China Grants 31101030, 31170717, 30900233, and 91129713.	Abd-Allah ARA, 2009, OXID MED CELL LONGEV, V2, P73, DOI 10.4161/oxim.2.2.8177; Bhattacharjya S, 2010, CURR MED CHEM, V17, P3080, DOI 10.2174/092986710791959756; Biswas B, 2011, AM J REPROD IMMUNOL, V65, P557, DOI 10.1111/j.1600-0897.2010.00937.x; Brackett NL, 2007, J ANDROL, V28, P717, DOI 10.2164/jandrol.106.002022; Cao DM, 2010, BIOL REPROD, V83, P1064, DOI 10.1095/biolreprod.109.082180; Diao H, 2007, BIOCHEM BIOPH RES CO, V357, P840, DOI 10.1016/j.bbrc.2007.03.149; Dong J, 2011, PROTEIN PEPTIDE LETT, V18, P1126, DOI 10.2174/092986611797201020; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Eggert-Kruse W, 2007, FERTIL STERIL, V87, P810, DOI 10.1016/j.fertnstert.2006.08.103; Fei Z, 2012, GENES IMMUN, V13, P445, DOI 10.1038/gene.2012.13; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Fujita Y, 2011, HUM REPROD, V26, P2799, DOI 10.1093/humrep/der234; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Huang GTJ, 2002, HUM GENE THER, V13, P2017, DOI 10.1089/10430340260395875; Jerala R, 2004, CURR TOP MED CHEM, V4, P1173, DOI 10.2174/1568026043388079; Kajihara T, 2006, MED MOL MORPHOL, V39, P203, DOI 10.1007/s00795-006-0334-7; Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Lampiao F, 2008, REPROD BIOMED ONLINE, V17, P628, DOI 10.1016/S1472-6483(10)60309-4; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lepper PM, 2002, INTENS CARE MED, V28, P824, DOI 10.1007/s00134-002-1330-6; Mignon A, 1999, AM J RESP CRIT CARE, V159, P1308, DOI 10.1164/ajrccm.159.4.9712012; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Motzkus D, 2006, FASEB J, V20, P1701, DOI 10.1096/fj.05-4970fje; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Okazaki T, 2010, THERIOGENOLOGY, V74, P1691, DOI 10.1016/j.theriogenology.2010.05.019; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Premratanachai P, 2004, ORAL MICROBIOL IMMUN, V19, P111, DOI 10.1111/j.0902-0055.2002.00127.x; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Semple CA, 2006, MOL DIVERS, V10, P575, DOI 10.1007/s11030-006-9031-7; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Semple F, 2010, EUR J IMMUNOL, V40, P1073, DOI 10.1002/eji.200940041; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tollner TL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002289; TURNER TT, 1995, J ANDROL, V16, P292; Verma Chandra, 2007, Biotechnology Journal, V2, P1353, DOI 10.1002/biot.200700148; Walker AK, 2011, BRAIN BEHAV IMMUN, V25, P674, DOI 10.1016/j.bbi.2011.01.004; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Zhang JS, 2006, MOL CELL ENDOCRINOL, V250, P169, DOI 10.1016/j.mce.2005.12.041; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127	49	46	52	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12270	12282		10.1074/jbc.M112.411884	http://dx.doi.org/10.1074/jbc.M112.411884			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482568	hybrid, Green Published			2022-12-25	WOS:000318157600058
J	Zhang, FX; Wang, Y; Wang, L; Luo, X; Huang, K; Wang, C; Du, M; Liu, FM; Luo, T; Huang, D; Huang, K				Zhang, Fengxiao; Wang, Yan; Wang, Lin; Luo, Xi; Huang, Kun; Wang, Cheng; Du, Meng; Liu, Fangmei; Luo, Ting; Huang, Dan; Huang, Kai			Poly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor alpha-dependent Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTORS; POSTTRANSLATIONAL MODIFICATION; COACTIVATOR COMPLEX; CARDIAC FIBROBLASTS; PARP-1; EXPRESSION; ACTIVATION; PROTEIN; ACETYLATION; MODULATION	Activation of nuclear receptor estrogen receptor alpha (ER alpha) exerts cardiovascular protective effects by modulating the expression of ER alpha target genes. However, the underlying mechanism remains unclear. PARP1 is a ubiquitous multifunctional nuclear enzyme. In this study, we examined the interplay between PARP1 and ER alpha, and identified PARP1 as an important regulator of ER alpha-dependent transcription. We showed that PARP1 could directly bind to ER alpha, and ER alpha could be poly(ADP-ribosyl)ated by PARP1. Poly(ADP-ribosyl)ation increased ER alpha binding to estrogen response element (ERE) present in the promoter of target genes and promoted ER alpha-mediated gene transcription. Estradiol, the ligand of ER alpha, increased PARP enzymatic activity and enhanced poly(ADP-ribosyl) ation of ER alpha. Upon treatment with estradiol, ER alpha binding to ERE- and ER alpha dependent gene expression was dramatically increased in cultured vascular smooth muscle cells (VSMCs). Inhibition of PARP1 by PARP inhibitor or PARP1 siRNA decreased ER alpha binding to ERE and prevented ER alpha-dependent gene transcription in VSMCs. Further studies revealed that PARP1 served as an indispensible component for the formation of the ER alpha-ERE complex by directly interacting with ER alpha. Thus, our results identify PARP1 as a key regulator of ER alpha in controlling ER alpha transactivation.	[Zhang, Fengxiao; Wang, Yan; Luo, Xi; Huang, Kun; Wang, Cheng; Du, Meng; Liu, Fangmei; Luo, Ting; Huang, Dan; Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430022, Peoples R China; [Zhang, Fengxiao; Huang, Dan; Huang, Kai] Huazhong Univ Sci & Technol, Clin Ctr Human Genom Res, Union Hosp, Wuhan 430022, Peoples R China; [Wang, Lin] Huazhong Univ Sci & Technol, Cent Lab, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Huang, D (corresponding author), HUST, Union Hosp, Dept Cardiovasc Dis, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	joy_huangdan@yahoo.com.cn; huangkai1@mail.hust.edu.cn		Zhang, Fengxiao/0000-0002-5109-4196; Fangmei, Liu/0000-0002-7430-4950	National Natural Science Foundation of China [30971245, 81170239, 81000112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30971245 and 81170239, to K. H. and 81000112, to D.H.).	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Ba XQ, 2010, J BIOL CHEM, V285, P11596, DOI 10.1074/jbc.M109.076984; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Glass CK, 2000, GENE DEV, V14, P121; Glidewell-Kenney C, 2005, MOL CELL ENDOCRINOL, V245, P53, DOI 10.1016/j.mce.2005.10.003; Huang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027123; Huang D, 2008, ARCH MED RES, V39, P775, DOI 10.1016/j.arcmed.2008.09.003; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kotova E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000387; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lalevee S, 2010, METHODS MOL BIOL, V647, P251, DOI 10.1007/978-1-60761-738-9_15; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Li GH, 1999, CIRCULATION, V100, P1639, DOI 10.1161/01.CIR.100.15.1639; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Paddock MN, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000428; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SIMONIN F, 1990, J BIOL CHEM, V265, P19249; Smirnov AN, 2002, BIOCHEMISTRY-MOSCOW+, V67, P957, DOI 10.1023/A:1020545200302; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Xu W, 2003, METHOD ENZYMOL, V364, P205; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96	33	52	52	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11348	11357		10.1074/jbc.M112.429134	http://dx.doi.org/10.1074/jbc.M112.429134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23493398	Green Published, hybrid			2022-12-25	WOS:000317915500037
J	Guo, YY; Yuan, HS; Cho, HS; Kuruppu, D; Jokivarsi, K; Agarwal, A; Shah, K; Josephson, L				Guo, Yanyan; Yuan, Hushan; Cho, Hoonsung; Kuruppu, Darshini; Jokivarsi, Kimmo; Agarwal, Aayush; Shah, Khalid; Josephson, Lee			High Efficiency Diffusion Molecular Retention Tumor Targeting	PLOS ONE			English	Article							RGD PEPTIDES; THERAPY; DESIGN; PROTEINS; DRUG	Here we introduce diffusion molecular retention (DMR) tumor targeting, a technique that employs PEG-fluorochrome shielded probes that, after a peritumoral (PT) injection, undergo slow vascular uptake and extensive interstitial diffusion, with tumor retention only through integrin molecular recognition. To demonstrate DMR, RGD (integrin binding) and RAD (control) probes were synthesized bearing DOTA (for (111) In3+), a NIR fluorochrome, and 5 kDa PEG that endows probes with a protein-like volume of 25 kDa and decreases non-specific interactions. With a GFP-BT-20 breast carcinoma model, tumor targeting by the DMR or IV methods was assessed by surface fluorescence, biodistribution of [In-111] RGD and [In-111] RAD probes, and whole animal SPECT. After a PT injection, both probes rapidly diffused through the normal and tumor interstitium, with retention of the RGD probe due to integrin interactions. With PT injection and the [In-111] RGD probe, SPECT indicated a highly tumor specific uptake at 24 h post injection, with 352% ID/g tumor obtained by DMR (vs 4.14% ID/g by IV). The high efficiency molecular targeting of DMR employed low probe doses (e. g. 25 ng as RGD peptide), which minimizes toxicity risks and facilitates clinical translation. DMR applications include the delivery of fluorochromes for intraoperative tumor margin delineation, the delivery of radioisotopes (e. g. toxic, short range alpha emitters) for radiotherapy, or the delivery of photosensitizers to tumors accessible to light.	[Guo, Yanyan; Yuan, Hushan; Cho, Hoonsung; Kuruppu, Darshini; Josephson, Lee] Massachusetts Gen Hosp, Dept Radiol, Ctr Translat Nucl Med & Mol Imaging, Charlestown, MA 02129 USA; [Jokivarsi, Kimmo; Josephson, Lee] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Jokivarsi, Kimmo] Univ Eastern Finland, AI Virtanen Inst, Dept Neurobiol, Kuopio, Finland; [Agarwal, Aayush; Shah, Khalid] Massachusetts Gen Hosp, Mol Neurotherapy & Imaging Lab, Dept Radiol, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Eastern Finland; Harvard University; Massachusetts General Hospital	Josephson, L (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Ctr Translat Nucl Med & Mol Imaging, Charlestown, MA 02129 USA.	ljosephson@mgh.harvard.edu		Cho, Hoonsung/0000-0003-0778-5640	National Institutes of Health [R01 EB 011996, R01 EB 009691]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009691, R01EB011996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	National Institutes of Health Grants to Josephson # R01 EB 011996 and # R01 EB 009691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antczak C, 2006, BIOCONJUGATE CHEM, V17, P1551, DOI 10.1021/bc060156+; BAGSHAWE KD, 1990, BIOCHEM SOC T, V18, P750, DOI 10.1042/bst0180750; Beer AJ, 2011, METHODS MOL BIOL, V680, P183, DOI 10.1007/978-1-60761-901-7_13; Benshushan A, 1998, Obstet Gynecol Surv, V53, P383, DOI 10.1097/00006254-199806000-00024; Butlin NG, 2006, ACCOUNTS CHEM RES, V39, P780, DOI 10.1021/ar020275e; Carlsson J, 2003, RADIOTHER ONCOL, V66, P107, DOI 10.1016/S0167-8140(02)00374-2; Cordier D, 2010, EUR J NUCL MED MOL I, V37, P1335, DOI 10.1007/s00259-010-1385-5; Cremonesi M, 2006, J NUCL MED, V47, P1467; Dapp S, 2011, NUCL MED BIOL, V38, P997, DOI 10.1016/j.nucmedbio.2011.02.014; Dmochowski Roger, 2003, Curr Urol Rep, V4, P350, DOI 10.1007/s11934-003-0005-3; Dubey PK, 2004, J DRUG TARGET, V12, P257, DOI 10.1080/10611860410001728040; Fani M, 2012, THERANOSTICS, V2, P481, DOI 10.7150/thno.4024; Fani M, 2012, EUR J NUCL MED MOL I, V39, P11, DOI 10.1007/s00259-011-2001-z; Fee Conan J, 2011, Methods Biochem Anal, V54, P339; Forrer F, 2005, J NUCL MED, V46, P1310; Garanger E, 2005, MOL THER, V12, P1168, DOI 10.1016/j.ymthe.2005.06.095; Garanger E, 2008, CHEM COMMUN, P4792, DOI 10.1039/b809537j; Garanger E, 2010, J COMB CHEM, V12, P57, DOI 10.1021/cc900141b; Goldenberg David M, 2007, Update Cancer Ther, V2, P19, DOI 10.1016/j.uct.2007.04.003; Goldenberg DM, 2012, THERANOSTICS, V2, P523, DOI 10.7150/thno.3582; Guo YY, 2012, J AM CHEM SOC, V134, P19338, DOI 10.1021/ja309085b; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; JAIN RK, 1990, CANCER METAST REV, V9, P253, DOI 10.1007/BF00046364; Kam BLR, 2012, EUR J NUCL MED MOL I, V39, P103, DOI 10.1007/s00259-011-2039-y; Kok RJ, 2002, BIOCONJUGATE CHEM, V13, P128, DOI 10.1021/bc015561+; Kuil J, 2011, BIOCONJUGATE CHEM, V22, P859, DOI 10.1021/bc2000947; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P947, DOI 10.1007/s00259-008-1045-1; Lohof E, 2000, ANGEW CHEM INT EDIT, V39, P2761, DOI 10.1002/1521-3773(20000804)39:15<2761::AID-ANIE2761>3.0.CO;2-9; McDevitt MR, 2002, APPL RADIAT ISOTOPES, V57, P841, DOI 10.1016/S0969-8043(02)00167-7; Meares CF, 2008, ADV DRUG DELIVER REV, V60, P1383, DOI 10.1016/j.addr.2008.04.010; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Mittra ES, 2011, RADIOLOGY, V260, P182, DOI 10.1148/radiol.11101139; Montet X, 2006, LAB INVEST, V86, P517, DOI 10.1038/labinvest.3700404; Montet X, 2006, J MED CHEM, V49, P6087, DOI 10.1021/jm060515m; Montet X, 2006, NEOPLASIA, V8, P214, DOI 10.1593/neo.05769; Mulder WJM, 2005, FASEB J, V19, P2008, DOI 10.1096/fj.05-4145fje; Naspro R, 2005, CURR OPIN UROL, V15, P49, DOI 10.1097/00042307-200501000-00012; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P157, DOI 10.1016/S0169-409X(01)00153-3; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Ricart AD, 2011, CLIN PHARMACOL THER, V89, P513, DOI 10.1038/clpt.2011.8; Shao FW, 2011, DYES PIGMENTS, V90, P119, DOI 10.1016/j.dyepig.2010.12.008; Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446; Shore N, 2010, EXPERT OPIN INV DRUG, V19, P305, DOI 10.1517/13543780903555196; Teicher BA, 2011, CLIN CANCER RES, V17, P6389, DOI 10.1158/1078-0432.CCR-11-1417; Thurber GM, 2008, TRENDS PHARMACOL SCI, V29, P57, DOI 10.1016/j.tips.2007.11.004; Velikyan I, 2012, NUCL MED BIOL, V39, P628, DOI 10.1016/j.nucmedbio.2011.12.010; Villard L, 2012, J CLIN ONCOL, V30, P1100, DOI 10.1200/JCO.2011.37.2151; Virgolini I, 2002, CURR PHARM DESIGN, V8, P1781, DOI 10.2174/1381612023393756; Wild D, 2011, CANCER RES, V71, P1009, DOI 10.1158/0008-5472.CAN-10-1186; Wu Anna M, 2004, Methods Mol Biol, V248, P209; Ye YP, 2006, J MED CHEM, V49, P2268, DOI 10.1021/jm050947h	52	10	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58290	10.1371/journal.pone.0058290	http://dx.doi.org/10.1371/journal.pone.0058290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505478	Green Submitted, gold, Green Published			2022-12-25	WOS:000316251100041
J	Dowling, MR; Josefsson, EC; Henley, KJ; Kile, BT; Hodgkin, PD				Dowling, Mark R.; Josefsson, Emma C.; Henley, Katya J.; Kile, Benjamin T.; Hodgkin, Philip D.			A Model for Studying the Hemostatic Consumption or Destruction of Platelets	PLOS ONE			English	Article							LIFE-SPAN; CELL SURVIVAL; SIALIC-ACID; SIZE; AGE; KINETICS	A fundamental issue in understanding homeostasis of the hematopoietic system is to what extent intrinsic and extrinsic factors regulate cell fate. We recently revisited this issue for the case of blood platelets and concluded that platelet life span is largely regulated by internal factors, in contrast to the long-held view that accumulated damage from the environment triggers clearance. However, it is known that in humans there is an ongoing fixed requirement for platelets to maintain hemostasis and prevent bleeding; hence a proportion of platelets may be consumed in such processes before the end of their natural life span. Whether it is possible to detect this random loss of platelets in normal individuals at steady-state is unknown. To address this question, we have developed a mathematical model that independently incorporates age-independent random loss and age-dependent natural senescent clearance. By fitting to population survival curves, we illustrate the application of the model in quantifying the fixed requirement for platelets to maintain hemostasis in mice, and discuss the relationship with previous work in humans. Our results suggest a higher requirement for platelets in mice than in humans, however experimental uncertainty in the data limits our ability to constrain this quantity. We then explored the relationship between experimental uncertainty and parameter constraint using simulated data. We conclude that in order to provide useful constraint on the random loss fraction the standard error in the mean of the data must be reduced substantially, either through improving experimental uncertainty or increasing the number of experimental replicates to impractical levels. Finally we find that parameter constraint is improved at higher values of the random loss fraction; thus the model find utility in situations where the random loss fraction is expected to be high, for example during active bleeding or some types of thrombocytopenia.	[Dowling, Mark R.; Hodgkin, Philip D.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; [Josefsson, Emma C.; Henley, Katya J.; Kile, Benjamin T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Canc & Hematol Div, Parkville, Vic 3050, Australia; [Dowling, Mark R.; Josefsson, Emma C.; Kile, Benjamin T.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Dowling, MR (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia.	dowling@wehi.edu.au	Kile, Benjamin/GNP-3246-2022; Josefsson, Emma/CAF-4970-2022; Kile, Benjamin T/F-6593-2011	Kile, Benjamin/0000-0002-8836-8947; Kile, Benjamin T/0000-0002-8836-8947; Dowling, Mark/0000-0002-8056-5348; Josefsson, Emma/0000-0001-6478-5204; Hodgkin, Philip/0000-0002-8604-1940	Independent Research Institutes Infrastructure Support Scheme from the Australian National Health and Medical Research Council [361646]; Sylvia and Charles Viertel Charitable Foundation; Leukemia & Lymphoma Society; Australian Cancer Research Fund; Victorian State Government;  [516725];  [575535];  [1010654];  [1016647]	Independent Research Institutes Infrastructure Support Scheme from the Australian National Health and Medical Research Council; Sylvia and Charles Viertel Charitable Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Australian Cancer Research Fund; Victorian State Government; ; ; ; 	This work was supported by project grants (516725, 575535, 1010654), a program grant (1016647), Fellowships (M. R. D., B. T. K. and P. D. H.) and an Independent Research Institutes Infrastructure Support Scheme Grant (361646) from the Australian National Health and Medical Research Council, a Fellowship from the Sylvia and Charles Viertel Charitable Foundation (B. T. K.), a Fellowship from the Leukemia & Lymphoma Society (E.C.J), the Australian Cancer Research Fund, and Victorian State Government Operational Infrastructure Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen AF, 1968, SCAND J HAEMATOL   S, V3, P7; Balduini CL, 1999, BRIT J HAEMATOL, V106, P202; DETWILER TC, 1962, AM J PHYSIOL, V203, P107, DOI 10.1152/ajplegacy.1962.203.1.107; DORNHORST AC, 1951, BLOOD, V6, P1284, DOI 10.1182/blood.V6.12.1284.1284; Dowling MR, 2010, BLOOD, V116, P1776, DOI 10.1182/blood-2009-12-259663; Dowling MR, 2005, J R SOC INTERFACE, V2, P517, DOI 10.1098/rsif.2005.0069; George J N, 1978, Prog Clin Biol Res, V28, P39; GINSBURG AD, 1972, THROMB DIATH HAEMOST, V27, P407; HANSON SR, 1985, BLOOD, V66, P1105; HARKER LA, 1977, CLIN HAEMATOL, V6, P671; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lomax, 2007, STAT CONCEPTS 2 COUR; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Motulsky H, 2003, PRACTICAL GUIDE CURV; MURPHY EA, 1969, THROMB DIATH HAEMOST, V22, P281; MURPHY EA, 1971, THROMB DIATH HAEMOST, V25, P53, DOI 10.1055/s-0038-1654280; MUSTARD JF, 1966, BRIT J HAEMATOL, V12, P1, DOI 10.1111/j.1365-2141.1966.tb00121.x; RAND ML, 1981, BLOOD, V57, P741; RITCHIE JL, 1977, AM J CARDIOL, V39, P595, DOI 10.1016/S0002-9149(77)80171-9; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; THOMPSON CB, 1982, BRIT J HAEMATOL, V50, P509, DOI 10.1111/j.1365-2141.1982.tb01947.x; THOMPSON CB, 1984, BLOOD, V63, P1372; THOMPSON CB, 1983, BLOOD, V62, P487	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57783	10.1371/journal.pone.0057783	http://dx.doi.org/10.1371/journal.pone.0057783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505441	gold, Green Published			2022-12-25	WOS:000318334500033
J	Kurt, K; Rasigade, JP; Laurent, F; Goering, RV; Zemlickova, H; Machova, I; Struelens, MJ; Zautner, AE; Holtfreter, S; Broker, B; Ritchie, S; Reaksmey, S; Limmathurotsakul, D; Peacock, SJ; Cuny, C; Layer, F; Witte, W; Nubel, U				Kurt, Kevin; Rasigade, Jean-Philippe; Laurent, Frederic; Goering, Richard V.; Zemlickova, Helena; Machova, Ivana; Struelens, Marc J.; Zautner, Andreas E.; Holtfreter, Silva; Broeker, Barbara; Ritchie, Stephen; Reaksmey, Sin; Limmathurotsakul, Direk; Peacock, Sharon J.; Cuny, Christiane; Layer, Franziska; Witte, Wolfgang; Nuebel, Ulrich			Subpopulations of Staphylococcus aureus Clonal Complex 121 Are Associated with Distinct Clinical Entities	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; RESISTANT IMPETIGO CLONE; CHROMOSOME MEC SCCMEC; METHICILLIN-RESISTANT; FUSIDIC ACID; EXFOLIATIVE TOXIN; EDIN-B; COMMUNITY; INFECTIONS; EMERGENCE	We investigated the population structure of Staphylococcus aureus clonal complex CC121 by mutation discovery at 115 genetic housekeeping loci from each of 154 isolates, sampled on five continents between 1953 and 2009. In addition, we pyro-sequenced the genomes from ten representative isolates. The genome-wide SNPs that were ascertained revealed the evolutionary history of CC121, indicating at least six major clades (A to F) within the clonal complex and dating its most recent common ancestor to the pre-antibiotic era. The toxin gene complement of CC121 isolates was correlated with their SNP-based phylogeny. Moreover, we found a highly significant association of clinical phenotypes with phylogenetic affiliations, which is unusual for S. aureus. All isolates evidently sampled from superficial infections (including staphylococcal scalded skin syndrome, bullous impetigo, exfoliative dermatitis, conjunctivitis) clustered in clade F, which included the European epidemic fusidic-acid resistant impetigo clone (EEFIC). In comparison, isolates from deep-seated infections (abscess, furuncle, pyomyositis, necrotizing pneumonia) were disseminated in several clades, but not in clade F. Our results demonstrate that phylogenetic lineages with distinct clinical properties exist within an S. aureus clonal complex, and that SNPs serve as powerful discriminatory markers, able to identify these lineages. All CC121 genomes harboured a 41-kilobase prophage that was dissimilar to S. aureus phages sequenced previously. Community-associated MRSA and MSSA from Cambodia were extremely closely related, suggesting this MRSA arose in the region.	[Kurt, Kevin; Cuny, Christiane; Layer, Franziska; Witte, Wolfgang; Nuebel, Ulrich] Robert Koch Inst, Wernigerode, Germany; [Rasigade, Jean-Philippe; Laurent, Frederic] Univ Lyon, Fac Med, Natl Reference Ctr Staphylococci, Lyon, France; [Goering, Richard V.] Creighton Univ, Sch Med, Omaha, NE USA; [Zemlickova, Helena; Machova, Ivana] Natl Inst Publ Hlth, Prague, Czech Republic; [Struelens, Marc J.] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Zautner, Andreas E.] Univ Med Gottingen, Inst Med Mikrobiol, Gottingen, Germany; [Holtfreter, Silva; Broeker, Barbara] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Ritchie, Stephen] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Reaksmey, Sin] Angkor Hosp Children, Siem Reap, Cambodia; [Limmathurotsakul, Direk; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Robert Koch Institute; Creighton University; National Institute of Public Health (SZU) - Czech Republic; European Centre for Disease Prevention & Control; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald; University of Auckland; Mahidol University; University of Cambridge	Nubel, U (corresponding author), Robert Koch Inst, Wernigerode, Germany.	nuebelu@rki.de	Zemlickova, Helena/G-6105-2017; Rasigade, Jean-Philippe/AAE-1667-2021; Rasigade, Jean-Philippe/L-9320-2014; Zautner, Andreas Erich/ABA-9655-2020; Laurent, Frederic/M-4719-2014; Zautner, Andreas Erich/AAE-7425-2019; Peacock, Sharon J/ABE-6331-2020; Bröker, Barbara M/O-4850-2015; LAURENT, Frederic/AGM-0706-2022	Zemlickova, Helena/0000-0002-3868-0545; Rasigade, Jean-Philippe/0000-0002-8264-0452; Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X; Bröker, Barbara M/0000-0002-5020-8542; Peacock, Sharon/0000-0002-1718-2782; Limmathurotsakul, Direk/0000-0001-7240-5320; Struelens, Marc/0000-0001-5150-4944; Layer, Franziska/0000-0002-4613-6478; Ritchie, Stephen/0000-0001-5001-8899; laurent, frederic/0000-0003-0609-9091; Goering, Richard/0000-0001-7502-7185; Holtfreter, Silva/0000-0002-2672-8230	European Commission, Framework Programme 7 (project TROCAR)	European Commission, Framework Programme 7 (project TROCAR)	This work was partially funded by the European Commission, Framework Programme 7 (project TROCAR). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P3790, DOI 10.1128/JCM.01192-06; Amagai M, 2002, J INVEST DERMATOL, V118, P845, DOI 10.1046/j.1523-1747.2002.01751.x; Basset P, 2012, J CLIN MICROBIOL, V50, P1475, DOI 10.1128/JCM.00664-11; Bukowski M, 2010, TOXINS, V2, P1148, DOI 10.3390/toxins2051148; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Chlebowicz MA, 2010, ANTIMICROB AGENTS CH, V54, P783, DOI 10.1128/AAC.00696-09; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durupt F, 2007, BRIT J DERMATOL, V157, P1161, DOI 10.1111/j.1365-2133.2007.08197.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Franke GC, 2010, MICROBIOL-SGM, V156, P860, DOI 10.1099/mic.0.030304-0; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gravet A, 2001, J CLIN MICROBIOL, V39, P4349, DOI 10.1128/JCM.39.12.4349-4356.2001; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; HOOD AM, 1953, J HYG-CAMBRIDGE, V51, P1, DOI 10.1017/S0022172400015448; Iwatsuki K, 2006, J DERMATOL SCI, V42, P203, DOI 10.1016/j.jdermsci.2006.03.011; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Larsen AR, 2008, J ANTIMICROB CHEMOTH, V61, P589, DOI 10.1093/jac/dkm532; Laurent F, 2009, J ANTIMICROB CHEMOTH, V63, P420, DOI 10.1093/jac/dkn456; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Masiuk H, 2010, J CLIN MICROBIOL, V48, P1527, DOI 10.1128/JCM.02094-09; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; Melles DC, 2006, EMERG INFECT DIS, V12, P1174, DOI 10.3201/eid1207.050865; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Nickerson EK, 2011, AM J TROP MED HYG, V84, P313, DOI 10.4269/ajtmh.2011.10-0300; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Noto MJ, 2006, ANTIMICROB AGENTS CH, V50, P2782, DOI 10.1128/AAC.00032-06; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; O'Hara FP, 2008, J INFECT DIS, V197, P187, DOI 10.1086/524684; O'Neill AJ, 2007, J CLIN MICROBIOL, V45, P1505, DOI 10.1128/JCM.01984-06; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Rijnders MIA, 2012, J ANTIMICROB CHEMOTH, V67, P1176, DOI 10.1093/jac/dkr590; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruzickova V, 2012, INT J MED MICROBIOL, V302, P237, DOI 10.1016/j.ijmm.2012.04.001; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; Wirtz C, 2010, VIROLOGY, V406, P322, DOI 10.1016/j.virol.2010.07.017; Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	45	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58155	10.1371/journal.pone.0058155	http://dx.doi.org/10.1371/journal.pone.0058155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505464	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500056
J	Liu, XJ; Zhou, Y; Yang, HS; Ru, SG				Liu, Xujia; Zhou, Yi; Yang, Hongsheng; Ru, Shaoguo			Eelgrass Detritus as a Food Source for the Sea Cucumber Apostichopus japonicus Selenka (Echinidermata: Holothuroidea) in Coastal Waters of North China: An Experimental Study in Flow-Through Systems	PLOS ONE			English	Article							STICHOPUS-TREMULUS; ECOSYSTEM SERVICES; SEAGRASS; GROWTH; ESTABLISHMENT; HABITAT	Eelgrass ecosystems have a wide variety of ecological functions in which living tissues and detritus may be a food source for many marine animals. In this study, we conducted a laboratory simulating experiment to understand the trophic relationship between the eelgrass Zostera marina L and the sea cucumber Apostichopus japonicus. A mixture of decaying eelgrass debris and seafloor surface muddy sediments was used as food to feed A. japonicus, and then specific growth rates (SGR) and fecal production rates (FPR) were measured. According to the proportion of eelgrass debris, we designed five treatment diets, i.e., ES0, ES10, ES20, ES40, and ES100, with eelgrass debris accounting for 0%, 10%, 20%, 40%, and 100% in dry weight, respectively. Results showed that diet composition had a great influence on the growth of A. japonicus. Sea cucumbers could use decaying eelgrass debris as their food source; and when the organic content of a mixture of eelgrass debris and sediment was 19.6% (ES40), a relatively high SGR (1.54%.d(-1)) and FPR (1.31 g.ind.(-1) d(-1)) of A. japonicus were obtained. It is suggested that eelgrass beds can not only provide habitat for the sea cucumber A. japonicus but can also provide an indirect food source for the deposit feeder. This means that the restoration and reconstruction of eelgrass beds, especially in coastal waters of China, would be a potential and effective measure for sea-cucumber fisheries, in respect to both resource restoration and aquaculture of this valuable species.	[Liu, Xujia; Zhou, Yi; Yang, Hongsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Liu, Xujia] Guangxi Inst Oceanol, Beihai, Peoples R China; [Ru, Shaoguo] Ocean Univ China, Sch Marine Life Sci, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Ocean University of China	Zhou, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	yizhou@qdio.ac.cn	Zhou, Yi/F-4219-2011	Zhou, Yi/0000-0001-7300-0173	National Natural Science Foundation of China [41121064/30972268]; Key Projects in the National Science & Technology Pillar Program [2011BAD13B06]; National Marine Public Welfare Research Project [201305043]; Science & Technology Development Project of Qingdao City South District [2009517HY]; Science & Technology Development Project of Tinjin Binhai New Area [2011-XJR12093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; National Marine Public Welfare Research Project; Science & Technology Development Project of Qingdao City South District; Science & Technology Development Project of Tinjin Binhai New Area	This research was supported by the National Natural Science Foundation of China (number 41121064/30972268), the Key Projects in the National Science & Technology Pillar Program during the 12th Five-Year Plan Period (2011BAD13B06), the National Marine Public Welfare Research Project (201305043), the Science & Technology Development Project of Qingdao City South District (2009517HY), and the Science & Technology Development Project of Tinjin Binhai New Area (2011-XJR12093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom C, 2000, MAR ECOL PROG SER, V205, P123, DOI 10.3354/meps205123; Chen J., 2003, BECHE INF BULL, V17, P18, DOI DOI 10.1038/S41598-019-45271-3; Chen JX., 2004, ADV SEA CUCUMBER AQU, V1, P25; CHOE S, 1963, STUDY SEA CUCUMBER M, P219; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Duarte CM, 2000, J EXP MAR BIOL ECOL, V250, P117, DOI 10.1016/S0022-0981(00)00194-5; Goshima Seiji, 1994, Suisan Zoshoku, V42, P261; Guo D, 2000, PERIODICAL OCEAN U C, V40, P51; Hamel JF, 2001, ADV MAR BIOL, V41, P129, DOI 10.1016/S0065-2881(01)41003-0; HAUKSSON E, 1979, SARSIA, V64, P155, DOI 10.1080/00364827.1979.10411376; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hemming MA, 2000, SEAGRASS ECOLOGY, P20; Hudson IR, 2004, J EXP MAR BIOL ECOL, V301, P75, DOI 10.1016/j.jembe.2003.09.015; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kang KH, 2003, AQUACULTURE, V216, P87, DOI 10.1016/S0044-8486(02)00203-X; Li H, 2006, J FISHERY SCI CHINA, V11, P77; [李文涛 Li Wentao], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P977; Liao YL, 1984, STUDIA MARINA SINICA, V23, P221; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; Nakamura Y, 2003, ICHTHYOL RES, V50, P15, DOI 10.1007/s102280300002; NELSON WG, 1981, MAR ECOL PROG SER, V5, P141, DOI 10.3354/meps005141; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Otero-Villanueva MDM, 2004, J EXP MAR BIOL ECOL, V304, P159, DOI 10.1016/j.jembe.2003.12.002; Park JI, 2007, MAR POLLUT BULL, V54, P1238, DOI 10.1016/j.marpolbul.2007.03.020; Ramofafia C, 1997, AQUACULTURE, V152, P119, DOI 10.1016/S0044-8486(96)01525-6; ROBERTSON ML, 1982, MAR ECOL PROG SER, V7, P279, DOI 10.3354/meps007279; SLOAN NA, 1980, MAR ECOL PROG SER, V2, P257, DOI 10.3354/meps002257; Tiensongrusmee B, 1988, SEAFARMING DEV PROJE, P18; Uthicke Sven, 2004, FAO Fisheries Technical Paper, V463, P163; Vizzini S, 2009, BOT MAR, V52, P383, DOI 10.1515/BOT.2009.056; WALKER DI, 1992, MAR POLLUT BULL, V25, P191, DOI 10.1016/0025-326X(92)90224-T; Wang XZ, 2000, MOD FISH INFORM, V15, P20; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Woods CMC, 1997, J EXP MAR BIOL ECOL, V214, P49, DOI 10.1016/S0022-0981(96)02767-0; Xu Z., 1999, SHANDONG FISHERIES, V16, P30; Yang Z.D., 1979, T OCEANOL LIMNOL, V2, P41; YU DY, 1999, J FISHERY SCI CHINA, V6, P109; [于函 YU Han], 2009, [渔业科学进展, Progress in Fishery Sciences], V30, P131; Yuan XT, 2006, AQUACULTURE, V256, P457, DOI 10.1016/j.aquaculture.2006.01.029; Zhang B., 1995, MAR SCI-CHINA, V3, P11; Zhou Y, 2006, MAR ECOL PROG SER, V317, P127, DOI 10.3354/meps317127; Zhou Y, 2006, AQUACULTURE, V256, P510, DOI 10.1016/j.aquaculture.2006.02.005	43	49	53	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58293	10.1371/journal.pone.0058293	http://dx.doi.org/10.1371/journal.pone.0058293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505480	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500064
J	Novozhilova, E; Olivius, P; Siratirakun, P; Lundberg, C; Englund-Johansson, U				Novozhilova, Ekaterina; Olivius, Petri; Siratirakun, Piyaporn; Lundberg, Cecilia; Englund-Johansson, Ulrica			Neuronal Differentiation and Extensive Migration of Human Neural Precursor Cells following Co-Culture with Rat Auditory Brainstem Slices	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DORSAL-ROOT GANGLION; PROGENITOR CELLS; INNER-EAR; IN-VITRO; HAIR-CELLS; SPIRAL GANGLION; COCHLEAR IMPLANTATION; SENSORY NEURONS; MAMMALIAN BRAIN	Congenital or acquired hearing loss is often associated with a progressive degeneration of the auditory nerve (AN) in the inner ear. The AN is composed of processes and axons of the bipolar spiral ganglion neurons (SGN), forming the connection between the hair cells in the inner ear cochlea and the cochlear nuclei (CN) in the brainstem (BS). Therefore, replacement of SGNs for restoring the AN to improve hearing function in patients who receive a cochlear implantation or have severe AN malfunctions is an attractive idea. A human neural precursor cell (HNPC) is an appropriate donor cell to investigate, as it can be isolated and expanded in vitro with maintained potential to form neurons and glia. We recently developed a post-natal rodent in vitro auditory BS slice culture model including the CN and the central part of the AN for initial studies of candidate cells. Here we characterized the survival, distribution, phenotypic differentiation, and integration capacity of HNPCs into the auditory circuitry in vitro. HNPC aggregates (spheres) were deposited adjacent to or on top of the BS slices or as a monoculture (control). The results demonstrate that co-cultured HNPCs compared to monocultures (1) survive better, (2) distribute over a larger area, (3) to a larger extent and in a shorter time-frame form mature neuronal and glial phenotypes. HNPC showed the ability to extend neurites into host tissue. Our findings suggest that the HNPC-BS slice co-culture is appropriate for further investigations on the integration capacity of HNPCs into the auditory circuitry.	[Olivius, Petri] Cty Council Ostergotland, UHL, Dept ENT Head & Neck Surg, Linkoping, Sweden; [Novozhilova, Ekaterina; Olivius, Petri] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Otorhinolaryngol & Head & Neck Surg, Linkoping, Sweden; [Novozhilova, Ekaterina; Olivius, Petri; Siratirakun, Piyaporn] Karolinska Univ Hosp, Ctr Hearing & Commun Res, Stockholm, Sweden; [Novozhilova, Ekaterina; Olivius, Petri; Siratirakun, Piyaporn] Karolinska Univ Hosp, Karolinska Inst, Sect Otorhinolaryngol, Dept Clin Neurosci, Stockholm, Sweden; [Lundberg, Cecilia] Lund Univ, Dept Expt Med Sci, CNS Gene Therapy Unit, Lund, Sweden; [Englund-Johansson, Ulrica] Lund Univ, Dept Ophthalmol, Inst Clin Sci Lund, Lund, Sweden	City Council Ostergotland; Linkoping University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Lund University	Olivius, P (corresponding author), Cty Council Ostergotland, UHL, Dept ENT Head & Neck Surg, Linkoping, Sweden.	petri.olivius@lio.se		Olivius, Petri/0000-0002-7401-9826; Lundberg, Cecilia/0000-0002-6959-2564	Swedish Research Council [2008-2822]; Marianne and Marcus Wallenbergs Foundation; Petrus and Augusta Hedlunds Foundation; Swedish Association of Hard of Hearing People; Acta Otolaryngologica's Foundation; Foundation Tysta Skolan; Ollie and Elof Ericssons Foundation for Medical Research; Karolinska Institutet Foundations; Medical faculty; Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenbergs Foundation; Petrus and Augusta Hedlunds Foundation; Swedish Association of Hard of Hearing People; Acta Otolaryngologica's Foundation; Foundation Tysta Skolan; Ollie and Elof Ericssons Foundation for Medical Research; Karolinska Institutet Foundations(Karolinska Institutet); Medical faculty; Lund University	P. Olivius: This work was supported by The Swedish Research Council n:o 2008-2822, Marianne and Marcus Wallenbergs Foundation, Petrus and Augusta Hedlunds Foundation, The Swedish Association of Hard of Hearing People, Acta Otolaryngologica's Foundation, The Foundation Tysta Skolan, Ollie and Elof Ericssons Foundation for Medical Research and Karolinska Institutet Foundations. U. Englund-Johansson: This work was supported by the Medical faculty and Lund University. The funders hade no role in the study design, data collection and analysis, descision to publish, or preparation of the manuscript.	Altschuler RA, 2008, HEARING RES, V242, P110, DOI 10.1016/j.heares.2008.06.004; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; Baker PS, 2009, CURR OPIN OPHTHALMOL, V20, P175, DOI 10.1097/ICU.0b013e328329b5f2; Benninger F, 2003, J NEUROSCI, V23, P7075, DOI 10.1523/JNEUROSCI.23-18-07075.2003; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Bjorklund A, 2000, NATURE, V405, P892, DOI 10.1038/35016175; Burnstein RM, 2004, INT J BIOCHEM CELL B, V36, P702, DOI 10.1016/j.biocel.2003.11.011; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Carricondo F, 2010, CELL TISSUE RES, V342, P13, DOI 10.1007/s00441-010-1039-8; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Coco A, 2007, HEARING RES, V225, P60, DOI 10.1016/j.heares.2006.12.004; Coleman B, 2007, EXP CELL RES, V313, P232, DOI 10.1016/j.yexcr.2006.10.010; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Englund U, 2000, NEUROREPORT, V11, P3973, DOI 10.1097/00001756-200012180-00014; Englund-Johansson U, 2010, EXP EYE RES, V90, P292, DOI 10.1016/j.exer.2009.11.005; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Glavaski-Joksimovic A, 2009, NEUROSCIENCE, V162, P472, DOI 10.1016/j.neuroscience.2009.04.070; Glavaski-Joksimovic A, 2008, CLONING STEM CELLS, V10, P75, DOI 10.1089/clo.2007.0065; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Gunewardene N, 2012, STEM CELL REV REP, V8, P741, DOI 10.1007/s12015-011-9320-0; Han Z, 2010, NEUROREPORT, V21, P490, DOI 10.1097/WNR.0b013e3283383410; Hu ZQ, 2005, NEUROBIOL DIS, V18, P184, DOI 10.1016/j.nbd.2004.09.010; Hu ZQ, 2004, BRAIN RES, V1026, P68, DOI 10.1016/j.brainres.2004.08.013; Hu ZQ, 2004, EXP NEUROL, V185, P7, DOI 10.1016/j.expneurol.2003.09.013; Ibekwe TS, 2012, J LARYNGOL OTOL, V126, P653, DOI 10.1017/S0022215112000850; Jongkamonwiwat N, 2010, CURR DRUG TARGETS, V11, P888, DOI 10.2174/138945010791320836; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kamei N, 2004, NEUROREPORT, V15, P2579, DOI 10.1097/00001756-200412030-00004; Kim Hyuk Min, 2010, Exp Neurobiol, V19, P106, DOI 10.5607/en.2010.19.2.106; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Lundberg C, 2002, EXP NEUROL, V175, P370, DOI 10.1006/exnr.2002.7888; Martinez-Moneder R, 2007, INT J DEV BIOL, V51, P655, DOI 10.1387/ijdb.072372rm; Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616; Matsumoto M, 2008, J NEUROSCI RES, V86, P3075, DOI 10.1002/jnr.21754; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Nishimura K, 2009, NEUROREPORT, V20, P1250, DOI 10.1097/WNR.0b013e32832ff287; Olivius P, 2004, BRAIN RES PROTOC, V12, P152, DOI 10.1016/j.brainresprot.2003.11.002; Olivius P, 2003, BRAIN RES, V979, P1, DOI 10.1016/S0006-8993(03)02802-6; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Palmgren B, 2011, BRAIN RES, V1377, P41, DOI 10.1016/j.brainres.2010.12.078; Pandit SR, 2011, STEM CELLS, V29, P670, DOI 10.1002/stem.609; Park DH, 2010, THESCIENTIFICWORLDJO, V10, P470, DOI 10.1100/tsw.2010.39; Pfingst BE, 2011, HEARING RES, V281, P65, DOI 10.1016/j.heares.2011.05.002; Radojevic V, 2004, EXP NEUROL, V188, P11, DOI 10.1016/j.expneurol.2004.03.015; Rask-Andersen H, 2005, HEARING RES, V203, P180, DOI 10.1016/j.heares.2004.12.005; Regala C, 2005, EXP NEUROL, V193, P326, DOI 10.1016/j.expneurol.2004.12.027; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rivolta Marcelo N., 2006, V330, P71; Rivolta MN, 2010, DRUG DISCOV TODAY, V15, P283, DOI 10.1016/j.drudis.2010.02.006; Roth TN, 2011, EUR ARCH OTO-RHINO-L, V268, P1101, DOI 10.1007/s00405-011-1597-8; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Scheffler B, 2003, DEVELOPMENT, V130, P5533, DOI 10.1242/dev.00714; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Sullivan JM, 2011, NEUROBIOL DIS, V41, P552, DOI 10.1016/j.nbd.2010.11.001; Takuma H, 2002, NEUROSCIENCE, V109, P359, DOI 10.1016/S0306-4522(01)00472-9; Thonabulsombat C, 2007, BRAIN RES, V1170, P48, DOI 10.1016/j.brainres.2007.06.085; Ulfendahl M, 2007, PHYSIOL BEHAV, V92, P75, DOI 10.1016/j.physbeh.2007.05.054; Visigalli I, 2010, BLOOD, V116, P5130, DOI 10.1182/blood-2010-04-278234; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7	72	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57301	10.1371/journal.pone.0057301	http://dx.doi.org/10.1371/journal.pone.0057301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505423	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500015
J	Takahashi, M; Obayashi, M; Ishiguro, T; Sato, N; Niimi, Y; Ozaki, K; Mogushi, K; Mahmut, Y; Tanaka, H; Tsuruta, F; Dolmetsch, R; Yamada, M; Takahashi, H; Kato, T; Mori, O; Eishi, Y; Mizusawa, H; Ishikawa, K				Takahashi, Makoto; Obayashi, Masato; Ishiguro, Taro; Sato, Nozomu; Niimi, Yusuke; Ozaki, Kokoro; Mogushi, Kaoru; Mahmut, Yasen; Tanaka, Hiroshi; Tsuruta, Fuminori; Dolmetsch, Ricardo; Yamada, Mitsunori; Takahashi, Hitoshi; Kato, Takeo; Mori, Osamu; Eishi, Yoshinobu; Mizusawa, Hidehiro; Ishikawa, Kinya			Cytoplasmic Location of alpha 1A Voltage-Gated Calcium Channel C-Terminal Fragment (Ca(v)2.1-CTF) Aggregate Is Sufficient to Cause Cell Death	PLOS ONE			English	Article							ATAXIA TYPE 6; PURE CEREBELLAR-ATAXIA; CREB-BINDING PROTEIN; EXPANDED POLYGLUTAMINE; PURKINJE-CELLS; INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE; LARGE COHORT; SPINOCEREBELLAR; TYPE-6	The human alpha(1A) voltage-dependent calcium channel (Ca(v)2.1) is a pore-forming essential subunit embedded in the plasma membrane. Its cytoplasmic carboxyl(C)-tail contains a small poly-glutamine (Q) tract, whose length is normally 4 similar to 19 Q, but when expanded up to 20 similar to 33Q, the tract causes an autosomal-dominant neurodegenerative disorder, spinocerebellar ataxia type 6 (SCA6). A recent study has shown that a 75-kDa C-terminal fragment (CTF) containing the polyQ tract remains soluble in normal brains, but becomes insoluble mainly in the cytoplasm with additional localization to the nuclei of human SCA6 Purkinje cells. However, the mechanism by which the CTF aggregation leads to neurodegeneration is completely elusive, particularly whether the CTF exerts more toxicity in the nucleus or in the cytoplasm. We tagged recombinant (r)CTF with either nuclear-localization or nuclear-export signal, created doxycyclin-inducible rat pheochromocytoma (PC12) cell lines, and found that the CTF is more toxic in the cytoplasm than in the nucleus, the observations being more obvious with Q28 (disease range) than with Q13 (normal-length). Surprisingly, the CTF aggregates co-localized both with cAMP response element-binding protein (CREB) and phosphorylated-CREB (p-CREB) in the cytoplasm, and Western blot analysis showed that the quantity of CREB and p-CREB were both decreased in the nucleus when the rCTF formed aggregates in the cytoplasm. In human brains, polyQ aggregates also co-localized with CREB in the cytoplasm of SCA6 Purkinje cells, but not in other conditions. Collectively, the cytoplasmic Ca(v)2.1-CTF aggregates are sufficient to cause cell death, and one of the pathogenic mechanisms may be abnormal CREB trafficking in the cytoplasm and reduced CREB and p-CREB levels in the nuclei.	[Takahashi, Makoto; Obayashi, Masato; Ishiguro, Taro; Sato, Nozomu; Niimi, Yusuke; Ozaki, Kokoro; Mizusawa, Hidehiro; Ishikawa, Kinya] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan; [Mogushi, Kaoru; Mahmut, Yasen; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Informat Ctr Med Sci, Bunkyo Ku, Tokyo, Japan; [Tsuruta, Fuminori; Dolmetsch, Ricardo] Stanford Univ, Sch Med, Dept Neurobiol, Palo Alto, CA 94304 USA; [Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Yamada, Mitsunori; Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Pathol Neurosci Branch, Niigata, Japan; [Yamada, Mitsunori] Saigata Natl Hosp, Natl Hosp Org, Dept Clin Res, Ohgata Ku, Johetsu, Niigata, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata 990, Japan; [Mori, Osamu] Hatsuishi Hosp, Dept Internal Med & Neurol, Nishihara, Chiba, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Stanford University; Tokyo Medical & Dental University (TMDU); Niigata University; Yamagata University	Ishikawa, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan.	pico.nuro@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670; Mogushi, Kaoru/0000-0002-2618-8684; Takahashi, Makoto/0000-0002-2452-0268; Sato, Nozomu/0000-0002-8906-2798; Ozaki, Kokoro/0000-0001-9081-8348	Japanese Ministry of Education, Sports and Culture; Japan Society for Promotion of Science (JSPS); Japanese Ministry of Education, Science and Culture; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Ministry of Health, Labour and Welfare, Japan	Japanese Ministry of Education, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare, Japan	This study was funded by the Japanese Ministry of Education, Sports and Culture (KI and HM), the Japan Society for Promotion of Science (JSPS) (KI and HM), the 21st Century COE Program on Brain Integration and its Disorders from the Japanese Ministry of Education, Science and Culture (HM), the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (HM) and from the Health and Labour Sciences Research Grants on Ataxic Diseases (HM) of the Japanese Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data cellection and analysis, decision to publish, or preparation of the manuscript.	Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0; Ishikawa K, 1999, HUM MOL GENET, V8, P1185, DOI 10.1093/hmg/8.7.1185; Ishikawa K, 2001, NEUROLOGY, V56, P1753, DOI 10.1212/WNL.56.12.1753; Ishikawa K, 1997, AM J HUM GENET, V61, P336, DOI 10.1086/514867; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Li L, 2009, GENES CELLS, V14, P1253, DOI 10.1111/j.1365-2443.2009.01348.x; Li XJ, 1999, MOL NEUROBIOL, V20, P111, DOI 10.1007/BF02742437; Marqueze-Pouey B, 2008, TRAFFIC, V9, P1088, DOI 10.1111/j.1600-0854.2008.00743.x; Matsuyama Z, 1999, J Neurosci, V19, pRC14; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Piedras-Renteria ES, 2001, J NEUROSCI, V21, P9185, DOI 10.1523/JNEUROSCI.21-23-09185.2001; Restituito S, 2000, J NEUROSCI, V20, P6394, DOI 10.1523/JNEUROSCI.20-17-06394.2000; Saegusa H, 2007, MOL CELL NEUROSCI, V34, P261, DOI 10.1016/j.mcn.2006.11.006; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Takahashi H, 2004, J HUM GENET, V49, P256, DOI 10.1007/s10038-004-0142-7; Takahashi M, 2012, NEUROPATHOL IN PRESS; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Yabe I, 1998, J NEUROL SCI, V156, P89, DOI 10.1016/S0022-510X(98)00009-4; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e50121	10.1371/journal.pone.0050121	http://dx.doi.org/10.1371/journal.pone.0050121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505410	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500002
J	Verhoef, SPM; Camps, SGJA; Bouwman, FG; Mariman, ECM; Westerterp, KR				Verhoef, Sanne P. M.; Camps, Stefan G. J. A.; Bouwman, Freek G.; Mariman, Edwin C. M.; Westerterp, Klaas R.			Physiological Response of Adipocytes to Weight Loss and Maintenance	PLOS ONE			English	Article							TISSUE GENE-EXPRESSION; ADIPOSE-TISSUE; FAT OXIDATION; RESTRICTION; AUTOPHAGY; OBESITY	Background: Metabolic processes in adipose tissue are dysregulated in obese subjects and, in response to weight loss, either normalize or change in favor of weight regain. Objective: To determine changes in adipocyte glucose and fatty acid metabolism in relation to changes in adipocyte size during weight loss and maintenance. Methods: Twenty-eight healthy subjects (12 males), age 20-50 y, and BMI 28-35 kg/m(2), followed a very low energy diet for 2 months, followed by a 10-month period of weight maintenance. Body weight, body composition (deuterium dilution and BodPod), protein levels (Western blot) and adipocyte size were assessed prior to and after weight loss and after the 10-month follow-up. Results: A 10% weight loss resulted in a 16% decrease in adipocyte size. A marker for glycolysis decreased (AldoC) during weight loss in association with adipocyte shrinking, and remained decreased during follow-up in association with weight maintenance. A marker for fatty acid transport increased (FABP4) during weight loss and remained increased during follow-up. Markers for mitochondrial beta-oxidation (HADHsc) and lipolysis (ATGL) were only increased after the 10-month follow-up. During weight loss HADHsc and ATGL were coordinately regulated, which became weaker during follow-up due to adipocyte size-related changes in HADHsc expression. AldoC was the major denominator of adipocyte size and body weight, whereas changes in ATGL during weight loss contributed to body weight during follow-up. Upregulation of ATGL and HADHsc occured in the absence of a negative energy balance and was triggered by adipocyte shrinkage or indicated preadipocyte differentiation. Conclusion: Markers for adipocyte glucose and fatty acid metabolism are changed in response to weight loss in line with normalization from a dysregulated obese status to an improved metabolic status.	[Verhoef, Sanne P. M.; Camps, Stefan G. J. A.; Bouwman, Freek G.; Mariman, Edwin C. M.; Westerterp, Klaas R.] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Verhoef, SPM (corresponding author), Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, Maastricht, Netherlands.	s.verhoef@maastrichtuniversity.nl	Biguzzi, Felipe A/E-4724-2015; Camps, Stefan/AAM-8648-2020	Camps, Stefan/0000-0003-2053-1135	NUTRIM	NUTRIM	This work was supported by NUTRIM (http://www.nutrim.unimaas.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin D, 2004, OBES RES, V12, P1231, DOI 10.1038/oby.2004.156; Bennetzen MF, 2005, INT J OBES LOND, V35, P1377; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; Bouwman FG, 2009, J PROTEOME RES, V8, P5532, DOI 10.1021/pr900606m; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capel F, 2008, J CLIN ENDOCR METAB, V93, P4315, DOI 10.1210/jc.2008-0814; Chen HC, 2002, J LIPID RES, V43, P986; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Frisancho AR, 2003, AM J HUM BIOL, V15, P522, DOI 10.1002/ajhb.10191; GOLDRICK RB, 1967, AM J PHYSIOL, V212, P777, DOI 10.1152/ajplegacy.1967.212.4.777; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; Kovsan J, 2010, AM J PHYSIOL-ENDOC M, V298, pE1, DOI 10.1152/ajpendo.00562.2009; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; MacLean PS, 2011, AM J PHYSIOL-REG I, V301, pR581, DOI 10.1152/ajpregu.00755.2010; Mariman ECM, 2012, J NUTRIGENET NUTRIGE, V5, P13, DOI 10.1159/000337081; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Marquez-Quinones A, 2010, AM J CLIN NUTR, V92, P975, DOI 10.3945/ajcn.2010.29808; Mutch DM, 2011, AM J CLIN NUTR, V94, P1399, DOI 10.3945/ajcn.110.006858; Siri W., 1961, TECHNIQUES MEASURING, P223; Walewski JL, 2010, OBES SURG, V20, P93, DOI 10.1007/s11695-009-0002-9; Wang P, 2009, PROTEOMICS, V9, P2955, DOI 10.1002/pmic.200800826; Westerterp KR, 2008, AM J CLIN NUTR, V87, P132, DOI 10.1093/ajcn/87.1.132; WESTERTERP KR, 1995, OBES RES, V3, P49, DOI 10.1002/j.1550-8528.1995.tb00007.x; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	26	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58011	10.1371/journal.pone.0058011	http://dx.doi.org/10.1371/journal.pone.0058011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505452	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500044
J	Wang, JS; Lei, YM; Xiong, K; Marek, K				Wang, Jinsung; Lei, Yuming; Xiong, Khongchee; Marek, Katie			Substantial Generalization of Sensorimotor Learning from Bilateral to Unilateral Movement Conditions	PLOS ONE			English	Article							SINGLE LIMB PERFORMANCE; INTERLIMB TRANSFER; VISUOMOTOR ROTATIONS; ADAPTATION; REHABILITATION; DYNAMICS; SKILL	Controversy exists regarding whether bimanual skill learning can generalize to unimanual performance. For example, some investigators showed that dynamic adaptation could only partially generalize between bilateral and unilateral movement conditions, while others demonstrated complete generalization of visuomotor adaptation. Here, we identified three potential factors that might have contributed to the discrepancy between the two sets of findings. In our first experiment, subjects performed reaching movements toward eight targets bilaterally with a novel force field applied to both arms, then unilaterally with the force field applied to one arm. Results showed that the dynamic adaptation generalized completely from bilateral to unilateral movements. In our second experiment, the same force field was only applied to one arm during both bilateral and unilateral movements. Results indicated complete transfer again. Finally, our subjects performed reaching movements toward a single target with the force field or a novel visuomotor rotation applied only to one arm during both bilateral and unilateral movements. The reduced breadth of experience obtained during bilateral movements resulted in incomplete transfer, which explains previous findings of limited generalization. These findings collectively suggest a substantial overlap between the neural processes underlying bilateral and unilateral movements, supporting the idea that bilateral training, often employed in stroke rehabilitation, is a valid method for improving unilateral performance. However, our findings also suggest that while the neural representations developed during bilateral training can generalize to facilitate unilateral performance, the extent of generalization may depend on the breadth of experience obtained during bilateral training.	[Wang, Jinsung; Lei, Yuming; Xiong, Khongchee; Marek, Katie] Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Wang, JS (corresponding author), Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA.	wang34@uwm.edu			National Institutes of Health [K01HD050245]; University of Wisconsin - Milwaukee SURF Awards; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD050245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin - Milwaukee SURF Awards; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the National Institutes of Health grant K01HD050245 (JW) and University of Wisconsin - Milwaukee SURF Awards (KX, KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraduc P, 2002, J NEUROPHYSIOL, V88, P973, DOI 10.1152/jn.2002.88.2.973; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Burgess JK, 2007, IEEE T NEUR SYS REH, V15, P347, DOI 10.1109/TNSRE.2007.903908; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Cauraugh JH, 2010, HUM MOVEMENT SCI, V29, P853, DOI 10.1016/j.humov.2009.09.004; FRANZ EA, 1992, J MOTOR BEHAV, V24, P281, DOI 10.1080/00222895.1992.9941623; Galea JM, 2007, EXP BRAIN RES, V182, P267, DOI 10.1007/s00221-007-1069-y; Heuer H., 1996, HDB PERCEPTION ACTIO, V2, P121; Howard IS, 2010, J NEUROPHYSIOL, V104, P2082, DOI 10.1152/jn.00299.2010; Jancke L, 2000, NEUROPSYCHOLOGIA, V38, P164, DOI 10.1016/S0028-3932(99)00062-7; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Sainburg RL, 2002, EXP BRAIN RES, V145, P437, DOI 10.1007/s00221-002-1140-7; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Seidler RD, 2004, J COGNITIVE NEUROSCI, V16, P65, DOI 10.1162/089892904322755566; Shadmehr R, 2000, J NEUROSCI, V20, P7807; SHEA CH, 1990, RES Q EXERCISE SPORT, V61, P169, DOI 10.1080/02701367.1990.10608671; Stewart KC, 2006, J NEUROL SCI, V244, P89, DOI 10.1016/j.jns.2006.01.005; Stinear JW, 2004, J CLIN NEUROPHYSIOL, V21, P124, DOI 10.1097/00004691-200403000-00008; Stoykov ME, 2009, OCCUP THER INT, V16, P190, DOI 10.1002/oti.277; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tcheang L, 2007, EXP BRAIN RES, V127, P182; Trlep M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-43; Waller SM, 2004, ARCH PHYS MED REHAB, V85, P1076, DOI 10.1016/j.apmr.2003.10.020; Wang JS, 2010, J NEUROPHYSIOL, V104, P2913, DOI 10.1152/jn.00225.2010; Wang JS, 2009, J NEUROPHYSIOL, V102, P2790, DOI 10.1152/jn.00444.2009; Wang JS, 2005, J NEUROSCI, V25, P4024, DOI 10.1523/JNEUROSCI.5000-04.2005; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58495	10.1371/journal.pone.0058495	http://dx.doi.org/10.1371/journal.pone.0058495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505519	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500092
J	Xu, HZ; Wang, ZQ; Wang, Y; Hu, SD; Liu, NF				Xu, Hongzeng; Wang, Zhongqun; Wang, Yan; Hu, Shengda; Liu, Naifeng			Biodistribution and Elimination Study of Fluorine-18 Labeled N-epsilon-Carboxymethyl-Lysine following Intragastric and Intravenous Administration	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; POSITRON-EMISSION-TOMOGRAPHY; CACO-2 CELL MONOLAYERS; TRANSEPITHELIAL FLUX; DIABETIC-NEPHROPATHY; MAILLARD REACTION; HUMAN HEALTH; AMINO-ACID; ENDPRODUCTS; N-EPSILON-(CARBOXYMETHYL)LYSINE	Background: N-epsilon-carboxymethyl-lysine (CML) is a major advanced glycation end-product (AGEs) widely found in foods. The aim of our study was to evaluate how exogenous CML-peptide is dynamically absorbed from the gastrointestinal tract and eliminated by renal tubular secretion using microPET imaging. Methods: The present study consisted of three investigations. In study I, we synthesized the imaging tracer F-18-CML by reacting N-succinimidyl 4-F-18-fluorobenzoate (F-18-SFB) with CML. In study II, the biological activity of F-18-CML was evaluated in RAW264.7 cells and HepG2 cells. In study III, the biodistribution and elimination of AGEs in ICR mice were studied in vivo following tail vein injection and intragastric administration of F-18-CML. Result: The formation of F-18-CML was confirmed by comparing its retention time with the corresponding reference compound F-19-CML. The radiochemical purity (RCP) of F-18-CML was >95%, and it showed a stable character in vitro and in vivo. Uptake of F-18-CML by RAW264.7 cells and HepG2 cells could be inhibited by unmodified CML. F-18-CML was quickly distributed via the blood, and it was rapidly excreted through the kidneys 20 min after tail vein injection. However, F-18-CML was only slightly absorbed following intragastric administration. After administration of F-18-CML via a stomach tube, the radioactivity was completely localized in the stomach for the first 15 min. At 150 min post intragastric administration, intense accumulation of radioactivity in the intestines was still observed. Conclusions: PET technology is a powerful tool for the in vivo analysis of the gastrointestinal absorption of orally administered drugs. F-18-CML is hardly absorbed by the gastrointestinal tract. It is rapidly distributed and eliminated from blood following intravenous administration. Thus, it may not be harmful to healthy bodies. Our study showed the feasibility of noninvasively imaging F-18-labeled AGEs and was the first to describe CML-peptide gastrointestinal absorption by means of PET.	[Xu, Hongzeng; Wang, Zhongqun; Hu, Shengda; Liu, Naifeng] Southeast Univ, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Wang, Yan] Jiangsu Inst Nucl Med, Wuxi, Peoples R China	Southeast University - China	Liu, NF (corresponding author), Southeast Univ, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	liunf@seu.edu.cn	Liu, Nai-feng/AAM-7836-2020		National Natural Science Foundation of China [81170254]; Research and Innovation Project for College Graduates of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Project for College Graduates of Jiangsu Province	This work was partly supported by the National Natural Science Foundation of China (No. 81170254) to Prof. Naifeng Liu (http://www.nsfc.gov.cn/Portal0/default124.htm) and sponsored by the Research and Innovation Project for College Graduates of Jiangsu Province (http://www.ec.js.edu.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2009, J CLIN BIOCHEM NUTR, V44, P14, DOI 10.3164/jcbn.08-190; Ames JM, 2008, ANN NY ACAD SCI, V1126, P20, DOI 10.1196/annals.1433.030; Ames JM, 2007, MOL NUTR FOOD RES, V51, P1085, DOI 10.1002/mnfr.200600304; Bergmann R, 2001, NAHRUNG, V45, P182, DOI 10.1002/1521-3803(20010601)45:3&lt;182::AID-FOOD182&gt;3.0.CO;2-Q; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Drusch S, 1999, FOOD CHEM, V65, P547, DOI 10.1016/S0308-8146(98)00244-1; Forster A, 2005, ANN NY ACAD SCI, V1043, P474, DOI 10.1196/annals.1333.054; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Grunwald S, 2006, BRIT J NUTR, V95, P1221, DOI 10.1079/BJN20061793; Gugliucci A, 1996, DIABETOLOGIA, V39, P149, DOI 10.1007/BF00403957; Hellwig M, 2011, CHEMBIOCHEM, V12, P1270, DOI 10.1002/cbic.201000759; Hellwig M, 2009, J AGR FOOD CHEM, V57, P6474, DOI 10.1021/jf901224p; Henle T, 2005, AMINO ACIDS, V29, P313, DOI 10.1007/s00726-005-0200-2; Henle T, 2003, KIDNEY INT, V63, pS145, DOI 10.1046/j.1523-1755.63.s84.16.x; Henle T, 2007, MOL NUTR FOOD RES, V51, P1075, DOI 10.1002/mnfr.200700067; Horiuchi S, 2002, J HEPATOL, V36, P123, DOI 10.1016/S0168-8278(01)00293-8; Hull GLJ, 2012, FOOD CHEM, V131, P170, DOI 10.1016/j.foodchem.2011.08.055; Hultsch C, 2006, NUCL MED BIOL, V33, P865, DOI 10.1016/j.nucmedbio.2006.07.007; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Kuchar M, 2012, AMINO ACIDS; Kuniyasu A, 2003, FEBS LETT, V537, P85, DOI 10.1016/S0014-5793(03)00096-6; Lasne MC, 2002, TOP CURR CHEM, V222, P201; Li ZB, 2010, ADV DRUG DELIVER REV, V62, P1031, DOI 10.1016/j.addr.2010.09.007; Lin RY, 2003, ATHEROSCLEROSIS, V168, P213, DOI 10.1016/S0021-9150(03)00050-9; Miyazaki A, 2002, TRENDS CARDIOVAS MED, V12, P258, DOI 10.1016/S1050-1738(02)00171-8; Ohgami N, 2001, J BIOL CHEM, V276, P13348, DOI 10.1074/jbc.M011613200; Ohgami Nobutaka, 2003, J Atheroscler Thromb, V10, P1; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Pawelke B, 2005, AMINO ACIDS, V29, P377, DOI 10.1007/s00726-005-0202-0; Perkins BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035655; Piroddi M, 2011, J RENAL NUTR, V21, P329, DOI 10.1053/j.jrn.2010.06.024; Rapin JR, 2010, CLINICS, V65, P635, DOI 10.1590/S1807-59322010000600012; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Saito A, 2005, ANN NY ACAD SCI, V1043, P637, DOI 10.1196/annals.1333.072; Sano H, 1999, MECH AGEING DEV, V107, P333, DOI 10.1016/S0047-6374(99)00011-1; Semba RD, 2012, EUR J CLIN NUTR, V66, P3, DOI 10.1038/ejcn.2011.139; Semba RD, 2010, J RENAL NUTR, V20, P74, DOI 10.1053/j.jrn.2009.08.001; Serdons K, 2009, METHODS, V48, P104, DOI 10.1016/j.ymeth.2009.03.010; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Svistounov D, 2004, J HEPATOL, V41, P1038, DOI 10.1016/j.jhep.2004.10.004; Tessier FJ, 2012, AMINO ACIDS, V42, P1119, DOI 10.1007/s00726-010-0776-z; Uribarri J, 2005, ANN NY ACAD SCI, V1043, P461, DOI 10.1196/annals.1333.052; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Vaidyanathan G, 2006, NAT PROTOC, V1, P1655, DOI 10.1038/nprot.2006.264; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Wuest F, 2005, AMINO ACIDS, V29, P323, DOI 10.1007/s00726-005-0201-1; Zheng F, 2002, DIABETES-METAB RES, V18, P224, DOI 10.1002/dmrr.283	50	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57897	10.1371/journal.pone.0057897	http://dx.doi.org/10.1371/journal.pone.0057897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505446	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500038
J	Adams, LV; Craig, SR; Mmbaga, EJ; Naburi, H; Lahey, T; Nutt, CT; Kisenge, R; Noel, GJ; Spielberg, SP				Adams, Lisa V.; Craig, Sienna R.; Mmbaga, Elia John; Naburi, Helga; Lahey, Timothy; Nutt, Cameron T.; Kisenge, Rodrick; Noel, Gary J.; Spielberg, Stephen P.			Children's Medicines in Tanzania: A National Survey of Administration Practices and Preferences	PLOS ONE			English	Article							DEVELOPING-WORLD; PHARMACOLOGY; INITIATIVES; FORMULATION; ADHERENCE; HEALTH	Objective: The dearth of age-appropriate formulations of many medicines for children poses a major challenge to pediatric therapeutic practice, adherence, and health care delivery worldwide. We provide information on current administration practices of pediatric medicines and describe key stakeholder preferences for new formulation characteristics. Patients and Methods: We surveyed children aged 6-12 years, parents/caregivers over age 18 with children under age 12, and healthcare workers in 10 regions of Tanzania to determine current pediatric medicine prescription and administration practices as well as preferences for new formulations. Analyses were stratified by setting, pediatric age group, parent/caregiver education, and healthcare worker cadre. Results: Complete data were available for 206 children, 202 parents/caregivers, and 202 healthcare workers. Swallowing oral solid dosage forms whole or crushing/dissolving them and mixing with water were the two most frequently reported methods of administration. Children frequently reported disliking medication taste, and many had vomited doses. Healthcare workers reported medicine availability most significantly influences prescribing practices. Most parents/caregivers and children prefer sweet-tasting medicine. Parents/caregivers and healthcare workers prefer oral liquid dosage forms for young children, and had similar thresholds for the maximum number of oral solid dosage forms children at different ages can take. Conclusions: There are many impediments to acceptable and accurate administration of medicines to children. Current practices are associated with poor tolerability and the potential for under-or over-dosing. Children, parents/caregivers, and healthcare workers in Tanzania have clear preferences for tastes and formulations, which should inform the development, manufacturing, and marketing of pediatric medications for resource-limited settings.	[Adams, Lisa V.; Lahey, Timothy] Audrey & Theodor Geisel Sch Med Dartmouth, Hanover, NH USA; [Craig, Sienna R.] Dartmouth Coll, Hanover, NH 03755 USA; [Mmbaga, Elia John; Naburi, Helga; Kisenge, Rodrick] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Nutt, Cameron T.] Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH USA; [Noel, Gary J.] Inst Pediat Innovat, Cambridge, MA USA; [Noel, Gary J.] Weill Cornell Med Coll, New York, NY USA; [Noel, Gary J.] AstraZeneca, Waltham, MA USA; [Spielberg, Stephen P.] US FDA, Washington, DC 20204 USA	Dartmouth College; Muhimbili University of Health & Allied Sciences; Dartmouth College; Cornell University; AstraZeneca; US Food & Drug Administration (FDA)	Adams, LV (corresponding author), Audrey & Theodor Geisel Sch Med Dartmouth, Hanover, NH USA.	Lisa.V.Adams@Dartmouth.edu		Naburi, Helga/0000-0003-1659-5224	World Health Organization (WHO), Better Medicines for Children project	World Health Organization (WHO), Better Medicines for Children project	This research was supported by a grant from the World Health Organization (WHO) as part of the Better Medicines for Children project. The funders had no role in the data collection, decision to publish, or preparation of the manuscript. Technical advice on the study design and data analysis was provided by appropriate experts at WHO. The named authors alone are responsible for the views expressed in this publication.	Access to Medicine Foundation, 2010, ACC MED IND 2010; [Anonymous], SOURC PRIC SEL MED C; Ansah EK, 2001, TROP MED INT HEALTH, V6, P496, DOI 10.1046/j.1365-3156.2001.00740.x; Baguley D, 2012, ARCH DIS CHILD, V97, P293, DOI 10.1136/archdischild-2011-300909; Beggs SA, 2005, ARCH DIS CHILD, V90, P1091, DOI 10.1136/adc.2005.076703; Breitkreutz J., 1999, PAEDIAT PERINAT DRUG, V3, P25; Craig SR, 2009, SOC SCI MED, V69, P1681, DOI 10.1016/j.socscimed.2009.08.024; Gazarian Madlen, 2009, Paediatr Drugs, V11, P41; Hill S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038055; Hill SR, 2012, B WORLD HEALTH ORGAN, V90, P236, DOI 10.2471/BLT.11.088658; Hoppu K, 2008, EUR J CLIN PHARMACOL, V64, P201, DOI 10.1007/s00228-007-0390-5; Hoppu K, 2012, EUR J CLIN PHARMACOL, V68, P1, DOI 10.1007/s00228-011-1089-1; Hoppu K, 2011, ARCH DIS CHILD, V96, P764, DOI 10.1136/adc.2009.180000; Knoppert David C, 2009, Paediatr Drugs, V11, P55; MacLeod Stuart, 2007, Paediatr Drugs, V9, P215, DOI 10.2165/00148581-200709040-00002; Mennella JA, 2008, CLIN THER, V30, P2120, DOI 10.1016/j.clinthera.2008.11.018; Nahirya-Ntege P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036186; NOTTERMAN DA, 1986, PEDIATRICS, V77, P850; Nunn T, 2005, BRIT J CLIN PHARMACO, V59, P674, DOI 10.1111/j.1365-2125.2005.02410.x; Peacock G, 2010, J AM PHARM ASSOC, V50, P84, DOI 10.1331/JAPhA.2010.09006; Rodriguez W, 2008, PEDIATRICS, V121, P530, DOI 10.1542/peds.2007-1529; Sachs AN, 2012, JAMA-J AM MED ASSOC, V307, P1914, DOI 10.1001/jama.2012.3435; Taylor DM, 2009, J PAEDIATR CHILD H, V45, P304, DOI 10.1111/j.1440-1754.2008.01462.x; Teng Jaja, 2002, J Am Pharm Assoc (Wash), V42, P195; United Nations, 2012, CONC NOT EST UN COMM; United Nations Children's Fund, 2012, LEV TRENDS CHILD MOR; World Health Organization, 2012, WORLD HLTH STAT 2012; Zucker H, 2007, CLIN PHARMACOL THER, V82, P503, DOI 10.1038/sj.clpt.6100395	28	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58303	10.1371/journal.pone.0058303	http://dx.doi.org/10.1371/journal.pone.0058303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484012	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100102
J	Athreya, V; Odden, M; Linnell, JDC; Krishnaswamy, J; Karanth, U				Athreya, Vidya; Odden, Morten; Linnell, John D. C.; Krishnaswamy, Jagdish; Karanth, Ullas			Big Cats in Our Backyards: Persistence of Large Carnivores in a Human Dominated Landscape in India	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; LEOPARDS PANTHERA-PARDUS; HYENA-HYENA; HUMAN DENSITIES; PREY ABUNDANCE; NATIONAL-PARK; CAMERA-TRAPS; CONSERVATION; TIGER; POPULATION	Protected areas are extremely important for the long term viability of biodiversity in a densely populated country like India where land is a scarce resource. However, protected areas cover only 5% of the land area in India and in the case of large carnivores that range widely, human use landscapes will function as important habitats required for gene flow to occur between protected areas. In this study, we used photographic capture recapture analysis to assess the density of large carnivores in a human-dominated agricultural landscape with density >300 people/km(2) in western Maharashtra, India. We found evidence of a wide suite of wild carnivores inhabiting a cropland landscape devoid of wilderness and wild herbivore prey. Furthermore, the large carnivores; leopard (Panthera pardus) and striped hyaena (Hyaena hyaena) occurred at relatively high density of 4.8 +/- 1.2 (sd) adults/100 km(2) and 5.03 +/- 1.3 (sd) adults/100 km(2) respectively. This situation has never been reported before where 10 large carnivores/100 km(2) are sharing space with dense human populations in a completely modified landscape. Human attacks by leopards were rare despite a potentially volatile situation considering that the leopard has been involved in serious conflict, including human deaths in adjoining areas. The results of our work push the frontiers of our understanding of the adaptability of both, humans and wildlife to each other's presence. The results also highlight the urgent need to shift from a PA centric to a landscape level conservation approach, where issues are more complex, and the potential for conflict is also very high. It also highlights the need for a serious rethink of conservation policy, law and practice where the current management focus is restricted to wildlife inside Protected Areas.	[Athreya, Vidya; Karanth, Ullas] Ctr Wildlife Studies, Wildlife Conservat Soc India, Bangalore, Karnataka, India; [Odden, Morten] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Elverum, Norway; [Linnell, John D. C.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Krishnaswamy, Jagdish] Ashoka Trust Res Ecol & Environm, Bangalore, Karnataka, India	Inland Norway University of Applied Sciences; Norwegian Institute Nature Research	Athreya, V (corresponding author), Ctr Wildlife Studies, Wildlife Conservat Soc India, Bangalore, Karnataka, India.	vidya.athreya@gmail.com	Linnell, John/V-4177-2019	Linnell, John/0000-0002-8370-5633; Krishnaswamy, Jagdish/0000-0001-7985-0005	Kaplan Graduate Award; Norwegian Embassy; Norwegian Research Council; Maharashtra Forest Department	Kaplan Graduate Award; Norwegian Embassy; Norwegian Research Council(Research Council of NorwayEuropean Commission); Maharashtra Forest Department	The project was funded by a Kaplan Graduate Award (http://www.panthera.org/); a Norwegian Embassy and Norwegian Research Council grant (http://www.nina.no/ninaenglish/Researchprojects/HumanWildlifeConflicts.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Maharashtra Forest Department for their support. We would also like to thank the Centre for Wildlife Studies and the Asian Nature Conservation Foundation, Bangalore for institutional support and N. Samba Kumar and D. Jathanna for providing support for the camera trapping study and for useful discussions and advice.	Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Athreya Vidya R., 2007, Journal of the Bombay Natural History Society, V104, P45; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Banerjee K, 2010, ORYX, V44, P248, DOI 10.1017/S0030605309990949; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Breitenmoser U, 2005, CONSERV BIOL SER, V9, P49; BURNHAM KP, 1993, BIOMETRICS, V49, P1194, DOI 10.2307/2532261; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Carbone C, 2011, BIOL LETTERS, V7, P312, DOI 10.1098/rsbl.2010.0996; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Chauvenet ALM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028671; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gupta Shilpi, 2009, Journal of the Bombay Natural History Society, V106, P284; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Harihar A, 2010, MAMMALIA, V74, P83, DOI 10.1515/MAMM.2009.072; Harihar A, 2009, MAMMALIA, V73, P68, DOI 10.1515/MAMM.2009.007; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Henschel P, 2003, LEOPARDS AFRICAN RAI; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; JHALA YV, 1991, CONSERV BIOL, V5, P476, DOI 10.1111/j.1523-1739.1991.tb00354.x; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P241; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P145, DOI 10.1007/978-4-431-99495-4_9; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2005, CONSERV BIOL SER, V9, P373; Karanth KU, 1998, ECOLOGY, V79, P2852; Khorozyan IG, 2008, INTEGR ZOOL, V3, P322, DOI 10.1111/j.1749-4877.2008.00111.x; Kruuk H, 2003, HUNTER HUNTED; Linnell JDC, 2000, BIODIVERS CONSERV, V9, P857, DOI 10.1023/A:1008969104618; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Linnell JDC, 2001, ENVIRON MANAGE, V27, P869; Loveridge Andrew J., 2010, P283; Maddox T.M., 2003, ECOLOGY CHEETAHS OTH; MAEHR DS, 1990, CONSERV BIOL, V4, P167, DOI 10.1111/j.1523-1739.1990.tb00105.x; Mazzolli M, 2010, ENVIRON MANAGE, V46, P237, DOI 10.1007/s00267-010-9528-9; Mech D., 2003, WOLVES BEHAV ECOLOGY; Negroes N, 2011, BIODIVERS CONSERV, V20, P505, DOI 10.1007/s10531-010-9961-3; Nichols JD, 2002, MONITORING TIGERS TH, P139; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; Ramesh T., 2009, J SCI T ENV TECHN, V2, P170, DOI DOI 10.20894/STET.116.002.003.010; Rexstad E., 1992, USERS GUIDE INTERACT; Rosas-Rosas OC, 2010, CONSERV BIOL, V24, P366, DOI 10.1111/j.1523-1739.2009.01441.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; Singh P, 2010, J MAMMAL, V91, P1152, DOI 10.1644/09-MAMM-A-159.1; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; TERBORGH J, 1999, REQUIEM NATURE; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe Rosie, 2005, P154; Working Plan, 2010, WORK PLAN AHM FOR DI	67	210	228	8	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57872	10.1371/journal.pone.0057872	http://dx.doi.org/10.1371/journal.pone.0057872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483933	Green Published, gold			2022-12-25	WOS:000316936100049
J	Corbacho, J; Romojaro, F; Pech, JC; Latche, A; Gomez-Jimenez, MC				Corbacho, Jorge; Romojaro, Felix; Pech, Jean-Claude; Latche, Alain; Gomez-Jimenez, Maria C.			Transcriptomic Events Involved in Melon Mature-Fruit Abscission Comprise the Sequential Induction of Cell-Wall Degrading Genes Coupled to a Stimulation of Endo and Exocytosis	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; CUCUMIS-MELO; ETHYLENE BIOSYNTHESIS; DIFFERENTIAL EXPRESSION; SIGNALING PATHWAYS; ORGAN ABSCISSION; ARABIDOPSIS; AUXIN; ZONE; IDENTIFICATION	Background: Mature-fruit abscission (MFA) in fleshy-fruit is a genetically controlled process with mechanisms that, contrary to immature-fruit abscission, has not been fully characterized. Here, we use pyrosequencing to characterize the transcriptomes of melon abscission zone (AZ) at three stages during AZ-cell separation in order to understand MFA control at an early stage of AZ-activation. Principal Findings: The results show that by early induction of MFA, the melon AZ exhibits major gene induction, while by late induction of MFA, melon AZ shows major gene repression. Although some genes displayed similar regulation in both early and late induction of abscission, such as EXT1-EXT4, EGase1, IAA2, ERF1, AP2D15, FLC, MADS2, ERAF17, SAP5 and SCL13 genes, the majority had different expression patterns. This implies that time-specific events occur during MFA, and emphasizes the value of characterizing multiple time-specific abscission transcriptomes. Analysis of gene-expression from these AZs reveal that a sequential induction of cell-wall-degrading genes is associated with the upregulation of genes involved in endo and exocytosis, and a shift in plant-hormone metabolism and signaling genes during MFA. This is accompanied by transcriptional activity of small-GTPases and synthaxins together with tubulins, dynamins, V-type ATPases and kinesin-like proteins potentially involved in MFA signaling. Early events are potentially controlled by down-regulation of MADS-box, AP2/ERF and Aux/IAA transcription-factors, and up-regulation of homeobox, zinc finger, bZIP, and WRKY transcription-factors, while late events may be controlled by up-regulation of MYB transcription-factors. Significance: Overall, the data provide a comprehensive view on MFA in fleshy-fruit, identifying candidate genes and pathways associated with early induction of MFA. Our comprehensive gene-expression profile will be very useful for elucidating gene regulatory networks of the MFA in fleshy-fruit.	[Corbacho, Jorge; Gomez-Jimenez, Maria C.] Univ Extremadura, Dept Plant Physiol, Badajoz, Spain; [Romojaro, Felix] CEBAS CSIC, Murcia, Spain; [Pech, Jean-Claude; Latche, Alain] UMR990 INRA INP ENSA Toulouse, Castanet Tolosan, France	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); INRAE	Gomez-Jimenez, MC (corresponding author), Univ Extremadura, Dept Plant Physiol, Avda Elvas S-N, Badajoz, Spain.	mcgomez@unex.es	Gomez-Jimenez, Maria-Carmen/A-6875-2011	Gomez-Jimenez, Maria-Carmen/0000-0003-2977-5814; Corbacho Sanchez, Jorge/0000-0002-0745-3374	'Ministerio de Ciencia e Innovacion', Spain [BFU2010-18116]	'Ministerio de Ciencia e Innovacion', Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the 'Ministerio de Ciencia e Innovacion', Spain (BFU2010-18116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-127; Ayub R, 1996, NAT BIOTECHNOL, V14, P862, DOI 10.1038/nbt0796-862; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Burr CA, 2011, PLANT PHYSIOL, V156, P1837, DOI 10.1104/pp.111.175224; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; Dal Cin V, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-139; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214; Eduardo I, 2005, THEOR APPL GENET, V112, P139, DOI 10.1007/s00122-005-0116-y; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farrar K, 2003, PLANT J, V33, P61, DOI 10.1046/j.1365-313X.2003.01608.x; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gil-Amado JA, 2012, PLANTA, V235, P1221, DOI 10.1007/s00425-011-1570-1; Gomez-Cadenas A, 2000, PLANTA, V210, P636, DOI 10.1007/s004250050054; Gomez-Jimenez MC, 2010, J PLANT PHYSIOL, V167, P1432, DOI 10.1016/j.jplph.2010.05.020; Gonzalez-Carranza ZH, 2012, ANNU PLANT REV, V44, P243, DOI 10.1002/9781118223086.ch10; Gonzalo MJ, 2005, THEOR APPL GENET, V110, P802, DOI 10.1007/s00122-004-1814-6; Gudesblat GE, 2011, CURR OPIN PLANT BIOL, V14, P530, DOI 10.1016/j.pbi.2011.05.004; Guis M, 1997, J AM SOC HORTIC SCI, V122, P748, DOI 10.21273/JASHS.122.6.748; Haizel T, 1997, PLANT J, V11, P93, DOI 10.1046/j.1365-313X.1997.11010093.x; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Kuromori T, 2010, PLANT SIGNAL BEHAV, V5, P1124, DOI 10.4161/psb.5.9.12566; Lewis MW, 2010, PLANT J, V62, P817, DOI 10.1111/j.1365-313X.2010.04194.x; Leyman B, 2000, PLANT J, V24, P369, DOI 10.1046/j.1365-313x.2000.00886.x; Li JG, 2008, J PLANT GROWTH REGUL, V27, P283, DOI 10.1007/s00344-008-9055-6; Li JG, 2010, J AM SOC HORTIC SCI, V135, P391, DOI 10.21273/JASHS.135.5.391; Li P, 2009, EUR J PLANT PATHOL, V125, P533, DOI 10.1007/s10658-009-9501-8; Liljegren SJ, 2009, DEVELOPMENT, V136, P1909, DOI 10.1242/dev.033605; Liu L, 2004, EUPHYTICA, V135, P305, DOI 10.1023/B:EUPH.0000013330.66819.6f; Lycett G, 2008, J EXP BOT, V59, P4061, DOI 10.1093/jxb/ern255; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; Merkouropoulos G, 2003, PLANTA, V217, P356, DOI 10.1007/s00425-003-1002-y; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano R, 2003, PLANT PHYSIOL, V131, P276, DOI 10.1104/pp.010462; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Ophir R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-269; Parra-Lobato MC, 2011, J EXP BOT, V62, P4447, DOI 10.1093/jxb/err124; Pattison RJ, 2012, PLANT J, V70, P585, DOI 10.1111/j.1365-313X.2011.04895.x; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; Perin C, 2002, PLANT PHYSIOL, V129, P300, DOI 10.1104/pp.010613; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Portnoy V, 2011, PLANT GENOME-US, V4, P36, DOI 10.3835/plantgenome2010.11.0026; Rasori A, 2002, J EXP BOT, V53, P2333, DOI [10.1093/jxb/\\, 10.1093/jxb/\\|[ast ]\\|, 10.1093/jxb/erf097]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rose JKC, 1998, PLANT PHYSIOL, V117, P345, DOI 10.1104/pp.117.2.345; Ruperti B, 2002, J EXP BOT, V53, P429, DOI 10.1093/jexbot/53.368.429; Singh AP, 2011, J EXP BOT, V62, P5091, DOI 10.1093/jxb/err209; Skottke KR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001370; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tucker ML, 2007, J EXP BOT, V58, P3395, DOI 10.1093/jxb/erm188; van Leeuwen H, 2003, PLANT MOL BIOL, V51, P703, DOI 10.1023/A:1022573230486; Vandenbussche F, 2010, DEVELOPMENT, V137, P597, DOI 10.1242/dev.040790; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang X, 2006, PLANT PHYSIOL, V140, P91, DOI 10.1104/pp.105.071670; WEBSTER BD, 1975, J AM SOC HORTIC SCI, V100, P180; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Zang AP, 2010, J EXP BOT, V61, P777, DOI 10.1093/jxb/erp341; Zhu H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-138	66	61	62	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58363	10.1371/journal.pone.0058363	http://dx.doi.org/10.1371/journal.pone.0058363			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484021	gold, Green Submitted, Green Published			2022-12-25	WOS:000316936100111
J	De Cecco, L; Berardi, M; Sommariva, M; Cataldo, A; Canevari, S; Mezzanzanica, D; Iorio, MV; Tagliabue, E; Balsari, A				De Cecco, Loris; Berardi, Martina; Sommariva, Michele; Cataldo, Alessandra; Canevari, Silvana; Mezzanzanica, Delia; Iorio, Marilena V.; Tagliabue, Elda; Balsari, Andrea			Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; DNA-DAMAGE RESPONSE; OVARIAN-CANCER; IMMUNE-SYSTEM; TLR9 AGONISTS; REPAIR GENES; CELLS; EXPRESSION; TUMOR; RESISTANCE	We recently reported that peritumoral CpG-ODN treatment, activating TLR-9 expressing cells in tumor microenvironment, induces modulation of genes involved in DNA repair and sensitizes cancer cells to DNA-damaging cisplatin treatment. Here, we investigated whether this treatment induces modulation of miRNAs in tumor cells and their relevance to chemotherapy response. Array analysis identified 20 differentially expressed miRNAs in human IGROV-1 ovarian tumor cells from CpG-ODN-treated mice versus controls (16 down-and 4 up-regulated). Evaluation of the role of the 3 most differentially expressed miRNAs on sensitivity to cisplatin of IGROV-1 cells revealed significantly increased cisplatin cytotoxicity upon ectopic expression of hsa-miR-302b (up-modulated in our array), but no increased effect upon reduced expression of hsa-miR-424 or hsa-miR-340 (down-modulated in our array). Accordingly, hsa-miR-302b expression was significantly associated with time to relapse or overall survival in two data sets of platinum-treated ovarian cancer patients. Use of bio-informatics tools identified 19 mRNAs potentially targeted by hsa-miR-302b, including HDAC4 gene, which has been reported to mediate cisplatin sensitivity in ovarian cancer. Both HDAC4 mRNA and protein levels were significantly reduced in IGROV-1 cells overexpressing hsa-miR-302b. Altogether, these findings indicate that hsa-miR-302b acts as a "chemosensitizer" in human ovarian carcinoma cells and may represent a biomarker able to predict response to cisplatin treatment. Moreover, the identification of miRNAs that improve sensitivity to chemotherapy provides the experimental underpinning for their possible future clinical use.	[De Cecco, Loris] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Funct Genom Core Facil, Milan, Italy; [Berardi, Martina; Sommariva, Michele; Tagliabue, Elda; Balsari, Andrea] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Mol Targeting Unit, Milan, Italy; [Sommariva, Michele; Cataldo, Alessandra; Balsari, Andrea] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Canevari, Silvana; Mezzanzanica, Delia] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Mol Therapies Unit, Milan, Italy; [Iorio, Marilena V.] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Start Unit, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Balsari, A (corresponding author), Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Mol Targeting Unit, Milan, Italy.	andrea.balsari@unimi.it	Mezzanzanica, Delia/C-2607-2017; Cataldo, Alessandra/C-6204-2017; Iorio, Marilena V/K-5446-2016; Sommariva, Michele/C-1174-2017; balsari, andrea/M-5657-2016; De Cecco, Loris/K-7036-2016; Tagliabue, Elda/B-9377-2017	Mezzanzanica, Delia/0000-0002-9664-6871; Cataldo, Alessandra/0000-0002-1882-9410; Iorio, Marilena V/0000-0002-6058-1527; Sommariva, Michele/0000-0002-7622-0996; balsari, andrea/0000-0002-3250-2668; De Cecco, Loris/0000-0002-7066-473X; Tagliabue, Elda/0000-0001-9877-2903	Associazione Italiana per la Ricerca sul Cancro (AIRC); "Dote ricerca": FSE, Regione Lombardia; Start Up AIRC Grant	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); "Dote ricerca": FSE, Regione Lombardia(Regione Lombardia); Start Up AIRC Grant(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC). MS was supported by "Dote ricerca": FSE, Regione Lombardia. MVI is supported by Start Up AIRC Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Bagnoli M, 2011, ONCOTARGET, V2, P1265, DOI 10.18632/oncotarget.401; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENARD J, 1985, CANCER RES, V45, P4970; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; De Cesare M, 2008, CLIN CANCER RES, V14, P5512, DOI 10.1158/1078-0432.CCR-08-0445; Dolezalova D, 2012, STEM CELLS, V30, P1362, DOI 10.1002/stem.1108; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Jackson AL, 2012, NUCLEIC ACID THER, V22, P213, DOI 10.1089/nat.2012.0356; Jin KL, 2010, J GYNECOL ONCOL, V21, P262, DOI 10.3802/jgo.2010.21.4.262; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Krieg Arthur M, 2007, Proc Am Thorac Soc, V4, P289, DOI 10.1513/pats.200701-021AW; Landau DA, 2011, SEMIN ONCOL, V38, P743, DOI 10.1053/j.seminoncol.2011.08.003; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ozaki K, 2008, CANCER SCI, V99, P376, DOI 10.1111/j.1349-7006.2007.00669.x; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shih KK, 2011, GYNECOL ONCOL, V121, P444, DOI 10.1016/j.ygyno.2011.01.025; Sommariva M, 2012, ONCOIMMUNOLOGY, V1, P258, DOI 10.4161/onci.1.2.18343; Sommariva M, 2011, CANCER RES, V71, P6382, DOI 10.1158/0008-5472.CAN-11-1285; Stiborova M, 2012, CURR MED CHEM; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Thurn KT, 2011, FUTURE ONCOL, V7, P263, DOI 10.2217/FON.11.2; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34	39	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58849	10.1371/journal.pone.0058849	http://dx.doi.org/10.1371/journal.pone.0058849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484053	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100139
J	de Graaf, M; Herfst, S; Aarbiou, J; Burgers, PC; Zaaraoui-Boutahar, F; Bijl, M; van IJcken, W; Schrauwen, EJA; Osterhaus, ADME; Luider, TM; Scholte, BJ; Fouchier, RAM; Andeweg, AC				de Graaf, Miranda; Herfst, Sander; Aarbiou, Jamil; Burgers, Peter C.; Zaaraoui-Boutahar, Fatiha; Bijl, Maarten; van IJcken, Wilfred; Schrauwen, Eefje J. A.; Osterhaus, Albert D. M. E.; Luider, Theo M.; Scholte, Bob J.; Fouchier, Ron A. M.; Andeweg, Arno C.			Small Hydrophobic Protein of Human Metapneumovirus Does Not Affect Virus Replication and Host Gene Expression In Vitro	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; AIRWAY EPITHELIAL-CELLS; SH GENE; G-GLYCOPROTEIN; INFECTION; TRANSCRIPTION; DELETION; LACKING; TRACT; NS2	Human metapneumovirus (HMPV) encodes a small hydrophobic (SH) protein of unknown function. HMPV from which the SH open reading frame was deleted (HMPV Delta SH) was viable and displayed similar replication kinetics, cytopathic effect and plaque size compared with wild type HMPV in several cell-lines. In addition, no differences were observed in infection efficiency or cell-to-cell spreading in human primary bronchial epithelial cells (HPBEC) cultured at an air-liquid interphase. Host gene expression was analyzed in A549 cells infected with HMPV or HMPV Delta SH using microarrays and mass spectrometry (MS) based techniques at multiple time points post infection. Only minor differences were observed in mRNA or protein expression levels. A possible function of HMPV SH as apoptosis blocker, as proposed for several members of the family Paramyxoviridae, was rejected based on this analysis. So far, a clear phenotype of HMPV SH deletion mutants in vitro at the virus and host levels is absent.	[de Graaf, Miranda; Herfst, Sander; Zaaraoui-Boutahar, Fatiha; Bijl, Maarten; Schrauwen, Eefje J. A.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Andeweg, Arno C.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Aarbiou, Jamil; Scholte, Bob J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Burgers, Peter C.; Luider, Theo M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [van IJcken, Wilfred] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [de Graaf, Miranda] Univ Cambridge, Dept Zool, Cambridge, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Cambridge	Andeweg, AC (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	a.andeweg@erasmusmc.nl	van ijcken, willem/N-9805-2018; de Graaf, Miranda/K-1262-2018; de Graaf, Miranda/AFM-6878-2022; Fouchier, Ron A/A-1911-2014	van ijcken, willem/0000-0002-0421-8301; de Graaf, Miranda/0000-0002-7831-0098; de Graaf, Miranda/0000-0002-7831-0098; Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172; Herfst, Sander/0000-0001-9866-8903	MedImmune Vaccines, Inc.; European Union; Virgo consortium	MedImmune Vaccines, Inc.(AstraZenecaMedimmune); European Union(European Commission); Virgo consortium	This work was sponsored by MedImmune Vaccines, Inc., framework five grant "Hammocsa" ''from the European Union, the Virgo consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative (BSIK 03012), Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao X, 2008, VIROLOGY, V374, P114, DOI 10.1016/j.virol.2007.12.024; Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biacchesi S, 2005, J VIROL, V79, P12608, DOI 10.1128/JVI.79.19.12608-12613.2005; Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Biacchesi S, 2007, J VIROL, V81, P6057, DOI 10.1128/JVI.00128-07; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Buchholz UJ, 2005, J VIROL, V79, P6588, DOI 10.1128/JVI.79.11.6588-6597.2005; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Bukreyev A, 1997, J VIROL, V71, P8973, DOI 10.1128/JVI.71.12.8973-8982.1997; de Graaf M, 2007, J VIROL METHODS, V143, P169, DOI 10.1016/j.jviromet.2007.03.005; Dekker LJ, 2007, J CHROMATOGR B, V847, P62, DOI 10.1016/j.jchromb.2006.08.031; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; He B, 2001, J VIROL, V75, P4068, DOI 10.1128/JVI.75.9.4068-4079.2001; Herfst S, 2004, J VIROL, V78, P8264, DOI 10.1128/JVI.78.15.8264-8270.2004; Herfst S, 2008, J GEN VIROL, V89, P1553, DOI 10.1099/vir.0.2008/002022-0; Jin H, 2000, VIROLOGY, V273, P210, DOI 10.1006/viro.2000.0393; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Lin YA, 2003, J VIROL, V77, P3371, DOI 10.1128/JVI.77.6.3371-3383.2003; Mustafa DAN, 2007, MOL CELL PROTEOMICS, V6, P1147, DOI 10.1074/mcp.M600295-MCP200; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perez M, 1997, VIROLOGY, V235, P342, DOI 10.1006/viro.1997.8696; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Skiba M, 2008, J VIROL, V82, P9689, DOI 10.1128/JVI.00995-08; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Teng MN, 2001, VIROLOGY, V289, P283, DOI 10.1006/viro.2001.1138; Titulaer MK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-403; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2004, EMERG INFECT DIS, V10, P658, DOI 10.3201/eid1004.030393; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van Wetering S, 2007, MOL IMMUNOL, V44, P803, DOI 10.1016/j.molimm.2006.04.008; Wang J, 2012, J BIOL CHEM; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wilson RL, 2006, J VIROL, V80, P1700, DOI 10.1128/JVI.80.4.1700-1709.2006; Yunus AS, 2003, VIRUS RES, V93, P91, DOI 10.1016/S0168-1702(03)00074-1; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58572	10.1371/journal.pone.0058572	http://dx.doi.org/10.1371/journal.pone.0058572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484037	gold, Green Submitted, Green Published			2022-12-25	WOS:000316936100125
J	Wu, ZL; MacNeil, AJ; Berman, JN; Lin, TJ				Wu, Zhengli; MacNeil, Adam J.; Berman, Jason N.; Lin, Tong-Jun			Syntaxin Binding Protein 1 Is Not Required for Allergic Inflammation via IgE-Mediated Mast Cell Activation	PLOS ONE			English	Article							STXBP1 MUTATIONS; MUNC18-1 BINDING; VESICLE DOCKING; MEMBRANE-FUSION; IL-4 PRODUCTION; RAT-BRAIN; KINASE-C; EXOCYTOSIS; DEGRANULATION; PHOSPHORYLATION	Mast cells play a central role in both innate and acquired immunity. When activated by IgE-dependent Fc epsilon RI cross-linking, mast cells rapidly initiate a signaling cascade and undergo an extensive release of their granule contents, including inflammatory mediators. Some SNARE ( soluble N-ethylmaleimide-sensitive fusion factor attachment protein receptor) proteins and SM (Sec1/Munc18) family proteins are involved in mast cell degranulation. However, the function of syntaxin binding protein 1 (STXBP1), a member of SM family, in mast cell degranulation is currently unknown. In this study, we examined the role of STXBP1 in IgE-dependent mast cell activation. Liver-derived mast cells (LMCs) from wild-type and STXBP1-deficient mice were cultured in vitro for the study of mast cell maturation, degranulation, cytokine and chemokine production, as well as MAPK, I kappa B-NF kappa B, and NFAT signaling pathways. In addition, in vivo models of passive cutaneous anaphylaxis and late-phase IgE-dependent inflammation were conducted in mast cell deficient W (sh) mice that had been reconstituted with wild-type or STXBP1-deficient mast cells. Our findings indicate that STXBP1 is not required for any of these important functional mechanisms in mast cells both in vitro and in vivo. Our results demonstrate that STXBP1 is dispensable during IgE-mediated mast cell activation and in IgE-dependent allergic inflammatory reactions.	[Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; IWK Hlth Ctr, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Lin, TJ (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	tong-jun.lin@dal.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; Bax HJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00229; Broeke JHP, 2010, BIOL CELL, V102, P479, DOI 10.1042/BC20100036; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Craig TJ, 2003, J NEUROCHEM, V86, P1450, DOI 10.1046/j.1471-4159.2003.01955.x; de Vries KJ, 2000, EUR J NEUROSCI, V12, P385, DOI 10.1046/j.1460-9568.2000.00931.x; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Deprez L, 2010, NEUROLOGY, V75, P1159, DOI 10.1212/WNL.0b013e3181f4d7bf; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dong YM, 2007, BIOCHEM BIOPH RES CO, V360, P609, DOI 10.1016/j.bbrc.2007.06.107; Endo S, 2011, CELL IMMUNOL, V271, P488, DOI 10.1016/j.cellimm.2011.08.019; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hamdan FF, 2009, ANN NEUROL, V65, P748, DOI 10.1002/ana.21625; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Li B, 2006, BLOOD, V107, P2814, DOI 10.1182/blood-2005-09-3610; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; MacNeil AJ, 2011, J IMMUNOL, V187, P3374, DOI 10.4049/jimmunol.1003126; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nanamori M, 2007, J IMMUNOL, V178, P416, DOI 10.4049/jimmunol.178.1.416; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Nigam R, 2005, BBA-GENE STRUCT EXPR, V1728, P77, DOI 10.1016/j.bbaexp.2005.01.018; Otsuka M, 2010, EPILEPSIA, V51, P2449, DOI 10.1111/j.1528-1167.2010.02767.x; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Quackenbush EJ, 1998, BLOOD, V92, P1887, DOI 10.1182/blood.V92.6.1887.418k17_1887_1897; Saitsu H, 2011, CLIN GENET, V80, P484, DOI 10.1111/j.1399-0004.2010.01575.x; Saitsu H, 2012, JASPERS BASIC MECH E, P1; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; Sharma VM, 2005, NEUROCHEM INT, V47, P225, DOI 10.1016/j.neuint.2005.01.005; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Suzuki Y, 2009, MOL IMMUNOL, V46, P2200, DOI 10.1016/j.molimm.2009.04.013; Tkaczyk C, 2002, MOL IMMUNOL, V38, P1289, DOI 10.1016/S0161-5890(02)00077-9; Vercelli D, 2005, J ALLERGY CLIN IMMUN, V116, P60, DOI 10.1016/j.jaci.2005.04.031; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Yang YJ, 2008, J BIOL CHEM, V283, P32110, DOI 10.1074/jbc.M802610200; Yang YJ, 2009, J EXP MED, V206, P195, DOI 10.1084/jem.20081140	50	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58560	10.1371/journal.pone.0058560	http://dx.doi.org/10.1371/journal.pone.0058560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484036	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100124
J	Liu, XY; He, YL; Xiao, K; White, JR; Fusco, DN; Papanicolaou, GA				Liu, Xinyan; He, Yaling; Xiao, Kun; White, Julie R.; Fusco, Dahlene N.; Papanicolaou, Genovefa A.			Effect of Linezolid on Clinical Severity and Pulmonary Cytokines in a Murine Model of Influenza A and Staphylococcus aureus Coinfection	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; COMBINATION ANTIBIOTIC-THERAPY; INTERFERON-GAMMA; NOSOCOMIAL PNEUMONIA; BACTERIAL PNEUMONIA; VIRUS-INFECTION; UNITED-STATES; MORTALITY; CELLS; IL-10	Excessive inflammation contributes to the severity of post influenza pneumonia caused by methicillin resistant S. aureus (MRSA). Linezolid, vancomycin, and clindamycin are antibiotics used for MRSA infections. Linezolid has immunomodulatory properties. We report on the effects of the three antibiotics on microbial clearance, pulmonary cytokines and clinical course in a murine model of influenza and MRSA coinfection. Methods: B6 mice were infected with influenza A virus and 3 days later with MRSA, both intranasally. Treatment with placebo, linezolid, vancomycin or clindamycin started immediately after MRSA infection and continued for 72 hours. Bacterial and viral titers as well as cytokine concentrations in the lungs were assessed 4 and 24 hours after MRSA coinfection. Mice were weighted daily for 13 days. Results: Coinfected mice had increased pulmonary IL-1 beta, TNF-alpha and mKC at 4 and 24 hours, IL-6, IL-10 and IL-12 at 4 hours and IFN-gamma at 24 hours after MRSA coinfection (all P<0.05). Compared to placebo, coinfected mice treated with linezolid, vancomycin or clindamycin had decreased pulmonary IL-6 and mKC at 4 hours and IFN-gamma at 24 hours after MRSA coinfection (all P<0.05). IL-1 beta, TNF-alpha and IL-12 were similar in antibiotic-treated and placebo groups. All antibiotics similarly reduced MRSA without effect on influenza titers. Linezolid-treated mice had less weight loss on days 4-6 after influenza infection compared to placebo (all P, 0.05). On all other days weight change was similar among all groups. Conclusions: This is the first report comparing the effects of antibiotics on cytokines and clinical outcome in a murine model of influenza and MRSA coinfection. Compared to placebo, antibiotic treatment reduced maximum concentration of IL-6, mKC and IFN-gamma in the lungs without any difference among antibiotics. During treatment, only linezolid delayed weight loss compared to placebo.	[Liu, Xinyan; He, Yaling; Xiao, Kun; Fusco, Dahlene N.; Papanicolaou, Genovefa A.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA; [White, Julie R.] Mem Sloan Kettering Canc Ctr, Lab Comparat Pathol, New York, NY 10021 USA; [Fusco, Dahlene N.; Papanicolaou, Genovefa A.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Papanicolaou, GA (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA.	papanicg@mskcc.org		Xiao, Kun/0000-0001-9373-7084; Papanicolaou, Genovefa/0000-0002-2891-079X	Pfizer, Inc; Weill Cornell Medical College Clinical and Translational Science Center; NIH [UL1 RR024996]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER	Pfizer, Inc(Pfizer); Weill Cornell Medical College Clinical and Translational Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a research grant from Pfizer, Inc (GAP) and a Pilot Award from the Weill Cornell Medical College Clinical and Translational Science Center, NIH Award Number UL1 RR024996 (GAP, DNF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Clinical and Translational Science Center, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aoki Naoko, 2004, Expert Opin Emerg Drugs, V9, P223, DOI 10.1517/14728214.9.2.223; Baddour LM, 2004, AM J RESP CRIT CARE, V170, P440, DOI 10.1164/rccm.200311-1578OC; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; Barman TK, 2009, INT J ANTIMICROB AG, V33, P280, DOI 10.1016/j.ijantimicag.2008.08.025; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Danin J, 2003, ORAL SURG ORAL MED O, V96, P492, DOI 10.1016/S1079-2104(03)00059-3; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Fusco D, 2010, VACCINE, V28, P3956, DOI 10.1016/j.vaccine.2010.03.047; Garcia-Roca P, 2006, ARCH MED RES, V37, P31, DOI 10.1016/j.arcmed.2005.05.022; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; HENNET T, 1992, J IMMUNOL, V149, P932; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Karlstrom A, 2009, J INFECT DIS, V199, P311, DOI 10.1086/596051; Leach KL, 2011, ANN NY ACAD SCI, V1222, P49, DOI 10.1111/j.1749-6632.2011.05962.x; Lee MH, 2010, J INFECT DIS, V201, P508, DOI 10.1086/650204; Lijek RS, 2012, CURR OPIN IMMUNOL, V24, P417, DOI 10.1016/j.coi.2012.05.005; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; MARKS JD, 1990, AM REV RESPIR DIS, V141, P94, DOI 10.1164/ajrccm/141.1.94; Martinez FJ, 2004, CLIN INFECT DIS, V38, pS328, DOI 10.1086/382689; Mufson MA, 2006, CLIN INFECT DIS, V42, P304, DOI 10.1086/499110; Murray RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008705; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nguyen JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031006; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pogue M., 2007, Morbidity and Mortality Weekly Report, V56, P325; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tessier PR, 2012, ANTIMICROB AGENTS CH, V56, P2342, DOI 10.1128/AAC.06427-11; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; van der Sluijs KF, 2010, CRIT CARE, V14, DOI 10.1186/cc8893; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Welshman IR, 2001, BIOPHARM DRUG DISPOS, V22, P91, DOI 10.1002/bdd.255; Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378/chest.124.5.1789; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC; Yao L, 1997, INFECT IMMUN, V65, P3889, DOI 10.1128/IAI.65.9.3889-3895.1997; Zhao YX, 1998, IMMUNOLOGY, V93, P80	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57483	10.1371/journal.pone.0057483	http://dx.doi.org/10.1371/journal.pone.0057483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23478252	Green Submitted, Green Published, gold			2022-12-25	WOS:000315637900025
J	Bignone, PA; Krupa, RA; Sternberg, H; Funk, WD; Snyder, EY; West, MD; Larocca, D				Bignone, Paola A.; Krupa, Rachel A.; Sternberg, Hal; Funk, Walter D.; Snyder, Evan Y.; West, Michael D.; Larocca, David			Identification of Human Embryonic Progenitor Cell Targeting Peptides Using Phage Display	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS	Human pluripotent stem (hPS) cells are capable of differentiation into derivatives of all three primary embryonic germ layers and can self-renew indefinitely. They therefore offer a potentially scalable source of replacement cells to treat a variety of degenerative diseases. The ability to reprogram adult cells to induced pluripotent stem (iPS) cells has now enabled the possibility of patient-specific hPS cells as a source of cells for disease modeling, drug discovery, and potentially, cell replacement therapies. While reprogramming technology has dramatically increased the availability of normal and diseased hPS cell lines for basic research, a major bottleneck is the critical unmet need for more efficient methods of deriving well-defined cell populations from hPS cells. Phage display is a powerful method for selecting affinity ligands that could be used for identifying and potentially purifying a variety of cell types derived from hPS cells. However, identification of specific progenitor cell-binding peptides using phage display may be hindered by the large cellular heterogeneity present in differentiating hPS cell populations. We therefore tested the hypothesis that peptides selected for their ability to bind a clonal cell line derived from hPS cells would bind early progenitor cell types emerging from differentiating hPS cells. The human embryonic stem (hES) cell-derived embryonic progenitor cell line, W10, was used and cell-targeting peptides were identified. Competition studies demonstrated specificity of peptide binding to the target cell surface. Efficient peptide targeted cell labeling was accomplished using multivalent peptide-quantum dot complexes as detected by fluorescence microscopy and flow cytometry. The cell-binding peptides were selective for differentiated hPS cells, had little or no binding on pluripotent cells, but preferential binding to certain embryonic progenitor cell lines and early endodermal hPS cell derivatives. Taken together these data suggest that selection of phage display libraries against a clonal progenitor stem cell population can be used to identify progenitor stem cell targeting peptides. The peptides may be useful for monitoring hPS cell differentiation and for the development of cell enrichment procedures to improve the efficiency of directed differentiation toward clinically relevant human cell types.	[Bignone, Paola A.; Krupa, Rachel A.; Larocca, David] Mandala Biosci LLC, San Diego, CA USA; [Sternberg, Hal; Funk, Walter D.; West, Michael D.] BioTime Inc, Alameda, CA USA; [Snyder, Evan Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Larocca, D (corresponding author), Mandala Biosci LLC, San Diego, CA USA.	dlarocca@mandalabio.com		Larocca, Dana/0000-0001-5863-9833; West, Michael/0000-0002-4842-5468; Bignone, Paola/0000-0003-2296-7039	California Institute for Regenerative Medicine (CIRM) [TR1-1276]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	The research was made possible by a grant from the California Institute for Regenerative Medicine (CIRM Grant Number TR1-1276). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of CIRM or any other agency of the State of California. CIRM had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanpain C, 2012, NAT REV MOL CELL BIO, V13, P471, DOI 10.1038/nrm3371; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Grutzkau A, 2010, CYTOM PART A, V77A, P643, DOI 10.1002/cyto.a.20918; Holig P, 2004, PROTEIN ENG DES SEL, V17, P433, DOI 10.1093/protein/gzh055; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Laposa RR, 2011, J CARDIOVASC PHARM, V58, P240, DOI 10.1097/FJC.0b013e31821823f5; Leonardo TR, 2012, HUMAN STEM CELL MANU, P3; Lin S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-67; Lu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012075; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Nakagawa M, 2010, ADV EXP MED BIOL, V695, P215, DOI 10.1007/978-1-4419-7037-4_14; Nelson TJ, 2010, STEM CELLS CLONING, V3, P29; Rasmussen UB, 2002, CANCER GENE THER, V9, P606, DOI 10.1038/sj.cgt.7700476; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; Spear MA, 2001, CANCER GENE THER, V8, P506, DOI 10.1038/sj.cgt.7700334; Sternberg H, 2012, REGEN MED, V7, P481, DOI [10.2217/RME.12.29, 10.2217/rme.12.29]; Teesalu T, 2012, METHOD ENZYMOL, V503, P35, DOI 10.1016/B978-0-12-396962-0.00002-1; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; West MD, 2008, REGEN MED, V3, P287, DOI 10.2217/17460751.3.3.287; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhao SJ, 2010, PEPTIDES, V31, P2027, DOI 10.1016/j.peptides.2010.08.004; Zhao WX, 2010, J BIOMOL SCREEN, V15, P687, DOI 10.1177/1087057110370997	24	8	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58200	10.1371/journal.pone.0058200	http://dx.doi.org/10.1371/journal.pone.0058200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483995	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900076
J	Jozefkowicz, C; Rosi, P; Sigaut, L; Soto, G; Pietrasanta, LI; Amodeo, G; Alleva, K				Jozefkowicz, Cintia; Rosi, Pablo; Sigaut, Lorena; Soto, Gabriela; Isabel Pietrasanta, Lia; Amodeo, Gabriela; Alleva, Karina			Loop A Is Critical for the Functional Interaction of Two Beta vulgaris PIP Aquaporins	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; XENOPUS OOCYTES; WATER TRANSPORT; PROTEIN; STRESS; IDENTIFICATION; EXPRESSION; EVOLUTION; CHANNELS; RESIDUE	Research done in the last years strongly support the hypothesis that PIP aquaporin can form heterooligomeric assemblies, specially combining PIP2 monomers with PIP1 monomers. Nevertheless, the structural elements involved in the ruling of homo versus heterooligomeric organization are not completely elucidated. In this work we unveil some features of monomer-monomer interaction in Beta vulgaris PIP aquaporins. Our results show that while BvPIP2;2 is able to interact with BvPIP1;1, BvPIP2;1 shows no functional interaction. The lack of functional interaction between BvPIP2;1 and BvPIP1;1 was further corroborated by dose-response curves of water permeability due to aquaporin activity exposed to different acidic conditions. We also found that BvPIP2;1 is unable to translocate BvPIP1;1-ECFP from an intracellular position to the plasma membrane when co-expressed, as BvPIP2;2 does. Moreover we postulate that the first extracellular loop (loop A) of BvPIP2;1, could be relevant for the functional interaction with BvPIP1;1. Thus, we investigate BvPIP2;1 loop A at an atomic level by Molecular Dynamics Simulation (MDS) and by direct mutagenesis. We found that, within the tetramer, each loop A presents a dissimilar behavior. Besides, BvPIP2;1 loop A mutants restore functional interaction with BvPIP1;1. This work is a contribution to unravel how PIP2 and PIP1 interact to form functional heterooligomeric assemblies. We postulate that BvPIP2;1 loop A is relevant for the lack of functional interaction with BvPIP1;1 and that the monomer composition of PIP assemblies determines their functional properties.	[Jozefkowicz, Cintia; Amodeo, Gabriela; Alleva, Karina] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Rosi, Pablo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Quim Fis Mat Medio Ambiente & Energia INQUIM, Buenos Aires, DF, Argentina; [Sigaut, Lorena; Isabel Pietrasanta, Lia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Ctr Microscopi Avanzadas CMA, Buenos Aires, DF, Argentina; [Sigaut, Lorena; Isabel Pietrasanta, Lia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Buenos Aires, DF, Argentina; [Soto, Gabriela] INTA, Inst Genet Ewald A Favret, CICVyA, Castelar, Argentina; [Jozefkowicz, Cintia; Rosi, Pablo; Sigaut, Lorena; Soto, Gabriela; Isabel Pietrasanta, Lia; Amodeo, Gabriela; Alleva, Karina] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Alleva, K (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina.	karina.alleva@bg.fcen.uba.ar	ALLEVA, KARINA/F-2577-2016	ALLEVA, KARINA/0000-0002-9081-2103; PIETRASANTA, LIA/0000-0002-2714-3162; Soto, Gabriela/0000-0002-3492-1268; Jozefkowicz, Cintia/0000-0001-8982-5698; Sigaut, Lorena/0000-0001-9417-9600	Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia) [2010-02042, 2007-655, 0457]; PIP (Proyecto de Investigacion Plurianual) [0190]; UBACyT (Programacion Cientifica de la Universidad de Buenos Aires) [2010-2012 659, 2010-2012 164]	Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia); PIP (Proyecto de Investigacion Plurianual); UBACyT (Programacion Cientifica de la Universidad de Buenos Aires)	Grants to KA: Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia) 2010-02042, PIP (Proyecto de Investigacion Plurianual) 0190, UBACyT (Programacion Cientifica de la Universidad de Buenos Aires)2010-2012 659. Grants to GA: Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia) 2007-655. Grants to LIP: Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia) 0457, UBACyT (Programacion Cientifica de la Universidad de Buenos Aires) 2010-2012 164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 1999, Methods Enzymol, V294, P550; Alleva K, 2006, J EXP BOT, V57, P609, DOI 10.1093/jxb/erj046; Alleva K, 2010, J EXP BOT, V61, P3935, DOI 10.1093/jxb/erq210; Alleva K, 2009, EUR BIOPHYS J BIOPHY, V38, P175, DOI 10.1007/s00249-008-0365-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ayadi M, 2011, PLANT PHYSIOL BIOCH, V49, P1029, DOI 10.1016/j.plaphy.2011.06.002; Barone LM, 1998, PLANT PHYSIOL, V118, P315, DOI 10.1104/pp.118.1.315; Bellati J, 2010, PLANT MOL BIOL, V74, P105, DOI 10.1007/s11103-010-9658-8; Betts MJ, 1999, PROTEIN ENG, V12, P271, DOI 10.1093/protein/12.4.271; Bienert GP, 2012, BIOCHEM J, V445, P101, DOI 10.1042/BJ20111704; Brooks JM, 2003, DEV BIOL, V261, P353, DOI 10.1016/S0012-1606(03)00301-4; Case D.A., 2022, AMBER 2020; Cavez D, 2009, PLANT SIGNAL BEHAV, V4, P890, DOI 10.4161/psb.4.9.9484; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fujiyoshi Y, 2002, CURR OPIN STRUC BIOL, V12, P509, DOI 10.1016/S0959-440X(02)00355-X; Hayward S, 2010, BIOPHYS J, V98, P1976, DOI 10.1016/j.bpj.2010.01.017; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Khandelia H, 2009, J PHYS CHEM B, V113, P5239, DOI 10.1021/jp809152c; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Matsumoto T, 2009, PLANT CELL PHYSIOL, V50, P216, DOI 10.1093/pcp/pcn190; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Otto B, 2010, J BIOL CHEM, V285, P31253, DOI 10.1074/jbc.M110.115881; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shi LB, 1996, BIOCHEMISTRY-US, V35, P538, DOI 10.1021/bi9520038; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Soto G, 2012, GENE, V503, P165, DOI 10.1016/j.gene.2012.04.021; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104; ZHANG R, 1991, AM J PHYSIOL, V260, pC26, DOI 10.1152/ajpcell.1991.260.1.C26; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x	43	31	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57993	10.1371/journal.pone.0057993	http://dx.doi.org/10.1371/journal.pone.0057993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483963	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900063
J	Ma, GL; Li, YF; Zhang, J; Liu, H; Hou, DY; Zhu, L; Zhang, ZY; Zhang, L				Ma, Guiling; Li, Yanfang; Zhang, Juan; Liu, Hao; Hou, Dongyan; Zhu, Lei; Zhang, Zhenyu; Zhang, Lin			Association between the Presence of Autoantibodies against Adrenoreceptors and Severe Pre-Eclampsia: A Pilot Study	PLOS ONE			English	Article							RECEPTOR AGONISTIC ANTIBODIES; PROTEIN; CELLS; CDNA; CLONING; GENE	Background: Pre-eclampsia is the leading cause of maternal and neonatal morbidity and mortality with incompletely understood etiopathogenesis. The purpose of the current study is to determine whether there is a relationship between the presence of autoantibodies against beta(1), beta(2) and alpha(1) adrenoreceptors and severe pre-eclampsia. Methodology/Principal Findings: Synthetic peptides corresponding to amino acid sequences of the second extracellular loops of beta(1), beta(2) and alpha(1) adrenoreceptors were synthesized as antigens to test 34 patients with severe pre-eclampsia, 36 normal pregnancy women and 40 non-pregnant controls for the presence of autoantibodies using enzyme-linked immunosorbent assay. The respective frequencies of autoantibodies against beta(1), beta(2) and alpha(1) adrenoreceptors were 50.0% (17/34), 52.9% (18/34) and 55.9% (19/34) in patients with severe pre-eclampsia, 19.4% (7/36) (p = 0.011), 19.4% (7/36) (p = 0.006) and 17.6% (6/36) (p = 0.001) in normal pregnancy women and 10% (4/40), 7.5% (3/40) and 10% (4/40) (p, 0.001) in non-pregnant controls. Titers of these autoantibodies were also significantly increased in patients with severe pre-eclampsia. By logistic regression analysis, the presence of these three autoantibodies significantly increased the risk of neonatal death (odds ratio, 13.5; 95% confidence interval, 1.3-141.3; p = 0.030) and long-term neonatal hospitalization (odds ratio, 5.0; 95% confidence interval, 1.3-19.1; p = 0.018). The risk of hypertension and fetal distress were also associated with the presence of these three autoantibodies. Conclusions/Significance: This novel pilot study demonstrated for the first time that the presence of autoantibodies against beta(1), beta(2) and alpha(1) adrenoreceptors are increased in patients with severe pre-eclampsia. Pregnant women who are positive for the three autoantibodies are at increased risks of neonatal mortality and morbidity. We posit that these autoantibodies may be involved in the pathogenesis of severe pre-eclampsia.	[Ma, Guiling; Zhang, Juan; Hou, Dongyan; Zhang, Lin] Capital Med Univ, Ctr Heart, Chao Yang Hosp, Beijing, Peoples R China; [Li, Yanfang; Liu, Hao; Zhu, Lei; Zhang, Zhenyu] Capital Med Univ, Dept Obstet & Gynaecol, Chao Yang Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, ZY (corresponding author), Capital Med Univ, Dept Obstet & Gynaecol, Chao Yang Hosp, Beijing, Peoples R China.	cyzhangzhenyu@sina.com; linzhangpeking@hotmail.com	Zhang, Juan/GRX-2638-2022; li, yan/GTI-4638-2022		Natural Science Foundation of China [30971236, 81250011]; Beijing Natural Science Foundation project [7102058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation project(Beijing Natural Science Foundation)	This study was funded by the Natural Science Foundation of China (30971236, 81250011) and Beijing Natural Science Foundation project (7102058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APGAR V, 1953, Curr Res Anesth Analg, V32, P260; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bobst SM, 2005, AM J HYPERTENS, V18, P330, DOI 10.1016/j.amjhyper.2004.10.002; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; Dekker GA, 1999, SEMIN PERINATOL, V23, P24, DOI 10.1016/S0146-0005(99)80057-3; Dietl J, 2000, J PERINAT MED, V28, P464, DOI 10.1515/JPM.2000.063; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; FU MLX, 1994, CLIN IMMUNOL IMMUNOP, V72, P15, DOI 10.1006/clin.1994.1101; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Graham RM, 1996, CIRC RES, V78, P737, DOI 10.1161/01.RES.78.5.737; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Lee RM, 2003, OBSTET GYNECOL, V102, P294, DOI 10.1016/S0029-7844(03)00477-0; Lei Z, 2003, CHIN J CLIN REHAB, V7, P2160; Lin Z, 1998, CHIN J HYPERTENS, V6, P5; LOMASNEY JW, 1991, J BIOL CHEM, V266, P6365; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roberts JM, 1998, LANCET, V352, P22; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Zhou CCY, 2008, HYPERTENSION, V51, P1010, DOI 10.1161/HYPERTENSIONAHA.107.097790	27	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57983	10.1371/journal.pone.0057983	http://dx.doi.org/10.1371/journal.pone.0057983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483958	Green Submitted, Green Published, gold			2022-12-25	WOS:000315634900062
J	Lei, R; Tang, J; Zhuang, X; Deng, R; Li, G; Yu, J; Liang, Y; Xiao, J; Wang, HY; Yang, Q; Hu, G				Lei, R.; Tang, J.; Zhuang, X.; Deng, R.; Li, G.; Yu, J.; Liang, Y.; Xiao, J.; Wang, H-Y; Yang, Q.; Hu, G.			Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis	ONCOGENE			English	Article						microRNA-182; MIM; breast cancer; metastasis; RhoA; cytoskeleton	HEDGEHOG-RESPONSIVE GENE; DOWN-REGULATION; 1 MTSS1; ACTIN; MIR-182; EXPRESSION; PROGRESSION; CYTOSKELETON; VARIANTS; PROTEIN	Breast cancer is the most common type of cancer among women worldwide, and metastasis represents the most devastating stage of the disease. Recent studies have revealed that microRNAs (miRNA) have critical roles to regulate cancer cell invasion and metastasis. Here we present evidence to show the role of miR-182 in breast cancer metastasis. miR-182 is upregulated in the malignant cell line variants of both human MCF10 and mouse 4T1 series. Ectopic expression of miR-182 enhanced breast cancer cell motility and invasiveness, whereas miR-182 inhibition resulted in opposite changes. In nude mice, miR-182 led to increased pulmonary colonization of cancer cells. We further demonstrated that miR-182 directly targets MIM (Missing in Metastasis), which suppresses metastasis by inhibiting ras homolog family member A (RhoA) activity and stress fiber formation in breast cancer cells. Restoring MIM expression completely blocked the pro-metastasis function of miR-182, while RhoA inhibition reversed the phenotypes of both miR-182 overexpression and MIM knockdown. In breast tumor samples, miR-182 induction is linked to downregulation of MIM, RhoA activation and poor prognosis. Hence, our data delineates the molecular pathway by which miR-182 promotes breast cancer invasion and metastasis, and may have important implication for the treatment of metastatic cancers.	[Lei, R.; Zhuang, X.; Li, G.; Yu, J.; Liang, Y.; Hu, G.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Lei, R.; Zhuang, X.; Li, G.; Yu, J.; Liang, Y.; Hu, G.] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Tang, J.] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, J.; Deng, R.; Wang, H-Y] Sun Yat Sen Univ, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, J.] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Oncol, Shanghai, Peoples R China; [Yang, Q.] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Naval Medical University; Shandong University	Hu, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Biol Sci,Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, 225 South Chongqing Rd, Shanghai 200025, Peoples R China.	ghhu@sibs.ac.cn	Xiao, Jian/GYU-4351-2022; yang, qiang/GYJ-0971-2022	Li, Gang/0000-0001-9761-1323; Yang, Qifeng/0000-0003-0576-8513; Hu, Guohong/0000-0002-2980-5166	Ministry of Science and Technology of China [2011CB510105, 2012ZX09506-001-005]; National Natural Science Foundation of China [81071754, 81222032]; Chinese Academy of Sciences [2009OHTP08, KSCX2-YW-R-192]; Shanghai Pujiang Talent Program [10PJ1411600]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Talent Program	We thank Dr Eva Hernando for providing the miR-182 overexpression plasmid. The study was funded by the grants from the Ministry of Science and Technology of China (2011CB510105, 2012ZX09506-001-005), National Natural Science Foundation of China (81071754, 81222032), Chinese Academy of Sciences (2009OHTP08, KSCX2-YW-R-192) and the Shanghai Pujiang Talent Program (10PJ1411600).	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bompard G, 2005, J CELL SCI, V118, P5393, DOI 10.1242/jcs.02640; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Dawson JC, 2012, ONCOGENE, V31, P1781, DOI 10.1038/onc.2011.376; Du P, 2011, ANTICANCER RES, V31, P3205; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; Gonzalez-Quevedo R, 2005, J CELL BIOL, V168, P453, DOI 10.1083/jcb.200409078; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; Lin JX, 2005, ONCOGENE, V24, P2059, DOI 10.1038/sj.onc.1208412; Liu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-428; Liu ZJ, 2012, J PATHOL, V228, P204, DOI 10.1002/path.4000; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Ma S, 2007, HUM PATHOL, V38, P1201, DOI 10.1016/j.humpath.2007.01.004; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Nixdorf S, 2004, CANCER LETT, V215, P209, DOI 10.1016/j.canlet.2004.05.002; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Wang D, 2011, J GASTROINTEST SURG, V15, P1205, DOI 10.1007/s11605-011-1546-2; Wang Y, 2007, CANCER INVEST, V25, P79, DOI 10.1080/07357900701205457; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Xie F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-95; Xie Fei, 2011, Front Biosci (Schol Ed), V3, P621, DOI 10.2741/s175; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200	47	99	107	1	27	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1287	1296		10.1038/onc.2013.65	http://dx.doi.org/10.1038/onc.2013.65			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23474751				2022-12-25	WOS:000332631100009
J	Liang, SY; Dai, JX; Hou, S; Su, LS; Zhang, DP; Guo, HZ; Hu, S; Wang, H; Rao, ZH; Guo, YJ; Lou, ZY				Liang, Shuaiyi; Dai, Jianxin; Hou, Sheng; Su, Lishu; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Rao, Zihe; Guo, Yajun; Lou, Zhiyong			Structural Basis for Treating Tumor Necrosis Factor alpha (TNF alpha)-associated Diseases with the Therapeutic Antibody Infliximab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; CRYSTAL-STRUCTURE; RHEUMATOID-ARTHRITIS; RECEPTOR; BINDING; EFFICACY; COMPLEX; METAANALYSIS; SUPERFAMILY; RESISTANCE	Monoclonal antibody (mAb) drugs have been widely used for treating tumor necrosis factor alpha (TNF alpha)-related diseases for over 10 years. Although their action has been hypothesized to depend in part on their ability to bind precursor cell surface TNF alpha, the precise mechanism and the epitope bound on TNF alpha remain unclear. In the present work, we report the crystal structure of the infliximab Fab fragment in complex with TNF alpha at a resolution of 2.6 angstrom. The key features of the TNF alpha E-F loop region in this complex distinguish the interaction between infliximab and TNF alpha from other TNF-receptor structures, revealing the mechanism of TNF alpha inhibition by overlapping with the TNF alpha-receptor interface and indicating the crucial role of the E-F loop in the action of this therapeutic antibody. This structure also indicates the formation of an aggregated network for the activation of complement-dependent cytolysis and antibody-dependent cell-mediated cytotoxicity, which result in development of granulomatous infections through TNF alpha blockage. These results provide the first experimental model for the interaction of TNF alpha with therapeutic antibodies and offer useful information for antibody optimization by understanding the precise molecular mechanism of TNF alpha inhibition.	[Liang, Shuaiyi; Su, Lishu; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Liang, Shuaiyi; Su, Lishu; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Minist Educ, Lab Prot Sci, Sch Med, Beijing 100084, Peoples R China; [Dai, Jianxin; Hou, Sheng; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Dai, Jianxin; Hou, Sheng; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai 201203, Peoples R China; [Dai, Jianxin; Hou, Sheng; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Guo, Yajun] Shanghai Key Lab Cell Engn & Antibody, Shanghai 201203, Peoples R China; [Dai, Jianxin; Hou, Sheng; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Guo, Yajun] Peoples Liberat Army Gen Hosp, Ctr Canc, PLA Postgrad Sch Med, Beijing 100853, Peoples R China	Tsinghua University; Tsinghua University; Naval Medical University; Chinese People's Liberation Army General Hospital	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn; louzy@xtal.tsinghua.edu.cn	Hu, Shi/A-2140-2015; Rao, Zihe/HCH-6944-2022	Hu, Shi/0000-0002-7905-4284; 	"973" Project [2010CB833600]; National Major Projects of China [2009ZX10004-304, 2009ZX09311-001]; National Natural Science Foundation of China [30830109]; Shanghai Leading Academic Discipline Project [B905]	"973" Project(National Basic Research Program of China); National Major Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by "973" Project Grant 2010CB833600, National Major Projects of China Grants 2009ZX10004-304 and 2009ZX09311-001, National Natural Science Foundation of China Grant 30830109, and Shanghai Leading Academic Discipline Project Grant B905.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; An ZQ, 2010, PROTEIN CELL, V1, P319, DOI 10.1007/s13238-010-0052-8; Bachmann F, 2010, SEMIN CUTAN MED SURG, V29, P35, DOI 10.1016/j.sder.2010.02.002; Baidoo L, 2005, AM J GASTROENTEROL, V100, P80, DOI 10.1111/j.1572-0241.2005.41716.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bernett MJ, 2010, J MOL BIOL, V396, P1474, DOI 10.1016/j.jmb.2009.12.046; Buch MH, 2004, ANN RHEUM DIS, V63, P1344, DOI 10.1136/ard.2003.014878; Byla P, 2010, J BIOL CHEM, V285, P12096, DOI 10.1074/jbc.M109.063305; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chiou HL, 1997, J GEN VIROL, V78, P2639, DOI 10.1099/0022-1317-78-10-2639; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gupta AK, 2004, J CUTAN MED SURG, V8, P77, DOI 10.1177/120347540400800202; Hasegawa Akihiro, 2001, Mini-Reviews in Medicinal Chemistry, V1, P5, DOI 10.2174/1389557013407214; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Kim MS, 2007, J MOL BIOL, V374, P1374, DOI 10.1016/j.jmb.2007.10.034; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Le J, 1997, Methods of treating TNF-a-mediated Crohn's disease using chimeric anti-TNF antibodies, Patent No. [5,656,272, 5656272, US5656272]; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Matthews N., 1987, LYMPHOKINES INTERFER; Mazza J, 2010, DERMATOL CLIN, V28, P559, DOI 10.1016/j.det.2010.03.009; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moreland LW, 1999, J RHEUMATOL, V26, P7; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Mukai Y, 2009, J MOL BIOL, V385, P1221, DOI 10.1016/j.jmb.2008.11.053; Murali R, 2005, P NATL ACAD SCI USA, V102, P10970, DOI 10.1073/pnas.0504301102; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Ono K, 2010, PROTEIN CELL, V1, P161, DOI 10.1007/s13238-010-0017-y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Ricart E, 1999, GASTROENTEROLOGY, V117, P429, DOI 10.1053/gast.1999.0029900429; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; Talbot C, 2005, COLORECTAL DIS, V7, P164, DOI 10.1111/j.1463-1318.2004.00749.x; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Yang ZR, 2009, NAT STRUCT MOL BIOL, V16, P1189, DOI 10.1038/nsmb.1683	54	65	77	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13799	13807		10.1074/jbc.M112.433961	http://dx.doi.org/10.1074/jbc.M112.433961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23504311	hybrid, Green Published			2022-12-25	WOS:000318850300061
J	Brown, DB; Muszynski, A; Salas, O; Speed, K; Carlson, RW				Brown, Dusty B.; Muszynski, Artur; Salas, Omar; Speed, Kacie; Carlson, Russell W.			Elucidation of the 3-O-Deacylase Gene, pagL, Required for the Removal of Primary beta-Hydroxy Fatty Acid from the Lipid A in the Nitrogen-fixing Endosymbiont Rhizobium etli CE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; LEGUME SYMBIOSIS; LIPOPOLYSACCHARIDES; BACTERIA; RECOGNITION; INFECTION; RESISTANCE; DEACYLASE	Until now, the gene responsible for the 3-O-deacylation of lipid A among nitrogen-fixing endosymbionts has not been characterized. Several Gram-negative animal pathogens such as Salmonella enterica, Pseudomonas aeruginosa, and Bordetella bronchiseptica contain an outer membrane 3-O-deacylase (PagL) that has been implicated in host immune evasion. The role of 3-O-deacylated lipid A among nitrogen-fixing endosymbionts, plant endophytes, and plant pathogens has not been studied. However, D'Haeze et al. (D'Haeze, W., Leoff, C., Freshour, G., Noel, K. D., and Carlson, R. W. (2007) J. Biol. Chem. 282, 17101-17113) reported that the lipopolysaccharide from Rhizobium etli CE3 bacteroids isolated from host bean root nodules contained exclusively tetraacylated lipid A that lacked a lipid A beta-hydroxymyristyl residue, an observation that is consistent with the possibility of PagL activity being important in symbiosis. A putative pagL gene was identified in the R. etli genome sequence. With this information, we created a pagL(-) mutant strain derived from R. etli CE3. Using mass spectrometry, we demonstrated that the mutant lacks 3-O-deacylated lipid A. The parent and mutant LPS were very similar as determined by gel electrophoresis and glycosyl composition analysis using gas chromatography/mass spectrometry. However, fatty acid analysis showed that the mutant lipid A contained larger amounts of beta-hydroxypentadecanoic acid than that of the parent. Furthermore, the mutant was adversely affected in establishing symbiosis with its host, Phaseolus vulgaris.	[Brown, Dusty B.; Muszynski, Artur; Salas, Omar; Speed, Kacie; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rcarlson@ccrc.uga.edu		Muszynski, Artur/0000-0003-3497-9977	National Institutes of Health [GM39583]; Department of Energy [DE-FG-02-09ER20097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM39583 (to R. W. C.). This work was also supported by Department of Energy Grant DE-FG-02-09ER20097 to the Complex Carbohydrate Research Center.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ardissone S, 2011, J BACTERIOL, V193, P2218, DOI 10.1128/JB.01260-10; Basu SS, 1999, J BIOL CHEM, V274, P11150, DOI 10.1074/jbc.274.16.11150; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Beringer J. E., 1974, MICROBIOLOGY, V84, P188; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Brown DB, 2011, J BACTERIOL, V193, P4766, DOI 10.1128/JB.00392-11; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; D'Haeze W, 2007, J BIOL CHEM, V282, P17101, DOI 10.1074/jbc.M611669200; Erbs G, 2010, SUBCELL BIOCHEM, V53, P387, DOI 10.1007/978-90-481-9078-2_17; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Ferguson GP, 2005, MOL MICROBIOL, V56, P68, DOI 10.1111/j.1365-2958.2005.04536.x; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; Forsberg LS, 2000, J BIOL CHEM, V275, P18851, DOI 10.1074/jbc.M001090200; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; KANNENBERG EL, 1998, RHIZOBIACEAE, P119; Kannenberg Elmar L., 1994, Trends in Microbiology, V2, P277, DOI 10.1016/0966-842X(94)90004-3; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Kawasaki K, 2007, J BACTERIOL, V189, P4911, DOI 10.1128/JB.00451-07; KITTELBERGER R, 1993, J BIOCHEM BIOPH METH, V26, P81, DOI 10.1016/0165-022X(93)90024-I; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; LEHMAN LJ, 1990, GENE, V95, P143, DOI 10.1016/0378-1119(90)90426-R; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; Manabe T, 2008, J BACTERIOL, V190, P5597, DOI 10.1128/JB.00587-08; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; NOEL KD, 1984, J BACTERIOL, V158, P148, DOI 10.1128/JB.158.1.148-155.1984; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PHADNIS SH, 1987, J BIOSCIENCE, V12, P131, DOI 10.1007/BF02702964; Que NLS, 2000, J BIOL CHEM, V275, P28006; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; REUHS BL, 1993, J BACTERIOL, V175, P3570, DOI 10.1128/jb.175.11.3570-3580.1993; Rutten L, 2006, P NATL ACAD SCI USA, V103, P7071, DOI 10.1073/pnas.0509392103; RYAN JM, 1974, ARCH BIOCHEM BIOPHYS, V162, P530, DOI 10.1016/0003-9861(74)90213-6; Spaink HP, 2004, TRENDS MICROBIOL, V12, P201, DOI 10.1016/j.tim.2004.03.001; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; YORK WS, 1986, METHOD ENZYMOL, V118, P3	46	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12004	12013		10.1074/jbc.M113.470484	http://dx.doi.org/10.1074/jbc.M113.470484			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23511636	Green Published, hybrid			2022-12-25	WOS:000318157600034
J	Pinart, M; Zhang, M; Li, F; Hussain, F; Zhu, J; Wiegman, C; Ryffel, B; Chung, KF				Pinart, Mariona; Zhang, Min; Li, Feng; Hussain, Farhana; Zhu, Jie; Wiegman, Coen; Ryffel, Bernard; Chung, Kian Fan			IL-17A Modulates Oxidant Stress-Induced Airway Hyperresponsiveness but Not Emphysema	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; T-CELLS; MICE; INTERLEUKIN-17; EXPRESSION; OZONE; INFLAMMATION; STIMULATION; CHEMOKINE; DISEASE	IL-17A induces the release of pro-inflammatory cytokines and of reactive oxygen species which could lead to neutrophilic inflammation. We determined the role of IL-17 receptor (IL-17R) signalling in oxidant-induced lung emphysema and airway hyperresponsiveness. IL-17R(-/-) and wild-type C57/BL6 mice were exposed to ozone (3 ppm; 3 hours) for 12 times over 6 weeks. Bronchial responsiveness to acetylcholine was measured, and lungs were retrieved. Mean linear intercept (L-m) and isometric contractile responses of intrapulmonary airways to acetylcholine were determined. In wild-type mice but not in IL-17R(-/-), chronic ozone exposure caused airway hyperresponsiveness. The increase in L-m after chronic ozone exposure of wild-type mice was also observed in IL-17R(-/-) mice. The increased maximal contractile response to acetylcholine seen in airways of wild-type mice exposed to ozone was abolished in IL-17R(-/-) mice. p38-mitogen-activated protein kinase (MAPK) and dexamethasone-dependent increase in contractile response was reduced in airways from IL-17R(-/-) ozone-exposed mice. Lung inflammation scores were not altered in IL-17R(-/-) mice exposed to ozone compared to wild-type mice. The increased release of IL-17 and IL-1 beta, and the activation of p38 MAPK in the lungs of ozone-exposed mice was reduced in IL-17R(-/-) mice. IL-17R signalling underlies the increase in airway hyperresponsiveness seen after ozone exposure, mediated by the increased contractility of airway smooth muscle. The emphysema and lung inflammation induced by ozone is not dependent on IL-17.	[Pinart, Mariona; Zhang, Min; Li, Feng; Hussain, Farhana; Zhu, Jie; Wiegman, Coen; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Ryffel, Bernard] Univ Orleans, Orleans, France; [Ryffel, Bernard] CNRS, UMR Mol Immunol & Embryol 6218, F-45071 Orleans, France	Imperial College London; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS)	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/I-8456-2019; Pinart, Mariona/L-1931-2015; Pinart Gilberga, Mariona/GLS-8842-2022; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Pinart, Mariona/0000-0002-8223-1325; Pinart Gilberga, Mariona/0000-0002-8223-1325; Chung, Kian Fan/0000-0001-7101-1426; Wiegman, Coen/0000-0001-9161-0581	Wellcome Trust [083905]; European Respiratory Society; European Respiratory Society/Marie Curie Joint Postdoctoral Research Fellowship [MC [0935]-2009]; European Community [PCOFUND-GA-2008-229571]	Wellcome Trust(Wellcome TrustEuropean Commission); European Respiratory Society; European Respiratory Society/Marie Curie Joint Postdoctoral Research Fellowship; European Community(European Commission)	This work was supported by Project Grant 083905 from the Wellcome Trust. MP and FL were supported by Long-term Fellowships from the European Respiratory Society. Dr Mariona Pinart is the recipient of a European Respiratory Society/Marie Curie Joint Postdoctoral Research Fellowship - Number MC [0935]-2009. The research leading to these results has received funding from the European Respiratory Society and the European Community's Seventh Framework Programme FP7/2007-2013 - Marie Curie Actions under grant agreement RESPIRE, PCOFUND-GA-2008-229571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Li F, 2011, EUR RESPIR J, V37, P933, DOI 10.1183/09031936.00021110; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Prause O, 2004, THORAX, V59, P313, DOI 10.1136/thx.2003.008854; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shapiro SD, 2007, EUR RESPIR J, V29, P375, DOI 10.1183/09031936.00087606; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Triantaphyllopoulos K, 2011, AM J PHYSIOL-LUNG C, V300, pL691, DOI 10.1152/ajplung.00252.2010; Vanaudenaerde BM, 2011, AM J RESP CRIT CARE, V183, P977, DOI 10.1164/rccm.201007-1196PP; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	23	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58452	10.1371/journal.pone.0058452	http://dx.doi.org/10.1371/journal.pone.0058452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505509	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100052
J	Schoffelen, AF; Wensing, AMJ; Tempelman, HA; Geelen, SPM; Hoepelman, AIM; Barth, RE				Schoffelen, Annelot F.; Wensing, Annemarie M. J.; Tempelman, Hugo A.; Geelen, Sibyl P. M.; Hoepelman, Andy I. M.; Barth, Roos E.			Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RESOURCE-LIMITED SETTINGS; HIGH EARLY MORTALITY; DRUG-RESISTANCE; OUTCOMES; MONOTHERAPY; PREDICTORS; CRITERIA; PROGRAM; VIREMIA	Objective: This study aims to describe the virological, immunological and clinical efficacy of protease inhibitor (PI)-based second-line antiretroviral therapy (ART) in rural South Africa. Methods: An observational cohort study was performed on 210 patients (including 39 children) who initiated PI-based second-line therapy at least 12 months prior to data collection. Biannual clinical, immunological and virological monitoring was performed. Primary endpoints were adequate virological response (plasma HIV-1 RNA<400 copies/ml), full virological suppression (plasma HIV-1 RNA<50 copies/ml) and treatment failure (virological failure (plasma HIV-1 RNA>1000 after initial virological response) or on-going viremia (plasma HIV-1 RNA never<400 copies/ml for more than six months)). Data were analyzed by an on-treatment (OT) and intention-to-treat (ITT) approach. Analyses were primarily performed on the group of patients who switched following first-line virological failure. Results: Median duration of follow-up after switch to second-line treatment was 20 months [IQR 11-35]. 191 patients had switched to second-line ART due to first-line virological failure. 139/191 of them (72.8%, ITT) were in care and on treatment at the end of follow-up and 11/191 (5.8%, ITT) had died. After twelve months, an adequate virological response was seen in 92/128 patients (71.9%, OT), of which 78/128 (60.9%, OT) experienced full virological suppression. Virological response remained stable after 24 months. Virological efficacy was similar amongst adult and pediatric patients. As in first-line ART, we observed a lack of correlation between virological failure and WHO-defined immunological failure. Conclusions: Good virological outcomes following first-line failure can be achieved with PI-based, second-line antiretroviral therapy in both adult and pediatric patients in rural South Africa. Retention rates were high and virological outcomes were sustainable during the two-year follow-up period, although persisting low-level viremia occurred in a subset of patients. The observed viro-immunological dissociation emphasizes the need for virological monitoring.	[Schoffelen, Annelot F.; Hoepelman, Andy I. M.; Barth, Roos E.] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Wensing, Annemarie M. J.] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands; [Tempelman, Hugo A.] Ndlovu Care Grp, Elandsdoorn, Limpopo, South Africa; [Geelen, Sibyl P. M.] Univ Med Ctr Utrecht, Dept Paediat Infect Dis, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schoffelen, AF (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	A.F.Schoffelen@umcutrecht.nl			ViiV healthcare; BMS; Gilead; Janssen; MSD; Virology Education; Pfizer; Royal Netherlands Embassy (RNE); USAID; PharmAccess Foundation; Roche	ViiV healthcare; BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; Virology Education; Pfizer(Pfizer); Royal Netherlands Embassy (RNE); USAID(United States Agency for International Development (USAID)); PharmAccess Foundation; Roche(Roche Holding)	None of the authors have a financial interest in or a financial conflict with the subject matter and materials discussed in this manuscript. A. F. S. has received financial support for travel, accommodation and meeting expenses from ViiV healthcare. A.M.J.W. has received financial support for research, travel, speaking engagement or consultancy from BMS, Gilead, Janssen, MSD, ViiV healthcare and Virology Education and grant support from MSD, Pfizer and ViiV healthcare. H. A. T. has received financial support for employment from Royal Netherlands Embassy (RNE) and grant support from USAID. S. P. M. G. has received financial support for employment from PharmAccess Foundation. A. I. M. H. is member of the advisory board of BMS, Gilead, ViiV healthcare, Janssen and MSD and has received financial grant support from Gilead, Janssen, MSD and Roche. R. E. B. has received no financial support. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; Barth RE, 2008, EUR J CLIN MICROBIOL, V27, P977, DOI 10.1007/s10096-008-0534-2; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Barth RE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/434375; Barth RE, 2011, PEDIATR INFECT DIS J, V30, P52, DOI 10.1097/INF.0b013e3181ed2af3; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bartlett JA, 2012, AIDS, V26, P1345, DOI 10.1097/QAD.0b013e328353b066; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cohen C, 2009, HIV CLIN TRIALS, V10, P116, DOI 10.1310/hct1002-116; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; DHHS, 2011, GUID US ANT AG HIV 1; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; Fox MP, 2010, JAIDS-J ACQ IMM DEF, V53, P500, DOI 10.1097/QAI.0b013e3181bcdac1; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; National Department of Health South Africa, 2021, 2019 NAT ANT HIV SEN; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; WHO, 2010, ANT THER HIV INF AD; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	32	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58526	10.1371/journal.pone.0058526	http://dx.doi.org/10.1371/journal.pone.0058526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505529	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100060
J	Bonnet, N; Lesclous, P; Saffar, JL; Ferrari, S				Bonnet, Nicolas; Lesclous, Philippe; Saffar, Jean Louis; Ferrari, Serge			Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice	PLOS ONE			English	Article							BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; ALVEOLAR BONE-RESORPTION; PLACEBO-CONTROLLED TRIAL; EXPERIMENTAL PERIODONTITIS; POSTMENOPAUSAL WOMEN; PREVENTIVE MEASURES; CANCER-PATIENTS; IN-VIVO; DISEASE; RATS	Osteoporosis and periodontal disease (PD) are frequently associated in the elderly, both concurring to the loss of jaw alveolar bone and finally of teeth. Bisphosphonates improve alveolar bone loss but have also been associated with osteonecrosis of the jaw (ONJ), particularly using oncological doses of zoledronate. The effects and therapeutic margin of zoledronate on jaw bone therefore remain uncertain. We reappraised the efficacy and safety of Zoledronate (Zol) in ovariectomized (OVX) periostin (Postn)-deficient mice, a unique genetic model of systemic and jaw osteopenia. Compared to vehicle, Zol 1M (100 mu g/kg/month) and Zol 1W (100 mu g/kg/week) for 3 months both significantly improved femur BMD, trabecular bone volume on tissue volume (BV/TV) and cortical bone volume in both OVX Postn(+/+) and Postn(-/-) (all p<0.01). Zol 1M and Zol 1W also improved jaw alveolar and basal BV/TV, although the highest dose (Zol 1W) was less efficient, particularly in Postn(-/-). Zol decreased osteoclast number and bone formation indices, i.e. MAR, MPm/BPm and BFR, independently in Postn(-/-) and Postn(+/+), both in the long bones and in deep jaw alveolar bone, without differences between Zol doses. Zol 1M and Zol 1W did not reactivate inflammation nor increase fibrous tissue in the bone marrow of the jaw, whereas the distance between the root and the enamel of the incisor (DRI) remained high in Postn(-/-) vs Postn(+/+) confirming latent inflammation and lack of crestal alveolar bone. Zol 1W and Zol 1M decreased osteocyte numbers in Postn(-/-) and Postn(+/+) mandible, and Zol 1W increased the number of empty lacunae in Postn(-/-), however no areas of necrotic bone were observed. These results demonstrate that zoledronate improves jaw osteopenia and suggest that in Postn(-/-) mice, zoledronate is not sufficient to induce bone necrosis.	[Bonnet, Nicolas; Ferrari, Serge] Univ Hosp Geneva, Dept Internal Med Specialties, Div Bone Dis, Geneva, Switzerland; [Lesclous, Philippe; Saffar, Jean Louis] Univ Paris 05, Fac Chirurg Dent, Lab Pathol Imagerie & Biotherapie Organe Dent EA, Paris, France; [Lesclous, Philippe] LUNAM Univ, STEP Skeletal Tissue Engn & Physiopathol Grp, Hotel Dieu Hosp,Univ Nantes,Sch Dent, INSERM UMRS 791,LIOAD Lab Ingn Osteoarticulaire &, Nantes, France	University of Geneva; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Bonnet, N (corresponding author), Univ Hosp Geneva, Dept Internal Med Specialties, Div Bone Dis, Geneva, Switzerland.	nicolas.bonnet@unige.ch	Ferrari, Serge/ABD-2730-2020; Lesclous, Philippe/P-6255-2014	Ferrari, Serge/0000-0002-1372-4417; lesclous, Philippe/0000-0002-9840-4542; Bonnet, Nicolas/0000-0001-9832-5767; Saffar, Jean-Louis/0000-0001-6288-9325	Swiss National Science Foundation [3100A0-116633/1, EC 201099-TALOS]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	These studies were supported by a Swiss National Science Foundation grant No. 3100A0-116633/1 and EC 201099-TALOS (to S. F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahi J, 2012, J ORAL PATH IN PRESS; Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; Aguirre JI, 2012, J BONE MINE IN PRESS; Albandar JM, 1999, J PERIODONTOL, V70, P30, DOI 10.1902/jop.1999.70.1.30; Alencar VBM, 2002, J PERIODONTOL, V73, P251, DOI 10.1902/jop.2002.73.3.251; Allen MR, 2011, OSTEOPOROSIS INT, V22, P693, DOI 10.1007/s00198-010-1268-4; Allen MR, 2011, IBMS BONEKEY, V8, P141; Bauss F, 2008, J BONE MINER METAB, V26, P406, DOI 10.1007/s00774-007-0837-x; Bilezikian JP, 2006, NEW ENGL J MED, V355, P2278, DOI 10.1056/NEJMp068157; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; CHAPPARD D, 1987, ACTA HISTOCHEM, V81, P183, DOI 10.1016/S0065-1281(87)80012-0; Contie S, 2010, CALCIFIED TISSUE INT, V87, P341, DOI 10.1007/s00223-010-9391-y; Cornish J, 2011, BONE, V49, P710, DOI 10.1016/j.bone.2011.07.020; Cremers S, 2011, BONE, V49, P42, DOI 10.1016/j.bone.2011.01.014; Dimopoulos MA, 2009, ANN ONCOL, V20, P117, DOI 10.1093/annonc/mdn554; Duarte PM, 2004, J PERIODONTOL, V75, P1196, DOI 10.1902/jop.2004.75.9.1196; El-Shinnawi Una M, 2003, J Int Acad Periodontol, V5, P5; Gasser JA, 2008, J BONE MINER RES, V23, P544, DOI 10.1359/JBMR.071207; GOTCHER JE, 1981, J PERIODONTAL RES, V16, P275, DOI 10.1111/j.1600-0765.1981.tb00976.x; Hansen T, 2006, J ORAL PATHOL MED, V35, P155, DOI 10.1111/j.1600-0714.2006.00391.x; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/jbmr.080205, 10.1359/JBMR.080205]; Huja SS, 2009, ARCH ORAL BIOL, V54, P851, DOI 10.1016/j.archoralbio.2009.06.002; Iida-Klein A, 2003, J CLIN DENSITOM, V6, P25, DOI 10.1385/JCD:6:1:25; Jeffcoat Marjorie K, 2007, J Int Acad Periodontol, V9, P70; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Koduganti Rekha Rani, 2009, J Indian Soc Periodontol, V13, P90, DOI 10.4103/0972-124X.55841; Lane N, 2005, J PERIODONTOL, V76, P1113, DOI 10.1902/jop.2005.76.7.1113; LASFARGUES JJ, 1993, ANAT REC, V237, P458, DOI 10.1002/ar.1092370404; LEONARD EP, 1979, ARCH ORAL BIOL, V24, P707, DOI 10.1016/0003-9969(79)90122-5; Lerner UH, 2006, J DENT RES, V85, P596, DOI 10.1177/154405910608500704; Lesclous P, 2009, BONE, V45, P843, DOI 10.1016/j.bone.2009.07.011; Ma DD, 2009, IN VITRO CELL DEV-AN, V45, P467, DOI 10.1007/s11626-009-9214-5; Masarachia P, 1996, BONE, V19, P281, DOI 10.1016/8756-3282(96)00182-2; Mavropoulos A, 2007, J BONE MINER RES, V22, P403, DOI 10.1359/JBMR.061208; MCMILLAN PJ, 1989, CALCIFIED TISSUE INT, V44, P399, DOI 10.1007/BF02555968; Merle B, 2012, OSTEOPOROS IN PRESS; Mitsuta T, 2002, J PERIODONTOL, V73, P479, DOI 10.1902/jop.2002.73.5.479; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ouyang GL, 2009, CANCER LETT, V281, P213, DOI 10.1016/j.canlet.2009.02.030; Padial-Molina M, 2012, J DENT RES IN PRESS; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rani S, 2009, BONE, V44, P502, DOI 10.1016/j.bone.2008.11.012; Ravosa MJ, 2011, ARCH ORAL BIOL, V56, P491, DOI 10.1016/j.archoralbio.2010.11.003; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Ripamonti CI, 2009, ANN ONCOL, V20, P137, DOI 10.1093/annonc/mdn526; Rizzoli R, 2008, BONE, V42, P841, DOI 10.1016/j.bone.2008.01.003; Rocha M, 2001, J PERIODONTOL, V72, P204, DOI 10.1902/jop.2001.72.2.204; Rocha ML, 2004, J PERIODONTOL, V75, P1579, DOI 10.1902/jop.2004.75.12.1579; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Scheper MA, 2009, BRIT J HAEMATOL, V144, P667, DOI 10.1111/j.1365-2141.2008.07504.x; Sheng ZF, 2009, OSTEOPOROSIS INT, V20, P151, DOI 10.1007/s00198-008-0640-0; SHOJI K, 1995, J PERIODONTAL RES, V30, P277, DOI 10.1111/j.1600-0765.1995.tb02134.x; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Tani-Ishii N, 2003, J PERIODONTOL, V74, P603, DOI 10.1902/jop.2003.74.5.603; Tezal M, 2005, J PERIODONTOL, V76, P1123, DOI 10.1902/jop.2005.76.7.1123; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Van Poznak CH, 2011, J ONCOL PRACT, V7, P117, DOI 10.1200/JOP.2011.000212; Wactawski-Wende J, 2001, Ann Periodontol, V6, P197, DOI 10.1902/annals.2001.6.1.197; WactawskiWende J, 1996, J PERIODONTOL, V67, P1076, DOI 10.1902/jop.1996.67.10s.1076; WEINREB M, 1994, J PERIODONTAL RES, V29, P35, DOI 10.1111/j.1600-0765.1994.tb01088.x; Weiss HM, 2008, DRUG METAB DISPOS, V36, P2043, DOI 10.1124/dmd.108.021071; Yu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031771; 2006, J AM DENT ASS, V137, P1144	71	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58726	10.1371/journal.pone.0058726	http://dx.doi.org/10.1371/journal.pone.0058726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505553	gold, Green Submitted, Green Published			2022-12-25	WOS:000318334500118
J	Gorzelak, P; Salamon, MA; Trzesiok, D; Niedzwiedzki, R				Gorzelak, Przemyslaw; Salamon, Mariusz A.; Trzesiok, Dawid; Niedzwiedzki, Robert			Drill Holes and Predation Traces versus Abrasion-Induced Artifacts Revealed by Tumbling Experiments	PLOS ONE			English	Article							BOREHOLES; SHELLS; BRACHIOPODS; COMPETITION; INTENSITY; PATTERNS; PLIOCENE; BORINGS; RECORD; SNAILS	Drill holes made by predators in prey shells are widely considered to be the most unambiguous bodies of evidence of predator-prey interactions in the fossil record. However, recognition of traces of predatory origin from those formed by abiotic factors still waits for a rigorous evaluation as a prerequisite to ascertain predation intensity through geologic time and to test macroevolutionary patterns. New experimental data from tumbling various extant shells demonstrate that abrasion may leave holes strongly resembling the traces produced by drilling predators. They typically represent singular, circular to oval penetrations perpendicular to the shell surface. These data provide an alternative explanation to the drilling predation hypothesis for the origin of holes recorded in fossil shells. Although various non-morphological criteria (evaluation of holes for non-random distribution) and morphometric studies (quantification of the drill hole shape) have been employed to separate biological from abiotic traces, these are probably insufficient to exclude abrasion artifacts, consequently leading to overestimate predation intensity. As a result, from now on, we must adopt more rigorous criteria to appropriately distinguish abrasion artifacts from drill holes, such as microstructural identification of micro-rasping traces.	[Gorzelak, Przemyslaw] Polish Acad Sci, Inst Paleobiol, Dept Biogeol, Warsaw, Poland; [Salamon, Mariusz A.; Trzesiok, Dawid] Univ Silesia, Fac Earth Sci, Dept Palaeontol & Biostratig, Sosnowiec, Poland; [Niedzwiedzki, Robert] Univ Wroclaw, Inst Geol Sci, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Silesia in Katowice; University of Wroclaw	Gorzelak, P (corresponding author), Polish Acad Sci, Inst Paleobiol, Dept Biogeol, Warsaw, Poland.	pgorzelak@twarda.pan.pl	Gorzelak, Przemyslaw/B-6329-2015	Gorzelak, Przemyslaw/0000-0001-5706-1881; Salamon, Mariusz/0000-0001-9399-2798; Niedzwiedzki, Robert/0000-0002-6222-3977	National Science Centre [UMO-2011/01/B/ST10/02639]	National Science Centre(National Science Centre, Poland)	This work was partly supported by National Science Centre grant no. UMO-2011/01/B/ST10/02639. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baumiller TK, 1996, PALAEOGEOGR PALAEOCL, V123, P343, DOI 10.1016/0031-0182(95)00124-7; Baumiller TK, 2006, LETHAIA, V39, P313, DOI 10.1080/00241160600847546; Baumiller TK, 2010, P NATL ACAD SCI USA, V107, P5893, DOI 10.1073/pnas.0914199107; Chave K. E., 1964, P377; Cintra-Buenrostro CE, 2007, J SHELLFISH RES, V26, P221, DOI 10.2983/0730-8000(2007)26[221:TPANMA]2.0.CO;2; Cintra-Buenrostro CE, 2005, PALAIOS, V20, P296, DOI 10.2110/palo-2004.p04-21; Dietl GP, 2004, SCIENCE, V306, P2229, DOI 10.1126/science.1106182; Dietl Gregory P., 2006, Ichnos, V13, P103, DOI 10.1080/10420940600848889; DRISCOLL EG, 1967, J SEDIMENT PETROL, V37, P1117; Gorzelak P, 2012, P NATL ACAD SCI USA, V109, P7004, DOI 10.1073/pnas.1201573109; Grey M, 2005, J MOLLUS STUD, V71, P253, DOI 10.1093/mollus/eyi035; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harper EM, 2005, PALAEONTOLOGY, V48, P197, DOI 10.1111/j.1475-4983.2004.00433.x; Hoffmeister AP, 2003, LETHAIA, V36, P107, DOI 10.1080/00241160310000408; Huntley JW, 2007, P NATL ACAD SCI USA, V104, P15006, DOI 10.1073/pnas.0704960104; Kaplan P, 2001, PALAIOS, V16, P525, DOI 10.2307/3515567; KELLEY P H, 1988, Palaios, V3, P436, DOI 10.2307/3514789; Kelley PH, 2006, PALAEOGEOGR PALAEOCL, V236, P302, DOI 10.1016/j.palaeo.2005.11.012; KITCHELL JA, 1981, PALEOBIOLOGY, V7, P533, DOI 10.1017/S0094837300025574; Kowalewski M, 2005, SCIENCE, V308, P1774, DOI 10.1126/science.1113408; KOWALEWSKI M, 1993, PALAEOGEOGR PALAEOCL, V102, P69, DOI 10.1016/0031-0182(93)90006-5; Kowalewski M, 2000, J PALEONTOL, V74, P532, DOI 10.1666/0022-3360(2000)074<0532:DHISOP>2.0.CO;2; Kowalewski M, 1998, GEOLOGY, V26, P1091, DOI 10.1130/0091-7613(1998)026<1091:AFRFOH>2.3.CO;2; Kowalewski M., 2002, PALEONTOLOGICAL SOC; KUENEN PH, 1956, J GEOL, V64, P336, DOI 10.1086/626370; Leighton LR, 2003, PALAEOGEOGR PALAEOCL, V210, P221, DOI 10.1016/S0031-0182(03)00627-8; Leighton LR, 2002, PALEOBIOLOGY, V28, P328, DOI 10.1666/0094-8373(2002)028<0328:IPIITM>2.0.CO;2; Leighton LR, 2001, PALAEOGEOGR PALAEOCL, V165, P53, DOI 10.1016/S0031-0182(00)00153-X; LESCINSKY HL, 1994, PALAIOS, V9, P599, DOI 10.2307/3515130; Oji T, 2003, PALEOBIOLOGY, V29, P520, DOI 10.1666/0094-8373(2003)029<0520:IOSPRI>2.0.CO;2; RICHARDS R P, 1969, Journal of Paleontology, V43, P838; Schiffbauer JD, 2008, PALAIOS, V23, P810, DOI 10.2110/palo.2008.p08-045r; SHEEHAN PM, 1978, J PALEONTOL, V52, P812; Stanley SM, 2008, PALEOBIOLOGY, V34, P1, DOI 10.1666/07026.1; Tyler CL, 2012, PALAIOS, V27, P659, DOI 10.2110/palo.2012.p12-014r; Urrutia GX, 2001, J EXP MAR BIOL ECOL, V258, P141, DOI 10.1016/S0022-0981(00)00349-X; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij G.J, 1987, EVOLUTION ESCALATION; Villier L, 2008, NEUES JAHRB GEOL P-A, V247, P147, DOI 10.1127/0077-7749/2008/0247-0147; Walker Sally E., 2007, P324, DOI 10.1016/B978-044452949-7/50144-3; Wilson MA, 2001, PALAIOS, V16, P524, DOI 10.2307/3515566	41	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58528	10.1371/journal.pone.0058528	http://dx.doi.org/10.1371/journal.pone.0058528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505530	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500098
J	Hambarde, S; Singh, V; Chandna, S				Hambarde, Shashank; Singh, Vijaypal; Chandna, Sudhir			Evidence for Involvement of Cytosolic Thioredoxin Peroxidase in the Excessive Resistance of Sf9 Lepidopteran Insect Cells against Radiation-Induced Apoptosis	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; PEROXIREDOXIN-I EXPRESSION; CYCLIN-DEPENDENT KINASES; 2-CYS PEROXIREDOXIN; UP-REGULATION; NITRIC-OXIDE; DROSOPHILA; PROTEIN; RADIOSENSITIVITY; PHOSPHORYLATION	Lepidopteran insect cells display 50-100 times higher radioresistance compared to human cells, and reportedly have more efficient antioxidant system that can significantly reduce radiation-induced oxidative stress and cell death. However, the antioxidant mechanisms that contribute substantially to this excessive resistance still need to be understood thoroughly. In this study, we investigated the role of thioredoxin peroxidase (TPx) in high-dose gamma-radiation response of Sf9 cell line derived from Spodoptera frugiperda, the Fall armyworm. We identified a TPx orthologue (Sf-TPx) in Spodoptera system, with primarily cytosolic localization. Gamma-irradiation at 500 Gy dose significantly up-regulated Sf-TPx, while higher doses (1000 Gy-2000 Gy) had no such effect. G2/M checkpoint induced following 500 Gy was associated with transition of Sf-TPx decamer into enzymatically active dimer. Same effect was observed during G2/M block induced by 5 nM okadaic acid or 10 mu M CDK1 (cycline dependent kinase-1) inhibitor roscovitine, thus indicating that radiation-induced Sf-TPx activity is mediated by CDKs. Accumulation of TPx dimer form during G2/M checkpoint might favour higher peroxidase activity facilitating efficient survival at this dose. Confirming this, higher lethal doses (1000 Gy-2000 Gy) caused significantly less accumulation of dimer form and induced dose-dependent apoptosis. A similar to 50% knock-down of Sf-TPx by siRNA caused remarkable increase in radiation-induced ROS as well as caspase-3 dependent radiation-induced apoptosis, clearly implying TPx role in the radioresistance of Sf9 cells. Quite importantly, our study demonstrates for the first time that thioredoxin peroxidase contributes significantly in the radioresistance of Lepidopteran Sf9 insect cells, especially in their exemplary resistance against radiation-induced apoptosis. This is an important insight into the antioxidant mechanisms existing in this highly stress-resistant model cell system.	[Hambarde, Shashank; Singh, Vijaypal; Chandna, Sudhir] Inst Nucl Med & Allied Sci, Div Radiat Biosci, Nat Radiat Response Mech Grp, Delhi, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Chandna, S (corresponding author), Inst Nucl Med & Allied Sci, Div Radiat Biosci, Nat Radiat Response Mech Grp, Delhi, India.	sudhirchandna@yahoo.com		Chandna, Sudhir/0000-0001-8210-5786	DRDO grant [INM-311.1.5]; Ministry of Defence, Government of India	DRDO grant; Ministry of Defence, Government of India	The present study was carried out as a part of DRDO grant no. INM-311.1.5 funded by Ministry of Defence, Government of India. SH is thankful to DRDO for providing a research fellowship during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Cha MK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-93; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chandna S, 2004, INT J RADIAT BIOL, V80, P301, DOI [10.1080/09553000440001679794, 10.1080/09553000410001679794]; Chandna S, 2009, MUTAGENESIS, V24, P259; Chandna S, 2010, MUTAGENESIS, V25, P431, DOI 10.1093/mutage/geq022; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Chung YM, 2001, ANTICANCER RES, V21, P1129; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Demasi APD, 2009, J ORAL PATHOL MED, V38, P514, DOI 10.1111/j.1600-0714.2009.00753.x; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; EVANS HJ, 1962, INT REV CYTOL, V13, P221; Hambarde S, 2010, BIOINFORMATION, V4, P399, DOI 10.6026/97320630004399; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KIM IH, 1989, P NATL ACAD SCI USA, V86, P6018, DOI 10.1073/pnas.86.16.6018; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; KOVAL TM, 1983, RADIAT RES, V96, P118, DOI 10.2307/3576171; Kumar JS, 2012, MOL CELL BIOCH; Kumarswamy R, 2009, INT J BIOCHEM CELL B, V41, P1430, DOI 10.1016/j.biocel.2008.12.009; Lee K, 2002, BIOCHEM BIOPH RES CO, V296, P337, DOI 10.1016/S0006-291X(02)00801-X; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, pW104, DOI 10.1093/nar/gkn250; Mathews DH, 2010, METHODS MOL BIOL, V629, P107, DOI 10.1007/978-1-60761-657-3_8; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Missirlis F, 2002, J BIOL CHEM, V277, P11521, DOI 10.1074/jbc.M111692200; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Park JJ, 2009, INT J RADIAT ONCOL, V73, P1196, DOI 10.1016/j.ijrobp.2008.10.070; Park SH, 2000, CLIN CANCER RES, V6, P4915; Radyuk SN, 2003, BIOCHEM J, V371, P743, DOI 10.1042/BJ20021522; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Reinartz M, 2008, J BIOL CHEM, V283, P17440, DOI 10.1074/jbc.M800126200; Suman S, 2011, INT J BIOCH CELL BIO; Suman S, 2007, FREE RADICAL BIO MED, V43, pS133; Suman S, 2009, BIOINFORMATION, V4, P19, DOI 10.6026/97320630004019; Suman S, 2008, BIOINFORMATION, V3, P8, DOI 10.6026/97320630003008; Suman S, 2009, INT J RADIAT BIOL, V85, P238, DOI 10.1080/09553000902748591; Tsuda M, 2010, FEBS LETT, V584, P3398, DOI 10.1016/j.febslet.2010.06.034; VANMAANEN JMS, 1988, J NATL CANCER I, V80, P1526, DOI 10.1093/jnci/80.19.1526; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; Wang Y, 2001, FREE RADICAL BIO MED, V30, P1254, DOI 10.1016/S0891-5849(01)00520-2; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1; Zhang B, 2008, BIOCHEM PHARMACOL, V75, P660, DOI 10.1016/j.bcp.2007.09.016	55	12	14	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58261	10.1371/journal.pone.0058261	http://dx.doi.org/10.1371/journal.pone.0058261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505474	gold, Green Submitted, Green Published			2022-12-25	WOS:000318334500061
J	Storm, P; Klausen, TK; Trulsson, M; Ho, CSJ; Dosnon, M; Westergren, T; Chao, YX; Rydstrom, A; Yang, H; Pedersen, SF; Svanborg, C				Storm, Petter; Klausen, Thomas Kjaer; Trulsson, Maria; Ho, James C. S.; Dosnon, Marion; Westergren, Tomas; Chao, Yinxia; Rydstroem, Anna; Yang, Henry; Pedersen, Stine Falsig; Svanborg, Catharina			A Unifying Mechanism for Cancer Cell Death through Ion Channel Activation by HAMLET	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; APOPTOSIS-LIKE MECHANISM; TUMOR-CELLS; OLEIC-ACID; VOLUME REGULATION; CATION CHANNELS; TRP CHANNELS; MAP KINASE; PROTEIN; LETHAL	Ion channels and ion fluxes control many aspects of tissue homeostasis. During oncogenic transformation, critical ion channel functions may be perturbed but conserved tumor specific ion fluxes remain to be defined. Here we used the tumoricidal protein-lipid complex HAMLET as a probe to identify ion fluxes involved in tumor cell death. We show that HAMLET activates a non-selective cation current, which reached a magnitude of 2.74 +/- 0.88 nA within 1.43 +/- 0.13 min from HAMLET application. Rapid ion fluxes were essential for HAMLET-induced carcinoma cell death as inhibitors (amiloride, BaCl2), preventing the changes in free cellular Na+ and K+ concentrations also prevented essential steps accompanying carcinoma cell death, including changes in morphology, uptake, global transcription, and MAP kinase activation. Through global transcriptional analysis and phosphorylation arrays, a strong ion flux dependent p38 MAPK response was detected and inhibition of p38 signaling delayed HAMLET-induced death. Healthy, differentiated cells were resistant to HAMLET challenge, which was accompanied by innate immunity rather than p38-activation. The results suggest, for the first time, a unifying mechanism for the initiation of HAMLET's broad and rapid lethal effect on tumor cells. These findings are particularly significant in view of HAMLET's documented therapeutic efficacy in human studies and animal models. The results also suggest that HAMLET offers a two-tiered therapeutic approach, killing cancer cells while stimulating an innate immune response in surrounding healthy tissues.	[Storm, Petter; Trulsson, Maria; Ho, James C. S.; Dosnon, Marion; Westergren, Tomas; Rydstroem, Anna; Svanborg, Catharina] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Klausen, Thomas Kjaer; Pedersen, Stine Falsig] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Chao, Yinxia; Yang, Henry] ASTAR, Singapore Immunol Network, Singapore, Singapore	Lund University; University of Copenhagen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Svanborg, C (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	catharina.svanborg@med.lu.se	Pedersen, Stine Falsig/O-1133-2019; Ho, James CS/ADQ-2735-2022; Ho, James CS/AAF-8197-2022; Pedersen, Stine Falsig/M-8347-2014	Pedersen, Stine Falsig/0000-0002-3044-7714; Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Pedersen, Stine Falsig/0000-0002-3044-7714; Storm, Petter/0000-0002-7655-3731; Chao, Yinxia/0000-0003-1185-3511; Rydstrom, Anna/0000-0002-3404-7195	Sharon D. Lund foundation; American Cancer Society; Swedish Cancer Society; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; H. J. Forssman Foundation for Medical Research; Royal Physiographic Society; Danish Council for Independent Research (Medical sciences)	Sharon D. Lund foundation; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; H. J. Forssman Foundation for Medical Research; Royal Physiographic Society; Danish Council for Independent Research (Medical sciences)(Det Frie Forskningsrad (DFF))	This study was supported by the Sharon D. Lund foundation grant and the American Cancer Society, the Swedish Cancer Society, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, the H. J. Forssman Foundation for Medical Research and the Royal Physiographic Society. Support was also obtained from the Danish Council for Independent Research (Medical sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; Ajiro K, 2008, EXP CELL RES, V314, P1237, DOI 10.1016/j.yexcr.2007.12.028; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Arcangeli A, 2011, AM J PHYSIOL-CELL PH, V301, pC762, DOI 10.1152/ajpcell.00113.2011; BARBIERO G, 1995, EXP CELL RES, V217, P410, DOI 10.1006/excr.1995.1104; Baumann A, 2012, J MOL BIOL; Beacham DW, 2010, J BIOMOL SCREEN, V15, P441, DOI 10.1177/1087057109359807; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Boriek AM, 2008, REGULATION INTRACELL; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; Drosopoulos K, 2007, EXPERT OPIN THER TAR, V11, P641, DOI 10.1517/14728222.11.5.641; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kukkonen JP, 2011, CELL CALCIUM, V50, P9, DOI 10.1016/j.ceca.2011.04.005; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Permyakov SE, 2011, BIOL CHEM; Poulsen KA, 2010, AM J PHYSIOL-CELL PH, V298, pC14, DOI 10.1152/ajpcell.00654.2008; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Spolaore B, 2010, BIOCHEMISTRY-US, V49, P8658, DOI 10.1021/bi1012832; Storm P, 2011, ONCOGENE; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Stuhmer W, 2010, FUTURE MED CHEM, V2, P745, DOI 10.4155/FMC.10.24; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x; Wilhelm K, 2009, FEBS J, V276, P3975, DOI 10.1111/j.1742-4658.2009.07107.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu W, 1999, J MEMBRANE BIOL, V171, P117, DOI 10.1007/s002329900564; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	58	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58578	10.1371/journal.pone.0058578	http://dx.doi.org/10.1371/journal.pone.0058578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505537	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500102
J	Walton, MB; Cowderoy, E; Lascelles, D; Innes, JF				Walton, Myles Benjamin; Cowderoy, Emily; Lascelles, Duncan; Innes, John F.			Evaluation of Construct and Criterion Validity for the 'Liverpool Osteoarthritis in Dogs' (LOAD) Clinical Metrology Instrument and Comparison to Two Other Instruments	PLOS ONE			English	Article							GROUND REACTION FORCES; CHRONIC PAIN; DETECT RESPONSE; ACCELEROMETER; QUESTIONNAIRE; COEFFICIENT; OWNERS	Objective: To test the 'Liverpool Osteoarthritis in Dogs' (LOAD) questionnaire for construct and criterion validity, and to similarly test the Helsinki Chronic Pain Index (HCPI) and the Canine Brief Pain Inventory (CBPI). Design: Prospective Study. Animals: 222 dogs with osteoarthritis. Procedure: Osteoarthritis was diagnosed in a cohort of dogs on the basis of clinical history and orthopedic examination. Force-platform analysis was performed and a "symmetry index'' for peak vertical force (PVF) was calculated. Owners completed LOAD, CBPI and HCPI instruments. As a test of construct validity, inter-instrument correlations were calculated. As a test of criterion validity, the correlations between instrument scores and PVF symmetry scores were calculated. Additionally, internal consistency of all instruments was calculated and compared to those previously reported. Factor analysis is reported for the first time for LOAD, and is compared to that previously reported for CBPI and HCPI. Results: Significant moderate correlations were found between all instruments, implying construct validity for all instruments. Significant weak correlations were found between LOAD scores and PVF symmetry index, and between CBPI scores and PVF symmetry index. Conclusion and Clinical Relevance: LOAD is an owner-completed clinical metrology instrument that can be recommended for the measurement of canine osteoarthritis. It is convenient to use, validated and, as demonstrated here for the first time, has a correlation with force-platform data.	[Walton, Myles Benjamin; Cowderoy, Emily; Innes, John F.] Univ Liverpool, Dept Musculoskeletal Biol, Wirral L64 7TE, Merseyside, England; [Walton, Myles Benjamin; Cowderoy, Emily; Innes, John F.] Univ Liverpool, Sch Vet Sci, Wirral L64 7TE, Merseyside, England; [Lascelles, Duncan] N Carolina State Univ, Comparat Pain Res Lab, Raleigh, NC 27695 USA; [Lascelles, Duncan] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Lascelles, Duncan] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA	University of Liverpool; University of Liverpool; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Innes, JF (corresponding author), Univ Liverpool, Dept Musculoskeletal Biol, Wirral L64 7TE, Merseyside, England.	j.f.innes@liv.ac.uk	Innes, John/ABI-6553-2020	Innes, John/0000-0003-2758-3851; Lascelles, B. Duncan X./0000-0002-2950-9009	Pfizer Animal Health; University of Liverpool	Pfizer Animal Health; University of Liverpool	Salary for MBW and EC was funded by Pfizer Animal Health during the data collection phase of this study. Remaining funding was provided by University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Bellamy N, 1991, MUSCULOSKELETAL CLIN; Brown DC, 2008, JAVMA-J AM VET MED A, V233, P1278, DOI 10.2460/javma.233.8.1278; Brown DC, 2007, AM J VET RES, V68, P631, DOI 10.2460/ajvr.68.6.631; Brown DC, 2010, JAVMA-J AM VET MED A, V237, P66, DOI 10.2460/javma.237.1.66; Brown DC, 2010, AM J VET RES, V71, P322, DOI 10.2460/ajvr.71.3.322; Budsberg SC, 2001, AM J VET RES, V62, P1207, DOI 10.2460/ajvr.2001.62.1207; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Costello A.B., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8, DOI 10.7275/JYJ1-4868]; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dow C, 2009, AM J VET RES, V70, P444, DOI 10.2460/ajvr.70.4.444; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Frost MH, 2007, VALUE HEALTH, V10, pS94, DOI 10.1111/j.1524-4733.2007.00272.x; GUILFORD JP, 1948, PSYCHOL REV, V55, P79, DOI 10.1037/h0056564; Hansen BD, 2007, AM J VET RES, V68, P468, DOI 10.2460/ajvr.68.5.468; Hercock CA, 2009, J SMALL ANIM PRACT, V50, P266, DOI 10.1111/j.1748-5827.2009.00765.x; Hielm-Bjorkman AK, 2003, J AM VET MED ASSOC, V222, P1552, DOI 10.2460/javma.2003.222.1552; Hielm-Bjorkman AK, 2009, AM J VET RES, V70, P727, DOI 10.2460/ajvr.70.6.727; Hudson JT, 2004, AM J VET RES, V65, P1634, DOI 10.2460/ajvr.2004.65.1634; Innes JF, 1998, J SMALL ANIM PRACT, V39, P373, DOI 10.1111/j.1748-5827.1998.tb03735.x; Innes JF, 2003, VET REC, V152, P457, DOI 10.1136/vr.152.15.457; Johnston SA, 1997, VET CLIN N AM-SMALL, V27, P699, DOI 10.1016/S0195-5616(97)50076-3; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; McCrory JL, 2001, GAIT POSTURE, V14, P104, DOI 10.1016/S0966-6362(01)00140-0; Michel KE, 2011, AM J VET RES, V72, P866, DOI 10.2460/ajvr.72.7.866; Preston T, 2012, RES VET SCI, V93, P412, DOI 10.1016/j.rvsc.2011.08.005; Schmidt J, 2005, US TODAY; VASSEUR PB, 1995, J AM VET MED ASSOC, V206, P807; Waxman AS, 2008, VET SURG, V37, P241, DOI 10.1111/j.1532-950X.2008.00372.x; Wernham BGJ, 2011, J VET INTERN MED, V25, P1298, DOI 10.1111/j.1939-1676.2011.00825.x; Wiseman ML, 2001, VET REC, V149, P423, DOI 10.1136/vr.149.14.423	31	129	129	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58125	10.1371/journal.pone.0058125	http://dx.doi.org/10.1371/journal.pone.0058125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505459	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500051
J	Mikolas, P; Kollarova, J; Sebkova, K; Saudek, V; Yilma, P; Kostrouchova, M; Krause, MW; Kostrouch, Z; Kostrouchova, M				Mikolas, Pavol; Kollarova, Johana; Sebkova, Katerina; Saudek, Vladimir; Yilma, Petr; Kostrouchova, Marketa; Krause, Michael W.; Kostrouch, Zdenek; Kostrouchova, Marta			GEI-8, a Homologue of Vertebrate Nuclear Receptor Corepressor NCoR/SMRT, Regulates Gonad Development and Neuronal Functions in Caenorhabditis elegans	PLOS ONE			English	Article							MEDIATED REPRESSION; NERVOUS-SYSTEM; PROTEIN; SMRT; COMPLEX; PROGRESSION; EXPRESSION; CELL; IDENTIFICATION; TRANSCRIPTION	NCoR and SMRT are two paralogous vertebrate proteins that function as corepressors with unliganded nuclear receptors. Although C. elegans has a large number of nuclear receptors, orthologues of the corepressors NCoR and SMRT have not unambiguously been identified in Drosophila or C. elegans. Here, we identify GEI-8 as the closest homologue of NCoR and SMRT in C. elegans and demonstrate that GEI-8 is expressed as at least two isoforms throughout development in multiple tissues, including neurons, muscle and intestinal cells. We demonstrate that a homozygous deletion within the gei-8 coding region, which is predicted to encode a truncated protein lacking the predicted NR domain, results in severe mutant phenotypes with developmental defects, slow movement and growth, arrested gonadogenesis and defects in cholinergic neurotransmission. Whole genome expression analysis by microarrays identified sets of de-regulated genes consistent with both the observed mutant phenotypes and a role of GEI-8 in regulating transcription. Interestingly, the upregulated transcripts included a predicted mitochondrial sulfide: quinine reductase encoded by Y9C9A.16. This locus also contains non-coding, 21-U RNAs of the piRNA class. Inhibition of the expression of the region coding for 21-U RNAs leads to irregular gonadogenesis in the homozygous gei-8 mutants, but not in an otherwise wild-type background, suggesting that GEI-8 may function in concert with the 21-U RNAs to regulate gonadogenesis. Our results confirm that GEI-8 is the orthologue of the vertebrate NCoR/SMRT corepressors and demonstrate important roles for this putative transcriptional corepressor in development and neuronal function.	[Mikolas, Pavol; Sebkova, Katerina; Kostrouchova, Marta] Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, Lab Mol Biol & Genet, Prague, Czech Republic; [Kollarova, Johana; Saudek, Vladimir; Yilma, Petr; Kostrouchova, Marketa; Kostrouch, Zdenek] Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, Lab Mol Pathol, Prague, Czech Republic; [Krause, Michael W.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Charles University Prague; Charles University Prague; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kostrouchova, M (corresponding author), Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, Lab Mol Biol & Genet, Prague, Czech Republic.	marta.kostrouchova@lf1.cuni.cz	Kollárová, Johana/M-9463-2017; Mikolas, Pavol/GLR-0797-2022	Kollárová, Johana/0000-0003-2686-4555; Mikolas, Pavol/0000-0002-3974-7115; Krause, Michael/0000-0001-6127-3940	Czech Science Foundation [304/08/0970]; Ministry of Education, Youth and Sports of the Czech Republic [0021620806]; Charles University in Prague [SVV 2012 264514, 579612]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036133, ZIADK036117] Funding Source: NIH RePORTER	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following grants: grant 304/08/0970 from the Czech Science Foundation (http://www.gacr.cz/international.htm), grant 0021620806 from the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz), Prvouk/1LF/1 and UNCE 204022 from the Charles University in Prague ( http://www.cuni.cz). PM, JK and KS were partially supported by the grant SVV 2012 264514 from the Charles University in Prague (http:// www.cuni.cz). KS was partially supported by the Grant 579612 from the Charles University in Prague. MWK is supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, USA (http://www2.niddk.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakawa Kazuharu, 2005, In Silico Biology, V5, P419; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Barberan-Soler S, 2009, RNA, V15, P1652, DOI 10.1261/rna.1711109; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boxem M, 2001, DEVELOPMENT, V128, P4349; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; BRENNER S, 1974, GENETICS, V77, P71; Budde MW, 2011, GENETICS, V189, P521, DOI 10.1534/genetics.111.129841; Cecere G, 2012, MOL CELL, V47, P734, DOI 10.1016/j.molcel.2012.06.021; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Choy SW, 2007, BIOCHEM BIOPH RES CO, V358, P802, DOI 10.1016/j.bbrc.2007.04.194; Codina A, 2005, P NATL ACAD SCI USA, V102, P6009, DOI 10.1073/pnas.0500299102; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Dorak M. T., 2006, REAL TIME PCR ADV ME; Fan XM, 1997, J COMP NEUROL, V387, P53, DOI 10.1002/(SICI)1096-9861(19971013)387:1<53::AID-CNE5>3.0.CO;2-M; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; Fay DS, 2000, DEVELOPMENT, V127, P4049; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Han HF, 2009, MOL BIOL CELL, V20, P2361, DOI 10.1091/mbc.E08-06-0584; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hodgson MC, 2008, MOL CANCER THER, V7, P3187, DOI 10.1158/1535-7163.MCT-08-0461; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kelly WG, 1997, GENETICS, V146, P227; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; MacMorris M, 2007, RNA, V13, P511, DOI 10.1261/rna.426707; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Malartre M, 2004, NUCLEIC ACIDS RES, V32, P4676, DOI 10.1093/nar/gkh786; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Maryon EB, 1998, J CELL SCI, V111, P2885; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Mercer KB, 2003, MOL BIOL CELL, V14, P2492, DOI 10.1091/mbc.E02-10-0676; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Park M, 1999, DEVELOPMENT, V126, P4849; Privalsky ML, 2001, CURR TOP MICROBIOL, V254, P117; RAIZEN DM, 1995, GENETICS, V141, P1365; Simeckova K, 2007, FOLIA BIOL-PRAGUE, V53, P85; Tahirov TH, 2001, ACTA CRYSTALLOGR D, V57, P1655, DOI 10.1107/S0907444901011982; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tsuboi D, 2002, BIOCHEM BIOPH RES CO, V292, P697, DOI 10.1006/bbrc.2002.6717; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Watanabe N, 2005, DEVELOPMENT, V132, P3175, DOI 10.1242/dev.01895; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326	68	6	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58462	10.1371/journal.pone.0058462	http://dx.doi.org/10.1371/journal.pone.0058462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484030	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100119
J	Tyagi, E; Agrawal, R; Zhuang, YM; Abad, C; Waschek, JA; Gomez-Pinilla, F				Tyagi, Ethika; Agrawal, Rahul; Zhuang, Yumei; Abad, Catalina; Waschek, James A.; Gomez-Pinilla, Fernando			Vulnerability Imposed by Diet and Brain Trauma for Anxiety-Like Phenotype: Implications for Post-Traumatic Stress Disorders	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; BDNF FUNCTION; DEPRESSION; INJURY; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; HOMEOSTASIS; MECHANISMS; EXPRESSION; PLASTICITY	Mild traumatic brain injury (mTBI, cerebral concussion) is a risk factor for the development of psychiatric illness such as posttraumatic stress disorder (PTSD). We sought to evaluate how omega-3 fatty acids during brain maturation can influence challenges incurred during adulthood (transitioning to unhealthy diet and mTBI) and predispose the brain to a PTSD-like pathobiology. Rats exposed to diets enriched or deficient in omega-3 fatty acids (n-3) during their brain maturation period, were transitioned to a western diet (WD) when becoming adult and then subjected to mTBI. TBI resulted in an increase in anxiety-like behavior and its molecular counterpart NPY1R, a hallmark of PTSD, but these effects were more pronounced in the animals exposed to n-3 deficient diet and switched to WD. The n-3 deficiency followed by WD disrupted BDNF signaling and the activation of elements of BDNF signaling pathway (TrkB, CaMKII, Akt and CREB) in frontal cortex. TBI worsened these effects and more prominently in combination with the n-3 deficiency condition. Moreover, the n-3 deficiency primed the immune system to the challenges imposed by the WD and brain trauma as evidenced by results showing that the WD or mTBI affected brain IL1b levels and peripheral Th17 and Treg subsets only in animals previously conditioned to the n-3 deficient diet. These results provide novel evidence for the capacity of maladaptive dietary habits to lower the threshold for neurological disorders in response to challenges.	[Tyagi, Ethika; Agrawal, Rahul; Zhuang, Yumei; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Abad, Catalina; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724; Abad, Catalina/0000-0001-9144-9310	National Institute of Health [NS050465, NS056413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050465, R01NS056413] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants NS050465 and NS056413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Bazarian JJ, 2012, J HEAD TRAUMA REHABI; Bowen A, 2010, ANXIETY STRESS COPIN, V23, P449, DOI 10.1080/10615800903414315; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chapkin RS, 2007, J NUTR, V137, p200S, DOI 10.1093/jn/137.1.200S; D R Jr BS, 2000, ENVIRON HEALTH PERSP, V108, P511; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Freeman MP, 2010, AM J PSYCHIAT, V167, P244, DOI 10.1176/appi.ajp.2009.09121746; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Issazadeh-Navikas S, 2012, MOL MED, V18, P95, DOI 10.2119/molmed.2011.00311; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Lewis MD, 2011, J CLIN PSYCHIAT, V72, P1585, DOI 10.4088/JCP.11m06879; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Neylan TC, 2011, BRAIN BEHAV IMMUN, V25, P524, DOI 10.1016/j.bbi.2010.12.001; Pandey SC, 2006, J NEUROSCI, V26, P8320, DOI 10.1523/JNEUROSCI.4988-05.2006; Primeaux SD, 2005, NEUROPSYCHOPHARMACOL, V30, P1589, DOI 10.1038/sj.npp.1300705; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Robidoux J, 2000, ENDOCRINOLOGY, V141, P2795, DOI 10.1210/en.141.8.2795; Sah R, 2009, BIOL PSYCHIAT, V66, P705, DOI 10.1016/j.biopsych.2009.04.037; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Stahl LA, 2008, CURR OPIN INVEST DR, V9, P57; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872	39	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57945	10.1371/journal.pone.0057945	http://dx.doi.org/10.1371/journal.pone.0057945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483949	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100059
J	Mero, IL; Gustavsen, MW; Saether, HS; Flam, ST; Berg-Hansen, P; Sondergaard, HB; Jensen, PEH; Berge, T; Bjolgerud, A; Muggerud, A; Aarseth, JH; Myhr, KM; Celius, EG; Sellebjerg, F; Hillert, J; Alfredsson, L; Olsson, T; Oturai, AB; Kockum, I; Lie, BA; Andreassen, BK; Harbo, HF				Mero, Inger-Lise; Gustavsen, Marte W.; Saether, Hanne S.; Flam, Siri T.; Berg-Hansen, Pal; Sondergaard, Helle B.; Jensen, Poul Erik H.; Berge, Tone; Bjolgerud, Anja; Muggerud, Aslaug; Aarseth, Jan H.; Myhr, Kjell-Morten; Celius, Elisabeth G.; Sellebjerg, Finn; Hillert, Jan; Alfredsson, Lars; Olsson, Tomas; Oturai, Annette Bang; Kockum, Ingrid; Lie, Benedicte A.; Andreassen, Bettina Kulle; Harbo, Hanne F.		Int Multiple Sclerosis Genetics	Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; DIAGNOSTIC-CRITERIA; CLINICAL-FEATURES; INTERFERON-BETA; SUSCEPTIBILITY; POPULATION; HLA-DRB1; GENOMEWIDE; DISABILITY; GUIDELINES	The presence of oligoclonal bands (OCB) in cerebrospinal fluid (CSF) is a typical finding in multiple sclerosis (MS). We applied data from Norwegian, Swedish and Danish (i.e. Scandinavian) MS patients from a genome-wide association study (GWAS) to search for genetic differences in MS relating to OCB status. GWAS data was compared in 1367 OCB positive and 161 OCB negative Scandinavian MS patients, and nine of the most associated SNPs were genotyped for replication in 3403 Scandinavian MS patients. HLA-DRB1 genotypes were analyzed in a subset of the OCB positive (n = 2781) and OCB negative (n = 292) MS patients and compared to 890 healthy controls. Results from the genome-wide analyses showed that single nucleotide polymorphisms (SNPs) from the HLA complex and six other loci were associated to OCB status. In SNPs selected for replication, combined analyses showed genome-wide significant association for two SNPs in the HLA complex; rs3129871 (p = 5.7x10(-15)) and rs3817963 (p = 5.7x10(-10)) correlating with the HLA-DRB1*15 and the HLA-DRB1*04 alleles, respectively. We also found suggestive association to one SNP in the Calsyntenin-2 gene (p = 8.83x10(-7)). In HLA-DRB1 analyses HLA-DRB1*15:01 was a stronger risk factor for OCB positive than OCB negative MS, whereas HLA-DRB1*04:04 was associated with increased risk of OCB negative MS and reduced risk of OCB positive MS. Protective effects of HLA-DRB1*01:01 and HLA-DRB1*07:01 were detected in both groups. The groups were different with regard to age at onset (AAO), MS outcome measures and gender. This study confirms both shared and distinct genetic risk for MS subtypes in the Scandinavian population defined by OCB status and indicates different clinical characteristics between the groups. This suggests differences in disease mechanisms between OCB negative and OCB positive MS with implications for patient management, which need to be further studied.	[Mero, Inger-Lise; Gustavsen, Marte W.; Saether, Hanne S.; Berg-Hansen, Pal; Berge, Tone; Bjolgerud, Anja; Muggerud, Aslaug; Celius, Elisabeth G.; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Mero, Inger-Lise; Saether, Hanne S.; Flam, Siri T.; Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Mero, Inger-Lise; Saether, Hanne S.; Flam, Siri T.; Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Sondergaard, Helle B.; Jensen, Poul Erik H.; Sellebjerg, Finn; Oturai, Annette Bang] Rigshosp, Dept Neurol, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark; [Berge, Tone] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Aarseth, Jan H.; Myhr, Kjell-Morten] Norwegian Multiple Sclerosis Registry, Bergen, Norway; [Aarseth, Jan H.; Myhr, Kjell-Morten] Haukeland Hosp, Dept Neurol, Biobank, N-5021 Bergen, Norway; [Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway; [Hillert, Jan] Karolinska Inst, Dept Clin Neurosci, Multiple Sclerosis Res Grp, Ctr Mol Med, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Olsson, Tomas; Kockum, Ingrid] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Res Grp, Stockholm, Sweden; [Andreassen, Bettina Kulle] Univ Oslo, Inst Clin Med, Dept Clin Mol Biol & Lab Sci EpiGen, Oslo, Norway; [Andreassen, Bettina Kulle] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Gustavsen, Marte W.; Berg-Hansen, Pal; Bjolgerud, Anja; Muggerud, Aslaug; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Rigshospitalet; University of Copenhagen; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Oslo; University of Oslo; University of Oslo	Harbo, HF (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	h.f.harbo@medisin.uio.no	Zipp, Frauke/C-9968-2015; Kockum, Ingrid/O-8781-2018; Alfredsson, Lars/AAC-9007-2019; Myhr, Kjell-Morten/H-1528-2018; Celius, Elisabeth Gulowsen/S-1387-2019; Goris, An/F-2943-2010; Saarela, Janna S/E-5369-2014; Goris, An/L-5852-2019; D'Alfonso, Sandra/K-7295-2014	Zipp, Frauke/0000-0002-1231-1928; Kockum, Ingrid/0000-0002-0867-4726; Alfredsson, Lars/0000-0003-1688-6697; Myhr, Kjell-Morten/0000-0002-0980-510X; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Goris, An/0000-0002-1276-6682; Goris, An/0000-0002-1276-6682; D'Alfonso, Sandra/0000-0002-3983-9925; Sondergaard, Helle Bach/0000-0001-9435-0658; Saarela, Janna/0000-0002-0853-6219; Olsson, Tomas/0000-0002-2938-1877; Comabella Lopez, Manuel/0000-0002-2373-6657; Sellebjerg, Finn/0000-0002-1333-9623	South-Eastern Norway Regional Health Authority; Research Council of Norway; Odd Fellow MS society; Danish Multiple Sclerosis Society; Swedish Medical Research Council; AFA foundation; Knut and Alice and Wallenbergs foundations; Council for Working Life and Social Research; Wellcome Trust, as part of the Wellcome Trust Case Control Consortium2 project [085475/B/08/Z, 085475/Z/08/Z]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Odd Fellow MS society; Danish Multiple Sclerosis Society; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AFA foundation; Knut and Alice and Wallenbergs foundations; Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Wellcome Trust, as part of the Wellcome Trust Case Control Consortium2 project; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for Health Research(National Institute for Health Research (NIHR))	The current study is funded by grants from the South-Eastern Norway Regional Health Authority, the Research Council of Norway, the Odd Fellow MS society, the Danish Multiple Sclerosis Society, the Swedish Medical Research Council, the AFA foundation, Knut and Alice and Wallenbergs foundations and Council for Working Life and Social Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all patients and healthy controls for their participation. The International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium2 provided the genotypes used in the screening phase of this study. We acknowledge the collaboration and principal funding for the genome-wide study provided by the Wellcome Trust, as part of the Wellcome Trust Case Control Consortium2 project (085475/B/08/Z and 085475/Z/08/Z). We thank all contributors to the collection of samples and clinical data in the Norwegian MS Registry and Biobank. The Norwegian Bone Marrow Donor Registry, Rikshospitalet, Oslo University Hospital are acknowledged for providing Norwegian controls. The Centre for Integrative Genetics; CIGENE, Norwegian University of Life Sciences (UMB) Aas is thanked for performing Sequenom analyses.	ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Annunziata P, 2006, J NEUROL SCI, V244, P97, DOI 10.1016/j.jns.2006.01.004; Ballerini C, 2004, J NEUROIMMUNOL, V150, P178, DOI 10.1016/j.jneuroim.2004.01.015; Balnyte R, 2011, MEDICINA-LITHUANIA, V47, P368, DOI 10.3390/medicina47070052; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Buck D, 2012, ANN NEUROL; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Idiman E, 2009, J NEUROIMMUNOL, V212, P121, DOI 10.1016/j.jneuroim.2009.04.014; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; Imrell K, 2009, J NEUROIMMUNOL, V210, P128, DOI 10.1016/j.jneuroim.2009.03.005; JERSILD C, 1972, LANCET, V1, P1240; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Kikuchi S, 2003, NEUROLOGY, V60, P647, DOI 10.1212/01.WNL.0000048202.09147.9E; Lechner-Scott J, 2011, MULT SCLER; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Link J, 2010, J NEUROIMMUNOL, V226, P172, DOI 10.1016/j.jneuroim.2010.07.006; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; Lorentzen AR, 2009, ANN NEUROL, V65, P658, DOI 10.1002/ana.21695; Lourenco P, 2012, MULT SCLER; Lundkvist M, 2010, MULT SCLER J, V16, P796, DOI 10.1177/1352458510373112; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romero-Pinel L, 2011, EUR J NEUROL, V18, P1258, DOI 10.1111/j.1468-1331.2011.03379.x; SaruhanDireskeneli G, 1997, HUM IMMUNOL, V55, P59, DOI 10.1016/S0198-8859(97)00086-4; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; Sedille-Mostafaie N, 2012, J NEURAL TRANSM, V119, P77, DOI 10.1007/s00702-011-0667-9; Siritho S, 2009, J NEUROL SCI, V279, P21, DOI 10.1016/j.jns.2008.12.029; Tintore M, 2009, MULT SCLER J, V15, P407, DOI 10.1177/1352458509104581; Wu JS, 2010, J NEUROL SCI, V288, P63, DOI 10.1016/j.jns.2009.10.005; Zhang QO, 2011, AUTOIMMUN REV, V10, P474, DOI 10.1016/j.autrev.2011.03.003	42	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58352	10.1371/journal.pone.0058352	http://dx.doi.org/10.1371/journal.pone.0058352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472185	gold, Green Published, Green Submitted			2022-12-25	WOS:000315637900131
J	Rodriguez, JE; Ramirez, AS; Salas, LP; Helguera-Repetto, C; Gonzalez-y-Merchand, J; Soto, CY; Hernandez-Pando, R				Rodriguez, Jimmy E.; Ramirez, Ana S.; Salas, Laura P.; Helguera-Repetto, Cecilia; Gonzalez-y-Merchand, Jorge; Soto, Carlos Y.; Hernandez-Pando, Rogelio			Transcription of Genes Involved in Sulfolipid and Polyacyltrehalose Biosynthesis of Mycobacterium tuberculosis in Experimental Latent Tuberculosis Infection	PLOS ONE			English	Article							NONREPLICATING PERSISTENCE; CELL-WALL; DIFFERENTIAL EXPRESSION; PULMONARY TUBERCULOSIS; HYPOXIC CONDITIONS; NEUTRAL-RED; VIRULENCE; SULFOGLYCOLIPIDS; ACYLTRANSFERASES; BIOGENESIS	The Influence of trehalose-based glycolipids in the virulence of Mycobacterium tuberculosis (Mtb) is recognised; however, the actual role of these cell-wall glycolipids in latent infection is unknown. As an initial approach, we determined by two-dimensional thin-layer chromatography the sulfolipid (SL) and diacyltrehalose/polyacyltrehalose (DAT/PAT) profile of the cell wall of hypoxic Mtb. Then, qRT-PCR was extensively conducted to determine the transcription profile of genes involved in the biosynthesis of these glycolipids in non-replicating persistent 1 (NRP1) and anaerobiosis (NRP2) models of hypoxia (Wayne model), and murine models of chronic and progressive pulmonary tuberculosis. A diminished content of SL and increased amounts of glycolipids with chromatographic profile similar to DAT were detected in Mtb grown in the NRP2 stage. A striking decrease in the transcription of mmpL8 and mmpL10 transporter genes and increased transcription of the pks (polyketidesynthase) genes involved in SL and DAT biosynthesis were detected in both the NRP2 stage and the murine model of chronic infection. All genes were found to be up-regulated in the progressive disease. These results suggest that SL production is diminished during latent infection and the DAT/PAT precursors can be accumulated inside tubercle bacilli and are possibly used in reactivation processes.	[Rodriguez, Jimmy E.; Ramirez, Ana S.; Soto, Carlos Y.] Univ Nacl Colombia, Fac Ciencias, Dept Quim, Bogota, Colombia; [Salas, Laura P.; Helguera-Repetto, Cecilia; Gonzalez-y-Merchand, Jorge] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Microbiol Mol, Mexico City, DF, Mexico; [Hernandez-Pando, Rogelio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Secc Patol Expt, Mexico City, DF, Mexico	Universidad Nacional de Colombia; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Hernandez-Pando, R (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Secc Patol Expt, Mexico City, DF, Mexico.	rhdezpando@hotmail.com	Ramirez, Ana S./AAS-9922-2021	Ramirez, Ana S./0000-0002-1619-0721; Hernandez-Pando, Rogelio/0000-0003-1292-3833; Helguera Repetto, A Cecilia/0000-0001-6715-9671; Soto Ospina, Carlos Yesid/0000-0001-8694-7489	Division de Investigacion Bogota, Vicerrectoria de Investigacion, Universidad Nacional de Colombia [8003272, 16060]; CONACyT [84456, CB-2010-01-156347]; 7th Framework Program, European Commission [HEALTH-F3-2008-200999]	Division de Investigacion Bogota, Vicerrectoria de Investigacion, Universidad Nacional de Colombia; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 7th Framework Program, European Commission	This work was supported by Division de Investigacion Bogota, Vicerrectoria de Investigacion, Universidad Nacional de Colombia [Grants number 8003272 and 16060]; CONACyT [contract 84456 and grant number CB-2010-01-156347] and the 7th Framework Program, European Commission [contract number HEALTH-F3-2008-200999].	Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Badillo-Lopez C, 2010, INT MICROBIOL, V13, P9, DOI 10.2436/20.1501.01.106; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cardona PJ, 2006, MICROBES INFECT, V8, P183, DOI 10.1016/j.micinf.2005.06.011; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Fritz C, 2002, INFECT IMMUN, V70, P286, DOI 10.1128/IAI.70.1.286-291.2002; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GonzalezyMerchand JA, 1996, MICROBIOL-UK, V142, P667, DOI 10.1099/13500872-142-3-667; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Hernandez-Pando R, 2001, EXP TOXICOL PATHOL, V53, P257, DOI 10.1078/0940-2993-00182; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kim SY, 2008, J MED MICROBIOL, V57, P1473, DOI 10.1099/jmm.0.2008/001545-0; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Layre E, 2011, J LIPID RES, V52, P1098, DOI 10.1194/jlr.M013482; LUQUIN M, 1991, INT J SYST BACTERIOL, V41, P390, DOI 10.1099/00207713-41-3-390; Munoz M, 1997, FEMS MICROBIOL LETT, V157, P251, DOI 10.1016/S0378-1097(97)00483-7; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Soto CY, 2000, FEMS MICROBIOL LETT, V187, P103, DOI 10.1016/S0378-1097(00)00183-X; Soto CY, 2002, J CLIN MICROBIOL, V40, P3021, DOI 10.1128/JCM.40.8.3021-3024.2002; Starck J, 2004, MICROBIOL-SGM, V150, P3821, DOI 10.1099/mic.0.27284-0; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WHO, 2011, WHO GLOBAL TUBERCULO; Yu GH, 2011, GENE, V489, P21, DOI 10.1016/j.gene.2011.08.019	43	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58378	10.1371/journal.pone.0058378	http://dx.doi.org/10.1371/journal.pone.0058378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472191	Green Submitted, gold, Green Published			2022-12-25	WOS:000315637900137
J	Alves, SP; Santos-Silva, J; Cabrita, ARJ; Fonseca, AJM; Bessa, RJB				Alves, Susana P.; Santos-Silva, Jose; Cabrita, Ana R. J.; Fonseca, Antonio J. M.; Bessa, Rui J. B.			Detailed Dimethylacetal and Fatty Acid Composition of Rumen Content from Lambs Fed Lucerne or Concentrate Supplemented with Soybean Oil	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; MILK-FAT; DICARBOXYLIC-ACIDS; OLEIC-ACID; IN-VITRO; IDENTIFICATION; BIOHYDROGENATION; BACTERIA; QUALITY; LIPIDS	Lipid metabolism in the rumen is responsible for the complex fatty acid profile of rumen outflow compared with the dietary fatty acid composition, contributing to the lipid profile of ruminant products. A method for the detailed dimethylacetal and fatty acid analysis of rumen contents was developed and applied to rumen content collected from lambs fed lucerne or concentrate based diets supplemented with soybean oil. The methodological approach developed consisted on a basic/acid direct transesterification followed by thin-layer chromatography to isolate fatty acid methyl esters from dimethylacetal, oxo- fatty acid and fatty acid dimethylesters. The dimethylacetal composition was quite similar to the fatty acid composition, presenting even-, odd- and branched-chain structures. Total and individual odd- and branched-chain dimethylacetals were mostly affected by basal diet. The presence of 18:1 dimethylacetals indicates that biohydrogenation intermediates might be incorporated in structural microbial lipids. Moreover, medium-chain fatty acid dimethylesters were identified for the first time in the rumen content despite their concentration being relatively low. The fatty acids containing 18 carbon-chain lengths comprise the majority of the fatty acids present in the rumen content, most of them being biohydrogenation intermediates of 18:2n-6 and 18:3n-3. Additionally, three oxo- fatty acids were identified in rumen samples, and 16-O-18:0 might be produced during biohydrogenation of the 18:3n-3.	[Alves, Susana P.; Santos-Silva, Jose] INRB, Unidade Prod Anim, Vale De Santarem, Portugal; [Alves, Susana P.; Bessa, Rui J. B.] Univ Tecn Lisboa, CIISA, FMV, P-1100 Lisbon, Portugal; [Cabrita, Ana R. J.] Univ Porto, REQUIMTE, Dept Geociencias Ambiente & OrdenamentoTerr, Fac Ciencias, Vairao, Portugal; [Fonseca, Antonio J. M.] Univ Porto, ICBAS, REQUIMTE, P-4100 Oporto, Portugal	Universidade de Lisboa; Universidade do Porto; Universidade do Porto	Alves, SP (corresponding author), INRB, Unidade Prod Anim, Vale De Santarem, Portugal.	susanaalves@fmv.utl.pt	Alves, Susana P/C-1447-2008; Cabrita, Ana/C-2731-2008; Santos-Silva, José M B/B-1931-2017; Bessa, Rui J. B./B-8006-2008; Alves, Susana/Q-3889-2019; Fonseca, António/A-5743-2008	Alves, Susana P/0000-0002-3171-9566; Cabrita, Ana/0000-0002-1904-0358; Santos-Silva, José M B/0000-0002-9171-0977; Bessa, Rui J. B./0000-0003-4109-3488; Alves, Susana/0000-0002-3171-9566; Fonseca, António/0000-0001-6237-417X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/76836/2011, PEst-OE/AGR/UI0276/2011, PEst-C/EQB/LA0006/2011]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	SPA was supported by Fundacao para a Ciencia e a Tecnologia (FCT) (www.fct.pt) through the grant SFRH/BPD/76836/2011. The work was also supported by Fundacao para a Ciencia e a Tecnologia through grants PEst-OE/AGR/UI0276/2011 and PEst-C/EQB/LA0006/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldai N, 2011, ANIMAL, V5, P1643, DOI 10.1017/S1751731111000607; Aldai N, 2012, MEAT SCI, V92, P687, DOI 10.1016/j.meatsci.2012.06.024; Alves SP, 2011, J ANIM SCI, V89, P2537, DOI 10.2527/jas.2010-3128; Alves SP, 2007, EUR J LIPID SCI TECH, V109, P879, DOI 10.1002/ejlt.200700035; Alves SP, 2009, J CHROMATOGR A, V1216, P5130, DOI 10.1016/j.chroma.2009.04.079; Bas P, 2003, J DAIRY SCI, V86, P2940, DOI 10.3168/jds.S0022-0302(03)73891-0; BAUMANN NA, 1965, J BIOL CHEM, V240, P1559; Bessa RJB, 2009, ANIM FEED SCI TECH, V150, P197, DOI 10.1016/j.anifeedsci.2008.09.005; Bessa RJB, 2005, LIVEST PROD SCI, V96, P185, DOI 10.1016/j.livprodsci.2005.01.017; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; BRECHANY EY, 1992, J DAIRY RES, V59, P57, DOI 10.1017/S0022029900030247; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Chilliard Y, 2007, EUR J LIPID SCI TECH, V109, P828, DOI 10.1002/ejlt.200700080; Cruz-Hernandez C, 2007, J DAIRY SCI, V90, P3786, DOI 10.3168/jds.2006-698; Dembitsky VM, 2001, BIOCHEMISTRY-MOSCOW+, V66, P72, DOI 10.1023/A:1002837830653; Destaillats F, 2005, J DAIRY SCI, V88, P3231, DOI 10.3168/jds.S0022-0302(05)73006-X; FARQUHAR JW, 1962, J LIPID RES, V3, P21; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; Gomez-Cortes P, 2009, J LIPID RES, V50, P2412, DOI 10.1194/jlr.M800662-JLR200; Green KD, 2000, ENZYME MICROB TECH, V27, P205, DOI 10.1016/S0141-0229(00)00217-9; GRIINARI J. M., 1999, BIOSYNTHESIS CONJUGA, V1, P180; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P186, DOI 10.1016/j.bbalip.2010.12.010; Harfoot C, 1997, RUMEN MICROBIAL ECOS, P382; Hudson JA, 1995, APPL MICROBIOL BIOT, V44, P1, DOI 10.1007/BF00164472; Jenkins TC, 2005, J DAIRY SCI, V88, P371; Jenkins TC, 2010, J DAIRY SCI, V93, P1170, DOI 10.3168/jds.2009-2509; JENKINS TC, 1982, J ANIM SCI, V55, P957, DOI 10.2527/jas1982.554957x; Jeronimo E, 2010, ANIM FEED SCI TECH, V158, P136, DOI 10.1016/j.anifeedsci.2010.04.010; Joint FAO/WHO Expert Consultation, 2009, ANN NUTR METAB, V55; Jouany JP, 2007, LIPIDS, V42, P351, DOI 10.1007/s11745-007-3032-x; Kairenius P, 2011, LIPIDS, V46, P587, DOI 10.1007/s11745-011-3561-1; Kalscheur KF, 1997, J DAIRY SCI, V80, P2104, DOI 10.3168/jds.S0022-0302(97)76156-3; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KATZ I, 1966, J DAIRY SCI, V49, P967, DOI 10.3168/jds.S0022-0302(66)87991-2; KATZ I, 1964, BIOCHIM BIOPHYS ACTA, V84, P128, DOI 10.1016/0926-6542(64)90068-X; KLEIN RA, 1979, BIOCHEM J, V183, P691, DOI 10.1042/bj1830691; KUSUNOSE M, 1964, J BIOL CHEM, V239, P1374; Laverroux S, 2011, LIPIDS, V46, P843, DOI 10.1007/s11745-011-3584-7; MAHADEVA.V, 1967, J LIPID RES, V8, P2; Maia MRG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-52; MINATO H, 1988, J GEN APPL MICROBIOL, V34, P303, DOI 10.2323/jgam.34.303; MIYAGAWA E, 1982, J GEN APPL MICROBIOL, V28, P389, DOI 10.2323/jgam.28.389; MORRISON WR, 1964, J LIPID RES, V5, P600; Pariza MW, 2001, PROG LIPID RES, V40, P283, DOI 10.1016/S0163-7827(01)00008-X; PASSI S, 1993, BIOCHIM BIOPHYS ACTA, V1168, P190, DOI 10.1016/0005-2760(93)90124-R; Precht D, 2000, EUR J LIPID SCI TECH, V102, P102, DOI 10.1002/(SICI)1438-9312(200002)102:2<102::AID-EJLT102>3.3.CO;2-3; Santercole V, 2007, LIPIDS, V42, P361, DOI 10.1007/s11745-006-3003-7; Shingfield KJ, 2008, BRIT J NUTR, V99, P971, DOI 10.1017/S0007114507853323; Shingfield KJ, 2010, ANIMAL, V4, P1140, DOI 10.1017/S1751731110000510; Van Kessel JS, 2002, J ANIM SCI, V80, P3027; Viviani R, 1970, Adv Lipid Res, V8, P267; Vlaeminck B, 2008, J DAIRY SCI, V91, P1122, DOI 10.3168/jds.2007-0537; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Vlaeminck B, 2006, J DAIRY SCI, V89, P2668, DOI 10.3168/jds.S0022-0302(06)72343-8; WEIHRAUCH JL, 1974, LIPIDS, V9, P883, DOI 10.1007/BF02532614; Wolff RL, 2002, LIPIDS, V37, P811, DOI 10.1007/s11745-002-0965-4	57	55	55	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58386	10.1371/journal.pone.0058386	http://dx.doi.org/10.1371/journal.pone.0058386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484024	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900084
J	Baek, SH; Shin, WC; Ryu, HS; Lee, DW; Moon, E; Seo, CS; Hwang, E; Lee, HS; Ahn, MH; Jeon, Y; Kang, HJ; Lee, SW; Kim, SY; D'Souza, R; Kim, HJ; Hong, ST; Jeon, JS				Baek, So-Hyeon; Shin, Woon-Chul; Ryu, Hak-Seung; Lee, Dae-Woo; Moon, Eunjung; Seo, Chun-Sun; Hwang, Eunson; Lee, Hyun-Seo; Ahn, Mi-Hyun; Jeon, Youngju; Kang, Hyeon-Jung; Lee, Sang-Won; Kim, Sun Yeou; D'Souza, Roshan; Kim, Hyeon-Jin; Hong, Seong-Tshool; Jeon, Jong-Seong			Creation of Resveratrol-Enriched Rice for the Treatment of Metabolic Syndrome and Related Diseases	PLOS ONE			English	Article							STILBENE SYNTHASE GENE; EXPRESSION; SIRT1; GLUCOSYLTRANSFERASE; SIRTUINS; RATS; MICE	Resveratrol has been clinically shown to possess a number of human health benefits. As a result, many attempts have been made to engineer resveratrol production in major cereal grains but have been largely unsuccessful. In this study, we report the creation of a transgenic rice plant that accumulates 1.9 mu g resveratrol/g in its grain, surpassing the previously reported anti-metabolic syndrome activity of resveratrol through a synergistic interaction between the transgenic resveratrol and the endogenous properties of the rice. Consumption of our transgenic resveratrol-enriched rice significantly improved all aspects of metabolic syndrome and related diseases in animals fed a high-fat diet. Compared with the control animals, the resveratrol-enriched rice reduced body weight, blood glucose, triglycerides, total cholesterol, and LDL-cholesterol by 24.7%, 22%, 37.4%, 27%, and 59.6%, respectively. The resveratrol-enriched rice from our study may thus provide a safe and convenient means of preventing metabolic syndrome and related diseases without major lifestyle changes or the need for daily medications. These results also suggest that future transgenic plants could be improved if the synergistic interactions of the transgene with endogenous traits of the plant are considered in the experimental design.	[Baek, So-Hyeon; Shin, Woon-Chul; Seo, Chun-Sun; Kang, Hyeon-Jung] Rural Dev Adm, Natl Inst Crop Sci, Iksan, South Korea; [Ryu, Hak-Seung; Lee, Dae-Woo; Jeon, Jong-Seong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, Gyeonggi, South Korea; [Ryu, Hak-Seung; Lee, Dae-Woo; Lee, Sang-Won; Jeon, Jong-Seong] Kyung Hee Univ, Crop Biotech Inst, Yongin, Gyeonggi, South Korea; [Moon, Eunjung; Hwang, Eunson] Kyung Hee Univ, Grad Sch East West Med Sci, Yongin, Gyeonggi, South Korea; [Lee, Hyun-Seo; Ahn, Mi-Hyun; Jeon, Youngju; Hong, Seong-Tshool] Chonbuk Natl Univ, Genet Lab, Sch Med, Jeonju, Chonbuk, South Korea; [Lee, Hyun-Seo; Ahn, Mi-Hyun; Jeon, Youngju; Hong, Seong-Tshool] Chonbuk Natl Univ, Dept Microbiol, Sch Med, Jeonju, Chonbuk, South Korea; [Lee, Sang-Won] Kyung Hee Univ, Dept Plant Mol Syst Biotechnol, Yongin, Gyeonggi, South Korea; [Kim, Sun Yeou] Gachon Univ, Coll Pharm, Inchon, South Korea; [D'Souza, Roshan; Kim, Hyeon-Jin] JINIS Biopharmaceut Inc, BDRD Res Inst, Wonju, Chonbuk, South Korea	Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Kyung Hee University; Kyung Hee University; Kyung Hee University; Jeonbuk National University; Jeonbuk National University; Kyung Hee University; Gachon University	Hong, ST (corresponding author), Chonbuk Natl Univ, Genet Lab, Sch Med, Jeonju, Chonbuk, South Korea.	seonghong@chonbuk.ac.kr; jjeon@khu.ac.kr	Jeon, Jong-Seong/AAJ-2161-2020; Dsouza, Roshan/Q-2965-2019; Kim, Hyeonjin/M-3761-2019	Jeon, Jong-Seong/0000-0001-6221-4993; Hong, Seong-Tshool/0000-0001-8254-6581; Kim, Hyeon Jin/0000-0003-3117-353X	Next-Generation BioGreen 21 Program [PJ0079732012]; RDA program, Rural Development Administration, Korea [PJ0075392012]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); RDA program, Rural Development Administration, Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ0079732012) and RDA program (No. PJ0075392012), Rural Development Administration, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekwilder J, 2006, APPL ENVIRON MICROB, V72, P5670, DOI 10.1128/AEM.00609-06; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Choi H, 2012, J KOREAN SOC APPL BI, V55, P19, DOI 10.1007/s13765-012-0004-5; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Delaunois B, 2009, PLANT BIOTECHNOL J, V7, P2, DOI 10.1111/j.1467-7652.2008.00377.x; Du H, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S42; Fischer R, 1997, PLANT J, V11, P489, DOI 10.1046/j.1365-313X.1997.11030489.x; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; Hall D, 2007, PLANT J, V49, P579, DOI 10.1111/j.1365-313X.2006.02987.x; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KIMURA Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P275; Leckband G, 1998, THEOR APPL GENET, V96, P1004, DOI 10.1007/s001220050832; Lee Sichul, 1999, Journal of Plant Biology, V42, P310; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Liu BL, 2007, CANCER BIOL THER, V6, P1833, DOI 10.4161/cbt.6.12.5161; Liu SJ, 2006, J AGR FOOD CHEM, V54, P8082, DOI 10.1021/jf061462k; Lunkenbein S, 2006, PLANT PHYSIOL, V140, P1047, DOI 10.1104/pp.105.074955; Meng XF, 2004, J AGR FOOD CHEM, V52, P935, DOI 10.1021/jf030582e; Morelli R, 2006, MOL CELL BIOCHEM, V282, P65, DOI 10.1007/s11010-006-1260-7; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NORMOLLE DP, 1993, STAT MED, V12, P2025, DOI 10.1002/sim.4780122106; Sobolev VS, 2011, J AGR FOOD CHEM, V59, P1673, DOI 10.1021/jf104742n; Souto AA, 2001, J FOOD COMPOS ANAL, V14, P441, DOI 10.1006/jfca.2000.0970; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; StarkLorenzen P, 1997, PLANT CELL REP, V16, P668, DOI 10.1007/s002990050299; Sydor T, 2010, APPL ENVIRON MICROB, V76, P3361, DOI 10.1128/AEM.02796-09; Yang W, 2001, PROTEIN EXPRES PURIF, V22, P472, DOI 10.1006/prep.2001.1453; Zhuang H, 2003, ANN NY ACAD SCI, V993, P276, DOI 10.1111/j.1749-6632.2003.tb07534.x	31	44	48	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57930	10.1371/journal.pone.0057930	http://dx.doi.org/10.1371/journal.pone.0057930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483945	Green Submitted, Green Published, gold			2022-12-25	WOS:000315634900056
J	Gouriou, Y; Bijlenga, P; Demaurex, N				Gouriou, Yves; Bijlenga, Philippe; Demaurex, Nicolas			Mitochondrial Ca2+ Uptake from Plasma Membrane Cav3.2 Protein Channels Contributes to Ischemic Toxicity in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; NA+/CA2+ EXCHANGER; CALCIUM UNIPORTER; NEURONAL DEATH; EXCITOTOXICITY; TRANSPORT; RESPONSES; ALPHA-1H; HYPOXIA; SIGNALS	T-type Ca2+ channel inhibitors protect hippocampal CA1 neurons from delayed death after global ischemia in rats, suggesting that Cav3.1, Cav3.2, or Cav3.3 channels generate cytotoxic Ca2+ elevations during anoxia. To test this hypothesis, we measured the Ca2+ concentration changes evoked by oxygen and glucose deprivation (OGD) in the cytosol and in the mitochondria of PC12 cells. OGD evoked long-lasting cytosolic Ca2+ elevations that were reduced by Cav3.2 inhibition (50 mu M Ni2+) and Cav3.1/Cav3.2 silencing and potentiated by Cav3.2 overexpression. The kinetics of the sustained cytosolic Ca2+ elevations occurring during OGD directly correlated to the extent of cell death measured 20 h after reoxygenation, which was decreased by Ni2+ and Cav3.1/Cav3.2 silencing and increased by Cav3.2 overexpression. Ni2+ and Cav3.1/Cav3.2 silencing delayed the decline of cellular ATP during OGD, consistent with a reduction in the Ca2+ load actively extruded by plasma membrane Ca2+ pumps. The cytosolic Ca2+ elevations were paralleled by mitochondrial Ca2+ elevations that were also increased by Cav3.2 overexpression and decreased by Ni2+ but not by Cav3.1/Cav3.2 silencing. Overexpression and silencing of the mitochondrial Ca2+ uniporter, the major mitochondrial Ca2+ uptake protein, revealed that the cytotoxicity was correlated to the amplitude of the mitochondrial, rather than the cytosolic, Ca2+ elevations. Selective activation of T-type Ca2+ channels evoked both cytosolic and mitochondrial Ca2+ elevations, but only the mitochondrial responses were reduced by Cav3.1/Cav3.2 silencing. We conclude that the opening of Cav3.2 channels during ischemia contribute to the entry of Ca2+ ions that are transmitted to mitochondria, resulting in a deleterious mitochondrial Ca2+ overload.	[Gouriou, Yves; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Gouriou, Yves; Bijlenga, Philippe] Univ Geneva, Dept Fundamental Neurosci, CH-1211 Geneva 4, Switzerland; [Bijlenga, Philippe] Univ Geneva, Dept Clin Neurosci, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Demaurex, N (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Nicolas.Demaurex@unige.ch	Gouriou, Yves/ADY-8018-2022; Bijlenga, Philippe/S-1049-2016	Bijlenga, Philippe/0000-0002-3586-2757; Gouriou, Yves/0000-0003-2565-4935; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [310030B-133126]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation Grant 310030B-133126 (to N. D.).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bancila M, 2011, FUND CLIN PHARMACOL, V25, P469, DOI 10.1111/j.1472-8206.2010.00879.x; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Bragadin M, 1997, J INORG BIOCHEM, V66, P227, DOI 10.1016/S0162-0134(96)00207-3; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1007/BF03206566; Czyz A, 2002, J NEUROCHEM, V83, P1321, DOI 10.1046/j.1471-4159.2002.01227.x; Davidson T, 2005, MOL CELL BIOCHEM, V279, P157, DOI 10.1007/s11010-005-8288-y; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Del Toro R, 2003, J BIOL CHEM, V278, P22316, DOI 10.1074/jbc.M212576200; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Demaurex N, 2009, NAT NEUROSCI, V12, P819, DOI 10.1038/nn0709-819; GARBER SS, 1989, J NEUROSCI, V9, P3976; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gouriou Y, 2011, BIOCHIMIE, V93, P2060, DOI 10.1016/j.biochi.2011.08.001; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jeffs GJ, 2007, J CLIN NEUROSCI, V14, P507, DOI 10.1016/j.jocn.2006.07.013; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nikonenko I, 2005, MOL PHARMACOL, V68, P84, DOI 10.1124/mol.104.010066; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pacher P, 2002, P NATL ACAD SCI USA, V99, P2380, DOI 10.1073/pnas.032423699; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zhu WH, 1996, AM J PHYSIOL-CELL PH, V271, pC658, DOI 10.1152/ajpcell.1996.271.2.C658	39	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12459	12468		10.1074/jbc.M112.428128	http://dx.doi.org/10.1074/jbc.M112.428128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508951	Green Published, hybrid			2022-12-25	WOS:000318555100005
J	Basak, S; Lim, J; Manimekalai, MSS; Balakrishna, AM; Gruber, G				Basak, Sandip; Lim, Jackwee; Manimekalai, Malathy Sony Subramanian; Balakrishna, Asha Manikkoth; Grueber, Gerhard			Crystal and NMR Structures Give Insights into the Role and Dynamics of Subunit F of the Eukaryotic V-ATPase from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR-TYPE ATPASE; H+-ATPASE; CENTRAL STALK; COUPLING SUBUNIT; PERIPHERAL STALK; TERMINAL DOMAIN; V1VO ATPASE; V-1 ATPASE; SYNTHASE; COMPLEX	Subunit F of V-ATPases is proposed to undergo structural alterations during catalysis and reversible dissociation from the V1VO complex. Recently, we determined the low resolution structure of F from Saccharomyces cerevisiae V-ATPase, showing an N-terminal egg shape, connected to a C-terminal hook-like segment via a linker region. To understand the mechanistic role of subunit F of S. cerevisiae V-ATPase, composed of 118 amino acids, the crystal structure of the major part of F, F(1-94), was solved at 2.3 angstrom resolution. The structural features were confirmed by solution NMR spectroscopy using the entire F subunit. The eukaryotic F subunit consists of the N-terminal F(1-94) domain with four-parallel beta-strands, which are intermittently surrounded by four alpha-helices, and the C terminus, including the alpha 5-helix encompassing residues 103 to 113. Two loops (26)GQITPETQEK(35) and (ERDDI64)-E-60 are described to be essential in mechanistic processes of the V-ATPase enzyme. The (26)GQITPETQEK(35) loop becomes exposed when fitted into the recently determined EM structure of the yeast V1VO-ATPase. A mechanism is proposed in which the (26)GQITPETQEK(35) loop of subunit F and the flexible C-terminal domain of subunit H move in proximity, leading to an inhibitory effect of ATPase activity in V-1. Subunits D and F are demonstrated to interact with subunit d. Together with NMR dynamics, the role of subunit F has been discussed in the light of its interactions in the processes of reversible disassembly and ATP hydrolysis of V-ATPases by transmitting movements of subunit d and H of the V-O and V-1 sector, respectively.	[Basak, Sandip; Lim, Jackwee; Manimekalai, Malathy Sony Subramanian; Balakrishna, Asha Manikkoth; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg	Manikkoth Balakrishna, Asha/AFP-1973-2022; Basak, sandip/B-8007-2018	Manikkoth Balakrishna, Asha/0000-0001-5239-9015; Basak, sandip/0000-0003-4018-8020; Lim, Jackwee/0000-0003-4344-6822	A*STAR Biomedical Research Council [09/1/22/19/609]; Nanyang Technological University; National Research Program for Genomic Medicine	A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Nanyang Technological University(Nanyang Technological University); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This work was supported by A*STAR Biomedical Research Council Grant 09/1/22/19/609.; Supported by a Nanyang Technological University research scholarship.; We thank the staff at beamline 13B1 at National Synchrotron Radiation Research Centre, a national user facility supported by the National Science Council of Taiwan, for expert help with data collection. The Synchrotron Radiation Protein Crystallography Facility at the National Synchrotron Radiation Research Centre is supported by the National Research Program for Genomic Medicine. We thank Professor M. Featherstone (SBS, NTU) for reading the manuscript.	Armbruster A, 2004, FEBS LETT, V570, P119, DOI 10.1016/j.febslet.2004.06.029; Balakrishna AM, 2012, J MOL BIOL, V420, P155, DOI 10.1016/j.jmb.2012.04.012; Basak S, 2012, ACTA CRYSTALLOGR F, V68, P1055, DOI 10.1107/S1744309112032526; Basak S, 2011, BBA-BIOMEMBRANES, V1808, P360, DOI 10.1016/j.bbamem.2010.09.003; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Boniecki MT, 2012, J BIOL CHEM, V287, P11285, DOI 10.1074/jbc.C111.325795; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Coskun U, 2004, J BIOENERG BIOMEMBR, V36, P249, DOI 10.1023/B:JOBB.0000031976.44466.6e; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gayen S, 2007, BIOCHEMISTRY-US, V46, P11684, DOI 10.1021/bi701102n; Goddard T., 1997, SPARKY VERSION 3; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Gruber G, 2008, BIOESSAYS, V30, P1096, DOI 10.1002/bies.20827; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Hosokawa H, 2013, J BIOL CHEM, V288, P5896, DOI 10.1074/jbc.M112.409169; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar A, 2010, J MOL BIOL, V396, P301, DOI 10.1016/j.jmb.2009.11.046; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Raghunathan D, 2010, BIOCHEMISTRY-US, V49, P4181, DOI 10.1021/bi9021236; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P447, DOI 10.1007/s10863-011-9379-y; Rishikesan S, 2010, BBA-BIOMEMBRANES, V1798, P1961, DOI 10.1016/j.bbamem.2010.06.012; Rishikesan S, 2009, BBA-BIOENERGETICS, V1787, P242, DOI 10.1016/j.bbabio.2009.01.010; Rusu M, 2008, BIOINFORMATICS, V24, P2460, DOI 10.1093/bioinformatics/btn461; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Schafer I, 2006, J BIOENERG BIOMEMBR, V38, P83, DOI 10.1007/s10863-006-9015-4; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thaker YR, 2007, J BIOENERG BIOMEMBR, V39, P275, DOI 10.1007/s10863-007-9089-7; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	57	8	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11930	11939		10.1074/jbc.M113.461533	http://dx.doi.org/10.1074/jbc.M113.461533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23476018	hybrid, Green Published			2022-12-25	WOS:000318157600028
J	Ramalho-Carvalho, J; Pires, M; Lisboa, S; Graca, I; Rocha, P; Barros-Silva, JD; Savva-Bordalo, J; Mauricio, J; Resende, M; Teixeira, MR; Honavar, M; Henrique, R; Jeronimo, C				Ramalho-Carvalho, Joao; Pires, Malini; Lisboa, Susana; Graca, Ines; Rocha, Patricia; Barros-Silva, Joao Diogo; Savva-Bordalo, Joana; Mauricio, Joaquina; Resende, Mario; Teixeira, Manuel R.; Honavar, Mrinalini; Henrique, Rui; Jeronimo, Carmen			Altered Expression of MGMT in High-Grade Gliomas Results from the Combined Effect of Epigenetic and Genetic Aberrations	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PROMOTER HYPERMETHYLATION; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; CPG METHYLATION; MS-MLPA; CANCER; DNA; GLIOBLASTOMA; TEMOZOLOMIDE	MGMT downregulation in high-grade gliomas (HGG) has been mostly attributed to aberrant promoter methylation and is associated with increased sensitivity to alkylating agent-based chemotherapy. However, HGG harboring 10q deletions also benefit from treatment with alkylating agents. Because the MGMT gene is mapped at 10q26, we hypothesized that both epigenetic and genetic alterations might affect its expression and predict response to chemotherapy. To test this hypothesis, promoter methylation and mRNA levels of MGMT were determined by quantitative methylation-specific PCR (qMSP) or methylation-specific multiplex ligation dependent probe amplification (MS-MLPA) and quantitative RT-PCR, respectively, in a retrospective series of 61 HGG. MGMT/chromosome 10 copy number variations were determined by FISH or MS-MLPA analysis. Molecular findings were correlated with clinical parameters to assess their predictive value. Overall, MGMT methylation ratios assessed by qMSP and MS-MLPA were inversely correlated with mRNA expression levels (best coefficient value obtained with MS-MLPA). By FISH analysis in 68.3% of the cases there was loss of 10q26.1 and in 15% of the cases polysomy was demonstrated; the latter displayed the highest levels of transcript. When genetic and epigenetic data were combined, cases with MGMT promoter methylation and MGMT loss depicted the lowest transcript levels, although an impact in response to alkylating agent chemotherapy was not apparent. Cooperation between epigenetic (promoter methylation) and genetic (monosomy, locus deletion) changes affecting MGMT in HGG is required for effective MGMT silencing. Hence, evaluation of copy number alterations might add relevant prognostic and predictive information concerning response to alkylating agent-based chemotherapy.	[Ramalho-Carvalho, Joao; Pires, Malini; Graca, Ines; Savva-Bordalo, Joana; Henrique, Rui; Jeronimo, Carmen] Res Ctr Portuguese Oncol Inst Porto, Canc Epigenet Grp, Oporto, Portugal; [Barros-Silva, Joao Diogo; Teixeira, Manuel R.] Res Ctr Portuguese Oncol Inst Porto, Canc Genet Grp, Oporto, Portugal; [Ramalho-Carvalho, Joao; Pires, Malini; Lisboa, Susana; Graca, Ines; Rocha, Patricia; Barros-Silva, Joao Diogo; Teixeira, Manuel R.; Jeronimo, Carmen] Portuguese Oncol Inst Porto, Dept Genet, Oporto, Portugal; [Savva-Bordalo, Joana; Mauricio, Joaquina] Portuguese Oncol Inst Porto, Dept Med Oncol, Oporto, Portugal; [Henrique, Rui] Portuguese Oncol Inst Porto, Dept Pathol, Oporto, Portugal; [Teixeira, Manuel R.; Henrique, Rui; Jeronimo, Carmen] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Resende, Mario] Hosp Pedro Hispano, Local Hlth Unit Matosinhos, Dept Neurosurg, Matosinhos, Portugal; [Honavar, Mrinalini] Hosp Pedro Hispano, Local Hlth Unit Matosinhos, Dept Pathol, Matosinhos, Portugal	Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Universidade do Porto	Jeronimo, C (corresponding author), Res Ctr Portuguese Oncol Inst Porto, Canc Epigenet Grp, Oporto, Portugal.	carmenjeronimo@ipoporto.min-saude.pt	Ramalho-Carvalho, João/U-2356-2017; Teixeira, Manuel AC/AAZ-7251-2020; Henrique, Rui Manuel Ferreira/I-2757-2013; Teixeira, Manuel António Rodrigues/E-4885-2011; Jerónimo, Carmen/H-3284-2013; Vilela Resende, Mário Lúcio de Resende Mário Lúcio Vilela de/AAT-6646-2021	Ramalho-Carvalho, João/0000-0001-6140-7363; Teixeira, Manuel AC/0000-0002-1959-0624; Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Jerónimo, Carmen/0000-0003-4186-5345; Pires, Malini/0000-0002-9609-7550; Savva-Bordalo, Joana/0000-0002-9585-7474; Rocha, Patricia/0000-0001-6275-026X; Lisboa, Susana/0000-0002-9773-331X; Pinho dos Santos Graca, Maria Ines/0000-0003-1383-4242; Barros Silva, Joao Diogo/0000-0002-6648-0217	Liga Portuguesa Contra o Cancro - Nucleo Regional do Norte; FCT - Fundacao para a Ciencia e a Tecnologia [SFRH/BD/64082/2009, SFRH/BD/46574/2008]; Research Center of Portuguese Oncology Institute - Porto [CI-IPOP 4-2008]	Liga Portuguesa Contra o Cancro - Nucleo Regional do Norte; FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Research Center of Portuguese Oncology Institute - Porto	JR-C was supported by a grant from Liga Portuguesa Contra o Cancro - Nucleo Regional do Norte. IG and JDB-S are supported by grants from FCT - Fundacao para a Ciencia e a Tecnologia (SFRH/BD/64082/2009 and SFRH/BD/46574/2008, respectively). This study was funded by a research grant from the Research Center of Portuguese Oncology Institute - Porto (CI-IPOP 4-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barros-Silva JD, 2011, GENE CHROMOSOME CANC, V50, P662, DOI 10.1002/gcc.20888; Bourne TD, 2010, NAT REV NEUROL, V6, P695, DOI 10.1038/nrneurol.2010.159; Burton EC, 2002, CANCER RES, V62, P6205; Choy KW, 2005, NEOPLASIA, V7, P200, DOI 10.1593/neo.04565; Christians A, PLOS ONE, V7; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2002, J NATL CANCER I, V94, P26; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Hata N, 2006, CLIN CHEM, V52, P370, DOI 10.1373/clinchem.2005.060954; Havik AB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-36; Herfarth KKF, 1999, MOL CARCINOGEN, V24, P90, DOI 10.1002/(SICI)1098-2744(199902)24:2<90::AID-MC3>3.0.CO;2-B; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Karayan-Tapon L, 2010, J NEURO-ONCOL, V97, P311, DOI 10.1007/s11060-009-0031-1; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malley DS, 2011, ACTA NEUROPATHOL, V121, P651, DOI 10.1007/s00401-011-0803-5; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Nygren AOH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni127; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; PEGG AE, 1990, CANCER RES, V50, P6119; Preusser M, 2009, HISTOL HISTOPATHOL, V24, P511, DOI 10.14670/HH-24.511; Qian XLC, 1997, CANCER RES, V57, P3672; Robinson MD, 2010, GENOME RES, V20, P1719, DOI 10.1101/gr.110601.110; Shima K, CANC CAUSES CONTROL, V22, P301; Smith-Sorensen B, 2002, ONCOGENE, V21, P8878, DOI 10.1038/sj.onc.1205978; van den Bent MJ, 2009, J CLIN ONCOL, V27, P5881, DOI 10.1200/JCO.2009.24.1034; van Nifterik KA, BR J CANC, V103, P29; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wemmert S, 2005, NEOPLASIA, V7, P883, DOI 10.1593/neo.05307; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xue Heng-Chuan, 2008, Ai Zheng, V27, P1256	37	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58206	10.1371/journal.pone.0058206	http://dx.doi.org/10.1371/journal.pone.0058206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505468	Green Submitted, Green Published, gold			2022-12-25	WOS:000316251100034
J	Nguyen, NP; Smith-Raymond, L; Vinh-Hung, V; Vos, P; Davis, R; Desai, A; Sroka, T; Abraham, D; Krafft, SP; Stevie, M; Modarresifar, H; Jo, BH; Ceizyk, M				Nguyen, Nam P.; Smith-Raymond, Lexie; Vinh-Hung, Vincent; Vos, Paul; Davis, Rick; Desai, Anand; Sroka, Thomas; Abraham, Dave; Krafft, Shane P.; Stevie, Michelle; Modarresifar, Homayoun; Jo, Beng-Hoey; Ceizyk, Misty			Feasibility of Tomotherapy-Based Image-Guided Radiotherapy to Reduce Aspiration Risk in Patients with Non-Laryngeal and Non-Pharyngeal Head and Neck Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; LOCALLY ADVANCED HEAD; RADIATION-THERAPY; DYSPHAGIA SEVERITY; CHEMORADIOTHERAPY; CHEMORADIATION; IMPACT	Purpose: The study aims to assess the feasibility of Tomotherapy-based image-guided radiotherapy (IGRT) to reduce the aspiration risk in patients with non-laryngeal and non-hypopharyngeal cancer. A retrospective review of 48 patients undergoing radiation for non-laryngeal and non-hypopharyngeal head and neck cancers was conducted. All patients had a modified barium swallow (MBS) prior to treatment, which was repeated one month following radiotherapy. Mean middle and inferior pharyngeal dose was recorded and correlated with the MBS results to determine aspiration risk. Results: Mean pharyngeal dose was 23.2 Gy for the whole group. Two patients (4.2%) developed trace aspiration following radiotherapy which resolved with swallowing therapy. At a median follow-up of 19 months (1-48 months), all patients were able to resume normal oral feeding without aspiration. Conclusion and Clinical Relevance: IGRT may reduce the aspiration risk by decreasing the mean pharyngeal dose in the presence of large cervical lymph nodes. Further prospective studies with IGRT should be performed in patients with non-laryngeal and non-hypopharyngeal head and neck cancers to verify this hypothesis.	[Nguyen, Nam P.; Smith-Raymond, Lexie; Davis, Rick; Abraham, Dave; Stevie, Michelle; Jo, Beng-Hoey; Ceizyk, Misty] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA; [Vinh-Hung, Vincent] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland; [Vos, Paul] E Carolina Univ, Greenville, NC USA; [Desai, Anand; Krafft, Shane P.] Univ Texas MD Anderson, Dept Radiat Oncol, Houston, TX USA; [Sroka, Thomas] Dartmouth Coll, Dept Radiat Oncol, Hanover, NH 03755 USA; [Modarresifar, Homayoun] Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA	University of Arizona; University of Geneva; University of North Carolina; East Carolina University; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College; University of Arizona	Nguyen, NP (corresponding author), Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA.	NamPhong.Nguyen@yahoo.com	Vinh-Hung, Vincent/A-5762-2008	Vinh-Hung, Vincent/0000-0002-6403-6120; Krafft, Shane/0000-0002-4582-8587				Amdur RJ, 2007, INT J RADIAT ONCOL, V69, pS46, DOI 10.1016/j.ijrobp.2007.04.091; Caglar HB, 2008, INT J RADIAT ONCOL, V72, P1110, DOI 10.1016/j.ijrobp.2008.02.048; Chao KSC, 2003, INT J RADIAT ONCOL, V55, P312, DOI 10.1016/S0360-3016(02)03940-8; Dirix P, 2009, INT J RADIAT ONCOL, V78, P1356; Eisbruch A, 2004, INT J RADIAT ONCOL, V60, P1425, DOI 10.1016/j.ijrobp.2004.05.050; Feng FY, 2007, INT J RADIAT ONCOL, V68, P1289, DOI 10.1016/j.ijrobp.2007.02.049; Feng FY, 2010, J CLIN ONCOL, V28, P2732, DOI 10.1200/JCO.2009.24.6199; Fua TF, 2007, INT J RADIAT ONCOL, V67, P976, DOI 10.1016/j.ijrobp.2006.10.028; Gokhale AS, 2010, ANN ONCOL, V21, P145, DOI 10.1093/annonc/mdp268; Kamprad F, 2008, STRAHLENTHER ONKOL, V184, P157, DOI 10.1007/s00066-008-1780-z; Langerman A, 2007, ARCH OTOLARYNGOL, V133, P1289, DOI 10.1001/archotol.133.12.1289; Lee N, 2007, INT J RADIAT ONCOL, V68, P1299, DOI 10.1016/j.ijrobp.2006.11.019; Levendag PC, 2007, RADIOTHER ONCOL, V85, P64, DOI 10.1016/j.radonc.2007.07.009; Logemann JA, 2006, HEAD NECK-J SCI SPEC, V28, P64, DOI 10.1002/hed.20299; Nguyen NP, 2008, BRIT J RADIOL, V81, P706, DOI 10.1259/bjr/98862877; Nguyen NP, 2009, BRIT J RADIOL, V82, P675, DOI 10.1259/bjr/72852974; Nguyen NP, 2008, ANTICANCER RES, V28, P431; Nguyen NP, 2007, ORAL ONCOL, V43, P352, DOI 10.1016/j.oraloncology.2006.04.002; Nguyen NP, 2006, RADIOTHER ONCOL, V80, P302, DOI 10.1016/j.radonc.2006.07.031; Nguyen NP, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-253; Nguyen NP, 2011, ORAL ONCOL, V47, P900, DOI 10.1016/j.oraloncology.2011.06.004; Nguyen NP, 2010, ORAL ONCOL, V46, P283, DOI 10.1016/j.oraloncology.2010.01.010; Schwartz DL, 2010, INT J RADIAT ONCOL, V78, P1356, DOI 10.1016/j.ijrobp.2009.10.002	23	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e56290	10.1371/journal.pone.0056290	http://dx.doi.org/10.1371/journal.pone.0056290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505414	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500007
J	Klassen, JL; Currie, CR				Klassen, Jonathan L.; Currie, Cameron R.			ORFcor: Identifying and Accommodating ORF Prediction Inconsistencies for Phylogenetic Analysis	PLOS ONE			English	Article							TRANSLATION INITIATION SITE; PROKARYOTIC GENOMES; MICROBIAL GENOMES; GENE PREDICTION; ANNOTATION; PHYLOGENOMICS; INFERENCE; PIPELINE; ERRORS	The high-throughput annotation of open reading frames (ORFs) required by modern genome sequencing projects necessitates computational protocols that sometimes annotate orthologous ORFs inconsistently. Such inconsistencies hinder comparative analyses by non-uniformly extending or truncating 5 ' and/or 3 ' sequence ends, causing ORFs that are in fact identical to artificially diverge. Whereas strategies exist to correct such inconsistencies during whole-genome annotation, equivalent software designed to correct subsets of these data without genome reannotation is lacking. We therefore developed ORFcor, which corrects annotation inconsistencies using consensus start and stop positions derived from sets of closely related orthologs. ORFcor corrects inconsistent ORF annotations in diverse test datasets with specificities and sensitivities approaching 100% when sufficiently related orthologs (e.g., from the same taxonomic family) are available for comparison. The ORFcor package is implemented in Perl, multithreaded to handle large datasets, includes related scripts to facilitate high-throughput phylogenomic analyses, and is freely available at www.currielab.wisc.edu/downloads.html.	[Klassen, Jonathan L.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Currie, Cameron R.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Klassen, JL (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jlklassen@wisc.edu	Klassen, Jonathan/B-5060-2010	Klassen, Jonathan/0000-0003-1745-8838	Department of Energy Great Lakes Bioenery Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; National Institute of Health [GM096347]; National Science Foundation [MCB 0731822]; (Canada) National Science and Engineering Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096347] Funding Source: NIH RePORTER	Department of Energy Great Lakes Bioenery Research Center (DOE Office of Science)(United States Department of Energy (DOE)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); (Canada) National Science and Engineering Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Department of Energy Great Lakes Bioenery Research Center (DOE Office of Science BER DE-FC02-07ER64494); National Institute of Health grant GM096347; National Science Foundation grant MCB 0731822; and a postdoctoral fellowship from the (Canada) National Science and Engineering Research Council to JLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dunbar J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-125; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Hoff KJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-520; Hu GQ, 2009, BIOINFORMATICS, V25, P1843, DOI 10.1093/bioinformatics/btp272; Hu GQ, 2009, BIOINFORMATICS, V25, P123, DOI 10.1093/bioinformatics/btn576; Hu GQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-160; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kislyuk Andrey, 2009, Int J Bioinform Res Appl, V5, P458, DOI 10.1504/IJBRA.2009.027519; Kislyuk AO, 2010, BIOINFORMATICS, V26, P1819, DOI 10.1093/bioinformatics/btq284; Klassen JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-14; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Palleja A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Starmer J, 2006, PLOS COMPUT BIOL, V2, P454, DOI 10.1371/journal.pcbi.0020057; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Wall ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002284; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Yu JF, 2011, DNA RES, V18, P435, DOI 10.1093/dnares/dsr030	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58387	10.1371/journal.pone.0058387	http://dx.doi.org/10.1371/journal.pone.0058387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484025	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100114
J	Li, H; Lui, N; Cheng, T; Tseng, HHK; Yue, DS; Giroux-Leprieur, E; Do, HT; Sheng, Q; Jin, JQ; Luh, TW; Jablons, DM; He, BA				Li, Hui; Lui, Natalie; Cheng, Tiffany; Tseng, Hsin-Hui K.; Yue, Dongsheng; Giroux-Leprieur, Etienne; Do, Hanh T.; Sheng, Qing; Jin, Joy Q.; Luh, Thomas W.; Jablons, David M.; He, Biao			Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; TGF-BETA; ACTIVATION; MECHANISMS; GENE	Malignant pleural mesothelioma (MPM) is a highly aggressive tumor with poor prognosis. Current treatment is rarely curative, thus novel meaningful therapies are urgently needed. Inhibition of Hedgehog (Hh) signaling at the cell membrane level in several cancers has shown anti-cancer activity in recent clinical studies. Evidence of Hh-independent Gli activation suggests Gli as a more potent therapeutic target. The current study is aimed to evaluate the potential of Gli as a therapeutic target to treat MPM. The expression profiles of Gli factors and other Hh signaling components were characterized in 46 MPM patient tissue samples by RT-PCR and immunohistochemistry. Cultured cell lines were employed to investigate the requirement of Gli activation in tumor cell growth by inhibiting Gli through siRNA or a novel small molecule Gli inhibitor (Gli-I). A xenograft model was used to evaluate Gli-I in vivo. In addition, a side by side comparison between Gli and Smoothened (Smo) inhibition was conducted in vitro using siRNA and small molecule inhibitors. Our study reported aberrant Gli1 and Gli2 activation in a large majority of tissues. Inhibition of Gli by siRNAs or Gli-I suppressed cell growth dramatically both in vitro and in vivo. Inhibition of Gli exhibited better cytotoxicity than that of Smo by siRNA and small molecule inhibitors vismodegib and cyclopamine. Combination of Gli-I and pemetrexed, as well as Gli-I and vismodegib demonstrated synergistic effects in suppression of MPM proliferation in vitro. In summary, Gli activation plays a critical role in MPM. Inhibition of Gli function holds strong potential to become a novel, clinically effective approach to treat MPM.	[Li, Hui; Lui, Natalie; Cheng, Tiffany; Tseng, Hsin-Hui K.; Yue, Dongsheng; Giroux-Leprieur, Etienne; Do, Hanh T.; Sheng, Qing; Jin, Joy Q.; Luh, Thomas W.; Jablons, David M.; He, Biao] Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA 94143 USA; [Sheng, Qing] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yue, Dongsheng] TianJin Med Univ, Dept Lung Canc, Lung Canc Ctr, Canc Inst & Hosp, Tianjin, Peoples R China	University of California System; University of California San Francisco; Zhejiang Sci-Tech University; Tianjin Medical University	He, BA (corresponding author), Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA 94143 USA.	biao.he@ucsfmedctr.org	Tseng, Hsin-Hui Katty/AAG-1941-2019; Leprieur, Etienne Giroux/H-6345-2015	Jin, Joy/0000-0002-1283-4665; Giroux Leprieur, Etienne/0000-0001-8441-1701	NIH/NCI [R01CA125030, R01CA132566]; Eileen D. Ludwig Endowed for Thoracic Oncology Research; Bonnie J. Addario Lung Cancer Foundation; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation; Paul and Michelle Zygielbaum; Honeywell Foundation; Jeffrey and Karen Peterson Family Foundation; NATIONAL CANCER INSTITUTE [R01CA125030, R01CA132566] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eileen D. Ludwig Endowed for Thoracic Oncology Research; Bonnie J. Addario Lung Cancer Foundation; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation; Paul and Michelle Zygielbaum; Honeywell Foundation; Jeffrey and Karen Peterson Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI grant R01CA125030; the Eileen D. Ludwig Endowed for Thoracic Oncology Research (to BH); NIH/NCI grant R01CA132566; the Bonnie J. Addario Lung Cancer Foundation; the Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation; Paul and Michelle Zygielbaum; the Honeywell Foundation; and the Jeffrey and Karen Peterson Family Foundation (to DMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; Carbone M, 2012, CLIN CANCER RES, V18, P598, DOI 10.1158/1078-0432.CCR-11-2259; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Crispi S, 2010, CURR CANCER DRUG TAR, V10, P19, DOI 10.2174/156800910790980232; Dennler S, 2009, J INVEST DERMATOL, V129, pS85; Dlugosz A, 2012, NAT REV DRUG DISCOV, V11, P437, DOI 10.1038/nrd3753; Dodge ME, 2011, ANNU REV PHARMACOL, V51, P289, DOI 10.1146/annurev-pharmtox-010510-100558; Greillier L, 2011, ANTI-CANCER DRUG, V22, P199, DOI 10.1097/CAD.0b013e328341ccdd; He BNF, 2010, United States patent, Patent No. [US 6,885,550, 6885550]; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Sekido Y, 2010, CANCER SCI, V101, P1, DOI 10.1111/j.1349-7006.2009.01336.x; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Shi YD, 2012, CLIN CANCER RES, V18, P4646, DOI 10.1158/1078-0432.CCR-12-0599; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stanton BZ, 2010, MOL BIOSYST, V6, P44, DOI 10.1039/b910196a; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Zucali PA, 2011, CANCER TREAT REV, V37, P543, DOI 10.1016/j.ctrv.2011.01.001	35	26	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57346	10.1371/journal.pone.0057346	http://dx.doi.org/10.1371/journal.pone.0057346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483902	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100019
J	Teraoka, Y; Ide, K; Morimoto, H; Tahara, H; Ohdan, H				Teraoka, Yoshifumi; Ide, Kentaro; Morimoto, Hiroshi; Tahara, Hiroyuki; Ohdan, Hideki			Expression of Recipient CD47 on Rat Insulinoma Cell Xenografts Prevents Macrophage-Mediated Rejection through SIRP alpha Inhibitory Signaling in Mice	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; NEGATIVE REGULATION; T-CELL; PHAGOCYTOSIS; LYMPHOCYTES; ADHESION; RECEPTOR; XENOTRANSPLANTATION; TRANSPLANTATION; BABOONS	We have previously proven that the interspecies incompatibility of CD47 is responsible for in vitro phagocytosis of xenogeneic cells by host macrophages. Utilizing an in vivo model in the present study, we investigated whether genetically engineered expression of mouse CD47 in rat insulinoma cells (INS-1E) could inhibit macrophage-mediated xenograft rejection. INS-1E cells transfected with the pRc/CMV-mouse CD47 vector (mCD47-INS-1E) induced SIRP alpha-tyrosine phosphorylation in mouse macrophages in vitro, whereas cells transfected with the control vector (cont-INS-1E) did not. When these cells were injected into the peritoneal cavity of streptozotocin-induced diabetic Rag2(-/-)gamma chain(-/-) mice, which lack T, B, and NK cells, the expression of mouse CD47 on the INS-1E cells markedly reduced the susceptibility of these cells to phagocytosis by macrophages. Moreover, these mice became normoglycemic after receiving mCD47-INS-1E, whereas the mice that received cont-INS-1E failed to achieve normoglycemia. Furthermore, injection of an anti-mouse SIRP alpha blocking monoclonal antibody into the mouse recipients of mCD47-INS-1E cells prevented achievement of normoglycemia. These results demonstrate that interspecies incompatibility of CD47 significantly contributes to in vivo rejection of xenogeneic cells by macrophages. Thus, genetic induction of the expression of recipient CD47 on xenogeneic donor cells could provide inhibitory signals to recipient macrophages via SIPR alpha; this constitutes a novel approach for preventing macrophage-mediated xenograft rejection.	[Teraoka, Yoshifumi; Ide, Kentaro; Morimoto, Hiroshi; Tahara, Hiroyuki; Ohdan, Hideki] Hiroshima Univ, Dept Surg, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci, Hiroshima, Japan	Hiroshima University	Ide, K (corresponding author), Hiroshima Univ, Dept Surg, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci, Hiroshima, Japan.	ideken@hiroshima-u.ac.jp; hohdan@hiroshima-u.ac.jp	Ide, Kentaro/G-4757-2019; Ohdan, Hideki/G-4719-2019	Ide, Kentaro/0000-0002-2293-1688; Ohdan, Hideki/0000-0002-9066-1288	Japan Society for the Promotion of Science; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was carried out at the Natural Science Center for Basic Research and Development, Hiroshima University, and was supported by Grant-in-Aid for Sciences Research (A) from the Japan Society for the Promotion of Science, Grand-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science, and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Cooper DKC, 2002, ANNU REV MED, V53, P133, DOI 10.1146/annurev.med.53.082901.103900; Ide K, 2005, XENOTRANSPLANTATION, V12, P181, DOI 10.1111/j.1399-3089.2005.00222.x; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; McKenzie I F, 1994, Transpl Immunol, V2, P81, DOI 10.1016/0966-3274(94)90032-9; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Nilsson A, 2012, BIOCHEM BIOPH RES CO, V417, P1304, DOI 10.1016/j.bbrc.2011.12.137; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; Shahein YEA, 2002, IMMUNOLOGY, V106, P564, DOI 10.1046/j.1365-2567.2002.01465.x; Simon AR, 1999, IMMUNOL TODAY, V20, P323, DOI 10.1016/S0167-5699(99)01485-1; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Tahara H, 2010, XENOTRANSPLANTATION, V17, P188, DOI 10.1111/j.1399-3089.2010.00575.x; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Waern JM, 2012, HEPATOLOGY, V56, P1479, DOI 10.1002/hep.25816; Wang H, 2007, BLOOD, V109, P836, DOI 10.1182/blood-2006-04-019794; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wu GS, 2000, XENOTRANSPLANTATION, V7, P214, DOI 10.1034/j.1399-3089.2000.00071.x; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099; Yoshida H, 2002, J IMMUNOL, V168, P3213, DOI 10.4049/jimmunol.168.7.3213	31	10	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58359	10.1371/journal.pone.0058359	http://dx.doi.org/10.1371/journal.pone.0058359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472187	gold, Green Published, Green Submitted			2022-12-25	WOS:000315637900133
J	Fassolari, M; Chemes, LB; Gallo, M; Smal, C; Sanchez, IE; de Prat-Gay, G				Fassolari, Marisol; Chemes, Lucia B.; Gallo, Mariana; Smal, Clara; Sanchez, Ignacio E.; de Prat-Gay, Gonzalo			Minute Time Scale Prolyl Isomerization Governs Antibody Recognition of an Intrinsically Disordered Immunodominant Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS E7; RETINOBLASTOMA TUMOR-SUPPRESSOR; CONFORMATIONAL SELECTION; MOLECULAR RECOGNITION; ANTIGEN RECOGNITION; PROTEIN-FRAGMENTS; VIRAL ONCOPROTEIN; LINEAR MOTIFS; INDUCED FIT; T-CELL	Conformational rearrangements in antibody antigen recognition are essential events where kinetic discrimination of isomers expands the universe of combinations. We investigated the interaction mechanism of a monoclonal antibody, M1, raised against E7 from human papillomavirus, a prototypic viral oncoprotein and a model intrinsically disordered protein. The mapped 12-amino acid immunodominant epitope lies within a "hinge" region between the N-terminal intrinsically disordered and the C-terminal globular domains. Kinetic experiments show that despite being within an intrinsically disordered region, the hinge E7 epitope has at least two populations separated by a high energy barrier. Nuclear magnetic resonance traced the origin of this barrier to a very slow (t(1/2) similar to 4 min) trans-cis prolyl isomerization event involving changes in secondary structure. The less populated (10%) cis isomer is the binding-competent species, thus requiring the 90% of molecules in the trans configuration to isomerize before binding. The association rate for the cis isomer approaches 6 x 10(7) M-1 s(-1), a ceiling for antigen-antibody interactions. Mutagenesis experiments showed that Pro-41 in E7Ep was required for both binding and isomerization. After a slow postbinding unimolecular rearrangement, a consolidated complex with K-D = 1.2 x 10(-7) M is reached. Our results suggest that presentation of this viral epitope by the antigen-presenting cells would have to be "locked" in the cis conformation, in opposition to the most populated trans isomer, in order to select the specific antibody clone that goes through affinity and kinetic maturation.	[Fassolari, Marisol; Chemes, Lucia B.; de Prat-Gay, Gonzalo] IIBBA CONICET, Fdn Inst Leloir, Prot Struct Funct & Engn Lab, RA-1405 Buenos Aires, DF, Argentina; [Gallo, Mariana; Smal, Clara] IIBBA CONICET, Fdn Inst Leloir, NMR Lab, RA-1405 Buenos Aires, DF, Argentina; [Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Prot Physiol Lab, RA-1428 Buenos Aires, DF, Argentina; [Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, RA-1428 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; University of Buenos Aires	de Prat-Gay, G (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	gpg@leloir.org.ar		Prat Gay, Gonzalo/0000-0001-5748-6863; Sanchez, Ignacio Enrique/0000-0003-4284-9013; Gallo, Mariana/0000-0002-0022-4499; Chemes, Lucia Beatriz/0000-0003-0192-9906	Agencia Nacional de Promocion Cientifica y Tecnologica Grant [PICT2010-1052]; Instituto Nacional de Cancer, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica Grant; Instituto Nacional de Cancer, Argentina	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT2010-1052 (to I. E. S.) and Instituto Nacional de Cancer, Argentina, Basic Research Grant 2012-2014 (to G. P. G.).	Accardi L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-17; Allcorn LC, 2002, BIOINFORMATICS, V18, P175, DOI 10.1093/bioinformatics/18.1.175; Alonso L. G., 2012, SMALL TUMOUR VIRUSES, P125; Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Cerutti M. L., INT J CANC, V130, P1813; Cerutti ML, 2006, BIOCHEMISTRY-US, V45, P15520, DOI 10.1021/bi0615184; Chemes LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047661; Chemes LB, 2012, J MOL BIOL, V422, P336, DOI 10.1016/j.jmb.2012.05.036; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; COMERFORD SA, 1991, J VIROL, V65, P4681, DOI 10.1128/JVI.65.9.4681-4690.1991; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; DYSON HJ, 1995, FASEB J, V9, P37, DOI 10.1096/fasebj.9.1.7821757; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Ferreiro DU, 2003, J MOL BIOL, V331, P89, DOI 10.1016/S0022-2836(03)00720-4; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Galloway D A, 1992, IARC Sci Publ, P147; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; GAY GD, 1994, BIOCHEMISTRY-US, V33, P7957, DOI 10.1021/bi00191a024; GAY GD, 1994, BIOCHEMISTRY-US, V33, P7964, DOI 10.1021/bi00191a025; Hans-Ulrich B., 2006, PAPILLOMAVIRUS RES N, P11; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Hung CF, 2008, EXPERT OPIN BIOL TH, V8, P421, DOI [10.1517/14712598.8.4.421, 10.1517/14712598.8.4.421 ]; James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KRCHNAK V, 1990, J GEN VIROL, V71, P2719, DOI 10.1099/0022-1317-71-11-2719; Leder L, 1995, BIOCHEMISTRY-US, V34, P16509, DOI 10.1021/bi00050a035; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; LUND O, 2005, IMMUNOLOGICAL BIOINF, P69; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; POLJAK RJ, 1972, NATURE-NEW BIOL, V235, P137, DOI 10.1038/newbio235137a0; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Sibille N., 2011, PROTEINS, DOI [10.1002/prot.23210, DOI 10.1002/PR0T.23210]; Smal C, 2009, BIOCHEMISTRY-US, V48, P11939, DOI 10.1021/bi901415k; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tetin SY, 2003, ANAL BIOCHEM, V321, P183, DOI 10.1016/S0003-2697(03)00458-5; TINDLE RW, 1990, J GEN VIROL, V71, P1347, DOI 10.1099/0022-1317-71-6-1347; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tsikaris V, 1996, INT J PEPT PROT RES, V48, P319; Tugarinov V, 1999, NAT STRUCT BIOL, V6, P331; Uversky V. N., INT J BIOCH CELL BIO, V43, P1090; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; WALTHO JP, 1989, FEBS LETT, V250, P400, DOI 10.1016/0014-5793(89)80764-1; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Zeng Q, 2011, HUM GENE THER, V22, P809, DOI 10.1089/hum.2010.071	66	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13110	13123		10.1074/jbc.M112.444554	http://dx.doi.org/10.1074/jbc.M112.444554			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504368	hybrid, Green Published			2022-12-25	WOS:000318555100061
J	Huang, Q; Wang, H; Perry, SW; Figueiredo-Pereira, ME				Huang, Qian; Wang, Hu; Perry, Seth W.; Figueiredo-Pereira, Maria E.			Negative Regulation of 26S Proteasome Stability via Calpain-mediated Cleavage of Rpn10 Subunit upon Mitochondrial Dysfunction in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE MTT; OXIDATIVE-STRESS; ALZHEIMERS-DISEASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); NEURODEGENERATIVE DISEASE; ENDOGENOUS ELECTROPHILE; PROTEIN-DEGRADATION; CELLULAR-RESPONSES; UBIQUITIN; CELLS	Proteasomal and mitochondrial dysfunctions are implicated in chronic neurodegenerative diseases. To investigate the impact of mitochondrial impairment on the proteasome, we treated rat cerebral cortical neurons with oligomycin, antimycin, or rotenone, which inhibit different elements of the electron transport chain. Firstly, we observed a reduction in ubiquitinated proteins and E1 activity. Secondly, we established that 26S proteasomes are disassembled with a decline in activity. Thirdly, we show, to our knowledge for the first time, that calpain activation triggers the selective processing of the 26S proteasome subunit Rpn10. Other proteasome subunits tested were not affected. Calpain also cleaved caspase 3 to an inactive fragment, thus preventing apoptosis that is an energy-dependent cell death pathway. In addition, calpain cleaved the microtubule-associated protein Tau, a major component of neurofibrillary tangles in Alzheimer disease and other tauopathies. Fourthly, we detected a rise in 20S proteasome levels and activity. Finally, we show that both acute (16 h) and long term (up to 7 days) mitochondrial impairment led to down-regulation of ubiquitinated-proteins, 26S proteasome disassembly, and a rise in 20S proteasomes. We postulate that upon mitochondrial dysfunction, ATP depletion and calpain activation contribute to the demise of protein turnover by the ubiquitin/proteasome pathway. The concomitant rise in 20S proteasomes, which seem to degrade proteins in an unregulated and energy-independent manner, in the short term may carry out the turnover of randomly unfolded oxidized proteins. However, if chronic, it could lead to neurodegeneration as regulated protein degradation by the ubiquitin/proteasome pathway is essential for neuronal survival.	[Huang, Qian; Wang, Hu; Figueiredo-Pereira, Maria E.] CUNY, Dept Biol Sci, Hunter Coll, New York, NY 10065 USA; [Huang, Qian; Wang, Hu; Figueiredo-Pereira, Maria E.] CUNY, Grad Ctr, New York, NY 10065 USA; [Perry, Seth W.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; University of Rochester	Figueiredo-Pereira, ME (corresponding author), CUNY, Dept Biol Sci, Hunter Coll, 695 Pk Ave, New York, NY 10065 USA.	pereira@genectr.hunter.cuny.edu		Perry, Seth W/0000-0002-1503-6634	National Institutes of Health Grants, NIA [R01 AG028847]; NINDS [U54 NS041073]; National Institutes of Health Grant, National Center for Research Resources (NCRR) [G12 RR003037]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028847] Funding Source: NIH RePORTER	National Institutes of Health Grants, NIA; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Grant, National Center for Research Resources (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG028847 (to M. E. F.-P.) from the NIA and U54 NS041073 (Specialized Neuroscience Research Programs (SNRP)) (to M. E. F.-P., head of sub-project) from the NINDS.; We thank Dr. L. Binder (Northwestern University, Chicago, IL) for the Tau C5 antibody. Hunter College, City University of New York was supported by National Institutes of Health Grant G12 RR003037 (to the Gene Center at Hunter College) from the National Center for Research Resources (NCRR).	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Akude E, 2011, DIABETES, V60, P288, DOI 10.2337/db10-0818; Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bedford L, 2009, AUTOPHAGY, V5, P224, DOI 10.4161/auto.5.2.7389; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; BREEUWER P, 1995, APPL ENVIRON MICROB, V61, P1614, DOI 10.1128/AEM.61.4.1614-1619.1995; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chandra A, 2010, CURR GENET, V56, P543, DOI 10.1007/s00294-010-0321-3; Dasuri K, 2010, FREE RADICAL BIO MED, V49, P1290, DOI 10.1016/j.freeradbiomed.2010.07.014; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Grimm S, 2011, FREE RADICAL RES, V45, P73, DOI 10.3109/10715762.2010.512040; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; HOYER S, 1992, MOL CHEM NEUROPATHOL, V16, P207, DOI 10.1007/BF03159971; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Huber N, 2009, HEPATOLOGY, V49, P1718, DOI 10.1002/hep.22840; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Jha N, 2002, J NEUROCHEM, V80, P555, DOI 10.1046/j.0022-3042.2001.00009.x; Kastle M, 2011, BIOCHIMIE, V93, P1076, DOI 10.1016/j.biochi.2011.03.004; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu MC, 2011, ASN NEURO, V3, P25, DOI 10.1042/AN20100012; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myeku N, 2011, METHODS MOL BIOL, V793, P273, DOI 10.1007/978-1-61779-328-8_18; Nam Y, 2007, J BIOMAT SCI-POLYM E, V18, P1091, DOI 10.1163/156856207781494430; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2; Papa L, 2008, APOPTOSIS, V13, P588, DOI 10.1007/s10495-008-0182-0; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Rego AC, 2001, CELL DEATH DIFFER, V8, P995, DOI 10.1038/sj.cdd.4400916; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Rinaldi T, 2002, GENE, V286, P43, DOI 10.1016/S0378-1119(01)00799-5; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shell JR, 2012, BIOCHEMISTRY-US, V51, P2258, DOI 10.1021/bi201573k; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; VITALE M, 1993, HISTOCHEMISTRY, V100, P223, DOI 10.1007/BF00269095; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; Zhu XW, 2013, J ALZHEIMERS DIS, V33, pS253, DOI 10.3233/JAD-2012-129005; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	68	47	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12161	12174		10.1074/jbc.M113.464552	http://dx.doi.org/10.1074/jbc.M113.464552			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23508964	hybrid, Green Published			2022-12-25	WOS:000318157600048
J	Li, W; Rao, DK; Kaur, P				Li, Wen; Rao, Divya K.; Kaur, Parjit			Dual Role of the Metalloprotease FtsH in Biogenesis of the DrrAB Drug Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; ESCHERICHIA-COLI; AAA+ PROTEASES; PROTEIN; MEMBRANE; DISAGGREGATION; DEGRADATION; MACHINES; SECY	This study provides the first direct evidence for the dual role of the metalloprotease FtsH in membrane protein biogenesis. Using the physiological substrate DrrAB, it is shown that FtsH is not only responsible for proteolysis of unassembled DrrB protein but also plays a much broader role in biogenesis of the DrrAB complex. Previous studies showed that the stable expression of DrrB in the membrane depends on simultaneous expression of DrrA. Here we show that DrrB is proteolyzed by FtsH when it is expressed alone. Moreover, DrrA and DrrB proteins expressed together in a temperature-sensitive ftsH mutant strain of Escherichia coli were found to be nonfunctional due to their incorrect assembly. Simultaneous expression of wild-type FtsH in trans resulted in normal doxorubicin efflux. Strikingly, doxorubicin efflux could be restored in mutant cells irrespective of whether FtsH was expressed simultaneously with DrrAB or expressed after these proteins had already accumulated in an inactive conformation, thus providing crucial evidence for the ability of FtsH to refold the misassembled proteins. Complementation experiments also showed that the catalytic AAA domain of FtsH contains a chaperone-like activity, however, unlike wild-type FtsH, it was unable to restore function. Our results therefore show for the first time that FtsH contains the protease as well as refolding functions, and both the AAA and the proteolytic domains of FtsH are required for each of these activities.	[Li, Wen; Rao, Divya K.; Kaur, Parjit] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Kaur, P (corresponding author), 161 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	pkaur@gsu.edu			National Institutes of Health [RO1 GM51981-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Service Award RO1 GM51981-09 (to P. K.).	AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Asahara Y, 2000, J BIOCHEM, V127, P931, DOI 10.1093/oxfordjournals.jbchem.a022689; Chiba S, 2002, J BACTERIOL, V184, P4775, DOI 10.1128/JB.184.17.4775-4782.2002; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; Gandlur SM, 2004, J BIOL CHEM, V279, P27799, DOI 10.1074/jbc.M402898200; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kaur P, 1997, J BACTERIOL, V179, P569, DOI 10.1128/jb.179.3.569-575.1997; Kaur P, 1998, J BIOL CHEM, V273, P17933, DOI 10.1074/jbc.273.28.17933; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; MAURIZI MR, 1985, J BACTERIOL, V164, P1124, DOI 10.1128/JB.164.3.1124-1135.1985; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Pak M, 1999, J BIOL CHEM, V274, P19316, DOI 10.1074/jbc.274.27.19316; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Shirai Y, 1996, J BACTERIOL, V178, P1141, DOI 10.1128/jb.178.4.1141-1145.1996; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Truscott KN, 2010, BIOCHEM CELL BIOL, V88, P97, DOI [10.1139/O09-167, 10.1139/o09-167]; Weibezahn J, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-1; Zhang H, 2010, J BIOL CHEM, V285, P38324, DOI 10.1074/jbc.M110.131540	29	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11854	11864		10.1074/jbc.M112.441915	http://dx.doi.org/10.1074/jbc.M112.441915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504316	Green Published, hybrid			2022-12-25	WOS:000318157600021
J	Ryzhakov, G; Teixeira, A; Saliba, D; Blazek, K; Muta, T; Ragoussis, J; Udalova, IA				Ryzhakov, Grigory; Teixeira, Ana; Saliba, David; Blazek, Katrina; Muta, Tatsushi; Ragoussis, Jiannis; Udalova, Irina A.			Cross-species Analysis Reveals Evolving and Conserved Features of the Nuclear Factor kappa B (NF-kappa B) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEMATOSTELLA-VECTENSIS; TRANSCRIPTION FACTORS; SEA-ANEMONE; IMMUNE-SYSTEM; DNA; BINDING; ZETA; REPERTOIRE; ACTIVATION; COMPLEXITY	NF-kappa B is a key regulator of immune gene expression in metazoans. It is currently unclear what changes occurred in NF-kappa B during animal evolution and what features remained conserved. To address this question, we compared the biochemical and functional properties of NF-kappa B proteins derived from human and the starlet sea anemone (Nematostella vectensis) in 1) a high-throughput assay of in vitro preferences for DNA sequences, 2) ChIP analysis of in vivo recruitment to the promoters of target genes, 3) a LUMIER-assisted examination of interactions with cofactors, and 4) a transactivation assay. We observed a remarkable evolutionary conservation of the DNA binding preferences of the animal NF-kappa B orthologs. We also show that NF-kappa B dimerization properties, nuclear localization signals, and binding to cytosolic I kappa Bs are conserved. Surprisingly, the Bcl3-type nuclear I kappa B proteins functionally pair up only with NF-kappa B derived from their own species. The basis of the differential NF-kappa B recognition by I kappa B subfamilies is discussed.	[Ryzhakov, Grigory; Saliba, David; Blazek, Katrina; Udalova, Irina A.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London W6 8LH, England; [Teixeira, Ana; Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Muta, Tatsushi] Tohoku Univ, Lab Cell Recognit & Response, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Tohoku University	Ryzhakov, G (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	grigory@ryzhakov.co.uk; irina.udalova@kennedy.ox.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; Blazek, Katrina/AAU-6194-2020	Saliba, David/0000-0001-9523-0586; Blazek, Katrina/0000-0002-4439-4756; Udalova, Irina/0000-0002-6716-2528; Ragoussis, Ioannis/0000-0002-8515-0934	European Community [222008]; Wellcome Trust [090532/Z/09/Z, 075491/Z/04]; Medical Research Council [G0700818, G0501087] Funding Source: researchfish; MRC [G0700818, G0501087] Funding Source: UKRI	European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Community Seventh Framework Programme FP7/2007-2013 under Grant 222008.; Supported by The Wellcome Trust Grants 090532/Z/09/Z and 075491/Z/04. Present address: McGill University and Genome Quebec Innovation Centre, 740 Docteur Penfield Avenue, Montreal (Quebec) H3A 0G1, Canada.	Augustin R, 2010, SEMIN IMMUNOL, V22, P54, DOI 10.1016/j.smim.2009.11.002; Bae S, 2009, J INVERTEBR PATHOL, V102, P79, DOI 10.1016/j.jip.2009.06.007; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Heusch M, 1999, ONCOGENE, V18, P6201, DOI 10.1038/sj.onc.1203022; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin L, 1996, MOL CELL BIOL, V16, P2248; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ragoussis Jiannis, 2006, V338, P261; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schuhmann KM, 2011, J VIROL, V85, P3162, DOI 10.1128/JVI.02342-10; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Steele RE, 2011, TRENDS GENET, V27, P7, DOI 10.1016/j.tig.2010.10.002; Sullivan JC, 2007, DEV GENES EVOL, V217, P63, DOI 10.1007/s00427-006-0111-6; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wolenski FS, 2011, MOL CELL BIOL, V31, P1076, DOI 10.1128/MCB.00927-10; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y	38	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11546	11554		10.1074/jbc.M113.451153	http://dx.doi.org/10.1074/jbc.M113.451153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23508954	Green Published, hybrid			2022-12-25	WOS:000317915500060
J	Kim, J; Lee, D; Kahng, B				Kim, Jinhong; Lee, Deokjae; Kahng, Byungnam			Microscopic Modelling Circadian and Bursty Pattern of Human Activities	PLOS ONE			English	Article							HEAVY TAILS; DYNAMICS; MEMORY	Recent studies for a wide range of human activities such as email communication, Web browsing, and library visiting, have revealed the bursty nature of human activities. The distribution of inter-event times (IETs) between two consecutive human activities exhibits a heavy-tailed decay behavior and the oscillating pattern with a one-day period, reflective of the circadian pattern of human life. Even though a priority-based queueing model was successful as a basic model for understanding the heavy-tailed behavior, it ignored important ingredients, such as the diversity of individual activities and the circadian pattern of human life. Here, we collect a large scale of dataset which contains individuals' time stamps when articles are posted on blog posts, and based on which we construct a theoretical model which can take into account of both ignored ingredients. Once we identify active and inactive time intervals of individuals and remove the inactive time interval, thereby constructing an ad hoc continuous time domain. Therein, the priority-based queueing model is applied by adjusting the arrival and the execution rates of tasks by comparing them with the activity data of individuals. Then, the obtained results are transferred back to the real-time domain, which produces the oscillating and heavy-tailed IET distribution. This microscopic model enables us to develop theoretical understanding towards more empirical results.	[Kim, Jinhong] NHN Corp, Complex Syst Anal Team, Songnam, Gyeonggi Do, South Korea; [Lee, Deokjae; Kahng, Byungnam] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea	Seoul National University (SNU)	Kahng, B (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.	bkahng@snu.ac.kr			National Research Foundation [2010-0015066]	National Research Foundation	National Research Foundation grant awarded through the Acceleration Research Program (Grant No. 2010-0015066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BURSTS HIDDEN PATTER; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chessa AG, 2004, PHYSICA A, V333, P541, DOI 10.1016/j.physa.2003.10.037; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Dezso Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066132; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Grinstein G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.130201; Harder U, 2006, PHYSICA A, V361, P329, DOI 10.1016/j.physa.2005.06.079; Hidalgo CA, 2006, PHYSICA A, V369, P877, DOI 10.1016/j.physa.2005.12.035; Holme P, 2003, EUROPHYS LETT, V64, P427, DOI 10.1209/epl/i2003-00505-4; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Jo HH, 2012, PHYS REV E, V85; Johansen A, 2004, PHYSICA A, V338, P286, DOI 10.1016/j.physa.2004.02.054; Johansen A, 2000, PHYSICA A, V276, P338, DOI 10.1016/S0378-4371(99)00468-9; Johansen A, 2001, PHYSICA A, V296, P539, DOI 10.1016/S0378-4371(01)00202-3; Karsai M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00397; Kivela M, 2011, J STAT MECH-THEORY E; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; LEWIS PAW, 1979, NAV RES LOG, V26, P403, DOI 10.1002/nav.3800260304; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026118; Scalas E, 2006, PHYSICA A, V366, P463, DOI 10.1016/j.physa.2005.09.047; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Vajna S, 2012, ARXIV12111175; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Vazquez A, 2007, PHYSICA A, V373, P747, DOI 10.1016/j.physa.2006.04.060; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Zhou T, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28002	32	103	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58292	10.1371/journal.pone.0058292	http://dx.doi.org/10.1371/journal.pone.0058292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505479	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100042
J	Molloy, EM; Field, D; O'Connor, PM; Cotter, PD; Hill, C; Ross, RP				Molloy, Evelyn M.; Field, Des; O'Connor, Paula M.; Cotter, Paul D.; Hill, Colin; Ross, R. Paul			Saturation Mutagenesis of Lysine 12 Leads to the Identification of Derivatives of Nisin A with Enhanced Antimicrobial Activity	PLOS ONE			English	Article							PRECURSOR LIPID II; LANTIBIOTIC NISIN; LISTERIA-MONOCYTOGENES; LACTOCOCCUS-LACTIS; INNATE RESISTANCE; PEPTIDES; GENE; BIOSYNTHESIS; PROTEIN; ACID	It is becoming increasingly apparent that innovations from the "golden age'' of antibiotics are becoming ineffective, resulting in a pressing need for novel therapeutics. The bacteriocin family of antimicrobial peptides has attracted much attention in recent years as a source of potential alternatives. The most intensively studied bacteriocin is nisin, a broad spectrum lantibiotic that inhibits Gram-positive bacteria including important food pathogens and clinically relevant antibiotic resistant bacteria. Nisin is gene-encoded and, as such, is amenable to peptide bioengineering, facilitating the generation of novel derivatives that can be screened for desirable properties. It was to this end that we used a site-saturation mutagenesis approach to create a bank of producers of nisin A derivatives that differ with respect to the identity of residue 12 (normally lysine; K12). A number of these producers exhibited enhanced bioactivity and the nisin A K12A producer was deemed of greatest interest. Subsequent investigations with the purified antimicrobial highlighted the enhanced specific activity of this modified nisin against representative target strains from the genera Streptococcus, Bacillus, Lactococcus, Enterococcus and Staphylococcus.	[Molloy, Evelyn M.; Field, Des; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [O'Connor, Paula M.; Cotter, Paul D.; Hill, Colin; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [O'Connor, Paula M.; Cotter, Paul D.; Ross, R. Paul] Teagasc Food Res Ctr, Fermoy, Cork, Ireland	University College Cork; University College Cork; Teagasc	Cotter, PD (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	paul.cotter@teagasc.ie; c.hill@ucc.ie	Hill, Colin/A-5611-2012; Cotter, Paul/B-7781-2008; Field, Des/AAU-6785-2021; Cotter, Paul/AAX-5449-2021; Ross, Paul/A-7584-2015; STANTON, CATHERINE/A-9549-2015	Hill, Colin/0000-0002-8527-1445; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; O'Connor, Paula M./0000-0001-6462-2077; STANTON, CATHERINE/0000-0002-6724-7011; Field, Des/0000-0003-4425-5817; Molloy, Evelyn/0000-0001-8822-7207	Irish Government under the National Development Plan; Irish Research Council for Science Engineering and Technology (IRCSET); Enterprise Ireland; Science Foundation Ireland (SFI), through the Alimentary Pharmabiotic Centre (APC) at University College Cork, Ireland; SFI	Irish Government under the National Development Plan; Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Enterprise Ireland; Science Foundation Ireland (SFI), through the Alimentary Pharmabiotic Centre (APC) at University College Cork, Ireland(Science Foundation Ireland); SFI(Science Foundation Ireland)	This work was supported by the Irish Government under the National Development Plan; by the Irish Research Council for Science Engineering and Technology (IRCSET); by Enterprise Ireland; and by Science Foundation Ireland (SFI), through the Alimentary Pharmabiotic Centre (APC) at University College Cork, Ireland, which is supported by the SFI-funded Centre for Science, Engineering and Technology (SFI-CSET) and provided P. D. C., C. H. and R. P. R. with SFI Principal Investigator funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bartoloni A, 2004, J CHEMOTHERAPY, V16, P119, DOI 10.1179/joc.2004.16.2.119; Begley M, 2010, APPL ENVIRON MICROB, V76, P6541, DOI 10.1128/AEM.00203-10; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1998, BIOCHEMISTRY-US, V37, P8153, DOI 10.1021/bi972797l; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; BROADBENT JR, 1989, J DAIRY SCI, V72, P3342, DOI 10.3168/jds.S0022-0302(89)79496-0; Castiglione F, 2008, CHEM BIOL, V15, P22, DOI 10.1016/j.chembiol.2007.11.009; Castiglione F, 2007, BIOCHEMISTRY-US, V46, P5884, DOI 10.1021/bi700131x; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4658, DOI 10.1128/AAC.00290-10; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4416, DOI 10.1128/AAC.00503-10; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; de Kwaadsteniet M, 2008, APPL ENVIRON MICROB, V74, P547, DOI 10.1128/AEM.01862-07; Delves-Broughton J, 2005, FOOD AUST, V57, P525; Dodd HM, 1996, MICROBIOL-SGM, V142, P47, DOI 10.1099/13500872-142-1-47; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Field D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046884; Field D, 2010, MOL MICROBIOL, V78, P1077, DOI 10.1111/j.1365-2958.2010.07406.x; Field D, 2010, MICROB BIOTECHNOL, V3, P473, DOI 10.1111/j.1751-7915.2010.00184.x; Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001; Glaser P, 2001, SCIENCE, V294, P849; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; Klein G, 2003, INT J FOOD MICROBIOL, V88, P123, DOI 10.1016/S0168-1605(03)00175-2; KUIPERS OP, 1992, J BIOL CHEM, V267, P24340; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kuipers OP, 1996, ANTON LEEUW INT J G, V69, P161, DOI 10.1007/BF00399421; Kuipers OP, 1994, 2 INT WORKSH LANT AR; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Maher S, 2006, BIOCHEM PHARMACOL, V71, P1289, DOI 10.1016/j.bcp.2006.01.012; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x; Molloy EM, 2012, BIOCHEM SOC T, V40, P1492, DOI 10.1042/BST20120193; Mondino SSB, 2003, MICROB DRUG RESIST, V9, P167, DOI 10.1089/107662903765826769; MULDERS JWM, 1991, EUR J BIOCHEM, V201, P581, DOI 10.1111/j.1432-1033.1991.tb16317.x; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Piper C, 2009, J ANTIMICROB CHEMOTH, V64, P546, DOI 10.1093/jac/dkp221; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rink R, 2007, APPL ENVIRON MICROB, V73, P5809, DOI 10.1128/AEM.01104-07; ROLLEMA HS, 1995, APPL ENVIRON MICROB, V61, P2873, DOI 10.1128/AEM.61.8.2873-2878.1995; Rouse S, 2012, MICROB BIOTECHNOL, V5, P501, DOI 10.1111/j.1751-7915.2011.00324.x; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SEARS PM, 1992, J DAIRY SCI, V75, P3185, DOI 10.3168/jds.S0022-0302(92)78083-7; Severina E, 1998, J ANTIMICROB CHEMOTH, V41, P341, DOI 10.1093/jac/41.3.341; STEVENS KA, 1991, APPL ENVIRON MICROB, V57, P3613, DOI 10.1128/AEM.57.12.3613-3615.1991; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; van Heusden HE, 2002, BIOCHEMISTRY-US, V41, P12171, DOI 10.1021/bi026090x; van Kraaij C, 2000, EUR J BIOCHEM, V267, P901, DOI 10.1046/j.1432-1327.2000.01075.x; vandenHooven HW, 1996, EUR J BIOCHEM, V235, P382, DOI 10.1111/j.1432-1033.1996.00382.x; VanKraaij C, 1997, EUR J BIOCHEM, V247, P114; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Wilson-Stanford S, 2009, APPL ENVIRON MICROB, V75, P1381, DOI 10.1128/AEM.01864-08; Wirawan RE, 2006, APPL ENVIRON MICROB, V72, P1148, DOI 10.1128/AEM.72.2.1148-1156.2006; Wu JQ, 2007, ANTIMICROB AGENTS CH, V51, P3131, DOI 10.1128/AAC.00629-07; Yuan J, 2004, APPL MICROBIOL BIOT, V64, P806, DOI 10.1007/s00253-004-1599-1; Zendo T, 2003, BIOSCI BIOTECH BIOCH, V67, P1616, DOI 10.1271/bbb.67.1616	67	44	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58530	10.1371/journal.pone.0058530	http://dx.doi.org/10.1371/journal.pone.0058530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505531	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100061
J	Pfaff, KL; King, RW				Pfaff, Kathleen L.; King, Randall W.			Determinants of Human Cyclin B1 Association with Mitotic Chromosomes	PLOS ONE			English	Article							MAMMALIAN-CELLS; NUCLEAR TRANSPORT; BINDING DOMAIN; IN-VITRO; MITOSIS; PHOSPHORYLATION; RCC1; LOCALIZATION; SEPARASE; SPINDLE	Cyclin B1-CDK1 activity is essential for mitotic entry, but questions remain regarding how the activity of this kinase is spatially regulated. Previous studies showed that the cyclin B1 subunit localizes to several compartments of a mitotic cell, including the centrosomes, mitotic spindle, kinetochores and chromosomes via distinct sequence elements. Mitotic chromosome association occurs through the unstructured N-terminal domain of cyclin B1 and is independent of CDK1 binding. Here, we use live cell imaging of human cyclin B1 fused to GFP to precisely define the sequence elements within cyclin B1 that mediate its association with condensed mitotic chromosomes. We find that a short, evolutionarily conserved N-terminal motif is required for cyclin B1 to localize to mitotic chromosomes. We further reveal a role for arginine residues within and near the destruction box sequence in the chromosome association of cyclin B1. Additionally, our data suggest that sequences further downstream in cyclin B1, such as the cytoplasmic retention sequence and the cyclin box, may negatively modulate chromosome association. Because multiple basic residues are required for cyclin B1 association with mitotic chromosomes, electrostatic interactions with DNA may facilitate cyclin B1 localization to chromosomes.	[Pfaff, Kathleen L.; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02114 USA.	randy_king@hms.harvard.edu		King, Randall/0000-0001-7882-8180	National Institutes of Health [R01-GM66492]; National Institutes of General Medical Sciences NRSA fellowship [5F32-GM085923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM085923, R01GM066492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of General Medical Sciences NRSA fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a National Institutes of Health grant R01-GM66492 (to RWK) and a National Institutes of General Medical Sciences NRSA fellowship 5F32-GM085923 (to KLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; BAILLY E, 1992, J CELL SCI, V101, P529; Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539; Boos D, 2008, J BIOL CHEM, V283, P816, DOI 10.1074/jbc.M706748200; Chen Q, 2008, CELL RES, V18, P268, DOI 10.1038/cr.2008.11; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Escargueil AE, 2001, FASEB J, V15, P2288, DOI 10.1096/fj.00-0726fje; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; HARTL P, 1993, J CELL BIOL, V120, P613, DOI 10.1083/jcb.120.3.613; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Huang JY, 2007, J CELL SCI, V120, P1990, DOI 10.1242/jcs.006833; Huang JY, 2002, J CELL SCI, V115, P2847; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jorgensen PM, 1998, MOL CELL BIOL, V18, P468; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NUGENT JHA, 1991, J CELL SCI, V99, P669; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; RATTNER JB, 1990, CELL MOTIL CYTOSKEL, V17, P227, DOI 10.1002/cm.970170309; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Santos SDM, 2012, CELL, V149, P1500, DOI 10.1016/j.cell.2012.05.028; SEINO H, 1992, J CELL SCI, V102, P393; Stals H, 1997, FEBS LETT, V418, P229, DOI 10.1016/S0014-5793(97)01368-9; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Topper LM, 2002, CELL CYCLE, V1, P282, DOI 10.4161/cc.1.4.139; West SM, 2010, J BIOMOL STRUCT DYN, V27, P861, DOI 10.1080/07391102.2010.10508587; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yang J, 2001, J BIOL CHEM, V276, P3604, DOI 10.1074/jbc.M008151200; Yuan K, 2009, CELL CYCLE, V8, P1433, DOI 10.4161/cc.8.9.8331	47	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59169	10.1371/journal.pone.0059169	http://dx.doi.org/10.1371/journal.pone.0059169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505570	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100125
J	Figarska, SM; Vonk, JM; Boezen, HM				Figarska, Sylwia M.; Vonk, Judith M.; Boezen, H. Marike			SIRT1 Polymorphism, Long-Term Survival and Glucose Tolerance in the General Population	PLOS ONE			English	Article							LIFE-SPAN; HUMAN LONGEVITY; CALORIE RESTRICTION; CHINESE POPULATION; INSULIN-SECRETION; INCREASED DOSAGE; LUNG-FUNCTION; VARIANTS; SIRTUINS; MICE	Mutations that increase activity of Sir2 (silent information regulator 2) are associated with extended lifespan of yeast, fruit flies and worms. SIRT1, the human homolog of Sir2, that controls numerous physiological processes including the glucose metabolism, is considered a candidate gene for predicting variation in human lifespan. Whereas the role of Sir2 has been extensively investigated in model organisms, less is known about the relation between SIRT1 and lifespan in humans. In the current study we included 1,390 subjects from a general population-based cohort with 18 years of follow-up to investigate associations between variation in single nucleotide polymorphisms (SNPs) in the SIRT1 gene and human survival. Additionally in 535 male subjects with available data we investigated associations between SIRT1 and glucose tolerance. Carriers of the minor allele of rs12778366 had a significantly reduced mortality risk compared to the wild types: Hazard Ratio 0.69 (95% CI 0.50 to 0.96; p = 0.025). The directions of the effect were the same in females and males, never and ever smokers and the effect was significantly protective in overweight/obese subjects. Carriers of the minor allele of SNP rs12778366 had better glucose tolerance indicated by 0.34 mmol/l lower glucose levels compared to wild type subjects (p = 0.03). This study shows that SIRT1 affects human long-term survival and therefore may be an important factor in modulating lifespan not only in lower organisms, but also in humans.	[Figarska, Sylwia M.; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	h.m.boezen@umcg.nl	Vonk, Judith M/ABA-3009-2020; Vonk, Judith/K-8477-2019	Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547; Figarska, Sylwia/0000-0003-3601-1548	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands; Stichting Astma Bestrijding [2005/020]; Netherlands Asthma Foundation [3.2.02.51]	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands; Stichting Astma Bestrijding; Netherlands Asthma Foundation	This work was supported by the Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands. The Vlagtwedde\Vlaardingen study was supported by unrestricted grants of Stichting Astma Bestrijding (grant number 2005/020) and Netherlands Asthma Foundation (grant number 3.2.02.51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2011, NAT MED, V17, P1350, DOI 10.1038/nm1111-1350; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Clark SJ, 2012, OBESITY, V20, P178, DOI 10.1038/oby.2011.200; Dong Y, 2011, MOL GENET METAB, V104, P661, DOI 10.1016/j.ymgme.2011.08.001; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Flachsbart F, 2006, EXP GERONTOL, V41, P98, DOI 10.1016/j.exger.2005.09.008; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kuningas M, 2007, J GERONTOL A-BIOL, V62, P960, DOI 10.1093/gerona/62.9.960; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Peeters AV, 2008, HUM GENET, V124, P431, DOI 10.1007/s00439-008-0567-8; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Shimoyama Y, 2011, TRANSL RES, V157, P339, DOI 10.1016/j.trsl.2011.02.004; Siedlinski M, 2012, EUR RESPIR J, V39, P385, DOI 10.1183/09031936.00184110; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; Weyrich P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-100; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang WG, 2010, CLIN CHIM ACTA, V411, P1679, DOI 10.1016/j.cca.2010.06.030; Zheng J, 2012, ENDOCR J, V59, P229, DOI 10.1507/endocrj.EJ11-0234; Zillikens MC, 2009, DIABETES, V58, P2828, DOI 10.2337/db09-0536; Zillikens MC, 2009, FREE RADICAL BIO MED, V46, P836, DOI 10.1016/j.freeradbiomed.2008.12.022	36	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58636	10.1371/journal.pone.0058636	http://dx.doi.org/10.1371/journal.pone.0058636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505545	gold, Green Submitted, Green Published			2022-12-25	WOS:000318334500109
J	Hess, CA; Cooper, MJ; Smith, MJ; Trueman, CN; Schutkowski, H				Hess, Catherine A.; Cooper, Matthew J.; Smith, Martin J.; Trueman, Clive N.; Schutkowski, Holger			Lead Exposure in Adult Males in Urban Transvaal Province, South Africa during the Apartheid Era	PLOS ONE			English	Article							BLOOD LEAD; BONE LEAD; UNITED-STATES; CAPE-TOWN; ATMOSPHERIC LEAD; NATIONAL-HEALTH; RISK-FACTORS; TIBIA LEAD; PRESSURE; JOHANNESBURG	Human exposure to lead is a substantial public health hazard worldwide and is particularly problematic in the Republic of South Africa given the country's late cessation of leaded petrol. Lead exposure is associated with a number of serious health issues and diseases including developmental and cognitive deficiency, hypertension and heart disease. Understanding the distribution of lifetime lead burden within a given population is critical for reducing exposure rates. Femoral bone from 101 deceased adult males living in urban Transvaal Province (now Gauteng Province), South Africa between 1960 and 1998 were analyzed for lead concentration by Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Of the 72 black and 29 white individuals sampled, chronic lead exposure was apparent in nearly all individuals. White males showed significantly higher median bone lead concentration (ME = 10.04 mu g.g(-1)), than black males (ME = 3.80 mu g.g(-1)) despite higher socioeconomic status. Bone lead concentration covaries significantly, though weakly, with individual age. There was no significant temporal trend in bone lead concentration. These results indicate that long-term low to moderate lead exposure is the historical norm among South African males. Unexpectedly, this research indicates that white males in the sample population were more highly exposed to lead.	[Hess, Catherine A.; Smith, Martin J.; Schutkowski, Holger] Bournemouth Univ, Sch Appl Sci, Poole BH12 5BB, Dorset, England; [Cooper, Matthew J.; Trueman, Clive N.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	Bournemouth University; NERC National Oceanography Centre; University of Southampton	Schutkowski, H (corresponding author), Bournemouth Univ, Sch Appl Sci, Talbot Campus, Poole BH12 5BB, Dorset, England.	hschutkowski@bournemouth.ac.uk	Trueman, Clive/E-6925-2011; Cooper, Matthew/I-8573-2012	Cooper, Matthew/0000-0002-2130-2759	University of Bournemouth Post Graduate Global Exchange Fund; Bournemouth University School of Applied Sciences Hilary Williams Fund; British Council Overseas Student Research Award Scheme	University of Bournemouth Post Graduate Global Exchange Fund; Bournemouth University School of Applied Sciences Hilary Williams Fund; British Council Overseas Student Research Award Scheme	The research was funded, in part, by the University of Bournemouth Post Graduate Global Exchange Fund, the Bournemouth University School of Applied Sciences Hilary Williams Fund, and the British Council Overseas Student Research Award Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGHURST PA, 1992, NEW ENGL J MED, V327, P1279, DOI 10.1056/NEJM199210293271805; Bandeen-Roche K, 2009, EPIDEMIOLOGY, V20, P831, DOI 10.1097/EDE.0b013e3181b5f100; BARANOWSKA I, 1995, SCI TOTAL ENVIRON, V159, P155, DOI 10.1016/0048-9697(95)04218-P; BARRY PSI, 1970, BRIT J IND MED, V27, P339; BARRY PSI, 1975, BRIT J IND MED, V32, P119; BELLINGER DC, 1992, PEDIATRICS, V90, P855; Bergdahl IA, 2008, J TOXICOL ENV HEAL A, V71, P1235, DOI 10.1080/15287390802209525; Brown RW, 2010, J IMMIGR MINOR HEALT, V12, P715, DOI 10.1007/s10903-009-9245-8; BYERLEE D, 1974, INT MIGR REV, V8, P543, DOI 10.2307/3002204; Carpenter DO, 2010, PHYSIOL BEHAV, V99, P260, DOI 10.1016/j.physbeh.2009.09.001; CDC, 2005, PREV LEAD POIS YOUNG; Cheng YW, 2001, AM J EPIDEMIOL, V153, P164, DOI 10.1093/aje/153.2.164; Dayal MR, 2009, AM J PHYS ANTHROPOL, V140, P324, DOI 10.1002/ajpa.21072; DEVEAUX P, 1986, S AFR MED J, V69, P421; Diab RD, 1999, S AFR J SCI, V95, P117; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Faber M, 2007, WATER SA, V33, P393; Glenn BS, 2006, EPIDEMIOLOGY, V17, P538, DOI 10.1097/01.ede.0000231284.19078.4b; GOYER RA, 1995, AM J CLIN NUTR, V61, p646S, DOI 10.1093/ajcn/61.3.646S; Grobler SR, 1996, S AFR MED J, V86, P169; Grosse SD, 2002, ENVIRON HEALTH PERSP, V110, P563, DOI 10.1289/ehp.02110563; HARLAN WR, 1988, ENVIRON HEALTH PERSP, V78, P9; Harper CC, 2003, INT J HYG ENVIR HEAL, V206, P315, DOI 10.1078/1438-4639-00227; Heckman J, 2010, SAMJ S AFR MED J, V100, P445, DOI 10.7196/SAMJ.3579; Herman DS, 2009, J HAZARD MATER, V166, P1410, DOI 10.1016/j.jhazmat.2008.12.070; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P961, DOI 10.2307/3434138; Hu H, 1996, AM J EPIDEMIOL, V144, P749, DOI 10.1093/oxfordjournals.aje.a008999; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Kon ZR, 2008, AM J PUBLIC HEALTH, V98, P2272, DOI 10.2105/AJPH.2007.127829; L'Abbe EN, 2005, HOMO, V56, P197, DOI 10.1016/j.jchb.2004.10.004; Lanphear BP, 1996, AM J PUBLIC HEALTH, V86, P1460, DOI 10.2105/AJPH.86.10.1460; Lemon A., 1991, HOMES APART S AFRICA; MAHAFFEY KR, 1983, FED PROC, V42, P1730; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; Mathee A, 2006, ENVIRON RES, V100, P319, DOI 10.1016/j.envres.2005.08.001; Mathee A, 2002, ENVIRON RES, V90, P181, DOI 10.1016/S0013-9351(02)00010-5; Mathee Angela, 2004, Reviews on Environmental Health, V19, P347; Mathee A, 2007, ENVIRON HEALTH PERSP, V115, P321, DOI 10.1289/ehp.9575; Mathee A, 2009, SAMJ S AFR MED J, V99, P819; Mielke HW, 2012, ENVIRON INT, V43, P48, DOI 10.1016/j.envint.2012.03.005; Monna F, 2006, ATMOS ENVIRON, V40, P6554, DOI 10.1016/j.atmosenv.2006.05.064; Montgomery M, 2005, ENVIRON RES, V98, P279, DOI 10.1016/j.envres.2004.10.006; Morrow L, 2007, ARCH ENVIRON OCCUP H, V62, P183, DOI 10.3200/AEOH.62.4.183-186; Motosue AM, 2009, J ALLERGY CLIN IMMUN, V123, pS20, DOI 10.1016/j.jaci.2008.12.089; Muntner P, 2005, ARCH INTERN MED, V165, P2155, DOI 10.1001/archinte.165.18.2155; Navas-Acien A, 2008, EPIDEMIOLOGY, V19, P496, DOI 10.1097/EDE.0b013e31816a2400; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Needleman HL, 1996, JAMA-J AM MED ASSOC, V275, P363, DOI 10.1001/jama.275.5.363; Needleman HL, 2002, NEUROTOXICOL TERATOL, V24, P711, DOI 10.1016/S0892-0362(02)00269-6; Nevin R, 2000, ENVIRON RES, V83, P1, DOI 10.1006/enrs.1999.4045; Nevin R, 2009, ENVIRON RES, V109, P301, DOI 10.1016/j.envres.2008.12.003; Nojilana B, 2007, SAMJ S AFR MED J, V97, P741; Norman R, 2007, SAMJ S AFR MED J, V97, P773; NRIAGU JO, 1992, SCI TOTAL ENVIRON, V121, P1, DOI 10.1016/0048-9697(92)90304-B; Nriagu JO, 1996, SCI TOTAL ENVIRON, V181, P93, DOI 10.1016/0048-9697(95)04954-1; Nweke OC, 2009, ENVIRON HEALTH PERSP, V117, P863, DOI 10.1289/ehp.0800126; Olowoyo JO, 2010, ATMOS ENVIRON, V44, P1826, DOI 10.1016/j.atmosenv.2010.01.048; Olowoyo JO, 2011, ENVIRON SCI POLLUT R, V18, P663, DOI 10.1007/s11356-010-0410-3; Peltzer K, 2002, J R SOC PROMO HEALTH, V122, P187, DOI 10.1177/146642400212200316; Peltzer K, 2001, SOC BEHAV PERSONAL, V29, P249, DOI 10.2224/sbp.2001.29.3.249; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; RABINOWITZ MB, 1991, ENVIRON HEALTH PERSP, V91, P33, DOI 10.2307/3430979; RABINOWITZ MB, 1976, J CLIN INVEST, V58, P260, DOI 10.1172/JCI108467; Smit R, 2001, J COMP FAM STUD, V32, P533, DOI 10.3138/jcfs.32.4.533; Thomas KJA, 2007, INT MIGR REV, V41, P40, DOI 10.1111/j.1747-7379.2007.00056.x; Todd AC, 2000, ENVIRON RES, V84, P282, DOI 10.1006/enrs.1999.4090; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; van Wijngaarden E, 2009, NEUROTOXICOLOGY, V30, P572, DOI 10.1016/j.neuro.2009.05.007; VONSCHIRNDING Y, 1991, ENVIRON HEALTH PERSP, V94, P125, DOI 10.2307/3431305; VONSCHIRNDING YER, 1991, S AFR MED J, V79, P454; VonSchirnding YER, 1996, SCI TOTAL ENVIRON, V188, P1, DOI 10.1016/0048-9697(96)05122-4; WEDEEN RP, 1988, ENVIRON HEALTH PERSP, V78, P57, DOI 10.2307/3430500; Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P1184, DOI 10.1093/aje/kwh333; WHITE NW, 1982, S AFR MED J, V62, P799; WITTMERS LE, 1988, ARCH ENVIRON HEALTH, V43, P381, DOI 10.1080/00039896.1988.9935855; Wright JP, 2009, YOUTH VIOLENCE JUV J, V7, P208, DOI 10.1177/1541204009333827	77	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58146	10.1371/journal.pone.0058146	http://dx.doi.org/10.1371/journal.pone.0058146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505462	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000318334500054
J	Ma, Y; Mi, YJ; Dai, YK; Fu, HL; Cui, DX; Jin, WL				Ma, Yue; Mi, Ya-Jing; Dai, Yun-Kai; Fu, Hua-Lin; Cui, Da-Xiang; Jin, Wei-Lin			The Inverse F-BAR Domain Protein srGAP2 Acts through srGAP3 to Modulate Neuronal Differentiation and Neurite Outgrowth of Mouse Neuroblastoma Cells	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; MIGRATION; SLIT; COMPLEX; GENES; EXPRESSION; MEMBRANE; NUCLEUS; SCHIZOPHRENIA; PROTRUSIONS	The inverse F-BAR (IF-BAR) domain proteins srGAP1, srGAP2 and srGAP3 are implicated in neuronal development and may be linked to mental retardation, schizophrenia and seizure. A partially overlapping expression pattern and highly similar protein structures indicate a functional redundancy of srGAPs in neuronal development. Our previous study suggests that srGAP3 negatively regulates neuronal differentiation in a Rac1-dependent manner in mouse Neuro2a cells. Here we show that exogenously expressed srGAP1 and srGAP2 are sufficient to inhibit valporic acid (VPA)-induced neurite initiation and growth in the mouse Neuro2a cells. While ectopic- or over-expression of RhoGAP-defective mutants, srGAP1(R542A) and srGAP2(R527A) exert a visible inhibitory effect on neuronal differentiation. Unexpectedly, knockdown of endogenous srGAP2 fails to facilitate the neuronal differentiation induced by VPA, but promotes neurite outgrowth of differentiated cells. All three IF-BAR domains from srGAP1-3 can induce filopodia formation in Neuro2a, but the isolated IF-BAR domain from srGAP2, not from srGAP1 and srGAP3, can promote VPA-induced neurite initiation and neuronal differentiation. We identify biochemical and functional interactions of the three srGAPs family members. We propose that srGAP3-Rac1 signaling may be required for the effect of srGAP1 and srGAP2 on attenuating neuronal differentiation. Furthermore, inhibition of Slit-Robo interaction can phenocopy a loss-of-function of srGAP3, indicating that srGAP3 may be dedicated to the Slit-Robo pathway. Our results demonstrate the interplay between srGAP1, srGAP2 and srGAP3 regulates neuronal differentiation and neurite outgrowth. These findings may provide us new insights into the possible roles of srGAPs in neuronal development and a potential mechanism for neurodevelopmental diseases.	[Ma, Yue; Mi, Ya-Jing; Dai, Yun-Kai; Jin, Wei-Lin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Ma, Yue; Fu, Hua-Lin; Cui, Da-Xiang; Jin, Wei-Lin] Shanghai Jiao Tong Univ, Inst Micronano Sci & Technol, Dept Bionanosci & Engn, Shanghai 200030, Peoples R China; [Mi, Ya-Jing] Xian Med Univ, Lab Cell Biol & Translat Med, Xian, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Xi'an Medical University	Jin, WL (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	weilinjin@yahoo.com	Jin, Wei-Lin/A-8355-2013	Jin, Wei-Lin/0000-0001-8011-2405	National Natural Science Foundation of China [31171033, 81272801]; National Key Basic Research Program of China ("973" Project) [2010CB933901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China ("973" Project)(National Basic Research Program of China)	National Natural Science Foundation of China (numbers 31171033 and 81272801; http://www.nsfc.gov.cn/Portal0/default166.htm) and National Key Basic Research Program of China ("973" Project) (number 2010CB933901; http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2009, CURR PSYCHIAT REP, V11, P156, DOI 10.1007/s11920-009-0024-y; Andrews W, 2008, DEV BIOL, V313, P648, DOI 10.1016/j.ydbio.2007.10.052; Armstrong L, 2004, MECH DEVELOP, V121, P1509, DOI 10.1016/j.mod.2004.07.005; Aspenstrom P, 2009, INT REV CEL MOL BIO, V272, P1, DOI 10.1016/S1937-6448(08)01601-8; Bacon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019887; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chen K, 2011, CELL MOL NEUROBIOL, V31, P675, DOI 10.1007/s10571-011-9664-7; Coutinho-Budd J, 2012, J CELL SCI; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Dingova H, 2009, HISTOCHEM CELL BIOL, V131, P425, DOI 10.1007/s00418-008-0539-z; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Dubash AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017380; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Endris V, 2011, J CELL SCI, V124, P3941, DOI 10.1242/jcs.077081; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Kim IH, 2012, J BIOL CHEM; Linkermann A, 2009, BBA-PROTEINS PROTEOM, V1794, P168, DOI 10.1016/j.bbapap.2008.10.013; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Okada H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002189; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Saitsu H, 2011, AM J MED GENET A; Sawamura N, 2005, P NATL ACAD SCI USA, V102, P1187, DOI 10.1073/pnas.0406543102; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sung P. J., 2012, CANC LETT; Waltereit R, 2012, FASEB J; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wilson NKA, 2011, CASE REPORTS GENETIC, V2011, P5; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Yao Q, 2008, CELL MOL NEUROBIOL, V28, P205, DOI 10.1007/s10571-007-9187-4; Ye BQ, 2010, J IMMUNOL, V185, P6294, DOI 10.4049/jimmunol.1001648; Zhao JC, 2012, J CELL PHYSIOL, V227, P2645, DOI 10.1002/jcp.23006	49	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57865	10.1371/journal.pone.0057865	http://dx.doi.org/10.1371/journal.pone.0057865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505444	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500036
J	Schreinemakers, JRC; Westers, P; van Amerongen, P; Kon, M				Schreinemakers, J. Rieneke C.; Westers, Paul; van Amerongen, Pieter; Kon, Moshe			Oxygen Mask Related Nasal Integument and Osteocartilagenous Disorders in F-16 Fighter Pilots	PLOS ONE			English	Article							NOSE	Background: A preliminary survey showed half of the participating Royal Netherlands Air Force (RNLAF) F-16 fighter pilots to have nasal integument and osteocartilagenous disorders related to wearing in-flight oxygen masks. Aim: To make an inventory of these disorders and possible associated factors. Methods: All RNLAF F-16 pilots were requested to fill out a semi-structured questionnaire for a cross-sectional survey. Additionally, one squadron in The Netherlands and pilots in operational theater were asked to participate in a prospective study that required filling out a pain score after each flight. Pilot- and flight-related variables on all participants were collected from the RNLAF database. A linear mixed model was built to identify associated factors with the post-flight pain score. Results: The response rate to the survey was 83%. Ninety of the 108 participants (88%, 6 missing) reported tenderness, irritation, pain, erythema, skin lesions, callous skin, or swelling of nasal bridge integument or architecture. Seventy-two participants (71%, 6 missing) reported their symptoms to be troublesome after a mean of 6 +/- 3 out of 10 flights (0;10, 54 missing). Sixty-six pilots participated in scoring post-flight pain. Pain scores were significantly higher if a participant had >= 3 nasal disorders, after longer than average flights, after flying abroad, and after flying with night vision goggles (respectively +2.7 points, p = 0.003; +0.2 points, p = 0.027; +1.8 points, p = 0.001; +1.2 points p = 0.005). Longer than average NVG flights and more than average NVG hours per annum decreased painscores (respectively -0.8 points, p = 0.017; -0.04 points, p = 0.005). Conclusions: The majority of the RNLAF F-16 fighter pilot community has nasal disorders in the contact area of the oxygen mask, including pain. Six pilot-or flight-related characteristics influence the experienced level of pain.	[Schreinemakers, J. Rieneke C.; Kon, Moshe] Univ Med Ctr Utrecht, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands; [Westers, Paul] Univ Med Ctr Utrecht, Dept Biostat, Utrecht, Netherlands; [Westers, Paul] Univ Med Ctr Utrecht, Res Support Julius Ctr, Utrecht, Netherlands; [van Amerongen, Pieter] Ctr Man Aviat, Soesterberg, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schreinemakers, JRC (corresponding author), Univ Med Ctr Utrecht, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands.	jrcschreinemakers@gmail.com			Central Military Hospital, Utrecht, The Netherlands	Central Military Hospital, Utrecht, The Netherlands	The study was supported by a research grant provided by the Central Military Hospital, Utrecht, The Netherlands. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevan MG, 2010, NECK TORQUE STUDY IN; Bodor RM, 2008, ANN PLAS SURG, V60, P658, DOI 10.1097/SAP.0b013e31814faf55; Callaghan S, 1998, Prof Nurse, V13, P361; Diesel DA., 1997, SAFE J, V27, P104; Gregoretti C, 2002, INTENS CARE MED, V28, P278, DOI 10.1007/s00134-002-1208-7; Krogman WM, 1973, HUMAN SKELETON FOREN, P244; McGREGOR M W, 1958, J Int Coll Surg, V30, P179; Mudry A, 2009, OTOL NEUROTOL, V30, P116, DOI 10.1097/MAO.0b013e318188e905; Muir P, 2007, BONE, V40, P948, DOI 10.1016/j.bone.2006.11.012; NOE JM, 1981, PLAST RECONSTR SURG, V67, P661, DOI 10.1097/00006534-198105000-00017; Paccagnella O, 2006, EVALUATION REV, DOI [10.1177/0193841X05275649Paccagnella, DOI 10.1177/0193841X05275649PACCAGNELLA2006]; Paice JA, 1997, CANCER NURS, V20, P88, DOI 10.1097/00002820-199704000-00002; Schreinemakers JRC, 2010, J PLAST RECONSTR AES, V63, P1217, DOI 10.1016/j.bjps.2009.10.030; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686	14	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e56251	10.1371/journal.pone.0056251	http://dx.doi.org/10.1371/journal.pone.0056251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505413	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500006
J	Vink, PM; Smout, WM; Driessen-Engels, LJ; de Bruin, AM; Delsing, D; Krajnc-Franken, MA; Jansen, AJ; Rovers, EF; van Puijenbroek, AA; Kaptein, A; Nolte, MA; Garritsen, A; van Eenennaam, H				Vink, Paul M.; Smout, Wendy M.; Driessen-Engels, Lilian J.; de Bruin, Alex M.; Delsing, Dianne; Krajnc-Franken, Magda A.; Jansen, Aswin J.; Rovers, Eric F.; van Puijenbroek, Andre A.; Kaptein, Allard; Nolte, Martijn A.; Garritsen, Anja; van Eenennaam, Hans			In Vivo Knockdown of TAK1 Accelerates Bone Marrow Proliferation/Differentiation and Induces Systemic Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED KINASE 1; MEDIATED ACTIVATION; GENE KNOCKDOWN; T-CELLS; BETA; MICE; EXPRESSION; ARTHRITIS; SURVIVAL	TAK1 (TGF-beta Activated Kinase 1) is a MAPK kinase kinase, which activates the p38- and JNK-MAPK and NF-kappa B pathways downstream of receptors such as Toll-Like-, cytokine-and T-cell and B-cell receptors. Representing such an important node in the pro-inflammatory signal-transduction network, the function of TAK1 has been studied extensively. TAK1 knock-out mice are embryonic lethal, while conditional knock-out mice demonstrated either a pro-or anti-inflammatory function. To study the function of TAK1 protein in the adult immune system, we generated and characterized a transgenic mouse expressing TAK1 shRNA under the control of a doxycycline-inducible promoter. Following treatment of TAK-1 shRNA transgenic mice with doxycycline an effective knockdown of TAK1 protein levels was observed in lymphoid organs and cells in the peritoneal cavity (>50% down regulation). TAK1 knockdown resulted in significant changes in leukocyte populations in blood, bone marrow, spleen and peritoneal cavity. Upon TAK1 knockdown mice demonstrated splenomegaly, signs of systemic inflammation (increased levels of circulating cytokines and increase in cellularity of the B-cell areas and in germinal center development in the follicles) and degenerative changes in heart, kidneys and liver. Not surprisingly, TAK1-Tg mice treated with LPS or anti-CD3 antibodies showed enhanced cytokine/chemokine secretion. Finally, analysis of progenitor cells in the bone marrow upon doxycycline treatment showed increased proliferation and differentiation of myeloid progenitor cells. Given the similarity of the phenotype with TGF-beta genetic models, our data suggest that in our model the function of TAK1 in TGF-beta signal-transduction is overruling its function in pro-inflammatory signaling.	[Vink, Paul M.; Smout, Wendy M.; Driessen-Engels, Lilian J.; Delsing, Dianne; Jansen, Aswin J.; Rovers, Eric F.; van Puijenbroek, Andre A.; Garritsen, Anja; van Eenennaam, Hans] MSD, Merck Res Labs, Dept Immune Therapeut, Oss, Netherlands; [de Bruin, Alex M.; Nolte, Martijn A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Krajnc-Franken, Magda A.] MSD, Merck Res Labs, Dept Toxicol & Drug Disposit, Oss, Netherlands; [Kaptein, Allard] MSD, Merck Res Labs, Dept Mol Pharmacol & DMPK, Oss, Netherlands; [Nolte, Martijn A.] Sanquin Res & Landsteiner Lab, Dept Hematopoiesis, Amsterdam, Netherlands	Merck & Company; University of Amsterdam; Academic Medical Center Amsterdam; Merck & Company; Merck & Company; University of Amsterdam	van Eenennaam, H (corresponding author), MSD, Merck Res Labs, Dept Immune Therapeut, Oss, Netherlands.	h.vaneenennaam@bionovion.com	Nolte, Martijn A./AAC-8092-2022	Nolte, Martijn A./0000-0002-5447-0839	VIDI grant from The Netherlands Organization of Scientific Research	VIDI grant from The Netherlands Organization of Scientific Research	M.A.N. was supported by a VIDI grant from The Netherlands Organization of Scientific Research. All authors except for M.A.N. and A.M.d.B. were employees of Merck at the time of these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; CHRIST M, 1994, J IMMUNOL, V153, P1936; Courties G, 2010, BLOOD, V116, P3505, DOI 10.1182/blood-2010-02-269605; DANG H, 1995, J IMMUNOL, V155, P3205; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Fan QW, 2002, CURR BIOL, V12, P1386, DOI 10.1016/S0960-9822(02)01070-9; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hammaker D, 2010, ANN RHEUM DIS, V69, P77, DOI 10.1136/ard.2009.119479; Hammaker DR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2215; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kajino-Sakamoto R, 2010, J IMMUNOL, V185, P4729, DOI 10.4049/jimmunol.0903587; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; Klatt AR, 2006, BIOMED PHARMACOTHER, V60, P55, DOI 10.1016/j.biopha.2005.08.007; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011275; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Shah AH, 2002, J IMMUNOL, V169, P3485, DOI 10.4049/jimmunol.169.7.3485; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Stanford LP, 1997, DEVELOPMENT, V124, P2569; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439	49	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57348	10.1371/journal.pone.0057348	http://dx.doi.org/10.1371/journal.pone.0057348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505428	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500020
J	Yoon, JH; Kim, EK; Moon, HJ; Kwak, JY				Yoon, Jung Hyun; Kim, Eun-Kyung; Moon, Hee Jung; Kwak, Jin Young			Is Follow-up BRAF(V600E) Mutation Analysis Helpful in the Differential Diagnosis of Thyroid Nodules with Negative Results on Initial Analysis?	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BRAF MUTATION; CLINICAL-IMPLICATIONS; MOLECULAR ANALYSIS; PATHOGENIC ROLE; PREVALENT AREA; CARCINOMA; BIOPSY; MANAGEMENT; CANCER	Background: We evaluated the usefulness of follow-up BRAF(V600E) mutation analysis using ultrasonography-guided fine-needle aspiration (US-FNA) in diagnosis of thyroid nodules showing negative BRAFV600E mutation on prior analysis. Methodology/Principal Finding: A total of 49 patients (men: 6, women: 43, mean age: 50.4 years) with 49 thyroid nodules were included. Patients had undergone initial and follow-up US-FNA and subsequent BRAF(V600E) mutation analysis from US-FNA aspirates. All patients had negative results on initial BRAF(V600E) mutation analysis. Clinicopathologic findings, US assessment, and BRAF(V600E) mutation results were analyzed according to the final pathology. Of the 49 nodules, 12 (24.5%) were malignant and 37 (75.5%) were benign. Seven (58.3%) of the 12 malignant nodules were positive for BRAF(V600E) mutation on follow-up, all showing suspicious US features. Initial US-FNA cytology of the 7 nodules were non-diagnostic (n = 2), benign (n = 2), or atypia (n = 3), while follow-up were benign (n = 1), indeterminate (n = 1), suspicious for malignancy (n = 4), and malignancy (n = 1). Conclusions/Significance: Follow-up BRAF(V600E) mutation analysis may be helpful in the diagnosis of selected thyroid nodules negative for BRAF(V600E) mutation on initial analysis, which are assessed as suspicious malignant on US, diagnosed as non-diagnostic, benign or atypia on follow-up US-FNA.	[Yoon, Jung Hyun; Kim, Eun-Kyung; Moon, Hee Jung; Kwak, Jin Young] Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea; [Yoon, Jung Hyun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University	Kwak, JY (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea.	docjin@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Kwak, Jin Young/0000-0002-6212-1495; Yoon, Jung Hyun/0000-0002-2100-3513; Moon, Hee Jung/0000-0002-5643-5885	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0007711]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0007711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung KW, 2006, CLIN ENDOCRINOL, V65, P660, DOI 10.1111/j.1365-2265.2006.02646.x; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cohen Y, 2004, CLIN CANCER RES, V10, P2761, DOI 10.1158/1078-0432.CCR-03-0273; Colanta A, 2011, ACTA CYTOL, V55, P563, DOI 10.1159/000333272; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Danese D, 1998, THYROID, V8, P15, DOI 10.1089/thy.1998.8.15; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Dincer N, 2012, CYTOPATHOLOGY; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; Haberal AN, 2009, CYTOPATHOLOGY, V20, P103, DOI 10.1111/j.1365-2303.2008.00594.x; HAMBURGER JI, 1986, NEW YORK STATE J MED, V86, P241; Hwang J, 2010, AM J ROENTGENOL, V194, pW425, DOI 10.2214/AJR.09.3512; Kabaker AS, 2012, THYROID; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kim KH, 2004, YONSEI MED J, V45, P818, DOI 10.3349/ymj.2004.45.5.818; Kim SK, 2008, DIAGN MOL PATHOL, V17, P118, DOI 10.1097/PDM.0b013e31815d059d; Kim SW, 2010, J CLIN ENDOCR METAB, V95, P3693, DOI 10.1210/jc.2009-2795; Kimura ET, 2003, CANCER RES, V63, P1454; Kwak JY, 2010, HEAD NECK-J SCI SPEC, V32, P490, DOI 10.1002/hed.21210; Kwak JY, 2010, RADIOLOGY, V254, P292, DOI 10.1148/radiol.2541090460; Kwak JY, 2009, RADIOLOGY, V253, P854, DOI 10.1148/radiol.2533090471; Kwak JY, 2009, EUR RADIOL; Lee EJ, 2011, CLIN ENDOCRINOL, V75, P844, DOI 10.1111/j.1365-2265.2011.04154.x; Lee MJ, 2011, YONSEI MED J, V52, P838, DOI 10.3349/ymj.2011.52.5.838; Leenhardt L, 2004, THYROID, V14, P1056, DOI 10.1089/thy.2004.14.1056; Mazzaferri E, 2011, CLIN ENDOCRINOL, V75, P740, DOI 10.1111/j.1365-2265.2011.04245.x; Mazzawi SJ, 2000, J OTOLARYNGOL, V29, P95; Moon HJ, 2011, ANN SURG ONCOL, V18, P792, DOI 10.1245/s10434-010-1354-z; Moon HJ, 2009, ANN SURG ONCOL, V16, P3125, DOI 10.1245/s10434-009-0644-9; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Nam SY, 2010, THYROID, V20, P273, DOI 10.1089/thy.2009.0226; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nikiforov YE, 2011, MODERN PATHOL, V24, pS34, DOI 10.1038/modpathol.2010.167; Ricarte-Filho J, 2011, THYROID; ROSEN IB, 1993, AM J SURG, V166, P346, DOI 10.1016/S0002-9610(05)80329-0; Rowe Leslie R, 2006, Cytojournal, V3, P10, DOI 10.1186/1742-6413-3-10; Sapio MR, 2007, CLIN ENDOCRINOL, V66, P678, DOI 10.1111/j.1365-2265.2007.02800.x; Tang KT, 2010, J CHIN MED ASSOC, V73, P113, DOI 10.1016/S1726-4901(10)70025-3; Trovisco V, 2004, J PATHOL, V202, P247, DOI 10.1002/path.1511; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2004, J CLIN ENDOCR METAB, V89, P2867, DOI 10.1210/jc.2003-032050; Ylagan LR, 2004, THYROID, V14, P35, DOI 10.1089/105072504322783821; Yoon JH, 2011, ANN SURG ONCOL; Yoon JH, 2011, ANN SURG ONCOL, V18, P1282, DOI 10.1245/s10434-011-1605-7	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58592	10.1371/journal.pone.0058592	http://dx.doi.org/10.1371/journal.pone.0058592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505540	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500105
J	Jung, KW; Kang, HA; Bahn, YS				Jung, Kwang-Woo; Kang, Hyun Ah; Bahn, Yong-Sun			Essential Roles of the Kar2/BiP Molecular Chaperone Downstream of the UPR Pathway in Cryptococcus neoformans	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; FUNGAL DRUG-RESISTANCE; CANDIDA-ALBICANS; ANTIFUNGAL AGENTS; YEAST; DEGRADATION; MECHANISMS; EVOLUTION; VIRULENCE	The endoplasmic reticulum (ER) is a central hub where secreted or membrane-bound proteins are maturated and folded properly in eukaryotes. Maintenance of ER homeostasis is particularly important for human fungal pathogens, such as Cryptococcus neoformans, which encounter a plethora of host-mediated stresses during infection. Our previous study demonstrated that the unfolded protein response (UPR) pathway, composed of the evolutionarily conserved Ire1 kinase and the unique Hxl1 transcription factor, has pleiotropic roles in ER stress response, thermotolerance, antifungal drug resistance, and virulence in C. neoformans. Here, we functionally characterized an ER-resident molecular chaperone, Kar2/BiP, in C. neoformans. Conditional expression of KAR2 by the copper-regulated promoter revealed that Kar2 is essential for the viability of C. neoformans. Constitutive expression of KAR2 by the strong histone H3 promoter partially restores resistance to ER stress, cell wall stress, thermotolerance, and genotoxic stress in ire1 Delta and hxl1 Delta mutants, suggesting that Kar2 mainly functions downstream of the UPR pathway. Furthermore, Kar2 appears to control azole resistance in C. neoformans downstream of the UPR pathway without regulation of ERG11 or ERG3. Interestingly, we discovered that azole treatment is sensed as ER-stress and subsequently activates the Ire1-dependent Hxl1 splicing event and induction of KAR2 by the UPR pathway. In contrast, the constitutive expression of Kar2 is not sufficient to restore the Ire1-mediated regulation of capsule production in C. neoformans UPR mutants. In conclusion, this study demonstrates that Kar2 is not only essential for vegetative growth but also required for response and adaptation to the environmental stresses and antifungal drugs downstream of the UPR pathway in C. neoformans.	[Jung, Kwang-Woo; Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Ctr Fungal Pathogenesis, Seoul 120749, South Korea; [Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Coll Nat Sci, Seoul 156756, South Korea	Yonsei University; Chung Ang University	Bahn, YS (corresponding author), Yonsei Univ, Dept Biotechnol, Ctr Fungal Pathogenesis, Seoul 120749, South Korea.	ysbahn@yonsei.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752	National Research Foundation of Korea from MEST [2010-0029117, 2008-0061963]	National Research Foundation of Korea from MEST(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea grants (no. 2010-0029117 and no. 2008-0061963) from MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Aksenov S I, 1973, Life Sci Space Res, V11, P55; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Csala M, 2010, ANTIOXID REDOX SIGN, V13, P77, DOI 10.1089/ars.2009.2529; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Henry KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012732; Hicks JK, 2004, EUKARYOT CELL, V3, P14, DOI 10.1128/EC.3.1.14-26.2004; Hsu CL, 2012, MOL BIOL CELL, V23, P630, DOI 10.1091/mbc.E11-04-0297; Jung KW, 2011, FUNGAL GENET BIOL, V48, P154, DOI 10.1016/j.fgb.2010.10.006; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Lee JW, 2011, EUKARYOT CELL, V10, P998, DOI 10.1128/EC.05124-11; Lee SC, 2012, EUKARYOT CELL, V11, P783, DOI 10.1128/EC.00066-12; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Morrow MW, 2011, CURR GENET, V57, P25, DOI 10.1007/s00294-010-0323-1; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; RITTBERG DAH, 1989, BIOCHEM CELL BIOL, V67, P352, DOI 10.1139/o89-055; Rodrigues ML, 2012, MYCOPATHOLOGIA, V173, P407, DOI 10.1007/s11046-011-9468-9; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; vanGemeren IA, 1997, GENE, V198, P43, DOI 10.1016/S0378-1119(97)00290-4; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; Wimalasena TT, 2008, FUNGAL GENET BIOL, V45, P1235, DOI 10.1016/j.fgb.2008.06.001; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003	49	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58956	10.1371/journal.pone.0058956	http://dx.doi.org/10.1371/journal.pone.0058956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484059	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100145
J	Koh, GCKW; Hawthorne, G; Turner, AM; Kunst, H; Dedicoat, M				Koh, Gavin C. K. W.; Hawthorne, Gemma; Turner, Alice M.; Kunst, Heinke; Dedicoat, Martin			Tuberculosis Incidence Correlates with Sunshine: An Ecological 28-Year Time Series Study	PLOS ONE			English	Article							VITAMIN-D; DOUBLE-BLIND; SEASONALITY; DISEASES; SUNLIGHT	Background: Birmingham is the largest UK city after London, and central Birmingham has an annual tuberculosis incidence of 80 per 100,000. We examined seasonality and sunlight as drivers of tuberculosis incidence. Hours of sunshine are seasonal, sunshine exposure is necessary for the production of vitamin D by the body and vitamin D plays a role in the host response to tuberculosis. Methods: We performed an ecological study that examined tuberculosis incidence in Birmingham from Dec 1981 to Nov 2009, using publicly-available data from statutory tuberculosis notifications, and related this to the seasons and hours of sunshine (UK Meteorological Office data) using unmeasured component models. Results: There were 9,739 tuberculosis cases over the study period. There was strong evidence for seasonality, with notifications being 24.1% higher in summer than winter (p<0.001). Winter dips in sunshine correlated with peaks in tuberculosis incidence six months later (4.7% increase in incidence for each 100 hours decrease in sunshine, p<0.001). Discussion and Conclusion: A potential mechanism for these associations includes decreased vitamin D levels with consequent impaired host defence arising from reduced sunshine exposure in winter. This is the longest time series of any published study and our use of statutory notifications means this data is essentially complete. We cannot, however, exclude the possibility that another factor closely correlated with the seasons, other than sunshine, is responsible. Furthermore, exposure to sunlight depends not only on total hours of sunshine but also on multiple individual factors. Our results should therefore be considered hypothesis-generating. Confirmation of a potential causal relationship between winter vitamin D deficiency and summer peaks in tuberculosis incidence would require a randomized-controlled trial of the effect of vitamin D supplementation on future tuberculosis incidence.	[Koh, Gavin C. K. W.; Dedicoat, Martin] Heartlands Hosp, Dept Infect & Trop Med, Birmingham, W Midlands, England; [Hawthorne, Gemma; Turner, Alice M.; Kunst, Heinke] Heartlands Hosp, Dept Resp Med, Birmingham, W Midlands, England; [Koh, Gavin C. K. W.; Dedicoat, Martin] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Hawthorne, Gemma; Turner, Alice M.; Kunst, Heinke] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England	Heart of England NHS Foundation Trust; Heart of England NHS Foundation Trust; University of Warwick; University of Birmingham	Koh, GCKW (corresponding author), Heartlands Hosp, Dept Infect & Trop Med, Birmingham, W Midlands, England.	gavin.koh@gmail.com	Dedicoat, Martin/AFC-7815-2022; Turner, Alice M/W-5171-2018	Turner, Alice M/0000-0002-5947-3254; Dedicoat, Martin/0000-0001-9833-4882				Altes HK, 2012, INT J TUBERC LUNG D, V16, P639, DOI 10.5588/ijtld.11.0680; Bennett J, 2001, INT J TUBERC LUNG D, V5, P158; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Douglas A S, 1998, Ethn Health, V3, P247; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; Durbin James, 2001, TIME SERIES ANAL STA, Vsecond; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Ganmaa D, 2012, AM J CLIN NUTR, V96, P391, DOI 10.3945/ajcn.112.034967; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Pedrazzoli D, 2012, TUBERCULOSIS UK 2012; Visser DH, 2013, EPIDEMIOL INFECT, V141, P459, DOI 10.1017/S0950268812001045; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373	22	38	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57752	10.1371/journal.pone.0057752	http://dx.doi.org/10.1371/journal.pone.0057752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483924	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100040
J	Lee, MR; Yang, CY; Chang, KP; Keng, LT; Yen, DHT; Wang, JY; Wu, HD; Lee, LN; Yu, CJ				Lee, Meng-Rui; Yang, Ching-Yao; Chang, Kai-Ping; Keng, Li-Ta; Yen, David Hung-Tsang; Wang, Jann-Yuan; Wu, Huey-Dong; Lee, Li-Na; Yu, Chong-Jen			Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease	PLOS ONE			English	Article							FORCED EXPIRATORY VOLUME; QUALITY-OF-LIFE; PERFORMANCE ASSESSMENT; TUBERCULOSIS; BRONCHIECTASIS; INFECTIONS; SPIROMETRY; ADULTS; ABSCESSUS; SMOKING	Background: There is paucity of risk factors on lung function decline among patients with non-tuberculous mycobacteria (NTM) pulmonary disease in literature. Methods: Patients with NTM pulmonary disease between January 2000 and April 2011 were retrospectively selected. Sixty-eight patients had at least two pulmonary function tests within a mean follow-up period of 47 months. Results: Sixty-eight patients were included. They had a median age of 65 years and 65% had impaired lung function (Forced expiratory volume in 1 second [FEV1] <80% of predicted value). The mean FEV1 decline was 48 ml/year. By linear regression, younger age (beta: 0.472, p < 0.001), initial FEV1 >50% of predicted value (beta: 0.349, p = 0.002), male sex (beta: 0.295, p = 0.018), bronchiectasis pattern (beta: 0.232, p = 0.035), and radiographic score >3 (beta: 0.217, p = 0.049) were associated with greater FEV1 decline. Initial FEV1 >50% of predicted value (beta: 0.263, p = 0.032) was also associated with greater FVC annual decline, whereas M. kansasii pulmonary disease was marginally associated with greater annual FVC decline (beta: 0.227, p = 0.062). Conclusions: NTM pulmonary disease is associated with greater decline in lung function in patients who are young, male, with bronchiectasis, and with a high radiographic score. Special attention should be given to patients with these risk factors.	[Lee, Meng-Rui; Yang, Ching-Yao; Chang, Kai-Ping; Keng, Li-Ta; Wang, Jann-Yuan; Wu, Huey-Dong; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Meng-Rui] Taoyuan Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Keng, Li-Ta; Yen, David Hung-Tsang] Kinmen Hosp, Dept Internal Med, Kinmen, Taiwan; [Yen, David Hung-Tsang] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Emergency Med, Taipei 112, Taiwan; [Lee, Li-Na] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital	Wang, JY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	jywang@ntu.edu.tw		Yu, Chong-Jen/0000-0001-5664-9392; Wu, Huey-Dong/0000-0001-6279-0384; WANG, JANN-YUAN/0000-0003-3406-366X; LEE, MENG-RUI/0000-0002-7220-4833; LEE, LI-NA/0000-0002-7654-2450; YANG, CHING-YAO/0000-0003-4927-4814; LI-TA, KENG/0000-0003-2772-8037				Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; BURROWS B, 1986, AM REV RESPIR DIS, V133, P974; BURROWS B, 1987, AM REV RESPIR DIS, V135, P788, DOI 10.1164/arrd.1987.135.4.788; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2012, CLIN CHEST MED, V33, P283, DOI 10.1016/j.ccm.2012.02.002; Huang CT, 2012, INT J TUBERC LUNG D, V16, P539, DOI 10.5588/ijtld.11.0412; Khan Zinobia, 2010, Open Respir Med J, V4, P76, DOI 10.2174/1874306401004010076; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; LANGE P, 1989, EUR RESPIR J, V2, P811; Lee MR, 2012, J CLIN MICROBIOL, V50, P3398, DOI 10.1128/JCM.01862-12; Lee MR, 2012, J INFECTION, V64, P228, DOI 10.1016/j.jinf.2011.11.006; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; Matveychuk A, 2012, RESP MED, V106, P1472, DOI 10.1016/j.rmed.2012.06.023; Mehta M, 2011, RESP MED, V105, P1718, DOI 10.1016/j.rmed.2011.08.004; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Roberts MH, 2012, AM J EPIDEMIOL, V176, P127, DOI 10.1093/aje/kwr503; Sheehan RE, 2002, EUR RESPIR J, V20, P581, DOI 10.1183/09031936.02.00284602; SHERMAN CB, 1992, AM REV RESPIR DIS, V146, P855, DOI 10.1164/ajrccm/146.4.855; Shu CC, 2011, LUNG, V189, P467, DOI 10.1007/s00408-011-9321-4; Shu CC, 2010, MEDICINE, V89, P53, DOI 10.1097/MD.0b013e3181cafcd3; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wallace RJ, 1998, AM J RESP CRIT CARE, V158, P1235, DOI 10.1164/ajrccm.158.4.9712098; Wang JY, 2007, MEDICINE, V86, P39, DOI 10.1097/MD.0b013e318030b605; Wang JY, 2004, J CLIN MICROBIOL, V42, P4599, DOI 10.1128/JCM.42.10.4599-4603.2004; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710; Weatherall M, 2009, EUR RESPIR J, V33, P1025, DOI 10.1183/09031936.00116808	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58214	10.1371/journal.pone.0058214	http://dx.doi.org/10.1371/journal.pone.0058214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483998	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100090
J	Sominsky, L; Fuller, EA; Bondarenko, E; Ong, LK; Averell, L; Nalivaiko, E; Dunkley, PR; Dickson, PW; Hodgson, DM				Sominsky, Luba; Fuller, Erin A.; Bondarenko, Evgeny; Ong, Lin Kooi; Averell, Lee; Nalivaiko, Eugene; Dunkley, Peter R.; Dickson, Phillip W.; Hodgson, Deborah M.			Functional Programming of the Autonomic Nervous System by Early Life Immune Exposure: Implications for Anxiety	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; TYROSINE-HYDROXYLASE PHOSPHORYLATION; MESSENGER-RNA EXPRESSION; ENDOTOXIN EXPOSURE; NEONATAL EXPOSURE; RAT HIPPOCAMPUS; GENE-EXPRESSION; STRESS; RECEPTOR; ALTERS	Neonatal exposure of rodents to an immune challenge alters a variety of behavioural and physiological parameters in adulthood. In particular, neonatal lipopolysaccharide (LPS; 0.05 mg/kg, i.p.) exposure produces robust increases in anxiety-like behaviour, accompanied by persistent changes in hypothalamic-pituitary-adrenal (HPA) axis functioning. Altered autonomic nervous system (ANS) activity is an important physiological contributor to the generation of anxiety. Here we examined the long term effects of neonatal LPS exposure on ANS function and the associated changes in neuroendocrine and behavioural indices. ANS function in Wistar rats, neonatally treated with LPS, was assessed via analysis of tyrosine hydroxylase (TH) in the adrenal glands on postnatal days (PNDs) 50 and 85, and via plethysmographic assessment of adult respiratory rate in response to mild stress (acoustic and light stimuli). Expression of genes implicated in regulation of autonomic and endocrine activity in the relevant brain areas was also examined. Neonatal LPS exposure produced an increase in TH phosphorylation and activity at both PNDs 50 and 85. In adulthood, LPS-treated rats responded with increased respiratory rates to the lower intensities of stimuli, indicative of increased autonomic arousal. These changes were associated with increases in anxiety-like behaviours and HPA axis activity, alongside altered expression of the GABA-A receptor alpha 2 subunit, CRH receptor type 1, CRH binding protein, and glucocorticoid receptor mRNA levels in the prefrontal cortex, hippocampus and hypothalamus. The current findings suggest that in addition to the commonly reported alterations in HPA axis functioning, neonatal LPS challenge is associated with a persistent change in ANS activity, associated with, and potentially contributing to, the anxiety-like phenotype. The findings of this study reflect the importance of changes in the perinatal microbial environment on the ontogeny of physiological processes.	[Sominsky, Luba; Fuller, Erin A.; Hodgson, Deborah M.] Univ Newcastle, Lab Neuroimmunol, Sch Psychol, Callaghan, NSW 2308, Australia; [Bondarenko, Evgeny; Ong, Lin Kooi; Nalivaiko, Eugene; Dunkley, Peter R.; Dickson, Phillip W.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Bondarenko, Evgeny; Ong, Lin Kooi; Nalivaiko, Eugene; Dunkley, Peter R.; Dickson, Phillip W.] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia; [Averell, Lee] Univ Newcastle, Newcastle Cognit Lab, Sch Psychol, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Sominsky, L (corresponding author), Univ Newcastle, Lab Neuroimmunol, Sch Psychol, Callaghan, NSW 2308, Australia.	luba.sominsky@newcastle.edu.au	Bondarenko, Evgeny/AAA-6088-2019; Ong, Lin Kooi/H-2797-2012; Hodgson, Deborah/C-1950-2008	Bondarenko, Evgeny/0000-0003-0631-8936; Ong, Lin Kooi/0000-0001-8664-0540; Hodgson, Deborah/0000-0002-1522-0212; Fuller, Erin/0000-0001-8653-1002; Sominsky, Luba/0000-0002-0674-8824; Nalivaiko, Eugene/0000-0002-6449-8181	University of Newcastle	University of Newcastle	University of Newcastle Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amath A, 2012, NEUROSCIENCE, V220, P90, DOI 10.1016/j.neuroscience.2012.06.037; Averell L, 2011, J MATH PSYCHOL, V55, P25, DOI 10.1016/j.jmp.2010.08.009; BARUCHIN A, 1990, J NEUROCHEM, V54, P1769, DOI 10.1111/j.1471-4159.1990.tb01232.x; Bilbo SD, 2008, BRAIN BEHAV IMMUN, V22, P451, DOI 10.1016/j.bbi.2007.10.003; Bilbo SD, 2007, BRAIN BEHAV IMMUN, V21, P332, DOI 10.1016/j.bbi.2006.10.005; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Bornstein SR, 2000, P NATL ACAD SCI USA, V97, P14742, DOI 10.1073/pnas.97.26.14742; Brinks Vera, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/90163; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Craske MG, 2001, J AM ACAD CHILD PSY, V40, P556, DOI 10.1097/00004583-200105000-00015; Davies MJ, 2002, TRENDS ENDOCRIN MET, V13, P386, DOI 10.1016/S1043-2760(02)00691-4; Dombrowski SC, 2003, BIRTH DEFECTS RES A, V67, P905, DOI 10.1002/bdra.10096; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; DUNN AJ, 1992, J PHARMACOL EXP THER, V261, P964; Enomoto T, 2011, BIOL PSYCHIAT, V69, P432, DOI 10.1016/j.biopsych.2010.09.038; FLUHARTY SJ, 1983, BRAIN RES, V267, P384, DOI 10.1016/0006-8993(83)90895-8; Gaiarsa JL, 2004, J CELL MOL MED, V8, P31, DOI 10.1111/j.1582-4934.2004.tb00257.x; Girod JP, 2004, CARDIOVASC RES, V64, P217, DOI 10.1016/j.cardiores.2004.07.006; Guo AL, 1996, J ENDOCRINOL INVEST, V19, P83, DOI 10.1007/BF03349841; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Herman JP, 1998, J NEUROSCI, V18, P7462; Hodgson DM, 2001, PEDIATR RES, V50, P750, DOI 10.1203/00006450-200112000-00020; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Jenkins TA, 2009, BEHAV BRAIN RES, V205, P355, DOI 10.1016/j.bbr.2009.07.014; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kabir MM, 2010, PHYSIOL BEHAV, V101, P22, DOI 10.1016/j.physbeh.2010.04.004; Karrow NA, 2006, BRAIN BEHAV IMMUN, V20, P144, DOI 10.1016/j.bbi.2005.05.003; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Nalivaiko E, 2011, RESP RESPONSES ACOUS; Nalivaiko E, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00114; Ong LK, 2011, NEUROSCIENCE, V192, P20, DOI 10.1016/j.neuroscience.2011.06.087; Ong LK, 2012, NEUROCHEM RES, V37, P1938, DOI 10.1007/s11064-012-0812-3; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Paine TA, 2011, NEUROPSYCHOPHARMACOL, V36, P1703, DOI 10.1038/npp.2011.51; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; SAPOLSKY RM, 1985, BRAIN RES, V339, P161, DOI 10.1016/0006-8993(85)90638-9; Seasholtz AF, 2001, PEPTIDES, V22, P743, DOI 10.1016/S0196-9781(01)00387-4; SHANKS N, 1995, J NEUROSCI, V15, P376, DOI 10.1523/jneurosci.15-01-00376.1995; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Sominsky L, 2012, BEHAV BRAIN RES, V226, P351, DOI 10.1016/j.bbr.2011.08.038; Sominsky L, 2012, HORM BEHAV, V62, P345, DOI 10.1016/j.yhbeh.2012.02.005; Stachowiak M K, 1988, Brain Res, V427, P275; Todorovic C, 2005, NEUROSCI BIOBEHAV R, V29, P1323, DOI 10.1016/j.neubiorev.2005.04.014; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; VANDIJKEN HH, 1993, NEUROENDOCRINOLOGY, V58, P57, DOI 10.1159/000126512; Walker AK, 2010, STRESS, V13, P506, DOI 10.3109/10253890.2010.489977; Walker AK, 2012, PSYCHONEUROENDOCRINO, V37, P1320, DOI 10.1016/j.psyneuen.2012.01.005; Walker AK, 2011, BRAIN BEHAV IMMUN, V25, P674, DOI 10.1016/j.bbi.2011.01.004; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Walker FR, 2004, BEHAV BRAIN RES, V154, P63, DOI 10.1016/j.bbr.2004.01.019; Walker FR, 2008, J PSYCHIATR RES, V42, P1094, DOI 10.1016/j.jpsychires.2007.12.006; Weninger SC, 1999, P NATL ACAD SCI USA, V96, P8283, DOI 10.1073/pnas.96.14.8283; Wilhelm FH, 2001, BEHAV MODIF, V25, P513, DOI 10.1177/0145445501254003; Wynne O, 2011, STRESS, V14, P247, DOI 10.3109/10253890.2010.532576	63	47	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57700	10.1371/journal.pone.0057700	http://dx.doi.org/10.1371/journal.pone.0057700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483921	Green Published, gold			2022-12-25	WOS:000316936100037
J	Righi, V; Constantinou, C; Mintzopoulos, D; Khan, N; Mupparaju, SP; Rahme, LG; Swartz, HM; Szeto, HH; Tompkins, RG; Tzika, AA				Righi, Valeria; Constantinou, Caterina; Mintzopoulos, Dionyssios; Khan, Nadeem; Mupparaju, S. P.; Rahme, Laurence G.; Swartz, Harold M.; Szeto, Hazel H.; Tompkins, Ronald G.; Tzika, A. Aria			Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo P-31 nuclear magnetic resonance and electron paramagnetic resonance spectroscopy	FASEB JOURNAL			English	Article						physiology; molecular medicine; mice; mitochondria; oxidative stress	INSULIN-RESISTANCE; INDUCED APOPTOSIS; NMR-SPECTROSCOPY; DOWN-REGULATION; PEPTIDE; INJURY; ACONITASE; METABOLISM; MODULATION; DYSFUNCTION	Burn injury causes a major systemic catabolic response that is associated with mitochondrial dysfunction in skeletal muscle. We investigated the effects of the mitochondria-targeted peptide antioxidant Szeto-Schiller 31 (SS-31) on skeletal muscle in a mouse burn model using in vivo phosphorus-31 nuclear magnetic resonance (P-31 NMR) spectroscopy to noninvasively measure high-energy phosphate levels; mitochondrial aconitase activity measurements that directly correlate with TCA cycle flux, as measured by gas chromatography mass spectrometry (GC-MS); and electron paramagnetic resonance (EPR) to assess oxidative stress. At 6 h postburn, the oxidative ATP synthesis rate was increased 5-fold in burned mice given a single dose of SS-31 relative to untreated burned mice (P=0.002). Furthermore, SS-31 administration in burned animals decreased mitochondrial aconitase activity back to control levels. EPR revealed a recovery in redox status of the SS-31-treated burn group compared to the untreated burn group (P<0.05). Our multidisciplinary convergent results suggest that SS-31 promotes recovery of mitochondrial function after burn injury by increasing ATP synthesis rate, improving mitochondrial redox status, and restoring mitochondrial coupling. These findings suggest use of noninvasive in vivo NMR and complementary EPR offers an approach to monitor the effectiveness of mitochondrial protective agents in alleviating burn injury symptoms.	[Righi, Valeria; Constantinou, Caterina; Mintzopoulos, Dionyssios; Tzika, A. Aria] Harvard Univ, Sch Med, Massachusetts Gen Hosp, NMR Surg Lab,Dept Surg, Boston, MA 02114 USA; [Constantinou, Caterina; Rahme, Laurence G.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Surg Lab,Dept Surg, Boston, MA 02114 USA; [Righi, Valeria; Constantinou, Caterina; Mintzopoulos, Dionyssios; Rahme, Laurence G.; Tompkins, Ronald G.; Tzika, A. Aria] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Surg,Div Burns, Boston, MA 02114 USA; [Righi, Valeria; Mintzopoulos, Dionyssios; Tzika, A. Aria] Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol,Massachusetts Gen Hosp, Boston, MA 02114 USA; [Righi, Valeria; Mintzopoulos, Dionyssios; Tzika, A. Aria] Harvard Univ, Sch Med, Shriners Burns Inst, Boston, MA 02114 USA; [Khan, Nadeem; Mupparaju, S. P.; Swartz, Harold M.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch,Dept Diagnost Radiol, Electron Paramagnet Resonance EPR Ctr Viable Syst, Hanover, NH 03756 USA; [Szeto, Hazel H.] Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Dartmouth College; Cornell University	Tzika, AA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, NMR Surg Lab,Dept Surg, 51 Blossom St,Rm 261, Boston, MA 02114 USA.	atzika@hms.harvard.edu	Righi, Valeria/N-4821-2014; Constantinou, Caterina/D-3844-2018	Righi, Valeria/0000-0003-2394-8462; Constantinou, Caterina/0000-0003-3589-0739	U.S. National Institute Institutes of Health (NIH) [P50GM021700]; Shriner's Hospital for Children [8893, 8892]; U.S. Defense Medical Research and Development Program (DMRDP) [DM103014]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI105902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	U.S. National Institute Institutes of Health (NIH); Shriner's Hospital for Children; U.S. Defense Medical Research and Development Program (DMRDP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a U.S. National Institute Institutes of Health (NIH) center grant (P50GM021700) to R. G. T. (A. A. T., director of the NMR core), Shriner's Hospital for Children research grants to A. A. T. (8893) and L. G. R. (8892), and a research support grant (DM103014) from the U.S. Defense Medical Research and Development Program (DMRDP). The authors thank Dr. Alan J. Fischman for his advice. The authors also thank Dr. Ann Power Smith (Write Science Right, Las Vegas, NV, USA) for editorial assistance. Disclosure: the SS peptides technology has been licensed for commercial development to Stealth Peptides Inc. (Newton Centre, MA, USA) by the Cornell Research Foundation (CRF), and both CRF and H. H. S. have financial interests.	ACKERMAN JJH, 1980, NATURE, V283, P167, DOI 10.1038/283167a0; ALGER JR, 1984, Q REV BIOPHYS, V17, P83, DOI 10.1017/S0033583500005266; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Apidianakis Y, 2012, FASEB J, V26, P730, DOI 10.1096/fj.11-192484; Astrakas LG, 2005, FASEB J, V19, P1431, DOI 10.1096/fj.04-2005com; BAILEY IA, 1981, BIOCHEM J, V196, P171, DOI 10.1042/bj1960171; Barret JP, 2003, ARCH SURG-CHICAGO, V138, P127, DOI 10.1001/archsurg.138.2.127; Befroy DE, 2009, METHOD ENZYMOL, V457, P373, DOI 10.1016/S0076-6879(09)05021-6; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BRINDLE KM, 1989, BIOCHEMISTRY-US, V28, P4887, DOI 10.1021/bi00437a054; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Carter EA, 2011, INT J MOL MED, V28, P589, DOI 10.3892/ijmm.2011.752; Cho S, 2007, J BIOL CHEM, V282, P4634, DOI 10.1074/jbc.M609388200; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; Dai DF, 2011, J AM COLL CARDIOL, V58, P73, DOI 10.1016/j.jacc.2010.12.044; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; HITZIG BM, 1987, FASEB J, V1, P22, DOI 10.1096/fasebj.1.1.3301494; Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997; Khan N, 2008, MOL MED REP, V1, P813, DOI 10.3892/mmr_00000033; KINGSLEYHICKMAN PB, 1990, J BIOL CHEM, V265, P1545; Lee HY, 2011, SHOCK, V36, P580, DOI 10.1097/SHK.0b013e3182366872; LEIMER KR, 1977, J CHROMATOGR, V141, P121, DOI 10.1016/S0021-9673(00)99131-3; Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011; Padfield KE, 2006, J TRAUMA, V61, P280, DOI 10.1097/01.ta.0000230567.56797.6c; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Righi V, 2009, INT J MOL MED, V24, P749, DOI 10.3892/ijmm_00000288; SAKO EY, 1988, J BIOL CHEM, V263, P10600; Sheridan RL, 2004, J AM COLL SURGEONS, V198, P243, DOI 10.1016/j.jamcollsurg.2003.11.007; Shestov AA, 2012, NEUROCHEM RES, V37, P2388, DOI 10.1007/s11064-012-0782-5; Siegel MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026963; TOMERA JF, 1988, BURNS, V14, P210, DOI 10.1016/0305-4179(88)90040-X; Tzika AA, 2008, INT J MOL MED, V21, P201; Tzika AA, 2008, INT J MOL MED, V21, P825; Tzika AA, 2009, INT J MOL MED, V24, P387, DOI 10.3892/ijmm_00000244; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; VERNIQUET F, 1991, BIOCHEM J, V276, P643, DOI 10.1042/bj2760643; Yo K, 2013, AM J PHYSIOL-ENDOC M, V304, pE331, DOI 10.1152/ajpendo.00098.2012; Yu YM, 2002, AM J PHYSIOL-ENDOC M, V282, pE247, DOI 10.1152/ajpendo.00206.2001; Yu YM, 1999, JPEN-PARENTER ENTER, V23, P160, DOI 10.1177/0148607199023003160; Zhang QH, 2006, INT J MOL MED, V18, P1223; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1154, DOI 10.1152/ajpcell.00110.2007; Zhao KS, 2005, BIOCHEM PHARMACOL, V70, P1796, DOI 10.1016/j.bcp.2005.08.022; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	45	24	25	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2521	2530		10.1096/fj.12-220764	http://dx.doi.org/10.1096/fj.12-220764			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23482635	Green Published			2022-12-25	WOS:000319667600040
J	Ito, T; Katayama, T; Hattie, M; Sakurama, H; Wada, J; Suzuki, R; Ashida, H; Wakagi, T; Yamamoto, K; Stubbs, KA; Fushinobu, S				Ito, Tasuku; Katayama, Takane; Hattie, Mitchell; Sakurama, Haruko; Wada, Jun; Suzuki, Ryuichiro; Ashida, Hisashi; Wakagi, Takayoshi; Yamamoto, Kenji; Stubbs, Keith A.; Fushinobu, Shinya			Crystal Structures of a Glycoside Hydrolase Family 20 Lacto-N-biosidase from Bifidobacterium bifidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; HUMAN-MILK OLIGOSACCHARIDES; BETA-HEXOSAMINIDASE-B; ACETYL-D-GLUCOSAMINE; MOLECULAR-CLONING; BIOSE; ACETYLHEXOSAMINIDASE; ENZYME; MECHANISM; INSIGHTS	Human milk oligosaccharides contain a large variety of oligosaccharides, of which lacto-N-biose I (Gal-beta 1,3-GlcNAc; LNB) predominates as a major core structure. A unique metabolic pathway specific for LNB has recently been identified in the human commensal bifidobacteria. Several strains of infant gut-associated bifidobacteria possess lacto-N-biosidase, a membrane-anchored extracellular enzyme, that liberates LNB from the nonreducing end of human milk oligosaccharides and plays a key role in the metabolic pathway of these compounds. Lacto-N-biosidase belongs to the glycoside hydrolase family 20, and its reaction proceeds via a substrate-assisted catalytic mechanism. Several crystal structures of GH20 beta-N-acetylhexosaminidases, which release monosaccharide GlcNAc from its substrate, have been determined, but to date, a structure of lacto-N-biosidase is unknown. Here, we have determined the first three-dimensional structures of lacto-N-biosidase from Bifidobacterium bifidum JCM1254 in complex with LNB and LNB-thiazoline (Gal-beta 1,3-GlcNAc-thiazoline) at 1.8-angstrom resolution. Lacto-N-biosidase consists of three domains, and the C-terminal domain has a unique beta-trefoil-like fold. Compared with other beta-N-acetylhexosaminidases, lacto-N-biosidase has a wide substrate-binding pocket with a -2 subsite specific for beta-1,3-linked Gal, and the residues responsible for Gal recognition were identified. The bound ligands are recognized by extensive hydrogen bonds at all of their hydroxyls consistent with the enzyme's strict substrate specificity for the LNB moiety. The GlcNAc sugar ring of LNB is in a distorted conformation near E-4, whereas that of LNB-thiazoline is in a C-4(1) conformation. A possible conformational pathway for the lacto-N-biosidase reaction is discussed.	[Ito, Tasuku; Suzuki, Ryuichiro; Wakagi, Takayoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Katayama, Takane; Sakurama, Haruko; Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Hattie, Mitchell; Stubbs, Keith A.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Wada, Jun] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Ashida, Hisashi] Kinki Univ, Fac Biol Oriented Sci & Technol, Dept Sci & Technol Food Safety, Wakayama 6496493, Japan	University of Tokyo; Ishikawa Prefecture University; University of Western Australia; Kyoto University; Kindai University (Kinki University)	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Ashida, Hisashi/HCI-0293-2022; Stubbs, Keith/H-5909-2014; Wakagi, Takayoshi/AAJ-4145-2021	Fushinobu, Shinya/0000-0003-1346-6435; Katayama, Takane/0000-0003-4009-7874; Ashida, Hisashi/0000-0001-5844-4075; Stubbs, Keith/0000-0001-6899-402X	Program for the Promotion of Basic Research Activities for Innovative Bioscience, Japan; Japan Society for the Promotion of Science KAKENHI [24380053]; Australian Research Council; Priority Program for Disaster-affected Quantum Beam Facilities [PF 2011G080, SPring-8 2011A1908]; Grants-in-Aid for Scientific Research [24580119] Funding Source: KAKEN	Program for the Promotion of Basic Research Activities for Innovative Bioscience, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Australian Research Council(Australian Research Council); Priority Program for Disaster-affected Quantum Beam Facilities; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for the Promotion of Basic Research Activities for Innovative Bioscience, Japan (to S. F., K. Y., and T. K.), by Japan Society for the Promotion of Science KAKENHI Grant 24380053 (to S. F. and H. A.), and by the Australian Research Council. Part of this work was performed under the Priority Program for Disaster-affected Quantum Beam Facilities Proposals PF 2011G080 and SPring-8 2011A1908.	Amorelli B, 2008, BIOORG MED CHEM LETT, V18, P2944, DOI 10.1016/j.bmcl.2008.03.067; Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Barboza M, 2009, APPL ENVIRON MICROB, V75, P7319, DOI 10.1128/AEM.00842-09; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Greig IR, 2008, J AM CHEM SOC, V130, P17620, DOI 10.1021/ja805640c; Hattie M, 2012, CHEMBIOCHEM, V13, P1128, DOI 10.1002/cbic.201200135; Hidaka M, 2009, J BIOL CHEM, V284, P7273, DOI 10.1074/jbc.M808525200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hou YM, 2001, BIOCHEMISTRY-US, V40, P2201, DOI 10.1021/bi002018s; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Liu T, 2011, BIOCHEM J, V438, P467, DOI 10.1042/BJ20110390; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MAGNANI JL, 1983, CANCER RES, V43, P5489; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P42131, DOI 10.1074/jbc.M107154200; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Rappleye J, 2002, J APPL CRYSTALLOGR, V35, P374, DOI 10.1107/S0021889802005782; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; SANO M, 1992, P NATL ACAD SCI USA, V89, P8512, DOI 10.1073/pnas.89.18.8512; SANO M, 1993, J BIOL CHEM, V268, P18560; Sattelle BM, 2011, GLYCOBIOLOGY, V21, P1651, DOI 10.1093/glycob/cwr101; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; SINNOTT ML, 1984, BIOCHEM J, V224, P817, DOI 10.1042/bj2240817; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Urashima T., 2011, MILK OLIGOSACCHARIDE; Urashima T, 2012, ADV NUTR, V3, p473S, DOI 10.3945/an.111.001412; Urashima T, 2009, GLYCOBIOLOGY, V19, P499, DOI 10.1093/glycob/cwp006; Usuki H, 2008, J AM CHEM SOC, V130, P4146, DOI 10.1021/ja077641f; Venema K, 2012, INT DAIRY J, V22, P123, DOI 10.1016/j.idairyj.2011.10.011; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Wada M, 2009, ACTA CRYSTALLOGR E, V65, pO1781, DOI 10.1107/S1600536809024775; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	71	38	40	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11795	11806		10.1074/jbc.M112.420109	http://dx.doi.org/10.1074/jbc.M112.420109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479733	Green Published, hybrid			2022-12-25	WOS:000318157600016
J	Nishii, K; Nakaseko, C; Jiang, MZ; Shimizu, N; Takeuchi, M; Schneider, WJ; Bujo, H				Nishii, Keigo; Nakaseko, Chiaki; Jiang, Meizi; Shimizu, Naomi; Takeuchi, Masahiro; Schneider, Wolfgang J.; Bujo, Hideaki			The Soluble Form of LR11 Protein Is a Regulator of Hypoxia-induced, Urokinase-type Plasminogen Activator Receptor (uPAR)-mediated Adhesion of Immature Hematological Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; SMOOTH-MUSCLE-CELLS; SCID-REPOPULATING CELLS; INDUCIBLE FACTOR-I; BONE-MARROW NICHE; FAMILY-MEMBER; OSTEOBLASTIC NICHE; ALZHEIMER-DISEASE; EXPRESSION; MIGRATION	A key property of hematopoietic stem and progenitor cells (HSPCs) regarding differentiation from the self-renewing quiescent to the proliferating stage is their adhesion to the bone marrow (BM) niche. An important molecule involved in proliferation and pool size of HSPCs in the BM is the hypoxia-induced urokinase-type plasminogen activator receptor (uPAR). Here, we show that the soluble form (sLR11) of LR11 (also called SorLA or SORL1) modulates the uPAR-mediated attachment of HSPCs under hypoxic conditions. Immunohistochemical and mRNA expression analyses revealed that hypoxia increased LR11 expression in hematological c-Kit(+) Lin(-) cells. In U937 cells, hypoxia induced a transient rise in LR11 transcription, production of cellular protein, and release of sLR11. Attachment to stromal cells of c-Kit(+) Lin(-) cells of lr11(-/-) mice was reduced by hypoxia much more than of lr11(+/+) animals. sLR11 induced the adhesion of U937 and c-Kit(+) Lin(-) cells to stromal cells. Cell attachment was increased by sLR11 and reduced in the presence of anti-uPAR antibodies. Furthermore, the fraction of uPAR co-immunoprecipitated with LR11 in membrane extracts of U937 cells was increased by hypoxia. CoCl2, a chemical inducer of HIF-1 alpha, enhanced the levels of LR11 and sLR11 in U937 cells. The decrease in hypoxia-induced attachment of HIF-1 alpha-knockdown cells was largely prevented by exogenously added sLR11. Finally, hypoxia induced HIF-1 alpha binding to a consensus binding site in the LR11 promoter. Thus, we conclude that sLR11 regulates the hypoxia-enhanced adhesion of HSPCs via an uPAR-mediated pathway that stabilizes the hematological pool size by controlling cell attachment to the BM niche.	[Nishii, Keigo; Jiang, Meizi; Bujo, Hideaki] Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat, Chiba 2608670, Japan; [Nakaseko, Chiaki; Shimizu, Naomi; Takeuchi, Masahiro] Chiba Univ Hosp, Dept Hematol, Chiba 2608670, Japan; [Shimizu, Naomi] Chiba Univ Hosp, Div Transfus Med & Cell Therapy, Chiba 2608670, Japan; [Schneider, Wolfgang J.] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1090 Vienna, Austria	Chiba University; Chiba University; Chiba University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Bujo, H (corresponding author), Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat, 1-8-1 Inohana, Chiba 2608670, Japan.	hbujo@faculty.chiba-u.jp		Takeuchi, Masahiro/0000-0003-2516-2199	Health and Labor Sciences Research Grants for Translational Research, Japan; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Austrian Science Fund; Grants-in-Aid for Scientific Research [23591368, 24790907] Funding Source: KAKEN	Health and Labor Sciences Research Grants for Translational Research, Japan; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Austrian Science Fund(Austrian Science Fund (FWF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Health and Labor Sciences Research Grants for Translational Research, Japan (to H. B.), and by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to H. B.).; Supported by grants from the Austrian Science Fund.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Bene MC, 2004, LEUKEMIA, V18, P394, DOI 10.1038/sj.leu.2403250; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Bujo H, 2006, ARTERIOSCL THROM VAS, V26, P1246, DOI 10.1161/01.ATV.0000219692.78477.17; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Ikeuchi T, 2010, DEMENT GERIATR COGN, V30, P28, DOI 10.1159/000315539; Ivanovic Z, 2004, STEM CELLS, V22, P716, DOI 10.1634/stemcells.22-5-716; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jiang M, 2008, J CLIN INVEST, V118, P2733, DOI 10.1172/JCI32381; Katayama K, 2004, FEBS LETT, V560, P178, DOI 10.1016/S0014-5793(04)00100-0; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Krishnamachary B, 2003, CANCER RES, V63, P1138; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Matsuo M, 2009, CLIN CHEM, V55, P1801, DOI 10.1373/clinchem.2009.127027; Ohwaki K, 2007, ARTERIOSCL THROM VAS, V27, P1050, DOI 10.1161/ATVBAHA.106.137091; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sakai S, 2012, CLIN CHIM ACTA, V413, P1542, DOI 10.1016/j.cca.2012.06.025; Shima H, 2010, EXP HEMATOL, V38, P1231, DOI 10.1016/j.exphem.2010.08.004; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Taira K, 2001, ARTERIOSCL THROM VAS, V21, P1501, DOI 10.1161/hq0901.094500; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tjwa M, 2009, J CLIN INVEST, V119, P1008, DOI 10.1172/JCI36010; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Winning S, 2010, J IMMUNOL, V185, P1786, DOI 10.4049/jimmunol.0903244; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang XM, 2000, EXP HEMATOL, V28, P1286, DOI 10.1016/S0301-472X(00)00539-7; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhu YJ, 2004, CIRC RES, V94, P752, DOI 10.1161/01.RES.0000120862.79154.0F; Zhu YJ, 2002, CIRCULATION, V105, P1830, DOI 10.1161/01.CIR.0000014413.91312.EF	54	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11877	11886		10.1074/jbc.M112.442491	http://dx.doi.org/10.1074/jbc.M112.442491			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486467	Green Published, hybrid			2022-12-25	WOS:000318157600023
J	Li, SH; Yang, ZH; Hu, J; Gordon, WC; Bazan, NG; Haas, AL; Bok, D; Jin, MH				Li, Songhua; Yang, Zhihui; Hu, Jane; Gordon, William C.; Bazan, Nicolas G.; Haas, Arthur L.; Bok, Dean; Jin, Minghao			Secretory Defect and Cytotoxicity THE POTENTIAL DISEASE MECHANISMS FOR THE RETINITIS PIGMENTOSA (RP)-ASSOCIATED INTERPHOTORECEPTOR RETINOID-BINDING PROTEIN (IRBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-BINDING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; PHYSIOLOGICALLY RELEVANT CARRIER; CARBONIC-ANHYDRASE-IV; DISULFIDE-ISOMERASE; ENDOPLASMIC-RETICULUM; ER-STRESS; GENE-EXPRESSION; MESSENGER-RNA; VISUAL CYCLE	Interphotoreceptor retinoid-binding protein (IRBP) secreted by photoreceptors plays a pivotal role in photoreceptor survival and function. Recently, a D1080N mutation in IRBP was found in patients with retinitis pigmentosa, a frequent cause of retinal degeneration. The molecular and cellular bases for pathogenicity of the mutation are unknown. Here, we show that the mutation abolishes secretion of IRBP and results in formation of insoluble high molecular weight complexes via disulfide bonds. Co-expression of protein disulfide isomerase A2 that regulates disulfide bond formation or introduction of double Cys-to-Ala substitutions at positions 304 and 1175 in D1080N IRBP promoted secretion of the mutated IRBP. D1080N IRBP was not transported to the Golgi apparatus, but accumulated in the endoplasmic reticulum (ER), bound with the ER-resident chaperone proteins such as BiP, protein disulfide isomerase, and heat shock proteins. Splicing of X-box-binding protein-1 mRNA, expression of activating transcription factor 4 (ATF4), and cleavage of ATF6 were significantly increased in cells expressing D1080N IRBP. Moreover, D1080N IRBP induced up-regulation and nuclear translocation of the C/EBP homologous protein, a proapoptotic transcription factor associated with the unfolded protein response. These results indicate that loss of normal function (nonsecretion) and gain of cytotoxic function (ER stress) are involved in the disease mechanisms of D1080N IRBP. Chemical chaperones and low temperature, which help proper folding of many mutated proteins, significantly rescued secretion of D1080N IRBP, suggesting that misfolding is the molecular basis for pathogenicity of D1080N substitution and that chemical chaperones are therapeutic candidates for the mutation-caused blinding disease.	[Li, Songhua; Yang, Zhihui; Gordon, William C.; Bazan, Nicolas G.; Jin, Minghao] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [Li, Songhua; Yang, Zhihui; Gordon, William C.; Bazan, Nicolas G.; Jin, Minghao] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Hu, Jane; Bok, Dean] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hu, Jane; Bok, Dean] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jin, MH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA.	mjin@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health [R01 EY021208]; NATIONAL EYE INSTITUTE [R01EY021208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY021208 (to M. J.).	Bonapace G, 2004, P NATL ACAD SCI USA, V101, P12300, DOI 10.1073/pnas.0404764101; BORST DE, 1989, J BIOL CHEM, V264, P1115; BRIDGES CDB, 1984, VISION RES, V24, P1581, DOI 10.1016/0042-6989(84)90316-X; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Byerley LO, 2010, AGE, V32, P497, DOI 10.1007/s11357-010-9146-8; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; CROUCH RK, 1992, PHOTOCHEM PHOTOBIOL, V56, P251, DOI 10.1111/j.1751-1097.1992.tb02154.x; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Datta R, 2009, P NATL ACAD SCI USA, V106, P3437, DOI 10.1073/pnas.0813178106; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; EISENFELD AJ, 1985, INVEST OPHTH VIS SCI, V26, P775; FONG SL, 1988, J BIOL CHEM, V263, P15330; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; GONZALEZFERNANDEZ F, 1984, J CELL BIOL, V99, P2092, DOI 10.1083/jcb.99.6.2092; GONZALEZFERNANDEZ F, 1990, J CELL BIOL, V111, P2775, DOI 10.1083/jcb.111.6.2775; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Haeri Mohammad, 2012, J Ophthalmic Vis Res, V7, P45; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Langton KP, 2005, HUM MOL GENET, V14, P3579, DOI 10.1093/hmg/ddi385; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; LIOU GI, 1994, DEV BIOL, V161, P345, DOI 10.1006/dbio.1994.1036; LIOU GI, 1982, VISION RES, V22, P1457, DOI 10.1016/0042-6989(82)90210-3; Liou GI, 1998, J NEUROSCI, V18, P4511; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Parker RO, 2009, J NEUROSCI, V29, P4616, DOI 10.1523/JNEUROSCI.0063-09.2009; Primm TP, 1996, J BIOL CHEM, V271, P33664, DOI 10.1074/jbc.271.52.33664; Qtaishat NM, 2005, EXP EYE RES, V81, P455, DOI 10.1016/j.exer.2005.03.005; Ripps H, 2000, VISUAL NEUROSCI, V17, P97, DOI 10.1017/S095252380017110X; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sideraki V, 2000, BIOCHEMISTRY-US, V39, P1180, DOI 10.1021/bi992246q; Surgucheva I, 2005, CELL MOL NEUROBIOL, V25, P1051, DOI 10.1007/s10571-005-8474-1; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; VANVEEN T, 1986, FEBS LETT, V208, P133, DOI 10.1016/0014-5793(86)81547-2; VANVEEN T, 1988, EXP EYE RES, V47, P291, DOI 10.1016/0014-4835(88)90012-7; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Wisard J, 2011, INVEST OPHTH VIS SCI, V52, P5804, DOI 10.1167/iovs.10-7129; Wiszniewski W, 2005, HUM MOL GENET, V14, P2769, DOI 10.1093/hmg/ddi310; Wu QQ, 2007, BIOCHEMISTRY-US, V46, P8669, DOI 10.1021/bi7004619; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhao TJ, 2005, J BIOL CHEM, V280, P13470, DOI 10.1074/jbc.M413882200; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	57	26	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11395	11406		10.1074/jbc.M112.418251	http://dx.doi.org/10.1074/jbc.M112.418251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23486466	hybrid, Green Published			2022-12-25	WOS:000317915500042
J	Chen, Z; Sun, HB; Li, PF; He, N; Zhu, TC; Li, Y				Chen, Zao; Sun, Hongbing; Li, Pengfei; He, Ning; Zhu, Taicheng; Li, Yin			Enhancement of the Gene Targeting Efficiency of Non-Conventional Yeasts by Increasing Genetic Redundancy	PLOS ONE			English	Article							CELL-WALL INTEGRITY; PICHIA-PASTORIS; YARROWIA-LIPOLYTICA; N-GLYCANS; DISRUPTION; STIPITIS; MAZF	In contrast to model yeasts, gene targeting efficiencies of non-conventional yeasts are usually low, which greatly limits the research and applications of these organisms. In this study, we aimed to enhance the gene targeting efficiency of non-conventional yeasts by improving the fitness of mutant strains, particularly by increasing the genetic redundancy of host cells. To demonstrate this process, OCH1 gene deletion in Pichia pastoris was performed. Extra copies of the OCH1 gene on a helper plasmid were provided for the P. pastoris GS115 strain before the native OCH1 gene in the genomic DNA was knocked out. The redundancy in OCH1 gene significantly eliminated the growth defects of the och1 mutant and increased the deletion efficiency of the OCH1 gene by two orders of magnitude with the same length of homologous flanks. The same strategy was used to delete the KU70 and SGS1 genes. The targeting efficiencies of KU70 and SGS1 were increased by 1- and 23-fold, respectively. Therefore, this study provided an efficient strategy for the deletion of "stubborn" genes in non-conventional yeasts. This study further showed that cellular fitness is potentially an important factor that can limit the efficiency of gene targeting.	[Chen, Zao; He, Ning] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China; [Sun, Hongbing; Zhu, Taicheng; Li, Yin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Li, Pengfei] Hainan Univ, Coll Life Sci & Agr, Haikou, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Hainan University	He, N (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China.	zhutc@im.ac.cn; hening@xmu.edu.cn	Zhu, Taicheng/E-9520-2011; Li, Yin/C-6644-2009	Zhu, Taicheng/0000-0002-3305-1141; Li, Yin/0000-0003-0995-3070	National Natural Science Foundation of China [31000026]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-G-15-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by National Natural Science Foundation of China (number 31000026) and the Knowledge Innovation Program of the Chinese Academy of Sciences (number KSCX2-EW-G-15-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Branduardi P, 2008, J MOL MICROB BIOTECH, V15, P31, DOI 10.1159/000111990; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Cosano IC, 2001, MOL GENET GENOMICS, V265, P604, DOI 10.1007/s004380100452; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Garcia S, 2002, J BIOL CHEM, V277, P37359, DOI 10.1074/jbc.M201091200; Gellissen G, 2005, FEMS YEAST RES, V5, P1079, DOI 10.1016/j.femsyr.2005.06.004; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Higgins D. R., 1998, PICHIA PROTOCOLS; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Klinner U, 2004, FEMS MICROBIOL REV, V28, P201, DOI 10.1016/j.femsre.2003.10.002; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Nett JH, 2005, YEAST, V22, P295, DOI 10.1002/yea.1202; Satyanarayana T, 2009, YEAST BIOTECHNOLOGY, P151; Shi NQ, 2002, YEAST, V19, P1203, DOI 10.1002/yea.915; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; Wahls WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002887; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Yang JJ, 2009, FEMS YEAST RES, V9, P600, DOI 10.1111/j.1567-1364.2009.00503.x; Zeeman AM, 2003, YEAST, V20, P13, DOI 10.1002/yea.936; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	27	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57952	10.1371/journal.pone.0057952	http://dx.doi.org/10.1371/journal.pone.0057952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505447	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500039
J	Kaznadzey, A; Alexandrova, N; Novichkov, V; Kaznadzey, D				Kaznadzey, Anna; Alexandrova, Natalia; Novichkov, Vladimir; Kaznadzey, Denis			PSimScan: Algorithm and Utility for Fast Protein Similarity Search	PLOS ONE			English	Article							SEQUENCE; ALIGNMENT; BLAST; GENERATION; TOOL; PARALIGN	In the era of metagenomics and diagnostics sequencing, the importance of protein comparison methods of boosted performance cannot be overstated. Here we present PSimScan (Protein Similarity Scanner), a flexible open source protein similarity search tool which provides a significant gain in speed compared to BLASTP at the price of controlled sensitivity loss. The PSimScan algorithm introduces a number of novel performance optimization methods that can be further used by the community to improve the speed and lower hardware requirements of bioinformatics software. The optimization starts at the lookup table construction, then the initial lookup table-based hits are passed through a pipeline of filtering and aggregation routines of increasing computational complexity. The first step in this pipeline is a novel algorithm that builds and selects 'similarity zones' aggregated from neighboring matches on small arrays of adjacent diagonals. PSimScan performs 5 to 100 times faster than the standard NCBI BLASTP, depending on chosen parameters, and runs on commodity hardware. Its sensitivity and selectivity at the slowest settings are comparable to the NCBI BLASTP's and decrease with the increase of speed, yet stay at the levels reasonable for many tasks. PSimScan is most advantageous when used on large collections of query sequences. Comparing the entire proteome of Streptocuccus pneumoniae (2,042 proteins) to the NCBI's non-redundant protein database of 16,971,855 records takes 6.5 hours on a moderately powerful PC, while the same task with the NCBI BLASTP takes over 66 hours. We describe innovations in the PSimScan algorithm in considerable detail to encourage bioinformaticians to improve on the tool and to use the innovations in their own software development.	[Kaznadzey, Anna] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia; [Alexandrova, Natalia] Genome Designs Inc, Walnut Creek, CA USA; [Novichkov, Vladimir] LabNext Inc, Glenview, IL USA; [Kaznadzey, Denis] DOE Joint Genome Inst, Walnut Creek, CA USA	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; United States Department of Energy (DOE)	Alexandrova, N (corresponding author), Genome Designs Inc, Walnut Creek, CA USA.	nat_al@yahoo.com	Kaznadzey, Anna/ABB-4970-2020	Kaznadzey, Anna/0000-0001-8968-029X				Agrawal R., 1993, LECT NOTES COMPUTER, V730; Altschul SF, 1998, PROTEINS, V32, P88, DOI 10.1002/(SICI)1097-0134(19980701)32:1<88::AID-PROT10>3.3.CO;2-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1993, J MOL EVOL, V36, P290, DOI 10.1007/BF00160485; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker M, 2010, NAT METHODS, V7, P495, DOI 10.1038/nmeth0710-495; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Brenner SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/pnas.95.11.6073; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Cameron M, 2007, IEEE ACM T COMPUT BI, V4, P349, DOI 10.1109/TCBB.2007.1029; Cameron M, 2007, J COMPUT BIOL, V14, P594, DOI 10.1089/cmb.2007.R005; Cameron M, 2006, J COMPUT BIOL, V13, P965, DOI 10.1089/cmb.2006.13.965; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Esteban David J., 2007, V395, P187; Gouveia-Oliveira R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-312; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hochreiter S, 2007, BIOINFORMATICS, V23, P1728, DOI 10.1093/bioinformatics/btm247; Hughey R, 1995, SAM SEQUENCE ALIGNME; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Merkeev IV, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-51; Mott R, 2000, J MOL BIOL, V300, P649, DOI 10.1006/jmbi.2000.3875; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pearson W R, 2000, Methods Mol Biol, V132, P185; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rajasekaran S, 2002, J COMPUT BIOL, V9, P23, DOI 10.1089/10665270252833172; Rajasekaran S, 2001, J COMB OPTIM, V5, P117, DOI 10.1023/A:1009893719470; Rognes T, 2001, NUCLEIC ACIDS RES, V29, P1647, DOI 10.1093/nar/29.7.1647; Saebo PE, 2005, NUCLEIC ACIDS RES, V33, pW535, DOI 10.1093/nar/gki423; Sedgewick R, 2011, ALGORITHMS; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wang CL, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-171; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	46	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58505	10.1371/journal.pone.0058505	http://dx.doi.org/10.1371/journal.pone.0058505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505522	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500094
J	Khrunin, AV; Khokhrin, DV; Filippova, IN; Esko, T; Nelis, M; Bebyakova, NA; Bolotova, NL; Klovins, J; Nikitina-Zake, L; Rehnstrom, K; Ripatti, S; Schreiber, S; Franke, A; Macek, M; Krulisova, V; Lubinski, J; Metspalu, A; Limborska, SA				Khrunin, Andrey V.; Khokhrin, Denis V.; Filippova, Irina N.; Esko, Tonu; Nelis, Mari; Bebyakova, Natalia A.; Bolotova, Natalia L.; Klovins, Janis; Nikitina-Zake, Liene; Rehnstrom, Karola; Ripatti, Samuli; Schreiber, Stefan; Franke, Andre; Macek, Milan; Krulisova, Veronika; Lubinski, Jan; Metspalu, Andres; Limborska, Svetlana A.			A Genome-Wide Analysis of Populations from European Russia Reveals a New Pole of Genetic Diversity in Northern Europe	PLOS ONE			English	Article							DIFFERENTIATION; HOMOZYGOSITY; PATTERNS; RUNS; POLYMORPHISMS; ASSOCIATION; ANCESTRY; LOCUS	Several studies examined the fine-scale structure of human genetic variation in Europe. However, the European sets analyzed represent mainly northern, western, central, and southern Europe. Here, we report an analysis of approximately 166,000 single nucleotide polymorphisms in populations from eastern (northeastern) Europe: four Russian populations from European Russia, and three populations from the northernmost Finno-Ugric ethnicities (Veps and two contrast groups of Komi people). These were compared with several reference European samples, including Finns, Estonians, Latvians, Poles, Czechs, Germans, and Italians. The results obtained demonstrated genetic heterogeneity of populations living in the region studied. Russians from the central part of European Russia (Tver, Murom, and Kursk) exhibited similarities with populations from central-eastern Europe, and were distant from Russian sample from the northern Russia (Mezen district, Archangelsk region). Komi samples, especially Izhemski Komi, were significantly different from all other populations studied. These can be considered as a second pole of genetic diversity in northern Europe (in addition to the pole, occupied by Finns), as they had a distinct ancestry component. Russians from Mezen and the Finnic-speaking Veps were positioned between the two poles, but differed from each other in the proportions of Komi and Finnic ancestries. In general, our data provides a more complete genetic map of Europe accounting for the diversity in its most eastern (northeastern) populations.	[Khrunin, Andrey V.; Khokhrin, Denis V.; Filippova, Irina N.; Limborska, Svetlana A.] Russian Acad Sci, Inst Mol Genet, Dept Mol Bases Human Genet, Moscow 123182, Russia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-50090 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Estonian Bioctr, Tartu, Estonia; [Nelis, Mari] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Bebyakova, Natalia A.] Northern State Med Univ, Deparment Med Biol & Genet, Arkhangelsk, Russia; [Bolotova, Natalia L.] Vologda State Pedag Univ, Deparment Ecol & Zool, Vologda, Russia; [Klovins, Janis; Nikitina-Zake, Liene] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Rehnstrom, Karola; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Rehnstrom, Karola; Ripatti, Samuli] Wellcome Trust Sanger Institiute, Hinxton, England; [Schreiber, Stefan] Univ Kiel, Dept Internal Med 1, Popgen Biobank, Kiel, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Macek, Milan; Krulisova, Veronika] Univ Hosp Motol, Dept Biol & Med Genet, Prague, Czech Republic; [Macek, Milan; Krulisova, Veronika] Charles Univ Prague, Sch Med 2, Prague, Czech Republic; [Lubinski, Jan] Pomeranian Med Univ, Szczecin, Poland	Russian Academy of Sciences; University of Tartu; University of Tartu; Estonian Biocentre; University of Geneva; Northern State Medical University; Vologda State University; Latvian Biomedical Research & Study Centre; University of Helsinki; University of Kiel; University of Kiel; Motol University Hospital; Charles University Prague; Pomeranian Medical University	Khrunin, AV (corresponding author), Russian Acad Sci, Inst Mol Genet, Dept Mol Bases Human Genet, Kurchatov Sq, Moscow 123182, Russia.	khrunin@img.ras.ru	Bebyakova, Natalya/C-8180-2018; Franke, Andre/B-2151-2010; Ripatti, Samuli/H-9446-2014; Nelis, Mari/ABG-7775-2020; Limborska, Svetlana/S-2961-2019; Limborska, Svetlana/A-5633-2016; Klovins, Janis/C-5695-2011	Franke, Andre/0000-0003-1530-5811; Ripatti, Samuli/0000-0002-0504-1202; Nelis, Mari/0000-0001-9748-1020; Limborska, Svetlana/0000-0002-1697-6820; Lubinski, Jan/0000-0003-2931-3003; Klovins, Janis/0000-0001-8362-5505; Esko, Tonu/0000-0003-1982-6569	Russian Academy of Sciences; Federal Support of Leading Scientific Schools [4294.2012.4]; Russian Basic Research Foundation; Ministry of education and science of Russian Federation [8805]; ENGAGE; OPENGENE; Estonian Government [SF0180142s08]; Estonian Research Roadmap through Estonian Ministry of Education and Research [3.2.0304.11-0312]; Center of Excellence in Genomics (EXCEGEN); University of Tartu [SP1GVARENG]; Czech Ministry of Health [NT/13770-4];  [CZ.2.16/3.1.00/24022]	Russian Academy of Sciences(Russian Academy of Sciences); Federal Support of Leading Scientific Schools(Leading Scientific Schools Program); Russian Basic Research Foundation(Russian Foundation for Basic Research (RFBR)); Ministry of education and science of Russian Federation(Ministry of Education and Science, Russian Federation); ENGAGE; OPENGENE; Estonian Government; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics (EXCEGEN); University of Tartu; Czech Ministry of Health(Ministry of Health, Czech Republic); 	This study was supported by grants from the Programs 'Molecular and Cell Biology' and 'Fundamental Science for Medicine' of the Russian Academy of Sciences; the Federal Support of Leading Scientific Schools (grant 4294.2012.4); Russian Basic Research Foundation and The Ministry of education and science of Russian Federation (project 8805). EGCUT received financing by (ENGAGE, OPENGENE), targeted financing from Estonian Government SF0180142s08, Estonian Research Roadmap through Estonian Ministry of Education and Research (3.2.0304.11-0312), Center of Excellence in Genomics (EXCEGEN) and Development Fund of University of Tartu (SP1GVARENG). MM was supported by CZ.2.16/3.1.00/24022, Institutional support for UH Motol (0064203) and by NT/13770-4 from the Czech Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alexeev VP, 1969, ORIGIN NATIONS E EUR; Alexeeva TI, 2002, E SLAVS ANTHR ETHNIC; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Flegontova OV, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-62; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Huyghe JR, 2011, EUR J HUM GENET, V19, P347, DOI 10.1038/ejhg.2010.179; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Khrunin A V, 2005, Genetika, V41, P1125; Khrunin A, 2007, AM J HUM BIOL, V19, P741, DOI 10.1002/ajhb.20620; Khrunin AV, 2008, GENETIKA, V47, P1565; Konakov ND, 1991, ETHNOAREALIC KOMI GR; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Milligan B, 1998, MOL GENETIC ANAL POP, P29; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pimenov VV, 1965, VEPS STUDY ETHNIC HI; Pistis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004654; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Savel'eva EA, 2001, ATLAS KOMI REPUBLIC; Savel'eva EA, 1997, ARCHEOLOGY KOMI REPU; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Spain SL, 2009, CANCER RES, V69, P7422, DOI 10.1158/0008-5472.CAN-09-0659; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; Verbenko DA, 2006, ANN HUM BIOL, V33, P570, DOI 10.1080/03014460601012077; Zherebtsov IL, 1996, POPULATION KOMI TERR; Zherebtsov LN, 1982, HIST CULTURAL RELATI	44	21	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58552	10.1371/journal.pone.0058552	http://dx.doi.org/10.1371/journal.pone.0058552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505534	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500100
J	Chen, X; Kang, JH; Fu, CJ; Tan, WC				Chen, Xi; Kang, Jianhong; Fu, Ceji; Tan, Wenchang			Modeling Calcium Wave Based on Anomalous Subdiffusion of Calcium Sparks in Cardiac Myocytes	PLOS ONE			English	Article							HEART; ACTIVATION; CURRENTS; RELEASE	Ca2+ sparks and Ca2+ waves play important roles in calcium release and calcium propagation during the excitation-contraction (EC) coupling process in cardiac myocytes. Although the classical Fick's law is widely used to model Ca2+ sparks and Ca2+ waves in cardiac myocytes, it fails to reasonably explain the full-width at half maximum(FWHM) paradox. However, the anomalous subdiffusion model successfully reproduces Ca2+ sparks of experimental results. In this paper, in the light of anomalous subdiffusion of Ca2+ sparks, we develop a mathematical model of calcium wave in cardiac myocytes by using stochastic Ca2+ release of Ca2+ release units (CRUs). Our model successfully reproduces calcium waves with physiological parameters. The results reveal how Ca2+ concentration waves propagate from an initial firing of one CRU at a corner or in the middle of considered region, answer how large in magnitude of an anomalous Ca2+ spark can induce a Ca2+ wave. With physiological Ca2+ currents (2pA) through CRUs, it is shown that an initial firing of four adjacent CRUs can form a Ca2+ wave. Furthermore, the phenomenon of calcium waves collision is also investigated.	[Tan, Wenchang] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; Peking Univ, Dept Mech & Aerosp Engn, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University	Tan, WC (corresponding author), Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	tanwch@mech.pku.edu.cn	Tan, Wenchang/I-9949-2014; Fu, Ceji/C-3262-2012		National Natural Science Foundation of China [11272014, 10825208]; National Key Basic Research Program of China [2013CB531200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 11272014 and No. 10825208), and National Key Basic Research Program of China (Grant No. 2013CB531200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylor SM, 1998, J GEN PHYSIOL, V112, P297, DOI 10.1085/jgp.112.3.297; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; Cheng H, 1996, CELL CALCIUM, V20, P129, DOI 10.1016/S0143-4160(96)90102-5; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; GIRARD S, 1992, BIOPHYS J, V61, P509, DOI 10.1016/S0006-3495(92)81855-6; Izu LT, 2001, BIOPHYS J, V80, P103, DOI 10.1016/S0006-3495(01)75998-X; Izu LT, 2001, BIOPHYS J, V80, P88, DOI 10.1016/S0006-3495(01)75997-8; John C, 1978, J CELL BIOL, V76, P448, DOI DOI 10.1083/JCB.76.2.448; Keizer J, 1998, BIOPHYS CHEM, V72, P87, DOI 10.1016/S0301-4622(98)00125-2; LAKATTA EG, 1993, J CARDIOVASC ELECTR, V4, P473, DOI 10.1111/j.1540-8167.1993.tb01285.x; Li KT, 2011, CELL MOL BIOENG, V4, P457, DOI 10.1007/s12195-011-0174-y; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Lu LY, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026005; Tadjeran C, 2006, J COMPUT PHYS, V213, P205, DOI 10.1016/j.jcp.2005.08.008; TAKAMATSU T, 1990, FASEB J, V4, P1519, DOI 10.1096/fasebj.4.5.2307330; Tan WC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805208	19	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57093	10.1371/journal.pone.0057093	http://dx.doi.org/10.1371/journal.pone.0057093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483894	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100012
J	Clavaud, C; Jourdain, R; Bar-Hen, A; Tichit, M; Bouchier, C; Pouradier, F; El Rawadi, C; Guillot, J; Menard-Szczebara, F; Breton, L; Latge, JP; Mouyna, I				Clavaud, Cecile; Jourdain, Roland; Bar-Hen, Avner; Tichit, Magali; Bouchier, Christiane; Pouradier, Florence; El Rawadi, Charles; Guillot, Jacques; Menard-Szczebara, Florence; Breton, Lionel; Latge, Jean-Paul; Mouyna, Isabelle			Dandruff Is Associated with Disequilibrium in the Proportion of the Major Bacterial and Fungal Populations Colonizing the Scalp	PLOS ONE			English	Article							ATOPIC-DERMATITIS PATIENTS; HEALTHY-HUMAN SKIN; REAL-TIME PCR; SEBORRHEIC DERMATITIS; MOLECULAR ANALYSIS; PSORIATIC LESIONS; MALASSEZIA; MICROBIOME; DIFFERENTIATION; RESTRICTA	The bacterial and fungal communities associated with dandruff were investigated using culture-independent methodologies in the French subjects. The major bacterial and fungal species inhabiting the scalp subject's were identified by cloning and sequencing of the conserved ribosomal unit regions (16S for bacterial and 28S-ITS for fungal) and were further quantified by quantitative PCR. The two main bacterial species found on the scalp surface were Propionibacterium acnes and Staphylococcus epidermidis, while Malassezia restricta was the main fungal inhabitant. Dandruff was correlated with a higher incidence of M. restricta and S. epidermidis and a lower incidence of P. acnes compared to the control population (p < 0.05). These results suggested for the first time using molecular methods, that dandruff is linked to the balance between bacteria and fungi of the host scalp surface.	[Clavaud, Cecile; Latge, Jean-Paul; Mouyna, Isabelle] Inst Pasteur, Unite Aspergillus, Paris, France; [Jourdain, Roland; El Rawadi, Charles; Breton, Lionel] LOreal Res & Innovat, Adv Res, Aulnay Sous Bois, France; [Bar-Hen, Avner] Univ Paris 05, MAP5, UFR Math & Informat, Paris, France; [Tichit, Magali; Bouchier, Christiane] Inst Pasteur, PF1, Paris, France; [Pouradier, Florence] LOreal Res & Innovat, Int Gen Direct Hair Metiers, St Ouen, France; [Guillot, Jacques] ENVA, UMR BIPAR, Ecopham, Maisons Alfort, France; [Menard-Szczebara, Florence] LOreal Res & Innovat, Corp Microbiol, Chevilly Larue, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; L'Oreal Group; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; L'Oreal Group; Ecole Nationale Veterinaire d'Alfort (ENVA); L'Oreal Group	Latge, JP (corresponding author), Inst Pasteur, Unite Aspergillus, Paris, France.	jean-paul.latge@pasteur.fr; isabelle.mouyna@pasteur.fr	Mouyna, Isabelle/O-7697-2018; Latge, Jean Paul/C-9846-2014; Guillot, Jacques/J-9428-2016	Mouyna, Isabelle/0000-0003-3140-5927; Guillot, Jacques/0000-0003-3577-6979	L'Oreal - Research Innovation; L'Oreal	L'Oreal - Research Innovation(L'Oreal Group); L'Oreal(L'Oreal Group)	This study was supported by a grant from L'Oreal - Research & Innovation and has been performed on the basis of a scientific collaboration. The panels of subjects with and without dandruff were selected by L'Oreal Research & Innovation. No additional external funding source was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist. This work was supported by a grant from L'Oreal. Cecile Clavaud, Roland Jourdain, Florence Pouradier, Charles El Rawadi, Florence Menard-Szczebara and Lionel Breton are employees of L'Oreal Research & Innovation. There are no patents, product in development or marketed product to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akaza N, 2009, MED MYCOL, V47, P618, DOI 10.1080/13693780802398026; [Anonymous], 2010, R LANG ENV STAT COMP; Ashbee HR, 2007, MED MYCOL, V45, P287, DOI 10.1080/13693780701191373; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Aspiroz C, 1999, MYCOPATHOLOGIA, V145, P69, DOI 10.1023/A:1007017917230; Clermont D, 2009, INT J SYST EVOL MICR, V59, P1016, DOI 10.1099/ijs.0.003160-0; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dawson TL, 2007, J INVEST DERM SYMP P, V12, P15, DOI 10.1038/sj.jidsymp.5650049; DeAngelis YM, 2005, J INVEST DERM SYMP P, V10, P295, DOI 10.1111/j.1087-0024.2005.10119.x; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2010, J CLIN MICROBIOL, V48, P3575, DOI 10.1128/JCM.00597-10; Gemmer CM, 2002, J CLIN MICROBIOL, V40, P3350, DOI 10.1128/JCM.40.9.3350-3357.2002; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gupta AK, 2004, J AM ACAD DERMATOL, V51, P785, DOI 10.1016/j.jaad.2003.12.034; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kerr K, 2011, INT J DERMATOL, V50, P102, DOI 10.1111/j.1365-4632.2010.04629.x; Lee YW, 2006, MYCOSES, V49, P405, DOI 10.1111/j.1439-0507.2006.01239.x; MCGINLEY KJ, 1975, J INVEST DERMATOL, V64, P401, DOI 10.1111/1523-1747.ep12512335; Misery L, 2012, ACTA DERM V IN PRESS; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Paulino LC, 2008, FEMS YEAST RES, V8, P460, DOI 10.1111/j.1567-1364.2008.00359.x; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Pierard-Franchimont C., 2006, International Journal of Cosmetic Science, V28, P311, DOI 10.1111/j.1467-2494.2006.00326.x; Pierard-Franchimont C, 2000, DERMATOLOGY, V200, P93, DOI 10.1159/000018337; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sugita T, 2001, J CLIN MICROBIOL, V39, P3486, DOI 10.3314/jjmm.42.217; Sugita T, 2006, MICROBIOL IMMUNOL, V50, P549, DOI 10.1111/j.1348-0421.2006.tb03825.x; Taylor DL, 2008, MOL ECOL RESOUR, V8, P742, DOI 10.1111/j.1755-0998.2008.02094.x; Van Abbe NJ., 1964, J SOC COSMET CHEM, V15, P609; Warner RR, 2001, J AM ACAD DERMATOL, V45, P897, DOI 10.1067/mjd.2001.117849; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104	36	117	126	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58203	10.1371/journal.pone.0058203	http://dx.doi.org/10.1371/journal.pone.0058203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483996	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100088
J	Rapa, RA; Shimmon, R; Djordjevic, SP; Stokes, HW; Labbate, M				Rapa, Rita A.; Shimmon, Ronald; Djordjevic, Steven P.; Stokes, H. W.; Labbate, Maurizio			Deletion of Integron-Associated Gene Cassettes Impact on the Surface Properties of Vibrio rotiferianus DAT722	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; CHOLERAE O1; ARRAYS; SEQUENCE; IDENTIFICATION; HEMAGGLUTININ; CONSTRUCTION; VULNIFICUS; EXPRESSION; RECOVERY	Background: The integron is a genetic recombination system that catalyses the acquisition of genes on mobilisable elements called gene cassettes. In Vibrio species, multiple acquired gene cassettes form a cassette array that can comprise 1-3% of the bacterial genome. Since 75% of these gene cassettes contain genes encoding proteins of uncharacterised function, how the integron has driven adaptation and evolution in Vibrio species remains largely unknown. A feature of cassette arrays is the presence of large indels. Using Vibrio rotiferianus DAT722 as a model organism, the aim of this study was to determine how large cassette deletions affect vibrio physiology with a view to improving understanding into how cassette arrays influence bacterial host adaptation and evolution. Methodology/Principal Findings: Biological assays and proteomic techniques were utilised to determine how artificially engineered deletions in the cassette array of V. rotiferianus DAT722 affected cell physiology. Multiple phenotypes were identified including changes to growth and expression of outer membrane porins/proteins and metabolic proteins. Furthermore, the deletions altered cell surface polysaccharide with Proton Nuclear Magnetic Resonance on whole cell polysaccharide identifying changes in the carbohydrate ring proton region indicating that gene cassette products may decorate host cell polysaccharide via the addition or removal of functional groups. Conclusions/Significance: From this study, it was concluded that deletion of gene cassettes had a subtle effect on bacterial metabolism but altered host surface polysaccharide. Deletion (and most likely rearrangement and acquisition) of gene cassettes may provide the bacterium with a mechanism to alter its surface properties, thus impacting on phenotypes such as biofilm formation. Biofilm formation was shown to be altered in one of the deletion mutants used in this study. Reworking surface properties may provide an advantage to the bacterium's interactions with organisms such as bacteriophage, protozoan grazers or crustaceans.	[Rapa, Rita A.; Djordjevic, Steven P.; Stokes, H. W.; Labbate, Maurizio] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Shimmon, Ronald] Univ Technol Sydney, Sydney, NSW 2007, Australia	University of Technology Sydney; University of Technology Sydney	Labbate, M (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia.	maurizio.labbate@uts.edu.au	djordjevic, steven/GNP-4000-2022; Djordjevic, Steven/A-2024-2013	djordjevic, steven/0000-0001-9301-5372; Djordjevic, Steven/0000-0001-9301-5372; Labbate, Maurizio/0000-0003-1428-3382	UTS; ithree Institute; UTS Faculty of Science Postgraduate Scholarship	UTS; ithree Institute; UTS Faculty of Science Postgraduate Scholarship	The research in this paper was funded by: 1. UTS Early Career Research Grant, 2. ithree Institute internal grant, 3. UTS Faculty of Science Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella Michael A., 2008, V431, P3; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barker A, 1997, MICROBIOL-SGM, V143, P1805, DOI 10.1099/00221287-143-6-1805; BARKER A, 1994, J BACTERIOL, V176, P5450, DOI 10.1128/JB.176.17.5450-5458.1994; Boucher Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-3; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Boucher Y, 2006, BIOLOGY OF VIBRIOS, P84; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Chen YS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-274; Chowdhury PR, 2011, J BACTERIOL, V193, P3381, DOI 10.1128/JB.05089-11; Deshpande CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016934; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; FRANZON VL, 1993, INFECT IMMUN, V61, P3032, DOI 10.1128/IAI.61.7.3032-3037.1993; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Hall RM, 1997, CIBA F SYMP, V207, P192; Hazen TH, 2010, FEMS MICROBIOL ECOL, V74, P485, DOI 10.1111/j.1574-6941.2010.00937.x; Heppelmann CJ, 2007, ELECTROPHORESIS, V28, P3988, DOI 10.1002/elps.200700252; Jobbins SE, 2010, J PROTEOME RES, V9, P3832, DOI 10.1021/pr100028t; Joseph LA, 2004, J BACTERIOL, V186, P889, DOI 10.1128/JB.186.3.889-893.2004; Koenig JE, 2008, ENVIRON MICROBIOL, V10, P1024, DOI 10.1111/j.1462-2920.2007.01524.x; Labbate M, 2007, MICROBIOL-SGM, V153, P1488, DOI 10.1099/mic.0.2006/001065-0; Labbate M, 2012, MOB GENET E IN PRESS; Labbate M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-253; Labbate Maurizio, 2009, V532, P103, DOI 10.1007/978-1-60327-853-9_6; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Michael CA, 2004, AM NAT, V164, P1, DOI 10.1086/421733; Michael CA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-82; Nield BS, 2004, PROTEIN SCI, V13, P1651, DOI 10.1110/ps.04638704; Nield BS, 2001, FEMS MICROBIOL LETT, V195, P59, DOI 10.1016/S0378-1097(00)00546-2; OGAWA A, 1993, MICROBIOL IMMUNOL, V37, P607, DOI 10.1111/j.1348-0421.1993.tb01683.x; PaludanMuller C, 1996, MICROBIOL-SGM, V142, P1675, DOI 10.1099/13500872-142-7-1675; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Post DMB, 2012, J BIOL CHEM; POUTREL B, 1995, CLIN DIAGN LAB IMMUN, V2, P166, DOI 10.1128/CDLI.2.2.166-171.1995; Robinson A, 2005, J MOL BIOL, V346, P1229, DOI 10.1016/j.jmb.2004.12.035; Robinson Andrew, 2008, V426, P589, DOI 10.1007/978-1-60327-058-8_39; Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471; Smith AB, 2003, INFECT IMMUN, V71, P1091, DOI 10.1128/IAI.71.3.1091-1097.2003; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58430	10.1371/journal.pone.0058430	http://dx.doi.org/10.1371/journal.pone.0058430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484028	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100118
J	Zhang, YR; Shi, LF; Li, S; Yang, ZY; Standley, C; Yang, Z; ZhuGe, RH; Savidge, T; Wang, XN; Feng, HP				Zhang, Yongrong; Shi, Lianfa; Li, Shan; Yang, Zhiyong; Standley, Clive; Yang, Zhong; ZhuGe, Ronghua; Savidge, Tor; Wang, Xiaoning; Feng, Hanping			A Segment of 97 Amino Acids within the Translocation Domain of Clostridium difficile Toxin B Is Essential for Toxicity	PLOS ONE			English	Article							CULTURED-CELLS; PORE FORMATION; CLEAVAGE; BINDING; MODEL; RHO	Clostridium difficile toxin B (TcdB) intoxicates target cells by glucosylating Rho GTPases. TcdB (269 kDa) consists of at least 4 functional domains including a glucosyltransferase domain (GTD), a cysteine protease domain (CPD), a translocation domain (TD), and a receptor binding domain (RBD). The function and molecular mode of action of the TD, which is the largest segment of TcdB and comprises nearly 50% of the protein, remain largely unknown. Here we show that a 97-amino-acid segment (AA1756 - 1852, designated as (a) over tilde 97 or D97), located in the C-terminus of the TD and adjacent to the RBD, is essential for the cellular activity of TcdB. Deletion of this segment in TcdB (designated as TxB-D97), did not adversely alter toxin enzymatic activities or its cellular binding and uptake capacity. TxB-D97 bound to and entered cells in a manner similar to TcdB holotoxin. Both wild type and mutant toxins released their GTDs similarly in the presence of inositol hexakisphosphate (InsP(6)), and showed a similar glucosyltransferase activity in a cell-free glucosylating assay. Despite these similarities, the cytotoxic activity of TxB-D97 was reduced by more than 5 logs compared to wild type toxin, supported by the inability of TxB-D97 to glucosylate Rac1 of target cells. Moreover, the mutant toxin failed to elicit tumor necrosis factor alpha (TNF-alpha) in macrophages, a process dependent on the glucosyltransferase activity of the toxin. Cellular fractionation of toxin-exposed cells revealed that TxB-D97 was unable to efficiently release the GTD into cytosol. Thereby, we conclude the 97-amino-acid region of the TD C-terminus of TcdB adjacent to the RBD, is essential for the toxicity of TcdB.	[Zhang, Yongrong; Yang, Zhong; Wang, Xiaoning] E China Univ Sci & Technol, Sch Bioengn, Shanghai 200237, Peoples R China; [Shi, Lianfa; Li, Shan; Yang, Zhiyong; Feng, Hanping] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Standley, Clive; ZhuGe, Ronghua] Univ Massachusetts, Sch Med, Worcester, MA USA; [Savidge, Tor] Baylor Coll Med, Houston, TX 77030 USA	East China University of Science & Technology; University System of Maryland; University of Maryland Baltimore; University of Massachusetts System; University of Massachusetts Worcester; Baylor College of Medicine	Feng, HP (corresponding author), Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA.	hfeng@umaryland.edu		Zhang, Yongrong/0000-0002-8594-4232	National Institutes of Health (NIH) [R01AI088748, R01DK084509, UL1TR000071, R01AI10094001]; John S. Dunn Gulf Coast Consortium for Chemical Genomics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088748, R01AI100914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084509] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. Dunn Gulf Coast Consortium for Chemical Genomics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by National Institutes of Health (NIH) Grants R01AI088748, R01DK084509, UL1TR000071, R01AI10094001 and John S. Dunn Gulf Coast Consortium for Chemical Genomics Robert A. Welch Collaborative Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARRINGTON WA, 1995, SCIENCE, V268, P1483, DOI 10.1126/science.7770772; Carter GP, 2010, GUT MICROBES, V1, P58, DOI 10.4161/gmic.1.1.10768; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; He XY, 2009, INFECT IMMUN, V77, P2294, DOI 10.1128/IAI.01577-08; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1994, J BIOL CHEM, V269, P10706; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Leonard JL, 2008, STEROIDS, V73, P1008, DOI 10.1016/j.steroids.2007.12.016; LIFSHITZ Y, 1994, PHYS REV LETT, V72, P2753, DOI 10.1103/PhysRevLett.72.2753; LIMA AAM, 1988, INFECT IMMUN, V56, P582, DOI 10.1128/IAI.56.3.582-588.1988; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MITCHELL TJ, 1986, GUT, V27, P78, DOI 10.1136/gut.27.1.78; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Sun XM, 2009, MICROB PATHOGENESIS, V46, P298, DOI 10.1016/j.micpath.2009.03.002; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192	28	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58634	10.1371/journal.pone.0058634	http://dx.doi.org/10.1371/journal.pone.0058634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484044	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100131
J	Becker, A; Ludwig, N; Keller, A; Tackenberg, B; Eienbroker, C; Oertel, WH; Fassbender, K; Meese, E; Ruprecht, K				Becker, Anne; Ludwig, Nicole; Keller, Andreas; Tackenberg, Bjoern; Eienbroeker, Christian; Oertel, Wolfgang H.; Fassbender, Klaus; Meese, Eckart; Ruprecht, Klemens			Myasthenia Gravis: Analysis of Serum Autoantibody Reactivities to 1827 Potential Human Autoantigens by Protein Macroarrays	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; AUTOIMMUNE-DISEASE; INTERFERON-ALPHA; IMMUNE-RESPONSE; ANTI-TITIN; T-CELLS; ANTIBODIES; THYMOMA; CANCER; IDENTIFICATION	Background: Myasthenia gravis is a disorder of neuromuscular transmission associated with autoantibodies against the nicotinic acetylcholine receptor. We have previously developed a customized protein macroarray comprising 1827 potential human autoantigens, which permitted to discriminate sera of patients with different cancers from sera of healthy controls, but has not yet been evaluated in antibody-mediated autoimmune diseases. Objective: To determine whether autoantibody signatures obtained by protein macroarray separate sera of patients with myasthenia gravis from healthy controls. Methods: Sera of patients with acetylcholine receptor antibody-positive myasthenia gravis (n = 25) and healthy controls (n = 32) were analyzed by protein macroarrays comprising 1827 peptide clones. Results: Autoantibody signatures did not separate patients with myasthenia gravis from controls with sufficient sensitivity, specificity, and accuracy. Intensity values of one antigen (poly A binding protein cytoplasmic 1, p = 0.0045) were higher in patients with myasthenia gravis, but the relevance of this and two further antigens, 40S ribosomal protein S13 (20.8% vs. 0%, p = 0.011) and proteasome subunit alpha type 1 (25% vs. 3.1%, p = 0.035), which were detected more frequently by myasthenia gravis than by control sera, currently remains uncertain. Conclusion: Seroreactivity profiles of patients with myasthenia gravis detected by a customized protein macroarray did not allow discrimination from healthy controls, compatible with the notion that the autoantibody response in myasthenia gravis is highly focussed against the acetylcholine receptor.	[Becker, Anne; Ludwig, Nicole; Meese, Eckart] Univ Saarland, Dept Human Genet, Homburg, Germany; [Keller, Andreas] Siemens Healthcare, Erlangen, Germany; [Tackenberg, Bjoern; Eienbroeker, Christian; Oertel, Wolfgang H.] Univ Marburg, Clin Neuroimmunol Grp, Dept Neurol, Marburg, Germany; [Fassbender, Klaus] Univ Saarland, Dept Neurol, Homburg, Germany; [Ruprecht, Klemens] Charite, Dept Neurol, D-13353 Berlin, Germany	Saarland University; Siemens AG; Siemens Germany; Philipps University Marburg; Saarland University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ruprecht, K (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	klemens.ruprecht@charite.de	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895; Fassbender, Klaus/0000-0003-3596-868X	Homburger Forschungsforderungsprogramm (HOMFOR)	Homburger Forschungsforderungsprogramm (HOMFOR)	This study was funded by Homburger Forschungsforderungsprogramm (HOMFOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARLI JA, 1990, CLIN EXP IMMUNOL, V82, P284; Aarli JA, 1999, ARCH NEUROL-CHICAGO, V56, P25, DOI 10.1001/archneur.56.1.25; Agius MA, 1998, ANN NY ACAD SCI, V841, P516, DOI 10.1111/j.1749-6632.1998.tb10972.x; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Baggi F, 1998, ANN NY ACAD SCI, V841, P538, DOI 10.1111/j.1749-6632.1998.tb10978.x; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Kemp EH, 2002, BIOCHEM BIOPH RES CO, V298, P169, DOI 10.1016/S0006-291X(02)02421-X; Kijanka G, 2009, J PROTEOMICS, V72, P936, DOI 10.1016/j.jprot.2009.02.006; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Leidinger P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-18; Leidinger P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-20; Lin HS, 2007, CANCER EPIDEM BIOMAR, V16, P2396, DOI 10.1158/1055-9965.EPI-07-0318; Ludwig N, 2008, CLIN CANCER RES, V14, P4767, DOI 10.1158/1078-0432.CCR-07-4715; Ludwig N, 2011, INT J CANCER, V128, P1493, DOI 10.1002/ijc.25467; Ludwig N, 2009, NEOPLASIA, V11, P1383, DOI 10.1593/neo.91018; Mayo I, 2002, BRAIN, V125, P2658, DOI 10.1093/brain/awf274; Meager A, 1997, LANCET, V350, P1596, DOI 10.1016/S0140-6736(05)64012-3; Meager A, 2003, CLIN EXP IMMUNOL, V132, P128, DOI 10.1046/j.1365-2249.2003.02113.x; MOHAN S, 1994, CLIN IMMUNOL IMMUNOP, V70, P266, DOI 10.1006/clin.1994.1039; Nakano S, 2005, NEUROLOGY, V65, P420, DOI 10.1212/01.wnl.0000171341.76482.15; OHTA M, 1990, CLIN CHIM ACTA, V187, P255, DOI 10.1016/0009-8981(90)90110-E; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Robinson WH, 2002, BIOTECHNIQUES, P66; Romi F, 2005, ARCH NEUROL-CHICAGO, V62, P442, DOI 10.1001/archneur.62.3.442; Scheffler S, 2008, RHEUMATOLOGY, V47, P622, DOI 10.1093/rheumatology/ken042; Schmitt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028951; Sommer N, 2008, HDB CLIN NEUROLOGY, P169; Tackenberg B, 2009, J NEUROIMMUNOL, V216, P85, DOI 10.1016/j.jneuroim.2009.08.018; Tackenberg B, 2007, EUR J IMMUNOL, V37, P849, DOI 10.1002/eji.200636449; Tzartos SJ, 1998, IMMUNOL REV, V163, P89, DOI 10.1111/j.1600-065X.1998.tb01190.x; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Vrolix K, 2010, AUTOIMMUNITY, V43, P380, DOI 10.3109/08916930903518073; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; WILLIAMS CL, 1986, J EXP MED, V164, P1043, DOI 10.1084/jem.164.4.1043; Yamamoto AM, 2001, ARCH NEUROL-CHICAGO, V58, P885, DOI 10.1001/archneur.58.6.885; YAMAMOTO T, 1987, NEUROLOGY, V37, P1329, DOI 10.1212/WNL.37.8.1329	40	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58095	10.1371/journal.pone.0058095	http://dx.doi.org/10.1371/journal.pone.0058095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483977	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900070
J	Mazerolle, EL; Gawryluk, JR; Dillen, KNH; Patterson, SA; Feindel, KW; Beyea, SD; Stevens, MTR; Newman, AJ; Schmidt, MH; D'Arcy, RCN				Mazerolle, Erin L.; Gawryluk, Jodie R.; Dillen, Kim N. H.; Patterson, Steven A.; Feindel, Kirk W.; Beyea, Steven D.; Stevens, M. Tynan R.; Newman, Aaron J.; Schmidt, Matthias H.; D'Arcy, Ryan C. N.			Sensitivity to White Matter fMRI Activation Increases with Field Strength	PLOS ONE			English	Article							HIGH MAGNETIC-FIELDS; HUMAN-BRAIN; INTERHEMISPHERIC-TRANSFER; CORPUS-CALLOSUM; FUNCTIONAL MRI; 1.5 T; VISUOMOTOR INFORMATION; PHYSIOLOGICAL NOISE; MOTION CORRECTION; MOTOR CORTEX	Functional magnetic resonance imaging (fMRI) activation in white matter is controversial. Given that many of the studies that report fMRI activation in white matter used high field MRI systems, we investigated the field strength dependence of sensitivity to white matter fMRI activation. In addition, we evaluated the temporal signal to noise ratio (tSNR) of the different tissue types as a function of field strength. Data were acquired during a motor task (finger tapping) at 1.5 T and 4 T. Group and individual level activation results were considered in both the sensorimotor cortex and the posterior limb of the internal capsule. We found that sensitivity increases associated with field strength were greater for white matter than gray matter. The analysis of tSNR suggested that white matter might be less susceptible to increases in physiological noise related to increased field strength. We therefore conclude that high field MRI may be particularly advantageous for fMRI studies aimed at investigating activation in both gray and white matter.	[Mazerolle, Erin L.; Gawryluk, Jodie R.; Dillen, Kim N. H.; Patterson, Steven A.; Feindel, Kirk W.; Beyea, Steven D.; Stevens, M. Tynan R.; D'Arcy, Ryan C. N.] CNR, Inst Biodiagnost Atlantic, Halifax, NS, Canada; [Mazerolle, Erin L.; Gawryluk, Jodie R.; Newman, Aaron J.; D'Arcy, Ryan C. N.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [Dillen, Kim N. H.] Res Ctr Juelich, Inst Neurosci & Med, Julich, Germany; [Patterson, Steven A.; Beyea, Steven D.; Stevens, M. Tynan R.] Dalhousie Univ, Dept Phys, Halifax, NS B3H 3J5, Canada; [Feindel, Kirk W.; Beyea, Steven D.] Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada; [Feindel, Kirk W.] IWK Hlth Ctr, Dept Pediat Neurol, Halifax, NS, Canada; [Beyea, Steven D.; Schmidt, Matthias H.] Dalhousie Univ, Dept Radiol, Halifax, NS, Canada; [D'Arcy, Ryan C. N.] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS, Canada	National Research Council Canada; Dalhousie University; Helmholtz Association; Research Center Julich; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	D'Arcy, RCN (corresponding author), CNR, Inst Biodiagnost Atlantic, Halifax, NS, Canada.	rdarcy@sfu.ca	Feindel, Kirk/H-9772-2014; Newman, Aaron/A-6835-2011	Feindel, Kirk/0000-0002-4402-0180; Dillen, Kim/0000-0002-0270-3338; Gawryluk, Jodie/0000-0003-4924-7517; Beyea, Steven/0000-0001-7851-0017; Newman, Aaron/0000-0001-5290-8342	National Research Council of Canada Genomics and Health Initiative; Natural Sciences and Engineering Research Council of Canada; Dalhousie Medical Research Foundation; Dalhousie Radiology Research Foundation; Canada Research Chairs	National Research Council of Canada Genomics and Health Initiative; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Dalhousie Medical Research Foundation; Dalhousie Radiology Research Foundation; Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by the National Research Council of Canada Genomics and Health Initiative (http://archive.nrc-cnrc.gc.ca/eng/ibp/ghi.html), the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), the Dalhousie Medical Research Foundation (http://www.dmrf.ca/), the Dalhousie Radiology Research Foundation (http://radiologyfoundation.medicine.dal.ca/), and Canada Research Chairs (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Aramaki Y, 2006, CEREB CORTEX, V16, P1338, DOI 10.1093/cercor/bhj075; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Chakravarty MM, 2009, HUM BRAIN MAPP, V30, P3574, DOI 10.1002/hbm.20780; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; D'Arcy RCN, 2006, MAGN RESON MED, V55, P952, DOI 10.1002/mrm.20839; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Di Salle F, 2003, EUR J RADIOL, V48, P138, DOI 10.1016/j.ejrad.2003.08.010; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Fabri M, 2011, BRAIN RES, V1370, P99, DOI 10.1016/j.brainres.2010.11.039; Fera F, 2004, J MAGN RESON IMAGING, V19, P19, DOI 10.1002/jmri.10440; Gati JS, 2000, MED RAD DIA IMG, P277; Gati JS, 1997, MAGNET RESON MED, V38, P296, DOI 10.1002/mrm.1910380220; Gawryluk JR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-56; Gawryluk JR, 2011, NEUROIMAGE, V54, P10, DOI 10.1016/j.neuroimage.2010.07.028; Gawryluk JR, 2009, NEUROIMAGE, V45, P83, DOI 10.1016/j.neuroimage.2008.11.005; Gonzalez-Castillo J, 2011, NEUROIMAGE, V54, P2764, DOI 10.1016/j.neuroimage.2010.11.020; Greve DN, 2011, MAGN RESON MED, V65, P1053, DOI 10.1002/mrm.22691; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Hoenig K, 2005, RADIOLOGY, V234, P860, DOI 10.1148/radiol.2343031565; Hu XP, 2004, ANNU REV BIOMED ENG, V6, P157, DOI 10.1146/annurev.bioeng.6.040803.140017; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Krasnow B, 2003, NEUROIMAGE, V18, P813, DOI 10.1016/S1053-8119(03)00002-8; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; Mazerolle EL, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-84; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meindl T, 2008, EUR RADIOL, V18, P1102, DOI 10.1007/s00330-008-0869-1; Menon RS, 2012, NEUROIMAGE, V62, P970, DOI 10.1016/j.neuroimage.2011.09.005; Mosier K, 2001, EXP BRAIN RES, V140, P280, DOI 10.1007/s002210100813; Newman AJ, 2010, P NATL ACAD SCI USA, V107, P7539, DOI 10.1073/pnas.1003174107; Oishi K., 2005, MRI ATLAS HUMAN WHIT; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omura K, 2004, NEUROREPORT, V15, P2707; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Ugurbil K, 1999, PHILOS T R SOC B, V354, P1195, DOI 10.1098/rstb.1999.0474; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Weber B, 2005, J COGNITIVE NEUROSCI, V17, P113, DOI 10.1162/0898929052880002; Weis S, 2011, INT J NEUROSCI, V121, P384, DOI 10.3109/00207454.2011.565892; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, IEEE T MED IMAGING, V23, P213, DOI 10.1109/TMI.2003.823065; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yang YH, 1999, NEUROIMAGE, V9, P446, DOI 10.1006/nimg.1998.0422; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zou KH, 2005, RADIOLOGY, V237, P781, DOI 10.1148/radiol.2373041630	63	37	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58130	10.1371/journal.pone.0058130	http://dx.doi.org/10.1371/journal.pone.0058130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483983	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900072
J	Hong, SY; Jerger, L; Jonas, A; Badi, A; Cohen, S; Nachega, JB; Parienti, JJ; Tang, AM; Wanke, C; Terrin, N; Pereko, D; Blom, A; Trotter, AB; Jordan, MR				Hong, Steven Y.; Jerger, Logan; Jonas, Anna; Badi, Alfons; Cohen, Steven; Nachega, Jean B.; Parienti, Jean-Jacques; Tang, Alice M.; Wanke, Christine; Terrin, Norma; Pereko, Dawn; Blom, Abraham; Trotter, Andrew B.; Jordan, Michael R.			Medication Possession Ratio Associated with Short-Term Virologic Response in Individuals Initiating Antiretroviral Therapy in Namibia	PLOS ONE			English	Article							HIV-INFECTED ADULTS; VIRAL LOAD; ASSESS ADHERENCE; SOUTH-AFRICA; SELF-REPORT; BASE-LINE; RESISTANCE; FAILURE; SUPPRESSION; PREDICTORS	The visual-analogue scale (VAS), Likert item (rating scale), pills identification test (PIT), and medication possession ratio (MPR) provide estimates of antiretroviral therapy (ART) adherence which correlate with HIV viral suppression. These simple adherence measures are inexpensive and easy to administer; however, require validation and adjustment prior to implementation. The objective of this study was to define the optimal adherence assessment measure in Namibia to identify patients at risk for sub-optimal adherence and poor virologic response 6 months after ART initiation. We conducted a cross-sectional survey in HIV-infected adults receiving ART for 6-12 months prior to the adherence assessment. Adherence measures included 30-day VAS, 30-day Likert item, self-reported treatment interruptions, PIT, and MPR. Association of adherence measures with 6-month HIV-1 RNA level was assessed using two thresholds (1000 copies/mL and 5000 copies/mL). Adherence was assessed in 236 patients, mean age 37.3 years, 54% female. Mean adherence was 98.1% by 30-day VAS, 84.7% by 30-day Likert item, 97.0% by self-reported treatment interruptions, 90.6% by PIT, and 98.8% by MPR. Agreement between adherence measures was poor using kappa statistic. 76% had HIV-1 RNA <1000 copies/ml, and 88% had HIV-1 RNA <5000 copies/ml. MPR (continuous) was associated with viral suppression <5000 copies/ml (p = 0.036). MPR <75% was associated with virologic failure at >= 5000 copies/ml with OR 3.89 (1.24, 12.21), p = 0.013. Adherence was high with all measures. Only MPR, was associated with short-term virologic response, suggesting its cross-culturally utility for early identification of patients at high risk for virologic failure.	[Hong, Steven Y.; Wanke, Christine; Trotter, Andrew B.; Jordan, Michael R.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Hong, Steven Y.; Jerger, Logan; Cohen, Steven; Tang, Alice M.; Wanke, Christine; Trotter, Andrew B.; Jordan, Michael R.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Jonas, Anna; Badi, Alfons; Blom, Abraham] Republ Namibia Minist Hlth & Social Serv, Directorate Special Programmes, Windhoek, Namibia; [Nachega, Jean B.] Johns Hopkins Univ, Ctr Global Hlth, Baltimore, MD USA; [Nachega, Jean B.] Univ Stellenbosch, Fac Hlth Sci, Ctr Infect Dis, Cape Town, South Africa; [Parienti, Jean-Jacques] Univ Hosp Ctr, Dept Biostat & Clin Res, Caen, France; [Terrin, Norma] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Pereko, Dawn] ABT Associates Inc, Strengthening Hlth Outcomes Private Sector, Windhoek, Namibia	Tufts Medical Center; Massachusetts Department of Public Health; Tufts University; Johns Hopkins University; Stellenbosch University; CHU de Caen NORMANDIE; Tufts Medical Center; ABT Associates	Hong, SY (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA.	shong@tuftsmedicalcenter.org	Parienti, Jean-Jacques/AAD-1701-2021	Parienti, Jean-Jacques/0000-0002-4774-5590; Trotter, Andrew/0000-0001-7069-2979; Nachega, Jean/0000-0002-2862-4443	National Institutes of Health (NIH) [K23 AI074423-05, L30 AI080268-02, 1K23AI097010-01A1];  [T32 AI007438-18]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007438, K23AI097010, K23AI074423, P30AI042853] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by T32 AI007438-18 (ABT), National Institutes of Health (NIH) K23 AI074423-05 (MRJ), and NIH L30 AI080268-02 (SYH), and NIH 1K23AI097010-01A1 (SYH). Publication expenses for this manuscript were supported in part by a gift from the Christine E. Driscoll O'Neill and James M. Driscoll, Driscoll-O'Neill Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD FACTB; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Jordan MR, 2008, ANTIVIR THER, V13, P15; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Luca D, 2011, J ACQUIR IMMUNE DEFI; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Maneesriwongul WL, 2006, JAIDS-J ACQ IMM DEF, V43, pS119, DOI 10.1097/01.qai.0000248346.79888.78; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Parienti JJ, 2001, JAMA-J AM MED ASSOC, V285, P412, DOI 10.1001/jama.285.4.412; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes, 2010, NAT GUID ANT THER; ROTH HP, 1978, CLIN PHARMACOL THER, V23, P361; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; The Republic of Namibia Ministry of Health and Social Services, 2010, REP 2010 NAT HIV SEN; UNAIDS, 2012, TOG WE WILL END AIDS; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS, 2011, UN ACC SCAL PRIOR HI; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed	35	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56307	10.1371/journal.pone.0056307	http://dx.doi.org/10.1371/journal.pone.0056307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23509605	Green Published, gold			2022-12-25	WOS:000315524900022
J	Kurokawa, K; Akaike, Y; Masuda, K; Kuwano, Y; Nishida, K; Yamagishi, N; Kajita, K; Tanahashi, T; Rokutan, K				Kurokawa, K.; Akaike, Y.; Masuda, K.; Kuwano, Y.; Nishida, K.; Yamagishi, N.; Kajita, K.; Tanahashi, T.; Rokutan, K.			Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells	ONCOGENE			English	Article						SRSF3 (SRp20); G1 arrest; apoptosis; alternative splicing; HIPK2	INTERACTING PROTEIN KINASE-2; SR PROTEINS; OVARIAN-CANCER; FACTOR SRP20; P53 ACTIVITY; DNA-DAMAGE; HIPK2; TRANSCRIPTION; EXPRESSION; PHOSPHORYLATION	Serine/arginine-rich splicing factor 3 (SRSF3) likely has wide-ranging roles in gene expression and facilitation of tumor cell growth. SRSF3 knockdown induced G1 arrest and apoptosis in colon cancer cells (HCT116) in association with altered expression of 833 genes. Pathway analysis revealed 'G1/S Checkpoint Regulation' as the most highly enriched category in the affected genes. SRSF3 knockdown did not induce p53 or stimulate phosphorylation of p53 or histone H2A. X in wild-type HCT116 cells. Furthermore, the knockdown induced G1 arrest in p53-null HCT116 cells, suggesting that p53-dependent DNA damage responses did not mediate the G1 arrest. Real-time reverse transcription-polymerase chain reaction and western blotting confirmed that SRSF3 knockdown reduced mRNA and protein levels of cyclins (D1, D3 and E1), E2F1 and E2F7. The decreased expression of cyclin D and E2F1 likely impaired the G1-to-S-phase progression. Consequently, retinoblastoma protein remained hypophosphorylated in SRSF3 knockdown cells. The knockdown also induced apoptosis in association with reduction of BCL2 protein levels. We also found that SRSF3 knockdown facilitated skipping of 81 5'-nucleotides (27 amino acids) from exon 8 of homeodomain-interacting protein kinase-2 (HIPK2) and produced a HIPK2 Delta e8 isoform. Full-length HIPK2 (HIPK2 FL) is constantly degraded through association with an E3 ubiquitin ligase (Siah-1), whereas HIPK2 Delta e8, lacking the 27 amino acids, lost Siah-1-binding ability and became resistant to proteasome digestion. Interestingly, selective knockdown of HIPK2 FL induced apoptosis in various colon cancer cells expressing wild-type or mutated p53. Thus, these findings disclose an important role of SRSF3 in the regulation of the G1-to-S-phase progression and alternative splicing of HIPK2 in tumor growth.	[Kurokawa, K.; Akaike, Y.; Masuda, K.; Kuwano, Y.; Nishida, K.; Yamagishi, N.; Kajita, K.; Tanahashi, T.; Rokutan, K.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, Tokushima 7708503, Japan	Tokushima University	Kurokawa, K (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	kurokawa178@basic.med.tokushima-u.ac.jp	Nishida, Kensei/AAF-2829-2020	Nishida, Kensei/0000-0003-2314-785X	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (to KR).	Anko ML, 2010, NAT STRUCT MOL BIOL, V17, P962, DOI 10.1038/nsmb.1862; Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; Ghigna C, 1998, CANCER RES, V58, P5818; Giraud S, 2004, J VIROL, V78, P2984, DOI 10.1128/JVI.78.6.2984-2993.2004; Hailemariam K, 2010, J CELL SCI, V123, P3863, DOI 10.1242/jcs.073627; He X, 2011, ONCOGENE, V30, P356, DOI 10.1038/onc.2010.426; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Kim SY, 2009, CANCER LETT, V279, P177, DOI 10.1016/j.canlet.2009.01.036; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kurokawa K, 2010, NEUROSCI LETT, V484, P128, DOI 10.1016/j.neulet.2010.08.031; Kuwano Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024723; Lazzari C, 2011, ONCOGENE, V30, P4802, DOI 10.1038/onc.2011.182; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stickeler E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/sj.onc.1202671; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	44	65	68	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1407	1417		10.1038/onc.2013.86	http://dx.doi.org/10.1038/onc.2013.86			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23503458				2022-12-25	WOS:000332943500008
J	Lum, MA; Pundt, KE; Paluch, BE; Black, AR; Black, JD				Lum, Michelle A.; Pundt, Krista E.; Paluch, Benjamin E.; Black, Adrian R.; Black, Jennifer D.			Agonist-induced Down-regulation of Endogenous Protein Kinase C alpha through an Endolysosomal Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAFT-DEPENDENT ENDOCYTOSIS; CLOSTRIDIUM-DIFFICILE TOXINS; INTESTINAL EPITHELIAL-CELLS; HAMSTER OVARY CELLS; PKC-ALPHA; PHORBOL ESTER; LIPID RAFTS; INDEPENDENT MECHANISM; DOPAMINE TRANSPORTER; RECYCLING ENDOSOMES	Protein kinase C (PKC) isozymes undergo down-regulation upon sustained stimulation. Previous studies have pointed to the existence of both proteasome-dependent and -independent pathways of PKC alpha processing. Here we demonstrate that these down-regulation pathways are engaged in different subcellular compartments; proteasomal degradation occurs mainly at the plasma membrane, whereas non-proteasomal processing occurs in the perinuclear region. Using cholesterol depletion, pharmacological inhibitors, RNA interference, and dominant-negative mutants, we define the mechanisms involved in perinuclear accumulation of PKC alpha and identify the non-proteasomal mechanism mediating its degradation. We show that intracellular accumulation of PKC alpha involves at least two clathrin-independent, cholesterol/lipid raft-mediated pathways that do not require ubiquitination of the protein; one is dynamin-dependent and likely involves caveolae, whereas the other is dynaminand small GTPase-independent. Internalized PKC alpha traffics through endosomes and is delivered to the lysosome for degradation. Supportive evidence includes (a) detection of the enzyme in EEA1-positive early endosomes, Rab7-positive late endosomes/multivesicular bodies, and LAMP1-positive lysosomes and (b) inhibition of its down-regulation by lysosome-disrupting agents and leupeptin. Only limited dephosphorylation of PKC alpha occurs during trafficking, with fully mature enzyme being the main target for lysosomal degradation. These studies define a novel and widespread mechanism of desensitization of PKC alpha signaling that involves endocytic trafficking and lysosome-mediated degradation of the mature, fully phosphorylated protein.	[Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Lum, Michelle A.; Pundt, Krista E.; Paluch, Benjamin E.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute	Black, JD (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jennifer.black@unmc.edu			National Institutes of Health [DK60632, DK54909, CA16056, CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, P30CA016056, T32CA009072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK060632, R01DK054909, R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60632, DK54909, CA16056, and CA036727.	Abrahamsen H, 2012, J BIOL CHEM, V287, P13262, DOI 10.1074/jbc.M112.349753; Agostinelli E, 2007, INT J ONCOL, V31, P473; ALLEN LAH, 1995, EMBO J, V14, P1109, DOI 10.1002/j.1460-2075.1995.tb07094.x; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Black JD, 2001, GASTROENTEROLOGY, V120, P1868, DOI 10.1053/gast.2001.25287; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Carmena D, 2007, BIOCHEM SOC T, V35, P1043, DOI 10.1042/BST0351043; Chua T, 1998, FEBS LETT, V436, P439, DOI 10.1016/S0014-5793(98)01161-2; CLEMENS MJ, 1992, J CELL SCI, V103, P881; COULDWELL WT, 1991, NEUROSURGERY, V29, P880, DOI 10.1227/00006123-199112000-00013; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; da Rocha AB, 2002, ONCOLOGIST, V7, P17, DOI 10.1634/theoncologist.7-1-17; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; Decathelineau AM, 2009, INFECT IMMUN, V77, P348, DOI 10.1128/IAI.01005-08; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Faghiri Z, 2006, INVEST OPHTH VIS SCI, V47, P397, DOI 10.1167/iovs.05-0290; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; FIORENTINI C, 1989, TOXICON, V27, P1209, DOI 10.1016/0041-0101(89)90029-9; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Hamer I, 1998, BIOCHEM J, V329, P183, DOI 10.1042/bj3290183; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; HATCH GM, 1993, J LIPID RES, V34, P1873; Heikkila O, 2010, J VIROL, V84, P3666, DOI 10.1128/JVI.01340-09; Hing JDNY, 2004, BIOCHEM BIOPH RES CO, V319, P810, DOI 10.1016/j.bbrc.2004.05.054; Hippenstiel S, 2002, AM J PHYSIOL-LUNG C, V283, pL830, DOI 10.1152/ajplung.00467.2001; HONG DH, 1995, BBA-MOL CELL RES, V1267, P45, DOI 10.1016/0167-4889(95)00024-M; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Junoy B, 2002, ENDOCRINOLOGY, V143, P1386, DOI 10.1210/en.143.4.1386; JUST I, 1994, J BIOL CHEM, V269, P10706; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; Kojic LD, 2007, J BIOL CHEM, V282, P29305, DOI 10.1074/jbc.M704069200; Kojic LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003597; Lahn M, 2004, ONCOLOGY-BASEL, V67, P1, DOI 10.1159/000080279; Lahn M, 2004, BJU INT, V93, P1076, DOI 10.1111/j.1464-410X.2003.04784.x; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Lee HW, 1996, AM J PHYSIOL-CELL PH, V271, pC304, DOI 10.1152/ajpcell.1996.271.1.C304; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Maccario H, 2004, NEUROENDOCRINOLOGY, V79, P204, DOI 10.1159/000078102; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Melnikov S, 2009, CELL SIGNAL, V21, P1607, DOI 10.1016/j.cellsig.2009.06.007; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Misinzo G, 2005, J GEN VIROL, V86, P2057, DOI 10.1099/vir.0.80652-0; Moskowitz HS, 2005, MOL BIOL CELL, V16, P1769, DOI 10.1091/mbc.E04-08-0739; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nankoe SR, 2006, TRENDS CELL BIOL, V16, P607, DOI 10.1016/j.tcb.2006.10.004; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Prevostel C, 2000, J CELL SCI, V113, P2575; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SAVART M, 1992, INT J CANCER, V52, P399, DOI 10.1002/ijc.2910520312; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Srivastava J, 2002, BIOCHEM J, V368, P349, DOI 10.1042/BJ20020737; STYRT B, 1986, BLOOD, V67, P334; Szallasi Z, 1996, CANCER RES, V56, P2105; TAPPER H, 1995, J LEUKOCYTE BIOL, V58, P485, DOI 10.1002/jlb.58.4.485; Torgersen ML, 2001, J CELL SCI, V114, P3737; van der Aa MAEM, 2007, PHARM RES-DORDR, V24, P1590, DOI 10.1007/s11095-007-9287-3; Vassilieva EV, 2008, AM J PHYSIOL-GASTR L, V295, pG965, DOI 10.1152/ajpgi.00082.2008; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Ward NE, 2000, BIOCHEMISTRY-US, V39, P10319, DOI 10.1021/bi000781g; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zemskov EA, 2003, NEUROREPORT, V14, P1435, DOI 10.1097/00001756-200308060-00006	106	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13093	13109		10.1074/jbc.M112.437061	http://dx.doi.org/10.1074/jbc.M112.437061			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508961	Green Published, hybrid			2022-12-25	WOS:000318555100060
J	Than, JYXL; Li, L; Hasan, R; Zhang, XM				Than, Jonathan Y. -X. L.; Li, Lin; Hasan, Raquibul; Zhang, Xuming			Excitation and Modulation of TRPA1, TRPV1, and TRPM8 Channel-expressing Sensory Neurons by the Pruritogen Chloroquine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; COLD; RECEPTOR; PAIN; HISTAMINE; G-ALPHA(Q/11); NOCICEPTORS; SENSATION	The sensations of pain, itch, and cold often interact with each other. Pain inhibits itch, whereas cold inhibits both pain and itch. TRPV1 and TRPA1 channels transduce pain and itch, whereas TRPM8 transduces cold. The pruritogen chloroquine (CQ) was reported to excite TRPA1, leading to the sensation of itch. It is unclear how CQ excites and modulates TRPA1(+), TRPV1(+), and TRPM8(+) neurons and thus affects the sensations of pain, itch, and cold. Here, we show that only 43% of CQ-excited dorsal root ganglion neurons expressed TRPA1; as expected, the responses of these neurons were completely prevented by the TRPA1 antagonist HC-030031. The remaining 57% of CQ-excited neurons did not express TRPA1, and excitation was not prevented by either a TRPA1 or TRPV1 antagonist but was prevented by the general transient receptor potential canonical (TRPC) channel blocker BTP2 and the selective TRPC3 inhibitor Pyr3. Furthermore, CQ caused potent sensitization of TRPV1 in 51.9% of TRPV1(+) neurons and concomitant inhibition of TRPM8 in 48.8% of TRPM8(+) dorsal root ganglion neurons. Sensitization of TRPV1 is caused mainly by activation of the phospholipase C-PKC pathway following activation of the CQ receptor MrgprA3. By contrast, inhibition of TRPM8 is caused by a direct action of activated G alpha(q) independent of the phospholipase C pathway. Our data suggest the involvement of the TRPC3 channel acting together with TRPA1 to mediate CQ-induced itch. CQ not only elicits itch by directly exciting itch-encoding neurons but also exerts previously unappreciated widespread actions on pain-, itch-, and cold-sensing neurons, leading to enhanced pain and itch.	[Than, Jonathan Y. -X. L.; Li, Lin; Hasan, Raquibul; Zhang, Xuming] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Zhang, XM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	xz213@cam.ac.uk		Zhang, Xuming/0000-0002-5331-8675; Than, Jonathan/0000-0002-0665-7359	Medical Research Council [G0801387]; Islamic Development Bank scholarship; MRC [G0801387] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Islamic Development Bank scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council New Investigator Research Grant G0801387 (to X.Z.).; Supported by an Islamic Development Bank scholarship.	Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Han JH, 2012, ACTA DERM-VENEREOL, V92, P561, DOI 10.2340/00015555-1244; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Harrington AM, 2011, PAIN, V152, P1459, DOI 10.1016/j.pain.2011.01.027; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Kammermeier PJ, 2000, J NEUROSCI, V20, P5623, DOI 10.1523/JNEUROSCI.20-15-05623.2000; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kress M, 2008, HISTOCHEM CELL BIOL, V130, P655, DOI 10.1007/s00418-008-0477-9; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Li L, 2013, CHANNELS, V7, P115, DOI 10.4161/chan.23466; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Papoiu ADP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017786; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Qu LT, 2012, J NEUROSCI, V32, P9554, DOI 10.1523/JNEUROSCI.6355-11.2012; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Vetter I, 2012, EMBO J, V31, P3795, DOI 10.1038/emboj.2012.207; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	33	59	60	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12818	12827		10.1074/jbc.M113.450072	http://dx.doi.org/10.1074/jbc.M113.450072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508958	hybrid, Green Published			2022-12-25	WOS:000318555100037
J	Malpede, BM; Lin, DH; Tolia, NH				Malpede, Brian M.; Lin, Daniel H.; Tolia, Niraj H.			Molecular Basis for Sialic Acid-dependent Receptor Recognition by the Plasmodium falciparum Invasion Protein Erythrocyte-binding Antigen-140/BAEBL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; GLYCOPHORIN-C; LIGAND; MEROZOITES; BAEBL; SPECIFICITY; ANTIGEN; SURFACE; VIVAX; HEMAGGLUTININ	Plasmodium falciparum erythrocyte invasion is dependent on high affinity recognition of sialic acid on cell surface receptors. The erythrocyte binding-like (EBL) family of invasion ligands mediates recognition of sialic acid on erythrocyte glycoproteins. Erythrocyte-binding antigen-140 (PfEBA-140/BAEBL) is a critical EBL ligand that binds sialic acid on its receptor glycophorin C. We present here the crystal structure of the two-domain receptor-binding region of PfEBA-140 in complex with a glycan containing sialic acid. The structure identifies two glycan-binding pockets unique to PfEBA-140 and not shared by other EBL ligands. Specific molecular interactions that enable receptor engagement are identified and reveal that the glycan binding mode is distinct from that of apicomplexan and viral cell surface recognition ligands as well as host immune factors that bind sialic acid. Erythrocyte binding experiments elucidated essential glycan contact residues and identified divergent functional roles for each receptor-binding site. One of four polymorphisms proposed to affect receptor binding was localized to a glycan-binding site, providing a structural basis for altered erythrocyte engagement. The studies described here provide the first full description of sialic acid-dependent molecular interactions at the P. falciparum erythrocyte invasion interface and define a framework for development of PfEBA-140-based therapeutics, vaccines, and diagnostics assessing vaccine efficacy and natural immunity to infection.	[Malpede, Brian M.; Lin, Daniel H.; Tolia, Niraj H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Tolia, NH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	tolia@wustl.edu	Tolia, Niraj H/D-2332-2014	Tolia, Niraj H/0000-0002-2689-1337	National Institutes of Health [AI080792]; Edward Mallinckrodt, Jr. Foundation; National Science Foundation [DGE-1143954]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080792, R01AI080792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; National Science Foundation(National Science Foundation (NSF)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI080792 from the National Institutes of Health and by a grant from the Edward Mallinckrodt, Jr. Foundation (to N. H. T.). This work was also supported by a National Science Foundation Graduate Research Fellowship (to B. M. M.) under Grant DGE-1143954.; We thank Nichole Salinas for assistance with experiments, Wandy Beatty for help with confocal imaging, David Sibley for constructive comments on the manuscript, the Structural Biology Center (SBC) at Argonne National Laboratory for use of beamline 19-ID at the Advanced Photon Source, and Stephen L. Ginell and SBC beamline scientists for assistance during data collection. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Baum J, 2003, GENETICS, V163, P1327; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford L, 2007, AM J TROP MED HYG, V77, P977, DOI 10.4269/ajtmh.2007.77.977; Gosi P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-112; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Jiang LB, 2009, MOL BIOCHEM PARASIT, V168, P49, DOI 10.1016/j.molbiopara.2009.06.006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobayashi K, 2010, J BIOL CHEM, V285, P1716, DOI 10.1074/jbc.M109.021576; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lin DH, 2012, J BIOL CHEM, V287, P36830, DOI 10.1074/jbc.M112.409276; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Mayer DCG, 2006, P NATL ACAD SCI USA, V103, P2358, DOI 10.1073/pnas.0510648103; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; MILLER LH, 1977, AM J TROP MED HYG, V26, P204, DOI 10.4269/ajtmh.1977.26.204; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; WATOWICH SJ, 1994, STRUCTURE, V2, P719, DOI 10.1016/S0969-2126(00)00073-3	41	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12406	12415		10.1074/jbc.M113.450643	http://dx.doi.org/10.1074/jbc.M113.450643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23508963	Green Published, hybrid			2022-12-25	WOS:000318157600071
J	Zhou, G; Marathe, GK; Hartiala, J; Hazen, SL; Allayee, H; Tang, WHW; McIntyre, TM				Zhou, Gang; Marathe, Gopal K.; Hartiala, Jaana; Hazen, Stanley L.; Allayee, Hooman; Tang, W. H. Wilson; McIntyre, Thomas M.			Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNITS; ESTERASE-ACTIVITY; RESISTANCE; CHOLINESTERASE; PHARMACOKINETICS; CYCLOOXYGENASE; PARAOXONASE-1; ACETYLATION; ASSOCIATION; ERYTHROCYTE	Aspirin is rapidly hydrolyzed within erythrocytes by a heterodimer of PAFAH1b2/PAFAH1b3 but also in plasma by an unidentified activity. Hydrolysis in both compartments was variable, with a 12-fold variation in plasma among 2226 Cleveland Clinic GeneBank patients. Platelet inhibition by aspirin was suppressed in plasma that rapidly hydrolyzed aspirin. Plasma aspirin hydrolysis was significantly higher in patients with coronary artery disease compared with control subjects (16.5 +/- 4.4 versus 15.1 +/- 3.7 nmol/ml/min; p = 3.4 x 10(-8)). A genome-wide association study of 2054 GeneBank subjects identified a single locus immediately adjacent to the BCHE (butyrylcholinesterase) gene associated with plasma aspirin hydrolytic activity (lead SNP, rs6445035; p = 9.1 x 10(-17)). However, its penetrance was low, and plasma from an individual with an inactivating mutation in BCHE still effectively hydrolyzed aspirin. A second aspirin hydrolase was identified in plasma, the purification of which showed it to be homomeric PAFAH1b2. This is distinct from the erythrocyte PAFAH1b2/PAFAH1b3 heterodimer. Inhibitors showed that both butyrylcholinesterase (BChE) and PAFAH1b2 contribute to aspirin hydrolysis in plasma, with variation primarily reflecting non-genetic variation of BChE activity. Therefore, aspirin is hydrolyzed in plasma by two enzymes, BChE and a new extracellular form of platelet-activating factor acetylhydrolase, PAFAH1b2. Hydrolytic effectiveness varies widely primarily from non-genetic variation of BChE activity that affects aspirin bioavailability in blood and the ability of aspirin to inhibit platelet aggregation.	[Zhou, Gang; Marathe, Gopal K.; Hazen, Stanley L.; Tang, W. H. Wilson; McIntyre, Thomas M.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Lerner Coll Med, Cleveland, OH 44195 USA; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Inst Med Genet, Keck Sch Med, Los Angeles, CA 90089 USA	Case Western Reserve University; Cleveland Clinic Foundation; University of Southern California; University of Southern California	McIntyre, TM (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Lerner Coll Med, NE10,9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org	Hartiala, Jaana A/GLR-1825-2022; Hazen, Stanley L/ABD-5845-2021; Tang, Wai Hong Wilson/I-1238-2013	Hartiala, Jaana A/0000-0003-4883-9318; Tang, W. H. Wilson/0000-0002-8335-735X; Marathe, Gopal/0000-0002-0025-6677	National Institutes of Health [P01 HL087018, AA017748, P50 HL081011]; NHLBI [P01 HL098055, P01 HL076491, R01 HL103866, P20 HL113452, R01 HL103931]; Cleveland Clinic Clinical Research Unit of the Case Western Reserve University through National Institutes of Health Clinical and Translational Science Award [1UL1RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081011, P01HL076491, R01HL103866, P01HL098055, P20HL113452, R01HL103931, P01HL087018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cleveland Clinic Clinical Research Unit of the Case Western Reserve University through National Institutes of Health Clinical and Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL087018, AA017748, and P50 HL081011. The Cleveland Clinic GeneBank study was supported by NHLBI Grants P01 HL098055, P01 HL076491, R01 HL103866, P20 HL113452, and R01 HL103931 and by the Cleveland Clinic Clinical Research Unit of the Case Western Reserve University through National Institutes of Health Clinical and Translational Science Award Grant 1UL1RR024989.	Adebayo GI, 2007, EUR J INTERN MED, V18, P299, DOI 10.1016/j.ejim.2006.12.004; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; AKOPOV SS, 1992, J CLIN PHARMACOL, V32, P133, DOI 10.1002/j.1552-4604.1992.tb03817.x; Alberts MJ, 2004, STROKE, V35, P175, DOI 10.1161/01.STR.0000106763.46123.F6; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coma-Canella I, 2005, INT J CARDIOL, V101, P71, DOI 10.1016/j.ijcard.2004.03.069; COSTELLO PB, 1984, ARTHRITIS RHEUM, V27, P422, DOI 10.1002/art.1780270409; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fitzgerald Desmond J, 2007, Hematology Am Soc Hematol Educ Program, P114; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; Goodall R, 2004, ANN CLIN BIOCHEM, V41, P98, DOI 10.1258/000456304322879971; Gresner P, 2006, BBA-GEN SUBJECTS, V1760, P207, DOI 10.1016/j.bbagen.2005.11.018; Grosser T, 2013, CIRCULATION, V127, P377, DOI 10.1161/CIRCULATIONAHA.112.117283; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hartiala J, 2011, HUM GENET, V129, P617, DOI 10.1007/s00439-011-0963-3; HELGASON CM, 1994, STROKE, V25, P2331, DOI 10.1161/01.STR.25.12.2331; HELGASON CM, 1993, STROKE, V24, P345, DOI 10.1161/01.STR.24.3.345; HIGGS GA, 1987, P NATL ACAD SCI USA, V84, P1417, DOI 10.1073/pnas.84.5.1417; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Jack DB, 1997, LANCET, V350, P437, DOI 10.1016/S0140-6736(97)07087-6; Koizumi H, 2003, J BIOL CHEM, V278, P12489, DOI 10.1074/jbc.M211836200; Kotani K, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-50; KUO CL, 1995, DRUG METAB DISPOS, V23, P935; Lev EI, 2009, J AM COLL CARDIOL, V53, P678, DOI 10.1016/j.jacc.2008.11.018; LEVY G, 1965, ANESTH ANAL CURR RES, V44, P837; Manya H, 1998, J BIOL CHEM, V273, P18567, DOI 10.1074/jbc.273.29.18567; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Masson P, 1998, BBA-PROTEIN STRUCT M, V1387, P41, DOI 10.1016/S0167-4838(98)00104-6; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; NOGUEIRA CP, 1990, AM J HUM GENET, V46, P934; Patrono C, 2007, NAT CLIN PRACT CARD, V4, P42, DOI 10.1038/ncpcardio0728; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; PUCHE E, 1993, ACTA ANAESTH SCAND, V37, P20, DOI 10.1111/j.1399-6576.1993.tb03590.x; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; ROWLAND M, 1972, J PHARM SCI-US, V61, P379, DOI 10.1002/jps.2600610312; Santanam N, 2007, ATHEROSCLEROSIS, V191, P272, DOI 10.1016/j.atherosclerosis.2006.05.027; Santilli F, 2009, J AM COLL CARDIOL, V53, P667, DOI 10.1016/j.jacc.2008.10.047; Simeon-Rudolf V, 1999, CHEM-BIOL INTERACT, V119, P165, DOI 10.1016/S0009-2797(99)00025-3; SMITH WL, 1990, ADV PROSTAG THROMB L, V20, P14; Soliday Flanna K, 2010, AANA J, V78, P313; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P516, DOI 10.1161/ATVBAHA.111.237040; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; WILLIAMS FM, 1987, EUR J CLIN PHARMACOL, V33, P387, DOI 10.1007/BF00637635; Zhou G, 2011, J BIOL CHEM, V286, P34820, DOI 10.1074/jbc.M111.267161	48	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11940	11948		10.1074/jbc.M112.427674	http://dx.doi.org/10.1074/jbc.M112.427674			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23508960	Green Published, hybrid			2022-12-25	WOS:000318157600029
J	Ali, JAM; Tagoe, DNA; Munday, JC; Donachie, A; Morrison, LJ; de Koning, HP				Ali, Juma A. M.; Tagoe, Daniel N. A.; Munday, Jane C.; Donachie, Anne; Morrison, Liam J.; de Koning, Harry P.			Pyrimidine Biosynthesis Is Not an Essential Function for Trypanosoma brucei Bloodstream Forms	PLOS ONE			English	Article							HIGH-AFFINITY NUCLEOSIDE; NUCLEOBASE TRANSPORTERS; LEISHMANIA-DONOVANI; AFRICAN TRYPANOSOMIASIS; TOXOPLASMA-GONDII; SLEEPING SICKNESS; DRUG TARGET; PURINE; INHIBITORS; SALVAGE	Background: African trypanosomes are capable of both pyrimidine biosynthesis and salvage of preformed pyrimidines from the host, but it is unknown whether either process is essential to the parasite. Methodology/Principal Findings: Pyrimidine requirements for growth were investigated using strictly pyrimidine-free media, with or without single added pyrimidine sources. Growth rates of wild-type bloodstream form Trypanosoma brucei brucei were unchanged in pyrimidine-free medium. The essentiality of the de novo pyrimidine biosynthesis pathway was studied by knocking out the PYR6-5 locus that produces a fusion product of orotate phosphoribosyltransferase (OPRT) and Orotidine Monophosphate Decarboxylase (OMPDCase). The pyrimidine auxotroph was dependent on a suitable extracellular pyrimidine source. Pyrimidine starvation was rapidly lethal and non-reversible, causing incomplete DNA content in new cells. The phenotype could be rescued by addition of uracil; supplementation with uridine, 2'deoxyuridine, and cytidine allowed a diminished growth rate and density. PYR6-5(-)/(-) trypanosomes were more sensitive to pyrimidine antimetabolites and displayed increased uracil transport rates and uridine phosphorylase activity. Pyrimidine auxotrophs were able to infect mice although the infection developed much more slowly than infection with the parental, prototrophic trypanosome line. Conclusions/Significance: Pyrimidine salvage was not an essential function for bloodstream T. b. brucei. However, trypanosomes lacking de novo pyrimidine biosynthesis are completely dependent on an extracellular pyrimidine source, strongly preferring uracil, and display reduced infectivity. As T. brucei are able to salvage sufficient pyrimidines from the host environment, the pyrimidine biosynthesis pathway is not a viable drug target, although any interruption of pyrimidine supply was lethal.	[Ali, Juma A. M.; Tagoe, Daniel N. A.; Munday, Jane C.; Donachie, Anne; de Koning, Harry P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Ali, Juma A. M.] Al Jabal Al Gharbi Univ, Fac Sci, Dept Zool, Gharyan, Libya; [Munday, Jane C.; Morrison, Liam J.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Morrison, Liam J.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland	University of Glasgow; University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	de Koning, HP (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	Harry.de-Koning@glasgow.ac.uk	Tagoe, Daniel Nii Aryee/P-9478-2019	Tagoe, Daniel Nii Aryee/0000-0001-6268-7838; De Koning, Harry/0000-0002-9963-1827; Munday, Jane/0000-0001-7792-2749; Morrison, Liam/0000-0002-8304-9066	Wellcome Trust [085349]; Libyan Government; Medical Research Council [84733]; MRC [G0701258] Funding Source: UKRI; Medical Research Council [G0701258] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Libyan Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust [085349], and DNAT is the recipient of a Wellcome Trust scholarship. The authors also gratefully acknowledge financial support from the Libyan Government (studentship to JAMA) and the Medical Research Council (contract number 84733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salabi MI, 2007, MOL PHARMACOL, V71, P921, DOI 10.1124/mol.106.031559; Ali JA, 2013, MOL PHARM; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; ARONOW B, 1987, MOL BIOCHEM PARASIT, V22, P29, DOI 10.1016/0166-6851(87)90066-1; Balasegaram M, 2009, T ROY SOC TROP MED H, V103, P280, DOI 10.1016/j.trstmh.2008.09.005; Bellofatto V, 2007, TRENDS PARASITOL, V23, P187, DOI 10.1016/j.pt.2007.03.003; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Berg M, 2010, CURR MED CHEM, V17, P2456, DOI 10.2174/092986710791556023; Berg M, 2010, ANTIMICROB AGENTS CH, V54, P1900, DOI 10.1128/AAC.01787-09; Bi DQ, 2000, J CHROMATOGR B, V738, P249, DOI 10.1016/S0378-4347(99)00528-9; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Castillo-Acosta VM, 2008, INT J BIOCHEM CELL B, V40, P2901, DOI 10.1016/j.biocel.2008.06.009; de Koning HP, 2007, TRENDS PARASITOL, V23, P190, DOI 10.1016/j.pt.2007.03.004; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; De Koning HP, 2003, INT J PARASITOL, V33, P821, DOI 10.1016/S0020-7519(03)00091-2; de Koning HP, 1998, BIOCHEM CELL BIOL, V76, P853, DOI 10.1139/bcb-76-5-853; de Koning HP, 2000, MOL BIOCHEM PARASIT, V106, P93, DOI 10.1016/S0166-6851(99)00203-0; deKoning HP, 1997, MOL BIOCHEM PARASIT, V89, P245, DOI 10.1016/S0166-6851(97)00129-1; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; French JB, 2011, J BIOL CHEM, V286, P20930, DOI 10.1074/jbc.M111.228213; Gao GH, 1999, J MOL BIOL, V285, P149, DOI 10.1006/jmbi.1998.2293; Gould MK, 2008, ANAL BIOCHEM, V382, P87, DOI 10.1016/j.ab.2008.07.036; Gudin S, 2006, EXP PARASITOL, V114, P118, DOI 10.1016/j.exppara.2006.02.018; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; HASSAN HF, 1988, FEMS MICROBIOL LETT, V54, P47, DOI 10.1111/j.1574-6968.1988.tb02709.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Ibrahim HMS, 2011, J ANTIMICROB CHEMOTH, V66, P111, DOI 10.1093/jac/dkq401; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Larson ET, 2010, J MOL BIOL, V396, P1244, DOI 10.1016/j.jmb.2010.01.013; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Martin DW, 1981, HARPERS REV BIOCH, P331; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; Natto MJ, 2005, EXP PARASITOL, V109, P80, DOI 10.1016/j.exppara.2004.11.004; Papageorgiou IG, 2005, PARASITOLOGY, V130, P275, DOI 10.1017/S0031182004006626; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Rodenko B, 2007, ANTIMICROB AGENTS CH, V51, P3796, DOI 10.1128/AAC.00425-07; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; STERNBERG N, 1981, J MOL BIOL, V150, P487, DOI 10.1016/0022-2836(81)90376-4; VANDYKE K, 1970, AM J TROP MED HYG, V19, P202, DOI 10.4269/ajtmh.1970.19.202; Wallace LJM, 2002, J BIOL CHEM, V277, P26149, DOI 10.1074/jbc.M202835200; WANG CC, 1984, MOL BIOCHEM PARASIT, V10, P171, DOI 10.1016/0166-6851(84)90005-7; Wilson ZN, 2012, J BIOL CHEM, V287, P12759, DOI 10.1074/jbc.M112.346502	47	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58034	10.1371/journal.pone.0058034	http://dx.doi.org/10.1371/journal.pone.0058034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505454	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000318334500046
J	Castaneda, LE; Nespolo, RF				Castaneda, Luis E.; Nespolo, Roberto F.			Phenotypic and Genetic Effects of Contrasting Ethanol Environments on Physiological and Developmental Traits in Drosophila melanogaster	PLOS ONE			English	Article							QUANTITATIVE GENETICS; DIRECTIONAL SELECTION; ENERGY-METABOLISM; NATURAL-SELECTION; DEVELOPMENT TIME; GRYLLUS-FIRMUS; TRADE-OFFS; BODY-SIZE; MORPHOLOGY; EVOLUTION	A central problem in evolutionary physiology is to understand the relationship between energy metabolism and fitness-related traits. Most attempts to do so have been based on phenotypic correlations that are not informative for the evolutionary potential of natural populations. Here, we explored the effect of contrasting ethanol environments on physiological and developmental traits, their genetic (co)variances and genetic architecture in Drosophila melanogaster. Phenotypic and genetic parameters were estimated in two populations (San Fernando and Valdivia, Chile), using a half-sib family design where broods were split into ethanol-free and ethanol-supplemented conditions. Our findings show that metabolic rate, body mass and development times were sensitive (i.e., phenotypic plasticity) to ethanol conditions and dependent on population origin. Significant heritabilities were found for all traits, while significant genetic correlations were only found between larval and total development time and between development time and metabolic rate for flies of the San Fernando population developed in ethanol-free conditions. Posterior analyses indicated that the G matrices differed between ethanol conditions for the San Fernando population (mainly explained by differences in genetic (co)variances of developmental traits), whereas the Valdivia population exhibited similar G matrices between ethanol conditions. Our findings suggest that ethanol-free environment increases the energy available to reduce development time. Therefore, our results indicate that environmental ethanol could modify the process of energy allocation, which could have consequences on the evolutionary response of natural populations of D. melanogaster.	[Castaneda, Luis E.] Univ Autonoma Barcelona, GBE, Dept Genet & Microbiol, Bellaterra, Barcelona, Spain; [Nespolo, Roberto F.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile	Autonomous University of Barcelona; Universidad Austral de Chile	Castaneda, LE (corresponding author), Univ Autonoma Barcelona, GBE, Dept Genet & Microbiol, Bellaterra, Barcelona, Spain.	lecastane@gmail.com	Nespolo, Roberto/D-5601-2015; Castañeda, Luis/G-5340-2011; Nespolo, Roberto/D-5601-2015	Nespolo, Roberto/0000-0001-9337-0606; Castañeda, Luis/0000-0001-5484-4573; Nespolo, Roberto/0000-0003-0825-9618	FONDECYT [3090056, 1090423]; Ministerio de Ciencia e Innovacion (Spain) [JCI-2010-06156]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by FONDECYT Postdoctoral grant No. 3090056 to L. E. C. and FONDECYT grant No. 1090423 to R.F.N. L.E.C is currently a Juan de la Cierva fellow (JCI-2010-06156) funded by the Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Artacho P, 2009, EVOLUTION, V63, P1044, DOI 10.1111/j.1558-5646.2008.00603.x; Begin M, 2004, J EVOLUTION BIOL, V17, P1255, DOI 10.1111/j.1420-9101.2004.00772.x; Blanckenhorn WU, 2004, EVOL ECOL, V18, P385, DOI 10.1007/s10682-004-2680-z; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; DAVID JR, 1986, GENET SEL EVOL, V18, P405, DOI 10.1186/1297-9686-18-4-405; Doroszuk A, 2008, AM NAT, V171, P291, DOI 10.1086/527478; ETGES WJ, 1989, PHYSIOL ZOOL, V62, P170, DOI 10.1086/physzool.62.1.30160004; Folguera G, 2010, J INSECT PHYSIOL, V56, P1679, DOI 10.1016/j.jinsphys.2010.06.015; Fry JD, 2008, EVOLUTION, V62, P66, DOI 10.1111/j.1558-5646.2007.00288.x; Fry JD, 2001, J EVOLUTION BIOL, V14, P296, DOI 10.1046/j.1420-9101.2001.00271.x; Gebhardt MD, 1988, J EVOLUTION BIOL, V6, P1; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HAYES JP, 1992, FUNCT ECOL, V6, P5, DOI 10.2307/2389765; Hereford J, 2004, EVOLUTION, V58, P2133; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Jumbo-Lucioni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-297; Kause A, 2001, EVOLUTION, V55, P1992, DOI 10.1111/j.0014-3820.2001.tb01316.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kraft PG, 2006, J EVOLUTION BIOL, V19, P1813, DOI 10.1111/j.1420-9101.2006.01185.x; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI 10.1111/j.1558-5646.1979.tb04678.x; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lynch Michael, 1998; Malherbe Y, 2005, J EVOLUTION BIOL, V18, P811, DOI 10.1111/j.1420-9101.2004.00877.x; MCKECHNIE SW, 1984, INSECT BIOCHEM, V14, P231, DOI 10.1016/0020-1790(84)90034-9; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Miller C, 2000, DROSOPHILA MELANOGAS; Nespolo RF, 2005, EVOLUTION, V59, P1829, DOI 10.1111/j.0014-3820.2005.tb01829.x; Nespolo RF, 2007, BIOL RES, V40, P5, DOI 10.4067/S0716-97602007000100001; OAKESHOTT JG, 1985, THEOR APPL GENET, V69, P603, DOI 10.1007/BF00251111; PARSONS PA, 1979, AUST J ZOOL, V27, P747, DOI 10.1071/ZO9790747; Pecsenye K, 2004, HEREDITY, V93, P215, DOI 10.1038/sj.hdy.6800497; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rantala MJ, 2006, J EVOLUTION BIOL, V19, P834, DOI 10.1111/j.1420-9101.2005.01048.x; Revell LJ, 2007, EVOLUTION, V61, P1857, DOI 10.1111/j.1558-5646.2007.00161.x; Roff D, 2002, EVOLUTION, V56, P1286; Roff D.A., 1997, EVOLUTIONARY QUANTIT; ROFF DA, 1987, HEREDITY, V58, P103, DOI 10.1038/hdy.1987.15; Roff Derek, 2002, pi; Santos M, 2004, J EVOLUTION BIOL, V17, P841, DOI 10.1111/j.1420-9101.2004.00721.x; Schwarzenbach GA, 2006, EVOLUTION, V60, P1612, DOI 10.1111/j.0014-3820.2006.tb00506.x; Serbezov D, 2010, J EVOLUTION BIOL, V23, P1631, DOI 10.1111/j.1420-9101.2010.02028.x; Sgro CM, 2004, HEREDITY, V93, P241, DOI 10.1038/sj.hdy.6800532; Shafiei M, 2001, PHYSIOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-3032.2001.00231.x; Stanley SM, 1981, P ECOL SOC AUST, V11, P121; Statsoft Inc, 2004, STATISTICA VERS 6 1; Stearns S.C., 1992, pi; TEJEDO M, 1994, HERPETOLOGICA, V50, P113; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; ZIOLO LK, 1982, GENETICA, V57, P231, DOI 10.1007/BF00056488	54	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58920	10.1371/journal.pone.0058920	http://dx.doi.org/10.1371/journal.pone.0058920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505567	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500132
J	Longarela, OL; Schmidt, TT; Schoeneweis, K; Romeo, R; Wedemeyer, H; Urban, S; Schulze, A				Longarela, Oscar Lamas; Schmidt, Tobias T.; Schoeneweis, Katrin; Romeo, Raffaella; Wedemeyer, Heiner; Urban, Stephan; Schulze, Andreas			Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors	PLOS ONE			English	Article							LARGE SURFACE PROTEIN; B-VIRUS; INFECTION; SURAMIN; BINDING; DOMAIN; GLYCOSAMINOGLYCANS; DETERMINANTS; REPLICATION; INHIBITORS	The hepatitis delta virus (HDV) is a small, defective RNA virus that requires the presence of the hepatitis B virus (HBV) for its life cycle. Worldwide more than 15 million people are co-infected with HBV and HDV. Although much effort has been made, the early steps of the HBV/HDV entry process, including hepatocyte attachment and receptor interaction are still not fully understood. Numerous possible cellular HBV/HDV binding partners have been described over the last years; however, so far only heparan sulfate proteoglycans have been functionally confirmed as cell-associated HBV attachment factors. Recently, it has been suggested that ionotrophic purinergic receptors (P2XR) participate as receptors in HBV/HDV entry. Using the HBV/HDV susceptible HepaRG cell line and primary human hepatocytes (PHH), we here demonstrate that HDV entry into hepatocytes depends on the interaction with the glycosaminoglycan (GAG) side chains of cellular heparan sulfate proteoglycans. We furthermore provide evidence that P2XR are not involved in HBV/HDV entry and that effects observed with inhibitors for these receptors are a consequence of their negative charge. HDV infection was abrogated by soluble GAGs and other highly sulfated compounds. Enzymatic removal of defined carbohydrate structures from the cell surface using heparinase III or the obstruction of GAG synthesis by sodium chlorate inhibited HDV infection of HepaRG cells. Highly sulfated P2XR antagonists blocked HBV/HDV infection of HepaRG cells and PHH. In contrast, no effect on HBV/HDV infection was found when uncharged P2XR antagonists or agonists were applied. In summary, HDV infection, comparable to HBV infection, requires binding to the carbohydrate side chains of hepatocyte-associated heparan sulfate proteoglycans as attachment receptors, while P2XR are not actively involved.	[Longarela, Oscar Lamas; Schmidt, Tobias T.; Schoeneweis, Katrin; Urban, Stephan; Schulze, Andreas] Univ Heidelberg Hosp, Dept Infect Dis Mol Virol, Heidelberg, Germany; [Romeo, Raffaella] Univ Milan, Fdn IRCCS Cagranda Osped Maggiore Policlin, Div Gastroenterol 1, Milan, Italy; [Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Ruprecht Karls University Heidelberg; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Hannover Medical School	Urban, S (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis Mol Virol, Heidelberg, Germany.	stephan.urban@med.uni-heidelberg.de	Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973; Romeo, Raffaella/0000-0002-7858-4670; Schmidt, Tobias/0000-0002-9064-6192	Sheila Dame Postdoctoral Grant; European Association for the Study of the Liver (EASL)	Sheila Dame Postdoctoral Grant; European Association for the Study of the Liver (EASL)	Oscar Lamas was supported by a Sheila Dame Postdoctoral Grant awarded by the European Association for the Study of the Liver (EASL) (www.easl.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Jaoude G, 2005, J VIROL, V79, P10460, DOI 10.1128/JVI.79.16.10460-10644.2005; Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; BALZARINI J, 1986, INT J CANCER, V37, P451, DOI 10.1002/ijc.2910370318; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; Blanchet M, 2007, J VIROL, V81, P5841, DOI 10.1128/JVI.00096-07; Bradley HJ, 2010, FEBS LETT, V584, P4740, DOI 10.1016/j.febslet.2010.11.007; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Croon J J, 1982, Acta Leiden, V48, P5; DECLERCQ E, 1987, ANTIVIR RES, V7, P1, DOI 10.1016/0166-3542(87)90034-9; Emmett DS, 2008, HEPATOLOGY, V47, P698, DOI 10.1002/hep.22035; Engelke M, 2006, HEPATOLOGY, V43, P750, DOI 10.1002/hep.21112; Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200; Funk A, 2004, J VIROL, V78, P3977, DOI 10.1128/JVI.78.8.3977-3983.2004; Germi R, 2002, J MED VIROL, V68, P206, DOI 10.1002/jmv.10196; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; GRIPON P, 1995, VIROLOGY, V213, P292, DOI 10.1006/viro.1995.0002; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Le Duff Y, 2009, J VIROL, V83, P12443, DOI 10.1128/JVI.01594-09; Le Seyec J, 1999, J VIROL, V73, P2052, DOI 10.1128/JVI.73.3.2052-2057.1999; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Lutgehetmann M, 2012, HEPATOLOGY, V55, P685, DOI 10.1002/hep.24758; LYON M, 1994, J BIOL CHEM, V269, P11208; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; OFFENSPERGER WB, 1993, ANTIMICROB AGENTS CH, V37, P1539, DOI 10.1128/AAC.37.7.1539; PETCU DJ, 1988, VIROLOGY, V167, P385, DOI 10.1016/0042-6822(88)90099-2; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; STOW JL, 1985, J CELL BIOL, V100, P975, DOI 10.1083/jcb.100.3.975; Sureau C, 2006, CURR TOP MICROBIOL, V307, P113; Sureau C, 2013, HEPATOLOGY, V57, P985, DOI 10.1002/hep.26125; Taylor JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015784; TSIQUAYE K, 1985, J HEPATOL, V1, P663, DOI 10.1016/S0168-8278(85)80009-X; Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Wedemeyer H, 2011, LIVER INT, V31, P140, DOI 10.1111/j.1478-3231.2010.02408.x; Wilson HL, 2007, BRIT J PHARMACOL, V151, P96, DOI 10.1038/sj.bjp.0707213; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	46	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58340	10.1371/journal.pone.0058340	http://dx.doi.org/10.1371/journal.pone.0058340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505490	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500070
J	Torda, G; Schmidt-Roach, S; Peplow, LM; Lundgren, P; van Oppen, MJH				Torda, Gergely; Schmidt-Roach, Sebastian; Peplow, Lesa M.; Lundgren, Petra; van Oppen, Madeleine J. H.			A Rapid Genetic Assay for the Identification of the Most Common Pocillopora damicornis Genetic Lineages on the Great Barrier Reef	PLOS ONE			English	Article							LUNAR PERIODICITY; CORAL; SCLERACTINIA; CNIDARIA; MORPHOLOGY; SHOW	Pocillopora damicornis (Linnaeus, 1758; Scleractinia, Pocilloporidae) has recently been found to comprise at least five distinct genetic lineages in Eastern Australia, some of which likely represent cryptic species. Due to similar and plastic gross morphology of these lineages, field identification is often difficult. Here we present a quick, cost effective genetic assay as well as three novel microsatellite markers that distinguish the two most common lineages found on the Great Barrier Reef. The assay is based on PCR amplification of two regions within the mitochondrial putative control region, which show consistent and easily identifiable fragment size differences for the two genetic lineages after Alu1 restriction enzyme digestion of the amplicons.	[Torda, Gergely] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Torda, Gergely; Schmidt-Roach, Sebastian; Peplow, Lesa M.; Lundgren, Petra; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Torda, Gergely; van Oppen, Madeleine J. H.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Torda, Gergely; van Oppen, Madeleine J. H.] James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia; [Schmidt-Roach, Sebastian] Univ Tasmania, Inst Antarctic & So Ocean Studies, Hobart, Tas, Australia; [Lundgren, Petra] Great Barrier Reef Marine Pk Author, Townsville, Qld, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University; University of Tasmania	van Oppen, MJH (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	m.vanoppen@aims.gov.au	Torda, Gergely/ABE-6400-2020; Schmidt-Roach, Sebastian/N-7129-2013; Torda, Gergely/ABE-6388-2020; van Oppen, Madeleine JH/C-3261-2008	Torda, Gergely/0000-0002-4585-3045; Schmidt-Roach, Sebastian/0000-0002-7783-0198; van Oppen, Madeleine/0000-0003-4607-0744; Lundgren, Petra/0000-0002-1270-2005	Australian Government's Marine and Tropical Sciences Research Fund (MTSRF); AIMS@JCU; Australian Institute for Marine Science; James Cook University; Endeavour International Postgraduate Research Scholarship	Australian Government's Marine and Tropical Sciences Research Fund (MTSRF)(Australian Government); AIMS@JCU; Australian Institute for Marine Science; James Cook University; Endeavour International Postgraduate Research Scholarship(Australian Government)	This work has been funded by the Australian Government's Marine and Tropical Sciences Research Fund (MTSRF), and AIMS@JCU, a collaborative scheme between the Australian Institute for Marine Science and James Cook University. G.T. is supported by the James Cook University Postgraduate Research Scholarship, and both G.T. and S.S-R. are supported by an Endeavour International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, 5000 CNRS UMR; Babcock RC, 2003, ZOOL STUD, V42, P211; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; COLEMAN AW, 1994, J PHYCOL, V30, P80, DOI 10.1111/j.0022-3646.1994.00080.x; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Flot JF, 2008, CORAL REEFS, V27, P789, DOI 10.1007/s00338-008-0407-2; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harriott V.J., 1983, Coral Reefs, V2, P151, DOI 10.1007/BF00336721; Magalon H, 2004, MOL ECOL NOTES, V4, P206, DOI 10.1111/j.1471-8286.2004.00618.x; Medina M, 1999, MAR BIOTECHNOL, V1, P89, DOI 10.1007/PL00011756; Negri A, 2005, MAR POLLUT BULL, V51, P370, DOI 10.1016/j.marpolbul.2004.10.053; Nunes F, 2008, CORAL REEFS, V27, P423, DOI 10.1007/s00338-007-0349-0; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pritchard JK, 2000, GENETICS, V155, P945; RICHMOND RH, 1984, B MAR SCI, V34, P280; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Souter P, 2010, MAR BIOL, V157, P875, DOI 10.1007/s00227-009-1370-3; Starger CJ, 2008, MOL ECOL RESOUR, V8, P619, DOI 10.1111/j.1471-8286.2007.02017.x; STOBART B, 1994, MAR BIOL, V118, P183, DOI 10.1007/BF00349784; STODDART JA, 1985, MAR ECOL PROG SER, V23, P153, DOI 10.3354/meps023153; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veron J.J., 1976, SCLERACTINIA E AUS 1; WARD S, 1992, MAR BIOL, V112, P641, DOI 10.1007/BF00346182; WILLIS BL, 1985, P 5 INT COR REEF S, V4, P107; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0	31	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58447	10.1371/journal.pone.0058447	http://dx.doi.org/10.1371/journal.pone.0058447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505507	Green Published, Green Accepted, gold			2022-12-25	WOS:000318334500084
J	Esslinger, C; Braun, U; Schirmbeck, F; Santos, A; Meyer-Lindenberg, A; Zink, M; Kirsch, P				Esslinger, Christine; Braun, Urs; Schirmbeck, Frederike; Santos, Andreia; Meyer-Lindenberg, Andreas; Zink, Mathias; Kirsch, Peter			Activation of Midbrain and Ventral Striatal Regions Implicates Salience Processing during a Modified Beads Task	PLOS ONE			English	Article							REWARD PREDICTION; DECISION-MAKING; LINKING BIOLOGY; SCHIZOPHRENIA; DELUSIONS; PSYCHOSIS; METACOGNITION; CONCLUSIONS; FMRI; PHENOMENOLOGY	Introduction: Metacognition, i.e. critically reflecting on and monitoring one's own reasoning, has been linked behaviorally to the emergence of delusions and is a focus of cognitive therapy in patients with schizophrenia. However, little is known about the neural processing underlying metacognitive function. To address this issue, we studied brain activity during a modified beads task which has been used to measure a "Jumping to Conclusions'' (JTC) bias in schizophrenia patients. Methods: We used functional magnetic resonance imaging to identify neural systems active in twenty-five healthy subjects when solving a modified version of the "beads task'', which requires a probabilistic decision after a variable amount of data has been requested by the participants. We assessed brain activation over the duration of a trial and at the time point of decision making. Results: Analysis of activation during the whole process of probabilistic reasoning showed an extended network including the prefronto-parietal executive functioning network as well as medial parieto-occipital regions. During the decision process alone, activity in midbrain and ventral striatum was detected, as well as in thalamus, medial occipital cortex and anterior insula. Conclusions: Our data show that probabilistic reasoning shares neural substrates with executive functions. In addition, our finding that brain regions commonly associated with salience processing are active during probabilistic reasoning identifies a candidate mechanism that could underlie the behavioral link between dopamine-dependent aberrant salience and JTC in schizophrenia. Further studies with delusional schizophrenia patients will have to be performed to substantiate this link.	[Esslinger, Christine; Braun, Urs; Schirmbeck, Frederike; Santos, Andreia; Meyer-Lindenberg, Andreas; Zink, Mathias; Kirsch, Peter] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Kirsch, Peter] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Clin Psychol, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Esslinger, C (corresponding author), Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany.	christine.esslinger@web.de	Schirmbeck, Frederike/G-8187-2016; Braun, Urs/AAS-8631-2021; Kirsch, Peter/C-2499-2008; Meyer-Lindenberg, Andreas/H-1076-2011	Kirsch, Peter/0000-0002-0817-1248; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Schirmbeck, Frederike/0000-0003-1700-0958	Deutsche Forschungsgesellschaft (DFG); Fyssen foundation (France); Deutsche Forschungsgesellschaft (DFG) [1253/3-1]	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); Fyssen foundation (France); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG))	C.E. was funded by the Deutsche Forschungsgesellschaft (DFG, http://www.dfg.de, Sonderforschungsbereich (SFB) 636, subproject B7). A.S. was supported by the Fyssen foundation (France www.fondationfyssen.fr). M.Z., A.M.-L., and P.K. were funded by the Deutsche Forschungsgesellschaft (DFG, http://www.dfg.de, project 1253/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck BB, 2011, SCHIZOPHR RES, V127, P115, DOI 10.1016/j.schres.2010.08.009; Baker CA, 1998, PSYCHOL MED, V28, P1199, DOI 10.1017/S0033291798007314; Bell V, 2006, TRENDS COGN SCI, V10, P219, DOI 10.1016/j.tics.2006.03.004; Blackwood N, 2004, COGNITIVE BRAIN RES, V20, P46, DOI 10.1016/j.cogbrainres.2003.12.009; Buck KD, 2012, PSYCHOPATHOLOGY, V45, P271, DOI 10.1159/000330892; Dudley REJ, 1997, BRIT J CLIN PSYCHOL, V36, P243, DOI 10.1111/j.2044-8260.1997.tb01410.x; Duvernoy H, 1995, HUMAN BRAINSTEM CERE; Fine Cordelia, 2007, Cogn Neuropsychiatry, V12, P46, DOI 10.1080/13546800600750597; Flavell J H, 1970, Adv Child Dev Behav, V5, P181, DOI 10.1016/S0065-2407(08)60467-X; Furl N, 2011, J NEUROSCI, V31, P17572, DOI 10.1523/JNEUROSCI.4236-11.2011; Garety PA, 2005, J ABNORM PSYCHOL, V114, P373, DOI 10.1037/0021-843X.114.3.373; Guitart-Masip M, 2010, J NEUROSCI, V30, P1721, DOI 10.1523/JNEUROSCI.5331-09.2010; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; HEMSLEY DR, 1986, BRIT J PSYCHIAT, V149, P51, DOI 10.1192/bjp.149.1.51; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Jensen J, 2009, PSYCHOL MED, V39, P197, DOI 10.1017/S0033291708003899; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Kapur S, 2005, SCHIZOPHR RES, V79, P59, DOI 10.1016/j.schres.2005.01.003; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lincoln TM, 2010, SCHIZOPHRENIA BULL, V36, P1140, DOI 10.1093/schbul/sbp029; Lysaker PH, 2008, J NERV MENT DIS, V196, P384, DOI 10.1097/NMD.0b013e3181710916; Lysaker PH, 2009, SCHIZOPHRENIA RES; Menon Mahesh, 2006, Cogn Neuropsychiatry, V11, P521, DOI 10.1080/13546800544000046; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Moritz S, 2005, BRIT J CLIN PSYCHOL, V44, P193, DOI 10.1348/014466505X35678; Moritz Steffen, 2006, Curr Psychiatry Rep, V8, P184, DOI 10.1007/s11920-006-0022-2; Moritz S, 2007, COGNITIVE THER RES, V31, P371, DOI 10.1007/s10608-006-9070-5; Moritz S, 2007, CURR OPIN PSYCHIATR, V20, P619, DOI 10.1097/YCO.0b013e3282f0b8ed; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Pohlack ST, 2012, BIOL PSYCHOL, V91, P74, DOI 10.1016/j.biopsycho.2012.04.004; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Speechley WJ, 2010, J PSYCHIATR NEUROSCI, V35, P7, DOI 10.1503/jpn.090025; Stratta P, 2009, SCHIZOPHR RES, V108, P301, DOI 10.1016/j.schres.2008.10.005; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Woodward TS, 2009, PSYCHIAT RES, V170, P119, DOI 10.1016/j.psychres.2008.10.018; Woodward TS, 2009, PSYCHIAT RES, V170, P124, DOI 10.1016/j.psychres.2008.10.020; Ziegler M, 2008, PSYCHOL PSYCHOTHER-T, V81, P237, DOI 10.1348/147608308X297104; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7; Zink CF, 2003, J NEUROSCI, V23, P8092	47	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58536	10.1371/journal.pone.0058536	http://dx.doi.org/10.1371/journal.pone.0058536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484034	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100122
J	Goto, M; Morita, A; Goto, A; Deura, K; Sasaki, S; Aiba, N; Shimbo, T; Terauchi, Y; Miyachi, M; Noda, M; Watanabe, S				Goto, Maki; Morita, Akemi; Goto, Atsushi; Deura, Kijo; Sasaki, Satoshi; Aiba, Naomi; Shimbo, Takuro; Terauchi, Yasuo; Miyachi, Motohiko; Noda, Mitsuhiko; Watanabe, Shaw		SCOP Study Grp	Reduction in Adiposity, beta-Cell Function, Insulin Sensitivity, and Cardiovascular Risk Factors: A Prospective Study among Japanese with Obesity	PLOS ONE			English	Article							MILD GLUCOSE-INTOLERANCE; CORONARY-HEART-DISEASE; DIABETES-MELLITUS; VISCERAL FAT; WEIGHT-LOSS; MEN; TOLERANCE; RESISTANCE; SECRETION; DIAGNOSIS	Background: A reduction in adiposity may be associated with an improvement in insulin sensitivity and beta-cell function as well as cardiovascular disease (CVD) risk factors; however, few studies have investigated these associations in a longitudinal setting. Methods: To investigate these associations over a 1-year period, we conducted an observational analysis of 196 Japanese subjects with obesity in the Saku Control Obesity Program. We investigated the relations between changes in adiposity (body mass index [BMI], waist circumference, subcutaneous fat area [SFAT], and visceral fat area [VFAT]) and changes in HbA1c, fasting plasma glucose (FPG), insulin sensitivity index (ISI), the homeostasis model assessment beta cell function (HOMA-beta), lipids, and blood pressure. Results: All adiposity changes were positively associated with HbA1c and FPG changes. Reductions in BMI and VFAT were associated with HOMA-beta reduction. Reductions in all adiposity measures were associated with an improvement in the ISI. Changes in most adiposity measures were positively associated with changes in blood pressure and lipid levels, except for LDL. Conclusion: The present findings provide additional supportive evidence indicating that a reduction in adiposity may lead to an improvement in insulin sensitivity and the reduction of CVD risk factors in obese individuals.	[Goto, Maki; Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan; [Goto, Maki; Goto, Atsushi; Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan; [Goto, Maki; Morita, Akemi; Goto, Atsushi; Miyachi, Motohiko; Watanabe, Shaw] Natl Inst Hlth & Nutr, Tokyo 162, Japan; [Morita, Akemi] Koshien Univ, Coll Nutr, Dept Nutr, Hyogo, Japan; [Deura, Kijo] Saku Cent Hosp, Nagano, Japan; [Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Aiba, Naomi] Kanagawa Inst Technol, Dept Nutr & Life Sci, Kanagawa, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Tokyo, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Diabet & Metab Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Yokohama City University; National Institute of Health & Nutrition - Japan; University of Tokyo; Kanagawa Institute Technology; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Noda, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan.	mnoda@hosp.ncgm.go.jp	Noda, Mitsuhiko/W-3905-2019; Miyachi, Motohiko/AAW-3403-2020; Terauchi, Yasuo/AAO-4347-2020	Noda, Mitsuhiko/0000-0003-0413-4631; Miyachi, Motohiko/0000-0002-1146-0905; Goto, Atsushi/0000-0003-0669-654X				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albu JB, 1997, DIABETES, V46, P456, DOI 10.2337/diabetes.46.3.456; Carr DB, 2005, DIABETES, V54, P340, DOI 10.2337/diabetes.54.2.340; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; DONAHUE RP, 1987, LANCET, V1, P821; FUJIMOTO WY, 1990, AM J MED, V89, P761, DOI 10.1016/0002-9343(90)90219-4; Goncalves FB, 2011, LANCET, V378, P227, DOI 10.1016/S0140-6736(11)61121-5; Hayashi T, 2008, DIABETES, V57, P1269, DOI 10.2337/db07-1378; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Kosaka K, 1996, DIABETIC MED, V13, pS109; KOSAKA K, 1977, DIABETES, V26, P944, DOI 10.2337/diab.26.10.944; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; Matsushita Y, 2012, DIABETES CARE, V35, P1139, DOI 10.2337/dc11-1320; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morita A, 2008, ANTIAGING MED, V5, P13, DOI 10.3793/jaam.5.13; Nakade M, 2012, ASIA PAC J CLIN NUTR, V21, P22; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tanaka T, 2011, ENDOCRINE J; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wareham N J, 1995, Diabet Med, V12, P931; Watanabe S, 2007, ANTIAGING MED, V4, P70; White WB, 2001, BLOOD PRESS MONIT, V6, P107, DOI 10.1097/00126097-200104000-00007; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; YONEDA H, 1992, DIABETES CARE, V15, P1517, DOI 10.2337/diacare.15.11.1517	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57964	10.1371/journal.pone.0057964	http://dx.doi.org/10.1371/journal.pone.0057964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483954	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100060
J	Hermes, R; Saragusty, J; Goritz, F; Bartels, P; Potier, R; Baker, B; Streich, WJ; Hildebrandt, TB				Hermes, Robert; Saragusty, Joseph; Goeritz, Frank; Bartels, Paul; Potier, Romain; Baker, Barbara; Streich, W. Juergen; Hildebrandt, Thomas B.			Freezing African Elephant Semen as a New Population Management Tool	PLOS ONE			English	Article							SUCCESSFUL ARTIFICIAL-INSEMINATION; FROZEN-THAWED SEMEN; ASIAN ELEPHANT; MAXIMUS SPERMATOZOA; LOXODONTA-AFRICANA; GENETIC DIVERSITY; VIABILITY; BEHAVIOR; MUSTH; CRYOPRESERVATION	Background: The captive elephant population is not self-sustaining and with a limited number of breeding bulls, its genetic diversity is in decline. One way to overcome this is to import young and healthy animals from the wild. We introduce here a more sustainable alternative method - importation of semen from wild bulls without removing them from their natural habitat. Due to the logistics involved, the only practical option would be to transport cryopreserved sperm. Despite some early reports on African elephant semen cryopreservation, the utility of this new population management tool has not been evaluated. Methodology/Principal Findings: Semen was collected by electroejaculation from 14 wild African savanna elephant (Loxodonta africana) bulls and cryopreserved using the directional freezing technique. Sperm treatments evaluated included the need for centrifugation, the use of hen or quail yolk, the concentration of glycerol (3%, 5% or 7%) in the extender, and maintenance of motility over time after thawing. Our results suggest that dilution in an extender containing hen yolk and 7% glycerol after centrifugation best preserved post-thaw sperm motility when compared to all other treatments (P <= 0.012 for all). Using this approach we were able to achieve after thawing (mean +/- SD) 54.6 +/- 3.9% motility, 85.3 +/- 2.4% acrosome integrity, and 86.8 +/- 4.6% normal morphology with no decrease in motility over 1 h incubation at 37 degrees C. Sperm cryopreserved during this study has already lead to a pregnancy of a captive female elephant following artificial insemination. Conclusions/Significance: With working techniques for artificial insemination and sperm cryopreservation of both African and Asian elephants in hand, population managers can now enrich captive or isolated wild elephant populations without removing valuable individuals from their natural habitat.	[Hermes, Robert; Saragusty, Joseph; Goeritz, Frank; Streich, W. Juergen; Hildebrandt, Thomas B.] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Bartels, Paul] Natl Res Fdn, NZG Biobank, Natl Zool Gardens South Africa, Pretoria, South Africa; [Potier, Romain] ZooParc Beauval, St Aignan Sur Cher, France; [Baker, Barbara] Pittsburgh Zoo & PPG Aquarium, Pittsburgh, PA USA	Leibniz Institut fur Zoo und Wildtierforschung; National Research Foundation - South Africa; National Zoological Gardens of South Africa	Hermes, R (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	hermes@izw-berlin.de	Saragusty, Joseph/M-5030-2016; Moreira, Nei/AAK-1357-2020	Saragusty, Joseph/0000-0002-9274-7800; Moreira, Nei/0000-0002-9236-667X	Association Beauval Conservation et Recherche (ABCR); Pittsburgh Zoo; PPG Aquarium; One Wild Place, Pittsburgh, PA, USA; Riverview Homes, Inc.	Association Beauval Conservation et Recherche (ABCR); Pittsburgh Zoo; PPG Aquarium; One Wild Place, Pittsburgh, PA, USA; Riverview Homes, Inc.	This study was funded by three entities: (1) The Association Beauval Conservation et Recherche (ABCR) which is the non-profit conservation organization adjunct to ZooParc de Beauval, 41110 Saint Aignan s/Cher, France; (2) The Pittsburgh Zoo and PPG Aquarium (also a non-profit organization), One Wild Place, Pittsburgh, PA 15206-1178, USA; and (3) Robert and Kim Fanelli of Riverview Homes, Inc., 2623 River Road, Vandergrift, PA 15690-0475, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors' therefore believe that these facts do not alter their adherence to all the PLOS ONE policies on sharing data and materials.; This study was partly supported by Riverview Homes, Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. One of the authors of this report (RP) is employed by ZooParc de Beauval and not by its financing arm (ABCR), and another (BB) is the president and CEO of the Pittsburgh Zoo.	Bal P, 2011, ENVIRON MANAGE, V47, P789, DOI 10.1007/s00267-011-9636-1; BALLOU JD, 1992, CRYOBIOLOGY, V29, P19, DOI 10.1016/0011-2240(92)90003-K; Belterman R, 2011, EUROPEAN REGIONAL EA; BLOTTNER S, 1995, THERIOGENOLOGY, V44, P321, DOI 10.1016/0093-691X(95)00187-D; BLOTTNER S, 1998, ADV ETHOL S, V33, P9; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Brown JL, 1999, BIOL REPROD, V61, P1294, DOI 10.1095/biolreprod61.5.1294; Brown JL, 2004, ZOO BIOL, V23, P45, DOI 10.1002/zoo.10116; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; Darwin G., 1871, P423; EISENBERG JF, 1971, BEHAVIOUR, V38, P193, DOI 10.1163/156853971X00087; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; Faust LJ, 2006, ZOO BIOL, V25, P201, DOI 10.1002/zoo.20054; Goeritz F, 2003, THERIOGENOLOGY, V59, P1487, DOI 10.1016/S0093-691X(02)01201-3; HANKS J, 1973, J ZOOL, V169, P29; Hermes R, 2009, THERIOGENOLOGY, V71, P393, DOI 10.1016/j.theriogenology.2008.10.008; Hildebrandt T. B., 2006, International Zoo Yearbook, V40, P20, DOI 10.1111/j.1748-1090.2006.00020.x; Hildebrandt TB, 2012, THERIOGENOLOGY, V78, P1398, DOI 10.1016/j.theriogenology.2012.06.014; Hildebrandt TB, 2009, THERIOGENOLOGY, V72, P1065, DOI 10.1016/j.theriogenology.2009.06.026; Hildebrandt TB, 1999, SUCCESSFUL ARTIFICIA, P41; Hildebrandt TB, 1998, ARTIFICIAL INSEMINAT, P546; Hodges JK, 1998, ANIM REPROD SCI, V53, P3, DOI 10.1016/S0378-4320(98)00123-7; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; HOWARD JG, 1986, J REPROD FERTIL, V78, P295, DOI 10.1530/jrf.0.0780295; Howard JG, 2002, GENOME RESOURCE BANK, V70; JONES RC, 1973, NATURE, V243, P38, DOI 10.1038/243038a0; Kapustin N, 1996, BIOL REPROD, V55, P1147, DOI 10.1095/biolreprod55.5.1147; KEELE M., 2010, ASIAN ELEPHANT ELEPH; Kiso WK, 2012, REPROD FERT DEVELOP, V24, P1134, DOI 10.1071/RD11266; Kutvolgyi G, 2006, BIOTECH HISTOCHEM, V81, P109, DOI 10.1080/10520290600931007; Laws R. M., 1969, Journal of Reproduction and Fertility Suppl, VNo. 6, P193; Lei R, 2008, J ZOOL, V275, P252, DOI 10.1111/j.1469-7998.2008.00437.x; Leimgruber P, 2008, ANIM CONSERV, V11, P198, DOI 10.1111/j.1469-1795.2008.00172.x; Mpanduji Donald G., 2003, Pachyderm, V35, P140; Olson D., 2011, N AM REGION STUDBOOK; Oswin perera B.M.A., 2009, Gajah, V30, P41; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; SANTIAPILLAI C, 1984, BIOL CONSERV, V29, P47, DOI 10.1016/0006-3207(84)90013-2; Saragusty J, 2010, THERIOGENOLOGY, V74, P1256, DOI 10.1016/j.theriogenology.2010.05.031; Saragusty J, 2006, THERIOGENOLOGY, V66, P775, DOI 10.1016/j.theriogenology.2006.01.055; Saragusty J, 2009, ANIM REPROD SCI, V115, P255, DOI 10.1016/j.anireprosci.2008.11.010; Schmitt DL, 1998, ANIM REPROD SCI, V53, P309, DOI 10.1016/S0378-4320(98)00120-1; Schulte BA, 2000, ZOO BIOL, V19, P447, DOI 10.1002/1098-2361(2000)19:5&lt;447::AID-ZOO12&gt;3.0.CO;2-#; Schwammer HM, 2011, AFRICAN ELEPHANT EEP; Stoops MA, 2011, THERIOGENOLOGY, V76, P1258, DOI 10.1016/j.theriogenology.2011.05.032; Stoops MA, 2011, J ZOO WILDLIFE MED, V42, P723, DOI 10.1638/2010-0186.1; Thongtip N, 2004, THERIOGENOLOGY, V62, P748, DOI 10.1016/j.theriogenology.2003.11.021; Thongtip N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-9; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z	51	28	31	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57616	10.1371/journal.pone.0057616	http://dx.doi.org/10.1371/journal.pone.0057616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483917	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100033
J	Narendra, A; Reid, SF; Raderschall, CA				Narendra, Ajay; Reid, Samuel F.; Raderschall, Chloe A.			Navigational Efficiency of Nocturnal Myrmecia Ants Suffers at Low Light Levels	PLOS ONE			English	Article							AUSTRALIAN DESERT ANT; ACTIVITY SCHEDULES; VISUAL NAVIGATION; VISION; NIGHT; ADAPTATIONS; FLIGHT; ORIENTATION; INFORMATION; BEHAVIOR	Insects face the challenge of navigating to specific goals in both bright sun-lit and dim-lit environments. Both diurnal and nocturnal insects use quite similar navigation strategies. This is despite the signal-to-noise ratio of the navigational cues being poor at low light conditions. To better understand the evolution of nocturnal life, we investigated the navigational efficiency of a nocturnal ant, Myrmecia pyriformis, at different light levels. Workers of M. pyriformis leave the nest individually in a narrow light-window in the evening twilight to forage on nest-specific Eucalyptus trees. The majority of foragers return to the nest in the morning twilight, while few attempt to return to the nest throughout the night. We found that as light levels dropped, ants paused for longer, walked more slowly, the success in finding the nest reduced and their paths became less straight. We found that in both bright and dark conditions ants relied predominantly on visual landmark information for navigation and that landmark guidance became less reliable at low light conditions. It is perhaps due to the poor navigational efficiency at low light levels that the majority of foragers restrict navigational tasks to the twilight periods, where sufficient navigational information is still available.	[Narendra, Ajay; Reid, Samuel F.; Raderschall, Chloe A.] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Res Sch Biol, Canberra, ACT, Australia; [Reid, Samuel F.] Ctr Genom Regulat, EMBL CRG Syst Biol Unit, Barcelona, Spain	Australian National University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Narendra, A (corresponding author), Australian Natl Univ, ARC Ctr Excellence Vis Sci, Res Sch Biol, Canberra, ACT, Australia.	ajay.narendra@anu.edu.au	Raderschall, Chloe/AFH-9100-2022; Narendra, Ajay/A-4960-2008	Raderschall, Chloe/0000-0003-2005-1705; Narendra, Ajay/0000-0002-1286-5373	Australian Research Council's (ARC) Centres of Excellence Scheme; ARC Discovery Project; Australian Postdoctoral Fellowship [DP0986606]; ARC Discovery Early Career Award [DE120100019]; Hermon Slade Foundation; Defence Science and Technology Organization	Australian Research Council's (ARC) Centres of Excellence Scheme(Australian Research Council); ARC Discovery Project(Australian Research Council); Australian Postdoctoral Fellowship; ARC Discovery Early Career Award(Australian Research Council); Hermon Slade Foundation; Defence Science and Technology Organization	AN acknowledges funding support from the Australian Research Council's (ARC) Centres of Excellence Scheme, ARC Discovery Project and Australian Postdoctoral Fellowship (DP0986606), ARC Discovery Early Career Award (DE120100019), Hermon Slade Foundation and The Defence Science and Technology Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2002, J EXP BIOL, V205, P1971; [Anonymous], 2008, R LANG ENV STAT COMP, P1; Baird E, 2011, BIOL LETTERS, V7, P499, DOI 10.1098/rsbl.2010.1205; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Cheung A, 2007, BIOL CYBERN, V97, P47, DOI 10.1007/s00422-007-0158-0; Dacke M, 2011, PHILOS T R SOC B, V366, P697, DOI 10.1098/rstb.2010.0191; Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Frederiksen R, 2008, CURR BIOL, V18, P349, DOI 10.1016/j.cub.2008.01.057; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Greiner B, 2005, CELL TISSUE RES, V322, P313, DOI 10.1007/s00441-005-0034-y; Greiner B, 2004, CELL TISSUE RES, V318, P429, DOI 10.1007/s00441-004-0945-z; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; Greiner B, 2007, CURR BIOL, V17, pR879, DOI 10.1016/j.cub.2007.08.015; Greiner B, 2006, INT REV CYTOL, V250, P1, DOI 10.1016/S0074-7696(06)50001-4; Heatwole H, 1996, ENERGETICS DESERT IN; Jayatilaka P, 2011, J EXP BIOL, V214, P2730, DOI 10.1242/jeb.053710; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Jonson ACJ, 1998, J COMP PHYSIOL A, V182, P1, DOI 10.1007/s003590050152; Kelber A, 2006, J EXP BIOL, V209, P781, DOI 10.1242/jeb.02060; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Land MF, 2002, ANIMAL EYES; McIntyre P, 1998, J COMP PHYSIOL A, V183, P45, DOI 10.1007/s003590050233; Merlin C, 2012, CURR OPIN NEUROBIOL, V22, P353, DOI 10.1016/j.conb.2011.11.009; Moser JC, 2004, J ZOOL, V264, P69, DOI 10.1017/S0952836904005527; Narendra A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1543, DOI 10.1007/s00265-007-0386-2; Narendra A, 2011, P ROY SOC B-BIOL SCI, V278, P1141, DOI 10.1098/rspb.2010.1378; Narendra A, 2010, P ROY SOC B-BIOL SCI, V277, P1531, DOI 10.1098/rspb.2009.2324; Norgaard T, 2008, J EXP BIOL, V211, P816, DOI 10.1242/jeb.010546; Reid SF, 2011, J EXP BIOL, V214, P363, DOI 10.1242/jeb.049338; Reid SF, 2010, THESIS AUSTR NATL U; ROSSEL S, 1986, NATURE, V323, P128, DOI 10.1038/323128a0; Schwarz S, 2011, ARTHROPOD STRUCT DEV, V40, P128, DOI 10.1016/j.asd.2010.10.003; Somanathan H, 2008, CURR BIOL, V18, pR996, DOI 10.1016/j.cub.2008.08.023; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Theobald JC, 2007, J EXP BIOL, V210, P4034, DOI 10.1242/jeb.003756; Wajnberg E, 2010, J R SOC INTERFACE, V7, pS207, DOI 10.1098/rsif.2009.0526.focus; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Warrant EJ, 2008, J EXP BIOL, V211, P1737, DOI 10.1242/jeb.015396; WEHNER R, 1989, TRENDS NEUROSCI, V12, P353, DOI 10.1016/0166-2236(89)90043-X; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912	43	32	33	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58801	10.1371/journal.pone.0058801	http://dx.doi.org/10.1371/journal.pone.0058801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484052	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100138
J	Yau, WL; Lam, CSC; Ng, L; Chow, AKM; Chan, STC; Chan, JYK; Wo, JYH; Ng, KTP; Man, K; Poon, RTP; Pang, RWC				Yau, Wing Lung; Lam, Colin Siu Chi; Ng, Lui; Chow, Ariel Ka Man; Chan, Sylvia Tsz Ching; Chan, Jacky Yu Ki; Wo, Jana Yim Hung; Ng, Kevin Tak Pan; Man, Kwan; Poon, Ronnie Tung Ping; Pang, Roberta Wen Chi			Over-Expression of miR-106b Promotes Cell Migration and Metastasis in Hepatocellular Carcinoma by Activating Epithelial-Mesenchymal Transition Process	PLOS ONE			English	Article							MICRORNA EXPRESSION; RHO GTPASES; CANCER; HEPATITIS; INVASION; MIR-21; IDENTIFICATION; CLUSTER; FAMILY; MODEL	Hepatocellular carcinoma (HCC) is one the the most fatal cancers worldwide. The poor prognosis of HCC is mainly due to the developement of distance metastasis. To investigate the mechanism of metastasis in HCC, an orthotopic HCC metastasis animal model was established. Two sets of primary liver tumor cell lines and corresponding lung metastasis cell lines were generated. In vitro functional analysis demonstrated that the metastatic cell line had higher invasion and migration ability when compared with the primary liver tumor cell line. These cell lines were subjected to microRNA (miRNAs) microarray analysis to identify differentially expressed miRNAs which were associated with the developement of metastasis in vivo. Fifteen human miRNAs, including miR-106b, were differentially expressed in 2 metastatic cell lines compared with the primary tumor cell lines. The clinical significance of miR-106b in 99 HCC clinical samples was studied. The results demonstrated that miR-106b was over-expressed in HCC tumor tissue compared with adjacent non-tumor tissue (p = 0.0005), and overexpression of miR-106b was signficantly correlated with higher tumor grade (p = 0.018). Further functional studies demonstrated that miR-106b could promote cell migration and stress fiber formation by over-expressing RhoGTPases, RhoA and RhoC. In vivo functional studies also showed that over-expression of miR-106b promoted HCC metastasis. These effects were related to the activation of the epithelial-mesenchymal transition (EMT) process. Our results suggested that miR-106b expression contributed to HCC metastasis by activating the EMT process promoting cell migration in vitro and metastasis in vivo.	[Yau, Wing Lung; Lam, Colin Siu Chi; Ng, Lui; Chow, Ariel Ka Man; Chan, Sylvia Tsz Ching; Chan, Jacky Yu Ki; Wo, Jana Yim Hung; Ng, Kevin Tak Pan; Man, Kwan; Poon, Ronnie Tung Ping; Pang, Roberta Wen Chi] Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Yau, Wing Lung; Lam, Colin Siu Chi; Ng, Lui; Chow, Ariel Ka Man; Chan, Sylvia Tsz Ching; Chan, Jacky Yu Ki; Ng, Kevin Tak Pan; Man, Kwan; Poon, Ronnie Tung Ping; Pang, Roberta Wen Chi] Univ Hong Kong, Ctr Canc Res, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yau, WL (corresponding author), Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	robertap@hku.hk	Chow, Ariel/HGF-2363-2022; NG, Kevin Tak-Pan/J-1510-2018; Ng, Lui/AAG-4397-2019	NG, Kevin Tak-Pan/0000-0001-9822-1335; Ng, Lui/0000-0002-9010-2654; Chow, Ariel/0000-0002-5729-5415				Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Brown JJ, 2000, HEPATOLOGY, V31, P173, DOI 10.1002/hep.510310126; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; FIDLER IJ, 1995, J NATL CANCER I, V87, P1588, DOI 10.1093/jnci/87.21.1588; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Lee TK, 2006, CLIN CANCER RES, V12, P6910, DOI 10.1158/1078-0432.CCR-06-0489; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Poon Ronnie Tung-Ping, 2004, Liver Transpl, V10, pS39, DOI 10.1002/lt.20040; Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Ziske C, 2008, PANCREAS, V36, P146, DOI 10.1097/MPA.0b013e3181586cd9	27	82	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57882	10.1371/journal.pone.0057882	http://dx.doi.org/10.1371/journal.pone.0057882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483935	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100051
J	Longo, G; Trovato, M; Mazzei, V; Ferrante, M; Conti, GO				Longo, Guglielmo; Trovato, Michelanna; Mazzei, Veronica; Ferrante, Margherita; Conti, Gea Oliveri			Ligia italica (Isopoda, Oniscidea) as Bioindicator of Mercury Pollution of Marine Rocky Coasts	PLOS ONE			English	Article							GULF-OF-TRIESTE; PORCELLIO-SCABER; HEAVY-METALS; HEPATOPANCREAS; CONTAMINATION; BIOMARKERS; BIOACCUMULATION; ULTRASTRUCTURE; LOCALIZATION; INDICATORS	In this study, we evaluated the possible role of Ligia italica as a bioindicator for the monitoring of heavy metals pollution in the suppralittoral zone of marine rocky coasts. Between 2004 and 2011 specimens of L. italica were collected along the Eastern Sicilian coasts from sites known for their high pollution levels as they are near to an area where in September 2001 a refinery plant discharged into the sea some waste containing Hg. Other specimens were collected from the Vendicari Natural Reserve located about 30 miles from the polluted sites and used as control area. On a consistent number of animals, the concentration in toto of As, Cd, Cr, Hg, Ni, Pb, V, was determined by Atomic Absorption Spectrometry. On other animals, investigations were carried out in order to check for ultrastructural alterations of the hepatopancreas, that is the main metals storage organ in isopods. Results revealed the presence, in the animals collected in 2004 from the polluted sites, of considerable concentrations of Hg and of lower concentrations of other metals such as As, Pb and V. The Hg bioaccumulation resulted in remarkable ultrastructural alterations of the two cellular types (B and S cells) in the epithelium of the hepatopancreas. Surprisingly, a moderate amount of Hg was also found in specimens collected in 2004 from the Vendicari Natural Reserve, proving that the Hg pollution can also spread many miles away. Animals collected from the polluted sites in the following years showed a progressively decreasing Hg content, reaching very low levels in those from the last sampling. Also, the ultrastructural alterations found in the hepatopancreas of the animals from the last sample were quite irrelevant. In conclusion, Ligia italica can represent a good bioindicator and the ultrastructure of the hepatopancreas could be used as ultrastructural biomarker of heavy metals pollution in the supralittoral zones.	[Longo, Guglielmo; Trovato, Michelanna; Mazzei, Veronica] Univ Catania, Dipartimento Sci Biol Geol & Ambientali, Catania, Italy; [Ferrante, Margherita; Conti, Gea Oliveri] Univ Catania, Dipartimento Anat Biol & Genet Med Legale Neurosc, Catania, Italy	University of Catania; University of Catania	Ferrante, M (corresponding author), Univ Catania, Dipartimento Anat Biol & Genet Med Legale Neurosc, Catania, Italy.	marfer@unict.it	Oliveri Conti, Gea/N-4034-2016; Ferrante, Margherita/B-2781-2011	Ferrante, Margherita/0000-0001-7596-2464; Oliveri Conti, Gea/0000-0003-1857-8612				ANDERSEN JT, 1988, AQUAT TOXICOL, V13, P309; [Anonymous], 1987, ENVIRON HEALTH PERSP, V74, P3; Bazairi H, 2010, MEDITERRANEAN SEA BI, P1; Belashov E, 1998, METAL IONS BIOL MED, V5, P317; Besse G, 1976, THESIS U POITIERS; Bianca S, 2003, REPROD TOXICOL, V17, P539, DOI 10.1016/S0890-6238(03)00099-6; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bianchi Fabrizio, 2004, Epidemiol Prev, V28, P87; Boero F, 2003, STATE KNOWLEDGE MARI; Braeckman B, 1999, TISSUE CELL, V31, P223, DOI 10.1054/tice.1999.0021; Carefoot Thomas H., 1995, Crustacean Issues, V9, P47; CLIFFORD B, 1971, J MORPHOL, V135, P335, DOI 10.1002/jmor.1051350307; Conti GO, 2012, B ENVIRON CONTAM TOX, V88, P946, DOI 10.1007/s00128-012-0611-1; Copat C, 2012, ECOTOX ENVIRON SAFE, V86, P31, DOI 10.1016/j.ecoenv.2012.09.006; Copat C, 2012, J ENVIRON MONITOR, V14, P187, DOI 10.1039/c1em10575b; Covelli S, 2001, APPL GEOCHEM, V16, P541, DOI 10.1016/S0883-2927(00)00042-1; DALLINGER R, 1992, OECOLOGIA, V89, P32, DOI 10.1007/BF00319012; De Domenico E, 2011, AQUAT TOXICOL, V105, P688, DOI 10.1016/j.aquatox.2011.08.026; Di Leonardo R, 2007, SCI TOTAL ENVIRON, V388, P168, DOI 10.1016/j.scitotenv.2007.08.009; Faganeli J, 2003, SCI TOTAL ENVIRON, V304, P315, DOI 10.1016/S0048-9697(02)00578-8; Fitzgerald WF, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P107; Hopkin S.P., 1989, MONIT ZOOL ITAL MONO, V4, P477; HOPKIN SP, 1986, ENVIRON POLLUT B, V11, P271, DOI 10.1016/0143-148X(86)90045-5; Hunsaker CN, 1990, EPA6003060; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; ISERENTANT R, 1976, Memoires de la Societe Royale de Botanique de Belgique, V7, P15; Kohler HR, 1996, APPL SOIL ECOL, V3, P1, DOI 10.1016/0929-1393(95)00073-9; Kouba A, 2010, WATER AIR SOIL POLL, V211, P5, DOI 10.1007/s11270-009-0273-8; Marigomez I, 1996, ARCH ENVIRON CON TOX, V31, P54, DOI 10.1007/BF00203907; Martin M.H., 1982, BIOL MONITORING HEAV; Mazzariol S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019417; Nicosia E, 2007, ATT GIORN GEOGR RISC; Paoletti MG, 1999, AGR ECOSYST ENVIRON, V74, P157, DOI 10.1016/S0167-8809(99)00035-3; RAES H, 1991, PROG HISTOCHEM CYTOC, V23, P316; Ramistella EM, 1990, B ACC GIOENIA SCI NA, V23, P437; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; SATO T, 1973, STAIN TECHNOL, V48, P223, DOI 10.3109/10520297309116628; Sciacca S, 2009, MEDITERR J NUTR META, V2, P157, DOI 10.1007/s12349-009-0052-5; Souty-Grosset C, 2005, EUR J SOIL BIOL, V41, P109, DOI 10.1016/j.ejsobi.2005.09.009; STORCH V, 1980, ZOOL ANZ, V204, P137; Storch V., 1984, Symposia of the Zoological Society of London, P167; STORCH V, 1982, ZOOMORPHOLOGY, V100, P131, DOI 10.1007/BF00310359; STRUS J, 1985, HELGOLANDER MEERESUN, V39, P367; Tomasello B, 2012, ECOTOX ENVIRON SAFE, V86, P168, DOI 10.1016/j.ecoenv.2012.09.012; WIESER W, 1976, OECOLOGIA, V23, P107, DOI 10.1007/BF00557849; Youn SeJin, 2010, Journal of Applied Sciences and Environmental Management, V14, P71; Zagar D, 2007, MAR CHEM, V107, P64, DOI 10.1016/j.marchem.2007.02.007	47	51	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58548	10.1371/journal.pone.0058548	http://dx.doi.org/10.1371/journal.pone.0058548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472204	Green Submitted, Green Published, gold			2022-12-25	WOS:000315637900150
J	Yu, Y; Zhang, J; Liu, J				Yu, Yang; Zhang, Jie; Liu, Jing			Biomedical Implementation of Liquid Metal Ink as Drawable ECG Electrode and Skin Circuit	PLOS ONE			English	Article								Background: Conventional ways of making bio-electrodes are generally complicated, expensive and unconformable. Here we describe for the first time the method of applying Ga-based liquid metal ink as drawable electrocardiogram (ECG) electrodes. Such material owns unique merits in both liquid phase conformability and high electrical conductivity, which provides flexible ways for making electrical circuits on skin surface and a prospective substitution of conventional rigid printed circuit boards (PCBs). Methods: Fundamental measurements of impedance and polarization voltage of the liquid metal ink were carried out to evaluate its basic electrical properties. Conceptual experiments were performed to draw the alloy as bio-electrodes to acquire ECG signals from both rabbit and human via a wireless module developed on the mobile phone. Further, a typical electrical circuit was drawn in the palm with the ink to demonstrate its potential of implementing more sophisticated skin circuits. Results: With an oxide concentration of 0.34%, the resistivity of the liquid metal ink was measured as 44.1 mu Omega.cm with quite low reactance in the form of straight line. Its peak polarization voltage with the physiological saline was detected as -0.73 V. The quality of ECG wave detected from the liquid metal electrodes was found as good as that of conventional electrodes, from both rabbit and human experiments. In addition, the circuit drawn with the liquid metal ink in the palm also runs efficiently. When the loop was switched on, all the light emitting diodes (LEDs) were lit and emitted colorful lights. Conclusions: The liquid metal ink promises unique printable electrical properties as both bio-electrodes and electrical wires. The implemented ECG measurement on biological surface and the successfully run skin circuit demonstrated the conformability and attachment of the liquid metal. The present method is expected to innovate future physiological measurement and biological circuit manufacturing technique in a large extent.	[Yu, Yang; Zhang, Jie; Liu, Jing] Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China; [Liu, Jing] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Cryogen, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS	Liu, J (corresponding author), Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China.	jliubme@tsinghua.edu.cn			Tsinghua University [20121088098]	Tsinghua University	This work is partially supported by Tsinghua University Grant No. 20121088098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; Cadwallader L. C., 2003, EN FAC CONTR GROUP E; Chen WC, 2012, INTERN EMERG MED, V7, P53, DOI 10.1007/s11739-011-0739-8; Cherepenin V, 2001, PHYSIOL MEAS, V22, P9, DOI 10.1088/0967-3334/22/1/302; Cherepenin VA, 2002, IEEE T MED IMAGING, V21, P662, DOI 10.1109/TMI.2002.800602; Chi Yu M., 2010, 2010 International Conference on Body Sensor Networks (BSN), P297, DOI 10.1109/BSN.2010.52; Chi YM, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P246, DOI 10.1109/P3644.51; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; Dean J.A., 1999, LANGES HDB CHEM, VFifteenth, P1291; Dunne SM, 2000, BRIT DENT J, V189, P310, DOI 10.1038/sj.bdj.4800755a; Gao Y, 2012, PLOS ONE, V7; HAGEMEISTER FB, 1990, CANCER, V65, P1090, DOI 10.1002/1097-0142(19900301)65:5<1090::AID-CNCR2820650509>3.0.CO;2-#; Ivanoff CS, 2012, FOOD CHEM TOXICOL, V50, P212, DOI 10.1016/j.fct.2011.10.041; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Li HY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4746397; Martens R. J., 2006, Proceedings of the 52nd Annual Convention of the American Association of Equine Practitioners, San Antonio, Texas, USA, 2-6 December, 2006, P219; MATULA RA, 1979, J PHYS CHEM REF DATA, V8, P1147, DOI 10.1063/1.555614; SCHWAN HP, 1966, BIOPHYSIK, V3, P181, DOI 10.1007/BF01191612; SELIGMAN PA, 1992, AM J HEMATOL, V41, P232, DOI 10.1002/ajh.2830410403; Thakor N. V., 1999, MEASUREMENT INSTRUME; Zhang Q, 2012, FRONT ENERGY, V6, P311, DOI 10.1007/s11708-012-0214-x	21	81	83	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58771	10.1371/journal.pone.0058771	http://dx.doi.org/10.1371/journal.pone.0058771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472220	Green Submitted, Green Published, gold			2022-12-25	WOS:000315637900167
J	Kim, YM; Gayen, S; Kang, CB; Joy, J; Huang, QW; Chen, AS; Wee, JLK; Ang, MJY; Lim, HA; Hung, AW; Li, R; Noble, CG; Lee, LT; Yip, A; Wang, QY; Chia, CSB; Hill, J; Shi, PY; Keller, TH				Kim, Young Mee; Gayen, Shovanlal; Kang, CongBao; Joy, Joma; Huang, Qiwei; Chen, Angela Shuyi; Wee, John Liang Kuan; Ang, Melgious Jin Yan; Lim, Huichang Annie; Hung, Alvin W.; Li, Rong; Noble, Christian G.; Lee, Le Tian; Yip, Andy; Wang, Qing-Yin; Chia, Cheng San Brian; Hill, Jeffrey; Shi, Pei-Yong; Keller, Thomas H.			NMR Analysis of a Novel Enzymatically Active Unlinked Dengue NS2B-NS3 Protease Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS NS3 PROTEASE; N-TERMINAL DOMAIN; WEST-NILE; INHIBITORS; PROTEINASE; EXPRESSION; COFACTOR; BINDING; FLAVIVIRUSES; PURIFICATION	The dengue virus (DENV) is a mosquito-borne pathogen responsible for an estimated 100 million human infections annually. The viral genome encodes a two-component trypsin-like protease that contains the cofactor region from the nonstructural protein NS2B and the protease domain from NS3 (NS3pro). The NS2B-NS3pro complex plays a crucial role in viral maturation and has been identified as a potential drug target. Using a DENV protease construct containing NS2B covalently linked to NS3pro via a Gly(4)-Ser-Gly(4) linker ("linked protease"), previous x-ray crystal structures show that the C-terminal fragment of NS2B is remote from NS3pro and exists in an open state in the absence of an inhibitor; however, in the presence of an inhibitor, NS2B complexes with NS3pro to form a closed state. This linked enzyme produced NMR spectra with severe signal overlap and line broadening. To obtain a protease construct with a resolved NMR spectrum, we expressed and purified an unlinked protease complex containing a 50-residue segment of the NS2B cofactor region and NS3pro without the glycine linker using a coexpression system. This unlinked protease complex was catalytically active at neutral pH in the absence of glycerol and produced dispersed cross-peaks in a H-1-N-15 heteronuclear single quantum correlation spectrum that enabled us to conduct backbone assignments using conventional techniques. In addition, titration with an active-site peptide aldehyde inhibitor and paramagnetic relaxation enhancement studies demonstrated that the unlinked DENV protease exists predominantly in a closed conformation in solution. This protease complex can serve as a useful tool for drug discovery against DENV.	[Kim, Young Mee; Gayen, Shovanlal; Kang, CongBao; Joy, Joma; Huang, Qiwei; Chen, Angela Shuyi; Wee, John Liang Kuan; Ang, Melgious Jin Yan; Lim, Huichang Annie; Hung, Alvin W.; Li, Rong; Chia, Cheng San Brian; Hill, Jeffrey; Keller, Thomas H.] ASTAR, Ctr Expt Therapeut, Singapore 138669, Singapore; [Noble, Christian G.; Lee, Le Tian; Yip, Andy; Wang, Qing-Yin; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore 138670, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Novartis	Kang, CB (corresponding author), ASTAR, Ctr Expt Therapeut, Nanos 03-01,31 Biopolis Way, Singapore 138669, Singapore.	cbkang@etc.a-star.edu.sg; qing_yin.wang@novatis.com; thkeller@etc.a-star.edu.sg	gayen, shovanlal/B-7409-2013; Kang, Congbao/AAP-7572-2020	gayen, shovanlal/0000-0002-3367-578X; Kang, Congbao/0000-0002-9886-9374; Ang Jin Yan, Melgious/0000-0002-4817-9658; Kanikadu Joy, Joma/0000-0002-8008-3365; Keller, Thomas/0000-0002-7553-6235	A*STAR; A*STAR investigatorship	A*STAR(Agency for Science Technology & Research (A*STAR)); A*STAR investigatorship(Agency for Science Technology & Research (A*STAR))	This work was supported in part by A*STAR.; Supported by an A*STAR investigatorship.	Bi YC, 2013, BIOMOL NMR ASSIGN, V7, P137, DOI 10.1007/s12104-012-9395-9; Chen AS, 2011, BBA-BIOMEMBRANES, V1808, P2224, DOI 10.1016/j.bbamem.2011.05.014; CHENG H, 1995, ARCH BIOCHEM BIOPHYS, V316, P619, DOI 10.1006/abbi.1995.1082; Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ekonomiuk D, 2009, J MED CHEM, V52, P4860, DOI 10.1021/jm900448m; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ezgimen M, 2012, ANTIVIR RES, V94, P18, DOI [10.1016/j.antivira1.2012.02.003, 10.1016/j.antiviral.2012.02.003]; Ezgimen MD, 2009, BIOORGAN MED CHEM, V17, P3278, DOI 10.1016/j.bmc.2009.03.050; Gayen S, 2012, BIOCHEM BIOPH RES CO, V423, P799, DOI 10.1016/j.bbrc.2012.06.043; Gayen S, 2011, PROTEINS, V79, P2557, DOI 10.1002/prot.23089; Huang QW, 2011, PROTEIN EXPRES PURIF, V80, P169, DOI 10.1016/j.pep.2011.08.008; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Li QX, 2010, BIOMOL NMR ASSIGN, V4, P211, DOI 10.1007/s12104-010-9248-3; Lim HA, 2011, EUR J MED CHEM, V46, P3130, DOI 10.1016/j.ejmech.2011.04.055; Lindback H, 2003, EMERG INFECT DIS, V9, P438, DOI 10.3201/eid0904.020267; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shiryaev SA, 2007, PROTEIN EXPRES PURIF, V52, P334, DOI 10.1016/j.pep.2006.11.009; Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015; Stevens AJ, 2009, J MED CHEM, V52, P7911, DOI 10.1021/jm900652e; Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y; Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu T., 2006, NOVART FDN SYMP, V277, P251; Xu T., 2006, NOVART FDN SYMP, V277, P97; Xu Ting, 2006, Novartis Found Symp, V277, P87, DOI 10.1002/0470058005.ch7; Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963	44	83	82	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12891	12900		10.1074/jbc.M112.442723	http://dx.doi.org/10.1074/jbc.M112.442723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511634	Green Published, hybrid			2022-12-25	WOS:000318555100043
J	Yang, YC; Yoshikai, Y; Hsu, SW; Saitoh, H; Chang, LK				Yang, Ya-Chun; Yoshikai, Yushi; Hsu, Shih-Wei; Saitoh, Hisato; Chang, Li-Kwan			Role of RNF4 in the Ubiquitination of Rta of Epstein-Barr Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; PROTEIN-KINASE-C; HISTONE DEACETYLASE INHIBITORS; IMMEDIATE-EARLY PROTEIN; DNA-BINDING-PROTEIN; E3 LIGASE ACTIVITY; LYTIC CYCLE; TRANSCRIPTION FACTOR; PROMOTES DEGRADATION; VIRAL REPLICATION	Epstein-Barr virus (EBV) encodes a transcription factor, Rta, which is required to activate the transcription of EBV lytic genes. This study demonstrates that treating P3HR1 cells with a proteasome inhibitor, MG132, causes the accumulation of SUMO-Rta and promotes the expression of EA-D. GST pulldown and coimmunoprecipitation studies reveal that RNF4, a RING-domain-containing ubiquitin E3 ligase, interacts with Rta. RNF4 also targets SUMO-2-conjugated Rta and promotes its ubiquitination in vitro. Additionally, SUMO interaction motifs in RNF4 are important to the ubiquitination of Rta because the RNF4 mutant with a mutation at the motifs eliminates ubiquitination. The mutation of four lysine residues on Rta that abrogated SUMO-3 conjugation to Rta also decreases the enhancement of the ubiquitination of Rta by RNF4. This finding demonstrates that RNF4 is a SUMO-targeted ubiquitin E3 ligase of Rta. Finally, knockdown of RNF4 enhances the expression of Rta and EA-D, subsequently promoting EBV lytic replication and virions production. Results of this study significantly contribute to efforts to elucidate a SUMO-targeted ubiquitin E3 ligase that regulates Rta ubiquitination to influence the lytic development of EBV.	[Yang, Ya-Chun; Hsu, Shih-Wei; Chang, Li-Kwan] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 106, Taiwan; [Yoshikai, Yushi; Saitoh, Hisato] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan	National Taiwan University; Kumamoto University	Saitoh, H (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	hisa@kumamoto-u.ac.jp; changlk@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013		National Health Research Institute [NHRI-EX102-10030BI]; National Science Council [NSC-100-2311-B-002-011]; National Science Council	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institute Grant NHRI-EX102-10030BI, National Science Council NSC-100-2311-B-002-011, and a National Science Council program, Funding for science and technology personnel engaging in short-term foreign research, for a visit to Kumamoto University, Japan.	Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Calderwood MA, 2008, J VIROL, V82, P8509, DOI 10.1128/JVI.00315-08; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chang FR, 2010, ANTIVIR RES, V85, P490, DOI 10.1016/j.antiviral.2009.12.002; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chang LK, 2010, NUCLEIC ACIDS RES, V38, P4687, DOI 10.1093/nar/gkq243; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; Chang PJ, 1998, J VIROL, V72, P5128, DOI 10.1128/JVI.72.6.5128-5136.1998; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; Chiu YF, 2007, J GEN VIROL, V88, P2463, DOI 10.1099/vir.0.82881-0; Countryman J, 2009, J VIROL, V83, P10694, DOI 10.1128/JVI.01172-09; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; CRAWFORD DH, 1986, IMMUNOLOGY, V59, P405; DAVIES AH, 1991, J VIROL, V65, P6838, DOI 10.1128/JVI.65.12.6838-6844.1991; Dong XN, 2012, J VIROL, V86, P1930, DOI 10.1128/JVI.06127-11; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Fryrear KA, 2012, BLOOD, V119, P1173, DOI 10.1182/blood-2011-06-358564; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; GIOT JF, 1991, NUCLEIC ACIDS RES, V19, P1251, DOI 10.1093/nar/19.6.1251; Gonzalez-Santamaria J, 2011, J VIROL, V85, P12890, DOI 10.1128/JVI.05628-11; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Gradoville L, 2002, J VIROL, V76, P5612, DOI 10.1128/JVI.76.11.5612-5626.2002; GRUFFAT H, 1990, NUCLEIC ACIDS RES, V18, P6835, DOI 10.1093/nar/18.23.6835; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Heilmann AMF, 2010, J VIROL, V84, P9920, DOI 10.1128/JVI.00573-10; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; KENNEY S, 1989, J VIROL, V63, P3878, DOI 10.1128/JVI.63.9.3878-3883.1989; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liu CN, 1996, J VIROL, V70, P2545, DOI 10.1128/JVI.70.4.2545-2555.1996; Liu ST, 2006, VIRUS RES, V119, P163, DOI 10.1016/j.virusres.2006.01.004; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Mullen JR, 2008, J BIOL CHEM, V283, P19912, DOI 10.1074/jbc.M802690200; Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11; Oh Y, 2012, CELL DEATH DIFFER, V19, P1196, DOI 10.1038/cdd.2011.209; Parker JL, 2012, NUCLEIC ACIDS RES, V40, P11380, DOI 10.1093/nar/gks892; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Poukka H, 2000, J BIOL CHEM, V275, P571, DOI 10.1074/jbc.275.1.571; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tojo M, 2002, J BIOL CHEM, V277, P46576, DOI 10.1074/jbc.M205987200; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; Wang Z, 2009, MOL CELL BIOL, V29, P1694, DOI 10.1128/MCB.01470-08; Wiedmer A, 2008, J VIROL, V82, P4647, DOI 10.1128/JVI.02198-07; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Ye JJ, 2007, J VIROL, V81, P9279, DOI 10.1128/JVI.00982-07; Ye JJ, 2010, J VIROL, V84, P12405, DOI 10.1128/JVI.01415-10; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zacny VL, 1998, J VIROL, V72, P8043, DOI 10.1128/JVI.72.10.8043-8051.1998	82	26	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12866	12879		10.1074/jbc.M112.413393	http://dx.doi.org/10.1074/jbc.M112.413393			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504328	hybrid, Green Published			2022-12-25	WOS:000318555100041
J	Ravindran, A; Sawant, KV; Sarmiento, J; Navarro, J; Rajarathnam, K				Ravindran, Aishwarya; Sawant, Kirti V.; Sarmiento, Jose; Navarro, Javier; Rajarathnam, Krishna			Chemokine CXCL1 Dimer Is a Potent Agonist for the CXCR2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-STIMULATING ACTIVITY; NEUTROPHIL-ACTIVATING PEPTIDE-2; STRUCTURAL BASIS; BINDING; INTERLEUKIN-8; RECOGNITION; AFFINITY; MONOMER; MUTANT; OLIGOMERIZATION	The CXCL1/CXCR2 axis plays a crucial role in recruiting neutrophils in response to microbial infection and tissue injury, and dysfunction in this process has been implicated in various inflammatory diseases. Chemokines exist as monomers and dimers, and compelling evidence now exists that both forms regulate in vivo function. Therefore, knowledge of the receptor activities of both CXCL1 monomer and dimer is essential to describe the molecular mechanisms by which they orchestrate neutrophil function. The monomer-dimer equilibrium constant (similar to 20 mu M) and the CXCR2 binding constant (1 nM) indicate that WT CXCL1 is active as a monomer. To characterize dimer activity, we generated a trapped dimer by introducing a disulfide across the dimer interface. This disulfide-linked CXCL1 dimer binds CXCR2 with nanomolar affinity and shows potent agonist activity in various cellular assays. We also compared the receptor binding mechanism of this dimer with that of a CXCL1 monomer, generated by deleting the C-terminal residues that stabilize the dimer interface. We observe that the binding interactions of the dimer and monomer to the CXCR2 N-terminal domain, which plays an important role in determining affinity and activity, are essentially conserved. The potent activity of the CXCL1 dimer is novel: dimers of the CC chemokines CCL2 and CCL4 are inactive, and the dimer of the CXC chemokine CXCL8 (which is closely related to CXCL1) is marginally active for CXCR1 but shows variable activity for CXCR2. We conclude that large differences in dimer activity among different chemokine-receptor pairs have evolved for fine-tuned leukocyte function.	[Ravindran, Aishwarya; Sawant, Kirti V.; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sarmiento, Jose; Navarro, Javier] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Ravindran, Aishwarya; Navarro, Javier; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, 5-142 Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	krrajara@utmb.edu	Sawant, Kirti V/H-3778-2013; Sawant, Kirti/L-1602-2013	Navarro, Javier/0000-0001-7098-4373	National Institutes of Health [P01 HL107152, R01AI069152, R01 HD049471]; American Heart Association Predoctoral Fellowship [0815354F]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL107152 and R01AI069152 (to K. R.) and R01 HD049471 (to J. N.). This work was also supported by American Heart Association Predoctoral Fellowship 0815354F (to A. R.).	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Baly DL, 1998, J IMMUNOL, V161, P4944; Barter EF, 2012, BIOCHEMISTRY-US, V51, P1322, DOI 10.1021/bi201615y; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; FAIRBROTHER WJ, 1993, FEBS LETT, V330, P302, DOI 10.1016/0014-5793(93)80893-Y; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fernando H, 2007, FEBS J, V274, P241, DOI 10.1111/j.1742-4658.2006.05579.x; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; HESSELGESSER J, 1995, J BIOL CHEM, V270, P11472, DOI 10.1074/jbc.270.19.11472; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Katancik JA, 2000, CYTOKINE, V12, P1480, DOI 10.1006/cyto.2000.0742; KIM KS, 1994, J BIOL CHEM, V269, P32909; Koelink PJ, 2012, PHARMACOL THERAPEUT, V133, P1, DOI 10.1016/j.pharmthera.2011.06.008; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Lowman HB, 1997, PROTEIN SCI, V6, P598; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; Mayer KL, 2000, BIOCHEMISTRY-US, V39, P8382, DOI 10.1021/bi000523j; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 1997, J BIOL CHEM, V272, P1725, DOI 10.1074/jbc.272.3.1725; Rajarathnam K, 2002, CURR PHARM DESIGN, V8, P2159, DOI 10.2174/1381612023393233; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359; Tan JHY, 2012, J BIOL CHEM, V287, P14692, DOI 10.1074/jbc.M111.334201; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Ye JP, 2000, J BIOL CHEM, V275, P27250	48	44	46	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12244	12252		10.1074/jbc.M112.443762	http://dx.doi.org/10.1074/jbc.M112.443762			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479735	hybrid, Green Published			2022-12-25	WOS:000318157600056
J	Ren, AX; Zhang, WQ; Yarlagadda, S; Sinha, C; Arora, K; Moon, CS; Naren, AP				Ren, Aixia; Zhang, Weiqiang; Yarlagadda, Sunitha; Sinha, Chandrima; Arora, Kavisha; Moon, Chang-Suk; Naren, Anjaparavanda P.			MAST205 Competes with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-associated Ligand for Binding to CFTR to Regulate CFTR-mediated Fluid Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-INTERACTING DOMAIN; PROTEIN; EXPRESSION; FAMILY; PHOSPHORYLATION; IDENTIFICATION; MICROTUBULES; TRAFFICKING; INHIBITION; GENE	The PDZ (postsynaptic density-95/discs large/zona occludens-1) domain-based interactions play important roles in regulating the expression and function of the cystic fibrosis transmembrane conductance regulator (CFTR). Several PDZ domain-containing proteins (PDZ proteins for short) have been identified as directly or indirectly interacting with the C terminus of CFTR. To better understand the regulation of CFTR processing, we conducted a genetic screen and identified MAST205 (a microtubule-associated serine/threonine kinase with a molecular mass of 205 kDa) as a new CFTR regulator. We found that overexpression of MAST205 increased the expression of CFTR and augmented CFTR-mediated fluid transport in a dose-dependent manner. Conversely, knockdown of MAST205 inhibited CFTR function. The PDZ motif of CFTR is required for the regulatory role of MAST205 in CFTR expression and function. We further demonstrated that MAST205 and the CFTR-associated ligand competed for binding to CFTR, which facilitated the processing of CFTR and consequently up-regulated the expression and function of CFTR at the plasma membrane. More importantly, we found that MAST205 could facilitate the processing of F508del-CFTR mutant and augment its quantity and channel function at the plasma membrane. Taken together, our data suggest that MAST205 plays an important role in regulating CFTR expression and function. Our findings have important clinical implications for treating CFTR-associated diseases such as cystic fibrosis and secretory diarrheas.	[Ren, Aixia; Zhang, Weiqiang; Yarlagadda, Sunitha; Sinha, Chandrima; Arora, Kavisha; Moon, Chang-Suk; Naren, Anjaparavanda P.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Zhang, Weiqiang] Univ Tennessee, Cyst Fibrosis Care & Res Ctr, Le Bonheur Childrens Hosp, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Naren, AP (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave,426 Nash Res Bldg, Memphis, TN 38163 USA.	anaren@uthsc.edu			National Institutes of Health [DK080834, DK093045]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093045, R01DK080834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK080834 and DK093045 (to A. P. N.).	Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Cutting GR, 2005, ANNU REV GENOM HUM G, V6, P237, DOI 10.1146/annurev.genom.6.080604.162254; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Guggino Sandra E., 1994, Trends in Microbiology, V2, P91, DOI 10.1016/0966-842X(94)90541-X; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Li CY, 2011, METHODS MOL BIOL, V741, P255, DOI 10.1007/978-1-61779-117-8_17; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Liang XB, 2012, MOL BIOL CELL, V23, P996, DOI 10.1091/mbc.E11-08-0662; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Okazaki N, 2002, CARCINOGENESIS, V23, P1139, DOI 10.1093/carcin/23.7.1139; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz BD, 1997, AM J PHYSIOL-CELL PH, V273, pC2080, DOI 10.1152/ajpcell.1997.273.6.C2080; SCHWIEBERT EM, 1994, AM J PHYSIOL, V267, pC272, DOI 10.1152/ajpcell.1994.267.1.C272; SFERRA TJ, 1993, ANNU REV MED, V44, P133, DOI 10.1146/annurev.med.44.1.133; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Tousson A, 1996, J CELL SCI, V109, P1325; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; WALDEN PD, 1993, MOL CELL BIOL, V13, P7625, DOI 10.1128/MCB.13.12.7625; Walden PD, 1996, BIOL REPROD, V55, P1039, DOI 10.1095/biolreprod55.5.1039; Walker NM, 2008, GASTROENTEROLOGY, V135, P1645, DOI 10.1053/j.gastro.2008.07.083; Wang DS, 2006, AM J PHYSIOL-RENAL, V290, pF428, DOI 10.1152/ajprenal.00161.2005; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Xiong HB, 2004, J BIOL CHEM, V279, P43675, DOI 10.1074/jbc.M404328200; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442	41	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12325	12334		10.1074/jbc.M112.432724	http://dx.doi.org/10.1074/jbc.M112.432724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504457	Green Published, hybrid			2022-12-25	WOS:000318157600063
J	Hoffmann, I; Jerneren, F; Oliw, EH				Hoffmann, Inga; Jerneren, Fredrik; Oliw, Ernst H.			Expression of Fusion Proteins of Aspergillus terreus Reveals a Novel Allene Oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS GAEUMANNOMYCES-GRAMINIS; HYDROPEROXIDE ISOMERASE; LINOLEIC-ACID; REACTION-MECHANISM; DIOL SYNTHASE; DIOXYGENASE; BIOSYNTHESIS; PATHWAYS; ENZYMES; STEREOCHEMISTRY	Aspergilli oxidize C-18 unsaturated fatty acids by dioxygenase-cytochrome P450 fusion proteins to signal molecules involved in reproduction and host-pathogen interactions. Aspergillus terreus expresses linoleate 9R-dioxygenase (9R-DOX) and allene oxide synthase (AOS) activities in membrane fractions. The genome contains five genes (ATEG), which may code for a 9R-DOX-AOS fusion protein. The genes were cloned and expressed, but none of them oxidized 18:2n-6 to 9R-hydroperoxy-10(E), 12(Z)-octadecadienoic acid (9R-HPODE). ATEG_02036 transformed 9R-HPODE to an unstable allene oxide, 9(R), 10-epoxy-10,12(Z)-octadecadienoic acid. A substitution in the P450 domain (C1073S) abolished AOS activity. The N964V and N964D mutants both showed markedly reduced AOS activity, suggesting that Asn(964) may facilitate homolytic cleavage of the dioxygen bond of 9R-HPODE with formation of compound II in analogy with plant AOS (CYP74) and prostacyclin synthase (CYP8A1). ATEG_03992 was identified as 5,8-linoleate diol synthase (5,8-LDS). Replacement of Asn(878) in 5,8-LDS with leucine (N878L) mainly shifted ferryl oxygen insertion from C-5 toward C-6, but replacements of Gln(881) markedly affected catalysis. The Q881L mutant virtually abolished the diol synthase activity. Replacement of Gln(881) with Asn, Glu, Asp, or Lys residues augmented the homolytic cleavage of 8R-HPODE with formation of 10-hydroxy-8(9)-epoxy-12(Z)-octadecenoic acid (erythro/threo, 1-4:1) and/or shifted ferryl oxygen insertion from C-5 toward C-11. We conclude that homolysis and heterolysis of the dioxygen bond with formation of compound II in AOS and compound I in 5,8-LDS are influenced by Asn and Gln residues, respectively, of the I-helices. AOS of A. terreus appears to have evolved independently of CYP74 but with an analogous reaction mechanism.	[Hoffmann, Inga; Jerneren, Fredrik; Oliw, Ernst H.] Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, Uppsala Biomed Ctr, SE-75124 Uppsala, Sweden	Uppsala University	Oliw, EH (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se		Oliw, Ernst/0000-0002-7986-8130; Jerneren, Fredrik/0000-0003-0897-7177	Vetenskapsradet Grant [03X-06523]; Knut and Alice Wallenberg Foundation [KAW 2004.123]; Uppsala University	Vetenskapsradet Grant; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Uppsala University	This work was supported by Vetenskapsradet Grant 03X-06523, Knut and Alice Wallenberg Foundation Grant KAW 2004.123, and Uppsala University.	ALDRIDGE DC, 1971, J CHEM SOC C, P1623, DOI 10.1039/j39710001623; Andersen MR, 2009, FUNGAL GENET BIOL, V46, pS180, DOI 10.1016/j.fgb.2008.07.006; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brodhun F, 2010, BIOCHEM J, V425, P553, DOI 10.1042/BJ20091096; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; CHAMPE SP, 1989, J BACTERIOL, V171, P3982, DOI 10.1128/jb.171.7.3982-3988.1989; Chang MS, 1996, BIOCHEMISTRY-US, V35, P464, DOI 10.1021/bi952081v; Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; CROSS BE, 1970, J CHEM SOC C, P1839, DOI 10.1039/j39700001839; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; ENDO A, 1992, J LIPID RES, V33, P1569; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; Hoffmann I, 2012, BBA-MOL CELL BIOL L, V1821, P1508, DOI 10.1016/j.bbalip.2012.09.001; Hoffmann I, 2011, ARCH BIOCHEM BIOPHYS, V506, P216, DOI 10.1016/j.abb.2010.11.022; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Jerneren F, 2012, LIPIDS, V47, P65, DOI 10.1007/s11745-011-3622-5; Jerneren F, 2010, ARCH BIOCHEM BIOPHYS, V495, P67, DOI 10.1016/j.abb.2009.12.022; Jerneren F, 2010, BBA-MOL CELL BIOL L, V1801, P503, DOI 10.1016/j.bbalip.2009.12.012; Jerneren F, 2010, J BIOL CHEM, V285, P5308, DOI 10.1074/jbc.M109.062810; Klinman JP, 2006, PHILOS T R SOC B, V361, P1323, DOI 10.1098/rstb.2006.1870; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Miersch O, 1999, PHYTOCHEMISTRY, V50, P517, DOI 10.1016/S0031-9422(98)00596-2; MIERSCH O, 1987, PHYTOCHEMISTRY, V26, P1037, DOI 10.1016/S0031-9422(00)82345-6; Nazir KHMNH, 2010, ARCH MICROBIOL, V192, P395, DOI 10.1007/s00203-010-0562-z; Nelson David R., 2009, Human Genomics, V4, P59; Oliw EH, 2011, J LIPID RES, V52, P1995, DOI 10.1194/jlr.M018259; PENG YL, 1994, J BIOL CHEM, V269, P3755; Poulos TL, 2010, ARCH BIOCHEM BIOPHYS, V500, P3, DOI 10.1016/j.abb.2010.02.008; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; SONG WC, 1993, P NATL ACAD SCI USA, V90, P8519, DOI 10.1073/pnas.90.18.8519; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsukada K, 2010, PHYTOCHEMISTRY, V71, P2019, DOI 10.1016/j.phytochem.2010.09.013; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; Vicente J, 2012, MOL PLANT, V5, P914, DOI 10.1093/mp/ssr105; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wennman A, 2013, J LIPID RES, V54, P762, DOI 10.1194/jlr.M033787; Wennman A, 2012, J BIOL CHEM, V287, P31757, DOI 10.1074/jbc.M112.364331; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wu G, 2011, J INORG BIOCHEM, V105, P382, DOI 10.1016/j.jinorgbio.2010.11.015; Yin GC, 2010, COORDIN CHEM REV, V254, P1826, DOI 10.1016/j.ccr.2010.01.016; Zain ME, 2009, AFR J MICROBIOL RES, V3, P280	53	26	26	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11459	11469		10.1074/jbc.M113.458257	http://dx.doi.org/10.1074/jbc.M113.458257			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479731	hybrid, Green Published			2022-12-25	WOS:000317915500047
J	Morishita, H; Eguchi, S; Kimura, H; Sasaki, J; Sakamaki, Y; Robinson, ML; Sasaki, T; Mizushima, N				Morishita, Hideaki; Eguchi, Satoshi; Kimura, Hirotaka; Sasaki, Junko; Sakamaki, Yuriko; Robinson, Michael L.; Sasaki, Takehiko; Mizushima, Noboru			Deletion of Autophagy-related 5 (Atg5) and Pik3c3 Genes in the Lens Causes Cataract Independent of Programmed Organelle Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBER CELL-DIFFERENTIATION; MOUSE EYE LENS; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSGENIC MICE; EPITHELIUM; NEURODEGENERATION; MACROAUTOPHAGY; MUTATIONS; ENDOSOMES; ZEBRAFISH	The lens of the eye is composed of fiber cells, which differentiate from epithelial cells and undergo programmed organelle degradation during terminal differentiation. Although autophagy, a major intracellular degradation system, is constitutively active in these cells, its physiological role has remained unclear. We have previously shown that Atg5-dependent macroautophagy is not necessary for lens organelle degradation, at least during the embryonic period. Here, we generated lens-specific Atg5 knock-out mice and showed that Atg5 is not required for lens organelle degradation at any period of life. However, deletion of Atg5 in the lens results in age-related cataract, which is accompanied by accumulation of polyubiquitinated and oxidized proteins, p62, and insoluble crystallins, suggesting a defect in intracellular quality control. We also produced lens-specific Pik3c3 knock-out mice to elucidate the possible involvement of Atg5-independent alternative autophagy, which is proposed to be dependent on Pik3c3 (also known as Vps34), in lens organelle degradation. Deletion of Pik3c3 in the lens does not affect lens organelle degradation, but it leads to congenital cataract and a defect in lens development after birth likely due to an impairment of the endocytic pathway. Taken together, these results suggest that clearance of lens organelles is independent of macroautophagy. These findings also clarify the physiological role of Atg5 and Pik3c3 in quality control and development of the lens, respectively.	[Morishita, Hideaki; Sakamaki, Yuriko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Sakamaki, Yuriko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Tokyo 1138519, Japan; [Eguchi, Satoshi; Kimura, Hirotaka; Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Eguchi, Satoshi; Kimura, Hirotaka; Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Global Ctr Excellence Program, Akita 0108543, Japan; [Robinson, Michael L.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Sasaki, Takehiko] Akita Univ, Biosignal Res Ctr, Akita 0108543, Japan; [Mizushima, Noboru] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Akita University; Akita University; University System of Ohio; Miami University; Akita University; University of Tokyo; University of Tokyo	Mizushima, N (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Sasaki, Takehiko/0000-0003-1837-3748; Morishita, Hideaki/0000-0003-0860-8371	National Institutes of Health from NEI [R01EY012995]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for Next Generation World-Leading Researchers; Takeda Science Foundation; Toray Science Foundation; Japan Society for the Promotion of Science for Young Scientists; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency; NATIONAL EYE INSTITUTE [R01EY012995] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Toray Science Foundation(Toray Industries, Inc.); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY012995 from NEI (to M. L. R.). This work was also supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Funding Program for Next Generation World-Leading Researchers (to T. S. and N. M.), the Takeda Science Foundation (to T. S. and N. M.), the Toray Science Foundation (to T. S.), grants for a research fellowship of the Japan Society for the Promotion of Science for Young Scientists (to H. M.), and Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (to J. S.).	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brennan LA, 2012, MOL VIS, V18, P1773; Caceres A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013331; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Frederikse PH, 2012, DEV BIOL, V368, P255, DOI 10.1016/j.ydbio.2012.05.022; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; HANNA C, 1961, ARCH OPHTHALMOL-CHIC, V66, P103; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Imai F, 2010, DEVELOPMENT, V137, P3257, DOI 10.1242/dev.053124; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P973; Li W, 2012, J CELL BIOL, V197, P27, DOI 10.1083/jcb.201111053; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Martinez G, 2009, INVEST OPHTH VIS SCI, V50, P4794, DOI 10.1167/iovs.09-3567; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mrakovic A, 2012, TRAFFIC, V13, P1667, DOI 10.1111/tra.12003; Murphy TR, 2011, EXP EYE RES, V93, P460, DOI 10.1016/j.exer.2011.06.010; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; RAFFERTY NS, 1981, J CELL PHYSIOL, V107, P309, DOI 10.1002/jcp.1041070302; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Simirskii VN, 2007, DEV BIOL, V306, P658, DOI 10.1016/j.ydbio.2007.04.004; Sugiyama Y, 2009, DEV BIOL, V336, P246, DOI 10.1016/j.ydbio.2009.10.010; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; WALTON J, 1984, EXP EYE RES, V39, P217, DOI 10.1016/0014-4835(84)90010-1; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Zandy AJ, 2007, INVEST OPHTH VIS SCI, V48, P293, DOI 10.1167/iovs.06-0656; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028; Zhao HT, 2004, INVEST OPHTH VIS SCI, V45, P1930, DOI 10.1167/iovs.03-0856; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhou XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016358; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	59	96	104	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11436	11447		10.1074/jbc.M112.437103	http://dx.doi.org/10.1074/jbc.M112.437103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479732	Green Published, hybrid			2022-12-25	WOS:000317915500045
J	Futamura, M; Thomas, KS; Grindlay, DJC; Doney, EJ; Torley, D; Williams, HC				Futamura, Masaki; Thomas, Kim S.; Grindlay, Douglas J. C.; Doney, Elizabeth J.; Torley, Donna; Williams, Hywel C.			Mapping Systematic Reviews on Atopic Eczema-An Essential Resource for Dermatology Professionals and Researchers	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-SIGNIFICANCE; FOOD INTOLERANCE; GUIDELINES; DERMATITIS; MANAGEMENT; PREVENTION; DISEASE; ACNE; METAANALYSES	Background: Many research studies have been published on atopic eczema and these are often summarised in systematic reviews (SRs). Identifying SRs can be time-consuming for health professionals, and researchers. In order to facilitate the identification of important research, we have compiled an on-line resource that includes all relevant eczema reviews published since 2000. Methods: SRs were searched for in MEDLINE (Ovid), EMBASE (Ovid), PubMed, the Cochrane Database of Systematic Reviews, DARE and NHS Evidence. Selected SRs were assessed against the pre-defined eligibility criteria and relevant articles were grouped by treatment category for the included interventions. All identified systematic reviews are included in the Global Resource of EczemA Trials (GREAT) database (www.greatdatabase.org.uk) and key clinical messages are summarised here. Results: A total of 128 SRs reviews were identified, including three clinical guidelines. Of these, 46 (36%) were found in the Cochrane Library. No single database contained all of the SRs found. The number of SRs published per year has increased substantially over the last thirteen years, and reviews were published in a variety of clinical journals. Of the 128 SRs, 1 (1%) was on mechanism, 37 (29%) were on epidemiology, 40 (31%) were on eczema prevention, 29 (23%) were on topical treatments, 31 (24%) were on systemic treatments, and 24 (19%) were on other treatments. All SRs included searches of MEDLINE in their search methods. One hundred six SRs (83%) searched more than one electronic database. There were no language restrictions reported in the search methods of 52 of the SRs (41%). Conclusions: This mapping of atopic eczema reviews is a valuable resource. It will help healthcare practitioners, guideline writers, information specialists, and researchers to quickly identify relevant up-to-date evidence in the field for improving patient care.	[Futamura, Masaki; Thomas, Kim S.; Doney, Elizabeth J.; Williams, Hywel C.] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England; [Futamura, Masaki] Natl Ctr Child Hlth & Dev, Div Allergy, Tokyo, Japan; [Grindlay, Douglas J. C.] Univ Nottingham, Ctr Evidence Based Vet Med, Loughborough, Leics, England; [Torley, Donna] So Gen Hosp, Alan Lyell Ctr Dermatol, Glasgow G51 4TF, Lanark, Scotland	University of Nottingham; National Center for Child Health & Development - Japan; University of Nottingham; University of Glasgow	Futamura, M (corresponding author), Univ Nottingham, Ctr Evidence Based Dermatol, Kings Meadow Campus, Nottingham NG7 2RD, England.	masaki.futamura@nottingham.ac.uk		Doney, Liz/0000-0002-3420-5034; Futamura, Masaki/0000-0002-7442-9649; Thomas, Kim/0000-0001-7785-7465; Grindlay, Douglas/0000-0002-0992-7182; williams, hywel/0000-0002-5646-3093	National Center for Child Health and Development; National Institute for Health Research (NIHR) [RP-PG-0407-10177]; NHS; National Institute for Health Research [RP-PG-0407-10177] Funding Source: researchfish	National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NHS; National Institute for Health Research(National Institute for Health Research (NIHR))	MF conducted this work as part of a research sabbatical funded by the National Center for Child Health and Development. Some of the searches for systematic reviews included in this study were carried out by DG in his previous role producing Annual Evidence Updates for the National Library for Health and NHS Evidence. The GREAT Database has been developed as part of independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10177). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This work was partially supported by NHS evidence. No other external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COCHRANE HDB SYSTEMA; Baron SE, 2012, CLIN EXP DERMATOL, V37, P7, DOI 10.1111/j.1365-2230.2012.04336.x; Batchelor JM, 2010, CLIN EXP DERMATOL, V35, P823, DOI 10.1111/j.1365-2230.2010.03901.x; Chiu YW, 2009, INFORM HEALTH SOC CA, V34, P127, DOI 10.1080/17538150903102372; Collier A, 2006, BRIT J DERMATOL, V155, P1230, DOI 10.1111/j.1365-2133.2006.07496.x; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Darsow U, 2010, J EUR ACAD DERMATOL, V24, P317, DOI 10.1111/j.1468-3083.2009.03415.x; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Flohr C, 2011, J INVEST DERMATOL, V131, P557, DOI 10.1038/jid.2010.369; Foulkes AC, 2011, CLIN EXP DERMATOL, V36, P585, DOI 10.1111/j.1365-2230.2011.04108.x; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Hanifin JM, 2004, J AM ACAD DERMATOL, V50, P391, DOI 10.1016/j.jaad.2003.08.003; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Hon KLE, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-26; Ingram JR, 2010, CLIN EXP DERMATOL, V35, P351, DOI 10.1111/j.1365-2230.2009.03683.x; Katayama Ichiro, 2011, Allergology International, V60, P205, DOI [10.2332/allergolint. 11-RAI-0333, 10.2332/allergolint.11-RAI-0333]; Krakowski AC, 2008, PEDIATRICS, V122, P812, DOI 10.1542/peds.2007-2232; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000133.pub2; Macbeth AE, 2011, CLIN EXP DERMATOL, V36, P453, DOI 10.1111/j.1365-2230.2011.04087.x; Moher D, 2006, LANCET, V367, P881, DOI 10.1016/S0140-6736(06)68358-X; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nankervis H, 2011, BMC DERMATOL, V11, DOI 10.1186/1471-5945-11-10; National Institute for Health and Clinical Excellence, 2011, IMPR OUTC PEOPL SKIN; National Institute for Health and Clinical Excellence, 2007, AT ECZ CHILDR MAN AT; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003741.pub4; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003664.pub3; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1045, DOI 10.1111/j.1468-3083.2012.04635.x; Saeki H, 2009, J DERMATOL, V36, P563, DOI 10.1111/j.1346-8138.2009.00706.x; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Scottish Intercollegiate Guidelines Network, 2011, MAN AT ECZ PRIM CAR; Shams K, 2011, CLIN EXP DERMATOL, V36, P573, DOI 10.1111/j.1365-2230.2011.04078.x; Simpson RC, 2011, CLIN EXP DERMATOL, V36, P840, DOI 10.1111/j.1365-2230.2011.04218.x; Sinclair W, 2008, SAMJ S AFR MED J, V98, P303; Smith EV, 2011, CLIN EXP DERMATOL, V36, P119, DOI 10.1111/j.1365-2230.2010.03921.x; Tsay MY, 2005, J MED LIBR ASSOC, V93, P450; Warren RB, 2010, CLIN EXP DERMATOL, V35, P688, DOI 10.1111/j.1365-2230.2010.03880.x; Werfel Thomas, 2009, J Dtsch Dermatol Ges, V7, P265, DOI 10.1111/j.1610-0387.2008.06901.x; Williams HC, 2008, CLIN EXP DERMATOL, V33, P685, DOI 10.1111/j.1365-2230.2008.02906.x; Williams HC, 2010, CLIN EXP DERMATOL, V35, P223, DOI 10.1111/j.1365-2230.2009.03734.x; Williams HC, 2010, CLIN EXP DERMATOL, V35, P12, DOI 10.1111/j.1365-2230.2009.03733.x	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58484	10.1371/journal.pone.0058484	http://dx.doi.org/10.1371/journal.pone.0058484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505516	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100054
J	Carvalho, SM; Kuipers, OP; Neves, AR				Carvalho, Sandra M.; Kuipers, Oscar P.; Neves, Ana Rute			Environmental and Nutritional Factors That Affect Growth and Metabolism of the Pneumococcal Serotype 2 Strain D39 and Its Nonencapsulated Derivative Strain R6	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; STREPTOCOCCUS-PNEUMONIAE; LACTOCOCCUS-LACTIS; IN-VIVO; PYRUVATE OXIDASE; SACCHAROMYCES-CEREVISIAE; SUGAR METABOLISM; SYNTHETIC MEDIUM; GENOME SEQUENCE; GENE-EXPRESSION	Links between carbohydrate metabolism and virulence in Streptococcus pneumoniae have been recurrently established. To investigate these links further we developed a chemically defined medium (CDM) and standardized growth conditions that allowed for high growth yields of the related pneumococcal strains D39 and R6. The utilization of the defined medium enabled the evaluation of different environmental and nutritional factors on growth and fermentation patterns under controlled conditions of pH, temperature and gas atmosphere. The same growth conditions impacted differently on the nonencapsulated R6, and its encapsulated progenitor D39. A semi-aerobic atmosphere and a raised concentration of uracil, a fundamental component of the D39 capsule, improved considerably D39 growth rate and biomass. In contrast, in strain R6, the growth rate was enhanced by strictly anaerobic conditions and uracil had no effect on biomass. In the presence of oxygen, the difference in the growth rates was mainly attributed to a lower activity of pyruvate oxidase in strain D39. Our data indicate an intricate connection between capsule production in strain D39 and uracil availability. In this study, we have also successfully applied the in vivo NMR technique to study sugar metabolism in S. pneumoniae R6. Glucose consumption, end-products formation and evolution of intracellular metabolite pools were monitored online by C-13-NMR. Additionally, the pools of NTP and inorganic phosphate were followed by P-31-NMR after a pulse of glucose. These results represent the first metabolic profiling data obtained non-invasively for S. pneumoniae, and pave the way to a better understanding of regulation of central metabolism.	[Carvalho, Sandra M.; Neves, Ana Rute] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Universidade Nova de Lisboa; University of Groningen	Neves, AR (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.	rute@biosustain.dtu.dk	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Carvalho, Sandra/0000-0002-3144-411X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/35947/2007]; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FEDER [PDCT/BIA-MIC/56235/2004, PTDC/BIA-MIC/099963/2008, PTDC/SAU-MII/100964/2008, PEst-OE/EQB/LA0004/2011]; Programa Operacional Ciencia e Inovacao (POCTI); FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); Programa Operacional Ciencia e Inovacao (POCTI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	S. M. Carvalho was supported by a Fundacao para a Ciencia e a Tecnologia (FCT) Ph. D. grant (SFRH/BD/35947/2007). This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and FEDER, projects PDCT/BIA-MIC/56235/2004, PTDC/BIA-MIC/099963/2008 and PTDC/SAU-MII/100964/2008 and grant PEst-OE/EQB/LA0004/2011. The NMR spectrometers are part of The National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010" and FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Balachandran P, 2001, J BACTERIOL, V183, P3108, DOI 10.1128/JB.183.10.3108-3116.2001; BEAL C, 1989, APPL MICROBIOL BIOT, V32, P148, DOI 10.1007/BF00165879; Belanger AE, 2004, J BACTERIOL, V186, P8164, DOI 10.1128/JB.186.24.8164-8171.2004; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; COCAIGNBOUSQUET M, 1995, J APPL BACTERIOL, V79, P108, DOI 10.1111/j.1365-2672.1995.tb03131.x; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Echenique JR, 2000, MOL MICROBIOL, V36, P688, DOI 10.1046/j.1365-2958.2000.01891.x; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Goncalves VMM, 2003, BIOTECHNOL APPL BIOC, V37, P283, DOI 10.1042/BA20020075; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hathaway LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002574; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; HIGUCHI M, 1993, J GEN MICROBIOL, V139, P2343, DOI 10.1099/00221287-139-10-2343; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Kaufman GE, 2007, J BACTERIOL, V189, P5183, DOI 10.1128/JB.00449-07; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Massaldi H, 2010, BIOTECHNOL APPL BIOC, V55, P37, DOI 10.1042/BA20090218; Meiattini F, 1988, METHOD ENZYMAT AN, VVII, P566; Mercade M, 2000, INT J FOOD MICROBIOL, V55, P161, DOI 10.1016/S0168-1605(00)00190-2; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Ramos-Montanez S, 2008, MOL MICROBIOL, V67, P729, DOI 10.1111/j.1365-2958.2007.06082.x; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; SICARD AM, 1964, GENETICS, V50, P31; SIMMONDS RJ, 1981, J CHROMATOGR, V226, P369, DOI 10.1016/S0378-4347(00)86071-5; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Taniai H, 2008, J BACTERIOL, V190, P3572, DOI 10.1128/JB.01882-07; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TOMASZ A, 1967, SCIENCE, V157, P694, DOI 10.1126/science.157.3789.694; TOMASZ A, 1964, BACTERIOL P, V64, P29; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Yesilkaya H, 2009, INFECT IMMUN, V77, P5418, DOI 10.1128/IAI.00178-09; Yu J, 2001, MICROBIOL-UK, V147, P431, DOI 10.1099/00221287-147-2-431; Zhang GY, 2009, APPL ENVIRON MICROB, V75, P1080, DOI 10.1128/AEM.01416-08	55	28	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58492	10.1371/journal.pone.0058492	http://dx.doi.org/10.1371/journal.pone.0058492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505518	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500091
J	Dorea, FC; Muckle, CA; Kelton, D; McClure, JT; McEwen, BJ; McNab, WB; Sanchez, J; Revie, CW				Dorea, Fernanda C.; Muckle, C. Anne; Kelton, David; McClure, J. T.; McEwen, Beverly J.; McNab, W. Bruce; Sanchez, Javier; Revie, Crawford W.			Exploratory Analysis of Methods for Automated Classification of Laboratory Test Orders into Syndromic Groups in Veterinary Medicine	PLOS ONE			English	Article							SURVEILLANCE; BIOTERRORISM	Background: Recent focus on earlier detection of pathogen introduction in human and animal populations has led to the development of surveillance systems based on automated monitoring of health data. Real-or near real-time monitoring of pre-diagnostic data requires automated classification of records into syndromes-syndromic surveillance-using algorithms that incorporate medical knowledge in a reliable and efficient way, while remaining comprehensible to end users. Methods: This paper describes the application of two of machine learning (Naive Bayes and Decision Trees) and rule-based methods to extract syndromic information from laboratory test requests submitted to a veterinary diagnostic laboratory. Results: High performance (F-1-macro = 0.9995) was achieved through the use of a rule-based syndrome classifier, based on rule induction followed by manual modification during the construction phase, which also resulted in clear interpretability of the resulting classification process. An unmodified rule induction algorithm achieved an F1-micro score of 0.979 though this fell to 0.677 when performance for individual classes was averaged in an unweighted manner (F1-macro), due to the fact that the algorithm failed to learn 3 of the 16 classes from the training set. Decision Trees showed equal interpretability to the rule-based approaches, but achieved an F1-micro score of 0.923 (falling to 0.311 when classes are given equal weight). A Naive Bayes classifier learned all classes and achieved high performance (F1-micro = 0.994 and F1-macro = .955), however the classification process is not transparent to the domain experts. Conclusion: The use of a manually customised rule set allowed for the development of a system for classification of laboratory tests into syndromic groups with very high performance, and high interpretability by the domain experts. Further research is required to develop internal validation rules in order to establish automated methods to update model rules without user input.	[Dorea, Fernanda C.; McClure, J. T.; Sanchez, Javier; Revie, Crawford W.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Muckle, C. Anne] Univ Prince Edward Isl, Dept Pathol & Microbiol, Charlottetown, PE C1A 4P3, Canada; [Kelton, David] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada; [McEwen, Beverly J.] Univ Guelph, Hlth Anim Lab, Guelph, ON N1G 2W1, Canada; [McNab, W. Bruce] Ontario Minist Agr Food & Rural Affairs, Anim Hlth & Welf Branch, Guelph, ON, Canada	University of Prince Edward Island; University of Prince Edward Island; University of Guelph; University of Guelph	Dorea, FC (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada.	dorea.meyer@gmail.com	sanchez, javier/AAA-4179-2022; Revie, Crawford/B-5002-2011	Revie, Crawford/0000-0002-5018-0340; Dorea, Fernanda/0000-0001-8638-8525	Animal Health Strategic Investment grant (OMAFRA/AHL) [09/21]; Canadian Regulatory Veterinary Epidemiology Network (CRVE-Net)	Animal Health Strategic Investment grant (OMAFRA/AHL); Canadian Regulatory Veterinary Epidemiology Network (CRVE-Net)	This project is funded by an Animal Health Strategic Investment grant (OMAFRA/AHL) (grant number 09/21) and the support of Canadian Regulatory Veterinary Epidemiology Network (CRVE-Net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INFECT DIS INFORM BI; BABIN S, 2003, NAT MULT S ON MED AP; Bravata DM, 2004, ANN INTERN MED, V140, P910, DOI 10.7326/0003-4819-140-11-200406010-00013; Centers for Disease Control and Prevention (CDC), 2006, ANN BIBL SYNDR SURV; Chapman WW, 2005, ARTIF INTELL MED, V33, P31, DOI 10.1016/j.artmed.2004.04.001; Dara J, 2008, J BIOMED INFORM, V41, P613, DOI 10.1016/j.jbi.2007.11.004; Davis RG, 2004, JAVMA-J AM VET MED A, V224, P1084, DOI 10.2460/javma.2004.224.1084; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Duda R.O., 2006, PATTERN CLASSIFICATI; Farkas R, 2009, J AM MED INFORM ASSN, V16, P601, DOI 10.1197/jamia.M3097; Glickman LT, 2006, VECTOR-BORNE ZOONOT, V6, P14, DOI 10.1089/vbz.2006.6.14; Goplin J., 2007, ADV DIS SURVEIL, V4, P8; Ivanov O, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P345; Kelly TK, 2004, OFFICE SCI TECHNOLOG; Lober William B, 2004, MMWR Suppl, V53, P203; Ma Haobo, 2005, MMWR Suppl, V54, P27; Mandl Kenneth D, 2004, MMWR Suppl, V53, P130; North Carolina Department of Agriculture and Consumer Services, 2010, MULT THREAT DAT MHTD; Reis BY, 2004, ANN EMERG MED, V44, P235, DOI 10.1016/j.annemergmed.2004.03.030; Rohatgi PK, 2011, CURR OPIN PULM MED, V17, P337, DOI 10.1097/MCP.0b013e328347c16a; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P165, DOI 10.1007/0-387-25465-X_9; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Shaffer LE, 2008, ADV DIS SURVEILL, V6, P1; Shiraishi J, 2011, SEMIN NUCL MED, V41, P449, DOI 10.1053/j.semnuclmed.2011.06.004; Shmilovici A, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P257, DOI 10.1007/0-387-25465-X_12; Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134; Solt I, 2009, J AM MED INFORM ASSN, V16, P580, DOI 10.1197/jamia.M3087; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Wagner M M, 2001, J Public Health Manag Pract, V7, P51; Wagner Michael M, 2004, MMWR Suppl, V53, P28; Wesolowski M, 2012, J AOAC INT, V95, P652, DOI 10.5740/jaoacint.SGE_Wesolowski_ANN; Zhang PG, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P487, DOI 10.1007/0-387-25465-X_22	32	25	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57334	10.1371/journal.pone.0057334	http://dx.doi.org/10.1371/journal.pone.0057334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505427	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000318334500019
J	Ikegami, K; Iigo, M; Yoshimura, T				Ikegami, Keisuke; Iigo, Masayuki; Yoshimura, Takashi			Circadian Clock Gene Per2 Is Not Necessary for the Photoperiodic Response in Mice	PLOS ONE			English	Article							PARS TUBERALIS; SUPRACHIASMATIC NUCLEUS; MELATONIN RECEPTOR; SIGNAL-TRANSDUCTION; PINEAL MELATONIN; SYRIAN-HAMSTER; EXPRESSION; LIGHT; RHYTHMS; PHOTORECEPTORS	In mammals, light information received by the eyes is transmitted to the pineal gland via the circadian pacemaker, i.e., the suprachiasmatic nucleus (SCN). Melatonin secreted by the pineal gland at night decodes night length and regulates seasonal physiology and behavior. Melatonin regulates the expression of the beta-subunit of thyroid-stimulating hormone (TSH; Tshb) in the pars tuberalis (PT) of the pituitary gland. Long day-induced PT TSH acts on ependymal cells in the mediobasal hypothalamus to induce the expression of type 2 deiodinase (Dio2) and reduce type 3 deiodinase (Dio3) that are thyroid hormone-activating and hormone-inactivating enzymes, respectively. The long day-activated thyroid hormone T-3 regulates seasonal gonadotropin-releasing hormone secretion. It is well established that the circadian clock is involved in the regulation of photoperiodism. However, the involvement of the circadian clock gene in photoperiodism regulation remains unclear. Although mice are generally considered non-seasonal animals, it was recently demonstrated that mice are a good model for the study of photoperiodism. In the present study, therefore, we examined the effect of changing day length in Per2 deletion mutant mice that show shorter wheel-running rhythms under constant darkness followed by arhythmicity. Although the amplitude of clock gene (Per1, Cry1) expression was greatly attenuated in the SCN, the expression profile of arylalkylamine N-acetyltransferase, a rate-limiting melatonin synthesis enzyme, was unaffected in the pineal gland, and robust photoperiodic responses of the Tshb, Dio2, and Dio3 genes were observed. These results suggested that the Per2 clock gene is not necessary for the photoperiodic response in mice.	[Ikegami, Keisuke; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Physiol Anim Lab, Nagoya, Aichi 4648601, Japan; [Iigo, Masayuki] Utsunomiya Univ, Dept Appl Biochem, Utsunomiya, Tochigi 321, Japan; [Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan; [Yoshimura, Takashi] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648601, Japan	Nagoya University; Utsunomiya University; Nagoya University; Nagoya University	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Physiol Anim Lab, Nagoya, Aichi 4648601, Japan.	takashiy@agr.nagoya-u.ac.jp	Iigo, Masayuki/I-7110-2013; Yoshimura, Takashi/C-8306-2012	Yoshimura, Takashi/0000-0001-7018-9652; Ikegami, Keisuke/0000-0001-5606-3965; Iigo, Masayuki/0000-0001-8251-4141	Funding Program for Next Generation World Leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP) [LS055]; World Premier International Research Center Initiative (WPI), MEXT, Japan;  [22005794]	Funding Program for Next Generation World Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); World Premier International Research Center Initiative (WPI), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	Takashi Yoshimura is supported by the Funding Program for Next Generation World Leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (CSTP)(LS055) and Keisuke Ikegami is supported by Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows (22005794). WPI-ITbM is supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari N, 2009, EUR J NEUROSCI, V29, P477, DOI 10.1111/j.1460-9568.2008.06605.x; Baggerman B., 1972, General and Comparative Endocrinology, V3, P466, DOI 10.1016/0016-6480(72)90177-3; BRONSON FH, 1985, BIOL REPROD, V32, P1, DOI 10.1095/biolreprod32.1.1; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; CARTER DS, 1983, ENDOCRINOLOGY, V113, P1268, DOI 10.1210/endo-113-4-1268; Christ E, 2010, NEUROSCIENCE, V171, P398, DOI 10.1016/j.neuroscience.2010.09.009; Dardente H, 2003, MOL BRAIN RES, V114, P101, DOI 10.1016/S0169-328X(03)00134-7; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Dawson A, 2007, GEN COMP ENDOCR, V153, P378, DOI 10.1016/j.ygcen.2007.01.043; EBIHARA S, 1986, SCIENCE, V231, P491, DOI 10.1126/science.3941912; ELLIOTT JA, 1972, SCIENCE, V178, P771, DOI 10.1126/science.178.4062.771; FOLLETT BK, 1969, NATURE, V223, P968, DOI 10.1038/223968b0; Garner WW, 1919, J AGRIC RES, V18, P0553; Gorman Michael R., 2001, Handbook of Behavioral Neurobiology, V12, P481; Guerrero HY, 2000, NEUROENDOCRINOLOGY, V71, P163, DOI 10.1159/000054533; HAMNER WM, 1966, GEN COMP ENDOCR, V7, P224, DOI 10.1016/0016-6480(66)90043-8; HAMNER WM, 1963, SCIENCE, V142, P1294, DOI 10.1126/science.142.3597.1294; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; HASTINGS MH, 1987, J ENDOCRINOL, V114, P221, DOI 10.1677/joe.0.1140221; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; HOFFMAN RA, 1965, SCIENCE, V148, P1609, DOI 10.1126/science.148.3677.1609; Ikegami K, 2009, J COMP NEUROL, V517, P397, DOI 10.1002/cne.22165; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Johnston JD, 2006, ENDOCRINOLOGY, V147, P959, DOI 10.1210/en.2005-1100; Johnston JD, 2005, EUR J NEUROSCI, V21, P2967, DOI 10.1111/j.1460-9568.2005.04148.x; Johnston JD, 2003, FASEB J, V17, P810, DOI 10.1096/fj.02-0837com; KEAST J. A., 1954, PROC ZOOL SOC LONDON, V124, P493; Lincoln G, 2002, P NATL ACAD SCI USA, V99, P13890, DOI 10.1073/pnas.212517599; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; Nakahara D, 2003, P NATL ACAD SCI USA, V100, P9584, DOI 10.1073/pnas.1631069100; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nuesslein-Hildesheim B, 2000, EUR J NEUROSCI, V12, P2856, DOI 10.1046/j.1460-9568.2000.00173.x; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reiter R J, 1980, Endocr Rev, V1, P109; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Rowan W, 1925, NATURE, V115, P494, DOI 10.1038/115494b0; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; STIRLAND JA, 1995, BIOL REPROD, V53, P361, DOI 10.1095/biolreprod53.2.361; Stirland JA, 1996, ENDOCRINOLOGY, V137, P2183, DOI 10.1210/en.137.5.2183; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; UNDERWOOD H, 1990, J COMP PHYSIOL A, V167, P231; Unfried C, 2009, ENDOCRINOLOGY, V150, P4653, DOI 10.1210/en.2009-0609; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; Vansteensel MJ, 2008, BRAIN RES REV, V58, P18, DOI 10.1016/j.brainresrev.2007.10.009; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; Von Gall C, 2005, ANN NY ACAD SCI, V1040, P508, DOI 10.1196/annals.1327.105; Yamamura T, 2004, ENDOCRINOLOGY, V145, P4264, DOI 10.1210/en.2004-0366; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2009, J NEUROSCI, V29, P2885, DOI 10.1523/JNEUROSCI.0145-09.2009; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zucker Irving, 2001, Handbook of Behavioral Neurobiology, V12, P509	67	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58482	10.1371/journal.pone.0058482	http://dx.doi.org/10.1371/journal.pone.0058482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505514	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500089
J	Zhou, XS; Kannisto, K; Curbo, S; von Dobeln, U; Hultenby, K; Isetun, S; Gafvels, M; Karlsson, A				Zhou, Xiaoshan; Kannisto, Kristina; Curbo, Sophie; von Dobeln, Ulrika; Hultenby, Kjell; Isetun, Sindra; Gafvels, Mats; Karlsson, Anna			Thymidine Kinase 2 Deficiency-Induced mtDNA Depletion in Mouse Liver Leads to Defect beta-Oxidation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DEPLETION; TANDEM MASS-SPECTROMETRY; DEOXYGUANOSINE KINASE; TK2 DEFICIENCY; MYOPATHY; MUTATIONS; GENE; MICE; COMPENSATION; METABOLISM	Thymidine kinase 2 (TK2) deficiency in humans causes mitochondrial DNA (mtDNA) depletion syndrome. To study the molecular mechanisms underlying the disease and search for treatment options, we previously generated and described a TK2 deficient mouse strain (TK2(-/-)) that progressively loses its mtDNA. The TK2(-/-) mouse model displays symptoms similar to humans harboring TK2 deficient infantile fatal encephalomyopathy. Here, we have studied the TK2(-/-) mouse model to clarify the pathological role of progressive mtDNA depletion in liver for the severe outcome of TK2 deficiency. We observed that a gradual depletion of mtDNA in the liver of the TK2(-/-) mice was accompanied by increasingly hypertrophic mitochondria and accumulation of fat vesicles in the liver cells. The levels of cholesterol and nonesterified fatty acids were elevated and there was accumulation of long chain acylcarnitines in plasma of the TK2(-/-) mice. In mice with hepatic mtDNA levels below 20%, the blood sugar and the ketone levels dropped. These mice also exhibited reduced mitochondrial beta-oxidation due to decreased transport of long chain acylcarnitines into the mitochondria. The gradual loss of mtDNA in the liver of the TK2(-/-) mice causes impaired mitochondrial function that leads to defect beta-oxidation and, as a result, insufficient production of ketone bodies and glucose. This study provides insight into the mechanism of encephalomyopathy caused by TK2 deficiency-induced mtDNA depletion that may be used to explore novel therapeutic strategies.	[Zhou, Xiaoshan; Curbo, Sophie; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol F68, Huddinge, Sweden; [Kannisto, Kristina; Gafvels, Mats] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Chem, Huddinge, Sweden; [von Dobeln, Ulrika; Isetun, Sindra] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Metab Dis, Huddinge, Sweden; [Hultenby, Kjell] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Res Ctr, Huddinge, Sweden; [Gafvels, Mats] Lund Univ, Dept Lab Med, Div Clin Chem, Lund, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University	Curbo, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol F68, Huddinge, Sweden.	Sophie.Curbo@ki.se	Karlsson, Anna/E-7945-2018; curbo, sophie/AAA-8614-2020	curbo, sophie/0000-0002-0964-0712; Karlsson, Anna/0000-0001-6843-6685	Swedish Research Council [2010-2828]; Medical Faculty of Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty of Karolinska Institutet	This work was supported by grants from the Swedish Research Council [A.K. grant number 2010-2828] and the Medical Faculty of Karolinska Institutet [A.K., S.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Chace DH, 2001, CLIN CHEM, V47, P1166; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453; Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghoshal AK, 2005, CLIN CHIM ACTA, V358, P104, DOI 10.1016/j.cccn.2005.02.011; Gotz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X; MORAES CT, 1991, AM J HUM GENET, V48, P492; Muller-Hocker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477; Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y; Rao JN, 2011, J BIOL CHEM, V286, P42545, DOI 10.1074/jbc.M111.306951; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saada Ann, 2009, Biochem J, V422, pe3, DOI 10.1042/BJ20091194; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Vila MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019; Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691; Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005; Weibel E, 1979, STEREOLOGICAL METHOD, V1, P91; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133	39	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58843	10.1371/journal.pone.0058843	http://dx.doi.org/10.1371/journal.pone.0058843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505564	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500129
J	Chou, IC; Chang, YT; Chin, ZN; Muo, CH; Sung, FC; Kuo, HT; Tsai, CH; Kao, CH				Chou, I-Ching; Chang, Yu-Tzu; Chin, Zheng-Nan; Muo, Chih-Hsin; Sung, Fung-Chang; Kuo, Huang-Tsung; Tsai, Chang-Hai; Kao, Chia-Hung			Correlation between Epilepsy and Attention Deficit Hyperactivity Disorder: A Population-Based Cohort Study	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; BEHAVIOR PROBLEMS; CHILDREN; ADHD; SEIZURES; ADOLESCENTS; SCHOOL	Background: This study presents an evaluation of the bidirectional correlation between attention deficit hyperactivity disorder (ADHD) and epilepsy using 2 cohorts from the same population database. Methods: We used data from the Taiwan National Health Insurance Research Database to establish 2 separate cohort studies with participants,19 years old. We subdivided Cohort 1 in 2 groups: (1) 2468 patients initially diagnosed with epilepsy during the period 1999-2008, and (2) 9810 randomly selected sex-and age-matched non-epileptic controls. We subdivided Cohort 2 into 2 groups: (1) 3664 patients with newly diagnosed ADHD and (2) 14 522 sex-and age-matched non-ADHD patients. We evaluated the risk of subsequent ADHD in relationship to epilepsy and vice versa in the 2 cohorts at the end of 2008. Results: The ADHD incidence in Cohort 1 was 7.76 in patients with epilepsy and 3.22 in those without epilepsy (per 1000 person-years) after a median follow-up of 7-7.5 years. The adjusted hazard ratio (HR) for ADHD was 2.54 (95% CI 2.02-3.18) in the epilepsy group compared to the non-epilepsy group. In Cohort 2, the incidence of epilepsy was 3.24 in patients with ADHD and 0.78 in those without ADHD (per 1000 person-years) after a median follow-up of 3-3.5 years and an HR of 3.94 (95% CI 2.58-6.03). Conclusion: This study shows a bidirectional association between ADHD and epilepsy in the 2 cohort studies. Causative factors may be common between these 2 disorders, leading to a cascade of transcriptional changes in the brain that alter behavior or cognition prior to seizures.	[Chou, I-Ching; Chang, Yu-Tzu; Chin, Zheng-Nan; Kuo, Huang-Tsung; Tsai, Chang-Hai] China Med Univ Hosp, Childrens Med Ctr, Taichung, Taiwan; [Chou, I-Ching] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH102-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH102-TD-C-111-005]; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) [NSC101-2911-I-002-303];  [DMR-101-045]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE); 	The study was supported in part by the study project (DMR-101-045) in our hospital; Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH102-TD-B-111-004), Taiwan Department of Health Cancer Research Center for Excellence (DOH102-TD-C-111-005); and International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) (NSC101-2911-I-002-303). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicardi J, 1998, DIS NERVOUS SYSTEM C, P575; Aircardi J., 1996, ACTA NEUROPEDIATRICA, V2, P249; Aldenkamp AP, 2001, J CHILD NEUROL, V16, P119, DOI 10.2310/7010.2001.6990; [Anonymous], 1998, NIH CONSENS STATEMEN, V16, P1; Austin JK, 2001, PEDIATRICS, V107, P115, DOI 10.1542/peds.107.1.115; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Chang YT, 2011, EPILEPSIA, V52, P2036, DOI 10.1111/j.1528-1167.2011.03268.x; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; Dunn DW, 1997, SEIZURE, V6, P283, DOI 10.1016/S1059-1311(97)80075-1; Gilby KL, 2008, EPILEPSIA, V49, P108, DOI 10.1111/j.1528-1167.2008.01851.x; Hesdorffer DC, 2004, ARCH GEN PSYCHIAT, V61, P731, DOI 10.1001/archpsyc.61.7.731; HOLDSWORTH L, 1974, DEV MED CHILD NEUROL, V16, P746; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; McIntyre DC, 2007, EPILEPSIA, V48, P30, DOI 10.1111/j.1528-1167.2007.01398.x; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Richer LP, 2002, PEDIATR NEUROL, V26, P125, DOI 10.1016/S0887-8994(01)00370-8; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Semrud-Clikeman M, 1999, EPILEPSIA, V40, P211, DOI 10.1111/j.1528-1157.1999.tb02077.x; STORES G, 1978, EPILEPSIA, V19, P169, DOI 10.1111/j.1528-1157.1978.tb05027.x; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Thome-Souza S, 2004, EPILEPSY BEHAV, V5, P988, DOI 10.1016/j.yebeh.2004.09.001; Williams J, 2001, CLIN PEDIATR, V40, P221, DOI 10.1177/000992280104000408; Zang YF, 2005, BRAIN DEV-JPN, V27, P544, DOI 10.1016/j.braindev.2004.11.009	25	56	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57926	10.1371/journal.pone.0057926	http://dx.doi.org/10.1371/journal.pone.0057926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483944	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100055
J	Holmes, KJ; Lourenco, SF				Holmes, Kevin J.; Lourenco, Stella F.			When Numbers Get Heavy: Is the Mental Number Line Exclusively Numerical?	PLOS ONE			English	Article							PARIETAL CORTEX; MAGNITUDE REPRESENTATION; HUMAN INFANTS; TIME; SPACE; ORGANIZATION; PERCEPTION; ATTENTION; QUANTITY; TASKS	The mental number line, with its left-to-right orientation of increasing numerical values, is often regarded as evidence for a unique connection between space and number. Yet left-to-right orientation has been shown to extend to other dimensions, consistent with a general magnitude system wherein different magnitudes share neural and conceptual resources. Such observations raise a fundamental, yet relatively unexplored, question about spatial-numerical associations: What is the nature of the information represented along the mental number line? Here we show that this information is not exclusive to number, simultaneously accommodating numerical and non-numerical magnitudes. Participants completed the classic SNARC (Spatial-Numerical Association of Response Codes) task while sometimes wearing wrist weights. Weighting the left wrist-thereby linking less and more weight to right and left, respectively-worked against left-to-right orientation of number, leaving no behavioral trace of the mental number line. Our findings point to the dynamic integration of magnitude dimensions, with spatial organization instantiating representational currency (i.e., more/less relations) shared across magnitudes.	[Holmes, Kevin J.] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA; [Lourenco, Stella F.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	University of California System; University of California Berkeley; Emory University	Holmes, KJ (corresponding author), Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA.	kjholmes@berkeley.edu	Holmes, Kevin/AEJ-8579-2022		John Merck Fund	John Merck Fund	This research was supported by a Scholars Award from the John Merck Fund (www.jmfund.org) to SFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Cappelletti M, 2011, NEUROPSYCHOLOGIA, V49, P3078, DOI 10.1016/j.neuropsychologia.2011.07.014; Casarotti M, 2007, COGNITION, V102, P101, DOI 10.1016/j.cognition.2006.09.001; Castronovo J, 2007, Q J EXP PSYCHOL, V60, P101, DOI 10.1080/17470210600598635; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Di Bono MG, 2012, J EXP PSYCHOL HUMAN, V38, P838, DOI 10.1037/a0028346; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Fabbri M, 2012, ACTA PSYCHOL, V139, P111, DOI 10.1016/j.actpsy.2011.09.006; Fias W., 2005, HDB MATH COGNITION, P43; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2008, CORTEX, V44, P386, DOI 10.1016/j.cortex.2007.08.004; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; Holmes KJ, 2012, Q J EXP PSYCHOL, V65, P1044, DOI 10.1080/17470218.2012.685079; Holmes KJ, 2011, BRAIN COGNITION, V77, P315, DOI 10.1016/j.bandc.2011.07.002; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Hurewitz F, 2006, P NATL ACAD SCI USA, V103, P19599, DOI 10.1073/pnas.0609485103; Ishihara M, 2008, CORTEX, V44, P454, DOI 10.1016/j.cortex.2007.08.010; Kadosh RC, 2008, PROG NEUROBIOL, V84, P132, DOI 10.1016/j.pneurobio.2007.11.001; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Loetscher T, 2008, CURR BIOL, V18, pR60, DOI 10.1016/j.cub.2007.11.015; Longo MR, 2010, BRAIN COGNITION, V72, P362, DOI 10.1016/j.bandc.2009.10.016; Lourenco SF, 2012, P NATL ACAD SCI USA, V109, P18737, DOI 10.1073/pnas.1207212109; Lourenco SF, 2011, ATTENTION PERFORM, P225, DOI 10.1016/B978-0-12-385948-8.00015-3; Lourenco SF, 2010, PSYCHOL SCI, V21, P873, DOI 10.1177/0956797610370158; Lu AT, 2011, J EXP PSYCHOL HUMAN, V37, P1855, DOI 10.1037/a0024673; Lu AT, 2009, COGNITION, V113, P117, DOI 10.1016/j.cognition.2009.07.001; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023553; Shaki S, 2008, COGNITION, V108, P590, DOI 10.1016/j.cognition.2008.04.001; Srinivasan M, 2010, COGNITION, V116, P217, DOI 10.1016/j.cognition.2010.05.005; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Vicario CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001716; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wood G., 2008, PSYCHOL SCI Q, V50, P489; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	44	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58381	10.1371/journal.pone.0058381	http://dx.doi.org/10.1371/journal.pone.0058381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23484023	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100113
J	Tilani, N; De Costa, S; Heemstra, JM				Tilani, N.; De Costa, S.; Heemstra, Jennifer M.			Evaluating the Effect of Ionic Strength on Duplex Stability for PNA Having Negatively or Positively Charged Side Chains	PLOS ONE			English	Article							PEPTIDE NUCLEIC-ACIDS; SEQUENCE B-DNA; STRAND INVASION; MIXED-SEQUENCE; HYBRIDIZATION PROPERTIES; CRYSTAL-STRUCTURE; MELTING CURVES; GAMMA-PNA; RECOGNITION; OLIGONUCLEOTIDES	The enhanced thermodynamic stability of PNA:DNA and PNA: RNA duplexes compared with DNA: DNA and DNA: RNA duplexes has been attributed in part to the lack of electrostatic repulsion between the uncharged PNA backbone and negatively charged DNA or RNA backbone. However, there are no previously reported studies that systematically evaluate the effect of ionic strength on duplex stability for PNA having a charged backbone. Here we investigate the role of charge repulsion in PNA binding by synthesizing PNA strands having negatively or positively charged side chains, then measuring their duplex stability with DNA or RNA at varying salt concentrations. At low salt concentrations, positively charged PNA binds more strongly to DNA and RNA than does negatively charged PNA. However, at medium to high salt concentrations, this trend is reversed, and negatively charged PNA shows higher affinity for DNA and RNA than does positively charged PNA. These results show that charge screening by counterions in solution enables negatively charged side chains to be incorporated into the PNA backbone without reducing duplex stability with DNA and RNA. This research provides new insight into the role of electrostatics in PNA binding, and demonstrates that introduction of negatively charged side chains is not significantly detrimental to PNA binding affinity at physiological ionic strength. The ability to incorporate negative charge without sacrificing binding affinity is anticipated to enable the development of PNA therapeutics that take advantage of both the inherent benefits of PNA and the multitude of charge-based delivery technologies currently being developed for DNA and RNA.	[Heemstra, Jennifer M.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Heemstra, JM (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	heemstra@chem.utah.edu			University of Utah	University of Utah	This research was funded by the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avitabile C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035774; Bentin T, 2003, BIOCHEMISTRY-US, V42, P13987, DOI 10.1021/bi0351918; Boxer MB, 2010, CHEMMEDCHEM, V5, P730, DOI 10.1002/cmdc.200900531; Boyarskaya NP, 2006, DOKL CHEM, V408, P57, DOI 10.1134/S0012500806050016; Braasch DA, 2002, CURR PROTOC NUCL ACI; BROWN SC, 1994, SCIENCE, V265, P777, DOI 10.1126/science.7519361; Cheatham TE, 1997, J AM CHEM SOC, V119, P4805, DOI 10.1021/ja963641w; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P10258, DOI 10.1021/ja0625576; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Efimov VA, 2005, NUCLEOS NUCLEOT NUCL, V24, P1853, DOI 10.1080/15257770500268830; Efimov VA, 1998, NUCLEIC ACIDS RES, V26, P566, DOI 10.1093/nar/26.2.566; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Englund EA, 2007, ANGEW CHEM INT EDIT, V46, P1414, DOI 10.1002/anie.200603483; Eriksson M, 1996, NAT STRUCT BIOL, V3, P410, DOI 10.1038/nsb0596-410; Grimm EL, 2004, BIOORGAN MED CHEM, V12, P845, DOI 10.1016/j.bmc.2004.01.007; Haaima G, 1996, ANGEW CHEM INT EDIT, V35, P1939; He GF, 2009, J AM CHEM SOC, V131, P12088, DOI 10.1021/ja900228j; Hyrup B, 1996, BIOORG MED CHEM LETT, V6, P1083, DOI 10.1016/0960-894X(96)00176-X; Ishihara T, 1999, J AM CHEM SOC, V121, P2012, DOI 10.1021/ja983834e; Janson CG, 2006, PEPTIDE NUCL ACIDS M; Joshi R, 2011, J PEPT SCI, V17, P8, DOI 10.1002/psc.1305; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kaihatsu K, 2003, BIOCHEMISTRY-US, V42, P13996, DOI 10.1021/bi035194k; Kleiner RE, 2008, J AM CHEM SOC, V130, P4646, DOI 10.1021/ja0753997; MANNING GS, 1972, BIOPOLYMERS, V11, P937, DOI 10.1002/bip.1972.360110502; Marchelli R., 2011, TARGETS GENE THERAPY, P29; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Menchise V, 2003, P NATL ACAD SCI USA, V100, P12021, DOI 10.1073/pnas.2034746100; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Mitra R, 2011, CHEM COMMUN, V47, P1198, DOI 10.1039/c0cc03988h; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Nielsen PE, 2004, PEPTIDE NUCL ACIDS P, V2nd; PARIKH JR, 1967, J AM CHEM SOC, V89, P5505, DOI 10.1021/ja00997a067; Peyman A, 1997, ANGEW CHEM INT EDIT, V36, P2809, DOI 10.1002/anie.199728091; Rapireddy S, 2007, J AM CHEM SOC, V129, P15596, DOI 10.1021/ja074886j; Rapireddy S, 2011, BIOCHEMISTRY-US, V50, P3913, DOI 10.1021/bi2002554; Sahu B, 2011, J ORG CHEM, V76, P5614, DOI 10.1021/jo200482d; Sahu B, 2009, J ORG CHEM, V74, P1509, DOI 10.1021/jo802211n; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Sforza S, 1999, EUR J ORG CHEM, V1999, P197; Shiraishi T, 2008, NUCLEIC ACIDS RES, V36, P4424, DOI 10.1093/nar/gkn401; THOMSON SA, 1995, TETRAHEDRON, V51, P6179, DOI 10.1016/0040-4020(95)00286-H; Tomac S, 1996, J AM CHEM SOC, V118, P5544, DOI 10.1021/ja960495l; Topham CM, 2007, BIOPHYS J, V92, P769, DOI 10.1529/biophysj.105.079723; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu Y, 2001, TETRAHEDRON, V57, P8107, DOI 10.1016/S0040-4020(01)00789-X; Yeh JI, 2010, J AM CHEM SOC, V132, P10717, DOI 10.1021/ja907225d; Zhou P, 2003, J AM CHEM SOC, V125, P6878, DOI 10.1021/ja029665m	51	14	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58670	10.1371/journal.pone.0058670	http://dx.doi.org/10.1371/journal.pone.0058670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484047	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100134
J	Chou, HJ; Lai, DM; Huang, CW; McLennan, IS; Wang, HD; Wang, PY				Chou, Hui-Ju; Lai, Dar-Ming; Huang, Cheng-Wen; McLennan, Ian S.; Wang, Horng-Dar; Wang, Pei-Yu			BMP4 Is a Peripherally-Derived Factor for Motor Neurons and Attenuates Glutamate-Induced Excitotoxicity In Vitro	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CILIARY NEUROTROPHIC FACTOR; SPINAL-CORD-INJURY; SCHWANN-CELLS; SCIATIC-NERVE; MOTONEURONS; SURVIVAL; MUSCLE; GROWTH; GENE	Bone morphogenetic proteins (BMPs), members of the transforming growth factor-beta (TGF-beta) superfamily, have been shown to play important roles in the nervous system, including neuronal survival and synaptogenesis. However, the physiological functions of BMP signaling in the mammalian neuromuscular system are not well understood. In this study, we found that proteins of the type II bone morphogenetic receptors (BMPRII) were detected at the neuromuscular junction (NMJ), and one of its ligands, BMP4, was expressed by Schwann cells and skeletal muscle fibers. In double-ligated nerves, BMP4 proteins accumulated at the proximal and distal portions of the axons, suggesting that Schwann cell-and muscle fiber-derived BMP4 proteins were anterogradely and retrogradely transported by motor neurons. Furthermore, BMP4 mRNA was down-regulated in nerves but up-regulated in skeletal muscles following nerve ligation. The motor neuron-muscle interactions were also demonstrated using differentiated C2C12 muscle cells and NG108-15 neurons in vitro. BMP4 mRNA and immunoreactivity were significantly up-regulated in differentiated C2C12 muscle cells when the motor neuron-derived factor, agrin, was present in the culture. Peripherally-derived BMP4, on the other hand, promotes embryonic motor neuron survival and protects NG108-15 neurons from glutamate-induced excitotoxicity. Together, these data suggest that BMP4 is a peripherally-derived factor that may regulate the survival of motor neurons.	[Chou, Hui-Ju; Huang, Cheng-Wen; Wang, Pei-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Chou, Hui-Ju; Wang, Pei-Yu] Natl Chengchi Univ, Inst Neurosci, Taipei 11623, Taiwan; [Chou, Hui-Ju; Wang, Pei-Yu] Natl Chengchi Univ, Res Ctr Mind Brain & Learning, Taipei 11623, Taiwan; [Lai, Dar-Ming] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Huang, Cheng-Wen; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [McLennan, Ian S.] Univ Otago, Dept Anat, Dunedin, New Zealand	National Taiwan University; National Chengchi University; National Chengchi University; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; University of Otago	Wang, PY (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan.	wangpeiyu@ntu.edu.tw		WANG, PEI-YU/0000-0002-1792-8935; Wang, Horng-Dar/0000-0001-9570-3611	National Science Council, Taiwan [NSC 98-2320-B-004-003-MY2, NSC 100-2311-B-002-017-MY3, NSC 101-2311-B-007-004-]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grants (NSC 98-2320-B-004-003-MY2 and NSC 100-2311-B-002-017-MY3) to P.-Y. Wang, and (NSC 101-2311-B-007-004-) to H.-D. Wang from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; CHOI DW, 1987, J NEUROSCI, V7, P369; Choi RCY, 1997, NEUROSCI LETT, V236, P167, DOI 10.1016/S0304-3940(97)00789-1; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; ISHII DN, 1989, P NATL ACAD SCI USA, V86, P2898, DOI 10.1073/pnas.86.8.2898; Jiang Y, 2000, NEUROSCIENCE, V97, P735, DOI 10.1016/S0306-4522(00)00084-1; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Lacazette E, 2003, J CELL BIOL, V161, P727, DOI 10.1083/jcb.200210156; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; LOWRIE MB, 1992, TRENDS NEUROSCI, V15, P80, DOI 10.1016/0166-2236(92)90014-Y; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Matsuura I, 2008, J NEUROCHEM, V105, P1471, DOI 10.1111/j.1471-4159.2008.05251.x; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McGeachie AB, 2001, NEUROSCIENCE, V104, P891, DOI 10.1016/S0306-4522(01)00129-4; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; Parikh P, 2011, P NATL ACAD SCI USA, V108, pE99, DOI 10.1073/pnas.1100426108; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Russell FD, 2000, NEUROSCIENCE, V97, P575, DOI 10.1016/S0306-4522(00)00079-8; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Sakamoto T, 2003, J NEUROSCI RES, V72, P54, DOI 10.1002/jnr.10558; SENDTNER M, 1992, J CELL BIOL, V118, P139, DOI 10.1083/jcb.118.1.139; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tan TW, 2012, J CELL PHYSIOL, V227, P2531, DOI 10.1002/jcp.22991; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Wang PY, 2007, MOL CELL NEUROSCI, V34, P653, DOI 10.1016/j.mcn.2007.01.008; Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106; Wang PY, 2005, P NATL ACAD SCI USA, V102, P16421, DOI 10.1073/pnas.0508304102; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	44	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58441	10.1371/journal.pone.0058441	http://dx.doi.org/10.1371/journal.pone.0058441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472198	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900144
J	Lim, KH; Choi, HS; Park, YK; Park, ES; Shin, GC; Kim, DH; Ahn, SH; Kim, KH				Lim, Keo-Heun; Choi, Hyo Sun; Park, Yong Kwang; Park, Eun-Sook; Shin, Gu Choul; Kim, Doo Hyun; Ahn, Sung Hyun; Kim, Kyun-Hwan			HBx-Induced NF-kappa B Signaling in Liver Cells Is Potentially Mediated by the Ternary Complex of HBx with p22-FLIP and NEMO	PLOS ONE			English	Article							VIRUS-X-PROTEIN; RECEPTOR-INDUCED APOPTOSIS; FLICE-INHIBITORY PROTEINS; HEPATITIS-B; C-FLIP; HEPATOCELLULAR-CARCINOMA; CANCER DEVELOPMENT; ACTIVATION; DEATH; PATHWAY	Sustained activation of NF-kappa B is one of the causative factors for various liver diseases, including liver inflammation and hepatocellular carcinoma (HCC). It has been known that activating the NF-kappa B signal by hepatitis B virus X protein (HBx) is implicated in the development of HCC. However, despite numerous studies on HBx-induced NF-kappa B activation, the detailed mechanisms still remain unsolved. Recently, p22-FLIP, a cleavage product of c-FLIPL, has been reported to induce NF-kappa B activation through interaction with the I kappa B kinase (IKK) complex in primary immune cells. Since our previous report on the interaction of HBx with c-FLIPL, we explored whether p22-FLIP is involved in the modulation of HBx function. First, we identified the expression of endogenous p22-FLIP in liver cells. NF-kappa B reporter assay and electrophoretic mobility shift assay (EMSA) revealed that the expression of p22-FLIP synergistically enhances HBx-induced NF-kappa B activation. Moreover, we found that HBx physically interacts with p22-FLIP and NEMO and potentially forms a ternary complex. Knock-down of c-FLIP leading to the downregulation of p22-FLIP showed that endogenous p22-FLIP is involved in HBx-induced NF-kappa B activation, and the formation of a ternary complex is necessary to activate NF-kappa B signaling. In conclusion, we showed a novel mechanism of HBx-induced NF-kappa B activation in which ternary complex formation is involved among HBx, p22-FLIP and NEMO. Our findings will extend the understanding of HBx-induced NF-kappa B activation and provide a new target for intervention in HBV-associated liver diseases and in the development of HCC.	[Lim, Keo-Heun; Choi, Hyo Sun; Park, Yong Kwang; Park, Eun-Sook; Shin, Gu Choul; Kim, Doo Hyun; Ahn, Sung Hyun; Kim, Kyun-Hwan] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul, South Korea; [Lim, Keo-Heun; Choi, Hyo Sun; Park, Yong Kwang; Park, Eun-Sook; Shin, Gu Choul; Kim, Doo Hyun; Ahn, Sung Hyun; Kim, Kyun-Hwan] Konkuk Univ, Ctr Canc Res & Diagnost Med, IBST, Seoul, South Korea; [Lim, Keo-Heun; Kim, Kyun-Hwan] Konkuk Univ, Inst Funct Genom, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University	Kim, KH (corresponding author), Konkuk Univ, Sch Med, Dept Pharmacol, Seoul, South Korea.	khkim10@kku.ac.kr		Park, Eun-Sook/0000-0002-6652-9404; Kim, Kyun-Hwan/0000-0001-5266-072X; Shin, Gu-Choul/0000-0001-8200-9700	Konkuk University	Konkuk University	This work was supported by Konkuk University in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Dolcet X, 2005, LAB INVEST, V85, P885, DOI 10.1038/labinvest.3700286; Du XL, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-24; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hong A, 2012, BIOCHEM BIOPH RES CO, V423, P6, DOI 10.1016/j.bbrc.2012.05.021; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Jiao BY, 2011, ARCH VIROL, V156, P2015, DOI 10.1007/s00705-011-1099-4; Jin HS, 2009, CANCER RES, V69, P1782, DOI 10.1158/0008-5472.CAN-08-2256; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kim HR, 2010, FEBS LETT, V584, P525, DOI 10.1016/j.febslet.2009.11.091; Kim KH, 2003, EMBO J, V22, P2104, DOI 10.1093/emboj/cdg210; Kim SY, 2008, BMB REP, V41, P158, DOI 10.5483/BMBRep.2008.41.2.158; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Korkolopoulou P, 2007, HISTOPATHOLOGY, V51, P150, DOI 10.1111/j.1365-2559.2007.02723.x; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Li XG, 2001, BIOCHEM BIOPH RES CO, V286, P587, DOI 10.1006/bbrc.2001.5442; Lim KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022258; Liu YH, 2012, HEPATOLOGY, V56, P1015, DOI 10.1002/hep.25751; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Ohata K, 2003, FEBS LETT, V553, P304, DOI 10.1016/S0014-5793(03)01034-2; Rippo MR, 2004, ONCOGENE, V23, P7753, DOI 10.1038/sj.onc.1208051; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sorokina EM, 2004, J BIOL CHEM, V279, P13469, DOI 10.1074/jbc.M305250200; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Sun SC, 2011, CURR TOP MICROBIOL, V349, P197, DOI 10.1007/82_2010_108; Sylla BS, 1998, P NATL ACAD SCI USA, V95, P10106, DOI 10.1073/pnas.95.17.10106; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Yun C, 2002, CANCER LETT, V184, P97, DOI 10.1016/S0304-3835(02)00187-8; Zhou XD, 2004, CLIN SCI, V106, P397, DOI 10.1042/CS20030238	49	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57331	10.1371/journal.pone.0057331	http://dx.doi.org/10.1371/journal.pone.0057331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483900	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900015
J	Sinici, I; Yonekawa, S; Tkachyova, I; Gray, SJ; Samulski, RJ; Wakarchuk, W; Mark, BL; Mahuran, DJ				Sinici, Incilay; Yonekawa, Sayuri; Tkachyova, Ilona; Gray, Steven J.; Samulski, R. Jude; Wakarchuk, Warren; Mark, Brian L.; Mahuran, Don J.			In Cellulo Examination of a Beta-Alpha Hybrid Construct of Beta-Hexosaminidase A Subunits, Reported to Interact with the GM2 Activator Protein and Hydrolyze GM2 Ganglioside	PLOS ONE			English	Article							TAY-SACHS-DISEASE; G(M2) GANGLIOSIDE; CRYSTAL-STRUCTURE; SANDHOFF-DISEASE; NONHUMAN-PRIMATES; MOUSE MODELS; GENE-THERAPY; DELIVERY; FIBROBLASTS; BRAIN	The hydrolysis in lysosomes of GM2 ganglioside to GM3 ganglioside requires the correct synthesis, intracellular assembly and transport of three separate gene products; i.e., the alpha and beta subunits of heterodimeric beta-hexosaminidase A, E. C. # 3.2.1.52 (encoded by the HEXA and HEXB genes, respectively), and the GM2-activator protein (GM2AP, encoded by the GM2A gene). Mutations in any one of these genes can result in one of three neurodegenerative diseases collectively known as GM2 gangliosidosis (HEXA, Tay-Sachs disease, MIM # 272800; HEXB, Sandhoff disease, MIM # 268800; and GM2A, AB-variant form, MIM # 272750). Elements of both of the hexosaminidase A subunits are needed to productively interact with the GM2 ganglioside-GM2AP complex in the lysosome. Some of these elements have been predicted from the crystal structures of hexosaminidase and the activator. Recently a hybrid of the two subunits has been constructed and reported to be capable of forming homodimers that can perform this reaction in vivo, which could greatly simplify vector-mediated gene transfer approaches for Tay-Sachs or Sandhoff diseases. A cDNA encoding a hybrid hexosaminidase subunit capable of dimerizing and hydrolyzing GM2 ganglioside could be incorporated into a single vector, whereas packaging both subunits of hexosaminidase A into vectors, such as adeno-associated virus, would be impractical due to size constraints. In this report we examine the previously published hybrid construct (H1) and a new more extensive hybrid (H2), with our documented in cellulo (live cell-based) assay utilizing a fluorescent GM2 ganglioside derivative. Unfortunately when Tay-Sachs cells were transfected with either the H1 or H2 hybrid construct and then were fed the GM2 derivative, no significant increase in its turnover was detected. In vitro assays with the isolated H1 or H2 homodimers confirmed that neither was capable of human GM2AP-dependent hydrolysis of GM2 ganglioside.	[Sinici, Incilay] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey; [Yonekawa, Sayuri; Tkachyova, Ilona; Mahuran, Don J.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Tkachyova, Ilona; Mahuran, Don J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gray, Steven J.; Samulski, R. Jude] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA; [Wakarchuk, Warren] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Hacettepe University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; Toronto Metropolitan University; University of Manitoba	Mahuran, DJ (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hex@sickkids.ca	Wakarchuk, Warren/Q-9514-2017; LAY, INCILAY/I-8315-2013; Wakarchuk, Warren/AAO-2774-2020	Wakarchuk, Warren/0000-0002-1539-1679; LAY, INCILAY/0000-0002-1466-5746; Wakarchuk, Warren/0000-0002-1539-1679; Mark, Brian/0000-0002-7344-1355	New Hope Research Foundation (USA); Canadian Institutes of Health Research (CIHR) Team Grant [CTP-82944]; Scientific and Technical Research Council of Turkey (TUBITAK)	New Hope Research Foundation (USA); Canadian Institutes of Health Research (CIHR) Team Grant(Canadian Institutes of Health Research (CIHR)); Scientific and Technical Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by grants from the New Hope Research Foundation (USA) and a Canadian Institutes of Health Research (CIHR) Team Grant (CTP-82944) to DM. Salary and expenses for IS were supplied by a scholarship from the Scientific and Technical Research Council of Turkey (TUBITAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni C, 1999, J BIOL CHEM, V274, P28612, DOI 10.1074/jbc.274.40.28612; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Cachon-Gonzalez MB, 2006, P NATL ACAD SCI USA, V103, P10373, DOI 10.1073/pnas.0603765103; CALLAHAN JW, 1970, BIOCHEM MED METAB B, V4, P295, DOI 10.1016/0006-2944(70)90056-6; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Federici T, 2012, GENE THER, V19, P852, DOI 10.1038/gt.2011.130; Fernandes MJG, 1997, J BIOL CHEM, V272, P814, DOI 10.1074/jbc.272.2.814; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gray SJ, 2012, NEUROPHARMA IN PRESS; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Guidotti JE, 1999, HUM MOL GENET, V8, P831, DOI 10.1093/hmg/8.5.831; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HIRABAYASHI Y, 1983, J NEUROCHEM, V40, P168, DOI 10.1111/j.1471-4159.1983.tb12667.x; Hou YM, 1998, J BIOL CHEM, V273, P21386, DOI 10.1074/jbc.273.33.21386; Igdoura SA, 1999, HUM MOL GENET, V8, P1111, DOI 10.1093/hmg/8.6.1111; KORNELUK RG, 1986, J BIOL CHEM, V261, P8407; Lacorazza HD, 1996, NAT MED, V2, P424, DOI 10.1038/nm0496-424; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Liu YJ, 1997, P NATL ACAD SCI USA, V94, P8138, DOI 10.1073/pnas.94.15.8138; MAHURAN DJ, 1988, J BIOL CHEM, V263, P4612; MAHURAN DJ, 1991, BIOCHIM BIOPHYS ACTA, V1096, P87, DOI 10.1016/0925-4439(91)90044-A; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Martin DR, 2004, EXP NEUROL, V187, P30, DOI 10.1016/j.expneurol.2004.01.008; Martino S, 2005, HUM MOL GENET, V14, P2113, DOI 10.1093/hmg/ddi216; Matsuoka K, 2011, MOL THER, V19, P1017, DOI 10.1038/mt.2011.27; NEOTE K, 1990, J BIOL CHEM, V265, P20799; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Samaranch L, 2012, HUM GENE THER, V23, P382, DOI 10.1089/hum.2011.200; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sharma R, 2003, BBA-MOL BASIS DIS, V1637, P113, DOI 10.1016/S0925-4439(02)00221-1; Sharma R, 2001, BIOCHEMISTRY-US, V40, P5440, DOI 10.1021/bi0029200; SmiljanicGeorgijev N, 1997, BBA-PROTEIN STRUCT M, V1339, P192, DOI 10.1016/S0167-4838(97)00002-2; SUZUKI Y, 1978, HUM GENET, V43, P127, DOI 10.1007/BF00293589; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Tropak MB, 2010, GLYCOBIOLOGY, V20, P356, DOI 10.1093/glycob/cwp183; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Yuziuk JA, 1998, J BIOL CHEM, V273, P66, DOI 10.1074/jbc.273.1.66; Zarghooni M, 2004, BIOCHEM BIOPH RES CO, V324, P1048, DOI 10.1016/j.bbrc.2004.09.159	40	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57908	10.1371/journal.pone.0057908	http://dx.doi.org/10.1371/journal.pone.0057908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483939	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900053
J	Ferreira, JG; Diniz, PMM; de Paula, CAA; Lobo, YA; Paredes-Gamero, EJ; Paschoalin, T; Nogueira-Pedro, A; Maza, PK; Toledo, MS; Suzuki, E; Oliva, MLV				Ferreira, Joana Gasperazzo; Motta Diniz, Paula Malloy; Andrade de Paula, Claudia Alessandra; Lobo, Yara Aparecida; Paredes-Gamero, Edgar Julian; Paschoalin, Thaysa; Nogueira-Pedro, Amanda; Maza, Paloma Korehisa; Toledo, Marcos Sergio; Suzuki, Erika; Vilela Oliva, Maria Luiza			The Impaired Viability of Prostate Cancer Cell Lines by the Recombinant Plant Kallikrein Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; KUNITZ PROTEINASE-INHIBITORS; ENTEROLOBIUM-CONTORTISILIQUUM; PLASMA KALLIKREIN; REACTIVE-SITE; GENE FAMILY; IN-VITRO; ANGIOGENESIS; EXPRESSION; BAUHINIA	Prostate cancer is the most common type of cancer, and kallikreins play an important role in the establishment of this disease. rBbKIm is the recombinant Bauhinia bauhinioides kallikreins inhibitor that was modified to include the RGD/RGE motifs of the inhibitor BrTI from Bauhinia rufa. This work reports the effects of rBbKIm on DU145 and PC3 prostate cancer cell lines. rBbKIm inhibited the cell viability of DU145 and PC3 cells but did not affect the viability of fibroblasts. rBbKIm caused an arrest of the PC3 cell cycle at the G0/G1 and G2/M phases but did not affect the DU145 cell cycle, although rBbKIm triggers apoptosis and cytochrome c release into the cytosol of both cell types. The differences in caspase activation were observed because rBbKIm treatment promoted activation of caspase-3 in DU145 cells, whereas caspase-9 but not caspase-3 was activated in PC3 cells. Because angiogenesis is important to the development of a tumor, the effect of rBbKIm in this process was also analyzed, and an inhibition of 49% was observed in in vitro endothelial cell capillary-like tube network formation. In summary, we demonstrated that different properties of the protease inhibitor rBbKIm may be explored for investigating the androgen-independent prostate cancer cell lines PC3 and DU145.	[Ferreira, Joana Gasperazzo; Motta Diniz, Paula Malloy; Andrade de Paula, Claudia Alessandra; Lobo, Yara Aparecida; Paredes-Gamero, Edgar Julian; Nogueira-Pedro, Amanda; Toledo, Marcos Sergio; Vilela Oliva, Maria Luiza] Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, BR-04044020 Sao Paulo, Brazil; [Paredes-Gamero, Edgar Julian] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-04044020 Sao Paulo, Brazil; [Paschoalin, Thaysa; Maza, Paloma Korehisa; Suzuki, Erika] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, BR-04044020 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Oliva, MLV (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Rua Tres Maio 100, BR-04044020 Sao Paulo, Brazil.	olivaml.bioq@epm.br	de Paula, Claudia/X-2904-2018; Suzuki, Erika/B-3456-2008; Vilela Oliva, Maria Luiza/AGI-6283-2022; Toledo, Marcos S/B-6243-2008; Oliva, Maria Luiza V/B-9537-2012; Paredes-Gamero, Edgar J/C-4791-2012; de Toledo, Marcos Sergio/M-7185-2019	Suzuki, Erika/0000-0002-4010-8716; Paredes-Gamero, Edgar J/0000-0003-3686-8402; de Toledo, Marcos Sergio/0000-0002-6605-0874; Oliva, Maria Luiza/0000-0002-5822-0060	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/53766-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 2009/53766-5, and by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Abdallah RT, 2010, J BIOL CHEM, V285, P35206, DOI 10.1074/jbc.M110.171769; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; de Paula CAA, 2012, J BIOL CHEM, V287, P170, DOI 10.1074/jbc.M111.263996; Andrade D, 2010, ARCH BIOCHEM BIOPHYS, V498, P74, DOI 10.1016/j.abb.2010.03.022; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Araujo APU, 2005, BIOL CHEM, V386, P561, DOI 10.1515/BC.2005.066; Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Birk Y., 2003, PLANT PROTEINASE INH, P1; Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Bok RA, 2003, PROSTATE CANCER P D, V6, P272, DOI 10.1038/sj.pcan.4500676; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chau CH, 2010, DRUG MANAGEMENT OF PROSTATE CANCER, P197, DOI 10.1007/978-1-60327-829-4_17; Chieng-Yane P, 2011, J PHARMACOL EXP THER, V336, P643, DOI 10.1124/jpet.110.175182; Clements JA, 2004, CRIT REV CL LAB SCI, V41, P265, DOI 10.1080/10408360490471931; Cohen I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011135; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Dardik R, 1997, INT J CANCER, V70, P201, DOI 10.1002/(SICI)1097-0215(19970117)70:2<201::AID-IJC11>3.0.CO;2-L; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DUFTON MJ, 1990, FEBS LETT, V271, P9, DOI 10.1016/0014-5793(90)80360-U; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Giannis A, 1997, ANGEW CHEM INT EDIT, V36, P588, DOI 10.1002/anie.199705881; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Kaushal V, 2006, PROSTATE, V66, P273, DOI 10.1002/pros.20326; Kennedy AR, 1998, PHARMACOL THERAPEUT, V78, P167, DOI 10.1016/S0163-7258(98)00010-2; KENNEDY AR, 1994, CANCER RES, V54, pS1999; Krem MM, 1999, J BIOL CHEM, V274, P28063, DOI 10.1074/jbc.274.40.28063; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu J, 2003, UROL RES, V31, P163, DOI 10.1007/s00240-003-0309-2; Loberg RD, 2007, J CELL BIOCHEM, V101, P1292, DOI 10.1002/jcb.21252; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MacGrogan D, 1997, SEMIN CANCER BIOL, V8, P11, DOI 10.1006/scbi.1997.0048; Meoli DF, 2009, AM J PHYSIOL-LUNG C, V297, pL706, DOI 10.1152/ajplung.90598.2008; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Nakahata AM, 2006, INT J BIOL MACROMOL, V40, P22, DOI 10.1016/j.ijbiomac.2006.05.008; Nakahata AM, 2011, BIOL CHEM, V392, P327, DOI [10.1515/bc.2011.031, 10.1515/BC.2011.031]; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Obiezu CV, 2005, CANCER LETT, V224, P1, DOI 10.1016/j.canlet.2004.09.024; Oliva MLV, 2010, BIOCHIMIE, V92, P1667, DOI 10.1016/j.biochi.2010.03.021; Oliva MLV, 2001, BIOL CHEM, V382, P109; Oliva MLV, 1999, IMMUNOPHARMACOLOGY, V45, P145, DOI 10.1016/S0162-3109(99)00146-0; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Podgorski I, 2005, NEOPLASIA, V7, P207, DOI 10.1593/neo.04349; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rodriguez Luis G., 2004, V294, P23; Salvesen, 1986, PROTEINASE INHIBITOR, P23; Shi XL, 2004, MOL CANCER RES, V2, P395; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sumikawa JT, 2010, PHYTOCHEMISTRY, V71, P214, DOI 10.1016/j.phytochem.2009.10.009; Tantivejkul K, 2004, J CELL BIOCHEM, V91, P706, DOI 10.1002/jcb.10664; Thompson IM, 2007, J CLIN ONCOL, V25, P3076, DOI 10.1200/JCO.2006.07.6836; Trabocchi A, 2010, J MED CHEM, V53, P7119, DOI 10.1021/jm100754z; Veiseh O, 2011, ADV DRUG DELIVER REV, V63, P582, DOI 10.1016/j.addr.2011.01.010; Oliva MLV, 2008, BIOL CHEM, V389, P1007, DOI 10.1515/BC.2008.119; Oliva MLV, 2011, CURR PROTEIN PEPT SC, V12, P348; Whitbread AK, 2006, BIOL CHEM, V387, P707, DOI 10.1515/BC.2006.089; Wilkinson R, 2012, CANCER IMMUNOL IMMUN, V61, P169, DOI 10.1007/s00262-011-1095-2; YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29	72	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13641	13654		10.1074/jbc.M112.404053	http://dx.doi.org/10.1074/jbc.M112.404053			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23511635	hybrid, Green Published			2022-12-25	WOS:000318850300048
J	Barber, CJS; Pujara, PT; Reed, DW; Chiwocha, S; Zhang, HX; Covello, PS				Barber, Carla J. S.; Pujara, Pareshkumar T.; Reed, Darwin W.; Chiwocha, Shiela; Zhang, Haixia; Covello, Patrick S.			The Two-step Biosynthesis of Cyclic Peptides from Linear Precursors in a Member of the Plant Family Caryophyllaceae Involves Cyclization by a Serine Protease-like Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL OLIGOPEPTIDASE; SAPONARIA-VACCARIA; CIRCULAR PROTEINS; NATURAL-PRODUCTS; MACROCYCLIZATION; CYCLOPEPTIDES; CYCLOTIDES; ARCHITECTURE; PROTEOLYSIS; EXTRACTION	Caryophyllaceae-type cyclic peptides (CPs) of 5-12 proteinogenic amino acids occur in 10 plant families. In Saponaria vaccaria (Caryophyllaceae), they have been shown to be formed from linear peptide precursors derived from ribosomal translation. There is also evidence for such precursors in other members of the Caryophyllaceae, Rutaceae, and Linaceae families. The biosynthesis of CP in the developing seeds of S. vaccaria was investigated with respect to the enzymes involved in precursor processing. Through biochemical assays with seed extracts and synthetic peptides, an enzyme named oligopeptidase 1 (OLP1) was found that catalyzes the cleavage of intermediates at the N terminus of the incipient CP. A second enzyme, peptide cyclase 1 (PCY1), which was separated chromatographically from OLP1, was found to act on the product of OLP1, giving rise to a cyclic peptide and concomitant removal of a C-terminal flanking sequence. PCY1 was partially purified, and using the methods of proteomics, a full-length cDNA clone encoding an enzyme matching the properties of PCY1 was obtained. The substrate specificity of purified recombinant PCY1, believed to be the first cloned plant enzyme whose function is peptide cyclization, was tested with synthetic peptides. The results are discussed in the light of CP biosynthetic systems of other organisms.	[Barber, Carla J. S.; Pujara, Pareshkumar T.; Reed, Darwin W.; Chiwocha, Shiela; Zhang, Haixia; Covello, Patrick S.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada	National Research Council Canada	Covello, PS (corresponding author), Natl Res Council Canada, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada.	patrick.covello@nrc-cnrc.gc.ca		Reed, Darwin/0000-0001-8038-8647	Genome Canada; McGill Innovation Centre; Saskatchewan Agriculture Development Fund	Genome Canada(Genome Canada); McGill Innovation Centre; Saskatchewan Agriculture Development Fund	This work was supported in part by Genome Canada and affiliates, McGill Innovation Centre, and the Saskatchewan Agriculture Development Fund.	Agarwal V, 2012, CHEM BIOL, V19, P1411, DOI 10.1016/j.chembiol.2012.09.012; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Berkers CR, 2009, INT J BIOCHEM CELL B, V41, P66, DOI 10.1016/j.biocel.2008.08.036; Cascales L, 2010, ORG BIOMOL CHEM, V8, P5035, DOI 10.1039/c0ob00139b; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Condie JA, 2011, PLANT J, V67, P682, DOI 10.1111/j.1365-313X.2011.04626.x; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gaasterland T, 1996, BIOCHIMIE, V78, P302, DOI 10.1016/0300-9084(96)84761-4; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Garcia Angie E, 2010, Curr Mol Pharmacol, V3, P153; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Gui B, 2012, J AGR FOOD CHEM, V60, P8571, DOI 10.1021/jf301847u; Hoogerhout P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019110; Hourani R, 2011, J AM CHEM SOC, V133, P15296, DOI 10.1021/ja2063082; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jia AQ, 2006, SCI CHINA SER B, V49, P63, DOI 10.1007/s11426-005-0204-5; JOHNSTON RB, 1950, J BIOL CHEM, V187, P205; Jones AC, 2009, CURR OPIN CHEM BIOL, V13, P216, DOI 10.1016/j.cbpa.2009.02.019; Katoh T, 2011, CHEM COMMUN, V47, P9946, DOI 10.1039/c1cc12647d; KAUFMANN HP, 1959, CHEM BER-RECL, V92, P2805, DOI 10.1002/cber.19590921122; Koehnke J, 2012, NAT STRUCT MOL BIOL, V19, P767, DOI 10.1038/nsmb.2340; Lee J, 2009, J AM CHEM SOC, V131, P2122, DOI 10.1021/ja8092168; Marx UC, 2003, J BIOL CHEM, V278, P21782, DOI 10.1074/jbc.M212996200; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Meesapyodsuk D, 2007, PLANT PHYSIOL, V143, P959, DOI 10.1104/pp.106.088484; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; MORITA H, 1994, TETRAHEDRON LETT, V35, P9593, DOI 10.1016/0040-4039(94)88519-2; Morita H, 2006, BIOORG MED CHEM LETT, V16, P4458, DOI 10.1016/j.bmcl.2006.06.083; Morita H, 2010, HETEROCYCLES, V80, P739, DOI 10.3987/REV-09-SR(S)7; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Namjoshi S, 2010, BIOPOLYMERS, V94, P673, DOI 10.1002/bip.21476; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Picur B, 2006, J PEPT SCI, V12, P569, DOI 10.1002/psc.779; Pomilio AB, 2006, CURR ORG CHEM, V10, P2075, DOI 10.2174/138527206778742669; Poth AG, 2012, J BIOL CHEM, V287, P27033, DOI 10.1074/jbc.M112.370841; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sancheti H, 2009, ADV DRUG DELIVER REV, V61, P908, DOI 10.1016/j.addr.2009.07.003; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Sheoran IS, 2005, PROTEOMICS, V5, P3752, DOI 10.1002/pmic.200401209; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szeltner Z, 2004, J MOL BIOL, V340, P627, DOI 10.1016/j.jmb.2004.05.011; Tan NH, 2006, CHEM REV, V106, P840, DOI 10.1021/cr040699h; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Walton JD, 2010, BIOPOLYMERS, V94, P659, DOI 10.1002/bip.21416; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984	56	65	70	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12500	12510		10.1074/jbc.M112.437947	http://dx.doi.org/10.1074/jbc.M112.437947			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486480	Green Published, hybrid			2022-12-25	WOS:000318555100009
J	Daddacha, W; Noble, E; Nguyen, LA; Kennedy, EM; Kim, B				Daddacha, Waaqo; Noble, Erin; Nguyen, Laura A.; Kennedy, Edward M.; Kim, Baek			Effect of Ribonucleotides Embedded in a DNA Template on HIV-1 Reverse Transcription Kinetics and Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SAMHD1 RESTRICTS; FREQUENT INCORPORATION; LEUKEMIA-VIRUS; RNA; PROCESSIVITY; POLYMERASE; SUBSTRATE; INFECTION; EXPRESSION	HIV-1 reverse transcriptase (RT) frequently incorporates ribonucleoside triphosphates (rNTPs) during proviral DNA synthesis, particularly under the limited dNTP conditions found in macrophages. We investigated the mechanistic impacts of an rNMP embedded in DNA templates on HIV-1 RT-mediated DNA synthesis. We observed that the template-embedded rNMP induced pausing of RT and delayed DNA synthesis kinetics at low macrophage dNTP concentrations but not at high T cell dNTP concentrations. Although the binding affinity of RT to the rNMP-containing template-primer was not altered, the dNTP incorporation kinetics of RT were significantly reduced at one nucleotide upstream and downstream of the rNMP site, leading to pause sites. Finally, HIV-1 RT becomes more error-prone at rNMP sites with an elevated mismatch extension capability but not enhanced misinsertion capability. Together these data suggest that rNMPs embedded in DNA templates may influence reverse transcription kinetics and impact viral mutagenesis in macrophages.	[Daddacha, Waaqo; Noble, Erin; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Nguyen, Laura A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Kennedy, Edward M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	University of Rochester; University of Rochester; Duke University	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu		Kennedy, Edward/0000-0002-2817-4809	National Institutes of Health [F31 GM095190, AI049781]; Oral Cellular and Molecular Biology Training Grant [T32 E007202]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral Cellular and Molecular Biology Training Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31 GM095190 (to W. D.), AI049781 (to B. K.), and Oral Cellular and Molecular Biology Training Grant T32 E007202 (to E. N.).	Amie SM, 2013, VIROLOGY, V436, P247, DOI 10.1016/j.virol.2012.11.010; Avidan O, 1998, NUCLEIC ACIDS RES, V26, P1713, DOI 10.1093/nar/26.7.1713; Avidan O, 2002, EUR J BIOCHEM, V269, P859, DOI 10.1046/j.0014-2956.2001.02719.x; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; Bishop G Reid, 2003, Curr Protoc Nucleic Acid Chem, VChapter 7, DOI 10.1002/0471142700.nc0711s11; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; DeRose EF, 2012, BIOCHEMISTRY-US, V51, P2407, DOI 10.1021/bi201710q; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; FRY M, 1992, P NATL ACAD SCI USA, V89, P763, DOI 10.1073/pnas.89.2.763; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GENDELMAN HE, 1986, J VIROL, V58, P67, DOI 10.1128/JVI.58.1.67-74.1986; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gorshkova II, 2001, ANAL BIOCHEM, V291, P198, DOI 10.1006/abio.2001.5053; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; JAISHREE TN, 1993, BIOCHEMISTRY-US, V32, P4903, DOI 10.1021/bi00069a027; Jenkins JL, 2011, J BIOL CHEM, V286, P24626, DOI 10.1074/jbc.M111.230375; JI JP, 1994, NUCLEIC ACIDS RES, V22, P47, DOI 10.1093/nar/22.1.47; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kennedy EM, 2011, J BIOL CHEM, V286, P25047, DOI 10.1074/jbc.M111.234047; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 1996, J BIOL CHEM, V271, P4872, DOI 10.1074/jbc.271.9.4872; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LETVIN NL, 1983, P NATL ACAD SCI-BIOL, V80, P2718, DOI 10.1073/pnas.80.9.2718; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Myszka DG, 1999, J MOL RECOGNIT, V12, P390, DOI 10.1002/(SICI)1099-1352(199911/12)12:6<390::AID-JMR482>3.0.CO;2-8; Nguyen LA, 2012, J MOL BIOL, V415, P248, DOI 10.1016/j.jmb.2011.11.014; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rezende LF, 2001, J BIOMED SCI, V8, P197, DOI 10.1007/BF02256413; Romainczyk O, 2011, MOL BIOSYST, V7, P1050, DOI 10.1039/c0mb00258e; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Skasko M, 2009, BIOCHEMISTRY-US, V48, P5389, DOI 10.1021/bi900346m; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Tsoi PY, 2004, BIOSENS BIOELECTRON, V19, P1209, DOI 10.1016/j.bios.2003.11.004; Van Cor-Hosmer SK, 2012, VIROLOGY, V422, P393, DOI 10.1016/j.virol.2011.11.004; Wawryn J, 1999, ACTA BIOCHIM POL, V46, P249, DOI 10.18388/abp.1999_4158; Weiss KK, 2000, BIOCHEMISTRY-US, V39, P10684, DOI 10.1021/bi000788y; YU H, 1992, J BIOL CHEM, V267, P10888	50	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12522	12532		10.1074/jbc.M113.458398	http://dx.doi.org/10.1074/jbc.M113.458398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23479739	hybrid, Green Published			2022-12-25	WOS:000318555100011
J	Aparicio, D; Perez-Luque, R; Carpena, X; Diaz, M; Ferrer, JC; Loewen, PC; Fita, I				Aparicio, David; Perez-Luque, Rosa; Carpena, Xavier; Diaz, Mireia; Ferrer, Joan C.; Loewen, Peter C.; Fita, Ignacio			Structural Asymmetry and Disulfide Bridges among Subunits Modulate the Activity of Human Malonyl-CoA Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAXIMUM-LIKELIHOOD; ACID; MITOCHONDRIAL; REFINEMENT; DEFICIENCY; SERVER	Decarboxylation of malonyl-CoA to acetyl-CoA by malonyl-CoA decarboxylase (MCD; EC 4.1.1.9) is an essential facet in the regulation of fatty acid metabolism. The structure of human peroxisomal MCD reveals a molecular tetramer that is best described as a dimer of structural heterodimers, in which the two subunits present markedly different conformations. This molecular organization is consistent with half-of-the-sites reactivity. Each subunit has an all-helix N-terminal domain and a catalytic C-terminal domain with an acetyltransferase fold (GNAT superfamily). Intersubunit disulfide bridges, Cys-206-Cys-206 and Cys-243-Cys-243, can link the four subunits of the tetramer, imparting positive cooperativity to the catalytic process. The combination of a half-of the-sites mechanism within each structural heterodimer and positive cooperativity in the tetramer produces a complex regulatory picture that is further complicated by the multiple intracellular locations of the enzyme. Transport into the peroxisome has been investigated by docking human MCD onto the peroxisomal import protein peroxin 5, which revealed interactions that extend beyond the C-terminal targeting motif.	[Aparicio, David; Perez-Luque, Rosa; Carpena, Xavier; Fita, Ignacio] CSIC, IBMB, E-08028 Barcelona, Spain; [Diaz, Mireia; Ferrer, Joan C.] Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Loewen, Peter C.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; University of Manitoba	Fita, I (corresponding author), CSIC, IBMB, Parc Cient,Baldiri Reixac 10, E-08028 Barcelona, Spain.	ifrcri@ibmb.csic.es	Ferrer, Joan C./AAP-2145-2021; Carpena, Xavi/J-5877-2017; Aparicio, David/R-4640-2019; Aparicio, David/AAX-7388-2020; Fita, Ignasi/R-4515-2019	Carpena, Xavi/0000-0002-8646-0440; Aparicio, David/0000-0002-1971-5335; Fita, Ignasi/0000-0002-7521-2679; Perez Luque, Rosa/0000-0003-0759-0608; Ferrer, Joan C./0000-0003-1212-5161	Natural Sciences and Engineering Research Council of Canada [9600]; Canada Research Chair Program; Ministerio de Ciencia e Innovacion (MICINN) [BFU2012-36827]; Generalitat de Catalunya [SGR2009-00327]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Discovery Grant 9600 from the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair Program (to P. C. L.) and by Grant BFU2012-36827 from the Ministerio de Ciencia e Innovacion (MICINN) and Grant SGR2009-00327 from the Generalitat de Catalunya (to I. F.).	Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Cowtan K., 1994, PROTEIN CRYSTALLOGR, V31, P34; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gu LC, 2007, SCIENCE, V318, P970, DOI 10.1126/science.1148790; HAAN EA, 1986, EUR J PEDIATR, V144, P567, DOI 10.1007/BF00496037; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HATCH MD, 1962, PLANT PHYSIOL, V37, P121, DOI 10.1104/pp.37.2.121; HAYAISHI O, 1955, J BIOL CHEM, V215, P125; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joly E, 2005, FEBS LETT, V579, P6581, DOI 10.1016/j.febslet.2005.10.050; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM YS, 1978, ARCH BIOCHEM BIOPHYS, V190, P234, DOI 10.1016/0003-9861(78)90273-4; Kolattukudy P E, 1981, Methods Enzymol, V71 Pt C, P150; LYNEN F, 1962, METHOD ENZYMOL, V5, P443, DOI 10.1016/S0076-6879(62)05256-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKADA HI, 1957, J BIOL CHEM, V226, P145; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; Sacksteder KA, 1999, J BIOL CHEM, V274, P24461, DOI 10.1074/jbc.274.35.24461; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WOLFE JB, 1954, J BIOL CHEM, V209, P885; Zhou W, 2009, ONCOGENE, V28, P2979, DOI 10.1038/onc.2009.160	26	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11907	11919		10.1074/jbc.M112.443846	http://dx.doi.org/10.1074/jbc.M112.443846			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482565	Green Published, hybrid			2022-12-25	WOS:000318157600026
J	Engelman, R; Weisman-Shomer, P; Ziv, T; Xu, JQ; Arner, ESJ; Benhar, M				Engelman, Rotem; Weisman-Shomer, Pnina; Ziv, Tamar; Xu, Jianqiang; Arner, Elias S. J.; Benhar, Moran			Multilevel Regulation of 2-Cys Peroxiredoxin Reaction Cycle by S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; PROTEIN DENITROSYLATION; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; THIOREDOXIN; PEROXYNITRITE; NITROSOTHIOLS; H2O2; MACROPHAGES; MECHANISMS	S-Nitrosothiols (SNOs), formed by nitric oxide (NO)-mediated S-nitrosylation, and hydrogen peroxide (H2O2), a prominent reactive oxygen species, are implicated in diverse physiological and pathological processes. Recent research has shown that the cellular action and metabolism of SNOs and H2O2 involve overlapping, thiol-based mechanisms, but how these reactive species may affect each other's fate and function is not well understood. In this study we investigated how NO/SNO may affect the redox cycle of mammalian peroxiredoxin-1 (Prx1), a representative of the 2-Cys Prxs, a group of thioredoxin (Trx)-dependent peroxidases. We found that, both in a cell-free system and in cells, NO/SNO donors such as S-nitrosocysteine and S-nitrosoglutathione readily induced the S-nitrosylation of Prx1, causing structural and functional alterations. In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity. A highly potent inhibition of the peroxidase catalytic reaction by NO/SNO was seen in assays employing the coupled Prx-Trx system. In this setting, S-nitrosocysteine (10 mu M) effectively blocked the Trx-mediated regeneration of oxidized Prx1. This effect appeared to be due to both competition between S-nitrosocysteine and Prx1 for the Trx system and direct modulation by S-nitrosocysteine of Trx reductase activity. Our findings that NO/SNO target both Prx and Trx reductase may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.	[Engelman, Rotem; Weisman-Shomer, Pnina; Benhar, Moran] Technion Israel Inst Technol, Fac Med, Rappaport Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-31096 Haifa, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Fac Biol, IL-31096 Haifa, Israel; [Xu, Jianqiang; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Karolinska Institutet	Benhar, M (corresponding author), Technion Israel Inst Technol, Fac Med, Rappaport Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel.	benhar@tx.technion.ac.il	Xu, Jianqiang/T-7507-2019; Arnér, Elias/K-6737-2019; Benhar, Moran/AAV-5764-2020; Arnér, Elias S.J./J-5832-2012	Xu, Jianqiang/0000-0002-1289-5943; Arnér, Elias/0000-0002-4807-6114; Benhar, Moran/0000-0002-7094-3456; Arnér, Elias S.J./0000-0002-4807-6114; Ziv, Tamar/0000-0003-4299-7454	Israel Science Foundation [1336/10]; FP7 European Commission (Marie Curie) grant program [256438]; Mallat family foundation; Karolinska Institutet; Swedish Research Council (Medicine); Swedish Cancer Society	Israel Science Foundation(Israel Science Foundation); FP7 European Commission (Marie Curie) grant program; Mallat family foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council (Medicine)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants from the Israel Science Foundation (1336/10), the FP7 European Commission (Marie Curie) grant program (256438), and the Mallat family foundation (to M. B.). This work was also supported by grants from the Karolinska Institutet, the Swedish Research Council (Medicine), and the Swedish Cancer Society (to E. S. J. A.).	ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Barglow KT, 2011, P NATL ACAD SCI USA, V108, pE600, DOI 10.1073/pnas.1110736108; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Bast A, 2010, FREE RADICAL BIO MED, V49, P1881, DOI 10.1016/j.freeradbiomed.2010.09.015; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2010, BIOCHEMISTRY-US, V49, P6963, DOI 10.1021/bi100619k; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Dammeyer P, 2011, BBA-GEN SUBJECTS, V1810, P111, DOI 10.1016/j.bbagen.2010.07.004; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Filep JG, 1997, BIOCHEM J, V321, P897, DOI 10.1042/bj3210897; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Karplus PA, 2012, MOL CELL, V45, P275, DOI 10.1016/j.molcel.2012.01.012; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Marcinkiewicz J, 1997, IMMUNOPHARMACOLOGY, V37, P35, DOI 10.1016/S0162-3109(96)00168-3; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Nelson Kimberly J, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0710s49; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Sengupta R, 2012, BBA-GEN SUBJECTS, V1820, P689, DOI 10.1016/j.bbagen.2011.08.012; Wang JY, 2003, J NEUROSCI RES, V72, P508, DOI 10.1002/jnr.10597; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu C, 2010, MOL CELL PROTEOMICS, V9, P2262, DOI 10.1074/mcp.M110.000034	47	49	49	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11312	11324		10.1074/jbc.M112.433755	http://dx.doi.org/10.1074/jbc.M112.433755			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479738	Green Published, hybrid			2022-12-25	WOS:000317915500034
J	Feng, L; Fong, KW; Wang, JD; Wang, WQ; Chen, JJ				Feng, Lin; Fong, Ka-Wing; Wang, Jiadong; Wang, Wenqi; Chen, Junjie			RIF1 Counteracts BRCA1-mediated End Resection during DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION; CELL-CYCLE; BRCA1 DEFICIENCY; DAMAGE-RESPONSE; BLM HELICASE; BREAK REPAIR; IN-VIVO	BRCA1 promotes homologous recombination repair and antagonizes 53BP1-dependent nonhomologous end joining (NHEJ) pathway. However, the molecular basis of the competition between BRCA1 and 53BP1 pathways remains elusive. Here we report that RIF1 protein translocates to damage sites via ATM-dependent 53BP1 phosphorylation. Strikingly, loss of RIF1 rescues initial DNA end resection and checkpoint activation in BRCA1-depleted cells. Interestingly RIF1 accumulation at damage sites is antagonized by BRCA1 in S and G(2) phases. Conversely, the translocation of BRCA1 to damage sites is inhibited by RIF1 in G(1) phase. However, loss of RIF1 differs from that of 53BP1 deficiency, as it cannot fully rescue RAD51 foci formation, homologous recombination defect, and radio-hypersensitivity in BRCA1-deficient cells. This is likely because RIF1, but not 53BP1, also regulates the foci formation and chromatin loading of BLM (the Bloom syndrome helicase). Thus, RIF1 not only acts downstream of 53BP1 and counteracts BRCA1-mediated end resection but also has a secondary role in promoting BLM function in DNA repair.	[Feng, Lin; Fong, Ka-Wing; Wang, Jiadong; Wang, Wenqi; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org		Wang, Wenqi/0000-0003-4053-5088; Fong, Ka-wing/0000-0001-6995-0264; Feng, Lin/0000-0001-6461-5838	National Institutes of Health [CA089239, CA092312, CA100109, CA016672]; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA089239, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470) and a member of MD Anderson Cancer Center (National Institutes of Health Grant CA016672). To whom correspondence should be addressed: Dept. of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-792-4863; Fax: 713-794-5369; E-mail: jchen8@mdanderson.org.	Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kousholt AN, 2012, J CELL BIOL, V197, P869, DOI 10.1083/jcb.201111065; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Liu JS, 2006, DNA REPAIR, V5, P369, DOI 10.1016/j.dnarep.2005.11.007; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Marcand S, 1997, CIBA F SYMP, V211, P76; Martinez P, 2012, J CELL BIOL, V197, P283, DOI 10.1083/jcb.201110124; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xue Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002417; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	51	194	200	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11135	11143		10.1074/jbc.M113.457440	http://dx.doi.org/10.1074/jbc.M113.457440			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23486525	Green Published, hybrid			2022-12-25	WOS:000317915500018
J	Ashbaugh, AR; Herbert, CF; Saimon, E; Azoulay, N; Olivera-Figueroa, L; Brunet, A				Ashbaugh, Andrea R.; Herbert, Christophe F.; Saimon, Elena; Azoulay, Nelson; Olivera-Figueroa, Lening; Brunet, Alain			The Decision to Vaccinate or Not during the H1N1 Pandemic: Selecting the Lesser of Two Evils?	PLOS ONE			English	Article							OBSESSIONAL-COMPULSIVE INVENTORY; ANXIETY STRESS SCALES; HEALTH-CARE WORKERS; INFLUENZA VACCINATION; SWINE FLU; PSYCHOMETRIC PROPERTIES; PUBLIC PERCEPTIONS; RISK; BEHAVIORS; IMPACT	Background: With the release of the H1N1 vaccine, there was much controversy surrounding its use despite strong encouragements to be vaccinated in the media. Though studies have examined factors influencing people's decision to be vaccinated, few have focused on how general beliefs about the world or where an individual gathers information might influence that decision. Methodology/Principal Findings: A cross-sectional web-based survey (N = 817) was conducted during the H1N1 outbreak after the vaccine was available. Variables examined included sociodemographic information, health related behaviours, specific beliefs concerning the H1N1 virus and its vaccine, as well as general beliefs, such as fear of contamination, intolerance of uncertainty, emotional states, coping behaviour, and the source of information concerning the virus. Three converging statistical methods were used to examine the associations - analysis of variance, logistic regression, and recursive partition modelling. The most consistent and strongest association was that negative beliefs about the H1N1 vaccine (e.g. fear of its side effects) was related to the decision not to be vaccinated, whereas beliefs about the dangers of the H1N1 virus was related to the decision to be vaccinated. Most notably, having very strong negative beliefs about the vaccine was a more powerful predictor than even strong beliefs about the dangers of the H1N1 virus. Furthermore, obtaining information from the Internet, as compared to more traditional sources of information (e.g., TV, newspapers) was related to the decision not to be vaccinated. Conclusions/Significance: These results are consistent with the Health Belief Model. Importantly they suggest that during future pandemics public health officials should not only discuss the dangers of the pandemic but also (i) take additional steps to reassure the public about the safety of vaccines and (ii) monitor the information disseminated over the Internet rather than strictly relying on the more traditional mass media.	[Ashbaugh, Andrea R.; Herbert, Christophe F.; Saimon, Elena; Azoulay, Nelson; Brunet, Alain] Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada; [Ashbaugh, Andrea R.; Herbert, Christophe F.; Azoulay, Nelson; Brunet, Alain] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Olivera-Figueroa, Lening] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [Olivera-Figueroa, Lening] US Dept Vet Affairs Connecticut Healthcare Syst, Dept Psychiat, West Haven, CT USA	McGill University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Ashbaugh, AR (corresponding author), Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada.	andrea.ashbaugh@mail.mcgill.ca		Olivera-Figueroa, Lening/0000-0001-6325-9819	Fonds de recherche du Quebec - Sante; Canadian Institutes of Health Research	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Alain Brunet acknowledges receiving a salary award from the Fonds de recherche du Quebec - Sante (formerly the FRSQ) while working on this manuscript. Andrea R. Ashbaugh acknowledges receiving a post-doctoral award from the Canadian Institutes of Health Research while working on this manuscript. Portions of this manuscript were presented at the 2011 annual convention of the Association for Behavioral and Cognitive Therapies in Toronto, Ontario. We would like to thank David Lightbown for help in creating the Figure.	[Anonymous], 2009, PAND H1N1 2009 UPD 7; [Anonymous], 2009, CBS NEWS; [Anonymous], INT US BROADB TEL RE; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arda B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-87; Aufderheide JJ, 2009, INGREDIENTS FOUND SP; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brewer NT, 2006, CLIN INFECT DIS, V43, P1379, DOI 10.1086/508466; Brien S, 2012, VACCINE, V30, P1255, DOI 10.1016/j.vaccine.2011.12.089; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Community and Hospital Infection Control Association - Canada, 2010, PAND H1N1 2009 VIR; COOK EF, 1984, J CHRON DIS, V37, P721, DOI 10.1016/0021-9681(84)90041-9; Dube Eve, 2010, BMC Res Notes, V3, P102, DOI 10.1186/1756-0500-3-102; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Fikretoglu D, 2006, J TRAUMA STRESS, V19, P847, DOI 10.1002/jts.20164; Finset A., 2002, PSYCHOL HEALTH MED, V7, P75, DOI [10.1080/13548500120101577, DOI 10.1080/13548500120101577]; Fox S., 2006, ONLINE HLTH SEARCH 2; Health Canada, 2009, HLTH CAN APPR PAND H; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Jones S., 2009, GENERATIONS ONLINE 2; Kiernan M, 2001, PSYCHOL METHODS, V6, P35, DOI 10.1037//1082-989X.6.1.35; Kusch L, 2009, GET READY ROLL YOUR; Lau JTF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-139; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Page LA, 2011, J MENT HEALTH, V20, P60, DOI 10.3109/09638237.2010.542787; Public Health Agency of Canada, 2009, CAN READ WHO MOV PHA; Public Health Agency of Canada, 2009, GUID H1N1 FLU VIR; Quinn SC, 2009, BIOSECUR BIOTERROR, V7, P275, DOI 10.1089/bsp.2009.0041; Radomsky Adam S., 2006, Cognitive Behaviour Therapy, V35, P164, DOI 10.1080/16506070600827198; Rosen NO, 2007, PSYCHOL HEALTH, V22, P413, DOI 10.1080/14768320600941038; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Savas E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-281; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; SHERBOURNE CD, 1992, J BEHAV MED, V15, P447, DOI 10.1007/BF00844941; Statistics Canada, 2010, CAN COMM HLTH SURV H; Steketee G, 2001, BEHAV RES THER, V39, P987; Thordarson DS, 2004, BEHAV RES THER, V42, P1289, DOI 10.1016/j.brat.2003.08.007; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; Wolfe RM, 2005, J HEALTH COMMUN, V10, P537, DOI 10.1080/10810730500228847	50	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58852	10.1371/journal.pone.0058852	http://dx.doi.org/10.1371/journal.pone.0058852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505565	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500130
J	Belluoccio, D; Rowley, L; Little, CB; Bateman, JF				Belluoccio, Daniele; Rowley, Lynn; Little, Christopher B.; Bateman, John F.			Maintaining mRNA Integrity during Decalcification of Mineralized Tissues	PLOS ONE			English	Article							CARTILAGE; EXPRESSION	Biomineralization of the extracellular matrix occurs inappropriately in numerous pathological conditions such as cancer and vascular disease, but during normal mammalian development calcification is restricted to the formation of the skeleton and dentition. The comprehensive study of gene expression in mineralized skeletal tissues has been compromized by the traditional decalcification/fixation methods that result in significant mRNA degradation. In this study we developed a novel RNAlater/EDTA decalcification method that protects the integrity of the mRNA in mature mouse tibial epiphyses. Furthermore, this method preserves the tissue structure to allow histological sectioning and microdissection to determine region-specific gene expression, in addition to immuno- and in situ histology. This method will be widely applicable to the molecular analysis of calcified tissues in various pathological conditions, and will be of particular importance in dissection of the gene expression in mouse bone and joint tissues during development and in important clinical conditions such as arthritis.	[Belluoccio, Daniele; Rowley, Lynn; Bateman, John F.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bateman, John F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Little, Christopher B.] Royal N Shore Hosp, Kolling Inst Med Res, Raymond Purves Bone & Joint Res Labs, St Leonards, NSW 2065, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Bateman, JF (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	john.bateman@mcri.edu.au	Little, Christopher B/A-9280-2015	Little, Christopher B/0000-0002-0353-7634; Bateman, John/0000-0001-8542-0730	National Health and Medical Research Council of Australia [1002797, 607399]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by Project Grants (#607399) and a Research Fellowship (#1002797) to JFB from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au), the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluoccio D, 2008, BBA-GENE REGUL MECH, V1779, P330, DOI 10.1016/j.bbagrm.2008.02.010; Cameron TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024600; Goldring SR, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3135; Little CB, 2008, CURR RHEUMATOL REV, V4, P175, DOI 10.2174/157339708785133523; Melrose J, 2008, BIOTECH HISTOCHEM, V83, P47, DOI 10.1080/10520290801990414; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Salmon CR, 2012, DIAGNOSTIC MOL PAT B; Shao YY, 2006, LAB INVEST, V86, P1089, DOI 10.1038/labinvest.3700459	8	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58154	10.1371/journal.pone.0058154	http://dx.doi.org/10.1371/journal.pone.0058154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505463	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500055
J	Brackett, DM; Qing, F; Amieux, PS; Sellers, DL; Horner, PJ; Morris, DR				Brackett, David M.; Qing, Feng; Amieux, Paul S.; Sellers, Drew L.; Horner, Philip J.; Morris, David R.			Fmr1 Transcript Isoforms: Association with Polyribosomes; Regional and Developmental Expression in Mouse Brain	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; RNA-BINDING; ADULT NEUROGENESIS; DIFFERENT TISSUES; MESSENGER-RNA; GENE; TRANSLATION; NEURONS; NUCLEAR	The primary transcript of the mammalian Fragile X Mental Retardation-1 gene (Fmr1), like many transcripts in the central nervous system, is alternatively spliced to yield mRNAs encoding multiple proteins, which can possess quite different biochemical properties. Despite the fact that the relative levels of the 12 Fmr1 transcript isoforms examined here vary by as much as two orders of magnitude amongst themselves in both adult and embryonic mouse brain, all are associated with polyribosomes, consistent with translation into the corresponding isoforms of the protein product, FMRP ( Fragile X Mental Retardation Protein). Employing the RiboTag methodology developed in our laboratory, the relative proportions of the 7 most abundant transcript isoforms were measured specifically in neurons and found to be similar to those identified in whole brain. Measurements of isoform profiles across 11 regions of adult brain yielded similar distributions, with the exceptions of the hippocampus and the olfactory bulb. These two regions differ from most of the brain in relative amounts of transcripts encoding an alternate form of one of the KH RNA binding domains. A possible relationship between patterns of expression in the hippocampus and olfactory bulb and the presence of neuroblasts in these two regions is suggested by the isoform patterns in early embryonic brain and in cultured neural progenitor cells. These results demonstrate that the relative levels of the Fmr1 isoforms are modulated according to developmental stage, highlighting the complex ramifications of losing all the protein isoforms in individuals with Fragile X Syndrome. It should also be noted that, of the eight most prominent FMRP isoforms (1-3, 6-9 and 12) in mouse, only two have the major site of phosphorylation at Ser-499, which is thought to be involved in some of the regulatory interactions of this protein.	[Brackett, David M.; Qing, Feng; Morris, David R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Amieux, Paul S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sellers, Drew L.; Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Morris, DR (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dmorris@u.washington.edu	Amieux, Paul/AAG-4102-2021; Horner, Philip J./AAF-7012-2021	Feng, Qing/0000-0001-9166-2760	Fragile X Research Foundation; NIH/NICHD [P30 HD02274-S]; NIH [1R21RR021704-02]; FRAXA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR021704] Funding Source: NIH RePORTER	Fragile X Research Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Fragile X Research Foundation; NIH/NICHD P30 HD02274-S. A portion of this work was support by NIH grant 1R21RR021704-02 (to DRM). DMB acknowledges a postdoctoral fellowship from FRAXA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 1999, J NEUROPATH EXP NEUR, V58, P867, DOI 10.1097/00005072-199908000-00009; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; Denman RB, 2004, CELL MOL LIFE SCI, V61, P1714, DOI 10.1007/s00018-004-4059-2; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Dolzhanskaya N, 2008, BIOCHEMISTRY-US, V47, P8491, DOI 10.1021/bi702298f; Dolzhanskaya N, 2006, BIOCHEMISTRY-US, V45, P10385, DOI 10.1021/bi0525019; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; Jacobs S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-132; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Pacey LKK, 2007, GLIA, V55, P1601, DOI 10.1002/glia.20573; Petit A, 2007, P NATL ACAD SCI USA, V104, P17837, DOI 10.1073/pnas.0703240104; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; Rebrikov D V, 2006, Prikl Biokhim Mikrobiol, V42, P520; Richter, 1997, ANAL MRNA FORMATION, P305, DOI 10.1016/B978-012587545-5/50017-3; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Tian HJ, 2005, MOL BRAIN RES, V137, P174, DOI 10.1016/j.molbrainres.2005.03.001; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; VERHEIJ C, 1995, HUM MOL GENET, V4, P895, DOI 10.1093/hmg/4.5.895; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Wen X, 2009, NEUROBIOL DIS, V35, P52, DOI 10.1016/j.nbd.2009.03.015; Yang Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003172; ZOMZELY CE, 1968, J BIOL CHEM, V243, P5396; ZOMZELY CE, 1966, J MOL BIOL, V19, P455, DOI 10.1016/S0022-2836(66)80016-5	59	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58296	10.1371/journal.pone.0058296	http://dx.doi.org/10.1371/journal.pone.0058296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505481	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500065
J	Dranchak, P; MacArthur, R; Guha, R; Zuercher, WJ; Drewry, DH; Auld, DS; Inglese, J				Dranchak, Patricia; MacArthur, Ryan; Guha, Rajarshi; Zuercher, William J.; Drewry, David H.; Auld, Douglas S.; Inglese, James			Profile of the GSK Published Protein Kinase Inhibitor Set Across ATP-Dependent and-Independent Luciferases: Implications for Reporter-Gene Assays	PLOS ONE			English	Article							FIREFLY LUCIFERASE; CHEMICAL LIBRARIES; RENILLA LUCIFERASE; POTENT INHIBITORS; TYROSINE KINASE; ENERGY-TRANSFER; IN-VITRO; DISCOVERY; IDENTIFICATION; BIOLUMINESCENCE	A library of 367 protein kinase inhibitors, the GSK Published Kinase Inhibitor Set (PKIS), which has been annotated for protein kinase family activity and is available for public screening efforts, was assayed against the commonly used luciferase reporter enzymes from the firefly, Photinus pyralis (FLuc) and marine sea pansy, Renilla reniformis (RLuc). A total of 22 compounds (similar to 6% of the library) were found to inhibit FLuc with 10 compounds showing potencies <= 1 mu M. Only two compounds were found to inhibit RLuc, and these showed relatively weak potency values (similar to 10 mu M). An inhibitor series of the VEGFR2/TIE2 protein kinase family containing either an aryl oxazole or benzimidazole-urea core illustrate the different structure activity relationship profiles FLuc inhibitors can display for kinase inhibitor chemotypes. Several FLuc inhibitors were broadly active toward the tyrosine kinase and CDK families. These data should aid in interpreting the results derived from screens employing the GSK PKIS in cell-based assays using the FLuc reporter. The study also underscores the general need for strategies such as the use of orthogonal reporters to identify kinase or non-kinase mediated cellular responses.	[Dranchak, Patricia; MacArthur, Ryan; Guha, Rajarshi; Auld, Douglas S.; Inglese, James] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Inglese, James] NHGRI, NIH, Bethesda, MD 20892 USA; [Zuercher, William J.; Drewry, David H.] GlaxoSmithKline, Dept Biol Chem, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); GlaxoSmithKline	Inglese, J (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA.	jinglese@mail.nih.gov		Drewry, David Harold/0000-0001-5973-5798	NIH Roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the NIH Roadmap for Medical Research (J.I. and D.S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell R, 2008, BIOORG MED CHEM LETT, V18, P4428, DOI 10.1016/j.bmcl.2008.06.048; Angell RM, 2007, BIOORG MED CHEM LETT, V17, P1296, DOI 10.1016/j.bmcl.2006.12.003; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bamborough P, 2007, BIOORG MED CHEM LETT, V17, P4363, DOI 10.1016/j.bmcl.2007.04.029; Bramson HN, 2001, J MED CHEM, V44, P4339, DOI 10.1021/jm010117d; Cheng KCC, 2012, NAT METHODS, V9, P937, DOI 10.1038/nmeth.2170; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Guiguemde WA, 2012, CHEM BIOL, V19, P116, DOI 10.1016/j.chembiol.2012.01.004; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Harris PA, 2005, J MED CHEM, V48, P1610, DOI 10.1021/jm049538w; HART RC, 1979, BIOCHEMISTRY-US, V18, P2204, DOI 10.1021/bi00578a011; Hasegawa M, 2007, J MED CHEM, V50, P4453, DOI 10.1021/jm0611051; Herbst KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005642; Hert J, 2004, ORG BIOMOL CHEM, V2, P3256, DOI 10.1039/b409865j; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jang SW, 2012, ACS CHEM BIOL, V7, P1205, DOI 10.1021/cb300048d; Liu Y, 2012, BIOORGAN MED CHEM, V20, P5473, DOI 10.1016/j.bmc.2012.07.035; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; MCELROY WD, 1967, SCIENCE, V157, P150, DOI 10.1126/science.157.3785.150; Michelini E, 2010, ANAL BIOANAL CHEM, V398, P227, DOI 10.1007/s00216-010-3933-z; Peat AJ, 2004, BIOORG MED CHEM LETT, V14, P2121, DOI 10.1016/j.bmcl.2004.02.036; Sammond DM, 2005, BIOORG MED CHEM LETT, V15, P3519, DOI 10.1016/j.bmcl.2005.05.096; Shukla SJ, 2009, ASSAY DRUG DEV TECHN, V7, P143, DOI 10.1089/adt.2009.193; Southall N. A., 2009, HDB DRUG SCREENING, P442; Stables J, 1999, J RECEPT SIGNAL TR R, V19, P395, DOI 10.3109/10799899909036660; Stavenger RA, 2007, J MED CHEM, V50, P2, DOI 10.1021/jm060873p; Stevens KL, 2008, BIOORG MED CHEM LETT, V18, P5758, DOI 10.1016/j.bmcl.2008.09.069; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Thorne N, 2012, CHEM BIOL, V19, P1060, DOI 10.1016/j.chembiol.2012.07.015; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Witherington J, 2003, BIOORG MED CHEM LETT, V13, P3055, DOI 10.1016/S0960-894X(03)00645-0; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Xiao JB, 2011, J MED CHEM, V54, P6215, DOI 10.1021/jm200497t	44	45	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57888	10.1371/journal.pone.0057888	http://dx.doi.org/10.1371/journal.pone.0057888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505445	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500037
J	Amirian, ES; Fickey, PA; Scheurer, ME; Chiao, EY				Amirian, E. Susan; Fickey, Paul A., Jr.; Scheurer, Michael E.; Chiao, Elizabeth Y.			Anal Cancer Incidence and Survival: Comparing the Greater San-Francisco Bay Area to Other SEER Cancer Registries	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS INFECTION; COST-EFFECTIVENESS; RISK-FACTORS; MEN; SEX; EPIDEMIOLOGY; INDIVIDUALS; PREVALENCE	The incidence of squamous cell carcinoma of the anus, anal canal, and anorectum (SCCA) has increased over time. However, there are still no national guidelines on screening for SCCA among high-risk populations. Providers at University of California, San Francisco have been at the forefront of providing anal dysplasia screening. To determine whether such a screening program allows for earlier detection of abnormalities and consequently, improves patient survival, we conducted an ecological study using data from the Surveillance, Epidemiology, and End Results (SEER) program to compare the San Francisco-Oakland catchment area (SF-O) to other SEER sites where routine screening has not been as accessible. Cox regression models were utilized to assess the impact of residing in the SF-O region, versus other SEER sites, on cause-specific mortality hazard. Logistic regression was used to determine if site was associated with the probability of having an in situ versus invasive tumor among SCCA cases. All analyses were stratified on calendar time (1985-1995 and 1996-2008) to compare differences pre- and post-highly active anti-retroviral therapy. Among SCCA cases, being reported by the SF-O registry was associated with a four fold higher probability of having an in situ tumor (rather than an invasive tumor) [95% CI: 3.48-4.61], compared to sites outside of California, between 1996 and 2008. Cases reported from the SF-O region between 1996 and 2008 had a 39% lower mortality risk than those reported from registries outside California (95% CI: 0.51-0.72). However, there was no decrease in the rate of invasive SCCA over this period. This is the first ecological study to evaluate whether access to anal cancer screening programs may help improve patient survival by allowing for earlier detection of lesions. Our results imply that routine screening programs may help detect SCCA at an earlier stage and thus, potentially impact patient survival.	[Amirian, E. Susan; Scheurer, Michael E.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Amirian, E. Susan; Scheurer, Michael E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Fickey, Paul A., Jr.; Chiao, Elizabeth Y.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Scheurer, ME (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	scheurer@bcm.edu		Scheurer, Michael/0000-0002-8379-6088; Chiao, Elizabeth/0000-0001-5752-2916	NCI NIH HHS [R01 CA163103] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA163103] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barroso LF, 2012, LANCET ONCOL, V13, pE278, DOI 10.1016/S1470-2045(12)70169-9; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Chiao EY, 2006, CLIN INFECT DIS, V43, P223, DOI 10.1086/505219; Chiao EY, 2005, JAIDS-J ACQ IMM DEF, V40, P451, DOI 10.1097/01.qai.0000159669.80207.12; Chin-Hong PV, 2008, ANN INTERN MED, V149, P300, DOI 10.7326/0003-4819-149-5-200809020-00004; Chin-Hong Peter V, 2005, Dermatol Ther, V18, P67, DOI 10.1111/j.1529-8019.2005.05009.x; Clark MA, 2004, LANCET ONCOL, V5, P149, DOI 10.1016/S1470-2045(04)01410-X; D'Souza G, 2008, J GEN INTERN MED, V23, P1452, DOI 10.1007/s11606-008-0698-6; Daibata M, 1998, LEUKEMIA, V12, P1002, DOI 10.1038/sj.leu.2401036; Goldie SJ, 2000, AM J MED, V108, P634, DOI 10.1016/S0002-9343(00)00349-1; Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Holly EA, 2001, J NATL CANCER I, V93, P843, DOI 10.1093/jnci/93.11.843; Howlader N, 2012, SEER CANC STAT REV 1; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Nielsen A, 2012, INT J CANCER, V130, P1168, DOI 10.1002/ijc.26115; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky J, 2012, LANCET ONCOL, V13, pE279, DOI 10.1016/S1470-2045(12)70215-2; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; UCSF Department of Medicine Anal Cancer Information, COMPL LIST HRA PROV	23	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58919	10.1371/journal.pone.0058919	http://dx.doi.org/10.1371/journal.pone.0058919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484057	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100143
J	de Juan-Sanz, J; Nunez, E; Lopez-Corcuera, B; Aragon, C				de Juan-Sanz, Jaime; Nunez, Enrique; Lopez-Corcuera, Beatriz; Aragon, Carmen			Constitutive Endocytosis and Turnover of the Neuronal Glycine Transporter GlyT2 Is Dependent on Ubiquitination of a C-Terminal Lysine Cluster	PLOS ONE			English	Article							DOPAMINE TRANSPORTER; SUBCELLULAR-LOCALIZATION; TRAFFICKING; INTERNALIZATION; HYPEREKPLEXIA; RECEPTORS; UCH-L1; UBIQUITYLATION; DEGRADATION; MUTATIONS	Inhibitory glycinergic neurotransmission is terminated by sodium and chloride-dependent plasma membrane glycine transporters (GlyTs). The mainly glial glycine transporter GlyT1 is primarily responsible for the completion of inhibitory neurotransmission and the neuronal glycine transporter GlyT2 mediates the reuptake of the neurotransmitter that is used to refill synaptic vesicles in the terminal, a fundamental role in the physiology and pathology of glycinergic neurotransmission. Indeed, inhibitory glycinergic neurotransmission is modulated by the exocytosis and endocytosis of GlyT2. We previously reported that constitutive and Protein Kinase C (PKC)-regulated endocytosis of GlyT2 is mediated by clathrin and that PKC accelerates GlyT2 endocytosis by increasing its ubiquitination. However, the role of ubiquitination in the constitutive endocytosis and turnover of this protein remains unexplored. Here, we show that ubiquitination of a C-terminus four lysine cluster of GlyT2 is required for constitutive endocytosis, sorting into the slow recycling pathway and turnover of the transporter. Ubiquitination negatively modulates the turnover of GlyT2, such that increased ubiquitination driven by PKC activation accelerates transporter degradation rate shortening its half-life while decreased ubiquitination increases transporter stability. Finally, ubiquitination of GlyT2 in neurons is highly responsive to the free pool of ubiquitin, suggesting that the deubiquitinating enzyme (DUB) ubiquitin C-terminal hydrolase-L1 (UCHL1), as the major regulator of neuronal ubiquitin homeostasis, indirectly modulates the turnover of GlyT2. Our results contribute to the elucidation of the mechanisms underlying the dynamic trafficking of this important neuronal protein which has pathological relevance since mutations in the GlyT2 gene (SLC6A5) are the second most common cause of human hyperekplexia.	[de Juan-Sanz, Jaime; Nunez, Enrique; Lopez-Corcuera, Beatriz; Aragon, Carmen] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [de Juan-Sanz, Jaime; Nunez, Enrique; Lopez-Corcuera, Beatriz; Aragon, Carmen] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [de Juan-Sanz, Jaime; Nunez, Enrique; Lopez-Corcuera, Beatriz; Aragon, Carmen] IdiPAZ Hosp Univ La Paz, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario La Paz	Aragon, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain.	caragon@cbm.uam.es	Corcuera, Beatriz López/D-5188-2009; Aragon, Carmen/K-9783-2014; de Juan-Sanz, Jaime/L-7990-2017	Corcuera, Beatriz López/0000-0002-0383-4241; Aragon, Carmen/0000-0001-8287-9386; de Juan-Sanz, Jaime/0000-0002-1212-5623	Spanish Direccion General de Investigacion Cientifica y Tecnica [SAF2008-05436, SAF2011-28674]; Fondo de Investigaciones Sanitarias (CIBERER); Comunidad Autonoma de Madrid; Fundacion Ramon Areces	Spanish Direccion General de Investigacion Cientifica y Tecnica(Spanish Government); Fondo de Investigaciones Sanitarias (CIBERER)(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	Spanish Direccion General de Investigacion Cientifica y Tecnica (Grant numbers: SAF2008-05436; SAF2011-28674). Grant sponsors: Fondo de Investigaciones Sanitarias (CIBERER), Comunidad Autonoma de Madrid, Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Armsen W, 2007, MOL CELL NEUROSCI, V36, P369, DOI 10.1016/j.mcn.2007.07.011; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; de Juan-Sanz J, 2011, TRAFFIC, V12, P1850, DOI 10.1111/j.1600-0854.2011.01278.x; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Fernandez-Sanchez E, 2009, J BIOL CHEM, V284, P19482, DOI 10.1074/jbc.M109.005165; Fornes A, 2004, J BIOL CHEM, V279, P22934, DOI 10.1074/jbc.M401337200; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Fujimuro M, 2005, METHOD ENZYMOL, V399, P75, DOI 10.1016/S0076-6879(05)99006-X; Geerlings A, 2002, J NEUROCHEM, V82, P58, DOI 10.1046/j.1471-4159.2002.00930.x; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Gill JL, 2011, NEUROBIOL DIS, V43, P184, DOI 10.1016/j.nbd.2011.03.010; Gimenez C, 2012, J BIOL CHEM, V287, P28986, DOI 10.1074/jbc.M111.319244; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Harvey RJ, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.001.2008; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kurihara LJ, 2001, HUM MOL GENET, V10, P1963, DOI 10.1093/hmg/10.18.1963; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Martinez-Villarreal J, 2012, GLIA, V60, P1356, DOI 10.1002/glia.22354; Michaely P, 2007, EMBO J, V26, P3273, DOI 10.1038/sj.emboj.7601769; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Walters BJ, 2008, MOL CELL NEUROSCI, V39, P539, DOI 10.1016/j.mcn.2008.07.028; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	52	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58863	10.1371/journal.pone.0058863	http://dx.doi.org/10.1371/journal.pone.0058863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484054	Green Published, gold			2022-12-25	WOS:000316936100140
J	Hua, WK; Chang, YI; Yao, CL; Hwang, SM; Chang, CY; Lin, WJ				Hua, Wei-Kai; Chang, Yuan-I; Yao, Chao-Ling; Hwang, Shiaw-Min; Chang, Chung-Yi; Lin, Wey-Jinq			Protein Arginine Methyltransferase 1 Interacts with and Activates p38 alpha to Facilitate Erythroid Differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; HEMATOPOIETIC STEM-CELL; P38 MAP-KINASE; MEGAKARYOCYTIC DIFFERENTIATION; METHYLATION; PRMT1; PHOSPHORYLATION; REGULATOR; MECHANISM; ERYTHROPOIETIN	Protein arginine methylation is emerging as a pivotal posttranslational modification involved in regulating various cellular processes; however, its role in erythropoiesis is still elusive. Erythropoiesis generates circulating red blood cells which are vital for body activity. Deficiency in erythroid differentiation causes anemia which compromises the quality of life. Despite extensive studies, the molecular events regulating erythropoiesis are not fully understood. This study showed that the increase in protein arginine methyltransferase 1 (PRMT1) levels, via transfection or protein transduction, significantly promoted erythroid differentiation in the bipotent human K562 cell line as well as in human primary hematopoietic progenitor CD34(+) cells. PRMT1 expression enhanced the production of hemoglobin and the erythroid surface marker glycophorin A, and also up-regulated several key transcription factors, GATA1, NF-E2 and EKLF, which are critical for lineage-specific differentiation. The shRNA-mediated knockdown of PRMT1 suppressed erythroid differentiation. The methyltransferase activity-deficient PRMT1G80R mutant failed to stimulate differentiation, indicating the requirement of arginine methylation of target proteins. Our results further showed that a specific isoform of p38 MAPK, p38 alpha, promoted erythroid differentiation, whereas p38 beta did not play a role. The stimulation of erythroid differentiation by PRMT1 was diminished in p38 alpha-but not p38 beta-knockdown cells. PRMT1 appeared to act upstream of p38 alpha, since expression of p38 alpha still promoted erythroid differentiation in PRMT1-knockdown cells, and expression of PRMT1 enhanced the activation of p38 MAPK. Importantly, we showed for the first time that PRMT1 was associated with p38 alpha in cells by co-immunoprecipitation and that PRMT1 directly methylated p38 alpha in in vitro methylation assays. Taken together, our findings unveil a link between PRMT1 and p38 alpha in regulating the erythroid differentiation program and provide evidence suggesting a novel regulatory mechanism for p38 alpha through arginine methylation.	[Hua, Wei-Kai; Chang, Yuan-I; Lin, Wey-Jinq] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Yao, Chao-Ling] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Chungli, Taiwan; [Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Chang, Chung-Yi] Cheng Hsin Gen Hosp, Ctr Heart, Taipei, Taiwan	National Yang Ming Chiao Tung University; Yuan Ze University; Cheng Hsin General Hospital	Lin, WJ (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.	wjlin@ym.edu.tw	Chang, Yuan-I/AAY-1711-2021; Yao, Chao-Ling/HDN-2709-2022	Yao, Chao-Ling/0000-0002-7196-5833	National Science Council, Taiwan [NSC 100-2311-B-010-002, NSC 99-2221-E-155-086-MY2, NSC-101-2221-E-155-044-MY3]; Ministry of Education, Aim for the Top University Plan; Cheng Hsin General Hospital and National Yang-Ming University [101F195CY19]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Cheng Hsin General Hospital and National Yang-Ming University	This work was supported by grants from the National Science Council, Taiwan (NSC 100-2311-B-010-002 to WJL; NSC 99-2221-E-155-086-MY2 and NSC-101-2221-E-155-044-MY3 to CLY), the Ministry of Education, Aim for the Top University Plan, and Cheng Hsin General Hospital and National Yang-Ming University (101F195CY19 to WJL and CYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Chang YI, 2011, BIOCHEM BIOPH RES CO, V404, P865, DOI 10.1016/j.bbrc.2010.12.076; Chang YI, 2010, ELECTROPHORESIS, V31, P3834, DOI 10.1002/elps.201000376; Chang YI, 2010, J BIOL CHEM, V285, P20595, DOI 10.1074/jbc.M109.092411; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cho JH, 2012, CELL DEATH DIFFER, V19, P859, DOI 10.1038/cdd.2011.168; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Duong FHT, 2005, J VIROL, V79, P15342, DOI 10.1128/JVI.79.24.15342-15350.2005; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lei NZ, 2009, NUCLEIC ACIDS RES, V37, P832, DOI 10.1093/nar/gkn941; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Pace BS, 2003, EXP HEMATOL, V31, P1089, DOI 10.1016/S0301-472X(03)00235-2; Park JI, 2001, CELL GROWTH DIFFER, V12, P481; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Sakamaki J, 2011, P NATL ACAD SCI USA, V108, P6085, DOI 10.1073/pnas.1015328108; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Tallack MR, 2009, HAEMATOLOGICA, V95, P144; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Wang D, 2005, APOPTOSIS, V10, P963, DOI 10.1007/s10495-005-1191-x; Wickrema A, 2007, ONCOGENE, V26, P6803, DOI 10.1038/sj.onc.1210763; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56715	10.1371/journal.pone.0056715	http://dx.doi.org/10.1371/journal.pone.0056715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483889	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100007
J	Swami, V; Tovee, MJ				Swami, Viren; Tovee, Martin J.			Resource Security Impacts Men's Female Breast Size Preferences	PLOS ONE			English	Article							TO-HIP RATIO; PHYSICAL ATTRACTIVENESS; BODY-WEIGHT; SEXUAL SELECTION; MAMMARY-GLAND; CANCER RISK; PERCEPTIONS; JUDGMENTS; PROFILE; WOMEN	It has been suggested human female breast size may act as signal of fat reserves, which in turn indicates access to resources. Based on this perspective, two studies were conducted to test the hypothesis that men experiencing relative resource insecurity should perceive larger breast size as more physically attractive than men experiencing resource security. In Study 1, 266 men from three sites in Malaysia varying in relative socioeconomic status ( high to low) rated a series of animated figures varying in breast size for physical attractiveness. Results showed that men from the low socioeconomic context rated larger breasts as more attractive than did men from the medium socioeconomic context, who in turn perceived larger breasts as attractive than men from a high socioeconomic context. Study 2 compared the breast size judgements of 66 hungry versus 58 satiated men within the same environmental context in Britain. Results showed that hungry men rated larger breasts as significantly more attractive than satiated men. Taken together, these studies provide evidence that resource security impacts upon men's attractiveness ratings based on women's breast size.	[Swami, Viren] Univ Westminster, Dept Psychol, London W1R 8AL, England; [Swami, Viren] HELP Univ Coll, Dept Psychol, Kuala Lumpur, Malaysia; [Tovee, Martin J.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Westminster; Help University; Newcastle University - UK	Swami, V (corresponding author), Univ Westminster, Dept Psychol, London W1R 8AL, England.	v.swami@westminster.ac.uk		Tovee, Martin/0000-0001-9642-4462				Adkins L., 1996, SEX SENSIBILITY GEND, P99, DOI DOI 10.1007/978-1-349-24536-9_6; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Bomalaski JJ, 2001, CURR OPIN OBSTET GYN, V13, P15, DOI 10.1097/00001703-200102000-00003; Brown N, 2012, AM J HUM BIOL, V24, P158, DOI 10.1002/ajhb.22212; CANT JGH, 1981, AM NAT, V117, P199, DOI 10.1086/283699; Cornelissen PL, 2009, EVOL HUM BEHAV, V30, P417, DOI 10.1016/j.evolhumbehav.2009.04.003; den Daas C, SOC PSYCHOL IN PRESS; Dettwyler Kathy A., 1995, BREASTFEEDING BIOCUL, P167, DOI DOI 10.4324/9781315081984-7; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P1271, DOI 10.1007/s10508-010-9680-6; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P51, DOI 10.1007/s10508-010-9601-8; Einon, 2007, BODY BEAUTIFUL EVOLU, P131; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Ford C. S., 1952, PATTERNS SEXUAL BEHA; Furnham A, 1998, SEX ROLES, V39, P311, DOI 10.1023/A:1018810723493; Furnham A., 2008, PSYCHOL PHYS ATTRACT; Furnham A, 2007, SOC BEHAV PERSONAL, V35, P1, DOI 10.2224/sbp.2007.35.1.1; Gallup G. G., 1982, J HUM EVOL, V19, P111; Gerald W., 2009, SPACES DIFFERENCE IN, V2, P3; GITTER AG, 1983, J SOC PSYCHOL, V121, P7, DOI 10.1080/00224545.1983.9924460; Government of Malaysia, 2001, 8 MAL PLAN 2001 2005; Gray PB, 2012, EVOL PSYCHOL-US, V10, P631, DOI 10.1177/147470491201000319; Halik M, 2011, J ECON PSYCHOL, V32, P231, DOI 10.1016/j.joep.2009.02.006; HORVATH T, 1981, ARCH SEX BEHAV, V10, P21, DOI 10.1007/BF01542671; HSIEH CC, 1991, EUR J CANCER, V27, P131, DOI 10.1016/0277-5379(91)90469-T; Huss-ashmore R, 1980, Yearb Phys Anthropol, V23, P65; Hytten FE, 1971, PHYSL HUMAN PREGNANC; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; KLEINKE CL, 1980, J SOC PSYCHOL, V110, P123, DOI 10.1080/00224545.1980.9924231; Koff E, 1998, SEX ROLES, V38, P655, DOI 10.1023/A:1018802928210; LOW BS, 1987, ETHOL SOCIOBIOL, V8, P249, DOI 10.1016/0162-3095(87)90027-6; Marlowe FW, 1998, HUM NATURE-INT BIOS, V9, P263, DOI 10.1007/s12110-998-1005-2; Merrill EP, 2002, APPETITE, V39, P181, DOI 10.1006/appe.2002.0496; Morris D., 1967, NAKED APE ZOOLOGISTS; NEIFERT MR, 1985, PEDIATRICS, V76, P823; Nelson LD, 2005, PSYCHOL SCI, V16, P167, DOI 10.1111/j.0956-7976.2005.00798.x; Nelson LD, 2007, BODY BEAUTIFUL EVOLU, P185; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Ortigosa A, 2002, ANIM BEHAV, V64, P369, DOI 10.1006/anbe.2002.3065; PATTON S, 1976, BIOMEDICAL ASPECTS L; Pawlowski B, 1999, HOMO, V50, P149; Pettijohn II T. F., 2003, N AM J PSYCHOL, V5, P335; Pettijohn II T. F., 1999, MEDIA PSYCHOL, V1, P229, DOI [10.1207/s1532785xmep0103_3, DOI 10.1207/S1532785XMEP0103_3]; Pettijohn T. F., 2009, J SOC EVOL CULT PSYC, V3, P216, DOI [DOI 10.1037/H0099321, 10.1037/h0099321]; Pettijohn TE, 2005, J SOC PSYCHOL, V145, P547, DOI 10.3200/SOCP.145.5.547-570; Pettijohn TF, 2004, PERS SOC PSYCHOL B, V30, P1186, DOI 10.1177/0146167204264078; Ramsay DT, 2005, J ANAT, V206, P525, DOI 10.1111/j.1469-7580.2005.00417.x; Seifert T, 2005, INT J EAT DISORDER, V37, P271, DOI 10.1002/eat.20086; Short R. V., 1980, REPROD ANIMALS BOOK; Singh D, 1995, ETHOL SOCIOBIOL, V16, P483, DOI 10.1016/0162-3095(95)00074-7; Smith N., 1986, J HUM EVOL, V1, P285; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Sugiyama LS, 2004, EVOL HUM BEHAV, V25, P51, DOI 10.1016/S1090-5138(03)00083-7; Swami V., 2011, EVOLUTIONARY PSYCHOL, P131; Swami V, 2012, ENCY BODY IMAGE HUMA, P622; Swami V., 2007, J EVOLUTIONARY PSYCH, V5, P149, DOI [10.1556/JEP.2007.1005, DOI 10.1556/JEP.2007.1005]; Swami V, ARCH SEX BE IN PRESS; Swami V., 2006, J ARTIC SUPPORT NULL, V4, P17; Swami V, 2007, BODY IMAGE, V4, P391, DOI 10.1016/j.bodyim.2007.07.002; Swami V, 2007, BODY IMAGE, V4, P219, DOI 10.1016/j.bodyim.2007.01.002; Swami V, 2007, SCAND J PSYCHOL, V48, P43, DOI 10.1111/j.1467-9450.2006.00526.x; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Swami V, 2006, BRIT J PSYCHOL, V97, P353, DOI 10.1348/000712605X80713; Swami V, 2012, INT J SOC PSYCHIATR, V58, P568, DOI 10.1177/0020764011415208; Swami V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042593; Swami Viren, 2005, Body Image, V2, P383, DOI 10.1016/j.bodyim.2005.08.001; Swami V, 2010, LEARN INDIVID DIFFER, V20, P51, DOI 10.1016/j.lindif.2009.11.002; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Swami V, 2009, BRIT J PSYCHOL, V100, P313, DOI 10.1348/000712608X329525; Swami Viren, 2007, BODY BEAUTIFUL EVOLU; Tantleff-Dunn S, 2001, SEX ROLES, V45, P231, DOI 10.1023/A:1013505928458; Tantleff-Dunn S, 2002, J APPL SOC PSYCHOL, V32, P2253, DOI 10.1111/j.1559-1816.2002.tb01862.x; TOBON H, 1975, J CLIN ENDOCR METAB, V40, P834, DOI 10.1210/jcem-40-5-834; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 2001, BRIT J PSYCHOL, V92, P391, DOI 10.1348/000712601162257; TRICHOPOULOS D, 1992, EPIDEMIOLOGY, V3, P523, DOI 10.1097/00001648-199211000-00011; Wade TD, 2010, TWIN RES HUM GENET, V13, P450, DOI 10.1375/twin.13.5.450; Ward LM, 2006, SEX ROLES, V55, P703, DOI 10.1007/s11199-006-9125-9; WIGGINS JS, 1968, J PERS SOC PSYCHOL, V10, P82, DOI 10.1037/h0026394; Zelazniewicz AM, 2011, ARCH SEX BEHAV, V40, P1129, DOI 10.1007/s10508-011-9850-1	79	23	23	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57623	10.1371/journal.pone.0057623	http://dx.doi.org/10.1371/journal.pone.0057623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483919	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000316936100035
J	Downes, CE; Wong, CHY; Henley, KJ; Guio-Aguilar, PL; Zhang, M; Ates, R; Mansell, A; Kile, BT; Crack, PJ				Downes, Catherine E.; Wong, Connie H. Y.; Henley, Katya J.; Guio-Aguilar, Pedro L.; Zhang, Moses; Ates, Robert; Mansell, Ashley; Kile, Benjamin T.; Crack, Peter J.			MyD88 Is a Critical Regulator of Hematopoietic Cell-Mediated Neuroprotection Seen after Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; BRAIN-INJURY; RECRUITMENT; MICE; ADAPTER; MODEL; TOLL-LIKE-RECEPTOR-2	Neuroinflammation is critical in the neural cell death seen in stroke. It has been shown that CNS and peripheral responses drive this neuroinflammatory response in the brain. The Toll-like receptors (TLRs) are important regulators of inflammation in response to both exogenous and endogenous stressors. Taking advantage of a downstream adapter molecule that controls the majority of TLR signalling, this study investigated the role of the TLR adaptor protein myeloid differentiation factor 88 (MyD88) in the control of CNS and peripheral inflammation. Reversible middle-cerebral artery occlusion was used as the model of stroke in vivo; in vitro primary cultured neurons and glia were subject to four hours of oxygen and glucose deprivation (OGD). Both in vitro and in vivo Myd88(-/-) animals or cells were compared with wild type (WT). We found that after stroke Myd88(-/-) animals have a larger infarct volume compared to WT animals. Interestingly, in vitro there was no difference between the survival of Myd88(-/-) and WT cells following OGD, suggesting that peripheral responses were influencing stroke outcome. We therefore generated bone marrow chimeras and found that Myd88(-/-) animals have a smaller stroke infarct than their radiation naive counterparts if their hematopoietic cells are WT. Furthermore, WT animals have a larger stroke than their radiation naive counterparts if the hematopoietic cells are Myd88(-/-). We have demonstrated that MyD88-dependent signalling in the hematopoietic cell lineage reduces infarct size following stroke and that infiltrating cells to the site of neuroinflammation are neuroprotective following stroke.	[Downes, Catherine E.; Wong, Connie H. Y.; Guio-Aguilar, Pedro L.; Zhang, Moses; Ates, Robert; Crack, Peter J.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Henley, Katya J.; Kile, Benjamin T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Henley, Katya J.; Kile, Benjamin T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Mansell, Ashley] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Monash University	Crack, PJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	pcrack@unimelb.edu	Kile, Benjamin T/F-6593-2011; Kile, Benjamin/GNP-3246-2022; Crack, Peter/ABE-2065-2020; Mansell, Ashley/B-9553-2008	Kile, Benjamin T/0000-0002-8836-8947; Kile, Benjamin/0000-0002-8836-8947; Crack, Peter/0000-0002-5030-0330; Mansell, Ashley/0000-0002-6540-1281; Wong, Connie/0000-0002-9020-1847	National Health and Medical Research Council (NHMRC) of Australia; National Heart Foundation of Australia; Australian Research Council (ARC) Future Fellowship; NHMRC; Sylvia and Charles Viertel Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council (ARC) Future Fellowship(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation	JC is supported by the National Health and Medical Research Council (NHMRC) of Australia, the National Heart Foundation of Australia and is a holder of an Australian Research Council (ARC) Future Fellowship. AM is supported by the NHMRC. BTK is supported by the NHMRC and the Sylvia and Charles Viertel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Famakin BM, 2011, BRAIN RES, V1388, P148, DOI 10.1016/j.brainres.2011.02.074; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Flentjar NJ, 2002, EXP NEUROL, V177, P9, DOI 10.1006/exnr.2002.7927; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Lelekov-Boissard T, 2009, PHILOS T R SOC A, V367, P4699, DOI 10.1098/rsta.2009.0184; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Ma QY, 2011, J CEREBR BLOOD F MET, V31, P881, DOI 10.1038/jcbfm.2010.167; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Phillips JB, 2000, STROKE, V31, P1686, DOI 10.1161/01.STR.31.7.1686; Schilling M, 2009, NEUROSCIENCE, V161, P806, DOI 10.1016/j.neuroscience.2009.04.025; Sharma S, 2010, J NEUROSCI RES, V88, P2869, DOI 10.1002/jnr.22452; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; UEDA A, 1994, J IMMUNOL, V153, P2052; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; YAMASAKI Y, 1994, ACTA NEUROCHIR, P300; Yang QW, 2008, J CEREBR BLOOD F MET, V28, P1588, DOI 10.1038/jcbfm.2008.50; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Ziegler G, 2010, J CEREB BLOOD FLOW M; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	33	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57948	10.1371/journal.pone.0057948	http://dx.doi.org/10.1371/journal.pone.0057948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483951	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900058
J	Monteith, A; Marszalec, W; Chan, P; Logan, J; Yu, WM; Schwarz, N; Wokosin, D; Hockberger, P				Monteith, Andrew; Marszalec, William; Chan, Philip; Logan, Juliette; Yu, Weiming; Schwarz, Nicholas; Wokosin, David; Hockberger, Philip			Imaging of Mitochondrial and Non-Mitochondrial Responses in Cultured Rat Hippocampal Neurons Exposed to Micromolar Concentrations of TMRM	PLOS ONE			English	Article							ISOLATED BRAIN; CALCIUM; THAPSIGARGIN; DEPOLARIZATION; OSCILLATIONS; METABOLISM; MODULATION; ACTIVATION; GRADIENT; RELEASE	Tetramethylrhodamine methyl ester (TMRM) is a fluorescent dye used to study mitochondrial function in living cells. Previously, we reported that TMRM effectively labeled mitochondria of neurons deep within mouse brain slices. Use of micromolar concentration of dye, which was required to get sufficient staining for two-photon imaging, resulted in typical fluctuations of TMRM. With prolonged exposure, we recorded additional responses in some neurons that included slow oscillations and propagating waves of fluorescence. (Note: We use the terms "fluctuation" to refer to a change in the fluorescent state of an individual mitochondrion, "oscillation" to refer to a localized change in fluorescence in the cytosol, and "wave" to refer to a change in cytosolic fluorescence that propagated within a cell. Use of these terms does not imply any underlying periodicity.) In this report we describe similar results using cultured rat hippocampal neurons. Prolonged exposure of cultures to 2.5 mu M TMRM produced a spontaneous increase in fluorescence in some neurons, but not glial cells, after 45-60 minutes that was followed by slow oscillations, waves, and eventually apoptosis. Spontaneous increases in fluorescence were insensitive to high concentrations of FCCP (100 mu M) and thapsigargin (10 mu M) indicating that they originated, at least in part, from regions outside of mitochondria. The oscillations did not correlate with changes in intracellular Ca2+, but did correlate with differences in fluorescence lifetime of the dye. Fluorescence lifetime and one-photon ratiometric imaging of TMRM suggested that the spontaneous increase and subsequent oscillations were due to movement of dye between quenched (hydrophobic) and unquenched (hydrophilic) compartments. We propose that these movements may be correlates of intracellular events involved in early stages of apoptosis.	[Monteith, Andrew; Chan, Philip; Logan, Juliette; Yu, Weiming; Schwarz, Nicholas; Wokosin, David; Hockberger, Philip] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Marszalec, William] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Hockberger, P (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-hockberger@northwestern.edu	Monteith, Andrew Joseph/ABF-3164-2021	Monteith, Andrew/0000-0002-7259-6574; Hockberger, Philip/0000-0002-4013-4885	National Institutes of Health (NIH) under NINDS [NS88450]	National Institutes of Health (NIH) under NINDS	The National Institutes of Health (NIH) funded development of the instruments and personnel involved in this study under an NINDS P-30 grant (NS88450, PI: D.J. Surmeier). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistrup GL, 1999, MOL PHARMACOL, V55, P39, DOI 10.1124/mol.55.1.39; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Collins A, 2005, J CELL PHYSIOL, V202, P76, DOI 10.1002/jcp.20093; Colyer RA, 2008, MICROSC RES TECHNIQ, V71, P201, DOI 10.1002/jemt.20540; Cortassa S, 2004, BIOPHYS J, V87, P2060, DOI 10.1529/biophysj.104.041749; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fall CP, 2007, BIOPHYS J A S; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Gerencser AA, 2005, BIOPHYS J, V88, P698, DOI 10.1529/biophysj.104.050062; Gomez JP, 1996, J CARDIOVASC PHARM, V27, P335, DOI 10.1097/00005344-199603000-00005; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hayakawa Y, 2005, CELL CALCIUM, V37, P359, DOI 10.1016/j.ceca.2004.11.005; Heytler P G, 1979, Methods Enzymol, V55, P462; Hockberger P, 2009, BIOPHYS J A S; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kasibhatla S., 2006, COLD SPRING HARB PRO; Kindmark H, 2001, J BIOL CHEM, V276, P34530, DOI 10.1074/jbc.M102492200; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Lamarca V, 2009, EMBO J, V28, P1681, DOI 10.1038/emboj.2009.135; LOEW LM, 1993, BIOPHYS J, V65, P2396, DOI 10.1016/S0006-3495(93)81318-3; Loontiens FG, 1990, BIOCHEM, V29, P9032; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Murray JD, 2007, MATH BIOL, P257; O'Reilly CM, 2003, BIOPHYS J, V85, P3350, DOI 10.1016/S0006-3495(03)74754-7; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Petty HR, 2000, PHYS REV LETT, V84, P2754, DOI 10.1103/PhysRevLett.84.2754; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Tretter L, 1998, MOL PHARMACOL, V53, P734, DOI 10.1124/mol.53.4.734; VERCESI AE, 1993, J BIOL CHEM, V268, P8564; Vergun O, 2005, BBA-BIOENERGETICS, V1709, P127, DOI 10.1016/j.bbabio.2005.07.006; Vergun O, 2004, BIOPHYS J, V87, P3585, DOI 10.1529/biophysj.104.042671; Vergun O, 2003, BIOPHYS J, V85, P3358, DOI 10.1016/S0006-3495(03)74755-9; Wiedemann N, 2009, SCIENCE, V325, P403, DOI 10.1126/science.1178016; Wokosin DL, 2004, BIOPHYS J, V86, P1726, DOI 10.1016/S0006-3495(04)74241-1; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Yu W, 2000, ADV OPTICAL MEASUREM, P139; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	51	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58059	10.1371/journal.pone.0058059	http://dx.doi.org/10.1371/journal.pone.0058059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483968	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900066
J	Chimploy, K; Song, SW; Wheeler, LJ; Mathews, CK				Chimploy, Korakod; Song, Shiwei; Wheeler, Linda J.; Mathews, Christopher K.			Ribonucleotide Reductase Association with Mammalian Liver Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PRECURSOR ASYMMETRIES; THYMIDINE TRIPHOSPHATE; REPLICATION FIDELITY; POOL ASYMMETRY; HUMAN-CELLS; DNTP POOLS; DISEASE; QUANTITATION; MUTAGENESIS; NUCLEOIDS	Deoxyribonucleoside triphosphate pools in mammalian mitochondria are highly asymmetric, and this asymmetry probably contributes to the elevated mutation rate for the mitochondrial genome as compared with the nuclear genome. To understand this asymmetry, we must identify pathways for synthesis and accumulation of dNTPs within mitochondria. We have identified ribonucleotide reductase activity specifically associated with mammalian tissue mitochondria. Examination of immunoprecipitated proteins by mass spectrometry revealed R1, the large ribonucleotide reductase subunit, in purified mitochondria. Significant enzymatic and immunological activity was seen in rat liver mitochondrial nucleoids, isolated as described by Wang and Bogenhagen (Wang, Y., and Bogenhagen, D. F. (2006) J. Biol. Chem. 281, 25791-25802). Moreover, incubation of respiring rat liver mitochondria with [C-14]cytidine diphosphate leads to accumulation of radiolabeled deoxycytidine and thymidine nucleotides within the mitochondria. Comparable results were seen with [C-14]guanosine diphosphate. Ribonucleotide reduction within the mitochondrion, as well as outside the organelle, needs to be considered as a possibly significant contributor to mitochondrial dNTP pools.	[Chimploy, Korakod; Song, Shiwei; Wheeler, Linda J.; Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.	mathewsc@onid.orst.edu			National Institutes of Health Grant [R01 GM073744]; Army Research Office Grant [55953-LS]; NIEHS Center Grant [ES000210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073744] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office Grant; NIEHS Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073744. This work was also supported by Army Research Office Grant 55953-LS and NIEHS Center Grant ES000210 (to the Oregon State University Environmental Health Sciences Center mass spectrometry facility).	Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; DARLEYUSMAR VM, 1987, MITOCHONDRIA PRACTIC, P113; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; ELFORD HL, 1970, J BIOL CHEM, V245, P5228; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Martomo SA, 2002, MUTAT RES-FUND MOL M, V499, P197, DOI 10.1016/S0027-5107(01)00283-4; Mathews CK, 2009, METHODS MOL BIOL, V554, P371, DOI 10.1007/978-1-59745-521-3_22; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Ragan C. I., 1987, MITOCHONDRIA PRACTIC, P113; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rotskaya UN, 2010, MUTAT RES-FUND MOL M, V685, P97, DOI 10.1016/j.mrfmmm.2009.12.010; Schaaper RM, 2013, DNA REPAIR, V12, P73, DOI 10.1016/j.dnarep.2012.10.011; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; SHEWACH DS, 1992, ANAL BIOCHEM, V206, P178, DOI 10.1016/S0003-2697(05)80030-2; SLABAUGH MB, 1984, J VIROL, V52, P507, DOI 10.1128/JVI.52.2.507-514.1984; Song S., 2005, THESIS OREGON STATE; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; TURNER MK, 1968, J BIOL CHEM, V243, P3725; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146	41	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13145	13155		10.1074/jbc.M113.461111	http://dx.doi.org/10.1074/jbc.M113.461111			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504325	Green Published, hybrid			2022-12-25	WOS:000318555100064
J	Padilla-Benavides, T; Long, JE; Raimunda, D; Sassetti, CM; Arguello, JM				Padilla-Benavides, Teresita; Long, Jarukit E.; Raimunda, Daniel; Sassetti, Christopher M.; Argueello, Jose M.			A Novel P-1B-type Mn2+-transporting ATPase Is Required for Secreted Protein Metallation in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; ZINC TRANSPORTER; TUBERCULOSIS; IDENTIFICATION; PATHOGEN; COPPER; RESISTANCE; ZNTA; EXPRESSION	Transition metals are central for bacterial virulence and host defense. P-1B-ATPases are responsible for cytoplasmic metal efflux and play roles either in limiting cytosolic metal concentrations or in the maturation of secreted metalloproteins. The P-1B-ATPase, CtpC, is required for Mycobacterium tuberculosis survival in a mouse model (Sassetti, C. M., and Rubin, E. J. (2003) Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. U. S. A. 100, 12989-12994). CtpC prevents Zn2+ toxicity, suggesting a role in Zn2+ export from the cytosol (Botella, H., Peyron, P., Levillain, F., Poincloux, R., Poquet, Y., Brandli, I., Wang, C., Tailleux, L., Tilleul, S., Charriere, G. M., Waddell, S. J., Foti, M., Lugo-Villarino, G., Gao, Q., Maridonneau-Parini, I., Butcher, P. D., Castagnoli, P. R., Gicquel, B., de Chastellier, C., and Neyrolles, O. (2011) Mycobacterial P-1-type ATPases mediate resistance to zinc poisoning in human macrophages. Cell Host Microbe 10, 248-259). However, key metal-coordinating residues and the overall structure of CtpC are distinct from Zn2+-ATPases. We found that isolated CtpC has metal-dependent ATPase activity with a strong preference for Mn2+ over Zn2+. In vivo, CtpC is unable to complement Escherichia coli lacking a functional Zn2+-ATPase. Deletion of M. tuberculosis or Mycobacterium smegmatis ctpC leads to cytosolic Mn2+ accumulation but no alterations in other metals levels. Whereas ctpC-deficient M. tuberculosis is sensitive to extracellular Zn2+, the M. smegmatis mutant is not. Both ctpC mutants are sensitive to oxidative stress, which might explain the Zn2+-sensitive phenotype of the M. tuberculosis ctpC mutant. CtpC is a high affinity/slow turnover ATPase, suggesting a role in protein metallation. Consistent with this hypothesis, mutation of CtpC leads to a decrease of Mn2+ bound to secreted proteins and of the activity of secreted Fe/Mn-superoxide dismutase, particularly in M. smegmatis. Alterations in the assembly of metalloenzymes involved in redox stress response might explain the sensitivity of M. tuberculosis ctpC mutants to oxidative stress and growth and persistence defects in mice infection models.	[Padilla-Benavides, Teresita; Raimunda, Daniel; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Long, Jarukit E.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Sassetti, Christopher M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Padilla-Benavides, Teresita/K-1968-2012; Arguello, Jose/D-1997-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; Raimunda, Daniel/0000-0001-7392-1407; Arguello, Jose/0000-0003-3940-6297	National Institutes of Health [1R21AI082484-01, F32A1093049]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082484, F32AI093049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21AI082484-01 (to J. M. A.) and Award F32A1093049 (to J. E. L.).	Achard-Joris M, 2007, BIOCHIMIE, V89, P1474, DOI 10.1016/j.biochi.2007.06.005; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Begum NA, 2002, GENOMICS, V80, P630, DOI 10.1006/geno.2002.7000; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Bunting K, 1998, EUR J BIOCHEM, V251, P795, DOI 10.1046/j.1432-1327.1998.2510795.x; Calder KM, 1998, MICROB PATHOGENESIS, V24, P133, DOI 10.1006/mpat.1997.9999; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Checa SK, 2007, MOL MICROBIOL, V63, P1307, DOI 10.1111/j.1365-2958.2007.05590.x; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; Dussurget O, 2001, INFECT IMMUN, V69, P529, DOI 10.1128/IAI.69.1.529-533.2001; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; GREGORY EM, 1983, ARCH BIOCHEM BIOPHYS, V220, P293, DOI 10.1016/0003-9861(83)90413-7; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Grover A, 2006, J BACTERIOL, V188, P7026, DOI 10.1128/JB.00643-06; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harth G, 1999, J BIOL CHEM, V274, P4281, DOI 10.1074/jbc.274.7.4281; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kim R, 1998, BIOTECHNOL LETT, V20, P207, DOI 10.1023/A:1005305330517; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; MEIER B, 1994, EUR J BIOCHEM, V219, P463, DOI 10.1111/j.1432-1033.1994.tb19960.x; MEIER B, 1982, J BIOL CHEM, V257, P3977; Okkeri J, 2006, BBA-BIOENERGETICS, V1757, P1485, DOI 10.1016/j.bbabio.2006.06.008; Osman D, 2011, ADV MICROB PHYSIOL, V58, P175, DOI 10.1016/B978-0-12-381043-4.00005-2; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Raimunda D, 2012, BBA-BIOMEMBRANES, V1818, P1374, DOI 10.1016/j.bbamem.2012.02.020; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rensing C, 1998, J BIOL CHEM, V273, P32614, DOI 10.1074/jbc.273.49.32614; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scherer J, 2009, MOL MICROBIOL, V73, P601, DOI 10.1111/j.1365-2958.2009.06792.x; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Thakur KG, 2010, J MOL BIOL, V397, P1199, DOI 10.1016/j.jmb.2010.02.026; TSAI KJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P267, DOI 10.1006/abbi.1993.1421; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Yamakura F, 1995, BIOCHEM MOL BIOL INT, V36, P233; Zielazinski EL, 2012, BIOCHEMISTRY-US, V51, P7891, DOI 10.1021/bi3006708	68	61	63	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11334	11347		10.1074/jbc.M112.448175	http://dx.doi.org/10.1074/jbc.M112.448175			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23482562	hybrid, Green Published			2022-12-25	WOS:000317915500036
J	Ramos, TN; Bullard, DC; Darley, MM; McDonald, K; Crawford, DF; Barnum, SR				Ramos, Theresa N.; Bullard, Daniel C.; Darley, Meghan M.; McDonald, Kristin; Crawford, David F.; Barnum, Scott R.			Experimental Cerebral Malaria Develops Independently of Endothelial Expression of Intercellular Adhesion Molecule-1 (ICAM-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM; LEUKOCYTE RECRUITMENT; ICAM-1-DEFICIENT MICE; MOUSE MODEL; TNF-ALPHA; IN-VIVO; RECEPTORS; SEQUESTRATION; VISUALIZATION; ERYTHROCYTES	Cerebral malaria (CM) is a severe clinical complication of Plasmodium falciparum malaria infection and is characterized by a high fatality rate and neurological damage. Sequestration of parasite-infected red blood cells in brain microvasculature utilizes host-and parasite-derived adhesion molecules and is an important factor in the development of CM. ICAM-1, an alternatively spliced adhesion molecule, is believed to be critical on endothelial cells for infected red blood cell sequestration in CM. Using ICAM-1 mutant mice, we found that the full-length ICAM-1 isoform is not required for development of murine experimental CM (ECM) and that ECM phenotype varies with the combination of ICAM-1 isoforms expressed. Furthermore, we observed development of ECM in transgenic mice expressing ICAM-1 only on leukocytes, indicating that endothelial cell expression of this adhesion molecule is not required for disease pathogenesis. We propose that ICAM-1-dependent cellular aggregation, independent of ICAM-1 expression on the cerebral microvasculature, contributes to ECM.	[Ramos, Theresa N.; Darley, Meghan M.; Barnum, Scott R.] Univ Alabama Birmingham, Dept Microbiol & Neurol, Birmingham, AL 35294 USA; [Bullard, Daniel C.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [McDonald, Kristin] Duke Univ, Ctr Human Genet, Durham, NC 27710 USA; [Crawford, David F.] Univ Oklahoma, Dept Pediat, Oklahoma City, OK 73104 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Duke University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Barnum, SR (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S, Birmingham, AL 35294 USA.	sbarnum@uab.edu		McDonald Gibson, Kristin/0000-0002-3297-2002	National Institutes of Health [T32 AI07051, F31NS077811, P30 CA13148, P30 AR048311]; National Multiple Sclerosis Society Grant [PP1058]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 AI07051 (to T.N.R.), F31NS077811 (to T.N.R.), and P30 CA13148 and P30 AR048311. This work was also supported by National Multiple Sclerosis Society Grant PP1058 (to S.R.B. and D.C.B.).	BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Chewning JH, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-44; Cox MA, 2013, P NATL ACAD SCI USA, V110, P1416, DOI 10.1073/pnas.1213480110; Craig A, 2000, HUM MOL GENET, V9, P525, DOI 10.1093/hmg/9.4.525; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dunne JL, 2003, J IMMUNOL, V171, P6105, DOI 10.4049/jimmunol.171.11.6105; DUSTIN ML, 1986, J IMMUNOL, V137, P245; FALANGA PB, 1991, EUR J IMMUNOL, V21, P2259, DOI 10.1002/eji.1830210938; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fry AE, 2008, GENES IMMUN, V9, P462, DOI 10.1038/gene.2008.38; Giorelli M, 2002, CELL COMMUN ADHES, V9, P259, DOI 10.1080/15419060216305; GRAU GE, 1991, EUR J IMMUNOL, V21, P2265, DOI 10.1002/eji.1830210939; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; Hu XZ, 2010, MOL IMMUNOL, V47, P1692, DOI 10.1016/j.molimm.2010.03.005; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; KING PD, 1995, J IMMUNOL, V154, P6080; Limb GA, 1999, CLIN EXP IMMUNOL, V118, P213; Liu LX, 2003, THROMB HAEMOSTASIS, V89, P213; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Ochietti B, 2002, GENE THER, V9, P939, DOI 10.1038/sj.gt.3301716; OCKENHOUSE CF, 1992, CELL, V68, P63, DOI 10.1016/0092-8674(92)90206-R; Ramos TN, 2012, PARASITE IMMUNOL, V34, P547, DOI 10.1111/pim.12002; Ramos TN, 2012, J BIOL CHEM, V287, P24734, DOI 10.1074/jbc.C112.378364; Robledo O, 2003, EUR J IMMUNOL, V33, P1351, DOI 10.1002/eji.200323195; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steeber DA, 2005, TRENDS IMMUNOL, V26, P9, DOI 10.1016/j.it.2004.11.012; Tailor A, 2005, MICROCIRCULATION, V12, P275, DOI 10.1080/10739680590925691; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; van den Engel NK, 2000, BLOOD, V95, P1350, DOI 10.1182/blood.V95.4.1350.004k07_1350_1355; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Werner A, 2001, CELL TISSUE RES, V305, P25, DOI 10.1007/s004410100393; WILLIMANN K, 1995, J EXP MED, V182, P643, DOI 10.1084/jem.182.3.643; Wohler JE, 2009, EUR J IMMUNOL, V39, P1516, DOI 10.1002/eji.200839176; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; Yipp BG, 2007, MICROCIRCULATION, V14, P593, DOI 10.1080/10739680701404705; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	43	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10962	10966		10.1074/jbc.C113.457028	http://dx.doi.org/10.1074/jbc.C113.457028			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23493396	hybrid, Green Published			2022-12-25	WOS:000317915500002
J	Christensen, JB; Hendricks, O; Chaki, S; Mukherjee, S; Das, A; Pal, TK; Dastidar, SG; Kristiansen, JE				Christensen, Jorn B.; Hendricks, Oliver; Chaki, Shaswati; Mukherjee, Sayanti; Das, Ayan; Pal, Tapan K.; Dastidar, Sujata G.; Kristiansen, Jette E.			A comparative Analysis of In Vitro and In Vivo Efficacies of the Enantiomers of Thioridazine and Its Racemate	PLOS ONE			English	Article							CLINICAL CONCENTRATIONS; NON-ANTIBIOTICS; ANTIBACTERIAL; METHDILAZINE; SYNERGISM; AGENT	A long list of chemotherapeutical drugs used in the treatment of the peripheral and the central nervous systems possess anti-microbial activity. Some of these neurotropic compounds are chiral, with the one stereo isomeric form exaggerating reduced neurotropism. This is the case for the levorotatory form of thioridazine. The phenothiazine thioridazine is an interesting compound, characterized by exhibiting a significant growth inhibiting activity on a wide array of microorganisms. Thioridazine is characterized by another challenging feature, because the compound is concentrated in certain human tissue cells. The present study describes a comparative study of the two enantiomers as well as the racemic form of thioridazine. The study exploits the stereochemical aspect and the in vitro and in vivo potential of these compounds, with a focus on the effects on Gram negative organism Salmonella enterica serover Typhimurium. In summary, the results of this study yielded a significant antibacterial activity of all forms of thioridazine, indicating the levorotatory (-)-form to be superior in terms of both its in vitro and in vivo efficacies.	[Christensen, Jorn B.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Hendricks, Oliver] Univ So Denmark, King Christian X Hosp Rheumat Dis, Grasten, Denmark; [Chaki, Shaswati; Mukherjee, Sayanti; Dastidar, Sujata G.] Herbicure Healthcare Bioherbal Res Fdn, Dept Microbiol, Kolkata, India; [Das, Ayan; Pal, Tapan K.] Jadavpur Univ, Dept Pharmaceut Technol, Bioequivalence Study Ctr, Kolkata, India	University of Copenhagen; University of Southern Denmark; Jadavpur University		jbc@chem.ku.dk	Christensen, Jørn B./J-8124-2012	Christensen, Jørn B./0000-0002-7641-8302				Amaral L, 2000, INT J ANTIMICROB AG, V14, P225, DOI 10.1016/S0924-8579(00)00136-9; Basu LR, 2005, MICROBIOL RES, V160, P95, DOI 10.1016/j.micres.2004.10.002; CHATTOPADHYAY D, 1988, ARZNEIMITTEL-FORSCH, V38-2, P869; Clinical and Laboratory Standards Institute, 2009, M7A7 CLIN LAB STAND; Dasgupta A, 2010, EUR J CLIN MICROBIOL, V29, P239, DOI 10.1007/s10096-009-0845-y; Dasgupta A, 2008, TOP HETEROCYCL CHEM, V15, P67, DOI 10.1007/7081_2007_108; Dasgupta A, 2010, INT J ANTIMICROB AG, V35, P174, DOI 10.1016/j.ijantimicag.2009.09.027; DASTIDAR SG, 1995, J CHEMOTHERAPY, V7, P201, DOI 10.1179/joc.1995.7.3.201; DASTIDAR SG, 1976, J APPL BACTERIOL, V41, P209, DOI 10.1111/j.1365-2672.1976.tb00621.x; Dastidar SG, 2000, INT J ANTIMICROB AG, V14, P249, DOI 10.1016/S0924-8579(99)00159-4; Dastidar Sujata G., 2004, Acta Microbiologica et Immunologica Hungarica, V51, P75; Dastidar Sujata G., 1997, Acta Microbiologica et Immunologica Hungarica, V44, P241; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; HENDRICKS O, 2007, THESIS U SO DENMARK; Jeyaseeli L, 2006, INT J ANTIMICROB AG, V27, P58, DOI 10.1016/j.ijantimicag.2005.08.014; Jeyaseeli L, 2012, EUR J CLIN MICROBIOL, V31, P1243, DOI 10.1007/s10096-011-1435-3; JORTANI SA, 1994, FORENSIC SCI INT, V64, P165, DOI 10.1016/0379-0738(94)90227-5; KRISTIANSEN JE, 1992, APMIS, V100, P7; Kristiansen JE, 1997, J ANTIMICROB CHEMOTH, V40, P319, DOI 10.1093/jac/40.3.319; Kumar K. Asok, 2003, Acta Microbiologica Polonica, V52, P285; Kumar KA, 2004, BIOL PHARM BULL, V27, P1116, DOI 10.1248/bpb.27.1116; Mazumder R, 2001, INT J ANTIMICROB AG, V18, P403, DOI 10.1016/S0924-8579(01)00324-7; MOLNAR J, 1976, ACTA MICROBIOL HUNG, V23, P45; Molnar J, 1992, THIAZINES STRUCTURAL, P197; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Ordway D, 2002, INT J ANTIMICROB AG, V20, P34, DOI 10.1016/S0924-8579(02)00110-3; Radhakrishnan V., 1999, Indian Journal of Experimental Biology, V37, P671; SVENDSEN CN, 1988, NEUROPHARMACOLOGY, V27, P1117, DOI 10.1016/0028-3908(88)90006-8	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57493	10.1371/journal.pone.0057493	http://dx.doi.org/10.1371/journal.pone.0057493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505431	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500023
J	Imai, S; Kano, M; Nonoyama, K; Ebihara, S				Imai, Saki; Kano, Makoto; Nonoyama, Keiko; Ebihara, Shizufumi			Behavioral Characteristics of Ubiquitin-Specific Peptidase 46-Deficient Mice	PLOS ONE			English	Article							GABA(A) RECEPTORS; SUCROSE PREFERENCE; STRESS; RESPONSES; SUBUNIT; ALCOHOL; SENSITIVITY; LACKING; MAP	We have previously identified Usp46, which encodes for ubiquitin-specific peptidase 46, as a quantitative trait gene affecting the immobility time of mice in the tail suspension test (TST) and forced swimming test. The mutation that we identified was a 3-bp deletion coding for lysine (Lys 92), and mice with this mutation (MT mice), as well as Usp46 KO mice exhibited shorter TST immobility times. Behavioral pharmacology suggests that the gamma aminobutyric acid A (GABA(A)) receptor is involved in regulating TST immobility time. In order to understand how far Usp46 controls behavioral phenotypes, which could be related to mental disorders in humans, we subjected Usp46 MT and KO mice to multiple behavioral tests, including the open field test, ethanol preference test, ethanol-induced loss of righting reflex test, sucrose preference test, novelty-suppressed feeding test, marble burying test, and novel object recognition test. Although behavioral phenotypes of the Usp46 MT and KO mice were not always identical, deficiency of Usp46 significantly affected performance in all these tests. In the open field test, activity levels were lower in Usp46 KO mice than wild type (WT) or MT mice. Both MT and KO mice showed lower ethanol preference and shorter recovery times after ethanol administration. Compared to WT mice, Usp46 MT and KO mice exhibited decreased sucrose preference, took longer latency periods to bite pellets, and buried more marbles in the sucrose preference test, novelty-suppressed feeding test, and marble burying test, respectively. In the novel object recognition test, neither MT nor KO mice showed an increase in exploration of a new object 24 hours after training. These findings indicate that Usp46 regulates a wide range of behavioral phenotypes that might be related to human mental disorders and provides insight into the function of USP46 deubiquitinating enzyme in the neural system.	[Imai, Saki; Kano, Makoto; Nonoyama, Keiko; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan	Nagoya University	Ebihara, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan.	ebihara@agr.nagoya-u.ac.jp			JSPS KAKENHI [22248033, 22658093]; Takeda Science Foundation; Life Science Foundation of Japan;  [22006714]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Life Science Foundation of Japan(Life Science Foundation of Japan); 	This research was supported by JSPS KAKENHI Grant Number 22248033, 22658093, Takeda Science Foundation, Life Science Foundation of Japan to SE and Grant-in-Aid for JSPS Fellows (22006714) to SI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albelda N, 2012, NEUROSCI BIOBEHAV R, V36, P47, DOI 10.1016/j.neubiorev.2011.04.006; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Blednov YA, 2003, J PHARMACOL EXP THER, V304, P30, DOI 10.1124/jpet.102.042960; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; Cai YQ, 2006, J NEUROSCI RES, V84, P255, DOI 10.1002/jnr.20884; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Egashira N, 2013, PSYCHOPHARMACOLOGY, V226, P295, DOI 10.1007/s00213-012-2904-9; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Hu JH, 2004, NEUROSCIENCE, V123, P807, DOI 10.1016/j.neuroscience.2003.11.018; Imai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039084; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Koob GF, 2004, BIOCHEM PHARMACOL, V68, P1515, DOI 10.1016/j.bcp.2004.07.031; Li X, 2012, ONCOGENE, DOI [10.1038/onc.2012.6632, DOI 10.1038/ONE.2012.6632]; Lobo IA, 2008, PHARMACOL BIOCHEM BE, V90, P90, DOI 10.1016/j.pbb.2008.03.006; Mamiya T, 1998, BRAIN RES, V783, P236, DOI 10.1016/S0006-8993(97)01406-6; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Miyamoto Y, 2002, J NEUROSCI, V22, P2335, DOI 10.1523/JNEUROSCI.22-06-02335.2002; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Shen QY, 2010, BIOL PSYCHIAT, V68, P512, DOI 10.1016/j.biopsych.2010.04.024; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Vollenweider I, 2011, BEHAV BRAIN RES, V217, P77, DOI 10.1016/j.bbr.2010.10.009; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026297	32	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58566	10.1371/journal.pone.0058566	http://dx.doi.org/10.1371/journal.pone.0058566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472206	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900152
J	Urbino, C; Gutierrez, S; Antolik, A; Bouazza, N; Doumayrou, J; Granier, M; Martin, DP; Peterschmitt, M				Urbino, Cica; Gutierrez, Serafin; Antolik, Anna; Bouazza, Nabila; Doumayrou, Juliette; Granier, Martine; Martin, Darren P.; Peterschmitt, Michel			Within-Host Dynamics of the Emergence of Tomato Yellow Leaf Curl Virus Recombinants	PLOS ONE			English	Article							INDIAN-OCEAN ISLANDS; SARDINIA-VIRUS; MOSAIC-VIRUS; EVOLUTION; GEMINIVIRUSES; DISPLACEMENT; EPIDEMICS	Tomato yellow leaf curl virus (TYLCV) is a highly damaging begomovirus native to the Middle East. TYLCV has recently spread worldwide, recombining with other begomoviruses. Recent analysis of mixed infections between TYLCV and Tomato leaf curl Comoros begomovirus (ToLCKMV) has shown that, although natural selection preserves certain co-evolved intragenomic interactions, numerous and diverse recombinants are produced at 120 days post-inoculation (dpi), and recombinant populations from different tomato plants are very divergent. Here, we investigate the population dynamics that lead to such patterns in tomato plants co-infected with TYLCV and ToLCKMV either by agro-inoculation or using the natural whitefly vector Bemisia tabaci. We monitored the frequency of parental and recombinant genotypes independently in 35 plants between 18 and 330 dpi and identified 177 recombinants isolated at different times. Recombinants were detected from 18 dpi and their frequency increased over time to reach about 50% at 150 dpi regardless of the inoculation method. The distribution of breakpoints detected on 96 fully sequenced recombinants was consistent with a continuous generation of new recombinants as well as random and deterministic effects in their maintenance. A severe population bottleneck of around 10 genomes was estimated during early systemic infection-a phenomenon that could account partially for the heterogeneity in recombinant patterns observed among plants. The detection of the same recombinant genome in six of the thirteen plants analysed beyond 30 dpi supported the influence of selection on observed recombination patterns. Moreover, a highly virulent recombinant genotype dominating virus populations within one plant has, apparently, the potential to be maintained in the natural population according to its infectivity, within-host accumulation, and transmission efficiency -all of which were similar or intermediate to those of the parent genotypes. Our results anticipate the outcomes of natural encounters between TYLCV and ToLCKMV.	[Urbino, Cica; Gutierrez, Serafin; Antolik, Anna; Bouazza, Nabila; Granier, Martine; Peterschmitt, Michel] UMR BGPI CIRAD, Montpellier, France; [Gutierrez, Serafin] CNRS 5290 IRD 224 UM1 UM2, UMR Malad Infect & Vecteurs Ecol Genet Evolut & Co, Montpellier, France; [Doumayrou, Juliette] INRA, UMR BGPI, F-34060 Montpellier, France; [Martin, Darren P.] Univ Cape Town, Inst Infect Dis & Mol Med, Computat Biol Grp, Observatory, South Africa	CIRAD; Universite de Montpellier; INRAE; University of Cape Town	Urbino, C (corresponding author), UMR BGPI CIRAD, Montpellier, France.	cica.urbino@cirad.fr	Martin, Darren P/C-4599-2008; Martin, Darren/ABE-3614-2021	Gutierrez, Serafin/0000-0002-5277-7239	CIRAD ATP Emergence; Agence Nationale de la Recherche; French ANR [2010-BLAN-170401]	CIRAD ATP Emergence; Agence Nationale de la Recherche(French National Research Agency (ANR)); French ANR(French National Research Agency (ANR))	This work was funded by CIRAD ATP Emergence and by the project "BemisiaRisk'' within the program "Agriculture et Developpement Durable'' of the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/). Serafin Gutierrez acknowledges support from the grant No. 2010-BLAN-170401 from the French ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1990, ANAL CATEGORICAL DAT; [Anonymous], 2010, R LANG ENV STAT COMP; Bates D, 2012, LINEAR MIXED EFFECTS; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Davino S, 2006, EUR J PLANT PATHOL, V114, P293, DOI 10.1007/s10658-005-5805-5; Davino S, 2012, J GEN VIROL, V93, P2712, DOI 10.1099/vir.0.045773-0; Delatte H, 2005, J GEN VIROL, V86, P1533, DOI 10.1099/vir.0.80805-0; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Fabre F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002654; French R, 2003, ANNU REV PHYTOPATHOL, V41, P199, DOI 10.1146/annurev.phyto.41.052002.095559; Garcia-Andres S, 2007, VIROLOGY, V365, P210, DOI 10.1016/j.virol.2007.03.045; Gutierrez S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003009; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lemey P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-126; Martin DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002203; Monci F, 2002, VIROLOGY, V303, P317, DOI 10.1006/viro.2002.1633; Monsion B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000174; Morilla G, 2004, J VIROL, V78, P10715, DOI [10.1128/JVI.78.19.10715-10723.2004, 10.1128/jvi.78.19.10715-10723.2004]; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pico B, 1996, SCI HORTIC-AMSTERDAM, V67, P151, DOI 10.1016/S0304-4238(96)00945-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sacristan S, 2003, J VIROL, V77, P9906, DOI 10.1128/JVI.77.18.9906-9911.2003; Sanchez-Campos S, 1999, PHYTOPATHOLOGY, V89, P1038, DOI 10.1094/PHYTO.1999.89.11.1038; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Urbino C, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-135; Vuillaume F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002028; Zwart MP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002122	30	19	20	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58375	10.1371/journal.pone.0058375	http://dx.doi.org/10.1371/journal.pone.0058375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472190	Green Published, gold			2022-12-25	WOS:000315637900136
J	Cho, HY; Lee, YH; Bae, YS; Kim, E; Kang, BS				Cho, Ha Yeon; Lee, Young-Hoon; Bae, Young-Seuk; Kim, Eungbin; Kang, Beom Sik			Activation of ATP Binding for the Autophosphorylation of DosS, a Mycobacterium tuberculosis Histidine Kinase Lacking an ATP Lid Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAF DOMAIN; SENSOR; MECHANISM; INSIGHTS	The sensor histidine kinases of Mycobacterium tuberculosis, DosS and DosT, are responsible for sensing hypoxic conditions and consist of sensor and kinase cores responsible for accepting signals and phosphorylation activity, respectively. The kinase core contains a dimerization and histidine phosphate-accepting (DHp) domain and an ATP binding domain (ABD). The 13 histidine kinase genes of M. tuberculosis can be grouped based on the presence or absence of the ATP lid motif and F box (elements known to play roles in ATP binding) in their ABDs; DosS and DosT have ABDs lacking both these elements, and the crystal structures of their ABDs indicated that they were unsuitable for ATP binding, as a short loop covers the putative ATP binding site. Although the ABD alone cannot bind ATP, the kinase core is functional in autophosphorylation. Appropriate spatial arrangement of the ABD and DHp domain within the kinase core is required for both autophosphorylation and ATP binding. An ionic interaction between Arg(440) in the DHp domain and Glu(537) in the short loop of the ABD is available and may open the ATP binding site, by repositioning the short loop away from the site. Mutations at Arg(440) and Glu(537) reduce autophosphorylation activity. Unlike other histidine kinases containing an ATP lid, which protects bound ATP, DosS is unable to accept ATP until the ABD is properly positioned relative to the histidine; this may prevent unexpected ATP reactions. ATP binding can, therefore, function as a control mechanism for histidine kinase activity.	[Cho, Ha Yeon; Lee, Young-Hoon; Bae, Young-Seuk; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Kim, Eungbin] Yonsei Univ, Dept Biol, Seoul 120749, South Korea	Kyungpook National University; Yonsei University	Kang, BS (corresponding author), 1370 Sangyeok Dong, Taegu 702701, South Korea.	bskang2@knu.ac.kr		, Eungbin/0000-0002-4851-4743; Bae, Young-Seuk/0000-0002-5520-4444	National Research Foundation of Korea by the Korean government (Ministry of Education, Science, and Technology) [2009-0077493, 2011-0015987]	National Research Foundation of Korea by the Korean government (Ministry of Education, Science, and Technology)	This work was supported by National Research Foundation of Korea Grants 2009-0077493 and 2011-0015987 by the Korean government (Ministry of Education, Science, and Technology).	Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cho HY, 2011, FEBS LETT, V585, P1873, DOI 10.1016/j.febslet.2011.04.050; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lee JM, 2008, J BACTERIOL, V190, P6795, DOI 10.1128/JB.00401-08; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nowak E, 2006, STRUCTURE, V14, P275, DOI 10.1016/j.str.2005.10.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Stewart RC, 2010, CURR OPIN MICROBIOL, V13, P133, DOI 10.1016/j.mib.2009.12.013; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Trajtenberg F, 2010, J BIOL CHEM, V285, P24892, DOI 10.1074/jbc.M110.147843; Tucker PA, 2007, METHOD ENZYMOL, V423, P479, DOI 10.1016/S0076-6879(07)23023-X; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139	30	11	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12437	12447		10.1074/jbc.M112.442467	http://dx.doi.org/10.1074/jbc.M112.442467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486471	Green Published, hybrid			2022-12-25	WOS:000318555100003
J	Nahomi, RB; Wang, B; Raghavan, CT; Voss, O; Doseff, AI; Santhoshkumar, P; Nagaraj, RH				Nahomi, Rooban B.; Wang, Benlian; Raghavan, Cibin T.; Voss, Oliver; Doseff, Andrea I.; Santhoshkumar, Puttur; Nagaraj, Ram H.			Chaperone Peptides of alpha-Crystallin Inhibit Epithelial Cell Apoptosis, Protein Insolubilization, and Opacification in Experimental Cataracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CRYSTALLIN; A-CRYSTALLIN; POSTTRANSLATIONAL MODIFICATIONS; FUNCTIONAL ELEMENT; HUMAN LENSES; EXPRESSION; ACTIVATION; PATHOLOGY; CATARACTOGENESIS; RAF/MEK/ERK	alpha-Crystallin is a member of the small heat-shock protein (sHSP) family and consists of two subunits, alpha A and alpha B. Both alpha A-and alpha B-crystallin act as chaperones and anti-apoptotic proteins. Previous studies have identified the peptide (KFVIFLD)-K-70-VKHFSPEDLTVK88 in alpha A-crystallin and the peptide (DRFS)-D-73-VNLDVKHFSPEELKVK92 in alpha B-crystallin as mini-chaperones. In the human lens, lysine 70 (Lys(70)) of alpha A and Lys92 of alpha B (in the mini-chaperone sequences) are acetylated. In this study, we investigated the cellular effects of the unmodified and acetyl mini-chaperones. The alpha A-and alpha B-crystallin peptides inhibited stress-induced aggregation of four client proteins, and the alpha A-acetyl peptide was more effective than the native peptide against three of the client proteins. Both the acetyl and native crystallin peptides inhibited stress-induced apoptosis in two mammalian cell types, and this property was directly related to the inhibition of cytochrome c release from mitochondria and the activity of caspase-3 and -9. In organ-cultured rat lenses, the peptides inhibited calcimycin-induced epithelial cell apoptosis. Intraperitoneal injection of the peptides inhibited cataract development in selenite-treated rats, which was accompanied by inhibition of oxidative stress, protein insolubilization, and caspase activity in the lens. These inhibitory effects were more pronounced for acetyl peptides than native peptides. A scrambled alpha A-crystallin peptide produced no such effects. The results suggest that the alpha-crystallin chaperone peptides could be used as therapeutic agents to treat cataracts and diseases in which protein aggregation and apoptosis are contributing factors.	[Nahomi, Rooban B.; Raghavan, Cibin T.; Nagaraj, Ram H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Voss, Oliver; Doseff, Andrea I.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Santhoshkumar, Puttur] Univ Missouri, Dept Ophthalmol, Columbia, MO 65212 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Ohio State University; University of Missouri System; University of Missouri Columbia	Nagaraj, RH (corresponding author), Rm 311,2085 Adelbert Rd, Cleveland, OH 44106 USA.	ram.nagaraj@case.edu	Santhoshkumar, Puttur/G-1798-2010; Doseff, Andrea/E-2991-2011	Santhoshkumar, Puttur/0000-0002-6897-7278; 	National Institutes of Health [R01EY-022061, R01EY-09912, P30EY-11373]; Research to Prevent Blindness, NY; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY009912, R01EY022061, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, NY(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY-022061 and R01EY-09912 (to R.H.N.), and P30EY-11373 to the Visual Sciences Research Center of Case Western Reserve University, and grants from the Research to Prevent Blindness, NY (to Case Western Reserve University and the University of Missouri-Columbia) and The Ohio Lions Eye Research Foundation.	Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Andley UP, 2009, CURR MOL MED, V9, P887, DOI 10.2174/156652409789105598; AOYAMA A, 1993, MOL CELL BIOL, V13, P1824, DOI 10.1128/MCB.13.3.1824; Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; DAVID LL, 1984, TOXICOL APPL PHARM, V74, P109, DOI 10.1016/0041-008X(84)90276-X; DAVID LL, 1984, INVEST OPHTH VIS SCI, V25, P1275; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Harrington V, 2007, MOL VIS, V13, P1680; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Kim YH, 2012, DIABETOLOGIA, V55, P2835, DOI 10.1007/s00125-012-2625-y; Kurnellas MP, 2012, J BIOL CHEM, V287, P36423, DOI 10.1074/jbc.M112.371229; Launay N, 2010, J BIOL CHEM, V285, P37324, DOI 10.1074/jbc.M110.124388; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; LI WC, 1995, EXP EYE RES, V61, P91, DOI 10.1016/S0014-4835(95)80062-X; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; MEHLEN P, 1995, J IMMUNOL, V154, P363; Nagaraj RH, 2012, BBA-MOL BASIS DIS, V1822, P120, DOI 10.1016/j.bbadis.2011.11.011; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Padival S, 2006, OPHTHALMIC RES, V38, P294, DOI 10.1159/000095773; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Rao NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033582; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; Santhoshkumar P, 2006, PROTEIN SCI, V15, P2488, DOI 10.1110/ps.062338206; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Shearer T R, 1997, Mol Vis, V3, P8; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Staniszewska MM, 2006, MOL CELL BIOCHEM, V288, P29, DOI 10.1007/s11010-005-9115-1; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x; Zhang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026102	47	61	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13022	13035		10.1074/jbc.M112.440214	http://dx.doi.org/10.1074/jbc.M112.440214			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508955	Green Published, hybrid			2022-12-25	WOS:000318555100054
J	Fu, XM; Shi, XD; Yin, LX; Liu, JF; Joo, K; Lee, J; Chang, ZY				Fu, Xinmiao; Shi, Xiaodong; Yin, Linxiang; Liu, Jiafeng; Joo, Keehyoung; Lee, Jooyoung; Chang, Zengyi			Small Heat Shock Protein IbpB Acts as a Robust Chaperone in Living Cells by Hierarchically Activating Its Multi-type Substrate-binding Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ALPHA-CRYSTALLIN; MOLECULAR CHAPERONES; 1,1'-BI(4-ANILINO)NAPHTHALENE-5,5'-DISULFONIC ACID; DENATURED PROTEINS; STRESS; HSP26; OLIGOMERIZATION; DISORDER; OVEREXPRESSION	As ubiquitous molecular chaperones, small heat shock proteins (sHSPs) are crucial for protein homeostasis. It is not clear why sHSPs are able to bind a wide spectrum of non-native substrate proteins and how such binding is enhanced by heat shock. Here, by utilizing a genetically incorporated photo-cross-linker (p-benzoyl-L-phenylalanine), we systematically characterized the substrate-binding residues in IbpB (a sHSP from Escherichia coli) in living cells over a wide spectrum of temperatures (from 20 to 50 degrees C). A total of 20 and 48 residues were identified at normal and heat shock temperatures, respectively. They are not necessarily hydrophobic and can be classified into three types: types I and II were activated at low and normal temperatures, respectively, and type III mediated oligomerization at low temperature but switched to substrate binding at heat shock temperature. In addition, substrate binding of IbpB in living cells began at temperatures as low as 25 degrees C and was further enhanced upon temperature elevation. Together, these in vivo data provide novel structural insights into the wide substrate spectrum of sHSPs and suggest that sHSP is able to hierarchically activate its multi-type substrate-binding residues and thus act as a robust chaperone in cells under fluctuating growth conditions.	[Fu, Xinmiao; Shi, Xiaodong; Yin, Linxiang; Liu, Jiafeng; Chang, Zengyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Fu, Xinmiao; Shi, Xiaodong; Yin, Linxiang; Liu, Jiafeng; Chang, Zengyi] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China; [Shi, Xiaodong] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221002, Peoples R China; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Ctr Silico Prot Sci, Seoul 130722, South Korea; [Joo, Keehyoung] Korea Inst Adv Study, Ctr Adv Computat, Seoul 130722, South Korea; [Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea	Peking University; Peking University; Xuzhou Medical University; Korea Institute for Advanced Study (KIAS); Korea Institute for Advanced Study (KIAS); Korea Institute for Advanced Study (KIAS)	Fu, XM (corresponding author), Peking Univ, Sch Life Sci, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	fuxinmiao@pku.edu.cn; changzy@pku.edu.cn	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904; Yin, Linxiang/0000-0002-9884-8194	National Basic Research Program of China (973 Program) [2012CB917300]; National Natural Science Foundation of China [31170738, 31100559, 31270804]; Creative Research Initiatives (Center for In Silico Protein Science) Grant from the National Research Foundation of Korea (MEST/KOSEF) [20110000040]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Creative Research Initiatives (Center for In Silico Protein Science) Grant from the National Research Foundation of Korea (MEST/KOSEF)	This work was supported by National Basic Research Program of China (973 Program) Research Grant 2012CB917300 (to Z. C. and X. F.), National Natural Science Foundation of China Research Grants 31170738 (to Z. C.) and 31100559 and 31270804 (to X. F.), and Creative Research Initiatives (Center for In Silico Protein Science) Grant 20110000040 from the National Research Foundation of Korea (MEST/KOSEF; to K. J. and J. Lee).	ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; ARATA S, 1995, J CELL PHYSIOL, V163, P458, DOI 10.1002/jcp.1041630305; Balogi Z, 2008, J BIOL CHEM, V283, P22983, DOI 10.1074/jbc.M710400200; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, J MOL BIOL, V343, P445, DOI 10.1016/j.jmb.2004.08.048; Haslbeck M, 2008, J MOL BIOL, V378, P362, DOI 10.1016/j.jmb.2008.01.095; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Jiao WW, 2008, BIOCHEM J, V410, P63, DOI 10.1042/BJ20071120; Jiao WW, 2005, BIOCHEM BIOPH RES CO, V335, P227, DOI 10.1016/j.bbrc.2005.07.065; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Joo K, 2008, BIOPHYS J, V95, P4813, DOI 10.1529/biophysj.108.129684; Joo K, 2007, PROTEINS, V69, P83, DOI 10.1002/prot.21628; Joo K, 2009, PROTEINS, V75, P1010, DOI 10.1002/prot.22312; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Laskowska E, 2010, CURR PHARM BIOTECHNO, V11, P146, DOI 10.2174/138920110790909669; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; LeThanh H, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-6; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; Raman B, 1997, J BIOL CHEM, V272, P23559, DOI 10.1074/jbc.272.38.23559; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Richards EH, 1996, CANCER RES, V56, P2446; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Shearstone JR, 1999, J BIOL CHEM, V274, P9937, DOI 10.1074/jbc.274.15.9937; Shi J, 2013, J BIOL CHEM, V288, P4819, DOI 10.1074/jbc.M112.388132; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Strozecka J, 2012, J BIOL CHEM, V287, P2843, DOI 10.1074/jbc.M111.273847; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	52	30	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11897	11906		10.1074/jbc.M113.450437	http://dx.doi.org/10.1074/jbc.M113.450437			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486475	Green Published, hybrid			2022-12-25	WOS:000318157600025
J	Medina, F; Carter, AM; Dada, O; Gutowski, S; Hadas, J; Chen, Z; Sternweis, PC				Medina, Frank; Carter, Angela M.; Dada, Olugbenga; Gutowski, Stephen; Hadas, Jana; Chen, Zhe; Sternweis, Paul C.			Activated RhoA Is a Positive Feedback Regulator of the Lbc Family of Rho Guanine Nucleotide Exchange Factor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; P115 RHOGEF; G-ALPHA(13); IDENTIFICATION; MECHANISMS; GTPASES	The monomeric Rho GTPases are essential for cellular regulation including cell architecture and movement. A direct mechanism for hormonal regulation of the RhoA-type GTPases is their modulation by the G(12) and G(13) proteins via RH (RGS homology) containing RhoGEFs. In addition to the interaction of the Gprotein alpha subunits with the RH domain, activated RhoA also binds to the pleckstrin homology (PH) domain of PDZRhoGEF. The latter interaction is now extended to all seven members of the homologous Lbc family of RhoGEFs which includes the RH-RhoGEFs. This is evinced by direct measurements of binding or through effects on selected signaling pathways in cells. Overexpression of these PH domains alone can block RhoA-dependent signaling in cells to various extents. Whereas activated RhoA does not modulate the intrinsic activity of the RhoGEFs, activated RhoA associated with phospholipid vesicles can facilitate increased activity of soluble RhoGEFs on vesicle-delimited substrate (RhoA-GDP). This demonstrates feasibility of the hypothesis that binding of activated RhoA to the PH domains acts as a positive feedback mechanism. This is supported by cellular studies in which mutation of this binding site on PH strongly attenuates the stimulation of RhoA observed by overexpression of five of the RhoGEF DH-PH domains. This mutation is even more dramatic in the context of full-length p115RhoGEF. The utilization of this mechanism by multiple RhoGEFs suggests that this regulatory paradigm may be a common feature in the broader family of RhoGEFs.	[Medina, Frank; Carter, Angela M.; Dada, Olugbenga; Gutowski, Stephen; Hadas, Jana; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Chen, Zhe] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sternweis, PC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	paul.sternweis@UTsouthwestern.edu		Carter, Angela/0000-0001-5766-3743; Chen, Zhe/0000-0002-1668-4051	National Institutes of Health [GM31954]; Robert A. Welch Foundation [I-1262]; Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31954 (to P. C. S.). This work was also supported by Robert A. Welch Foundation Grant I-1262 (to P. C. S.) and the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Blomquist A, 2000, BIOCHEM J, V352, P319, DOI 10.1042/0264-6021:3520319; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Cheng L, 2004, J BIOL CHEM, V279, P12786, DOI 10.1074/jbc.M313099200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200	20	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11325	11333		10.1074/jbc.M113.450056	http://dx.doi.org/10.1074/jbc.M113.450056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23493395	Green Published, hybrid			2022-12-25	WOS:000317915500035
J	Resch, G; Francois, P; Morisset, D; Stojanov, M; Bonetti, EJ; Schrenzel, J; Sakwinska, O; Moreillon, P				Resch, Gregory; Francois, Patrice; Morisset, Delphine; Stojanov, Milos; Bonetti, Eve J.; Schrenzel, Jacques; Sakwinska, Olga; Moreillon, Philippe			Human-to-Bovine Jump of Staphylococcus aureus CC8 Is Associated with the Loss of a beta-Hemolysin Converting Prophage and the Acquisition of a New Staphylococcal Cassette Chromosome	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MOLECULAR CHARACTERIZATION; BIOFILM FORMATION; HOST; VIRULENCE; RESISTANCE; STRAINS; LIPOPROTEIN; ADAPTATION; GENES	Staphylococcus aureus can colonize and infect both humans and animals, but isolates from both hosts tend to belong to different lineages. Our recent finding of bovine-adapted S. aureus showing close genetic relationship to the human S. aureus clonal complex 8 (CC8) allowed us to examine the genetic basis of host adaptation in this particular CC. Using total chromosome microarrays, we compared the genetic makeup of 14 CC8 isolates obtained from cows suffering subclinical mastitis, with nine CC8 isolates from colonized or infected human patients, and nine S. aureus isolates belonging to typical bovine CCs. CC8 isolates were found to segregate in a unique group, different from the typical bovine CCs. Within this CC8 group, human and bovine isolates further segregated into three subgroups, among which two contained a mix of human and bovine isolates, and one contained only bovine isolates. This distribution into specific clusters and subclusters reflected major differences in the S. aureus content of mobile genetic elements (MGEs). Indeed, while the mixed human-bovine clusters carried commonly human-associated beta-hemolysin converting prophages, the bovine-only isolates were devoid of such prophages but harbored an additional new non-mec staphylococcal cassette chromosome (SCC) unique to bovine CC8 isolates. This composite cassette carried a gene coding for a new LPXTG-surface protein sharing homologies with a protein found in the environmental bacterium Geobacillus thermoglucosidans. Thus, in contrast to human CC8 isolates, the bovine-only CC8 group was associated with the combined loss of b-hemolysin converting prophages and gain of a new SCC probably acquired in the animal environment. Remaining questions are whether the new LPXTG-protein plays a role in bovine colonization or infection, and whether the new SCC could further acquire antibiotic-resistance genes and carry them back to human.	[Resch, Gregory; Morisset, Delphine; Stojanov, Milos; Sakwinska, Olga; Moreillon, Philippe] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Francois, Patrice; Bonetti, Eve J.; Schrenzel, Jacques] Univ Hosp Geneva, Genom Res Lab, Geneva, Switzerland; [Schrenzel, Jacques] Univ Hosp Geneva, Bacteriol Lab, Geneva, Switzerland; [Morisset, Delphine] RUWAG Handels AG, Bettlach, Switzerland; [Sakwinska, Olga] Nestle Res Ctr, CH-1000 Lausanne, Switzerland	University of Lausanne; University of Geneva; University of Geneva; Nestle SA	Resch, G (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	gregory.resch@unil.ch	francois, patrice/AAL-5583-2020; Schrenzel, Jacques/P-8525-2017; Stojanov, Milos/C-8163-2016; Schrenzel, Jacques/AAC-5685-2021	Schrenzel, Jacques/0000-0001-5464-7764; Stojanov, Milos/0000-0002-5166-5841; Schrenzel, Jacques/0000-0001-5464-7764; Sakwinska, Olga/0000-0002-3142-9542; resch, gregory/0000-0003-2341-4591; francois, patrice/0000-0002-0540-750X	Swiss National Science Foundation grant (SNF) [PMPDA-106195]; SNF grant [32003B-113854]	Swiss National Science Foundation grant (SNF); SNF grant	This work was supported by the Swiss National Science Foundation grant (SNF) PMPDA-106195 (Marie Heim Voegtlin) to O.S. and SNF grant 32003B-113854 to P. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar SL, 2009, MICROBIOL-SGM, V155, P3247, DOI 10.1099/mic.0.029124-0; Alves PDD, 2009, VET MICROBIOL, V137, P190, DOI 10.1016/j.vetmic.2008.12.014; Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206; Burgess SA, 2010, INT J FOOD MICROBIOL, V144, P215, DOI 10.1016/j.ijfoodmicro.2010.09.027; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DEVRIESE LA, 1976, RES VET SCI, V21, P284, DOI 10.1016/S0034-5288(18)33337-X; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; FRANCIOLLI M, 1991, J INFECT DIS, V163, P514, DOI 10.1093/infdis/163.3.514; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hiramatsu K, 2002, INT J MED MICROBIOL, V292, P67, DOI 10.1078/1438-4221-00192; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; KAPUR V, 1995, J CLIN MICROBIOL, V33, P376, DOI 10.1128/JCM.33.2.376-380.1995; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koessler T, 2006, J CLIN MICROBIOL, V44, P1040, DOI 10.1128/JCM.44.3.1040-1048.2006; Kozytska S, 2010, VET MICROBIOL, V145, P360, DOI 10.1016/j.vetmic.2010.03.020; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mattew A, 2006, M2A9 CLSI; McCarthy AJ, 2011, GENOME BIOL EVOL; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rose WE, 2008, ANTIMICROB AGENTS CH, V52, P831, DOI 10.1128/AAC.00869-07; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Smyth DS, 2005, J MED MICROBIOL, V54, P401, DOI 10.1099/jmm.0.45863-0; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Ythier M, 2010, INFECT IMMUN, V78, P1711, DOI 10.1128/IAI.01274-09; Zhao Y, 2012, J BACTERIOL, V194, P4118, DOI 10.1128/JB.00318-12	56	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58187	10.1371/journal.pone.0058187	http://dx.doi.org/10.1371/journal.pone.0058187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505465	gold, Green Published, Green Submitted			2022-12-25	WOS:000316251100031
J	Atemnkeng, VA; Pink, M; Schmitz-Spanke, S; Wu, XJ; Dong, LL; Zhao, KH; May, C; Laufer, S; Langer, B; Kaiser, A				Atemnkeng, Veronika Anyigoh; Pink, Mario; Schmitz-Spanke, Simone; Wu, Xian-Jun; Dong, Liang-Liang; Zhao, Kai-Hong; May, Caroline; Laufer, Stefan; Langer, Barbara; Kaiser, Annette			Deoxyhypusine Hydroxylase from Plasmodium vivax, the Neglected Human Malaria Parasite: Molecular Cloning, Expression and Specific Inhibition by the 5-LOX Inhibitor Zileuton	PLOS ONE			English	Article							PROTEIN; 5-LIPOXYGENASE; BIOSYNTHESIS; FALCIPARUM; THERAPY	Primaquine, an 8-aminoquinoline, is the only drug which cures the dormant hypnozoites of persistent liver stages from P. vivax. Increasing resistance needs the discovery of alternative pathways as drug targets to develop novel drug entities. Deoxyhypusine hydroxylase (DOHH) completes hypusine biosynthesis in eukaryotic initiation factor (eIF-5A) which is the only cellular protein known to contain the unusual amino acid hypusine. Modified EIF-5A is important for proliferation of the malaria parasite. Here, we present the first successful cloning and expression of DOHH from P. vivax causing tertiary malaria. The nucleic acid sequence of 1041 bp encodes an open reading frame of 346 amino acids. Histidine tagged expression of P. vivax DOHH detected a protein of 39.01 kDa in E. coli. The DOHH protein from P. vivax shares significant amino acid identity to the simian orthologues from P. knowlesi and P. yoelii strain H. In contrast to P. falciparum only four E-Z-type HEAT-like repeats are present in P. vivax DOHH with different homology to phycocyanin lyase subunits from cyanobacteria and in proteins participating in energy metabolism of Archaea and Halobacteria. However, phycocyanin lyase activity is absent in P. vivax DOHH. The dohh gene is present as a single copy gene and transcribed throughout the whole erythrocytic cycle. Specific inhibition of recombinant P. vivax DOHH is possible by complexing the ferrous iron with zileuton, an inhibitor of mammalian 5-lipoxygenase (5-LOX). Ferrous iron in the active site of 5-LOX is coordinated by three conserved histidines and the carboxylate of isoleucine(673). Zileuton inhibited the P. vivax DOHH protein with an IC50 of 12,5 nmol determined by a relative quantification by GC/MS. By contrast, the human orthologue is only less affected with an IC50 of 90 nmol suggesting a selective iron-complexing strategy for the parasitic enzyme.	[Atemnkeng, Veronika Anyigoh; Langer, Barbara; Kaiser, Annette] Univ Duisburg Essen, Inst Pharmacogenet, Essen, Germany; [Pink, Mario; Schmitz-Spanke, Simone] Univ Duisburg Essen, Essen, Germany; [Wu, Xian-Jun; Dong, Liang-Liang; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [May, Caroline] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany; [Laufer, Stefan] Univ Tubingen, Inst Pharmazeut, Tubingen, Germany	University of Duisburg Essen; University of Duisburg Essen; Huazhong Agricultural University; Ruhr University Bochum; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kaiser, A (corresponding author), Univ Duisburg Essen, Inst Pharmacogenet, Essen, Germany.	annette.kaiser@uk-essen.de		Laufer, Stefan/0000-0001-6952-1486; Kaiser, Annette/0000-0001-7873-3958	DAAD (German Academic Exchange Service) [PI:56154387]; P.U.R.E. (Protein Unit for Research in Europe)	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); P.U.R.E. (Protein Unit for Research in Europe)	This work was funded by a DAAD grant PI:56154387 (German Academic Exchange Service) to AK and a grant from P.U.R.E. (Protein Unit for Research in Europe) to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparoy P, 2008, J COMPUT AID MOL DES, V22, P611, DOI 10.1007/s10822-008-9180-0; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chawla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033138; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; de Miranda Aline Silva, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P285; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Foth BJ, 2003, INT REV CYTOL, V224, P57, DOI 10.1016/S0074-7696(05)24003-2; Frommholz D, 2009, FEBS J, V276, P5881, DOI 10.1111/j.1742-4658.2009.07272.x; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Kaiser A, 2006, MINI-REV MED CHEM, V6, P1231, DOI 10.2174/138955706778742795; Kerscher B, 2010, AMINO ACIDS, V38, P471, DOI 10.1007/s00726-009-0406-9; Kippert F, 2008, PLOS ONE, V4, P1; Krotoski W A, 1989, Prog Clin Parasitol, V1, P1; Kubavat AH, 2012, AM J THER, V23; Kupka M, 2009, J BIOL CHEM, V284, P36405, DOI 10.1074/jbc.M109.056382; LEE BC, 1992, J GEN MICROBIOL, V138, P2647, DOI 10.1099/00221287-138-12-2647; Njuguna JT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-91; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2011, CURR OPIN INFECT DIS, V24, P578, DOI 10.1097/QCO.0b013e32834c61e3; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rossi A, 2010, BRIT J PHARMACOL, V161, P555, DOI 10.1111/j.1476-5381.2010.00930.x; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Sievert H, 2012, MOL CELL PROTEOMICS; Udomsangpetch R, 2007, PARASITOL INT, V56, P65, DOI 10.1016/j.parint.2006.12.005; Wu YR, 2012, J MED CHEM, V55, P2597, DOI 10.1021/jm201497k; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010	40	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58318	10.1371/journal.pone.0058318	http://dx.doi.org/10.1371/journal.pone.0058318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505486	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500068
J	Bode, F; Burgdorf, C; Schunkert, H; Kurowski, V				Bode, Frank; Burgdorf, Christof; Schunkert, Heribert; Kurowski, Volkhard			24 Hour ST Segment Analysis in Transient Left Ventricular Apical Ballooning	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; TAKO-TSUBO CARDIOMYOPATHY; TAKOTSUBO CARDIOMYOPATHY; EMOTIONAL-STRESS; ENDOTHELIAL DYSFUNCTION; AMPULLA CARDIOMYOPATHY; ANIMAL-MODEL; WOMEN; ELEVATION; ISCHEMIA	Objective: The etiologic basis of transient left ventricular apical ballooning, a novel cardiac syndrome, is not clear. Among the proposed pathomechanisms is coronary vasospasm. Long-term ST segment analysis may detect vasospastic episodes but has not been reported. Methods: 30 consecutive patients with transient left ventricular apical ballooning, left ventricular dysfunction and normal or near-normal coronary arteries were investigated. A 24-hour Holter ECG was obtained after emergency admission. ST segment analysis was performed automatically in 2 leads and confirmed by visual inspection. Criteria for an ischemic event were: 1. ST elevation or 2. horizontal or down-sloping ST segments >= 1 min duration and >= 100 mu V J+80 point deviation corrected for baseline ST-deviation. Results: Patients presented with ST segment elevation (n = 19) and/or T wave inversion (n = 20) on admission ECG. Ejection fraction was 50 +/- 12%. No transient ST elevations were observed during Holter ECG analysis. In 3 patients, 8 transient episodes of ST depression were recorded. Durations of episodes varied between 75s and 790s (mean 229s). Maximal ST deviation averaged -191 +/- 71 mu V. Ischemic burden was -1 to -22 mVs (mean -8 mVs). 27 patients showed no ischemic events. Conclusions: ST segment analysis of 24 h Holter recordings revealed minor ischemic events in only 10% of patients with transient left ventricular apical ballooning. Overall, ST segment changes were not indicative of recurrent coronary spasm playing a major role in the genesis of transient left ventricular apical ballooning.	[Bode, Frank; Burgdorf, Christof; Schunkert, Heribert; Kurowski, Volkhard] Univ Lubeck, Med Dept II, Lubeck, Germany	University of Lubeck	Bode, F (corresponding author), Univ Lubeck, Med Dept II, Lubeck, Germany.	frank.bode@uk-sh.de	Bode, Frank/A-6395-2015					Abe Y, 2003, J AM COLL CARDIOL, V41, P737, DOI 10.1016/S0735-1097(02)02925-X; Ako J, 2001, JPN HEART J, V42, P355, DOI 10.1536/jhj.42.355; Angelini P, 2008, CATHETER CARDIO INTE, V71, P342, DOI 10.1002/ccd.21338; Bahlmann E, 2008, INT J CARDIOL, V124, P32, DOI 10.1016/j.ijcard.2006.12.090; Bonnemeier H, 2006, EUR HEART J, V27, P2246, DOI 10.1093/eurheartj/ehi820; Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Crawford MH, 1999, CIRCULATION, V100, P886, DOI 10.1161/01.CIR.100.8.886; Desmet WJR, 2003, HEART, V89, P1027, DOI 10.1136/heart.89.9.1027; Dote K, 1991, J Cardiol, V21, P203; Elesber AA, 2006, J AM COLL CARDIOL, V47, P1082, DOI 10.1016/j.jacc.2005.12.004; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Gill JB, 1996, NEW ENGL J MED, V334, P65, DOI 10.1056/NEJM199601113340201; GOTTLIEB SO, 1986, NEW ENGL J MED, V314, P1214, DOI 10.1056/NEJM198605083141903; Hurst RT, 2006, J AM COLL CARDIOL, V48, P579, DOI 10.1016/j.jacc.2006.06.015; Ito K, 2003, ANN NUCL MED, V17, P115, DOI 10.1007/BF02988449; Ito K, 2001, ANN NUCL MED, V15, P351, DOI 10.1007/BF02988242; Kume T, 2005, CIRC J, V69, P934, DOI 10.1253/circj.69.934; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; Kurisu S, 2004, CIRC J, V68, P77, DOI 10.1253/circj.68.77; Kurisu S, 2003, J AM COLL CARDIOL, V41, P743, DOI 10.1016/S0735-1097(02)02924-8; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; Lee YP, 2009, INT J CARDIOL, V133, P272, DOI 10.1016/j.ijcard.2007.11.039; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Ortak J, 2005, J AM COLL CARDIOL, V46, P1959, DOI 10.1016/j.jacc.2005.08.026; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4; Samniah N, 1997, J ELECTROCARDIOL, V30, P197, DOI 10.1016/S0022-0736(97)80004-0; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; Taddei S, 1996, HYPERTENSION, V28, P576, DOI 10.1161/01.HYP.28.4.576; Takizawa M, 2007, INT J CARDIOL, V114, pE15, DOI 10.1016/j.ijcard.2006.07.125; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Ueyama T, 2003, J CARDIOVASC PHARM, V42, pS117, DOI 10.1097/00005344-200312001-00024; Ueyama T, 2002, CIRC J, V66, P712, DOI 10.1253/circj.66.712; WHITE M, 1995, CIRCULATION, V92, P2183, DOI 10.1161/01.CIR.92.8.2183; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; WOLF E, 1974, BRIT HEART J, V36, P90; Yanagi Shiro, 2002, J Cardiol, V39, P305	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58349	10.1371/journal.pone.0058349	http://dx.doi.org/10.1371/journal.pone.0058349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505493	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500072
J	Friedrich, K; Rupp, C; Hov, JR; Steinebrunner, N; Weiss, KH; Stiehl, A; Brune, M; Schaefer, PKY; Schemmer, P; Sauer, P; Schirmacher, P; Runz, H; Karlsen, TH; Stremmel, W; Gotthardt, DN				Friedrich, Kilian; Rupp, Christian; Hov, Johannes Roksund; Steinebrunner, Niels; Weiss, Karl-Heinz; Stiehl, Adolf; Brune, Maik; Schaefer, Petra Kloeters Yvonne; Schemmer, Peter; Sauer, Peter; Schirmacher, Peter; Runz, Heiko; Karlsen, Tom Hemming; Stremmel, Wolfgang; Gotthardt, Daniel Nils			A Frequent PNPLA3 Variant Is a Sex Specific Disease Modifier in PSC Patients with Bile Duct Stenosis	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; FATTY LIVER-DISEASE; WIDE ASSOCIATION ANALYSIS; HISTOLOGICAL SEVERITY; SUSCEPTIBILITY; ADIPONUTRIN	Background & Aims: Primary sclerosing cholangitis predominantly affects males and is an important indication for liver transplantation. The rs738409 variant (I148M) of the PNPLA3 gene is associated with alcoholic and non-alcoholic liver disease and we evaluated its impact on the disease course of PSC. Methods: The I148M polymorphism was genotyped in 121 German PSC patients of a long-term prospective cohort and 347 Norwegian PSC patients. Results: In the prospective German cohort, actuarial survival free of liver transplantation was significantly reduced for I148M carriers (p = 0.011) compared to wildtype patients. This effect was restricted to patients with severe disease, as defined by development of dominant stenosis (DS) requiring endoscopic intervention. DS patients showed markedly decreased survival (p = 0.004) when carrying the I148M variant (I148M: mean 13.8 years; 95% confidence interval: 11.6-16.0 vs. wildtype: mean 18.6 years; 95% confidence interval: 16.3-20.9) while there was no impact on survival in patients without a DS (p = 0.87). In line with previous observations of sex specific effects of the I148M polymorphism, the effect on survival was further restricted to male patients (mean survival 11.9 years; 95% confidence interval: 10.0-14.0 in I148M carriers vs. 18.8 years; 95% confidence interval: 16.2-21.5 in wildtype; p<0.001) while female patients were unaffected by the polymorphism (p = 0.65). These sex specific findings were validated in the Norwegian cohort (p = 0.013). Conclusions: In male PSC patients with severe disease with bile duct stenosis requiring intervention, the common I148M variant of the PNPLA3 gene is a risk factor for reduced survival.	[Friedrich, Kilian; Rupp, Christian; Steinebrunner, Niels; Weiss, Karl-Heinz; Stiehl, Adolf; Sauer, Peter; Stremmel, Wolfgang; Gotthardt, Daniel Nils] Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Baden Wuerttemb, Germany; [Brune, Maik] Univ Heidelberg Hosp, Dept Internal Med 1, Heidelberg, Baden Wuerttemb, Germany; [Schemmer, Peter] Univ Heidelberg Hosp, Dept Gen Surg, Heidelberg, Baden Wuerttemb, Germany; [Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Baden Wuerttemb, Germany; [Runz, Heiko] Univ Heidelberg Hosp, Inst Human Genet, Heidelberg, Baden Wuerttemb, Germany; [Hov, Johannes Roksund; Karlsen, Tom Hemming] Oslo Univ Hosp, Internal Med Res Inst, Norwegian PSC Res Ctr, Oslo, Norway; [Hov, Johannes Roksund; Karlsen, Tom Hemming] Oslo Univ Hosp, Div Canc Surg & Transplantat, Dept Gastroenterol, Oslo, Norway; [Hov, Johannes Roksund] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Karlsen, Tom Hemming] Univ Bergen, Fac Med & Dent, Inst Med, Bergen, Norway	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Oslo; University of Oslo; University of Oslo; University of Bergen	Gotthardt, DN (corresponding author), Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Baden Wuerttemb, Germany.	Daniel.Gotthardt@med.uni-heidelberg.de	Hov, Johannes R/J-1480-2019; Weiss, Karl Heinz/AAA-9117-2022; Rupp, Christian/E-7652-2019	Hov, Johannes R/0000-0002-5900-8096; Rupp, Christian/0000-0003-2808-9230; Stremmel, Wolfgang/0000-0002-8545-1753	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	D.N.G. was funded by a grant of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambha K, 2003, GASTROENTEROLOGY, V125, P1364, DOI 10.1016/j.gastro.2003.07.011; Bergquist A, 2005, J HEPATOL, V42, P252, DOI 10.1016/j.jhep.2004.10.011; Boonstra K, 2012, J HEPATOL; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; Gotthardt DN, 2010, GASTROINTEST ENDOSC, V71, P527, DOI 10.1016/j.gie.2009.10.041; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Lazaridis KN, 2006, SEMIN LIVER DIS, V26, P42, DOI 10.1055/s-2006-933562; Li Q, 2012, CLIN INVEST MED, V35, pL237; Liu YM, 2004, J CLIN ENDOCR METAB, V89, P2684, DOI 10.1210/jc.2003-031978; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Pollheimer MJ, 2011, BEST PRACT RES CL GA, V25, P727, DOI 10.1016/j.bpg.2011.10.009; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Rudolph G, 2009, J HEPATOL, V51, P149, DOI 10.1016/j.jhep.2009.01.023; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Storm Niels, 2003, Methods Mol Biol, V212, P241; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Tischendorf JJW, 2007, AM J GASTROENTEROL, V102, P107, DOI 10.1111/j.1572-0241.2006.00872.x; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200	22	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58734	10.1371/journal.pone.0058734	http://dx.doi.org/10.1371/journal.pone.0058734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505555	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500120
J	Gillberg, L; Jacobsen, S; Ribel-Madsen, R; Gjesing, AP; Boesgaard, TW; Ling, C; Pedersen, O; Hansen, T; Vaag, A				Gillberg, Linn; Jacobsen, Stine; Ribel-Madsen, Rasmus; Gjesing, Anette Prior; Boesgaard, Trine W.; Ling, Charlotte; Pedersen, Oluf; Hansen, Torben; Vaag, Allan			Does DNA Methylation of PPARGC1A Influence Insulin Action in First Degree Relatives of Patients with Type 2 Diabetes?	PLOS ONE			English	Article							GENE-EXPRESSION; SKELETAL-MUSCLE; MITOCHONDRIAL DENSITY; 1ST-DEGREE RELATIVES; GLUCOSE-TOLERANCE; COACTIVATOR PGC-1; ADIPOSE-TISSUE; RESISTANCE; PGC-1-ALPHA; PHOSPHORYLATION	Epigenetics may play a role in the pathophysiology of type 2 diabetes (T2D), and increased DNA methylation of the metabolic master regulator peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) has been reported in muscle and pancreatic islets from T2D patients and in muscle from individuals at risk of T2D. This study aimed to investigate DNA promoter methylation and gene expression of PPARGC1A in skeletal muscle from first degree relatives (FDR) of T2D patients, and to determine the association with insulin action as well as the influence of family relation. We included 124 Danish FDR of T2D patients from 46 different families. Skeletal muscle biopsies were excised from vastus lateralis and insulin action was assessed by oral glucose tolerance tests. DNA methylation and mRNA expression levels were measured using bisulfite sequencing and quantitative real-time PCR, respectively. The average PPARGC1A methylation at four CpG sites situated 867-624 bp from the transcription start was associated with whole-body insulin sensitivity in a paradoxical positive manner (beta = 0.12, P = 0.03), supported by a borderline significant inverse correlation with fasting insulin levels (beta = -0.88, P = 0.06). Excluding individuals with prediabetes and overt diabetes did not affect the overall result. DNA promoter methylation was not associated with PPARGC1A gene expression. The familiality estimate of PPARGC1A gene expression was high (h(2) = 79 +/- 27% (h(2) +/- SE), P = 0.002), suggesting genetic regulation to play a role. No significant effect of familiality on DNA methylation was found. Taken together, increased DNA methylation of the PPARGC1A promoter is unlikely to play a major causal role for the development of insulin resistance in FDR of patients with T2D.	[Gillberg, Linn; Jacobsen, Stine; Vaag, Allan] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Gillberg, Linn; Jacobsen, Stine; Boesgaard, Trine W.; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Ribel-Madsen, Rasmus; Gjesing, Anette Prior; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark; [Boesgaard, Trine W.; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Ling, Charlotte] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Vaag, Allan] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Steno Diabetes Center; Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Lund University; Aarhus University; University of Southern Denmark; University of Copenhagen	Gillberg, L (corresponding author), Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark.	linn.gillberg@rh.regionh.dk	Gjesing, Anette/ACC-7521-2022; Ling, Charlotte/Q-2432-2015; Pedersen, Oluf/AAG-8015-2020; Gillberg, Linn/A-1417-2017	Gjesing, Anette/0000-0003-4580-1576; Ling, Charlotte/0000-0003-0587-7154; Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Gillberg, Linn/0000-0003-0588-1663; Vaag, Allan Arthur/0000-0002-3690-2191	Danish Strategic Research Council; Danish Council for Independent Research; EASD; Exgenesis; Rigshospitalets forskningsudvalg; Steno Diabetes Center	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); EASD; Exgenesis(European Commission); Rigshospitalets forskningsudvalg; Steno Diabetes Center	This work was supported by The Danish Strategic Research Council, The Danish Council for Independent Research, EASD, Exgenesis, Rigshospitalets forskningsudvalg and Steno Diabetes Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Alibegovic AC, 2009, DIABETES, V58, P2749, DOI 10.2337/db09-0369; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Boesgaard TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007236; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Carey AL, 2006, DIABETOLOGIA, V49, P1000, DOI 10.1007/s00125-006-0178-7; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gervin K, 2011, GENOME RES, V21, P1813, DOI 10.1101/gr.119685.110; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Lomba A, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-60; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mcrae AF, 2007, HUM MOL GENET, V16, P364, DOI 10.1093/hmg/ddl456; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Patti ME, 2004, CURR OPIN CLIN NUTR, V7, P383, DOI 10.1097/01.mco.0000134359.23288.72; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Rhinn H, 2008, ANAL BIOCHEM, V372, P116, DOI 10.1016/j.ab.2007.08.023; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; VAAG A, 1992, J CLIN INVEST, V89, P782, DOI 10.1172/JCI115656; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	43	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58384	10.1371/journal.pone.0058384	http://dx.doi.org/10.1371/journal.pone.0058384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505498	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500076
J	Kao, A; Meenderink, SWF; Bozovic, D				Kao, Albert; Meenderink, Sebastiaan W. F.; Bozovic, Dolores			Mechanical Overstimulation of Hair Bundles: Suppression and Recovery of Active Motility	PLOS ONE			English	Article							MECHANOELECTRICAL-TRANSDUCTION CHANNELS; THRESHOLD SHIFT TTS; COCHLEAR AMPLIFIER; SPONTANEOUS OSCILLATIONS; BULLFROGS SACCULUS; CELL TRANSDUCTION; ADAPTATION; AMPLIFICATION; EAR; STIMULATION	We explore the effects of high-amplitude mechanical stimuli on hair bundles of the bullfrog sacculus. Under in vitro conditions, these bundles exhibit spontaneous limit cycle oscillations. Prolonged deflection exerted two effects. First, it induced an offset in the position of the bundle. Recovery to the original position displayed two distinct time scales, suggesting the existence of two adaptive mechanisms. Second, the stimulus suppressed spontaneous oscillations, indicating a change in the hair bundle's dynamic state. After cessation of the stimulus, active bundle motility recovered with time. Both effects were dependent on the duration of the imposed stimulus. External calcium concentration also affected the recovery to the oscillatory state. Our results indicate that both offset in the bundle position and calcium concentration control the dynamic state of the bundle.	[Kao, Albert; Meenderink, Sebastiaan W. F.; Bozovic, Dolores] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Bozovic, Dolores] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bozovic, D (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	bozovic@physics.ucla.edu		Meenderink, Bas/0000-0001-5487-2232	National Institutes of Health (NIH) [R01DC011380]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) under grant R01DC011380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Benser ME, 1996, J NEUROSCI, V16, P5629; Beurg M, 2008, BIOPHYS J, V94, P2639, DOI 10.1529/biophysj.107.123257; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Cheung ELM, 2006, BIOPHYS J, V90, P124, DOI 10.1529/biophysj.105.061226; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; CLARK WW, 1991, J ACOUST SOC AM, V90, P155, DOI 10.1121/1.401309; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DALLOS P, 1992, J NEUROSCI, V12, P4575; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; Han LJ, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041913; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4, P590; Kennedy HJ, 2006, J NEUROSCI, V26, P2757, DOI 10.1523/JNEUROSCI.3808-05.2006; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; LEWIS ER, 1988, BIOPHYS J, V53, P441, DOI 10.1016/S0006-3495(88)83120-5; Lichtenhan JT, 2008, J ACOUST SOC AM, V123, P2200, DOI 10.1121/1.2885748; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Martin P, 2003, J NEUROSCI, V23, P4533; Martin P, 2001, P NATL ACAD SCI USA, V98, P14380, DOI 10.1073/pnas.251530598; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; MELNICK W, 1991, J ACOUST SOC AM, V90, P147, DOI 10.1121/1.401308; Nadrowski B, 2004, P NATL ACAD SCI USA, V101, P12195, DOI 10.1073/pnas.0403020101; NARINS PM, 1984, J ACOUST SOC AM, V76, P1384, DOI 10.1121/1.391455; Nuttall AL, 2002, AUDIOL NEURO-OTOL, V7, P21, DOI 10.1159/000046858; Patuzzi R, 2002, AUDIOL NEURO-OTOL, V7, P17, DOI 10.1159/000046857; Rabbitt RD, 2010, P NATL ACAD SCI USA, V107, P3864, DOI 10.1073/pnas.0906765107; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Roongthumskul Y, 2011, BIOPHYS J, V101, P603, DOI 10.1016/j.bpj.2011.06.027; RUSSELL IJ, 1992, P ROY SOC B-BIOL SCI, V250, P217, DOI 10.1098/rspb.1992.0152; Shlomovitz R, 2013, BIOPHY J UNPUB; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Vilfan A, 2003, BIOPHYS J, V85, P191, DOI 10.1016/S0006-3495(03)74465-8; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58143	10.1371/journal.pone.0058143	http://dx.doi.org/10.1371/journal.pone.0058143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505461	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500053
J	Osei-Kwakye, K; Asante, KP; Mahama, E; Apanga, S; Owusu, R; Kwara, E; Adjei, G; Abokyi, L; Yeetey, E; Dosoo, DK; Punguyire, D; Owusu-Agyei, S				Osei-Kwakye, Kingsley; Asante, Kwaku Poku; Mahama, Emmanuel; Apanga, Stephen; Owusu, Ruth; Kwara, Evans; Adjei, George; Abokyi, Livesy; Yeetey, Enuameh; Dosoo, David Kwame; Punguyire, Damien; Owusu-Agyei, Seth			The Benefits or Otherwise of Managing Malaria Cases with or without Laboratory Diagnosis: The Experience in a District Hospital in Ghana	PLOS ONE			English	Article							COST-EFFECTIVENESS; FEBRILE ILLNESS; TESTS; TANZANIA; AREA; MISDIAGNOSIS; COMMUNITY; CHILDREN; BURDEN; UGANDA	Background: This study was conducted at the Kintampo Municipal Hospital in Ghana to determine whether there was any benefit (or otherwise) in basing the management of cases of suspected malaria solely on laboratory confirmation (microscopy or by RDT) as compared with presumptive diagnosis. Method: Children under five years who reported at the Out-Patient Department of the Hospital with axillary temperature >= 37.5 degrees C or with a 48 hr history of fever were enrolled and had malaria microscopy and RDT performed. The attending clinician was blinded from laboratory results unless a request for these tests had been made earlier. Diagnosis of malaria was based on three main methods: presumptive or microscopy and/or RDT. Cost implication for adopting laboratory diagnosis or not was determined to inform malaria control programmes. Results: In total, 936 children were enrolled in the study. Proportions of malaria diagnosed presumptively, by RDT and microscopy were 73.6% (689/936), 66.0% (618/936) and 43.2% (404/936) respectively. Over 50% (170/318) of the children who were RDT negative and 60% (321/532) who were microscopy negative were treated for malaria when presumptive diagnoses were used. Comparing the methods of diagnoses, the cost of malaria treatment could have been reduced by 24% and 46% in the RDT and microscopy groups respectively; the reduction was greater in the dry season (43% vs. 50%) compared with the wet season (20% vs. 45%) for the RDT and microscopy confirmed cases respectively. Discussion/Conclusion: Over-diagnosis of malaria was prevalent in Kintampo during the period of the study. Though the use of RDT for diagnosis of malaria might have improved the quality of care for children, it appeared not to have a cost saving effect on the management of children with suspected malaria. Further research may be needed to confirm this.	[Osei-Kwakye, Kingsley; Asante, Kwaku Poku; Mahama, Emmanuel; Apanga, Stephen; Owusu, Ruth; Kwara, Evans; Adjei, George; Abokyi, Livesy; Yeetey, Enuameh; Dosoo, David Kwame; Owusu-Agyei, Seth] Minist Hlth, Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana; [Owusu-Agyei, Seth] London Sch Hyg & Trop Med, Dis Control Dept, London WC1, England; [Punguyire, Damien] Minist Hlth, Kintampo Municipal Hosp, Ghana Hlth Serv, Kintampo, Ghana	Ghana Health Service; Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; Ghana Health Service	Owusu-Agyei, S (corresponding author), Minist Hlth, Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana.	seth.owusu-agyei@kintampo-hrc.org	Enuameh, Yeetey/AAO-7304-2020	Enuameh, Yeetey/0000-0003-3772-7425; Owusu-Agyei, Seth/0000-0002-0807-1781	Kintampo Health Research Centre	Kintampo Health Research Centre	The study was funded by the Kintampo Health Research Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Murray Clinton K, 2009, Interdiscip Perspect Infect Dis, V2009, P415953, DOI 10.1155/2009/415953; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; OLIVAR M, 1991, T ROY SOC TROP MED H, V85, P729, DOI 10.1016/0035-9203(91)90432-X; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Polage CR, 2006, AM J TROP MED HYG, V75, P526, DOI 10.4269/ajtmh.2006.75.526; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; ROOTH I, 1992, T ROY SOC TROP MED H, V86, P479, DOI 10.1016/0035-9203(92)90076-O; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Webster J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S8; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wongsrichanalai C, 2001, TRENDS PARASITOL, V17, P307, DOI 10.1016/S1471-4922(01)01925-0	28	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58107	10.1371/journal.pone.0058107	http://dx.doi.org/10.1371/journal.pone.0058107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505457	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000318334500049
J	Kashima, Y; Takahashi, M; Shiba, Y; Itano, N; Izawa, A; Koyama, J; Nakayama, J; Taniguchi, S; Kimata, K; Ikeda, U				Kashima, Yuichiro; Takahashi, Masafumi; Shiba, Yuji; Itano, Naoki; Izawa, Atsushi; Koyama, Jun; Nakayama, Jun; Taniguchi, Shun'ichiro; Kimata, Koji; Ikeda, Uichi			Crucial Role of Hyaluronan in Neointimal Formation after Vascular Injury	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BONE-MARROW-CELLS; 4-METHYLUMBELLIFERONE; ATHEROSCLEROSIS; MICE; PROLIFERATION; MIGRATION; PROMOTES; SYSTEM; HYPERPLASIA	Background: Hyaluronan (HA) is a primary component of the extracellular matrix of cells, and it is involved in the pathogenesis of atherosclerosis. The purpose of this study was to investigate the role of HA in neointimal formation after vascular injury and determine its tissue-specific role in vascular smooth muscle cells (VSMCs) by using a cre-lox conditional transgenic (cTg) strategy. Methods and Results: HA was found to be expressed in neointimal lesions in humans with atherosclerosis and after wire-mediated vascular injury in mice. Inhibition of HA synthesis using 4-methylumbelliferone markedly inhibited neointimal formation after injury. In vitro experiments revealed that low-molecular-weight HA (LMW-HA) induced VSMC activation, including migration, proliferation, and production of inflammatory cytokines, and reactive oxygen species (ROS). The migration and proliferation of VSMCs were mediated by the CD44/RhoA and CD44/ERK1/2 pathways, respectively. Because HA synthase 2 (HAS2) is predominantly expressed in injured arteries, we generated cTg mice that overexpress the murine HAS2 gene specifically in VSMCs (cHAS2/CreSM22 alpha mice) and showed that HA overexpression markedly enhanced neointimal formation after cuff-mediated vascular injury. Further, HA-overexpressing VSMCs isolated from cHAS2/CreSM22 alpha mice showed augmented migration, proliferation, and production of inflammatory cytokines and ROS. Conclusion: VSMC-derived HA promotes neointimal formation after vascular injury, and HA may be a potential therapeutic target for cardiovascular disease.	[Kashima, Yuichiro; Takahashi, Masafumi; Shiba, Yuji; Izawa, Atsushi; Koyama, Jun; Ikeda, Uichi] Shinshu Univ, Dept Cardiovasc Med, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Bioimaging Sci, Shimotsuke, Tochigi, Japan; [Itano, Naoki] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kyoto 603, Japan; [Nakayama, Jun] Shinshu Univ, Dept Mol Pathol, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Dept Mol Oncol, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Kimata, Koji] Aichi Med Univ, Aichi, Japan	Shinshu University; Jichi Medical University; Kyoto Sangyo University; Shinshu University; Shinshu University; Aichi Medical University	Takahashi, M (corresponding author), Shinshu Univ, Dept Cardiovasc Med, Grad Sch Med, Matsumoto, Nagano 390, Japan.	masafumi2@jichi.ac.jp		Shiba, Yuji/0000-0002-0311-2919	Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Vehicle Racing Commemorative Foundation; Daiichi-Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research [23590566, 23591035] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Vehicle Racing Commemorative Foundation; Daiichi-Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program)," initiated by the Council for Science and Technology Policy (CSTP) (to M. T.), the Vehicle Racing Commemorative Foundation (to M. T.), and the Daiichi-Sankyo Foundation of Life Science (to M. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Fischer JW, 2007, THROMB HAEMOSTASIS, V98, P287, DOI 10.1160/TH07-02-0155; FONTAINE L, 1968, Therapie (London/Paris), V23, P51; Goueffic Y, 2006, CARDIOVASC RES, V72, P339, DOI 10.1016/j.cardiores.2006.07.017; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jain M, 1996, J CLIN INVEST, V98, P877; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Murayama H, 2008, CARDIOVASC RES, V80, P175, DOI 10.1093/cvr/cvn250; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Shiba Y, 2007, ARTERIOSCL THROM VAS, V27, P283, DOI 10.1161/01.ATV.0000250606.70669.14; Stacchino C, 1983, Boll Chim Farm, V122, P158; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Yokouchi K, 2006, ARTERIOSCL THROM VAS, V26, P2231, DOI 10.1161/01.ATV.0000239441.29687.97; Yoshihara S, 2005, FEBS LETT, V579, P2722, DOI 10.1016/j.febslet.2005.03.079; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013; Zhao L, 2008, ARTERIOSCL THROM VAS, V28, P1283, DOI 10.1161/ATVBAHA.108.165753	33	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58760	10.1371/journal.pone.0058760	http://dx.doi.org/10.1371/journal.pone.0058760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484050	gold, Green Submitted, Green Published			2022-12-25	WOS:000316936100136
J	Pazzaglia, M; Galli, G; Scivoletto, G; Molinari, M				Pazzaglia, Mariella; Galli, Giulia; Scivoletto, Giorgio; Molinari, Marco			A Functionally Relevant Tool for the Body following Spinal Cord Injury	PLOS ONE			English	Article							SPATIAL REQUIREMENTS; INDEPENDENCE MEASURE; RE-EMBODIMENT; WHEELCHAIR; BRAIN; REORGANIZATION; DISTORTIONS; DISABILITY; LOCOMOTION; REPRESENTATION	A tool such as a prosthetic device that extends or restores movement may become part of the identity of the person to whom it belongs. For example, some individuals with spinal cord injury (SCI) adapt their body and action representation to incorporate their wheelchairs. However, it remains unclear whether the bodily assimilation of a relevant external tool develops as a consequence of altered sensory and motor inputs from the body or of prolonged confinement sitting or lying in the wheelchair. To explore such relationships, we used a principal component analysis (PCA) on collected structured reports detailing introspective experiences of wheelchair use in 55 wheelchair-bound individuals with SCI. Among all patients, the regular use of a wheelchair induced the perception that the body's edges are not fixed, but are instead plastic and flexible to include the wheelchair. The PCA revealed the presence of three major components. In particular, the functional aspect of the sense of embodiment concerning the wheelchair appeared to be modulated by disconnected body segments. Neither an effect of time since injury nor an effect of exposure to/experience of was detected. Patients with lesions in the lower spinal cord and with loss of movement and sensation in the legs but who retained upper body movement showed a higher degree of functional embodiment than those with lesions in the upper spinal cord and impairment in the entire body. In essence, the tool did not become an extension of the immobile limbs; rather, it became an actual tangible substitution of the functionality of the affected body part. These findings suggest that the brain can incorporate relevant artificial tools into the body schema via the natural process of continuously updating bodily signals. The ability to embody new essential objects extends the potentiality of physically impaired persons and can be used for their rehabilitation.	[Pazzaglia, Mariella; Galli, Giulia] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Pazzaglia, Mariella; Scivoletto, Giorgio; Molinari, Marco] Fdn Santa Lucia, IRCCS, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Pazzaglia, M (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	mariella.pazzaglia@uniroma1.it	Galli, Giulia/K-8109-2016; Pazzaglia, Mariella/C-9388-2011; Molinari, Marco/A-9624-2010; Scivoletto, Giorgio/J-3030-2018	Galli, Giulia/0000-0002-4684-0908; Pazzaglia, Mariella/0000-0002-9196-7078; Molinari, Marco/0000-0001-9808-9688; Scivoletto, Giorgio/0000-0001-5766-6952	International Foundation for Research in Paraplegie [IRP, P133]; EU Information and Communication Technologies [FP7-ICT-2009-5]	International Foundation for Research in Paraplegie; EU Information and Communication Technologies	Funded by the International Foundation for Research in Paraplegie (IRP, P133) and EU Information and Communication Technologies Grant (VERE project, FP7-ICT-2009-5, Prot. Num. 257695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1996, NEUROREPORT, V8, P293, DOI 10.1097/00001756-199612200-00058; Anderson KD, 2011, SPINAL CORD, V49, P880, DOI 10.1038/sc.2011.20; Andre JM, 2001, REV NEUROL-FRANCE, V157, P1237; ARNHOFF FN, 1963, J NERV MENT DIS, V137, P88, DOI 10.1097/00005053-196307000-00010; Arrindell WA, 1985, APPL PSYCHOL MEASURE, V9; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Avillion A E, 1986, Rehabil Nurs, V11, P11; Bassolino M, 2010, NEUROPSYCHOLOGIA, V48, P803, DOI 10.1016/j.neuropsychologia.2009.11.009; BATES PS, 1993, AM J OCCUP THER, V47, P1014, DOI 10.5014/ajot.47.11.1014; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Blanke O, 2005, NEUROSCIENTIST, V11, P16, DOI 10.1177/1073858404270885; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Bryant FB, 1995, READING UNDERSTANDIN, DOI DOI 10.3109/07420528.2010.540363; Cardinali L, 2012, EXP BRAIN RES, V218, P259, DOI 10.1007/s00221-012-3028-5; Cardinali L, 2009, CURR BIOL, V19, pR478, DOI 10.1016/j.cub.2009.05.009; Catz A, 1997, SPINAL CORD, V35, P850, DOI 10.1038/sj.sc.3100504; Cole J., 2004, STILL LIVES; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; De Preester H, 2011, FOUND SCI, V16, P119, DOI 10.1007/s10699-010-9188-5; de Vignemont F, 2011, CONSCIOUS COGN, V20, P82, DOI 10.1016/j.concog.2010.09.004; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Field A., 2009, DISCOVERING STAT USI; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gimbel L, 1975, Can J Psychiatr Nurs, V16, P12; Gorsuch R., 1983, FACTOR ANAL; Hair J.F., 1998, PEARSON LOND, V5th; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Higuchi T, 2004, J EXP PSYCHOL-APPL, V10, P55, DOI 10.1037/1076-898X.10.1.55; Higuchi T, 2006, EXP BRAIN RES, V175, P50, DOI 10.1007/s00221-006-0525-4; Higuchi Takahiro, 2009, Journal of Physiological Anthropology, V28, P15, DOI 10.2114/jpa2.28.15; Jauregui-Renaud K, 2008, J NEUROL NEUROSUR PS, V79, P276, DOI 10.1136/jnnp.2007.122119; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Kulig K, 2001, CLIN BIOMECH, V16, P744, DOI 10.1016/S0268-0033(01)00066-3; Lenggenhager B, 2006, REV NEUROSCIENCE, V17, P643; Lenggenhager B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050757; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2012, BEHAV BRAIN SCI, V35, P229, DOI 10.1017/S0140525X11001907; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Merleau-Ponty Maurice, 2013, PHENOMENOLOGY PERCEP; Murray CD, 2004, DISABIL REHABIL, V26, P963, DOI 10.1080/09638280410001696764; Navarro X, 2009, INT REV NEUROBIOL, V87, P483, DOI 10.1016/S0074-7742(09)87027-X; Newport R, 2010, PERCEPTION, V39, P1296, DOI 10.1068/p6742; Nizzi MC, 2012, CONSCIOUS COGN, V21, P431, DOI 10.1016/j.concog.2011.10.010; Olsson CJ, 2012, EXP NEUROL, V236, P46, DOI 10.1016/j.expneurol.2012.03.022; Papadimitriou C, 2008, DISABIL SOC, V23, P691, DOI 10.1080/09687590802469420; Paqueron X, 2003, BRAIN, V126, P702, DOI 10.1093/brain/awg063; Pereira BP, 1996, J HAND SURG-AM, V21A, P222, DOI 10.1016/S0363-5023(96)80104-3; Standal OF, 2011, MED HEALTH CARE PHIL, V14, P177, DOI 10.1007/s11019-010-9286-8; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Winance M, 2006, SCI TECHNOL HUM VAL, V31, P52, DOI 10.1177/0162243905280023; Winance M, 2006, DISABIL REHABIL, V28, P1109, DOI 10.1080/09638280500531800	64	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58312	10.1371/journal.pone.0058312	http://dx.doi.org/10.1371/journal.pone.0058312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23484015	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100105
J	Wyckoff, AC; Lockwood, KL; Meyerett-Reid, C; Michel, BA; Bender, H; VerCauteren, KC; Zabel, MD				Wyckoff, A. Christy; Lockwood, Krista L.; Meyerett-Reid, Crystal; Michel, Brady A.; Bender, Heather; VerCauteren, Kurt C.; Zabel, Mark D.			Estimating Prion Adsorption Capacity of Soil by BioAssay of Subtracted Infectivity from Complex Solutions (BASICS)	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; SCRAPIE AGENT; IN-VITRO; ENVIRONMENTAL SOURCES; HUMIC SUBSTANCES; PROTEIN; DEER; FATE; PRP; TRANSMISSION	Prions, the infectious agent of scrapie, chronic wasting disease and other transmissible spongiform encephalopathies, are misfolded proteins that are highly stable and resistant to degradation. Prions are known to associate with clay and other soil components, enhancing their persistence and surprisingly, transmissibility. Currently, few detection and quantification methods exist for prions in soil, hindering an understanding of prion persistence and infectivity in the environment. Variability in apparent infectious titers of prions when bound to soil has complicated attempts to quantify the binding capacity of soil for prion infectivity. Here, we quantify the prion adsorption capacity of whole, sandy loam soil (SLS) typically found in CWD endemic areas in Colorado; and purified montmorillonite clay (Mte), previously shown to bind prions, by BioAssay of Subtracted Infectivity in Complex Solutions (BASICS). We incubated prion positive 10% brain homogenate from terminally sick mice infected with the Rocky Mountain Lab strain of mouse-adapted prions (RML) with 10% SLS or Mte. After 24 hours samples were centrifuged five minutes at 200xg and soil-free supernatant was intracerebrally inoculated into prion susceptible indicator mice. We used the number of days post inoculation to clinical disease to calculate the infectious titer remaining in the supernatant, which we subtracted from the starting titer to determine the infectious prion binding capacity of SLS and Mte. BASICS indicated SLS bound and removed >= 95% of infectivity. Mte bound and removed lethal doses (99.98%) of prions from inocula, effectively preventing disease in the mice. Our data reveal significant prion-binding capacity of soil and the utility of BASICS to estimate prion loads and investigate persistence and decomposition in the environment. Additionally, since Mte successfully rescued the mice from prion disease, Mte might be used for remediation and decontamination protocols.	[Wyckoff, A. Christy; Lockwood, Krista L.; Meyerett-Reid, Crystal; Michel, Brady A.; Bender, Heather; Zabel, Mark D.] Colorado State Univ, Prion Res Ctr, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wyckoff, A. Christy; VerCauteren, Kurt C.] Wildlife Serv, Natl Wildlife Res Ctr, USDA, Ft Collins, CO USA	Colorado State University; United States Department of Agriculture (USDA)	Zabel, MD (corresponding author), Colorado State Univ, Prion Res Ctr, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mark.zabel@colostate.edu			United States Department of Agriculture Animal and Plant Health Inspection Services [08-7488-0680]	United States Department of Agriculture Animal and Plant Health Inspection Services	United States Department of Agriculture Animal and Plant Health Inspection Services Cooperative Agreement number 08-7488-0680 (CA) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Brown P, 1991, LANCET; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Clark KJ, 1998, VET MICROBIOL, V63, P137, DOI 10.1016/S0378-1135(98)00241-7; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; de Motes CM, 2008, WATER RES, V42, P2465, DOI 10.1016/j.watres.2008.01.031; Dexter G, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-38; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Genovesi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001069; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Hinckley GT, 2008, ENVIRON SCI TECHNOL, V42, P5254, DOI 10.1021/es703186e; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Maddison BC, 2010, J VIROL, V84, P11560, DOI 10.1128/JVI.01133-10; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; May BCH, 2007, J MED CHEM, V50, P65, DOI 10.1021/jm061045z; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nagaoka K, 2010, BIOCHEM BIOPH RES CO, V397, P626, DOI 10.1016/j.bbrc.2010.06.013; Nelson J., 1992, EXPANSIVE SOILS PROB; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Phillips G, 2007, J WILDLIFE; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1978, BIOCHEMISTRY-US, V17, P4987, DOI 10.1021/bi00616a020; REED L. J., 1938, AMER JOUR HYG, V27, P493; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Rodriguez CM, 2012, PRION, V6, P11, DOI 10.4161/pri.6.1.17414; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Saunders S, 2011, J VIROLOGY; Saunders SE, 2008, ENVIRON SCI TECHNOL, V42, P6573, DOI 10.1021/es800590k; Saunders SE, 2011, APPL ENVIRON MICROB, V77, P4313, DOI 10.1128/AEM.00421-11; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI 10.1021/es901385t; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P5242, DOI 10.1021/es900502f; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; SENESI N, 1992, SCI TOTAL ENVIRON, V123, P63, DOI 10.1016/0048-9697(92)90133-D; Shaban IS, 1998, J RADIOANAL NUCL CH, V229, P73, DOI 10.1007/BF02389449; Tuo WB, 2001, J BIOL CHEM, V276, P18229, DOI 10.1074/jbc.M008887200; Vasina EN, 2005, BIOMACROMOLECULES, V6, P3425, DOI 10.1021/bm050492d; Violante A, 1995, CLAY MINER, V30, P325, DOI 10.1180/claymin.1995.030.4.06; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Wiggins RC, 2009, NEUROCHEM RES, V34, P158, DOI 10.1007/s11064-008-9741-6; Wildlife CPA, 2012, COLORADO GAME MANAGE, P1; Williams ES, 2003, REV SCI TECH OIE, V22, P145, DOI 10.20506/rst.22.1.1385; Zabel MD, 2007, J IMMUNOL, V179, P6144, DOI 10.4049/jimmunol.179.9.6144	59	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58630	10.1371/journal.pone.0058630	http://dx.doi.org/10.1371/journal.pone.0058630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484043	Green Submitted, Green Published, gold			2022-12-25	WOS:000315634900096
J	Han, H; Bourboulia, D; Jensen-Taubman, S; Isaac, B; Wei, B; Stetler-Stevenson, WG				Han, H.; Bourboulia, D.; Jensen-Taubman, S.; Isaac, B.; Wei, B.; Stetler-Stevenson, W. G.			An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells	ONCOGENE			English	Article						side population; lung cancer; TIMP-2; ABCG2; chemosensitivity; cell migration	STEM-LIKE CELLS; TISSUE INHIBITOR; ABC TRANSPORTERS; TUMOR; RESISTANCE; OVARIAN; TIMP-2; LINES; GROWTH	The side population (SP) in human lung cancer cell lines and tumors is enriched with cancer stem cells. An endogenous inhibitor of angiogenesis known as tissue inhibitor of matrix metalloproteinase-2 (TIMP-2), characterized for its ability to inhibit matrix metalloproteinases (MMPs), has been shown by several laboratories to impede tumor progression through MMP-dependent or -independent mechanisms. We recently reported that forced expression of TIMP-2, as well as the modified form Ala+TIMP-2 (that lacks MMP inhibitory activity) significantly blocks growth of A549 human lung cancer cells in vivo. However, the mechanisms underlying TIMP-2 antitumor effects are not fully characterized. Here, we examine the hypothesis that the TIMP-2 antitumor activity may involve regulation of the SP in human lung cancer cells. Indeed, using Hoechst dye efflux assay and flow cytometry, as well as quantitative reverse transcriptase-PCR analysis, we found that endogenous TIMP-2 mRNA levels showed a significant inverse correlation with SP fraction size in six non-small cell lung cancer cell lines. In A549 cells expressing increased levels of TIMP-2, a significant decrease in SP was observed, and this decrease was associated with lowered gene expression of ABCG2, ABCB1 and AKR1C1. Functional analysis of A549 cells showed that TIMP-2 overexpression increased chemosensitivity to cytotoxic drugs. The SP isolated from TIMP-2-overexpressing A549 cells also demonstrated impaired migratory capacity compared with the SP from empty vector control. More importantly, our data provide strong evidence that these TIMP-2 functions occur independent of MMP inhibition, as A549 cells overexpressing Ala+TIMP-2 exhibited identical behavior to those overexpressing TIMP-2 alone. Our findings provide the first indication that TIMP-2 modulates SP phenotype and function, and suggests that TIMP-2 may act as an endogenous suppressor of the SP in human lung cancer cells.	[Han, H.; Bourboulia, D.; Jensen-Taubman, S.; Isaac, B.; Wei, B.; Stetler-Stevenson, W. G.] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH,Adv Technol Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bourboulia, D (corresponding author), NCI, Extracellular Matrix Pathol Sect, Radiat Oncol Branch,Adv Technol Ctr, Ctr Canc Res,NIH, 8717 Grovemont Circle, Bethesda, MD 20892 USA.	bourmpouliad@mail.nih.gov	Stetler-Stevenson, William/AAE-3501-2020; Stetler-Stevenson, William G/H-6956-2012	Stetler-Stevenson, William/0000-0002-5500-5808; Stetler-Stevenson, William G/0000-0002-5500-5808; Issac, Biju/0000-0002-7311-678X	NCI Center for Cancer Research Intramural Research Grant [ZIA SC009179-22]; NATIONAL CANCER INSTITUTE [ZIABC011204, ZIASC009179] Funding Source: NIH RePORTER	NCI Center for Cancer Research Intramural Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Laboratory of Molecular Technology, NCI Frederick for the microarray experiment. We also thank the members of the Extracellular Matrix Pathology Section, Radiation Oncology Branch, NCI for critical discussions. This work was supported by the NCI Center for Cancer Research Intramural Research Grant # ZIA SC009179-22.	Akunuru S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016951; An Y, 2009, EXPERT OPIN DRUG MET, V5, P1529, DOI 10.1517/17425250903228834; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Deng HB, 2004, CANCER CHEMOTH PHARM, V54, P301, DOI 10.1007/s00280-004-0815-0; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Fernandez CA, 2010, J BIOL CHEM, V285, P41886, DOI 10.1074/jbc.M110.166439; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Halon A, 2012, J HISTOCHEM CYTOCHEM, V60, P491, DOI 10.1369/0022155412446978; HEPPNER GH, 1983, CANCER METAST REV, V2, P5, DOI 10.1007/BF00046903; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Salcido CD, 2010, BRIT J CANCER, V102, P1636, DOI 10.1038/sj.bjc.6605668; Seo DC, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-75; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wanichwatanadecha P, 2012, J GEN VIROL, V93, P1081, DOI 10.1099/vir.0.038265-0; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	30	10	11	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1198	1206		10.1038/onc.2013.61	http://dx.doi.org/10.1038/onc.2013.61			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23474755	Green Accepted			2022-12-25	WOS:000331933800013
J	Donnelly, BF; Needham, PG; Snyder, AC; Roy, A; Khadem, S; Brodsky, JL; Subramanya, AR				Donnelly, Bridget F.; Needham, Patrick G.; Snyder, Avin C.; Roy, Ankita; Khadem, Shaheen; Brodsky, Jeffrey L.; Subramanya, Arohan R.			Hsp70 and Hsp90 Multichaperone Complexes Sequentially Regulate Thiazide-sensitive Cotransporter Endoplasmic Reticulum-associated Degradation and Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NA-CL COTRANSPORTER; HEAT-SHOCK PROTEINS; CHAPERONE MACHINERY; QUALITY-CONTROL; MOLECULAR CHAPERONES; GITELMANS-SYNDROME; MUTATIONS; CHIP; CFTR	The thiazide-sensitive NaCl cotransporter (NCC) is the primary mediator of salt reabsorption in the distal convoluted tubule and is a key determinant of the blood pressure set point. Given its complex topology, NCC is inefficiently processed and prone to endoplasmic reticulum (ER)-associated degradation (ERAD), although the mechanisms governing this process remain obscure. Here, we identify factors that impact the ER quality control of NCC. Analyses of NCC immunoprecipitates revealed that the cotransporter formed complexes with the core chaperones Hsp90, Hsp70, and Hsp40. Disruption of Hsp90 function accelerated NCC degradation, suggesting that Hsp90 promotes NCC folding. In addition, two cochaperones, the C terminus of Hsp70-interacting protein (CHIP) and the Hsp70/Hsp90 organizer protein, were associated with NCC. Although CHIP, an E3 ubiquitin ligase, promoted NCC ubiquitination and ERAD, the Hsp70/Hsp90 organizer protein stabilized NCC turnover, indicating that these two proteins differentially remodel the core chaperone systems to favor cotransporter degradation and biogenesis, respectively. Adjusting the folding environment in mammalian cells via reduced temperature enhanced NCC biosynthetic trafficking, increased Hsp90-NCC interaction, and diminished binding to Hsp70. In contrast, cotransporters harboring disease-causing mutations that impair NCC biogenesis failed to escape ERAD as efficiently as the wild type protein when cells were incubated at a lower temperature. Instead, these mutants interacted more strongly with Hsp70, Hsp40, and CHIP, consistent with a role for the Hsp70/Hsp40 system in selecting misfolded NCC for ERAD. Collectively, these observations indicate that Hsp70 and Hsp90 comprise two functionally distinct ER quality control checkpoints that sequentially monitor NCC biogenesis.	[Needham, Patrick G.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Donnelly, Bridget F.; Snyder, Avin C.; Roy, Ankita; Khadem, Shaheen; Subramanya, Arohan R.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Khadem, Shaheen; Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Subramanya, AR (corresponding author), 3550 Terrace St,S832 Scaife Hall, Pittsburgh, PA 15261 USA.	ars129@pitt.edu	Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643; ROY, ANKITA/0000-0002-3032-6365	National Institutes of Health [DK79307, GM75061]; U.S. Dept. of Veterans Affairs; James A. Shaver Fund of the American Heart Association [10BGIA3890010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs); James A. Shaver Fund of the American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK79307 (to the Pittsburgh Center for Kidney Research, Model Organisms Core) and GM75061 (to J. L. B.). This work was also supported by a Mid-Level Career Development Award from the U.S. Dept. of Veterans Affairs (to A. R. S.) and Grant 10BGIA3890010 from the James A. Shaver Fund of the American Heart Association (to A. R. S.).	Acuna R, 2011, J HYPERTENS, V29, P475, DOI 10.1097/HJH.0b013e328341d0fd; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Warmuth S, 2009, STRUCTURE, V17, P538, DOI 10.1016/j.str.2009.02.009; Whitesell L, 2012, CURR MOL MED, V12, P1108, DOI 10.2174/156652412803306657; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	52	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13124	13135		10.1074/jbc.M113.455394	http://dx.doi.org/10.1074/jbc.M113.455394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23482560	hybrid, Green Published			2022-12-25	WOS:000318555100062
J	Diaz-Hernandez, ME; Bustamante, M; Galvan-Hernandez, CI; Chimal-Monroy, J				Elena Diaz-Hernandez, Martha; Bustamante, Marcia; Ivan Galvan-Hernandez, Claudio; Chimal-Monroy, Jesus			Irx1 and Irx2 Are Coordinately Expressed and Regulated by Retinoic Acid, TGF beta and FGF Signaling during Chick Hindlimb Development	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MOLECULAR CASCADE; VERTEBRATE LIMB; IROQUOIS FAMILY; PATTERN; GENES; CHONDROGENESIS; MORPHOGENESIS; MUTATION; DIGITS	The Iroquois homeobox (Irx) genes play a crucial role in the regionalization and patterning of tissues and organs during metazoan development. The Irx1 and Irx2 gene expression pattern during hindlimb development has been investigated in different species, but its regulation during hindlimb morphogenesis has not been explored yet. The aim of this study was to evaluate the gene expression pattern of Irx1 and Irx2 as well as their regulation by important regulators of hindlimb development such as retinoic acid (RA), transforming growth factor beta (TGF beta) and fibroblast growth factor (FGF) signaling during chick hindlimb development. Irx1 and Irx2 were coordinately expressed in the interdigital tissue, digital primordia, joints and in the boundary between cartilage and non-cartilage tissue. Down-regulation of Irx1 and Irx2 expression at the interdigital tissue coincided with the onset of cell death. RA was found to down-regulate their expression by a bone morphogenetic protein-independent mechanism before any evidence of cell death. Furthermore, TGF beta protein regulated Irx1 and Irx2 in a stage-dependent manner at the interdigital tissue, it inhibited their expression when it was administered to the interdigital tissue at developing stages before their normal down-regulation. TGF beta administered to the interdigital tissue at developing stages after normal down-regulation of Irx1 and Irx2 evidenced that expression of these genes marked the boundary between cartilage tissue and non-cartilage tissue. It was also found that at early stages of hindlimb development FGF signaling inhibited the expression of Irx2. In conclusion, the present study demonstrates that Irx1 and Irx2 are coordinately expressed and regulated during chick embryo hindlimb development as occurs in other species of vertebrates supporting the notion that the genomic architecture of Irx clusters is conserved in vertebrates.	[Elena Diaz-Hernandez, Martha; Bustamante, Marcia; Ivan Galvan-Hernandez, Claudio; Chimal-Monroy, Jesus] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Chimal-Monroy, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico.	jchimal@unam.mx		Chimal-Monroy, Jesus/0000-0002-6511-7408	CONACyT [168642, 53484, 42568-Q, 34334-N]; DGAPA, UNAM [IN220808, IN200205, IX200410, IN214511]; CONACYT, UNAM; Red de desarrollo de farmacos y metodos de diagnostico (FARMED)	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA, UNAM(Universidad Nacional Autonoma de Mexico); CONACYT, UNAM(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Universidad Nacional Autonoma de Mexico); Red de desarrollo de farmacos y metodos de diagnostico (FARMED)	This work was partially supported by grants 168642, 53484, 42568-Q, 34334-N from CONACyT, and by grants IN220808, IN200205, IX200410, IN214511 from DGAPA, UNAM. MEDH was the recipient of a scholarship from CONACYT, UNAM. MEDH and CIGH were the recipient of a scholarship from Red de desarrollo de farmacos y metodos de diagnostico (FARMED). DGAPA, UNAM IN214511, IX200410, CONACYT 168842. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Buis RF, 2011, DEV GROWTH DIFFER, V53, P780, DOI 10.1111/j.1440-169X.2011.01285.x; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Cheng CW, 2007, DEV DYNAM, V236, P2661, DOI 10.1002/dvdy.21272; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Chimal-Monroy J, 2011, IUBMB LIFE, V63, P922, DOI 10.1002/iub.563; Chuang HN, 2010, DEV DYNAM, V239, P639, DOI 10.1002/dvdy.22187; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Glavic A, 2001, DEV DYNAM, V222, P368, DOI 10.1002/dvdy.1189; Feijoo CG, 2009, MOL CELL NEUROSCI, V40, P328, DOI 10.1016/j.mcn.2008.11.003; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Gomez-Skarmeta JL, 2001, DEVELOPMENT, V128, P551; Goriely A, 1999, MECH DEVELOP, V87, P203, DOI 10.1016/S0925-4773(99)00149-5; Grotewold L, 2002, DEV BIOL, V251, P129, DOI 10.1006/dbio.2002.0817; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hernandez-Martinez R, 2009, DEVELOPMENT, V136, P3669, DOI 10.1242/dev.041954; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Liu Y, 2002, DEVELOPMENT, V129, P5289; Macias D, 1997, DEVELOPMENT, V124, P1109; McDonald LA, 2010, J ANAT, V216, P683, DOI 10.1111/j.1469-7580.2010.01233.x; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Merino R, 1999, DEVELOPMENT, V126, P5515; Montero JA, 2001, DEVELOPMENT, V128, P2075; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Montero JA, 2007, BIOESSAYS, V29, P725, DOI 10.1002/bies.20607; Newman Stuart A., 2007, Birth Defects Research, V81, P305, DOI 10.1002/bdrc.20112; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Rodriguez-Leon J, 1999, NAT CELL BIOL, V1, P125, DOI 10.1038/10098; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; van Tuyl M, 2006, AM J PHYSIOL-LUNG C, V290, pL777, DOI 10.1152/ajplung.00293.2005; Villa-Cuesta E, 2005, DEVELOPMENT, V132, P4087, DOI 10.1242/dev.01977; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zulch A, 2001, MECH DEVELOP, V106, P159, DOI 10.1016/S0925-4773(01)00411-7	37	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58549	10.1371/journal.pone.0058549	http://dx.doi.org/10.1371/journal.pone.0058549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505533	gold, Green Published, Green Submitted			2022-12-25	WOS:000316251100062
J	Chakrabarti, R; Rawat, PS; Cooke, BM; Coppel, RL; Patankar, S				Chakrabarti, Rimi; Rawat, Parkash S.; Cooke, Brian M.; Coppel, Ross L.; Patankar, Swati			Cellular Effects of Curcumin on Plasmodium falciparum Include Disruption of Microtubules	PLOS ONE			English	Article							NF-KAPPA-B; IN-VITRO; ERYTHROCYTIC DEVELOPMENT; COLCHICINE-BINDING; ENDOTHELIAL-CELLS; INHIBITION; EXPRESSION; TUBULIN; LOCALIZATION; ACTIVATION	Curcumin has been widely investigated for its myriad cellular effects resulting in reduced proliferation of various eukaryotic cells including cancer cells and the human malaria parasite Plasmodium falciparum. Studies with human cancer cell lines HT-29, Caco-2, and MCF-7 suggest that curcumin can bind to tubulin and induce alterations in microtubule structure. Based on this finding, we investigated whether curcumin has any effect on P. falciparum microtubules, considering that mammalian and parasite tubulin are 83% identical. IC50 of curcumin was found to be 5 mu M as compared to 20 mu M reported before. Immunofluorescence images of parasites treated with 5 or 20 mu M curcumin showed a concentration-dependent effect on parasite microtubules resulting in diffuse staining contrasting with the discrete hemispindles and subpellicular microtubules observed in untreated parasites. The effect on P. falciparum microtubules was evident only in the second cycle for both concentrations tested. This diffuse pattern of tubulin fluorescence in curcumin treated parasites was similar to the effect of a microtubule destabilizing drug vinblastine on P. falciparum. Molecular docking predicted the binding site of curcumin at the interface of alpha and beta tubulin, similar to another destabilizing drug colchicine. Data from predicted drug binding is supported by results from drug combination assays showing antagonistic interactions between curcumin and colchicine, sharing a similar binding site, and additive/synergistic interactions of curcumin with paclitaxel and vinblastine, having different binding sites. This evidence suggests that cellular effects of curcumin are at least, in part, due to its perturbing effect on P. falciparum microtubules. The action of curcumin, both direct and indirect, on P. falciparum microtubules is discussed.	[Chakrabarti, Rimi; Rawat, Parkash S.; Patankar, Swati] IITB, Dept Biosci & Bioengn, Mumbai, Maharashtra, India; [Chakrabarti, Rimi; Cooke, Brian M.; Coppel, Ross L.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Chakrabarti, Rimi] Indian Inst Technol, IITB Monash Res Acad, Mumbai, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Patankar, S (corresponding author), IITB, Dept Biosci & Bioengn, Mumbai, Maharashtra, India.	patankar@iitb.ac.in	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124	Australian National Health and Medical Research Council (NHMRC); IITB-Monash Research Academy; IIT Bombay	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); IITB-Monash Research Academy; IIT Bombay	This work has been supported in part by an Australian National Health and Medical Research Council (NHMRC) project grant to RLC, an IITB-Monash Research Academy project grant to RC and IIT Bombay intramural funding to SP. BMC is supported by a Senior Research Fellowship from the Australian National Health and Medical Research Council(NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aditya NP, 2010, EUR J PHARM SCI, V40, P448, DOI 10.1016/j.ejps.2010.05.007; Agrawal DK, 2010, MED RES REV, V30, P818, DOI 10.1002/med.20188; [Anonymous], BIOL MODEL SYSTEMS T; Bejon PA, 1997, PARASITOLOGY, V114, P1, DOI 10.1017/S0031182096008050; BELL A, 1993, PARASITOL RES, V79, P146, DOI 10.1007/BF00932261; Bell A, 1998, PARASITOL TODAY, V14, P234, DOI 10.1016/S0169-4758(98)01246-0; Bentzen PJ, 2007, CELL PHYSIOL BIOCHEM, V19, P153, DOI 10.1159/000099203; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; DHAMODHARAN R, 1995, MOL BIOL CELL, V6, P1215, DOI 10.1091/mbc.6.9.1215; DIECKMANNSCHUPPERT A, 1989, CELL BIOL INT REP, V13, P411, DOI 10.1016/0309-1651(89)90135-5; Fennell BJ, 2006, MOL BIOCHEM PARASIT, V145, P226, DOI 10.1016/j.molbiopara.2005.08.020; Fennell BJ, 2003, J ANTIMICROB CHEMOTH, V51, P833, DOI 10.1093/jac/dkg151; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; Goel A, 2001, CANCER LETT, V172, P111, DOI 10.1016/S0304-3835(01)00655-3; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Gupta KK, 2006, FEBS J, V273, P5320, DOI 10.1111/j.1742-4658.2006.05525.x; Holy JM, 2002, MUTAT RES-GEN TOX EN, V518, P71, DOI 10.1016/S1383-5718(02)00076-1; Ji HF, 2009, BIOORG MED CHEM LETT, V19, P2453, DOI 10.1016/j.bmcl.2009.03.060; Jobin C, 1999, J IMMUNOL, V163, P3474; JORDAN MA, 1990, BIOCHEMISTRY-US, V29, P2730, DOI 10.1021/bi00463a016; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kappes B, 2007, FUTURE MICROBIOL, V2, P409, DOI 10.2217/17460913.2.4.409; KORUTLA L, 1995, CARCINOGENESIS, V16, P1741, DOI 10.1093/carcin/16.8.1741; KUNCHANDY E, 1990, INT J PHARM, V58, P237, DOI 10.1016/0378-5173(90)90201-E; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LU YP, 1994, CARCINOGENESIS, V15, P2363, DOI 10.1093/carcin/15.10.2363; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Mimche PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S10; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Nandakumar DN, 2006, ANTIMICROB AGENTS CH, V50, P1859, DOI 10.1128/AAC.50.5.1859-1860.2006; Payton F, 2007, J NAT PROD, V70, P143, DOI 10.1021/np060263s; POUVELLE B, 1994, J CLIN INVEST, V94, P413, DOI 10.1172/JCI117338; Rai SS, 1996, J BIOL CHEM, V271, P14707, DOI 10.1074/jbc.271.25.14707; Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Sasin JM, 2004, NUCLEIC ACIDS RES, V32, pW586, DOI 10.1093/nar/gkh440; SCHREVEL J, 1994, P NATL ACAD SCI USA, V91, P8472, DOI 10.1073/pnas.91.18.8472; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SINDEN RE, 1979, PARASITOLOGY, V79, P277, DOI 10.1017/S003118200005335X; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Sinou V, 1998, J EUKARYOT MICROBIOL, V45, P171, DOI 10.1111/j.1550-7408.1998.tb04522.x; Sinou V, 1996, ANTIMICROB AGENTS CH, V40, P358, DOI 10.1128/AAC.40.2.358; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Thaloor D, 1998, CELL GROWTH DIFFER, V9, P305; TONNESEN HH, 1994, INT J PHARM, V110, P161, DOI 10.1016/0378-5173(94)90154-6; UPPULURI S, 1993, P NATL ACAD SCI USA, V90, P11598, DOI 10.1073/pnas.90.24.11598; Urscher M, 2010, MOL MICROBIOL, V76, P92, DOI 10.1111/j.1365-2958.2010.07082.x; USANGA EA, 1986, FEBS LETT, V209, P23, DOI 10.1016/0014-5793(86)81077-8; Van Erk Marjan J, 2004, J Carcinog, V3, P8, DOI 10.1186/1477-3163-3-8	56	43	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57302	10.1371/journal.pone.0057302	http://dx.doi.org/10.1371/journal.pone.0057302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505424	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500016
J	Janke, D; Jankowski, J; Ruth, M; Buschmann, I; Lemke, HD; Jacobi, D; Knaus, P; Spindler, E; Zidek, W; Lehmann, K; Jankowski, V				Janke, Doreen; Jankowski, Joachim; Rueth, Marieke; Buschmann, Ivo; Lemke, Horst-Dieter; Jacobi, Dorit; Knaus, Petra; Spindler, Ernst; Zidek, Walter; Lehmann, Kerstin; Jankowski, Vera			The "Artificial Artery" as In Vitro Perfusion Model	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SHEAR-STRESS; MECHANICAL-PROPERTIES; TUBULAR CONSTRUCTS; ENDOTHELIAL-CELLS; COLLAGEN-GEL; EXPRESSION; MEDIA; FABRICATION; DIFFERENTIATION	Metabolic stimuli, pressure, and fluid shear stress (FSS) are major mediators of vascular plasticity. The exposure of the vessel wall to increased laminar FSS is the main trigger of arteriogenesis, the remodelling of pre-existent arterio-arteriolar anastomoses to functional conductance arteries. In this study, we have used an in vitro bioreactor to investigate cell-specific interactions, molecular mechanisms as well as time-dependent effects under laminar FSS conditions. This bioreactor termed "artificial artery" can be used for screening potential arterio-protective substances, pro-arteriogenic factors, and for investigating biomarkers of cardiovascular diseases such as cardiac diseases. The bioreactor is built up out of 14 hollow fiber membranes colonized with endothelial cells (HUVECs) on the inside and smooth muscle cells (HUASMCs) on the outside. By means of Hoechst 33342 staining as well as immunocytochemistry of beta-catenin and alpha-smooth-muscle-actin, a microporous polypropylene membrane was characterized as being the appropriate polymer for co-colonization. Defined arterial flow conditions (0.1 N/m2 and 3 N/m2), metabolic exchange, and cross-talk of HUVECs and HUASMCs through hollow fibers mimic physiological in vivo conditions of the vasculature. Analysing mono-and co-culture secretomes by MALDI-TOF-TOF mass spectrometry, we could show that HUVECs secreted Up4A upon 3 N/m2. A constant cellular secretion of randomly chosen peptides verified viability of the "artificial artery" for a cultivation period up to five days. qRT-PCR analyses revealed an up-regulation of KLF2 and TIMP1 as mechano-regulated genes and demonstrated arterio-protective, homeostatic FSS conditions by a down-regulation of EDN1. Expression analyses of VWF and EDN1 furthermore confirmed that RNA of both cell types could separately be isolated without cross-contamination. CCND1 mRNA expression in HUVECs did not change upon FSS indicating a quiescent endothelial phenotype. Taken together, the "artificial artery" provides a solid in vitro model to test pharmacological active compounds for their impact on arterio-damaging or arterio-protective properties on vascular response.	[Janke, Doreen; Jacobi, Dorit; Lehmann, Kerstin] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Janke, Doreen; Jacobi, Dorit; Lehmann, Kerstin] Charite, Berlin Brandenburg Ctr Regenerat Therapies CVK, D-13353 Berlin, Germany; [Jankowski, Joachim; Rueth, Marieke; Zidek, Walter; Jankowski, Vera] Charite, Med Klin CBF 4, D-13353 Berlin, Germany; [Rueth, Marieke; Lemke, Horst-Dieter; Spindler, Ernst] eXcorlab GmbH, Ind Ctr Obernburg, Obernburg, Germany; [Buschmann, Ivo] Charite, Ctr Cardiovasc Res CCM, D-13353 Berlin, Germany; [Knaus, Petra] FU Berlin, Inst Chem & Biochem, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Jankowski, V (corresponding author), Charite, Med Klin CBF 4, D-13353 Berlin, Germany.	Vera.Jankowski@charite.de		Ruth, Marieke/0000-0002-2369-1639	Federal Ministry of Education and Research (BMBF) [13920B, 01GR0807]; Rahel-Hirsch-scholarship from the Charite (Germany); Sonnenfeld Stiftung; German Research Foundation; graduate school 203 "Berlin-Brandenburg School of Regenerative Therapies"	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Rahel-Hirsch-scholarship from the Charite (Germany); Sonnenfeld Stiftung; German Research Foundation(German Research Foundation (DFG)); graduate school 203 "Berlin-Brandenburg School of Regenerative Therapies"	This study was supported from Federal Ministry of Education and Research (BMBF; 13920B and 01GR0807 (KL/JJ)). VJ is recipient of a Rahel-Hirsch-scholarship from the Charite (Germany) and Sonnenfeld Stiftung (VJ). DJ was partially supported through the German Research Foundation by funding through the graduate school 203 "Berlin-Brandenburg School of Regenerative Therapies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avvisato CL, 2007, J CELL SCI, V120, P2672, DOI 10.1242/jcs.03476; BALLERMANN BJ, 1995, BLOOD PURIFICAT, V13, P125, DOI 10.1159/000170195; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Burnstock G, 2008, CIRC RES, V103, P1056, DOI 10.1161/CIRCRESAHA.108.187963; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cai WJ, 2004, MOL CELL BIOCHEM, V264, P201, DOI 10.1023/B:MCBI.0000044389.65590.57; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Dudash LA, 2012, J BIOMED MATER RES A, V100A, P2204, DOI 10.1002/jbm.a.34119; Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021; Galbusera M, 1997, BLOOD, V90, P1558, DOI 10.1182/blood.V90.4.1558.1558_1558_1564; Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Godbey WT, 2002, ANN NY ACAD SCI, V961, P10, DOI 10.1111/j.1749-6632.2002.tb03041.x; Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589; Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Gupta S, 2007, N-S ARCH PHARMACOL, V375, P29, DOI 10.1007/s00210-007-0137-y; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hillmeister P, 2008, J CEREBR BLOOD F MET, V28, P1811, DOI 10.1038/jcbfm.2008.69; HIRAI J, 1995, CELL TRANSPLANT, V4, P597, DOI 10.1016/0963-6897(95)00029-1; Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0; Huddleson JP, 2005, J BIOL CHEM, V280, P23371, DOI 10.1074/jbc.M413839200; Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662; Ito A, 2005, TISSUE ENG, V11, P1553, DOI 10.1089/ten.2005.11.1553; Jankowski J, 1999, ANAL BIOCHEM, V269, P72, DOI 10.1006/abio.1999.3097; Jankowski J, 2003, RAPID COMMUN MASS SP, V17, P1189, DOI 10.1002/rcm.1035; Jankowski J, 2001, ANAL BIOCHEM, V290, P324, DOI 10.1006/abio.2001.5001; Jankowski V, 2005, NAT MED, V11, P223, DOI 10.1038/nm1188; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P297, DOI 10.1161/01.ATV.0000253889.09765.5f; Jankowski V, 2011, FASEB J, V25, P2987, DOI 10.1096/fj.11-185470; Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036; Jian-Wei X, 2005, PLAST RECONSTR SURG, V116, P577, DOI 10.1097/01.prs.0000172985.81897.dc; Jiang RZ, 2006, CHINESE MED J-PEKING, V119, P384, DOI 10.1097/00029330-200603010-00006; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kinard F, 1997, IN VITRO CELL DEV-AN, V33, P92; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; MALEK A, 1992, AM J PHYSIOL, V263, pC389, DOI 10.1152/ajpcell.1992.263.2.C389; Malek AM, 1996, J CELL SCI, V109, P713; Matsumoto T, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/435132; McCulloch AD, 2004, TISSUE ENG, V10, P565, DOI 10.1089/107632704323061924; Mendis Shanthi, 2011, GLOB ATL CARD DIS PR; Messner B, 2010, BIOMETALS, V23, P811, DOI 10.1007/s10534-010-9314-4; Moeinzadeh S, 2012, BIOMACROMOLECULES, V13, P2073, DOI 10.1021/bm300453k; Morawietz H, 2000, J PHYSIOL-LONDON, V525, P761, DOI 10.1111/j.1469-7793.2000.00761.x; Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0; NICOSIA RF, 1990, LAB INVEST, V63, P115; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Owens NC, 1996, EXP BRAIN RES, V110, P55; Park J, 2010, AUTON NEUROSCI-BASIC, V152, P11, DOI 10.1016/j.autneu.2009.08.008; Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Ratcliffe A, 2002, ANN NY ACAD SCI, V961, P210, DOI 10.1111/j.1749-6632.2002.tb03087.x; REDMOND EM, 1995, IN VITRO CELL DEV-AN, V31, P601; Russell WMSB, 1959, HUMANE EXPT TECHNIQU, P238; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sakai S, 2012, BIOTECHNOL BIOENG, V109, P2911, DOI 10.1002/bit.24550; Salabei JK, 2012, TOXICOL APPL PHARM, V262, P265, DOI 10.1016/j.taap.2012.04.036; Satoh H, 1999, BIOCHEM BIOPH RES CO, V254, P757, DOI 10.1006/bbrc.1998.0126; Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275; SPRAGUE EA, 1987, CIRCULATION, V76, P648, DOI 10.1161/01.CIR.76.3.648; Su JC, 2012, INT J NANOMED, V7, P2547, DOI 10.2147/IJN.S29819; Takagi Mutsumi, 2003, J Artif Organs, V6, P222, DOI 10.1007/s10047-003-0218-8; Takei T, 2007, J BIOSCI BIOENG, V104, P435, DOI 10.1263/jbb.104.435; Takei T, 2006, BIOTECHNOL BIOENG, V95, P1, DOI 10.1002/bit.20903; THIE M, 1991, EUR J CELL BIOL, V55, P295; Ucuzian AA, 2007, WORLD J SURG, V31, P654, DOI 10.1007/s00268-006-0763-4; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang SC, 2012, J MATER SCI-MATER M, V23, P2001, DOI 10.1007/s10856-012-4673-8	74	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57227	10.1371/journal.pone.0057227	http://dx.doi.org/10.1371/journal.pone.0057227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505419	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500011
J	Pornwilard, MM; Weiskirchen, R; Gassler, N; Bosserhoff, AK; Becker, JS				Pornwilard, M-M; Weiskirchen, Ralf; Gassler, Nikolaus; Bosserhoff, Anja K.; Becker, J. Sabine			Novel Bioimaging Techniques of Metals by Laser Ablation Inductively Coupled Plasma Mass Spectrometry for Diagnosis Of Fibrotic and Cirrhotic Liver Disorders	PLOS ONE			English	Article							WILSON-DISEASE; TRACE-ELEMENTS; ICP-MS; COPPER; IRON; ZINC; MANGANESE; FIBROSIS; TISSUE; BRAIN	Background and Aims: Hereditary disorders associated with metal overload or unwanted toxic accumulation of heavy metals can lead to morbidity and mortality. Patients with hereditary hemochromatosis or Wilson disease for example may develop severe hepatic pathology including fibrosis, cirrhosis or hepatocellular carcinoma. While relevant disease genes are identified and genetic testing is applicable, liver biopsy in combination with metal detecting techniques such as energy-dispersive X-ray spectroscopy (EDX) is still applied for accurate diagnosis of metals. Vice versa, several metals are needed in trace amounts for carrying out vital functions and their deficiency due to rapid growth, pregnancy, excessive blood loss, and insufficient nutritional or digestive uptake results in organic and systemic shortcomings. Established in situ techniques, such as EDX-ray spectroscopy, are not sensitive enough to analyze trace metal distribution and the quantification of metal images is difficult. Methods: In this study, we developed a quantitative biometal imaging technique of human liver tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) in order to compare the distribution of selected metals in cryosections of healthy and fibrotic/cirrhotic livers. Results: Most of the metals are homogeneous distributed within the normal tissue, while they are redirected within fibrotic livers resulting in significant metal deposits. Moreover, total iron and copper concentrations in diseased liver were found about 3-5 times higher than in normal liver samples. Conclusions: Biometal imaging via LA-ICP-MS is a sensitive innovative diagnostic tool that will impact clinical practice in identification and evaluation of hepatic metal disorders and to detect subtle metal variations during ongoing hepatic fibrogenesis.	[Pornwilard, M-M; Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Pornwilard, M-M; Becker, J. Sabine] Forschungszentrum Julich, Cent Div Analyt Chem, D-52425 Julich, Germany; [Pornwilard, M-M] Mahidol Univ, Dept Chem, Bangkok 10700, Thailand; [Pornwilard, M-M] Mahidol Univ, Ctr Innovat Chem, Bangkok 10700, Thailand; [Gassler, Nikolaus] RWTH Univ Hosp Aachen, Inst Pathol, Aachen, Germany; [Bosserhoff, Anja K.] Univ Hosp Regensburg, Inst Pathol, Regensburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; Research Center Julich; Mahidol University; Mahidol University; RWTH Aachen University; RWTH Aachen University Hospital; University of Regensburg	Weiskirchen, R (corresponding author), RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany.	rweiskirchen@ukaachen.de	Bosserhoff, Anja/GNH-4801-2022; Weiskirchen, Ralf/O-1734-2018	Weiskirchen, Ralf/0000-0003-3888-0931; Bosserhoff, Anja/0000-0001-8147-394X	Deutsche Forschungsgemeinschaft (DFG) [BE 2649/5-1]; IZKF Aachen;  [SFB/TRR 57]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IZKF Aachen; 	The authors are grateful to the Deutsche Forschungsgemeinschaft (DFG grant number BE 2649/5-1) for instrumental support of the BrainMet laboratory. RW is sponsored by the SFB/TRR 57 and the IZKF Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alustiza JM, 2007, EUR J RADIOL, V61, P499, DOI 10.1016/j.ejrad.2006.11.012; Barst BD, 2011, ENVIRON SCI TECHNOL, V45, P8982, DOI 10.1021/es201641x; Becker J.S., 2007, INORGANIC MASS SPECT; Becker JS, 2010, INT J MASS SPECTROM, V289, P65, DOI 10.1016/j.ijms.2009.10.011; Becker JS, 2010, MASS SPECTROM REV, V29, P156, DOI 10.1002/mas.20239; Becker JS, 2011, INT J MASS SPECTROM, V307, P3, DOI 10.1016/j.ijms.2011.01.015; Brissot P, 2011, TRENDS MOL MED, V17, P707, DOI 10.1016/j.molmed.2011.07.004; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; CAPOCACCIA L, 1991, ITAL J GASTROENTEROL, V23, P386; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Corradini E, 2012, J GASTROEN HEPATOL, V27, P42, DOI 10.1111/j.1440-1746.2011.07014.x; de Sousa Isadora Karolina Freitas, 2012, Vet Med Int, V2012, P207950, DOI 10.1155/2012/207950; Desmet VJ, 2003, J HEPATOL, V38, P382, DOI 10.1016/S0168-8278(03)00005-9; Feldmann J, 2002, J ANAL ATOM SPECTROM, V17, P813, DOI 10.1039/b201960d; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Guerra MBB, 2011, J ANAL ATOM SPECTROM, V26, P2238, DOI 10.1039/c1ja10198f; Gunter TE, 2004, J NEUROCHEM, V88, P266, DOI 10.1046/j.1471-4159.2003.02122.x; HAUSER RA, 1994, ANN NEUROL, V36, P871, DOI 10.1002/ana.410360611; Ishikawa T, 2012, WORLD J GASTROENTERO, V18, P3196, DOI 10.3748/wjg.v18.i25.3196; Kindness A, 2003, CLIN CHEM, V49, P1916, DOI 10.1373/clinchem.2003.022046; Kinoshita H, 2010, MED MOL MORPHOL, V43, P19, DOI 10.1007/s00795-009-0474-7; KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8; LECHENE CP, 1977, ANNU REV BIOPHYS BIO, V6, P57, DOI 10.1146/annurev.bb.06.060177.000421; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Matusch A, 2012, ANAL CHEM, V84, P3170, DOI 10.1021/ac203112c; Matusch A, 2010, J AM SOC MASS SPECTR, V21, P161, DOI 10.1016/j.jasms.2009.09.022; Maxwell KL, 2012, CURR OPIN GASTROEN, V28, P217, DOI 10.1097/MOG.0b013e3283521d82; Nelson James E, 2012, Curr Gastroenterol Rep, V14, P8, DOI 10.1007/s11894-011-0234-4; Nobili V, 2013, J PEDIATR GASTR NUTR, V56, P370, DOI 10.1097/MPG.0b013e31827aced4; Osterholt T, 2011, INT J MASS SPECTROM, V307, P232, DOI 10.1016/j.ijms.2011.03.010; Philippe MA, 2007, WORLD J GASTROENTERO, V13, P4746, DOI 10.3748/wjg.v13.i35.4746; Pietrangelo A, 2002, J BIOENERG BIOMEMBR, V34, P67, DOI 10.1023/A:1013874804911; Pietrangelo A, 2011, SEMIN LIVER DIS, V31, P302, DOI 10.1055/s-0031-1286061; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Qin ZY, 2011, METALLOMICS, V3, P28, DOI 10.1039/c0mt00048e; Rashed MN, 2011, J TRACE ELEM MED BIO, V25, P181, DOI 10.1016/j.jtemb.2011.07.001; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Rosencrantz R, 2011, SEMIN LIVER DIS, V31, P245, DOI 10.1055/s-0031-1286056; SCHILSKY ML, 1994, HEPATOLOGY, V19, P583, DOI 10.1002/hep.1840190307; Sebastiani G, 2012, J VIRAL HEPATITIS, V19, pE170, DOI 10.1111/j.1365-2893.2011.01508.x; SETH TD, 1976, B ENVIRON CONTAM TOX, V16, P190, DOI 10.1007/BF01685226; Sirlin CB, 2010, MAGN RESON IMAGING C, V18, P359, DOI 10.1016/j.mric.2010.08.014; Song M, 2011, J PHARMACOL EXP THER, V339, P298, DOI 10.1124/jpet.111.184325; SPICKETT JT, 1979, B ENVIRON CONTAM TOX, V23, P627, DOI 10.1007/BF01770016; Stamoulis I, 2007, DIGEST DIS SCI, V52, P1595, DOI 10.1007/s10620-006-9462-0; Sussulini A, 2013, CONTRAST MEDIA MOL I, V8, P204, DOI 10.1002/cmmi.1509; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; VERSIECK J, 1974, CLIN CHEM, V20, P1141; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Zoriy MV, 2007, INT J MASS SPECTROM, V264, P175, DOI 10.1016/j.ijms.2007.04.009	50	36	37	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58702	10.1371/journal.pone.0058702	http://dx.doi.org/10.1371/journal.pone.0058702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505552	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500117
J	Song, AP; Lou, WH; Jiang, JF; Chen, SM; Sun, ZX; Guan, ZY; Fang, WM; Teng, NJ; Chen, FD				Song, Aiping; Lou, Wanghuai; Jiang, Jiafu; Chen, Sumei; Sun, Zuxia; Guan, Zhiyong; Fang, Weimin; Teng, Nianjun; Chen, Fadi			An Isoform of Eukaryotic Initiation Factor 4E from Chrysanthemum morifolium Interacts with Chrysanthemum Virus B Coat Protein	PLOS ONE			English	Article							TURNIP-MOSAIC-VIRUS; CAP-BINDING PROTEIN; RECESSIVE BYMOVIRUS RESISTANCE; TRANSLATION INITIATION; ARABIDOPSIS-THALIANA; MESSENGER-RNA; POTYVIRUS RESISTANCE; FACTORS EIF(ISO)4E; GENE-EXPRESSION; FACTOR EIF4E	Background: Eukaryotic translation initiation factor 4E (eIF4E) plays an important role in plant virus infection as well as the regulation of gene translation. Methodology/Principal Findings: Here, we describe the isolation of a cDNA encoding CmeIF(iso)4E (GenBank accession no. JQ904592), an isoform of eIF4E from chrysanthemum, using RACE PCR. We used the CmeIF(iso)4E cDNA for expression profiling and to analyze the interaction between CmeIF(iso)4E and the Chrysanthemum virus B coat protein (CVBCP). Multiple sequence alignment and phylogenetic tree analysis showed that the sequence similarity of CmeIF(iso)4E with other reported plant eIF(iso)4E sequences varied between 69.12% and 89.18%, indicating that CmeIF(iso)4E belongs to the eIF(iso)4E subfamily of the eIF4E family. CmeIF(iso) 4E was present in all chrysanthemum organs, but was particularly abundant in the roots and flowers. Confocal microscopy showed that a transiently transfected CmeIF(iso)4E-GFP fusion protein distributed throughout the whole cell in onion epidermis cells. A yeast two hybrid assay showed CVBCP interacted with CmeIF(iso)4E but not with CmeIF4E. BiFC assay further demonstrated the interaction between CmeIF(iso)4E and CVBCP. Luminescence assay showed that CVBCP increased the RLU of Luc-CVB, suggesting CVBCP might participate in the translation of viral proteins. Conclusions/Significance: These results inferred that CmeIF(iso)4E as the cap-binding subunit eIF(iso)4F may be involved in Chrysanthemum Virus B infection in chrysanthemum through its interaction with CVBCP in spatial.	[Song, Aiping; Lou, Wanghuai; Jiang, Jiafu; Chen, Sumei; Sun, Zuxia; Guan, Zhiyong; Fang, Weimin; Teng, Nianjun; Chen, Fadi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, FD (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenfd@njau.edu.cn			Program for New Century Excellent Talents in University of Chinese Ministry of Education [NCET-10-0492]; Sci-Tech Support Plan of Jiangsu Province [BE2011325]; 863 Project [2011AA100208]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Fundamental Research Funds for the Central Universities [KYZ201147]; Youth Science and Technology Innovation Fund [KJ2011009]	Program for New Century Excellent Talents in University of Chinese Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Sci-Tech Support Plan of Jiangsu Province; 863 Project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Youth Science and Technology Innovation Fund	This study is supported by the Program for New Century Excellent Talents in University of Chinese Ministry of Education (Grant No. NCET-10-0492), Sci-Tech Support Plan of Jiangsu Province (BE2011325), 863 Project (2011AA100208), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Fundamental Research Funds for the Central Universities (KYZ201147) and Youth Science and Technology Innovation Fund (KJ2011009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 2005, VIRUS TAXONOMY, P1089; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Ayme V, 2007, J GEN VIROL, V88, P1594, DOI 10.1099/vir.0.82702-0; Boisnard A, 2007, THEOR APPL GENET, V116, P53, DOI 10.1007/s00122-007-0646-6; Bol JF, 1999, J GEN VIROL, V80, P1089, DOI 10.1099/0022-1317-80-5-1089; Bol JF, 2003, MOL PLANT PATHOL, V4, P1, DOI 10.1046/j.1364-3703.2003.00146.x; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Culjkovic B, 2007, CELL CYCLE, V6, P65, DOI 10.4161/cc.6.1.3688; Dadlani NK., 2000, COMMERCIAL FLORICULT, P1; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Gallois JL, 2010, J GEN VIROL, V91, P288, DOI 10.1099/vir.0.015321-0; Gao ZH, 2004, PLANT J, V40, P376, DOI 10.1111/j.1365-313X.2004.02215.x; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Jaspars EMJ, 1999, ARCH VIROL, V144, P843, DOI 10.1007/s007050050551; Jenner CE, 2010, MOL PLANT MICROBE IN, V23, P1498, DOI 10.1094/MPMI-05-10-0104; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Kanyuka K, 2005, MOL PLANT PATHOL, V6, P449, DOI [10.1111/j.1364-3703.2005.00294.x, 10.1111/J.1364-3703.2005.00294.X]; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; Krab IM, 2005, J GEN VIROL, V86, P1841, DOI 10.1099/vir.0.80796-0; LANG V, 1994, J BIOL CHEM, V269, P6117; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Malik PS, 2005, VIROLOGY, V337, P273, DOI 10.1016/j.virol.2005.04.030; McKendrick L, 1999, INT J BIOCHEM CELL B, V31, P31, DOI 10.1016/S1357-2725(98)00129-0; Miyoshi H, 2008, BIOCHIMIE, V90, P1427, DOI 10.1016/j.biochi.2008.03.013; Neeleman L, 2001, P NATL ACAD SCI USA, V98, P14286, DOI 10.1073/pnas.251542798; Nicaise V, 2003, PLANT PHYSIOL, V132, P1272, DOI 10.1104/pp.102.017855; Nieto C, 2006, PLANT J, V48, P452, DOI 10.1111/j.1365-313X.2006.02885.x; Ren T, 2005, VIROLOGY, V331, P316, DOI 10.1016/j.virol.2004.10.039; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rodriguez CM, 1998, PLANT J, V13, P465, DOI 10.1046/j.1365-313X.1998.00047.x; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Ruffel S, 2004, GENE, V338, P209, DOI 10.1016/j.gene.2004.05.010; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Sato M, 2005, FEBS LETT, V579, P1167, DOI 10.1016/j.febslet.2004.12.086; Singh L, 2007, ARCH VIROL, V152, P405, DOI 10.1007/s00705-006-0854-4; Singh L, 2012, ARCH VIROL, V157, P531, DOI 10.1007/s00705-011-1190-x; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Thivierge K, 2005, PLANT PHYSIOL, V138, P1822, DOI 10.1104/pp.105.064105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshii M, 2004, J VIROL, V78, P6102, DOI 10.1128/JVI.78.12.6102-6111.2004; Zhang YY, 2006, J INTEGR PLANT BIOL, V48, P1129, DOI 10.1111/j.1744-7909.2006.00322.x; Zhang YY, 2009, PLANT MOL BIOL REP, V27, P400, DOI 10.1007/s11105-009-0090-7	54	17	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57229	10.1371/journal.pone.0057229	http://dx.doi.org/10.1371/journal.pone.0057229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505421	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500013
J	Duan, WX; Yang, Y; Yi, W; Yan, JJ; Liang, ZX; Wang, N; Li, Y; Chen, WS; Yu, SQ; Jin, ZX; Yi, DH				Duan, Weixun; Yang, Yang; Yi, Wei; Yan, Juanjuan; Liang, Zhenxin; Wang, Ning; Li, Yue; Chen, Wensheng; Yu, Shiqiang; Jin, Zhenxiao; Yi, Dinghua			New Role of JAK2/STAT3 Signaling in Endothelial Cell Oxidative Stress Injury and Protective Effect of Melatonin	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ISCHEMIA-REPERFUSION; HEME OXYGENASE-1; GLIOMA-CELLS; PC12 CELLS; PATHWAY; APOPTOSIS; ACTIVATION; STAT3; EXPRESSION	Previous studies have shown that the JAK2/STAT3 signaling pathway plays a regulatory role in cellular oxidative stress injury (OSI). In this study, we explored the role of the JAK2/STAT3 signaling pathway in hydrogen peroxide (H2O2)-induced OSI and the protective effect of melatonin against (H2O2)-induced injury in human umbilical vein endothelial cells (HUVECs). AG490 (a specific inhibitor of the JAK2/STAT3 signaling pathway) and JAK2 siRNA were used to manipulate JAK2/STAT3 activity, and the results showed that AG490 and JAK2 siRNA inhibited OSI and the levels of p-JAK2 and p-STAT3. HUVECs were then subjected to H2O2 in the absence or presence of melatonin, the main secretory product of the pineal gland. Melatonin conferred a protective effect against H2O2, which was evidenced by improvements in cell viability, adhesive ability and migratory ability, decreases in the apoptotic index and reactive oxygen species (ROS) production and several biochemical parameters in HUVECs. Immunofluorescence and Western blotting showed that H2O2 treatment increased the levels of p-JAK2, p-STAT3, Cytochrome c, Bax and Caspase3 and decreased the levels of Bcl2, whereas melatonin treatment partially reversed these effects. We, for the first time, demonstrate that the inhibition of the JAK2/STAT3 signaling pathway results in a protective effect against endothelial OSI. The protective effects of melatonin against OSI, at least partially, depend upon JAK2/STAT3 inhibition.	[Duan, Weixun; Yang, Yang; Yi, Wei; Liang, Zhenxin; Wang, Ning; Li, Yue; Chen, Wensheng; Yu, Shiqiang; Jin, Zhenxiao; Yi, Dinghua] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shanxi Province, Peoples R China; [Yang, Yang] Beijing Mil Area Command, Beidaihe Sanat, Dept Med Adm, Qinhuangdao, Hebei Province, Peoples R China; [Yan, Juanjuan] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian, Shanxi Province, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Jin, ZX (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shanxi Province, Peoples R China.	jinzx1026cn@yahoo.com.cn; dinghuayi210@126.com	Jin, Zhenxiao/AAJ-5777-2020; Li, Yue/AAU-1580-2021	Yu, Shiqiang/0000-0003-3519-0943; Yi, Wei/0000-0002-4349-910X	12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81102687, 81070198]; Academic Promotion Project of Xijing Hospital [XJZT09 M16, XJZT10 M12]; Social Development Project of Shaanxi Province [2012JQ4001]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Promotion Project of Xijing Hospital; Social Development Project of Shaanxi Province	This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81102687 and 81070198), the Academic Promotion Project of Xijing Hospital (XJZT09 M16 and XJZT10 M12), and Social Development Project of Shaanxi Province (2012JQ4001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia V, 2012, J PINEAL RES, V52, P282, DOI 10.1111/j.1600-079X.2011.00940.x; Arany I, 2006, KIDNEY INT, V70, P669, DOI 10.1038/sj.ki.5001604; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; Chen SD, 2012, FREE RADICAL RES, V46, P940, DOI 10.3109/10715762.2012.674640; Cheong SM, 2012, EXP CELL RES, V318, P550, DOI 10.1016/j.yexcr.2012.01.013; Chetsawang B, 2006, J PINEAL RES, V41, P116, DOI 10.1111/j.1600-079X.2006.00335.x; Chiu MH, 2012, TRANSPL P, V44, P962, DOI 10.1016/j.transproceed.2012.01.097; Choi JS, 2009, J AGR FOOD CHEM, V57, P2079, DOI 10.1021/jf803390m; Coto-Montes A, 2012, MOL CELL ENDOCRINOL, V361, P12, DOI 10.1016/j.mce.2012.04.009; Dominguez-Rodriguez A, 2012, EXPERT OPIN INVESTIG; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Du W, 2012, J CELL MOL MED, V16, P1878, DOI 10.1111/j.1582-4934.2011.01483.x; Duan WX, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0263-7; Gitto E, 2012, J PINEAL RES, V52, P291, DOI 10.1111/j.1600-079X.2011.00941.x; Gorina R, 2005, J NEUROCHEM, V92, P505, DOI 10.1111/j.1471-4159.2004.02878.x; Gorina R, 2007, GLIA, V55, P1313, DOI 10.1002/glia.20542; Huang PH, 2011, J MOL CELL CARDIOL, V51, P109, DOI 10.1016/j.yjmcc.2011.03.008; Jung KH, 2010, J PINEAL RES, V48, P239, DOI 10.1111/j.1600-079X.2010.00748.x; Kang JW, 2012, J PINEAL RES, V53, P67, DOI 10.1111/j.1600-079X.2012.00972.x; Kim US, 2010, JPN J OPHTHALMOL, V54, P151, DOI 10.1007/s10384-009-0772-6; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Koksal M, 2012, EUR REV MED PHARMACO, V16, P582; Lamont KT, 2011, J PINEAL RES, V50, P374, DOI 10.1111/j.1600-079X.2010.00853.x; Lau WWI, 2012, J PINEAL RES, V52, P477, DOI 10.1111/j.1600-079X.2011.00965.x; Li JX, 2008, J BIOL CHEM, V283, P34260, DOI 10.1074/jbc.M806087200; Li R, 2012, INT IMMUNOPHARMACOL, V14, P157, DOI 10.1016/j.intimp.2012.07.001; Lim HD, 2012, J PINEAL RES; Lim HD, 2012, J PINEAL RES, V53, P225, DOI 10.1111/j.1600-079X.2012.00991.x; Liu HT, 2009, PHARMACOL RES, V59, P167, DOI 10.1016/j.phrs.2008.12.001; Liu J, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-80; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037841; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Nduhirabandi F, 2011, J PINEAL RES, V50, P171, DOI 10.1111/j.1600-079X.2010.00826.x; Ponnusamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1361, DOI 10.1152/ajprenal.00251.2009; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Sonmez MF, 2012, RENAL FAILURE, V34, P480, DOI 10.3109/0886022X.2011.649678; Tanaka T, 2009, CHEM-BIOL INTERACT, V177, P128, DOI 10.1016/j.cbi.2008.10.047; Tao RR, 2012, J PINEAL RES; Tawfik A, 2005, VASC PHARMACOL, V43, P320, DOI 10.1016/j.vph.2005.08.018; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Valdembri D, 2001, FASEB J, V15, P225, DOI 10.1096/fj.01-0633fje; Wang JT, 2012, J PINEAL RES, V53, P180, DOI 10.1111/j.1600-079X.2012.00985.x; Wang Z, 2012, J PINEAL RES, V52, P253, DOI 10.1111/j.1600-079X.2011.00952.x; Wang Z, 2012, J PINEAL RES, V53, P129, DOI 10.1111/j.1600-079X.2012.00978.x; Wu CC, 2012, J PINEAL RES, V52, P460, DOI 10.1111/j.1600-079X.2011.00960.x; Xu SC, 2011, J PINEAL RES, V51, P426, DOI 10.1111/j.1600-079X.2011.00906.x; Yoo YM, 2010, J PINEAL RES, V48, P83, DOI 10.1111/j.1600-079X.2009.00730.x; Yu HM, 2006, APOPTOSIS, V11, P931, DOI 10.1007/s10495-006-6578-9; Yuan XC, 2011, J PINEAL RES, V51, P220, DOI 10.1111/j.1600-079X.2011.00882.x; Zhai L, 2011, PHARMACOL REP, V63, P1469, DOI 10.1016/S1734-1140(11)70711-3; Zhao Mei, 2011, Zhonghua Yi Xue Za Zhi, V91, P375; Zhu HQ, 2008, J PINEAL RES, V45, P328, DOI 10.1111/j.1600-079X.2008.00595.x	54	63	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57941	10.1371/journal.pone.0057941	http://dx.doi.org/10.1371/journal.pone.0057941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483946	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100056
J	Faiz, A; Tjin, G; Harkness, L; Weckmann, M; Bao, SS; Black, JL; Oliver, BGG; Burgess, JK				Faiz, Alen; Tjin, Gavin; Harkness, Louise; Weckmann, Markus; Bao, Shisan; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.			The Expression and Activity of Cathepsins D, H and K in Asthmatic Airways	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; ANTIGEN PRESENTATION; PULMONARY-FIBROSIS; IV COLLAGEN; HUMAN LUNG; ANGIOGENESIS; CANCER; MACROPHAGES; INHIBITORS; TUMSTATIN	Tumstatin is an anti-angiogenic collagen IV alpha 3 fragment, levels of which are reduced in the airways of asthmatics. Its reduction may be due to the degradation by extracellular matrix (ECM) proteases. Cathepsins play a role in ECM remodelling, with cathepsin D, H and K (CTSD, CTSH and CTSK) being associated with lung diseases. CTSD modulates the NC1 domains of collagen molecules including tumstatin, while CTSH and CTSK are involved in ECM degradation. The role of these cathepsins in the regulation of tumstatin in the lung has not previously been examined. We demonstrated that CTSB, D, F, H, K, L and S mRNA was expressed in the airways. Quantification of immunohistochemistry showed that there is no difference in the global expression of CTSD, CTSH and CTSK between asthmatics and non-asthmatics. CTSD and CTSK, but not CTSH had the capacity to degrade tumstatin. No difference was observed in the activity of CTSD and H in bronchoalveolar lavage fluid of asthmatic and non-asthmatics, while CTSK was undetectable. This indicates that while CTSD possesses the potential to directly regulate tumstatin, and thus angiogenesis through this mechanism however, it is not likely to be involved in the dysregulation of tumstatin found in asthmatic airways.	[Faiz, Alen; Tjin, Gavin; Harkness, Louise; Weckmann, Markus; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Faiz, Alen; Tjin, Gavin; Bao, Shisan; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Harkness, Louise; Weckmann, Markus; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Weckmann, Markus; Bao, Shisan] Univ Sydney, Discipline Pathol, Sch Med Sci, Sydney, NSW 2006, Australia; [Weckmann, Markus; Bao, Shisan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Weckmann, Markus; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.] Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Faiz, A (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	afai4257@uni.sydney.edu.au	Burgess, Janette K/A-3597-2010; Faiz, Alen/HII-9884-2022; Oliver, Brian/E-7939-2010; Black, Judith L/C-6559-2008; Faiz, Alen/AAB-7132-2019; Burgess, Janette/M-7117-2019; Weckmann, Markus/GXG-3428-2022; Bao, Shisan/C-6072-2014; Bao, Shisan/AAF-6464-2020	Faiz, Alen/0000-0003-1740-3538; Oliver, Brian/0000-0002-7122-9262; Faiz, Alen/0000-0003-1740-3538; Weckmann, Markus/0000-0001-5342-979X; Bao, Shisan/0000-0002-6687-3846; Tjin, Gavin/0000-0002-7235-6909; Burgess, Janette/0000-0001-9868-9966	National Health and Medical Research Council, Australia [570867]; NHMRC [1032695, 571098, 1026880]; Australian Postgraduate Award (APA); Asthma Foundation of NSW Scholarship	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award (APA)(Australian Government); Asthma Foundation of NSW Scholarship	This work was supported by the National Health and Medical Research Council, Australia (Grant # 570867). J.K. Burgess is supported by a NHMRC Career Development Fellowship # 1032695 A. Faiz is supported by a Australian Postgraduate Award (APA) L. Harkness is supported by an Asthma Foundation of NSW Scholarship J.L. Black is supported by a NHMRC senior Principal Research Fellowship # 571098 B. G. G. Oliver is supported by a NHMRC Career Development Fellowship # 1026880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SR, 2009, PULM PHARMACOL THER, V22, P417, DOI 10.1016/j.pupt.2009.04.007; Baraket M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-11; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; BOUSQUET J., 1992, ALLERGY, V74, P3; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Brouillet JP, 1997, CANCER, V79, P2132, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2132::AID-CNCR10>3.3.CO;2-L; Buhling F, 2001, J PATHOL, V195, P375; Burgess JK, 2010, AM J RESP CRIT CARE, V181, P106, DOI 10.1164/rccm.200904-0631OC; Burgess JK, 2009, PULM PHARMACOL THER, V22, P379, DOI 10.1016/j.pupt.2008.12.007; Burgess JK, 2009, AM J RESP CRIT CARE, P106; Carroll NG, 1997, AM J RESP CRIT CARE, V155, P689, DOI 10.1164/ajrccm.155.2.9032214; Chilosi M, 2009, MODERN PATHOL, V22, P161, DOI 10.1038/modpathol.2008.189; Cimerman N, 2001, CLIN CHIM ACTA, V310, P113, DOI 10.1016/S0009-8981(01)00530-7; Deschamps K, 2011, AM J RESP CELL MOL, V45, P81, DOI 10.1165/rcmb.2009-0392OC; DIMENT S, 1990, J IMMUNOL, V145, P417; ERDEL M, 1990, J HISTOCHEM CYTOCHEM, V38, P1313, DOI 10.1177/38.9.2201737; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Gu QL, 2006, PROTEIN EXPRES PURIF, V47, P461, DOI 10.1016/j.pep.2006.01.011; HARGREAVE FE, 1986, J ALLERGY CLIN IMMUN, V78, P825, DOI 10.1016/0091-6749(86)90226-5; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Kasper M, 1996, VIRCHOWS ARCH, V428, P207; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Lau JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013360; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; MARAGOUDAKIS ME, 1993, KIDNEY INT, V43, P147, DOI 10.1038/ki.1993.24; Meier C, 2006, CLIN LAB, V52, P1; Minarowska A, 2008, FOLIA HISTOCHEM CYTO, V46, P23, DOI 10.2478/v10042-008-0003-x; Minarowska A, 2007, FOLIA HISTOCHEM CYTO, V45, P165; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Munoz-Torres M, 2009, MATURITAS, V64, P188, DOI 10.1016/j.maturitas.2009.09.011; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Oorni K, 2004, J BIOL CHEM, V279, P34776, DOI 10.1074/jbc.M310814200; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Schweiger A, 2000, BRIT J CANCER, V82, P782, DOI 10.1054/bjoc.1999.0999; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Srivastava M, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-54; Sudhakar A, 2008, PHARM RES-DORD, V25, P2731, DOI 10.1007/s11095-008-9634-z; van den Brule S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-84; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Woischnik M, 2008, EUR RESPIR J, V31, P1197, DOI 10.1183/09031936.00081207; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Xia Q, 2012, INT J CARDIOL, V154, P187, DOI 10.1016/j.ijcard.2011.10.093; Xiang XG, 2012, IMMUNOL CELL BIOL, V90, P611, DOI 10.1038/icb.2011.79	50	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57245	10.1371/journal.pone.0057245	http://dx.doi.org/10.1371/journal.pone.0057245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483898	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100016
J	Jiang, W; Crossman, DK; Mitchell, EH; Sohn, P; Crowley, MR; Serra, R				Jiang, Wen; Crossman, David K.; Mitchell, Elizabeth H.; Sohn, Philip; Crowley, Michael R.; Serra, Rosa			WNT5A Inhibits Metastasis and Alters Splicing of Cd44 in Breast Cancer Cells	PLOS ONE			English	Article							SIGNALING PATHWAY; EPITHELIAL-CELLS; RNA-SEQ; EXPRESSION; MOTILITY; ADHESION; WNT-5A; SURVIVAL; INVASION; NETWORK	Wnt5a is a non-canonical signaling Wnt. Low expression of WNT5A is correlated with poor prognosis in breast cancer patients. The highly invasive breast cancer cell lines, MDA-MB-231 and 4T1, express very low levels of WNT5A. To determine if enhanced expression of WNT5A would affect metastatic behavior, we generated WNT5A expressing cells from the 4T1 and MDA-MB-231 parental cell lines. WNT5A expressing cells demonstrated cobblestone morphology and reduced in vitro migration relative to controls. Cell growth was not altered. Metastasis to the lung via tail vein injection was reduced in the 4T1-WNT5A expressing cells relative to 4T1-vector controls. To determine the mechanism of WNT5A action on metastasis, we performed microarray and whole-transcriptome sequence analysis (RNA-seq) to compare gene expression in 4T1-WNT5A and 4T1-vector cells. Analysis indicated highly significant alterations in expression of genes associated with cellular movement. Down-regulation of a subset of these genes, Mmp13, Nos2, Il1a, Cxcl2, and Lamb3, in WNT5A expressing cells was verified by semi-quantitative RT-PCR. Significant differences in transcript splicing were also detected in cell movement associated genes including Cd44. Cd44 is an adhesion molecule with a complex genome structure. Variable exon usage is associated with metastatic phenotype. Alternative spicing of Cd44 in WNT5A expressing cells was confirmed using RT-PCR. We conclude that WNT5A inhibits metastasis through down-regulation of multiple cell movement pathways by regulating transcript levels and splicing of key genes like Cd44.	[Jiang, Wen; Mitchell, Elizabeth H.; Sohn, Philip; Serra, Rosa] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Crossman, David K.; Crowley, Michael R.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Serra, R (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA.	rserra@uab.edu	Jiang, Wen G./AAF-1876-2020; jiang, wen/GYI-9662-2022	Jiang, Wen G./0000-0002-3283-1111; Crossman, David/0000-0002-0981-169X	NIH [R01 CA126942]; NATIONAL CANCER INSTITUTE [R01CA126942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was through NIH grant R01 CA126942 to R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Benhaj K, 2006, ONCOL REP, V15, P701; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Carpenter PM, 2009, MOL CANCER RES, V7, P462, DOI 10.1158/1541-7786.MCR-08-0148; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dejmek J, 2003, INT J CANCER, V103, P344, DOI 10.1002/ijc.10752; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Han W, 2010, ONCOL REP, V23, P763, DOI 10.3892/or_00000696; Hansen C, 2009, J BIOL CHEM, V284, P27533, DOI 10.1074/jbc.M109.048884; Hebbard L, 2000, J CELL SCI, V113, P2619; Jansson M, 2001, J CELL SCI, V114, P2043; Jonsson M, 2002, CANCER RES, V62, P409; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Leris ACA, 2005, ANTICANCER RES, V25, P731; Mao SH, 2012, BIOTECHNIQUES, V53, P91, DOI 10.2144/0000113903; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029615; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wansleeben C, 2011, DEV DYNAM, V240, P616, DOI 10.1002/dvdy.22564; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892	40	32	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58329	10.1371/journal.pone.0058329	http://dx.doi.org/10.1371/journal.pone.0058329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484019	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100109
J	Korner, R; Preuss, KD; Fadle, N; Madjidi, D; Neumann, F; Bergeler, L; Graber, S; Muller, CSL; Grunhage, F; Pfreundschuh, M; Lammert, F; Vogt, T; Pfohler, C				Koerner, Rebecca; Preuss, Klaus-Dieter; Fadle, Natalie; Madjidi, Darius; Neumann, Frank; Bergeler, Lennart; Graeber, Stefan; Mueller, Cornelia S. L.; Gruenhage, Frank; Pfreundschuh, Michael; Lammert, Frank; Vogt, Thomas; Pfoehler, Claudia			Serum Antibodies against CD28-A New Potential Marker of Dismal Prognosis in Melanoma Patients	PLOS ONE			English	Article							T-CELL-ACTIVATION; INTERFERON; AUTOIMMUNITY; EXPRESSION; MEMORY	Background: Autoantibodies against CD28 have been found in patients with autoimmune and atopic diseases. These antibodies may act as superagonists and activate T cells but may also be antagonistic or induce immunosuppressive effects by activating regulatory T cells. Autoimmunity in melanoma patients has been discussed controversially. Objective: We investigated 230 melanoma patients for the occurrence of CD28 antibodies and the effect of the latter on overall and progress-free survival. Methods: We constructed an ELISA assay to measure CD28 serum antibodies. 230 patients with melanoma and a control-group of 625 patients consistent of 212 patients with virus hepatitis b or c, 149 patients with allergies, 78 patients with psoriasis, 46 patients with plasmocytoma and 140 healthy blood donors were investigated for the occurrence of CD28 antibodies. Results: CD28 abs occur at a higher percentage in patients with melanoma and in patients with viral hepatitis than in other groups investigated (p< 0.001). Occurrence of CD28 abs is significantly higher in patients receiving interferons independent from the underlying disease (p< 0.001). In vitro CD28 serum antibodies have an inhibitory effect on the CD28 receptor as they lead to reduced stimulation of Jurkat cells. Presence of CD28 was correlated with a higher risk of dying from melanoma (p = 0.043), but not with a significantly shortened overall survival or progression-free survival. Conclusion: Interferon therapy appears to induce the production of CD28 abs. In light of reports that these CD28 abs induce immunosuppressive Tregs and - as our data show - that they are inhibitors of CD28 receptor mediated stimulation, the continuation of therapies with interferons in melanoma patients developing CD28 antibodies should be critically reconsidered, since our data indicate a worse outcome of patients with CD28 abs.	[Koerner, Rebecca; Madjidi, Darius; Bergeler, Lennart; Mueller, Cornelia S. L.; Vogt, Thomas; Pfoehler, Claudia] Saarland Univ Hosp, Dept Dermatol, Homburg, Germany; [Preuss, Klaus-Dieter; Fadle, Natalie; Neumann, Frank; Pfreundschuh, Michael] Saarland Univ Hosp, Dept Internal Med 1, Homburg, Germany; [Preuss, Klaus-Dieter; Fadle, Natalie; Neumann, Frank; Pfreundschuh, Michael] Saarland Univ Hosp, Jose Carreras Ctr Immuno & Gene Therapy, Homburg, Germany; [Graeber, Stefan] Saarland Univ Hosp, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Gruenhage, Frank; Lammert, Frank] Saarland Univ Hosp, Dept Internal Med 2, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Korner, R (corresponding author), Saarland Univ Hosp, Dept Dermatol, Homburg, Germany.	rebecca.koerner@uks.eu						Bakacs T, 2011, IMMUNOBIOLOGY; Bouwhuis MG, 2011, CURR OPIN ONCOL, V23, P170, DOI 10.1097/CCO.0b013e328341edff; Bouwhuis MG, 2010, J CLIN ONCOL, V28, P2460, DOI 10.1200/JCO.2009.24.6264; Bouwhuis MG, 2009, JNCI-J NATL CANCER I, V101, P869, DOI 10.1093/jnci/djp132; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Eastwood D, 2010, BRIT J PHARMACOL, V161, P512, DOI 10.1111/j.1476-5381.2010.00922.x; Effros RB, 2000, MECH AGEING DEV, V121, P161; Feng X, 2002, J NEUROIMMUNOL, V129, P205, DOI 10.1016/S0165-5728(02)00182-0; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Hakansson A, 2002, CANCER IMMUNOL IMMUN, V51, P499, DOI 10.1007/s00262-002-0304-4; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Holzel M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1055; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Margulies DH, 2003, J EXP MED, V197, P949, DOI 10.1084/jem.20030303; Marshall E, 2006, SCIENCE, V311, P1688, DOI 10.1126/science.311.5768.1688; Neuber K, 2006, CLIN EXP IMMUNOL, V146, P262, DOI 10.1111/j.1365-2249.2006.03218.x; Pfohler C, 2008, BRIT J DERMATOL, V159, P735, DOI 10.1111/j.1365-2133.2008.08675.x; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Stuckert JJ, 2007, P AM SOC CLIN ONCOL, V25; Urbaniak-Kujda D, 2009, POSTEP HIG MED DOSW, V63, P355; Wolchok JD, 2008, ONCOLOGIST, V13, P2, DOI 10.1634/theoncologist.13-S4-2	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58087	10.1371/journal.pone.0058087	http://dx.doi.org/10.1371/journal.pone.0058087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483974	gold, Green Submitted, Green Published			2022-12-25	WOS:000316936100075
J	Ling, XY; Spaeth, E; Chen, Y; Shi, YX; Zhang, WG; Schober, W; Hail, N; Konopleva, M; Andreeff, M				Ling, Xiaoyang; Spaeth, Erika; Chen, Ye; Shi, Yuexi; Zhang, Weiguo; Schober, Wendy; Hail, Numsen, Jr.; Konopleva, Marina; Andreeff, Michael			The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; TUMOR-GROWTH; CELLS; EXPRESSION; INHIBITION; MICROENVIRONMENT; LEUKEMIA; KINASE; DIFFERENTIATION; IDENTIFICATION	CXCR4, the receptor for stromal-derived factor-1, is reportedly involved in breast carcinogenesis. However, the mechanisms through which CXCR4 contributes to breast cancer cell growth and metastases are poorly understood. In this study, we examined the putative in vitro and in vivo anti-cancer effects of the specific CXCR4 inhibitor AMD3465. Here, we report that AMD3465 triggers a reduction in breast cancer cell invasiveness in vitro, and promotes marked changes in oncogenic signaling proteins including a reduction in STAT3, JAK2, AKT, and CXCR4 phosphorylation and the reduced expression of GSK3 and cMYC. Using three breast cancer cell lines as murine syngeneic immunocompetent breast cancer models, we found that AMD3465 inhibited breast tumor formation and reduced tumor cell metastases to the lung and liver. Furthermore, treatment with AMD3465 significantly reduced the infiltration of myeloid CD11b positive cells at the aforementioned metastatic sites as well as the spleen implying this agent could regulate the formation of the tumor microenvironment and conceivably the premetastatic niche. In conclusion, our studies suggest that AMD3465 inhibits breast cancer growth and metastases by acting on tumor cells as well as immune cells that constitute the tumor microenvironment. This process appears to be regulated, at least in part, through the modulation of oncogenic signaling that includes the STAT3 pathway. Thus, CXCR4 could be a novel target for breast cancer therapy.	[Ling, Xiaoyang; Spaeth, Erika; Chen, Ye; Shi, Yuexi; Zhang, Weiguo; Schober, Wendy; Hail, Numsen, Jr.; Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Andreeff, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	mandreef@mdanderson.org	Chen, Ye/D-1164-2015	Chen, Ye/0000-0003-3671-2504; Spaeth, Erika/0000-0002-5397-3493	NCI [CCSG CA106672]; Paul and Mary Haas Chair in Genetics; Anderson Breast SPORE; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Paul and Mary Haas Chair in Genetics; Anderson Breast SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NCI CCSG CA106672. Breast SPORE (Michael Andreeff) and by the Paul and Mary Haas Chair in Genetics (MA), in part by a Career Developmental Award of the MD Anderson Breast SPORE grant (to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; AZZAM HS, 1993, J NATL CANCER I, V85, P1758, DOI 10.1093/jnci/85.21.1758; Bachelder RE, 2002, CANCER RES, V62, P7203; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Fidler IJ, 2007, J CELL BIOCHEM, V101, P927, DOI 10.1002/jcb.21148; Fiegl M, 2009, BLOOD, V113, P1504, DOI 10.1182/blood-2008-06-161539; Hail N, 2008, FREE RADICAL BIO MED, V44, P1382, DOI 10.1016/j.freeradbiomed.2007.12.034; Harvey JR, 2007, CLIN CANCER RES, V13, P1562, DOI 10.1158/1078-0432.CCR-06-1987; Hatse S, 2005, BIOCHEM PHARMACOL, V70, P752, DOI 10.1016/j.bcp.2005.05.035; Hesselgesser J, 1998, J BIOL CHEM, V273, P15687, DOI 10.1074/jbc.273.25.15687; Hinton CV, 2008, J CELL MOL MED, V12, P1517, DOI 10.1111/j.1582-4934.2008.00300.x; Jin FY, 2012, MOL CANCER RES, V10, P1021, DOI 10.1158/1541-7786.MCR-11-0498; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Konoplev S, 2011, CANCER-AM CANCER SOC, V117, P4689, DOI 10.1002/cncr.26113; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Mannello F, 2006, STEM CELLS, V24, P1904, DOI 10.1634/stemcells.2005-0608; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Rahimi M, 2010, INT J CANCER, V126, P1850, DOI 10.1002/ijc.24964; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Zeng Z, 2006, MOL CANCER THER, V5, P3113, DOI 10.1158/1535-7163.MCT-06-0228; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhang M, 2012, ULTRASTRUCT PATHOL, V36, P381, DOI 10.3109/01913123.2012.728687	42	58	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58426	10.1371/journal.pone.0058426	http://dx.doi.org/10.1371/journal.pone.0058426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484027	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100117
J	Mabry, KE; Shelley, EL; Davis, KE; Blumstein, DT; Van Vuren, DH				Mabry, Karen E.; Shelley, Erin L.; Davis, Katie E.; Blumstein, Daniel T.; Van Vuren, Dirk H.			Social Mating System and Sex-Biased Dispersal in Mammals and Birds: A Phylogenetic Analysis	PLOS ONE			English	Article							CORRELATED EVOLUTION; INBREEDING AVOIDANCE; DISCRETE CHARACTERS; SPATIAL DYNAMICS; BEHAVIOR; REAPPRAISAL; COMPETITION; PHILOPATRY; REVOLUTION; MONOGAMY	The hypothesis that patterns of sex-biased dispersal are related to social mating system in mammals and birds has gained widespread acceptance over the past 30 years. However, two major complications have obscured the relationship between these two behaviors: 1) dispersal frequency and dispersal distance, which measure different aspects of the dispersal process, have often been confounded, and 2) the relationship between mating system and sex-biased dispersal in these vertebrate groups has not been examined using modern phylogenetic comparative methods. Here, we present a phylogenetic analysis of the relationship between mating system and sex-biased dispersal in mammals and birds. Results indicate that the evolution of female-biased dispersal in mammals may be more likely on monogamous branches of the phylogeny, and that females may disperse farther than males in socially monogamous mammalian species. However, we found no support for a relationship between social mating system and sex-biased dispersal in birds when the effects of phylogeny are taken into consideration. We caution that although there are larger-scale behavioral differences in mating system and sex-biased dispersal between mammals and birds, mating system and sex-biased dispersal are far from perfectly associated within these taxa.	[Mabry, Karen E.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Shelley, Erin L.; Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Davis, Katie E.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Van Vuren, Dirk H.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	New Mexico State University; University of California System; University of California Los Angeles; University of Bath; University of California System; University of California Davis	Mabry, KE (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	kmabry@nmsu.edu		Blumstein, Daniel/0000-0001-5793-9244	National Science Foundation (NSF) [IOS-1149056]; NSF [DEB-1119660]; Direct For Biological Sciences [1149056] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	During the preparation of this work, KEM was partially supported by National Science Foundation (NSF) IOS-1149056 and DTB was partially supported by NSF DEB-1119660. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bradley RD, 2007, J MAMMAL, V88, P1146, DOI 10.1644/06-MAMM-A-342R.1; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Crawford JC, 2008, J MAMMAL, V89, P575, DOI 10.1644/07-MAMM-A-251R1.1; Davis KE, 2010, BMC RES NOTES, V3; Dobson FS, 2010, BEHAV ECOL, V21, P747, DOI 10.1093/beheco/arq048; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; DOBSON FS, 1985, EVOLUTION, V39, P1384, DOI 10.1111/j.1558-5646.1985.tb05703.x; DOBSON FS, 1985, AM NAT, V126, P855, DOI 10.1086/284457; Dobson FS, 1980, ANIMAL BEHA IN PRESS; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Harrison Richard G., 2003, Journal of Mammalian Evolution, V10, P249, DOI 10.1023/B:JOMM.0000015105.96065.f0; Helgen KM, 2009, J MAMMAL, V90, P270, DOI 10.1644/07-MAMM-A-309.1; Hughes C, 1998, ECOLOGY, V79, P383, DOI 10.1890/0012-9658(1998)079[0383:IMTWFM]2.0.CO;2; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Le Galliard JF, 2012, MOL ECOL, V21, P505, DOI 10.1111/j.1365-294X.2011.05410.x; Maddison WP, 2011, MESQUITE MODULAR SYS; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Midford P. E., 2005, PDAP PACKAGE MESQUIT; Miller JR, 2008, J MAMMAL, V89, P1279, DOI 10.1644/07-MAMM-A-195.1; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Solomon NG, 2004, CAN J ZOOL, V82, P1667, DOI 10.1139/Z04-142; Stamps Judy A., 2001, P230; WASER PM, 1985, ECOLOGY, V66, P1170, DOI 10.2307/1939169; Weber JN, 2009, ANIM BEHAV, V77, P603, DOI 10.1016/j.anbehav.2008.10.031; Wolff JO, 1998, OIKOS, V83, P327, DOI 10.2307/3546844	39	94	95	2	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57980	10.1371/journal.pone.0057980	http://dx.doi.org/10.1371/journal.pone.0057980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483957	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100063
J	Valle, D; Clark, J				Valle, Denis; Clark, James			Conservation Efforts May Increase Malaria Burden in the Brazilian Amazon	PLOS ONE			English	Article							ANOPHELES-DARLINGI; DEFORESTATION; BIODIVERSITY; TRANSMISSION; FRONTIER; FORESTS; POVERTY; VECTOR; PARKS	Background: Large-scale forest conservation projects are underway in the Brazilian Amazon but little is known regarding their public health impact. Current literature emphasizes how land clearing increases malaria incidence, leading to the conclusion that forest conservation decreases malaria burden. Yet, there is also evidence that proximity to forest fringes increases malaria incidence, which implies the opposite relationship between forest conservation and malaria. We compare the effect of these environmental factors on malaria and explore its implications. Methods and Findings: Using a large malaria dataset (similar to 1,300,000 positive malaria tests collected over similar to 4.5 million km(2)), satellite imagery, permutation tests, and hierarchical Bayesian regressions, we show that greater forest cover (as a proxy for proximity to forest fringes) tends to be associated with higher malaria incidence, and that forest cover effect was 25 times greater than the land clearing effect, the often cited culprit of malaria in the region. These findings have important implications for land use/land cover (LULC) policies in the region. We find that cities close to protected areas (PA's) tend to have higher malaria incidence than cities far from PA's. Using future LULC scenarios, we show that avoiding 10% of deforestation through better governance might result in an average 2-fold increase in malaria incidence by 2050 in urban health posts. Conclusions: Our results suggest that cost analysis of reduced carbon emissions from conservation efforts in the region should account for increased malaria morbidity, and that conservation initiatives should consider adopting malaria mitigation strategies. Coordinated actions from disparate science fields, government ministries, and global initiatives (e. g., Reduced Emissions from Deforestation and Degradation; Millenium Development Goals; Roll Back Malaria; and Global Fund to Fight AIDS, Tuberculosis and Malaria), will be required to decrease malaria toll in the region while preserving these important ecosystems.	[Valle, Denis] Duke Univ, Univ Program Ecol, Durham, NC 27706 USA; [Clark, James] Duke Univ, Nicholas Sch Environm, Dept Biol, Dept Stat Sci, Durham, NC 27708 USA	Duke University; Duke University	Valle, D (corresponding author), Duke Univ, Univ Program Ecol, Durham, NC 27706 USA.	drv4@duke.edu		Valle, Denis/0000-0002-9830-8876	Duke Global Health Initiative	Duke Global Health Initiative	Denis Valle was partly supported by a pilot project grant from the Duke Global Health Initiative. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, HAMBURGER CONNECTION; [Anonymous], **NON-TRADITIONAL**; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Barbieri AF, 2005, HUM ECOL, V33, P847, DOI 10.1007/s10745-005-8213-8; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Barreto P., 2006, HUMAN PRESSURE BRAZI; Barrett MA, 2011, FRONT ECOL ENVIRON, V9, P239, DOI 10.1890/090159; Barros FSM, 2011, B ENTOMOL RES, V101, P643, DOI 10.1017/S0007485311000265; Barros FSM, 2011, PLOS ONE, V6; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Brandao AO, 2006, INT J REMOTE SENS, V27, P177, DOI 10.1080/01431160500353841; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; CBD PAHO/WHO, 2012, REG WORKSH INT HUM H; Clark J. S, 2007, MODELS ECOLOGICAL DA; Coimbra CEA, 1988, HUM FACTORS, V47; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; INPE [Brazilian National Space Research Institute], 2010, PROJ PROD MON FLOR A; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; Ministerio da Saude, 2010, SIVEP MAL; Ministerio da Saude. SecretarYa de vigilancia em saude, 2005, GUIA VIG EP, P07; de Barros FSM, 2011, J VECTOR ECOL, V36, P159, DOI 10.1111/j.1948-7134.2011.00153.x; Moutinho PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-174; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NASA, 2010, 3B43 MONTHL 0 25 X 0; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Povoa MM, 2003, J MED ENTOMOL, V40, P379, DOI 10.1603/0022-2585-40.4.379; Pruss-Ustun A., 2006, WORLD HEALTH; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Ricketts TH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000331; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Singer B, 2006, AM J TROP MED HYG, V74, P1; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Tiwari Piyusha, 2001, Journal of Human Ecology, V12, P371; Tollefson J, 2009, NATURE, V460, P936, DOI 10.1038/460936a; Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295; USAID, 2012, AM MAL IN OV; Valle D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027462; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	71	42	42	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57519	10.1371/journal.pone.0057519	http://dx.doi.org/10.1371/journal.pone.0057519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483912	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100028
J	Benkoe, T; Baumann, S; Weninger, M; Pones, M; Reck, C; Rebhandl, W; Oehler, R				Benkoe, Thomas; Baumann, Suzann; Weninger, Manfred; Pones, Mario; Reck, Carlos; Rebhandl, Winfried; Oehler, Rudolf			Comprehensive Evaluation of 11 Cytokines in Premature Infants with Surgical Necrotizing Enterocolitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MESSENGER-RNA EXPRESSION; CRITICALLY-ILL INFANTS; BIRTH-WEIGHT INFANTS; GENE-EXPRESSION; PRETERM INFANTS; INTERLEUKIN-10; SEPSIS; MORBIDITY; MORTALITY	Objective: A prospective study to investigate the pattern of pro-and anti-inflammatory cytokine responses in neonates with surgical necrotizing enterocolitis (NEC) and identify those cytokines being the most promising for future research. Methods: A panel of 11 different cytokines were measured in 9 infants with proven NEC and compared with 18 age-matched healthy neonates. Results: The serum concentrations of the interleukins (IL)-6, IL-8, and IL-10 were significantly (32-fold to 56-fold) higher in NEC infants compared with controls. In contrast, IL-5, IFN gamma, IL-4 and IL-2 showed slightly (1.4-fold to 5.9-fold) lower levels in the NEC samples. However, these cytokines showed a very low absolute concentration in infants with NEC and in controls. The sum of the serum concentrations of IL-6, IL-8 and IL-10 was able to clearly separate infants with NEC from control samples. IL-1 beta and TNF-alpha showed no statistically different levels. The serum levels of TNF-beta and IL-12p70 were below the detection limit in more than 50% of all samples per group. Conclusion: In spite of strong local inflammation only three out of eleven cytokines (IL-6, IL-8, and IL-10) showed strongly increased serum levels indicating an important role of them in the pathogenesis of NEC. At least two of these three cytokines were elevated in every single NEC patient. Thus, longitudinal monitoring of combined IL-8, IL-6, and IL-10 levels could reveal their potency in being clinical relevant markers in NEC.	[Benkoe, Thomas; Baumann, Suzann; Pones, Mario; Reck, Carlos; Rebhandl, Winfried] Med Univ Vienna, Dept Pediat Surg, Vienna, Austria; [Weninger, Manfred] Med Univ Vienna, Dept Pediat, Div Neonatol Intens Care & Neuropediat, Vienna, Austria; [Oehler, Rudolf] Med Univ Vienna, Surg Res Labs, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Benkoe, T (corresponding author), Med Univ Vienna, Dept Pediat Surg, Vienna, Austria.	thomas.benkoe@meduniwien.ac.at	Oehler, Rudolf/ABC-7836-2020; Burneo, Carlos Albert Reck/D-1099-2009	Oehler, Rudolf/0000-0003-2891-7155; Burneo, Carlos Albert Reck/0000-0003-4284-8969; rebhandl, winfried/0000-0002-9177-3564; Benkoe, Thomas/0000-0002-3428-9186				Benkoe T, 2012, J PEDIATR SURG, V47, P1548, DOI 10.1016/j.jpedsurg.2011.11.049; Berrington JE, 2012, J PEDIATR-US, V160, P49, DOI 10.1016/j.jpeds.2011.06.046; Chan KYY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036977; Chuang SL, 2009, PEDIAT ALLERG IMM-UK, V20, P45, DOI 10.1111/j.1399-3038.2008.00729.x; COMINELLI F, 1990, J CLIN INVEST, V86, P972, DOI 10.1172/JCI114799; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Emami CN, 2012, AM J SURG, V203, P428, DOI 10.1016/j.amjsurg.2011.08.016; Ford H R, 1996, Semin Pediatr Surg, V5, P155; Goepfert AR, 2004, AM J OBSTET GYNECOL, V191, P1375, DOI 10.1016/j.ajog.2004.06.086; Halpern MD, 2002, PEDIATR RES, V51, P733, DOI 10.1023/01.PDR.0000017480.64723.56; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; JORDAN M, 1995, J IMMUNOL, V154, P4081; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lane JS, 1997, SURGERY, V122, P288, DOI 10.1016/S0039-6060(97)90020-9; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Linch SN, 2012, AM J RESP CRIT CARE, V186, P246, DOI 10.1164/rccm.201201-0134OC; Lodha A, 2010, ACTA PAEDIATR, V99, P338, DOI 10.1111/j.1651-2227.2009.01600.x; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; MATTHES T, 1993, J EXP MED, V178, P521, DOI 10.1084/jem.178.2.521; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Nadler EP, 2001, J PEDIATR SURG, V36, P1122, DOI 10.1053/jpsu.2001.25726; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Rees CM, 2007, ARCH DIS CHILD-FETAL, V92, pF193, DOI 10.1136/adc.2006.099929; Romagnoli C, 2001, EUR J PEDIATR, V160, P345, DOI 10.1007/PL00008445; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P21, DOI 10.1016/0016-5085(95)90004-7; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Viscardi RM, 1997, PEDIATR PATHOL LAB M, V17, P547, DOI 10.1080/107710497174516; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; West GA, 1996, GASTROENTEROLOGY, V110, P1683, DOI 10.1053/gast.1996.v110.pm8964392	35	53	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58720	10.1371/journal.pone.0058720	http://dx.doi.org/10.1371/journal.pone.0058720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472217	Green Submitted, Green Published, gold			2022-12-25	WOS:000315637900163
J	Cyktor, JC; Carruthers, B; Beamer, GL; Turner, J				Cyktor, Joshua C.; Carruthers, Bridget; Beamer, Gillian L.; Turner, Joanne			Clonal Expansions of CD8(+) T Cells with IL-10 Secreting Capacity Occur during Chronic Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							GAMMA-INTERFERON; VIRUS-INFECTION; PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; PROGRAMMED DEATH-1; MELANOMA PATIENTS; VIRAL-INFECTION; CUTTING EDGE; C57BL/6 MICE; CBA/J MICE	The exact role of CD8(+) T cells during Mycobacterium tuberculosis (Mtb) infection has been heavily debated, yet it is generally accepted that CD8(+) T cells contribute to protection against Mtb. In this study, however, we show that the Mtb-susceptible CBA/J mouse strain accumulates large numbers of CD8(+) T cells in the lung as infection progresses, and that these cells display a dysfunctional and immunosuppressive phenotype (PD-1(+), Tim-3(+), CD122(+)). CD8(+) T cell expansions from the lungs of Mtb-infected CBA/J mice were also capable of secreting the immunosuppressive cytokine interleukin-10 (IL-10), although in vivo CD8(+) T cell depletion did not significantly alter Mtb burden. Further analysis revealed that pulmonary CD8(+) T cells from Mtb-infected CBA/J mice were clonally expanded, preferentially expressing T cell receptor (TcR) V beta chain 8 (8.2, 8.3) or V beta 14. Although V beta 8(+) CD8(+) T cells were responsible for the majority of IL-10 production, in vivo depletion of V beta 8(+) did not significantly change the outcome of Mtb infection, which we hypothesize was a consequence of their dual IL-10/IFN-gamma secreting profiles. Our data demonstrate that IL-10-secreting CD8(+) T cells can arise during chronic Mtb infection, although the significance of this T cell population in tuberculosis pathogenesis remains unclear.	[Cyktor, Joshua C.; Turner, Joanne] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Beamer, Gillian L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Cyktor, Joshua C.; Carruthers, Bridget; Beamer, Gillian L.; Turner, Joanne] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Turner, J (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	joanne.turner@osumc.edu	Turner, Joanne/F-4118-2015		National Institutes of Health (NIH) [AI-064522]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064522] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health (NIH) R01 (AI-064522; JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel M, 2006, HEPATOLOGY, V44, P1607, DOI 10.1002/hep.21438; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Beamer GL, 2008, CLIN VACCINE IMMUNOL, V15, P474, DOI 10.1128/CVI.00408-07; Beamer GL, 2012, EUR J IMMUNOL, V42, P870, DOI 10.1002/eji.201142054; Beamer GL, 2011, CELL IMMUNOL, V271, P53, DOI 10.1016/j.cellimm.2011.06.002; Beamer GL, 2005, ARCH IMMUNOL THER EX, V53, P469; Begum D, 2009, IMMUNOLOGY, V128, P556, DOI 10.1111/j.1365-2567.2009.03141.x; BEHLKE MA, 1986, P NATL ACAD SCI USA, V83, P767, DOI 10.1073/pnas.83.3.767; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bold TD, 2012, J IMMUNOL, V189, P2530, DOI 10.4049/jimmunol.1200994; Boom WH, 2007, J CLIN INVEST, V117, P2092, DOI 10.1172/JCI32933; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Chen JZ, 2009, J LEUKOCYTE BIOL, V86, P1305, DOI 10.1189/jlb.0609406; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; D'Souza CD, 2000, AM J RESP CELL MOL, V23, P188, DOI 10.1165/ajrcmb.23.2.4063; Dai HH, 2010, J IMMUNOL, V185, P803, DOI 10.4049/jimmunol.1000661; Dalakas MC, 2007, ANN NEUROL, V61, P466, DOI 10.1002/ana.21103; Du G, 2010, J IMMUNOL, V185, P3940, DOI 10.4049/jimmunol.1001222; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; FLYNN JAL, 1993, INFECT AGENT DIS, V2, P259; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Hofmeyer KA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/451694; Huang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030631; Itoh S, 2002, AM J HEMATOL, V69, P59, DOI 10.1002/ajh.10005; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; JOUVINMARCHE E, 1992, P NATL ACAD SCI USA, V89, P3232, DOI 10.1073/pnas.89.8.3232; Junqueira-Kipnis AP, 2005, IMMUNOLOGY, V115, P246, DOI 10.1111/j.1365-2567.2005.02136.x; Kang HS, 2010, J VIROL, V84, P2774, DOI 10.1128/JVI.01948-09; Kaufmann DE, 2008, CURR OPIN HIV AIDS, V3, P362, DOI 10.1097/COH.0b013e3282f9ae8b; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Lalvani A, 2002, AM J RESP CRIT CARE, V166, P789, DOI 10.1164/rccm.2206002; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; MULLER I, 1987, INFECT IMMUN, V55, P2037; Mumprecht S, 2009, BLOOD, V114, P1528, DOI 10.1182/blood-2008-09-179697; Rowbottom AW, 1999, IMMUNOLOGY, V98, P80; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Shams H, 2001, INFECT IMMUN, V69, P3497, DOI 10.1128/IAI.69.5.3497-3501.2001; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Silva RA, 2001, J IMMUNOL, V167, P1535, DOI 10.4049/jimmunol.167.3.1535; Sousa AO, 2000, P NATL ACAD SCI USA, V97, P4204, DOI 10.1073/pnas.97.8.4204; STAERZ UD, 1985, J IMMUNOL, V134, P3994; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Turner J, 2001, INFECT IMMUN, V69, P3264, DOI 10.1128/IAI.69.5.3264-3270.2001; Urdahl KB, 2003, J IMMUNOL, V170, P1987, DOI 10.4049/jimmunol.170.4.1987; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Vesosky B, 2006, INFECT IMMUN, V74, P3314, DOI 10.1128/IAI.01475-05; Wang J, 2004, J IMMUNOL, V173, P4590, DOI 10.4049/jimmunol.173.7.4590; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001	63	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58612	10.1371/journal.pone.0058612	http://dx.doi.org/10.1371/journal.pone.0058612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472214	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900160
J	Quartino, ML; Deregibus, D; Campana, GL; Latorre, GEJ; Momo, FR				Liliana Quartino, Maria; Deregibus, Dolores; Laura Campana, Gabriela; Juan Latorre, Gustavo Edgar; Roberto Momo, Fernando			Evidence of Macroalgal Colonization on Newly Ice-Free Areas following Glacial Retreat in Potter Cove (South Shetland Islands), Antarctica	PLOS ONE			English	Article							CORALLINE ALGAE; COMMUNITIES; PENINSULA; ABUNDANCE; RESPONSES; PATTERNS; BIOMASS; LIGHT	Climate warming has been related to glacial retreat along the Western Antarctic Peninsula. Over the last years, a visible melting of Fourcade Glacier (Potter Cove, South Shetland Islands) has exposed newly ice-free hard bottom areas available for benthic colonization. However, ice melting produces a reduction of light penetration due to an increase of sediment input and higher ice impact. Seventeen years ago, the coastal sites close to the glacier cliffs were devoid of macroalgae. Are the newly ice-free areas suitable for macroalgal colonization? To tackle this question, underwater video transects were performed at six newly ice-free areas with different degree of glacial influence. Macroalgae were found in all sites, even in close proximity to the retreating glacier. We can show that: 1. The complexity of the macroalgal community is positively correlated to the elapsed time from the ice retreat, 2. Algae development depends on the optical conditions and the sediment input in the water column; some species are limited by light availability, 3. Macroalgal colonization is negatively affected by the ice disturbance, 4. The colonization is determined by the size and type of substrate and by the slope of the bottom. As macroalgae are probably one of the main energy sources for the benthos, an expansion of the macroalgal distribution can be expected to affect the matter and energy fluxes in Potter Cove ecosystem.	[Liliana Quartino, Maria; Deregibus, Dolores; Laura Campana, Gabriela] Inst Antartico Argentino, Dept Biol Costera, Buenos Aires, DF, Argentina; [Liliana Quartino, Maria] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Laura Campana, Gabriela] Univ Nacl Lujan, Dept Ciencias Basicas, Lujan, Argentina; [Juan Latorre, Gustavo Edgar] Univ Nacl La Plata, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina; [Roberto Momo, Fernando] Univ Nacl Gen Sarmiento, Inst Ciencias, Los Polvorines, Argentina	Instituto Antartico Argentino; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidad Nacional de Lujan; National University of La Plata; Museo La Plata	Quartino, ML (corresponding author), Inst Antartico Argentino, Dept Biol Costera, Buenos Aires, DF, Argentina.	lquartino@dna.gov.ar	Momo, Fernando/A-5984-2015; Momo, Fernando R/E-3426-2012	Momo, Fernando R/0000-0003-0710-1149	DNA-IAA [PICTA 7/2008-2011]; ANPCyT-DNA [PICTO 0116/2012-2015]	DNA-IAA; ANPCyT-DNA	This research was supported by grants from DNA-IAA (PICTA 7/2008-2011) and ANPCyT-DNA (PICTO 0116/2012-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSLER CD, 1995, PHYCOLOGIA, V34, P424, DOI 10.2216/i0031-8884-34-5-424.1; BARNES DKA, 1995, MAR BIOL, V121, P565, DOI 10.1007/BF00349467; Barnes DKA, 1996, J EXP MAR BIOL ECOL, V196, P251, DOI 10.1016/0022-0981(95)00132-8; Becker S, 2011, ANTARCT SCI, V23, P419, DOI 10.1017/S0954102011000575; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; de Aranzamendi C, 2010, 31 SCAR 4 OP SCI C 2; Eriksson BK, 2005, OECOLOGIA, V143, P438, DOI 10.1007/s00442-004-1810-1; Gomez I, 2009, BOT MAR, V52, P593, DOI 10.1515/BOT.2009.073; Huang YM, 2007, POLAR BIOL, V30, P1417, DOI 10.1007/s00300-007-0303-1; Iken K, 1999, MAR ECOL-P S Z N I, V20, P11, DOI 10.1046/j.1439-0485.1999.00060.x; Iken K., 2011, BIOL POLAR BENTHIC A; Iken K, 1996, REP POLAR RES, V201, P1; Irving AD, 2005, MAR BIOL, V147, P1075, DOI 10.1007/s00227-005-0007-4; Johnston EL, 2007, POLAR BIOL, V30, P781, DOI 10.1007/s00300-006-0237-z; Kirk J. T. O., 1983, LIGHT PHOTOSYNTHESIS; Kloser H, 1996, HYDROBIOLOGIA, V333, P1, DOI 10.1007/BF00020959; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Campana GL, 2009, BOT MAR, V52, P655, DOI 10.1515/BOT.2009.076; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; McDonald JI, 2006, J ENVIRON MANAGE, V80, P148, DOI 10.1016/j.jenvman.2005.08.021; Quartino ML, 2008, POLAR BIOL, V31, P281, DOI 10.1007/s00300-007-0356-1; Quartino ML, 2005, BOT MAR, V48, P187, DOI 10.1515/BOT.2005.029; Ruckamp M, 2011, GLOBAL PLANET CHANGE, V79, P99, DOI 10.1016/j.gloplacha.2011.06.009; Schloss IR, 2002, POLAR BIOL, V25, P41, DOI 10.1007/s003000100309; Schloss IR, 2012, J MARINE SYST, V92, P53, DOI 10.1016/j.jmarsys.2011.10.006; Schwarz AM, 2005, MAR ECOL PROG SER, V294, P131, DOI 10.3354/meps294131; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Spurkland T, 2011, J COASTAL RES, V27, P133, DOI 10.2112/JCOASTRES-D-10-00194.1; SYVITSKI JPM, 1989, ARCTIC, V42, P232; Tatian M, 2004, ANTARCT SCI, V16, P123, DOI 10.1017/S0954102004001890; Turner J., 2010, ANTARCTIC CLIMATE CH; Wiencke C., 2002, SYNOPSES ANTARCTIC B; Zacher K, 2010, 31 SCAR 4 OP SCI C 2; ZIELINSKI K, 1990, Polish Polar Research, V11, P95	34	86	87	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58223	10.1371/journal.pone.0058223	http://dx.doi.org/10.1371/journal.pone.0058223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484000	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900077
J	Asiedu, MK; Beauchamp-Perez, FD; Ingle, JN; Behrens, MD; Radisky, DC; Knutson, KL				Asiedu, M. K.; Beauchamp-Perez, F. D.; Ingle, J. N.; Behrens, M. D.; Radisky, D. C.; Knutson, K. L.			AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells	ONCOGENE			English	Article						AXL; EMT; CSCs; BCSCs; tyrosine kinase	TYROSINE KINASE INHIBITOR; TUMOR-GROWTH; THERAPEUTIC TARGET; METASTASIS; EXPRESSION; PROGRESSION; ACTIVATION; INVASION; MP470	Despite significant progress in the treatment of breast cancer, particularly through the use of targeted therapy, relapse and chemoresistance remain a major hindrance to the fight to minimize the burden of the disease. It is becoming increasingly clear that a rare subpopulation of cells known as cancer stern cells (CSC), able to be generated through epithelial-to-mesenchymal transition (EMT) and capable of tumor initiation and self-renewal, contributes to treatment resistance and metastases. This means that a more effective therapy should target both the chemoresistant CSCs and the proliferating epithelial cells that give rise to them to reverse EMT and to attenuate their conversion to CSCs. Here, we demonstrate a novel function of AXL in acting upstream to induce EMT in normal and immortalized human mammary epithelial cells in an apparent positive feedback loop mechanism and regulate breast CSC (BCSC) self-renewal and chemoresistance. Downregulation of AXL using MP470 (Amuvatinib) reversed EMT in mesenchymal normal human mammary epithelial cells and murine BCSCs attenuating self-renewal and restored chemosensitivity of the BCSCs. AXL expression was also found to be associated with the expression of stem cell genes, regulation of metastases genes, increased tumorigenicity and was important for BCSC invasion and migration. Inactivation of AXL also led to the downregulation of nuclear factor-kappa B pathway and reduced tumor formation in vivo. Taken together, our data suggest that targeted therapy against AXL, in combination with systemic therapies, has the potential to improve response to anticancer therapies and to reduce breast cancer recurrence and metastases.	[Asiedu, M. K.; Beauchamp-Perez, F. D.; Behrens, M. D.; Knutson, K. L.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Ingle, J. N.] Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA; [Radisky, D. C.] Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Asiedu, MK (corresponding author), Mayo Clin, Coll Med, 228 Med Sci Bldg,200 First St SW, Rochester, MN 55905 USA.	asiedu.michael@mayo.edu; knutson.keith@mayo.edu	Radisky, Derek/B-6569-2018	Radisky, Derek/0000-0002-1962-8784	Martha; Bruce Atwater; Howard Temin Award [K01-CA100764, R01-CA122086]; Mayo Clinic Breast Cancer Specialized Program of Research Excellence Award [P50-CA116201]; NIH/NCRR CTSA [UL1 RR024150]; NATIONAL CANCER INSTITUTE [P30CA015083, K01CA100764, P50CA116201, R01CA122086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER	Martha; Bruce Atwater; Howard Temin Award; Mayo Clinic Breast Cancer Specialized Program of Research Excellence Award; NIH/NCRR CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a generous gift from Martha and Bruce Atwater (KLK); Howard Temin Award, K01-CA100764 (KLK); R01-CA122086 (DCR); and the Mayo Clinic Breast Cancer Specialized Program of Research Excellence Award, P50-CA116201 (JNI). This publication was also supported by NIH/NCRR CTSA Grant Number UL1 RR024150. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. We acknowledge the strong support of the Mayo Clinic Comprehensive Cancer Center for providing access to core facilities.	Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Chen WS, 2011, FRONT BIOSCI-LANDMRK, V16, P1172, DOI 10.2741/3782; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; Cowin P, 2007, J MAMMARY GLAND BIOL, V12, P99, DOI 10.1007/s10911-007-9041-9; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Gangemi R, 2009, CURR MED CHEM, V16, P1688, DOI 10.2174/092986709788186147; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Han JS, 2009, INT J ONCOL, V34, P1449, DOI 10.3892/ijo_00000273; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee WP, 1999, MOL CELL BIOL, V19, P8075; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng FY, 2002, J BIOL CHEM, V277, P29674, DOI 10.1074/jbc.M112464200; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Qi WQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-142; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Shipitsin M, 2008, LAB INVEST, V88, P459, DOI 10.1038/labinvest.2008.14; Song X, CANCER, V117, P734; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; van Ginkel PR, 2004, CANCER RES, V64, P128, DOI 10.1158/0008-5472.CAN-03-0245; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vicente-Duenas C, 2010, DIS MODEL MECH, V3, P149, DOI 10.1242/dmm.002774; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Welsh JW, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-69; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	47	189	193	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1316	1324		10.1038/onc.2013.57	http://dx.doi.org/10.1038/onc.2013.57			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23474758	Green Accepted			2022-12-25	WOS:000332631100012
J	Fang, M; Simeonova, I; Bardot, B; Lejour, V; Jaber, S; Bouarich-Bourimi, R; Morin, A; Toledo, F				Fang, M.; Simeonova, I.; Bardot, B.; Lejour, V.; Jaber, S.; Bouarich-Bourimi, R.; Morin, A.; Toledo, F.			Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival	ONCOGENE			English	Article						p53; Mdm4; p21; Plk1; Rb	PROLINE-RICH DOMAIN; THERAPEUTIC TARGET; PATHWAY; REPRESSION; MUTATION; LACKING; RB	The p53 pathway is inactivated in most human cancers, and its reactivation in tumors appears as a promising therapeutic strategy. Overexpression of Mdm4, a p53 negative regulator, occurs in a significant fraction of human cancers. Mouse models were used to evaluate the therapeutic potential of strategies against Mdm4, and encouraging results were obtained for tumor cells in which Mdm4 overexpression prevents wild-type p53 to exert its tumor suppressive functions. However, missense mutations in the p53 gene occur in about half of human cancers, and 15% of such mutations lead to the expression of a mutant protein that retains partial activity. In this report, we used mouse models to address the therapeutic potential of strategies against Mdm4 in tumors expressing an hypomorphic p53 mutant. We found that, in an Rb+/- background promoting pituitary and thyroid tumors, decreased Mdm4 levels improved the survival of mice expressing wild-type p53, but not that of mice expressing p53(Delta P), a p53 hypomorph lacking the proline-rich domain. Importantly, however, most Rb+/- p53(Delta P/Delta P) mice developped pituitary adenomas, but these tumors were rare in Rb+/- p53(Delta P/Delta P) mdm4(-/-) animals, because Mdm4 loss led to increased p21 levels, a suppressor of pituitary tumor growth. On the contrary, Rb+/- p53(Delta P/Delta P) and Rb+/- p53(Delta P/Delta P) Mdm4(-/-) mice developped anaplastic thyroid carcinomas at equal frequencies. Importantly, wild-type p53 represses the Plk1 gene, which encodes a promising therapeutic target in anaplastic thyroid carcinomas, and this repression is improved when Mdm4 levels are decreased. On the opposite, p53(Delta P) is a mediocre transcriptional repressor that is not improved by Mdm4 loss. In sum, depending on the tumor type, strategies against Mdm4 that work in cells expressing wild-type p53 may not work in cells expressing an hypomorphic p53. Furthermore, p53-mediated transcriptional repression should be considered when evaluating strategies to reactivate p53 in tumors.	[Fang, M.; Simeonova, I.; Bardot, B.; Lejour, V.; Jaber, S.; Bouarich-Bourimi, R.; Morin, A.; Toledo, F.] Inst Curie, Ctr Rech, F-75248 Paris 05, France; [Fang, M.; Simeonova, I.; Bardot, B.; Lejour, V.; Jaber, S.; Bouarich-Bourimi, R.; Morin, A.; Toledo, F.] Univ Paris 06, Paris, France; [Fang, M.; Simeonova, I.; Bardot, B.; Lejour, V.; Jaber, S.; Bouarich-Bourimi, R.; Morin, A.; Toledo, F.] CNRS, UMR 3244, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Toledo, F (corresponding author), Inst Curie, UMR 3244, Ctr Rech, 26 Rue Ulm, F-75248 Paris 05, France.	franck.toledo@curie.fr	Simeonova, Iva/Y-9412-2019	Jaber, Sara/0000-0002-3796-102X; Toledo, Franck/0000-0003-3798-4106; Bardot, Boris/0000-0003-4976-9593	Fondation de France; Association pour la Recherche sur le Cancer; Ligue Nationale contre le Cancer; Institut National du Cancer; Canceropole Ile de France; Ministere de l'Enseignement Superieur et de la Recherche	Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Ile de France(Region Ile-de-France); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	We thank members of the Curie technological platforms for their contribution to this study: I Grandjean, C Daviaud and M Garcia from the Animal facility and M Richardson, M Huerre and A Nicolas from the Pathology service. We also thank L Plancke and L Charbonnier for their help with mouse dissections, and GM Wahl and M Debatisse for their support. Funding was provided from the Fondation de France (Comite Tumeurs), the Association pour la Recherche sur le Cancer, the Ligue Nationale contre le Cancer (Comite Ile de France) and the Institut National du Cancer. MF and IS received predoctoral fellowships from the Canceropole Ile de France, the Ministere de l'Enseignement Superieur et de la Recherche and the Ligue Nationale Contre le Cancer.	Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Leroy B, 2013, NUCLEIC ACIDS RES, V41, pD962, DOI 10.1093/nar/gks1033; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Marine JC, 2011, CURR TOP DEV BIOL, V94, P45, DOI 10.1016/B978-0-12-380916-2.00003-6; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nappi TC, 2009, CANCER RES, V69, P1916, DOI 10.1158/0008-5472.CAN-08-1693; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Prophet E, 1992, AFIP LAB METHODS HIS; Salvatore G, 2007, CANCER RES, V67, P10158; Simeonova I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002731; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vaseva AV, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.39; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	25	9	9	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1336	1339		10.1038/onc.2013.62	http://dx.doi.org/10.1038/onc.2013.62			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23474762				2022-12-25	WOS:000332631100014
J	Vereide, DT; Seto, E; Chiu, YF; Hayes, M; Tagawa, T; Grundhoff, A; Hammerschmidt, W; Sugden, B				Vereide, D. T.; Seto, E.; Chiu, Y-F; Hayes, M.; Tagawa, T.; Grundhoff, A.; Hammerschmidt, W.; Sugden, B.			Epstein-Barr virus maintains lymphomas via its miRNAs	ONCOGENE			English	Article						EBV; BART miRNAs; apoptosis; RISC-IP; Burkitt's lymphoma	HUMAN GAMMA-HERPESVIRUSES; MICRORNA TARGETS; DOWN-REGULATION; LMP1 ONCOGENE; PROTEIN; EBV; EXPRESSION; APOPTOSIS; CELLS; BIM	Epstein-Barr virus (EBV) has evolved exquisite controls over its host cells, human B lymphocytes, not only directing these cells during latency to proliferate and thereby expand the pool of infected cells, but also to survive and thereby persist for the lifetime of the infected individual. Although these activities ensure the virus is successful, they also make the virus oncogenic, particularly when infected people are immunosuppressed. Here we show, strikingly, that one set of EBVs microRNAs (miRNAs) both sustain Burkitt's lymphoma (BL) cells in the absence of other viral oncogenes and promote the transformation of primary B lymphocytes. BL cells were engineered to lose EBV and found to die by apoptosis and could be rescued by constitutively expressing viral miRNAs in them. Two of these EBV miRNAs were found to target caspase 3 to inhibit apoptosis at physiological concentrations.	[Vereide, D. T.; Chiu, Y-F; Hayes, M.; Sugden, B.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Seto, E.; Tagawa, T.; Hammerschmidt, W.] DZIF German Ctr Infect Res, Res Unit Gene Vectors, Munich, Germany; [Seto, E.; Tagawa, T.; Hammerschmidt, W.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Munich, Germany; [Grundhoff, A.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	University of Wisconsin System; University of Wisconsin Madison; German Center for Infection Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Pette Institute	Sugden, B (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Room 814,1400 Univ Ave, Madison, WI 53706 USA.	sugden@oncology.wisc.edu	Hammerschmidt, Wolfgang/ABG-3921-2021; Tagawa, Takanobu/AAZ-2351-2021; Chiu, Ya-Fang/AAS-7536-2020	Hammerschmidt, Wolfgang/0000-0002-4659-0427; Tagawa, Takanobu/0000-0001-8637-2996; Chiu, Ya-Fang/0000-0002-7506-9032; Grundhoff, Adam/0000-0003-0940-7045	National Cancer Institute, National Institutes of Health [P01 CA022443, R01 CA133027, R01 CA070723]; Deutsche Forschungsgemeinschaft [SFB455, SEBTR5]; National Cancer Center; DAAD, German Academic Exchange Service; NATIONAL CANCER INSTITUTE [P01CA022443, R01CA133027, P30CA014520, T32CA009135, R01CA070723] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Cancer Center; DAAD, German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Alan Rickinson for kindly providing the early passage BL cell lines and Dagmar Pich for her invaluable support This work was funded by grants from the National Cancer Institute, National Institutes of Health (grant P01 CA022443, grants R01 CA133027 and R01 CA070723) and Deutsche Forschungsgemeinschaft (grants SFB455 and SEBTR5). David Vereide was supported by a predoctoral fellowship from the National Cancer Center. Takanobu Tagawa is supported by a predoctoral grant of DAAD, German Academic Exchange Service, Bill Sugden is an American Cancer Society Research Professor,	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Clybouw C, 2005, J IMMUNOL, V175, P2968, DOI 10.4049/jimmunol.175.5.2968; Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008; GAILLARD C, 1990, NUCLEIC ACIDS RES, V18, P378, DOI 10.1093/nar/18.2.378; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Kirchmaier AL, 1997, J VIROL, V71, P1766, DOI 10.1128/JVI.71.3.1766-1775.1997; Kuzembayeva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047409; Lee DY, 2008, BLOOD, V111, P2280, DOI 10.1182/blood-2007-07-100032; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oliver PM, 2006, J EXP MED, V203, P731, DOI 10.1084/jem.20051407; Paschos K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000492; Pratt ZL, 2012, J VIROL, V86, P4380, DOI 10.1128/JVI.06966-11; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Schafer A, 2007, VIROLOGY, V364, P21, DOI 10.1016/j.virol.2007.03.029; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Suffert G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002405; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vereide D, 2010, ADV CANCER RES, V108, P1, DOI 10.1016/S0065.230X(10)08004.8; Vereide DT, 2011, BLOOD, V117, P1977, DOI 10.1182/blood-2010-05-285791; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09	30	110	119	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1258	1264		10.1038/onc.2013.71	http://dx.doi.org/10.1038/onc.2013.71			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23503461	Green Accepted			2022-12-25	WOS:000332631100006
J	Choi, HJ; Kim, J; Do, KH; Park, SH; Moon, Y				Choi, H. J.; Kim, J.; Do, K. H.; Park, S-H; Moon, Y.			Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination	ONCOGENE			English	Article						epithelial tumor cell survival; enteropathogenic Escherichia coli; macrophage inhibitory cytokine 1	INFLAMMATORY-BOWEL-DISEASE; ACTIN PEDESTAL FORMATION; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; RHO-GTPASES; MIC-1; APOPTOSIS; INVASION; PROSTATE; RISK	Mucosally adherent Escherichia coli is frequently observed in intestinal surface of patients with colorectal cancer, but rarely in healthy control. Particularly, enteropathogenic Escherichia coli (EPEC) is known to be closely associated with colorectal carcinogenesis in human. In this study, one consequence of EPEC infection in human intestinal cancer cells was induction of macrophage inhibitory cytokine 1 (MIC-1), which is a multifunctional cytokine with biological activities involved in cancer cell growth, differentiation and migration. The present investigation assessed the involvement of MIC-1 protein in EPEC infectionmediated cancer cell survival. The challenge with EPEC induced cancer cell detachment via cytoskeleton rearrangement, which was positively associated with induced MIC-1 expression. Moreover, MIC-1 also mediated RhoA GTPase-linked survival of the detached cancer cells. Blocking of MIC-1 or RhoA activity increased cellular apoptosis of the detached cancer cells. In terms of signaling pathway, MIC-1 triggered transforming growth factorb-activated kinase 1 (TAK1), which enhanced expression of RhoA GTPase. We conclude that EPEC enhances MIC-1 gene expression in the human intestinal cancer cells, which can be associated with enhanced tumor cell resistance to anchorage-dependent tumor cell death via enhanced TAK1 and RhoA GTPase.	[Choi, H. J.; Kim, J.; Do, K. H.; Park, S-H; Moon, Y.] Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Lab Mucosal Exposome & Biomodulat, Yangsan 626870, Kyungnam, South Korea; [Choi, H. J.; Kim, J.; Do, K. H.; Park, S-H; Moon, Y.] Pusan Natl Univ, Sch Med, Med Res Inst, Yangsan 626870, Kyungnam, South Korea; [Moon, Y.] Pusan Natl Univ, Res Inst Basic Sci, Pusan, South Korea; [Moon, Y.] Pusan Natl Univ, Med Res Inst, Pusan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Lab Mucosal Exposome & Biomodulat, Room 704, Yangsan 626870, Kyungnam, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020	MOON, YUSEOK/0000-0001-8686-8166	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012R1A1A2005837]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by Ministry of Education, Science and Technology Grant 2012R1A1A2005837.	Aepfelbacher M, 2005, CURR TOP MICROBIOL, V291, P167; Agarwal MK, 2006, P NATL ACAD SCI USA, V103, P16278, DOI 10.1073/pnas.0607210103; BARTHOLD SW, 1977, CANCER RES, V37, P4352; Batchelor M, 2004, EMBO REP, V5, P104, DOI 10.1038/sj.embor.7400038; Bellizzi A, 2008, INT J MOL MED, V22, P25; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005; Braga V, 2000, EXP CELL RES, V261, P83, DOI 10.1006/excr.2000.5050; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Crane JK, 1999, INFECT IMMUN, V67, P2575, DOI 10.1128/IAI.67.5.2575-2584.1999; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Detrich R E, 1976, J Maine Med Assoc, V67, P52; Dittert DD, 2008, HUM PATHOL, V39, P1002, DOI 10.1016/j.humpath.2007.11.016; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Faried A, 2007, ANN SURG ONCOL, V14, P3593, DOI 10.1245/s10434-007-9562-x; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hecht G, 2001, AM J PHYSIOL-GASTR L, V281, pG1, DOI 10.1152/ajpgi.2001.281.1.G1; Iczkowski KA, 2003, INT J SURG PATHOL, V11, P159, DOI 10.1177/106689690301100302; Kim KS, 2002, GASTROENTEROLOGY, V122, P1388, DOI 10.1053/gast.2002.32972; Lee DH, 2003, CANCER RES, V63, P4648; Lieberman D, 2009, CURR OPIN GASTROEN, V25, P422, DOI 10.1097/MOG.0b013e32832d1e2a; Lim DY, 2009, AM J PHYSIOL-GASTR L, V296, pG1060, DOI 10.1152/ajpgi.90490.2008; Liu T, 2003, CANCER RES, V63, P5034; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Maddocks ODK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005517; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Mahida YR, 2004, CLIN SCI, V107, P331, DOI 10.1042/CS20040136; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Matsuzawa T, 2004, EMBO J, V23, P3570, DOI 10.1038/sj.emboj.7600359; MOSCOW JA, 1994, ONCOGENE, V9, P189; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Nougayrede JP, 2007, CELL MICROBIOL, V9, P680, DOI 10.1111/j.1462-5822.2006.00820.x; Oliva C A, 1997, Rev Assoc Med Bras (1992), V43, P283; POTTER JD, 1993, EPIDEMIOL REV, V15, P499, DOI 10.1093/oxfordjournals.epirev.a036132; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Rihet S, 2001, J CANCER RES CLIN, V127, P733; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Rogers Arlin B., 2009, V511, P267, DOI 10.1007/978-1-59745-447-6_11; ROTHBAUM R, 1982, GASTROENTEROLOGY, V83, P441; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; Stypulkowska-Misiurewicz H, 1984, Przegl Epidemiol, V38, P19; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Thomas R, 2001, INT J CANCER, V93, P47, DOI 10.1002/ijc.1291; Thompson Patricia A, 2009, Expert Rev Gastroenterol Hepatol, V3, P369, DOI 10.1586/egh.09.28; Tomson FL, 2005, MOL MICROBIOL, V56, P447, DOI 10.1111/j.1365-2958.2005.04571.x; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; ULSHEN MH, 1980, NEW ENGL J MED, V302, P99, DOI 10.1056/NEJM198001103020207; Vermeulen SJ, 1999, CLIN EXP METASTAS, V17, P663, DOI 10.1023/A:1006724300022; Vermeulen SJ, 1997, ANN NY ACAD SCI, V833, P186, DOI 10.1111/j.1749-6632.1997.tb48607.x; Viswanathan VK, 2004, CELL MICROBIOL, V6, P987, DOI 10.1111/j.1462-5822.2004.00416.x; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wollmann W, 2005, CARCINOGENESIS, V26, P900, DOI 10.1093/carcin/bgi031; Yang H, 2009, BIOCHEM PHARMACOL, V78, P1205, DOI 10.1016/j.bcp.2009.06.012	61	23	24	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2013	32	41					4960	4969		10.1038/onc.2012.508	http://dx.doi.org/10.1038/onc.2012.508			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	235KQ	23503457				2022-12-25	WOS:000325717800012
J	Cheshenko, N; Trepanier, JB; Stefanidou, M; Buckley, N; Gonzalez, P; Jacobs, W; Herold, BC				Cheshenko, Natalia; Trepanier, Janie B.; Stefanidou, Martha; Buckley, Niall; Gonzalez, Pablo; Jacobs, William; Herold, Betsy C.			HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression	FASEB JOURNAL			English	Article						glycoprotein B; glycoprotein D; miltefosine; genital herpes	HERPES-SIMPLEX-VIRUS; LEUKOCYTE PROTEASE INHIBITOR; GLYCOPROTEIN-B; KINASE-B; MILTEFOSINE; RECEPTOR; BINDING; PLAYS; EXPRESSION; INFECTION	HSV triggers intracellular calcium release to promote viral entry. We hypothesized that Akt signaling induces the calcium responses and contributes to HSV entry. Exposure of human cervical and primary genital tract epithelial, neuronal, or keratinocyte cells to HSV serotype 2 resulted in rapid phosphorylation of Akt. Silencing of Akt with small interfering RNA prevented the calcium responses, blocked viral entry, and inhibited plaque formation by 90% compared to control siRNA. Susceptibility to infection was partially restored if Akt was reintroduced into silenced cells with an Akt-expressing plasmid. HSV-2 variants deleted in glycoproteins B or D failed to induce Akt phosphorylation, and coimmunoprecipitation studies indicated that Akt interacts with glycoprotein B. Cell-surface expression of Akt was rapidly induced in response to HSV exposure. Miltefosine (50 M), a licensed drug that blocks Akt phosphorylation, inhibited HSV-induced calcium release, viral entry, and plaque formation following infection with acyclovir-sensitive and resistant clinical isolates. Miltefosine blocked amplification of HSV from explanted ganglia to epithelial cells; viral yields were significantly less in miltefosine compared to control-treated cocultures (P<0.01). Together, these findings identify a novel role for Akt in viral entry, link Akt and calcium signaling, and suggest a new target for HSV treatment and suppression.Cheshenko, N., Trepanier, J. B., Stefanidou, M., Buckley, N., Gonzalez, P., Jacobs, W., and Herold, B. C. HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression.	[Cheshenko, Natalia; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Cheshenko, Natalia; Trepanier, Janie B.; Stefanidou, Martha; Buckley, Niall; Gonzalez, Pablo; Jacobs, William; Herold, Betsy C.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10461 USA; [Jacobs, William] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Jacobs, William] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Gonzalez, Pablo; Jacobs, William] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA; [Gonzalez, Pablo] Pontificia Univ Catolica Chile, Millennium Inst Immunol & Immunotherapy, Santiago, Chile	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Pontificia Universidad Catolica de Chile	Herold, BC (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	betsy.herold@einstein.yu.edu	Cheshenko, Natalia/ABF-5896-2021; Gonzalez, Pablo/L-1973-2013	Gonzalez, Pablo/0000-0001-7709-6870; Jacobs, William/0000-0003-3321-3080; Herold, Betsy/0000-0001-9974-0786	U.S. National Institutes of Health (NIH) [AI-061679]; Center for AIDS Research at the Albert Einstein College of Medicine; Montefiore Medical Center [NIH AI-51519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061679, R56AI061679, P30AI051519] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research at the Albert Einstein College of Medicine; Montefiore Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Briana Nixon and Theodore Segarra for assistance with animal experiments, Prashant Desai (Johns Hopkins University, Baltimore, MD, USA) for the KVP26GFP virus and Greg Smith (Northwestern University, Evanston, IL, USA) for HSV-1 (F-GS2822). The authors also thank Yungtai Lo for statistical advice. The authors thank the Analytical Imaging Facility at Albert Einstein College of Medicine for assistance with confocal laser and E. A. Eugenin (Albert Einstein College of Medicine) for scientific advice. This work was supported in part by U.S. National Institutes of Health (NIH) grant AI-061679 and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (NIH AI-51519).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Antinone SE, 2010, J VIROL, V84, P1504, DOI 10.1128/JVI.02029-09; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Benetti L, 2006, J VIROL, V80, P3341, DOI 10.1128/JVI.80.7.3341-3348.2006; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carfi A, 2002, ACTA CRYSTALLOGR D, V58, P836, DOI 10.1107/S0907444902001270; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Cheshenko N, 2002, J GEN VIROL, V83, P2247, DOI 10.1099/0022-1317-83-9-2247; Cheshenko N, 2007, MOL BIOL CELL, V18, P3119, DOI 10.1091/mbc.E07-01-0062; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Connolly SA, 2005, J VIROL, V79, P1282, DOI 10.1128/JVI.79.2.1282-1295.2005; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; Fakioglu E, 2008, J VIROL, V82, P9337, DOI 10.1128/JVI.00603-08; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Garg R, 2012, VIROLOGY, V432, P271, DOI 10.1016/j.virol.2012.05.032; GERBER SI, 1995, VIROLOGY, V214, P29, DOI 10.1006/viro.1995.9957; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Hwang JY, 2009, CELL CALCIUM, V45, P233, DOI 10.1016/j.ceca.2008.10.006; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Koulen P, 2008, CELL PHYSIOL BIOCHEM, V21, P161, DOI 10.1159/000113758; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Oram RJ, 2000, J INFECT DIS, V181, P1458, DOI 10.1086/315387; Patterson RL, 2005, P NATL ACAD SCI USA, V102, P1357, DOI 10.1073/pnas.0409657102; Richardson PG, 2012, EXPERT OPIN DRUG MET, V8, P623, DOI 10.1517/17425255.2012.681376; Ruiter GA, 2003, ANTI-CANCER DRUG, V14, P167, DOI 10.1097/00001813-200302000-00011; Segarra TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027675; Sindermann H, 2004, CLIN INFECT DIS, V39, P1520, DOI 10.1086/425359; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Wagner MJ, 2011, J VIROL, V85, P2803, DOI 10.1128/JVI.01877-10; Wilson SS, 2009, EXPERT REV ANTI-INFE, V7, P559, DOI [10.1586/eri.09.34, 10.1586/ERI.09.34]; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263	50	60	63	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2584	2599		10.1096/fj.12-220285	http://dx.doi.org/10.1096/fj.12-220285			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23507869	Green Published			2022-12-25	WOS:000328841000008
J	Tonkin, ML; Arredondo, SA; Loveless, BC; Serpa, JJ; Makepeace, KAT; Sundar, N; Petrotchenko, EV; Miller, LH; Grigg, ME; Boulanger, MJ				Tonkin, Michelle L.; Arredondo, Silvia A.; Loveless, Bianca C.; Serpa, Jason J.; Makepeace, Karl A. T.; Sundar, Natarajan; Petrotchenko, Evgeniy V.; Miller, Louis H.; Grigg, Michael E.; Boulanger, Martin J.			Structural and Biochemical Characterization of Plasmodium falciparum 12 (Pf12) Reveals a Unique Interdomain Organization and the Potential for an Antiparallel Arrangement with Pf41	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMETE-SURFACE PROTEIN; TRANSMISSION-BLOCKING IMMUNITY; MULTIPLE SEQUENCE ALIGNMENT; TOXOPLASMA-GONDII; TARGET ANTIGEN; MALARIA; POLYMORPHISM; PFS230; GENES; IDENTIFICATION	Plasmodium falciparum is the most devastating agent of human malaria. A major contributor to its virulence is a complex lifecycle with multiple parasite forms, each presenting a different repertoire of surface antigens. Importantly, members of the 6-Cys s48/45 family of proteins are found on the surface of P. falciparum in every stage, and several of these antigens have been investigated as vaccine targets. Pf12 is the archetypal member of the 6-Cys protein family, containing just two s48/45 domains, whereas other members have up to 14 of these domains. Pf12 is strongly recognized by immune sera from naturally infected patients. Here we show that Pf12 is highly conserved and under purifying selection. Immunofluorescence data reveals a punctate staining pattern with an apical organization in late schizonts. Together, these data are consistent with an important functional role for Pf12 in parasite-host cell attachment or invasion. To infer the structural and functional diversity between Pf12 and the other 11 6-Cys domain proteins, we solved the 1.90A resolution crystal structure of the Pf12 ectodomain. Structural analysis reveals a unique organization between the membrane proximal and membrane distal domains and clear homology with the SRS-domain containing proteins of Toxoplasma gondii. Cross-linking and mass spectrometry confirm the previously identified Pf12-Pf41 heterodimeric complex, and analysis of individual cross-links supports an unexpected antiparallel organization. Collectively, the localization and structure of Pf12 and details of its interaction with Pf41 reveal important insight into the structural and functional properties of this archetypal member of the 6-Cys protein family.	[Tonkin, Michelle L.; Loveless, Bianca C.; Boulanger, Martin J.] Univ Victoria, Victoria, BC V8W 3P6, Canada; [Arredondo, Silvia A.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Serpa, Jason J.; Makepeace, Karl A. T.; Petrotchenko, Evgeniy V.] Univ Victoria, Genome British Columbia Prote Ctr, Victoria, BC V8Z 7X8, Canada; [Sundar, Natarajan; Grigg, Michael E.] NIAID, Mol Parasitol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	University of Victoria; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Victoria; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Boulanger, MJ (corresponding author), Univ Victoria, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca		Makepeace, Karl/0000-0001-9584-2750	Canadian Institutes of Health Research [MOP82915]; NIAID, National Institutes of Health; Natural Sciences and Engineering Research Council of Canada [CGS-D3]; Genome Canada/Genome British Columbia Technology Development Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI001017] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome Canada/Genome British Columbia Technology Development Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Canadian Institutes of Health Research Grant MOP82915 (to M.J.B.). This work was also supported by the intramural funds of the NIAID, National Institutes of Health (to L.H.M.); Supported by a Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship (CGS-D3).; Supported by a Genome Canada/Genome British Columbia Technology Development Grant.	Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Beeson JG, 2007, J BIOL CHEM, V282, P22426, DOI 10.1074/jbc.M700231200; Boothroyd JC, 1998, INT J PARASITOL, V28, P3, DOI 10.1016/S0020-7519(97)00182-3; Boulanger MJ, 2010, CURR OPIN STRUC BIOL, V20, P551, DOI 10.1016/j.sbi.2010.08.003; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; CESBRONDELAUW MF, 1994, J BIOL CHEM, V269, P16217; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Crawford J, 2010, J BIOL CHEM, V285, P12063, DOI 10.1074/jbc.M109.054866; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; Davidson EA, 2001, BIOCHIMIE, V83, P601, DOI 10.1016/S0300-9084(01)01316-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escalante AA, 1998, GENETICS, V149, P189; Escalante AA, 2002, MOL BIOCHEM PARASIT, V119, P17, DOI 10.1016/S0166-6851(01)00386-3; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMAR N, 1992, MOL BIOCHEM PARASIT, V53, P113, DOI 10.1016/0166-6851(92)90013-A; KUMAR N, 1987, PARASITE IMMUNOL, V9, P321, DOI 10.1111/j.1365-3024.1987.tb00511.x; Lekutis C, 2000, EXP PARASITOL, V96, P89, DOI 10.1006/expr.2000.4556; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li J, 2012, PARASITOL INT, V61, P443, DOI 10.1016/j.parint.2012.02.008; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno-Perez DA, 2013, PROTIST, V164, P37, DOI 10.1016/j.protis.2012.03.001; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Petrotchenko EV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013524; Petrotchenko EV, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-64; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polley SD, 2001, GENETICS, V158, P1505; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; Reeder JC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-126; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Taechalertpaisarn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041937; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe K, 2007, MOL BIOCHEM PARASIT, V156, P74, DOI 10.1016/j.molbiopara.2007.07.002; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015121; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters A, 2006, CELL, V124, P689, DOI 10.1016/j.cell.2006.02.011; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; WILLIAMSON KC, 1993, MOL BIOCHEM PARASIT, V58, P355, DOI 10.1016/0166-6851(93)90058-6; Williamson KC, 2003, PARASITE IMMUNOL, V25, P351, DOI 10.1046/j.1365-3024.2003.00643.x; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3; WILLIAMSON KC, 1993, MOL BIOCHEM PARASIT, V62, P125, DOI 10.1016/0166-6851(93)90186-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2010, WORLD MALARIA REPORT	68	48	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12805	12817		10.1074/jbc.M113.455667	http://dx.doi.org/10.1074/jbc.M113.455667			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511632	Green Published, hybrid			2022-12-25	WOS:000318555100036
J	Das, S; Samant, RS; Shevde, LA				Das, Shamik; Samant, Rajeev S.; Shevde, Lalita A.			Nonclassical Activation of Hedgehog Signaling Enhances Multidrug Resistance and Makes Cancer Cells Refractory to Smoothened-targeting Hedgehog Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; MULTIFACETED ROLES; GENE-EXPRESSION; OSTEOPONTIN; PATHWAY; WNT; IDENTIFICATION; TRANSCRIPTION; CHEMOTHERAPY	The Hedgehog (Hh) pathway is critical in normal development. However, it has been reported to be up-regulated in numerous cancers and implicated in tumorigenicity and metastasis. Classical activation of Hh signaling initiated by Hh ligands results in activation of Smoothened (SMOH) and culminates in the activation of the GLI transcription factors. Classical Hh signaling is autocrine or paracrine (involving interaction between tumor cells and their stroma/microenvironment). The tumor milieu is rich in inflammatory cytokines that can modulate tumor cell behavior. Here, we show for the first time that the Hh pathway can be nonclassically up-regulated by the inflammatory cytokine, osteopontin (OPN). OPN-initiated Akt-GSK3 beta signaling mediates the subcellular distribution and activation of GLI1 resulting in the modulation of epithelial mesenchymal plasticity and drug resistance. Interestingly, the SMOH inhibitor cyclopamine was unable to uncouple the effects of OPN on Hh signaling, indicating that OPN nonclassically activates GLI-mediated transcription. Given the fact that OPN is itself transcriptionally activated upon Hh signaling, our current findings highlight the possibility of a feedforward vicious cycle such that the Hh pathway might be turned on nonclassically by stimuli from the tumor milieu. Thus, drugs that target the classical Hh ligand-mediated activation of Hh signaling may be compromised in their ability to interfere with the functioning of the pathway.	[Das, Shamik; Samant, Rajeev S.; Shevde, Lalita A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA; [Samant, Rajeev S.; Shevde, Lalita A.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shevde, LA (corresponding author), Univ Alabama Birmingham, Dept Pathol, WTI320D,1720 2nd Ave South, Birmingham, AL 35294 USA.	lsamant@uab.edu		Samant, Rajeev/0000-0001-5681-4976	National Institutes of Health from NCI [R01CA138850, R01CA140472]; Mayer Mitchell award; University of Alabama at Birmingham Center for Metabolic Bone Disease pilot grant; NATIONAL CANCER INSTITUTE [R01CA140472, R01CA138850] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayer Mitchell award; University of Alabama at Birmingham Center for Metabolic Bone Disease pilot grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA138850 (to L. A. S.) and R01CA140472 (to R. S. S.) from NCI. This work was also supported by a Mayer Mitchell award (to L. A. S.) and a University of Alabama at Birmingham Center for Metabolic Bone Disease pilot grant (to L. A. S.).	Benelli R, 2006, CURR PHARM DESIGN, V12, P3101, DOI 10.2174/138161206777947461; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chikazawa N, 2010, ANTICANCER RES, V30, P2041; Cook AC, 2005, MOL CARCINOGEN, V43, P225, DOI 10.1002/mc.20105; CRAIG AM, 1988, BIOCHEM BIOPH RES CO, V157, P166, DOI 10.1016/S0006-291X(88)80028-7; Das R, 2003, J BIOL CHEM, V278, P28593, DOI 10.1074/jbc.M303445200; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Gibalova L, 2012, TOXICOL IN VITRO, V26, P435, DOI 10.1016/j.tiv.2012.01.014; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Harris LG, 2012, ONCOGENE, V31, P3370, DOI 10.1038/onc.2011.496; Harris LG, 2011, MOL CANCER RES, V9, P1165, DOI 10.1158/1541-7786.MCR-11-0175; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lauth M, 2010, MOL PHARMACOL, V78, P486, DOI 10.1124/mol.110.066431; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ougolkov Andrei V, 2006, Future Oncol, V2, P91, DOI 10.2217/14796694.2.1.91; Philip S, 2004, GLYCOCONJUGATE J, V21, P429, DOI 10.1007/s10719-004-5533-7; Rangaswami H, 2006, GLYCOCONJUGATE J, V23, P221, DOI 10.1007/s10719-006-7927-1; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Robinson SC, 2005, ADV CANCER RES, V93, P159, DOI 10.1016/S0065-230X(05)93005-4; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744	40	80	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11824	11833		10.1074/jbc.M112.432302	http://dx.doi.org/10.1074/jbc.M112.432302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23508962	hybrid, Green Published			2022-12-25	WOS:000318157600018
J	Kang, H; Viollet, B; Wu, DQ				Kang, Heeseog; Viollet, Benoit; Wu, Dianqing			Genetic Deletion of Catalytic Subunits of AMP-activated Protein Kinase Increases Osteoclasts and Reduces Bone Mass in Young Adult Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEPTIN REGULATION; DIFFERENTIATION; INFLAMMATION; OVARIECTOMY; PROGENITOR; METFORMIN; FUSION	AMP-activated protein kinase (AMPK) is a key regulator of cellular and systemic energy homeostasis and a potential therapeutic target for the intervention of cancer and metabolic disorders. However, the role of AMPK in bone homeostasis remains incompletely understood. Here we assessed the skeletal phenotype of mice lacking catalytic subunits of AMPK and found that mice lacking AMPK alpha 1 (Prkaa1(-/-)) or AMPK alpha 2 (Prkaa2(-/-)) had reduced bone mass compared with the WT mice, although the reduction was less in Prkaa2(-/-) mice than in Prkaa1(-/-) mice. Static and dynamic bone histomorphometric analyses revealed that Prkaa1(-/-) mice had an elevated rate of bone remodeling because of increases in bone formation and resorption, whereas AMPK alpha 2 KO-induced bone mass reduction was largely attributable to elevated bone resorption. In agreement with our in vivo results, AMPK alpha deficiency was associated with increased osteoclastogenesis in vitro. Moreover, we found that AMPK alpha 1 inhibited the receptor activator of nuclear factor kappa B (RANK) signaling, providing an explanation for AMPK-mediated inhibition of osteoclastogenesis. Therefore, our findings further underscore the importance of AMPKin bone homeostasis, in particular osteoclastogenesis, in young adult mammals.	[Kang, Heeseog; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol & Vasc Biol, New Haven, CT 06520 USA; [Kang, Heeseog; Wu, Dianqing] Yale Univ, Sch Med, Therapeut Program, New Haven, CT 06520 USA; [Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Viollet, Benoit] Univ Paris 05, F-75014 Paris, France	Yale University; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kang, H (corresponding author), Yale Univ, Sch Med, Dept Orthopaed & Rehabil, 330 Cedar St, New Haven, CT 06520 USA.	heeseog.kang@yale.edu; dan.wu@yale.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	National Institutes of Health [AR046032]; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by a National Institutes of Health Grant AR046032 (to D. W.).	Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; BURGESS AW, 1985, J BIOL CHEM, V260, P6004; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; HA J, 1994, J BIOL CHEM, V269, P22162; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; INGEBRITSEN TS, 1978, BIOCHEM BIOPH RES CO, V81, P1268, DOI 10.1016/0006-291X(78)91273-1; Jeyabalan J, 2012, J ENDOCRINOL, V214, P349, DOI 10.1530/JOE-12-0184; Jeyabalan J, 2012, J ENDOCRINOL, V212, P277, DOI 10.1530/JOE-11-0306; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kasai T, 2009, J CELL PHYSIOL, V221, P740, DOI 10.1002/jcp.21917; Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Khaliulin I, 2007, J PHYSIOL-LONDON, V581, P1147, DOI 10.1113/jphysiol.2007.130369; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lee SH, 2012, CALCIFIED TISSUE INT, V90, P404, DOI 10.1007/s00223-012-9584-7; Lee YS, 2010, BONE, V47, P926, DOI 10.1016/j.bone.2010.08.001; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu F, 2007, BONE, V40, P1135, DOI 10.1016/j.bone.2006.12.003; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Merrell GA, 2005, BIOTECH HISTOCHEM, V80, P139, DOI 10.1080/10520290500303414; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Quinn JMW, 2010, FASEB J, V24, P275, DOI 10.1096/fj.09-137158; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; Molinuevo MS, 2010, J BONE MINER RES, V25, P211, DOI 10.1359/jbmr.090732; Suda T, 1997, METHOD ENZYMOL, V282, P223; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tanaka Yoshiya, 2005, Nihon Rinsho, V63, P1535; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	48	45	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12187	12196		10.1074/jbc.M112.430389	http://dx.doi.org/10.1074/jbc.M112.430389			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486478	Green Published, hybrid			2022-12-25	WOS:000318157600050
J	Kaiser, BK; Carleton, M; Hickman, JW; Miller, C; Lawson, D; Budde, M; Warrener, P; Paredes, A; Mullapudi, S; Navarro, P; Cross, F; Roberts, JM				Kaiser, Brett K.; Carleton, Michael; Hickman, Jason W.; Miller, Cameron; Lawson, David; Budde, Mark; Warrener, Paul; Paredes, Angel; Mullapudi, Srinivas; Navarro, Patricia; Cross, Fred; Roberts, James M.			Fatty Aldehydes in Cyanobacteria Are a Metabolically Flexible Precursor for a Diversity of Biofuel Products	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; ESCHERICHIA-COLI; DEHYDROGENASE GENES; LIPID-PEROXIDATION; ACID SYNTHESIS; WAX ESTER; PURIFICATION; EXPRESSION; COENZYME; BIOSYNTHESIS	We describe how pathway engineering can be used to convert a single intermediate derived from lipid biosynthesis, fatty aldehydes, into a variety of biofuel precursors including alkanes, free fatty acids and wax esters. In cyanobacteria, long-chain acyl-ACPs can be reduced to fatty aldehydes, and then decarbonylated to alkanes. We discovered a cyanobacteria class-3 aldehyde-dehydrogenase, AldE, that was necessary and sufficient to instead oxidize fatty aldehyde precursors into fatty acids. Overexpression of enzymes in this pathway resulted in production of 50 to 100 fold more fatty acids than alkanes, and the fatty acids were secreted from the cell. Co-expression of acyl-ACP reductase, an alcohol-dehydrogenase and a wax-ester-synthase resulted in a third fate for fatty aldehydes: conversion to wax esters, which accumulated as intracellular lipid bodies. Conversion of acyl-ACP to fatty acids using endogenous cyanobacterial enzymes may allow biofuel production without transgenesis.	[Kaiser, Brett K.; Carleton, Michael; Hickman, Jason W.; Miller, Cameron; Lawson, David; Budde, Mark; Warrener, Paul] Matrix Genet, Seattle, WA USA; [Roberts, James M.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Paredes, Angel; Mullapudi, Srinivas; Navarro, Patricia] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA; [Cross, Fred] Rockefeller Univ, New York, NY 10021 USA; [Roberts, James M.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; Rockefeller University; Fred Hutchinson Cancer Center	Roberts, JM (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	jroberts@fhcrc.org	Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207	Matrix Genetics	Matrix Genetics	This work was carried out by Matrix Genetics, a privately held biotechnology company who funded this study. The funders had no role in study design, data collection and analysis. Jim Roberts became a stockholder (funder) in Matrix at a later date.	Achterholt S, 1998, J BACTERIOL, V180, P4387, DOI 10.1128/JB.180.17.4387-4391.1998; Andersson CR, 2000, METHOD ENZYMOL, V305, P527; [Anonymous], 1998, [No title captured]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bozzola J. J., 1992, ELECT MICROSCOPY PRI; BUSTOS SA, 1991, J BACTERIOL, V173, P7525, DOI 10.1128/jb.173.23.7525-7533.1991; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; CHO HS, 1995, J BIOL CHEM, V270, P4216, DOI 10.1074/jbc.270.9.4216; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; DeLaurenzi V, 1996, NAT GENET, V12, P52; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDEN SS, 1987, METHOD ENZYMOL, V153, P215; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Holtman CK, 2005, DNA RES, V12, P103, DOI 10.1093/dnares/12.2.103; JIANG P, 1994, J BACTERIOL, V176, P2814, DOI 10.1128/JB.176.10.2814-2821.1994; Kaczmarzyk D, 2010, PLANT PHYSIOL, V152, P1598, DOI 10.1104/pp.109.148007; Kaiser BK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00156; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; Kirch HH, 2001, PLANT J, V28, P555, DOI 10.1046/j.1365-313X.2001.01176.x; KOK M, 1989, J BIOL CHEM, V264, P5442; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; LINDAHL R, 1991, BIOCHEM PHARMACOL, V41, P1583, DOI 10.1016/0006-2952(91)90157-Z; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; MITCHELL DY, 1987, TOXICOL APPL PHARM, V87, P403, DOI 10.1016/0041-008X(87)90245-6; NAKAYASU H, 1978, BIOCHEM BIOPH RES CO, V83, P697, DOI 10.1016/0006-291X(78)91045-8; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Robertson DE, 2011, PHOTOSYNTH RES, V107, P269, DOI 10.1007/s11120-011-9631-7; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Vidal R, 2009, J BACTERIOL, V191, P4383, DOI 10.1128/JB.00183-09; VOELKER TA, 1994, J BACTERIOL, V176, P7320, DOI 10.1128/JB.176.23.7320-7327.1994; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467	46	49	50	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58307	10.1371/journal.pone.0058307	http://dx.doi.org/10.1371/journal.pone.0058307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505484	gold, Green Published, Green Submitted			2022-12-25	WOS:000316251100044
J	Rey, O; Estoup, A; Facon, B; Loiseau, A; Aebi, A; Duron, O; Vavre, F; Foucaud, J				Rey, Olivier; Estoup, Arnaud; Facon, Benoit; Loiseau, Anne; Aebi, Alexandre; Duron, Olivier; Vavre, Fabrice; Foucaud, Julien			Distribution of Endosymbiotic Reproductive Manipulators Reflects Invasion Process and Not Reproductive System Polymorphism in the Little Fire Ant Wasmannia auropunctata	PLOS ONE			English	Article							WOLBACHIA; SYMBIONTS; POPULATIONS; HYMENOPTERA; FORMICIDAE; EVOLUTION; INFECTION; GENETICS; APHIDS; COST	Endosymbiotic reproductive manipulators may have drastic effects on the ecological and evolutionary dynamics of their hosts. The prevalence of these endosymbionts reflects both their ability to manipulate their hosts and the history of the host populations. The little fire ant Wasmannia auropunctata displays a polymorphism in both its reproductive system (sexual versus clonal populations) and the invasive status of its populations (associated to a habitat shift). We first screened for the presence of a diverse array of reproductive parasites in sexual and clonal populations of W. auropunctata, as a means to investigate the role of endosymbionts in reproductive phenotypes. Wolbachia was the only symbiont found and we then focused on its worldwide distribution and diversity in natural populations of W. auropunctata. Using a multilocus scheme, we further characterized the Wolbachia strains present in these populations. We found that almost all the native sexual populations and only a few clonal populations are infected by Wolbachia. The presence of similar Wolbachia strains in both sexual and clonal populations indicates that they are probably not the cause of the reproductive system polymorphism. The observed pattern seems rather associated to the invasion process of W. auropunctata. In particular, the observed loss of Wolbachia in clonal populations, that recurrently emerged from sexual populations, likely resulted from natural heat treatment and/or relaxed selection during the shift in habitat associated to the invasion process.	[Rey, Olivier; Estoup, Arnaud; Facon, Benoit; Loiseau, Anne; Foucaud, Julien] INRA, CBGP, UMR1062, F-34060 Montpellier, France; [Aebi, Alexandre] Univ Neuchatel, Lab Biol Sol, CH-2000 Neuchatel, Switzerland; [Duron, Olivier] Univ Montpellier 2, Inst Sci Evolut, CNRS, UMR5554, Montpellier, France; [Vavre, Fabrice] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, F-69622 Villeurbanne, France	INRAE; Institut de Recherche pour le Developpement (IRD); University of Neuchatel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Rey, O (corresponding author), INRA, CBGP, UMR1062, F-34060 Montpellier, France.	olivier.rey.1@gmail.com	vavre, fabrice/N-2945-2017; Rey, olivier/R-5453-2016	vavre, fabrice/0000-0003-0909-2936; Duron, Olivier/0000-0002-7426-782X; Foucaud, Julien/0000-0003-2272-3149; Rey, olivier/0000-0003-3699-7204	French Ministere de l'Ecologie et du Developpement Durable (ECOTROP programme); French Agropolis foundation (RTRA- Montpellier, BIOFIS project) [1001-001]	French Ministere de l'Ecologie et du Developpement Durable (ECOTROP programme); French Agropolis foundation (RTRA- Montpellier, BIOFIS project)	This work was supported by grants from the French Ministere de l'Ecologie et du Developpement Durable (ECOTROP programme) awarded to AE and from the French Agropolis foundation (RTRA- Montpellier, BIOFIS project 1001-001) to AE and BF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Delabie JHC, 2007, BIODIVERS CONSERV, V16, P2359, DOI 10.1007/s10531-007-9190-6; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Fleury F, 2000, PARASITOLOGY, V121, P493, DOI 10.1017/S0031182099006599; Foucaud J, 2010, HEREDITY; Foucaud J, 2007, MOL BIOL EVOL, V24, P2465, DOI 10.1093/molbev/msm180; Foucaud J, 2010, EVOL APPL, V3, P363, DOI 10.1111/j.1752-4571.2010.00119.x; Foucaud J, 2009, MOL ECOL, V18, P5059, DOI 10.1111/j.1365-294X.2009.04440.x; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Jaenike J, 2012, TRENDS ECOL EVOL, V27, P226, DOI 10.1016/j.tree.2011.10.005; Jaenike J, 2011, ECOL LETT, V14, P150, DOI 10.1111/j.1461-0248.2010.01564.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Orivel J, 2009, ECOL ENTOMOL, V34, P504, DOI 10.1111/j.1365-2311.2009.01096.x; Pearcy M, 2011, P ROY SOC B-BIOL SCI, V278, P2677, DOI 10.1098/rspb.2010.2562; Reuter M, 2005, HEREDITY, V94, P364, DOI 10.1038/sj.hdy.6800601; Rey O, 2012, ECOL LETT, V15, P1266, DOI 10.1111/j.1461-0248.2012.01849.x; Rey O, 2011, MOL BIOL EVOL, V28, P2591, DOI 10.1093/molbev/msr082; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2012, MYRMECOL NEWS, V16, P7; Sebastien A, 2012, INSECT SOC, V59, P33, DOI 10.1007/s00040-011-0184-8; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Sirvio A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-335; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmermans MJTN, 2009, EVOL ECOL, V23, P931, DOI 10.1007/s10682-008-9282-0; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Ward Philip S., 2005, Myrmecologische Nachrichten, V7, P87; Weeks AR, 2001, P ROY SOC B-BIOL SCI, V268, P2245, DOI 10.1098/rspb.2001.1797; Wenseleers T, 2002, P ROY SOC B-BIOL SCI, V269, P623, DOI 10.1098/rspb.2001.1927; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; White TA, 2012, FUNCT ECOL, V26, P1313, DOI 10.1111/1365-2435.12012; Yang CC, 2010, BIOL INVASIONS, V12, P3307, DOI 10.1007/s10530-010-9724-9	48	18	18	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58467	10.1371/journal.pone.0058467	http://dx.doi.org/10.1371/journal.pone.0058467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505512	Green Submitted, gold, Green Published			2022-12-25	WOS:000316251100053
J	Kulkarni, R; Randis, TM; Antala, S; Wang, A; Amaral, FE; Ratner, AJ				Kulkarni, Ritwij; Randis, Tara M.; Antala, Swati; Wang, Alice; Amaral, Fabio E.; Ratner, Adam J.			beta-Hemolysin/Cytolysin of Group B Streptococcus Enhances Host Inflammation but Is Dispensable for Establishment of Urinary Tract Infection	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; PATHOGENESIS; MECHANISMS; BACTERIA; DISEASE	Group B Streptococcus (GBS; Streptococcus agalactiae) is a major human pathogen that disproportionately affects neonates and women in the peripartum period and is an emerging cause of infection in older adults. The primary toxin of GBS, beta-hemolysin/cytolysin (beta H/C), has a well-defined role in the pathogenesis of invasive disease, but its role in urinary tract infection (UTI) is unknown. Using both in vitro and in vivo models, we analyzed the importance of beta H/C in GBS uropathogenesis. There were no significant differences in bacterial density from the bladders or kidneys from mice infected with wild-type or isogenic beta H/C-deficient GBS, and competitive indices from co-infection experiments were near 1. Thus, beta H/C is dispensable for the establishment of GBS-UTI. However, beta H/C-sufficient GBS induced a more robust proinflammatory cytokine response in cultured bladder epithelial cells and in the urinary tracts of infected mice. Given the near ubiquity of beta H/C-expressing strains in epidemiologic studies and the importance of local inflammation in dictating outcomes and sequelae of UTI, we hypothesize that beta H/C-driven inflammatory signaling may be important in the clinical course of GBS-UTI.	[Kulkarni, Ritwij; Randis, Tara M.; Antala, Swati; Wang, Alice; Amaral, Fabio E.; Ratner, Adam J.] Columbia Univ, Dept Pediat, New York, NY 10027 USA	Columbia University	Ratner, AJ (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	ar127@columbia.edu		Ratner, Adam/0000-0003-1761-794X; Randis, Tara/0000-0003-0348-6766; Amaral, Fabio/0000-0002-1547-8213	National Institutes of Health [R01 AI092743, R21 AI098654, K23 HD065844, UL1 TR000040]; Flight Attendant Medical Research Institute [YCSA_092417]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD065844] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI098654, R21AI098654, R01AI092743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (R01 AI092743, R21 AI098654 to A.J.R.; K23 HD065844, UL1 TR000040 (formerly UL1 UU024156) to T.M.R.). R.K. was supported by the Flight Attendant Medical Research Institute (YCSA_092417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P109; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Jahnukainen T, 2005, PEDIATR NEPHROL, V20, P1043, DOI 10.1007/s00467-005-1898-5; Kessous R, 2012, J MATERN-FETAL NEO M, V25, P1983, DOI 10.3109/14767058.2012.671872; Kline KA, 2011, INFECT IMMUN, V79, P3588, DOI 10.1128/IAI.00122-11; Kulkarni R, 2010, INFECT IMMUN, V78, P2146, DOI 10.1128/IAI.01410-09; LINDER H, 1990, INFECT IMMUN, V58, P2056, DOI 10.1128/IAI.58.7.2056-2060.1990; Melin P, 2011, CLIN MICROBIOL INFEC, V17, P1294, DOI 10.1111/j.1469-0691.2011.03576.x; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Tan CK, 2012, INFECT IMMUN; Ulett GC, 2010, J INFECT DIS, V201, P866, DOI 10.1086/650696; Van Dyke MK, 2009, NEW ENGL J MED, V360, P2626, DOI 10.1056/NEJMoa0806820; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183	18	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e59091	10.1371/journal.pone.0059091	http://dx.doi.org/10.1371/journal.pone.0059091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505569	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500134
J	Steinhauser, G; Schauer, V; Shozugawa, K				Steinhauser, Georg; Schauer, Viktoria; Shozugawa, Katsumi			Concentration of Strontium-90 at Selected Hot Spots in Japan	PLOS ONE			English	Article							FUKUSHIMA-DERIVED RADIONUCLIDES; DEPOSITION; PACIFIC; CS-134; SEAWATER; FISSION; I-131	This study is dedicated to the environmental monitoring of radionuclides released in the course of the Fukushima nuclear accident. The activity concentrations of beta(-) -emitting Sr-90 and beta(-)/gamma-emitting Cs-134 and Cs-137 from several hot spots in Japan were determined in soil and vegetation samples. The Sr-90 contamination levels of the samples were relatively low and did not exceed the Bq.g(-1) range. They were up four orders of magnitude lower than the respective Cs-137 levels. This study, therefore, experimentally confirms previous predictions indicating a low release of Sr-90 from the Fukushima reactors, due to its low volatility. The radiocesium contamination could be clearly attributed to the Fukushima nuclear accident via its activity ratio fingerprint (Cs-134/Cs-137). Although the correlation between Sr-90 and Cs-137 is relatively weak, the data set suggests an intrinsic coexistence of both radionuclides in the contaminations caused by the Fukushima nuclear accident. This observation is of great importance not only for remediation campaigns but also for the current food monitoring campaigns, which currently rely on the assumption that the activity concentrations of beta(-)-emitting Sr-90 (which is relatively laborious to determine) is not higher than 10% of the level of gamma-emitting Cs-137 (which can be measured quickly). This assumption could be confirmed for the samples investigated herein.	[Steinhauser, Georg] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Steinhauser, Georg; Schauer, Viktoria] Vienna Univ Technol, Atominst, A-1040 Vienna, Austria; [Shozugawa, Katsumi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	Colorado State University; Technische Universitat Wien; University of Tokyo	Steinhauser, G (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	georg.steinhauser@ati.ac.at	Steinhauser, Georg/O-7283-2014; Steinhauser, Georg/HHS-2636-2022	Steinhauser, Georg/0000-0002-6114-5890; 	Austrian Federal Ministry for Agriculture, Forestry, Environment and Water Management (BMLFUW); Dr. Michael-Haupl-Fonds	Austrian Federal Ministry for Agriculture, Forestry, Environment and Water Management (BMLFUW); Dr. Michael-Haupl-Fonds	Partial funding of this work by the Austrian Federal Ministry for Agriculture, Forestry, Environment and Water Management (BMLFUW) and the Dr. Michael-Haupl-Fonds is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Michio, 2004, ScientificWorldJournal, V4, P200; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Caffrey JA, 2012, J ENVIRON RADIOACTIV, V111, P120, DOI 10.1016/j.jenvrad.2011.12.015; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Higaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034766; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Inoue M, 2012, J ENVIRON RADIOACTIV, V111, P116, DOI 10.1016/j.jenvrad.2011.09.012; Inoue M, 2012, J ENVIRON RADIOACTIV, V109, P45, DOI 10.1016/j.jenvrad.2012.01.004; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Kim CK, 2012, J ENVIRON RADIOACTIV, V111, P70, DOI 10.1016/j.jenvrad.2011.10.018; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; KODAIRA K, 1964, J Radiat Res, V5, P116, DOI 10.1269/jrr.5.116; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Manley SL, 2012, ENVIRON SCI TECHNOL, V46, P3731, DOI 10.1021/es203598r; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; Merz S, 2013, ENVIRON SCI TECHNOL, V47, P1248, DOI 10.1021/es3037498; MEXT, 2011, RES NUCL AN PLUT STR; MEXT: Ministry of Education Culture Sports Science and Technology-Japan, 2011, MON INF ENV RAD LEV; Norman EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024330; Povinec PP, 2012, ENVIRON SCI TECHNOL, V46, P10356, DOI 10.1021/es301997c; Povinec PP, 2004, J ENVIRON RADIOACTIV, V76, P113, DOI 10.1016/j.jenvrad.2004.03.022; Schwantes JM, 2012, ENVIRON SCI TECHNOL, V46, P8621, DOI 10.1021/es300556m; Schwantes JM, 2009, ANAL CHEM, V81, P1297, DOI 10.1021/ac802286a; Shimura H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044200; Shozugawa K, 2012, ENVIRON POLLUT, V163, P243, DOI 10.1016/j.envpol.2012.01.001; Steinhauser G, 2008, APPL RADIAT ISOTOPES, V66, P1, DOI 10.1016/j.apradiso.2007.07.010; Steinhauser G, 2007, APPL RADIAT ISOTOPES, V65, P488, DOI 10.1016/j.apradiso.2006.12.004; Steinhauser G, 2013, ENVIRON SCI POLLUT R, V20, P2527, DOI 10.1007/s11356-012-1140-5; Steinhauser G, 2012, ENVIRON SCI TECHNOL, V46, P12890, DOI 10.1021/es303280g; TEPCO, 2011, HAND PRESS C; Vesterlund A, 2009, J RADIOANAL NUCL CH, V282, P951, DOI 10.1007/s10967-009-0184-6; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108	32	88	89	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57760	10.1371/journal.pone.0057760	http://dx.doi.org/10.1371/journal.pone.0057760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505440	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500032
J	Kulma, K; Saddler, A; Koella, JC				Kulma, Katarzyna; Saddler, Adam; Koella, Jacob C.			Effects of Age and Larval Nutrition on Phenotypic Expression of Insecticide-Resistance in Anopheles Mosquitoes	PLOS ONE			English	Article							MALARIA VECTOR; PERMETHRIN RESISTANCE; PYRETHROID RESISTANCE; DDT RESISTANCE; GAMBIAE; SUSCEPTIBILITY	Insecticide-resistance threatens the control of mosquito-borne diseases like malaria or dengue fever. To ensure sustainable vector control we need a full understanding of the factors driving the evolution of resistance. We test the hypothesis that the expression of insecticide-resistance depends on the available resources by rearing genetically DDT-resistant and sensitive larvae of Anopheles mosquitoes at three diet regimes, which correspond to 40%, 70% and 100% of the normal diet and exposing the adult females to DDT 5, 10 and 15 days after emergence. In both colonies post-exposure survival decreased with age at exposure. Additionally, the food levels and DDT-resistance were positively correlated in both colonies, although only in the DDT-resistant one was this relationship statistically significant. The impact of larval diet was smaller than the effect of age at exposure. We discuss our results and explain the implication of this study to resistance monitoring for public health and vector management.	[Kulma, Katarzyna] Uppsala Univ, Dept Anim Ecol, Uppsala, Sweden; [Saddler, Adam; Koella, Jacob C.] Imperial Coll London, Div Biol, Ascot, Berks, England	Uppsala University; Imperial College London	Saddler, A (corresponding author), Imperial Coll London, Div Biol, Ascot, Berks, England.	a.saddler09@imperial.ac.uk	Saddler, Adam/AGZ-4740-2022	Saddler, Adam/0000-0001-7750-3958; Kulma, Katarzyna/0000-0002-2952-9720	Leverhulme Trust [F/07058/BC]; Zoologiska Stiftelse (Uppsala University); Graduate School on Genomes and Phenotypes; Helge Ax:son Johnsons Stiftelse	Leverhulme Trust(Leverhulme Trust); Zoologiska Stiftelse (Uppsala University); Graduate School on Genomes and Phenotypes; Helge Ax:son Johnsons Stiftelse	This work was funded by grant F/07058/BC of the Leverhulme Trust to JCK, Zoologiska Stiftelse (Uppsala University), Graduate School on Genomes and Phenotypes (UU) and Helge Ax:son Johnsons Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-225; [Anonymous], 1998, WHOCDCMAL98; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Chouaibou MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-214; Christian RN, 2011, GENET MOL RES, V10, P3220, DOI 10.4238/2011.December.21.4; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Farenhorst M, 2009, P NATL ACAD SCI; Hardstone MC, 2010, J MED ENTOMOL, V47, P188, DOI 10.1603/ME09131; Hardstone MC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-42; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hodjati MH, 1999, MED VET ENTOMOL, V13, P415, DOI 10.1046/j.1365-2915.1999.00198.x; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Kikuchi Y, 2012, P NATL ACAD SCI; Lorenz LM, 2011, EVOL APPL, V4, P783, DOI 10.1111/j.1752-4571.2011.00199.x; McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054; Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Rivero A, 2011, J MED ENTOMOL, V48, P694, DOI 10.1603/ME10121; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x	19	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58322	10.1371/journal.pone.0058322	http://dx.doi.org/10.1371/journal.pone.0058322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484017	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100107
J	Roberts, G				Roberts, Gilbert			When Punishment Pays	PLOS ONE			English	Article							STRONG RECIPROCITY; ALTRUISTIC PUNISHMENT; COSTLY PUNISHMENT; NEURAL BASIS; EVOLUTION; COOPERATION; BEHAVIOR; SELECTION; BENEFITS	Explaining cooperation in groups remains a key problem because reciprocity breaks down between more than two. Punishing individuals who contribute little provides a potential answer but changes the dilemma to why pay the costs of punishing which, like cooperation itself, provides a public good. Nevertheless, people are observed to punish others in behavioural economic games, posing a problem for existing theory which highlights the difficulty in explaining the spread and persistence of punishment. Here, I consider the apparent mismatch between theory and evidence and show by means of instructive analysis and simulation how much of the experimental evidence for punishment comes from scenarios in which punishers may expect to obtain a net benefit from punishing free-riders. In repeated games within groups, punishment works by imposing costs on defectors so that it pays them to switch to cooperating. Both punishers and non-punishers then benefit from the resulting increase in cooperation, hence investing in punishment can constitute a social dilemma. However, I show the conditions in which the benefits of increased cooperation are so great that they more than offset the costs of punishing, thereby removing the temptation to free-ride on others' investments and making punishment explicable in terms of direct self-interest. Crucially, this is because of the leveraging effect imposed in typical studies whereby people can pay a small cost to inflict a heavy loss on a punished individual. In contrast to previous models suggesting punishment is disadvantaged when rare, I show it can invade until it comes into a producer-scrounger equilibrium with non-punishers. I conclude that adding punishment to an iterated public goods game can solve the problem of achieving cooperation by removing the social dilemma.	Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Roberts, G (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.	Gilbert.Roberts@ncl.ac.uk	Roberts, Gilbert/K-5449-2019					Atkinson QD, 2011, EVOL HUM BEHAV, V32, P41, DOI 10.1016/j.evolhumbehav.2010.07.008; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barclay P, 2006, EVOL HUM BEHAV, V27, P325, DOI 10.1016/j.evolhumbehav.2006.01.003; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; Boehm C, 1999, HUM NATURE-INT BIOS, V10, P205, DOI 10.1007/s12110-999-1003-z; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Boyd R, 2007, SCIENCE, V316, P1858, DOI 10.1126/science.1144339; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Bshary A, 2010, CURR BIOL, V20, P2032, DOI 10.1016/j.cub.2010.10.027; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Burnham TC., 2005, ANAL KRITIK, V27, P113, DOI [10.1515/auk-2005-0107, DOI 10.1515/AUK-2005-0107]; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colman AM, 2006, NATURE, V440, P744, DOI 10.1038/440744b; DAWES RM, 1988, J ECON PERSPECT, V2, P187, DOI 10.1257/jep.2.3.187; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Frank SA, 2003, EVOLUTION, V57, P693; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; Johnson DDP, 2003, NATURE, V421, P911, DOI 10.1038/421912a; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lehmann L, 2007, AM NAT, V170, P21, DOI 10.1086/518568; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Mathew S, 2009, P R SOC B, V276, P1167, DOI 10.1098/rspb.2008.1623; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MULDER RA, 1993, ANIM BEHAV, V45, P830, DOI 10.1006/anbe.1993.1100; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Raihani NJ, 2010, SCIENCE, V327, P171, DOI 10.1126/science.1183068; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Rankin DJ, 2009, P NATL ACAD SCI USA, V106, pE135, DOI 10.1073/pnas.0911990107; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Roberts G, 2005, ANIM BEHAV, V70, P901, DOI 10.1016/j.anbehav.2005.02.006; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Sherratt T. N., 2009, FRONT BIOSCI E, VE1, P340; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; WILSON DS, 1990, OIKOS, V59, P135, DOI 10.2307/3545133; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106; Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103	62	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57378	10.1371/journal.pone.0057378	http://dx.doi.org/10.1371/journal.pone.0057378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483907	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100024
J	Spaapen, F; van den Akker, GGH; Caron, MMJ; Prickaerts, P; Rofel, C; Dahlmans, VEH; Surtel, DAM; Paulis, Y; Schweizer, F; Welting, TJM; Eijssen, LM; Voncken, JW				Spaapen, Frank; van den Akker, Guus G. H.; Caron, Marjolein M. J.; Prickaerts, Peggy; Rofel, Celine; Dahlmans, Vivian E. H.; Surtel, Don A. M.; Paulis, Yvette; Schweizer, Finja; Welting, Tim J. M.; Eijssen, Lars M.; Voncken, Jan Willem			The Immediate Early Gene Product EGR1 and Polycomb Group Proteins Interact in Epigenetic Programming during Chondrogenesis	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTION FACTOR; HISTONE H3; PROMOTER ACTIVITY; GROWTH-FACTOR; TARGET GENES; HOX GENES; FACTOR-I; NGFI-A; EXPRESSION	Initiation of and progression through chondrogenesis is driven by changes in the cellular microenvironment. At the onset of chondrogenesis, resting mesenchymal stem cells are mobilized in vivo and a complex, step-wise chondrogenic differentiation program is initiated. Differentiation requires coordinated transcriptomic reprogramming and increased progenitor proliferation; both processes require chromatin remodeling. The nature of early molecular responses that relay differentiation signals to chromatin is poorly understood. We here show that immediate early genes are rapidly and transiently induced in response to differentiation stimuli in vitro. Functional ablation of the immediate early factor EGR1 severely deregulates expression of key chondrogenic control genes at the onset of differentiation. In addition, differentiating cells accumulate DNA damage, activate a DNA damage response and undergo a cell cycle arrest and prevent differentiation associated hyper-proliferation. Failed differentiation in the absence of EGR1 affects global acetylation and terminates in overall histone hypermethylation. We report novel molecular connections between EGR1 and Polycomb Group function: Polycomb associated histone H3 lysine27 trimethylation (H3K27me3) blocks chromatin access of EGR1. In addition, EGR1 ablation results in abnormal Ezh2 and Bmi1 expression. Consistent with this functional interaction, we identify a number of co-regulated targets genes in a chondrogenic gene network. We here describe an important role for EGR1 in early chondrogenic epigenetic programming to accommodate early gene-environment interactions in chondrogenesis.	[Spaapen, Frank; van den Akker, Guus G. H.; Prickaerts, Peggy; Rofel, Celine; Dahlmans, Vivian E. H.; Paulis, Yvette; Voncken, Jan Willem] Maastricht Univ Med Ctr, Dept Mol Genet, Maastricht, Netherlands; [Caron, Marjolein M. J.; Surtel, Don A. M.; Schweizer, Finja; Welting, Tim J. M.] Maastricht Univ Med Ctr, Dept Orthopaed Surg, Maastricht, Netherlands; [Eijssen, Lars M.] Maastricht Univ Med Ctr, Dept Bioinformat BiGCaT, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Voncken, JW (corresponding author), Maastricht Univ Med Ctr, Dept Mol Genet, Maastricht, Netherlands.	w.voncken@maastrichtuniversity.nl	van den Akker, Guus/A-1642-2016; van den Akker, Guus/AAD-9536-2019	van den Akker, Guus/0000-0002-7071-1487; 	European Molecular Biology Organization (Germany) [ASTF5-2009]; Rene Vogels foundation (FS); Dutch Scientific Organization (ZonMW-NWO) [016.046.362]; tUL Grant; Netherlands Reuma foundation [LLP14]; University of Limburg	European Molecular Biology Organization (Germany)(European Molecular Biology Organization (EMBO)); Rene Vogels foundation (FS); Dutch Scientific Organization (ZonMW-NWO); tUL Grant; Netherlands Reuma foundation; University of Limburg	This work was supported by European Molecular Biology Organization (Germany) ASTF5-2009 (FS) and the Rene Vogels foundation (FS); Dutch Scientific Organization (ZonMW-NWO): VIDI grant 016.046.362 (JWV); tUL Grant (JWV). LLP14 Grant Netherlands Reuma foundation (JWV, LWvR) and a transnational University of Limburg grant (JWV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSHAKRA SR, 1993, MOL BRAIN RES, V18, P216, DOI 10.1016/0169-328X(93)90192-R; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2011, J BONE MINER METAB, V29, P390, DOI 10.1007/s00774-011-0273-9; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Belluoccio D, 2008, BBA-GENE REGUL MECH, V1779, P330, DOI 10.1016/j.bbagrm.2008.02.010; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bougault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036964; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burdan F, 2009, FOLIA HISTOCHEM CYTO, V47, P5, DOI 10.2478/v10042-009-0007-1; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CARTER DA, 1992, MOL BRAIN RES, V16, P111, DOI 10.1016/0169-328X(92)90200-U; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chen L, 2006, EXP CELL RES, V312, P1727, DOI 10.1016/j.yexcr.2006.02.013; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Deschamps J, 2004, SCIENCE, V304, P1610, DOI 10.1126/science.1099162; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Erno H, 1996, MECH DEVELOP, V60, P139, DOI 10.1016/S0925-4773(96)00605-3; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giri S, 2012, BRIEF FUNCT GENOMICS, V11, P188, DOI 10.1093/bfgp/elr047; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grigolo B, 2005, J BONE JOINT SURG AM, V87A, P46, DOI 10.2106/JBJS.C.01685; Hemenway CS, 1998, ONCOGENE, V16, P2541, DOI 10.1038/sj.onc.1202042; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Hutchison MR, 2007, ENDOCRINOLOGY, V148, P3122, DOI 10.1210/en.2006-1264; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kawamata A, 2008, J CELL BIOCHEM, V103, P1037, DOI 10.1002/jcb.21660; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Langmann T, 2009, NEUROMOL MED, V11, P87, DOI 10.1007/s12017-009-8061-6; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nebbaki SS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3788; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Prickaerts P, 2012, MK3 CONTROL IN PRESS; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Reumann MK, 2011, BONE, V49, P743, DOI 10.1016/j.bone.2011.06.023; Reumann MK, 2011, CALCIFIED TISSUE INT, V89, P1, DOI 10.1007/s00223-011-9486-0; Rockel JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2595; Rodier F, 2009, NAT CELL BIOL; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Silverman ES, 1998, BIOCHEM J, V336, P183, DOI 10.1042/bj3360183; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Svaren J, 1996, MOL CELL BIOL, V16, P3545; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Thiel G, 2000, BBA-GENE STRUCT EXPR, V1493, P289, DOI 10.1016/S0167-4781(00)00207-4; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; van Lohuizen M, 1998, CELL MOL LIFE SCI, V54, P71, DOI 10.1007/s000180050126; Vincenti MP, 2001, ARTHRITIS RES, V3, P381, DOI 10.1186/ar331; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wahl M, 2004, GENOMICS, V83, P45, DOI 10.1016/S0888-7543(03)00201-5; Walters JN, 2012, BIOCHEM J, V443, P561, DOI 10.1042/BJ20111801; Wang FL, 2000, OSTEOARTHR CARTILAGE, V8, P161, DOI 10.1053/joca.1999.0295; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Welting T J M, 2011, Eur Cell Mater, V22, P420; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	112	32	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58083	10.1371/journal.pone.0058083	http://dx.doi.org/10.1371/journal.pone.0058083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483971	gold, Green Submitted, Green Published			2022-12-25	WOS:000316936100072
J	Cannuyer, J; Loriot, A; Parvizi, GK; De Smet, C				Cannuyer, Julie; Loriot, Axelle; Parvizi, Gregory K.; De Smet, Charles			Epigenetic Hierarchy within the MAGEA1 Cancer-Germline Gene: Promoter DNA Methylation Dictates Local Histone Modifications	PLOS ONE			English	Article							MELANOMA CELL-LINES; SILENCED GENES; STEM-CELLS; HYPOMETHYLATION; EXPRESSION; MAGE-A1; CPG; IMMUNOTHERAPY; DEMETHYLATION; TRANSCRIPTION	Gene MAGEA1 belongs to a group of human germline-specific genes that rely on DNA methylation for repression in somatic tissues. Many of these genes, termed cancer-germline (CG) genes, become demethylated and activated in a wide variety of tumors, where they encode tumor-specific antigens. The process leading to DNA demethylation of CG genes in tumors remains unclear. Previous data suggested that histone acetylation might be involved. Here, we investigated the relative contribution of DNA methylation and histone acetylation in the epigenetic regulation of gene MAGEA1. We show that MAGEA1 DNA hypomethylation in expressing melanoma cells is indeed correlated with local increases in histone H3 acetylation (H3ac). However, when MAGEA1-negative cells were exposed to a histone deacetylase inhibitor (TSA), we observed only short-term activation of the gene and detected no demethylation of its promoter. As a more sensitive assay, we used a cell clone harboring a methylated MAGEA1/hph construct, which confers resistance to hygromycin upon stable re-activation. TSA induced only transient de-repression of the transgene, and did not lead to the emergence of hygromycin-resistant cells. In striking contrast, transient depletion of DNA-methyltransferase-1 in the reporter cell clone gave rise to a hygromycin-resistant population, in which the re-activated MAGEA1/hph transgene displayed not only marked DNA hypomethylation, but also significant reversal of histone marks, including gains in H3ac and H3K4me2, and losses of H3K9me2. Collectively, our results indicate that DNA methylation has a dominant role in the epigenetic hierarchy governing MAGEA1 expression.	[Cannuyer, Julie; Loriot, Axelle; Parvizi, Gregory K.; De Smet, Charles] Catholic Univ Louvain, de Duve Inst, Grp Genet & Epigenet, B-1200 Brussels, Belgium	Universite Catholique Louvain	De Smet, C (corresponding author), Catholic Univ Louvain, de Duve Inst, Grp Genet & Epigenet, B-1200 Brussels, Belgium.	charles.desmet@uclouvain.be			FSR-FNRS-Televie grant; FSR-FNRS-FRIA; FSR-FNRS [3.4563.11]	FSR-FNRS-Televie grant(Fonds de la Recherche Scientifique - FNRS); FSR-FNRS-FRIA(Fonds de la Recherche Scientifique - FNRS); FSR-FNRS(Fonds de la Recherche Scientifique - FNRS)	JC is the recipient of a FSR-FNRS-Televie grant (http://www2.frs-fnrs.be/). GKP received a fellowship from FSR-FNRS-FRIA (http://www2.frs-fnrs.be/). This work was supported by a FRSM grant from the FSR-FNRS (ref. 3.4563.11, http://www2.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Anichini A, 1999, HUMAN CELL CULTURE, V1, P283; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Brasseur F, 1999, HUMAN CELL CULTURE, V1, P275; Campbell MJ, 2013, ADV EXP MED BIOL, V754, P81, DOI 10.1007/978-1-4419-9967-2_4; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; D'Alessio AC, 2007, MOL CELL BIOL, V27, P7462, DOI 10.1128/MCB.01120-07; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; De Smet C, 2013, ADV EXP MED BIOL, V754, P149, DOI 10.1007/978-1-4419-9967-2_7; De Smet Charles, 2010, Epigenetics, V5, P206; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Link PA, 2009, MOL CANCER RES, V7, P851, DOI 10.1158/1541-7786.MCR-08-0497; Loriot A, 2006, J BIOL CHEM, V281, P10118, DOI 10.1074/jbc.M510469200; Loriot A, 2003, INT J CANCER, V105, P371, DOI 10.1002/ijc.11104; Loriot A, 2012, BIOCHEM BIOPH RES CO, V417, P187, DOI 10.1016/j.bbrc.2011.11.120; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Rao M, 2011, CANCER RES, V71, P4192, DOI 10.1158/0008-5472.CAN-10-2442; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Steele N, 2009, BRIT J CANCER, V100, P758, DOI 10.1038/sj.bjc.6604932; Tilman G, 2009, ONCOGENE, V28, P1682, DOI 10.1038/onc.2009.23; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Wischnewski F, 2007, MOL CANCER RES, V5, P749, DOI 10.1158/1541-7786.MCR-06-0364; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07	39	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58743	10.1371/journal.pone.0058743	http://dx.doi.org/10.1371/journal.pone.0058743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472218	gold, Green Submitted, Green Published			2022-12-25	WOS:000315637900165
J	Cirilo, PDR; Marchi, FA; Barros, MD; Rocha, RM; Domingues, MAC; Jurisica, I; Pontes, A; Rogatto, SR				Ramos Cirilo, Priscila Daniele; Marchi, Fabio Albuquerque; Barros Filho, Mateus de Camargo; Rocha, Rafael Malagoli; Custodio Domingues, Maria Aparecida; Jurisica, Igor; Pontes, Anagloria; Rogatto, Silvia Regina			An Integrative Genomic and Transcriptomic Analysis Reveals Potential Targets Associated with Cell Proliferation in Uterine Leiomyomas	PLOS ONE			English	Article							BINDING-PROTEIN IGFBP; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; GROWTH-FACTORS; COPY NUMBER; RECEPTOR; PATHOGENESIS; INHIBITOR; DELETION; TUMORS	Background: Uterine Leiomyomas (ULs) are the most common benign tumours affecting women of reproductive age. ULs represent a major problem in public health, as they are the main indication for hysterectomy. Approximately 40-50% of ULs have non-random cytogenetic abnormalities, and half of ULs may have copy number alterations (CNAs). Gene expression microarrays studies have demonstrated that cell proliferation genes act in response to growth factors and steroids. However, only a few genes mapping to CNAs regions were found to be associated with ULs. Methodology: We applied an integrative analysis using genomic and transcriptomic data to identify the pathways and molecular markers associated with ULs. Fifty-one fresh frozen specimens were evaluated by array CGH (JISTIC) and gene expression microarrays (SAM). The CONEXIC algorithm was applied to integrate the data. Principal Findings: The integrated analysis identified the top 30 significant genes (P, 0.01), which comprised genes associated with cancer, whereas the protein-protein interaction analysis indicated a strong association between FANCA and BRCA1. Functional in silico analysis revealed target molecules for drugs involved in cell proliferation, including FGFR1 and IGFBP5. Transcriptional and protein analyses showed that FGFR1 (P = 0.006 and P, 0.01, respectively) and IGFBP5 (P = 0.0002 and P = 0.006, respectively) were up-regulated in the tumours when compared with the adjacent normal myometrium. Conclusions: The integrative genomic and transcriptomic approach indicated that FGFR1 and IGFBP5 amplification, as well as the consequent up-regulation of the protein products, plays an important role in the aetiology of ULs and thus provides data for potential drug therapies development to target genes associated with cellular proliferation in ULs.	[Ramos Cirilo, Priscila Daniele] UNESP Sao Paulo State Univ, Dept Genet, Inst Biosci, Sao Paulo, Brazil; [Ramos Cirilo, Priscila Daniele; Marchi, Fabio Albuquerque; Barros Filho, Mateus de Camargo; Rogatto, Silvia Regina] Fundacao Antonio Prudente, CIPE NeoGene Lab, AC Camargo Hosp, Sao Paulo, Brazil; [Marchi, Fabio Albuquerque] Univ Sao Paulo, Interinst Grad Program Bioinformat, Inst Math & Stat, Sao Paulo, Brazil; [Rocha, Rafael Malagoli] Fundacao Antonio Prudente, Dept Anat Pathol, AC Camargo Hosp, Sao Paulo, Brazil; [Custodio Domingues, Maria Aparecida] UNESP Sao Paulo State Univ, Dept Pathol, Sch Med, Sao Paulo, Brazil; [Jurisica, Igor] Campbell Family Inst Canc Res, Ontario Canc Inst, Toronto, ON, Canada; [Jurisica, Igor] Univ Hlth Network, Techna Inst, Toronto, ON, Canada; [Pontes, Anagloria] Sao Paulo State Univ, Dept Obstet & Gynaecol, Sch Med, Sao Paulo, Brazil; [Rogatto, Silvia Regina] UNESP Sao Paulo State Univ, Dept Urol, Sch Med, Sao Paulo, Brazil	Universidade Estadual Paulista; A.C.Camargo Cancer Center; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Universidade Estadual Paulista; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universidade Estadual Paulista; Universidade Estadual Paulista	Rogatto, SR (corresponding author), Fundacao Antonio Prudente, CIPE NeoGene Lab, AC Camargo Hosp, Sao Paulo, Brazil.	rogatto@fmb.unesp.br	Marchi, Fabio A/N-9288-2018; Rogatto, Silvia R/E-6535-2012; Filho, Mateus C Barros/J-1544-2015; Cirillo, Priscila Daniele Ramos/AAH-4246-2020	Marchi, Fabio A/0000-0001-5815-8423; Filho, Mateus C Barros/0000-0003-3893-5269; Cirillo, Priscila Daniele Ramos/0000-0001-5453-3978; Rogatto, Silvia/0000-0003-4637-5687; Custodio Domingues, Maria Aparecida/0000-0002-4023-3410	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2007/51643-8, 2008/58835-2]; Conselho Nacional de Pesquisa [485032/2007-4]; Ontario Research Fund [GL2-01-030]; Canada Foundation for Innovation (CFI) [12301, 203373]; CIHR Research Grant [93579]; Ontario Ministry of Health and Long Term Care; Canada Research Chair Program	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa; Ontario Research Fund; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); CIHR Research Grant(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canada Research Chair Program(Canada Research Chairs)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2007/51643-8 to PDRC, 2008/58835-2 to SRR), and Conselho Nacional de Pesquisa (485032/2007-4 to SRR). Computational analysis was supported in part by Ontario Research Fund (GL2-01-030 to IJ), Canada Foundation for Innovation (CFI #12301, CFI #203373 to IJ), CIHR Research Grant (#93579 to IJ), the Ontario Ministry of Health and Long Term Care. IJ is funded by Canada Research Chair Program. The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesanya OO, 1996, J CLIN ENDOCR METAB, V81, P2495, DOI 10.1210/jc.81.7.2495; Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Anania CA, 1997, MOL HUM REPROD, V3, P685, DOI 10.1093/molehr/3.8.685; Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Baird DD, 2003, EPIDEMIOLOGY, V14, P247; Becker MA, 2012, CLIN CANCER RES, V18, P1808, DOI 10.1158/1078-0432.CCR-11-1806; Behera Millie A, 2007, Reprod Sci, V14, P63, DOI 10.1177/1933719107309591; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonatz G, 1998, AM J OBSTET GYNECOL, V179, P591, DOI 10.1016/S0002-9378(98)70050-X; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Canevari RA, 2007, ASIAN J CANC, V6, P15; Canevari RD, 2005, MOL CARCINOGEN, V42, P177, DOI 10.1002/mc.20074; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Cook H, 2010, Minerva Ginecol, V62, P225; Courjal F, 1997, CANCER RES, V57, P4360; Crabtree JS, 2009, CANCER RES, V69, P6171, DOI 10.1158/0008-5472.CAN-08-4471; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Desai SS, 2011, J HAND SURG-AM, V36A, P936, DOI 10.1016/j.jhsa.2011.03.002; Dimitrova IK, 2009, FERTIL STERIL, V91, P2650, DOI 10.1016/j.fertnstert.2008.03.071; Dixon D, 2000, ENVIRON HEALTH PERSP, V108, P795, DOI 10.2307/3454309; El-Gharib MN, 2010, J OBSTET GYNAECOL RE, V36, P101, DOI 10.1111/j.1447-0756.2009.01099.x; Elsheikh SE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1665; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Georgieva B, 2012, GENOMICS, V99, P275, DOI 10.1016/j.ygeno.2012.03.003; GIUDICE LC, 1993, HUM REPROD, V8, P1796, DOI 10.1093/oxfordjournals.humrep.a137937; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Gullu G, 2012, CHIN J CANCER, V31, P266, DOI 10.5732/cjc.011.10405; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Hodge JC, 2012, HUM MOL GENET, V21, P2312, DOI 10.1093/hmg/dds051; Hodge JC, 2009, GENE CHROMOSOME CANC, V48, P865, DOI 10.1002/gcc.20692; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Keisner SV, 2011, DRUGS, V71, P443, DOI 10.2165/11588960-000000000-00000; Levy B, 2000, CANCER GENET CYTOGEN, V121, P1, DOI 10.1016/S0165-4608(00)00225-9; Lin N, 2011, AM J PHYSIOL-CELL PH, V301, pC469, DOI 10.1152/ajpcell.00452.2010; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik M, 2010, SEMIN REPROD MED, V28, P168, DOI 10.1055/s-0030-1251475; Mantovani MS, 1999, GYNECOL ONCOL, V72, P71, DOI 10.1006/gyno.1998.5222; MCGUIRE WL, 1992, J NATL CANCER I, V84, P1336, DOI 10.1093/jnci/84.17.1336; Nikitenko LL, 2006, CLIN CANCER RES, V12, P5648, DOI 10.1158/1078-0432.CCR-06-0852; Packenham JP, 1997, MOL CARCINOGEN, V19, P273, DOI 10.1002/(SICI)1098-2744(199708)19:4<273::AID-MC9>3.0.CO;2-D; Pascale A, 2012, CELL MOL LIFE SCI, V69, P501, DOI 10.1007/s00018-011-0810-7; Quade BJ, 2004, GENE CHROMOSOME CANC, V40, P97, DOI 10.1002/gcc.20018; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rosa FE, 2008, HUM PATHOL, V39, P720, DOI 10.1016/j.humpath.2007.09.019; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shah, 1996, Medscape Womens Health, V1, P8; Solyom S, 2011, CANCER LETT, V302, P113, DOI 10.1016/j.canlet.2010.12.020; Sozen I, 2002, FERTIL STERIL, V78, P1, DOI 10.1016/S0015-0282(02)03154-0; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorvaldsdottir H., 2012, BRIEF BIOIN IN PRESS; Tsibris JCM, 2002, FERTIL STERIL, V78, P114, DOI 10.1016/S0015-0282(02)03191-6; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vanharanta S, 2005, ONCOGENE, V24, P6545, DOI 10.1038/sj.onc.1208784; Vanharanta S, 2007, GENE CHROMOSOME CANC, V46, P451, DOI 10.1002/gcc.20427; Yu LD, 2008, MOL MED, V14, P264, DOI 10.2119/2007-00101.Yu; Zavadil J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012362	69	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57901	10.1371/journal.pone.0057901	http://dx.doi.org/10.1371/journal.pone.0057901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483937	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900051
J	Lee, JY; Park, MK; Park, JH; Lee, HJ; Shin, DH; Kang, Y; Lee, CH; Kong, G				Lee, J-Y; Park, M. K.; Park, J-H; Lee, H. J.; Shin, D. H.; Kang, Y.; Lee, C. H.; Kong, G.			Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer	ONCOGENE			English	Article						Mel-18; miR-205; ZEB1; ZEB2; epithelial-mesenchymal transition; polycomb	GROWTH-FACTOR-BETA; TUMOR INVASION; MICRORNAS; BMI-1; CELLS; OVEREXPRESSION; REPRESSION; FAMILY	The epithelial-mesenchymal transition (EMT) is the pivotal mechanism underlying the initiation of cancer invasion and metastasis. Although Mel-18 has been implicated in several biological processes in cancer, its function in the EMT of human cancers has not yet been studied. Here, we demonstrate that Mel-18 negatively regulates the EMT by epigenetically modulating miR-205. We identified miR-205 as a novel target of Mel-18 using a microRNA microarray analysis and found that Mel-18 increased miR-205 transcription by the inhibition of DNA methyltransferase-mediated DNA methylation of the miR-205 promoter, thereby downregulating its target genes, ZEB1 and ZEB2. Furthermore, the loss of Mel-18 promoted ZEB1- and ZEB2-mediated downregulation of E-cadherin transcription and also enhanced the expression of mesenchymal markers, leading to increased migration and invasion in MCF-7 cells. In MDA-MB-231 cells, Mel-18 overexpression restored E-cadherin expression, resulting in reduced migration and invasion. These effects were reversed by miR-205 overexpression or inhibition. A tumor xenograft with Mel-18 knockdown MCF-7 cells consistently showed increased ZEB1 and ZEB2 expression and decreased E-cadherin expression. Taken together, these results suggest that Mel-18 functions as a tumor suppressor by its novel negative control of the EMT, achieved through regulating the expression of miR-205 and its target genes, ZEB1 and ZEB2.	[Lee, J-Y; Kong, G.] Hanyang Univ, IBBR, Seoul 133791, South Korea; [Park, M. K.; Lee, H. J.; Lee, C. H.] Dongguk Univ Seoul, Coll Pharm, Seoul 410820, South Korea; [Park, J-H; Shin, D. H.; Kong, G.] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea; [Kang, Y.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Hanyang University; Dongguk University; Hanyang University; Princeton University	Lee, CH (corresponding author), Dongguk Univ Seoul, Coll Pharm, Seoul 410820, South Korea.	uatheone@gmail.com; gkong@hanyang.ac.kr		Kang, Yibin/0000-0002-1626-6730	Korea Healthcare Technology RD Project [A101836]; Ministry of Health Welfare and Family Affairs; Research Program for New Drug Target Discovery [2011-0030173]	Korea Healthcare Technology RD Project; Ministry of Health Welfare and Family Affairs(Ministry of Health & Welfare (MOHW), Republic of Korea); Research Program for New Drug Target Discovery(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants from the Korea Healthcare Technology R&D Project (A101836), the Ministry of Health Welfare and Family Affairs and the Research Program for New Drug Target Discovery (2011-0030173).	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; AuS Leung-Kuen, 2012, HEPATOLOGY, V56, P622; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Blumenberg M, 2007, CELLS TISSUES ORGANS, V185, P162, DOI 10.1159/000101317; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2010, BBA-GENE REGUL MECH, V1799, P694, DOI 10.1016/j.bbagrm.2010.05.005; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee JY, 2008, CANCER RES, V68, P4201, DOI 10.1158/0008-5472.CAN-07-2570; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; Qian T, 2010, ONCOGENE, V29, P5818, DOI 10.1038/onc.2010.317; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rush Margaret, 2009, Epigenetics, V4, P404; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shin DH, 2011, J CELL PHYSIOL, V226, P1340, DOI 10.1002/jcp.22462; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wanami LS, 2008, EXP CELL RES, V314, P2448, DOI 10.1016/j.yexcr.2008.05.004; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099	44	92	94	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1325	1335		10.1038/onc.2013.53	http://dx.doi.org/10.1038/onc.2013.53			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23474752				2022-12-25	WOS:000332631100013
J	Steen, A; Thiele, S; Guo, D; Hansen, LS; Frimurer, TM; Rosenkilde, MM				Steen, Anne; Thiele, Stefanie; Guo, Dong; Hansen, Laerke S.; Frimurer, Thomas M.; Rosenkilde, Mette M.			Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC-ACID RECEPTOR; SMALL-MOLECULE; CRYSTAL-STRUCTURE; HIV-1 INFECTION; BETA-ARRESTIN; PROTEIN; POTENT; IDENTIFICATION; ANTAGONISTS; MECHANISM	The equilibrium state of CCR5 is manipulated here toward either activation or inactivation by introduction of single amino acid substitutions in the transmembrane domains (TMs) 6 and 7. Insertion of a steric hindrance mutation in the center of TM7 (G286F in position VII:09/7.42) resulted in biased signaling. Thus, beta-arrestin recruitment was eliminated, whereas constitutive activity was observed in G alpha(i)-mediated signaling. Furthermore, the CCR5 antagonist aplaviroc was converted to a full agonist (a so-called efficacy switch). Computational modeling revealed that the position of the 7TM receptor-conserved Trp in TM6 (Trp-248 in position VI:13/6.48, part of the CWXP motif) was influenced by the G286F mutation, causing Trp-248 to change orientation away from TM7. The essential role of Trp-248 in CCR5 activation was supported by complete inactivity of W248A-CCR5 despite maintaining chemokine binding. Furthermore, replacing Trp-248 with a smaller aromatic amino acid (Tyr/Phe) impaired the beta-arrestin recruitment, yet with maintained G protein activity (biased signaling); also, here aplaviroc switched to a full agonist. Thus, the altered positioning of Trp-248, induced by G286F, led to a constraint of G protein active, but beta-arrestin inactive and thus biased, CCR5 conformation. These results provide important information on the molecular interplay and impact of TM6 and TM7 for CCR5 activity, which may be extrapolated to other chemokine receptors and possibly to other 7TM receptors.	[Steen, Anne; Thiele, Stefanie; Hansen, Laerke S.; Rosenkilde, Mette M.] Univ Copenhagen, Panum Inst, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Guo, Dong] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2333 CC Leiden, Netherlands; [Frimurer, Thomas M.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	University of Copenhagen; Leiden University; Leiden University - Excl LUMC; Novo Nordisk Foundation; University of Copenhagen	Rosenkilde, MM (corresponding author), Univ Copenhagen, Panum Inst, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Guo, Dong/T-6126-2019; Gasbjerg, Lærke Smidt/AAR-9363-2020	Guo, Dong/0000-0001-6142-4825; Gasbjerg, Lærke Smidt/0000-0002-7880-8515; Rosenkilde, Mette Marie/0000-0001-9600-3254; Frimruer, Thomas/0000-0002-9682-8245; Karlshoj, Stefanie/0000-0001-6505-0883	Danish Council for Independent Research Medical Sciences; Aase and Einar Danielsen Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC0001900] Funding Source: researchfish	Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Aase and Einar Danielsen Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by The Danish Council for Independent Research Medical Sciences, the Aase and Einar Danielsen Foundation, and the Novo Nordisk Foundation.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Castonguay LA, 2003, BIOCHEMISTRY-US, V42, P1544, DOI 10.1021/bi026639s; Chen WW, 2012, CURR PHARM DESIGN, V18, P100, DOI 10.2174/138161212798919084; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cho W, 1996, MOL PHARMACOL, V50, P1338; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Ditzel HJ, 1998, P NATL ACAD SCI USA, V95, P5241, DOI 10.1073/pnas.95.9.5241; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Ferain T, 2011, J PHARMACOL EXP THER, V337, P655, DOI 10.1124/jpet.111.179622; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gbahou F, 2010, J PHARMACOL EXP THER, V333, P51, DOI 10.1124/jpet.109.162131; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Heydorn A, 2004, MOL PHARMACOL, V66, P250, DOI 10.1124/mol.66.2.250; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jardon-Valadez E, 2008, J PHYS CHEM B, V112, P10704, DOI 10.1021/jp800544x; Kissow H, 2012, REGUL PEPTIDES, V179, P91, DOI 10.1016/j.regpep.2012.08.016; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Marie J, 1999, MOL PHARMACOL, V55, P92, DOI 10.1124/mol.55.1.92; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; O'Hayre M, 2010, EXPERT OPIN DRUG DIS, V5, P1109, DOI 10.1517/17460441.2010.525633; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenkilde MM, 2004, J BIOL CHEM, V279, P32524, DOI 10.1074/jbc.M313392200; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Semple G, 2008, J MED CHEM, V51, P5101, DOI 10.1021/jm800258p; Sharman JL, 2011, NUCLEIC ACIDS RES, V39, pD534, DOI 10.1093/nar/gkq1062; Shiraishi M, 2000, J MED CHEM, V43, P2049, DOI 10.1021/jm9906264; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Singh IP, 2011, EXPERT OPIN THER PAT, V21, P227, DOI 10.1517/13543776.2011.542412; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Steen A, 2009, MINI-REV MED CHEM, V9, P1605, DOI 10.2174/138955709791012265; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	72	50	50	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12511	12521		10.1074/jbc.M112.449587	http://dx.doi.org/10.1074/jbc.M112.449587			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493400	Green Published, hybrid			2022-12-25	WOS:000318555100010
J	Hakim, A; Nguyen, JB; Basu, K; Zhu, DF; Thakral, D; Davies, PL; Isaacs, FJ; Modis, Y; Meng, WY				Hakim, Aaron; Nguyen, Jennifer B.; Basu, Koli; Zhu, Darren F.; Thakral, Durga; Davies, Peter L.; Isaacs, Farren J.; Modis, Yorgo; Meng, Wuyi			Crystal Structure of an Insect Antifreeze Protein and Its Implications for Ice Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BETA-HELIX; MODEL; MECHANISM; INSIGHTS; IDENTIFICATION; INTERFACES; BEETLES; ISOFORM; SURFACE	Antifreeze proteins (AFPs) help some organisms resist freezing by binding to ice crystals and inhibiting their growth. The molecular basis for how these proteins recognize and bind ice is not well understood. The longhorn beetle Rhagium inquisitor can supercool to below -25 degrees C, in part by synthesizing the most potent antifreeze protein studied thus far (RiAFP). We report the crystal structure of the 13-kDa RiAFP, determined at 1.21 angstrom resolution using direct methods. The structure, which contains 1,914 nonhydrogen protein atoms in the asymmetric unit, is the largest determined ab initio without heavy atoms. It reveals a compressed beta-solenoid fold in which the top and bottom sheets are held together by a silk-like interdigitation of short side chains. RiAFP is perhaps the most regular structure yet observed. It is a second independently evolved AFP type in beetles. The two beetle AFPs have in common an extremely flat ice-binding surface comprising regular outward-projecting parallel arrays of threonine residues. The more active, wider RiAFP has four (rather than two) of these arrays between which the crystal structure shows the presence of ice-like waters. Molecular dynamics simulations independently reproduce the locations of these ordered crystallographic waters and predict additional waters that together provide an extensive view of the AFP interaction with ice. By matching several planes of hexagonal ice, these waters may help freeze the AFP to the ice surface, thus providing the molecular basis of ice binding.	[Hakim, Aaron; Nguyen, Jennifer B.; Zhu, Darren F.; Thakral, Durga; Modis, Yorgo; Meng, Wuyi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hakim, Aaron; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Basu, Koli; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA	Yale University; Yale University; Queens University - Canada; Yale University	Meng, WY (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	wuyi.meng@yale.edu	Nguyen, Jennifer/GVS-4347-2022	Modis, Yorgo/0000-0002-6084-0429; Hakim, Aaron/0000-0002-9752-8826	National Institutes of Health [P01 GM022778, T32 GM08383]; Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease award; Yale College Dean's fellowships; Arnold and Mabel Beckman Foundation; Barry M. Goldwater scholarships; Canadian Institutes for Health Research; Canada Research Chair Program; Raymond and Beverly Sackler Institute for Biological, Physical, and Engineering Sciences; Yale Science and Engineering Association; Yale University West Campus; Yale Department of Molecular Biophysics and Biochemistry, Molecular, Cellular; Yale Department of Molecular, Cellular, and Developmental Biology; Yale Department of Biomedical Engineering; Yale Department of Physics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease award(Burroughs Wellcome Fund); Yale College Dean's fellowships; Arnold and Mabel Beckman Foundation; Barry M. Goldwater scholarships; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs); Raymond and Beverly Sackler Institute for Biological, Physical, and Engineering Sciences; Yale Science and Engineering Association; Yale University West Campus; Yale Department of Molecular Biophysics and Biochemistry, Molecular, Cellular; Yale Department of Molecular, Cellular, and Developmental Biology; Yale Department of Biomedical Engineering; Yale Department of Physics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM022778 (to Y. M.) and Training Grant T32 GM08383. This work was also supported by a Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease award (to Y. M.), Yale College Dean's fellowships (to A. H. and D. F. Z.), the Arnold and Mabel Beckman Foundation and Barry M. Goldwater scholarships (to D. T.), funds from the Canadian Institutes for Health Research and the Canada Research Chair Program (to P. L. D.) and by the Raymond and Beverly Sackler Institute for Biological, Physical, and Engineering Sciences, the Yale Science and Engineering Association, Yale University West Campus, and the Yale Departments of Molecular Biophysics and Biochemistry, Molecular, Cellular, and Developmental Biology, Biomedical Engineering, and Physics.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Antson AA, 2001, J MOL BIOL, V305, P875, DOI 10.1006/jmbi.2000.4336; Asakura T, 2002, PROTEIN SCI, V11, P2706, DOI 10.1110/ps.0221702; Baardsnes J, 2003, J BIOL CHEM, V278, P38942, DOI 10.1074/jbc.M306776200; Bar-Dolev M, 2012, J R SOC INTERFACE, V9, P3249, DOI 10.1098/rsif.2012.0388; Chao H, 1996, PROTEIN SCI, V5, P1150; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garnham CP, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-36; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Hakim A, 2012, ACTA CRYSTALLOGR F, V68, P547, DOI 10.1107/S1744309112010421; Hayward JA, 2001, J CHEM PHYS, V114, P3713, DOI 10.1063/1.1333680; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hobbes P. V., 1974, ICE PHYS, P525; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Jia-xing Yao, 2005, Acta Crystallogr D Biol Crystallogr, V61, P1465, DOI 10.1107/S090744490502576X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Knight CA, 2000, NATURE, V406, P249, DOI 10.1038/35018671; Kristiansen E, 2011, INSECT BIOCHEM MOLEC, V41, P109, DOI 10.1016/j.ibmb.2010.11.002; Kristiansen E, 2012, J INSECT PHYSIOL, V58, P1502, DOI 10.1016/j.jinsphys.2012.09.004; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leinala EK, 2002, J BIOL CHEM, V277, P33349, DOI 10.1074/jbc.M205575200; Leinala EK, 2002, STRUCTURE, V10, P619, DOI 10.1016/S0969-2126(02)00745-1; Lin FH, 2011, BIOCHEMISTRY-US, V50, P4467, DOI 10.1021/bi2003108; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000548; Marshall CB, 2004, BIOCHEMISTRY-US, V43, P11637, DOI 10.1021/bi0488909; Marshall CB, 2002, FEBS LETT, V529, P261, DOI 10.1016/S0014-5793(02)03355-0; Matthews BHM, 2006, ACTA CRYSTALLOGR D, V62, P165, DOI 10.1107/S0907444905037212; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Modig K, 2010, PHYS CHEM CHEM PHYS, V12, P10189, DOI 10.1039/c002970j; Mok YF, 2010, BIOCHEMISTRY-US, V49, P2593, DOI 10.1021/bi901929n; Nada H, 2011, PHYS CHEM CHEM PHYS, V13, P19936, DOI 10.1039/c1cp21929d; Nishimiya Y, 2008, J MOL BIOL, V382, P734, DOI 10.1016/j.jmb.2008.07.042; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; Oszlanyi G, 2004, ACTA CRYSTALLOGR A, V60, P134, DOI 10.1107/S0108767303027569; Palatinus L, 2004, ACTA CRYSTALLOGR A, V60, P604, DOI 10.1107/S0108767304022433; Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Scotter AJ, 2006, CRYOBIOLOGY, V53, P229, DOI 10.1016/j.cryobiol.2006.06.006; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; Takamichi M, 2007, FEBS J, V274, P6469, DOI 10.1111/j.1742-4658.2007.06164.x; Venketesh S, 2008, CRIT REV BIOTECHNOL, V28, P57, DOI [10.1080/07388550801891152, 10.1080/07388550801891152 ]; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang DSC, 1998, BIOPHYS J, V74, P2142, DOI 10.1016/S0006-3495(98)77923-8; Zachariassen KE, 2008, J COMP PHYSIOL B, V178, P977, DOI 10.1007/s00360-008-0284-6	49	78	78	3	121	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12295	12304		10.1074/jbc.M113.450973	http://dx.doi.org/10.1074/jbc.M113.450973			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486477	Green Published, hybrid			2022-12-25	WOS:000318157600060
J	Mills, LD; Zhang, YQ; Marler, RJ; Herreros-Villanueva, M; Zhang, LZ; Almada, LL; Couch, F; Wetmore, C; di Magliano, MP; Fernandez-Zapico, ME				Mills, Lisa D.; Zhang, Yaqing; Marler, Ronald J.; Herreros-Villanueva, Marta; Zhang, Lizhi; Almada, Luciana L.; Couch, Fergus; Wetmore, Cynthia; di Magliano, Marina Pasca; Fernandez-Zapico, Martin E.			Loss of the Transcription Factor GLI1 Identifies a Signaling Network in the Tumor Microenvironment Mediating KRAS Oncogene-induced Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KI-RAS GENE; PANCREATIC INTRADUCTAL NEOPLASIAS; DUCTAL ADENOCARCINOMA; CODON-12 MUTATIONS; CANCER; STAT3; PROGRESSION; ACTIVATION; FREQUENCY; COMBINATION	Although the biological role of KRAS is clearly established in carcinogenesis, the molecular mechanisms underlying this phenomenon are not completely understood. In this study, we provide evidence of a novel signaling network regulated by the transcription factor GLI1 mediating KRAS-induced carcinogenesis. Using pancreatic cancer (a disease with high prevalence of KRAS mutations) as a model, we show that loss of GLI1 blocks the progression of KRAS-induced pancreatic preneoplastic lesions in mice with pancreas-specific Cre-activated oncogenic mutant kras. Mice lacking GLI1 develop only low-grade lesions at low frequency, and in most cases, the pancreata are histologically normal. Further characterization of the phenotype showed a decrease in the activation of STAT3 in pancreatic preneoplastic lesions; STAT3 is a transcription factor required for the development of premalignant lesions and their progression into pancreatic cancer. Analysis of the mechanisms revealed a key role for GLI1 in maintaining the levels of activated STAT3 through the modulation of IL-6 signaling. GLI1 binds to the IL-6 mouse promoter and regulates the activity and expression of this cytokine. This newly identified GLI1/IL-6 axis is active in fibroblasts, a known source of IL-6 in the tumor microenvironment. Sonic hedgehog induces GLI1 binding to the IL-6 promoter and increases IL-6 expression in fibroblasts in a paracrine manner. Finally, we demonstrate that mutant KRAS initiates this cascade by inducing the expression of Sonic hedgehog in cancer cells. Collectively, these results define a novel role for GLI1 in carcinogenesis acting as a downstream effector of oncogenic KRAS in the tumor microenvironment.	[Mills, Lisa D.; Herreros-Villanueva, Marta; Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Zhang, Lizhi; Couch, Fergus] Mayo Clin, Rochester, MN 55905 USA; [Zhang, Yaqing; di Magliano, Marina Pasca] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI 48109 USA; [Marler, Ronald J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Wetmore, Cynthia] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic Phoenix; St Jude Children's Research Hospital	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu	zhang, yaqing/C-2283-2015; , Herreros-Villanueva/M-5702-2016	, Herreros-Villanueva/0000-0002-6905-0693; Pasca di Magliano, Marina/0000-0001-9632-9035	National Institutes of Health from NCI [CA136526]; Mayo Clinic Pancreatic SPORE Grant [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Pancreatic SPORE Grant; Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136526 from NCI. This work was also supported by Mayo Clinic Pancreatic SPORE Grant P50 CA102701 and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK84567 (to M. E. F.-Z.).	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Brat DJ, 1998, AM J SURG PATHOL, V22, P163, DOI 10.1097/00000478-199802000-00003; Brockie E, 1998, Ann Diagn Pathol, V2, P286, DOI 10.1016/S1092-9134(98)80020-8; CALDAS C, 1995, INT J PANCREATOL, V18, P1; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Ellis CA, 2000, CELL SIGNAL, V12, P425, DOI 10.1016/S0898-6568(00)00084-X; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Fan JG, 1997, ONCOGENE, V14, P2595, DOI 10.1038/sj.onc.1201105; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; GRUNEWALD K, 1989, INT J CANCER, V43, P1037, DOI 10.1002/ijc.2910430614; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; HRUBAN RH, 1993, AM J PATHOL, V143, P545; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Hruban RH, 1999, CURR OPIN GASTROEN, V15, P404, DOI 10.1097/00001574-199909000-00006; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lohr M, 2005, NEOPLASIA, V7, P17, DOI 10.1593/neo.04445; Luttges J, 2005, PATHOLOGE, V26, P12, DOI 10.1007/s00292-004-0735-0; MARIYAMA M, 1989, JPN J CANCER RES, V80, P622, DOI 10.1111/j.1349-7006.1989.tb01687.x; NAGATA Y, 1990, JPN J CANCER RES, V81, P135, DOI 10.1111/j.1349-7006.1990.tb02539.x; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2006, CLIN CANCER RES, V12, P5277, DOI 10.1158/1078-0432.CCR-06-0436; Park HL, 2000, DEVELOPMENT, V127, P1593; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; VANLAETHEM JL, 1995, GUT, V36, P781, DOI 10.1136/gut.36.5.781	37	81	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11786	11794		10.1074/jbc.M112.438846	http://dx.doi.org/10.1074/jbc.M112.438846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482563	Green Published, hybrid			2022-12-25	WOS:000318157600015
J	Zhang, ZH; Xu, XH; Xiang, ZH; Yu, ZW; Feng, JF; He, C				Zhang, Zhaohuan; Xu, Xiaohui; Xiang, Zhenghua; Yu, Zhongwang; Feng, Jifeng; He, Cheng			LINGO-1 Receptor Promotes Neuronal Apoptosis by Inhibiting WNK3 Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CELL-SURVIVAL; MOUSE-BRAIN; EXPRESSION; PHOSPHORYLATION; INACTIVATION; HYPERTENSION; REGULATOR; REPAIR; DOMAIN	LINGO-1 is a functional component of the Nogo receptor 1.p75(NTR).LINGO-1 and Nogo receptor 1.TAJ (TNFRSF19/TROY).LINGO-1 signaling complexes. It has recently been shown that LINGO-1 antagonists significantly improve neuronal survival after neural injury. However, the mechanism by which LINGO-1 signaling influences susceptibility to apoptosis remains unknown. In an effort to better understand how LINGO-1 regulates these signaling pathways, we used an established model of serum deprivation (SD) to induce neuronal apoptosis. We demonstrate that treatment either with a construct containing the intracellular domain of LINGO-1 or with Nogo66, a LINGO-1 receptor complex agonist, resulted in an enhanced rate of apoptosis in primary cultured cortical neurons under SD. Reducing the expression levels of the serine/threonine kinase WNK3 using shRNA or inhibiting its kinase activity had similar effects on the survival of serum-deprived neurons. Consistent with these observations, we found that LINGO-1 and WNK3 co-localized and co-precipitated in cultured cortical neurons and brain tissue. Significantly, this co-association was enhanced by Nogo66 treatment. Binding of WNK3 to the intracellular domain of LINGO-1 led to a reduction in WNK3 kinase activity, as did Nogo66 stimulation. Moreover, in vitro and in vivo evidence indicates that endogenous WNK3 suppresses SD-induced neuronal apoptosis in a kinase-dependent manner, as the expression of either a WNK3 RNAi construct or a kinase-dead N-terminal fragment of WNK3 led to increased apoptosis. Taken together, our results show that LINGO-1 potentiates neuronal apoptosis, likely by inhibiting WNK3 kinase activity.	[He, Cheng] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, MOE Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	He, C (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn		Zhang, Zhaohuan/0000-0001-6882-9761	National Key Basic Research Program Grant [2011CB504401]; National Natural Science Foundation [81000524, 31070922, 31130024]	National Key Basic Research Program Grant(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program Grant 2011CB504401 and National Natural Science Foundation Grants 81000524, 31070922, and 31130024.	Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; Arboleda G, 2009, BRAIN RES REV, V59, P333, DOI 10.1016/j.brainresrev.2008.10.001; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cheng CJ, 2011, J AM SOC NEPHROL, V22, P460, DOI 10.1681/ASN.2010060681; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Fu QL, 2010, EUR J NEUROSCI, V31, P1091, DOI 10.1111/j.1460-9568.2010.07127.x; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; Gerin CG, 2011, SYNAPSE, V65, P1255, DOI 10.1002/syn.20903; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Holden S, 2004, GENE, V335, P109, DOI 10.1016/j.gene.2004.03.009; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Leng Q, 2006, J PHYSIOL-LONDON, V571, P275, DOI 10.1113/jphysiol.2005.102202; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029771; Lorenzo-Betancor O, 2011, MOVEMENT DISORD, V26, P722, DOI 10.1002/mds.23452; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Pepinsky RB, 2011, BIOCONJUGATE CHEM, V22, P200, DOI 10.1021/bc1002746; Qi B, 2003, J CELL PHYSIOL, V196, P312, DOI 10.1002/jcp.10297; Qiao Y, 2008, CLIN GENET, V74, P134, DOI 10.1111/j.1399-0004.2008.01028.x; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Satoh J, 2007, NEUROPATH APPL NEURO, V33, P99, DOI 10.1111/j.1365-2990.2006.00787.x; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Verissimo F, 2006, ONCOGENE, V25, P4172, DOI 10.1038/sj.onc.1209449; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zhang W, 2008, AM J PHYSIOL-RENAL, V295, pF1472, DOI 10.1152/ajprenal.90229.2008; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200; Zhao XH, 2008, CELL MOL NEUROBIOL, V28, P727, DOI 10.1007/s10571-007-9258-6	42	17	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12152	12160		10.1074/jbc.M112.447771	http://dx.doi.org/10.1074/jbc.M112.447771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482566	Green Published, hybrid			2022-12-25	WOS:000318157600047
J	Biedenkopf, N; Hartlieb, B; Hoenen, T; Becker, S				Biedenkopf, Nadine; Hartlieb, Bettina; Hoenen, Thomas; Becker, Stephan			Phosphorylation of Ebola Virus VP30 Influences the Composition of the Viral Nucleocapsid Complex IMPACT ON VIRAL TRANSCRIPTION AND REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MARBURG-VIRUS; GENOME RNA; SECONDARY STRUCTURE; VACCINE DEVELOPMENT; BINDING PROTEIN; MESSENGER-RNA; P-PROTEIN; IDENTIFICATION; M2-1	Ebola virus is a non-segmented negative-sense RNA virus causing severe hemorrhagic fever with high fatality rates in humans and nonhuman primates. For transcription of the viral genome four viral proteins are essential: the nucleoprotein NP, the polymerase L, the polymerase cofactor VP35, and VP30. VP30 represents an essential Ebola virus-specific transcription factor whose activity is regulated via its phosphorylation state. In contrast to viral transcription, VP30 is not required for viral replication. Using a minigenome assay, we show that phosphorylation of VP30 inhibits viral transcription while viral replication is increased. Concurrently, phosphorylation of VP30 reciprocally regulates a newly described interaction of VP30 with VP35, and strengthens the interaction with NP. Our results indicate a critical role of VP30 phosphorylation for viral transcription and replication, suggesting a mechanism by which VP30 phosphorylation modulates the composition of the viral polymerase complex presumably forming a transcriptase in the presence of non-phosphorylated VP30 or a replicase in the presence of phosphorylated VP30.	[Biedenkopf, Nadine; Hartlieb, Bettina; Hoenen, Thomas; Becker, Stephan] Univ Marburg, Inst Virol, D-35043 Marburg, Germany	Philipps University Marburg	Becker, S (corresponding author), Univ Marburg, Inst Virol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	becker@staff.uni-marburg.de	Hoenen, Thomas/H-8990-2019	Hoenen, Thomas/0000-0002-5829-6305	Schering Foundation; Deutsche Forschungsgemeinschaft [SFB 593, TP B12]	Schering Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Schering Foundation (to N. B. and T. H.) and the Deutsche Forschungsgemeinschaft through the SFB 593, TP B12 (to N. B.).	Asenjo A, 2006, J GEN VIROL, V87, P3637, DOI 10.1099/vir.0.82165-0; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chen MZ, 2007, J VIROL, V81, P13478, DOI 10.1128/JVI.01244-07; Falzarano D, 2011, EXPERT REV VACCINES, V10, P63, DOI [10.1586/erv.10.152, 10.1586/ERV.10.152]; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; Gupta AK, 2003, J VIROL, V77, P732, DOI 10.1128/JVI.77.1.732-738.2003; Hartlieb B, 2003, J BIOL CHEM, V278, P41830, DOI 10.1074/jbc.M307036200; Hartlieb B, 2007, P NATL ACAD SCI USA, V104, P624, DOI 10.1073/pnas.0606730104; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Hoenen T, 2006, TRENDS MOL MED, V12, P206, DOI 10.1016/j.molmed.2006.03.006; Hoenen T, 2006, J VIROL, V80, P7260, DOI 10.1128/JVI.00051-06; Hoenen T, 2011, ANTIVIR RES, V91, P195, DOI 10.1016/j.antiviral.2011.06.003; John SP, 2007, J VIROL, V81, P8967, DOI 10.1128/JVI.02523-06; Kolesnikova L, 2004, J VIROL, V78, P12277, DOI 10.1128/JVI.78.22.12277-12287.2004; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; Martinez MJ, 2011, J INFECT DIS, V204, pS934, DOI 10.1093/infdis/jir320; Martinez MJ, 2008, J VIROL, V82, P12569, DOI 10.1128/JVI.01395-08; Mason SW, 2003, J VIROL, V77, P10670, DOI 10.1128/JVI.77.19.10670-10676.2003; Modrof J, 2003, J VIROL, V77, P3334, DOI 10.1128/JVI.77.5.3334-3338.2003; Modrof J, 2002, J BIOL CHEM, V277, P33099, DOI 10.1074/jbc.M203775200; Muhlberger E, 1999, J VIROL, V73, P2333; Muhlberger E, 1996, VIROLOGY, V223, P376, DOI 10.1006/viro.1996.0490; Noda T, 2011, J INFECT DIS, V204, pS878, DOI 10.1093/infdis/jir310; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Saikia P, 2008, ARCH VIROL, V153, P615, DOI 10.1007/s00705-008-0034-9; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; SANCHEZ A, 1987, VIROLOGY, V157, P414, DOI 10.1016/0042-6822(87)90283-2; Sanchez A., 2007, VIROLOGY, P1409; Sarwar UN, 2011, TRAVEL MED INFECT DI, V9, P126, DOI 10.1016/j.tmaid.2010.05.003; Watanabe S, 2006, J VIROL, V80, P3743, DOI 10.1128/JVI.80.8.3743-3751.2006; Weik M, 2002, J VIROL, V76, P8532, DOI 10.1128/JVI.76.17.8532-8539.2002; Wenigenrath J, 2010, J GEN VIROL, V91, P1325, DOI 10.1099/vir.0.018226-0	34	68	71	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11165	11174		10.1074/jbc.M113.461285	http://dx.doi.org/10.1074/jbc.M113.461285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23493393	hybrid, Green Published			2022-12-25	WOS:000317915500021
J	Das, T; Kutty, SK; Kumar, N; Manefield, M				Das, Theerthankar; Kutty, Samuel K.; Kumar, Naresh; Manefield, Mike			Pyocyanin Facilitates Extracellular DNA Binding to Pseudomonas aeruginosa Influencing Cell Surface Properties and Aggregation	PLOS ONE			English	Article							BACTERIAL ADHESION; BIOFILM FORMATION; RELEASE; FORCES; DEATH; MODE	Pyocyanin is an electrochemically active metabolite produced by the human pathogen Pseudomonas aeruginosa. It is a recognized virulence factor and is involved in a variety of significant biological activities including gene expression, maintaining fitness of bacterial cells and biofilm formation. It is also recognized as an electron shuttle for bacterial respiration and as an antibacterial and antifungal agent. eDNA has also been demonstrated to be a major component in establishing P. aeruginosa biofilms. In this study we discovered that production of pyocyanin influences the binding of eDNA to P. aeruginosa PA14 cells, mediated through intercalation of pyocyanin with eDNA. P. aeruginosa cell surface properties including cell size (hydrodynamic diameter), hydrophobicity and attractive surface energies were influenced by eDNA in the presence of pyocyanin, affecting physico-chemical interactions and promoting aggregation. A Delta phzA-G PA14 mutant, deficient in pyocynain production, could not bind with eDNA resulting in a reduction in hydrodynamic diameter, a decrease in hydrophobicity, repulsive physico-chemical interactions and reduction in aggregation in comparison to the wildtype strain. Removal of eDNA by DNase I treatment on the PA14 wildtype strain resulted in significant reduction in aggregation, cell surface hydrophobicity and size and an increase in repulsive physico-chemical interactions, similar to the level of the Delta phzA-G mutant. The cell surface properties of the Delta phzA-G mutant were not affected by DNase I treatment. Based on these findings we propose that pyocyanin intercalation with eDNA promotes cell-to-cell interactions in P. aeruginosa cells by influencing their cell surface properties and physico-chemical interactions.	[Das, Theerthankar; Manefield, Mike] Univ New S Wales, Sch Biotechnol & Biomol Sci BABS, Ctr Marine BioInnovat, Sydney, NSW, Australia; [Kutty, Samuel K.; Kumar, Naresh] Univ New S Wales, Sch Chem, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Das, T (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci BABS, Ctr Marine BioInnovat, Sydney, NSW, Australia.	theerthankar_das11@rediffmail.com		Kumar, Naresh/0000-0002-0951-9621; Kutty, Samuel/0000-0001-8137-9988	Australian Research Council (ARC) [FT100100078]	Australian Research Council (ARC)(Australian Research Council)	This work was funded by Australian Research Council (ARC) Future Fellowship Project ID FT100100078, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Bakker E M, 2007, Expert Rev Respir Med, V1, P317, DOI 10.1586/17476348.1.3.317; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Carrozzo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015638; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Dhanasekaran D, 2009, INT J ENVIRON SCI TE, V6, P197; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; KHOLODENKO AL, 1995, PHYS REV E, V51, P1081, DOI 10.1103/PhysRevE.51.1081; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Petersen FC, 2004, J BACTERIOL, V186, P6327, DOI 10.1128/JB.186.18.6327-6331.2004; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Sharma PK, 2003, COLLOID SURFACE B, V29, P21, DOI 10.1016/S0927-7765(02)00180-7; SUH D, 1995, BIOORGAN MED CHEM, V3, P723, DOI 10.1016/0968-0896(95)00053-J; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; Venkataraman A, 2010, ELECTROCHEM COMMUN, V12, P459, DOI 10.1016/j.elecom.2010.01.019; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zheng LY, 2011, J BACTERIOL, V193, P516, DOI 10.1128/JB.01131-10	34	68	73	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58299	10.1371/journal.pone.0058299	http://dx.doi.org/10.1371/journal.pone.0058299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505483	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100043
J	Dearth, CL; Goh, Q; Marino, JS; Cicinelli, PA; Torres-Palsa, MJ; Pierre, P; Worth, RG; Pizza, FX				Dearth, Christopher L.; Goh, Qingnian; Marino, Joseph S.; Cicinelli, Peter A.; Torres-Palsa, Maria J.; Pierre, Philippe; Worth, Randall G.; Pizza, Francis X.			Skeletal Muscle Cells Express ICAM-1 after Muscle Overload and ICAM-1 Contributes to the Ensuing Hypertrophic Response	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; DYSTROPHIN-GLYCOPROTEIN COMPLEX; CYTOKINE-INDUCED EXPRESSION; ENDOTHELIAL-CELLS; SATELLITE CELLS; HUMAN MYOBLASTS; IN-VITRO; LENGTHENING CONTRACTIONS; INFLAMMATORY MYOPATHIES; PASSIVE STRETCHES	We previously reported that leukocyte specific beta 2 integrins contribute to hypertrophy after muscle overload in mice. Because intercellular adhesion molecule-1 (ICAM-1) is an important ligand for beta 2 integrins, we examined ICAM-1 expression by murine skeletal muscle cells after muscle overload and its contribution to the ensuing hypertrophic response. Myofibers in control muscles of wild type mice and cultures of skeletal muscle cells (primary and C2C12) did not express ICAM-1. Overload of wild type plantaris muscles caused myofibers and satellite cells/myoblasts to express ICAM-1. Increased expression of ICAM-1 after muscle overload occurred via a beta 2 integrin independent mechanism as indicated by similar gene and protein expression of ICAM-1 between wild type and beta 2 integrin deficient (CD18-/-) mice. ICAM-1 contributed to muscle hypertrophy as demonstrated by greater (p<0.05) overload-induced elevations in muscle protein synthesis, mass, total protein, and myofiber size in wild type compared to ICAM-1-/-mice. Furthermore, expression of ICAM-1 altered (p, 0.05) the temporal pattern of Pax7 expression, a marker of satellite cells/myoblasts, and regenerating myofiber formation in overloaded muscles. In conclusion, ICAM-1 expression by myofibers and satellite cells/ myoblasts after muscle overload could serve as a mechanism by which ICAM-1 promotes hypertrophy by providing a means for cell-to-cell communication with beta 2 integrin expressing myeloid cells.	[Dearth, Christopher L.; Goh, Qingnian; Marino, Joseph S.; Cicinelli, Peter A.; Torres-Palsa, Maria J.; Pizza, Francis X.] Univ Toledo, Dept Kinesiol, Toledo, OH 43606 USA; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy U2M, Marseille, France; [Pierre, Philippe] INSERM, Inst Natl Sante & Rech Med, U631, F-13258 Marseille, France; [Pierre, Philippe] CNRS, Ctr Natl Rech Sci, UMR6102, Marseille, France; [Worth, Randall G.] Univ Toledo, Coll Med & Life Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); University System of Ohio; University of Toledo	Pizza, FX (corresponding author), Univ Toledo, Dept Kinesiol, 2801 W Bancroft St, Toledo, OH 43606 USA.	Francis.Pizza@utoledo.edu	Dearth, Christopher L./AAG-6877-2020	Dearth, Christopher L./0000-0003-3701-0950; Pizza, Francis/0000-0002-0857-6384; Marino, Joseph/0000-0002-6207-5986; pierre, philippe/0000-0003-0863-8255; Goh, Qingnian/0000-0003-4108-2957; Worth, Randall/0000-0002-2626-7964	American College of Sports Medicine Doctoral Student Research Program; University of Toledo Interdisciplinary Research Initiation Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR064858] Funding Source: NIH RePORTER	American College of Sports Medicine Doctoral Student Research Program; University of Toledo Interdisciplinary Research Initiation Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by grants from the American College of Sports Medicine Doctoral Student Research Program (C. L. Dearth) and the University of Toledo Interdisciplinary Research Initiation Program (F. X. Pizza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; BARTOCCIONI E, 1994, CLIN EXP IMMUNOL, V95, P166; Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Brickson S, 2003, J APPL PHYSIOL, V95, P969, DOI 10.1152/japplphysiol.00005.2003; Bruusgaard JC, 2010, P NATL ACAD SCI USA, V107, P15111, DOI 10.1073/pnas.0913935107; Charlton CA, 2000, DEV BIOL, V221, P112, DOI 10.1006/dbio.2000.9654; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Cheng JJ, 1996, HYPERTENSION, V28, P386, DOI 10.1161/01.HYP.28.3.386; Clayton A, 1998, J CELL SCI, V111, P443; DEBLEECKER JL, 1994, J NEUROPATH EXP NEUR, V53, P369, DOI 10.1097/00005072-199407000-00008; DiPasquale DM, 2007, AM J PHYSIOL-CELL PH, V293, pC1278, DOI 10.1152/ajpcell.00201.2007; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Esser K., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P338; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; GOEBELS N, 1992, J IMMUNOL, V149, P661; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Guerette B, 1997, J IMMUNOL, V159, P2522; Hardy KM, 2009, AM J PHYSIOL-REG I, V296, pR1855, DOI 10.1152/ajpregu.00076.2009; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Huey KA, 2007, J APPL PHYSIOL, V102, P2307, DOI 10.1152/japplphysiol.00021.2007; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; KLIETSCH R, 1993, CIRC RES, V72, P349, DOI 10.1161/01.RES.72.2.349; Koyama Y, 1996, J IMMUNOL, V157, P5097; Kukreti S, 1997, BLOOD, V89, P4104, DOI 10.1182/blood.V89.11.4104; Lawson C, 1999, J IMMUNOL, V162, P2990; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lockhart NC, 2008, J APPL PHYSIOL, V104, P1109, DOI 10.1152/japplphysiol.00850.2007; Marino JS, 2008, AM J PHYSIOL-CELL PH, V295, pC1026, DOI 10.1152/ajpcell.212.2008; Marino M, 2003, J NEUROIMMUNOL, V134, P151, DOI 10.1016/S0165-5728(02)00399-5; Marino M, 2001, J NEUROIMMUNOL, V116, P94, DOI 10.1016/S0165-5728(01)00287-9; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McLoughlin TJ, 2003, CELL TISSUE RES, V313, P313, DOI 10.1007/s00441-003-0767-4; McLoughlin TJ, 2003, J APPL PHYSIOL, V94, P876, DOI 10.1152/japplphysiol.00766.2002; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; MICHAELIS D, 1993, AM J PATHOL, V143, P1142; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Nguyen HX, 2003, J PHYSIOL-LONDON, V547, P125, DOI 10.1113/jphysiol.2002.031450; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Panes J, 1995, AM J PHYSIOL-HEART C, V269, pH1955, DOI 10.1152/ajpheart.1995.269.6.H1955; Pattillo CB, 2010, FREE RADICAL BIO MED, V49, P1119, DOI 10.1016/j.freeradbiomed.2010.06.030; PAVLATH GK, 1994, J CELL BIOL, V127, P1923, DOI 10.1083/jcb.127.6.1923; Peterson JM, 2009, J APPL PHYSIOL, V106, P130, DOI 10.1152/japplphysiol.90584.2008; Pizza FX, 2005, J PHYSIOL-LONDON, V562, P899, DOI 10.1113/jphysiol.2004.073965; Pizza FX, 2002, J APPL PHYSIOL, V92, P1873, DOI 10.1152/japplphysiol.01055.2001; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Robker RL, 2004, OBES RES, V12, P936, DOI 10.1038/oby.2004.114; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Smith RE, 1997, J LEUKOCYTE BIOL, V62, P612, DOI 10.1002/jlb.62.5.612; Thompson RW, 2006, EXP GERONTOL, V41, P1136, DOI 10.1016/j.exger.2006.08.013; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tsivitse SK, 2005, AM J PHYSIOL-CELL PH, V288, pC721, DOI 10.1152/ajpcell.00237.2004; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; WILSON RW, 1993, J IMMUNOL, V151, P1571; Zoico E, 2002, NUTR REV, V60, P39, DOI 10.1301/00296640260085949	62	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58486	10.1371/journal.pone.0058486	http://dx.doi.org/10.1371/journal.pone.0058486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505517	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100055
J	Okazawa, S; Furusawa, Y; Kariya, A; Hassan, MA; Arai, M; Hayashi, R; Tabuchi, Y; Kondo, T; Tobe, K				Okazawa, Seisuke; Furusawa, Yukihiro; Kariya, Ayako; Hassan, Mariame Ali; Arai, Mie; Hayashi, Ryuji; Tabuchi, Yoshiaki; Kondo, Takashi; Tobe, Kazuyuki			Inactivation of DNA-Dependent Protein Kinase Promotes Heat-Induced Apoptosis Independently of Heat-Shock Protein Induction in Human Cancer Cell Lines	PLOS ONE			English	Article							NF-KAPPA-B; ARYL-HYDROCARBON RECEPTOR; LYMPHOMA U937 CELLS; GENE-EXPRESSION; REGIONAL HYPERTHERMIA; CYTOKINE EXPRESSION; ACTIVATION; STRESS; IDENTIFICATION; DEATH	The inhibition of DNA damage response pathway seems to be an attractive strategy for cancer therapy. It was previously reported that in rodent cells exposed to heat stress, cell growth was promoted by the activity of DNA-dependent protein kinase (DNA-PK), an enzyme involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair. The absence of a functioning DNA-PK was associated with down regulation of heat shock protein 70 (HSP70). The objective of this study is thus to investigate the role of DNA-PK inhibition in heat-induced apoptosis in human cell lines. The inhibitors of phosphorylation of the DNA-PK catalytic subunit (DNA-PKcs) at Ser2056, such as NU7026 and NU7441, were utilized. Furthermore, knock down of DNA-PKcs was carried out using small interfering RNA (siDNA-PKcs). For heat exposure, cells were placed in water bath at 44 degrees C for 60 min. Apoptosis was evaluated after 24 h incubation flow cytometrically. Proteins were extracted after 24 h and analyzed for HSP70 and HSP40 expression by Western blotting. Total RNA was extracted 6 h after treatment and analyzed using a GeneChip (R) microarray system to identify and select the up-regulated genes (>= 1.5 fold). The results showed an enhancement in heat-induced apoptosis in absence of functioning DNA-PKcs. Interestingly, the expression levels of HSP70 and HSP40 were elevated in the absence of DNA-PKcs under heat stress. The results of genetic network analysis showed that HSPs and JUN genes were up-regulated independently of DNA-PKcs in exposed parent and knock out cells. In the presence of functioning DNA-PKcs, there was an observed up-regulation of anti-apoptotic genes, such as NR1D1, whereas in the absence of DNA-PKcs the pro-apoptotic genes, such as EGR2, were preferentially up-regulated. From these findings, we concluded that in human cells, the inactivation of DNA-PKcs can promote heat-induced apoptosis independently of heat-shock proteins.	[Okazawa, Seisuke; Hayashi, Ryuji; Tobe, Kazuyuki] Toyama Univ, Grad Sch Med Pharmaceut Sci, Dept Internal Med 1, Toyama 930, Japan; [Okazawa, Seisuke; Furusawa, Yukihiro; Kariya, Ayako; Hassan, Mariame Ali; Arai, Mie; Kondo, Takashi] Toyama Univ, Dept Radiol Sci, Grad Sch Med Pharmaceut Sci, Toyama 930, Japan; [Hassan, Mariame Ali] Cairo Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Cairo, Egypt; [Tabuchi, Yoshiaki] Toyama Univ, Div Mol Genet Res, Life Sci Res Ctr, Grad Sch Med Pharmaceut Sci, Toyama 930, Japan	University of Toyama; University of Toyama; Egyptian Knowledge Bank (EKB); Cairo University; University of Toyama	Tobe, K (corresponding author), Toyama Univ, Grad Sch Med Pharmaceut Sci, Dept Internal Med 1, Toyama 930, Japan.	tobe@med.u-toyama.ac.jp		Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [22390229]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this study was provided by a Grant-in-Aid for Scientific Research (B) (22390229), Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Dietrich C, 2010, CARCINOGENESIS, V31, P1319, DOI 10.1093/carcin/bgq028; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Furusawa Y, 2012, CANCER LETT, V322, P107, DOI 10.1016/j.canlet.2012.02.020; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Furusawa Y, 2011, INT J MOL MED, V28, P143, DOI 10.3892/ijmm.2011.702; Furusawa Y, 2010, CANCER LETT, V288, P107, DOI 10.1016/j.canlet.2009.06.029; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He LS, 2006, J BIOL CHEM, V281, P11235, DOI 10.1074/jbc.M508779200; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Huang GM, 2012, MOL PHARMACOL, V81, P338, DOI 10.1124/mol.111.075952; Huang JR, 1997, J BIOL CHEM, V272, P26009, DOI 10.1074/jbc.272.41.26009; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jalal S, 2011, CLIN CANCER RES, V17, P6973, DOI 10.1158/1078-0432.CCR-11-0761; Ju JH, 2010, J BIOL CHEM, V285, P41152, DOI 10.1074/jbc.M110.158352; Kourtidis A, 2010, CANCER RES, V70, P1783, DOI 10.1158/0008-5472.CAN-09-1550; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Menendez JA, 2010, BBA-MOL CELL BIOL L, V1801, P381, DOI 10.1016/j.bbalip.2009.09.005; Miyakoda M, 2002, ONCOGENE, V21, P1090, DOI 10.1038/sj.onc.1205196; Nueda A, 1999, J BIOL CHEM, V274, P14988, DOI 10.1074/jbc.274.21.14988; Oshita C, 2012, ONCOL REP, V28, P1131, DOI 10.3892/or.2012.1956; Palma JP, 2009, CLIN CANCER RES, V15, P7277, DOI 10.1158/1078-0432.CCR-09-1245; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Schroeder C, 2012, INT J HYPERTHER, V28, P707, DOI 10.3109/02656736.2012.722263; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Suk K, 2001, J BIOL CHEM, V276, P13153, DOI 10.1074/jbc.M007646200; Sung HH, 2012, PROSTATE, V72, P1399, DOI 10.1002/pros.22491; Tabuchi Y, 2008, CANCER LETT, V270, P286, DOI 10.1016/j.canlet.2008.05.018; Tabuchi Y, 2006, BIOCHEM BIOPH RES CO, V345, P1044, DOI 10.1016/j.bbrc.2006.04.177; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; van der Zee J, 2000, LANCET, V355, P1119, DOI 10.1016/S0140-6736(00)02059-6; Wada S, 2007, FREE RADICAL RES, V41, P73, DOI 10.1080/10715760600946432; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	49	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58325	10.1371/journal.pone.0058325	http://dx.doi.org/10.1371/journal.pone.0058325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505488	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100046
J	Sdek, P; Oyama, K; Angelis, E; Chan, SS; Schenke-Layland, K; MacLellan, WR				Sdek, Patima; Oyama, Kyohei; Angelis, Ekaterini; Chan, Shing S.; Schenke-Layland, Katja; MacLellan, W. Robb			Epigenetic Regulation of Myogenic Gene Expression by Heterochromatin Protein 1 Alpha	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; II HISTONE DEACETYLASES; TERMINAL DIFFERENTIATION; HP1; DROSOPHILA; TRANSCRIPTION; ASSOCIATION; DOMAIN; CYCLE; PRB	Heterochromatin protein 1 (HP1) is an essential heterochromatin-associated protein typically involved in the epigenetic regulation of gene silencing. However, recent reports have demonstrated that HP1 can also activate gene expression in certain contexts including differentiation. To explore the role of each of the three mammalian HP1 family members (alpha, beta and gamma) in skeletal muscle, their expression was individually disrupted in differentiating skeletal myocytes. Among the three isoforms of HP1, HP1 alpha was specifically required for myogenic gene expression in myoblasts only. Knockdown of HP1 alpha led to a defect in transcription of skeletal muscle-specific genes including Lbx1, MyoD and myogenin. HP1 alpha binds to the genomic region of myogenic genes and depletion of HP1 alpha results in a paradoxical increase in histone H3 lysine 9 trimethylation (H3K9me3) at these sites. JHDM3A, a H3K9 demethylase also binds to myogenic gene's genomic regions in myoblasts in a HP1 alpha-dependent manner. JHDM3A interacts with HP1 alpha and knockdown of JHDM3A in myoblasts recapitulates the decreased myogenic gene transcription seen with HP1 alpha depletion. These results propose a novel mechanism for HP1 alpha-dependent gene activation by interacting with the demethylase JHDM3A and that HP1 alpha is required for maintenance of myogenic gene expression in myoblasts.	[Sdek, Patima; Oyama, Kyohei; Angelis, Ekaterini; Chan, Shing S.; Schenke-Layland, Katja; MacLellan, W. Robb] Univ Washington, Sch Med, Inst Stem Cell Res, Dept Med Cardiol,Ctr Cardiovasc Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	MacLellan, WR (corresponding author), Univ Washington, Sch Med, Inst Stem Cell Res, Dept Med Cardiol,Ctr Cardiovasc Biol, Seattle, WA 98195 USA.	WRMacLellan@cardiology.washington.edu	Schenke-Layland, Katja/E-5940-2013	Schenke-Layland, Katja/0000-0001-8066-5157; Oyama, Kyohei/0000-0002-8478-4417	 [NIHR01 HL70748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070748] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the NIHR01 HL70748 to WRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Angelis E, 2008, CIRC RES, V102, P1222, DOI 10.1161/CIRCRESAHA.107.163550; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Forcales SV, 2005, SEMIN CELL DEV BIOL, V16, P596, DOI 10.1016/j.semcdb.2005.07.005; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gross MK, 2000, DEVELOPMENT, V127, P413; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Lin CH, 2008, MOL CELL, V32, P696, DOI 10.1016/j.molcel.2008.11.008; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; MacLellan WR, 2000, MOL CELL BIOL, V20, P8903, DOI 10.1128/MCB.20.23.8903-8915.2000; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mennerich D, 2001, EMBO J, V20, P7174, DOI 10.1093/emboj/20.24.7174; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; Yahi H, 2008, J BIOL CHEM, V283, P23692, DOI 10.1074/jbc.M802647200; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yamano S, 2010, MOL BIOTECHNOL, V46, P287, DOI 10.1007/s12033-010-9302-5; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	45	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58319	10.1371/journal.pone.0058319	http://dx.doi.org/10.1371/journal.pone.0058319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505487	Green Submitted, gold, Green Published			2022-12-25	WOS:000316251100045
J	Chiu, PS; Lai, SC				Chiu, Ping-Sung; Lai, Shih-Chan			Matrix Metalloproteinase-9 Leads to Claudin-5 Degradation via the NF-kappa B Pathway in BALB/c Mice with Eosinophilic Meningoencephalitis Caused by Angiostrongylus cantonensis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CEREBROSPINAL FLUID BARRIER; ENDOTHELIAL-CELLS; IN-VITRO; PLASMINOGEN ACTIVATORS; TIGHT JUNCTIONS; MENINGITIS; EXPRESSION; INDUCTION; OCCLUDIN	The epithelial barrier regulates the movement of ions, macromolecules, immune cells and pathogens. The objective of this study was to investigate the role of the matrix metalloproteinase (MMP)-9 in the degradation of tight junction protein during infection with rat nematode lungworm Angiostrongylus cantonensis. The results showed that phosphorylation of I kappa B and NF-kappa B was increased in mice with eosinophilic meningoencephalitis. Treatment with MG132 reduced the phosphorylation of NF-kappa B and the activity of MMP-9, indicating upregulation of MMP-9 through the NF-kappa B signaling pathway. Claudin-5 was reduced in the brain but elevated in the cerebrospinal fluid (CSF), implying that A. cantonensis infection caused tight junction breakdown and led to claudin-5 release into the CSF. Degradation of claudin-5 coincided with alteration of the blood-CSF barrier permeability and treatment with the MMP inhibitor GM6001 attenuated the degradation of claudin-5. These results suggested that degradation of claudin-5 was caused by MMP-9 in angiostrongyliasis meningoencephalitis. Claudin-5 could be used for the pathophysiologic evaluation of the blood-CSF barrier breakdown and tight junction disruption after infection with A. cantonensis.	[Chiu, Ping-Sung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lai, Shih-Chan] Chung Shan Med Univ, Dept Parasitol, Taichung, Taiwan; [Lai, Shih-Chan] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lai, SC (corresponding author), Chung Shan Med Univ, Dept Parasitol, Taichung, Taiwan.	shih@csmu.edu.tw			National Science Council, Republic of China [NSC 101-2320-B-040-021]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported in part by research grant No. NSC 101-2320-B-040-021 from the National Science Council, Republic of China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras IE, 2003, J NEUROSCI RES, V74, P255, DOI 10.1002/jnr.10762; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Chen KM, 2006, INT J EXP PATHOL, V87, P113, DOI 10.1111/j.0959-9673.2006.00459.x; Deng Xiao-Lu, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P908; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GARDINER CH, 1990, AM J TROP MED HYG, V42, P70, DOI 10.4269/ajtmh.1990.42.70; Girard M, 2005, MOL BIOCHEM PARASIT, V139, P41, DOI 10.1016/j.molbiopara.2004.09.008; Hartz AMS, 2012, STROKE, V43, P514, DOI 10.1161/STROKEAHA.111.627562; Hou RF, 2004, INT J PARASITOL, V34, P1355, DOI 10.1016/j.ijpara.2004.08.010; HSU WY, 1990, PEDIATR INFECT DIS J, V9, P443, DOI 10.1097/00006454-199006000-00016; Lai SC, 2004, ANN TROP MED PARASIT, V98, P715, DOI 10.1179/000349804225021479; Lan KP, 2004, J HELMINTHOL, V78, P311, DOI 10.1079/JOH2004256; Lee HH, 2000, EXP PARASITOL, V95, P202, DOI 10.1006/expr.2000.4530; Lee HH, 2004, PARASITOL RES, V94, P321, DOI 10.1007/s00436-004-1196-3; Liao CW, 2008, PARASITE IMMUNOL, V30, P525, DOI 10.1111/j.1365-3024.2008.01048.x; Lippoldt A, 2000, NEUROREPORT, V11, P1427, DOI 10.1097/00001756-200005150-00015; Louboutin JP, 2010, J NEUROPATH EXP NEUR, V69, P801, DOI 10.1097/NEN.0b013e3181e8c96f; MACKERRAS MJ, 1954, NATURE, V173, P956, DOI 10.1038/173956a0; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; PARSONS JC, 1990, J PARASITOL, V76, P53, DOI 10.2307/3282627; Tenenbaum T, 2005, FEMS IMMUNOL MED MIC, V44, P25, DOI 10.1016/j.femsim.2004.12.006; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Wei PC, 2011, INT J PARASITOL, V41, P1175, DOI 10.1016/j.ijpara.2011.07.002; Wewer C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-51; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052; Zeni P, 2007, AM J PHYSIOL-CELL PH, V293, pC855, DOI 10.1152/ajpcell.00470.2006	27	44	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e53370	10.1371/journal.pone.0053370	http://dx.doi.org/10.1371/journal.pone.0053370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505411	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500003
J	Mhedbi-Hajri, N; Hajri, A; Boureau, T; Darrasse, A; Durand, K; Brin, C; Fischer-Le Saux, M; Manceau, C; Poussier, S; Pruvost, O; Lemaire, C; Jacques, MA				Mhedbi-Hajri, Nadia; Hajri, Ahmed; Boureau, Tristan; Darrasse, Armelle; Durand, Karine; Brin, Chrystelle; Fischer-Le Saux, Marion; Manceau, Charles; Poussier, Stephane; Pruvost, Olivier; Lemaire, Christophe; Jacques, Marie-Agnes			Evolutionary History of the Plant Pathogenic Bacterium Xanthomonas axonopodis	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; PSEUDOMONAS-SYRINGAE; POPULATION-STRUCTURE; MOSAIC STRUCTURE; CROP DEBRIS; RECOMBINATION; GENE; RELATEDNESS; DIVERGENCE; INFERENCE	Deciphering mechanisms shaping bacterial diversity should help to build tools to predict the emergence of infectious diseases. Xanthomonads are plant pathogenic bacteria found worldwide. Xanthomonas axonopodis is a genetically heterogeneous species clustering, into six groups, strains that are collectively pathogenic on a large number of plants. However, each strain displays a narrow host range. We address the question of the nature of the evolutionary processes geographical and ecological speciation - that shaped this diversity. We assembled a large collection of X. axonopodis strains that were isolated over a long period, over continents, and from various hosts. Based on the sequence analysis of seven housekeeping genes, we found that recombination occurred as frequently as point mutation in the evolutionary history of X. axonopodis. However, the impact of recombination was about three times greater than the impact of mutation on the diversity observed in the whole dataset. We then reconstructed the clonal genealogy of the strains using coalescent and genealogy approaches and we studied the diversification of the pathogen using a model of divergence with migration. The suggested scenario involves a first step of generalist diversification that spanned over the last 25 000 years. A second step of ecology-driven specialization occurred during the past two centuries. Eventually, secondary contacts between host-specialized strains probably occurred as a result of agricultural development and intensification, allowing genetic exchanges of virulence-associated genes. These transfers may have favored the emergence of novel pathotypes. Finally, we argue that the largest ecological entity within X. axonopodis is the pathovar.	[Mhedbi-Hajri, Nadia; Hajri, Ahmed; Boureau, Tristan; Darrasse, Armelle; Durand, Karine; Brin, Chrystelle; Fischer-Le Saux, Marion; Manceau, Charles; Poussier, Stephane; Lemaire, Christophe; Jacques, Marie-Agnes] INRA, Inst Rech Hort & Semences UMR1345, Beaucouze, France; [Mhedbi-Hajri, Nadia; Hajri, Ahmed; Boureau, Tristan; Darrasse, Armelle; Durand, Karine; Brin, Chrystelle; Fischer-Le Saux, Marion; Manceau, Charles; Poussier, Stephane; Lemaire, Christophe; Jacques, Marie-Agnes] Univ Angers, Inst Rech Hort & Semences UMR1345, PRES LUNAM, QUASAV SFR4207, Angers, France; [Mhedbi-Hajri, Nadia; Hajri, Ahmed; Boureau, Tristan; Darrasse, Armelle; Durand, Karine; Brin, Chrystelle; Fischer-Le Saux, Marion; Manceau, Charles; Poussier, Stephane; Lemaire, Christophe; Jacques, Marie-Agnes] AgroCampus Ouest, Inst Rech Hort & Semences UMR1345, Angers, France; [Pruvost, Olivier] CIRAD, UMR PVBMT, St Pierre, Reunion, France	INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; CIRAD	Jacques, MA (corresponding author), INRA, Inst Rech Hort & Semences UMR1345, Beaucouze, France.	marie-agnes.jacques@angers.inra.fr	Manceau, Charles/AAS-8130-2021; Darrasse, Armelle/ABB-3712-2021; Hajri, Ahmed/F-7603-2011	Hajri, Ahmed/0000-0002-1516-3852; Fischer-Le Saux, Marion/0000-0002-9567-9444; Pruvost, Olivier/0000-0002-3175-9795; Poussier, Stephane/0000-0003-0273-3518; DURAND, KARINE/0000-0001-6518-8401; Manceau, Charles/0000-0003-3590-6454	Tunisian Government; CG Maine et Loire; INRA; Region Pays de la Loire (Xanthost); Plant Health and Environment Department of INRA [SPE 2007-0077-01, AIP Bioressources 2008-077-01]	Tunisian Government; CG Maine et Loire(Region Pays de la Loire); INRA; Region Pays de la Loire (Xanthost)(Region Pays de la Loire); Plant Health and Environment Department of INRA	N. Mhedbi-Hajri and A. Hajri were supported by grants from the Tunisian Government, from CG Maine et Loire and from INRA. This study was funded by the Region Pays de la Loire (Xanthost) and the Plant Health and Environment Department of INRA (SPE 2007-0077-01, AIP Bioressources 2008-077-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2009, GENETICS, V183, P249, DOI 10.1534/genetics.109.104042; Achtman M, 2012, PHILOS T R SOC B, V367, P860, DOI 10.1098/rstb.2011.0303; Ah-You N, 2009, INT J SYST EVOL MICR, V59, P306, DOI 10.1099/ijs.0.65453-0; Alavi SM, 2008, APPL ENVIRON MICROB, V74, P3295, DOI 10.1128/AEM.02507-07; Alavi SM, 2007, APPL ENVIRON MICROB, V73, P1678, DOI 10.1128/AEM.02031-06; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Barak JD, 2001, PLANT DIS, V85, P169, DOI 10.1094/PDIS.2001.85.2.169; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bucheli E, 2001, MOL ECOL, V10, P285, DOI 10.1046/j.1365-294x.2001.01146.x; BURDON JJ, 1989, ANNU REV ECOL SYST, V20, P119, DOI 10.1146/annurev.es.20.110189.001003; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Cohan FM, 2002, GENETICA, V116, P359, DOI 10.1023/A:1021232409545; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Comas I, 2006, MOL BIOL EVOL, V23, P2049, DOI 10.1093/molbev/msl075; Costechareyre D, 2009, MOL BIOL EVOL, V26, P167, DOI 10.1093/molbev/msn236; Coyne JA, 2004, SPECIATION; Darrasse A, 2010, APPL ENVIRON MICROB, V76, P6787, DOI 10.1128/AEM.01098-10; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Didelot X, 2010, BACTERIAL POPULATION, P103; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; FU YX, 1993, GENETICS, V133, P693; Gent DH, 2005, PHYTOPATHOLOGY, V95, P918, DOI 10.1094/PHYTO-95-0918; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Grunwald NJ, 2011, ANNU REV PHYTOPATHOL, V49, P249, DOI 10.1146/annurev-phyto-072910-095246; Hajri A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006632; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hancock JF, 2006, PLANT EVOLUTION; Hayward A. C., 1993, Xanthomonas., P1; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; HUDSON RR, 1985, GENETICS, V111, P147; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovell HC, 2011, MOL PLANT PATHOL, V12, P167, DOI 10.1111/j.1364-3703.2010.00658.x; Maddison, 2019, MESQUITE MODULAR SYS; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mhedbi-Hajri N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-67; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Nei M, 1987, MOL EVOLUTIONARY GEN; Ngoc LBT, 2010, INT J SYST EVOL MICR, V60, P515, DOI 10.1099/ijs.0.009514-0; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Pritchard JK, 2000, GENETICS, V155, P945; Rademaker JLW, 2005, PHYTOPATHOLOGY, V95, P1098, DOI 10.1094/PHYTO-95-1098; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Sheppard SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015708; Sikirou R, 2004, EUR J PLANT PATHOL, V110, P939, DOI 10.1007/s10658-004-8949-9; SMITH JM, 1992, J MOL EVOL, V34, P126; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Stukenbrock EH, 2007, MOL BIOL EVOL, V24, P398; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vauterin L, 2000, PHYTOPATHOLOGY, V90, P677, DOI 10.1094/PHYTO.2000.90.7.677; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zeller KA, 2004, MOL ECOL, V13, P563, DOI 10.1046/j.1365-294X.2004.02098.x	87	58	58	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58474	10.1371/journal.pone.0058474	http://dx.doi.org/10.1371/journal.pone.0058474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505513	Green Published, gold			2022-12-25	WOS:000318334500088
J	Lopez, RP; Valdivia, S; Rivera, ML; Rios, RS				Pablo Lopez, Ramiro; Valdivia, Sergio; Rivera, Monica L.; Rios, Rodrigo S.			Co-occurrence Patterns along a Regional Aridity Gradient of the Subtropical Andes Do Not Support Stress Gradient Hypotheses	PLOS ONE			English	Article							DESERT PLANT-COMMUNITIES; POSITIVE INTERACTIONS; SPECIES RICHNESS; ABIOTIC STRESS; INTERACTIONS INCREASE; BIOTIC INTERACTIONS; NURSE PLANTS; FACILITATION; ENVIRONMENTS; SHRUB	The stress gradient hypothesis posits that facilitation and stress are positively correlated. The hump-shaped hypothesis, on the contrary, proposes that facilitation is greater at intermediate stress levels. The relationship between facilitation and environmental stress is commonly studied at small spatial scales and/or considering few species; thus, the implications of facilitation at a community level remain poorly understood. Here, we analyzed local co-occurrence patterns of all plant species at 25 sites within the subtropical Andes to evaluate the role of facilitation and competition as drivers of community structure. We considered a wide latitudinal gradient (19-26 degrees S) that incorporates great variation in aridity. No previous studies have attempted to study these patterns across such a broad scale in warm deserts. Each locality was sampled at two scales (quadrat and patch), and co-occurrence was analyzed via null models. Furthermore, we tested for a relationship between plant co-occurrences and environmental aridity. Resulting patterns depended on life form. When all species were considered, negative associations were found, indicating competition. Woody/cactus life forms tended to be associated across communities, suggesting that there is facilitation between these life forms. Additionally, and unlike previous studies, we found positive associations among shrubs. The strength of the association between woody species changed non-monotonically with aridity. Herbs showed an inverted hump-shaped relationship, albeit ranging mostly among neutral values. Independent of the association type exhibited by different life forms, our community level results do not support current stress gradient hypotheses.	[Pablo Lopez, Ramiro; Rios, Rodrigo S.] Inst Ecol UMSA, Herbario Nacl Bolivia, La Paz, Bolivia; [Valdivia, Sergio] Inst Ecol, CPEC, La Paz, Bolivia; [Pablo Lopez, Ramiro; Rivera, Monica L.] Univ La Serena, Dept Biol, Inst Ecol & Biodiversidad IEB, Lab Ecofisiol Vegetal, La Serena, Chile; [Rios, Rodrigo S.] Univ La Serena, Dept Biol, Lab Ecol Func, La Serena, Chile	Universidad Mayor de San Andres; Universidad de La Serena; Universidad de La Serena	Lopez, RP (corresponding author), Inst Ecol UMSA, Herbario Nacl Bolivia, La Paz, Bolivia.	rlopez@userena.cl	Rios, Rodrigo/G-4937-2013; Lopez, Ramiro Pablo/O-3491-2019; Rios, Rodrigo S./C-5098-2015	Rios, Rodrigo S./0000-0003-3068-0118	IFS [AD/21235]	IFS(International Foundation for Science)	The study was supported by IFS Grant to S. Valdivia (No. AD/21235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1997, ECOLOGY, V78, P93, DOI 10.1890/0012-9658(1997)078[0093:SDCTDO]2.0.CO;2; Anthelme F, 2009, BASIC APPL ECOL, V10, P437, DOI 10.1016/j.baae.2008.10.008; Armas C, 2011, J VEG SCI, V22, P818, DOI 10.1111/j.1654-1103.2011.01301.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bowker MA, 2010, J ECOL, V98, P551, DOI 10.1111/j.1365-2745.2010.01647.x; Brooker R, 2005, OIKOS, V109, P63, DOI 10.1111/j.0030-1299.2005.13557.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burnham KP, 2002, MULTIMODEL INFERENCE; Cabrera A. L., 1980, BIOGEOGRAFIA AM LATI; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; Cuesta B, 2010, J ECOL, V98, P687, DOI 10.1111/j.1365-2745.2010.01655.x; de Viana ML, 2001, PLANT ECOL, V156, P193, DOI 10.1023/A:1012621106009; Dullinger S, 2007, J ECOL, V95, P1284, DOI 10.1111/j.1365-2745.2007.01288.x; Eccles NS, 1999, PLANT ECOL, V142, P71, DOI 10.1023/A:1009857824912; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; Garcia D, 2000, BIOL CONSERV, V95, P31, DOI 10.1016/S0006-3207(00)00016-1; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2; Gotelli NJ, 2006, ECOSIM NULL MODELS S; Gross N, 2010, PERSPECT PLANT ECOL, V12, P9, DOI 10.1016/j.ppees.2009.09.001; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holzapfel C, 2006, BASIC APPL ECOL, V7, P268, DOI 10.1016/j.baae.2005.08.003; Kikvidze Z, 2011, ALPINE BOT, V121, P63, DOI 10.1007/s00035-010-0085-x; Le Bagousse-Pinguet Y, 2013, J VEG SCI, V24, P375, DOI 10.1111/j.1654-1103.2012.01462.x; Liancourt P, 2005, ECOLOGY, V86, P1611, DOI 10.1890/04-1398; Lopez R. P., 2000, Ecologia en Bolivia, P45; Lopez RP, 2007, OECOLOGIA, V152, P779, DOI 10.1007/s00442-007-0698-y; Lopez Ramiro Pablo, 2002, Candollea, V57, P77; Lopez RP, 2009, J VEG SCI, V20, P728, DOI 10.1111/j.1654-1103.2009.01067.x; Luzuriaga AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041270; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Maltez-Mouro S, 2010, ACTA OECOL, V36, P80, DOI 10.1016/j.actao.2009.10.003; MCAULIFFE JR, 1988, AM NAT, V131, P459, DOI 10.1086/284802; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Mueller-Dombois H., 1974, AIMS METHODS VEGETAT; Lopez RP, 2010, J ARID ENVIRON, V74, P1534, DOI 10.1016/j.jaridenv.2010.06.008; Rayburn AP, 2012, ECOGRAPHY, V35, P341, DOI 10.1111/j.1600-0587.2011.07058.x; Rousset O, 1999, J VEG SCI, V10, P493, DOI 10.2307/3237184; Schenk HJ, 2003, J ECOL, V91, P383, DOI 10.1046/j.1365-2745.2003.00782.x; Seifan M, 2010, OIKOS, V119, P1601, DOI 10.1111/j.1600-0706.2010.18206.x; Smit C, 2009, J ECOL, V97, P1215, DOI 10.1111/j.1365-2745.2009.01555.x; Soliveres S, 2011, PERSPECT PLANT ECOL, V13, P247, DOI 10.1016/j.ppees.2011.06.001; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tirado R, 2005, OIKOS, V111, P437, DOI 10.1111/j.1600-0706.2005.14094.x; VALIENTEBANUET A, 1991, J VEG SCI, V2, P15, DOI 10.2307/3235893; WELDEN CW, 1986, Q REV BIOL, V61, P23, DOI 10.1086/414724; YEATON RI, 1978, J ECOL, V66, P651, DOI 10.2307/2259156	52	37	39	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58518	10.1371/journal.pone.0058518	http://dx.doi.org/10.1371/journal.pone.0058518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505527	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500097
J	Yuan, JM; Jin, CH; Qin, HD; Wang, JD; Sha, WW; Wang, MZ; Zhang, YB; Zhang, FQ; Li, JJ; Li, JF; Yu, S; Qi, SG; Shugart, YY				Yuan, Jianmin; Jin, Chunhui; Qin, Hai-De; Wang, Jidong; Sha, Weiwei; Wang, Mingzhong; Zhang, Yunbiao; Zhang, Fuquan; Li, Jijiang; Li, Jianfeng; Yu, Shui; Qi, Shuguang; Shugart, Yin Yao			Replication Study Confirms Link between TSPAN18 Mutation and Schizophrenia in Han Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; MENTAL-RETARDATION; BIPOLAR DISORDER; RISK	Schizophrenia (SCZ) is a severe psychiatric disorder associated with many different risk factors, both genetic and environmental. A recent genome-wide association study (GWAS) of Han Chinese identified three single-nucleotide polymorphisms (SNPs rs11038167, rs11038172, and rs835784) in the tetraspanins gene TSPAN18 as possible susceptibility loci for schizophrenia. Hoping to validate these findings, we conducted a case-control study of Han Chinese with 1093 schizophrenia cases and 1022 healthy controls. Using the LDR-PCR method to genotype polymorphisms in TSPAN18, we found no significant differences (P>0.05) between patients and controls in either the allele or genotype frequency of the SNPs rs11038167 and rs11038172. We did find, however, that the frequency of the 'A' allele of SNP rs835784 is significantly higher in patients than in controls. We further observed a significant association (OR = 1.197, 95% CI = 1.047-1.369) between risk for SCZ and this 'A' allele. These results confirm the significant association, in Han Chinese populations, of increased SCZ risk and the variant of the TSPAN18 gene containing the 'A' allele of SNP rs835784.	[Yuan, Jianmin; Jin, Chunhui; Wang, Jidong; Zhang, Yunbiao; Zhang, Fuquan; Yu, Shui; Qi, Shuguang] Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Jin, Chunhui] Jiangsu Inst Psychol, Wuxi, Jiangsu, Peoples R China; [Qin, Hai-De; Shugart, Yin Yao] NIMH, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Sha, Weiwei; Li, Jijiang] Yangzhou Wutaishan Hosp, Yangzhou, Jiangsu, Peoples R China; [Wang, Mingzhong; Li, Jianfeng] Nanjing Qinglongshan Mental Hosp, Nanjing, Jiangsu, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Qi, SG (corresponding author), Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China.	shuguangqi0208@126.com; kay1yao@mail.nih.gov		YAO, YIN/0000-0003-3053-8429; Zhang, Fuquan/0000-0003-3204-8191	Key Characteristic Specialty/Discipline of Wuxi Hospital Management Center; Wuxi Municipal Health Bureau [Q201208]; Intramural Research Program at the National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002930, ZIAMH002934, ZIAMH002929] Funding Source: NIH RePORTER	Key Characteristic Specialty/Discipline of Wuxi Hospital Management Center; Wuxi Municipal Health Bureau; Intramural Research Program at the National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the Key Characteristic Specialty/Discipline of Wuxi Hospital Management Center, from the Research Project of the Wuxi Municipal Health Bureau (Q201208). HDQ and YYS are supported by supported by the Intramural Research Program at the National Institute of Mental Health (NIMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this presentation do not necessarily represent the views of the NIMH, National Institutes of Health, Health and Human Services, or the United States Government.	Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Ma L, 2012, MOL PSYCHIATR, P1; Maranduba CMD, 2004, AM J MED GENET A, V124A, P413, DOI 10.1002/ajmg.a.20401; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Scholz CJ, 2010, AM J MED GENET B, V153B, P967, DOI 10.1002/ajmg.b.31057; Scholz CJ, 2009, CANCER LETT, V275, P198, DOI 10.1016/j.canlet.2008.10.014; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Thaker GK, 2001, NAT MED, V7, P667, DOI 10.1038/89040; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhou Z, 2008, CLIN EXP METASTAS, V25, P537, DOI 10.1007/s10585-008-9168-0	19	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58785	10.1371/journal.pone.0058785	http://dx.doi.org/10.1371/journal.pone.0058785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505562	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500127
J	Allan, BJM; Domenici, P; McCormick, MI; Watson, SA; Munday, PL				Allan, Bridie J. M.; Domenici, Paolo; McCormick, Mark I.; Watson, Sue-Ann; Munday, Philip L.			Elevated CO2 Affects Predator-Prey Interactions through Altered Performance	PLOS ONE			English	Article							CORAL-REEF FISH; OCEAN ACIDIFICATION DISRUPTS; CLIMATE-CHANGE; POMACENTRUS AMBOINENSIS; COLOR POLYMORPHISM; CARBONIC-ACID; MARINE FISH; BEHAVIOR; ESCAPE; START	Recent research has shown that exposure to elevated carbon dioxide (CO2) affects how fishes perceive their environment, affecting behavioral and cognitive processes leading to increased prey mortality. However, it is unclear if increased mortality results from changes in the dynamics of predator-prey interactions or due to prey increasing activity levels. Here we demonstrate that ocean pCO(2) projected to occur by 2100 significantly effects the interactions of a predator-prey pair of common reef fish: the planktivorous damselfish Pomacentrus amboinensis and the piscivorous dottyback Pseudochromis fuscus. Prey exposed to elevated CO2 (880 mu atm) or a present-day control (440 matm) interacted with similarly exposed predators in a cross-factored design. Predators had the lowest capture success when exposed to elevated CO2 and interacting with prey exposed to present-day CO2. Prey exposed to elevated CO2 had reduced escape distances and longer reaction distances compared to prey exposed to present-day CO2 conditions, but this was dependent on whether the prey was paired with a CO2 exposed predator or not. This suggests that the dynamics of predator-prey interactions under future CO2 environments will depend on the extent to which the interacting species are affected and can adapt to the adverse effects of elevated CO2.	[Allan, Bridie J. M.; McCormick, Mark I.; Watson, Sue-Ann; Munday, Philip L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Allan, Bridie J. M.; McCormick, Mark I.; Watson, Sue-Ann; Munday, Philip L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Domenici, Paolo] CNR IAMC, Ist Ambiente Marino Costiero, Torregrande, Oristano, Italy	James Cook University; James Cook University; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Allan, BJM (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	bridie.allan@my.jcu.edu.au	Watson, Sue-Ann/C-3172-2013; McCormick, Mark I/J-8301-2014; Domenici, Paolo/F-6958-2010; Munday, Philip L/F-5443-2011	Watson, Sue-Ann/0000-0002-9818-7429; McCormick, Mark I/0000-0001-9289-1645; Munday, Philip L/0000-0001-9725-2498	Australian Research Council; ARC Centre of Excellence for Coral Reef Studies [CE0561432]	Australian Research Council(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	Funding was provided by the Australian Research Council (MIM) and the ARC Centre of Excellence for Coral Reef Studies (Grant No. CE0561432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; de la Haye KL, 2011, ANIM BEHAV, V82, P495, DOI 10.1016/j.anbehav.2011.05.030; DIAMOND J, 1968, J PHYSIOL-LONDON, V194, P669, DOI 10.1113/jphysiol.1968.sp008432; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; DILL LM, 1974, ANIM BEHAV, V22, P711, DOI 10.1016/S0003-3472(74)80022-9; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Domenici P, 1997, J EXP BIOL, V200, P1165; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Kerrigan BA, 1996, MAR ECOL PROG SER, V135, P27, DOI 10.3354/meps135027; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Lanczos C., 1956, APPL ANAL; Landes A, 2012, MAR ECOL PROG SER, V450, P1, DOI 10.3354/meps09666; Langerhans RB, 2009, ECOLOGY EVOLUTION SW, P200; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Meekan MG, 2001, MAR BIOL, V139, P373; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Messmer V, 2005, CORAL REEFS, V24, P392, DOI 10.1007/s00338-005-0001-9; Munday P.L., 2012, J EXPT BIOL IN PRESS; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 1997, J FISH BIOL, V51, P931, DOI 10.1006/jfbi.1997.0498; Munday PL, 2003, OECOLOGIA, V137, P519, DOI 10.1007/s00442-003-1356-7; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Pierrot D., 2006, ORNLCDIAC105A US DEP; Planes S, 2004, MOL ECOL, V13, P2049, DOI 10.1111/j.1365-294X.2004.02202.x; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; SWEATMAN HPA, 1984, COPEIA, P187; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; WEBB PW, 1976, J EXP BIOL, V65, P157; WEBB PW, 1982, J COMP PHYSIOL, V147, P371, DOI 10.1007/BF00609671; Wisenden BD, 2012, FUNCT ECOL, V26, P551, DOI 10.1111/j.1365-2435.2011.01956.x; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646	43	77	79	1	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58520	10.1371/journal.pone.0058520	http://dx.doi.org/10.1371/journal.pone.0058520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484032	gold, Green Published, Green Accepted			2022-12-25	WOS:000316936100120
J	Kudgus, RA; Szabolcs, A; Khan, JA; Walden, CA; Reid, JM; Robertson, JD; Bhattacharya, R; Mukherjee, P				Kudgus, Rachel A.; Szabolcs, Annamaria; Khan, Jameel Ahmad; Walden, Chad A.; Reid, Joel M.; Robertson, J. David; Bhattacharya, Resham; Mukherjee, Priyabrata			Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics	PLOS ONE			English	Article							PHASE-III TRIAL; FACTOR-RECEPTOR; NUCLEOSIDE TRANSPORTERS; COMPARING GEMCITABINE; CANCER NANOTECHNOLOGY; CLINICAL BENEFIT; NANOPARTICLES; SIZE; CHEMISTRY; MECHANISM	Background: Pancreatic cancer is one of the deadliest of all human malignancies with limited options for therapy. Here, we report the development of an optimized targeted drug delivery system to inhibit advanced stage pancreatic tumor growth in an orthotopic mouse model. Method/Principal Findings: Targeting specificity in vitro was confirmed by preincubation of the pancreatic cancer cells with C225 as well as Nitrobenzylthioinosine (NBMPR - nucleoside transporter (NT) inhibitor). Upon nanoconjugation functional activity of gemcitabine was retained as tested using a thymidine incorporation assay. Significant stability of the nanoconjugates was maintained, with only 12% release of gemcitabine over a 24-hour period in mouse plasma. Finally, an in vivo study demonstrated the inhibition of tumor growth through targeted delivery of a low dose of gemcitabine in an orthotopic model of pancreatic cancer, mimicking an advanced stage of the disease. Conclusion: We demonstrated in this study that the gold nanoparticle-based therapeutic containing gemcitabine inhibited tumor growth in an advanced stage of the disease in an orthotopic model of pancreatic cancer. Future work would focus on understanding the pharmacokinetics and combining active targeting with passive targeting to further improve the therapeutic efficacy and increase survival.	[Kudgus, Rachel A.; Szabolcs, Annamaria; Khan, Jameel Ahmad; Bhattacharya, Resham; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Walden, Chad A.; Reid, Joel M.; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Robertson, J. David] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO USA; [Mukherjee, Priyabrata] Mayo Clin, Coll Med, Mayo Clin Canc Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Mayo Clinic	Mukherjee, P (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Mukherjee.priyabrata@mayo.edu		Robertson, John/0000-0002-6675-8469	National Institutes of Health [CA135011, CA136494]; NATIONAL CANCER INSTITUTE [R01CA135011, R01CA136494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health CA135011, CA136494 (PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvizo RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033650; Arvizo RR, 2012, CHEM SOC REV, V41, P2943, DOI 10.1039/c2cs15355f; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013; Bhattacharyya S, 2011, PHARM RES-DORDR, V28, P237, DOI 10.1007/s11095-010-0318-0; Bramhall SR, 2002, BRIT J CANCER, V87, P161, DOI 10.1038/sj.bjc.6600446; Brigger I, 2012, ADV DRUG DELIV REV; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Burris H, 1997, EUR J CANCER, V33, pS18, DOI 10.1016/S0959-8049(96)00324-3; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cobley CM, 2011, CHEM SOC REV, V40, P44, DOI 10.1039/b821763g; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Han G, 2007, NANOMEDICINE-UK, V2, P113, DOI 10.2217/17435889.2.1.113; Herbst RS, 2001, EXPERT OPIN BIOL TH, V1, P719, DOI 10.1517/14712598.1.4.719; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165; Khan JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020347; Kim ES, 2001, LUNG CANCER-J IASLC, V34, P427, DOI 10.1016/S0169-5002(01)00278-1; Kim ES, 2001, CURR OPIN ONCOL, V13, P506, DOI 10.1097/00001622-200111000-00014; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kleeff J, 2006, PANCREAS, V33, P111, DOI 10.1097/01.mpa.0000229010.62538.f2; Kudgus RA, 2011, ANTI-CANCER AGENT ME, V11, P965; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liao HJ, 2009, CANCER RES, V69, P6179, DOI 10.1158/0008-5472.CAN-09-0049; Mackey JR, 1998, CANCER RES, V58, P4349; Mackey JR, 1998, DRUG RESIST UPDATE, V1, P310, DOI 10.1016/S1368-7646(98)80047-2; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mangeney C, 2002, J AM CHEM SOC, V124, P5811, DOI 10.1021/ja010796h; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mukherjee Priyabrata, 2007, Journal of Nanobiotechnology, V5, P4, DOI 10.1186/1477-3155-5-4; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Patra CR, 2010, ADV DRUG DELIVER REV, V62, P346, DOI 10.1016/j.addr.2009.11.007; Patra CR, 2010, J MATER CHEM, V20, P547, DOI 10.1039/b913224d; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Philip PA, 2010, SURG ONCOL CLIN N AM, V19, P419, DOI 10.1016/j.soc.2009.11.012; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Rathos MJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-161; Rocha-Lima Caio M, 2007, Cancer Control, V14, P295; Saha K, 2011, SMALL, V7, P1903, DOI 10.1002/smll.201100478; Sardar R, 2009, LANGMUIR, V25, P13840, DOI 10.1021/la9019475; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Shore S, 2004, SURG ONCOL, V13, P201, DOI 10.1016/j.suronc.2004.11.001; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	60	28	29	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57522	10.1371/journal.pone.0057522	http://dx.doi.org/10.1371/journal.pone.0057522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483913	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100029
J	Li, XR; Wang, SH; Sitaram, RT; Andersson, C; Ljungberg, B; Li, AH				Li, Xingru; Wang, Sihan; Sitaram, Raviprakash T.; Andersson, Charlotta; Ljungberg, Borje; Li, Aihong			Single Nucleotide Polymorphisms in the Wilms' Tumour Gene 1 in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; WT1 GENE; GERMLINE MUTATIONS; PROGNOSTIC IMPACT; SUPPRESSOR GENE; GROUP-B; CANCER; EXPRESSION; CHEMOTHERAPY	The Wilms' tumour gene 1 (WT1) single nucleotide polymorphism (SNP) rs16754 has recently been described as an independent prognostic factor in acute myeloid leukaemia (AML) patients. It is of great interest to test whether WT1 SNPs can be used as a molecular marker in other cancer types in order to improve risk and treatment stratification. We performed sequencing analysis on all 10 exons of the WT1 gene in a total of 182 patients with clear cell renal cell carcinoma (ccRCC). Six different SNPs were identified, in descending order for minor allele frequency: rs2234582, rs16754, rs1799925, rs5030315, rs2234583, and rs2234581. At least one minor allele for WT1 SNP was identified in 61% of ccRCC patients. In the entire study population, only 6% carried two copies of the minor allele. The genotypes of WT1 SNPs in 78 tumour-free kidney tissue specimens were found to be in 95% concordance with corresponding tumour samples. No correlation was observed between WT1 SNP genotypes and RNA expression level. WT1 SNP genotypes did not associate with clinical and pathological characteristics. We found favourable outcomes associated with the homozygous minor allele for WT1 SNP. However, SNP genotypes did not show to be of prognostic significance when comparing wild-type versus homozygous or heterozygous for the minor allele in the entire cohort. None of the previously reported WT1 mutations in AML was found in the present study. A novel WT1 missense mutation was identified in only one patient. Our data suggest that common WT1 mutations are not involved in ccRCC. Due to too few cases harbouring the homozygous minor allele, the prognostic impact needs to be verified in larger study populations.	[Li, Xingru; Wang, Sihan; Andersson, Charlotta; Li, Aihong] Umea Univ, Dept Med Biosci, Umea, Sweden; [Sitaram, Raviprakash T.; Ljungberg, Borje] Umea Univ, Dept Perioperat Sci Urol & Androl, Umea, Sweden	Umea University; Umea University	Li, AH (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	aihong.li@medbio.umu.se		Ljungberg, Borje/0000-0002-4121-3753	Children's Cancer Foundation in Sweden; Lion's Cancer Research Foundation, Umea, Sweden; County Council of Vasterbotten, Umea, Sweden	Children's Cancer Foundation in Sweden; Lion's Cancer Research Foundation, Umea, Sweden; County Council of Vasterbotten, Umea, Sweden	This study was supported by the Children's Cancer Foundation in Sweden, the Lion's Cancer Research Foundation, Umea, Sweden and the County Council of Vasterbotten, Umea, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersson C, 2012, DIAGN MOL PATHOL, V21, P225, DOI 10.1097/PDM.0b013e318257ddb9; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Becker H, 2011, HAEMATOL-HEMATOL J, V96, P1488, DOI 10.3324/haematol.2011.041905; Chen X, 2012, LEUK LYMPHOMA; Choi YS, 2012, MEAT SCI, V91, P1, DOI 10.1016/j.meatsci.2011.11.011; Cilloni D, 2008, HAEMATOLOGICA, V93, P921, DOI 10.3324/haematol.12165; Cilloni D, 2009, J CLIN ONCOL, V27, P5195, DOI 10.1200/JCO.2009.22.4865; Dallosso AR, 2004, HUM MOL GENET, V13, P405, DOI 10.1093/hmg/ddh038; Damm F, 2010, J CLIN ONCOL, V28, P578, DOI 10.1200/JCO.2009.23.0342; Engholm G, 2012, NORDCAN CANC INCIDEN; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gaidzik VI, 2009, BLOOD, V113, P4505, DOI 10.1182/blood-2008-10-183392; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; Ho PA, 2011, J CLIN ONCOL, V29, P704, DOI 10.1200/JCO.2010.31.9327; Hollink IHIM, 2010, J CLIN ONCOL, V28, pE523, DOI 10.1200/JCO.2010.29.3860; Hollink IHIM, 2009, BLOOD, V113, P5951, DOI 10.1182/blood-2008-09-177949; Hou HA, 2010, BLOOD, V115, P5222, DOI 10.1182/blood-2009-12-259390; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Iliopoulos O, 1997, MOL MED, V3, P289, DOI 10.1007/BF03401807; Inoue K, 1997, BLOOD, V89, P1405, DOI 10.1182/blood.V89.4.1405; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; KAGEYAMA Y, 1995, JPN J CLIN ONCOL, V25, P173; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KingUnderwood L, 1996, BLOOD, V87, P2171, DOI 10.1182/blood.V87.6.2171.bloodjournal8762171; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; Ljungberg B, 2007, EUR UROL, V51, P1502, DOI 10.1016/j.eururo.2007.03.035; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Osaka M, 1997, INT J CANCER, V72, P696, DOI 10.1002/(SICI)1097-0215(19970807)72:4<696::AID-IJC23>3.0.CO;2-8; Ostergaard M, 2004, BRIT J HAEMATOL, V125, P590, DOI 10.1111/j.1365-2141.2004.04952.x; Paschka P, 2008, J CLIN ONCOL, V26, P4595, DOI 10.1200/JCO.2007.15.2058; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Renneville A, 2010, LEUKEMIA, V24, P476, DOI 10.1038/leu.2009.221; Royer-Pokora B, 2004, AM J MED GENET A, V127A, P249, DOI 10.1002/ajmg.a.30015; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sitaram RT, 2010, BRIT J CANCER, V103, P1255, DOI 10.1038/sj.bjc.6605878; Sugiyama H, 2001, INT J HEMATOL, V73, P177, DOI 10.1007/BF02981935; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Virappane P, 2008, J CLIN ONCOL, V26, P5429, DOI 10.1200/JCO.2008.16.0333; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58396	10.1371/journal.pone.0058396	http://dx.doi.org/10.1371/journal.pone.0058396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484026	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100116
J	Wang, RY; Shi, ZY; Guo, YY; Chen, JC; Chen, GQ				Wang, Rui-Yan; Shi, Zhen-Yu; Guo, Ying-Ying; Chen, Jin-Chun; Chen, Guo-Qiang			DNA Fragments Assembly Based on Nicking Enzyme System	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; ESCHERICHIA-COLI; PCR PRODUCTS; HOMOLOGOUS RECOMBINATION; SYNTHETIC BIOLOGY; URACIL-EXCISION; USER FUSION; IN-VITRO; ENDONUCLEASES; PLASMIDS	A couple of DNA ligation-independent cloning (LIC) methods have been reported to meet various requirements in metabolic engineering and synthetic biology. The principle of LIC is the assembly of multiple overlapping DNA fragments by single-stranded (ss) DNA overlaps annealing. Here we present a method to generate single-stranded DNA overlaps based on Nicking Endonucleases (NEases) for LIC, the method was termed NE-LIC. Factors related to cloning efficiency were optimized in this study. This NE-LIC allows generating 3'-end or 5'-end ss DNA overlaps of various lengths for fragments assembly. We demonstrated that the 10 bp/15 bp overlaps had the highest DNA fragments assembling efficiency, while 5 bp/10 bp overlaps showed the highest efficiency when T4 DNA ligase was added. Its advantage over Sequence and Ligation Independent Cloning (SLIC) and Uracil-Specific Excision Reagent (USER) was obvious. The mechanism can be applied to many other LIC strategies. Finally, the NEases based LIC (NE-LIC) was successfully applied to assemble a pathway of six gene fragments responsible for synthesizing microbial poly-3-hydroxybutyrate (PHB).	[Wang, Rui-Yan; Guo, Ying-Ying; Chen, Jin-Chun; Chen, Guo-Qiang] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Dept Biol Sci & Biotechnol,MOE Key Lab Bioinforma, Beijing 100084, Peoples R China; [Chen, Guo-Qiang] Tsinghua Univ, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China; [Shi, Zhen-Yu] Synthenome Com, Dingley Village, Vic, Australia	Tsinghua University; Tsinghua University	Chen, GQ (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Dept Biol Sci & Biotechnol,MOE Key Lab Bioinforma, Beijing 100084, Peoples R China.	chengq@mail.tsinghua.edu.cn	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Basic Research 973 Program of China [2012CB725201]; Natural Science Foundation of China [31270146]	National Basic Research 973 Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research 973 Program of China (Grant No. 2012CB725201 to GQC and JCC). GQC was also supported by Natural Science Foundation of China (Grant No. 31270146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaluru Narayana, 2012, Methods Mol Biol, V852, P77, DOI 10.1007/978-1-61779-564-0_7; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; Bitinaite Jurate, 2009, Curr Protoc Mol Biol, VChapter 3, DOI 10.1002/0471142727.mb0321s86; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Higgins LS, 2001, NUCLEIC ACIDS RES, V29, P2492, DOI 10.1093/nar/29.12.2492; Joneja A, 2011, ANAL BIOCHEM, V414, P58, DOI 10.1016/j.ab.2011.02.025; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li ZJ, 2009, APPL MICROBIOL BIOT, V83, P939, DOI 10.1007/s00253-009-1943-6; Liu Q, 2011, METAB ENG, V13, P11, DOI 10.1016/j.ymben.2010.10.004; Luzzietti N, 2012, NAT PROTOC, V7, P643, DOI 10.1038/nprot.2012.008; Luzzietti N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1004; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; Shao Zengyi, 2012, Methods Mol Biol, V898, P251, DOI 10.1007/978-1-61779-918-1_17; Shao ZY, 2011, MOL BIOSYST, V7, P1056, DOI 10.1039/c0mb00338g; Shi ZY, 2012, THESIS U MELBOURNE; Tachibana A, 2009, J BIOSCI BIOENG, V107, P668, DOI 10.1016/j.jbiosc.2009.01.019; Too PHM, 2010, NUCLEIC ACIDS RES, V38, P1294, DOI 10.1093/nar/gkp1092; Tsvetanova B, 2011, METHOD ENZYMOL, V498, P327, DOI 10.1016/B978-0-12-385120-8.00014-0; Xu SY, 2007, NUCLEIC ACIDS RES, V35, P4608, DOI 10.1093/nar/gkm481; Yang J, 2010, BIOTECHNIQUES, V49, P817, DOI 10.2144/000113520; Zheleznaya LA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1457, DOI 10.1134/S0006297909130033; Zhou Q, 2011, METAB ENG, V13, P777, DOI 10.1016/j.ymben.2011.10.002; Zhu ZY, 2004, J MOL BIOL, V337, P573, DOI 10.1016/j.jmb.2004.02.003	34	23	31	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57943	10.1371/journal.pone.0057943	http://dx.doi.org/10.1371/journal.pone.0057943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483947	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100057
J	Kupper, N; Pelle, AJ; Szabo, BM; Denollet, J				Kupper, Nina; Pelle, Aline J.; Szabo, Balazs M.; Denollet, Johan			The Relationship between Type D Personality, Affective Symptoms and Hemoglobin Levels in Chronic Heart Failure	PLOS ONE			English	Article							KIDNEY-FUNCTION DECLINE; QUALITY-OF-LIFE; PSYCHOLOGICAL-FACTORS; MYOCARDIAL-INFARCTION; CANCER-PATIENTS; EPOETIN-ALPHA; RISK-FACTORS; ANEMIA; DEPRESSION; INFLAMMATION	Background: Anemia is associated with poor prognosis in heart failure (HF) patients. Contributors to the risk of anemia in HF include hemodilution, renal dysfunction and inflammation. Hemoglobin levels may also be negatively affected by alterations in stress regulatory systems. Therefore, psychological distress characterized by such alterations may adversely affect hemoglobin in HF. The association between hemoglobin and Type D personality and affective symptomatology in the context of HF is poorly understood. Aim: To examine the relationship between Type D personality and affective symptomatology with hemoglobin levels at inclusion and 12-month follow-up, controlling for relevant clinical factors. Methods: Plasma levels of hemoglobin and creatinine were assessed in 264 HF patients at inclusion and at 12-month follow-up. Type D personality and affective symptomatology were assessed at inclusion. Results: At inclusion, hemoglobin levels were similar for Type D and non-Type D HF patients (p=.23), and were moderately associated with affective symptomatology (r=-.14, p=.02). Multivariable regression showed that Type D personality (beta=-.15; p=.02), was independently associated with future hemoglobin levels, while controlling for renal dysfunction, gender, NYHA class, time since diagnosis, BMI, the use of angiotensin-related medication, and levels of affective symptomatology. Change in renal function was associated with Type D personality (beta=.20) and hemoglobin at 12 months (beta=-.25). Sobel mediation analysis showed significant partial mediation of the Type D - hemoglobin association by renal function deterioration (p=.01). Anemia prevalence increased over time, especially in Type D patients. Female gender, poorer baseline renal function, deterioration of renal function and a longer HF history predicted the observed increase in anemia prevalence over time, while higher baseline hemoglobin was protective. Conclusion: Type D personality, but not affective symptomatology, was associated with reduced future hemoglobin levels, independent of clinical factors. The relation between Type D personality and future hemoglobin levels was mediated by renal function deterioration.	[Kupper, Nina; Pelle, Aline J.; Denollet, Johan] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands; [Kupper, Nina] TweeSteden Hosp, Dept Cardiol, Tilburg, Netherlands; [Szabo, Balazs M.] St Elizabeth Hosp, Dept Cardiol, Tilburg, Netherlands	Tilburg University; Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ)	Kupper, N (corresponding author), Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.	h.m.kupper@tilburguniversity.edu	Kupper, Nina M/B-6337-2011; Kupper, Nina/B-7045-2011	Kupper, Nina M/0000-0001-8721-5239; 	Dutch Research Organization VICI grant [NWO 453-04-004]	Dutch Research Organization VICI grant	This work was supported by a Dutch Research Organization VICI grant (grant number: NWO 453-04-004; www.nwo.nl) awarded to Prof. Dr. J. Denollet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlbrecht C, 2008, EUR HEART J, V29, P2343, DOI 10.1093/eurheartj/ehn359; Adomaitiene V, 2008, EUR PSYCHIAT, V23, pS269, DOI 10.1016/j.eurpsy.2008.01.549; Anand IS, 2008, HEART FAIL REV, V13, P379, DOI 10.1007/s10741-008-9088-8; Anand IS, 2008, J AM COLL CARDIOL, V52, P501, DOI 10.1016/j.jacc.2008.04.044; Bansal N, 2007, AM J CARDIOL, V99, P1137, DOI 10.1016/j.amjcard.2006.11.055; CASADEVALL N, 1995, NEPHROL DIAL TRANSPL, V10, P27, DOI 10.1093/ndt/10.supp6.27; Comin-Colet J, 2012, EUR HEART J; de Jonge P, 2007, J PSYCHOSOM RES, V63, P477, DOI 10.1016/j.jpsychores.2007.06.002; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2008, BRAIN BEHAV IMMUN, V22, P736, DOI 10.1016/j.bbi.2007.10.015; Denollet J, 2006, PSYCHOTHER PSYCHOSOM, V75, P346, DOI 10.1159/000095440; Denollet J, 2009, AM J CARDIOL, V103, P399, DOI 10.1016/j.amjcard.2008.09.096; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Geiser F, 2007, SUPPORT CARE CANCER, V15, P273, DOI 10.1007/s00520-006-0132-8; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; He F, 2011, CELL BIOCHEM BIOPHYS, V61, P65, DOI 10.1007/s12013-011-9162-z; Heffner KL, 2011, IMMUNOL ALLERGY CLIN, V31, P95, DOI 10.1016/j.iac.2010.09.005; Hiramoto JS, 2012, AM J KIDNEY DIS, V60, P225, DOI 10.1053/j.ajkd.2012.02.335; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555; Kleijn L, 2012, HEART, V98, P1237, DOI 10.1136/heartjnl-2012-301954; Kourea K, 2008, EUR J CARDIOV PREV R, V15, P365, DOI 10.1097/HJR.0b013e3282f849d0; Kraai IH, 2012, INT J CARDIOL; Krishnan Gokul, 2006, BMC Pulm Med, V6, P23, DOI 10.1186/1471-2466-6-23; Kupper N, 2012, J AFFECT DISORDERS, V136, P567, DOI 10.1016/j.jad.2011.10.029; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lind M, 2002, BRIT J CANCER, V86, P1243, DOI 10.1038/sj.bjc.6600247; Lucca U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001920; Maas AJBM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-46; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P39, DOI 10.1093/ndt/17.suppl_11.39; MacMahon KMA, 2002, ARCH INTERN MED, V162, P509, DOI 10.1001/archinte.162.5.509; Martens EJ, 2007, J PSYCHOSOM RES, V63, P545, DOI 10.1016/j.jpsychores.2007.06.005; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; Members ATF, 2012, EUR HEART J; Messina A, 2011, ANN CLIN PSYCHIATRY, V23, P125; Molloy GJ, 2008, PSYCHOSOM MED, V70, P863, DOI 10.1097/PSY.0b013e3181842e0c; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Okonko DO, 2005, AM J CARDIOL, V96, P101, DOI 10.1016/j.amjcard.2005.02.053; Onder G, 2005, J GERONTOL A-BIOL, V60, P1168, DOI 10.1093/gerona/60.9.1168; Pelle AJ, 2010, INT J CARDIOL, V145, P82, DOI 10.1016/j.ijcard.2009.05.018; Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086; Pelle AJ, 2010, CIRC-HEART FAIL, V3, P261, DOI 10.1161/CIRCHEARTFAILURE.109.871483; Silverberg DS, 2009, CLIN EXP NEPHROL, V13, P101, DOI 10.1007/s10157-008-0074-1; SINGER JW, 1976, J CELL PHYSIOL, V88, P127, DOI 10.1002/jcp.1040880202; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666; Teng WF, 2008, BIOL TRACE ELEM RES, V121, P243, DOI 10.1007/s12011-007-8047-x; van der Meer P, 2009, HEART, V95, P1309, DOI 10.1136/hrt.2008.161091; von Haehling S, 2011, EUR J HEART FAIL, V13, P656, DOI 10.1093/eurjhf/hfr044; Wei CL, 2008, INT J HEMATOL, V88, P52, DOI 10.1007/s12185-008-0105-4; Whitehead DL, 2007, J PSYCHOSOM RES, V62, P419, DOI 10.1016/j.jpsychores.2006.11.005; WHO, 2011, WHONMHNHDMNM111; Williams L, 2011, PSYCHOL HEALTH, V26, P703, DOI 10.1080/08870446.2010.488265	57	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58370	10.1371/journal.pone.0058370	http://dx.doi.org/10.1371/journal.pone.0058370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472188	Green Submitted, Green Published, gold			2022-12-25	WOS:000315637900134
J	Hoffmann-Thoms, S; Weininger, U; Eckert, B; Jakob, RP; Koch, JR; Balbach, J; Schmid, FX				Hoffmann-Thoms, Stephanie; Weininger, Ulrich; Eckert, Barbara; Jakob, Roman P.; Koch, Johanna R.; Balbach, Jochen; Schmid, Franz X.			Initiation of Phage Infection by Partial Unfolding and Prolyl Isomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS ISOMERIZATION; N-TERMINAL DOMAINS; CRYSTAL-STRUCTURE; PROTEIN; FD; STATE; G3P; GENE-3-PROTEIN; STABILIZATION; CORECEPTOR	Infection of Escherichia coli by the filamentous phage fd starts with the binding of the N2 domain of the phage gene-3-protein to an F pilus. This interaction triggers partial unfolding of the gene-3-protein, cis -> trans isomerization at Pro-213, and domain disassembly, thereby exposing its binding site for the ultimate receptor TolA. The trans-proline sets a molecular timer to maintain the binding-active state long enough for the phage to interact with TolA. We elucidated the changes in structure and local stability that lead to partial unfolding and thus to the activation of the gene-3-protein for phage infection. Protein folding and TolA binding experiments were combined with real-time NMR spectroscopy, amide hydrogen exchange measurements, and phage infectivity assays. In combination, the results provide a molecular picture of how a local unfolding reaction couples with prolyl isomerization not only to generate the activated state of a protein but also to maintain it for an extended time.	[Hoffmann-Thoms, Stephanie; Eckert, Barbara; Jakob, Roman P.; Koch, Johanna R.; Schmid, Franz X.] Univ Bayreuth, Biochem Lab, D-95440 Bayreuth, Germany; [Weininger, Ulrich; Balbach, Jochen] Univ Halle Wittenberg, Biophys & Mitteldeutsches Zentrum Struktur & Dyna, Inst Phys, D-06120 Halle, Germany	University of Bayreuth; Martin Luther University Halle Wittenberg	Balbach, J (corresponding author), Univ Halle Wittenberg, Biophys & Mitteldeutsches Zentrum Struktur & Dyna, Inst Phys, Betty Heinemann Str 7, D-06120 Halle, Germany.	jochen.balbach@physik.uni-halle.de; fx.schmid@uni-bayreuth.de		Jakob, Roman/0000-0002-6451-8656; Weininger, Ulrich/0000-0003-0841-8332	Deutsche Forschungsgemeinschaft [SCHM 444/17-3, BA 1821/5-2]; German Bundesministerium fuer Forschung und Entwicklung [ProNet-T3]; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Bundesministerium fuer Forschung und Entwicklung; European Union(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (SCHM 444/17-3 and BA 1821/5-2) and the German Bundesministerium fuer Forschung und Entwicklung (ProNet-T3).; We thank the members of our groups for many fruitful discussions and Hartmut Oschkinat, Forschungsinstitut fur Molekulare Pharmakologie Berlin, for NMR time at the 900-MHz instrument. Significant investments into the NMR infrastructure from the European Regional Development Fund by the European Union are also gratefully acknowledged.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Click EM, 1997, J BACTERIOL, V179, P6464, DOI 10.1128/jb.179.20.6464-6471.1997; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Eckert B, 2007, J MOL BIOL, V373, P452, DOI 10.1016/j.jmb.2007.07.060; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Holliger P, 1999, J MOL BIOL, V288, P649, DOI 10.1006/jmbi.1999.2720; Jakob RP, 2008, J MOL BIOL, V377, P1560, DOI 10.1016/j.jmb.2008.02.010; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Krebber C, 1997, J MOL BIOL, V268, P607, DOI 10.1006/jmbi.1997.0981; Lorenz SH, 2011, J MOL BIOL, V405, P989, DOI 10.1016/j.jmb.2010.11.030; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; Martin A, 2003, J MOL BIOL, V328, P863, DOI 10.1016/S0022-2836(03)00359-0; Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7; Martin A, 2003, J MOL BIOL, V329, P599, DOI 10.1016/S0022-2836(03)00433-9; MAYR LM, 1993, BIOCHEMISTRY-US, V32, P7994, DOI 10.1021/bi00082a021; Pletneva EV, 2006, J MOL BIOL, V357, P550, DOI 10.1016/j.jmb.2005.12.073; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; RUSSEL M, 1988, J BACTERIOL, V170, P5312, DOI 10.1128/jb.170.11.5312-5316.1988; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Schwartz TU, 2006, P NATL ACAD SCI USA, V103, P6823, DOI 10.1073/pnas.0602083103; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Thiele A, 2011, J MOL BIOL, V411, P896, DOI 10.1016/j.jmb.2011.06.040; Weininger U, 2009, P NATL ACAD SCI USA, V106, P12335, DOI 10.1073/pnas.0902102106; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	31	11	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12979	12991		10.1074/jbc.M112.442525	http://dx.doi.org/10.1074/jbc.M112.442525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486474	Green Published, hybrid			2022-12-25	WOS:000318555100051
J	Sharma, M; Celver, J; Octeau, JC; Kovoor, A				Sharma, Meenakshi; Celver, Jeremy; Octeau, J. Christopher; Kovoor, Abraham			Plasma Membrane Compartmentalization of D2 Dopamine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; G-PROTEIN; SIGNAL-TRANSDUCTION; CELL-MEMBRANES; LIVE CELLS; MICRODOMAINS; DOMAIN; DISSOCIATION; TRAFFICKING	Plasma membrane microcompartments could allow different signaling pathways to operate more efficiently and prevent cross-talk. We utilized a novel in-cell biotin transfer assay to demonstrate that the majority of plasma membrane-expressed D2 dopamine receptor (D2R) is microcompartmentalized within detergent-resistant structures. Conversely, a minority of D2R existed in a detergent-soluble form and interacted in a relatively unrestricted manner with other cellular proteins. The microcompartmentalization of D2R had functional consequences because dopamine-induced internalization of D2R was largely restricted to the compartmentalized receptor. The D2R-containing microcompartments did not correspond to putative detergent-resistant lipid raft structures. First, the detergent-insoluble D2R structures were significantly denser than detergent-resistant membrane fragments containing flotillin, a widely utilized lipid raft marker protein. Second, the detergent solubility of D2R was unaffected by treatment of cells with the cholesterol chelating agent, methyl-beta-cyclodextrin, that is thought to disrupt lipid rafts. Finally, the in-cell biotinylation assay did not provide any evidence for the membrane compartmentalization of peptide motifs thought to target to lipid rafts. Thus, our observations form one of the first demonstrations, in living cells, of plasma membrane microcompartments defined by the ability of the compartment structure to broadly restrict the interaction of resident molecules with other cellular proteins.	[Sharma, Meenakshi; Celver, Jeremy; Octeau, J. Christopher; Kovoor, Abraham] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	University of Rhode Island	Celver, J (corresponding author), Univ Rhode Isl, 7 Green House Rd, Kingston, RI 02881 USA.	jeremy.celver@hotmail.com; abekovoor@uri.edu			National Institutes of Health, NIMH [R15MH091639]; Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award from the National Center for Research Resources (NCRR), National Institutes of Health [P20RR016457-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH091639] Funding Source: NIH RePORTER	National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award from the National Center for Research Resources (NCRR), National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health, NIMH, Grant R15MH091639 (to A. K. and M. S.) and a Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award, P20RR016457-10, from the National Center for Research Resources (NCRR), National Institutes of Health.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Celver J, 2012, J NEUROCHEM, V120, P56, DOI 10.1111/j.1471-4159.2011.07559.x; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Cho D, 2010, MOL ENDOCRINOL, V24, P574, DOI 10.1210/me.2009-0369; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Krager KJ, 2012, J LIPID RES, V53, P2214, DOI 10.1194/jlr.D026468; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lindner R, 2009, EXP CELL RES, V315, P2871, DOI 10.1016/j.yexcr.2009.07.020; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Prou D, 2001, J CELL SCI, V114, P3517; Remington G, 2003, J PSYCHIATR NEUROSCI, V28, P275; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Tanner W, 2011, PLANT CELL, V23, P1191, DOI 10.1105/tpc.111.086249; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	40	21	21	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12554	12568		10.1074/jbc.M112.443945	http://dx.doi.org/10.1074/jbc.M112.443945			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493394	Green Published, hybrid			2022-12-25	WOS:000318555100014
J	Riaz, A; Ilan, N; Vlodavsky, I; Li, JP; Johansson, S				Riaz, Anjum; Ilan, Neta; Vlodavsky, Israel; Li, Jin-Ping; Johansson, Staffan			Characterization of Heparanase-induced Phosphatidylinositol 3-Kinase-AKT Activation and Its Integrin Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; EPIDERMAL-GROWTH-FACTOR; SRC FAMILY KINASES; CELL-MIGRATION; SULFATE PROTEOGLYCANS; CLINICAL-SIGNIFICANCE; AKT PHOSPHORYLATION; SIGNALING PATHWAY; TYROSINE KINASE; TERMINAL DOMAIN	Heparanase functions as a heparan sulfate-degrading enzyme and as a ligand for an unidentified signaling receptor(s). Here, several reactions involved in the activation of the PI3K-AKT pathway by latent heparanase were characterized. Protein suppression using specific siRNAs revealed that heparanase-induced phosphorylation of AKT at Ser-473 was RICTOR-mTOR-dependent, whereas ILK and PAK1/2 were dispensable. p110 alpha was the PI3K catalytic isoform preferred by heparanase for AKT activation and cell proliferation because the p110 alpha inhibitor YM024 blocked these processes. Heparanase-induced AKT phosphorylation was low in mouse embryonic fibroblast cells expressing a RAS interaction-defective p110 alpha compared with wild type cells, indicating that RAS has an important role in the PI3K-AKT activation. The response to heparanase was also inefficient in suspension cultures of several cell lines, suggesting a requirement of integrins in this pathway. Adhesion via either alpha V beta 3 or alpha 5 beta 1 promoted heparanase-induced AKT phosphorylation, and a stronger effect was seen when both integrins were engaged. Simultaneous inhibition of FAK and PYK2 using a chemical inhibitor, or suppression of their expression, inhibited heparanase-induced AKT activation and cell proliferation. Stimulation of cells with heparanase enhanced their resistance against oxidative stress-or growth factor starvation-induced apoptosis. These results demonstrate that there is an intimate crosstalk between the heparanase receptor(s) and integrins during induction of the prosurvival PI3K-AKT pathway by heparanase.	[Riaz, Anjum; Li, Jin-Ping; Johansson, Staffan] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Johansson, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr Box 582, S-75123 Uppsala, Sweden.	staffan.johanason@imbim.uu.se			National Institutes of Health from the NCI [CA106456]; Swedish Cancer Foundation; Swedish Childhood Cancer Foundation; Swedish Research Council; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Foundation; Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA106456 from the NCI (to I. V). This work was also supported by grants from the Swedish Cancer Foundation and Swedish Childhood Cancer Foundation (to S. J.) and the Swedish Research Council and Swedish Cancer Foundation (to J.-P. L.)	Astier A, 1997, J BIOL CHEM, V272, P228; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Cohen-Kaplan V, 2012, J BIOL CHEM, V287, P6668, DOI 10.1074/jbc.M111.271346; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Edin ML, 2005, MOL CELL BIOL, V25, P4466, DOI 10.1128/MCB.25.11.4466-4475.2005; Edmondson JM., 1988, J TISSUE CULT METHOD, V11, P15, DOI DOI 10.1007/BF01404408; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Gohji K, 2001, J UROLOGY, V166, P1286, DOI 10.1016/S0022-5347(05)65754-0; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Maeda T, 2006, ONCOGENE, V25, P1408, DOI 10.1038/sj.onc.1209168; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Riaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032081; Rohloff J, 2002, BRIT J CANCER, V86, P1270, DOI 10.1038/sj.bjc.6600232; Salazar EP, 2001, J BIOL CHEM, V276, P17788, DOI 10.1074/jbc.M100984200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shinyo Y, 2003, ANN ONCOL, V14, P1505, DOI 10.1093/annonc/mdg407; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Svineng G, 1998, BIOCHEM J, V330, P1255, DOI 10.1042/bj3301255; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Velling T, 2008, EXP CELL RES, V314, P309, DOI 10.1016/j.yexcr.2007.08.018; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	54	46	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12366	12375		10.1074/jbc.M112.435172	http://dx.doi.org/10.1074/jbc.M112.435172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504323	hybrid, Green Published			2022-12-25	WOS:000318157600067
J	Aki, K; Fujii, N; Fujii, N				Aki, Kenzo; Fujii, Norihiko; Fujii, Noriko			Kinetics of Isomerization and Inversion of Aspartate 58 of alpha A-Crystallin Peptide Mimics under Physiological Conditions	PLOS ONE			English	Article							ACID-CONTAINING PROTEINS; HUMAN LENS; IMMUNOHISTOCHEMICAL LOCALIZATION; SIMULTANEOUS STEREOINVERSION; RACEMIZATION; RESIDUES; AGE; DEAMIDATION; DEGRADATION; ASPARAGINYL	Although proteins consist exclusively of L-amino acids, we have reported that aspartyl (Asp) 58 and Asp 151 residues of alpha A-crystallin of eye lenses from elderly cataract donors are highly inverted and isomerized to D-beta, D-alpha and L-beta-Asp residues through succinimide intermediates. Of these Asp isomers, large amounts of D-beta- and L-beta-isomers are present but the amount of D-alpha-isomer is not significant. The difference in abundance of the Asp isomers in the protein may be due to the rate constants for the formation of the isomers. However, the kinetics have not been well defined. Therefore, in this study, we synthesized a peptide corresponding to human alpha A-crystallin residues 55 to 65 (T(55)VLD(58)SGISEVR(65)) and its isomers in which L-alpha-Asp at position 58 was replaced with L-beta-, D-beta- and D-alpha-Asp and determined the rate of isomerization and inversion of Asp residues under physiological conditions (37 degrees C, pH7.4). The rate constant for dehydration from L-alpha-Asp peptide to L-succinimidyl peptide was 3 times higher than the rate constant for dehydration from L-beta-Asp peptide to L-succinimidyl peptide. The rate constant for hydrolysis from L-succinimidyl peptide to L-beta-Asp peptide was about 5 times higher than the rate constant for hydrolysis from L-succinimidyl peptide to L-alpha-Asp peptide. The rate constant for dehydration from L-alpha-Asp peptide to L-succinimidyl peptide was 2 times higher than the rate constant for dehydration from D-alpha-Asp peptide to D-succinimidyl peptide. The rate constants for hydrolysis from L-succinimidyl peptide to L-beta-Asp peptide and for hydrolysis from D-succinimidyl peptide to D-beta-Asp peptide were almost equal. Using these rate constants, we calculated the change in the abundance ratios of the 4 Asp isomers during a human lifespan. This result is consistent with the fact that isomerized Asp residues accumulate in proteins during the ageing process.	[Aki, Kenzo; Fujii, Norihiko; Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan	Kyoto University	Fujii, N (corresponding author), Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan.	nfujii@rri.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capasso S, 1996, THERMOCHIM ACTA, V286, P41, DOI 10.1016/0040-6031(96)02937-1; Cloos PAC, 2000, BIOCHEM J, V345, P473, DOI 10.1042/0264-6021:3450473; FISHER GH, 1992, NEUROSCI LETT, V143, P215, DOI 10.1016/0304-3940(92)90268-C; Fujii N, 2007, AMINO ACIDS, V32, P87, DOI 10.1007/s00726-006-0303-4; Fujii N, 1999, BIOCHEM BIOPH RES CO, V263, P322, DOI 10.1006/bbrc.1999.1279; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663, DOI 10.1093/oxfordjournals.jbchem.a124577; Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Fujii N, 2012, J BIOL CHEM; Fujii N, 2011, BIOCHEMISTRY-US, V50, P8628, DOI 10.1021/bi200983g; GEIGER T, 1987, J BIOL CHEM, V262, P785; HELFMAN PM, 1976, NATURE, V262, P279; Kaji Y, 2009, BRIT J OPHTHALMOL, V93, P977, DOI 10.1136/bjo.2008.144212; Kaji Y, 2009, BRIT J OPHTHALMOL, V93, P974, DOI 10.1136/bjo.2007.135889; Kaji Y, 2007, INVEST OPHTH VIS SCI, V48, P3923, DOI 10.1167/iovs.06-1284; MASTERS PM, 1978, P NATL ACAD SCI USA, V75, P1204, DOI 10.1073/pnas.75.3.1204; Miura Y, 2004, J CUTAN PATHOL, V31, P51, DOI 10.1046/j.0303-6987.2004.0144.x; Mori Y, 2011, J CHROMATOGR B, V879, P3303, DOI 10.1016/j.jchromb.2011.05.010; Ohtani S, 1998, GROWTH DEVELOP AGING, V62, P141; POWELL JT, 1992, ATHEROSCLEROSIS, V97, P201, DOI 10.1016/0021-9150(92)90132-Z; Ritz-Timme S, 2003, INT J LEGAL MED, V117, P96, DOI 10.1007/s00414-002-0355-2; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Sadakane Y, 2011, J CHROMATOGR B, V879, P3240, DOI 10.1016/j.jchromb.2011.03.020; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; Young GW, 2005, J BIOL CHEM, V280, P26094, DOI 10.1074/jbc.M503624200	26	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58515	10.1371/journal.pone.0058515	http://dx.doi.org/10.1371/journal.pone.0058515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505525	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500096
J	Hagglund, MGA; Roshanbin, S; Lofqvist, E; Hellsten, SV; Nilsson, VCO; Todkar, A; Zhu, YN; Stephansson, O; Drgonova, J; Uhl, GR; Schioth, HB; Fredriksson, R				Hagglund, Maria G. A.; Roshanbin, Sahar; Lofqvist, Erik; Hellsten, Sofie V.; Nilsson, Victor C. O.; Todkar, Aniruddha; Zhu, Yinan; Stephansson, Olga; Drgonova, Jana; Uhl, George R.; Schioth, Helgi B.; Fredriksson, Robert			B(0)AT2 (SLC6A15) Is Localized to Neurons and Astrocytes, and Is Involved in Mediating the Effect of Leucine in the Brain	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; COA-BINDING PROTEIN; ORPHAN TRANSPORTER; EXPRESSION PATTERN; V7-3 SLC6A15; RAT; CHAIN; IDENTIFICATION; HYPOTHALAMUS; METABOLISM	The B(0)AT2 protein is a product of the SLC6A15 gene belonging to the SLC6 subfamily and has been shown to be a transporter of essential branched-chain amino acids. We aimed to further characterize the B(0)AT2 transporter in CNS, and to use Slc6a15 knock out (KO) mice to investigate whether B(0)AT2 is important for mediating the anorexigenic effect of leucine. We used the Slc6a15 KO mice to investigate the role of B(0)AT2 in brain in response to leucine and in particular the effect on food intake. Slc6a15 KO mice show lower reduction of food intake as well as lower neuronal activation in the ventromedial hypothalamic nucleus (VMH) in response to leucine injections compared to wild type mice. We also used RT-PCR on rat tissues, in situ hybridization and immunohistochemistry on mouse CNS tissues to document in detail the distribution of SLC6A15 on gene and protein levels. We showed that B(0)AT2 immunoreactivity is mainly neuronal, including localization in many GABAergic neurons and spinal cord motor neurons. B(0)AT2 immunoreactivity was also found in astrocytes close to ventricles, and co-localized with cytokeratin and diazepam binding inhibitor (DBI) in epithelial cells of the choroid plexus. The data suggest that B(0)AT2 play a role in leucine homeostasis in the brain.	[Hagglund, Maria G. A.; Roshanbin, Sahar; Lofqvist, Erik; Hellsten, Sofie V.; Nilsson, Victor C. O.; Todkar, Aniruddha; Zhu, Yinan; Stephansson, Olga; Schioth, Helgi B.; Fredriksson, Robert] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Drgonova, Jana; Uhl, George R.] NIDA, Mol Neurobiol Branch, NIH, Baltimore, MD USA	Uppsala University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Fredriksson, R (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Robert.Fredriksson@neuro.uu.se	Fredriksson, Robert/AAH-3921-2019; Schioth, Helgi/AAQ-7239-2020	Fredriksson, Robert/0000-0002-2810-3226; Drgonova, Jana/0000-0002-4623-8466	Swedish Research Council; Ahlens Foundation; Novo Nordisk Foundation; Goran Gustafsson Foundation; Engkvist Foundation; Magnus Bergvall Foundation; National Institutes of Health Intramural Research Program (NIDA); Novo Nordisk Fonden [NNF12OC1016287] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000165] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Goran Gustafsson Foundation; Engkvist Foundation; Magnus Bergvall Foundation; National Institutes of Health Intramural Research Program (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Swedish Research Council as well as the Ahlens Foundation, the Novo Nordisk Foundation, the Goran Gustafsson Foundation, Engkvist Foundation and Magnus Bergvall Foundation, and the National Institutes of Health Intramural Research Program (NIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; Blais A, 2003, J NUTR, V133, P2156, DOI 10.1093/jn/133.7.2156; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; BUSCH AE, 1994, J BIOL CHEM, V269, P25581; Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Drgonova J, 2007, BRAIN RES, V1183, P10, DOI 10.1016/j.brainres.2007.09.001; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Faipoux R, 2008, J NUTR, V138, P1172, DOI 10.1093/jn/138.6.1172; Farmer MK, 2000, GENOMICS, V70, P241, DOI 10.1006/geno.2000.6387; Fischer J, 1999, NEUROSCIENCE, V92, P729, DOI 10.1016/S0306-4522(99)00017-2; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GRILL V, 1992, METABOLISM, V41, P28, DOI 10.1016/0026-0495(92)90186-E; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; He Lei, 2009, Human Genomics, V3, P195; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Hoglund PJ, 2005, BIOCHEM BIOPH RES CO, V336, P175, DOI 10.1016/j.bbrc.2005.08.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue K, 1996, MOL BRAIN RES, V37, P217, DOI 10.1016/0169-328X(95)00298-7; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; KNUDSEN J, 1989, BIOCHEM J, V262, P513, DOI 10.1042/bj2620513; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; Lagerstrom MC, 2007, J NEUROCHEM, V100, P1129, DOI 10.1111/j.1471-4159.2006.04281.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Luque JM, 1996, EUR J NEUROSCI, V8, P127, DOI 10.1111/j.1460-9568.1996.tb01173.x; Masson J, 1999, EUR J NEUROSCI, V11, P1349, DOI 10.1046/j.1460-9568.1999.00540.x; Masson J, 1996, RECEPTOR CHANNEL, V4, P227; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Parra LA, 2008, MOL PHARMACOL, V74, P1521, DOI 10.1124/mol.108.050005; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Sakai R, 2004, J NEUROCHEM, V88, P612, DOI 10.1111/j.1471-4159.2004.02179.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Sweatt AJ, 2004, J COMP NEUROL, V477, P360, DOI 10.1002/cne.20200; Takanaga H, 2005, BIOCHEM BIOPH RES CO, V337, P892, DOI 10.1016/j.bbrc.2005.09.128; Tome D, 2004, BRIT J NUTR, V92, pS27, DOI 10.1079/BJN20041138; UHL GR, 1992, MOL BRAIN RES, V16, P353, DOI 10.1016/0169-328X(92)90246-8; UHL GR, 1994, J EXP BIOL, V196, P229; VONOVERBECK J, 1985, VIRCHOWS ARCH A, V407, P1; Watts J, 2005, J PHYSIOL-LONDON, V562, P89, DOI 10.1113/jphysiol.2004.076984; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Yanase H, 2001, ARCH HISTOL CYTOL, V64, P449, DOI 10.1679/aohc.64.449; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S; Zaia KA, 2009, J BIOL CHEM, V284, P8439, DOI 10.1074/jbc.M806407200; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	64	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58651	10.1371/journal.pone.0058651	http://dx.doi.org/10.1371/journal.pone.0058651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505546	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500110
J	Rajadas, J; Sun, WC; Li, H; Inayathullah, M; Cereghetti, D; Tan, A; Coelho, VD; Chrest, FJ; Kusiak, JW; Smith, WW; Taub, D; Wu, JC; Rifkind, JM				Rajadas, Jayakumar; Sun, Wenchao; Li, Hai; Inayathullah, Mohammed; Cereghetti, Damiano; Tan, Aaron; Coelho, Valeria de Mello; Chrest, Francis J.; Kusiak, John W.; Smith, Wanli Wei; Taub, Dennis; Wu, Joseph C.; Rifkind, Joseph M.			Enhanced A beta(1-40) Production in Endothelial Cells Stimulated with Fibrillar A beta(1-42)	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; BLOOD-BRAIN-BARRIER; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; POSSIBLE INVOLVEMENT; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; IN-VITRO	Amyloid accumulation in the brain of Alzheimer's patients results from altered processing of the 39- to 43-amino acid amyloid beta protein (A beta). The mechanisms for the elevated amyloid (A beta(1-42)) are considered to be over-expression of the amyloid precursor protein (APP), enhanced cleavage of APP to A beta, and decreased clearance of A beta from the central nervous system (CNS). We report herein studies of A beta stimulated effects on endothelial cells. We observe an interesting and as yet unprecedented feedback effect involving A beta(1-42) fibril-induced synthesis of APP by Western blot analysis in the endothelial cell line Hep-1. We further observe an increase in the expression of A beta(1-40) by flow cytometry and fluorescence microscopy. This phenomenon is reproducible for cultures grown both in the presence and absence of serum. In the former case, flow cytometry reveals that A beta(1-40) accumulation is less pronounced than under serum-free conditions. Immunofluorescence staining further corroborates these observations. Cellular responses to fibrillar A beta(1-42) treatment involving eNOS upregulation and increased autophagy are also reported.	[Rifkind, Joseph M.] NIA, Mol Dynam Sect, Baltimore, MD 21224 USA; [Coelho, Valeria de Mello; Taub, Dennis] NIA, Immunol Lab, Baltimore, MD 21224 USA; [Chrest, Francis J.; Kusiak, John W.; Smith, Wanli Wei] NIA, Res Resources Branch, Baltimore, MD 21224 USA; [Rajadas, Jayakumar; Sun, Wenchao; Li, Hai; Inayathullah, Mohammed; Cereghetti, Damiano] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA; [Tan, Aaron] UCL, UCL Med Sch, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England; [Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Stanford University; University of London; University College London; Stanford University; Stanford University	Rajadas, J (corresponding author), Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA.	jayraja@stanford.edu; rifkindj@mail.nih.gov	Sun, Wenchao/H-7738-2017; de Mello Coelho, Valeria/ABA-1201-2021; Rajadas, Jayakumar/AHC-0630-2022; Inayathullah, Mohammed/C-6953-2015; Li, Haitong/S-9629-2019; Wu, Joseph/H-1067-2013; de Mello-Coelho, Valeria/N-2242-2014	Sun, Wenchao/0000-0003-4306-2896; Inayathullah, Mohammed/0000-0001-7646-1709; Rajadas, Jayakumar/0000-0001-6520-3923; Wu, Joseph/0000-0002-6068-8041; de Mello-Coelho, Valeria/0000-0002-9367-8181; Tan, Aaron/0000-0002-8935-0773	Intramural Research Program the National Institute of Health; National Institute on Aging; National Institute of Health [HL095571]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000047] Funding Source: NIH RePORTER	Intramural Research Program the National Institute of Health; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was in part supported by the Intramural Research Program the National Institute of Health, National Institute on Aging and National Institute of Health HL095571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman R, 2010, CLIN SCI, V119, P407, DOI 10.1042/CS20100094; Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Armstrong RA, 2006, CURR NEUROVASC RES, V3, P289, DOI 10.2174/156720206778792948; Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080; Bar-Am O, 2005, FASEB J, V19, P1899, DOI 10.1096/fj.05-3794fje; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Breton-Romero R, 2012, FREE RADICAL BIO MED, V52, P1093, DOI 10.1016/j.freeradbiomed.2011.12.026; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Cecchi C, 2007, NEUROBIOL AGING, V28, P863, DOI 10.1016/j.neurobiolaging.2006.05.014; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Eisenhauer PB, 2000, J NEUROSCI RES, V60, P804, DOI 10.1002/1097-4547(20000615)60:6<804::AID-JNR13>3.3.CO;2-T; EVIN G, 1995, BIOCHEMISTRY-US, V34, P14185, DOI 10.1021/bi00043a024; Francis P, 2006, ALZ DIS ASSOC DIS, V20, pS3, DOI 10.1097/01.wad.0000213803.82058.46; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guo QX, 2012, CELL RES, V22, P78, DOI 10.1038/cr.2011.116; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kisilevsky R, 2000, NAT MED, V6, P633, DOI 10.1038/76203; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; LeBlanc A, 1995, J NEUROSCI, V15, P7837; MAJUMDAR A, 2007, NEUROBIOL AGING; Mattson MP, 2002, METHOD ENZYMOL, V352, P455; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Naiki H, 1996, LAB INVEST, V74, P374; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Olivieri G, 2000, J NEUROCHEM, V74, P231, DOI 10.1046/j.1471-4159.2000.0740231.x; Origlia N, 2009, EXPERT REV NEUROTHER, V9, P1635, DOI [10.1586/ern.09.107, 10.1586/ERN.09.107]; Parvathy S, 2009, NEUROBIOL AGING, V30, P1792, DOI 10.1016/j.neurobiolaging.2008.01.011; Reed-Cossairt A, 2012, CURR GERONTOL GERIAT, V2012; Rockenstein E, 2005, J NEURAL TRANSM, V112, P269, DOI 10.1007/s00702-004-0181-4; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Thomas T, 1997, NEUROREPORT, V8, P1387, DOI 10.1097/00001756-199704140-00014; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; Ueno M, 2010, CURR MED CHEM, V17, P1125, DOI 10.2174/092986710790827816; Vinters Harry V, 2003, Adv Neurol, V92, P105; Vinters HV, 1998, ACTA NEUROPATHOL, V95, P235, DOI 10.1007/s004010050793; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yu D, 2012, NEUROBIOL AGING; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; ZLOKOVIC BV, 1993, BIOCHEM BIOPH RES CO, V197, P1034, DOI 10.1006/bbrc.1993.2582	56	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58194	10.1371/journal.pone.0058194	http://dx.doi.org/10.1371/journal.pone.0058194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505467	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500058
J	Rao, K; Walk, ST; Micic, D; Chenoweth, E; Deng, LL; Galecki, AT; Jain, R; Trivedi, I; Yu, M; Santhosh, K; Ring, C; Young, VB; Huffnagle, GB; Aronoff, DM				Rao, Krishna; Walk, Seth T.; Micic, Dejan; Chenoweth, Elizabeth; Deng, Lili; Galecki, Andrzej T.; Jain, Ruchika; Trivedi, Itishree; Yu, Marie; Santhosh, Kavitha; Ring, Cathrin; Young, Vincent B.; Huffnagle, Gary B.; Aronoff, David M.			Procalcitonin Levels Associate with Severity of Clostridium difficile Infection	PLOS ONE			English	Article							INTENSIVE-CARE PATIENTS; ANTIBIOTIC-TREATMENT; SERUM PROCALCITONIN; TREATMENT DURATION; DISEASE SEVERITY; CONTROLLED-TRIAL; NORTH-AMERICA; SEVERE SEPSIS; SHORT-TERM; MORTALITY	Objective: Clostridium difficile infection (CDI) is a major cause of morbidity and biomarkers that predict severity of illness are needed. Procalcitonin (PCT), a serum biomarker with specificity for bacterial infections, has been little studied in CDI. We hypothesized that PCT associated with CDI severity. Design: Serum PCT levels were measured for 69 cases of CDI. Chart review was performed to evaluate the presence of severity markers and concurrent acute bacterial infection (CABI). We defined the binary variables clinical score as having fever (T > 38 degrees C), acute organ dysfunction (AOD), and/or WBC > 15,000 cells/mm(3) and expanded score, which included the clinical score plus the following: ICU admission, no response to therapy, colectomy, and/or death. Results: In univariate analysis log(10) PCT associated with clinical score (OR 3.13, 95% CI 1.69-5.81, P<.001) and expanded score (OR 3.33, 95% CI 1.77-6.23, P<.001). In a multivariable model including the covariates log(10) PCT, enzyme immunoassay for toxin A/B, ribotype 027, age, weighted Charlson-Deyo comorbidity index, CABI, and extended care facility residence, log(10) PCT associated with clinical score (OR 3.09, 95% CI 1.5-6.35, P = .002) and expanded score (OR 3.06, 95% CI 1.49-6.26, P = .002). PCT >0.2 ng/mL was 81% sensitive/73% specific for a positive clinical score and had a negative predictive value of 90%. Conclusion: An elevated PCT level associated with the presence of CDI severity markers and CDI was unlikely to be severe with a serum PCT level below 0.2 ng/mL. The extent to which PCT changes during CDI therapy or predicts recurrent CDI remains to be quantified.	[Rao, Krishna; Walk, Seth T.; Micic, Dejan; Deng, Lili; Galecki, Andrzej T.; Jain, Ruchika; Trivedi, Itishree; Yu, Marie; Santhosh, Kavitha; Ring, Cathrin; Young, Vincent B.; Huffnagle, Gary B.; Aronoff, David M.] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA; [Rao, Krishna; Walk, Seth T.; Jain, Ruchika; Yu, Marie; Santhosh, Kavitha; Ring, Cathrin; Young, Vincent B.; Aronoff, David M.] Univ Michigan Hlth Syst, Div Infect Dis, Ann Arbor, MI USA; [Deng, Lili; Galecki, Andrzej T.] Univ Michigan Hlth Syst, Div Geriatr Med, Ann Arbor, MI USA; [Huffnagle, Gary B.] Univ Michigan Hlth Syst, Div Pulm & Crit Care, Ann Arbor, MI USA; [Deng, Lili; Galecki, Andrzej T.] Univ Michigan Hlth Syst, Dept Biostat, Ann Arbor, MI USA; [Young, Vincent B.; Huffnagle, Gary B.; Aronoff, David M.] Univ Michigan Hlth Syst, Dept Microbiol & Immunol, Ann Arbor, MI USA; [Yu, Marie] Univ Michigan Hlth Syst, Dept Pharm Serv, Ann Arbor, MI USA; [Chenoweth, Elizabeth] Univ Michigan, Sch Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Aronoff, DM (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA.	daronoff@umich.edu	Huffnagle, Gary B./ABF-1323-2020; Young, Vincent B/B-3179-2009; Rao, Krishna/R-3726-2019; Young, Vincent Bensan/M-9916-2019	Young, Vincent B/0000-0003-3687-2364; Rao, Krishna/0000-0002-9213-7850; Young, Vincent Bensan/0000-0003-3687-2364; Aronoff, David/0000-0003-4587-6121; Trivedi, Itishree/0000-0002-5338-5528	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [5U19AI090871-02]; bioMerieux, Inc., Durham, NC; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI097281, U19AI090871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); bioMerieux, Inc., Durham, NC; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (grant number 5U19AI090871-02) and by bioMerieux, Inc. (www.biomerieux-usa.com, Durham, NC), who provided research reagents for PCT measurements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received support from a commercial source, bioMerieux. The support granted by this commercial funder (to provide raw materials for measuring procalcitonin) did not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akerlund T, 2006, J CLIN MICROBIOL, V44, P353, DOI 10.1128/JCM.44.2.353-358.2006; [Anonymous], 2008, AM J RESP CRIT CARE, DOI DOI 10.1164/rccm.200708-1238OC; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Belmares J, 2008, EXPERT REV ANTI-INFE, V6, P897, DOI 10.1586/14787210.6.6.897; Burckhardt F, 2008, EMERG INFECT DIS, V14, P691, DOI 10.3201/eid1404.071023; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cloud J, 2009, CLIN GASTROENTEROL H, V7, P868, DOI 10.1016/j.cgh.2009.05.018; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Das R, 2010, AM J GASTROENTEROL, V105, P2040, DOI 10.1038/ajg.2010.142; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dubberke ER, 2008, CLIN INFECT DIS, V46, P497, DOI 10.1086/526530; Dubberke ER, 2007, INFECT CONT HOSP EP, V28, P208, DOI 10.1086/511792; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; Gould CV, 2008, CRIT CARE, V12, DOI 10.1186/cc6207; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Henrich TJ, 2009, EMERG INFECT DIS, V15, P415, DOI 10.3201/eid1503.080312; Herrlinger KR, 2004, INFLAMM BOWEL DIS, V10, P229, DOI 10.1097/00054725-200405000-00008; Hochreiter M, 2009, CRIT CARE, V13, DOI 10.1186/cc7903; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Humphries RM, 2012, J CLIN MICROBIOL; Korczowski B, 2004, ACTA PAEDIATR, V93, P169, DOI 10.1080/08035250310021127; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kyne L, 2002, INFECT CONT HOSP EP, V23, P653, DOI 10.1086/501989; Kyne L, 1999, AGE AGEING, V28, P107, DOI 10.1093/ageing/28.2.107; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Meisner M, 1997, EUR J CLIN CHEM CLIN, V35, P597; Morgan OW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001812; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Schroeder S, 2009, LANGENBECK ARCH SURG, V394, P221, DOI 10.1007/s00423-008-0432-1; Schuetz P, 2010, CLIN BIOCHEM, V43, P341, DOI 10.1016/j.clinbiochem.2009.08.029; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Simon P, 2008, CRIT CARE, V12, DOI 10.1186/cc7124; Stolz D, 2009, EUR RESPIR J, V34, P1364, DOI 10.1183/09031936.00053209; Venugopal AA, 2012, SCAND J INFECT DIS, V44, P243, DOI 10.3109/00365548.2011.631029; Verdoorn BP, 2010, DIAGN MICR INFEC DIS, V66, P24, DOI 10.1016/j.diagmicrobio.2009.08.015; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Welfare MR, 2011, J HOSP INFECT, V79, P359, DOI 10.1016/j.jhin.2011.08.015; Wilcox MH, 2012, CLIN MICROBIOL INFEC, V18, P13, DOI 10.1111/1469-0691.12057	43	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58265	10.1371/journal.pone.0058265	http://dx.doi.org/10.1371/journal.pone.0058265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505476	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500062
J	Suez, J; Porwollik, S; Dagan, A; Marzel, A; Schorr, YI; Desai, PT; Agmon, V; McClelland, M; Rahav, G; Gal-Mor, O				Suez, Jotham; Porwollik, Steffen; Dagan, Amir; Marzel, Alex; Schorr, Yosef Ilan; Desai, Prerak T.; Agmon, Vered; McClelland, Michael; Rahav, Galia; Gal-Mor, Ohad			Virulence Gene Profiling and Pathogenicity Characterization of Non-Typhoidal Salmonella Accounted for Invasive Disease in Humans	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; HOST ADAPTATION; BACTERIAL VIRULENCE; EPITHELIAL-CELLS; GENOMIC ISLAND; TYPHIMURIUM; EVOLUTION; MICE; IDENTIFICATION; INFECTION	Human infection with non-typhoidal Salmonella serovars (NTS) infrequently causes invasive systemic disease and bacteremia. To understand better the nature of invasive NTS (iNTS), we studied the gene content and the pathogenicity of bacteremic strains from twelve serovars (Typhimurium, Enteritidis, Choleraesuis, Dublin, Virchow, Newport, Bredeney, Heidelberg, Montevideo, Schwarzengrund, 9,12:l,v:- and Hadar). Comparative genomic hybridization using a Salmonella enterica microarray revealed a core of 3233 genes present in all of the iNTS strains, which include the Salmonella pathogenicity islands 1-5, 9, 13, 14; five fimbrial operons (bcf, csg, stb, sth, sti); three colonization factors (misL, bapA, sinH); and the invasion gene, pagN. In the iNTS variable genome, we identified 16 novel genomic islets; various NTS virulence factors; and six typhoid-associated virulence genes (tcfA, cdtB, hlyE, taiA, STY1413, STY1360), displaying a wider distribution among NTS than was previously known. Characterization of the bacteremic strains in C3H/HeN mice showed clear differences in disease manifestation. Previously unreported characterization of serovars Schwarzengrund, 9,12: l, v:-, Bredeney and Virchow in the mouse model showed low ability to elicit systemic disease, but a profound and elongated shedding of serovars Schwarzengrund and 9,12:l, v:-(as well as Enteritidis and Heidelberg) due to chronic infection of the mouse. Phenotypic comparison in macrophages and epithelial cell lines demonstrated a remarkable intra-serovar variation, but also showed that S. Typhimurium bacteremic strains tend to present lower intracellular growth than gastroenteritis isolates. Collectively, our data demonstrated a common core of virulence genes, which might be required for invasive salmonellosis, but also an impressive degree of genetic and phenotypic heterogeneity, highlighting that bacteremia is a complex phenotype, which cannot be attributed merely to an enhanced invasion or intracellular growth of a particular strain.	[Suez, Jotham; Dagan, Amir; Marzel, Alex; Rahav, Galia; Gal-Mor, Ohad] Chaim Sheba Med Ctr, Infect Dis Res Lab, IL-52621 Tel Hashomer, Israel; [Suez, Jotham; Marzel, Alex; Rahav, Galia] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Porwollik, Steffen; Desai, Prerak T.; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Schorr, Yosef Ilan; Agmon, Vered] Minist Hlth, Govt Cent Labs, Jerusalem, Israel; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Irvine	Gal-Mor, O (corresponding author), Chaim Sheba Med Ctr, Infect Dis Res Lab, IL-52621 Tel Hashomer, Israel.	Ohad.Gal-Mor@sheba.health.gov.il	Suez, Jotham/AAZ-5433-2020; Desai, Prerak/ABF-8529-2020; dagan, amir/AAF-4295-2021; dagan, amir/L-4250-2018	Suez, Jotham/0000-0003-3836-972X; dagan, amir/0000-0002-6572-8110; dagan, amir/0000-0002-6572-8110; Gal-Mor, Ohad/0000-0002-2540-6790; McClelland, Michael/0000-0003-1788-9347; Marzel, Alex/0000-0002-4795-6224	European Community's Seventh Framework Program [1096.39.11/2010]; United States National Institute of Allergy and Infectious Diseases; United States Department of Agriculture; United States - Israel Binational Agricultural Research and Development Fund	European Community's Seventh Framework Program; United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Agriculture(United States Department of Agriculture (USDA)); United States - Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation)	Work in the Infectious Diseases Research Laboratory was supported by grant number 249241 from the European Community's Seventh Framework Program (PF7/2007-2013) and a GIF Research grant number 1096.39.11/2010 to O.G. Work in the McClelland lab was supported by grants from the United States National Institute of Allergy and Infectious Diseases, the United States Department of Agriculture, and the United States - Israel Binational Agricultural Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba M, 2006, JPN J INFECT DIS, V59, P341; Anjum MF, 2005, INFECT IMMUN, V73, P7894, DOI 10.1128/IAI.73.12.7894-7905.2005; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Baumler AJ, 1997, ADV EXP MED BIOL, V412, P149; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Bronowski C, 2009, FEMS MICROBIOL LETT, V298, P29, DOI 10.1111/j.1574-6968.2009.01697.x; COLLINS FM, 1966, J EXP MED, V124, P601, DOI 10.1084/jem.124.4.601; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Faucher SP, 2009, MICROBIOL-SGM, V155, P477, DOI 10.1099/mic.0.022988-0; Feasey NA, 2012, LANCET; Folkesson A, 1999, MOL MICROBIOL, V33, P612, DOI 10.1046/j.1365-2958.1999.01508.x; Fuentes JA, 2008, RES MICROBIOL, V159, P279, DOI 10.1016/j.resmic.2008.02.006; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Gal-Mor O, 2006, MICROBES INFECT, V8, P2154, DOI 10.1016/j.micinf.2006.04.015; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Guiney DG, 1997, J CLIN INVEST, V99, P565, DOI 10.1172/JCI119196; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; HELMUTH R, 1985, INFECT IMMUN, V48, P175, DOI 10.1128/IAI.48.1.175-182.1985; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Karasova D, 2009, VET MICROBIOL, V139, P304, DOI 10.1016/j.vetmic.2009.06.023; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lawrence JG, 2005, CURR OPIN GENET DEV, V15, P584, DOI 10.1016/j.gde.2005.09.007; Mastroeni P, 2011, INFECT IMMUN, V79, P636, DOI 10.1128/IAI.00954-10; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oscarsson J, 2002, INFECT IMMUN, V70, P5759, DOI 10.1128/IAI.70.10.5759-5769.2002; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Petermann SR, 2008, MICROB PATHOGENESIS, V45, P110, DOI 10.1016/j.micpath.2008.04.001; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; ROUDIER C, 1990, INFECT IMMUN, V58, P1180, DOI 10.1128/IAI.58.5.1180-1185.1990; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Silva CA, 2012, INFECT IMMUN, V80, P839, DOI 10.1128/IAI.05497-11; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Suar M, 2006, INFECT IMMUN, V74, P632, DOI 10.1128/IAI.74.1.632-644.2006; Swearingen MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036043; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003	48	114	119	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58449	10.1371/journal.pone.0058449	http://dx.doi.org/10.1371/journal.pone.0058449			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505508	Green Published, gold			2022-12-25	WOS:000318334500085
J	Wu, B; Yang, HX				Wu, Bo; Yang, Hongxiao			Spatial Patterns and Natural Recruitment of Native Shrubs in a Semi-arid Sandy Land	PLOS ONE			English	Article							PLANT-POPULATIONS; SOIL-MOISTURE; ECOLOGICAL RESTORATION; SEEDLING EMERGENCE; DESERT; COMPETITION; CHINA; FACILITATION; DESERTIFICATION; LANDSCAPE	Passive restoration depending on native shrubs is an attractive approach for restoring desertified landscapes in semi-arid sandy regions. We sought to understand the relationships between spatial patterns of native shrubs and their survival ability in sandy environments. Furthermore, we applied our results to better understand whether passive restoration is feasible for desertified landscapes in semi-arid sandy regions. The study was conducted in the semi-arid Mu Us sandy land of northern China with the native shrub Artemisia ordosica. We analyzed population structures and patterns of A. ordosica at the edges and centers of land patches where sand was stabilized by A. ordosica-dominated vegetation. Saplings were more aggregated than adults, and both were more aggregated at the patch edges than at the patch centers. At the patch edges, spatial association of the saplings with the adults was mostly positive at distances 0.3-6.6 m, and turned from positive to neutral, and even negative, at other distances. At the patch centers, the saplings were spaced almost randomly around the adults, and their distances from the adults did not seem to affect their locations. A greater number of A. ordosica individuals emerged at the patch edges than at the patch centers. Such patterns may have resulted from their integrative adjustment to specific conditions of soil water supply and sand drift intensity. These findings suggest that in semi-arid sandy regions, native shrubs that are well-adapted to local environments may serve as low-cost and competent ecological engineers that can promote the passive restoration of surrounding patches of mobile sandy land.	[Wu, Bo] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Yang, Hongxiao] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Shandong, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Qingdao Agricultural University	Yang, HX (corresponding author), Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Shandong, Peoples R China.	yanghxny@gmail.com						BERKOWITZ AR, 1995, ECOLOGY, V76, P1156, DOI 10.2307/1940923; BERTNESS MD, 1989, ECOLOGY, V70, P257, DOI 10.2307/1938431; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bradshaw A, 2000, LANDSCAPE URBAN PLAN, V51, P89, DOI 10.1016/S0169-2046(00)00099-2; Brandle J.R., 1991, WINDBREAKS WORK; Breshears DD, 1997, ECOL APPL, V7, P1201, DOI 10.1890/1051-0761(1997)007[1201:OIHISR]2.0.CO;2; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Callaway RM, 1996, ECOLOGY, V77, P2130, DOI 10.2307/2265707; Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597; Cui LQ, 2010, J ARID LAND RESOURCE, V24, P77; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Guo K., 2000, ACTA ECOL SIN, V24, P275; HEISLER GM, 1988, AGR ECOSYST ENVIRON, V22-3, P41, DOI 10.1016/0167-8809(88)90007-2; HU XL, 1996, INNER MONGOLIA FORES, V3, P32; Jia X, 2011, OIKOS, V120, P472, DOI 10.1111/j.1600-0706.2010.18674.x; Jia ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045902; Kobayashi T, 2005, LANDSC ECOL ENG, V1, P17; Li SL, 2010, ECOL RES, V25, P655, DOI 10.1007/s11284-010-0699-x; Li XR, 2006, ECOL ENG, V28, P149, DOI 10.1016/j.ecoleng.2006.05.020; [凌裕泉 Ling Yuquan], 2003, [中国沙漠, Journal of Desert Research], V23, P12; Liu T, 2011, HYDROL EARTH SYST SC, V15, P3511, DOI [10.5194/hess-15-3511-2011, 10.5194/hess-15-1865-2011]; [马骥 Ma Ji], 2002, [中国沙漠, Journal of Desert Research], V22, P586; Ma Quan-lin, 2012, Shengtaixue Zazhi, V31, P1639; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Montane F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028652; Murrell DJ, 2001, TRENDS ECOL EVOL, V16, P529, DOI 10.1016/S0169-5347(01)02292-3; PHILLIPS DL, 1981, J ECOL, V69, P97, DOI 10.2307/2259818; Rodhouse TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028635; Schurr FM, 2004, PLANT ECOL, V173, P271, DOI 10.1023/B:VEGE.0000029335.13948.87; Shen W. S., 1986, J DESERT RES, V6, P13; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Stoll P, 2005, J ECOL, V93, P395, DOI 10.1111/j.0022-0477.2005.00989.x; Svoray T, 2007, LANDSCAPE ECOL, V22, P105, DOI 10.1007/s10980-006-9004-3; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Tobe K, 2005, ANN BOT-LONDON, V95, P649, DOI 10.1093/aob/mci060; Tobe K, 2007, AUST J BOT, V55, P55, DOI 10.1071/BT06060; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; [王妍 Wang Yan], 2011, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V25, P167; [魏宝 Wei Bao], 2012, [干旱区研究, Arid Zone Research], V29, P213; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2009, AM NAT, V174, pE106, DOI 10.1086/605368; Wu B, 2002, J ARID ENVIRON, V50, P429, DOI 10.1006/jare.2001.0847; Wu B, 2001, J ECOL, V21, P191; [吴晓旭 WU Xiaoxu], 2011, [中国沙漠, Journal of Desert Research], V31, P828; Xu JX, 2006, CATENA, V65, P279, DOI 10.1016/j.catena.2005.12.006; Yang H, 2006, J ARID ENVIRON, V65, P619, DOI 10.1016/j.jaridenv.2005.08.010; [杨洪晓 Yang Hongxiao], 2004, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University], V40, P684; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034597; Zhang GL, 2012, ECOL ENG, V38, P20, DOI 10.1016/j.ecoleng.2011.09.005; Zhang Q, 1983, CHINESE J ECOL, V2, P14; Zhang Xin-Shi, 2010, Chinese Journal of Plant Ecology, V34, P112, DOI 10.3773/j.issn.1005-264x.2010.01.014; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010; Zhao JZ, 2002, INT J SUST DEV WORLD, V9, P292, DOI 10.1080/13504500209470124; [No title captured]	56	20	23	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58331	10.1371/journal.pone.0058331	http://dx.doi.org/10.1371/journal.pone.0058331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505489	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500069
J	Chowdhury, R; Rasheed, M; Keidel, D; Moussalem, M; Olson, A; Sanner, M; Bajaj, C				Chowdhury, Rezaul; Rasheed, Muhibur; Keidel, Donald; Moussalem, Maysam; Olson, Arthur; Sanner, Michel; Bajaj, Chandrajit			Protein-Protein Docking with F(2)Dock 2.0 and GB-Rerank	PLOS ONE			English	Article							SHAPE COMPLEMENTARITY; MOLECULAR-MECHANICS; FORCE-FIELD; SOLVATION; ELECTROSTATICS; REFINEMENT; POTENTIALS; PRINCIPLES; PREDICTION; ALGORITHM	Motivation: Computational simulation of protein-protein docking can expedite the process of molecular modeling and drug discovery. This paper reports on our new F-2 Dock protocol which improves the state of the art in initial stage rigid body exhaustive docking search, scoring and ranking by introducing improvements in the shape-complementarity and electrostatics affinity functions, a new knowledge-based interface propensity term with FFT formulation, a set of novel knowledge-based filters and finally a solvation energy (GBSA) based reranking technique. Our algorithms are based on highly efficient data structures including the dynamic packing grids and octrees which significantly speed up the computations and also provide guaranteed bounds on approximation error. Results: The improved affinity functions show superior performance compared to their traditional counterparts in finding correct docking poses at higher ranks. We found that the new filters and the GBSA based reranking individually and in combination significantly improve the accuracy of docking predictions with only minor increase in computation time. We compared F-2 Dock 2.0 with ZDock 3.0.2 and found improvements over it, specifically among 176 complexes in ZLab Benchmark 4.0, F-2 Dock 2.0 finds a near-native solution as the top prediction for 22 complexes; where ZDock 3.0.2 does so for 13 complexes. F-2 Dock 2.0 finds a near-native solution within the top 1000 predictions for 106 complexes as opposed to 104 complexes for ZDock 3.0.2. However, there are 17 and 15 complexes where F-2 Dock 2.0 finds a solution but ZDock 3.0.2 does not and vice versa; which indicates that the two docking protocols can also complement each other. Availability: The docking protocol has been implemented as a server with a graphical client (TexMol) which allows the user to manage multiple docking jobs, and visualize the docked poses and interfaces. Both the server and client are available for download. Server: http://www.cs.utexas.edu/similar to bajaj/cvc/software/f2dock.shtml. Client: http://www.cs.utexas.edu/similar to bajaj/cvc/software/f2dockclient.shtml.	[Chowdhury, Rezaul; Rasheed, Muhibur; Moussalem, Maysam] Univ Texas Austin, Dept Comp Sci, Inst Computat Engn & Sci, Austin, TX 78712 USA; [Keidel, Donald; Olson, Arthur; Sanner, Michel; Bajaj, Chandrajit] Scripps Res Inst, La Jolla, CA 92037 USA	University of Texas System; University of Texas Austin; Scripps Research Institute	Bajaj, C (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	bajaj@cs.utexas.edu		Bajaj, Chandrajit/0000-0002-9619-3278	National Science Foundation (NSF) [CNS-0540033]; National Institutes of Health (NIH) [R01-GM074258, R01-GM073087, R01-EB004873]; NSF Graduate Research Fellowship; NIH [R01-GM073087]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074258, R01GM073087] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research of C. B., R. C., M. M., and M. R. of University of Texas, was supported in part by National Science Foundation (NSF) grant CNS-0540033, and grants from the National Institutes of Health (NIH) R01-GM074258, R01-GM073087, R01-EB004873. The research of M. M. was additionally supported by an NSF Graduate Research Fellowship. The research of M. S. and A.O. of TSRI was supported in part by a subcontract on NIH grant R01-GM073087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Bajaj C, 2004, IEEE VISUALIZATION 2004, PROCEEEDINGS, P243, DOI 10.1109/VISUAL.2004.103; Bajaj C, 2011, BIOINFORMATICS, V27, P55, DOI 10.1093/bioinformatics/btq627; Bajaj C, 2011, IEEE ACM T COMPUT BI, V8, P45, DOI 10.1109/TCBB.2009.57; Bajaj C, 2010, SIAM J SCI COMPUT, V31, P4524, DOI 10.1137/090746173; Ben-Zeev E, 2003, PROTEINS, V52, P41, DOI 10.1002/prot.10392; Ben-Zeev E, 2003, PROTEINS, V52, P24, DOI 10.1002/prot.10391; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Castrillon-Candas J, 2005, 0544 ICES U TEX AUST; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Chowdhury RA, 2010, 1032 ICES U TEX AUST; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DUNCAN BS, 1993, BIOPOLYMERS, V33, P219, DOI 10.1002/bip.360330204; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Fruton J. S., 1999, PROTEINS ENZYMES GEN; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; GILSON MK, 1993, J PHYS CHEM-US, V97, P3591, DOI 10.1021/j100116a025; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Gu SY, 2012, PROTEINS, V80, P221, DOI 10.1002/prot.23192; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; HERMANN RB, 1972, J PHYS CHEM-US, V76, P2754, DOI 10.1021/j100663a023; Huang W, 2012, PROTEINS, V80, P691, DOI 10.1002/prot.23223; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; JACKINS CL, 1980, COMPUT VISION GRAPH, V14, P249, DOI 10.1016/0146-664X(80)90055-6; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kovacs JA, 2003, ACTA CRYSTALLOGR D, V59, P1371, DOI 10.1107/S0907444903011247; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; LATTMAN EA, 1972, ACTA CRYSTALL B-STRU, VB 28, P1065, DOI 10.1107/S0567740872003723; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Liu S, 2011, BMC BIOINFORMATICS, V12; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Martin ACR, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P33, DOI 10.1007/978-3-642-01147-4_3; MAX NL, 1988, IEEE COMPUT GRAPH, V8, P42, DOI 10.1109/38.7748; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Mitchell JC, 2008, SIAM J SCI COMPUT, V30, P525, DOI 10.1137/030601879; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Pierce B, 2007, COMPUTATIONAL METHOD, P109; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Ravikant DVS, 2010, PROTEINS, V78, P400, DOI 10.1002/prot.22550; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Ritchie DW, 1998, THESIS U ABERDEEN AB; SHARP K, 1991, J COMPUT CHEM, V12, P454, DOI 10.1002/jcc.540120407; SIMONSON T, 1994, J PHYS CHEM-US, V98, P4683, DOI 10.1021/j100068a033; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103; WANG HJ, 1991, J COMPUT CHEM, V12, P746, DOI 10.1002/jcc.540120612; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190	64	28	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e51307	10.1371/journal.pone.0051307	http://dx.doi.org/10.1371/journal.pone.0051307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483883	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100001
J	Kim, RB; Phillips, A; Herrick, K; Helou, M; Rafie, C; Anscher, MS; Mikkelsen, RB; Ning, Y				Kim, Roy B.; Phillips, Allison; Herrick, Kirsten; Helou, Marieka; Rafie, Carlin; Anscher, Mitchell S.; Mikkelsen, Ross B.; Ning, Yi			Physical Activity and Sedentary Behavior of Cancer Survivors and Non-Cancer Individuals: Results from a National Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH BEHAVIORS; STATISTICS; FATIGUE; MEN	Increasing physical activity and decreasing sedentary behavior are associated with a higher quality of life and lower mortality rates for cancer survivors, a growing population group. Studies detailing the behavior of cancer survivors are limited. Therefore, we investigated physical activity and sedentary behavior of cancer survivors using data from the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Participants were those who provided physical activity and sedentary behavior data. Those who were pregnant, <20 years old, or <3 years from their cancer diagnosis were excluded. A cancer case was a self-reported diagnosis by a physician. We identified 741 cancer survivors and 10,472 non-cancer participants. After adjustment for age, race, gender, education status, body mass index, and smoking status, cancer survivors (n = 10,472) reported significantly longer duration of sedentary behavior (OR = 1.42, 95% CI (1.12, 1.80) for 8 or more hours, p-value for trend = 0.09), compared to non-cancer participants (n = 741). They also reported non-significant increases in maximum intensity, duration, frequency, and energy expenditure, whereas they reported significant increases in moderate intensity (OR = 1.26, 95% CI (1.01, 1.57)), moderate frequency (1-4 times/week) (OR = 1.32, 95% CI (1.00, 1.74)), and moderate energy expenditure (4018.5-7623.5 kcal) (OR = 1.30, 95% CI (1.00, 1.71)) of physical activity, compared to non-cancer participants. These patterns are similar for breast and prostate cancer survivors, with prostate cancer survivors more likely to engage in physical activity for more than one hour per day (OR = 1.98, 95% CI (1.05, 3.71)). Our findings suggest that cancer survivors tend to have more physical activity, but they are also more likely to engage in sedentary behavior.	[Kim, Roy B.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Phillips, Allison; Herrick, Kirsten; Helou, Marieka; Ning, Yi] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Sch Med, Richmond, VA 23284 USA; [Helou, Marieka] Virginia Commonwealth Univ, Dept Pediat Oncol, Med Ctr, Richmond, VA USA; [Rafie, Carlin] Virginia Commonwealth Univ, Massey Canc Ctr, Med Ctr, Richmond, VA USA; [Anscher, Mitchell S.; Mikkelsen, Ross B.] Virginia Commonwealth Univ, Dept Radiat Oncol, Med Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Ning, Y (corresponding author), Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Sch Med, Richmond, VA 23284 USA.	yning2@vcu.edu	Rafie, Carlin/AAS-3063-2021	Rafie, Carlin/0000-0002-1402-5650; Herrick, Kirsten A./0000-0001-8646-599X; Anscher, Mitchell/0000-0003-4480-111X	VCU School of Medicine; National Institutes of Health (NIH) through CTSA award from the National Center for Advancing Translational Sciences [UL1TR000058]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	VCU School of Medicine; National Institutes of Health (NIH) through CTSA award from the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors would like to thank the VCU School of Medicine for its support in this project. Partial support was provided by the National Institutes of Health (NIH) through CTSA award No. UL1TR000058 from the National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2009, CANC FACTS FIG 2009; Aziz NM, 2003, SEMIN RADIAT ONCOL, V13, P248, DOI 10.1016/S1053-4296(03)00024-9; Bellizzi KM, 2005, J CLIN ONCOL, V23, P8884, DOI 10.1200/JCO.2005.02.2343; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Blanchard CM, 2003, AM J HEALTH BEHAV, V27, P246, DOI 10.5993/AJHB.27.3.6; Bray F, 2012, LANCET ONCOLOGY; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Courneya KS, 2003, J CLIN ONCOL, V21, P1660, DOI 10.1200/JCO.2003.04.093; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; Eakin EG, 2007, CANCER CAUSE CONTROL, V18, P881, DOI 10.1007/s10552-007-9033-5; Garcia M, 2007, GLOBAL CANC FACTS FI; GOTAY CC, 1984, SOC SCI MED, V18, P605, DOI 10.1016/0277-9536(84)90076-5; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kendall AR, 2005, QUAL LIFE RES, V14, P361, DOI 10.1007/s11136-004-1468-5; Lee CD, 2011, ANN EPIDEMIOL, V21, P749, DOI 10.1016/j.annepidem.2011.04.010; Mock V, 2000, ONCOLOGY-NY, V14, P151; Park CL, 2008, J HEALTH PSYCHOL, V13, P1198, DOI 10.1177/1359105308095978; Petrelli NJ, 2009, J CLIN ONCOL, V27, P6052, DOI 10.1200/JCO.2009.26.6171; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STEPHENS T, 1985, PUBLIC HEALTH REP, V100, P147; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; Webster K, 1998, ONCOLOGY-NY, V12, P697; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255	24	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57598	10.1371/journal.pone.0057598	http://dx.doi.org/10.1371/journal.pone.0057598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483916	Green Published, gold			2022-12-25	WOS:000316936100032
J	Garcin, G; Bordat, Y; Chuchana, P; Monneron, D; Law, HKW; Piehler, J; Uze, G				Garcin, Genevieve; Bordat, Yann; Chuchana, Paul; Monneron, Daniele; Law, Helen K. W.; Piehler, Jacob; Uze, Gilles			Differential Activity of Type I Interferon Subtypes for Dendritic Cell Differentiation	PLOS ONE			English	Article							CD8(+) T-CELLS; PBL-SCID MICE; APOPTOTIC CELLS; IFN-ALPHA; FUNCTIONAL-ACTIVITIES; COMPLEMENT RECEPTOR; EXPRESSION; PHAGOCYTOSIS; ACTIVATION; TOLERANCE	The type I interferon (IFN) family comprises 15 cytokines (in human 13 alpha, 1 beta, 1 omega), which exert several cellular functions through binding to a common receptor. Despite initial activation of the same Jak/Stat signalling pathway, the cellular response may differ depending on type I IFN subtype. We investigated the activity of six type I IFN subtypes -IFN alpha 1, alpha 2, alpha 8, alpha 21, omega and beta- to promote the differentiation of dendritic cells (DC). Transcriptome analyses identified two distinct groups, the IFN alpha/omega-DC and the IFN beta-DC. In addition, the expression level of seven chemokines and several cell surface markers characteristic of DC distinguished IFN alpha-DC and IFN beta-DC. These differences are unlikely to impact the efficacy of T cell functional response since IFN alpha 2-DC and IFN beta-DC were equipotent in inducing the proliferation and the polarization of allogenic naive CD4 T cells into Th1 cells and in stimulating autologous antigen specific CD4 or CD8 T cells. Of the functional parameters analysed, the only one that showed a modest differential was the phagocytic uptake of dead cells which was higher for IFN alpha 2-DC.	[Garcin, Genevieve; Bordat, Yann; Monneron, Daniele; Uze, Gilles] Univ Montpellier 2, Ctr Natl Rech Sci, Unite Mixte Rech 5235, Montpellier, France; [Chuchana, Paul] Inst Natl Sante & Rech Med 844, Inst Neurosci Montpellier, Montpellier, France; [Law, Helen K. W.] Inst Pasteur, Ctr Human Immunol, Paris, France; [Piehler, Jacob] Univ Osnabruck, Div Biophys, Osnabruck, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University Osnabruck	Uze, G (corresponding author), Univ Montpellier 2, Ctr Natl Rech Sci, Unite Mixte Rech 5235, Montpellier, France.	uze@univ-montp2.fr	Uzé, Gilles/O-6383-2019; LAW, Helen Ka-Wai/C-7345-2013	Garcin, Genevieve/0000-0001-9669-7057; LAW, Helen Ka-Wai/0000-0002-5579-9054; BORDAT, Yann/0000-0001-8616-6498; Uze, Gilles/0000-0002-4150-5772	European Community [223608]; Centre of Human Immunology	European Community(European Commission); Centre of Human Immunology	Funding was from the European Community's Seventh Framework Programme under grant agreement no 223608 (GU and JP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sandra Pellegrini, Mark Livingstone and Frederique Michel for critical reading of the manuscript, Maria Ferrantini, Stefano Santini, Caterina Lapenta, Sylvie van der Werf and Guillaume Cartron for helpful discussions, Christophe Duperray for his assistance in FACS sorting, Matthew Albert and the Centre of Human Immunology for support, Hella Kenneweg for protein production, Veronique Pantesco and the microarray core facility of IRB, Montpellier.	Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chuchana P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm093; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farkas A, 2011, BRIT J DERMATOL, V165, P247, DOI 10.1111/j.1365-2133.2011.10301.x; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Gorgani NN, 2008, J IMMUNOL, V181, P7902, DOI 10.4049/jimmunol.181.11.7902; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Lapenta C, 2003, J EXP MED, V198, P361, DOI 10.1084/jem.20021924; Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lorenzi S, 2011, J IMMUNOL, V186, P5142, DOI 10.4049/jimmunol.1004163; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Paquette RL, 1998, J LEUKOCYTE BIOL, V64, P358, DOI 10.1002/jlb.64.3.358; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Santini SM, 2005, METH MOLEC MED, V116, P167; Santini SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017364; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; UZE G, 1994, J MOL BIOL, V243, P245, DOI 10.1006/jmbi.1994.1651; Vermi W, 2011, J INVEST DERMATOL, V131, P426, DOI 10.1038/jid.2010.256; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600	46	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58465	10.1371/journal.pone.0058465	http://dx.doi.org/10.1371/journal.pone.0058465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472200	Green Submitted, Green Published, gold			2022-12-25	WOS:000315637900146
J	Kato, H; Lu, QP; Rapaport, D; Kozjak-Pavlovic, V				Kato, Hiroki; Lu, Qiping; Rapaport, Doron; Kozjak-Pavlovic, Vera			Tom70 Is Essential for PINK1 Import into Mitochondria	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; PARKINSONS-DISEASE; INTRACELLULAR MEMBRANES; QUALITY-CONTROL; PATHWAY; RECRUITMENT; BIOGENESIS; MECHANISMS; COMPLEX; BINDING	PTEN induced kinase 1 (PINK1) is a serine/threonine kinase in the outer membrane of mitochondria (OMM), and known as a responsible gene of Parkinson's disease (PD). The precursor of PINK1 is synthesized in the cytosol and then imported into the mitochondria via the translocase of the OMM (TOM) complex. However, a large part of PINK1 import mechanism remains unclear. In this study, we examined using cell-free system the mechanism by which PINK1 is targeted to and assembled into mitochondria. Surprisingly, the main component of the import channel, Tom40 was not necessary for PINK1 import. Furthermore, we revealed that the import receptor Tom70 is essential for PINK1 import. In addition, we observed that although PINK1 has predicted mitochondrial targeting signal, it was not processed by the mitochondrial processing peptidase. Thus, our results suggest that PINK1 is imported into mitochondria by a unique pathway that is independent of the TOM core complex but crucially depends on the import receptor Tom70.	[Kato, Hiroki; Lu, Qiping; Rapaport, Doron] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Kozjak-Pavlovic, Vera] Univ Wurzburg, Dept Microbiol, Bioctr, D-97070 Wurzburg, Germany	Eberhard Karls University of Tubingen; University of Wurzburg	Kato, H (corresponding author), Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan.	hmg1@tokyo-med.ac.jp	Kato, Hiroki/L-2346-2013; Kato, Hiroki/N-3495-2019; Kozjak-Pavlovic, Vera/E-1494-2013; Lu, Qiping/GLV-2085-2022	Kato, Hiroki/0000-0002-3292-2160; Kato, Hiroki/0000-0002-6529-659X; Kozjak-Pavlovic, Vera/0000-0001-9658-7018; lu, qi ping/0000-0002-5011-3762	Faculty of Medicine, University of Tubingen [Fortuene 1959-0-0]; Deutsche Forschungsgemeinschaft [KO3882/1-1]; UEHARA MEMORIAL FOUNDATION; German Academic Exchange Service	Faculty of Medicine, University of Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UEHARA MEMORIAL FOUNDATION(Uehara Memorial Foundation); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Faculty of Medicine, University of Tubingen (Fortuene 1959-0-0 to H. K.) and the Deutsche Forschungsgemeinschaft (KO3882/1-1 to V. K.-P.). This work was also supported by a postdoctoral fellowship from the UEHARA MEMORIAL FOUNDATION to H. K. and a fellowship from the German Academic Exchange Service to Q. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker D., 2012, J BIOL CHEM; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P228, DOI 10.1177/0891988710383572; Burbulla LF, 2011, J NEUROL SCI, V306, P1, DOI 10.1016/j.jns.2011.04.005; CONBOY JG, 1982, BIOCHEM BIOPH RES CO, V105, P1, DOI 10.1016/S0006-291X(82)80002-8; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; IWAHASHI J, 1994, J BIOCHEM-TOKYO, V116, P156, DOI 10.1093/oxfordjournals.jbchem.a124488; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kato H, 2008, BIOCHEM BIOPH RES CO, V369, P958, DOI 10.1016/j.bbrc.2008.02.150; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Luciano P, 1997, J MOL BIOL, V272, P213, DOI 10.1006/jmbi.1997.1231; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; OHBA M, 1987, EMBO J, V6, P2117, DOI 10.1002/j.1460-2075.1987.tb02478.x; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Papic D, 2011, J CELL BIOL, V194, P397, DOI 10.1083/jcb.201102041; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Yamamoto H, 2009, J BIOL CHEM, V284, P31635, DOI 10.1074/jbc.M109.041756; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	33	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58435	10.1371/journal.pone.0058435	http://dx.doi.org/10.1371/journal.pone.0058435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472196	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900142
J	Onami, H; Nagai, N; Kaji, H; Nishizawa, M; Sato, Y; Osumi, N; Nakazawa, T; Abe, T				Onami, Hideyuki; Nagai, Nobuhiro; Kaji, Hirokazu; Nishizawa, Matsuhiko; Sato, Yasufumi; Osumi, Noriko; Nakazawa, Toru; Abe, Toshiaki			Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; GANCICLOVIR; RELEASE; PHARMACOKINETICS; PERMEABILITY; INFLIXIMAB; INDUCTION; IMPLANT	We established a sustained vasohibin-1 (a 42-kDa protein), delivery device by a novel method using photopolymerization of a mixture of polyethylene glycol dimethacrylate, triethylene glycol dimethacrylate, and collagen microparticles. We evaluated its effects in a model of rat laser-induced choroidal neovascularization (CNV) using a transscleral approach. We used variable concentrations of vasohibin-1 in the devices, and used an enzyme-linked immunosorbent assay and Western blotting to measure the released vasohibin-1 (0.31 nM/day when using the 10 mu M vasohibin-1 delivery device [ 10VDD]). The released vasohibin-1 showed suppression activity comparable to native effects when evaluated using endothelial tube formation. We also used pelletized vasohibin-1 and fluorescein isothiocyanate-labeled 40 kDa dextran as controls. Strong fluorescein staining was observed on the sclera when the device was used for drug delivery, whereas pellet use produced strong staining in the conjunctiva and surrounding tissue, but not on the sclera. Vasohibin-1 was found in the sclera, choroid, retinal pigment epithelium (RPE), and neural retina after device implantation. Stronger immunoreactivity at the RPE and ganglion cell layers was observed than in other retinal regions. Significantly lower fluorescein angiography (FA) scores and smaller CNV areas in the flat mounts of RPE-choroid-sclera were observed for the 10VDD, VDD (1 mu M vasohibin-1 delivery device), and vasohibin-1 intravitreal direct injection (0.24 mu M) groups when compared to the pellet, non-vasohibin-1 delivery device, and intravitreal vehicle injection groups. Choroidal neovascularization can be treated with transscleral sustained protein delivery using our novel device. We offer a safer sustained protein release for treatment of retinal disease using the transscleral approach.	[Onami, Hideyuki; Nagai, Nobuhiro; Abe, Toshiaki] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med ART, Div Clin Cell Therapy, Sendai, Miyagi 980, Japan; [Onami, Hideyuki; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Kaji, Hirokazu; Nishizawa, Matsuhiko] Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan; [Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi 980, Japan; [Osumi, Noriko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med ART, Div Dev Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Abe, T (corresponding author), Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med ART, Div Clin Cell Therapy, Sendai, Miyagi 980, Japan.	toshi@oph.med.tohoku.ac.jp	Osumi, Noriko/T-2823-2019; Sato, Yasufumi/AAF-3367-2019; Kaji, Hirokazu/T-2219-2019	Osumi, Noriko/0000-0003-0548-6452; Kaji, Hirokazu/0000-0003-2566-4172	Ministry of Education, Culture, Sports, Science, and Technology [21592214, 23680054]; Ministry of Health Labour and Welfare [H23-iryokiki-wakate-003, H23-kankaku-ippan-004, H24-nanchitoh-ippan-067]; Suzuken Memorial Foundation; Ichiro Kanehara Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Suzuken Memorial Foundation; Ichiro Kanehara Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (No. 21592214) and Young Scientists (A) (No. 23680054) from the Ministry of Education, Culture, Sports, Science, and Technology, Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare (No. H23-iryokiki-wakate-003, H23-kankaku-ippan-004, H24-nanchitoh-ippan-067), the Suzuken Memorial Foundation, and the Ichiro Kanehara Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral J, 2005, INVEST OPHTH VIS SCI, V46, P4383, DOI 10.1167/iovs.05-0492; [Anonymous], 1986, Arch Ophthalmol, V104, P694; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Cashman SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019078; Chan JW, 2003, SURV OPHTHALMOL, V48, P12, DOI 10.1016/S0039-6257(02)00416-2; Charles NC, 2002, AM J OPHTHALMOL, V133, P273, DOI 10.1016/S0002-9394(01)01307-1; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; de Carvalho RAP, 2006, INVEST OPHTH VIS SCI, V47, P4532, DOI 10.1167/iovs.06-0030; Eckardt C, 1999, GRAEF ARCH CLIN EXP, V237, P313, DOI 10.1007/s004170050239; Edelman JL, 2000, EXP EYE RES, V71, P523, DOI 10.1006/exer.2000.0907; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Hayreh SS, 2010, AM J OPHTHALMOL, V150, P940, DOI 10.1016/j.ajo.2010.08.011; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Ishikawa Y, 2012, ADV EXP MED BIOL, V723, P305, DOI 10.1007/978-1-4614-0631-0_40; Kawashima T, 2011, BIOMATERIALS, V32, P1950, DOI 10.1016/j.biomaterials.2010.11.006; Kim H, 2010, J CONTROL RELEASE, V142, P286, DOI 10.1016/j.jconrel.2009.10.031; Kim SH, 2008, PHARM RES-DORDR, V25, P512, DOI 10.1007/s11095-007-9408-z; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kondo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019911; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kunou N, 2000, J CONTROL RELEASE, V68, P263, DOI 10.1016/S0168-3659(00)00267-4; Lassota N, 2008, ACTA OPHTHALMOL, V86, P495, DOI [10.1111/j.1600-0420.2007.01127.x, 10.1111/j.1755-3768.2008.01412.x]; Lee SJ, 2010, INVEST OPHTH VIS SCI, V51, P5205, DOI 10.1167/iovs.10-5337; Lutty G, 1999, MOL VIS, V5; MARTIN DF, 1994, ARCH OPHTHALMOL-CHIC, V112, P1531, DOI 10.1001/archopht.1994.01090240037023; McHugh AJ, 2005, J CONTROL RELEASE, V109, P211, DOI 10.1016/j.jconrel.2005.09.038; MILLER JW, 1994, AM J PATHOL, V145, P574; Ohno S, 2004, J RHEUMATOL, V31, P1362; Olsen TW, 2011, INVEST OPHTH VIS SCI, V52, P4749, DOI 10.1167/iovs.10-6291; Onami H, 2012, RETINA-J RET VIT DIS, V32, P1204, DOI 10.1097/IAE.0b013e318233ad0b; Pilu S, 2008, AM J OPHTHALMOL, V145, P879, DOI 10.1016/j.ajo.2007.12.036; Raghava Swita, 2004, Expert Opin Drug Deliv, V1, P99, DOI 10.1517/17425247.1.1.99; Ranta VP, 2010, J CONTROL RELEASE, V148, P42, DOI 10.1016/j.jconrel.2010.08.028; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Reichel E, 1999, OPHTHALMOLOGY, V106, P1908, DOI 10.1016/S0161-6420(99)90400-1; Robinson MR, 2006, EXP EYE RES, V82, P479, DOI 10.1016/j.exer.2005.08.007; Sfikakis PP, 2001, LANCET, V358, P295, DOI 10.1016/S0140-6736(01)05497-6; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Smiddy WE, 2005, RETINA-J RET VIT DIS, V25, P751, DOI 10.1097/00006982-200509000-00011; Srivastava S, 2004, OPHTHAL SURG LAS IM, V35, P254, DOI 10.3928/1542-8877-20040501-16; Stefansson E, 2011, PROG RETIN EYE RES, V30, P72, DOI 10.1016/j.preteyeres.2010.09.003; THIRKILL CE, 1989, NEW ENGL J MED, V321, P1589, DOI 10.1056/NEJM198912073212307; THOMAS MA, 1992, OPHTHALMOLOGY, V99, P952; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Wakusawa R, 2011, INVEST OPHTH VIS SCI, V52, P3272, DOI 10.1167/iovs.10-6295; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003; Yu HG, 2008, INVEST OPHTH VIS SCI, V49, P2599, DOI 10.1167/iovs.07-1508	50	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58580	10.1371/journal.pone.0058580	http://dx.doi.org/10.1371/journal.pone.0058580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472209	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900155
J	Kerenyi, A; Bihary, D; Venturi, V; Pongor, S				Kerenyi, Adam; Bihary, Dora; Venturi, Vittorio; Pongor, Sandor			Stability of Multispecies Bacterial Communities: Signaling Networks May Stabilize Microbiomes	PLOS ONE			English	Article							TO-CELL COMMUNICATION; QUORUM; EVOLUTION; FAMILY	Multispecies bacterial communities can be remarkably stable and resilient even though they consist of cells and species that compete for environmental resources. In silico models suggest that common signals released into the environment may help selected bacterial species cluster at common locations and that sharing of public goods (i.e. molecules produced and released for mutual benefit) can stabilize this coexistence. In contrast, unilateral eavesdropping on signals produced by a potentially invading species may protect a community by keeping invaders away from limited resources. Shared bacterial signals, such as those found in quorum sensing systems, may thus play a key role in fine tuning competition and cooperation within multi-bacterial communities. We suggest that in addition to metabolic complementarity, signaling dynamics may be important in further understanding complex bacterial communities such as the human, animal as well as plant microbiomes.	[Kerenyi, Adam] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Bihary, Dora; Pongor, Sandor] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary; [Venturi, Vittorio] Int Ctr Genet Engn & Biotechnol, Grp Bacteriol & Plant Bacteriol, I-34012 Trieste, Italy; [Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, Grp Prot Struct & Bioinformat, I-34012 Trieste, Italy	Hungarian Academy of Sciences; Hungarian Biological Research Center; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB)	Venturi, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Grp Bacteriol & Plant Bacteriol, Padriciano 99, I-34012 Trieste, Italy.	venturi@icgeb.org; pongor@icgeb.org	Venturi, Vittorio/AAO-3069-2021	Venturi, Vittorio/0000-0003-4307-5697	OTKA [K. 84335]; ICGEB;  [TET 10-1-2011-0058];  [TAMOP-4.2.1.B-11/2/KMR-2011-0002];  [TAMOP-4.2.2/B-10/1-2010-0014]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ICGEB; ; ; 	Work at the Biological Research Centre of Szeged was partly funded by OTKA grant K. 84335. The research at Pazmany Peter Catholic University, Budapest was partially supported by grants TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, and TAMOP-4.2.2/B-10/1-2010-0014. Funding for open access charge and for the services of a scientific writer/editor was provided by ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bihary D, 2012, SCALABLE COMPUT-PRAC, V13, P21; Chalupowicz L, 2009, MOL PLANT MICROBE IN, V22, P849, DOI 10.1094/MPMI-22-7-0849; Chandler JR, 2012, ISME J, V6, P2219, DOI 10.1038/ismej.2012.69; Degrassi G, 2007, FEMS MICROBIOL LETT, V269, P213, DOI 10.1111/j.1574-6968.2006.00624.x; Duan K, 2009, CONTRIB MICROBIOL, V16, P1, DOI 10.1159/000219369; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Fuqua C., 2002, MODERN MICROBIAL GEN, P362; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Gause GF, 1932, J EXP BIOL, V9, P389; GAVINI F, 1989, INT J SYST BACTERIOL, V39, P337, DOI 10.1099/00207713-39-3-337; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hosni T, 2011, ISME J, V5, P1857, DOI 10.1038/ismej.2011.65; Jakubovics NS, 2010, ORAL DIS, V16, P729, DOI 10.1111/j.1601-0825.2010.01701.x; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Kerenyi A, 2010, MED MYCOL, V17, P113; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Larsen PE, 2012, FEMS MICROBIOL LETT, V332, P91, DOI 10.1111/j.1574-6968.2012.02588.x; Licciardello G, 2009, MOL PLANT MICROBE IN, V22, P1514, DOI 10.1094/MPMI-22-12-1514; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Mitri S, 2011, P NATL ACAD SCI USA, V108, P10839, DOI 10.1073/pnas.1100292108; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Netotea S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-6; Pacheco AR, 2009, CURR OPIN MICROBIOL, V12, P192, DOI 10.1016/j.mib.2009.01.006; Pacheco AR, 2012, NATURE; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Rojas AM, 2004, INT J SYST EVOL MICR, V54, P2217, DOI 10.1099/ijs.0.02924-0; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Venturi V, 2012, TRENDS MICROBIOL, V20, P160, DOI 10.1016/j.tim.2012.02.003; Venturi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009998; Visick KL, 2005, J BACTERIOL, V187, P5507, DOI 10.1128/JB.187.16.5507-5519.2005; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	39	15	15	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57947	10.1371/journal.pone.0057947	http://dx.doi.org/10.1371/journal.pone.0057947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483950	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000315634900057
J	Nallagatla, SR; Jones, CN; Ghosh, SKB; Sharma, SD; Cameron, CE; Spremulli, LL; Bevilacqua, PC				Nallagatla, Subba Rao; Jones, Christie N.; Ghosh, Saikat Kumar B.; Sharma, Suresh D.; Cameron, Craig E.; Spremulli, Linda L.; Bevilacqua, Philip C.			Native Tertiary Structure and Nucleoside Modifications Suppress tRNA's Intrinsic Ability to Activate the Innate Immune Sensor PKR	PLOS ONE			English	Article							PROTEIN-KINASE PKR; DOUBLE-STRANDED-RNA; MITOCHONDRIAL TRANSFER-RNAS; ESCHERICHIA-COLI; 5'-TRIPHOSPHATE-DEPENDENT ACTIVATION; SUBSTRATE RECOGNITION; BINDING DOMAIN; IN-VITRO; TRANSLATION; DIMERIZATION	Interferon inducible protein kinase PKR is an essential component of innate immunity. It is activated by long stretches of dsRNA and provides the first line of host defense against pathogens by inhibiting translation initiation in the infected cell. Many cellular and viral transcripts contain nucleoside modifications and/or tertiary structure that could affect PKR activation. We have previously demonstrated that a 5'-end triphosphate-a signature of certain viral and bacterial transcripts-confers the ability of relatively unstructured model RNA transcripts to activate PKR to inhibit translation, and that this activation is abrogated by certain modifications present in cellular RNAs. In order to understand the biological implications of native RNA tertiary structure and nucleoside modifications on PKR activation, we study here the heavily modified cellular tRNAs and the unmodified or the lightly modified mitochondrial tRNAs (mt-tRNA). We find that both a T7 transcript of yeast tRNA(Phe) and natively extracted total bovine liver mt-tRNA activate PKR in vitro, whereas native E. coli, bovine liver, yeast, and wheat tRNA(Phe) do not, nor do a variety of base-or sugar-modified T7 transcripts. These results are further supported by activation of PKR by a natively folded T7 transcript of tRNA(Phe) in vivo supporting the importance of tRNA modification in suppressing PKR activation in cells. We also examine PKR activation by a T7 transcript of the A14G pathogenic mutant of mt-tRNA(Leu), which is known to dimerize, and find that the misfolded dimeric form activates PKR in vitro while the monomeric form does not. Overall, the in vitro and in vivo findings herein indicate that tRNAs have an intrinsic ability to activate PKR and that nucleoside modifications and native RNA tertiary folding may function, at least in part, to suppress such activation, thus serving to distinguish self and non-self tRNA in innate immunity.	[Nallagatla, Subba Rao; Ghosh, Saikat Kumar B.; Bevilacqua, Philip C.] Penn State Univ, Dept Chem, University Pk, PA USA; [Nallagatla, Subba Rao; Ghosh, Saikat Kumar B.; Bevilacqua, Philip C.] Penn State Univ, Ctr RNA Mol Biol, University Pk, PA USA; [Jones, Christie N.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Sharma, Suresh D.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bevilacqua, PC (corresponding author), Penn State Univ, Dept Chem, University Pk, PA USA.	pcb5@psu.edu	SHARMA, Suresh/C-4431-2008; Ghosh, Saikat/AAD-1176-2022; SHARMA, Suresh D./AAD-7723-2022	SHARMA, Suresh/0000-0002-8633-4145; SHARMA, Suresh D./0000-0002-8633-4145; Bevilacqua, Philip/0000-0001-8074-3434	NIH [GM58709, GM 32734]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734, R01GM058709] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by NIH GM58709 to PCB and NIH GM 32734 to LLS (https://commonfund.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Bjork Glenn R., 1995, P165; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023; Byrne RT, 2010, NUCLEIC ACIDS RES, V38, P4154, DOI 10.1093/nar/gkq133; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dauber B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000473; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005; Heinicke LA, 2012, RNA, V18, P2157, DOI 10.1261/rna.034744.112; Heinicke LA, 2011, RNA, V17, P957, DOI 10.1261/rna.2636911; Heinicke LA, 2009, J MOL BIOL, V390, P319, DOI 10.1016/j.jmb.2009.05.005; HOVANESSIAN AG, 1993, SEMIN VIROL, V4, P237, DOI 10.1006/smvy.1993.1020; Huichalaf C, 2010, FASEB J, V24, P3706, DOI 10.1096/fj.09-151159; Hunter SE, 2004, BBA-PROTEINS PROTEOM, V1699, P173, DOI 10.1016/j.bbapap.2004.02.015; JEFFREY IW, 1995, EXP CELL RES, V218, P17, DOI 10.1006/excr.1995.1126; Jones CN, 2008, J BIOL CHEM, V283, P34445, DOI 10.1074/jbc.M806992200; Jones CI, 2006, J MOL BIOL, V362, P771, DOI 10.1016/j.jmb.2006.07.036; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; LOEHR JS, 1968, P NATL ACAD SCI USA, V61, P1115, DOI 10.1073/pnas.61.3.1115; Madore E, 1999, NUCLEIC ACIDS RES, V27, P3583, DOI 10.1093/nar/27.17.3583; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Morel M, 2009, J CELL MOL MED, V13, P1476, DOI 10.1111/j.1582-4934.2009.00849.x; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nallagatla SR, 2008, RNA, V14, P1201, DOI 10.1261/rna.1007408; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Nallagatla SR, 2011, CURR OPIN STRUC BIOL, V21, P119, DOI 10.1016/j.sbi.2010.11.003; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06; Nobles KN, 2002, NUCLEIC ACIDS RES, V30, P4751, DOI 10.1093/nar/gkf595; Nussbaum JM, 2002, NUCLEIC ACIDS RES, V30, P1205, DOI 10.1093/nar/30.5.1205; Peel AL, 2001, HUM MOL GENET, V10, P1531, DOI 10.1093/hmg/10.15.1531; Pindel A., 2010, J INTERFERON CYTOKIN, V31, P59, DOI DOI 10.1089/JIR.2010.009921166592; Puthenveetil S, 2006, NUCLEIC ACIDS RES, V34, P4900, DOI 10.1093/nar/gkl464; Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2010, J INTERF CYTOK RES, V30, P195, DOI 10.1089/jir.2010.0005; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Shimoike T, 2009, ANTIVIR RES, V83, P228, DOI 10.1016/j.antiviral.2009.05.004; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sohm N, 2004, J MOL BIOL, V339, P17, DOI 10.1016/j.jmb.2004.03.066; Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w; STEIN A, 1976, BIOCHEMISTRY-US, V15, P160, DOI 10.1021/bi00646a025; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Toroney R, 2012, RNA, V18, P1862, DOI 10.1261/rna.034520.112; Toroney R, 2010, J MOL BIOL, V400, P393, DOI 10.1016/j.jmb.2010.04.059; VanOudenhove J, 2009, J MOL BIOL, V387, P910, DOI 10.1016/j.jmb.2009.02.019; WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347; Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09; Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820; YANG SK, 1972, BIOCHEMISTRY-US, V11, P2311, DOI 10.1021/bi00762a016; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804	66	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57905	10.1371/journal.pone.0057905	http://dx.doi.org/10.1371/journal.pone.0057905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483938	Green Published, Green Submitted, gold			2022-12-25	WOS:000315634900052
J	Tanner, GJ; Blundell, MJ; Colgrave, ML; Howitt, CA				Tanner, Gregory J.; Blundell, Malcolm J.; Colgrave, Michelle L.; Howitt, Crispin A.			Quantification of Hordeins by ELISA: The Correct Standard Makes a Magnitude of Difference	PLOS ONE			English	Article							CELIAC-DISEASE; STRUCTURAL BASIS; WHEAT PROTEINS; GLUTEN; BARLEY; GLIADIN; MALT; IMMUNOASSAY; EXTRACTION; BEER	Background: Coeliacs require a life-long gluten-free diet supported by accurate measurement of gluten (hordein) in gluten-free food. The gluten-free food industry, with a value in excess of $6 billion in 2011, currently depends on two ELISA protocols calibrated against standards that may not be representative of the sample being assayed. Aim: The factors affecting the accuracy of ELISA analysis of hordeins in beer were examined. Results: A simple alcohol-dithiothreitol extraction protocol successfully extracts the majority of hordeins from barley flour and malt. Primary hordein standards were purified by FPLC. ELISA detected different classes of purified hordeins with vastly different sensitivity. The dissociation constant (Kd) for a given ELISA reaction with different hordeins varied by three orders of magnitude. The Kd of the same hordein determined by ELISA using different antibodies varied by up to two orders of magnitude. The choice of either ELISA kit or hordein standard may bias the results and confound interpretation. Conclusions: Accurate determination of hordein requires that the hordein standard used to calibrate the ELISA reaction be identical in composition to the hordeins present in the test substance. In practice it is not feasible to isolate a representative hordein standard from each test food. We suggest that mass spectrometry is more reliable than ELISA, as ELISA enumerates only the concentration of particular amino-acid epitopes which may vary between different hordeins and may not be related to the absolute hordein concentration. MS quantification is undertaken using peptides that are specific and unique enabling the quantification of individual hordein isoforms.	[Tanner, Gregory J.; Blundell, Malcolm J.; Colgrave, Michelle L.; Howitt, Crispin A.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia; [Tanner, Gregory J.; Blundell, Malcolm J.; Howitt, Crispin A.] Commonwealth Sci & Ind Res Org Food Futures Flags, N Ryde, NSW, Australia; [Colgrave, Michelle L.] Commonwealth Sci & Ind Res Org Anim Food & Hlth, St Lucia, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tanner, GJ (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia.	Tanner@csiro.au	Howitt, Crispin/B-6058-2009; Tanner, Greg J/A-3210-2010; Colgrave, Michelle/A-5710-2012	Howitt, Crispin/0000-0002-1533-6602; Colgrave, Michelle/0000-0001-8463-805X	Grains Research and Development Commission (Australia) [CSP00051, CSP00067, CSP00088, CSP00113]; Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship	Grains Research and Development Commission (Australia)(Grains R&D Corp); Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship	This work was supported by grants CSP00051, CSP00067, CSP00088, and CSP00113 from the Grains Research and Development Commission (Australia), and appropriation funds from the Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Bobalova J, 2007, J CHROMATOGR A, V1163, P80, DOI 10.1016/j.chroma.2007.06.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugyi Z, 2012, J AOAC INT, V95, P382, DOI 10.5740/jaoacint.SGE_Bugyi; Colgrave ML, 2012, J PROTEOME RES, V11, P386, DOI 10.1021/pr2008434; Comino I, 2012, J SCI FOOD AGR; DOLL H, 1973, HEREDITAS, V74, P293; Doll H, 1983, SEED PROTEINS, P207; Dona VV, 2008, EUR FOOD RES TECHNOL, V226, P591, DOI 10.1007/s00217-007-0597-9; Dostalek P, 2006, FOOD ADDIT CONTAM, V23, P1074, DOI 10.1080/02652030600740637; Dostalek P, 2009, J FOOD COMPOS ANAL, V22, P762, DOI 10.1016/j.jfca.2009.01.018; ELLIS HJ, 1990, CLIN CHIM ACTA, V189, P123, DOI 10.1016/0009-8981(90)90082-4; Garcia E, 2005, EUR J GASTROEN HEPAT, V17, P529, DOI 10.1097/00042737-200505000-00010; GenStat, 2011, GENSTAT WINDOWS; Gessendorfer B, 2010, J CEREAL SCI, V52, P331, DOI 10.1016/j.jcs.2010.04.010; Green PHR, 2009, JAMA-J AM MED ASSOC, V302, P1225, DOI 10.1001/jama.281.24.2344; Green PHR, 2003, AM J MED, V115, P191, DOI 10.1016/S0002-9343(03)00302-4; Guerdrum LJ, 2011, FOOD CHEM, V129, P1783, DOI 10.1016/j.foodchem.2011.06.021; Haas-Lauterbach S, 2012, J AOAC INT, V95, P377, DOI 10.5740/jaoacint.SGE_Haas-Lauterbach; Halbmayr-Jech E, 2012, J AOAC INT, V95, P372, DOI 10.5740/jaoacint.SGE_Halbmayr-Jech; HEJGAARD J, 1983, J I BREWING, V89, P402, DOI 10.1002/j.2050-0416.1983.tb04215.x; HILL A S, 1990, Food and Agricultural Immunology, V2, P21, DOI 10.1080/09540109009354699; Holopainen URM, 2012, J SCI FOOD AGR, V92, P2944, DOI 10.1002/jsfa.5706; Jin B, 2012, J FOOD PROCESS PRES, V36, P169, DOI 10.1111/j.1745-4549.2011.00571.x; Kahlenberg F, 2006, EUR FOOD RES TECHNOL, V222, P78, DOI 10.1007/s00217-005-0100-4; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Lastovickova M, 2010, J I BREWING, V116, P245, DOI 10.1002/j.2050-0416.2010.tb00427.x; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Lukaskova ZR, 2011, FOOD ADDIT CONTAM A, V28, P817, DOI 10.1080/19440049.2011.572292; Mena MC, 2012, TALANTA, V91, P33, DOI 10.1016/j.talanta.2011.12.073; Mendez E, 2005, EUR J GASTROEN HEPAT, V17, P1053; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Naiyer AJ, 2009, J CLIN GASTROENTEROL, V43, P225, DOI 10.1097/MCG.0b013e31816200e5; Ohlund K, 2010, J HUM NUTR DIET, V23, P294, DOI 10.1111/j.1365-277X.2010.01060.x; Perrocheau L, 2005, PROTEOMICS, V5, P2849, DOI 10.1002/pmic.200401153; Petry-Podgorska I, 2010, J CHROMATOGR B, V878, P3143, DOI 10.1016/j.jchromb.2010.09.023; Sealey-Voyksner JA, 2010, J CHROMATOGR A, V1217, P4167, DOI 10.1016/j.chroma.2010.01.067; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sharma GM, 2012, J AOAC INT, V95, P364, DOI 10.5740/jaoacint.SGE_Sharma; Shewry PR, 2001, PLANT GROWTH REGUL, V34, P105, DOI 10.1023/A:1013382803849; Shewry PR, 1999, SEED PROTEINS, P35; SKERRITT JH, 1992, J CEREAL SCI, V16, P219, DOI 10.1016/S0733-5210(09)80086-6; SKERRITT JH, 1991, J ASSOC OFF ANA CHEM, V74, P257; Skerritt JH, 2000, J CEREAL SCI, V32, P259, DOI 10.1006/jcrs.2000.0316; Snegaroff J, 2006, INT ARCH ALLERGY IMM, V139, P201, DOI 10.1159/000091165; Snegaroff J, 2012, BIOCH BIOPHYS ACTA; Sunwoo HH, 2012, FOOD AGR IMMUNOL, V23, P169, DOI 10.1080/09540105.2011.608121; Tanner GJ, 2010, ALIMENT PHARM THER, V32, P1184, DOI 10.1111/j.1365-2036.2010.04452.x; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; TURLEY RH, 1986, CROP SCI, V26, P778, DOI 10.2135/cropsci1986.0011183X002600040032x; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Voyksner RD, 2012, NOVEL APPROACHES DIS; Wild D, 2010, ALIMENT PHARM THER, V32, P573, DOI 10.1111/j.1365-2036.2010.04386.x; Wu MJ, 2012, J CEREAL SCI, V55, P53, DOI 10.1016/j.jcs.2011.08.015; Zhao FJ, 2006, J CEREAL SCI, V43, P369, DOI 10.1016/j.jcs.2005.12.003	57	42	44	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56456	10.1371/journal.pone.0056456	http://dx.doi.org/10.1371/journal.pone.0056456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23509607	gold, Green Published			2022-12-25	WOS:000315524900026
J	Koch, V; Peckham, H; Mancini, A; Eguchi, T				Koch, Volker; Peckham, Hoyt; Mancini, Agnese; Eguchi, Tomoharu			Estimating At-Sea Mortality of Marine Turtles from Stranding Frequencies and Drifter Experiments	PLOS ONE			English	Article							BAJA-CALIFORNIA-SUR; FISHERIES BYCATCH; BAHIA MAGDALENA; JELLYFISH; CONSERVATION; CONSUMPTION; POPULATION; PATTERNS	Strandings of marine megafauna can provide valuable information on cause of death at sea. However, as stranding probabilities are usually very low and highly variable in space and time, interpreting the results can be challenging. We evaluated the magnitude and distribution of at-sea mortality of marine turtles along the Pacific coast of Baja California Sur, Mexico during 2010-11, using a combination of counting stranded animals and drifter experiments. A total of 594 carcasses were found during the study period, with loggerhead (62%) and green turtles (31%) being the most common species. 87% of the strandings occurred in the southern Gulf of Ulloa, a known hotspot of loggerhead distribution in the Eastern Pacific. While only 1.8% of the deaths could be definitively attributed to bycatch (net marks, hooks), seasonal variation in stranding frequencies closely corresponded to the main fishing seasons. Estimated stranding probabilities from drifter experiments varied among sites and trials (0.05-0.8), implying that only a fraction of dead sea turtles can be observed at beaches. Total mortality estimates for 15-day periods around the floater trials were highest for PSL, a beach in the southern Gulf of Ulloa, ranging between 11 sea turtles in October 2011 to 107 in August 2010. Loggerhead turtles were the most numerous, followed by green and olive ridley turtles. Our study showed that drifter trials combined with beach monitoring can provide estimates for death at sea to measure the impact of small-scale fisheries that are notoriously difficult to monitor for by-catch. We also provided recommendations to improve the precision of the mortality estimates for future studies and highlight the importance of estimating impacts of small-scale fisheries on marine megafauna.	[Koch, Volker; Mancini, Agnese] Univ Autonoma Baja Calif Sur, Dept Marine Biol, La Paz, Baja Calif Sur, Mexico; [Koch, Volker] Invest Conservacio & El Desarrollo, La Paz, Baja Calif Sur, Mexico; [Koch, Volker] Leibniz Ctr Trop Marine Ecol, Dept Directorate, Bremen, Germany; [Peckham, Hoyt] Grp Tortuguero Calif AC, La Paz, Baja Calif Sur, Mexico; [Peckham, Hoyt] Stanford Univ, Ctr Ocean Solut, Pacific Grove, CA USA; [Mancini, Agnese] Boomerang Earth Conservat, Antony, France; [Eguchi, Tomoharu] NOAA, Protected Resources Div, Southwest Fisheries Sci Ctr, Natl Marine Fishery Serv, La Jolla, CA USA	Universidad Autonoma de Baja California; Leibniz Zentrum fur Marine Tropenforschung (ZMT); Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	Koch, V (corresponding author), Univ Autonoma Baja Calif Sur, Dept Marine Biol, La Paz, Baja Calif Sur, Mexico.	vokoch68@gmail.com	Koch, Volker/J-1587-2012		Western Pacific Regional Fishery Management Council pursuant to National Oceanic and Atmospheric Administration Award [NA10NMF4410219]	Western Pacific Regional Fishery Management Council pursuant to National Oceanic and Atmospheric Administration Award	This study was funded by the Western Pacific Regional Fishery Management Council pursuant to National Oceanic and Atmospheric Administration Award No. NA10NMF4410219 (http://wpcouncil.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro Shigueto Joanna, 2008, Endangered Species Research, V5, P129, DOI 10.3354/esr00142; Alfaro-Shigueto J, 2011, J APPL ECOL, V48, P1432, DOI 10.1111/j.1365-2664.2011.02040.x; Casale P, 2010, AQUAT CONSERV, V20, P611, DOI 10.1002/aqc.1133; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Eguchi T, 2002, MAR MAMMAL SCI, V18, P698, DOI 10.1111/j.1748-7692.2002.tb01067.x; Epperly SP, 1996, B MAR SCI, V59, P289; Espinosa-Carreon TL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002105; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Geraci Joseph R., 1999, P367; Geraci JR., 2005, MARINE MAMMALS ASHOR; GILMAN E, 2009, P TECHN WORKSH MIT S; Godley Brendan, 1998, Zoology in the Middle East, V16, P49; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Hays GC, 2012, P ROY SOC B-BIOL SCI, V279, P465, DOI 10.1098/rspb.2011.0978; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Peckham SH, 2011, MAR ECOL PROG SER, V425, P269, DOI 10.3354/meps08995; *INEGI, 2005, AN EST EST BAJ CAL; IUCN, 2022, IUCN RED LIST THREAT; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Koch V, 2007, MAR BIOL, V153, P35, DOI 10.1007/s00227-007-0782-1; Legaard KR, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003282; Lewison RL, 2011, B MAR SCI, V87, P235, DOI 10.5343/bms.2010.1062; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lopez-Castro Melania C., 2010, Endangered Species Research, V11, P35, DOI 10.3354/esr00264; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MANCINI A, 2009, THESIS U AUTONOMA BC; Mancini A, 2012, ORYX, V46, P69, DOI 10.1017/S0030605310001833; Mancini A, 2011, HUM ECOL, V39, P743, DOI 10.1007/s10745-011-9425-8; Mancini Agnese, 2009, Endangered Species Research, V7, P1, DOI 10.3354/esr00165; Mangel JC, 2010, BIOL CONSERV, V143, P136, DOI 10.1016/j.biocon.2009.09.017; Mercuri M, 2008, THESIS I POLITECNICO; Monzon-Arguello C, 2012, J R SOC INTERFACE, V9, P1725, DOI 10.1098/rsif.2011.0788; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; NICHOLS WJ, 2004, CONSERVATION PRACTIC, V5, P30; NICHOLS WJ, 2003, THESIS U ARIZONA TUC; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Peckham S. Hoyt, 2008, Endangered Species Research, V5, P171, DOI 10.3354/esr00123; Petersen Samantha L., 2008, Endangered Species Research, V5, P117, DOI 10.3354/esr00132; Prellezo Raul, 2008, Endangered Species Research, V5, P335, DOI 10.3354/esr00140; RAFTERY AE, 1988, BIOMETRIKA, V75, P223, DOI 10.1093/biomet/75.2.223; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Secretaria de Agricultura Ganaderia Desarrollo Rural Pesca y Alimentacion (SAGARPA), 2010, AN PESC; Shanker K, 2004, BIOL CONSERV, V115, P149, DOI 10.1016/S0006-3207(03)00104-6; Sharifi M, 2007, INT AGROPHYS, V21, P391; Shaver D.J., 1990, Marine Turtle Newsletter, P25; Soykan Candan U., 2008, Endangered Species Research, V5, P91, DOI 10.3354/esr00175; Tomas Jesus, 2008, Endangered Species Research, V5, P161, DOI 10.3354/esr00116; Wallace BP, 2010, CONSERV LETT, V3, P1; Wingfield DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027874; WITHERINGTON BE, 1989, COPEIA, P696; Zaytsev O, 2003, J OCEANOGR, V59, P489, DOI 10.1023/A:1025544700632	54	45	48	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56776	10.1371/journal.pone.0056776	http://dx.doi.org/10.1371/journal.pone.0056776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23483880	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200157
J	Kiss, G; Konrad, C; Doczi, J; Starkov, AA; Kawamata, H; Manfredi, G; Zhang, SF; Gibson, GE; Beal, MF; Adam-Vizi, V; Chinopoulos, C				Kiss, Gergely; Konrad, Csaba; Doczi, Judit; Starkov, Anatoly A.; Kawamata, Hibiki; Manfredi, Giovanni; Zhang, Steven F.; Gibson, Gary E.; Beal, M. Flint; Adam-Vizi, Vera; Chinopoulos, Christos			The negative impact of alpha-ketoglutarate dehydrogenase complex deficiency on matrix substrate-level phosphorylation	FASEB JOURNAL			English	Article						succinyl-CoA ligase; adenine nucleotide translocase; F-0-F-1 ATP synthase; reversal potential	ADENINE-NUCLEOTIDE TRANSLOCASE; ENERGY-YIELDING OXIDATION; SUCCINYL-COA SYNTHETASES; ACID-CYCLE METABOLITES; GUINEA-PIG HEART; MITOCHONDRIAL DYSFUNCTION; ANAEROBIC METABOLISM; PYRIDINE NUCLEOTIDE; HYDROGEN-PEROXIDE; ATP DEPLETION	A decline in alpha-ketoglutarate dehydrogenase complex (KGDHC) activity has been associated with neurodegeneration. Provision of succinyl-CoA by KGDHC is essential for generation of matrix ATP (or GTP) by substrate-level phosphorylation catalyzed by succinyl-CoA ligase. Here, we demonstrate ATP consumption in respiration-impaired isolated and in situ neuronal somal mitochondria from transgenic mice with a deficiency of either dihydrolipoyl succinyltransferase (DLST) or dihydrolipoyl dehydrogenase (DLD) that exhibit a 20-48% decrease in KGDHC activity. Import of ATP into the mitochondrial matrix of transgenic mice was attributed to a shift in the reversal potential of the adenine nucleotide translocase toward more negative values due to diminished matrix substrate-level phosphorylation, which causes the translocase to reverse prematurely. Immunoreactivity of all three subunits of succinyl-CoA ligase and maximal enzymatic activity were unaffected in transgenic mice as compared to wild-type littermates. Therefore, decreased matrix substrate-level phosphorylation was due to diminished provision of succinyl-CoA. These results were corroborated further by the finding that mitochondria from wild-type mice respiring on substrates supporting substrate-level phosphorylation exhibited similar to 30% higher ADP-ATP exchange rates compared to those obtained from DLST-/- or DLD-/- littermates. We propose that KGDHC-associated pathologies are a consequence of the inability of respiration-impaired mitochondria to rely on "in-house" mitochondrial ATP reserves.-Kiss, G., Konrad, C., Doczi, J., Starkov, A. A., Kawamata, H., Manfredi, G., Zhang, S. F., Gibson, G. E., Beal, M. F., Adam-Vizi, V., Chinopoulos, C. The negative impact of alpha-ketoglutarate dehydrogenase complex deficiency on matrix substrate-level phosphorylation.	[Kiss, Gergely; Konrad, Csaba; Doczi, Judit; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary; [Starkov, Anatoly A.; Kawamata, Hibiki; Manfredi, Giovanni; Zhang, Steven F.; Beal, M. Flint; Chinopoulos, Christos] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Gibson, Gary E.] Cornell Univ, Coll Med, Burke Med Res Inst, Dept Neurol & Neurosci,Weill Cornell Med Coll, White Plains, NY 10605 USA	Semmelweis University; Cornell University; Cornell University	Chinopoulos, C (corresponding author), Semmelweis Univ, Dept Med Biochem, Tuzolto St 37-47, H-1094 Budapest, Hungary.	chinopoulos.christos@eok.sote.hu	Starkov, Anatoly/B-2688-2012	Starkov, Anatoly/0000-0002-1334-4828; Chinopoulos, Christos/0000-0003-0183-4149	U.S. National Institutes of Health (NIH) [P01 AG014930]; NIH/National Institute of Neurological Disease and Stroke [F31 NS054554]; NIH [1R21NS065396, R01 GM088999]; Orszagos Tudomanyos Kutatasi Alapprogram (OTKA); Magyar Tudomanyos Akademia (MTA); MTA-SE Lendulet Neurobiochemistry Research Division [95003]; OTKA NNF [78905]; OTKA [NNF2 85658, K 100918]; Egeszsegugyi Tudomanyos Tanacs ETT [55160]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065396, F31NS054554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Orszagos Tudomanyos Kutatasi Alapprogram (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Magyar Tudomanyos Akademia (MTA); MTA-SE Lendulet Neurobiochemistry Research Division; OTKA NNF; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Egeszsegugyi Tudomanyos Tanacs ETT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health (NIH) grant P01 AG014930 to G.E.G., A.A.S.. and M.F.B.; NIH/National Institute of Neurological Disease and Stroke grant F31 NS054554 to H.K.; NIH grant 1R21NS065396 to A.A.S.; NIH grant R01 GM088999 to G.M.; grants from the Orszagos Tudomanyos Kutatasi Alapprogram (OTKA), Magyar Tudomanyos Akademia (MTA) to V.A.-V.; and grants MTA-SE Lendulet Neurobiochemistry Research Division 95003, OTKA NNF 78905, OTKA NNF2 85658, OTKA K 100918, and Egeszsegugyi Tudomanyos Tanacs ETT 55160 to C.C. The authors thank Katalin Zolde for excellent technical assistance. The authors declare no conflicts of interest.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Alarcon C, 2002, DIABETES, V51, P2496, DOI 10.2337/diabetes.51.8.2496; ALEXANDRE A, 1978, P NATL ACAD SCI USA, V75, P5296, DOI 10.1073/pnas.75.11.5296; Alves TC, 2012, METHODS MOL BIOL, V810, P281, DOI 10.1007/978-1-61779-382-0_18; Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Browne SE, 2002, INT REV NEUROBIOL, V53, P243; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Bubber P, 2011, EUR NEUROPSYCHOPHARM, V21, P254, DOI 10.1016/j.euroneuro.2010.10.007; Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; CHICK WL, 1968, AM J PHYSIOL, V215, P1107, DOI 10.1152/ajplegacy.1968.215.5.1107; Chinopoulos C, 2004, J NEUROCHEM, V91, P471, DOI 10.1111/j.1471-4159.2004.02732.x; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Chinopoulos C, 2013, J NEUROSCI RES, V91, P1030, DOI 10.1002/jnr.23196; Chinopoulos C, 2011, J NEUROSCI RES, V89, P1897, DOI 10.1002/jnr.22659; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Chinopoulos C, 2011, FEBS J, V278, P1112, DOI 10.1111/j.1742-4658.2011.08026.x; Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Cooper AJL, 2012, NEUROCHEM RES, V37, P2439, DOI 10.1007/s11064-012-0803-4; Demin OV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P634; Dumont M, 2009, FREE RADICAL BIO MED, V47, P1019, DOI 10.1016/j.freeradbiomed.2009.07.008; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Gibson GE, 2000, NEUROCHEM INT, V36, P97, DOI 10.1016/S0197-0186(99)00114-X; HUNTER FE, 1949, J BIOL CHEM, V177, P361; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; Johnson MT, 1997, P NATL ACAD SCI USA, V94, P14512, DOI 10.1073/pnas.94.26.14512; KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S; Kanamori T, 2003, EMBO J, V22, P2913, DOI 10.1093/emboj/cdg299; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Klivenyi P, 2004, J NEUROCHEM, V88, P1352, DOI 10.1046/j.1471-4159.2003.02263.x; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Martell A. E., 1974, CRITICAL STABILITY C; MCMILLIN JB, 1988, MOL CELL BIOCHEM, V81, P121; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; NICHOLLS DG, 1977, EUR J BIOCHEM, V75, P601, DOI 10.1111/j.1432-1033.1977.tb11560.x; Nilsen LH, 2011, J NEUROSCI RES, V89, P1997, DOI 10.1002/jnr.22606; PENNEY DG, 1970, BIOCHEM J, V118, P221, DOI 10.1042/bj1180221; PETRONILLI V, 1988, BIOCHIM BIOPHYS ACTA, V932, P306, DOI 10.1016/0005-2728(88)90167-3; PEUHKURINEN KJ, 1983, AM J PHYSIOL, V244, pH281, DOI 10.1152/ajpheart.1983.244.2.H281; Phillips D, 2009, BIOCHEMISTRY-US, V48, P7140, DOI 10.1021/bi900725c; PISARENKO O, 1987, BIOMED BIOCHIM ACTA, V46, pS568; PISARENKO O, 1988, BIOCHIM BIOPHYS ACTA, V934, P55, DOI 10.1016/0005-2728(88)90119-3; PISARENKO OI, 1985, BASIC RES CARDIOL, V80, P126, DOI 10.1007/BF01910459; PORPACZY Z, 1983, BIOCHIM BIOPHYS ACTA, V749, P172, DOI 10.1016/0167-4838(83)90249-2; RANDALL HM, 1966, AM J PHYSIOL, V211, P493, DOI 10.1152/ajplegacy.1966.211.2.493; ROUSLIN W, 1986, AM J PHYSIOL, V250, pH503, DOI 10.1152/ajpheart.1986.250.3.H503; ROUSLIN W, 1990, AM J PHYSIOL, V259, pH1759, DOI 10.1152/ajpheart.1990.259.6.H1759; SANADI DR, 1963, BIOCHEMISTRY-US, V2, P523, DOI 10.1021/bi00903a023; SANBORN T, 1979, AM J PHYSIOL, V237, pH535, DOI 10.1152/ajpheart.1979.237.5.H535; Sheu KFR, 1999, ANN NY ACAD SCI, V893, P61; Shi QL, 2009, J NEUROCHEM, V109, P214, DOI 10.1111/j.1471-4159.2009.05955.x; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; TAEGTMEYER H, 1977, J BIOL CHEM, V252, P5010; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Tretter L, 2000, J NEUROSCI, V20, P8972; Tretter L, 2007, J NEUROCHEM, V103, P1864, DOI 10.1111/j.1471-4159.2007.04891.x; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Weinberg JM, 2000, AM J PHYSIOL-RENAL, V279, pF927, DOI 10.1152/ajprenal.2000.279.5.F927; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; WILSON MA, 1970, BIOCHIM BIOPHYS ACTA, V216, P54, DOI 10.1016/0005-2728(70)90158-1; WISNIEWSKI E, 1993, J BIOL CHEM, V268, P9343; Yang LC, 2009, NEUROBIOL DIS, V36, P320, DOI 10.1016/j.nbd.2009.07.023; Zacharias NM, 2012, J AM CHEM SOC, V134, P934, DOI 10.1021/ja2040865	72	40	42	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2392	2406		10.1096/fj.12-220202	http://dx.doi.org/10.1096/fj.12-220202			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23475850	Green Published			2022-12-25	WOS:000319667600027
J	Sachse, CC; Kim, YH; Agsten, M; Huth, T; Alzheimer, C; Kovacs, DM; Kim, DY				Sachse, Carolyn C.; Kim, Young Hye; Agsten, Marianne; Huth, Tobias; Alzheimer, Christian; Kovacs, Dora M.; Kim, Doo Yeon			BACE1 and presenilin/gamma-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels	FASEB JOURNAL			English	Article						MinK; MiRP; Alzheimer's disease; KCNQ1	BETA-SECRETASE; ALZHEIMERS-DISEASE; I-KS; TARGETED DISRUPTION; MEDIATED CLEAVAGE; SODIUM-CHANNELS; ALPHA-SECRETASE; UP-REGULATION; MINK; ENZYME	BACE1 and presenilin (PS)/gamma-secretase play a major role in Alzheimer's disease pathogenesis by regulating amyloid-beta peptide generation. We recently showed that these secretases also regulate the processing of voltage-gated sodium channel auxiliary beta-subunits and thereby modulate membrane excitability. Here, we report that KCNE1 and KCNE2, auxiliary subunits of voltage-gated potassium channels, undergo sequential cleavage mediated by either alpha-secretase and PS/gamma-secretase or BACE1 and PS/gamma-secretase in cells. Elevated alpha-secretase or BACE1 activities increased C-terminal fragment (CTF) levels of KCNE1 and 2 in human embryonic kidney (HEK293T) and rat neuroblastoma (B104) cells. KCNE-CTFs were then further processed by PS/gamma-secretase to KCNE intracellular domains. These KCNE cleavages were specifically blocked by chemical inhibitors of the secretases in the same cell models. We also verified our results in mouse cardiomyocytes and cultured primary neurons. Endogenous KCNE1- and KCNE2-CTF levels increased by 2- to 4-fold on PS/gamma-secretase inhibition or BACE1 overexpression in these cells. Furthermore, the elevated BACE1 activity increased KCNE1 processing and shifted KCNE1/KCNQ1 channel activation curve to more positive potentials in HEK cells. KCNE1/KCNQ1 channel is a cardiac potassium channel complex, and the positive shift would lead to a decrease in membrane repolarization during cardiac action potential. Together, these results clearly showed that KCNE1 and KCNE2 cleavages are regulated by BACE1 and PS/gamma-secretase activities under physiological conditions. Our results also suggest a functional role of KCNE cleavage in regulating voltage-gated potassium channels.-Sachse, C. C., Kim, Y. H., Agsten, M., Huth, T., Alzheimer, C., Kovacs, D. M., and Kim, D. Y. BACE1 and presenilin/gamma-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels.	[Sachse, Carolyn C.; Kim, Young Hye; Kovacs, Dora M.; Kim, Doo Yeon] Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Neurobiol Dis Lab,Genet & Aging Res Unit,Med Sch, Charlestown, MA USA; [Kim, Young Hye] Korea Basic Sci Inst, Div Mass Spectrometry Res, Ochang, South Korea; [Agsten, Marianne; Huth, Tobias; Alzheimer, Christian] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	Harvard University; Massachusetts General Hospital; Korea Basic Science Institute (KBSI); University of Erlangen Nuremberg	Kim, DY (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Unit, 114 16th St, Charlestown, MA 02129 USA.	dkim@helix.mgh.harvard.edu		Huth, Tobias/0000-0002-6414-8923	Cure Alzheimer's fund; U.S. National Institutes of Health/National Institute on Aging; Dr. Ernst und Anita Bauer-Stiftung; Johannes und Frieda Marohn-Stiftung; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014713, P01AG015379, R21AG031483] Funding Source: NIH RePORTER	Cure Alzheimer's fund; U.S. National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Dr. Ernst und Anita Bauer-Stiftung; Johannes und Frieda Marohn-Stiftung; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Stephanie Hartmann (University of Erlangen-Nurnberg) for her contribution in revising this manuscript and Dr. Jordan Tang (University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA) for BACE1 inhibitor <INF>D</INF>R9. This work is supported by grants from the Cure Alzheimer's fund to D.Y.K, the U.S. National Institutes of Health/National Institute on Aging to D.M.K and D.Y.K., the Dr. Ernst und Anita Bauer-Stiftung to S.H., and the Johannes und Frieda Marohn-Stiftung to T.H. and C.A.	Angulo E, 2004, J NEUROCHEM, V91, P547, DOI 10.1111/j.1471-4159.2004.02771.x; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Balasubramaniam R, 2003, J PHYSIOL-LONDON, V552, P535, DOI 10.1113/jphysiol.2003.048249; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bianchi L, 1999, HUM MOL GENET, V8, P1499, DOI 10.1093/hmg/8.8.1499; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Carey BW, 2007, BIOCHEM J, V401, P121, DOI 10.1042/BJ20060847; Clancy SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006330; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; de Leon M J, 1995, Neuroimaging Clin N Am, V5, P1; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Haapasalo A, 2007, J BIOL CHEM, V282, P9063, DOI 10.1074/jbc.M611324200; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Huth T, 2011, PFLUG ARCH EUR J PHY, V461, P355, DOI 10.1007/s00424-010-0913-2; Huth T, 2009, NEUROBIOL DIS, V33, P282, DOI 10.1016/j.nbd.2008.10.015; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2011, J BIOL CHEM, V286, P8106, DOI 10.1074/jbc.M110.134692; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Kovacs DM, 2010, NEUROSCI LETT, V486, P68, DOI 10.1016/j.neulet.2010.08.048; Larner AJ, 2010, NEUROMOL MED, V12, P71, DOI 10.1007/s12017-009-8076-z; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pannaccione A, 2007, MOL PHARMACOL, V72, P665, DOI 10.1124/mol.107.034868; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Rossner S, 2001, J NEUROSCI RES, V64, P437; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shepherd C, 2009, ACTA NEUROPATHOL, V118, P37, DOI 10.1007/s00401-009-0521-4; Temple J, 2005, CIRC RES, V97, P62, DOI 10.1161/01.RES.0000173047.42236.88; Thomas G, 2007, J PHYSIOL-LONDON, V578, P99, DOI 10.1113/jphysiol.2006.118133; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wolfe MS, 2008, CURR ALZHEIMER RES, V5, P158, DOI 10.2174/156720508783954767; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839	48	30	32	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2458	2467		10.1096/fj.12-214056	http://dx.doi.org/10.1096/fj.12-214056			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23504710	Green Published			2022-12-25	WOS:000319667600033
J	Feng, J; Hu, YT; Yi, H; Yin, SJ; Han, S; Hu, J; Chen, ZY; Yang, WS; Cao, ZJ; De Waard, M; Sabatier, JM; Li, WX; Wu, YL				Feng, Jing; Hu, Youtian; Yi, Hong; Yin, Shijin; Han, Song; Hu, Jun; Chen, Zongyun; Yang, Weishan; Cao, Zhijian; De Waard, Michel; Sabatier, Jean-Marc; Li, Wenxin; Wu, Yingliang			Two Conserved Arginine Residues from the SK3 Potassium Channel Outer Vestibule Control Selectivity of Recognition by Scorpion Toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; NUCLEAR-MAGNETIC-RESONANCE; PEPTIDE INHIBITOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INACTIVATION; SIMULATIONS; PLASTICITY; CONDUCTION; LIGAND	Potassium channel functions are often deciphered by using selective and potent scorpion toxins. Among these toxins, only a limited subset is capable of selectively blocking small conductance Ca2+-activated K+ (SK) channels. The structural bases of this selective SK channel recognition remain unclear. In this work, we demonstrate the key role of the electric charges of two conserved arginine residues (Arg-485 and Arg-489) from the SK3 channel outer vestibule in the selective recognition by the SK3-blocking BmP05 toxin. Indeed, individually substituting these residues with histidyl or lysyl (maintaining the positive electric charge partially or fully), although decreasing BmP05 affinity, still preserved the toxin sensitivity profile of the SK3 channel (as evidenced by the lack of recognition by many other types of potassium channel-sensitive charybdotoxin). In contrast, when Arg-485 or Arg-489 of the SK3 channel was mutated to an acidic (Glu) or alcoholic (Ser) amino acid residue, the channel lost its sensitivity to BmP05 and became susceptible to the "new" blocking activity by charybdotoxin. In addition to these SK3 channel basic residues important for sensitivity, two acidic residues, Asp-492 and Asp-518, also located in the SK3 channel outer vestibule, were identified as being critical for toxin affinity. Furthermore, molecular modeling data indicate the existence of a compact SK3 channel turret conformation (like a peptide screener), where the basic rings of Arg-485 and Arg-489 are stabilized by strong ionic interactions with Asp-492 and Asp-518. In conclusion, the unique properties of Arg-485 and Arg-489 (spatial orientations and molecular interactions) in the SK3 channel account for its toxin sensitivity profile.	[Feng, Jing; Hu, Youtian; Yi, Hong; Yin, Shijin; Han, Song; Hu, Jun; Chen, Zongyun; Yang, Weishan; Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [De Waard, Michel] Univ Grenoble 1, INSERM U836, Grenoble Neurosci Inst, Lab Excellence Ion Channels Sci & Therapeut, F-38042 Grenoble 09, France; [De Waard, Michel] Smartox Biotechnol, F-38700 La Tronche, France; [Sabatier, Jean-Marc] Aix Marseille Univ, INSERM UMR1097, F-13288 Marseille, France	Wuhan University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	ylwu@whu.edu.cn	Feng, Jing/C-1729-2018; De Waard, Michel/G-7406-2014; Hu, Youtian/G-5408-2014	Feng, Jing/0000-0001-6726-7912; De Waard, Michel/0000-0002-2782-9615; SABATIER, Jean-Marc/0000-0002-9040-5647	National Basic Research Program of China [2010CB529800]; National High Technology Research and Development Program of China [2012AA020304]; National Natural Sciences Foundation of China [30530140, 30973636, 31170789]; New Century Excellent Talents in Wuhan University from the Ministry of Education of China [NCET-10-0651]; Hubei Province Natural Sciences Foundation of China [2009CDA076]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020304] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in Wuhan University from the Ministry of Education of China; Hubei Province Natural Sciences Foundation of China; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Basic Research Program of China Grant 2010CB529800; National High Technology Research and Development Program of China Grant 2012AA020304; National Natural Sciences Foundation of China Grants 30530140, 30973636, and 31170789; New Century Excellent Talents in Wuhan University Grant NCET-10-0651 from the Ministry of Education of China; and Hubei Province Natural Sciences Foundation of China Grant 2009CDA076.	Ader C, 2008, NAT STRUCT MOL BIOL, V15, P605, DOI 10.1038/nsmb.1430; Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; Andreotti N, 2005, PEPTIDES, V26, P1095, DOI 10.1016/j.peptides.2005.01.022; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cui M, 2002, J MOL BIOL, V318, P417, DOI 10.1016/S0022-2836(02)00095-5; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; PEASE JHB, 1988, BIOCHEMISTRY-US, V27, P8491, DOI 10.1021/bi00422a029; Regaya I, 2004, J BIOL CHEM, V279, P55690, DOI 10.1074/jbc.M410055200; SABATIER JM, 1993, BIOCHEMISTRY-US, V32, P2763, DOI 10.1021/bi00062a005; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Subbotina J, 2010, PROTEINS, V78, P2922, DOI 10.1002/prot.22815; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wittekindt OH, 2004, MOL PHARMACOL, V65, P788, DOI 10.1124/mol.65.3.788; Wu JJ, 2002, BIOCHEMISTRY-US, V41, P2844, DOI 10.1021/bi011367z; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d	38	26	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12544	12553		10.1074/jbc.M112.433888	http://dx.doi.org/10.1074/jbc.M112.433888			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511633	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000318555100013
J	Hunt, LC; Gorman, C; Kintakas, C; McCulloch, DR; Mackie, EJ; White, JD				Hunt, Liam C.; Gorman, Chris; Kintakas, Christopher; McCulloch, Daniel R.; Mackie, Eleanor J.; White, Jason D.			Hyaluronan Synthesis and Myogenesis A REQUIREMENT FOR HYALURONAN SYNTHESIS DURING MYOGENIC DIFFERENTIATION INDEPENDENT OF PERICELLULAR MATRIX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; HUMAN ARTICULAR CHONDROCYTES; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; INTRACELLULAR HYALURONAN; MYOBLAST DIFFERENTIATION; OVER-EXPRESSION; BINDING PROTEIN; ACID; SYNTHASE	Exogenous hyaluronan is known to alter muscle precursor cell proliferation, migration, and differentiation, ultimately inhibiting myogenesis in vitro. The aim of the current study was to investigate the role of endogenous hyaluronan synthesis during myogenesis. In quantitative PCR studies, the genes responsible for synthesizing hyaluronan were found to be differentially regulated during muscle growth, repair, and pathology. Although all Has genes (Has1, Has2, and Has3) were differentially regulated in these models, only Has2 gene expression consistently associated with myogenic differentiation. During myogenic differentiation in vitro, Has2 was the most highly expressed of the synthases and increased after induction of differentiation. To test whether this association between Has2 expression and myogenesis relates to a role for Has2 in myoblast differentiation and fusion, C2C12 myoblasts were depleted of Has2 by siRNA and induced to differentiate. Depletion of Has2 inhibited differentiation and caused a loss of cell-associated hyaluronan and the hyaluronan-dependent pericellular matrix. The inhibition of differentiation caused by loss of hyaluronan was confirmed with the hyaluronan synthesis inhibitor 4-methylumbelliferone. In hyaluronan synthesis-blocked cultures, restoration of the pericellular matrix could be achieved through the addition of exogenous hyaluronan and the proteoglycan versican, but this was not sufficient to restore differentiation to control levels. These data indicate that intrinsic hyaluronan synthesis is necessary for myoblasts to differentiate and form syncytial muscle cells, but the hyaluronan-dependent pericellular matrix is not sufficient to support differentiation alone; additional hyaluronan-dependent cell functions that are yet unknown may be required for myogenic differentiation.	[Hunt, Liam C.; Gorman, Chris; Kintakas, Christopher; White, Jason D.] Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Kintakas, Christopher; McCulloch, Daniel R.] Deakin Univ, Sch Med, Waurn Ponds, Vic 3216, Australia; [Gorman, Chris; Mackie, Eleanor J.; White, Jason D.] Univ Melbourne, Sch Vet Sci, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Deakin University; University of Melbourne	White, JD (corresponding author), Murdoch Childrens Res Inst, Muscular Dystrophy Res Grp, Flemington Rd, Parkville, Vic 3052, Australia.	jasondw@unimelb.edu.au	White, Jason/AAF-8712-2020; Mackie, Eleanor J/B-2045-2008; Hunt, Liam/C-7344-2017; McCulloch, Daniel/N-9142-2013	White, Jason/0000-0002-0557-392X; Mackie, Eleanor J/0000-0002-8057-5407; Hunt, Liam/0000-0001-5192-1473; McCulloch, Daniel/0000-0003-0269-5857	Muscular Dystrophy Association of Australia (MDA); Victorian Government	Muscular Dystrophy Association of Australia (MDA)(Muscular Dystrophy Association); Victorian Government	This work was supported by the Muscular Dystrophy Association of Australia (MDA) and the Victorian Government's Operational Infrastructure Support Program.	Allingham PG, 2006, ARCH BIOCHEM BIOPHYS, V452, P83, DOI 10.1016/j.abb.2006.05.010; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Caskey RC, 2013, CELL TISSUE RES, V351, P117, DOI 10.1007/s00441-012-1504-7; Cohen M, 2007, SOFT MATTER, V3, P327, DOI 10.1039/b613770a; ELSON HF, 1980, J SUPRAMOL STR CELL, V14, P313, DOI 10.1002/jss.400140306; FOSANG AJ, 1990, MATRIX, V10, P306, DOI 10.1016/S0934-8832(11)80186-1; GRAMMATIKAKIS N, 1995, J BIOL CHEM, V270, P16198, DOI 10.1074/jbc.270.27.16198; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Huang L, 2000, J BIOL CHEM, V275, P29829, DOI 10.1074/jbc.M002737200; Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535; Hunt L. C., 2011, PLOS CURR, V3; Hunt LC, 2013, HISTOCHEM CELL BIOL, V139, P13, DOI 10.1007/s00418-012-1018-0; Hunt LC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-17; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; KELLY AM, 1983, HDB PHYSL 10, P507; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; KUJAWA MJ, 1986, DEV BIOL, V113, P10, DOI 10.1016/0012-1606(86)90103-X; KUJAWA MJ, 1983, DEV BIOL, V99, P277, DOI 10.1016/0012-1606(83)90277-4; KUJAWA MJ, 1986, DEV BIOL, V114, P519, DOI 10.1016/0012-1606(86)90215-0; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; LAURENT C, 1991, CELL TISSUE RES, V263, P201, DOI 10.1007/BF00318761; Laurent T.C, 1970, CHEM MOL BIOL INTERC, P703; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Mikami T, 2012, J BIOL CHEM, V287, P38531, DOI 10.1074/jbc.M111.336925; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; NANDAN D, 1990, J CELL BIOL, V110, P1673, DOI 10.1083/jcb.110.5.1673; Nishida Y, 2000, ARTHRITIS RHEUM-US, V43, P206, DOI 10.1002/1529-0131(200001)43:1<206::AID-ANR25>3.0.CO;2-1; Nishida Y, 1999, J BIOL CHEM, V274, P21893, DOI 10.1074/jbc.274.31.21893; Nishida Y, 2000, ARTHRITIS RHEUM, V43, P1315, DOI 10.1002/1529-0131(200006)43:6<1315::AID-ANR14>3.0.CO;2-#; ORKIN RW, 1985, DEV BIOL, V107, P527, DOI 10.1016/0012-1606(85)90333-1; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Osses N, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-73; Pedrosa-Domellof F, 1998, HISTOCHEM CELL BIOL, V110, P179, DOI 10.1007/s004180050279; Petillo O, 1999, J MATER SCI-MATER M, V10, P595, DOI 10.1023/A:1008998604276; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIEHLAULIN K, 1991, J APPL PHYSIOL, V71, P2493, DOI 10.1152/jappl.1991.71.6.2493; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; REED RK, 1988, ACTA PHYSIOL SCAND, V134, P405, DOI 10.1111/j.1748-1716.1988.tb08508.x; SAITOH O, 1992, EXP CELL RES, V200, P70, DOI 10.1016/S0014-4827(05)80072-2; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stupka N, 2013, J BIOL CHEM, V288, P1907, DOI 10.1074/jbc.M112.429647; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wang H, 2001, STROKE, V32, P1020, DOI 10.1161/01.STR.32.4.1020; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; YOSHIMURA M, 1985, CELL DIFFER DEV, V16, P175, DOI 10.1016/0045-6039(85)90515-9; Yun BG, 2005, EXP CELL RES, V307, P212, DOI 10.1016/j.yexcr.2005.03.003	61	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13006	13021		10.1074/jbc.M113.453209	http://dx.doi.org/10.1074/jbc.M113.453209			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493399	Green Published, hybrid			2022-12-25	WOS:000318555100053
J	Yamakawa, D; Kidoya, H; Sakimoto, S; Jia, W; Naito, H; Takakura, N				Yamakawa, Daishi; Kidoya, Hiroyasu; Sakimoto, Susumu; Jia, Weizhen; Naito, Hisamichi; Takakura, Nobuyuki			Ligand-independent Tie2 Dimers Mediate Kinase Activity Stimulated by High Dose Angiopoietin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-TYROSINE KINASE; VASCULAR MORPHOGENESIS; VENOUS MALFORMATIONS; ENDOTHELIAL-CELLS; LIVING CELLS; ACTIVATION; GROWTH; ANGIOGENESIS; SURVIVAL; DOMAIN	Tie2 is a receptor tyrosine kinase expressed on vascular endothelial cells (ECs). It has dual roles in promoting angiogenesis and stabilizing blood vessels, and it has been suggested that Tie2 forms dimers and/or oligomers in the absence of angiopoietin-1 (Ang1); however, the mechanism of ligand-independent dimerization of Tie2 and its biological significance have not been clarified. Using a bimolecular fluorescence complementation assay and a kinase-inactive Tie2 mutant, we show here that ligand-independent Tie2 dimerization is induced without Tie2 phosphorylation. Moreover, based on the fact that Tie1 never forms heterodimers with Tie2 in the absence of Ang1 despite having high amino acid sequence homology with Tie2, we searched for ligand-independent dimerization domains of Tie2 by reference to the difference with Tie1. We found that the YIA sequence of the intracellular domain of Tie2 corresponding to the LAS sequence in Tie1 is essential for this dimerization. When the YIA sequence was replaced by LAS in Tie2 (Tie2YIA/LAS), ligand-independent dimer was not formed in the absence of Ang1. When activation of Tie2YIA/LAS was induced by a high dose of Ang1, phosphorylation of Tie2 was limited compared with wild-type Tie2, resulting in retardation of activation of Erk downstream of Tie2. Therefore, these data suggest that ligand-independent dimerization of Tie2 is essential for a strong response upon stimulation with high dose Ang1.	[Yamakawa, Daishi; Kidoya, Hiroyasu; Sakimoto, Susumu; Jia, Weizhen; Naito, Hisamichi; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 5650871, Japan; [Takakura, Nobuyuki] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ntakaku@biken.osaka-u.ac.jp		Naito, Hisamichi/0000-0002-0750-1743	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Science, Sports, and Culture of Japan.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Bogdanovic E, 2009, HISTOCHEM CELL BIOL, V132, P225, DOI 10.1007/s00418-009-0603-3; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morris PN, 2005, J MOL MED, V83, P58, DOI 10.1007/s00109-004-0601-9; Niu XL, 2002, J BIOL CHEM, V277, P31768, DOI 10.1074/jbc.M203995200; Patan S, 1998, MICROVASC RES, V56, P1, DOI 10.1006/mvre.1998.2081; Puri MC, 1999, DEVELOPMENT, V126, P4569; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Singh H, 2009, CELL SIGNAL, V21, P1346, DOI 10.1016/j.cellsig.2009.04.002; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Yabkowitz R, 1999, BLOOD, V93, P1969, DOI 10.1182/blood.V93.6.1969.406k14_1969_1979; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com	37	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12469	12477		10.1074/jbc.M112.433979	http://dx.doi.org/10.1074/jbc.M112.433979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504320	Green Published, hybrid			2022-12-25	WOS:000318555100006
J	Evertts, AG; Zee, BM; DiMaggio, PA; Gonzales-Cope, M; Coller, HA; Garcia, BA				Evertts, Adam G.; Zee, Barry M.; DiMaggio, Peter A.; Gonzales-Cope, Michelle; Coller, Hilary A.; Garcia, Benjamin A.			Quantitative Dynamics of the Link between Cellular Metabolism and Histone Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; METHYLATION; DEACETYLASE; TRANSCRIPTION; EXTRACTION; COMPLEXES; CHROMATIN; TURNOVER; TARGETS; REVEAL	Acetylation on the tails of histones plays an important role in controlling transcription initiation. Although the steady-state abundances of histone acetyl groups have been reported, the rate at which histones are acetylated and deacetylated on a residue-specific basis has not been quantitatively established. We added [C-13]glucose to human cells and monitored the dynamic incorporation of C-13-labeled acetyl groups onto specific histone lysines with quantitative mass spectrometry. We determined the turnover of acetylation to be generally slower than phosphorylation, but fast relative to methylation, and that the rate varied depending on the histone, the residue modified, and also the neighboring modifications. Cells were also treated with a deacetylase inhibitor to determine the rate due to histone acetyltransferase activity alone and in the absence of deacetylase activity. Introduction of C-13-labeled glucose also resulted in the incorporation of C-13 into alanine, which allowed us to partition histones into existing and newly synthesized protein categories. Newly synthesized histones were slower to accumulate histone modifications, especially modifications associated with silent chromatin. Finally, we applied our new approaches to find that quiescent fibroblasts exhibited lower levels of labeled acetyl accumulation compared with proliferating fibroblasts. This suggests that acetylation rates can be modulated in cells in different biological states and that these changes can be detected with the approach presented here. The methods we describe can be broadly applied to defining the turnover of histone acetylation in other cell states such as during cellular reprogramming and to quantify non-histone protein acetylation dynamics.	[Evertts, Adam G.; Zee, Barry M.; Gonzales-Cope, Michelle; Coller, Hilary A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Zee, Barry M.; Gonzales-Cope, Michelle; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Epigenet Program, Philadelphia, PA 19104 USA; [DiMaggio, Peter A.] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England	Princeton University; University of Pennsylvania; Pennsylvania Medicine; Imperial College London	Garcia, BA (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Epigenet Program, Philadelphia, PA 19104 USA.	bgarci@mail.med.upenn.edu		Zee, Barry/0000-0002-3123-8375; DiMaggio, Peter/0000-0003-1996-0813	National Institutes of Health [5T32CA009528, 5T32HG003284, DP2OD007447]; National Science Foundation; NATIONAL CANCER INSTITUTE [T32CA009528] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health Training Grants 5T32CA009528 and 5T32HG003284.; Supported by a National Science Foundation graduate research fellowship.; Supported by a National Science Foundation Early Faculty CAREER award and National Institutes of Health Innovator Grant DP2OD007447. To whom correspondence should be addressed. Tel.: 215-573-9423; Fax: 215-898-4217; E-mail: bgarci@ mail.med.upenn.edu.	ALLFREY VG, 1968, SCIENCE, V159, P314, DOI 10.1126/science.159.3812.314; Aponte AM, 2009, J PROTEOME RES, V8, P2679, DOI 10.1021/pr800913j; Baliban RC, 2010, MOL CELL PROTEOMICS, V9, P764, DOI 10.1074/mcp.M900487-MCP200; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; DiMaggio PA, 2009, MOL CELL PROTEOMICS, V8, P2527, DOI 10.1074/mcp.M900144-MCP200; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Dose A, 2011, ACS CHEM BIOL, V6, P419, DOI 10.1021/cb1003866; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Ito T, 2011, CHEM BIOL, V18, P495, DOI 10.1016/j.chembiol.2011.02.009; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Morrish F, 2010, J BIOL CHEM, V285, P36267, DOI 10.1074/jbc.M110.141606; Mosley AL, 2003, J BIOL CHEM, V278, P19660, DOI 10.1074/jbc.M212375200; ODESSEY R, 1974, J BIOL CHEM, V249, P7623; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PERRIELLO G, 1995, AM J PHYSIOL-ENDOC M, V269, pE443, DOI 10.1152/ajpendo.1995.269.3.E443; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Simone C, 2004, ONCOGENE, V23, P2177, DOI 10.1038/sj.onc.1207327; Sinha I, 2010, EPIGENOMICS-UK, V2, P377, DOI 10.2217/EPI.10.18; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Waterborg JH, 1998, J BIOL CHEM, V273, P27602, DOI 10.1074/jbc.273.42.27602; Waterborg JH, 2001, BIOCHEMISTRY-US, V40, P2599, DOI 10.1021/bi002480c; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu Y, 2013, J PROTEOME RES, V12, P316, DOI 10.1021/pr300408v; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Zee BM, 2012, MOL CELL BIOL, V32, P2503, DOI 10.1128/MCB.06673-11; Zee BM, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-22; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; ZHANG DE, 1988, BIOCHEM J, V250, P233, DOI 10.1042/bj2500233	49	75	76	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12142	12151		10.1074/jbc.M112.428318	http://dx.doi.org/10.1074/jbc.M112.428318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482559	Green Published, hybrid			2022-12-25	WOS:000318157600046
J	Chiba, Y; Horita, S; Ohtsuka, J; Arai, H; Nagata, K; Igarashi, Y; Tanokura, M; Ishii, M				Chiba, Yoko; Horita, Shoichiro; Ohtsuka, Jun; Arai, Hiroyuki; Nagata, Koji; Igarashi, Yasuo; Tanokura, Masaru; Ishii, Masaharu			Structural Units Important for Activity of a Novel-type Phosphoserine Phosphatase from Hydrogenobacter thermophilus TK-6 Revealed by Crystal Structure Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHOGLYCERATE MUTASE; BROAD-SPECIFICITY PHOSPHATASE; BACILLUS-STEAROTHERMOPHILUS; SWISS-MODEL; FUNCTIONAL-ANALYSIS; PROTEIN; SUPERFAMILY; MECHANISM; HOMOLOG; ENVIRONMENT	Novel-type serine-synthesizing enzymes, termed metal-independent phosphoserine phosphatases (iPSPs), were recently identified and characterized from Hydrogenobacter thermophilus, a chemolithoautotrophic bacterium belonging to the order Aquificales. iPSPs are cofactor-dependent phosphoglycerate mutase (dPGM)-like phosphatases that have significant amino acid sequence similarity to dPGMs but lack phosphoglycerate mutase activity. Genes coding dPGM-like phosphatases have been identified in a broad range of organisms; however, predicting the function of the corresponding proteins based on sequence information alone is difficult due to their diverse substrate preferences. Here, we determined the crystal structure of iPSP1 from H. thermophilus in the apo-form and in complex with its substrate L-phosphoserine to find structural units important for its phosphatase activity toward L-phosphoserine. Structural and biochemical characterization of iPSP1 revealed that the side chains of His(85) and C-terminal region characteristic of iPSP1 are responsible for the PSP activity. The importance of these structural units for PSP activity was confirmed by high PSP activity observed in two novel dPGM-like proteins from Cyanobacteria and Chloroflexus in which the two structural units were conserved. We anticipate that our present findings will facilitate understanding of the serine biosynthesis pathways of organisms that lack gene(s) encoding conventional PSPs, as the structural information revealed here will help to identify iPSP from sequence databases.	[Chiba, Yoko; Arai, Hiroyuki; Igarashi, Yasuo; Ishii, Masaharu] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Horita, Shoichiro; Ohtsuka, Jun; Nagata, Koji; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Ishii, M (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amishii@mail.ecc.u-tokyo.ac.jp		Nagata, Koji/0000-0002-4704-0603; Tanokura, Masaru/0000-0001-5072-2480; Chiba, Yoko/0000-0002-2734-0836	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Platform for Drug Discovery, Informatics and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [21248010]; Japan Society for the Promotion of Science Fellows [23-3030]; Grants-in-Aid for Scientific Research [11J03030] Funding Source: KAKEN	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Platform for Drug Discovery, Informatics and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Masahiko Ikeuchi (University of Tokyo), Shin Haruta, Katsumi Matsuura, and Hiromi Fukushima (Tokyo Metropolitan University) for providing T. elongatus and R. castenholzii cells. Homology modeling was supported by Tohru Terada and Kentaro Shimizu (University of Tokyo). We also thank Masafumi Kameya (Toyama Prefectural University) for frequent and fruitful discussions. The synchrotron radiation experiments were performed at beamline BL- 32XU at SPring- 8 (Hyogo, Japan) with the approval of the Targeted Proteins Research Program Office at RIKEN/SPring-8 and at beamline NE3A at Photon Factory-Advanced Ring (Ibaraki, Japan) under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2008S2-001).; This work was supported in part by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Platform for Drug Discovery, Informatics and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-aid for Scientific Research (A) 21248010 from the Japan Society for the Promotion of Science, and Grant-in-aid for Japan Society for the Promotion of Science Fellows 23-3030.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bond CS, 2001, J BIOL CHEM, V276, P3247, DOI 10.1074/jbc.M007318200; Bourgis F, 2005, J EXP BOT, V56, P1129, DOI 10.1093/jxb/eri105; Chiba Y, 2012, ACTA CRYSTALLOGR F, V68, P911, DOI 10.1107/S1744309112025213; Chiba Y, 2012, J BIOL CHEM, V287, P11934, DOI 10.1074/jbc.M111.330621; Chiba Y, 2012, FEBS J, V279, P504, DOI 10.1111/j.1742-4658.2011.08443.x; Colman B, 1997, PHYSIOL PLANTARUM, V100, P133, DOI 10.1034/j.1399-3054.1997.1000114.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamada K, 2005, GENES CELLS, V10, P1, DOI 10.1111/j.1365-2443.2005.00817.x; Hills T, 2011, MOL BIOCHEM PARASIT, V179, P69, DOI 10.1016/j.molbiopara.2011.06.001; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAWASUMI T, 1984, INT J SYST BACTERIOL, V34, P5, DOI 10.1099/00207713-34-1-5; KAWASUMI T, 1980, AGR BIOL CHEM TOKYO, V44, P1985, DOI 10.1080/00021369.1980.10864255; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Parkinson G, 1996, NAT STRUCT BIOL, V3, P837, DOI 10.1038/nsb1096-837; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 2002, J MOL BIOL, V315, P1129, DOI 10.1006/jmbi.2001.5290; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; Rigden DJ, 1999, J MOL BIOL, V286, P1507, DOI 10.1006/jmbi.1999.2566; SASAKI R, 1966, ARCH BIOCHEM BIOPHYS, V115, P53, DOI 10.1016/S0003-9861(66)81037-8; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Smiechowski M, 2010, CHEM PHYS LETT, V501, P123, DOI 10.1016/j.cplett.2010.10.063; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Walter RA, 1999, BIOCHEM J, V337, P89, DOI 10.1042/0264-6021:3370089; Watkins HA, 2006, J BACTERIOL, V188, P3589, DOI 10.1128/JB.188.10.3589-3599.2006; WHITE MF, 1992, EUR J BIOCHEM, V207, P709, DOI 10.1111/j.1432-1033.1992.tb17099.x; Zachariou M, 1996, J PHYS CHEM-US, V100, P12680, DOI 10.1021/jp9601476	35	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11448	11458		10.1074/jbc.M112.449561	http://dx.doi.org/10.1074/jbc.M112.449561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479726	Green Published, hybrid			2022-12-25	WOS:000317915500046
J	Best, RJ; Stachowicz, JJ				Best, Rebecca J.; Stachowicz, John J.			Phylogeny as a Proxy for Ecology in Seagrass Amphipods: Which Traits Are Most Conserved?	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA SECONDARY STRUCTURE; SUBUNIT RIBOSOMAL DNA; MORPHOLOGICAL EVOLUTION; COMMUNITY ECOLOGY; STABLE-ISOTOPE; CRUSTACEA; DIVERSITY; PATTERNS; SIGNAL	Increasingly, studies of community assembly and ecosystem function combine trait data and phylogenetic relationships to gain novel insight into the ecological and evolutionary constraints on community dynamics. However, the key to interpreting these two types of information is an understanding of the extent to which traits are phylogenetically conserved. In this study, we develop the necessary framework for community phylogenetics approaches in a system of marine crustacean herbivores that play an important role in the ecosystem functioning of seagrass systems worldwide. For 16 species of amphipods and isopods, we (1) reconstructed phylogenetic relationships using COI, 16S, and 18S sequences and Bayesian analyses, (2) measured traits that are potentially important for assembling species between and within habitats, and (3) compared the degree to which each of these traits are evolutionarily conserved. Despite poor phylogenetic resolution for the order Amphipoda as a whole, we resolved almost all of the topology for the species in our system, and used a sampling of ultrametric trees from the posterior distribution to account for remaining uncertainty in topology and branch lengths. We found that traits varied widely in their degree of phylogenetic signal. Body mass, fecundity, and tube building showed very strong phylogenetic signal, and temperature tolerance and feeding traits showed much less. As such, the degree of signal was not predictable based on whether the trait is related to environmental filtering or to resource partitioning. Further, we found that even with strong phylogenetic signal in body size, (which may have large impacts on ecosystem function), the predictive relationship between phylogenetic diversity and ecosystem function is not straightforward. We show that patterns of phylogenetic diversity in communities of seagrass mesograzers could lead to a variety of interpretations and predictions, and that detailed study of trait similarities and differences will be necessary to interpret these patterns.	[Best, Rebecca J.; Stachowicz, John J.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Best, RJ (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	rjbest@ucdavis.edu	Best, Rebecca/D-2934-2013	Best, Rebecca/0000-0003-2103-064X	Fulbright Science and Technology PhD Award; NSERC PGS-D; UC Davis Center for Population Biology; College of Biological Sciences; Bodega Marine Laboratory; National Science Foundation [OCE 08-50707]	Fulbright Science and Technology PhD Award; NSERC PGS-D(Natural Sciences and Engineering Research Council of Canada (NSERC)); UC Davis Center for Population Biology; College of Biological Sciences; Bodega Marine Laboratory; National Science Foundation(National Science Foundation (NSF))	This project was supported by a Fulbright Science and Technology PhD Award (http://scienceandtech.fulbrightonline.org/), an NSERC PGS-D Award (www.nserc.ca), the UC Davis Center for Population Biology (http://cpb.ucdavis.edu/), a College of Biological Sciences Dean's Mentorship Award, and the Bodega Marine Laboratory (http://bml.ucdavis.edu/)(grants to RJB). Additional funding was provided through the National Science Foundation (OCE 08-50707 to JJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; BARNARD J L, 1974, Crustaceana (Leiden), V27, P137, DOI 10.1163/156854074X00343; BARNARD JL, 1987, P BIOL SOC WASH, V100, P856; Benson DA, 2012, NUCLEIC ACIDS RES, V40, pD48, DOI 10.1093/nar/gkr1202; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Best RJ, 2012, MAR ECOL PROG SER, V456, P29, DOI 10.3354/meps09678; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347; Bousfield E.L., 1982, P254; Bousfield Edward L., 2001, Amphipacifica, V3, P49; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; CAINE EA, 1980, MAR BIOL, V56, P327, DOI 10.1007/BF00386871; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chapman John W., 2007, P545; Dangles O, 2012, ECOLOGY, V93, P2615, DOI 10.1890/12-0510.1; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; De Broyer Claude, 2007, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V77, P1; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond A. J., 2011, GENEIOUS V5 4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; DUFFY JE, 1994, ECOLOGY, V75, P1304, DOI 10.2307/1937456; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Englisch U, 2001, ORG DIVERS EVOL, V1, P139, DOI 10.1078/1439-6092-00011; Englisch U, 2003, J NAT HIST, V37, P2461, DOI 10.1080/00222930210144352; Englisch U, 2001, THESIS RUHR U BOCHUM; Farlin JP, 2010, MAR ECOL PROG SER, V420, P277, DOI 10.3354/meps08873; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Glazier DS, 1999, ARCH HYDROBIOL, V146, P257; Glor RE, 2003, EVOLUTION, V57, P2383; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Hart EA, 2003, ECOLOGY, V84, P3317, DOI 10.1890/02-0629; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI 10.1017/CBO9780511525551; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hou ZG, 2007, MOL PHYLOGENET EVOL, V45, P596, DOI 10.1016/j.ympev.2007.06.006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hultgren KM, 2012, ECOL LETT, V15, P704, DOI 10.1111/j.1461-0248.2012.01788.x; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Jaschinski S, 2008, MAR ECOL PROG SER, V358, P103, DOI 10.3354/meps07327; Jeong S, 2012, MAR BIOL, P1; Johnson MA, 2008, ANIM BEHAV, V75, P555, DOI 10.1016/j.anbehav.2007.06.012; Kjer KM, 2007, SYST BIOL, V56, P133, DOI 10.1080/10635150601156305; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Korpinen S, 2010, MAR BIOL, V157, P361, DOI 10.1007/s00227-009-1323-x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Limen H, 2005, J GREAT LAKES RES, V31, P97, DOI 10.1016/S0380-1330(05)70241-0; Littell R.C., 1996, SAS SYSTEM MIXED MOD; Losos JB, 1996, ECOLOGY, V77, P1344, DOI 10.2307/2265532; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lowry J, 2012, WORLD AMPHIPODA DATA; Macdonald KS, 2005, MOL PHYLOGENET EVOL, V35, P323, DOI 10.1016/j.ympev.2005.01.013; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Mattern D, 2001, MOL PHYLOGENET EVOL, V18, P54, DOI 10.1006/mpev.2000.0861; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; Myers AA, 2003, J CRUSTACEAN BIOL, V23, P443, DOI 10.1651/0278-0372(2003)023[0443:APAANC]2.0.CO;2; Nawrocki EP, 2009, THESIS; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NELSON WG, 1980, SARSIA, V65, P61; Nylander J. A. A., 2004, MRMODELTEST V2; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; Poore AGB, 2008, EVOLUTION, V62, P21, DOI 10.1111/j.1558-5646.2007.00261.x; R Core Team, 2021, R LANG ENV STAT COMP; Rabosky DL, 2011, AM NAT, V178, P579, DOI 10.1086/662162; Rambaut A., 2007, TRACER V1 4; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; SAS Institute Inc, 2008, SAS WIND 9 2; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; SCHRAM FR, 1970, SCIENCE, V169, P854, DOI 10.1126/science.169.3948.854; Silvertown J, 2001, J ECOL, V89, P428, DOI 10.1046/j.1365-2745.2001.00553.x; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Smit AJ, 2006, AQUAT BOT, V84, P277, DOI 10.1016/j.aquabot.2005.11.005; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Spears T, 2005, P BIOL SOC WASH, V118, P117, DOI 10.2988/0006-324X(2005)118[117:PMAIPI]2.0.CO;2; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Therneau T.M., 2012, PACKAGE SURVIVAL ANA; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Verdu M, 2012, P ROY SOC B-BIOL SCI, V279, P1761, DOI 10.1098/rspb.2011.2268; WATLING L, 1993, J NAT HIST, V27, P837, DOI 10.1080/00222939300770511; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240	92	34	34	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57550	10.1371/journal.pone.0057550	http://dx.doi.org/10.1371/journal.pone.0057550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505433	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500025
J	Kalinowska, M; Bazdar, DA; Lederman, MM; Funderburg, N; Sieg, SF				Kalinowska, Magdalina; Bazdar, Douglas A.; Lederman, Michael M.; Funderburg, Nicholas; Sieg, Scott F.			Decreased IL-7 Responsiveness Is Related to Oxidative Stress in HIV Disease	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NAIVE T-CELLS; INFECTED PATIENTS; CD127 EXPRESSION; MICROBIAL TRANSLOCATION; IL-7R-ALPHA EXPRESSION; LIPID-PEROXIDATION; IMMUNE ACTIVATION; EPITHELIAL-CELLS; DOWN-REGULATION	HIV disease results in decreased IL-7 receptor expression and IL-7 responsiveness in T cells. To explore mechanisms of these deficiencies, we compared CD127 expression and IL-7 induction of P-STAT5 in T cells from HIV-infected persons with serum concentrations of cytokines (IL-7, IL-6 and IL-15), markers of microbial translocation (sCD14 and LPS), and with an indicator of oxidative stress (malondialdehyde (MDA) adducts). CD127 expression was directly related to IL-7 responsiveness in most CD8+ T cell subsets but not in CD4+ T cells from HIV-infected persons. MDA adducts were increased in serum of HIV-infected patients and were inversely related to IL-7 responsiveness in CD8+ T cells and in central memory CD4+ T cells. Incubation of T cells from healthy controls with hydrogen peroxide resulted in impairments in IL-7 induction of P-STAT5. These findings suggest that oxidative stress that is characteristic of HIV disease could contribute to impairments in IL-7 responsiveness and disrupt T cell homeostasis.	[Kalinowska, Magdalina] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Bazdar, Douglas A.; Lederman, Michael M.; Funderburg, Nicholas; Sieg, Scott F.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Bazdar, Douglas A.; Lederman, Michael M.; Funderburg, Nicholas; Sieg, Scott F.] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Yeshiva University; Albert Einstein College of Medicine; Case Western Reserve University; University Hospitals of Cleveland	Sieg, SF (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	scott.sieg@case.edu	Funderburg, Nicholas/L-8022-2013; Sieg, Scott/AAV-2429-2021	Funderburg, Nicholas/0000-0003-3113-1217	National Institutes of Health [AI 076174]; Center for AIDS Research [AI 36219]; James B. Pendleton Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL108743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, P01AI076174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research; James B. Pendleton Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institutes of Health (AI 076174), the Center for AIDS Research (AI 36219) and a grant from the James B. Pendleton Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUKRUST P, 1995, BLOOD, V86, P258, DOI 10.1182/blood.V86.1.258.bloodjournal861258; Bai F, 2010, AIDS, V24, P2581, DOI 10.1097/QAD.0b013e32833f9d64; Bazdar DA, 2009, J INFECT DIS, V199, P1019, DOI 10.1086/597210; Benito JM, 2008, J INFECT DIS, V198, P1466, DOI 10.1086/592716; Benoit A, 2009, AIDS, V23, P1341, DOI 10.1097/QAD.0b013e32832b51be; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Di Bona D, 2006, J HEPATOL, V45, P271, DOI 10.1016/j.jhep.2006.01.037; Duhe RJ, 1998, P NATL ACAD SCI USA, V95, P126, DOI 10.1073/pnas.95.1.126; Frossi B, 2003, EUR J IMMUNOL, V33, P2168, DOI 10.1002/eji.200323995; Frossi B, 2008, MOL IMMUNOL, V45, P58, DOI 10.1016/j.molimm.2007.05.008; Gil L, 2006, FREE RADICAL RES, V40, P495, DOI 10.1080/10715760600592962; Gil L, 2003, PHARMACOL RES, V47, P217, DOI 10.1016/S1043-6618(02)00320-1; Gil L, 2010, BIOMED PHARMACOTHER; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kim MJ, 1997, J NUTR, V127, P2293, DOI 10.1093/jn/127.12.2293; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; Lahdenpohja N, 1996, CELL IMMUNOL, V173, P282; Malmberg KJ, 2001, J IMMUNOL, V167, P2595, DOI 10.4049/jimmunol.167.5.2595; Mehmetcik G, 1997, ARCH GERONTOL GERIAT, V25, P305, DOI 10.1016/S0167-4943(97)00023-X; Mutlu-Turkoglu U, 2003, CLIN BIOCHEM, V36, P397, DOI 10.1016/S0009-9120(03)00035-3; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Read SW, 2006, JAIDS-J ACQ IMM DEF, V42, P537, DOI 10.1097/01.qai.0000223027.47456.d0; Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Rodriguez B, 2011, J LEUKOCYTE BIOL, V90, P621, DOI 10.1189/jlb.1210661; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Simeonova PP, 1997, J IMMUNOL, V159, P3921; Slatter DA, 1999, J BIOL CHEM, V274, P19661, DOI 10.1074/jbc.274.28.19661; SONNERBORG A, 1988, SCAND J INFECT DIS, V20, P287, DOI 10.3109/00365548809032453; STAAL FJT, 1992, AIDS RES HUM RETROV, V8, P305, DOI 10.1089/aid.1992.8.305; Takahashi A, 2005, J IMMUNOL, V174, P6080, DOI 10.4049/jimmunol.174.10.6080; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Vranjkovic A, 2011, J LEUKOCYTE BIOL, V89, P499, DOI 10.1189/jlb.0710430; Wu WC, 2010, MOL VIS, V16, P1864; Yamamoto Y, 2002, NEPHROL DIAL TRANSPL, V17, P630, DOI 10.1093/ndt/17.4.630	46	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58764	10.1371/journal.pone.0058764	http://dx.doi.org/10.1371/journal.pone.0058764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505558	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500123
J	Kasalicky, V; Jezbera, J; Hahn, MW; Simek, K				Kasalicky, Vojtech; Jezbera, Jan; Hahn, Martin W.; Simek, Karel			The Diversity of the Limnohabitans Genus, an Important Group of Freshwater Bacterioplankton, by Characterization of 35 Isolated Strains	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; INTERNAL TRANSCRIBED SPACER; NICHE SEPARATION; POLYNUCLEOBACTER-NECESSARIUS; PHOSPHORUS AVAILABILITY; ORGANIC-MATTER; ABUNDANT GROUP; LAKE; DYNAMICS; PATTERNS	Bacteria of the genus Limnohabitans, more precisely the R-BT lineage, have a prominent role in freshwater bacterioplankton communities due to their high rates of substrate uptake and growth, growth on algal-derived substrates and high mortality rates from bacterivory. Moreover, due to their generally larger mean cell volume, compared to typical bacterioplankton cells, they contribute over-proportionally to total bacterioplankton biomass. Here we present genetic, morphological and ecophysiological properties of 35 bacterial strains affiliated with the Limnohabitans genus newly isolated from 11 non-acidic European freshwater habitats. The low genetic diversity indicated by the previous studies using the ribosomal SSU gene highly contrasted with the surprisingly rich morphologies and different patterns in substrate utilization of isolated strains. Therefore, the intergenic spacer between 16S and 23S rRNA genes was successfully tested as a fine-scale marker to delineate individual lineages and even genotypes. For further studies, we propose the division of the Limnohabitans genus into five lineages (provisionally named as LimA, LimB, LimC, LimD and LimE) and also additional sublineages within the most diversified lineage LimC. Such a delineation is supported by the morphology of isolated strains which predetermine large differences in their ecology.	[Kasalicky, Vojtech; Simek, Karel] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Kasalicky, Vojtech; Jezbera, Jan; Simek, Karel] Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic; [Hahn, Martin W.] Univ Innsbruck, Res Inst Limnol, A-6020 Innsbruck, Austria	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Innsbruck	Kasalicky, V (corresponding author), Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vv I, Ceske Budejovice, Czech Republic.	vojtech.ves@post.cz	Hahn, Martin W./B-9998-2008; Šimek, Karel/AAB-1956-2021; Jezbera, Jan/B-5657-2015; Kasalicky, Vojtech/F-8578-2014; Kasalicky, Vojtech/AAC-2903-2021; Simek, Karel/F-8930-2014	Hahn, Martin W./0000-0003-0501-2556; Šimek, Karel/0000-0002-7058-9063; Kasalicky, Vojtech/0000-0002-9132-8321; Kasalicky, Vojtech/0000-0002-9132-8321; 	Grant Agency of the Czech Republic [206/08/0015, P504/10/0566]; institutional project of the ASCR [AV0Z 60170517]; Czech-Austrian mobility found KONTAKT [MEB 060602/CZ 05-2007, MEB 060901/WTZ, 406600]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); institutional project of the ASCR; Czech-Austrian mobility found KONTAKT	This study was largely supported by the Grant Agency of the Czech Republic under research grants 206/08/0015 (granted to KS) and P504/10/0566 (granted to JJ), the institutional project of the ASCR No. AV0Z 60170517. The authors also profited from the Czech-Austrian mobility found KONTAKT projects MEB 060602/CZ 05-2007 (granted to KS and MWH) and MEB 060901/WTZ project 406600 (granted to JJ and MWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2009, ENVIRON MICROBIOL, V11, P867, DOI 10.1111/j.1462-2920.2008.01807.x; Boenigk J, 2004, APPL ENVIRON MICROB, V70, P5787, DOI 10.1128/AEM.70.10.5787-5793.2004; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Buck U, 2009, ENVIRON MICROBIOL, V11, P1854, DOI 10.1111/j.1462-2920.2009.01910.x; Crump BC, 2003, APPL ENVIRON MICROB, V69, P2253, DOI 10.1128/AEM.69.4.2253-2268.2003; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Freese HM, 2011, MICROB ECOL, V62, P882, DOI 10.1007/s00248-011-9886-8; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Giroldo D, 2005, J PLANKTON RES, V27, P695, DOI 10.1093/plankt/fbi043; Giroldo D, 2002, J APPL PHYCOL, V14, P185, DOI 10.1023/A:1019972109619; Glaeser SP, 2010, ENVIRON MICROBIOL, V12, P3124, DOI 10.1111/j.1462-2920.2010.02285.x; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hahn MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032772; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P2946, DOI 10.1099/ijs.0.022384-0; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P1358, DOI 10.1099/ijs.0.013292-0; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hahn MW, 2005, APPL ENVIRON MICROB, V71, P4539, DOI 10.1128/AEM.71.8.4539-4547.2005; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hortnagl P, 2010, FEMS MICROBIOL ECOL, V73, P458, DOI 10.1111/j.1574-6941.2010.00904.x; Hoffmann M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-90; Hornak K, 2008, AQUAT MICROB ECOL, V52, P107, DOI 10.3354/ame01210; Hornak K, 2006, AQUAT MICROB ECOL, V45, P277, DOI 10.3354/ame045277; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jezbera J, 2006, ENVIRON MICROBIOL, V8, P1330, DOI 10.1111/j.1462-2920.2006.01026.x; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Mueller-Spitz SR, 2009, FEMS MICROBIOL ECOL, V67, P511, DOI 10.1111/j.1574-6941.2008.00639.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Page KA, 2004, APPL ENVIRON MICROB, V70, P6542, DOI 10.1128/AEM.70.11.6542-6550.2004; Percent SF, 2008, APPL ENVIRON MICROB, V74, P1856, DOI 10.1128/AEM.01719-07; Perez MT, 2006, LIMNOL OCEANOGR, V51, P2527, DOI 10.4319/lo.2006.51.6.2527; Perez MT, 2010, ENVIRON MICROBIOL, V12, P74, DOI 10.1111/j.1462-2920.2009.02043.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posch T, 1997, APPL ENVIRON MICROB, V63, P867, DOI 10.1128/AEM.63.3.867-873.1997; Posch T, 2009, AQUAT MICROB ECOL, V54, P113, DOI 10.3354/ame01269; Risso C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-447; Salcher MM, 2008, ENVIRON MICROBIOL, V10, P2074, DOI 10.1111/j.1462-2920.2008.01628.x; Salcher MM, 2007, FEMS MICROBIOL ECOL, V60, P40, DOI 10.1111/j.1574-6941.2006.00274.x; Salcher MM, 2010, LIMNOL OCEANOGR, V55, P846, DOI 10.4319/lo.2009.55.2.0846; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Simek K, 2008, AQUAT MICROB ECOL, V51, P249, DOI 10.3354/ame01193; Simek K, 2007, ENVIRON MICROBIOL, V9, P789, DOI 10.1111/j.1462-2920.2006.01201.x; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2011, APPL ENVIRON MICROB, V77, P7307, DOI 10.1128/AEM.05107-11; Simek K, 2010, APPL ENVIRON MICROB, V76, P1406, DOI 10.1128/AEM.02517-09; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Vannini C, 2007, ENVIRON MICROBIOL, V9, P347, DOI 10.1111/j.1462-2920.2006.01144.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu QLL, 2006, ENVIRON MICROBIOL, V8, P1660, DOI 10.1111/j.1462-2920.2006.01049.x; Wu QLL, 2010, MICROB ECOL, V59, P614, DOI 10.1007/s00248-009-9603-z; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zeng YH, 2012, J BACTERIOL, V194, P6302, DOI 10.1128/JB.01481-12; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	72	123	126	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58209	10.1371/journal.pone.0058209	http://dx.doi.org/10.1371/journal.pone.0058209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505469	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500059
J	Tseng, HC; Lee, IT; Lin, CC; Chi, PL; Cheng, SE; Shih, RH; Hsiao, LD; Yang, CM				Tseng, Hui-Ching; Lee, I-Ta; Lin, Chih-Chung; Chi, Pei-Ling; Cheng, Shin-Ei; Shih, Ruey-Horng; Hsiao, Li-Der; Yang, Chuen-Mao			IL-1 beta Promotes Corneal Epithelial Cell Migration by Increasing MMP-9 Expression through NF-kappa B- and AP-1-Dependent Pathways	PLOS ONE			English	Article							VIRUS INDUCES MATRIX-METALLOPROTEINASE-9; MATRIX METALLOPROTEINASES; OCULAR SURFACE; P38 MAPK; INTERLEUKIN-1; ACTIVATION; ACID; CASCADE; ERK1/2; AP-1	Interleukin-1 beta (IL-1 beta) plays a critical mediator in the pathogenesis of eye diseases. The implication of IL-1 beta in inflammatory responses has been shown to be mediated through up-regulation of inflammatory genes, including matrix metalloproteinase-9 (MMP-9). However, the detailed mechanisms of IL-1 beta-induced MMP-9 expression in Statens Seruminstitut Rabbit Corneal Cells (SIRCs) are largely unclear. Here, we demonstrated that in SIRCs, IL-1 beta induced MMP-9 promoter activity and mRNA expression associated with an increase in the secretion of pro-MMP-9. IL-1 beta-induced pro-MMP-9 expression and MMP-9 mRNA levels were attenuated by pretreatment with the inhibitor of MEK1/2 (U0126), JNK1/2 (SP600125), NF-kappa B (Bay11-7082), or AP-1 (Tanshinone IIA) and transfection with siRNA of p42 or JNK2. Moreover, IL-1 beta markedly stimulated p42/p44 MAPK and JNK1/2 phosphorylation in SIRCs. In addition, IL-1 beta also enhanced p42/p44 MAPK translocation from the cytosol into the nucleus. On the other hand, IL-1 beta induced c-Jun and c-Fos mRNA expression, c-Jun phosphorylation, and AP-1 promoter activity. NF-kappa B translocation, I kappa B alpha degradation, and NF-kappa B promoter activity were also enhanced by IL-1 beta. Pretreatment with U0126 or SP600125 inhibited IL-1 beta-induced AP-1 and NF-kappa B promoter activity, but not NF-kappa B translocation from the cytosol into the nucleus. Finally, we established that IL-1 beta could stimulate SIRCs migration via p42/p44 MAPK-, JNK1/2-, AP-1-, and NF-kappa B-dependent MMP-9 induction. These results suggested that NF-kappa B and AP-1 activated by JNK1/2 and p42/p44 MAPK cascade are involved in IL-1 beta-induced MMP-9 expression in SIRCs.	[Tseng, Hui-Ching; Lee, I-Ta; Chi, Pei-Ling; Cheng, Shin-Ei; Shih, Ruey-Horng; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Tseng, Hui-Ching; Lee, I-Ta; Chi, Pei-Ling; Cheng, Shin-Ei; Shih, Ruey-Horng; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Lee, I-Ta; Lin, Chih-Chung] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Anesthet, Tao Yuan, Taiwan; [Lee, I-Ta; Lin, Chih-Chung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Yang, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan.	chuenmao@mail.cgu.edu.tw		Yang, Chuen-Mao/0000-0002-3208-5438; Chi, Belinda/0000-0003-0332-6682	National Science Council, Taiwan [NSC101-2314-B-182A-112, NSC98-2321-B-182-004, NSC99-2321-B-182-003, NSC98-2320-B-182-004-MY3, NSC98-2314-B-182-021-MY3]; Ministry of Education, Taiwan [EMRPD1B0311, EMRPD1B0321]; Chang Gung Medical Research Foundation, Taiwan [CMRPG391032, CMRPG381522, CMRPD170493, CMRPD180373, CMRPD1A0151, CMRPD1B0381, CMRPG3B1091]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC101-2314-B-182A-112, NSC98-2321-B-182-004, NSC99-2321-B-182-003, NSC98-2320-B-182-004-MY3, and NSC98-2314-B-182-021-MY3, from National Science Council, Taiwan; EMRPD1B0311, and EMRPD1B0321 from Ministry of Education, Taiwan; and CMRPG391032, CMRPG381522, CMRPD170493, CMRPD180373, CMRPD1A0151, CMRPD1B0381, and CMRPG3B1091 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Adachi T, 2012, ARCH BIOCHEM BIOPHYS, V520, P30, DOI 10.1016/j.abb.2012.01.014; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Chang SJ, 2007, J ENDOCRINOL, V193, P393, DOI 10.1677/JOE-06-0168; Chen Y, 2011, MOL VIS, V17, P3072; Chen YT, 2010, AM J PATHOL, V177, P1333, DOI 10.2353/ajpath.2010.100227; Cheng CY, 2010, BRIT J PHARMACOL, V160, P1595, DOI 10.1111/j.1476-5381.2010.00858.x; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Hassan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037912; Jauhonen HM, 2011, MOL VIS, V17, P2311; Jeong S, 2012, AM J PATHOL, V180, P2028, DOI 10.1016/j.ajpath.2012.01.025; Kowluru RA, 2012, EXPERT OPIN INV DRUG, V21, P797, DOI 10.1517/13543784.2012.681043; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee EJ, 2012, ONCOL REP, V28, P1084, DOI 10.3892/or.2012.1857; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Matache C, 2003, J AUTOIMMUN, V20, P323, DOI 10.1016/S0896-8411(03)00037-4; Muhlen S, 2009, VIRUS RES, V139, P100, DOI 10.1016/j.virusres.2008.09.007; Narayanan S, 2008, CORNEA, V27, P811, DOI 10.1097/ICO.0b013e31816bf46c; Okanobo A, 2012, AM J OPHTHALMOL, V154, P63, DOI 10.1016/j.ajo.2012.01.034; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Suh SJ, 2012, CHEM-BIOL INTERACT, V199, P112, DOI 10.1016/j.cbi.2012.06.003; Tung WH, 2010, BRIT J PHARMACOL, V161, P1566, DOI 10.1111/j.1476-5381.2010.00982.x; Wu CY, 2008, J NEUROCHEM, V105, P1499, DOI 10.1111/j.1471-4159.2008.05318.x; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12	25	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57955	10.1371/journal.pone.0057955	http://dx.doi.org/10.1371/journal.pone.0057955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505448	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500040
J	Walter, P; Metzger, J; Thiel, C; Helms, V				Walter, Peter; Metzger, Jennifer; Thiel, Christoph; Helms, Volkhard			Predicting where Small Molecules Bind at Protein-Protein Interfaces	PLOS ONE			English	Article							HOT-SPOTS; EVOLUTIONARY CONSERVATION; TRANSIENT POCKETS; IDENTIFICATION; PRINCIPLES; DISCOVERY; SEQUENCE; SERVER	Small molecules that bind at protein-protein interfaces may either block or stabilize protein-protein interactions in cells. Thus, some of these binding interfaces may turn into prospective targets for drug design. Here, we collected 175 pairs of protein-protein (PP) complexes and protein-ligand (PL) complexes with known three-dimensional structures for which (1) one protein from the PP complex shares at least 40% sequence identity with the protein from the PL complex, and (2) the interface regions of these proteins overlap at least partially with each other. We found that those residues of the interfaces that may bind the other protein as well as the small molecule are evolutionary more conserved on average, have a higher tendency of being located in pockets and expose a smaller fraction of their surface area to the solvent than the remaining protein-protein interface region. Based on these findings we derived a statistical classifier that predicts patches at binding interfaces that have a higher tendency to bind small molecules. We applied this new prediction method to more than 10 000 interfaces from the protein data bank. For several complexes related to apoptosis the predicted binding patches were in direct contact to co-crystallized small molecules.	[Walter, Peter; Metzger, Jennifer; Thiel, Christoph; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-66123 Saarbrucken, Germany	Saarland University	Helms, V (corresponding author), Univ Saarland, Ctr Bioinformat, D-66123 Saarbrucken, Germany.	volkhard.helms@bioinformatik-uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154				Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; Choi YS, 2009, PROTEINS, V77, P14, DOI 10.1002/prot.22410; Davis FP, 2011, MOL BIOSYST, V7, P545, DOI 10.1039/c0mb00200c; Davis FP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000668; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Geppert T, 2012, J COMPUT CHEM, V33, P573, DOI 10.1002/jcc.22894; Gruber J, 2007, ACTA CRYSTALLOGR D, V63, P50, DOI 10.1107/S0907444906046762; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hubbard S, 1996, NACCESS VERSION 2 1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Illingworth CJR, 2010, J COMPUT CHEM, V31, P2677, DOI 10.1002/jcc.21561; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Klebe G, 2009, WIRKSTOFFDESIGN ENTW; Koes DR, 2012, BIOINFORMATICS, V28, P784, DOI 10.1093/bioinformatics/btr717; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Metz A, 2012, J CHEM INF MODEL, V52, P120, DOI 10.1021/ci200322s; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pintar A, 2002, BIOINFORMATICS, V18, P980, DOI 10.1093/bioinformatics/18.7.980; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Sugaya N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-263; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Walter P, 2007, J INTEGR BIOINFORMAT, V4; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Zhong SJ, 2007, CURR TOP MED CHEM, V7, P63, DOI 10.2174/156802607779318334	42	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58583	10.1371/journal.pone.0058583	http://dx.doi.org/10.1371/journal.pone.0058583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505538	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500103
J	Wanic, K; Krolewski, B; Ju, WJ; Placha, G; Niewczas, MA; Walker, W; Warram, JH; Kretzler, M; Krolewski, AS				Wanic, Krzysztof; Krolewski, Bozena; Ju, Wenjun; Placha, Grzegorz; Niewczas, Monika A.; Walker, William; Warram, James H.; Kretzler, Matthias; Krolewski, Andrzej S.			Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline	PLOS ONE			English	Article							TNF RECEPTORS 1; NEPHROTIC SYNDROME; URINARY PROTEINS; EPITHELIAL-CELLS; NECROSIS-FACTOR; NEPHROPATHY; MICROALBUMINURIA; EXPRESSION; DISEASE; VEGF	Background: In patients with Type 1 Diabetes (T1D) who develop microalbuminuria, progressive decline in glomerular filtration rate (GFR) may be initiated by leakage into the urine of toxic proteins (txUPs). This study tested this hypothesis. Methods: After archiving baseline urine, we followed T1D patients with microalbuminuria for 8-12 years to distinguish those in whom GFR declined (Decliners) and those in whom it remained stable (Non-decliners). Human proximal tubular cells (HK-2 cells) were grown in serum-free medium enriched with pooled urines from Decliners or Non-decliners. We determined genome-wide expression profiles in extracted mRNA. Results: The two pooled urines induced differential expression of 312 genes. In terms of gene ontology, molecular functions of the 119 up-regulated genes were enriched for protein binding and peptidase inhibitor activities. Their biologic processes were enriched for defense response, responses to other organisms, regulation of cellular processes, or response to stress or stimulus, and programmed cell death. The 195 down-regulated genes were disproportionately represented in molecular functions of cation binding, hydrolase activity, and DNA binding. They were disproportionately represented in biological processes for regulation of metabolic processes, nucleic acid metabolic processes, cellular response to stress and macromolecule biosynthesis. The set of up-regulated genes in HK-2 cells overlaps significantly with sets of over-expressed genes in tubular and interstitial compartments of kidney biopsies from patients with advanced DN (33 genes in one study and 25 in the other compared with 10.3 expected by chance, p<10(-9) and p<10(-4), respectively). The overlap included genes encoding chemokines and cytokines. Overlap of down-regulated genes was no more than expected by chance. Conclusions: Molecular processes in tubules and interstitium seen in advanced diabetic nephropathy can be induced in vitro by exposure to urine from patients with minimal microalbuminuria who subsequently developed progressive renal function decline, presumably due to putative txUPs.	[Wanic, Krzysztof; Krolewski, Bozena; Placha, Grzegorz; Niewczas, Monika A.; Walker, William; Warram, James H.; Krolewski, Andrzej S.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Wanic, Krzysztof; Krolewski, Bozena; Placha, Grzegorz; Niewczas, Monika A.; Krolewski, Andrzej S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wanic, Krzysztof] Jagiellonian Univ, Dept Metab Dis, Krakow, Poland; [Ju, Wenjun; Kretzler, Matthias] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Placha, Grzegorz] Warsaw Med Univ, Dept Hypertens, Warsaw, Poland	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Jagiellonian University; University of Michigan System; University of Michigan; Medical University of Warsaw	Krolewski, AS (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA.	Andrzej.Krolewski@joslin.harvard.edu		Ju, Wenjun/0000-0002-9136-8454	NIH [DK41526, DK67638]; JDRF [JDRF 3-2005-908, JDRF 3-2004-631]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041526, P30DK081943, R01DK067638, P30DK020572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grants DK41526 & DK67638 (to ASK); KW and GP were supported by the JDRF fellowships (JDRF 3-2005-908, & JDRF 3-2004-631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines RJ, 2008, NEPHRON EXP NEPHROL, V110, pE67, DOI 10.1159/000161982; Baines RJ, 2011, NAT REV NEPHROL, V7, P177, DOI 10.1038/nrneph.2010.174; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; Gerritsma JSJ, 1996, CLIN EXP IMMUNOL, V103, P289, DOI 10.1046/j.1365-2249.1996.d01-617.x; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; HASEGAWA G, 1991, KIDNEY INT, V40, P1007, DOI 10.1038/ki.1991.308; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huang Z, 2008, CYTOKINE, V42, P222, DOI 10.1016/j.cyto.2008.02.005; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lindenmeyer MT, 2007, J AM SOC NEPHROL, V18, P1765, DOI 10.1681/ASN.2006121304; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Mogensen CE, 1999, DIABETOLOGIA, V42, P263, DOI 10.1007/s001250051151; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Pollock CA, 2007, CURR OPIN NEPHROL HY, V16, P359, DOI 10.1097/MNH.0b013e3281eb9059; Reich H, 2005, J AM SOC NEPHROL, V16, P1266, DOI 10.1681/ASN.2004030222; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Wen Q, 2010, NEPHROLOGY, V15, P63, DOI 10.1111/j.1440-1797.2009.01152.x; Wolkow PP, 2008, J AM SOC NEPHROL, V19, P789, DOI 10.1681/ASN.2007050556; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57751	10.1371/journal.pone.0057751	http://dx.doi.org/10.1371/journal.pone.0057751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505438	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500030
J	Mboma, SM; Houben, RMGJ; Glynn, JR; Sichali, L; Drobniewski, F; Mpunga, J; Fine, PEM; French, N; Crampin, AC				Mboma, Sebastian M.; Houben, Rein M. G. J.; Glynn, Judith R.; Sichali, Lifted; Drobniewski, Francis; Mpunga, James; Fine, Paul E. M.; French, Neil; Crampin, Amelia C.			Control of (Multi) Drug Resistance and Tuberculosis Incidence over 23 Years in the Context of a Well-Supported Tuberculosis Programme in Rural Malawi	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; UNDERMINES POTENTIAL IMPACT; HIGH HIV PREVALENCE; XPERT(R) MTB/RIF; NORTHERN MALAWI; KARONGA DISTRICT; MYCOBACTERIUM-TUBERCULOSIS; CENTRALIZED LABORATORIES; TRENDS; INFECTION	Background: The rise in tuberculosis (TB) incidence following generalized HIV epidemics can overwhelm TB control programmes in resource-limited settings, sometimes accompanied by rising rates of drug resistance. This has led to claims that DOTS-based TB control has failed in such settings. However, few studies have described the effect of a sustained and well-supported DOTS programme on TB incidence and drug resistance over a long period. We present long-term trends in incidence and drug resistance in rural Malawi. Methods: Karonga District in northern Malawi has an adult HIV prevalence of similar to 10%. A research group, the Karonga Prevention Study, collaborates with the National Tuberculosis Programme to support core TB control activities. Bacteriological, demographic and clinical (including HIV status) information from all patients starting TB treatment in the District have been recorded since 1988. During that period isolates from each culture-positive TB patient were exported for drug sensitivity testing. Antiretroviral therapy (ART) has been widely available since 2005. Results: Incidence of new smear-positive adult TB peaked at 124/100,000/year in the mid-90s, but has since fallen to 87/100,000/year. Drug sensitivity information was available for 95% (3132/3307) of all culture-positive cases. Initial resistance to isoniazid was around 6% with no evidence of an increase. Fewer than 1% of episodes involved a multi-drug resistant strain. Discussion: In this setting with a generalised HIV epidemic and medium TB burden, a well-supported DOTS programme enhanced by routine culture and drug sensitivity testing may well have reduced TB incidence and maintained drug resistance at low levels.	[Mboma, Sebastian M.; Houben, Rein M. G. J.; Sichali, Lifted; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [Houben, Rein M. G. J.; Glynn, Judith R.; Fine, Paul E. M.; Crampin, Amelia C.] London Sch Hyg & Trop Med, London WC1, England; [Mpunga, James] Natl TB Control Programme, Lilongwe, Malawi; [French, Neil] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Drobniewski, Francis] Hlth Protect Agcy, Natl Mycobacterium Reference Lab, London, England	Malawi Epidemiology and Intervention Research Unit; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; Health Protection Agency	Houben, RMGJ (corresponding author), Karonga Prevent Study, Chilumba, Malawi.	rein.houben@lshtm.ac.uk		French, Neil/0000-0003-4814-8293; Crampin, Amelia/0000-0002-1513-4330	LEPRA (The British Leprosy Relief Association); Wellcome Trust	LEPRA (The British Leprosy Relief Association); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was primarily funded by LEPRA (The British Leprosy Relief Association) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID SURV DRUG RES T; [Anonymous], MAL POP HOUS CENS; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Crampin AC, 2001, INT J TUBERC LUNG D, V5, P994; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000443; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Floyd S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013499; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Glynn JR, 2004, AIDS, V18, P1459, DOI 10.1097/01.aids.0000131336.15301.06; GLYNN JR, 1995, LANCET, V345, P907, DOI 10.1016/S0140-6736(95)90016-0; Glynn JR, 2008, EMERG INFECT DIS, V14, P1060, DOI 10.3201/eid1407.060468; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Mulenga C., 2010, TUBERC RES TREAT, V2010; Mwaungulu FD, 2002, MALAWI MED J, V13, P3; Ngwira B, 2002, MALAWI MED J, V13, P14; NTP, 2007, MAL NAT TUB CONTR PR; Peters D, 2012, INT J TUBERC LUNG D, V16, P702, DOI 10.5588/ijtld.12.0034; Ponnighaus J M, 1986, Lepr Rev, V57 Suppl 2, P285; PONNIGHAUS JM, 1993, LEPROSY REV, V64, P338; Talbot EA, 2003, INT J TUBERC LUNG D, V7, P72; Trebucq A, 2012, INT J TUBERC LUNG D, V16, P703, DOI 10.5588/ijtld.12.0034-2; Trebucq A, 2012, INT J TUBERC LUNG D, V16, P702, DOI 10.5588/ijtld.12.0131-2; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Warndorff DK, 2000, INT J TUBERC LUNG D, V4, P752; White RG, 2007, EPIDEMIOL INFECT, V135, P922, DOI 10.1017/S0950268806007680; World Health Organization, 2010, GLOB TUB CONTR WHO R; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	33	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58192	10.1371/journal.pone.0058192	http://dx.doi.org/10.1371/journal.pone.0058192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483994	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000316936100087
J	Virostko, J; Radhika, A; Poffenberger, G; Dula, AN; Moore, DJ; Powers, AC				Virostko, John; Radhika, Armandla; Poffenberger, Greg; Dula, Adrienne N.; Moore, Daniel J.; Powers, Alvin C.			Bioluminescence Imaging Reveals Dynamics of Beta Cell Loss in the Non-Obese Diabetic (NOD) Mouse Model	PLOS ONE			English	Article							MICE; ONSET; DISEASE; EXPRESSION; PREVENTION; STRAINS; PREDICT	We generated a mouse model (MIP-Luc-VU-NOD) that enables non-invasive bioluminescence imaging (BLI) of beta cell loss during the progression of autoimmune diabetes and determined the relationship between BLI and disease progression. MIP-Luc-VU-NOD mice displayed insulitis and a decline in bioluminescence with age which correlated with beta cell mass, plasma insulin, and pancreatic insulin content. Bioluminescence declined gradually in female MIP-Luc-VU-NOD mice, reaching less than 50% of the initial BLI at 10 weeks of age, whereas hyperglycemia did not ensue until mice were at least 16 weeks old. Mice that did not become diabetic maintained insulin secretion and had less of a decline in bioluminescence than mice that became diabetic. Bioluminescence measurements predicted a decline in beta cell mass prior to the onset of hyperglycemia and tracked beta cell loss. This model should be useful for investigating the fundamental processes underlying autoimmune diabetes and developing new therapies targeting beta cell protection and regeneration.	[Virostko, John; Dula, Adrienne N.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Radhika, Armandla; Poffenberger, Greg; Powers, Alvin C.] Vanderbilt Univ, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN USA; [Moore, Daniel J.] Vanderbilt Univ, Dept Pathol Immunol & Microbiol, Nashville, TN USA; [Moore, Daniel J.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Powers, Alvin C.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Virostko, J (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA.	jack.virostko@Vanderbilt.edu; Al.Powers@Vanderbilt.edu	Moore, Daniel J/A-4924-2008; Moore, Daniel/V-6145-2019; Virostko, Jack/AAR-5947-2021	Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Virostko, Jack/0000-0003-3413-8801	Juvenile Diabetes Research Foundation; VA Research Service [BX000666]; National Institutes of Health [DK072473, DK69603, DK68764, DK66636, DK89572, DK89583]; South-Eastern Center for small animal imaging [U24CA126588]; Vanderbilt Mouse Metabolic Phenotyping Center [DK59637]; Vanderbilt Diabetes Research and Training Center [DK20593]; NATIONAL CANCER INSTITUTE [U24CA126588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068764, U01DK089572, P60DK020593, R33DK066636, U24DK059637, R01DK094199, R21DK066636, U2CDK059637, P30DK057516, P30DK020593, R01DK069603] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000666] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); VA Research Service(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South-Eastern Center for small animal imaging; Vanderbilt Mouse Metabolic Phenotyping Center; Vanderbilt Diabetes Research and Training Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The study was supported by grants from the Juvenile Diabetes Research Foundation, the VA Research Service (BX000666), the National Institutes of Health (DK072473, DK69603, DK68764, DK66636, DK89572, DK89583), the South-Eastern Center for small animal imaging (U24CA126588), the Vanderbilt Mouse Metabolic Phenotyping Center (DK59637), and the Vanderbilt Diabetes Research and Training Center (DK20593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru N, 2001, J AUTOIMMUN, V17, P1, DOI 10.1006/jaut.2001.0530; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andralojc K, 2012, DIABETOLOGIA, V55, P1247, DOI 10.1007/s00125-012-2491-7; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Angstetra E, 2009, IMMUNOL CELL BIOL, V87, P178, DOI 10.1038/icb.2008.81; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BAXTER AG, 1991, CLIN EXP IMMUNOL, V85, P464; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; ELLIOTT RB, 1988, DIABETOLOGIA, V31, P62; Fowler M, 2005, TRANSPLANTATION, V79, P768, DOI 10.1097/01.TP.0000152798.03204.5C; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; KLOPPEL G, 1984, VIRCHOWS ARCH A, V403, P441, DOI 10.1007/BF00737292; Melanitou E, 2004, J IMMUNOL, V173, P6603, DOI 10.4049/jimmunol.173.11.6603; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Sever D, 2011, FASEB J, V25, P676, DOI 10.1096/fj.10-158121; Smith SJ, 2006, MOL IMAGING, V5, P65, DOI 10.2310/7290.2006.00007; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Virostko J, 2004, MOL IMAGING, V3, P333, DOI 10.1162/1535350042973508; Virostko J, 2011, P NATL ACAD SCI USA, V108, P20719, DOI 10.1073/pnas.1109480108; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Virostko J, 2009, GASTROENTEROLOGY, V136, P407, DOI 10.1053/j.gastro.2008.12.024; WILLIAMS AJK, 1990, DIABETOLOGIA, V33, P635, DOI 10.1007/BF00400211; Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57784	10.1371/journal.pone.0057784	http://dx.doi.org/10.1371/journal.pone.0057784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483929	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100045
J	de Busserolles, F; Fitzpatrick, JL; Paxton, JR; Marshall, NJ; Collin, SP				de Busserolles, Fanny; Fitzpatrick, John L.; Paxton, John R.; Marshall, N. Justin; Collin, Shaun P.			Eye-Size Variability in Deep-Sea Lanternfishes (Myctophidae): An Ecological and Phylogenetic Study	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; MESOPELAGIC FISHES; FAMILY MYCTOPHIDAE; RETINAL SPECIALIZATIONS; SPECIES COMPOSITION; BIOLUMINESCENCE; VISION; MORPHOLOGY; PATTERNS; SLOPE	One of the most common visual adaptations seen in the mesopelagic zone (200-1000 m), where the amount of light diminishes exponentially with depth and where bioluminescent organisms predominate, is the enlargement of the eye and pupil area. However, it remains unclear how eye size is influenced by depth, other environmental conditions and phylogeny. In this study, we determine the factors influencing variability in eye size and assess whether this variability is explained by ecological differences in habitat and lifestyle within a family of mesopelagic fishes characterized by broad intra-and interspecific variance in depth range and luminous patterns. We focus our study on the lanternfish family (Myctophidae) and hypothesise that lanternfishes with a deeper distribution and/or a reduction of bioluminescent emissions have smaller eyes and that ecological factors rather than phylogenetic relationships will drive the evolution of the visual system. Eye diameter and standard length were measured in 237 individuals from 61 species of lanternfishes representing all the recognised tribes within the family in addition to compiling an ecological dataset including depth distribution during night and day and the location and sexual dimorphism of luminous organs. Hypotheses were tested by investigating the relationship between the relative size of the eye (corrected for body size) and variations in depth and/or patterns of luminous-organs using phylogenetic comparative analyses. Results show a great variability in relative eye size within the Myctophidae at all taxonomic levels (from subfamily to genus), suggesting that this character may have evolved several times. However, variability in eye size within the family could not be explained by any of our ecological variables (bioluminescence and depth patterns), and appears to be driven solely by phylogenetic relationships.	[de Busserolles, Fanny; Collin, Shaun P.] Univ Western Australia, Sch Anim Biol, Neuroecol Grp, Crawley, WA, Australia; [de Busserolles, Fanny; Collin, Shaun P.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Fitzpatrick, John L.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia; [Fitzpatrick, John L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Paxton, John R.] Australian Museum, Sydney, NSW 2000, Australia; [Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, Sensory Neurobiol Grp, Brisbane, Qld, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Manchester; Australian Museum; University of Queensland	de Busserolles, F (corresponding author), Univ Western Australia, Sch Anim Biol, Neuroecol Grp, Crawley, WA, Australia.	debusf01@student.uwa.edu.au	Fitzpatrick, John/E-8766-2011; de Busserolles, Fanny/A-1769-2013; Collin, Shaun/K-8827-2012	de Busserolles, Fanny/0000-0002-4602-9840; Collin, Shaun/0000-0001-6236-0771; Marshall, Justin/0000-0001-9006-6713; Fitzpatrick, John/0000-0002-2834-4409	Australian Research Council; West Australian State Government; Australian Research Council Postdoctoral Fellowship	Australian Research Council(Australian Research Council); West Australian State Government; Australian Research Council Postdoctoral Fellowship(Australian Research Council)	This work was funded by the Australian Research Council (Discovery grant to SPC and a Linkage Grant to NJM and SPC) and the West Australian State Government. JLF is supported by an Australian Research Council Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom E.H., 1976, Report Calif Coop Oceanic Fish Invest, V18, P167; [Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Beebe William, 1944, ZOOLOGICA [NEW YORK], V29, P59; CASE JF, 1977, NATURE, V265, P179, DOI 10.1038/265179a0; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Collin SP, 1998, BRAIN BEHAV EVOLUT, V51, P291; Collin SP, 1996, J FISH BIOL, V49, P157, DOI 10.1111/j.1095-8649.1996.tb06073.x; Collin SP, 1997, BRAIN BEHAV EVOLUT, V50, P335, DOI 10.1159/000113345; DENTON EJ, 1990, LIGHT AND LIFE IN THE SEA, P127; EDWARDS AS, 1977, MAR BIOL, V41, P59, DOI 10.1007/BF00390582; Flynn A, 2012, DEEP SEA RES 1; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; GARTNER JV, 1987, FISH B-NOAA, V85, P81; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HANSEN K, 1977, J ZOOL, V182, P103; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HAYGOOD MG, 1994, J EXP ZOOL, V270, P225, DOI 10.1002/jez.1402700212; Herring P.J., 1985, Symposia of the Society for Experimental Biology, P323; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; HULLEY PA, 1981, ARCH FISCHEREIWISS, V31, P1; HULLEY PA, LIVING MARI IN PRESS; Kaartvedt S, 2012, MAR ECOL PROG SER, V456, P1, DOI 10.3354/meps09785; Karnella C, 1987, BIOL MIDWATER FISHES, V452, P51; Kawasaki K., 1978, Bulletin, Shinshu University Forests, P1; KINZER J, 1985, MAR BIOL, V85, P313, DOI 10.1007/BF00393252; Kristoffersen JB, 1998, SARSIA, V83, P95; Land M.F., 1981, HDB SENSORY PHYSL, Vvii; LAND MF, 1990, LIGHT AND LIFE IN THE SEA, P149; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LAWRY JV, 1974, NATURE, V247, P155, DOI 10.1038/247155a0; Linkowski TB, 1996, MAR BIOL, V124, P495, DOI 10.1007/BF00351031; Locket N. A., 1977, HDB SENSORY PHYSL  5, P67; Madison W., 2011, MESQUITE MODULAR SYS; Mahe J.-C., 2005, MANUEL PROTOCOLES CA; Mallefet J, 1995, MAR BIOL, V124, P381, DOI 10.1007/BF00363911; Marshall N. B., 1954, ASPECTS DEEP SEA BIO; MATTHIESSEN L, 1882, PFLUG ARCH GES PHYS, V38, P521; Matthiessen L., 1882, ARCH GESAMTE PHYSIOL, V27, P510, DOI DOI 10.1007/BF01802978; Moser H. G, 1970, Bull. Los Ang. Cty Mus. Sci., VNo. 7, P1; MOSER HG, 1974, FISH B-NOAA, V72, P391; MOSER HG, 1972, FISH BULL NATL OC AT, V70, P541; Munk O., 1965, GALATHEA REP, V8, P21; MUNK OLE, 1966, DANA REP CARLSBERG FOUND, V70, P5; Murray J, 1902, DEPTHS OCEAN; Nafpaktitis B. G, 1977, Memoirs Sears Fdn mem. Res., V1, P13; NAFPAKTITIS B G, 1978, Natural History Museum of Los Angeles County Science Bulletin, P1; Nafpaktitis B. G., 1969, Bulletin Los Angeles City Museum Sci, VNo. 5, P1; ODAY WT, 1976, MAR BIOL, V37, P187, DOI 10.1007/BF00389128; Olivar MP, 2012, DEEP-SEA RES PT I, V62, P53, DOI 10.1016/j.dsr.2011.12.014; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PANKHURST NW, 1987, ENVIRON BIOL FISH, V19, P269, DOI 10.1007/BF00003228; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paxton J.R., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P239; Paxton JR, 1972, SCI B LOS ANGELES CO, V13, P1; Poulsen JY, BMC EVOLUTI IN PRESS; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; ROBISON BH, 1972, COPEIA, P448; Ross SW, 2010, DEEP-SEA RES PT II, V57, P1926, DOI 10.1016/j.dsr2.2010.05.008; STEFANESCU C, 1992, Scientia Marina, V56, P69; TSUJI FI, 1971, NATURE, V233, P623, DOI 10.1038/233623a0; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; VILTER V, 1951, CR SOC BIOL, V145, P52; Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2; Wagner HJ, 2001, BRAIN BEHAV EVOLUT, V57, P117, DOI 10.1159/000047231; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant E, 2000, PHILOS T ROY SOC B, V355, P1155, DOI 10.1098/rstb.2000.0658; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Warrant Eric J., 2003, P303, DOI 10.1007/978-0-387-22628-6_16; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Williams A, 1997, MAR BIOL, V130, P259, DOI 10.1007/s002270050246; Zahuranec Bernard J., 2000, Smithsonian Contributions to Zoology, V607, P1	75	33	33	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58519	10.1371/journal.pone.0058519	http://dx.doi.org/10.1371/journal.pone.0058519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472203	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900149
J	Dwivedi, S; AlKhedhairy, AA; Ahamed, M; Musarrat, J				Dwivedi, Sourabh; AlKhedhairy, Abdulaziz A.; Ahamed, Maqusood; Musarrat, Javed			Biomimetic Synthesis of Selenium Nanospheres by Bacterial Strain JS-11 and Its Role as a Biosensor for Nanotoxicity Assessment: A Novel Se-Bioassay	PLOS ONE			English	Article							ELEMENTAL RED SELENIUM; SILVER NANOPARTICLES; CARBON NANOTUBES; REDUCTION; SELENATE; BIOSYNTHESIS; TELLURITE; TOXICITY; GROWTH; PHENAZINE-1-CARBOXAMIDE	Selenium nanoparticles (Se-NPs) were synthesized by green technology using the bacterial isolate Pseudomonas aeruginosa strain JS-11. The bacteria exhibited significant tolerance to selenite (SeO32-) up to 100 mM concentration with an EC50 value of 140 mM. The spent medium (culture supernatant) contains the potential of reducing soluble and colorless SeO32- to insoluble red elemental selenium (Se-0) at 37 degrees C. Characterization of red Se degrees product by use of UV-Vis spectroscopy, X-ray diffraction (XRD), atomic force microscopy (AFM) and transmission electron microscopy (TEM) with energy dispersive X-ray spectrum (EDX) analysis revealed the presence of stable, predominantly monodispersed and spherical selenium nanoparticles (Se-NPs) of an average size of 21 nm. Most likely, the metabolite phenazine-1-carboxylic acid (PCA) released by strain JS-11 in culture supernatant along with the known redox agents like NADH and NADH dependent reductases are responsible for biomimetic reduction of SeO32- to Se degrees nanospheres. Based on the bioreduction of a colorless solution of SeO32- to elemental red Se-0, a high throughput colorimetric bioassay (Se-Assay) was developed for parallel detection and quantification of nanoparticles (NPs) cytotoxicity in a 96 well format. Thus, it has been concluded that the reducing power of the culture supernatant of strain JS-11 could be effectively exploited for developing a simple and environmental friendly method of Se-NPs synthesis. The results elucidated that the red colored Se degrees nanospheres may serve as a biosensor for nanotoxicity assessment, contemplating the inhibition of SeO32- bioreduction process in NPs treated bacterial cell culture supernatant, as a toxicity end point.	[Dwivedi, Sourabh; AlKhedhairy, Abdulaziz A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Ahamed, Maqusood] King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh, Saudi Arabia; [Musarrat, Javed] Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India	King Saud University; King Saud University; Aligarh Muslim University	Musarrat, J (corresponding author), Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India.	musarratj1@yahoo.com	Al-Khedhairy, Abdulaziz A A/F-8327-2011; Ahamed, Maqusood/R-8619-2017; Musarrat, Javed/N-4094-2019; Dwivedi, Sourabh/I-2060-2013; Musarrat, Javed/I-1942-2013	Al-Khedhairy, Abdulaziz A A/0000-0002-1210-6262; Ahamed, Maqusood/0000-0001-6025-1950; Musarrat, Javed/0000-0001-5981-3813; dwivedi, sourabh/0000-0002-7591-5358	National Plan for Sciences and Technology (NPST), King Saud University, Riyadh [10-NAN1115-02]	National Plan for Sciences and Technology (NPST), King Saud University, Riyadh	Financial support through the National Plan for Sciences and Technology (NPST Project No. 10-NAN1115-02), King Saud University, Riyadh, for this study, is greatly acknowledged. (http://npst.ksu.edu.sa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkar E, 2003, FEMS MICROBIOL LETT, V226, P107, DOI 10.1016/S0378-1097(03)00609-8; Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; Anjaiah V, 1998, MOL PLANT MICROBE IN, V11, P847, DOI 10.1094/MPMI.1998.11.9.847; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Avazeri C, 1997, MICROBIOL-SGM, V143, P1181, DOI 10.1099/00221287-143-4-1181; Binaeian E., 2012, WASET, V67, P1219, DOI [10.5281/zenodo.1077312, DOI 10.5281/ZENODO.1077312]; Bledsoe TL, 1999, APPL MICROBIOL BIOT, V51, P682, DOI 10.1007/s002530051452; Casey A, 2007, CARBON, V45, P34, DOI 10.1016/j.carbon.2006.08.009; DEMOLLDECKER H, 1993, ARCH MICROBIOL, V160, P241; Dhanjal S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-52; Dong Y, 2003, CANCER RES, V63, P52; Dudev T, 2010, J AM CHEM SOC, V132, P16533, DOI 10.1021/ja106600k; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Etezad SM, 2009, ENZYME MICROB TECH, V45, P1, DOI 10.1016/j.enzmictec.2009.04.004; EUSTICE DC, 1981, PLANT PHYSIOL, V67, P1054, DOI 10.1104/pp.67.5.1054; Euzeby J, 2008, INT J SYST EVOL MICR, V58, P1057; Fesharaki PJ, 2010, BRAZ J MICROBIOL, V41, P461, DOI [10.1590/S1517-83822010000200028, 10.1590/S1517-838220100002000028]; He SY, 2007, MATER LETT, V61, P3984, DOI 10.1016/j.matlet.2007.01.018; Hull RV, 2001, BIOPHYS CHEM, V90, P9, DOI 10.1016/S0301-4622(00)00239-8; Hunter WJ, 2007, CURR MICROBIOL, V55, P455, DOI 10.1007/s00284-007-9020-9; Hunter WJ, 2007, CURR MICROBIOL, V55, P344, DOI 10.1007/s00284-007-0202-2; Hunter WJ, 2009, CURR MICROBIOL, V58, P493, DOI 10.1007/s00284-009-9358-2; Hurt RH, 2006, CARBON, V44, P1028, DOI 10.1016/j.carbon.2005.12.023; Lin H, 2007, ORG BIOMOL CHEM, V5, P2541, DOI 10.1039/b706887e; Lin ZH, 2005, MATER CHEM PHYS, V92, P591, DOI 10.1016/j.matchemphys.2005.02.023; Lloyd-Jones G, 2006, J MICROBIOL METH, V67, P549, DOI 10.1016/j.mimet.2006.05.006; LORTIE L, 1992, APPL ENVIRON MICROB, V58, P4042, DOI 10.1128/AEM.58.12.4042-4044.1992; Losi ME, 1997, APPL ENVIRON MICROB, V63, P3079, DOI 10.1128/AEM.63.8.3079-3084.1997; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Monteiro-Riviere NA, 2006, CARBON, V44, P1070, DOI 10.1016/j.carbon.2005.11.004; Musarrat J, 2010, BIORESOURCE TECHNOL, V101, P8772, DOI 10.1016/j.biortech.2010.06.065; Narasingarao P, 2007, APPL ENVIRON MICROB, V73, P3519, DOI 10.1128/AEM.02737-06; OREMLAND RS, 1994, APPL ENVIRON MICROB, V60, P3011, DOI 10.1128/AEM.60.8.3011-3019.1994; OREMLAND RS, 1989, APPL ENVIRON MICROB, V55, P2333, DOI 10.1128/AEM.55.9.2333-2343.1989; OREMLAND RS, 1990, ENVIRON SCI TECHNOL, V24, P1157, DOI 10.1021/es00078a001; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; Prakash NT, 2009, BIOTECHNOL LETT, V31, P1857, DOI 10.1007/s10529-009-0096-0; Roux M, 2001, APPL ENVIRON MICROB, V67, P769, DOI 10.1128/AEM.67.2.769-773.2001; Sabaty M, 2001, APPL ENVIRON MICROB, V67, P5122, DOI 10.1128/AEM.67.11.5122-5126.2001; Sarret G, 2005, APPL ENVIRON MICROB, V71, P2331, DOI 10.1128/AEM.71.5.2331-2337.2005; TOMEI FA, 1992, CAN J MICROBIOL, V38, P1328, DOI 10.1139/m92-219; Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729; Turner RJ, 1998, BIOMETALS, V11, P223, DOI 10.1023/A:1009290213301; van Rij ET, 2004, MOL PLANT MICROBE IN, V17, P557, DOI 10.1094/MPMI.2004.17.5.557; Vinod Yadav, 2008, Biotechnology, V7, P299; Wang B, 2007, B ENVIRON CONTAM TOX, V78, P503, DOI 10.1007/s00128-007-9144-4; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; YANKE LJ, 1995, ANAEROBE, V1, P61, DOI 10.1016/S1075-9964(95)80457-9; Zhang J, 2004, CHINESE CHEM LETT, V15, P1345	50	69	74	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57404	10.1371/journal.pone.0057404	http://dx.doi.org/10.1371/journal.pone.0057404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483909	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900017
J	Gupta, V; Doshi, N; Mitragotri, S				Gupta, Vivek; Doshi, Nishit; Mitragotri, Samir			Permeation of Insulin, Calcitonin and Exenatide across Caco-2 Monolayers: Measurement Using a Rapid, 3-Day System	PLOS ONE			English	Article							ORAL PEPTIDE DELIVERY; CELL-LINE CACO-2; IN-VITRO; SALMON-CALCITONIN; INTESTINAL EPITHELIUM; COMPLEXATION HYDROGELS; DRUG ABSORPTION; CULTURE-SYSTEM; TRANSPORT; PERMEABILITY	Objectives: Caco-2 monolayers are one of the most widely used in vitro models for prediction of intestinal permeability of therapeutic molecules. However, the conventional Caco-2 monolayer model has several drawbacks including labor-intensive culture process, unphysiological growth conditions, lack of reproducibility and limited throughput. Here, we report on the use of 3-day Caco-2 monolayers for assessing permeability of polypeptide drugs. Methods: The 3-day monolayers were grown in a commercially available transwell set-up, which facilitates rapid development of the Caco-2 monolayers in an intestinal epithelial differentiation mimicking environment. This set-up included use of serum-free medium of defined composition with supplements such as butyric acid, hormones, growth factors, and other metabolites, reported to regulate the differentiation of intestinal epithelial cells in vivo. We measured permeability of 3 different therapeutic polypeptides; insulin, calcitonin, and exenatide across the monolayer. Results: Preliminary validation of the monolayer was carried out by confirming dose-dependent permeation of FITC-insulin and sulforhodamine-B. Transport of insulin, calcitonin, and exenatide measured at different loading concentrations suggests that the permeability values obtained with 3-day cultures resemble more closely the values obtained with ex vivo models compared to permeability values obtained with conventional 21-day cultures. Conclusions: Short-term 3-day Caco-2 monolayers provide new opportunities for developing reproducible and high-throughput models for screening of therapeutic macromolecules for oral absorption.	[Gupta, Vivek; Doshi, Nishit; Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Mitragotri, S (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	samir@engineering.ucsb.edu		Gupta, Vivek/0000-0002-3618-8178	Entrega Inc.; Otis Williams Fellowship; Otis Williams Fellowship at UCSB	Entrega Inc.; Otis Williams Fellowship; Otis Williams Fellowship at UCSB	This work was supported by Entrega Inc. VG acknowledges support from Otis Williams Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The research was funded by Entrega Inc. VG was supported by Otis Williams Fellowship at UCSB. SM is a shareholder and consultant of Entrega Inc. Funding does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anand BS, 2003, J PHARMACOL EXP THER, V304, P781, DOI 10.1124/jpet.102.044313; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Asa D, 2008, COMP BD BIOCOAT INTE, V416, P1; Basson MD, 1996, EXP CELL RES, V225, P301, DOI 10.1006/excr.1996.0180; Brewis Ian A., 1993, Biochemical Society Transactions, V21, p252S; Burton PS, 1996, J PHARM SCI, V85, P1336, DOI 10.1021/js960067d; Camenisch G, 1998, EUR J PHARM SCI, V6, P313, DOI 10.1016/S0928-0987(97)10019-7; Cetin M, 2008, AAPS PHARMSCITECH, V9, P1191, DOI 10.1208/s12249-008-9165-2; Chong SH, 1997, PHARMACEUT RES, V14, P1835, DOI 10.1023/A:1012112820371; Collett A, 1996, PHARMACEUT RES, V13, P216, DOI 10.1023/A:1016082829111; CONRADI RA, 1991, PHARMACEUT RES, V8, P1453, DOI 10.1023/A:1015825912542; Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828; Fasano A, 1998, TRENDS BIOTECHNOL, V16, P152, DOI 10.1016/S0167-7799(97)01170-0; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; GOMEZ G, 1995, AM J PHYSIOL-GASTR L, V268, pG71, DOI 10.1152/ajpgi.1995.268.1.G71; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; HARDIN JA, 1993, AM J PHYSIOL, V264, pG312, DOI 10.1152/ajpgi.1993.264.2.G312; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; HO NFH, 1995, J PHARM SCI, V84, P21, DOI 10.1002/jps.2600840107; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Ichikawa H, 2003, J BIOMED MATER RES A, V67A, P609, DOI 10.1002/jbm.a.10128; Le Ferrec E, 2001, ATLA-ALTERN LAB ANIM, V29, P649, DOI 10.1177/026119290102900604; Lee HJ, 2002, ARCH PHARM RES, V25, P572, DOI 10.1007/BF02976925; Lentz KA, 2000, INT J PHARM, V200, P41, DOI 10.1016/S0378-5173(00)00334-3; Ma EL, 2006, ACTA PHARMACOL SIN, V27, P1382, DOI 10.1111/j.1745-7254.2006.00424.x; Mahato RI, 2003, CRIT REV THER DRUG, V20, P153, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30; Mayfield JA, 2004, AM FAM PHYSICIAN, V70, P489; Morishita M, 2006, DRUG DISCOV TODAY, V11, P905, DOI 10.1016/j.drudis.2006.08.005; Munoz-Torres Manuel, 2004, Treat Endocrinol, V3, P117; Nollevaux G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-20; Sajeesh S, 2010, J CONTROL RELEASE, V147, P377, DOI 10.1016/j.jconrel.2010.08.007; Salamat-Miller N, 2005, INT J PHARMACEUT, V294, P201, DOI 10.1016/j.ijpharm.2005.01.022; Shah RB, 2004, AAPS J, V6; Sinko PJ, 1999, PHARMACEUT RES, V16, P527, DOI 10.1023/A:1018819012405; Soikkeli A, 2010, J BIOMOL SCREEN, V15, P30, DOI 10.1177/1087057109352236; Song KH, 2005, J CONTROL RELEASE, V106, P298, DOI 10.1016/j.jconrel.2005.05.016; SOULEIMANI A, 1993, FEBS LETT, V326, P45, DOI 10.1016/0014-5793(93)81758-R; Thompson C, 2011, PHARM RES-DORDR, V28, P886, DOI 10.1007/s11095-010-0345-x; Whitehead K, 2004, J CONTROL RELEASE, V98, P37, DOI 10.1016/j.jconrel.2004.04.013; Whitehead K, 2008, PHARM RES-DORDR, V25, P1782, DOI 10.1007/s11095-007-9488-9; Woitiski CB, 2011, INT J PHARMACEUT, V412, P123, DOI 10.1016/j.ijpharm.2011.04.003; Wood KM, 2010, ACTA BIOMATER, V6, P48, DOI 10.1016/j.actbio.2009.05.032; Yamashita S, 2002, J PHARM SCI, V91, P669, DOI 10.1002/jps.10050; Yang HT, 2003, ACTA PHARMACOL SIN, V24, P1185; Yang TZ, 2005, J DRUG TARGET, V13, P29, DOI 10.1080/10611860400020191; Youn YS, 2008, EUR J PHARM BIOPHARM, V68, P667, DOI 10.1016/j.ejpb.2007.07.009; Youn YS, 2006, J CONTROL RELEASE, V114, P334, DOI 10.1016/j.jconrel.2006.06.007	49	32	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57136	10.1371/journal.pone.0057136	http://dx.doi.org/10.1371/journal.pone.0057136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23483881	Green Published, gold, Green Submitted			2022-12-25	WOS:000315519000066
J	Vishnivetskiy, SA; Baameur, F; Findley, KR; Gurevich, VV				Vishnivetskiy, Sergey A.; Baameur, Faiza; Findley, Kristen R.; Gurevich, Vsevolod V.			Critical Role of the Central 139-Loop in Stability and Binding Selectivity of Arrestin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; BETA-ARRESTIN; PHOSPHORYLATION-RECOGNITION; FUNCTIONAL FORMS; LIGAND-BINDING; RHODOPSIN; MECHANISM; SPECIFICITY	Arrestin-1 selectively binds active phosphorylated rhodopsin (P-Rh*), demonstrating much lower affinity for inactive phosphorylated (P-Rh) and unphosphorylated active (Rh*) forms. Receptor interaction induces significant conformational changes in arrestin-1, which include large movement of the previously neglected 139-loop in the center of the receptor binding surface, away from the incoming receptor. To elucidate the functional role of this loop, in mouse arrestin-1 we introduced deletions of variable lengths and made several substitutions of Lys-142 in it and Asp-72 in the adjacent loop. Several mutants with perturbations in the 139-loop demonstrate increased binding to P-Rh*, dark P-Rh, Rh*, and phospho-opsin. Enhanced binding of arrestin-1 mutants to non-preferred forms of rhodopsin correlates with decreased thermal stability. The 139-loop perturbations increase P-Rh* binding of arrestin-1 at low temperatures and further change its binding profile on the background of 3A mutant, where the C-tail is detached from the body of the molecule by triple alanine substitution. Thus, the 139-loop stabilizes basal conformation of arrestin-1 and acts as a brake, preventing its binding to non-preferred forms of rhodopsin. Conservation of this loop in other subtypes suggests that it has the same function in all members of the arrestin family.	[Vishnivetskiy, Sergey A.; Baameur, Faiza; Findley, Kristen R.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [EY011500, GM077561, GM081756]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011500, GM077561, and GM081756 (to V. V. G.).	Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Cleghorn WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022797; Dinculescu A, 2002, J BIOL CHEM, V277, P11703, DOI 10.1074/jbc.M111833200; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Gurevich VV, 2012, CELL SIGNAL, V24, P1899, DOI 10.1016/j.cellsig.2012.05.012; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; PLANGGER A, 1994, J BIOL CHEM, V269, P26969; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Sommer ME, 2011, J BIOL CHEM, V286, P7359, DOI 10.1074/jbc.M110.204941; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P3394, DOI 10.1074/jbc.M112.445437; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	74	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11741	11750		10.1074/jbc.M113.450031	http://dx.doi.org/10.1074/jbc.M113.450031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23476014	hybrid, Green Published			2022-12-25	WOS:000318157600011
J	Basu, S; Srinivasan, DK; Yang, K; Raina, H; Banerjee, S; Zhang, RL; Fisher, SA; Proweller, A				Basu, Sanchita; Srinivasan, Dinesh Kumar; Yang, Ke; Raina, Hema; Banerjee, Suhanti; Zhang, Rongli; Fisher, Steven A.; Proweller, Aaron			Notch Transcriptional Control of Vascular Smooth Muscle Regulatory Gene Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; AUTOSOMAL-DOMINANT ARTERIOPATHY; MESENTERIC RESISTANCE ARTERIES; TRANSGENIC MOUSE MODEL; MYOSIN PHOSPHATASE; CELL DIFFERENTIATION; SUBCORTICAL INFARCTS; MICE LACKING; HYPERTENSION; TARGET	Notch receptors and ligands mediate heterotypic cell signaling that is required for normal vascular development. Dysregulation of select Notch receptors in mouse vascular smooth muscle (VSM) and in genetic human syndromes causes functional impairment in some regional circulations, the mechanistic basis of which is undefined. In this study, we used a dominant-negative Mastermind-like (DNMAML1) to block signaling through all Notch receptors specifically in VSM to more broadly test a functional role for this pathway in vivo. Mutant DNMAML1-expressing mice exhibited blunted blood pressure responses to vasoconstrictors, and their aortic, femoral, and mesenteric arteries had reduced contractile responses to agonists and depolarization in vitro. The mutant arteries had significant and specific reduction in the expression and activity of myosin light chain kinase (MLCK), a primary regulator of VSM force production. Conversely, activated Notch signaling in VSM cells induced endogenous MLCK transcript levels. We identified MLCK as a direct target of activated Notch receptor as demonstrated by an evolutionarily conserved Notch-responsive element within the MLCK promoter that binds the Notch receptor complex and is required for transcriptional activity. We conclude that Notch signaling through the transcriptional control of key regulatory proteins is required for contractile responses of mature VSM. Genetic or pharmacological manipulation of Notch signaling is a potential strategy for modulating arterial function in human disease.	Case Western Reserve Univ, Dept Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Proweller, A (corresponding author), Case Western Reserve Univ, Dept Med, 4530 Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44122 USA.	aaron.proweller@case.edu	Srinivasan, Dinesh Kumar/A-9872-2008; Srinivasan, Dinesh Kumar/E-6383-2017; Srinivasan, Dinesh Kumar/P-6528-2019	Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Srinivasan, Dinesh Kumar/0000-0001-6535-5441	National Institutes of Health [HL096603, HL066171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066171, R01HL096603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL096603 (to A. P.) and HL066171 (to S. F.).	Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Boulos N, 2011, HYPERTENSION, V57, P1176, DOI 10.1161/HYPERTENSIONAHA.111.170746; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Christ GJ, 1999, AM J PHYSIOL-HEART C, V276, pH1911, DOI 10.1152/ajpheart.1999.276.6.H1911; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; Del Bianco C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015034; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dubroca C, 2005, STROKE, V36, P113, DOI 10.1161/01.STR.0000149949.92854.45; Earley S, 2004, AM J PHYSIOL-HEART C, V287, pH2677, DOI 10.1152/ajpheart.00016.2004; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Lacombe P, 2005, STROKE, V36, P1053, DOI 10.1161/01.STR.0000163080.82766.eb; Lagaud G, 2002, AM J PHYSIOL-HEART C, V283, pH2187, DOI 10.1152/ajpheart.00554.2002; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Loufrani L, 2001, CIRCULATION, V103, P864, DOI 10.1161/01.CIR.103.6.864; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Ruchoux MM, 2003, AM J PATHOL, V162, P329, DOI 10.1016/S0002-9440(10)63824-2; Sakata Y, 2004, ARTERIOSCL THROM VAS, V24, P2069, DOI 10.1161/01.ATV.0000143936.77094.a4; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Yang K, 2011, J BIOL CHEM, V286, P13741, DOI 10.1074/jbc.M110.181842; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	42	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11191	11202		10.1074/jbc.M112.442996	http://dx.doi.org/10.1074/jbc.M112.442996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23482558	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000317915500023
J	Hu, ZG; Hu, J; Zhang, ZH; Shen, WJ; Yun, CC; Berlot, CH; Kraemer, FB; Azhar, S				Hu, Zhigang; Hu, Jie; Zhang, Zhonghua; Shen, Wen-Jun; Yun, C. Chris; Berlot, Catherine H.; Kraemer, Fredric B.; Azhar, Salman			Regulation of Expression and Function of Scavenger Receptor Class B, Type I (SR-BI) by Na+/H+ Exchanger Regulatory Factors (NHERFs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTERYL ESTER UPTAKE; PROTEIN-COUPLED-RECEPTORS; DOMAIN-CONTAINING PROTEIN; CAMP-MEDIATED INHIBITION; OVARIAN GRANULOSA-CELLS; SELECTIVE UPTAKE; H+ EXCHANGER; PDZ PROTEINS; BETA(2)-ADRENERGIC RECEPTOR	Scavenger receptor class B, type I (SR-BI) binds HDL and mediates selective delivery of cholesteryl esters (CEs) to the liver, adrenals, and gonads for product formation (bile acids and steroids). Because relatively little is known about SR-BI posttranslational regulation in steroidogenic cells, we examined the roles of Na+/H+ exchanger regulatory factors (NHERFs) in regulating SR-BI expression, SR-BI-mediated selective CE uptake, and steroidogenesis. NHERF1 and NHERF2 mRNA and protein are expressed at varying levels in model steroidogenic cell lines and the adrenal, with only low expression of PDZK1 (NHERF3) and NHERF4. Dibutyryl cyclic AMP decreased NHERF1 and NHERF2 and increased SR-BI mRNA expression in primary rat granulosa cells and MLTC-1 cells, whereas ACTH had no effect on NHERF1 and NHERF2 mRNA levels but decreased their protein levels in rat adrenals. Co-immunoprecipitation, colocalization, bimolecular fluorescence complementation, and mutational analysis indicated that SR-BI associates with NHERF1 and NHERF2. NHERF1 and NHERF2 down-regulated SR-BI protein expression through inhibition of its de novo synthesis. NHERF1 and NHERF2 also inhibited SR-BI-mediated selective CE transport and steroidogenesis, which were markedly attenuated by partial deletions of the PDZ1 or PDZ2 domain of NHERF1, the PDZ2 domain of NHERF2, or the MERM domains of NHERF1/2 or by gene silencing of NHERF1/2. Moreover, an intact COOH-terminal PDZ recognition motif (EAKL) in SR-BI is needed. Transient transfection of hepatic cell lines with NHERF1 or NHERF2 caused a significant reduction in endogenous protein levels of SR-BI. Collectively, these data establish NHERF1 and NHERF2 as SR-BI protein binding partners that play a negative role in the regulation of SR-BI expression, selective CE transport, and steroidogenesis.	[Hu, Zhigang; Hu, Jie; Zhang, Zhonghua; Shen, Wen-Jun; Kraemer, Fredric B.; Azhar, Salman] Vet Affairs Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA; [Hu, Zhigang; Hu, Jie; Zhang, Zhonghua; Shen, Wen-Jun; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol, Stanford, CA 94305 USA; [Azhar, Salman] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Berlot, Catherine H.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Emory University	Azhar, S (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, GRECC 182B,3801 Miranda Ave, Palo Alto, CA 94304 USA.	salman.azhar@va.gov	Kraemer, Fredric/AAC-3633-2019; zhang, zh/GWV-4677-2022	Kraemer, Fredric/0000-0003-2468-7807; Shen, Wen-Jun/0000-0001-5150-1698	National Institutes of Health, NHLBI [2R01HL33881]; Office of Research and Development, Medical Service, Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061418, R01DK071597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050369] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398, I01BX001923] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Research and Development, Medical Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant 2R01HL33881. This work was also supported by the Office of Research and Development, Medical Service, Department of Veterans Affairs.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Azhar S, 1998, J CLIN ENDOCR METAB, V83, P983, DOI 10.1210/jc.83.3.983; Azhar S, 2003, FRONT BIOSCI-LANDMRK, V8, pS998, DOI 10.2741/1165; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; Azhar S, 2002, J LIPID RES, V43, P861; Azhar S, 1998, J LIPID RES, V39, P1616; AZHAR S, 1989, J LIPID RES, V30, P1799; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cherradi N, 2001, ENDOCRINOLOGY, V142, P4540, DOI 10.1210/en.142.10.4540; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Ediger TR, 1999, ENDOCRINOLOGY, V140, P2976, DOI 10.1210/en.140.7.2976; Fanellli T, 2008, BIOL CELL, V100, P399, DOI 10.1042/BC20070095; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; GWYNNE JT, 1980, J BIOL CHEM, V255, P875; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hu J, 2011, BIOCHEMISTRY-US, V50, P10860, DOI 10.1021/bi201264y; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Leiva A, 2011, ATHEROSCLEROSIS, V217, P299, DOI 10.1016/j.atherosclerosis.2011.05.036; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mardones P, 2001, J LIPID RES, V42, P170; Minkoff C, 1999, CURR OPIN NEPHROL HY, V8, P603, DOI 10.1097/00041552-199909000-00012; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; Rao RM, 2003, BIOL REPROD, V68, P114, DOI 10.1095/biolreprod.102.007518; REAVEN E, 1995, J LIPID RES, V36, P1602; Reaven E, 1999, BBA-MOL CELL BIOL L, V1436, P565, DOI 10.1016/S0005-2760(98)00169-6; Reaven E, 1998, ENDOCRINOLOGY, V139, P2847, DOI 10.1210/en.139.6.2847; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Reaven E, 2000, J LIPID RES, V41, P343; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; RINNINGER F, 1994, HEPATOLOGY, V19, P1100, DOI 10.1002/hep.1840190507; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Scott RO, 2002, J BIOL CHEM, V277, P22934, DOI 10.1074/jbc.M202434200; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Slattery C, 2011, CELL PHYSIOL BIOCHEM, V27, P171, DOI 10.1159/000325219; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Temel RE, 1997, P NATL ACAD SCI USA, V94, P13600, DOI 10.1073/pnas.94.25.13600; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Towns R, 2005, ENDOCRINE, V27, P269, DOI 10.1385/ENDO:27:3:269; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856	87	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11416	11435		10.1074/jbc.M112.437368	http://dx.doi.org/10.1074/jbc.M112.437368			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23482569	Green Published, hybrid			2022-12-25	WOS:000317915500044
J	Kanaoka, Y; Maekawa, A; Austen, KF				Kanaoka, Yoshihide; Maekawa, Akiko; Austen, K. Frank			Identification of GPR99 Protein as a Potential Third Cysteinyl Leukotriene Receptor with a Preference for Leukotriene E-4 Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG TRACHEAL; ASTHMATIC SUBJECTS; SMOOTH-MUSCLE; HISTAMINE HYPERRESPONSIVENESS; CYSLT(2) RECEPTOR; CONTROLLED-TRIAL; IN-VITRO; MONTELUKAST; ANTAGONIST; BIOSYNTHESIS	The cysteinyl leukotrienes (cys-LTs), leukotriene C-4 (LTC4), a conjugation product of glutathione and eicosatetraenoic acid, and its metabolites, LTD4 and LTE4, are lipid mediators of smooth muscle constriction and inflammation in asthma. LTD4 is the most potent ligand for the type 1 cys-LT receptor (CysLT(1)R), and LTC4 and LTD4 have similar lesser potency for CysLT(2)R, whereas LTE4 has little potency for either receptor. Cysltr1/Cysltr2(-/-) mice, lacking the two defined receptors, exhibited a comparable dose-dependent vascular leak to intradermal injection of LTC4 or LTD4 and an augmented response to LTE4 as compared with WT mice. As LTE4 retains a cysteine residue and might provide recognition via a dicarboxylic acid structure, we screened cDNAs within the P2Y nucleotide receptor family containing CysLTRs and dicarboxylic acid receptors with trans-activator reporter gene assays. GPR99, previously described as an oxoglutarate receptor (Oxgr1), showed both a functional and a binding response to LTE4 in these transfectants. We generated Gpr99(-/-) and Gpr99/Cysltr1/Cysltr2(-/-) mice for comparison with WT and Cysltr1/Cysltr2(-/-) mice. Strikingly, GPR99 deficiency in the Cysltr1/Cysltr2(-/-) mice virtually eliminated the vascular leak in response to the cys-LT ligands, indicating GPR99 as a potential CysLT(3)R active in the Cysltr1/Cysltr2(-/-) mice. Importantly, the Gpr99(-/-) mice showed a dose-dependent loss of LTE4-mediated vascular permeability, but not to LTC4 or LTD4, revealing a preference of GPR99 for LTE4 even when CysLT(1)R is present. As LTE4 is the predominant cys-LT species in inflamed tissues, GPR99 may provide a new therapeutic target.	Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kanaoka, Y (corresponding author), Brigham & Womens Hosp, Smith Bldg,Rm 626C,1 Jimmy Fund Way, Boston, MA 02115 USA.	ykanaoka@rics.bwh.harvard.edu			National Institutes of Health [U19AI095219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U19AI095219 (to Y.K.).	ARM JP, 1990, AM REV RESPIR DIS, V142, P1112, DOI 10.1164/ajrccm/142.5.1112; Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1531, DOI 10.1164/ajrccm/146.6.1531; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1506, DOI 10.1164/ajrccm/146.6.1506; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; DAVIDSON AB, 1987, AM REV RESPIR DIS, V135, P333; DRAZEN JM, 1992, AM REV RESPIR DIS, V146, P104, DOI 10.1164/ajrccm/146.1.104; Gauvreau GM, 2001, AM J RESP CRIT CARE, V164, P1495, DOI 10.1164/ajrccm.164.8.2102033; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hui YQ, 2001, J BIOL CHEM, V276, P47489, DOI 10.1074/jbc.M107556200; Inbe H, 2004, J BIOL CHEM, V279, P19790, DOI 10.1074/jbc.M400360200; JACQUES CAJ, 1991, BRIT J PHARMACOL, V104, P859, DOI 10.1111/j.1476-5381.1991.tb12518.x; Kamohara M, 2001, BIOCHEM BIOPH RES CO, V287, P1088, DOI 10.1006/bbrc.2001.5695; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; LAM BK, 1989, J BIOL CHEM, V264, P12885; LAM S, 1988, J ALLERGY CLIN IMMUN, V81, P711, DOI 10.1016/0091-6749(88)91043-3; LEE TH, 1984, P NATL ACAD SCI-BIOL, V81, P4922, DOI 10.1073/pnas.81.15.4922; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; LEWIS RA, 1980, BIOCHEM BIOPH RES CO, V96, P271, DOI 10.1016/0006-291X(80)91210-3; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2001, P NATL ACAD SCI USA, V98, P2256, DOI 10.1073/pnas.041624398; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Ogasawara H, 2002, J BIOL CHEM, V277, P18763, DOI 10.1074/jbc.M109447200; Park JS, 2010, ALLERGY ASTHMA IMMUN, V2, P48, DOI 10.4168/aair.2010.2.1.48; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; SALA A, 1990, J BIOL CHEM, V265, P21771; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Shirasaki H, 2002, CLIN EXP ALLERGY, V32, P1007, DOI 10.1046/j.1365-2222.2002.01425.x; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Wittenberger T, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-17; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106	35	137	141	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10967	10972		10.1074/jbc.C113.453704	http://dx.doi.org/10.1074/jbc.C113.453704			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23504326	hybrid, Green Published			2022-12-25	WOS:000317915500003
J	Costa-Urrutia, P; Sanvito, S; Victoria-Cota, N; Enriquez-Paredes, L; Gendron, D				Costa-Urrutia, Paula; Sanvito, Simona; Victoria-Cota, Nelva; Enriquez-Paredes, Luis; Gendron, Diane			Fine-Scale Population Structure of Blue Whale Wintering Aggregations in the Gulf of California	PLOS ONE			English	Article							SOUTHERN RIGHT WHALES; GENETIC-STRUCTURE; BALAENOPTERA-MUSCULUS; HUMPBACK WHALES; SITE FIDELITY; MEGAPTERA-NOVAEANGLIAE; NYCTIPHANES-SIMPLEX; BREEDING GROUNDS; SPERM-WHALES; MITOCHONDRIAL	Population differentiation in environments without well-defined geographical barriers represents a challenge for wildlife management. Based on a comprehensive database of individual sighting records (1988-2009) of blue whales from the winter/calving Gulf of California, we assessed the fine-scale genetic and spatial structure of the population using individual-based approaches. Skin samples of 187 individuals were analyzed for nine microsatellite loci. A single population with no divergence among years and months and no isolation by distance (Rxy = 0.1-0.001, p>0.05) were found. We ran two Bayesian clustering methods using Structure and Geneland softwares in two different ways: 1) a general analysis including all individuals in which a single cluster was identified with both softwares; 2) a specific analysis of females only in which two main clusters (Loreto Bay and northern areas, and San Jose-La Paz Bay area) were revealed by Geneland program. This study provides information indicating that blue whales wintering in the Gulf of California are part of a single population unit and showed a fine-scale structure among females, possibly associated with their high site fidelity, particularly when attending calves. It is likely that the loss of genetic variation is minimized by male mediated gene flow, which may reduce the genetic drift effect. Opportunities for kin selection may also influence calf survival and, in consequence, have a positive impact on population demography in this small and endangered population.	[Costa-Urrutia, Paula; Sanvito, Simona; Enriquez-Paredes, Luis] Univ Autonoma Baja California, Fac Ciencias Marinas, Lab Ecol Mol, Mexicali 21100, Baja California, Mexico; [Victoria-Cota, Nelva] Univ Autonoma Baja California, Escuela Ciencias Salud, Lab Ecol & Epidemiol Mol, Mexicali 21100, Baja California, Mexico; [Gendron, Diane] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Cetaceos & Quelonios, Mexico City, DF, Mexico	Universidad Autonoma de Baja California; Universidad Autonoma de Baja California; Instituto Politecnico Nacional - Mexico	Gendron, D (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Cetaceos & Quelonios, Mexico City, DF, Mexico.	dgendron@ipn.mx		Enriquez-Paredes, Luis Manuel/0000-0002-9835-1225; Costa-Urrutia, Paula/0000-0002-6747-5380	Instituto Politecnico Nacional Consejo Nacional de Ciencias y Tecnologia [SEMARNAT-2002-C01-0628]; Universidad Autonoma de Baja California [12C-0351]; American Cetacean Society - Monterey Bay Whales and Dolphin Conservation Society [081209]	Instituto Politecnico Nacional Consejo Nacional de Ciencias y Tecnologia; Universidad Autonoma de Baja California; American Cetacean Society - Monterey Bay Whales and Dolphin Conservation Society	Instituto Politecnico Nacional Consejo Nacional de Ciencias y Tecnologia (SEMARNAT-2002-C01-0628. Universidad Autonoma de Baja California (Project 12C-0351). The American Cetacean Society - Monterey Bay (081209) Whales and Dolphin Conservation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; AMOS B, 1991, P99; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Andersen LW, 2003, MAR ECOL PROG SER, V247, P263, DOI 10.3354/meps247263; Attard CRM, 2010, CONSERV GENET, V11, P2437, DOI 10.1007/s10592-010-0121-9; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; BAKER CS, 1990, NATURE, V344, P238, DOI 10.1038/344238a0; BEKOFF M, 1984, BEHAV RES METH INS C, V16, P32, DOI 10.3758/BF03201046; Benjamini Y, 2001, ANN STAT, V29, P1165; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; Berube M, 2005, CONSERV GENET, V6, P631, DOI 10.1007/s10592-005-9017-5; Berube M, 2000, MOL ECOL, V9, P2181; Berube M, 1996, MOL ECOL, V5, P283; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Brinton E, 1980, CALCOFI REP, V21, P212; Buchanan FC, 1996, MOL ECOL, V5, P571; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; CALAMBOKIDIS J, 1990, REPORTS INT WHALING, V12, P343; Campbell RA, 2008, BIOL LETTERS, V4, P139, DOI 10.1098/rsbl.2007.0487; Carroll EL, 2012, MOL ECOL, V21, P3960, DOI 10.1111/j.1365-294X.2012.05676.x; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Clapham PJ, 1996, MAMMAL REV, V26, P27, DOI 10.1111/j.1365-2907.1996.tb00145.x; Coltman DW, 2003, MOL ECOL, V12, P733, DOI 10.1046/j.1365-294X.2003.01762.x; Craig AS, 1997, CAN J ZOOL, V75, P1923, DOI 10.1139/z97-822; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; de Silva-Davila R, 1998, J CRUSTACEAN BIOL, V18, P490, DOI 10.2307/1549413; Elwen SH, 2004, MAR MAMMAL SCI, V20, P567, DOI 10.1111/j.1748-7692.2004.tb01180.x; Elwen SH, 2004, MAR ECOL PROG SER, V269, P289, DOI 10.3354/meps269289; Escorza-Trevino S, 2004, J MAMMAL, V85, P347, DOI 10.1644/1545-1542(2004)085<0347:MAOTTA>2.0.CO;2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Frasier Timothy R., 2011, Endangered Species Research, V14, P39, DOI 10.3354/esr00340; Gaskin DE., 1982, ECOLOGY WHALES DOLPH; Gendron D., 2012, Journal of Cetacean Research and Management, V12, P79; GENDRON D, 1992, MAR ECOL PROG SER, V87, P1, DOI 10.3354/meps087001; GENDRON D, 2002, THESIS CTR INVESTIGA; Goerlitz DS, 2003, CAN J ZOOL, V81, P1965, DOI 10.1139/Z03-203; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hucke-Gaete R, 2004, P ROY SOC B-BIOL SCI, V271, pS170, DOI 10.1098/rsbl.2003.0132; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Leduc R.G., 2007, Journal of Cetacean Research and Management, V9, P73; Lockyer C.H., 1981, Society for Experimental Biology Seminar Series, P105; Lynch M, 1999, GENETICS, V152, P1753; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Lyrholm T, 1998, P ROY SOC B-BIOL SCI, V265, P1679, DOI 10.1098/rspb.1998.0488; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Okello JBA, 2008, MOL ECOL, V17, P3788, DOI 10.1111/j.1365-294X.2008.03871.x; Palsboll PJ, 1999, GENETICS, V151, P285; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; Reilly SB, 2008, IUCN 2010 IUCN RED L, P4; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roden GI, 1964, AAPG BULL, V3, P30; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Rosenbaum HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007318; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; SANTAMARIADELANGEL E, 1994, J GEOPHYS RES-OCEANS, V99, P7411, DOI 10.1029/93JC02154; SCHAEFF CM, 1993, CAN J ZOOL, V71, P339, DOI 10.1139/z93-047; Sears RJ, 1990, REPORT INT WHALING C, P335; SLATKIN M, 1995, GENETICS, V139, P457; Sremba AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032579; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafford KM, 1999, J ACOUST SOC AM, V106, P3687, DOI 10.1121/1.428220; THOMAS PO, 1984, BEHAVIOUR, V88, P42, DOI 10.1163/156853984X00470; Tiedemann R, 2000, MOL ECOL, V9, P1159, DOI 10.1046/j.1365-294x.2000.00975.x; Valenzuela LO, 2009, MOL ECOL, V18, P782, DOI 10.1111/j.1365-294X.2008.04069.x; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang IJ, 2009, MOL ECOL, V18, P3847, DOI 10.1111/j.1365-294X.2009.04338.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wright S., 1978, EVOLUTION GENETICS P	87	17	17	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58315	10.1371/journal.pone.0058315	http://dx.doi.org/10.1371/journal.pone.0058315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505485	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500067
J	Mera-Varela, A; Ferreiro-Iglesias, A; Perez-Pampin, E; Porto-Silva, M; Gomez-Reino, JJ; Gonzalez, A				Mera-Varela, Antonio; Ferreiro-Iglesias, Aida; Perez-Pampin, Eva; Porto-Silva, Marisol; Gomez-Reino, Juan J.; Gonzalez, Antonio			Ultrasonographic Assessment of Enthesitis in HLA-B27 Positive Patients with Rheumatoid Arthritis, a Matched Case-Only Study	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; REAL-TIME PCR; ANKYLOSING-SPONDYLITIS; PSORIATIC-ARTHRITIS; PERIPHERAL ENTHESITIS; CLINICAL-FEATURES; POWER DOPPLER; DISEASE ONSET; HLA ALLELES; SPONDYLOARTHRITIS	Introduction: HLA-B27 has a modifier effect on the phenotype of multiple diseases, both associated and non-associated with it. Among these effects, an increased frequency of clinical enthesitis in patients with Rheumatoid Arthritis (RA) has been reported but never explored again. We aimed to replicate this study with a sensitive and quantitative assessment of enthesitis by using standardized ultrasonography (US). Methods: The Madrid Sonography Enthesitis Index (MASEI) was applied to the US assessment of 41 HLA-B27 positive and 41 matched HLA-B27 negative patients with longstanding RA. Clinical characteristics including explorations aimed to evaluate spondyloarthrtitis and laboratory tests were also done. Results: A significant degree of abnormalities in the entheses of the patients with RA were found, but the MASEI values, and each of its components including the Doppler signal, were similar in HLA-B27 positive and negative patients. An increase of the MASEI scores with age was identified. Differences in two clinical features were found: a lower prevalence of rheumatoid factor and a more common story of low back pain in the HLA-B27 positive patients than in the negative. The latter was accompanied by radiographic sacroiliitis in two HLA-B27 positive patients. No other differences were detected. Conclusion: We have found that HLA-B27 positive patients with RA do not have more enthesitis as assessed with US than the patients lacking this HLA allele. However, HLA-B27 could be shaping the RA phenotype towards RF seronegativity and axial involvement.	[Mera-Varela, Antonio; Ferreiro-Iglesias, Aida; Perez-Pampin, Eva; Porto-Silva, Marisol; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Res Lab 10, Santiago De Compostela, Spain; [Mera-Varela, Antonio; Ferreiro-Iglesias, Aida; Perez-Pampin, Eva; Porto-Silva, Marisol; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Rheumatol Unit, Santiago De Compostela, Spain; [Mera-Varela, Antonio; Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Hosp Clin Univ Santiago, Inst Invest Sanitaria, Res Lab 10, Santiago De Compostela, Spain.	antonio.gonzalez.martinez-pedrayo@sergas.es	Perez-Pampin, Eva/ABF-7200-2020; Gomez-Reino, Juan/ABI-2853-2020; VARELA, ANTONIO MERA/ABH-1886-2020; Gonzalez, Antonio/C-4444-2008	VARELA, ANTONIO MERA/0000-0001-9380-6975; Gonzalez, Antonio/0000-0002-2624-0606; Gomez-Reino, Juan/0000-0001-5229-6294; Perez-Pampin, Eva/0000-0003-0319-4456	Xunta de Galicia [10CSA918040PR]; Instituto de Salud Carlos III [PI08/0744]; European Regional Development Fund of the European Union; Instituto de Salud Carlos III (Spain)	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund of the European Union; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III)	The study was supported by grants 10CSA918040PR from the Xunta de Galicia (http://www.sergas.e/MostrarContidos_N3_T01.aspx?IdPaxina=10142) and PI08/0744 of the Instituto de Salud Carlos III (http://www.isciii.es/) that are partially financed by the European Regional Development Fund of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors acknowledge the patients with RA participating in this study by their availability and generosity. AF-I has a pre-doctoral bursary from the Instituto de Salud Carlos III (Spain).	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balint PV, 2002, ANN RHEUM DIS, V61, P905, DOI 10.1136/ard.61.10.905; Berntson L, 2008, J RHEUMATOL, V35, P2055; Bon MAM, 2000, CLIN CHEM, V46, P1000; Chung HY, 2011, ANN RHEUM DIS, V70, P1930, DOI 10.1136/ard.2011.152975; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; D'Agostino MA, 2003, ARTHRITIS RHEUM, V48, P523, DOI 10.1002/art.10812; D'Agostino MA, 2011, ANN RHEUM DIS, V70, P1433, DOI 10.1136/ard.2010.138701; DAHLQVIST SR, 1984, J RHEUMATOL, V11, P27; de Miguel E, 2009, ANN RHEUM DIS, V68, P169, DOI 10.1136/ard.2007.084251; de Miguel E, 2011, ANN RHEUM DIS, V70, P434, DOI 10.1136/ard.2010.134965; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; El-Gabalawy HS, 1999, ARTHRITIS RHEUM-US, V42, P1696, DOI 10.1002/1529-0131(199908)42:8<1696::AID-ANR19>3.0.CO;2-K; Falsetti P, 2003, SCAND J RHEUMATOL, V32, P229, DOI 10.1080/03009740310003721; Faner R, 2004, HUM IMMUNOL, V65, P826, DOI 10.1016/j.humimm.2004.05.009; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Flato B, 2002, ARTHRITIS RHEUM, V46, P986, DOI 10.1002/art.10146; Genc H, 2005, CLIN RHEUMATOL, V24, P272, DOI 10.1007/s10067-004-0997-1; Gregersen PK, 2010, BULL HOSP JT DIS, V68, P179; Gutierrez M, 2011, CLIN RHEUMATOL, V30, P907, DOI 10.1007/s10067-011-1703-8; JAJIC Z, 1991, Acta Medica Iugoslavica, V45, P195; JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627, DOI 10.1136/ard.45.8.627; JURIK AG, 1987, FORTSCHR RONTG NEUEN, V147, P14; Kaarela K, 2009, CLIN EXP RHEUMATOL, V27, P325; Kasifoglu T, 2009, CLIN RHEUMATOL, V28, P41, DOI 10.1007/s10067-008-0980-3; Knevel R, 2012, ANN RHEUM DIS; Maksymowych WP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2665; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McGonagle D, 1998, LANCET, V352, P1137, DOI 10.1016/S0140-6736(97)12004-9; MOLL JMH, 1971, ANN RHEUM DIS, V30, P381, DOI 10.1136/ard.30.4.381; Munoz-Fernandez S, 2009, ARTHRITIS RHEUM-US, V60, P1985, DOI 10.1002/art.24636; Naredo E, 2011, RHEUMATOLOGY, V50, P1838, DOI 10.1093/rheumatology/ker078; Orchard TR, 2009, ALIMENT PHARM THER, V29, P193, DOI 10.1111/j.1365-2036.2008.03868.x; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Plenge RM, 2010, RHEUM DIS CLIN N AM, V36, P259, DOI 10.1016/j.rdc.2010.03.002; Queiro R, 2003, J RHEUMATOL, V30, P505; Queiro R, 2002, SEMIN ARTHRITIS RHEU, V31, P413, DOI 10.1053/sarh.2002.33470; Reveille JD, 2009, ADV EXP MED BIOL, V649, P159; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; RUNDBACK JH, 1993, SKELETAL RADIOL, V22, P263; Ruta S, 2011, JCR-J CLIN RHEUMATOL, V17, P18, DOI 10.1097/RHU.0b013e318204a6f8; Saraux A, 1997, SCAND J RHEUMATOL, V26, P269, DOI 10.3109/03009749709105315; Seddighzadeh M, 2012, J RHEUMATOL, V39, P1509, DOI 10.3899/jrheum.111284; SHAIBANI A, 1993, CLIN EXP RHEUMATOL, V11, P399; Skare TL, 2012, CLIN EXP RHEUMATOL, V30, P351; Rodriguez-Reyna TS, 2009, WORLD J GASTROENTERO, V15, P5517, DOI 10.3748/wjg.15.5517; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721	48	10	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58616	10.1371/journal.pone.0058616	http://dx.doi.org/10.1371/journal.pone.0058616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505543	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500107
J	Taniguchi, M; Fukunaka, A; Hagihara, M; Watanabe, K; Kamino, S; Kambe, T; Enomoto, S; Hiromura, M				Taniguchi, Masanari; Fukunaka, Ayako; Hagihara, Mitsue; Watanabe, Keiko; Kamino, Shinichiro; Kambe, Taiho; Enomoto, Shuichi; Hiromura, Makoto			Essential Role of the Zinc Transporter ZIP9/SLC39A9 in Regulating the Activations of Akt and Erk in B-Cell Receptor Signaling Pathway in DT40 Cells	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; SECRETORY PATHWAY; VERTEBRATE CELLS; TYROSINE PHOSPHATASES; ALKALINE-PHOSPHATASES; ANTIGEN RECEPTOR; IMMUNE FUNCTION; T-CELLS; PROTEIN; HOMEOSTASIS	The essential trace element zinc is important for all living organisms. Zinc functions not only as a nutritional factor, but also as a second messenger. However, the effects of intracellular zinc on the B cell-receptor (BCR) signaling pathway remain poorly understood. Here, we present data indicating that the increase in intracellular zinc level induced by ZIP9/SLC39A9 (a ZIP Zrt-/Irt-like protein) plays an important role in the activation of Akt and Erk in response to BCR activation. In DT40 cells, the enhancement of Akt and Erk phosphorylation following BCR activation requires intracellular zinc. To clarify this event, we used chicken ZnT5/6/7-gene-triple-knockout DT40 (TKO) cells and chicken Zip9-knockout DT40 (cZip9KO) cells. The levels of Akt and ERK phosphorylation significantly decreased in cZip9KO cells. In addition, the enzymatic activity of protein tyrosine phosphatase (PTPase) increased in cZip9KO cells. These biochemical events were restored by overexpressing the human Zip9 (hZip9) gene. Moreover, we found that the increase in intracellular zinc level depends on the expression of ZIP9. This observation is in agreement with the increased levels of Akt and Erk phosphorylation and the inhibition of total PTPase activity. We concluded that ZIP9 regulates cytosolic zinc level, resulting in the enhancement of Akt and Erk phosphorylation. Our observations provide new mechanistic insights into the BCR signaling pathway underlying the regulation of intracellular zinc level by ZIP9 in response to the BCR activation.	[Taniguchi, Masanari; Enomoto, Shuichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Taniguchi, Masanari; Fukunaka, Ayako; Hagihara, Mitsue; Watanabe, Keiko; Kamino, Shinichiro; Enomoto, Shuichi; Hiromura, Makoto] RIKEN, Ctr Mol Imaging Sci, Multiple Mol Imaging Res Lab, Kobe, Hyogo, Japan; [Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan	Okayama University; RIKEN; Kyoto University	Enomoto, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	senomoto@pharm.okayama-u.ac.jp; mhiromura@riken.jp	Enomoto, Shuichi/G-8524-2012	Hagihara, Mitsue/0000-0002-7613-5054	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Kieikai Research Foundation; Salt Science Research Foundation; Grants-in-Aid for Scientific Research [24790936] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Kieikai Research Foundation(Kieikai Research Foundation); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a consignment expense for the Molecular Imaging Research Programs entitled "Research Base for Exploring New Drugs" and "Kobe Cluster" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to SE), grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to SE and TK), from the Ministry of Health, Labor, and Welfare of Japan for scientific research (to SE), the Kieikai Research Foundation (to TK), and The Salt Science Research Foundation (to SE and MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Clegg MS, 2005, IUBMB LIFE, V57, P661, DOI 10.1080/15216540500264554; Colvin RA, 2006, BRAIN RES, V1085, P1, DOI 10.1016/j.brainres.2006.02.043; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Haase H, 2006, ANAL BIOCHEM, V352, P222, DOI 10.1016/j.ab.2006.02.009; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Kaltenberg J, 2010, EUR J IMMUNOL, V40, P1496, DOI 10.1002/eji.200939574; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Knoell DL, 2010, INT J VITAM NUTR RES, V80, P271, DOI 10.1024/0300-9831/a000034; Kurosaki T, 2011, MOL IMMUNOL, V48, P1287, DOI 10.1016/j.molimm.2010.12.007; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Kurosaki T, 2009, IMMUNOL REV, V228, P132, DOI 10.1111/j.1600-065X.2008.00748.x; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Morita T, 2004, BIOCHEM J, V382, P793, DOI 10.1042/BJ20031970; Morita T, 2009, J CELL SCI, V122, P1220, DOI 10.1242/jcs.041640; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Rink L, 2000, J NUTR, V130, p1407S, DOI 10.1093/jn/130.5.1407S; Samet JM, 1999, AM J RESP CELL MOL, V21, P357, DOI 10.1165/ajrcmb.21.3.3656; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Watjen W, 2002, ENVIRON HEALTH PERSP, V110, P865, DOI 10.1289/ehp.110-1241262; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yu M, 2002, NAT GENET, V31, P239; Zalewski P D, 1994, Chem Biol, V1, P153, DOI 10.1016/1074-5521(94)90005-1	50	66	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58022	10.1371/journal.pone.0058022	http://dx.doi.org/10.1371/journal.pone.0058022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505453	Green Published, gold			2022-12-25	WOS:000318334500045
J	Craft, ME; Beyer, HL; Haydon, DT				Craft, Meggan E.; Beyer, Hawthorne L.; Haydon, Daniel T.			Estimating the Probability of a Major Outbreak from the Timing of Early Cases: An Indeterminate Problem?	PLOS ONE			English	Article							DISEASE; MODELS; DISTRIBUTIONS; EPIDEMICS; DYNAMICS	Conservation biologists, as well as veterinary and public health officials, would benefit greatly from being able to forecast whether outbreaks of infectious disease will be major. For values of the basic reproductive number (R-0) between one and two, infectious disease outbreaks have a reasonable chance of either fading out at an early stage or, in the absence of intervention, spreading widely within the population. If it were possible to predict when fadeout was likely to occur, the need for costly precautionary control strategies could be minimized. However, the predictability of even simple epidemic processes remains largely unexplored. Here we conduct an examination of simulated data from the early stages of a fatal disease outbreak and explore how observable information might be useful for predicting major outbreaks. Specifically, would knowing the time of deaths for the first few cases allow us to predict whether an outbreak will be major? Using two approaches, trajectory matching and discriminant function analysis, we find that even in our best-case scenario (with accurate knowledge of epidemiological parameters, and precise times of death), it was not possible to reliably predict the outcome of a stochastic Susceptible-Exposed-Infectious-Recovered (SEIR) process.	[Craft, Meggan E.; Beyer, Hawthorne L.; Haydon, Daniel T.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland; [Craft, Meggan E.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Beyer, Hawthorne L.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia	University of Glasgow; University of Minnesota System; University of Minnesota Twin Cities; University of Queensland	Craft, ME (corresponding author), Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland.	craft@umn.edu	Craft, Meggan E/A-9393-2012; Beyer, Hawthorne/F-8050-2013	Craft, Meggan E/0000-0001-5333-8513; Beyer, Hawthorne/0000-0002-5430-0784; Haydon, Daniel/0000-0002-1240-1886	National Science Foundation [OISE-0804186]; Leverhulme Trust	National Science Foundation(National Science Foundation (NSF)); Leverhulme Trust(Leverhulme Trust)	Financial support for MC was provided by the National Science Foundation (OISE-0804186) and for HLB was provided by the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D, 1980, BIOMETRIKA, V67, P191; ANDERSON R M, 1991; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; BAILEY NTJ, 1953, BIOMETRIKA, V40, P279; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Conlan AJK, 2010, J R SOC INTERFACE, V7, P623, DOI 10.1098/rsif.2009.0284; Cox D. R., 1965, THEORY STOCHASTIC PR; Drake JM, 2006, PLOS MED, V3, P57, DOI 10.1371/journal.pmed.0030003; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kenah E, 2011, INTERDISCIPLINARY PE, V2011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; MOLLISON D, 1994, J R STAT SOC A STAT, V157, P115, DOI 10.2307/2983509; R Development Core Team, 2012, R LANG ENV STAT COMP; Trapman P, 2009, MATH BIOSCI, V219, P15, DOI 10.1016/j.mbs.2009.02.001; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2	24	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57878	10.1371/journal.pone.0057878	http://dx.doi.org/10.1371/journal.pone.0057878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483934	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000316936100050
J	Liau, WS; Nasri, U; Elmatari, D; Rothman, J; LaMunyon, CW				Liau, Wei-Siang; Nasri, Ubaydah; Elmatari, Daniel; Rothman, Jason; LaMunyon, Craig W.			Premature Sperm Activation and Defective Spermatogenesis Caused by Loss of spe-46 Function in Caenorhabditis elegans	PLOS ONE			English	Article							FAMILY-MEMBER SPE-4; PROTEIN PHOSPHATASE; MOLECULAR ANALYSIS; MEMBRANE-PROTEIN; GENE-EXPRESSION; SEA-URCHIN; C-ELEGANS; NEMATODE; SPERMIOGENESIS; INITIATION	Given limited resources for motility, sperm cell activation must be precisely timed to ensure the greatest likelihood of fertilization. Like those of most species, the sperm of C. elegans become active only after encountering an external signaling molecule. Activation coincides with spermiogenesis, the final step in spermatogenesis, when the spherical spermatid undergoes wholesale reorganization to produce a pseudopod. Here, we describe a gene involved in sperm activation, spe-46. This gene was identified in a suppressor screen of spe-27(it132ts), a sperm-expressed gene whose product functions in the transduction of the spermatid activation signal. While spe-27(it132ts) worms are sterile at 25 degrees C, the spe-46(hc197)I; spe-27(it132ts)IV double mutants regain partial fertility. Single nucleotide polymorphism mapping, whole genome sequencing, and transformation rescue were employed to identify the spe-46 coding sequence. It encodes a protein with seven predicted transmembrane domains but with no other predicted functional domains or homology outside of nematodes. Expression is limited to spermatogenic tissue, and a transcriptional GFP fusion shows expression corresponds with the onset of the pachytene stage of meiosis. The spe-46(hc197) mutation bypasses the need for the activation signal; mutant sperm activate prematurely without an activation signal in males, and mutant males are sterile. In an otherwise wild-type genome, the spe-46(hc197) mutation induces a sperm defective phenotype. In addition to premature activation, spe-46(hc197) sperm exhibit numerous defects including aneuploidy, vacuolization, protruding spikes, and precocious fusion of membranous organelles. Hemizygous worms [spe-46(hc197)/mnDf111] are effectively sterile. Thus, spe-46 appears to be involved in the regulation of spermatid activation during spermiogenesis, with the null phenotype being an absence of functional sperm and hypomorphic phenotypes being premature spermatid activation and numerous sperm cell defects.	[Liau, Wei-Siang; Nasri, Ubaydah; Elmatari, Daniel; Rothman, Jason; LaMunyon, Craig W.] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	LaMunyon, CW (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	cwlamunyon@csupomona.edu	Rothman, Jason/I-2382-2019	Rothman, Jason/0000-0002-4848-8901; Liau, Wei-Siang/0000-0001-8547-4712	U.S. National Institutes of Health [1 SC3 GM087212]; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM087212] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by U.S. National Institutes of Health award 1 SC3 GM087212. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduengo PM, 1998, J CELL SCI, V111, P3645; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOATMAN DE, 1991, BIOL REPROD, V44, P806, DOI 10.1095/biolreprod44.5.806; BRENNER S, 1974, GENETICS, V77, P71; BURKE DJ, 1983, J MOL BIOL, V171, P1, DOI 10.1016/S0022-2836(83)80312-X; CHRISTEN R, 1982, J BIOL CHEM, V257, P4881; del Castillo-Olivares A, 2009, DEV BIOL, V333, P397, DOI 10.1016/j.ydbio.2009.06.044; Dell'Angelica EC, 2001, CELL, V106, P395, DOI 10.1016/S0092-8674(01)00470-6; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gadella BM, 2000, DEVELOPMENT, V127, P2407; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; Geldziler B, 2005, DEV BIOL, V283, P424, DOI 10.1016/j.ydbio.2005.04.036; Gosney R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-44; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Han X, 2009, GENETICS, V181, P933, DOI 10.1534/genetics.108.096016; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Kaupp UB, 2006, J CELL PHYSIOL, V208, P487, DOI 10.1002/jcp.20669; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kulkarni M, 2012, PLOS GENET, V8, P587, DOI 10.1371/journal.pgen.1002678; L'Hernault Steven W., 1997, Cold Spring Harbor Monograph Series, V33, P271; LHERNAULT SW, 1988, GENETICS, V120, P435; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; Machaca K, 1996, DEV BIOL, V176, P1, DOI 10.1006/dbio.1996.9999; Minniti AN, 1996, GENETICS, V143, P213; Muhlrad PJ, 2002, GENETICS, V161, P143; Muhlrad PJ, 2001, THESIS U ARIZONA TUC; Nance J, 1999, GENETICS, V152, P209; Nance J, 2000, GENETICS, V156, P1623; Neill AT, 2004, REPRODUCTION, V127, P141, DOI 10.1530/rep.1.00085; NELSON GA, 1980, CELL, V19, P457, DOI 10.1016/0092-8674(80)90520-6; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; ROBERTS TM, 1986, J CELL BIOL, V102, P1787, DOI 10.1083/jcb.102.5.1787; ROBERTS TM, 1982, J CELL BIOL, V92, P113, DOI 10.1083/jcb.92.1.113; Sadler PL, 2000, DEVELOPMENT, V127, P355; SCHACKMANN RW, 1981, DEV BIOL, V81, P145, DOI 10.1016/0012-1606(81)90357-2; SEPSENWOL S, 1989, J CELL BIOL, V108, P55, DOI 10.1083/jcb.108.1.55; SHAKES DC, 1989, DEV BIOL, V134, P189, DOI 10.1016/0012-1606(89)90088-2; Smith JR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002375; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Stanfield GM, 2006, CURR BIOL, V16, P252, DOI 10.1016/j.cub.2005.12.041; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; VARKEY JP, 1993, GENETICS, V133, P79; Veljkovic E, 2004, J BIOL CHEM, V279, P49268, DOI 10.1074/jbc.M404470200; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	53	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57266	10.1371/journal.pone.0057266	http://dx.doi.org/10.1371/journal.pone.0057266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483899	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100017
J	Ricciardi, E; Handjaras, G; Bonino, D; Vecchi, T; Fadiga, L; Pietrini, P				Ricciardi, Emiliano; Handjaras, Giacomo; Bonino, Daniela; Vecchi, Tomaso; Fadiga, Luciano; Pietrini, Pietro			Beyond Motor Scheme: A Supramodal Distributed Representation in the Action-Observation Network	PLOS ONE			English	Article							PREMOTOR CORTEX; MIRROR NEURONS; CLASSIFICATION; SELECTION; PARIETAL; BLINDNESS; PATTERNS; REVEALS; IMAGERY; VISION	The representation of actions within the action-observation network is thought to rely on a distributed functional organization. Furthermore, recent findings indicate that the action-observation network encodes not merely the observed motor act, but rather a representation that is independent from a specific sensory modality or sensory experience. In the present study, we wished to determine to what extent this distributed and 'more abstract' representation of action is truly supramodal, i.e. shares a common coding across sensory modalities. To this aim, a pattern recognition approach was employed to analyze neural responses in sighted and congenitally blind subjects during visual and/or auditory presentation of hand-made actions. Multivoxel pattern analyses-based classifiers discriminated action from non-action stimuli across sensory conditions (visual and auditory) and experimental groups (blind and sighted). Moreover, these classifiers labeled as 'action' the pattern of neural responses evoked during actual motor execution. Interestingly, discriminative information for the action/non action classification was located in a bilateral, but left-prevalent, network that strongly overlaps with brain regions known to form the action-observation network and the human mirror system. The ability to identify action features with a multivoxel pattern analyses-based classifier in both sighted and blind individuals and independently from the sensory modality conveying the stimuli clearly supports the hypothesis of a supramodal, distributed functional representation of actions, mainly within the action-observation network.	[Ricciardi, Emiliano; Handjaras, Giacomo; Bonino, Daniela; Pietrini, Pietro] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Lab Clin Biochem & Mol Biol, Pisa, Italy; [Ricciardi, Emiliano] CNR, Fdn G Monasterio Reg Toscana, MRI Lab, I-56100 Pisa, Italy; [Vecchi, Tomaso] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy; [Vecchi, Tomaso] IRCCS Mondino, Brain Connect Ctr, Pavia, Italy; [Fadiga, Luciano] Univ Ferrara, Sect Human Physiol, I-44100 Ferrara, Italy; [Fadiga, Luciano] Italian Inst Technol, RBCS Dept, Genoa, Italy; [Pietrini, Pietro] Pisa Univ Hosp, Clin Psychol Branch, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); University of Pavia; IRCCS Fondazione Casimiro Mondino; University of Ferrara; Istituto Italiano di Tecnologia - IIT; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Ricciardi, E (corresponding author), Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Lab Clin Biochem & Mol Biol, Pisa, Italy.	emiliano.ricciardi@bioclinica.unipi.it	Fadiga, Luciano/AAC-7404-2022; Pietrini, Pietro/Z-4202-2019; Ricciardi, Emiliano/E-6929-2011	Ricciardi, Emiliano/0000-0002-7178-9534; Handjaras, Giacomo/0000-0001-5677-8434; Pietrini, Pietro/0000-0002-6768-5556; fadiga, luciano/0000-0001-5691-5080	European Union; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca; University of Pisa-Faculty of Medicine; Strategic Project Region-University; 'Poeticon++'	European Union(European Commission); Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Pisa-Faculty of Medicine; Strategic Project Region-University; 'Poeticon++'	This work was supported by European Union Grants 'THE: The Hand Embodied' to E. R. and P. P. and 'Poeticon++' to L.F., by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca grant to P.P., by the Young Investigator Award of the University of Pisa-Faculty of Medicine to E.R. and by the Strategic Project Region-University to L.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; Cattaneo L, 2010, CEREB CORTEX, V20, P2252, DOI 10.1093/cercor/bhp291; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Dinstein I, 2008, J NEUROSCI, V28, P11231, DOI 10.1523/JNEUROSCI.3585-08.2008; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Joachims T., 1999, MAKING LARGE SCALE S; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kupers R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00019; Lewis JW, 2011, HUM BRAIN MAPP, V32, P2241, DOI 10.1002/hbm.21185; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lowry R., 1999, CONCEPTS APPL INFERE; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Molenberghs P, 2012, NEUROIMAGE, V59, P608, DOI 10.1016/j.neuroimage.2011.07.080; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Oosterhof NN, 2012, NEUROIMAGE, V63, P262, DOI 10.1016/j.neuroimage.2012.06.045; Oosterhof NN, 2012, J COGNITIVE NEUROSCI, V24, P975, DOI 10.1162/jocn_a_00195; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Ricciardi E, 2011, CURR OPIN NEUROL, V24, P357, DOI 10.1097/WCO.0b013e328348bdbf; Ricciardi E, 2009, J NEUROSCI, V29, P9719, DOI 10.1523/JNEUROSCI.0274-09.2009; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Scholkopf B., 1999, ADV KERNEL METHODS S; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; TAILAIRACH J, 1988, COPLANAR STEREOTAXIC	47	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58632	10.1371/journal.pone.0058632	http://dx.doi.org/10.1371/journal.pone.0058632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472216	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000315637900162
J	Wang, XJ; Wang, JZ; Su, M; Wang, CX; Chen, JZ; Wang, H; Song, L; Zou, YB; Zhang, LF; Zhang, YY; Hui, RT				Wang, Xiaojian; Wang, Jizheng; Su, Ming; Wang, Changxin; Chen, Jingzhou; Wang, Hu; Song, Lei; Zou, Yubao; Zhang, Lianfeng; Zhang, Youyi; Hui, Rutai			TNNI3K, a Cardiac-Specific Kinase, Promotes Physiological Cardiac Hypertrophy in Transgenic Mice	PLOS ONE			English	Article							TROPONIN-I PHOSPHORYLATION; PROTEIN-C PHOSPHORYLATION; HUMAN HEART-MUSCLE; FAILURE; BINDING; OVEREXPRESSION; CARDIOMYOCYTES; EXPRESSION; GENE	Purpose: Protein kinase plays an essential role in controlling cardiac growth and hypertrophic remodeling. The cardiac troponin I-interacting kinase (TNNI3K), a novel cardiac specific kinase, is associated with cardiomyocyte hypertrophy. However, the precise function of TNNI3K in regulating cardiac remodeling has remained controversial. Methods and Results: In a rat model of cardiac hypertrophy generated by transverse aortic constriction, myocardial TNNI3K expression was significantly increased by 1.62 folds (P<0.05) after constriction for 15 days. To investigate the role of TNNI3K in cardiac hypertrophy, we generated transgenic mouse lines with overexpression of human TNNI3K specifically in the heart. At the age of 3 months, the high-copy-number TNNI3K transgenic mice demonstrated a phenotype of concentric hypertrophy with increased heart weight normalized to body weight (1.31 fold, P<0.01). Echocardiography and non-invasive hemodynamic assessments showed enhanced cardiac function. No necrosis or myocyte disarray was observed in the heart of TNNI3K transgenic mice. This concentric hypertrophy maintained up to 12 months of age without cardiac dysfunction. The phospho amino acid analysis revealed that TNNI3K is a protein-tyrosine kinase. The yeast two-hybrid screen and co-immunoprecipitation assay identified cTnI as a target for TNNI3K. Moreover, TNNI3K overexpression induced cTnI phosphorylation at Ser22/Ser23 in vivo and in vitro, suggesting that TNNI3K is a novel upstream regulator for cTnI phosphorylation. Conclusion: TNNI3K promotes a concentric hypertrophy with enhancement of cardiac function via regulating the phosphorylation of cTnI. TNNI3K could be a potential therapeutic target for preventing from heart failure.	[Wang, Xiaojian; Wang, Jizheng; Su, Ming; Wang, Changxin; Chen, Jingzhou; Wang, Hu; Hui, Rutai] Chinese Acad Med Sci, Peking Union Med Coll, FuWai Hosp, Sinogerman Lab Mol Med,State Key Lab Cardiovasc D, Beijing 100730, Peoples R China; [Wang, Xiaojian; Wang, Jizheng; Su, Ming; Wang, Changxin; Chen, Jingzhou; Wang, Hu; Song, Lei; Zou, Yubao; Hui, Rutai] Chinese Acad Med Sci, Peking Union Med Coll, Cardiovasc Inst, Beijing 100730, Peoples R China; [Song, Lei; Zou, Yubao] Chinese Acad Med Sci, Peking Union Med Coll, FuWai Hosp, Dept Cardiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100730, Peoples R China; [Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Zhang, Youyi] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Hui, RT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, FuWai Hosp, Sinogerman Lab Mol Med,State Key Lab Cardiovasc D, Beijing 100730, Peoples R China.	huirutai@sglab.org			Ministry of Science and Technology of China [2007DFC30340]; National Science and Technology Major Projects [2009ZX09501-026]; National Natural Science Foundation of China [30840041, 30700322]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China (2007DFC30340 to RTH); National Science and Technology Major Projects (2009ZX09501-026 to RTH); and the National Natural Science Foundation of China (30840041 to XJW, 30700322 to JZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Catalucci D, 2009, J BIOL CHEM, V284, P28180, DOI 10.1074/jbc.M109.036566; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Juan F, 2008, INT J CARDIOL, V128, P83, DOI 10.1016/j.ijcard.2008.03.006; Kooij V, 2010, J MOL CELL CARDIOL, V48, P954, DOI 10.1016/j.yjmcc.2010.01.002; Lai ZF, 2008, AM J PHYSIOL-HEART C, V295, pH708, DOI 10.1152/ajpheart.00252.2008; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Milano A, 2011, CIRCULATION, V124; Scruggs SB, 2011, ARCH BIOCHEM BIOPHYS, V510, P129, DOI 10.1016/j.abb.2011.02.013; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; VOROTNIKOV A V, 1988, Biokhimiya, V53, P31; Wang H, 2008, J CELL MOL MED, V12, P304, DOI 10.1111/j.1582-4934.2007.00155.x; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Wang L, 2011, CLIN EXP PHARMACOL P, V38, P278, DOI 10.1111/j.1440-1681.2011.05499.x; Wang XJ, 2010, CLIN SCI, V118, P137, DOI 10.1042/CS20080637; Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010; Wheeler FC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000647; Wiltshire SA, 2011, J IMMUNOL, V186, P6398, DOI 10.4049/jimmunol.1100159; Zhao Y, 2003, J MOL MED-JMM, V81, P297, DOI 10.1007/s00109-003-0427-x	33	8	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58570	10.1371/journal.pone.0058570	http://dx.doi.org/10.1371/journal.pone.0058570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472207	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900153
J	Dowling, DJ; Tan, Z; Prokopowicz, ZM; Palmer, CD; Matthews, MAH; Dietsch, GN; Hershberg, RM; Levy, O				Dowling, David J.; Tan, Zhen; Prokopowicz, Zofia M.; Palmer, Christine D.; Matthews, Maura-Ann H.; Dietsch, Gregory N.; Hershberg, Robert M.; Levy, Ofer			The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes	PLOS ONE			English	Article							YELLOW-FEVER VACCINE; TOLL-LIKE RECEPTORS; T-CELL RESPONSES; INNATE IMMUNITY; CYTOKINE RESPONSES; BASIC MECHANISMS; DISTINCT; EXPRESSION; ADJUVANTS; EFFICACY	Background: Newborns display distinct immune responses that contribute to susceptibility to infection and reduced vaccine responses. Toll-like receptor (TLR) agonists may serve as vaccine adjuvants, when given individually or in combination, but responses of neonatal leukocytes to many TLR agonists are diminished. TLR8 agonists are more effective than other TLR agonists in activating human neonatal leukocytes in vitro, but little is known about whether different TLR8 agonists may distinctly activate neonatal leukocytes. We characterized the in vitro immuno-stimulatory activities of a novel benzazepine TLR8 agonist, VTX-294, in comparison to imidazoquinolines that activate TLR8 (R-848; (TLR7/8) CL075; (TLR8/7)), with respect to activation of human newborn and adult leukocytes. Effects of VTX-294 and R-848 in combination with monophosphoryl lipid A (MPLA; TLR4) were also assessed. Methods: TLR agonist specificity was assessed using TLR-transfected HEK293 cells expressing a NF-kappa B reporter gene. TLR agonist-induced cytokine production was measured in human newborn cord and adult peripheral blood using ELISA and multiplex assays. Newborn and adult monocytes were differentiated into monocyte-derived dendritic cells (MoDCs) and TLR agonist-induced activation assessed by cytokine production (ELISA) and co-stimulatory molecule expression (flow cytometry). Results: VTX-294 was similar to 100x more active on TLR8-than TLR7-transfected HEK cells (EC50, similar to 50 nM vs. similar to 5700 nM). VTX-294-induced TNF and IL-1 beta production were comparable in newborn cord and adult peripheral blood, while VTX-294 was similar to 1 log more potent in inducing TNF and IL-1 beta production than MPLA, R848 or CL075. Combination of VTX-294 and MPLA induced greater blood TNF and IL-1 beta responses than combination of R-848 and MPLA. VTX-294 also potently induced expression of cytokines and co-stimulatory molecules HLA-DR and CD86 in human newborn MoDCs. Conclusions: VTX-294 is a novel ultra-potent TLR8 agonist that activates newborn and adult leukocytes and is a candidate vaccine adjuvant in both early life and adulthood.	[Dowling, David J.; Tan, Zhen; Prokopowicz, Zofia M.; Palmer, Christine D.; Levy, Ofer] Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA USA; [Dowling, David J.; Tan, Zhen; Prokopowicz, Zofia M.; Palmer, Christine D.; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Tan, Zhen] Shanghai Jiao Tong Univ, Div Pediat, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Matthews, Maura-Ann H.; Dietsch, Gregory N.; Hershberg, Robert M.] VentiRx Pharmaceut Inc, Seattle, WA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Shanghai Jiao Tong University	Levy, O (corresponding author), Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA USA.	ofer.levy@childrens.harvard.edu	Palmer, Christine/GXH-4415-2022	Dowling, David/0000-0003-1095-6156; Levy, Ofer/0000-0002-5859-1945; Palmer, Christine Denise/0000-0003-3213-0398	VentiRx Pharmaceuticals; National Institutes of Health [RO1 AI067353-01A1, 3R01AI067353-05S1]; Global Health Awards from Bill & Melinda Gates Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067353, R01AI100135] Funding Source: NIH RePORTER	VentiRx Pharmaceuticals; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Health Awards from Bill & Melinda Gates Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by sponsored research support from VentiRx Pharmaceuticals. OL's laboratory is supported by grants from National Institutes of Health grants RO1 AI067353-01A1 and Administrative Supplement 3R01AI067353-05S1 as well as a Global Health Awards from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; [Anonymous], 2012, N ENGL J MED; Bowen RS, 2005, J SOC GYNECOL INVEST, V12, P428, DOI 10.1016/j.jsgi.2005.04.001; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coombs MRP, 2011, EXPERT REV ANTI-INFE, V9, P261, DOI [10.1586/eri.10.158, 10.1586/ERI.10.158]; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Dasari P, 2011, PEDIAT ALLERG IMM-UK, V22, P221, DOI 10.1111/j.1399-3038.2010.01091.x; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Demirjian A, 2009, EUR J IMMUNOL, V39, P36, DOI 10.1002/eji.200838620; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Embry CA, 2011, SCI SIGNAL, V4, P20, DOI 10.1126/scisignal.2001486; Ghosh TK, 2007, INT IMMUNOPHARMACOL, V7, P1111, DOI 10.1016/j.intimp.2007.04.006; Ghosh TK, 2006, CELL IMMUNOL, V243, P48, DOI 10.1016/j.cellimm.2006.12.002; Godaly G, 2005, CELL MICROBIOL, V7, P591, DOI 10.1111/j.1462-5822.2004.00489.x; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hood JD, 2010, HUM VACCINES, V6, P322, DOI 10.4161/hv.6.4.10866; Horak F, 2011, EXPERT OPIN INV DRUG, V20, P981, DOI 10.1517/13543784.2011.583237; Howbert JJ, 2010, METHODS SYNTHESIS BE; Itoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028500; Jacobson KA, 2000, J BIOL CHEM, V275, P30272, DOI 10.1074/jbc.M001520200; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579; Lavoie PM, 2010, J INFECT DIS, V202, P1754, DOI 10.1086/657143; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O., 2012, VACCINE; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lu H, 2011, CLIN CANC RES; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Ma YF, 2010, IMMUNOLOGY, V130, P374, DOI 10.1111/j.1365-2567.2009.03237.x; Marodi L, 2006, CLIN IMMUNOL, V118, P137, DOI 10.1016/j.clim.2005.10.012; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; NAGASHIMA K, 1986, BIOL NEONATE, V49, P307; Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; Philbin VJ, 2012, J ALLERGY CLIN IMMUN; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Schwarz H, 2012, IMMUNOBIOLOGY; Shi C, 2012, ACS MED CHEM LETT, V3, P501, DOI 10.1021/ml300079e; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Smirnov D, 2011, VACCINE, V29, P5434, DOI 10.1016/j.vaccine.2011.05.061; Tomai MA, 2011, EXPERT REV VACCINES, V10, P405, DOI [10.1586/erv.11.26, 10.1586/ERV.11.26]; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van den Biggelaar AHJ, 2009, VACCINE, V27, P1340, DOI 10.1016/j.vaccine.2008.12.046; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	62	51	53	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58164	10.1371/journal.pone.0058164	http://dx.doi.org/10.1371/journal.pone.0058164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483986	Green Published, Green Submitted, gold			2022-12-25	WOS:000315634900073
J	Kendellen, MF; Bradford, JW; Lawrence, CL; Clark, KS; Baldwin, AS				Kendellen, M. F.; Bradford, J. W.; Lawrence, C. L.; Clark, K. S.; Baldwin, A. S.			Canonical and non-canonical NF-kappa B signaling promotes breast cancer tumor-initiating cells	ONCOGENE			English	Article						NF-kappa B; basal-like breast cancer; tumor-initiating cells; EMT; IL-6; IL-1 beta	EPITHELIAL-MESENCHYMAL TRANSITION; STEM-LIKE CELLS; KINASE-BETA; PROGRESSION; METASTASIS; ACTIVATION; CHEMOTHERAPY; RESISTANCE; INHIBITOR; RADIATION	Tumor-initiating cells (TICs) are a sub-population of cells that exhibit a robust ability to self-renew and contribute to the formation of primary tumors, the relapse of previously treated tumors and the development of metastases. TICs have been identified in various tumors including those of the breast, and are particularly enriched in the basal-like and claudin-low subtypes of breast cancer. The signaling pathways that contribute to the function and maintenance of TlCs are under intense study. We explored the potential involvement of the nuclear factor-kappa B (NF-kappa B) family of transcription factors in TICs in cell lines that are representative of basal-like and claudin-low breast cancer. NF-kappa B was found to be activated in breast cancer cells that form tumorspheres efficiently. Moreover, both canonical and non-canonical NF-kappa B signaling is required for these cells to self-renew in vitro and to form xenograft tumors efficiently in vivo using limiting dilutions of cells. Consistent with this fact, canonical and non-canonical NF-kappa B signaling is activated in TICs isolated from breast cancer cell lines. Experimental results indicate that NF-kappa B promotes the function of TICs by stimulating epithelial-to-mesenchymal transition and by upregulating the expression of the inflammatory cytokines interleukin-1 beta and interleukin-6. The results suggest the use of NE-a inhibitors for clinical therapy of certain breast cancers.	[Kendellen, M. F.; Bradford, J. W.; Lawrence, C. L.; Clark, K. S.; Baldwin, A. S.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baldwin, AS (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	abaldwin@med.unc.edu			T32 National Research Service Award [5-T32-CA009156-37]; F32 National Research Service Award from the National Institutes of Health [1F32CA153439-01, 1F32CA162628-01]; American Cancer Society [120296-PF-11-093-01-DDC]; National Cancer Institute [CA138937, CA73756]; Department of Defense [BC073048]; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA075080, F32CA162628, T32CA009156, R01CA138937, R01CA073756, F32CA153439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035098] Funding Source: NIH RePORTER	T32 National Research Service Award; F32 National Research Service Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank members of the Baldwin lab for helpful discussions and comments. MFK and JWB were supported by a T32 National Research Service Award (5-T32-CA009156-37) awarded to the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. MFK was also supported by an F32 National Research Service Award (1F32CA153439-01) from the National Institutes of Health and a post-doctoral Fellowship from the American Cancer Society (120296-PF-11-093-01-DDC). JWB was also supported by an F32 National Research Service Award (1F32CA162628-01) from the National Institutes of Health. Research support was provided by National Cancer Institute, grants CA138937 and CA73756, and by Department of Defense grant BC073048. Additional research support was provided by the Samuel Waxman Cancer Research Foundation.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Charafe-Jauffret E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-202; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Hambardzumyan D, 2006, CANCER CELL, V10, P454, DOI 10.1016/j.ccr.2006.11.008; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnstone PAS, 2002, CURR PROB CANCER, V26, P282, DOI 10.1067/mcn.2002.129997; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lawson JC, 2009, BREAST CANCER RES TR, V118, P241, DOI 10.1007/s10549-009-0524-9; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Nakshatri H, 2009, CURR STEM CELL RES T, V4, P50, DOI 10.2174/157488809787169110; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	56	83	83	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1297	1305		10.1038/onc.2013.64	http://dx.doi.org/10.1038/onc.2013.64			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23474754	Green Submitted, Green Accepted			2022-12-25	WOS:000332631100010
J	Holmquist, E; Okroj, M; Nodin, B; Jirstrom, K; Blom, AM				Holmquist, Emelie; Okroj, Marcin; Nodin, Bjorn; Jirstrom, Karin; Blom, Anna M.			Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase	FASEB JOURNAL			English	Article						innate immunity; CCP domain	SARCOMA-ASSOCIATED HERPESVIRUS; C4B-BINDING PROTEIN; PLASMA-PROTEINS; SYSTEM; PURIFICATION; EXPRESSION	Recently discovered Sushi domain-containing protein 4 (SUSD4) contains several Sushi or complement control protein domains; therefore, we hypothesized that it may act as complement inhibitor. Two isoforms of human SUSD4, fused to the Fc part of human IgG, were recombinantly expressed in Chinese hamster ovary (CHO) cells. The secreted soluble isoform of SUSD4 (SUSD4b) inhibited the classical and lectin complement pathways by 50% at a concentration of 0.5 mu M. This effect was due to the fact that 1 mu M SUSD4b inhibited the formation of the classical C3 convertase by 90%. The membrane-bound isoform (SUSD4a) inhibited the classical and alternative complement pathways when expressed on the surface of CHO cells but not when expressed as a soluble, truncated protein. In all functional studies, we used known complement inhibitors as positive controls, while Coxsackie adenovirus receptor, which has no effect on complement, expressed with Fc tag, was a negative control. We also studied the mRNA expression of both isoforms of SUSD4 in a panel of human tissues using quantitative PCR and primarily found SUSD4a in esophagus and brain, while SUSD4b was highly expressed in esophagus, ovary, and heart. Overall, our results show that SUSD4 is a novel complement inhibitor with restricted expression.-Holmquist, E., Okroj, M., Nodin, B., Jirstrom, K. Blom, A. M. Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.	[Holmquist, Emelie; Okroj, Marcin; Blom, Anna M.] Lund Univ, Dept Lab Med, Div Med Prot Chem, S-20502 Malmo, Sweden; [Nodin, Bjorn; Jirstrom, Karin] Lund Univ, Div Pathol, Dept Clin Sci, Lund, Sweden	Lund University; Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med Malmo, Skane Univ Hosp, Wallenberg Lab, Inga Maria Nilssons Gata 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; 	Cancerfonden, Swedish Research Council [K2012-66X-14928-09-5, K2010-80X-21514-01-4]; National Board of Health and Welfare; Foundation of Osterlund; Foundation of Crafoord; Foundation of Greta and Johan Kock; Foundation of Thelma Zoega; Foundation of Tore Nilsson; Foundation of King Gustav V's 80th anniversary; Skane University Hospital	Cancerfonden, Swedish Research Council(Swedish Research Council); National Board of Health and Welfare; Foundation of Osterlund; Foundation of Crafoord; Foundation of Greta and Johan Kock; Foundation of Thelma Zoega; Foundation of Tore Nilsson; Foundation of King Gustav V's 80th anniversary; Skane University Hospital	This work was supported by the Cancerfonden, Swedish Research Council (K2012-66X-14928-09-5 and K2010-80X-21514-01-4), National Board of Health and Welfare and the Foundations of Osterlund, Crafoord, Greta and Johan Kock, Thelma Zoega, Tore Nilsson, King Gustav V's 80th anniversary, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg, as well as a grant from the Skane University Hospital.	Cardone J, 2011, CLIN EXP IMMUNOL, V164, P301, DOI 10.1111/j.1365-2249.2011.04400.x; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; FEARON DT, 1975, NEW ENGL J MED, V292, P937, DOI 10.1056/NEJM197505012921802; FRYNS JP, 1987, J MED GENET, V24, P271, DOI 10.1136/jmg.24.5.271; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; LAURELL CB, 1983, J CHROMATOGR, V278, P53, DOI 10.1016/S0378-4347(00)84755-6; Lundwall A, 2002, MOL HUM REPROD, V8, P805, DOI 10.1093/molehr/8.9.805; Mark L, 2004, J BIOL CHEM, V279, P45093, DOI 10.1074/jbc.M407558200; Nilsson SC, 2011, MOL IMMUNOL, V48, P1611, DOI 10.1016/j.molimm.2011.04.004; Nodin B, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-14; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Okroj M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047245; Okroj M, 2012, J BIOL CHEM, V287, P20100, DOI 10.1074/jbc.M111.324913; Okroj M, 2009, J BIOL CHEM, V284, P505, DOI 10.1074/jbc.M806669200; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Shaffer LG, 2007, GENET MED, V9, P607, DOI 10.1097/GIM.0b013e3181484b49; Spiller OB, 2006, J VIROL, V80, P4068, DOI 10.1128/JVI.80.8.4068-4078.2006; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Spiller OB, 2003, J VIROL, V77, P592, DOI 10.1128/JVI.77.1.592-599.2003; Sun SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026838; TENNER AJ, 1981, J IMMUNOL, V127, P648; Thurman JM, 2011, LAB INVEST, V91, P4, DOI 10.1038/labinvest.2010.173; Tu ZD, 2010, AM J PATHOL, V176, P2378, DOI 10.2353/ajpath.2010.091036; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	27	23	25	0	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2355	2366		10.1096/fj.12-222042	http://dx.doi.org/10.1096/fj.12-222042			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23482636				2022-12-25	WOS:000319667600024
J	Seol, Y; Gentry, AC; Osheroff, N; Neuman, KC				Seol, Yeonee; Gentry, Amanda C.; Osheroff, Neil; Neuman, Keir C.			Chiral Discrimination and Writhe-dependent Relaxation Mechanism of Human Topoisomerase II alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; SINGLE-MOLECULE MEASUREMENTS; POSITIVELY SUPERCOILED DNA; MAGNETIC TWEEZERS; IN-VITRO; ATP; TOPOLOGY; ENZYME; IV; DECATENATION	Type IIA topoisomerases (Topo IIA) are essential enzymes that relax DNA supercoils and remove links joining replicated chromosomes. Human topoisomerase II alpha (htopo II alpha), one of two human isoforms, preferentially relaxes positive supercoils, a feature shared with Escherichia coli topoisomerase IV (Topo IV). The mechanistic basis of this chiral discrimination remains unresolved. To address this important issue, we measured the relaxation of individual supercoiled and "braided" DNA molecules by htopo II alpha using a magnetic tweezers-based single-molecule assay. Our study confirmed the chiral discrimination activity of htopo II alpha and revealed that the strand passage rate depends on DNA twist, tension on the DNA, and the C-terminal domain (CTD). Similar to Topo IV, chiral discrimination by htopo II alpha results from chiral interactions of the CTDs with DNA writhe. In contrast to Topo IV, however, these interactions lead to chiral differences in relaxation rate rather than processivity. Increasing tension or twist disrupts the CTD-DNA interactions with a subsequent loss of chiral discrimination. Together, these results suggest that transfer segment (T-segment) capture is the rate-limiting step in the strand passage cycle. We propose a model for T-segment capture that provides a mechanistic basis for chiral discrimination and provides a coherent explanation for the effects of DNA twist and tension on eukaryotic type IIA topoisomerases.	[Seol, Yeonee; Neuman, Keir C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Gentry, Amanda C.; Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Gentry, Amanda C.; Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vanderbilt University; Vanderbilt University	Neuman, KC (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA.	neumankc@mail.nih.gov	Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671	National Heart, Lung, and Blood Institute, National Institutes of Health; National Institutes of Health [GM033944, 5 T32 CA09582]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by the Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health (to K. C. N.) and by extramural National Institutes of Health Grant GM033944 (to N. O.); Recipient of National Institutes of Health Trainee Grant 5 T32 CA09582.	Adachi N, 1997, NUCLEIC ACIDS RES, V25, P3135, DOI 10.1093/nar/25.15.3135; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Baird CL, 2001, J BIOL CHEM, V276, P27893, DOI 10.1074/jbc.M102544200; Bates A. D., 2005, DNA TOPOLOGY; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Charvin G, 2005, BIOPHYS J, V88, P4124, DOI 10.1529/biophysj.104.056945; Charvin G, 2005, ANNU REV BIOPH BIOM, V34, P201, DOI 10.1146/annurev.biophys.34.040204.144433; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21328; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Jensen S, 1996, MOL CELL BIOL, V16, P3866; Kingma PS, 1997, BIOCHEMISTRY-US, V36, P5934, DOI 10.1021/bi970507v; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Marko JF, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021926; McClendon AK, 2008, BIOCHEMISTRY-US, V47, P13169, DOI 10.1021/bi800453h; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; Mirski SEL, 1997, EXP CELL RES, V237, P452, DOI 10.1006/excr.1997.3805; Mueller-Planitz F, 2006, J BIOL CHEM, V281, P23395, DOI 10.1074/jbc.M604119200; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; Neuman KC, 2005, J PHYS-CONDENS MAT, V17, pS3811, DOI 10.1088/0953-8984/17/47/012; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Neuman KC, 2010, J BIOL CHEM, V285, P18967, DOI 10.1074/jbc.R109.092437; Ramamoorthy M, 2012, NUCLEIC ACIDS RES, V40, P1621, DOI 10.1093/nar/gkr844; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Roca J, 1996, GENES CELLS, V1, P17, DOI 10.1046/j.1365-2443.1996.01001.x; Roca J, 2011, CHROMOSOMA, V120, P323, DOI 10.1007/s00412-011-0324-y; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Seol Y, 2011, METHODS MOL BIOL, V783, P265, DOI 10.1007/978-1-61779-282-3_15; Seol Y, 2011, METHODS MOL BIOL, V778, P229, DOI 10.1007/978-1-61779-261-8_15; Stone MD, 2003, P NATL ACAD SCI USA, V100, P8654, DOI 10.1073/pnas.1133178100; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Timsit Y, 2011, NUCLEIC ACIDS RES, V39, P8665, DOI 10.1093/nar/gkr556; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Tretter EM, 2010, P NATL ACAD SCI USA, V107, P22055, DOI 10.1073/pnas.1012938107; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 2009, UNTANGLING DOUBLE HE; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Yogo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034920	50	20	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13695	13703		10.1074/jbc.M112.444745	http://dx.doi.org/10.1074/jbc.M112.444745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23508957	Green Published, hybrid			2022-12-25	WOS:000318850300052
J	Prowse, PDH; Elliott, CG; Hutter, J; Hamilton, DW				Prowse, Paul D. H.; Elliott, Christopher G.; Hutter, Jeff; Hamilton, Douglas W.			Inhibition of Rac and ROCK Signalling Influence Osteoblast Adhesion, Differentiation and Mineralization on Titanium Topographies	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACTIN STRESS FIBERS; DENTAL IMPLANTS; CYTOSKELETAL ORGANIZATION; NANOSCALE TOPOGRAPHY; SURFACE-ENERGY; RHO GTPASES; ACTIVATION; EXPRESSION; KINASE	Reducing the time required for initial integration of bone-contacting implants with host tissues would be of great clinical significance. Changes in osteoblast adhesion formation and reorganization of the F-actin cytoskeleton in response to altered topography are known to be upstream of osteoblast differentiation, and these processes are regulated by the Rho GTPases. Rac and RhoA (through Rho Kinase (ROCK)). Using pharmacological inhibitors, we tested how inhibition of Rac and ROCK influenced osteoblast adhesion, differentiation and mineralization on PT (Pre-treated) and SLA (sandblasted large grit, acid etched) topographies. Inhibition of ROCK, but not Rac, significantly reduced adhesion number and size on PT, with adhesion size consistent with focal complexes. After 1 day, ROCK, but not Rac inhibition increased osteocalcin mRNA levels on SLA and PT, with levels further increasing at 7 days post seeding. ROCK inhibition also significantly increased bone sialoprotein expression at 7 days, but not BMP-2 levels. Rac inhibition significantly reduced BMP-2 mRNA levels. ROCK inhibition increased nuclear translocation of Runx2 independent of surface roughness. Mineralization of osteoblast cultures was greater on SLA than on PT, but was increased by ROCK inhibition and attenuated by Rac inhibition on both topographies. In conclusion, inhibition of ROCK signalling significantly increases osteoblast differentiation and biomineralization in a topographic dependent manner, and its pharmacological inhibition could represent a new therapeutic to speed bone formation around implanted metals and in regenerative medicine applications.	[Prowse, Paul D. H.; Hamilton, Douglas W.] Univ Western Ontario, Dept Anat, Grad Program Biomed Engn, London, ON, Canada; [Elliott, Christopher G.; Hamilton, Douglas W.] Univ Western Ontario, Dept Cell Biol, Grad Program Biomed Engn, London, ON, Canada; [Hutter, Jeff] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Hamilton, Douglas W.] Univ Western Ontario, Div Oral Biol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Hamilton, DW (corresponding author), Univ Western Ontario, Dept Anat, Grad Program Biomed Engn, London, ON, Canada.	dhamil2@uwo.ca	Hamilton, Douglas W/L-8932-2015	Hamilton, Douglas W/0000-0002-9798-5197	Canadian Foundation for Innovation Leaders Opportunity Fund [18742]; Natural Sciences and Engineering Research Council of Canada [355615-2009]; Ontario Ministry of Research and Innovation Early Researcher Award; Joint Motion Program(JuMP) - A CIHR Training Program in Musculoskeletal Health Research and Leadership	Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Innovation Early Researcher Award(Ministry of Research and Innovation, Ontario); Joint Motion Program(JuMP) - A CIHR Training Program in Musculoskeletal Health Research and Leadership(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Foundation for Innovation Leaders Opportunity Fund(Grant no: 18742) and the Natural Sciences and Engineering Research Council of Canada(Grant Number: 355615-2009) to DWH. DWH is a recipient of the Ontario Ministry of Research and Innovation Early Researcher Award. This work was also supported by the Joint Motion Program(JuMP) - A CIHR Training Program in Musculoskeletal Health Research and Leadership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RDAM, 2010, J PROTEOME RES, V9, P4688, DOI 10.1021/pr100400d; Anselme K, 2004, BIO-MED MATER ENG, V14, P545; Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Berenjeno IM, 2008, CLIN TRANSL ONCOL, V10, P726, DOI 10.1007/s12094-008-0279-5; Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035; Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6; Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196; Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P1034, DOI 10.1111/j.1600-0501.2008.01573.x; Bornstein MM, 2005, CLIN ORAL IMPLAN RES, V16, P631, DOI 10.1111/j.1600-0501.2005.01209.x; Chen NX, 2010, AM J PHYSIOL-RENAL, V299, pF674, DOI 10.1152/ajprenal.00730.2009; de Vicente JC, 2006, INT J ORAL MAX SURG, V35, P1047, DOI 10.1016/j.ijom.2006.06.008; Elias BC, 2010, CELL ADHES MIGR, V4, P419, DOI 10.4161/cam.4.3.12043; Galli C, 2012, ACTA BIOMATER, V8, P2963, DOI 10.1016/j.actbio.2012.04.043; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamamura K, 2012, CONNECT TISSUE RES; Hamilton DW, 2006, CALCIFIED TISSUE INT, V78, P314, DOI 10.1007/s00223-005-0238-x; Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041; Harmey D, 2004, J BONE MINER RES, V19, P661, DOI 10.1359/JBMR.040105; Higuchi C, 2009, J BONE MINER METAB, V27, P158, DOI 10.1007/s00774-009-0037-y; Javed F, 2011, IMPLANT DENT, V20, P40, DOI 10.1097/ID.0b013e31820867da; Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013; Jung UW, 2008, J PERIODONTOL, V79, P1857, DOI [10.1902/jop.2008.070632, 10.1902/jop.2008.070632 ]; Kanazawa I, 2010, ENDOCR J, V57, P415, DOI 10.1507/endocrj.K09E-328; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Koh RU, 2010, IMPLANT DENT, V19, P98, DOI 10.1097/ID.0b013e3181d47eaf; Lai HC, 2010, J BIOMED MATER RES A, V93A, P289, DOI 10.1002/jbm.a.32542; Lamers E, 2010, EUR CELLS MATER, V20, P329; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lethaus B, 2011, INT J ORAL MAX IMPL, V26, P887; Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; Neto PT, 2004, QUINTESSENCE INT, V35, P717; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olivares-Navarrete R, 2011, BIOMATERIALS, V32, P6399, DOI 10.1016/j.biomaterials.2011.05.036; PARR GR, 1985, J PROSTHET DENT, V54, P410, DOI 10.1016/0022-3913(85)90562-1; Passeri G, 2010, CLIN ORAL IMPLAN RES, V21, P756, DOI 10.1111/j.1600-0501.2009.01906.x; Qu J, 1996, Oral Dis, V2, P102; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Schwarz F, 2007, J PERIODONTOL, V78, P2171, DOI 10.1902/jop.2007.070157; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; Wieland M, 2005, BIOMATERIALS, V26, P1119, DOI 10.1016/j.biomaterials.2004.04.020; Wieland M, 2001, INT J ORAL MAX IMPL, V16, P163; Yamanouchi K, 1997, J BONE MINER METAB, V15, P23, DOI DOI 10.1007/BF02439451; Yoshikawa H, 2009, CLIN ORTHOP RELAT R, V467, P3087, DOI 10.1007/s11999-009-0976-6; Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139; Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035	58	34	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58898	10.1371/journal.pone.0058898	http://dx.doi.org/10.1371/journal.pone.0058898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505566	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500131
J	Qin, GH; Jia, M; Liu, T; Zhang, XY; Guo, YP; Zhu, KY; Ma, EB; Zhang, JZ				Qin, Guohua; Jia, Miao; Liu, Ting; Zhang, Xueyao; Guo, Yaping; Zhu, Kun Yan; Ma, Enbo; Zhang, Jianzhen			Characterization and Functional Analysis of Four Glutathione S-Transferases from the Migratory Locust, Locusta migratoria	PLOS ONE			English	Article							2 FIELD POPULATIONS; HETEROLOGOUS EXPRESSION; EPSILON-CLASS; BIOCHEMICAL-CHARACTERIZATION; GENOMIC ORGANIZATION; MOLECULAR-CLONING; RAT-LIVER; IDENTIFICATION; MANILENSIS; RESISTANCE	Glutathione S-transferases (GSTs) play an important role in detoxification of xenobiotics in both prokaryotic and eukaryotic cells. In this study, four GSTs (LmGSTd1, LmGSTs5, LmGSTt1, and LmGSTu1) representing different classes were identified from the migratory locust, Locusta migratoria. These four proteins were heterologously expressed in Escherichia coli as soluble fusion proteins, purified by Ni2+-nitrilotriacetic acid agarose column and biochemically characterized. LmGSTd1, LmGSTs5, and LmGSTu1 showed high activities with 1-chloro-2, 4-dinitrobenzene (CDNB), detectable activity with p-nitro-benzyl chloride (p-NBC) and 1, 2-dichloro-4-nitrobenzene (DCNB), whereas LmGSTt1 showed high activity with p-NBC and detectable activity with CDNB. The optimal pH of the locust GSTs ranged between 7.0 to 9.0. Ethacrynic acid and reactive blue effectively inhibited all four GSTs. LmGSTs5 was most sensitive to heavy metals (Cu2+ and Cd2+). The maximum expression of the four GSTs was observed in Malpighian tubules and fat bodies as evaluated by western blot. The nymph mortalities after carbaryl treatment increased by 28 and 12% after LmGSTs5 and LmGSTu1 were silenced, respectively. The nymph mortalities after malathion and chlorpyrifos treatments increased by 26 and 18% after LmGSTs5 and LmGSTu1 were silenced, respectively. These results suggest that sigma GSTs in L. migratoria play a significant role in carbaryl detoxification, whereas some of other GSTs may also involve in the detoxification of carbaryl and chlorpyrifos.	[Qin, Guohua; Jia, Miao; Liu, Ting; Zhang, Xueyao; Guo, Yaping; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi Province, Peoples R China; [Qin, Guohua] Shanxi Univ, Coll Environm Sci & Resources, Taiyuan, Shanxi Province, Peoples R China; [Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Shanxi University; Shanxi University; Kansas State University	Ma, EB (corresponding author), Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi Province, Peoples R China.	maenbo2003@sxu.edu.cn; zjz@sxu.edu.cn		Zhu, Kun Yan/0000-0001-9372-8030	National Natural Science Foundation of China [30810103907, 31172161, 21007036, 31101463]; Natural Science Foundation of Shanxi Province [2011011033-1, 2012011036-6]; Public Welfare Fund for Agriculture [200903021]; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi [20120303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Public Welfare Fund for Agriculture; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	This research was supported by the National Natural Science Foundation of China (International Cooperation and Exchange Program, Grant number 30810103907; Regular Research Program, Grant number 31172161, 21007036, 31101463), the Natural Science Foundation of Shanxi Province (Grant number 2011011033-1, 2012011036-6), the Public Welfare Fund for Agriculture (Grant number 200903021), and Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi (Grant number 20120303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWASTHI S, 1993, BIOCHIM BIOPHYS ACTA, V1164, P173, DOI 10.1016/0167-4838(93)90245-M; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTIE NT, 1984, BIOL TRACE ELEM RES, V6, P139, DOI 10.1007/BF02916931; CLARK AG, 1989, COMP BIOCHEM PHYS B, V92, P419, DOI 10.1016/0305-0491(89)90114-4; CLARK AG, 1984, PESTIC BIOCHEM PHYS, V22, P249, DOI 10.1016/0048-3575(84)90018-X; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Deng HM, 2009, J INSECT PHYSIOL, V55, P1174, DOI 10.1016/j.jinsphys.2009.08.017; DIERICKX PJ, 1982, ENZYME, V27, P25, DOI 10.1159/000459018; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Ferrari A, 2007, PESTIC BIOCHEM PHYS, V88, P134, DOI 10.1016/j.pestbp.2006.10.005; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; Fujioka K, 2007, CHEM RES TOXICOL, V20, P1211, DOI 10.1021/tx700133c; Gullipalli D, 2010, COMP BIOCHEM PHYS B, V156, P33, DOI 10.1016/j.cbpb.2010.01.016; Gunasekara AS, 2008, REV ENVIRON CONTAM T, V196, P95, DOI 10.1007/978-0-387-78444-1_4; HARRISON JF, 1994, PHYSIOL ZOOL, V67, P120, DOI 10.1086/physzool.67.1.30163838; He YP, 2004, PESTIC BIOCHEM PHYS, V78, P103, DOI 10.1016/j.pestbp.2003.09.009; Huang YF, 2011, J INSECT PHYSIOL, V57, P1033, DOI 10.1016/j.jinsphys.2011.05.001; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Jirajaroenrat K, 2001, INSECT BIOCHEM MOLEC, V31, P867, DOI 10.1016/S0965-1748(01)00032-7; Keeley L.L., 1985, P211; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lyubenova L, 2007, INT J PHYTOREMEDIAT, V9, P465, DOI 10.1080/15226510701709556; Ma EB, 2004, PESTIC BIOCHEM PHYS, V78, P67, DOI 10.1016/j.pestbp.2003.09.001; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Miyamoto T, 2005, J PESTIC SCI, V30, P31, DOI 10.1584/jpestics.30.31; Qin GH, 2012, J INSECT PHYSIOL, V58, P220, DOI 10.1016/j.jinsphys.2011.10.011; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Ranson H, 1997, BIOCHEM J, V324, P97, DOI 10.1042/bj3240097; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Rauch N, 2004, INSECT BIOCHEM MOLEC, V34, P321, DOI 10.1016/j.ibmb.2003.12.001; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Salazar-Medina AJ, 2010, J BIOCHEM MOL TOXIC, V24, P218, DOI 10.1002/jbt.20326; Samra AI, 2012, PEST MANAG SCI, V68, P764, DOI 10.1002/ps.2324; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; SERAFINI MT, 1991, BIOCHEM INT, V24, P497; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; TANG AH, 1994, J BIOL CHEM, V269, P27876; Udomsinprasert R, 2005, BIOCHEM J, V388, P763, DOI 10.1042/BJ20042015; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wang Y, 2012, PESTIC BIOCH PHYSL; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Yamamoto K, 2005, COMP BIOCHEM PHYS B, V141, P340, DOI 10.1016/j.cbpc.2005.04.012; Yamamoto K, 2007, BIOSCI BIOTECH BIOCH, V71, P553, DOI 10.1271/bbb.60592; Yang ML, 2008, PESTIC BIOCHEM PHYS, V91, P32, DOI 10.1016/j.pestbp.2007.12.004; Yong ML, 2009, ARCH INSECT BIOCHEM, V71, P3, DOI 10.1002/arch.20254; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Yu SJ, 2002, PESTIC BIOCHEM PHYS, V72, P100, DOI 10.1006/pest.2001.2585; Yu SJ, 2000, PESTIC BIOCHEM PHYS, V67, P36, DOI 10.1006/pest.1999.2472; Zou FM, 2011, MOL BIOL REP, V38, P639, DOI 10.1007/s11033-010-0150-y	53	58	64	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58410	10.1371/journal.pone.0058410	http://dx.doi.org/10.1371/journal.pone.0058410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505503	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500080
J	Sonthiphand, P; Neufeld, JD				Sonthiphand, Puntipar; Neufeld, Josh D.			Evaluating Primers for Profiling Anaerobic Ammonia Oxidizing Bacteria within Freshwater Environments	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-SITU DETECTION; ANAMMOX BACTERIA; OXIDATION ANAMMOX; MARINE-SEDIMENTS; BLACK-SEA; MOLECULAR-DETECTION; SEQUENCE ALIGNMENT; NITROGEN LOSS; DIVERSITY	Anaerobic ammonia oxidizing (anammox) bacteria play an important role in transforming ammonium to nitrogen gas and contribute to fixed nitrogen losses in freshwater environments. Understanding the diversity and abundance of anammox bacteria requires reliable molecular tools, and these are not yet well established for these important Planctomycetes. To help validate PCR primers for the detection of anammox bacteria within freshwater ecosystems, we analyzed representative positive controls and selected samples from Grand River and groundwater sites, both from Ontario, Canada. The objectives of this study were to identify a suitable anammox denaturing gradient gel electrophoresis (DGGE) fingerprint method by using GC-clamp modifications to existing primers, and to verify the specificity of anammox-specific primers used for DGGE, cloning and qPCR methods. Six primer combinations were tested from four published primer sets (i.e. A438f/A684r, Amx368f/Amx820r, An7f/An1388r, and Pla46/1392r) for both direct and nested PCR amplifications. All PCR products were run subsequently on DGGE gels to compare the resulting patterns. Two anammox-specific primer combinations were also used to generate clone libraries and quantify anammox bacterial 16S rRNA genes with qPCR. The primer set A438f/A684r was highly specific to anammox bacteria, provided reliable DGGE fingerprints and generated a high proportion of anammox-related clones. A second primer set (Amx368f/Amx820r) was anammox specific, based on clone library analysis, but PCR products from different candidate species of anammox bacteria resolved poorly using DGGE analysis. Both DGGE and cloning results revealed that Ca. Brocadia and an uncharacterized anammox bacterial cluster represented the majority of anammox bacteria found in Grand River sediment and groundwater samples, respectively. Together, our results demonstrate that although Amx368f/Amx820r was useful for anammox-specific qPCR and clone library analysis, A438f/A684r was the most suitable primer set for multiple molecular assessments of anammox bacteria in freshwater environments.	[Sonthiphand, Puntipar; Neufeld, Josh D.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Neufeld, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	jneufeld@uwaterloo.ca			National Science and Engineering Research Council of Canada (NSERC)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Strategic Projects Grant from the National Science and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2007, MICROBES ENVIRON, V22, P232, DOI 10.1264/jsme2.22.232; Bae H, 2010, PROCESS BIOCHEM, V45, P323, DOI 10.1016/j.procbio.2009.10.004; Brandsma J, 2011, ENV MICROBIOL REP, V3, P360, DOI 10.1111/j.1758-2229.2010.00233.x; BRODA E, 1977, Z ALLG MIKROBIOL, V17, P491, DOI 10.1002/jobm.3630170611; Dale OR, 2009, ENVIRON MICROBIOL, V11, P1194, DOI 10.1111/j.1462-2920.2008.01850.x; Dalsgaard T, 2005, RES MICROBIOL, V156, P457, DOI 10.1016/j.resmic.2005.01.011; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engstrom P, 2009, LIMNOL OCEANOGR, V54, P1643, DOI 10.4319/lo.2009.54.5.1643; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamersley MR, 2009, SYST APPL MICROBIOL, V32, P571, DOI 10.1016/j.syapm.2009.07.009; Harhangi HR, 2012, APPL ENVIRON MICROB, V78, P752, DOI 10.1128/AEM.07113-11; Helmer C, 1999, WATER SCI TECHNOL, V39, P13, DOI 10.2166/wst.1999.0317; Hirsch MD, 2011, MICROB ECOL, V61, P264, DOI 10.1007/s00248-010-9743-1; Hong YG, 2011, MICROB ECOL, V62, P36, DOI 10.1007/s00248-011-9849-0; Hong YG, 2011, APPL MICROBIOL BIOT, V89, P1233, DOI 10.1007/s00253-010-2925-4; Hu BL, 2011, APPL ENVIRON MICROB, V77, P966, DOI 10.1128/AEM.02402-10; Hu BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033826; Humbert S, 2012, ENV MICROBIOL REP, V4, P484, DOI 10.1111/j.1758-2229.2012.00347.x; Humbert S, 2010, ISME J, V4, P450, DOI 10.1038/ismej.2009.125; Jetten MSM, 2003, APPL MICROBIOL BIOT, V63, P107, DOI 10.1007/s00253-003-1422-4; Kirkpatrick J, 2006, APPL ENVIRON MICROB, V72, P3079, DOI 10.1128/AEM.72.4.3079-3083.2006; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Li H, 2010, MICROB ECOL, V60, P771, DOI 10.1007/s00248-010-9733-3; Li M, 2011, ECOTOXICOLOGY, V20, P1780, DOI 10.1007/s10646-011-0711-4; Li M, 2011, ENVIRON SCI TECHNOL, V45, P3547, DOI 10.1021/es103826w; Li M, 2010, APPL MICROBIOL BIOT, V86, P781, DOI 10.1007/s00253-009-2361-5; Lynch MDJ, 2013, GIGASCIENCE IN PRESS; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Moore TA, 2011, ENVIRON SCI TECHNOL, V45, P7217, DOI 10.1021/es201243t; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1016/0168-6496(94)00081-7; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neef A, 1998, MICROBIOL-UK, V144, P3257, DOI 10.1099/00221287-144-12-3257; Neufeld JD, 2007, ISME J, V1, P480, DOI 10.1038/ismej.2007.65; Penton CR, 2006, APPL ENVIRON MICROB, V72, P6829, DOI 10.1128/AEM.01254-06; Rich JJ, 2008, MICROB ECOL, V55, P311, DOI 10.1007/s00248-007-9277-3; Richards F.A., 1965, CHEM OCEANOGRAPHY, P611; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schmid M, 2003, SYST APPL MICROBIOL, V26, P529, DOI 10.1078/072320203770865837; Schmid M, 2001, ENVIRON MICROBIOL, V3, P450, DOI 10.1046/j.1462-2920.2001.00211.x; Schmid MC, 2007, ENVIRON MICROBIOL, V9, P1476, DOI 10.1111/j.1462-2920.2007.01266.x; Schmid MC, 2005, APPL ENVIRON MICROB, V71, P1677, DOI 10.1128/AEM.71.4.1677-1684.2005; Schubert CJ, 2006, ENVIRON MICROBIOL, V8, P1857, DOI 10.1111/j.1462-2920.2006.01074.x; Sonthiphand P, 2012, ENV MICROBIOL UNPUB; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589, DOI 10.1007/s002530051340; Tal Y, 2006, APPL ENVIRON MICROB, V72, P2896, DOI 10.1128/AEM.72.4.2896-2904.2006; Tal Y, 2005, APPL ENVIRON MICROB, V71, P1816, DOI 10.1128/AEM.71.4.1816-1821.2005; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P577, DOI 10.4319/lo.2009.54.2.0577; van der Star WRL, 2008, BIOTECHNOL BIOENG, V101, P286, DOI 10.1002/bit.21891; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Woebken D, 2008, ENVIRON MICROBIOL, V10, P3106, DOI 10.1111/j.1462-2920.2008.01640.x; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Yoshinaga I, 2011, MICROBES ENVIRON, V26, P189, DOI 10.1264/jsme2.ME10184; Zhang Y, 2007, ENVIRON MICROBIOL, V9, P2375, DOI 10.1111/J.1462-2920.2007.01357.x; Zhu GB, 2011, ENVIRON SCI TECHNOL, V45, P9951, DOI 10.1021/es202183w; Zhu GB, 2011, ISME J, V5, P1905, DOI 10.1038/ismej.2011.63	64	27	29	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57242	10.1371/journal.pone.0057242	http://dx.doi.org/10.1371/journal.pone.0057242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505422	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500014
J	Buchalski, MR; Fontaine, JB; Heady, PA; Hayes, JP; Frick, WF				Buchalski, Michael R.; Fontaine, Joseph B.; Heady, Paul A., III; Hayes, John P.; Frick, Winifred F.			Bat Response to Differing Fire Severity in Mixed-Conifer Forest California, USA	PLOS ONE			English	Article							WESTERN OREGON; SURROGATE TREATMENTS; INSECTIVOROUS BATS; EVERGREEN FOREST; PRESCRIBED FIRE; SITE OCCUPANCY; PREY SELECTION; CONSERVATION; HABITAT; STANDS	Wildlife response to natural disturbances such as fire is of conservation concern to managers, policy makers, and scientists, yet information is scant beyond a few well-studied groups (e.g., birds, small mammals). We examined the effects of wildfire severity on bats, a taxon of high conservation concern, at both the stand (<1 ha) and landscape scale in response to the 2002 McNally fire in the Sierra Nevada region of California, USA. One year after fire, we conducted surveys of echolocation activity at 14 survey locations, stratified in riparian and upland habitat, in mixed-conifer forest habitats spanning three levels of burn severity: unburned, moderate, and high. Bat activity in burned areas was either equivalent or higher than in unburned stands for all six phonic groups measured, with four groups having significantly greater activity in at least one burn severity level. Evidence of differentiation between fire severities was observed with some Myotis species having higher levels of activity in stands of high-severity burn. Larger-bodied bats, typically adapted to more open habitat, showed no response to fire. We found differential use of riparian and upland habitats among the phonic groups, yet no interaction of habitat type by fire severity was found. Extent of high-severity fire damage in the landscape had no effect on activity of bats in unburned sites suggesting no landscape effect of fire on foraging site selection and emphasizing stand-scale conditions driving bat activity. Results from this fire in mixed-conifer forests of California suggest that bats are resilient to landscape-scale fire and that some species are preferentially selecting burned areas for foraging, perhaps facilitated by reduced clutter and increased post-fire availability of prey and roosts.	[Buchalski, Michael R.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Fontaine, Joseph B.] Murdoch Univ, Sch Environm Sci, Perth, WA, Australia; [Heady, Paul A., III] Cent Coast Bat Res Grp, Aptos, CA USA; [Hayes, John P.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Frick, Winifred F.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	Western Michigan University; Murdoch University; State University System of Florida; University of Florida; University of California System; University of California Santa Cruz	Buchalski, MR (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	michael.buchalski@wmich.edu	Fontaine, Joseph/O-2758-2019; Fontaine, Joseph B/M-9186-2013; Hayes, John/C-7967-2016; Frick, Winifred/ABA-3519-2020	Fontaine, Joseph/0000-0002-6515-7864; Fontaine, Joseph B/0000-0002-6515-7864; Hayes, John/0000-0002-6462-6876; Frick, Winifred/0000-0002-9469-1839	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	W. Frick was funded by National Science Foundation during parts of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Armitage DW, 2012, J MAMMAL, V93, P102, DOI 10.1644/11-MAMM-A-169.1; Barclay RMR, 1999, J MAMMAL, V80, P290, DOI 10.2307/1383229; Betts BJ, 1998, J MAMMAL, V79, P643, DOI 10.2307/1382994; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Boyles JG, 2006, FOREST ECOL MANAG, V222, P108, DOI 10.1016/j.foreco.2005.09.024; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; Brigham RM, 1997, J MAMMAL, V78, P1231, DOI 10.2307/1383066; BRIGHAM RM, 1992, J MAMMAL, V73, P640, DOI 10.2307/1382036; Broders HG, 2003, ACTA CHIROPTEROL, V5, P235, DOI 10.3161/001.005.0206; Carter T.C., 2002, FIRE BATS SE MIDATLA, P139; Clark DA, 2011, J RAPTOR RES, V45, P38, DOI 10.3356/JRR-10-42.1; Clarke FM, 2005, J APPL ECOL, V42, P409, DOI 10.1111/j.1365-2664.2005.01024.x; Cooper IA, 2003, ECOLOGICAL RESTORATI, V21, P204; Crampton LH, 1998, CONSERV BIOL, V12, P1347, DOI 10.1046/j.1523-1739.1998.97209.x; Donato DC, 2009, J ECOL, V97, P142, DOI 10.1111/j.1365-2745.2008.01456.x; Erickson JL, 2003, BIOL CONSERV, V109, P95, DOI 10.1016/S0006-3207(02)00141-6; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; Fenton MB, 1997, J MAMMAL, V78, P1, DOI 10.2307/1382633; Fisher JT, 2005, MAMMAL REV, V35, P51, DOI 10.1111/j.1365-2907.2005.00053.x; Fontaine JB, 2012, ECOL APPL, V22, P1547, DOI 10.1890/12-0009.1; Fontaine JB, 2009, FOREST ECOL MANAG, V257, P1496, DOI 10.1016/j.foreco.2008.12.030; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Goodman K, 2008, ENCY ENTOMOLOGY, P3090; Halofsky JE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00184.1; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; Hayes JP, 2000, ACTA CHIROPTEROL, V2, P225; Humes ML, 1999, J WILDLIFE MANAGE, V63, P553, DOI 10.2307/3802642; Hutto RL, 2008, ECOL APPL, V18, P1827, DOI 10.1890/08-0895.1; Jung TS, 2000, J WILDLIFE MANAGE, V64, P1099; Kalcounis MC, 1998, J WILDLIFE MANAGE, V62, P603, DOI 10.2307/3802336; Key CH, 2005, LANDSCAPE ASSESSMENT; Kotliar NB, 2007, ECOL APPL, V17, P491, DOI 10.1890/06-0253; Lacki MJ, 2007, NORTHWEST SCI, V81, P199, DOI 10.3955/0029-344X-81.3.199; Lacki MJ, 2009, J MAMMAL, V90, P1165, DOI 10.1644/08-MAMM-A-349.1; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Loeb SC, 2008, FOREST ECOL MANAG, V255, P3185, DOI 10.1016/j.foreco.2007.10.060; Loeb SC, 2011, MANAG FOR ECOSYST, V21, P167, DOI 10.1007/978-94-007-1620-9_10; Malison RL, 2010, J N AM BENTHOL SOC, V29, P1324, DOI 10.1899/09-022.1; Malison RL, 2010, CAN J FISH AQUAT SCI, V67, P570, DOI 10.1139/F10-006; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Nimmo DG, 2012, CONSERV BIOL; Ober HK, 2008, J MAMMAL, V89, P1191, DOI 10.1644/08-MAMM-A-025.1; Odion DC, 2006, ECOSYSTEMS, V9, P1177, DOI 10.1007/s10021-003-0134-z; Owen SF, 2004, NORTH J APPL FOR, V21, P154, DOI 10.1093/njaf/21.3.154; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Perry DA, 2011, FOREST ECOL MANAG, V262, P703, DOI 10.1016/j.foreco.2011.05.004; Peters SL, 2006, CONSERV BIOL, V20, P1410, DOI 10.1111/j.1523-1739.2006.00526.x; Powell EN, 2012, ECOL MONOGR, V82, P69, DOI 10.1890/11-0607.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Reed CC, 1997, NAT AREA J, V17, P380; Roberts SL, 2011, BIOL CONSERV, V144, P610, DOI 10.1016/j.biocon.2010.11.002; Saab VA, 2005, FIRE AVIAN ECOLOGY N; Safford HD, 2008, ECOSYSTEMS, V11, P1, DOI 10.1007/s10021-007-9094-z; Schurbon JM, 2003, CONSERV BIOL, V17, P1338, DOI 10.1046/j.1523-1739.2003.01514.x; Sleep DJH, 2003, J MAMMAL, V84, P216, DOI 10.1644/1545-1542(2003)084<0216:AETOCT>2.0.CO;2; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Taylor RS, 2012, DIVERS DISTRIB, V18, P519, DOI 10.1111/j.1472-4642.2011.00842.x; TURNER MG, 1994, J VEG SCI, V5, P731, DOI 10.2307/3235886; U. S. Forest Service [USFS], 2006, MCNALLY FIR RDNBR VE; Webala PW, 2011, J APPL ECOL, V48, P398, DOI 10.1111/j.1365-2664.2010.01934.x; WILSON DE, 1993, MAMMALIAN SPECIES WO; Yates MD, 2006, J WILDLIFE MANAGE, V70, P1238, DOI 10.2193/0022-541X(2006)70[1238:EOFSAF]2.0.CO;2; Zeiner D. C., 1990, CALIFORNIAS WILDLIFE, VIII; Zielinski WJ, 2004, J MAMMAL, V85, P649, DOI 10.1644/BOS-126; [No title captured]	71	51	54	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57884	10.1371/journal.pone.0057884	http://dx.doi.org/10.1371/journal.pone.0057884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483936	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100052
J	Jamin, EL; Riu, A; Douki, T; Debrauwer, L; Cravedi, JP; Zalko, D; Audebert, M				Jamin, Emilien L.; Riu, Anne; Douki, Thierry; Debrauwer, Laurent; Cravedi, Jean-Pierre; Zalko, Daniel; Audebert, Marc			Combined Genotoxic Effects of a Polycyclic Aromatic Hydrocarbon (B(a)P) and an Heterocyclic Amine (PhIP) in Relation to Colorectal Carcinogenesis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; COLON EPITHELIAL-CELLS; INTESTINAL NEOPLASIA MICE; ADDUCT FORMATION; DNA-ADDUCTS; APC(MIN) MUTATION; GAMMA-H2AX ASSAY; MEAT CONSUMPTION; CANCER; RISK	Colorectal neoplasia is the third most common cancer worldwide. Environmental factors such as diet are known to be involved in the etiology of this cancer. Several epidemiological studies have suggested that specific neo-formed mutagenic compounds related to meat consumption are an underlying factor involved in the association between diet and colorectal cancer. Heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) are known mutagens and possible human carcinogens formed at the same time in meat during cooking processes. We studied the genotoxicity of the model PAH benzo(a) pyrene (B(a) P) and HCA 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), alone or in mixture, using the mouse intestinal cell line Apc(Min/+), mimicking the early step of colorectal carcinogenesis, and control Apc(+/+) cells. The genotoxicity of B(a) P and PhIP was investigated using both cell lines, through the quantification of B(a) P and PhIP derived DNA adducts, as well as the use of a genotoxic assay based on histone H2AX phosphorylation quantification. Our results demonstrate that heterozygous Apc mutated cells are more effective to metabolize B(a) P. We also established in different experiments that PhIP and B(a) P were more genotoxic on Apc(Min/+) cells compared to Apc(+/+). Moreover when tested in mixture, we observed a combined genotoxicity of B(a) P and PhIP on the two cell lines, with an increase of PhIP derived DNA adducts in the presence of B(a) P. Because of their genotoxic effects observed on heterozygous Apc mutated cells and their possible combined genotoxic effects, both B(a) P and PhIP, taken together, could be implicated in the observed association between meat consumption and colorectal cancer.	[Jamin, Emilien L.; Riu, Anne; Debrauwer, Laurent; Cravedi, Jean-Pierre; Zalko, Daniel; Audebert, Marc] INRA, Toxalim, Res Ctr Food Toxicol, UMR1331, F-31931 Toulouse, France; [Jamin, Emilien L.; Riu, Anne; Debrauwer, Laurent; Cravedi, Jean-Pierre; Zalko, Daniel; Audebert, Marc] Univ Toulouse, INPT, UPS, UMR1331, Toulouse, France; [Douki, Thierry] Univ Grenoble 1, CEA, Inst Nanosci & Cryogenie, SCIB,Lab Les Acides Nucl,UMR E3, Grenoble, France	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Audebert, M (corresponding author), INRA, Toxalim, Res Ctr Food Toxicol, UMR1331, F-31931 Toulouse, France.	marc.audebert@toulouse.inra.fr	Jamin, Emilien L/AAI-4388-2021; AUDEBERT, Marc A/C-1153-2008; Thierry, Douki/H-2108-2018; Debrauwer, Laurent/H-7807-2013; Jamin, Emilien L/B-7407-2009	Jamin, Emilien L/0000-0002-4568-9177; AUDEBERT, Marc A/0000-0001-7898-6912; Thierry, Douki/0000-0002-5022-071X; 	NeoMeaTox Inca program	NeoMeaTox Inca program	This research was funded in part by the NeoMeaTox Inca program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alexandrov K, 1996, CARCINOGENESIS, V17, P2081, DOI 10.1093/carcin/17.9.2081; Audebert M, 2012, TOXICOL APPL PHARM, V260, P58, DOI 10.1016/j.taap.2012.01.022; Audebert M, 2010, TOXICOL LETT, V199, P182, DOI 10.1016/j.toxlet.2010.08.022; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Baradat M, 2011, CHEM RES TOXICOL, V24, P1984, DOI 10.1021/tx2003036; Bellocq D, 2008, MUTAT RES-GEN TOX EN, V653, P34, DOI 10.1016/j.mrgentox.2008.02.010; Bellocq D, 2010, STEROIDS, V75, P665, DOI 10.1016/j.steroids.2010.04.003; Brown K, 2001, P NATL ACAD SCI USA, V98, P8507, DOI 10.1073/pnas.151251898; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Diggs DL, 2012, TUMOR BIOL, V33, P1255, DOI 10.1007/s13277-012-0375-6; Dingley KH, 1999, CANCER EPIDEM BIOMAR, V8, P507; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fenton JI, 2006, CARCINOGENESIS, V27, P893, DOI 10.1093/carcin/bgi355; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrucci LM, 2012, BRIT J CANCER, V106, P608, DOI 10.1038/bjc.2011.549; Fontana RJ, 1999, GASTROENTEROLOGY, V117, P89, DOI 10.1016/S0016-5085(99)70554-8; Forest V, 2003, CELL IMMUNOL, V223, P70, DOI 10.1016/S0008-8749(03)00149-7; Forest V, 2003, NUTR CANCER, V45, P84, DOI 10.1207/S15327914NC4501_10; Garner RC, 1999, CANCER LETT, V143, P161, DOI 10.1016/S0304-3835(99)00118-4; Gil J, 2012, MOL BIOL REP, V39, P527, DOI 10.1007/s11033-011-0767-5; Girard H, 2008, MUTAT RES-FUND MOL M, V644, P56, DOI 10.1016/j.mrfmmm.2008.07.002; Graillot V, 2012, MUTAT RES-GEN TOX EN, V748, P8, DOI 10.1016/j.mrgentox.2012.05.014; Graillot V, 2012, ENVIRON MOL MUTAGEN, V53, P173, DOI 10.1002/em.21676; Hakura A, 1998, MUTAT RES-FUND MOL M, V398, P123, DOI 10.1016/S0027-5107(97)00248-0; Jacques C, 2010, ANAL BIOANAL CHEM, V396, P1691, DOI 10.1007/s00216-009-3389-1; Jamin EL, 2007, J AM SOC MASS SPECTR, V18, P2107, DOI 10.1016/j.jasms.2007.09.008; Joshi AD, 2009, CARCINOGENESIS, V30, P472, DOI 10.1093/carcin/bgn260; Keating GA, 2004, J CHROMATOGR B, V802, P127, DOI 10.1016/j.jchromb.2003.10.047; Kemp MG, 2011, J BIOL CHEM, V286, P19237, DOI 10.1074/jbc.M111.235036; Knize M G, 1999, Adv Exp Med Biol, V459, P179; Loeppen S, 2005, CARCINOGENESIS, V26, P239, DOI 10.1093/carcin/bgh298; Louiz I, 2008, SCI TOTAL ENVIRON, V402, P318, DOI 10.1016/j.scitotenv.2008.05.005; Marian B, 2002, FOOD CHEM TOXICOL, V40, P1099, DOI 10.1016/S0278-6915(02)00061-3; Marie C, 2008, J APPL TOXICOL, V28, P579, DOI 10.1002/jat.1306; Martinez ME, 2007, CARCINOGENESIS, V28, P2019, DOI 10.1093/carcin/bgm179; McGregor WG, 1997, MUTAT RES-FUND MOL M, V376, P143, DOI 10.1016/S0027-5107(97)00037-7; Nagao M, 1996, ENVIRON HEALTH PERSP, V104, P497, DOI 10.2307/3432812; Narayan Satya, 2003, Mol Cancer, V2, P41, DOI 10.1186/1476-4598-2-41; Pierre F, 2007, CARCINOGENESIS, V28, P321, DOI 10.1093/carcin/bgl127; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Reeves DA, 2011, NUCLEIC ACIDS RES, V39, P8752, DOI 10.1093/nar/gkr537; RINDGEN D, 1995, CHEM RES TOXICOL, V8, P1005, DOI 10.1021/tx00050a003; Shimada T, 2006, CHEM RES TOXICOL, V19, P288, DOI 10.1021/tx050291v; Sinha R, 2005, CANCER EPIDEM BIOMAR, V14, P2030, DOI 10.1158/1055-9965.EPI-04-0854; Sinha R, 2005, CANCER RES, V65, P8034, DOI 10.1158/0008-5472.CAN-04-3429; Slyskova J, 2012, MUTAGENESIS, V27, P225, DOI 10.1093/mutage/ger088; Smart DJ, 2011, MUTAT RES-FUND MOL M, V715, P25, DOI 10.1016/j.mrfmmm.2011.07.001; Steffensen IL, 2001, CANCER RES, V61, P8689; Steffensen IL, 1997, CARCINOGENESIS, V18, P1049, DOI 10.1093/carcin/18.5.1049; Steffensen IL, 2006, CANCER LETT, V240, P289, DOI 10.1016/j.canlet.2005.09.015; Toyota M, 1996, CANCER, V77, P1593; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Turteltaub KW, 1999, CANCER LETT, V143, P149, DOI 10.1016/S0304-3835(99)00116-0; Watters GP, 2009, MUTAT RES-GEN TOX EN, V679, P50, DOI 10.1016/j.mrgentox.2009.07.007; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004	60	41	43	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58591	10.1371/journal.pone.0058591	http://dx.doi.org/10.1371/journal.pone.0058591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484039	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100127
J	Lord, CEN; Dauphinee, AN; Watts, RL; Gunawardena, AHLAN				Lord, Christina E. N.; Dauphinee, Adrian N.; Watts, Rebecca L.; Gunawardena, Arunika H. L. A. N.			Unveiling Interactions among Mitochondria, Caspase-Like Proteases, and the Actin Cytoskeleton during Plant Programmed Cell Death (PCD)	PLOS ONE			English	Article							SELF-INCOMPATIBILITY RESPONSE; LACE PLANT; APONOGETON-MADAGASCARIENSIS; PERMEABILITY TRANSITION; CYTOCHROME-C; IN-VIVO; DYNAMICS; REORGANIZATION; EMBRYOGENESIS; ARABIDOPSIS	Aponogeton madagascariensis produces perforations over its leaf surface via programmed cell death (PCD). PCD begins between longitudinal and transverse veins at the center of spaces regarded as areoles, and continues outward, stopping several cells from these veins. The gradient of PCD that exists within a single areole of leaves in an early stage of development was used as a model to investigate cellular dynamics during PCD. Mitochondria have interactions with a family of proteases known as caspases, and the actin cytoskeleton during metazoan PCD; less is known regarding these interactions during plant PCD. This study employed the actin stain Alexa Fluor 488 phalloidin, the actin depolymerizer Latrunculin B (Lat B), a synthetic caspase peptide substrate and corresponding specific inhibitors, as well as the mitochondrial pore inhibitor cyclosporine A (CsA) to analyze the role of these cellular constituents during PCD. Results depicted that YVADase (caspase-1) activity is higher during the very early stages of perforation formation, followed by the bundling and subsequent breakdown of actin. Actin depolymerization using Lat B caused no change in YVADase activity. In vivo inhibition of YVADase activity prevented PCD and actin breakdown, therefore substantiating actin as a likely substrate for caspase-like proteases (CLPs). The mitochondrial pore inhibitor CsA significantly decreased YVADase activity, and prevented both PCD and actin breakdown; therefore suggesting the mitochondria as a possible trigger for CLPs during PCD in the lace plant. To our knowledge, this is the first in vivo study using either caspase-1 inhibitor (Ac-YVAD-CMK) or CsA, following which the actin cytoskeleton was examined. Overall, our findings suggest the mitochondria as a possible upstream activator of YVADase activity and implicate these proteases as potential initiators of actin breakdown during perforation formation via PCD in the lace plant.	[Lord, Christina E. N.; Dauphinee, Adrian N.; Watts, Rebecca L.; Gunawardena, Arunika H. L. A. N.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	Gunawardena, AHLAN (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	arunika.gunawardena@dal.ca	Dauphinee, Adrian/AAI-7757-2021	Dauphinee, Adrian/0000-0002-3363-198X	Natural Sciences and Engineering Research Council (NSERC); Canadian Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpagaus S, 2002, J BIOL CHEM, V277, P1780, DOI 10.1074/jbc.M109416200; Balk J, 2003, PLANT J, V34, P573, DOI 10.1046/j.1365-313X.2003.01748.x; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Bosch M, 2008, MOL PLANT, V1, P879, DOI 10.1093/mp/ssn053; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Contran N, 2007, PROTOPLASMA, V231, P193, DOI 10.1007/s00709-007-0250-2; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Curtis MJ, 2002, PLANT J, V29, P295, DOI 10.1046/j.0960-7412.2001.01213.x; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; Diamond M., 2007, PLANT MITOCHONDRIA, V31, P308; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Giuliani C, 2002, ANN BOT-LONDON, V90, P287, DOI 10.1093/aob/mcf173; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gunawardena AHLAN, 2006, BOT J LINN SOC, V150, P25, DOI 10.1111/j.1095-8339.2006.00487.x; Gunawardena AHLAN, 2004, PLANT CELL, V16, P60, DOI 10.1105/tpc.016188; Gunawardena AHLAN, 2008, J EXP BOT, V59, P445, DOI 10.1093/jxb/erm189; Gunawardena AHLAN, 2007, AM J BOT, V94, P1116, DOI 10.3732/ajb.94.7.1116; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Higaki T, 2007, PLANT CELL PHYSIOL, V48, P1414, DOI 10.1093/pcp/pcm109; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jones A, 2000, TRENDS PLANT SCI, V5, P225, DOI 10.1016/S1360-1385(00)01605-8; Kacprzyk J, 2011, ADV BOT RES, V60, P169, DOI 10.1016/B978-0-12-385851-1.00004-4; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Liu ZQ, 2007, PROTOPLASMA, V232, P61, DOI 10.1007/s00709-007-0269-4; Lord CEN, 2012, EUR J CELL BIOL, V91, P603, DOI 10.1016/j.ejcb.2012.02.002; Lord CEN, 2012, PHYSIOL PLANTARUM, V145, P114, DOI 10.1111/j.1399-3054.2012.01570.x; Lord CEN, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-102; Lord CEN, 2011, PLANTA, V233, P407, DOI 10.1007/s00425-010-1304-9; Mishra S., 2011, BIOTECHNOL BIOINFORM, V1, P1; Piszczek E, 2007, ACTA PHYSIOL PLANT, V29, P391, DOI 10.1007/s11738-007-0086-6; Potten C., 2004, APOPTOSIS LIFE DEATH; Poulter NS, 2008, PLANT PHYSIOL, V146, P1358, DOI 10.1104/pp.107.107052; Poulter NS, 2010, PLANT PHYSIOL, V152, P1274, DOI 10.1104/pp.109.152066; Rogers HJ, 2005, CURR TOP DEV BIOL, V71, P225, DOI 10.1016/S0070-2153(05)71007-3; Sanmartin M, 2005, PLANT PHYSIOL, V137, P841, DOI 10.1104/pp.104.058552; Schwarzerova K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-89; Scott I, 2008, NEW PHYTOL, V177, P90, DOI 10.1111/j.1469-8137.2007.02255.x; Scott Iain, 2007, V31, P1, DOI 10.1002/9780470986592.ch1; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Smertenko AP, 2003, PLANT J, V33, P813, DOI 10.1046/j.1365-313X.2003.01670.x; Staiger CJ, 2003, J EXP BOT, V54, P103, DOI 10.1093/jxb/54.380.103; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; Vacca RA, 2006, PLANT PHYSIOL, V141, P208, DOI 10.1104/pp.106.078683; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Wertman J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-115; Wright H, 2009, AM J BOT, V96, P865, DOI 10.3732/ajb.0800343; Yao N, 2004, PLANT J, V40, P596, DOI 10.1111/j.1365-313X.2004.02239.x	54	24	24	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57110	10.1371/journal.pone.0057110	http://dx.doi.org/10.1371/journal.pone.0057110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483897	Green Published, gold			2022-12-25	WOS:000316936100015
J	Werdelin, L; Lewis, ME				Werdelin, Lars; Lewis, Margaret E.			Temporal Change in Functional Richness and Evenness in the Eastern African Plio-Pleistocene Carnivoran Guild	PLOS ONE			English	Article							MAMMALIAN EVOLUTION; HOMINID; HYPERCARNIVORY; TURNOVER; DIET	We analyze functional richness and functional evenness of the carnivoran guild in eastern Africa from 3.5 Ma to 1.5 Ma, and compare them to the present day. The data consist of characters of the craniodental apparatus of 76 species of fossil and extant carnivorans, divided into four 0.5 Ma time slices from 3.5 to 1.5 Ma, together with the modern fauna. Focus is on large (>21.5 kg) carnivores. Results show that the large carnivore guild has lost nearly 99% of its functional richness since 3.5 Ma, in a process starting prior to 2 Ma. Measurement of functional evenness shows the modern large carnivore guild to be unique in being randomly distributed in morphospace while in all past time slices there is significant clustering of species. The results are analyzed in the light of known changes to climate and environment in eastern Africa. We conclude that climate change is unlikely to explain all of the changes found and suggest that the evolution of early hominins into carnivore niche space, especially the evolution of derived dietary strategies after 2 Ma, played a significant part in the reduction of carnivore functional richness.	[Werdelin, Lars] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Lewis, Margaret E.] Richard Stockton Coll New Jersey, NAMS Biol, Galloway, NJ USA	Swedish Museum of Natural History	Werdelin, L (corresponding author), Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden.	werdelin@nrm.se	Lewis, Margaret E/P-8243-2016	Lewis, Margaret E/0000-0002-2661-1489	Swedish Research Council; LSB Leakey Foundation; Stockton Distinguished Faculty Fellowships	Swedish Research Council(Swedish Research CouncilEuropean Commission); LSB Leakey Foundation; Stockton Distinguished Faculty Fellowships	This research was supported by a series of grants from the Swedish Research Council (www.vr.se) to LW, a grant from the LSB Leakey Foundation (leakeyfoundation.org) to MEL and K.E. Reed, and Stockton Distinguished Faculty Fellowships to MEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2010, QUATERN INT, V217, P10, DOI 10.1016/j.quaint.2009.11.017; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; Benzecri J.-P., 1980, PRATIQUE ANAL DONNEE; BLUMENSCHINE RJ, 1994, J HUM EVOL, V27, P197, DOI 10.1006/jhev.1994.1042; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobe R, 2002, J HUM EVOL, V42, P475, DOI 10.1006/jhev.2001.0535; Brantingham PJ, 1998, J ANTHROPOL ARCHAEOL, V17, P327, DOI 10.1006/jaar.1998.0326; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cunnane SC, 2005, SURVIVAL OF THE FATTEST: THE KEY TO HUMAN BRAIN EVOLUTION, P1; Davis J.C., 1986, STAT DATA ANAL GEOLO; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Feakins Sarah J., 2010, P45; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herries AIR, 2011, J HUM EVOL, V60, P523, DOI 10.1016/j.jhevol.2010.09.001; Holliday JA, 2004, PALEOBIOLOGY, V30, P108, DOI 10.1666/0094-8373(2004)030<0108:EOHTEO>2.0.CO;2; Holliday Jill A., 2010, P189; Illian J, 2008, STAT ANAL MODELLING; Kingdon J, 1997, KINGDON FIELD GUIDE; Lariviere Serge, 2001, Mammalian Species, V671, P1, DOI 10.1644/1545-1410(2001)671<0001:AC>2.0.CO;2; Lewis ME, 2007, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-1-4020-3098-7_4; Lewis ME, 1997, J HUM EVOL, V32, P257, DOI 10.1006/jhev.1996.0103; MAREAN CW, 1989, J HUM EVOL, V18, P559, DOI 10.1016/0047-2484(89)90018-3; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Palombo MR, 2008, QUATERN INT, V179, P176, DOI 10.1016/j.quaint.2007.08.029; Palombo MR, 2006, QUATERN INT, V149, P94, DOI 10.1016/j.quaint.2005.11.022; Palombo MR, 2009, EVOL ECOL, V23, P569, DOI 10.1007/s10682-008-9256-2; PETTER G., 1973, FOSSIL VERTEBRATES A, V3, P44; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Pobiner Briana L., 2003, Journal of Taphonomy, V1, P115; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Ripple WJ, 2010, BIOSCIENCE, V60, P516, DOI 10.1525/bio.2010.60.7.7; Rose L, 1996, CURR ANTHROPOL, V37, P307, DOI 10.1086/204494; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; TURNER A, 1990, GEOBIOS-LYON, V23, P349, DOI 10.1016/0016-6995(90)80006-2; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Vrba ES, 2000, OXFORD MGR GEOL GEOP, P277; Walker A., 1984, P119; Werdelin L, 2005, ZOOL J LINN SOC-LOND, V144, P121, DOI 10.1111/j.1096-3642.2005.00165.x; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; Werdelin Lars, 2010, P225; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; Wesley-Hunt Gina D., 2010, P246; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x	51	67	67	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57944	10.1371/journal.pone.0057944	http://dx.doi.org/10.1371/journal.pone.0057944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483948	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100058
J	Freeman, ED; Larsen, RT; Clegg, K; McMillan, BR				Freeman, Eric D.; Larsen, Randy T.; Clegg, Ken; McMillan, Brock R.			Long-Lasting Effects of Maternal Condition in Free-Ranging Cervids	PLOS ONE			English	Article							WHITE-TAILED DEER; CAUSE-SPECIFIC MORTALITY; GLOBAL CLIMATE-CHANGE; CENTRAL NEW-MEXICO; MULE DEER; REPRODUCTIVE SUCCESS; WINTER WEATHER; ANTLER SIZE; RED DEER; ROE DEER	Causes of phenotypic variation are fundamental to evolutionary ecology because they influence the traits acted upon by natural selection. One such cause of phenotypic variation is a maternal effect, which is the influence of the environment experienced by a female (and her corresponding phenotype) on the phenotype of her offspring (independent of the offspring's genotype). While maternal effects are well documented, the longevity and fitness impact of these effects remains unclear because it is difficult to follow free-living individuals through their reproductive lifetimes. For long-lived species, it has been suggested that maternal effects are masked by environmental variables acting on offspring in years following the period of dependence. Our objective was to use indirect measures of maternal condition to determine if maternal effects have long-lasting influences on male offspring in two species of cervid. Because antlers are sexually selected, we used measures of antler size at time of death, 1.5-21.5 years after gestation to investigate maternal effects. We quantified antler size of 11,000 male elk and mule deer born throughout the intermountain western US (6 states) over nearly 30 years. Maternal condition during development was estimated indirectly using a suite of abiotic variables known to influence condition of cervids (i.e., winter severity, spring and summer temperature, and spring and summer precipitation). Antler size of male cervids was significantly associated with our indirect measure of maternal condition during gestation and lactation. Assuming the correctness of our indirect measure, our findings demonstrate that antler size is a sexually selected trait that is influenced-into adulthood-by maternal condition. This link emphasizes the importance of considering inherited environmental effects when interpreting population dynamics or examining reproductive success of long-lived organisms.	[Freeman, Eric D.; Larsen, Randy T.; McMillan, Brock R.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Clegg, Ken] Private Lands Consulting, Springville, UT USA	Brigham Young University	Freeman, ED (corresponding author), Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA.	edfreeman1@gmail.com						Akaike H, 1973, INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Albon Stephen D., 1992, P15; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; ANTHONY RG, 1976, J WILDLIFE MANAGE, V40, P140, DOI 10.2307/3800168; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bender LC, 2008, WILDLIFE BIOL, V14, P70, DOI 10.2981/0909-6396(2008)14[70:RBNCAS]2.0.CO;2; Bender LC, 2007, J WILDLIFE MANAGE, V71, P1118, DOI 10.2193/2006-226; Bernardo J, 1996, AM ZOOL, V36, P83; Bishop CJ, 2005, J WILDLIFE MANAGE, V69, P311, DOI 10.2193/0022-541X(2005)069<0311:MDSAAP>2.0.CO;2; BOWYER RT, 1986, SOUTHWEST NAT, V31, P289, DOI 10.2307/3671833; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; CLUTTONBROCK TH, 1982, BEHAVIOUR, V79, P108, DOI 10.1163/156853982X00201; Dale BW, 2008, J MAMMAL, V89, P1130, DOI 10.1644/07-MAMM-A-137.1; Ericsson G, 2001, ECOLOGY, V82, P1613, DOI 10.1890/0012-9658(2001)082[1613:ARREAS]2.0.CO;2; Festa-Bianchet M, 2000, BEHAV ECOL, V11, P633, DOI 10.1093/beheco/11.6.633; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; Festa-Bianchet M, 1998, BEHAV ECOL, V9, P144, DOI 10.1093/beheco/9.2.144; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; Garroway CJ, 2005, CAN J ZOOL, V83, P1246, DOI 10.1139/Z05-118; Gendreau Y, 2005, BEHAV ECOL SOCIOBIOL, V58, P237, DOI 10.1007/s00265-005-0938-2; GILBERT P F, 1970, Journal of Wildlife Management, V34, P15, DOI 10.2307/3799486; Glover T., 2002, INTRO BIOSTATISTICS; GREEN WCH, 1991, BEHAV ECOL SOCIOBIOL, V29, P373, DOI 10.1007/BF00165963; Hamlin KL, 2000, J WILDLIFE MANAGE, V64, P441, DOI 10.2307/3803242; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Hurley MA, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.4; Huxley JS, 1931, RELATIVE SIZE ANTLER, P819; Jones OR, 2005, P ROY SOC B-BIOL SCI, V272, P2619, DOI 10.1098/rspb.2005.3267; KEISS RE, 1969, J WILDLIFE MANAGE, V33, P175, DOI 10.2307/3799668; Kirkpatrick M, 1989, EVOLUTION MATERNAL C, P485; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; KOJOLA I, 1993, CAN J ZOOL, V71, P753, DOI 10.1139/z93-099; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Leckenby DA, 1986, J RANGE MANAGE, P244; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lomas LA, 2007, J WILDLIFE MANAGE, V71, P884, DOI 10.2193/2006-203; Maestripieri D., 2009, MATERNAL EFFECTS MAM; Marshal JP, 2008, SOUTHWEST NAT, V53, P311, DOI 10.1894/CJ-143.1; Marshal JP, 2005, RANGELAND ECOL MANAG, V58, P360, DOI 10.2111/1551-5028(2005)058[0360:RTAFDA]2.0.CO;2; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; MECH LD, 1991, J MAMMAL, V72, P146, DOI 10.2307/1381989; Merrill EH, 1991, SUMMER RANGE ELK POP, P263; Monteith KL, 2009, J MAMMAL, V90, P651, DOI 10.1644/08-MAMM-A-191R1.1; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nesbitt WH, 1989, RECORDS N AM BIG GAM; OZOGA JJ, 1986, J WILDLIFE MANAGE, V50, P480, DOI 10.2307/3801110; Peek JM, 2002, J WILDLIFE MANAGE, V66, P729, DOI 10.2307/3803138; PICTON HD, 1984, J APPL ECOL, V21, P869, DOI 10.2307/2405052; PICTON HD, 1979, INT J BIOMETEOROL, V23, P115, DOI 10.1007/BF01560091; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Post E, 1997, P ROY SOC B-BIOL SCI, V264, P1317, DOI 10.1098/rspb.1997.0182; Reimers E, 1997, CAN J ZOOL, V75, P648, DOI 10.1139/z97-082; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; SAUER JR, 1983, J WILDLIFE MANAGE, V47, P31, DOI 10.2307/3808049; SCHULTZ SR, 1995, J MAMMAL, V76, P575, DOI 10.2307/1382366; Smith BL, 1998, J MAMMAL, V79, P1038, DOI 10.2307/1383113; SMITH WP, 1987, AM NAT, V130, P310, DOI 10.1086/284712; Team RC, 2012, R LANG ENV STAT COMP; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Vanpe C, 2007, AM NAT, V169, P481, DOI 10.1086/512046; VERME LJ, 1968, J WILDLIFE MANAGE, V32, P566, DOI 10.2307/3798937; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x; WAUTERS LA, 1995, BEHAV ECOL SOCIOBIOL, V37, P189, DOI 10.1007/s002650050180; Weladji RB, 2003, OECOLOGIA, V136, P317, DOI 10.1007/s00442-003-1257-9; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238	73	11	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58373	10.1371/journal.pone.0058373	http://dx.doi.org/10.1371/journal.pone.0058373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472189	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900135
J	Lunghi, C; Alais, D				Lunghi, Claudia; Alais, David			Touch Interacts with Vision during Binocular Rivalry with a Tight Orientation Tuning	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; SPATIAL-FREQUENCY; CATEGORICAL PERCEPTION; TACTILE; DISCRIMINATION; ATTENTION; MOTION; REPRESENTATION; INFORMATION; ACTIVATION	Multisensory integration is a common feature of the mammalian brain that allows it to deal more efficiently with the ambiguity of sensory input by combining complementary signals from several sensory sources. Growing evidence suggests that multisensory interactions can occur as early as primary sensory cortices. Here we present incompatible visual signals (orthogonal gratings) to each eye to create visual competition between monocular inputs in primary visual cortex where binocular combination would normally take place. The incompatibility prevents binocular fusion and triggers an ambiguous perceptual response in which the two images are perceived one at a time in an irregular alternation. One key function of multisensory integration is to minimize perceptual ambiguity by exploiting cross-sensory congruence. We show that a haptic signal matching one of the visual alternatives helps disambiguate visual perception during binocular rivalry by both prolonging the dominance period of the congruent visual stimulus and by shortening its suppression period. Importantly, this interaction is strictly tuned for orientation, with a mismatch as small as 7.5 degrees between visual and haptic orientations sufficient to annul the interaction. These results indicate important conclusions: first, that vision and touch interact at early levels of visual processing where interocular conflicts are first detected and orientation tunings are narrow, and second, that haptic input can influence visual signals outside of visual awareness, bringing a stimulus made invisible by binocular rivalry suppression back to awareness sooner than would occur without congruent haptic input.	[Lunghi, Claudia] Univ Florence, Dept Neurosci, Florence, Italy; [Lunghi, Claudia] CNR, Inst Neurosci, Pisa, Italy; [Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Sydney	Lunghi, C (corresponding author), Univ Florence, Dept Neurosci, Florence, Italy.	c.lunghi@in.cnr.it	Lunghi, Claudia/C-7274-2014	Lunghi, Claudia/0000-0003-3811-5404	Italian Ministry of Universities and Research; EC project "STANIB" (FP7 ERC); Australian Research Council [DP130102336]	Italian Ministry of Universities and Research(Ministry of Education, Universities and Research (MIUR)); EC project "STANIB" (FP7 ERC); Australian Research Council(Australian Research Council)	This research was supported by the Italian Ministry of Universities and Research (PRIN2009), by EC project "STANIB" (FP7 ERC) and the Australian Research Council, Discovery Project #DP130102336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Alais D, 2010, VISION RES, V50, P929, DOI 10.1016/j.visres.2010.03.010; Arabzadeh E, 2008, PSYCHOL SCI, V19, P635, DOI 10.1111/j.1467-9280.2008.02134.x; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen YC, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00212; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Conrad V, 2010, J VISION, V10, DOI 10.1167/10.10.27; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Falchier A, 2002, J NEUROSCI, V22, P5749; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gori M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00055; Goyal MS, 2006, NEUROREPORT, V17, P1381, DOI 10.1097/01.wnr.0000227990.23046.fe; Guzman-Martinez E, 2012, CURR BIOL, V22, P383, DOI 10.1016/j.cub.2012.01.004; Hancock S, 2007, PERCEPTION, V36, P288, DOI 10.1068/p5494; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Holcombe AO, 2008, VISION RES, V48, P1743, DOI 10.1016/j.visres.2008.05.019; Hsiao SS, 2002, BEHAV BRAIN RES, V135, P93, DOI 10.1016/S0166-4328(02)00160-2; HUBEL DH, 1977, NATURE, V269, P328, DOI 10.1038/269328a0; Kang M-S, 2005, PSYCHOLOGIJA, V32; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; Klink PC, 2012, PHILOS T R SOC B, V367, P932, DOI 10.1098/rstb.2011.0358; Koch C., 2007, QUEST CONSCIOUSNESS; Levelt W., 1965, BINOCULAR RIVALRY; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Ling S, 2009, PSYCHOL SCI, V20, P1348, DOI 10.1111/j.1467-9280.2009.02446.x; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; MAFFEI L, 1973, VISION RES, V13, P1255, DOI 10.1016/0042-6989(73)90201-0; Maruya K, 2007, PSYCHOL SCI, V18, P1090, DOI 10.1111/j.1467-9280.2007.02030.x; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; MOVSHON JA, 1973, PERCEPTION, V2, P53, DOI 10.1068/p020053; Munhall KG, 2009, CURR BIOL, V19, P735, DOI 10.1016/j.cub.2009.03.019; Newell FN, 2002, COGNITION, V85, P113, DOI 10.1016/S0010-0277(02)00104-X; Paffen CLE, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00105; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PHILLIPS GC, 1984, J OPT SOC AM A, V1, P226, DOI 10.1364/JOSAA.1.000226; RASKIN LA, 1983, PSYCHOL RES-PSYCH FO, V45, P135, DOI 10.1007/BF00308665; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vasconcelos N, 2011, P NATL ACAD SCI USA, V108, P15408, DOI 10.1073/pnas.1102780108; Viviani P, 2007, VIS COGN, V15, P420, DOI 10.1080/13506280600761134; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zhou W, 2010, CURR BIOL, V20, P1356, DOI 10.1016/j.cub.2010.05.059	55	47	47	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58754	10.1371/journal.pone.0058754	http://dx.doi.org/10.1371/journal.pone.0058754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472219	Green Published, gold			2022-12-25	WOS:000315637900166
J	Stijntjes, M; de Craen, AJM; van Heemst, D; Meskers, CGM; van Buchem, MA; Westendorp, RGJ; Slagboom, PE; Maier, AB				Stijntjes, Marjon; de Craen, Anton J. M.; van Heemst, Diana; Meskers, Carel G. M.; van Buchem, Mark A.; Westendorp, Rudi G. J.; Slagboom, P. Eline; Maier, Andrea B.			Familial Longevity Is Marked by Better Cognitive Performance at Middle Age: The Leiden Longevity Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; BIOLOGICAL AGE; DEMENTIA; DECLINE; IMPAIRMENT; RISK; APOE; SURVIVAL; LIFE	Background: Decline in cognitive performance is a highly prevalent health condition in elderly. We studied whether offspring of nonagenarian siblings with a familial history of longevity, perform better on cognitive tests compared to their partners as controls. This is relevant since it could provide insights into determinants underlying decline in cognitive performance. Methods: Cross-sectional analysis within the longitudinal cohort of the Leiden Longevity Study consisting of middle-aged offspring of nonagenarian siblings together with their partners (n = 500, mean age (SD) 66.3 (6.1) and 65.7 (7.2) years, respectively) as controls. Memory function, attention and processing speed were tested using the 15-Picture Learning Test, Stroop test and Digit Symbol Substitution Test. Data were analyzed with regression adjusted for age, gender, years of education and additionally for diabetes mellitus, cardiovascular diseases, alcohol use, smoking, inflammatory markers and apolipoprotein E genotype. Robust standard errors were used to account for familial relationships among the offspring. Results: Cognitive performance was worse at higher calendar age (p<0.001, all except Stroop test part 1). The offspring performed better compared to their partners on trial 3 (p = 0.005), the immediate (p = 0.016) and delayed (p = 0.004) recall of the 15-Picture Learning Test as well as on the interference and combined interference score of the Stroop test (p = 0.014 and p = 0.036, respectively) in the fully adjusted model. The difference between offspring and partners was estimated to be more than three years according to the observed difference in calendar age. Conclusions: Offspring of nonagenarian siblings with a familial history of longevity have better cognitive performance compared to the group of their partners of comparable age. This effect is independent of age-related diseases and known possible confounders. Possible explanations might be differences in subclinical vascular pathology between both groups.	[Stijntjes, Marjon; de Craen, Anton J. M.; van Heemst, Diana; Westendorp, Rudi G. J.; Maier, Andrea B.] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Stijntjes, Marjon; Maier, Andrea B.] Vrije Univ Amsterdam, Dept Internal Med, Sect Gerontol & Geriatr, Med Ctr, Amsterdam, Netherlands; [Stijntjes, Marjon; de Craen, Anton J. M.; van Heemst, Diana; van Buchem, Mark A.; Westendorp, Rudi G. J.; Slagboom, P. Eline; Maier, Andrea B.] Netherlands Consortium Healthy Ageing, Leiden, Netherlands; [Meskers, Carel G. M.] Leiden Univ, Dept Rehabil Med, Med Ctr, Leiden, Netherlands; [van Buchem, Mark A.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Dept Med Stat, Sect Mol Epidemiol, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Maier, AB (corresponding author), Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands.	a.maier@vumc.nl	van Buchem, Mark/AAC-9843-2022; Maier, Andrea B./Q-5548-2019; Slagboom, P. Eline/R-4790-2016; Maier, Andrea/W-7060-2019	van Buchem, Mark/0000-0003-1881-1998; Slagboom, P. Eline/0000-0002-2875-4723; Maier, Andrea/0000-0001-7206-1724; Meskers, Carel/0000-0002-5056-5611	Innovation Oriented research Program on Genomics (SenterNovem) [IGE01014, IGE5007]; Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO) [05040202, 050-060-810]; Netherlands Consortium for Healthy Aging (NCHA); European Commission [HEALTH-2007-2.4.5-10, Health-F2-2010-259772]	Innovation Oriented research Program on Genomics (SenterNovem); Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Consortium for Healthy Aging (NCHA); European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding provided by The Leiden Longevity Study was funded by the Innovation Oriented research Program on Genomics (SenterNovem; www.agentschapnl.nl; IGE01014 and IGE5007), the Centre for Medical Systems Biology (CMSB; www.cmsb.nl), the Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO; www.genomics.nl/www.nwo.nl; 05040202 and 050-060-810 Netherlands Consortium for Healthy Aging (NCHA; www.healty-ageing.nl)), the European Commission funded project Myoage (FP7, HEALTH-2007-2.4.5-10; www.myoage.eu) and Switchbox (FP7, Health-F2-2010-259772; www.switchbox-online.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann-Schneider I, 2013, STROKE, V44, P9, DOI 10.1161/STROKEAHA.112.671438; Basta NE, 2008, EUR J PUBLIC HEALTH, V18, P48, DOI 10.1093/eurpub/ckm076; Beeri Michal Schnaider, 2009, Dialogues Clin Neurosci, V11, P201; Bennett Susan J, 2003, J Cardiovasc Nurs, V18, P219; BORKAN GA, 1980, J GERONTOL, V35, P177, DOI 10.1093/geronj/35.2.177; Campbell IL, 1997, MOL PSYCHIATR, V2, P125, DOI 10.1038/sj.mp.4000225; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Dekker P, 2009, AGING CELL, V8, P595, DOI 10.1111/j.1474-9726.2009.00506.x; Derhovanessian E, 2010, J IMMUNOL, V185, P4618, DOI 10.4049/jimmunol.1001629; Eikelenboom P, 1999, EXP GERONTOL, V34, P453, DOI 10.1016/S0531-5565(99)00022-4; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; HENDERSON AS, 1995, LANCET, V346, P1387, DOI 10.1016/S0140-6736(95)92405-1; Koster A, 2005, ANN EPIDEMIOL, V15, P564, DOI 10.1016/j.annepidem.2005.02.008; Marengoni A, 2011, J ALZHEIMERS DIS, V24, P559, DOI 10.3233/JAD-2011-101863; Marshall RS, 2011, STROKE, V42, P221, DOI 10.1161/STROKEAHA.110.595645; Nilsson LG, 2009, NEUROBIOL AGING, V30, P521, DOI 10.1016/j.neurobiolaging.2008.11.013; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Rozing MP, 2011, AGE, V33, P623, DOI 10.1007/s11357-011-9206-8; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; STROOP JR, 1992, J EXP PSYCHOL GEN, V121, P15; Waaijer MEC, 2012, AGE, V34, P1543, DOI 10.1007/s11357-011-9314-5; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x	30	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57962	10.1371/journal.pone.0057962	http://dx.doi.org/10.1371/journal.pone.0057962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099PY	23483953	Green Submitted, Green Published, gold			2022-12-25	WOS:000315634900060
J	Lee-Sherick, AB; Eisenman, KM; Sather, S; McGranahan, A; Armistead, PM; McGary, CS; Hunsucker, SA; Schlegel, J; Martinson, H; Cannon, C; Keating, AK; Earp, HS; Liang, X; DeRyckere, D; Graham, DK				Lee-Sherick, A. B.; Eisenman, K. M.; Sather, S.; McGranahan, A.; Armistead, P. M.; McGary, C. S.; Hunsucker, S. A.; Schlegel, J.; Martinson, H.; Cannon, C.; Keating, A. K.; Earp, H. S.; Liang, X.; DeRyckere, D.; Graham, D. K.			Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia	ONCOGENE			English	Article						tyrosine kinase; targeted therapy; acute leukemia; pediatric	ACUTE LYMPHOBLASTIC-LEUKEMIA; PEDIATRIC AML; FLT3 MUTATIONS; SURVIVAL; CELLS; AXL; PROTOONCOGENE; APOPTOSIS; CREB; OVEREXPRESSION	Acute myeloid leukemia (AML) continues to be extremely difficult to treat successfully, and the unacceptably low overall survival rates mandate that we assess new potential therapies to ameliorate poor clinical response to conventional therapy. Abnormal tyrosine kinase activation in AML has been associated with poor prognosis and provides strategic targets for novel therapy development. We found that Mer receptor tyrosine kinase was over-expressed in a majority of pediatric (29/36, 80%) and adult (10/10, 100%) primary AML patient blasts at the time of diagnosis, and 100% of patient samples at the time of relapse. Mer was also found to be expressed in 12 of 14 AML cell lines (86%). In contrast, normal bone marrow myeloid precursors expressed little to no Mer. Following AML cell line stimulation with Gas6, a Mer ligand, we observed activation of prosurvival and proliferative signaling pathways, including phosphorylation of ERK1/2, p38, MSK1, CREB, ATF1, AKT and STAT6. To assess the phenotypic role of Mer in AML, two independent short-hairpin RNA (shRNA) constructs were used to decrease Mer expression in the AML cell lines Nomo-1 and Kasumi-1. Reduction of Mer protein levels significantly increased rates of myeloblast apoptosis two to threefold in response to serum starvation. Furthermore, myeloblasts with knocked-down Mer demonstrated decreased colony formation by 67-87%, relative to control cell lines (P<0.01). NOD-SCID-gamma mice transplanted with Nomo-1 myeloblasts with reduced levels of Mer had a significant prolongation in survival compared with mice transplanted with the parental or control cell lines (median survival 17 days in parental and control cell lines, versus 32-36 days in Mer knockdown cell lines, P<0.0001). These data suggest a role for Mer in acute myeloid leukemogenesis and indicate that targeted inhibition of Mer may be an effective therapeutic strategy in pediatric and adult AML.	[Lee-Sherick, A. B.; Eisenman, K. M.; Sather, S.; Schlegel, J.; Cannon, C.; Keating, A. K.; DeRyckere, D.; Graham, D. K.] Dept Pediat, Div Hematol Oncol & Bone Marrow Transplantat, Aurora, CO USA; [McGranahan, A.; Liang, X.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Armistead, P. M.; McGary, C. S.; Hunsucker, S. A.; Earp, H. S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Martinson, H.] Univ Colorado, Dept Med Oncol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus	Graham, DK (corresponding author), Univ Colorado, Dept Pediat, Anschutz Med Campus,12800 E 19th Ave,P18-4408,MS, Aurora, CO 80045 USA.	doug.graham@ucdenver.edu		Lee Sherick, Alisa/0000-0002-1177-7208; Hunsucker, Sally/0000-0002-7034-7355; Armistead, Paul/0000-0003-3983-5534; Martinson, Holly/0000-0003-2745-2755	American Academy of Pediatrics; American Pediatric Society; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12-HD000850]; National Institutes of Health [R01CA137078]; For Julie Foundation; Damon Runyon Cancer Research Foundation [CI-39-07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA082086, P30CA046934, R01CA137078] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL113594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER	American Academy of Pediatrics; American Pediatric Society; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); For Julie Foundation; Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank the Children's Oncology Group, AML Biology Reference Laboratory for providing us with the frozen pediatric patient samples, and for the help of Christine Childs and Karen Helm of the University of Colorado Cancer Center Flow Cytometry Shared Resource, and the DERC Molecular Biology Core (NIH P30-DK57516) for expert technical assistance. ABLS is a Fellow of the Pediatric Scientist Development Program, supported by grants from the American Academy of Pediatrics, the American Pediatric Society, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12-HD000850). This research was also supported by grants from the National Institutes of Health (R01CA137078, DKG), and the For Julie Foundation (KE). DKG is a Damon Runyon-Novartis Clinical Investigator supported (in part) by the Damon Runyon Cancer Research Foundation (CI-39-07).	Advani AS, 2008, LEUKEMIA RES, V32, P913, DOI 10.1016/j.leukres.2007.08.019; Advani AS, 2010, LEUKEMIA RES, V34, P1622, DOI 10.1016/j.leukres.2010.03.021; Avanzi GC, 1997, EXP HEMATOL, V25, P1219; Brown P, 2004, BLOOD, V104, P1841, DOI 10.1182/blood-2004-03-1034; Bunting KD, 2004, J LEUKOCYTE BIOL, V76, P484, DOI 10.1189/jlb.0903440; Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; Guttridge KL, 2002, J BIOL CHEM, V277, P24057, DOI 10.1074/jbc.M112086200; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Kinjo K, 2005, CELL CYCLE, V4, P1134, DOI 10.4161/cc.4.9.1991; LING L, 1995, MOL CELL BIOL, V15, P6582; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu J, 2012, ACS MED CHEM LETT, V3, P129, DOI 10.1021/ml200239k; Lunghi P, 2003, LEUKEMIA, V17, P1783, DOI 10.1038/sj.leu.2403032; Meshinchi S, 2006, BLOOD, V108, P3654, DOI 10.1182/blood-2006-03-009233; Migdall-Wilson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031635; Muller-Tidow C, 2010, BLOOD, V116, P3564, DOI 10.1182/blood-2009-09-240978; Odgerel T, 2010, LEUKEMIA, V24, P1087, DOI 10.1038/leu.2010.48; Pfirrmann M, 2012, LANCET ONCOL, V13, P207, DOI 10.1016/S1470-2045(11)70326-6; Pigazzi M, 2007, HAEMATOLOGICA, V92, P1435, DOI 10.3324/haematol.11122; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Pulte D, 2010, ANN ONCOL, V21, P335, DOI 10.1093/annonc/mdp309; Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588; Sander A, 2010, LEUKEMIA, V24, P1422, DOI 10.1038/leu.2010.127; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Trifilio SM, 2012, LEUKEMIA RES, V36, P394, DOI 10.1016/j.leukres.2011.10.027; Wang HK, 2007, HAEMATOL-HEMATOL J, V92, P643, DOI 10.3324/haematol.10939; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429	35	62	73	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2013	32	46					5359	5368		10.1038/onc.2013.40	http://dx.doi.org/10.1038/onc.2013.40			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IU	23474756	Green Published, hybrid			2022-12-25	WOS:000326922400006
J	Gunning, AP; Kirby, AR; Fuell, C; Pin, C; Tailford, LE; Juge, N				Gunning, A. Patrick; Kirby, Andrew R.; Fuell, Christine; Pin, Carmen; Tailford, Louise E.; Juge, Nathalie			Mining the "glycocode"-exploring the spatial distribution of glycans in gastrointestinal mucin using force spectroscopy	FASEB JOURNAL			English	Article						atomic force microscopy; lectin-carbohydrate interaction; adhesion; molecular recognition	PORCINE SUBMAXILLARY MUCIN; TN-ANTIGEN FORM; O-GLYCANS; PEANUT AGGLUTININ; INTESTINAL-TRACT; MUCUS LAYERS; SIALIC ACIDS; MICROSCOPY; RECOGNITION; LECTINS	Mucins are the main components of the gastrointestinal mucus layer. Mucin glycosylation is critical to most intermolecular and intercellular interactions. However, due to the highly complex and heterogeneous mucin glycan structures, the encoded biological information remains largely encrypted. Here we have developed a methodology based on force spectroscopy to identify biologically accessible glycoepitopes in purified porcine gastric mucin (pPGM) and purified porcine jejunal mucin (pPJM). The binding specificity of lectins Ricinus communis agglutinin I (RCA), peanut (Arachis hypogaea) agglutinin (PNA), Maackia amurensis lectin II (MALII), and Ulex europaeus agglutinin I (UEA) was utilized in force spectroscopy measurements to quantify the affinity and spatial distribution of their cognate sugars at the molecular scale. Binding energy of 4, 1.6, and 26 aJ was determined on pPGM for RCA, PNA, and UEA. Binding was abolished by competition with free ligands, demonstrating the validity of the affinity data. The distributions of the nearest binding site separations estimated the number of binding sites in a 200-nm mucin segment to be 4 for RCA, PNA, and UEA, and 1.8 for MALII. Binding site separations were affected by partial defucosylation of pPGM. Furthermore, we showed that this new approach can resolve differences between gastric and jejunum mucins.-Gunning, A. P., Kirby, A. R., Fuell, C., Pin, C., Tailford L. E., Juge, N. Mining the "glycocode"-exploring the spatial distribution of glycans in gastrointestinal mucin using force spectroscopy.	[Gunning, A. Patrick; Kirby, Andrew R.; Fuell, Christine; Pin, Carmen; Tailford, Louise E.; Juge, Nathalie] Inst Food Res, Norwich NR4 7UA, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Juge, N (corresponding author), Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	nathalie.juge@ifr.ac.uk	pin, carmen/C-8959-2014	Juge, Nathalie/0000-0001-8515-1315	BBSRC Institute Strategic Programme, Gut Health and Food Safety [BB/J004529/1]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044406, BBS/E/F/00044452, BB/K019554/1] Funding Source: researchfish; BBSRC [BB/K019554/1, BBS/E/F/00044406, BBS/E/F/00044452] Funding Source: UKRI	BBSRC Institute Strategic Programme, Gut Health and Food Safety; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the UK Biotechnology and Biological Sciences Research Council (BBSRC). This research was partly funded by the BBSRC Institute Strategic Programme BB/J004529/1, Gut Health and Food Safety. The authors thank Mark Philo [Institute for Food Research (IFR) Metabolomics Department] as well as Mike Naldrett and Gerhard Saalbach (John Innes Centre Proteomics Facility, Norwich Research Park, Norwich, UK) for their technical support with mass spectrometry, and Emmanuelle Crost and Neil Rigby for help with mucin purification. The authors also thank Jack Dainty (IFR Bioinformatics and Statistics group) for assistance with statistical analysis and Gary Barker for assistance with the binding modeling theory and implementation. The authors are grateful to Vic Morris (IFR) for his critical review of the manuscript.	Adams EL, 2004, CARBOHYD RES, V339, P579, DOI 10.1016/j.carres.2003.11.023; Baos SC, 2012, BIOPHYS J, V102, P176, DOI 10.1016/j.bpj.2011.08.058; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Brown D, 1994, MODELS BIOL MATH STA; Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+; Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; CHEN YX, 1995, GLYCOCONJUGATE J, V12, P55, DOI 10.1007/BF00731869; Dam TK, 2007, J BIOL CHEM, V282, P28256, DOI 10.1074/jbc.M704677200; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Gunning AP, 2008, FASEB J, V22, P2331, DOI 10.1096/fj.07-100578; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Hinterdorfer P, 2002, COLLOID SURFACE B, V23, P115, DOI 10.1016/S0927-7765(01)00256-9; Hong ZN, 2005, BIOMACROMOLECULES, V6, P3458, DOI 10.1021/bm0505843; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Jeffers F, 2010, CARBOHYD RES, V345, P1486, DOI 10.1016/j.carres.2010.05.012; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jonckheere N, 2010, BIOCHIMIE, V92, P1, DOI 10.1016/j.biochi.2009.09.018; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; Kilcoyne M, 2012, ANAL CHEM, V84, P3330, DOI 10.1021/ac203404n; MARTINEZMENARGUEZ JA, 1992, HISTOCHEM J, V24, P207, DOI 10.1007/BF01046790; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; MILLER RS, 1981, GASTROENTEROLOGY, V81, P759; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Morris V. J., 2009, ATOMIC FORCE MICROSC; Oxley D., 2004, PURIFYING PROTEINS P, P579; Pierres A, 2001, BIOPHYS J, V81, P25, DOI 10.1016/S0006-3495(01)75677-9; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Robbe C, 2003, ELECTROPHORESIS, V24, P611, DOI 10.1002/elps.200390071; Robbe-Masselot C, 2009, GLYCOCONJUGATE J, V26, P397, DOI 10.1007/s10719-008-9186-9; Round AN, 2004, J STRUCT BIOL, V145, P246, DOI 10.1016/j.jsb.2003.10.029; Round AN, 2002, BIOPHYS J, V83, P1661, DOI 10.1016/S0006-3495(02)73934-9; Round AN, 2007, GLYCOBIOLOGY, V17, P578, DOI 10.1093/glycob/cwm027; Round AN, 2012, BIOMACROMOLECULES, V13, P3253, DOI 10.1021/bm301024x; Sharma V, 1998, GLYCOBIOLOGY, V8, P1007, DOI 10.1093/glycob/8.10.1007; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Sletmoen M, 2009, BIOPOLYMERS, V91, P719, DOI 10.1002/bip.21213; Wang YF, 2011, FEBS LETT, V585, P3927, DOI 10.1016/j.febslet.2011.10.035; Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3791, DOI 10.1021/bm700721c; YAO K, 1989, ANAL BIOCHEM, V179, P332, DOI 10.1016/0003-2697(89)90138-3; Zhu R, 2010, NAT NANOTECHNOL, V5, P788, DOI 10.1038/nnano.2010.212; Znamenskaya Y, 2012, J PHYS CHEM B, V116, P5047, DOI 10.1021/jp212495t	45	25	25	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2342	2354		10.1096/fj.12-221416	http://dx.doi.org/10.1096/fj.12-221416			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23493619	hybrid, Green Published			2022-12-25	WOS:000319667600023
J	Wheatley, RW; Lo, S; Jancewicz, LJ; Dugdale, ML; Huber, RE				Wheatley, Robert W.; Lo, Summie; Jancewicz, Larisa J.; Dugdale, Megan L.; Huber, Reuben E.			Structural Explanation for Allolactose (lac Operon Inducer) Synthesis by lacZ beta-Galactosidase and the Evolutionary Relationship between Allolactose Synthesis and the lac Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; KLUYVEROMYCES-LACTIS; LACTOSE HYDROLYSIS; METAL-BINDING; CONFORMATIONS; OPTIMIZATION; REACTIVITY; CATALYSIS; VARIANTS	beta-Galactosidase (lacZ) has bifunctional activity. It hydrolyzes lactose to galactose and glucose and catalyzes the intramolecular isomerization of lactose to allolactose, the lac operon inducer. beta-Galactosidase promotes the isomerization by means of an acceptor site that binds glucose after its cleavage from lactose and thus delays its exit from the site. However, because of its relatively low affinity for glucose, details of this site have remained elusive. We present structural data mapping the glucose site based on a substituted enzyme (G794A-beta-galactosidase) that traps allolactose. Various lines of evidence indicate that the glucose of the trapped allolactose is in the acceptor position. The evidence includes structures with Bis-Tris (2,2-bis(hydroxymethyl)-2,2',2 ''-nitrilotriethanol) and L-ribose in the site and kinetic binding studies with substituted beta-galactosidases. The site is composed of Asn-102, His-418, Lys-517, Ser796, Glu-797, and Trp-999. Ser-796 and Glu-797 are part of a loop (residues 795-803) that closes over the active site. This loop appears essential for the bifunctional nature of the enzyme because it helps form the glucose binding site. In addition, because the loop is mobile, glucose binding is transient, allowing the release of some glucose. Bioinformatics studies showed that the residues important for interacting with glucose are only conserved in a subset of related enzymes. Thus, intramolecular isomerization is not a universal feature of beta-galactosidases. Genomic analyses indicated that lac repressors were co-selected only within the conserved subset. This shows that the glucose binding site of beta-galactosidase played an important role in lac operon evolution.	[Wheatley, Robert W.; Lo, Summie; Jancewicz, Larisa J.; Dugdale, Megan L.; Huber, Reuben E.] Univ Calgary, Fac Sci, Div Biochem, Calgary, AB T2N 1N4, Canada	University of Calgary	Huber, RE (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	huber@ucalgary.ca						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; BOOS W, 1982, METHOD ENZYMOL, V89, P59; BURCHHARDT G, 1991, GENE, V106, P13, DOI 10.1016/0378-1119(91)90560-X; BURSTEIN C, 1965, BIOCHIM BIOPHYS ACTA, V95, P634, DOI 10.1016/0005-2787(65)90517-4; Daber R, 2007, J MOL BIOL, V370, P609, DOI 10.1016/j.jmb.2007.04.028; DESCHAVANNE PJ, 1978, J BIOL CHEM, V253, P833; Dugdale ML, 2010, BIOCHEM CELL BIOL, V88, P969, DOI 10.1139/O10-144; Dugdale ML, 2010, BIOCHEM CELL BIOL, V88, P861, DOI 10.1139/O10-009; EDWARDS RA, 1992, BIOCHEM CELL BIOL, V70, P63, DOI 10.1139/o92-009; EGEL R, 1979, J THEOR BIOL, V79, P117, DOI 10.1016/0022-5193(79)90260-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; FOWLER AV, 1978, J BIOL CHEM, V253, P5521; GEBLER JC, 1992, J BIOL CHEM, V267, P11126; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALL BG, 1974, GENETICS, V76, P391; Huber RE, 2003, BIOCHEMISTRY-US, V42, P1796, DOI 10.1021/bi0270642; HUBER RE, 1984, ARCH BIOCHEM BIOPHYS, V234, P151, DOI 10.1016/0003-9861(84)90336-9; Huber RE, 1996, J PROTEIN CHEM, V15, P621, DOI 10.1007/BF01886744; HUBER RE, 1976, BIOCHEMISTRY-US, V15, P1994, DOI 10.1021/bi00654a029; HUBER RE, 1975, CAN J BIOCHEM CELL B, V53, P1035, DOI 10.1139/o75-142; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jancewicz L., 2008, THESIS U CALGARY CAL; Jancewicz LJ, 2012, ARCH BIOCHEM BIOPHYS, V517, P111, DOI 10.1016/j.abb.2011.11.017; JOBE A, 1972, J MOL BIOL, V69, P397, DOI 10.1016/0022-2836(72)90253-7; Juers DH, 2003, BIOCHEMISTRY-US, V42, P13505, DOI 10.1021/bi035506j; Juers DH, 2001, BIOCHEMISTRY-US, V40, P14781, DOI 10.1021/bi011727i; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Juers DH, 2009, PROTEIN SCI, V18, P1281, DOI 10.1002/pro.140; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim CS, 2004, BIOCHEM BIOPH RES CO, V316, P738, DOI 10.1016/j.bbrc.2004.02.118; Kumari M, 2011, PHYS CHEM CHEM PHYS, V13, P6517, DOI 10.1039/c0cp02559c; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, P50; Lo S, 2010, PROTEIN J, V29, P26, DOI 10.1007/s10930-009-9216-x; Mahoney RR, 1998, FOOD CHEM, V63, P147, DOI 10.1016/S0308-8146(98)00020-X; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Martinez-Villaluenga C, 2008, FOOD CHEM, V107, P258, DOI 10.1016/j.foodchem.2007.08.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pereira-Rodriguez A, 2012, J STRUCT BIOL, V177, P392, DOI 10.1016/j.jsb.2011.11.031; Richard JP, 1996, BIOCHEMISTRY-US, V35, P12377, DOI 10.1021/bi961028j; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stoebel DM, 2005, MOL BIOL EVOL, V22, P683, DOI 10.1093/molbev/msi056; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; TURNER CL, 1977, J MOL BIOL, V115, P195, DOI 10.1016/0022-2836(77)90096-1; Wheatley RW, 2012, ARCH BIOCHEM BIOPHYS, V521, P51, DOI 10.1016/j.abb.2012.03.014	51	30	31	3	216	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12993	13005		10.1074/jbc.M113.455436	http://dx.doi.org/10.1074/jbc.M113.455436			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486479	Green Published, hybrid			2022-12-25	WOS:000318555100052
J	Gallego, P; Velazquez-Campoy, A; Regue, L; Roig, J; Reverter, D				Gallego, Pablo; Velazquez-Campoy, Adrian; Regue, Laura; Roig, Joan; Reverter, David			Structural Analysis of the Regulation of the DYNLL/LC8 Binding to Nek9 by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; NIMA-FAMILY KINASE; INTERMEDIATE CHAIN; CYTOPLASMIC DYNEIN; LC8; DIMERIZATION; SWALLOW; DIMER; CENTROSOME; SEPARATION	The NIMA family protein kinases Nek9/Nercc1, Nek6, and Nek7 constitute a signaling module activated in early mitosis involved in the control of spindle organization. DYNLL/LC8 (dynein light chain 8) was originally described as a component of the dynein complex, but the recent discovery of multiple interaction partners for LC8 has suggested that it has a general role as a dimerization hub that organizes different protein partners. Recent experiments suggested that LC8 binding to Nek9 was regulated by Nek9 autophosphorylation on Ser(944), a residue immediately located N-terminal to the LC8 conserved (K/R)x-TQT binding motif, and that this was crucial for the control of signal transduction through the Nek/Nek6/7 module. In the present work, we present two crystal structures of LC8 with a peptide corresponding to the Nek9 binding region with and without a phosphorylation on Ser944. Structural analysis of LC8 with both Nek9 peptides, together with different biophysical experiments, explains the observed diminished binding affinity of Nek9 to LC8 upon phosphorylation on Ser944 within the Nek9 sequence, thus shedding light into a novel phosphorylation regulatory mechanism that interferes with LC8 protein.protein complex formation.	[Gallego, Pablo; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Struct Biol Unit, Bellaterra 08193, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Consejo Super Invest Cient BIFI, Dept Biochem & Mol & Cell Biol, E-50009 Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Consejo Super Invest Cient BIFI, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit IQFR, E-50009 Zaragoza, Spain; [Velazquez-Campoy, Adrian] 500018 Govt Aragon, Fdn ARAID, Aragon, Spain; [Regue, Laura; Roig, Joan] Inst Res Biomed, Barcelona 08028, Spain	Autonomous University of Barcelona; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Reverter, D (corresponding author), Univ Autonoma Barcelona, E-08193 Barcelona, Spain.	david.reverter@uab.cat	Velazquez-Campoy, Adrian/E-7946-2012; Barrufet, Laura Regue/AAB-9465-2020; Reverter, David/H-5360-2015; Roig, Joan/E-2836-2017	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Barrufet, Laura Regue/0000-0003-1341-3413; Reverter, David/0000-0002-5347-0992; Roig, Joan/0000-0002-3872-4712	"Ministerio de Ciencia e Innovacion" of Spain [BFU2012-37116, BFU2010-19451, BFU2011-25855]; European Community Grant [MIRG-CT-2007-200346]; Formacion Personal Investigador fellowship from the "Ministerio de Ciencia e Innovacion" of Spain; I3 program from the "Ministerio de Ciencia e Innovacion" of Spain; Ramon y Cajal program from the "Ministerio de Ciencia e Innovacion" of Spain	"Ministerio de Ciencia e Innovacion" of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community Grant(European Commission); Formacion Personal Investigador fellowship from the "Ministerio de Ciencia e Innovacion" of Spain; I3 program from the "Ministerio de Ciencia e Innovacion" of Spain; Ramon y Cajal program from the "Ministerio de Ciencia e Innovacion" of Spain	This work was supported by "Ministerio de Ciencia e Innovacion" of Spain Grants BFU2012-37116 (to D. R.), BFU2010-19451 (to A. V. C.), and BFU2011-25855 (to J. R.) and European Community Grant MIRG-CT-2007-200346 (to D. R.).; Supported by the Formacion Personal Investigador fellowship from the "Ministerio de Ciencia e Innovacion" of Spain.; Supported by the I3 program from the "Ministerio de Ciencia e Innovacion" of Spain.; Supported by the Ramon y Cajal program from the "Ministerio de Ciencia e Innovacion" of Spain. To whom the correspondence should be addressed: Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. Tel.: 93-5868955; Fax: 93-5812011; E-mail: david.reverter@uab.cat.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; GOMEZ J, 1995, J MOL BIOL, V252, P337, DOI 10.1006/jmbi.1995.0501; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaiser FJ, 2003, HUM MOL GENET, V12, P1349, DOI 10.1093/hmg/ddg145; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mohan PMK, 2006, PROTEIN SCI, V15, P335, DOI 10.1110/ps.051854906; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Radnai L, 2010, J BIOL CHEM, V285, P38649, DOI 10.1074/jbc.M110.165894; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Regue L, 2011, J BIOL CHEM, V286, P18118, DOI 10.1074/jbc.M110.209080; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Sdelci S, 2012, CURR BIOL, V22, P1516, DOI 10.1016/j.cub.2012.06.027; Sdelci S, 2011, CELL CYCLE, V10, P3816, DOI 10.4161/cc.10.22.18226; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Velazquez-Campoy A, 2000, PROTEIN SCI, V9, P1801, DOI 10.1110/ps.9.9.1801; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069	48	20	22	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12283	12294		10.1074/jbc.M113.459149	http://dx.doi.org/10.1074/jbc.M113.459149			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482567	Green Published, hybrid			2022-12-25	WOS:000318157600059
J	Al-Faqheri, W; Ibrahim, F; Thio, THG; Moebius, J; Joseph, K; Arof, H; Madou, M				Al-Faqheri, Wisam; Ibrahim, Fatimah; Thio, Tzer Hwai Gilbert; Moebius, Jacob; Joseph, Karunan; Arof, Hamzah; Madou, Marc			Vacuum/Compression Valving (VCV) Using Parrafin-Wax on a Centrifugal Microfluidic CD Platform	PLOS ONE			English	Article							VALVES	This paper introduces novel vacuum/compression valves (VCVs) utilizing paraffin wax. A VCV is implemented by sealing the venting channel/hole with wax plugs (for normally-closed valve), or to be sealed by wax (for normally-open valve), and is activated by localized heating on the CD surface. We demonstrate that the VCV provides the advantages of avoiding unnecessary heating of the sample/reagents in the diagnostic process, allowing for vacuum sealing of the CD, and clear separation of the paraffin wax from the sample/reagents in the microfluidic process. As a proof of concept, the microfluidic processes of liquid flow switching and liquid metering is demonstrated with the VCV. Results show that the VCV lowers the required spinning frequency to perform the microfluidic processes with high accuracy and ease of control.	[Al-Faqheri, Wisam; Ibrahim, Fatimah; Thio, Tzer Hwai Gilbert; Moebius, Jacob; Joseph, Karunan; Madou, Marc] Univ Malaya, Dept Biomed Engn, Med Informat & Biol Microelectromech Syst Special, Fac Engn, Kuala Lumpur, Malaysia; [Arof, Hamzah] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Moebius, Jacob; Madou, Marc] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Madou, Marc] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92717 USA; [Madou, Marc] World Class Univ, Ulsan Natl Inst Sci & Technol, Ulsan, South Korea	Universiti Malaya; Universiti Malaya; University of California System; University of California Irvine; University of California System; University of California Irvine; Ulsan National Institute of Science & Technology (UNIST)	Ibrahim, F (corresponding author), Univ Malaya, Dept Biomed Engn, Med Informat & Biol Microelectromech Syst Special, Fac Engn, Kuala Lumpur, Malaysia.	fatimah@um.edu.my	AROF, HAMZAH/ABI-1052-2020; Madou, Marc J./E-5869-2013; Thio, Tzer Hwai Gilbert/AGG-4429-2022; IBRAHIM, FATIMAH/B-8506-2010	Madou, Marc J./0000-0003-4847-3117; IBRAHIM, FATIMAH/0000-0003-1804-4362; Thio, Tzer Hwai Gilbert/0000-0002-4192-3720	University of Malaya, Ministry of Higher Education High Impact Research [UM/HIR/MOHE/ENG/05]; University of Malaya Research Grant [UMRG: RG023/09AET]; grant "Hitsto-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Ministry of Science, Technology and Innovation" [MOSTI IPHARM 53-02-03-1049]; WCU (World Class University) program through the National Research Foundation of Korea [R32-2008-000-20054-0]; Ministry of Education, Science and Technology	University of Malaya, Ministry of Higher Education High Impact Research; University of Malaya Research Grant; grant "Hitsto-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Ministry of Science, Technology and Innovation"; WCU (World Class University) program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was financially supported by University of Malaya, Ministry of Higher Education High Impact Research (UM/HIR/MOHE/ENG/05), and University of Malaya Research Grant (UMRG: RG023/09AET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to acknowledge Prof. Dr. Noorsaadah Abd Rahman from Department of Chemistry, Faculty of Science, University of Malaya and her grant "Hitsto-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Ministry of Science, Technology and Innovation (MOSTI IPHARM 53-02-03-1049)" for partially sponsoring the initial set-up of the CD Spin Test System. MM also acknowledges support of WCU (World Class University) program (R32-2008-000-20054-0) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Abi-Samra K, 2011, LAB CHIP, V11, P723, DOI 10.1039/c0lc00160k; Allen BP, 2005, Patent No US, Patent No. [2007/0227592 A1, 20070227592]; Amasia M, 2012, SENSOR ACTUAT B-CHEM, V161, P1191, DOI 10.1016/j.snb.2011.11.080; Benito-Lopez F, 2010, LAB CHIP, V10, P195, DOI 10.1039/b914709h; Burger R, 2012, LAB CHIP, V12, P1289, DOI 10.1039/c2lc21170j; Cho YC, 2008, Patent No US, Patent No. [8,057,759 B2, 8057759]; Ducree J, 2007, J MICROMECH MICROENG, V17, pS103, DOI 10.1088/0960-1317/17/7/S07; Focke M, 2010, LAB CHIP, V10, P2519, DOI 10.1039/c004954a; Ibrahim F., 2010, 2010 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2010), P466, DOI 10.1109/IECBES.2010.5742282; Imaad SM, 2011, LAB CHIP, V11, P1448, DOI 10.1039/c0lc00451k; Kim J, 2008, SENSOR ACTUAT B-CHEM, V128, P613, DOI 10.1016/j.snb.2007.07.079; Kong MCR, 2011, ANAL CHEM, V83, P1148, DOI 10.1021/ac102563g; Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322; Liu RH, 2004, SENSOR ACTUAT B-CHEM, V98, P328, DOI 10.1016/j.snb.2003.09.037; Madou M, 2006, ANNU REV BIOMED ENG, V8, P601, DOI 10.1146/annurev.bioeng.8.061505.095758; Mark D, 2011, MICROFLUID NANOFLUID, V10, P1279, DOI 10.1007/s10404-010-0759-0; Mark D, 2009, LAB CHIP, V9, P3599, DOI 10.1039/b914415c; Morijiri T, 2012, MICROFLUID NANOFLUID, P722; Oh K.W., 2005, MICROTOTAL ANAL SYST, V1, P554; Oh KW, 2006, J MICROMECH MICROENG, V16, pR13, DOI 10.1088/0960-1317/16/5/R01; Siegrist J, 2010, MICROFLUID NANOFLUID, V9, P55, DOI 10.1007/s10404-009-0523-5; Sugiura S, 2009, LAB CHIP, V9, P196, DOI 10.1039/b810717c; Thio T, 2011, IFMBE PROC, V35, P578, DOI 10.1007/978-3-642-21729-6_144; Thio THG, 2013, MED BIOL ENG COMPUT, V51, P525, DOI 10.1007/s11517-012-1020-7; Yang EH, 1996, SENSOR ACTUAT A-PHYS, V57, P75, DOI 10.1016/S0924-4247(97)80097-0; Yusoff Nurul Aini, 2009, 2009 IEEE Symposium on Industrial Electronics & Applications (ISIEA 2009), P946, DOI 10.1109/ISIEA.2009.5356330; Zoval JV, 2004, P IEEE, V92, P140, DOI 10.1109/JPROC.2003.820541	27	49	50	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58523	10.1371/journal.pone.0058523	http://dx.doi.org/10.1371/journal.pone.0058523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505528	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000316251100059
J	Guiraldelli, MF; Franca, CN; de Souza, DA; da Silva, EZM; Toso, VD; Carvalho, CC; Jamur, MC; Oliver, C				Guiraldelli, Michel Farchi; Franca, Carolina Nunes; de Souza, Devandir Antonio, Jr.; Marcelino da Silva, Elaine Zayas; Toso, Vanina Danuza; Carvalho, Celiane Cardoso; Jamur, Maria Celia; Oliver, Constance			Rat Embryonic Mast Cells Originate in the AGM	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BASOPHILIC LEUKEMIA-CELLS; GONAD-MESONEPHROS REGION; MONOCLONAL-ANTIBODY AA4; YOLK-SAC; BONE-MARROW; MOUSE EMBRYO; FETAL LIVER; PRECURSORS; BINDING	Mast cells originate from pluripotent hematopoietic stem cells. Two mast cell specific antibodies, mAbsAA4 and BGD6, have previously been used to identify and study committed mast cell precursors (MCcps) in the bone marrow of adult mice and rats. However, the embryonic origin of MCcps is still not known. In the present study, we identified MCcps in rat embryos using these previously characterized mast cell specific antibodies. The MCcps were found in the AGM (aorta-gonad-mesonephros) region of rat embryos at E11.5. These cells were BGD6+, CD34(+), c-kit(+), CD13(+), Fc epsilon RI-, AA4(-) CD40(-), and Thy-1(-). By PCR the cells contained message for the alpha and beta subunits of Fc epsilon RI and mast cell specific proteases. In vitro, the MCcps differentiated into metachromatic mast cells. With age of gestation the percent of MCcps diminished while the percent of mast cell progenitors increased. An increased knowledge of the biology and embryonic origin of mast cells may contribute to a greater understanding of allergy, asthma, and other mast cell related diseases.	[Guiraldelli, Michel Farchi; Franca, Carolina Nunes; de Souza, Devandir Antonio, Jr.; Marcelino da Silva, Elaine Zayas; Toso, Vanina Danuza; Carvalho, Celiane Cardoso; Jamur, Maria Celia; Oliver, Constance] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol & Pathogen Bioagents, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo	Oliver, C (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol & Pathogen Bioagents, BR-14049 Ribeirao Preto, Brazil.	coliver@fmrp.usp.br	França, Carolina Nunes/J-2429-2015; Da Silva, Elaine Z/O-5535-2015; Jamur, Maria Celia/L-5520-2016; Guiraldelli, Michel/H-1710-2013	França, Carolina Nunes/0000-0002-4167-4293; Da Silva, Elaine Z/0000-0002-2749-6275; Jamur, Maria Celia/0000-0001-7065-8543; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 03/00543-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/) and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 03/00543-2, http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BASCIANO LK, 1986, J BIOL CHEM, V261, P1823; BEAUPAIN D, 1979, BLOOD, V53, P212; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Boisset JC, 2012, STEM CELL RES, V8, P1, DOI 10.1016/j.scr.2011.07.002; Combs JW, 1966, J CELL BIOL, V48, P676; Costa G, 2012, TRENDS IMMUNOL, V33, P215, DOI 10.1016/j.it.2012.01.012; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; Frossi B, 2010, TRENDS IMMUNOL, V31, P97, DOI 10.1016/j.it.2009.12.007; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Guiraldelli MF, 2008, MOL IMMUNOL, V45, P2411, DOI 10.1016/j.molimm.2007.07.041; GUO N, 1989, J BIOL CHEM, V264, P13267; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Jamur MC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-32; Jamur MC, 1997, J HISTOCHEM CYTOCHEM, V45, P1715, DOI 10.1177/002215549704501215; Jamur MC, 2001, J HISTOCHEM CYTOCHEM, V49, P219, DOI 10.1177/002215540104900209; Jamur MC, 2005, BLOOD, V105, P4282, DOI 10.1182/blood-2004-02-0756; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; KITAMURA Y, 1979, DEV BIOL, V70, P510, DOI 10.1016/0012-1606(79)90042-3; KITAMURA Y, 1979, J EXP MED, V150, P482, DOI 10.1084/jem.150.3.482; LASSILA O, 1982, BLOOD, V59, P377; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; OLIVER C, 1992, J CELL BIOL, V116, P635, DOI 10.1083/jcb.116.3.635; Palis J, 1999, DEVELOPMENT, V126, P5073; Palis J, 2001, P NATL ACAD SCI USA, V98, P4528, DOI 10.1073/pnas.071002398; SONODA T, 1983, DEV BIOL, V97, P89, DOI 10.1016/0012-1606(83)90066-0; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; Taylor E, 2010, INT J DEV BIOL, V54, P1055, DOI 10.1387/ijdb.103152et; TURPEN JB, 1981, DEV BIOL, V85, P99, DOI 10.1016/0012-1606(81)90239-6; WONG PMC, 1986, P NATL ACAD SCI USA, V83, P3851, DOI 10.1073/pnas.83.11.3851; Yong LCJ, 1997, EXP TOXICOL PATHOL, V49, P409, DOI 10.1016/S0940-2993(97)80129-7; Yuan Q, 1998, J IMMUNOL, V161, P5143	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57862	10.1371/journal.pone.0057862	http://dx.doi.org/10.1371/journal.pone.0057862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505443	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500035
J	Hebert, SL; Daniel, ML; McLoon, LK				Hebert, Sadie L.; Daniel, Mark L.; McLoon, Linda K.			The Role of Pitx2 in Maintaining the Phenotype of Myogenic Precursor Cells in the Extraocular Muscles	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; HETEROGENEITY; PROLIFERATION; SPECIFICATION; MYOBLASTS; PATHOLOGY; MYOFIBERS	Many differences exist between extraocular muscles (EOM) and non-cranial skeletal muscles. One striking difference is the sparing of EOM in various muscular dystrophies compared to non-cranial skeletal muscles. EOM undergo continuous myonuclear remodeling in normal, uninjured adults, and distinct transcription factors are required for the early determination, development, and maintenance of EOM compared to limb skeletal muscle. Pitx2, a bicoid-like homeobox transcription factor, is required for the development of EOM and the maintenance of characteristic properties of the adult EOM phenotype, but is not required for the development of limb muscle. We hypothesize that these unique properties of EOM contribute to the constitutive differences between EOM and non-craniofacial skeletal muscles. Using flow cytometry, CD34(+)/Sca1(-/)CD45(-/)CD31(-) cells (EECD34 cells) were isolated from extraocular and limb skeletal muscle and in vitro, EOM EECD34 cells proliferated faster than limb muscle EECD34 cells. To further define these myogenic precursor cells from EOM and limb skeletal muscle, they were analyzed for their expression of Pitx2. Western blotting and immunohistochemical data demonstrated that EOM express higher levels of Pitx2 than limb muscle, and 80% of the EECD34 cells expressed Pitx2. siRNA knockdown of Pitx2 expression in EECD34 cells in vitro decreased proliferation rates and impaired the ability of EECD34 cells to fuse into multinucleated myotubes. High levels of Pitx2 were retained in dystrophic and aging mouse EOM and the EOM EECD34 cells compared to limb muscle. The differential expression of Pitx2 between EOM and limb skeletal muscle along with the functional changes in response to lower levels of Pitx2 expression in the myogenic precursor cells suggest a role for Pitx2 in the maintenance of constitutive differences between EOM and limb skeletal muscle that may contribute to the sparing of EOM in muscular dystrophies.	[Hebert, Sadie L.; Daniel, Mark L.; McLoon, Linda K.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [McLoon, Linda K.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McLoon, LK (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	mcloo001@tc.umn.edu		McLoon, LInda/0000-0001-9714-4681	National Eye Institute from NIDCR [EY55137, EY11375, T32DE007288]; Medical School; Minnesota Medical Foundation; Minnesota Lions; Lionesses; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [P30EY011374, R01EY015313] Funding Source: NIH RePORTER	National Eye Institute from NIDCR; Medical School; Minnesota Medical Foundation; Minnesota Lions; Lionesses; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by EY55137 and EY11375 from the National Eye Institute, T32DE007288 from NIDCR (SLH), Medical School Grant-in-Aid, Minnesota Medical Foundation, Minnesota Lions and Lionesses, and an unrestricted grant to the Department of Ophthalmology from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BEHR T, 1994, CLIN INVESTIGATOR, V72, P150; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Diehl AG, 2006, INVEST OPHTH VIS SCI, V47, P1785, DOI 10.1167/iovs.05-1424; Fischer MD, 2002, PHYSIOL GENOMICS, V9, P71, DOI 10.1152/physiolgenomics.00115.2001; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gherzi R, 2010, CELL DEATH DIFFER, V17, P975, DOI 10.1038/cdd.2009.194; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grefte S, 2012, EUR J ORAL SCI, V120, P38, DOI 10.1111/j.1600-0722.2011.00920.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Kallestad KM, 2011, EXP CELL RES, V317, P873, DOI 10.1016/j.yexcr.2011.01.018; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; KARPATI G, 1988, MUSCLE NERVE, V11, P795, DOI 10.1002/mus.880110802; KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606; KHURANA TS, 1995, J EXP MED, V182, P467, DOI 10.1084/jem.182.2.467; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kitamura K, 1999, DEVELOPMENT, V126, P5749; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Lagord C, 1998, CELL TISSUE RES, V291, P455, DOI 10.1007/s004410051015; Lucas CA, 1997, INVEST OPHTH VIS SCI, V38, P2817; Martinez-Fernandez S, 2006, DEV DYNAM, V235, P2930, DOI 10.1002/dvdy.20924; McLoon Linda K, 2002, Trans Am Ophthalmol Soc, V100, P119; McLoon LK, 2004, MUSCLE NERVE, V29, P707, DOI 10.1002/mus.20012; McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P1927, DOI 10.1167/iovs.02-0673; McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056; McLoon LK, 2011, ADLERS PHYSL EYE, P182; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Perie S, 2006, NEUROMUSCULAR DISORD, V16, P770, DOI 10.1016/j.nmd.2006.07.022; Porter JD, 2001, P NATL ACAD SCI USA, V98, P12062, DOI 10.1073/pnas.211257298; Porter JD, 2003, FASEB J, V17, P893, DOI 10.1096/fj.02-0810fje; Ragusa RJ, 1997, NEUROMUSCULAR DISORD, V7, P379, DOI 10.1016/S0960-8966(97)00096-5; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Ugalde I, 2005, INVEST OPHTH VIS SCI, V46, P4114, DOI 10.1167/iovs.05-0549; Wehling M, 1998, NEUROMUSCULAR DISORD, V8, P22, DOI 10.1016/S0960-8966(97)00136-3; Zacharias AL, 2011, DEV BIOL, V349, P395, DOI 10.1016/j.ydbio.2010.10.028; Zhou YF, 2011, J PHYSIOL-LONDON, V589, P4601, DOI 10.1113/jphysiol.2011.207076; Zhou YF, 2009, INVEST OPHTH VIS SCI, V50, P4531, DOI 10.1167/iovs.08-2950	44	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58405	10.1371/journal.pone.0058405	http://dx.doi.org/10.1371/journal.pone.0058405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505501	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500078
J	La Marca, A; Sighinolfi, G; Papaleo, E; Cagnacci, A; Volpe, A; Faddy, MJ				La Marca, Antonio; Sighinolfi, Giovanna; Papaleo, Enrico; Cagnacci, Angelo; Volpe, Annibale; Faddy, Malcolm J.			Prediction of Age at Menopause from Assessment of Ovarian Reserve May Be Improved by Using Body Mass Index and Smoking Status	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ANTIMULLERIAN HORMONE; NATURAL MENOPAUSE; BREAST-CANCER; WOMEN; POPULATION; TRANSITION; NUMBER; BIRTH; RISK	Objective: Menopause is the consequence of exhaustion of the ovarian follicular pool. AMH, an indirect hormonal marker of ovarian reserve, has been recently proposed as a predictor for age at menopause. Since BMI and smoking status are relevant independent factors associated with age at menopause we evaluated whether a model including all three of these variables could improve AMH-based prediction of age at menopause. Methods: In the present cohort study, participants were 375 eumenorrheic women aged 19-44 years and a sample of 2,635 Italian menopausal women. AMH values were obtained from the eumenorrheic women. Results: Regression analysis of the AMH data showed that a quadratic function of age provided a good description of these data plotted on a logarithmic scale, with a distribution of residual deviates that was not normal but showed significant left-skewness. Under the hypothesis that menopause can be predicted by AMH dropping below a critical threshold, a model predicting menopausal age was constructed from the AMH regression model and applied to the data on menopause. With the AMH threshold dependent on the covariates BMI and smoking status, the effects of these covariates were shown to be highly significant. Conclusions: In the present study we confirmed the good level of conformity between the distributions of observed and AMH-predicted ages at menopause, and showed that using BMI and smoking status as additional variables improves AMH-based prediction of age at menopause.	[La Marca, Antonio; Sighinolfi, Giovanna; Cagnacci, Angelo; Volpe, Annibale] Univ Modena, Inst Obstet & Gynaecol, Mother Infant Dept, I-41100 Modena, Italy; [La Marca, Antonio; Sighinolfi, Giovanna; Cagnacci, Angelo; Volpe, Annibale] Reggio Emilia, Modena, Italy; [Papaleo, Enrico] Hosp San Raffaele, Ctr Natalita, Dept Obstet Gynecol, I-20132 Milan, Italy; [Faddy, Malcolm J.] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Queensland University of Technology (QUT)	La Marca, A (corresponding author), Univ Modena, Inst Obstet & Gynaecol, Mother Infant Dept, I-41100 Modena, Italy.	antlamarca@libero.it	La Marca, Antonio/A-5940-2015; Sighinolfi, Giovanna/AAM-4723-2021; Cagnacci, Angelo/Q-7432-2016; Papaleo, Enrico/AAN-9591-2021	La Marca, Antonio/0000-0001-7921-9547; Cagnacci, Angelo/0000-0003-2714-623X; Papaleo, Enrico/0000-0003-0281-9143				BAILEY A, 1977, LANCET, V2, P722; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Broekmans Frank J, 2004, Menopause, V11, P607, DOI 10.1097/01.GME.0000123643.76105.27; Broekmans FJM, 2010, FERTIL STERIL, V94, P1044, DOI 10.1016/j.fertnstert.2009.04.040; Broer SL, 2011, J CLIN ENDOCR METAB, V96, P2532, DOI 10.1210/jc.2010-2776; Cagnacci A, SEASONAL ONSET MENOP; DANIELL HW, 1978, LANCET, V2, P373; Farley T, 2006, HUM REPROD UPDATE, V12, P483, DOI 10.1093/humupd/dml028; Gougeon A, 1998, MATURITAS, V30, P137, DOI 10.1016/S0378-5122(98)00069-3; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Hardy R, 2000, INT J EPIDEMIOL, V29, P845, DOI 10.1093/ije/29.5.845; Jones MC, 2003, J R STAT SOC B, V65, P159, DOI 10.1111/1467-9868.00378; Kok HS, 2006, MENOPAUSE, V13, P19, DOI 10.1097/01.gme.0000196592.36711.a0; KRITZSILVERSTEIN D, 1993, AM J PUBLIC HEALTH, V83, P983, DOI 10.2105/AJPH.83.7.983; La Marca A, 2010, REPROD BIOMED ONLINE, V21, P463, DOI 10.1016/j.rbmo.2010.05.009; La Marca A, 2012, EUR J OBSTET GYN R B, V163, P180, DOI 10.1016/j.ejogrb.2012.04.013; Lambalk CB, 1998, MATURITAS, V30, P215, DOI 10.1016/S0378-5122(98)00076-0; Monninkhof EM, 1999, BREAST CANCER RES TR, V55, P285, DOI 10.1023/A:1006277207963; Nelson SM, 2011, FERTIL STERIL, V95, P736, DOI 10.1016/j.fertnstert.2010.08.022; Parazzini F, 2007, MATURITAS, V56, P280, DOI 10.1016/j.maturitas.2006.09.003; Plante BJ, 2010, MENOPAUSE, V17, P571, DOI 10.1097/gme.0b013e3181c7deba; Schildkraut JM, 2001, OBSTET GYNECOL, V98, P85, DOI 10.1016/S0029-7844(01)01388-6; SHERMAN B, 1981, J CLIN ENDOCR METAB, V52, P488, DOI 10.1210/jcem-52-3-488; Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3478, DOI 10.1210/jc.2008-0567; Tehrani FR, 2011, MENOPAUSE, V18, P766, DOI 10.1097/gme.0b013e318205e2ac; Tehrani FR, 2009, MENOPAUSE, V16, P797, DOI 10.1097/gme.0b013e318193e95d; van Disseldorp J, 2008, J CLIN ENDOCR METAB, V93, P2129, DOI 10.1210/jc.2007-2093; van Disseldorp J, 2010, HUM REPROD, V25, P221, DOI 10.1093/humrep/dep366; van Wayenburg CAM, 2000, EPIDEMIOLOGY, V11, P304, DOI 10.1097/00001648-200005000-00013; vanNoord PAH, 1997, FERTIL STERIL, V68, P95, DOI 10.1016/S0015-0282(97)81482-3; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Waylen AL, 2010, REPROD BIOMED ONLINE, V20, P861, DOI 10.1016/j.rbmo.2010.02.021	33	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57005	10.1371/journal.pone.0057005	http://dx.doi.org/10.1371/journal.pone.0057005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505417	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500009
J	Shull, AY; Clendenning, ML; Ghoshal-Gupta, S; Farrell, CL; Vangapandu, HV; Dudas, L; Wilkerson, BJ; Buckhaults, PJ				Shull, Austin Y.; Clendenning, Megan L.; Ghoshal-Gupta, Sampa; Farrell, Christopher L.; Vangapandu, Hima V.; Dudas, Larry; Wilkerson, Brent J.; Buckhaults, Phillip J.			Somatic Mutations, Allele Loss, and DNA Methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) Gene Reveals Association with Early Age of Diagnosis in Colorectal Cancer Patients	PLOS ONE			English	Article							STEM-CELLS; HOMOZYGOUS DELETION; COUNTING ALLELES; HUMAN BREAST; EARLY-STAGE; HEAD; NECK; INACTIVATION; INSTABILITY; SEQUENCES	Background: The Cub and Sushi Multiple Domains 1 (CSMD1) gene, located on the short arm of chromosome 8, codes for a type I transmembrane protein whose function is currently unknown. CSMD1 expression is frequently lost in many epithelial cancers. Our goal was to characterize the relationships between CSMD1 somatic mutations, allele imbalance, DNA methylation, and the clinical characteristics in colorectal cancer patients. Methods: We sequenced the CSMD1 coding regions in 54 colorectal tumors using the 454FLX pyrosequencing platform to interrogate 72 amplicons covering the entire coding sequence. We used heterozygous SNP allele ratios at multiple CSMD1 loci to determine allelic balance and infer loss of heterozygosity. Finally, we performed methylation-specific PCR on 76 colorectal tumors to determine DNA methylation status for CSMD1 and known methylation targets ALX4, RUNX3, NEUROG1, and CDKN2A. Results: Using 454FLX sequencing and confirming with Sanger sequencing, 16 CSMD1 somatic mutations were identified in 6 of the 54 colorectal tumors (11%). The nonsynonymous to synonymous mutation ratio of the 16 somatic mutations was 15:1, a ratio significantly higher than the expected 2:1 ratio (p = 0.014). This ratio indicates a presence of positive selection for mutations in the CSMD1 protein sequence. CSMD1 allelic imbalance was present in 19 of 37 informative cases (56%). Patients with allelic imbalance and CSMD1 mutations were significantly younger (average age, 41 years) than those without somatic mutations (average age, 68 years). The majority of tumors were methylated at one or more CpG loci within the CSMD1 coding sequence, and CSMD1 methylation significantly correlated with two known methylation targets ALX4 and RUNX3. C:G>T:A substitutions were significantly overrepresented (47%), suggesting extensive cytosine methylation predisposing to somatic mutations. Conclusions: Deep amplicon sequencing and methylation-specific PCR reveal that CSMD1 alterations can correlate with earlier clinical presentation in colorectal tumors, thus further implicating CSMD1 as a tumor suppressor gene.	[Shull, Austin Y.; Clendenning, Megan L.; Ghoshal-Gupta, Sampa; Buckhaults, Phillip J.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA; [Shull, Austin Y.; Buckhaults, Phillip J.] Georgia Hlth Sci Univ, Dept Biochem & Canc Biol, Augusta, GA USA; [Farrell, Christopher L.] Presbyterian Coll Sch Pharm, Dept Pharmaceut & Adm Sci, Clinton, SC USA; [Vangapandu, Hima V.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Dudas, Larry] Northeast Georgia Med Ctr, Dept Internal Med, Gainesville, GA USA; [Wilkerson, Brent J.] Univ Calif Davis, Med Ctr, Dept Otolaryngol Head & Neck Surg, Sacramento, CA 95817 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis	Buckhaults, PJ (corresponding author), Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA.	phillip.buckhaults@gmail.com		Vangapandu, Hima/0000-0003-4762-1990	National Institutes of Health [7R21CA127683]; NATIONAL CANCER INSTITUTE [U01CA158428, R21CA127683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this project was provided by National Institutes of Health grant 7R21CA127683. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Beckman RA, 2006, P NATL ACAD SCI USA, V103, P14140, DOI 10.1073/pnas.0606271103; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benvenuti S, 2008, HUM MUTAT, V29, P284, DOI 10.1002/humu.20648; Beuten J, 2009, CARCINOGENESIS, V30, P1372, DOI 10.1093/carcin/bgp148; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan MWY, 2004, BIOTECHNOL LETT, V26, P1289, DOI 10.1023/B:BILE.0000044922.43572.2d; Cheng XD, 2011, PROG MOL BIOL TRANSL, V101, P1, DOI 10.1016/B978-0-12-387685-0.00001-9; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Dyachenko OV, 2010, EPIGENETICS-US, V5, P569, DOI 10.4161/epi.5.7.12702; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Farrell CL, 2008, CANCER BIOL THER, V7, P609, DOI 10.4161/cbt.7.4.5623; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Herbst A, 2011, AM J GASTROENTEROL, V106, P1110, DOI 10.1038/ajg.2011.6; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Hornstein Max, 2008, Cancer Genomics & Proteomics, V5, P123; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Kashuba VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005231; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Kodach LL, 2010, CARCINOGENESIS, V31, P1567, DOI 10.1093/carcin/bgq147; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Lang MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036248; Lau WL, 2003, GENOMICS, V82, P412, DOI 10.1016/S0888-7543(03)00149-6; Lorente A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-61; Ma CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/cbt.8.10.8132; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pavlicek A, 2002, GENE, V300, P189, DOI 10.1016/S0378-1119(02)01047-8; Peltomaki P, 2012, EXP CELL RES, V318, P299, DOI 10.1016/j.yexcr.2011.12.001; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Richter TM, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-29; Scholnick SB, 2003, GENE CHROMOSOME CANC, V38, P281, DOI 10.1002/gcc.10279; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Shih IM, 2001, CANCER RES, V61, P818; Siegmund KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021657; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stratton MR, 2004, NATURE, V430, P30, DOI 10.1038/430030a; Sun PC, 2001, GENOMICS, V75, P17, DOI 10.1006/geno.2001.6587; Toomes C, 2003, GENE CHROMOSOME CANC, V37, P132, DOI 10.1002/gcc.10191; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zeitoun G, 2008, ANTICANCER RES, V28, P3609; Zhou W, 2002, LANCET, V359, P219, DOI 10.1016/S0140-6736(02)07448-2; Zhou W, 2001, NAT BIOTECHNOL, V19, P78, DOI 10.1038/83572; Zou Hongzhi, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P499	62	24	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58731	10.1371/journal.pone.0058731	http://dx.doi.org/10.1371/journal.pone.0058731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505554	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500119
J	Ueda, Y; Kaido, T; Ogura, Y; Ogawa, K; Yoshizawa, A; Hata, K; Fujimoto, Y; Miyagawa-Hayashino, A; Haga, H; Marusawa, H; Teramukai, S; Uemoto, S; Chiba, T				Ueda, Yoshihide; Kaido, Toshimi; Ogura, Yasuhiro; Ogawa, Kohei; Yoshizawa, Atsushi; Hata, Koichiro; Fujimoto, Yasuhiro; Miyagawa-Hayashino, Aya; Haga, Hironori; Marusawa, Hiroyuki; Teramukai, Satoshi; Uemoto, Shinji; Chiba, Tsutomu			Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; RIBAVIRIN THERAPY; GENOTYPE 1B; PEGYLATED INTERFERON; PLUS RIBAVIRIN; COMBINATION THERAPY; NATURAL-HISTORY; PEG-INTERFERON; RECURRENCE; INFECTION	Background: Given the limited efficacy and high adverse event rate associated with treatment of recurrent hepatitis C after liver transplantation, an individualized treatment strategy should be considered. The aim of this study was to identify predictors of response to antiviral therapy for hepatitis C after living donor liver transplantation (LDLT) and to study the associated adverse events. Methods: A retrospective chart review was performed on 125 hepatitis C virus (HCV)-positive LDLT recipients who received interferon plus ribavirin and/or peginterferon plus ribavirin therapy at Kyoto University between January 2001 and June 2011. Results: Serum HCV RNA reached undetectable levels within 48 weeks in 77 (62%) of 125 patients, and these patients were defined as showing virological response (VR). Of 117 patients, 50 (43%) achieved sustained VR (SVR). Predictive factors associated with both VR and SVR by univariate analysis included low pretransplant serum HCV RNA levels, a non-1 HCV genotype, and low pretreatment serum HCV RNA levels. In addition, LDLT from ABO-mismatched donors was significantly associated with VR, and white cell and neutrophil counts before interferon therapy were associated with SVR. Multivariate analysis showed that 2 variables-pretransplant serum HCV RNA level less than 500 kIU/mL and a non-1 HCV genotype-remained in models of both VR and SVR and that an ABO mismatch was associated with VR. No variables with a significant effect on treatment withdrawal were found. Conclusions: Virological response to antiviral therapy in patients with hepatitis C recurring after LDLT can be predicted prior to transplant, based on pretransplant serum HCV-RNA levels and HCV genotype. LDLT from ABO-mismatched donors may contribute to more efficacious interferon therapy.	[Ueda, Yoshihide; Marusawa, Hiroyuki; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Kaido, Toshimi; Ogura, Yasuhiro; Ogawa, Kohei; Yoshizawa, Atsushi; Hata, Koichiro; Fujimoto, Yasuhiro; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Miyagawa-Hayashino, Aya; Haga, Hironori] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Teramukai, Satoshi] Kyoto Univ Hosp, Translat Res Ctr, Div Clin Trial Design & Management, Kyoto 606, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ueda, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	yueda@kuhp.kyoto-u.ac.jp	Ueda, Yoshihide/S-7620-2016; Teramukai, Satoshi/I-2249-2019; Ogura, Yasuhiro/A-2557-2016	Ueda, Yoshihide/0000-0003-3196-3494; Teramukai, Satoshi/0000-0003-2184-0597; Ogura, Yasuhiro/0000-0001-5768-6160; Marusawa, Hiroyuki/0000-0002-4286-2712; Hata, Koichiro/0000-0002-3609-6396; Haga, Hironori/0000-0003-4322-9561	Japan Society for the Promotion of Science (JSPS) [21229009, 23590972]; Health and Labour Sciences Research Grants for Research on Intractable Diseases; Research on Hepatitis from the Ministry of Health, Labour and Welfare, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Sciences Research Grants for Research on Intractable Diseases; Research on Hepatitis from the Ministry of Health, Labour and Welfare, Japan	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-aid for Scientific Research 21229009 and 23590972, and Health and Labour Sciences Research Grants for Research on Intractable Diseases, and Research on Hepatitis from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berardi S, 2007, GUT, V56, P237, DOI 10.1136/gut.2006.092064; Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993; Berenguer M, 2008, J HEPATOL, V49, P274, DOI 10.1016/j.jhep.2008.05.002; Berenguer M, 2006, LIVER TRANSPLANT, V12, P1067, DOI 10.1002/lt.20737; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Charlton MR, 2011, HEPATOLOGY, V53, P317, DOI 10.1002/hep.24074; Egawa H, 2008, HEPATOLOGY, V47, P143, DOI 10.1002/hep.21928; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Feray C, 1999, GASTROENTEROLOGY, V117, P619, DOI 10.1016/S0016-5085(99)70454-3; Fernandez I, 2009, LIVER TRANSPLANT, V15, P948, DOI 10.1002/lt.21780; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Fukuhara T, 2010, J HEPATOL, V52, P672, DOI 10.1016/j.jhep.2009.10.034; Gane E, 2003, LIVER TRANSPLANT, V9, pS28, DOI 10.1053/jlts.2003.50248; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gordon FD, 2009, LIVER TRANSPLANT, V15, P126, DOI 10.1002/lt.21694; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Neumann U, 2006, TRANSPLANTATION, V82, P43, DOI 10.1097/01.tp.0000225827.18034.be; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Oton E, 2006, AM J TRANSPLANT, V6, P2348, DOI 10.1111/j.1600-6143.2006.01470.x; Picciotto FP, 2007, J HEPATOL, V46, P459, DOI 10.1016/j.jhep.2006.10.017; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Prieto M, 1999, HEPATOLOGY, V29, P250, DOI 10.1002/hep.510290122; Raut V, 2012, TRANSPLANTATION, V93, P99, DOI 10.1097/TP.0b013e318239e8e4; Rodriguez-Luna H, 2004, TRANSPLANTATION, V77, P190, DOI 10.1097/01.TP.0000100481.14514.BB; Sanchez-Fueyo A, 2002, TRANSPLANTATION, V73, P56, DOI 10.1097/00007890-200201150-00010; Sharma P, 2007, LIVER TRANSPLANT, V13, P1100, DOI 10.1002/lt.21121; Stanca CM, 2007, TRANSPLANTATION, V84, P180, DOI 10.1097/01.tp.0000269609.08495.45; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terrault NA, 2008, LIVER TRANSPLANT, V14, pS58, DOI 10.1002/lt.21624; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Triantos C, 2005, TRANSPLANTATION, V79, P261, DOI 10.1097/01.TP.0000149696.76204.38; Ueda Y, 2010, J VIRAL HEPAT; Ueda Y, 2008, TRANSPLANTATION, V85, P855, DOI 10.1097/TP.0b013e3181671df0; Ueda Y, 2010, TRANSPLANTATION, V90, P661, DOI 10.1097/TP.0b013e3181d2bfca; Velidedeoglu E, 2004, TRANSPLANTATION, V77, P1834, DOI 10.1097/01.tp.0000130468.36131.0d; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	48	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58380	10.1371/journal.pone.0058380	http://dx.doi.org/10.1371/journal.pone.0058380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505497	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500075
J	Bakir-Gungor, B; Sezerman, OU				Bakir-Gungor, Burcu; Sezerman, Osman Ugur			The Identification of Pathway Markers in Intracranial Aneurysm Using Genome-Wide Association Data from Two Different Populations	PLOS ONE			English	Article							SUBARACHNOID HEMORRHAGE; RISK-FACTORS; MISSING HERITABILITY; DISEASE; SNPS; NETWORK; RUPTURE; GROWTH; LOCI; MAP	The identification of significant individual factors causing complex diseases is challenging in genome-wide association studies (GWAS) since each factor has only a modest effect on the disease development mechanism. In this study, we hypothesize that the biological pathways that are targeted by these individual factors show higher conservation within and across populations. To test this hypothesis, we searched for the disease related pathways on two intracranial aneurysm GWAS in European and Japanese case-control cohorts. Even though there were a few significantly conserved SNPs within and between populations, seven of the top ten affected pathways were found significant in both populations. The probability of random occurrence of such an event is 2.44E-36. We therefore claim that even though each individual has a unique combination of factors involved in the mechanism of disease development, most targeted pathways that need to be altered by these factors are, for the most part, the same. These pathways can serve as disease markers. Individuals, for example, can be scanned for factors affecting the genes in marker pathways. Hence, individual factors of disease development can be determined; and this knowledge can be exploited for drug development and personalized therapeutic applications. Here, we discuss the potential avenues of pathway markers in medicine and their translation to preventive and individualized health care.	[Bakir-Gungor, Burcu] Bahcesehir Univ, Dept Genet & Bioinformat, Fac Arts & Sci, Istanbul, Turkey; [Bakir-Gungor, Burcu] TUBITAK, Adv Genom & Bioinformat Res Ctr, UEKAE, Kocaeli, Turkey; [Sezerman, Osman Ugur] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Bahcesehir University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Sabanci University	Bakir-Gungor, B (corresponding author), Bahcesehir Univ, Dept Genet & Bioinformat, Fac Arts & Sci, Istanbul, Turkey.	burcu.gungor@bahcesehir.edu.tr	SEZERMAN, OSMAN U/X-6441-2018	Bakir-Gungor, Burcu/0000-0002-2272-6270; Sezerman, Osman Ugur/0000-0003-0905-6783	Intensified Cooperation (IntenC): Promotion of German-Turkish Higher Education Research Grant of TUBITAK [109S218]	Intensified Cooperation (IntenC): Promotion of German-Turkish Higher Education Research Grant of TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by the Intensified Cooperation (IntenC): Promotion of German-Turkish Higher Education Research Grant # 109S218 of TUBITAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; Bakir-Gungor B, 2012, THESIS SABANCI U IST; Bakir-Gungor B, 2012, NATURE PROTOCOL EXCH; Bakir-Gungor B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026277; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Couzin J, 2007, SCIENCE, V317, P320; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Feigin VL, 2006, STROKE, V37, P305, DOI 10.1161/01.STR.0000200558.38774.d5; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gaal EI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002563; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gieteling EW, 2003, J NEUROL, V250, P418, DOI 10.1007/s00415-003-0997-0; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldstein DB, 2007, SCIENCE, V318, P391; Goldstein DB, 2004, NAT GENET, V36, P1243, DOI 10.1038/ng1204-1243; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofer AM, 2005, J CELL SCI, V118, P855, DOI 10.1242/jcs.01705; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Holtzman DM, 2011, SCI TRANSL MED, V3; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jia PL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S15; Juvela S, 2001, STROKE, V32, P485, DOI 10.1161/01.STR.32.2.485; Juvela S, 2000, STROKE, V31, P392, DOI 10.1161/01.STR.31.2.392; Kholodenko BN, 2009, WIRES SYST BIOL MED, V1, P28, DOI 10.1002/wsbm.16; Krischek B, 2008, NEUROSCIENCE, V154, P1398, DOI 10.1016/j.neuroscience.2008.04.049; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Laaksamo E, 2008, STROKE, V39, P886, DOI 10.1161/STROKEAHA.107.497875; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lindekleiv H, 2012, STROKE J CEREBRAL CI; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Matur Z, 2010, NOROPSIKIYATRI ARS, V47, P162, DOI 10.4274/npa.47.5425; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pera J, 2010, STROKE, V41, P224, DOI 10.1161/STROKEAHA.109.562009; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Roberts N.J., 2012, SCI TRANSL MED, V4; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruigrok YM, 2008, J NEUROL NEUROSUR PS, V79, P722, DOI 10.1136/jnnp.2007.128041; Ruigrok YM, 2010, GENOME MED, V2, DOI 10.1186/gm182; Saccone SF, 2010, NUCLEIC ACIDS RES, V38, pW201, DOI 10.1093/nar/gkq513; Schadt EE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002132; Shriner D, 2007, SCIENCE, V316, P1840; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wilke R. A., 2008, Current Pharmacogenomics & Personalized Medicine, V6, P150; Williams SM, 2007, SCIENCE, V316, P1841; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zhou YL, 2011, ACTA NEUROCHIR SUPPL, V110, P15, DOI 10.1007/978-3-7091-0353-1_3	76	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57022	10.1371/journal.pone.0057022	http://dx.doi.org/10.1371/journal.pone.0057022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483893	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100011
J	Barua, H; Biswas, PK; Olsen, KEP; Shil, SK; Christensen, JP				Barua, Himel; Biswas, Paritosh K.; Olsen, Katharina E. P.; Shil, Subrata K.; Christensen, Jens P.			Molecular Characterization of Motile Serovars of Salmonella enterica from Breeder and Commercial Broiler Poultry Farms in Bangladesh	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; INTERNATIONAL SPREAD; KENTUCKY; CIPROFLOXACIN; PREVALENCE; STRAIN; SURVEILLANCE; ENTERITIDIS; CHICKENS	Contaminated poultry and poultry products are a major source of motile Salmonellae for human salmonellosis worldwide. Local circulation of any motile Salmonella serovar in poultry has a wider public health impact beyond its source of origin for being dispersed elsewhere through poultry trades or human travels. To investigate the status of motile Salmonella serovars in breeder farms in Bangladesh, multiple flocks of two breeder farms were observed for a period of six months. In addition, a cross-sectional survey was carried out to determine the prevalence and serovar distribution of motile Salmonella by randomly selecting 100 commercial broiler poultry farms. Five pooled faecal samples representing an entire housed flock of breeders or broilers were screened for presence of motile Salmonella following conventional bacteriological procedures. The Salmonella isolates obtained were subsequently serotyped, and characterized by plasmid profiling and pulsed-field gel electrophoresis (PFGE). The results revealed that both the breeder farms were positive with three Salmonella serovars: S. Virchow, S. Paratyphi B var Java (S. Java) and S. Enteritidis. Eleven of the 100 broiler farms investigated were positive for motile Salmonella, giving a farm-level prevalence of 11% (95% confidence interval 5-17%). S. Virchow and S. Kentucky were the two predominant serovars isolated from the broiler farms. The PFGE genotyping demonstrated that the isolates belonging to the same serovars were closely related due to variation in only 1-4 bands. All the S. Virchow and S. Java isolates, irrespective of breeder or broiler farm origin, were plasmid-free, except for one S. Virchow isolate from a broiler farm that harboured a 9.7 kb-sized plasmid. The S. Kentucky isolates belonged to three plasmid profiles having plasmids of four different sizes, ranging from 2.7 to 109 kb. This is the first report of any motile Salmonella serovars from breeder and commercial broiler poultry farms in Bangladesh.	[Barua, Himel; Christensen, Jens P.] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Barua, Himel; Biswas, Paritosh K.] Chittagong Vet & Anim Sci Univ, Dept Microbiol, Fac Vet Med, Chittagong, Bangladesh; [Olsen, Katharina E. P.] Statens Serum Inst, Natl Reference Lab Enteropathogen Bacteria, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Shil, Subrata K.] Chittagong Vet & Anim Sci Univ, Dept Anat & Histol, Fac Vet Med, Chittagong, Bangladesh	University of Copenhagen; Statens Serum Institut	Barua, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark.	hiba@sund.ku.dk		Christensen, Jens Peter/0000-0002-6430-9010; Shil, Dr. Subrata Kumar/0000-0002-8047-6169	University of Copenhagen	University of Copenhagen	The study was supported by the University of Copenhagen, in the form of a PhD grant. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2007, EMERG INFECT DIS, V13, P726, DOI 10.3201/eid1305.061489; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Barua H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035914; Brown D J, 2003, Euro Surveill, V8, P35; Byrd JA, 1999, AVIAN DIS, V43, P39, DOI 10.2307/1592760; Centers for Disease Control and Prevention (CDC), 2009, ONE DAY 24 28 H STAN; Collard JM, 2007, J ANTIMICROB CHEMOTH, V60, P190, DOI 10.1093/jac/dkm114; Cox JM, 2010, J APPL MICROBIOL, V108, P745, DOI 10.1111/j.1365-2672.2009.04456.x; Cox NA, 2000, POULTRY SCI, V79, P1571, DOI 10.1093/ps/79.11.1571; Dione MM, 2009, J FOOD PROTECT, V72, P2423, DOI 10.4315/0362-028X-72.11.2423; Dorn C, 2001, BERL MUNCH TIERARZTL, V114, P179; Elgroud R, 2009, ZOONOSES PUBLIC HLTH, V56, P84, DOI 10.1111/j.1863-2378.2008.01164.x; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; FAO, 2008, POULTRY SECTOR COUNT; FAO and OIE in collaboration with WHO, 2005, GLOB STRAT PROGR CON; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gast R. K., 2003, DIS POULTRY, P583; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Gutierrez M, 2009, FOODBORNE PATHOG DIS, V6, P111, DOI 10.1089/fpd.2008.0163; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842; Humphrey T., 2000, Salmonella in domestic animals., P245, DOI 10.1079/9780851992617.0245; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kalender H, 2009, FOODBORNE PATHOG DIS, V6, P265, DOI 10.1089/fpd.2008.9989; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; MACRINA FL, 1978, PLASMID, V1, P417, DOI 10.1016/0147-619X(78)90056-2; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Majtan V, 2006, JPN J INFECT DIS, V59, P358; Nogrady N, 2008, INT J FOOD MICROBIOL, V127, P162, DOI 10.1016/j.ijfoodmicro.2008.07.005; Olsen J. E., 2000, Salmonella in domestic animals., P429, DOI 10.1079/9780851992617.0429; OLSEN JE, 1993, VET QUART, V15, P125, DOI 10.1080/01652176.1993.9694390; Padungtod P, 2006, INT J FOOD MICROBIOL, V108, P346, DOI 10.1016/j.ijfoodmicro.2005.11.020; Papadopoulou C, 2009, VET REC, V165, P681; Poppe C., 2000, Salmonella in domestic animals., P107, DOI 10.1079/9780851992617.0107; ROCHELLE PA, 1986, J GEN MICROBIOL, V132, P53; Snow LC, 2008, VET REC, V163, P649, DOI 10.1136/vr.163.22.649; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609; van Asselt ED, 2009, POULTRY SCI, V88, P2695, DOI 10.3382/ps.2009-00074; Van Immerseel F, 2004, POULTRY SCI, V83, P1911, DOI 10.1093/ps/83.11.1911; van Pelt W, 2003, Euro Surveill, V8, P31; Weill FX, 2006, EMERG INFECT DIS, V12, P1611, DOI 10.3201/eid1210.060589; Wray C., 1999, Poultry meat science., P257	43	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57811	10.1371/journal.pone.0057811	http://dx.doi.org/10.1371/journal.pone.0057811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483931	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100047
J	Demchev, V; Malana, G; Vangala, D; Stoll, J; Desai, A; Kang, HW; Li, YX; Nayeb-Hashemi, H; Niepel, M; Cohen, DE; Ukomadu, C				Demchev, Valeriy; Malana, Geraldine; Vangala, Divya; Stoll, Janis; Desai, Anal; Kang, Hye Won; Li, Yingxia; Nayeb-Hashemi, Hamed; Niepel, Michele; Cohen, David E.; Ukomadu, Chinweike			Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization	PLOS ONE			English	Article							LIVER-SPECIFIC GENE; MOLECULAR-CLONING; LIPID-METABOLISM; HUMAN HEPASSOCIN; GLUCOSE-UPTAKE; COLD-EXPOSURE; OVEREXPRESSION; INHIBITION; ANGPTL3; MICE	Fibrinogen like protein 1(Fgl1) is a secreted protein with mitogenic activity on primary hepatocytes. Fgl1 is expressed in the liver and its expression is enhanced following acute liver injury. In animals with acute liver failure, administration of recombinant Fgl1 results in decreased mortality supporting the notion that Fgl1 stimulates hepatocyte proliferation and/or protects hepatocytes from injury. However, because Fgl1 is secreted and detected in the plasma, it is possible that the role of Fgl1 extends far beyond its effect on hepatocytes. In this study, we show that Fgl1 is additionally expressed in brown adipose tissue. We find that signals elaborated following liver injury also enhance the expression of Fgl1 in brown adipose tissue suggesting that there is a cross talk between the injured liver and adipose tissues. To identify extra hepatic effects, we generated Fgl1 deficient mice. These mice exhibit a phenotype suggestive of a global metabolic defect: Fgl1 null mice are heavier than wild type mates, have abnormal plasma lipid profiles, fasting hyperglycemia with enhanced gluconeogenesis and exhibit differences in white and brown adipose tissue morphology when compared to wild types. Because Fgl1 shares structural similarity to Angiopoietin like factors 2, 3, 4 and 6 which regulate lipid metabolism and energy utilization, we postulate that Fgl1 is a member of an emerging group of proteins with key roles in metabolism and liver regeneration.	[Demchev, Valeriy; Malana, Geraldine; Vangala, Divya; Stoll, Janis; Desai, Anal; Kang, Hye Won; Li, Yingxia; Nayeb-Hashemi, Hamed; Niepel, Michele; Cohen, David E.; Ukomadu, Chinweike] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ukomadu, C (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA.	cukomadu@partners.org			Sidney A. Swensrud Foundation; Brigham and Women's Hospital Institutional Research Funds; National Institutes of Health (NIH) [DK080789, DK48873, DK56628]; Digestive Disease Center [5P30 DK034854]; NIH [DK07477, 007533]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007477, P30DK034854, R01DK080789, R01DK048873, R29DK048873, R01DK056626, R37DK048873] Funding Source: NIH RePORTER	Sidney A. Swensrud Foundation; Brigham and Women's Hospital Institutional Research Funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported by a grant from The Sidney A. Swensrud Foundation, Brigham and Women's Hospital Institutional Research Funds and National Institutes of Health (NIH) DK080789 (to CU) and DK48873, DK56628 (to DEC). Lipid assays were performed by the Core D of Harvard Digestive Disease Center supported by 5P30 DK034854. JS and HN were supported by a NIH T32 grant (DK07477 and 007533 respectively). HWK is a recipient of a Founders Affiliate Postdoctoral Fellowship from the American Heart Association. The authors thank Dr Emily Oken for help with statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021209; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Chu J, 2012, MOL BIOL CELL; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; German JP, 2011, ENDOCRINOLOGY, V152, P394, DOI 10.1210/en.2010-0890; Hara H, 2001, BBA-GENE STRUCT EXPR, V1520, P45, DOI 10.1016/S0167-4781(01)00249-4; Hara H, 2000, BBA-GENE STRUCT EXPR, V1492, P31, DOI 10.1016/S0167-4781(00)00056-7; Hyogo H, 2002, J BIOL CHEM, V277, P34117, DOI 10.1074/jbc.M203912200; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Li CY, 2010, GUT, V59, P817, DOI 10.1136/gut.2008.171124; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Liu ZL, 2008, BIOCHEM BIOPH RES CO, V365, P729, DOI 10.1016/j.bbrc.2007.11.069; Miyoshi H, 2010, J LIPID RES, V51, P975, DOI 10.1194/jlr.M002352; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Rijken DC, 2006, BIOCHEM BIOPH RES CO, V350, P191, DOI 10.1016/j.bbrc.2006.09.018; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; SHIBATA H, 1989, AM J PHYSIOL, V257, pR96, DOI 10.1152/ajpregu.1989.257.1.R96; Shimamura M, 2003, BIOCHEM BIOPH RES CO, V301, P604, DOI 10.1016/S0006-291X(02)03058-9; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; SIMEK J, 1966, Sbornik Vedeckych Praci Lekarske Fakulty University Karlovy v Hradci Kralove, V9, P579; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Ukomadu C, 2003, J BIOL CHEM, V278, P4840, DOI 10.1074/jbc.M208658200; VALLERAND AL, 1990, AM J PHYSIOL, V259, pR1043, DOI 10.1152/ajpregu.1990.259.5.R1043; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; YAMAMOTO T, 1993, BIOCHEM BIOPH RES CO, V193, P681, DOI 10.1006/bbrc.1993.1678; Yan J, 2002, CELL RES, V12, P353, DOI 10.1038/sj.cr.7290137; Yu HT, 2009, J BIOL CHEM, V284, P13335, DOI 10.1074/jbc.M806393200; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	35	46	50	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58084	10.1371/journal.pone.0058084	http://dx.doi.org/10.1371/journal.pone.0058084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483972	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100073
J	Liu, DW; Tsai, SM; Lin, BF; Jiang, YJ; Wang, WP				Liu, Da-Wei; Tsai, Su-Mei; Lin, Bih-Fen; Jiang, Yun-Jin; Wang, Wen-Pin			Fibroblast Growth Factor Receptor 2c Signaling Is Required for Intestinal Cell Differentiation in Zebrafish	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; EPITHELIAL-CELLS; PROGENITOR CELLS; PROLIFERATION; GUT; BMP; FIBROBLAST-GROWTH-FACTOR-10; COMMITMENT; INHIBITORS	Background: There are four cell lineages derived from intestinal stem cells that are located at the crypt and villus in the mammalian intestine the non-secretory absorptive enterocytes, and the secretory cells, which include mucous-secreting goblet cells, regulatory peptide-secreting enteroendocrine cells and antimicrobial peptide-secreting Paneth cells. Although fibroblast growth factor (Fgf) signaling is important for cell proliferation and differentiation in various tissues, its role in intestinal differentiation is less well understood. Methodology/Principal Findings: We used a loss of function approach to investigate the importance of Fgf signaling in intestinal cell differentiation in zebrafish; abnormal differentiation of goblet cells was observed when Fgf signaling was inhibited using SU5402 or in the Tg(hsp70ldnfgfr1-EGFP) transgenic line. We identified Fgfr2c as an important receptor for cell differentiation. The number of goblet cells and enteroendocrine cells was reduced in fgfr2c morphants. In addition to secretory cells, enterocyte differentiation was also disrupted in fgfr2c morphants. Furthermore, proliferating cells were increased in the morphants. Interestingly, the loss of fgfr2c expression repressed secretory cell differentiation and increased cell proliferation in the mib (ta52b) mutant that had defective Notch signaling. Conclusions/Significance: In conclusion, we found that Fgfr2c signaling derived from mesenchymal cells is important for regulating the differentiation of zebrafish intestine epithelial cells by promoting cell cycle exit. The results of Fgfr2c knockdown in mib (ta52b) mutants indicated that Fgfr2c signaling is required for intestinal cell differentiation. These findings provide new evidences that Fgf signaling is required for the differentiation of intestinal cells in the zebrafish developing gut.	[Liu, Da-Wei; Tsai, Su-Mei; Wang, Wen-Pin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Lin, Bih-Fen] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Jiang, Yun-Jin] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan Town, Miaoli County, Taiwan; [Wang, Wen-Pin] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Health Research Institutes - Taiwan; Tzu Chi University	Wang, WP (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	wpwang@mail.tcu.edu.tw	Jiang, Yun-Jin/E-3995-2010	Jiang, Yun-Jin/0000-0003-0499-7306	National Science Council [NSC100-2311-B-320-001]; Tzu Chi University [TCMRC-P-99013-01]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu Chi University	This work was supported by grants from the National Science Council (NSC100-2311-B-320-001), and Tzu Chi University (TCMRC-P-99013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Arnaud-Dabernat S, 2008, J CELL PHYSIOL, V216, P261, DOI 10.1002/jcp.21401; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Burns RC, 2004, DEV BIOL, V265, P61, DOI 10.1016/j.ydbio.2003.09.021; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034408; Chen YH, 2009, DEV DYNAM, V238, P1021, DOI 10.1002/dvdy.21908; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Esain V, 2010, DEVELOPMENT, V137, P33, DOI 10.1242/dev.038026; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Faro A, 2009, ZEBRAFISH, V6, P59, DOI 10.1089/zeb.2009.0580; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hochmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030365; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; Kan NG, 2009, FASEB J, V23, P3516, DOI 10.1096/fj.09-131730; Klein C, 2011, DEVELOPMENT, V138, P1935, DOI 10.1242/dev.056861; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Liu DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021793; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Nakayama Y, 2008, DEV BIOL, V313, P752, DOI 10.1016/j.ydbio.2007.11.013; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Nyeng P, 2007, DEV BIOL, V303, P295, DOI 10.1016/j.ydbio.2006.11.017; Nyeng P, 2011, DEV BIOL, V349, P20, DOI 10.1016/j.ydbio.2010.09.010; Ornitz DM, 2001, GENOME BIOL, V2; Paffett-Lugassy N, 2007, BLOOD, V110, P2718, DOI 10.1182/blood-2006-04-016535; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Sala FG, 2006, DEV BIOL, V299, P373, DOI 10.1016/j.ydbio.2006.08.001; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shih LJ, 2007, GENE EXPR PATTERNS, V7, P452, DOI 10.1016/j.modgep.2006.11.003; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Sinha J, 2008, AM J PHYSIOL-GASTR L, V295, pG996, DOI 10.1152/ajpgi.90343.2008; Spencer-Dene B, 2006, GASTROENTEROLOGY, V130, P1233, DOI 10.1053/j.gastro.2006.02.018; Tonou-Fujimori Noriko, 2002, Gene Expression Patterns, V2, P183, DOI 10.1016/S0925-4773(02)00422-7; Tsai SM, 2012, TRANSGENIC RES; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vidrich A, 2004, DEV DYNAM, V230, P114, DOI 10.1002/dvdy.20018; Vidrich A, 2009, AM J PHYSIOL-GASTR L, V297, pG168, DOI 10.1152/ajpgi.90589.2008; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041; Zeng L, 2012, DEV BIOL, V367, P178, DOI 10.1016/j.ydbio.2012.05.009; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhang XQ, 2006, DEVELOPMENT, V133, P173, DOI 10.1242/dev.02175	57	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58310	10.1371/journal.pone.0058310	http://dx.doi.org/10.1371/journal.pone.0058310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484013	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100103
J	Mutha, PK; Haaland, KY; Sainburg, RL				Mutha, Pratik K.; Haaland, Kathleen Y.; Sainburg, Robert L.			Rethinking Motor Lateralization: Specialized but Complementary Mechanisms for Motor Control of Each Arm	PLOS ONE			English	Article							UNILATERAL BRAIN-DAMAGE; HEMISPHERIC ASYMMETRIES; EVOLUTION; HAND; HYPOTHESIS; HANDEDNESS; COMPONENTS; ADVANTAGES; MOVEMENTS; DOMINANT	Motor lateralization in humans has primarily been characterized as "handedness", resulting in the view that one armhemisphere system is specialized for all aspects of movement while the other is simply a weaker analogue. We have proposed an alternative view that motor lateralization reflects proficiency of each arm for complementary functions that arises from a specialization of each hemisphere for distinct movement control mechanisms. However, before this idea of hemispheric specialization can be accepted, it is necessary to precisely identify these distinct, lateralized mechanisms. Here we show in right-handers that dominant arm movements rely on predictive mechanisms that anticipate and account for the dynamic properties of the arm, while the non-dominant arm optimizes positional stability by specifying impedance around equilibrium positions. In a targeted-reaching paradigm, we covertly and occasionally shifted the hand starting location either orthogonal to or collinear with a particular direction of movement. On trials on which the start positions were shifted orthogonally, we did not notice any strong interlimb differences. However, on trials on which start positions were shifted orthogonally, the dominant arm largely maintained the direction and straightness of its trajectory, while the non-dominant arm deviated towards the previously learned goal position, consistent with the hypothesized control specialization of each arm-hemisphere system. These results bring together two competing theories about mechanisms of movement control, and suggest that they coexist in the brain in different hemispheres. These findings also question the traditional view of handedness, because specialized mechanisms for each arm-hemisphere system were identified within a group of right-handers. It is likely that such hemispheric specialization emerged to accommodate increasing motor complexity during evolution.	[Mutha, Pratik K.; Haaland, Kathleen Y.] NM VA Healthcare Syst, Albuquerque, NM USA; [Mutha, Pratik K.; Haaland, Kathleen Y.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Haaland, Kathleen Y.] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Sainburg, Robert L.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Sainburg, Robert L.] Penn State Univ, Dept Neurol, University Pk, PA 16802 USA	University of New Mexico; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mutha, PK (corresponding author), NM VA Healthcare Syst, Albuquerque, NM USA.	pkm@unm.edu; rls45@psu.edu		Sainburg, Robert/0000-0003-2627-1258	United States National Institutes of Health [R01HD39311, R01HD059783]; VA RD Merit Review [101BX007080, B4125R]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059783] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039311] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA RD Merit Review; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by United States National Institutes of Health grants R01HD39311 and R01HD059783 to R. L. Sainburg, and VA R&D Merit Review (101BX007080) and RR&D (B4125R) grants to K. Y. Haaland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagesteiro LB, 2003, J NEUROPHYSIOL, V90, P1503, DOI 10.1152/jn.00189.2003; Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; CARSON RG, 1990, NEUROPSYCHOLOGIA, V28, P1215, DOI 10.1016/0028-3932(90)90056-T; CARSON RG, 1993, J MOTOR BEHAV, V25, P21, DOI 10.1080/00222895.1993.9941636; CARSON RG, 1995, BRAIN COGNITION, V28, P133, DOI 10.1006/brcg.1995.1161; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; DEAN RS, 1987, NEUROPSYCHOLOGIA, V25, P585, DOI 10.1016/0028-3932(87)90083-2; DELIS DC, 1986, NEUROPSYCHOLOGIA, V24, P205, DOI 10.1016/0028-3932(86)90053-9; Duff SV, 2007, EXP BRAIN RES, V179, P551, DOI 10.1007/s00221-006-0811-1; ELLIOTT D, 1993, CAN J EXP PSYCHOL, V47, P570, DOI 10.1037/h0078856; Elliott D, 1995, CORTEX, V31, P685, DOI 10.1016/S0010-9452(13)80020-2; Federmeier KD, 2008, LANG LINGUIST COMPAS, V2, P1, DOI 10.1111/j.1749-818x.2007.00042.x; Feldman A G, 1998, Motor Control, V2, P189; Feldman AG, 2009, ADV EXP MED BIOL, V629, P699, DOI 10.1007/978-0-387-77064-2_38; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; Gazzaniga MS, 1998, SCI AM, V279, P50, DOI 10.1038/scientificamerican0798-50; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Gentilucci M, 2006, J COGNITIVE NEUROSCI, V18, P1059, DOI 10.1162/jocn.2006.18.7.1059; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Gottlieb G L, 1998, Motor Control, V2, P10; Grimshaw GM, 1998, BRAIN COGNITION, V36, P108, DOI 10.1006/brcg.1997.0949; Haaland KY, 2004, BRAIN, V127, P1145, DOI 10.1093/brain/awh133; HAALAND KY, 1994, BRAIN COGNITION, V24, P104, DOI 10.1006/brcg.1994.1006; HAALAND KY, 1989, NEUROPSYCHOLOGIA, V27, P961, DOI 10.1016/0028-3932(89)90071-7; Harrington DL, 1997, BRAIN DAM B, P111; Herculano-Houzel S, 2010, P NATL ACAD SCI USA, V107, P19008, DOI 10.1073/pnas.1012590107; Hermsdorfer J, 1999, EXP BRAIN RES, V128, P41, DOI 10.1007/s002210050815; Hermsdorfer J, 1996, BRAIN, V119, P1575, DOI 10.1093/brain/119.5.1575; Hinder MR, 2003, J PHYSIOL-LONDON, V549, P953, DOI 10.1113/jphysiol.2002.033845; KUYPERS H. G. J. M., 1964, PROGR BRAIN RES, V11, P178; KUYPERS HGJ, 1970, BRAIN RES, V24, P29, DOI 10.1016/0006-8993(70)90272-6; Latash ML, 2010, MED LITH, V46, P382, DOI 10.3390/medicina46060054; Latash ML, 2010, MOTOR CONTROL, V14, P294; Marzke MW, 2009, J BONE JOINT SURG AM, V91A, P26, DOI 10.2106/JBJS.I.00102; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; Medland SE, 2004, LATERALITY, V9, P287, DOI 10.1080/13576500342000040a; Mutha PK, 2011, BRAIN, V134, P3644, DOI 10.1093/brain/awr275; Mutha PK, 2011, J NEUROSCI, V31, P6972, DOI 10.1523/JNEUROSCI.6432-10.2011; Nirkko AC, 2001, NEUROIMAGE, V13, P825, DOI 10.1006/nimg.2000.0739; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ostry DJ, 2003, EXP BRAIN RES, V153, P275, DOI 10.1007/s00221-003-1624-0; REEVES WH, 1985, INT J NEUROSCI, V28, P291, DOI 10.3109/00207458508985397; Rilling JK, 1999, NEUROREPORT, V10, P1453, DOI 10.1097/00001756-199905140-00012; ROY EA, 1983, HUM MOVEMENT SCI, V2, P271, DOI 10.1016/0167-9457(83)90022-2; ROY EA, 1994, BRAIN COGNITION, V24, P289, DOI 10.1006/brcg.1994.1017; Sainburg R. L., 2010, VISION GOAL DIRECTED, P219; Sainburg RL, 2004, J NEUROPHYSIOL, V92, P1374, DOI 10.1152/jn.00181.2004; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Schaefer SY, 2008, J MOTOR BEHAV, V40, P325, DOI 10.3200/JMBR.40.4.325-336; Schaefer SY, 2009, BRAIN RES, V1298, P78, DOI 10.1016/j.brainres.2009.08.063; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290; Wang JS, 2007, EXP BRAIN RES, V178, P565, DOI 10.1007/s00221-007-0936-x; Weissman DH, 2005, CEREB CORTEX, V15, P870, DOI 10.1093/cercor/bhh187; WINSTEIN CJ, 1995, EXP BRAIN RES, V105, P163; Yadav V, 2011, NEUROSCIENCE, V196, P153, DOI 10.1016/j.neuroscience.2011.08.039; Yeo R. A., 2002, HDB NEUROPSYCHOLOGY, P331	59	74	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58582	10.1371/journal.pone.0058582	http://dx.doi.org/10.1371/journal.pone.0058582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472210	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900156
J	Hu, JZ; He, Y; Yan, M; Zhu, C; Ye, WM; Zhu, HG; Chen, WT; Zhang, CP; Zhang, ZY				Hu, Jingzhou; He, Yue; Yan, Ming; Zhu, Chao; Ye, Weimin; Zhu, Hanguang; Chen, Wantao; Zhang, Chenping; Zhang, Zhiyuan			Dose Dependent Activation of Retinoic Acid-Inducible Gene-I Promotes Both Proliferation and Apoptosis Signals in Human Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							RIG-I; STRANDED-RNA; PROTEIN; PATHWAY; RECOGNITION; KINASE; AKT	The retinoic-acid-inducible gene (RIG)-like receptor (RLR) family proteins are major pathogen reorganization receptors (PRR) responsible for detection of viral RNA, which initiates antiviral response. Here, we evaluated the functional role of one RLR family member, RIG-I, in human head and neck squamous cell carcinoma (HNSCC). RIG-I is abundantly expressed both in poorly-differentiated primary cancer and lymph node metastasis, but not in normal adjacent tissues. Activation of RIG-I by transfection with low dose of 5'-triphosphate RNA (3p-RNA) induces low levels of interferon and proinflammatory cytokines and promotes NF-kappa B- and Akt-dependent cell proliferation, migration and invasion. In contrast, activation of RIG-I by a high dose of 3p-RNA induces robust mitochondria-derived apoptosis accompanied by decreased activation of Akt, which is independent of the interferon and TNF alpha receptor, but can be rescued by over-expression of constitutively active Akt. Furthermore, co-immunoprecipitation experiments indicate that the CARD domain of RIG-I is essential for inducing apoptosis by interacting with caspase-9. Together, our results reveal a dual role of RIG-I in HNSCC through regulating activation of Akt, in which RIG-I activation by low-dose viral dsRNA increases host cell surviral, whereas higher level of RIG-I activation leads to apopotosis. These findings highlight the therapeutic potential of dsRNA mediated RIG-I activation in the treatment of HNSCC.	[Hu, Jingzhou; He, Yue; Yan, Ming; Zhu, Chao; Ye, Weimin; Zhu, Hanguang; Chen, Wantao; Zhang, Chenping; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Head & Neck Oncol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Hu, Jingzhou; He, Yue; Yan, Ming; Zhu, Chao; Chen, Wantao; Zhang, Chenping; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Head & Neck Oncol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	zhzhyomschina@gmail.com	zhang, zhiyuan/GRS-2141-2022		Project of National Natural Science Foundation of China [31140007]; Shanghai Leading Academic Discipline Project [S30206]	Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This study was supported by Project of National Natural Science Foundation of China( Grant No. 31140007) to JH and Shanghai Leading Academic Discipline Project ( Project No. S30206) to ZZ. The URL of National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm). The URL of Shanghai education committee: http://www.shec.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cao W, 2012, CANCER-AM CANCER SOC, V118, P2858, DOI 10.1002/cncr.26575; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Evan GI, 2006, CANCER CELL, V10, P345, DOI 10.1016/j.ccr.2006.10.013; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lichtenstein DL, 2004, INT REV IMMUNOL, V23, P75, DOI 10.1080/08830180490265556; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mori I, 2006, MICROBES INFECT, V8, P1806, DOI 10.1016/j.micinf.2006.02.018; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Rampias T, 2009, JNCI-J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Swart R, 2000, J VIROL, V74, P10838, DOI 10.1128/JVI.74.22.10838-10845.2000; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; van Domselaar R, 2011, REV MED VIROL	33	77	77	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58273	10.1371/journal.pone.0058273	http://dx.doi.org/10.1371/journal.pone.0058273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484008	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900081
J	Zhou, J; Chen, ZM; Malysa, A; Li, X; Oliveira, P; Zhang, YT; Bepler, G				Zhou, Jun; Chen, Zhengming; Malysa, Agnes; Li, Xin; Oliveira, Paula; Zhang, Yingtao; Bepler, Gerold			A Kinome Screen Identifies Checkpoint Kinase 1 (CHK1) as a Sensitizer for RRM1-Dependent Gemcitabine Efficacy	PLOS ONE			English	Article							CELL LUNG-CANCER; RIBONUCLEOTIDE REDUCTASE; IN-VIVO; PANCREATIC-CANCER; EXPRESSION; RRM1; ABROGATION; RESISTANCE; SUBUNIT; CHEMOTHERAPY	Gemcitabine is among the most efficacious and widely used antimetabolite agents. Its molecular targets are ribonucleotide reductase M1 (RRM1) and elongating DNA. Acquired and de novo resistance as a result of RRM1 overexpression are major obstacles to therapeutic efficacy. We deployed a synthetic lethality screen to investigate if knockdown of 87 selected protein kinases by siRNA could overcome RRM1-dependent gemcitabine resistance in high and low RRM1-expressing model systems. The models included genetically RRM1-modified lung and breast cancer cell lines, cell lines with gemcitabine-induced RRM1 overexpression, and a series of naturally gemcitabine-resistant cell lines. Lead molecular targets were validated by determination of differential gemcitabine activity using cell lines with and without target knock down, and by assessing synergistic activity between gemcitabine and an inhibitor of the lead target. CHK1 was identified has the kinase with the most significant and robust interaction, and it was validated using AZD7762, a small-molecule ATP-competitive inhibitor of CHK1 activation. Synergism between CHK1 inhibition and RRM1-dependent gemcitabine efficacy was observed in cells with high RRM1 levels, while antagonism was observed in cells with low RRM1 levels. In addition, four cell lines with natural gemcitabine resistance demonstrated improved gemcitabine efficacy after CHK1 inhibition. In tumor specimens from 187 patients with non-small-cell lung cancer, total CHK1 and RRM1 in situ protein levels were significantly (p = 0.003) and inversely correlated. We conclude that inhibition of CHK1 may have its greatest clinical utility in malignancies where gemcitabine resistance is a result of elevated RRM1 levels. We also conclude that CHK1 inhibition in tumors with low RRM1 levels may be detrimental to gemcitabine efficacy.	[Bepler, Gerold] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; Karmanos Canc Inst, Mol Imaging & Biomarkers Program, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Barbara Ann Karmanos Cancer Institute	Bepler, G (corresponding author), Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA.	beplerg@karmanos.org			National Cancer Institute [R01-CA129343]; NATIONAL CANCER INSTITUTE [R01CA129343] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute R01-CA129343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Akita H, 2009, ONCOGENE, V28, P2903, DOI 10.1038/onc.2009.158; Artin E, 2009, BIOCHEMISTRY-US, V48, P11622, DOI 10.1021/bi901590q; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Bepler G, 2010, J NUCL ACID, V2010, P1; Bepler G, 2008, J THORAC ONCOL, V3, P1112, DOI 10.1097/JTO.0b013e3181874936; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Carlomagno F, 2002, CANCER RES, V62, P7284; Chen ZM, 2011, BIOCHEM BIOPH RES CO, V413, P383, DOI 10.1016/j.bbrc.2011.08.111; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Koniaras K, 2001, ONCOGENE, V20, P7453, DOI 10.1038/sj.onc.1204942; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Pereira S, 2004, J COMPUT CHEM, V25, P1286, DOI 10.1002/jcc.20054; Plunkett W, 1996, SEMIN ONCOL, V23, P3; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; RUSSELL KJ, 1995, CANCER RES, V55, P1639; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Spielmann M, 2001, ONCOLOGY-BASEL, V60, P303, DOI 10.1159/000058524; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58091	10.1371/journal.pone.0058091	http://dx.doi.org/10.1371/journal.pone.0058091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483975	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900068
J	Allen-Petersen, BL; Carter, CJ; Ohm, AM; Reyland, ME				Allen-Petersen, B. L.; Carter, C. J.; Ohm, A. M.; Reyland, M. E.			Protein kinase C delta is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer	ONCOGENE			English	Article						PKC delta; breast cancer; ErbB2; Src	GROWTH-FACTOR RECEPTOR; SRC FAMILY KINASES; ERBB RECEPTORS; PKC-DELTA; PANCREATIC-CANCER; NEU PROTOONCOGENE; EPITHELIAL ACINI; CELL-MIGRATION; NUCLEAR IMPORT; ACTIVATION	Protein kinase C delta (PKC delta) regulates apoptosis in the mammary gland, however, the functional contribution of PKC delta to the development or progression of breast cancer has yet to be determined. Meta-analysis of ErbB2-positive breast cancers shows increased PKC delta expression, and a negative correlation between PKC delta expression and prognosis. Here, we present in-vivo evidence that PKC delta is essential for the development of mammary gland tumors in a ErbB2-overexpressing transgenic mouse model, and in-vitro evidence that PKC delta is required for proliferative signaling downstream of the ErbB2 receptor. Mouse mammary tumor virus (MMTV)-ErbB2 mice lacking PKC delta (delta KO) have increased tumor latency compared with MMTV-ErbB2 wild-type (delta WT) mice, and the tumors show a dramatic decrease in Ki-67 staining. To explore the relationship between PKC delta and ErbB2-driven proliferation more directly, we used MCF-10A cells engineered to express a synthetic ligand-inducible form of the ErbB2 receptor. Depletion of PKC delta with short hairpin RNA inhibited ligand-induced growth in both two-dimensional (2D) (plastic) and three-dimensional (3D) (Matrigel) culture, and correlated with decreased phosphorylation of the ErbB2 receptor and reduced activation of Src and MAPK/ERK pathways. Similarly, in human breast cancer cell lines in which ErbB2 is overexpressed, depletion of PKC delta suppresses proliferation, Src and ERK activation. PKC delta appears to drive proliferation through the formation of an active ErbB2/PKC delta/Src signaling complex, as depletion of PKC delta disrupts association of Src with the ErbB2 receptor. Taken together, our studies present the first evidence that PKC delta is a critical regulator of ErbB2-mediated tumorigenesis, and suggest further investigation of PKC delta as a target in ErbB2-positive breast cancer.	[Allen-Petersen, B. L.] Univ Colorado, Sch Med, Program Cell Biol Stem Cells & Dev, Aurora, CO 80045 USA; [Carter, C. J.; Ohm, A. M.; Reyland, M. E.] Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Anschutz Med Campus,Mail Stop 8120,POB 6511, Aurora, CO 80045 USA.	Mary.Reyland@UCDenver.edu	Allen-Petersen, Brittany/AAC-8504-2020	Allen-Petersen, Brittany/0000-0002-7436-9412	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015648] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA046934] Funding Source: Medline; NICHD NIH HHS [P01 HD038129] Funding Source: Medline; NIDCR NIH HHS [R01 DE015648] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; Allen-Petersen BL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.20; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; D'Costa AM, 2006, ONCOGENE, V25, P378, DOI 10.1038/sj.onc.1209065; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Evans JD, 2003, AM J CLIN PATHOL, V119, P392, DOI 10.1309/BKPC9DX98R781B87; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Grossoni VC, 2007, MOL CARCINOGEN, V46, P381, DOI 10.1002/mc.20287; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jackson D, 2005, ONCOGENE, V24, P3067, DOI 10.1038/sj.onc.1208465; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Kiley SC, 1999, CANCER RES, V59, P3230; Kraus S, 2003, J BIOL CHEM, V278, P32618, DOI 10.1074/jbc.M303886200; Kruger JS, 2003, MOL CANCER RES, V1, P801; Kwon YK, 1997, J NEUROSCI, V17, P8293; Liu Dong, 2000, Shengli Xuebao, V52, P483; Lu ZM, 1997, MOL CELL BIOL, V17, P3418, DOI 10.1128/MCB.17.6.3418; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Mauro LV, 2010, PANCREAS, V39, pE31, DOI 10.1097/MPA.0b013e3181bce796; McKiernan E, 2008, BRIT J CANCER, V99, P1644, DOI 10.1038/sj.bjc.6604728; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; MUTHUSWAMY SK, 1994, MOL CELL BIOL, V14, P735, DOI 10.1128/MCB.14.1.735; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PONGRACZ J, 1995, INT J CANCER, V61, P35, DOI 10.1002/ijc.2910610107; Rexer BN, 2011, ONCOGENE, V30, P4163, DOI 10.1038/onc.2011.130; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Schade B, 2007, CANCER RES, V67, P7579, DOI 10.1158/0008-5472.CAN-06-4724; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song JS, 1998, ONCOGENE, V16, P3357, DOI 10.1038/sj.onc.1201886; Symonds JM, 2011, CANCER RES, V71, P2087, DOI 10.1158/0008-5472.CAN-10-1511; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Tolwinski NS, 1999, J BIOL CHEM, V274, P6168, DOI 10.1074/jbc.274.10.6168; Varga A, 2004, EUR UROL, V46, P462, DOI 10.1016/j.eururo.2004.04.014; Xu WP, 2007, MOL CELL BIOL, V27, P220, DOI 10.1128/MCB.00899-06; Zhang HT, 1998, ONCOGENE, V16, P2835, DOI 10.1038/sj.onc.1201820; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhou XD, 2009, J BIOL CHEM, V284, P12226, DOI 10.1074/jbc.M900020200	61	38	39	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1306	1315		10.1038/onc.2013.59	http://dx.doi.org/10.1038/onc.2013.59			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23474764	Green Accepted			2022-12-25	WOS:000332631100011
J	Tinnes, S; Ringwald, J; Haas, CA				Tinnes, Stefanie; Ringwald, Julia; Haas, Carola A.			TIMP-1 inhibits the proteolytic processing of Reelin in experimental epilepsy	FASEB JOURNAL			English	Article						hippocampus; dispersion; kainate; metalloprotease; organotypic slice cultures	GRANULE CELL DISPERSION; TISSUE INHIBITOR; GENE-EXPRESSION; SECRETED REELIN; KAINIC ACID; PROTEIN; NEURONS; METALLOPROTEINASES-1; ACTIVATION; MOLECULES	Temporal lobe epilepsy is frequently associated with granule cell dispersion (GCD), an abnormal widening of the granule cell layer in the dentate gyrus. There is increasing evidence that a loss and the functional inactivation of the positional signal Reelin is involved in GCD formation. Reelin is synthesized and released by Cajal-Retzius cells and interneurons, and its function depends on proteolytic cleavage after secretion. Epileptic conditions impair Reelin processing by inhibition of matrix metalloprotease (MMP) activity and cause the extracellular accumulation of unprocessed Reelin. Here we investigated how epileptic conditions inhibit MMP activity. We used kainate (KA) treatment of organotypic hippocampal slice cultures as an epilepsy model and found a significant increase of tissue inhibitor of metalloproteases 1 (TIMP-1) levels and strongly enhanced TIMP-1 immunolabeling in hippocampal neurons. Functional inhibition of TIMP-1 prevented the KA-induced impairment of Reelin cleavage indicating that TIMP-1 inhibits MMP activity. Moreover, application of recombinant TIMP-1 alone was sufficient to impair Reelin processing and to induce GCD, similar to that observed after KA treatment. In summary, we present evidence that epileptic conditions inhibit MMP activity by up-regulation of endogenous TIMP-1, which in turn leads to extracellular accumulation of uncleaved and inactive Reelin and thereby to GCD.Tinnes, S., Ringwald, J., Haas, C. A. TIMP-1 inhibits the proteolytic processing of Reelin in experimental epilepsy.	[Tinnes, Stefanie; Ringwald, Julia] Univ Freiburg, Dept Neurosurg, D-79106 Freiburg, Germany; [Haas, Carola A.] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Haas, CA (corresponding author), Univ Clin Freiburg, Dept Neurosurg, Breisacher Str 64, D-79106 Freiburg, Germany.	carola.haas@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [Transregio SFB TR3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank J. Gerlach for critical reading of the manuscript and S. Huber and A. Djie-Maletz for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (DFG; Transregio SFB TR3).	Alcantara S, 1998, J NEUROSCI, V18, P7779; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; Dzwonek J, 2004, FEBS LETT, V567, P129, DOI 10.1016/j.febslet.2004.03.070; Fatemi SH, 2001, NEUROREPORT, V12, P3209, DOI 10.1097/00001756-200110290-00014; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gorter JA, 2007, EPILEPSIA, V48, P53, DOI 10.1111/j.1528-1167.2007.01290.x; Haas CA, 2002, J NEUROSCI, V22, P5797; Haas CA, 2010, EXP BRAIN RES, V200, P141, DOI 10.1007/s00221-009-1948-5; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Hisanaga A, 2012, FEBS LETT, V586, P3349, DOI 10.1016/j.febslet.2012.07.017; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Ignatova N, 2004, NEUROBIOL DIS, V15, P326, DOI 10.1016/j.nbd.2003.11.008; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Jaworski J, 1999, J BIOL CHEM, V274, P28106, DOI 10.1074/jbc.274.40.28106; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Jourquin J, 2003, EUR J NEUROSCI, V18, P1507, DOI 10.1046/j.1460-9568.2003.02876.x; Krstic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047793; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Lugli Giovanni, 2003, BMC Biochem, V4, P9, DOI 10.1186/1471-2091-4-9; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; Lukasiuk K, 2011, EPILEPSY RES, V96, P191, DOI 10.1016/j.eplepsyres.2011.08.002; Mannello F, 2001, APOPTOSIS, V6, P479, DOI 10.1023/A:1012493808790; Motti D, 2010, EUR J NEUROSCI, V32, P1364, DOI 10.1111/j.1460-9568.2010.07403.x; Muller MC, 2009, EXP NEUROL, V216, P390, DOI 10.1016/j.expneurol.2008.12.029; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Ramos-Moreno T, 2006, EUR J NEUROSCI, V23, P401, DOI 10.1111/j.1460-9568.2005.04567.x; Rivera S, 1997, J NEUROSCI, V17, P4223; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Tinnes S, 2011, FASEB J, V25, P1002, DOI 10.1096/fj.10-168294; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Wright JW, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/579382; Yasui N, 2011, J BIOL CHEM, V286, P35247, DOI 10.1074/jbc.M111.242719; Zhang JW, 1998, EUR J NEUROSCI, V10, P3358, DOI 10.1046/j.1460-9568.1998.00347.x	42	26	26	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2542	2552		10.1096/fj.12-224899	http://dx.doi.org/10.1096/fj.12-224899			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23493620				2022-12-25	WOS:000328841000004
J	Chen, L; Bi, DL; Tian, LJ; McClafferty, H; Steeb, F; Ruth, P; Knaus, HG; Shipston, MJ				Chen, Lie; Bi, Danlei; Tian, Lijun; McClafferty, Heather; Steeb, Franziska; Ruth, Peter; Knaus, Hans Guenther; Shipston, Michael J.			Palmitoylation of the beta 4-Subunit Regulates Surface Expression of Large Conductance Calcium-activated Potassium Channel Splice Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT REGULATION; BETA-SUBUNITS; BK CHANNELS; MODULATION; FAMILY; ALPHA; SITE	Regulatory beta-subunits of large conductance calcium- and voltage-activated potassium (BK) channels play an important role in generating functional diversity and control of cell surface expression of the pore forming alpha-subunits. However, in contrast to alpha-subunits, the role of reversible post-translational modification of intracellular residues on beta-subunit function is largely unknown. Here we demonstrate that the human beta 4-subunit is S-acylated (palmitoylated) on a juxtamembrane cysteine residue (Cys-193) in the intracellular C terminus of the regulatory beta-subunit. beta 4-Subunit palmitoylation is important for cell surface expression and endoplasmic reticulum (ER) exit of the beta 4-subunit alone. Importantly, palmitoylated beta 4-subunits promote the ER exit and surface expression of the pore-forming alpha-subunit, whereas beta 4-subunits that cannot be palmitoylated do not increase ER exit or surface expression of alpha-subunits. Strikingly, however, this palmitoylation-and beta 4-dependent enhancement of alpha-subunit surface expression was only observed in alpha-subunits that contain a putative trafficking motif (... REVEDEC) at the very C terminus of the alpha-subunit. Engineering this trafficking motif to other C-terminal alpha-subunit splice variants results in alpha-subunits with reduced surface expression that can be rescued by palmitoylated, but not depalmitoylated, beta 4-subunits. Our data reveal a novel mechanism by which palmitoylated beta 4-subunit controls surface expression of BK channels through masking of a trafficking motif in the C terminus of the alpha-subunit. As palmitoylation is dynamic, this mechanism would allow precise control of specific splice variants to the cell surface. Our data provide new insights into how complex interplay between the repertoire of post-transcriptional and post-translational mechanisms controls cell surface expression of BK channels.	[Chen, Lie; Bi, Danlei; Tian, Lijun; McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Steeb, Franziska; Ruth, Peter] Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; [Knaus, Hans Guenther] Univ Tubingen, Inst Pharm, Div Pharmacol & Toxicol, D-72076 Tubingen, Germany	University of Edinburgh; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Michael/C-7309-2013	Shipston, Michael/0000-0001-7544-582X; Chen, Lie/0000-0001-9764-4299	Wellcome Trust program grant; British Heart Foundation [PG/12/57/29782] Funding Source: researchfish	Wellcome Trust program grant(Wellcome Trust); British Heart Foundation(British Heart Foundation)	This work was supported by a Wellcome Trust program grant (to M. J. S., H. G. K., and P. R.).	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burgoyne JR, 2012, FASEB J, V26, P832, DOI 10.1096/fj.11-189415; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; Chiu YH, 2010, MOL PHARMACOL, V77, P497, DOI 10.1124/mol.109.061929; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Grimm PR, 2009, P NATL ACAD SCI USA, V106, P11800, DOI 10.1073/pnas.0904635106; Holtzclaw JD, 2010, J AM SOC NEPHROL, V21, P634, DOI 10.1681/ASN.2009080817; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Jin P, 2002, J BIOL CHEM, V277, P10014, DOI 10.1074/jbc.M107682200; Jin P, 2002, J BIOL CHEM, V277, P43724, DOI 10.1074/jbc.M205795200; Kim EY, 2007, NEUROSCIENCE, V146, P1652, DOI 10.1016/j.neuroscience.2007.03.038; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; King JT, 2006, J NEUROPHYSIOL, V95, P2878, DOI 10.1152/jn.01352.2005; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Ma DH, 2007, FEBS LETT, V581, P1000, DOI 10.1016/j.febslet.2007.01.077; Martin GE, 2008, P NATL ACAD SCI USA, V105, P17543, DOI 10.1073/pnas.0801068105; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Petrik D, 2007, NEUROSCIENCE, V149, P789, DOI 10.1016/j.neuroscience.2007.07.066; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Wu RS, 2009, J NEUROSCI, V29, P8321, DOI 10.1523/JNEUROSCI.6191-08.2009; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006135	32	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13136	13144		10.1074/jbc.M113.461830	http://dx.doi.org/10.1074/jbc.M113.461830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504458	Green Published, hybrid			2022-12-25	WOS:000318555100063
J	Minami, A; Shimono, Y; Mizutani, K; Nobutani, K; Momose, K; Azuma, T; Takai, Y				Minami, Akihiro; Shimono, Yohei; Mizutani, Kiyohito; Nobutani, Kentaro; Momose, Kenji; Azuma, Takeshi; Takai, Yoshimi			Reduction of the ST6 beta-Galactosamide alpha-2,6-Sialyltransferase 1 (ST6GAL1)-catalyzed Sialylation of Nectin-like Molecule 2/Cell Adhesion Molecule 1 and Enhancement of ErbB2/ErbB3 Signaling by MicroRNA-199a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; OVARIAN-CANCER CELLS; IMMUNOGLOBULIN SUPERFAMILY; HEPATOCELLULAR-CARCINOMA; PROTEIN GLYCOSYLATION; PROLIFERATION; EXPRESSION; GENE; SIALYLTRANSFERASE; TARGETS	Nectin-like molecule 2 (Necl-2)/cell adhesion molecule 1 (CADM1) is shown to be down-regulated by the promoter hypermethylation and/or loss of heterozygosity at chromosome 11q23.2 in many types of cancers, including lung and breast cancers, and is proposed to serve as a tumor suppressor. However, the incidence of these epigenetic and genetic abnormalities of Necl-2 is 30-60% in these cancers, and other mechanisms for the suppression of Necl-2 are presumed to be present. We previously showed that Necl-2 interacts in cis with ErbB3 and suppresses the heregulin (HRG)-induced ErbB2/ErbB3 signaling for cell movement and death. We studied here the relationship between Necl-2 and microRNA-199a (miR-199a) that is up-regulated or down-regulated in a variety of cancers. miR-199a did not directly target the Necl-2 mRNA or affect its mRNA level in human lung cancer A549 cells and human embryonic kidney HEK293 cells. Necl-2 was at least sialylated by the sialyltransferase ST6 beta-galactosamide alpha-2,6-sialyltransferase 1 (ST6GAL1). miR-199a targeted ST6GAL1 and reduced both the sialylation and the protein level of Necl-2. In addition, miR-199a enhanced the HRG-induced ErbB2/ErbB3 signaling. These results indicate that the suppressive role of Necl-2 in the HRG-induced ErbB2/ErbB3 signaling is regulated by miR-199a at least through the reduction of the ST6GAL1catalyzed sialylation of Necl-2 and/or through the reduction of the protein level of Necl-2 presumably by the protein degradation.	[Minami, Akihiro; Shimono, Yohei; Mizutani, Kiyohito; Nobutani, Kentaro; Momose, Kenji; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Minami, Akihiro; Nobutani, Kentaro; Momose, Kenji; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Div Gastroenterol, Dept Internal Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Mizutani, Kiyohito; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling,Chuo Ku, Kobe, Hyogo 6500047, Japan	Kobe University; Kobe University; Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Mizutani, Kiyohito/L-8474-2019	Shimono, Yohei/0000-0002-6256-4704	Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology"; Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; Naito Foundation; Sagawa Foundation; Yasuda Medical Foundation; Cell Science Research Foundation; Grants-in-Aid for Scientific Research [24790284, 23130510] Funding Source: KAKEN	Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology"; Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; Naito Foundation(Naito Memorial Foundation); Sagawa Foundation; Yasuda Medical Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by Grants-in-Aid from the Japan Society for the Promotion of Science; by Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; and by grants from the Naito Foundation, the Sagawa Foundation, the Yasuda Medical Foundation, and the Cell Science Research Foundation.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Barker A, 2010, CURR OPIN PHARMACOL, V10, P655, DOI 10.1016/j.coph.2010.08.011; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Dai L, 2012, MOL HUM REPROD, V18, P136, DOI 10.1093/molehr/gar066; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Hagen JW, 2008, CELL CYCLE, V7, P2327, DOI 10.4161/cc.6447; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Henry JC, 2010, BIOCHEM BIOPH RES CO, V403, P120, DOI 10.1016/j.bbrc.2010.10.130; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033762; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Konishi A, 2003, J BIOL CHEM, V278, P35049, DOI 10.1074/jbc.M304913200; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lee M, 2008, MOL CANCER RES, V6, P1316, DOI 10.1158/1541-7786.MCR-07-2209; LENNARZ W, 1983, METHOD ENZYMOL, V98, P91; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Momose K, 2013, GENES CELLS, V18, P195, DOI 10.1111/gtc.12027; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Santhakumar D, 2010, P NATL ACAD SCI USA, V107, P13830, DOI 10.1073/pnas.1008861107; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Serino G, 2012, J AM SOC NEPHROL, V23, P814, DOI 10.1681/ASN.2011060567; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SPIRO MJ, 1968, J BIOL CHEM, V243, P6520; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tsukigi M, 2012, CANCER LETT, V315, P189, DOI 10.1016/j.canlet.2011.10.008; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Zhou FB, 2010, J BIOCHEM, V148, P273, DOI 10.1093/jb/mvq062	59	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11845	11853		10.1074/jbc.M112.405993	http://dx.doi.org/10.1074/jbc.M112.405993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504322	Green Published, hybrid			2022-12-25	WOS:000318157600020
J	Shah, P; Fatehchand, K; Patel, H; Fang, HQ; Justiniano, SE; Mo, XK; Jarjoura, D; Tridandapani, S; Butchar, JP				Shah, Prexy; Fatehchand, Kavin; Patel, Hemal; Fang, Huiqing; Justiniano, Steven E.; Mo, Xiaokui; Jarjoura, David; Tridandapani, Susheela; Butchar, Jonathan P.			Toll-like Receptor 2 Ligands Regulate Monocyte Fc gamma Receptor Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL PHOSPHATASE SHIP; CYTOKINE RESPONSE; IMMUNE-RESPONSES; MYELOID CELLS; TUMOR-CELLS; B-CELLS; IMMUNOTHERAPY; ACTIVATION; CANCER; TLR2	Fc gamma receptor (Fc gamma R) clustering on monocytes/macrophages results in phagocytosis and inflammatory cytokine production, which serve to eliminate antibody-opsonized targets and activate neighboring immune cells. Toll-like receptor 2 (TLR2), which recognizes a range of both bacterial and fungal components, elicits strong proinflammatory responses in these cells when stimulated by ligands, either natural or synthetic. Thus, we explored the possibility that TLR2 agonists could strengthen Fc gamma R activity within the context of antibody therapy. Human peripheral blood monocytes treated with the TLR2 agonist Pam2CSK4 showed significantly enhanced Fc gamma R-mediated cytokine production as well as phagocytic ability. An examination of the molecular mechanism behind this enhancement revealed increased expression of both Fc gamma RIIa and the common gamma subunit following Pam2CSK4 treatment. Interestingly however, expression of the inhibitory receptor Fc gamma RIIb was also modestly increased. Further investigation revealed that Pam2CSK4 also dramatically decreased the expression of SHIP, the major mediator of Fc gamma RIIb inhibitory activity. Using a murine Her2/neu solid tumor model of antibody therapy, we found that Pam2CSK4 significantly enhanced the ability of anti-Her2 antibody to reduce the rate of tumor growth. To verify that the Fc gamma R enhancement was not unique to the diacylated Pam2CSK4, we also tested Pam3CSK4, a related triacylated TLR2 agonist. Results showed significant enhancement in Fc gamma R function and expression. Taken together, these findings indicate that TLR2 activation can positively modulate Fc gamma R and suggest that TLR2 agonists should be considered for testing as adjuvants for antitumor antibody therapy.	[Shah, Prexy; Fatehchand, Kavin; Patel, Hemal; Fang, Huiqing; Justiniano, Steven E.; Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui; Jarjoura, David] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Tridandapani, S (corresponding author), Ohio State Univ, Dept Internal Med, 415 DHLRI,473 W 12th Ave, Columbus, OH 43210 USA.	tridandapani.2@osu.edu; butchar.2@osu.edu	Butchar, Jonathan/E-2825-2011; Tridandapani, Susheela/E-4209-2011	Justiniano, Steven/0000-0003-1381-9309	National Institutes of Health [P01-CA095426, K12-CA133250, T32 60013191]; American Cancer Society [IRG-67-003-47]; NATIONAL CANCER INSTITUTE [P01CA095426, K12CA133250, P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-CA095426 (to S. T.) and K12-CA133250 (to J. P. B.) and National Institutes of Health Postdoctoral Fellowship T32 60013191 (to S. E. J.). This work was also supported by American Cancer Society Grant IRG-67-003-47 (to J. P. B.).	Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Chtarbanova S, 2011, ARTERIOSCL THROM VAS, V31, P1734, DOI 10.1161/ATVBAHA.108.179523; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Cremer TJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00073; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Ha TZ, 2010, AM J PHYSIOL-HEART C, V298, pH984, DOI 10.1152/ajpheart.01109.2009; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Ho M, 2012, MABS-AUSTIN, V4, P562, DOI 10.4161/mabs.21521; Joshi T, 2006, MOL IMMUNOL, V43, P839, DOI 10.1016/j.molimm.2005.06.037; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Maresco DL, 1999, J IMMUNOL, V162, P6458; Nakamura K, 2000, J IMMUNOL, V164, P631, DOI 10.4049/jimmunol.164.2.631; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Parihar R, 2002, J CLIN INVEST, V110, P983, DOI 10.1172/JCI200215950; Penichet ML, 1999, LAB ANIM SCI, V49, P179; Roda JM, 2007, CLIN CANCER RES, V13, P6419, DOI 10.1158/1078-0432.CCR-07-0865; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Saber T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023540; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Tsai YG, 2010, J IMMUNOL, V184, P7229, DOI 10.4049/jimmunol.1000083; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8	37	16	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12345	12352		10.1074/jbc.M113.449983	http://dx.doi.org/10.1074/jbc.M113.449983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504312	hybrid, Green Published			2022-12-25	WOS:000318157600065
J	Ma, YM; Duan, FB; Chapeau-Blondeau, F; Abbott, D				Ma, Yumei; Duan, Fabing; Chapeau-Blondeau, Francois; Abbott, Derek			Weak-Periodic Stochastic Resonance in a Parallel Array of Static Nonlinearities	PLOS ONE			English	Article							SIGNAL-DETECTION; NOISE; INFORMATION; IMPROVEMENT; BENEFITS	This paper studies the output-input signal-to-noise ratio (SNR) gain of an uncoupled parallel array of static, yet arbitrary, nonlinear elements for transmitting a weak periodic signal in additive white noise. In the small-signal limit, an explicit expression for the SNR gain is derived. It serves to prove that the SNR gain is always a monotonically increasing function of the array size for any given nonlinearity and noisy environment. It also determines the SNR gain maximized by the locally optimal nonlinearity as the upper bound of the SNR gain achieved by an array of static nonlinear elements. With locally optimal nonlinearity, it is demonstrated that stochastic resonance cannot occur, i.e. adding internal noise into the array never improves the SNR gain. However, in an array of suboptimal but easily implemented threshold nonlinearities, we show the feasibility of situations where stochastic resonance occurs, and also the possibility of the SNR gain exceeding unity for a wide range of input noise distributions.	[Ma, Yumei; Duan, Fabing] Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China; [Chapeau-Blondeau, Francois] Univ Angers, Lab Ingn Syst Automatises, Angers, France; [Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Qingdao University; Universite d'Angers; University of Adelaide; University of Adelaide	Duan, FB (corresponding author), Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China.	fabing.duan@gmail.com	Abbott, Derek/E-8352-2011	Abbott, Derek/0000-0002-0945-2674; CHAPEAU-BLONDEAU, Francois/0000-0003-0536-7146	National Science Foundation of Shandong Province, China [ZR2010FM006]	National Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	This work is sponsored by the National Science Foundation of Shandong Province, China (No. ZR2010FM006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Benzi R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01052; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Chapeau-Blondeau F, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.060101; Chapeau-Blondeau F, 2008, DIGIT SIGNAL PROCESS, V18, P434, DOI 10.1016/j.dsp.2007.04.012; Chapeau-Blondeau F, 2006, CIRC SYST SIGNAL PR, V25, P431, DOI 10.1007/s00034-005-0528-6; Chapeau-Blondeau F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021124; ChapeauBlondeau F, 1997, PHYS REV E, V55, P1478, DOI 10.1103/PhysRevE.55.1478; Chen H, 2008, IEEE T SIGNAL PROCES, V56, P5031, DOI 10.1109/TSP.2008.928509; Chen H, 2008, IEEE T SIGNAL PROCES, V56, P5074, DOI 10.1109/TSP.2008.928508; Chen HO, 2007, IEEE T SIGNAL PROCES, V55, P3172, DOI 10.1109/TSP.2007.893757; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Collins JJ, 2003, IEEE ENG MED BIOL, V22, P76, DOI 10.1109/MEMB.2003.1195700; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Cover TM, 1991, ELEMENTS INFORM THEO; Duan F, 2006, ELECTRON LETT, V42, P1008, DOI 10.1049/el:20061670; Duan F, 2008, PHYS LETT A, V372, P2159, DOI 10.1016/j.physleta.2007.10.092; Duan FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034282; Duan FB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051107; Dykman MI, 1998, NATURE, V391, P344, DOI 10.1038/34812; Gailey PC, 1997, PHYS REV LETT, V79, P4701, DOI 10.1103/PhysRevLett.79.4701; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gan CB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/4/040508; Godivier X, 1997, SIGNAL PROCESS, V56, P293, DOI 10.1016/S0165-1684(96)00176-4; Gosak M, 2011, EUR PHYS J B, V80, P519, DOI 10.1140/epjb/e2011-10573-8; Gosak M, 2012, MOL CRYST LIQ CRYST, V553, P13, DOI 10.1080/15421406.2011.609343; Greenwood PE, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051110; Hanggi P, 2000, PHYS REV E, V62, P6155, DOI 10.1103/PhysRevE.62.6155; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Hutt MT, 2012, CHAOS SOLITON FRACT, V45, P611, DOI 10.1016/j.chaos.2011.12.011; Inchiosa ME, 1996, PHYS REV E, V53, pR2021, DOI 10.1103/PhysRevE.53.R2021; JUNG P, 1991, PHYS REV A, V44, P8032, DOI 10.1103/PhysRevA.44.8032; Kassam S. A., 1988, SIGNAL DETECTION NON; Kay S, 2000, IEEE SIGNAL PROC LET, V7, P8, DOI 10.1109/97.809511; Kitajo K, 2006, EUROPHYS LETT, V76, P1029, DOI 10.1209/epl/i2006-10377-0; Li JL, 2006, CHINESE PHYS, V15, P2867, DOI 10.1088/1009-1963/15/12/017; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; LINDNER JF, 1995, PHYS REV LETT, V75, P3, DOI 10.1103/PhysRevLett.75.3; McDonnell M.D., 2008, STOCH RES SUPR, DOI DOI 10.1017/CBO9780511535239; Mori T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.218101; MOSS F, 1995, NATURE, V376, P211, DOI 10.1038/376211a0; Patel A, 2011, IEEE T SIGNAL PROCES, V59, P488, DOI 10.1109/TSP.2010.2091409; Patel A, 2010, IEEE SIGNAL PROC LET, V17, P1005, DOI 10.1109/LSP.2010.2059376; Perc M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066203; Perc M, 2008, SOFT MATTER, V4, P1861, DOI 10.1039/b804566f; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036105; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Rousseau D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021102; Rousseau D, 2005, DIGIT SIGNAL PROCESS, V15, P19, DOI 10.1016/j.dsp.2004.09.006; Rousseau D, 2004, PHYS LETT A, V321, P280, DOI 10.1016/j.physleta.2003.12.042; Rousseau D, 2007, IEEE T INSTRUM MEAS, V56, P2658, DOI 10.1109/TIM.2007.908125; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Stacey WC, 2001, J NEUROPHYSIOL, V86, P1104, DOI 10.1152/jn.2001.86.3.1104; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stocks NG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041114; Teramae J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00485; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; Zozor S, 2003, IEEE T SIGNAL PROCES, V51, P3177, DOI 10.1109/TSP.2003.818905	61	6	7	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58507	10.1371/journal.pone.0058507	http://dx.doi.org/10.1371/journal.pone.0058507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505523	Green Submitted, Green Published, gold			2022-12-25	WOS:000316251100057
J	Wang, J; Urbanowicz, RA; Tighe, PJ; Todd, I; Corne, JM; Fairclough, LC				Wang, Jia; Urbanowicz, Richard A.; Tighe, Patrick J.; Todd, Ian; Corne, Jonathan M.; Fairclough, Lucy C.			Differential Activation of Killer Cells in the Circulation and the Lung: A Study of Current Smoking Status and Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article							T-LYMPHOCYTE SUBSETS; INDUCED SPUTUM; BRONCHOALVEOLAR LAVAGE; BRONCHIAL BIOPSIES; EFFECTOR FUNCTION; CYTOTOXIC-CELLS; SYSTEMIC CD4+; NK CELLS; EXPRESSION; RECEPTORS	Background: CD8(+) T-lymphocytes, natural killer T-like cells (NKT-like cells, CD56(+)CD3(+)) and natural killer cells (NK cells, CD56(+)CD3(-)) are the three main classes of human killer cells and they are implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). Activation of these cells can initiate immune responses by virtue of their production of inflammatory cytokines and chemokines that cause lung tissue damage, mucus hypersecretion and emphysema. The objective of the current study was to investigate the activation levels of human killer cells in healthy non-smokers, healthy smokers, ex-smokers with COPD and current smokers with COPD, in both peripheral blood and induced sputum. Methods/Principal Findings: After informed consent, 124 participants were recruited into the study and peripheral blood or induced sputum was taken. The activation states and receptor expression of killer cells were measured by flow cytometry. In peripheral blood, current smokers, regardless of disease state, have the highest proportion of activated CD8(+) T-lymphocytes, NKT-like cells and NK cells compared with ex-smokers with COPD and healthy non-smokers. Furthermore, CD8+ T-lymphocyte and NK cell activation is positively correlated with the number of cigarettes currently smoked. Conversely, in induced sputum, the proportion of activated killer cells was related to disease state rather than current smoking status, with current and ex-smokers with COPD having significantly higher rates of activation than healthy smokers and healthy non-smokers. Conclusions: A differential effect in systemic and lung activation of killer cells in COPD is evident. Systemic activation appears to be related to current smoking whereas lung activation is related to the presence or absence of COPD, irrespective of current smoking status. These findings suggest that modulating killer cell activation may be a new target for the treatment of COPD.	[Wang, Jia; Urbanowicz, Richard A.; Tighe, Patrick J.; Todd, Ian; Fairclough, Lucy C.] Univ Nottingham, Sch Mol Med Sci, COPD Res Grp, Nottingham NG7 2RD, Notts, England; [Corne, Jonathan M.] Nottingham Univ Hosp NHS Trust, Dept Resp Med, Nottingham NG7 2UH, Notts, England	University of Nottingham; Nottingham University Hospital NHS Trust	Fairclough, LC (corresponding author), Univ Nottingham, Sch Mol Med Sci, COPD Res Grp, Nottingham NG7 2RD, Notts, England.	lucy.fairclough@nottingham.ac.uk	Fairclough, Lucy/Q-8685-2018; Urbanowicz, Richard Antoni/M-3354-2019	Fairclough, Lucy/0000-0003-4581-9741; Urbanowicz, Richard Antoni/0000-0002-2461-4993; Tighe, Patrick/0000-0001-8326-093X	University of Nottingham; Jones' 1986 Charitable Trust; Nottingham Respiratory Biomedical Research Unit	University of Nottingham; Jones' 1986 Charitable Trust; Nottingham Respiratory Biomedical Research Unit	This work was supported by University of Nottingham (JW) and The Jones' 1986 Charitable Trust (RAU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge our research nurse, Lizz Everitt, for recruiting the patients. LF and JC are grateful for the support of the Nottingham Respiratory Biomedical Research Unit. We also appreciate all participants for their willingness to contribute to this study.	Agusti A, 2012, AM J RESP CRIT CARE, V185, P1171, DOI 10.1164/rccm.201203-0505UP; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Crapo RO, 2003, EUR RESPIR J, V21, p19S, DOI 10.1183/09031936.03.00077902; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Ekberg-Jansson A, 2000, RESP MED, V94, P264, DOI 10.1053/rmed.1999.0735; Fairclough L, 2008, CLIN SCI, V114, P533, DOI 10.1042/CS20070356; FERRINI S, 1994, EUR J IMMUNOL, V24, P2294, DOI 10.1002/eji.1830241005; Glader P, 2006, RESP MED, V100, P1088, DOI 10.1016/j.rmed.2005.09.025; Kim WD, 2002, CHEST, V122, P437, DOI 10.1378/chest.122.2.437; Knight DA, 2012, RESPIROLOGY, V17, P563, DOI 10.1111/j.1440-1843.2012.02126.x; Lane N, 2010, CLIN SCI, V119, P75, DOI 10.1042/CS20100033; Leckie MJ, 2003, THORAX, V58, P23, DOI 10.1136/thorax.58.1.23; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Marquez ME, 2010, CELL IMMUNOL, V264, P86, DOI 10.1016/j.cellimm.2010.05.002; McDonald DR, 2010, J ALLERGY CLIN IMMUN, V126, P332, DOI 10.1016/j.jaci.2010.05.013; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; Paats MS, 2012, EUR RESPIR J, V40, P330, DOI 10.1183/09031936.00079611; Parasa VRR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037448; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Patterson S, 2008, J IMMUNOL, V181, P3268, DOI 10.4049/jimmunol.181.5.3268; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; Profita M, 2012, IMMUNOBIOLOGY, V217, P345, DOI 10.1016/j.imbio.2011.07.013; Roos-Engstrand E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-128; Roos-Engstrand E, 2009, COPD, V6, P112, DOI 10.1080/15412550902755358; Rutgers SR, 2000, EUR RESPIR J, V15, P109, DOI 10.1183/09031936.00.15110900; Siena L, 2011, RESP MED, V105, P1491, DOI 10.1016/j.rmed.2011.04.014; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; Urbanowicz RA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-53; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Young NT, 2001, J IMMUNOL, V166, P3933, DOI 10.4049/jimmunol.166.6.3933	36	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58556	10.1371/journal.pone.0058556	http://dx.doi.org/10.1371/journal.pone.0058556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505535	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100063
J	Allerston, CK; von Delft, F; Gileadi, O				Allerston, Charles K.; von Delft, Frank; Gileadi, Opher			Crystal Structures of the Catalytic Domain of Human Soluble Guanylate Cyclase	PLOS ONE			English	Article							MAMMALIAN ADENYLYL-CYCLASE; ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE; FUNCTIONAL-CHARACTERIZATION; ACTIVATION; ANGIOGENESIS; INHIBITION; EXPRESSION; ENZYME; SITE	Soluble guanylate cyclase (sGC) catalyses the synthesis of cyclic GMP in response to nitric oxide. The enzyme is a heterodimer of homologous alpha and beta subunits, each of which is composed of multiple domains. We present here crystal structures of a heterodimer of the catalytic domains of the alpha and beta subunits, as well as an inactive homodimer of beta subunits. This first structure of a metazoan, heteromeric cyclase provides several observations. First, the structures resemble known structures of adenylate cyclases and other guanylate cyclases in overall fold and in the arrangement of conserved active-site residues, which are contributed by both subunits at the interface. Second, the subunit interaction surface is promiscuous, allowing both homodimeric and heteromeric association; the preference of the full-length enzyme for heterodimer formation must derive from the combined contribution of other interaction interfaces. Third, the heterodimeric structure is in an inactive conformation, but can be superposed onto an active conformation of adenylate cyclase by a structural transition involving a 26 degrees rigid-body rotation of the alpha subunit. In the modelled active conformation, most active site residues in the subunit interface are precisely aligned with those of adenylate cyclase. Finally, the modelled active conformation also reveals a cavity related to the active site by pseudo-symmetry. The pseudosymmetric site lacks key active site residues, but may bind allosteric regulators in a manner analogous to the binding of forskolin to adenylate cyclase. This indicates the possibility of developing a new class of small-molecule modulators of guanylate cyclase activity targeting the catalytic domain.	[Allerston, Charles K.; von Delft, Frank; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford, England	University of Oxford	Gileadi, O (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford, England.	opher.gileadi@sgc.ox.ac.uk	Gileadi, Opher/F-1105-2013	Gileadi, Opher/0000-0001-6886-898X; von Delft, Frank/0000-0003-0378-0017	Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; AbbVie; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust [092809/ /10/Z]; SGC	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission); SGC	The SGC (Structural Genomics Consortium) is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, AbbVie, the Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust [092809/ /10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. This study was funded by The SGC which is a charity funded by a public-private partnership that includes commercial entities (GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, and AbbVie). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amini A, 2012, CURR CANCER DRUG TAR, V12, P23, DOI 10.2174/156800912798888956; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bricogne G., 2011, BUSTER VERSION 2 10; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-26; Friebe A, 1999, BIOCHEMISTRY-US, V38, P15253, DOI 10.1021/bi9908944; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; HUMBERT P, 1990, EUR J BIOCHEM, V190, P273, DOI 10.1111/j.1432-1033.1990.tb15572.x; Hurley JH, 1998, CURR OPIN STRUC BIOL, V8, P770, DOI 10.1016/S0959-440X(98)80097-3; IGNARRO LJ, 1991, BLOOD VESSELS, V28, P67; Jeganathan VSE, 2011, CURR PHARM BIOTECHNO, V12, P369; Kajiya K, 2008, FASEB J, V22, P530, DOI 10.1096/fj.07-8873com; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Linder JU, 2000, J BIOL CHEM, V275, P11235, DOI 10.1074/jbc.275.15.11235; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Majumder S, 2009, BRIT J PHARMACOL, V158, P1720, DOI 10.1111/j.1476-5381.2009.00446.x; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Mergia Evanthia, 2009, V191, P33, DOI 10.1007/978-3-540-68964-5_3; Mitrovic Veselin, 2011, Curr Heart Fail Rep, V8, P38, DOI 10.1007/s11897-010-0045-1; Morbidelli L, 2010, AM J PHYSIOL-REG I, V298, pR824, DOI 10.1152/ajpregu.00222.2009; Morton DB, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.12; Morton DB, 2003, J EXP BIOL, V206, P937, DOI 10.1242/jeb.00160; Mou TC, 2006, MOL PHARMACOL, V70, P878, DOI 10.1124/mol.106.026427; Mou TC, 2009, BIOCHEMISTRY-US, V48, P3387, DOI 10.1021/bi802122k; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Russwurm M, 2002, MOL CELL BIOCHEM, V230, P159, DOI 10.1023/A:1014252309493; Saino M, 2004, ONCOL REP, V12, P47; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Surmeli NB, 2012, CHEMBIOCHEM; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Whisnant RE, 1996, P NATL ACAD SCI USA, V93, P6621, DOI 10.1073/pnas.93.13.6621; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Yan SZ, 1996, J BIOL CHEM, V271, P10941, DOI 10.1074/jbc.271.18.10941; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zhu HF, 2011, MOL PHARMACOL, V80, P1076, DOI 10.1124/mol.111.073585	63	73	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57644	10.1371/journal.pone.0057644	http://dx.doi.org/10.1371/journal.pone.0057644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505436	gold, Green Submitted, Green Published			2022-12-25	WOS:000318334500028
J	Njuguna, HN; Cosmas, L; Williamson, J; Nyachieo, D; Olack, B; Ochieng, JB; Wamola, N; Oundo, JO; Feikin, DR; Mintz, ED; Breiman, RF				Njuguna, Henry N.; Cosmas, Leonard; Williamson, John; Nyachieo, Dhillon; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Oundo, Joseph O.; Feikin, Daniel R.; Mintz, Eric D.; Breiman, Robert F.			Use of Population-based Surveillance to Define the High Incidence of Shigellosis in an Urban Slum in Nairobi, Kenya	PLOS ONE			English	Article							RURAL WESTERN KENYA; ANTIMICROBIAL RESISTANCE; BACTERIAL DIARRHEA; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; COUNTRIES; DISEASE; SUSCEPTIBILITY; MULTICENTER	Background: Worldwide, Shigella causes an estimated 160 million infections and >1 million deaths annually. However, limited incidence data are available from African urban slums. We investigated the epidemiology of shigellosis and drug susceptibility patterns within a densely populated urban settlement in Nairobi, Kenya through population-based surveillance. Methods: Surveillance participants were interviewed in their homes every 2 weeks by community interviewers. Participants also had free access to a designated study clinic in the surveillance area where stool specimens were collected from patients with diarrhea (>= 3 loose stools within 24 hours) or dysentery (>= 1 stool with visible blood during previous 24 hours). We adjusted crude incidence rates for participants meeting stool collection criteria at household visits who reported visiting another clinic. Results: Shigella species were isolated from 224 (23%) of 976 stool specimens. The overall adjusted incidence rate was 408/100,000 person years of observation (PYO) with highest rates among adults 34-49 years old (1,575/100,000 PYO). Isolates were: Shigella flexneri (64%), S. dysenteriae (11%), S. sonnei (9%), and S. boydii (5%). Over 90% of all Shigella isolates were resistant to trimethoprim-sulfamethoxazole and sulfisoxazole. Additional resistance included nalidixic acid (3%), ciprofloxacin (1%) and ceftriaxone (1%). Conclusion: More than 1 of every 200 persons experience shigellosis each year in this Kenyan urban slum, yielding rates similar to those in some Asian countries. Provision of safe drinking water, improved sanitation, and hygiene in urban slums are needed to reduce disease burden, in addition to development of effective Shigella vaccines.	[Njuguna, Henry N.; Cosmas, Leonard; Williamson, John; Nyachieo, Dhillon; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Oundo, Joseph O.; Feikin, Daniel R.; Breiman, Robert F.] Ctr Dis Control & Prevent Kenya CDC K Collaborat, Kenya Med Res Inst KEMRI, Global Dis Detect Program, Nairobi, Kenya; [Njuguna, Henry N.; Cosmas, Leonard; Williamson, John; Nyachieo, Dhillon; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Oundo, Joseph O.; Feikin, Daniel R.; Breiman, Robert F.] Ctr Dis Control & Prevent Kenya CDC K Collaborat, Kenya Med Res Inst KEMRI, Global Dis Detect Program, Kisumu, Kenya; [Mintz, Eric D.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Njuguna, HN (corresponding author), Ctr Dis Control & Prevent Kenya CDC K Collaborat, Kenya Med Res Inst KEMRI, Global Dis Detect Program, Nairobi, Kenya.	hnjuguna@ke.cdc.gov			Centers for Disease Control and Prevention (CDC US)	Centers for Disease Control and Prevention (CDC US)	This work was supported by the Centers for Disease Control and Prevention (CDC US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 1997, AM J TROP MED HYG, V56, P258, DOI 10.4269/ajtmh.1997.56.258; ALAM N, 1989, INT J EPIDEMIOL, V18, P697, DOI 10.1093/ije/18.3.697; [Anonymous], NOAA KEN WEATH; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Basualdo W, 2003, PEDIATR INFECT DIS J, V22, P374; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beatty M E, 2009, East Afr Med J, V86, P387; BENNISH ML, 1992, CLIN INFECT DIS, V14, P1055, DOI 10.1093/clinids/14.5.1055; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; CDC, 1986, MMWR-MORBID MORTAL W, P35; CDC, 1986, MMWR-MORBID MORTAL W, P753; *CLSI, 2006, CLIN LAB STAND I QUA; Crump JA, 2003, CLIN INFECT DIS, V37, P75, DOI 10.1086/375602; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; FONTAINE O, 1989, REV INFECT DIS, V11, pS1145; Ghaemi Ezzat Ollah, 2007, Saudi J Gastroenterol, V13, P129; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Herwana E, 2010, SE ASIAN J TROP MED, V41, P418; Iwalokun BA, 2001, J HEALTH POPUL NUTR, V19, P183; Kosek M, 2003, B WORLD HEALTH ORGAN, P986; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Krieg NR, 1984, BERGEYS MANUAL SYSTE, V1; LEVINE OS, 1991, REV INFECT DIS, V13, P688; Mandomando I, 2009, ANTIMICROB AGENTS CH, V53, P2450, DOI 10.1128/AAC.01282-08; MUNDY LS, 1991, AM J CLIN PATHOL, V96, P364, DOI 10.1093/ajcp/96.3.364; Murphy MS, 2008, BRIT MED J, V336, P1010, DOI 10.1136/bmj.39542.440417.BE; Niyogi SK, 2005, J MICROBIOL, V43, P133; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Ram PK, 2008, EPIDEMIOL INFECT, V136, P577, DOI 10.1017/S0950268807009351; RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035; Sack DA, 2001, ANIMICROBIAL RESISTA; Shapiro RL, 2001, J INFECT DIS, V183, P1701, DOI 10.1086/320710; Sire JM, 2008, JPN J INFECT DIS, V61, P307; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Udo S M, 2004, Asia Pac J Public Health, V16, P41, DOI 10.1177/101053950401600107; UN-HABITAT, 2010, STAT URB YOUTH 2010; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Zwane AP, 2007, WORLD BANK RES OBSER	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58437	10.1371/journal.pone.0058437	http://dx.doi.org/10.1371/journal.pone.0058437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505506	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500083
J	Pfeiffer, V; Gotz, R; Xiang, CM; Camarero, G; Braun, A; Zhang, YN; Blum, R; Heinsen, H; Nieswandt, B; Rapp, UR				Pfeiffer, Verena; Goetz, Rudolf; Xiang, Chaomei; Camarero, Guadelupe; Braun, Attila; Zhang, Yina; Blum, Robert; Heinsen, Helmut; Nieswandt, Bernhard; Rapp, Ulf R.			Ablation of BRaf Impairs Neuronal Differentiation in the Postnatal Hippocampus and Cerebellum	PLOS ONE			English	Article							FACIO-CUTANEOUS SYNDROME; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; B-RAF; ADULT NEUROGENESIS; IN-VIVO; C-RAF; HUMAN CANCER; A-RAF; KINASE	This study focuses on the role of the kinase BRaf in postnatal brain development. Mice expressing truncated, non-functional BRaf in neural stem cell-derived brain tissue demonstrate alterations in the cerebellum, with decreased sizes and fuzzy borders of the glomeruli in the granule cell layer. In addition we observed reduced numbers and misplaced ectopic Purkinje cells that showed an altered structure of their dendritic arborizations in the hippocampus, while the overall cornus ammonis architecture appeared to be unchanged. In male mice lacking BRaf in the hippocampus the size of the granule cell layer was normal at postnatal day 12 (P12) but diminished at P21, as compared to control littermates. This defect was caused by a reduced ability of dentate gyrus progenitor cells to differentiate into NeuN positive granule cell neurons. In vitro cell culture of P0/P1 hippocampal cells revealed that BRaf deficient cells were impaired in their ability to form microtubule-associated protein 2 positive neurons. Together with the alterations in behaviour, such as autoaggression and loss of balance fitness, these observations indicate that in the absence of BRaf all neuronal cellular structures develop, but neuronal circuits in the cerebellum and hippocampus are partially disturbed besides impaired neuronal generation in both structures.	[Pfeiffer, Verena; Goetz, Rudolf; Xiang, Chaomei; Camarero, Guadelupe; Zhang, Yina; Rapp, Ulf R.] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, D-97070 Wurzburg, Germany; [Goetz, Rudolf; Blum, Robert] Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Braun, Attila; Nieswandt, Bernhard] Univ Hosp Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, Wurzburg, Germany; [Heinsen, Helmut] Univ Wurzburg, Morphol Brain Res Unit, Dept Psychiat, D-97070 Wurzburg, Germany; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, Dept Mol Mech Lung Canc, Bad Nauheim, Germany	University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; Max Planck Society	Rapp, UR (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, D-97070 Wurzburg, Germany.	Ulf.Rapp@mpi-bn.mpg.de	Blum, Robert/E-8899-2013	Blum, Robert/0000-0002-5270-3854	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 581]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 581) to UR Rapp. Grants of the Deutsche Forschungsgemeinschaft to the Graduate College 1048 University of Wurzburg to C. Xiang and V. Pfeiffer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Allanson JE, 2011, AM J MED GENET C, V157C, P129, DOI 10.1002/ajmg.c.30295; ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BAYER SA, 1980, J COMP NEUROL, V190, P115, DOI 10.1002/cne.901900108; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Causeret F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019367; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chong A, 2004, GENOMICS, V84, P762, DOI 10.1016/j.ygeno.2004.05.007; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; REYNOLDS JF, 1986, AM J MED GENET, V25, P413, DOI 10.1002/ajmg.1320250303; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schultz KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017736; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Valluet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015272; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wu X, 2012, MOL CELL BIOL, V32, P3872, DOI 10.1128/MCB.00751-12; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	57	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58259	10.1371/journal.pone.0058259	http://dx.doi.org/10.1371/journal.pone.0058259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505473	gold, Green Submitted, Green Published			2022-12-25	WOS:000318334500060
J	Ramani, RG; Jacob, SG				Ramani, R. Geetha; Jacob, Shomona Gracia			Improved Classification of Lung Cancer Tumors Based on Structural and Physicochemical Properties of Proteins Using Data Mining Models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; TNM CLASSIFICATION; WEB SERVER; FEATURES; ALGORITHMS; PREDICTION; PEPTIDES; PROFEAT; MARKERS; GENES	Detecting divergence between oncogenic tumors plays a pivotal role in cancer diagnosis and therapy. This research work was focused on designing a computational strategy to predict the class of lung cancer tumors from the structural and physicochemical properties (1497 attributes) of protein sequences obtained from genes defined by microarray analysis. The proposed methodology involved the use of hybrid feature selection techniques (gain ratio and correlation based subset evaluators with Incremental Feature Selection) followed by Bayesian Network prediction to discriminate lung cancer tumors as Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC) and the COMMON classes. Moreover, this methodology eliminated the need for extensive data cleansing strategies on the protein properties and revealed the optimal and minimal set of features that contributed to lung cancer tumor classification with an improved accuracy compared to previous work. We also attempted to predict via supervised clustering the possible clusters in the lung tumor data. Our results revealed that supervised clustering algorithms exhibited poor performance in differentiating the lung tumor classes. Hybrid feature selection identified the distribution of solvent accessibility, polarizability and hydrophobicity as the highest ranked features with Incremental feature selection and Bayesian Network prediction generating the optimal Jack-knife cross validation accuracy of 87.6%. Precise categorization of oncogenic genes causing SCLC and NSCLC based on the structural and physicochemical properties of their protein sequences is expected to unravel the functionality of proteins that are essential in maintaining the genomic integrity of a cell and also act as an informative source for drug design, targeting essential protein properties and their composition that are found to exist in lung cancer tumors.	[Ramani, R. Geetha] Anna Univ, Coll Engn, Dept Informat Sci & Technol, Chennai 600025, Tamil Nadu, India; [Jacob, Shomona Gracia] Anna Univ, Fac Informat & Commun Engn, Chennai 600025, Tamil Nadu, India	Anna University; Anna University Chennai; Anna University; Anna University Chennai	Jacob, SG (corresponding author), Anna Univ, Fac Informat & Commun Engn, Chennai 600025, Tamil Nadu, India.	graciarun@gmail.com	Jacob, Shomona/GZB-1912-2022; r, geetharamani/AHH-4747-2022	r, geetharamani/0000-0003-2283-3428	All India Council for Technical Education (AICTE), India [8023/RID/RPS-56/2010-11, 200-62/FIN/04/05/1624]	All India Council for Technical Education (AICTE), India	This research work is a part of the All India Council for Technical Education (AICTE), India-funded Research Promotion Scheme project titled "Efficient Classifier for clinical life data (Parkinson, Breast Cancer and P53 mutants) through feature relevance analysis and classification'' with Reference numbers 8023/RID/RPS-56/2010-11 and 200-62/FIN/04/05/1624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, EUR J SCI RES, V78, P468; [Anonymous], MACH LEARN TOOL; [Anonymous], 1999, CORRELATION BASED FE; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barash O, 2012, NANOMED-NANOTECHNOL, V8, P580, DOI 10.1016/j.nano.2011.10.001; Breiman Leo, RANDOM TREES; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Cios KJ, 1998, DATA MINING METHODS, P1; Crimins F, 2003, CAMDA 03; Dagliyan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014579; Deng HT, 2011, LECT NOTES COMPUT SC, V6792, P293, DOI 10.1007/978-3-642-21738-8_38; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Eick CF, 2004, PROC INT C TOOLS ART, P774; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Furney SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-3; Gracia J, 2013, RES J BIOTECHNOL, V8, P16; Guan P, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-103; Guyon I, 2009, NIPS WORKSH CLUST TH; Han J, 2006, DATA MINING CONCEPTS; Harris Jr Earl, 2003, INFORM GAIN VERSUS G; Heckerman D., 1995, TECHNICAL REPORT; Hosseinzadeh F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040017, 10.1371/annotation/2b218d50-a9d5-45b2-80d0-0e806e530749]; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Iba W, 1992, P 9 INT C MACH LEARN, P233, DOI DOI 10.1016/B978-1-55860-247-2.50035-8; Jacob SG, 2012, P INT C ADV COMP COM, P997, DOI 10.1145/2345396.2345557; Jacob SG., 2011, INT J COMPUTERS APPL, V32, P46, DOI DOI 10.5120/3920-5521; Jacob Shomona Gracia, 2012, P INT C COMP APPL PO, DOI 10.73445/ISBN_0768; Jacob Shomona Gracia, 2011, P IEEE INT C COMP IN, P661; Jiang X, 2010, J AM MED INFORM ASSN, V17, P462, DOI 10.1136/jamia.2009.000356; Kligerman S, 2010, AM J ROENTGENOL, V194, P562, DOI 10.2214/AJR.09.3354; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kotsiantis SB, 2007, INFORMATICA, P31249; Kraskov A., 2003, QBIO0311039 ARXIV; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037657; Li J, 2010, BAYES NET CLASSIFIER, V39, P144; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Lin Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034457; Lucas Peter, 2004, Curr Opin Crit Care, V10, P399, DOI 10.1097/01.ccx.0000141546.74590.d6; Manning C.D., 2008, INTRO INFORM RETRIEV; Marchevsky AM, 2004, J MOL DIAGN, V6, P28, DOI 10.1016/S1525-1578(10)60488-6; Markey MK, 2003, PROTEOMICS, V3, P1678, DOI 10.1002/pmic.200300521; Mehan MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035157; Meila M., 2003, LECT NOTES COMPUTER, P462; Mitchell T.M, 2003, MACH LEARN; Nevins Joseph R, 2011, Proc Am Thorac Soc, V8, P180, DOI 10.1513/pats.201006-040MS; Nguyen AN, 2010, J AM MED INFORM ASSN, V17, P440, DOI 10.1136/jamia.2010.003707; Nie Guang-jin, 2009, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V27, P257; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pourret O., 2008, BAYESIAN NETWORKS PR; Raj V, 2011, CURR PROBL DIAGN RAD, V40, P85, DOI 10.1067/j.cpradiol.2010.02.002; Ramani RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055401; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Selvakuberan K, 2008, J INFORM COMPUTING S, V3, P083; Travis WD, 2011, SEMIN ROENTGENOL, V46, P178, DOI 10.1053/j.ro.2011.02.003; Uebersax, 2004, GEN COUNS CANC RISK; Watt Emily W, 2008, AMIA Annu Symp Proc, P788; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Wrona Anna, 2010, Pneumonol Alergol Pol, V78, P407; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yang Yan, 2008, Zhonghua Zhongliu Zazhi, V30, P616; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	66	25	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58772	10.1371/journal.pone.0058772	http://dx.doi.org/10.1371/journal.pone.0058772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505559	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500124
J	Song, JS; Kim, EJ; Choi, J; Gong, G; Sung, CO				Song, Joon Seon; Kim, Eun Ju; Choi, Jene; Gong, Gyungyub; Sung, Chang Ohk			Significance of HPV-58 Infection in Women Who Are HPV-Positive, Cytology-Negative and Living in a Country with a High Prevalence of HPV-58 Infection	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE DISTRIBUTION; AMERICAN-CANCER-SOCIETY; CERVICAL-CANCER; CONSENSUS PRIMERS; KOREAN WOMEN; RISK; METAANALYSIS; PERSISTENCE; NEOPLASIA; TYPE-58	Purpose: Cervical cytology and human papillomavirus (HPV) DNA co-testing is recommended as a screening method for detecting cervical lesions. However, for women who are HPV-positive but cytology-negative, the appropriate management and significance of HPV-58 infection remain unknown. Methods: This study of prevalent HPV detected at baseline with a median follow-up of 3.2 years evaluated the risk factors associated with cervical abnormalities and assessed the significance of HPV-58 infection. A total of 265 women were enrolled. All high-grade squamous intraepithelial lesions (HSIL) that were detected by cytology were confirmed by histology. Histological diagnoses of cervical intraepithelial neoplasia 2/3 were classified as HSIL. Women were classified into four groups according to the HPV genotype that was detected at their first visit: HPV-58 (n = 27), HPV-16 (n = 52; 3 women had HPV-58 co-infection), ten other high risk (HR) types (n = 79), or low/undetermined risk types (n = 107). Results: Of 265 women, 20 (7.5%) had HSIL on their follow-up examinations. There were significant differences in the cumulative incidence of HSIL between the four groups (p<0.001). The 5-year cumulative incidence rates of HSIL were 34.0% (95% CI: 17.3-59.8%) in HPV-58 positive cases, 28.0% (95% CI: 13.8-51.6) in HPV-16 positive cases, 5.5% (95% CI: 2.1-14.0%) in one of the ten other types of HR-HPV positive cases, and 0% in women with low/undetermined risk HPV. When seen in women with HR-HPV (n = 158), persistent HPV infection was a significant factor associated with the development of HSIL (hazard ratio = 15.459, 95% CI: 2.042-117.045). Women with HPV-58 had a higher risk (hazard ratio = 5.260, 95% CI: 1.538-17.987) for the development of HSIL than women with HPV-16 (hazard ratio = 3.822, 95% CI: 1.176-12.424) in comparison with women with other types of HR-HPV. Conclusion: HPV-58 has a high association with the development of HSIL in women who are HPV-positive and cytology-negative.	[Song, Joon Seon; Kim, Eun Ju; Choi, Jene; Gong, Gyungyub; Sung, Chang Ohk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Sung, CO (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	co.sung@amc.seoul.kr		Sung, Chang Ohk/0000-0002-8567-456X				Asato T, 2004, J INFECT DIS, V189, P1829, DOI 10.1086/382896; Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; Chan PKS, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-17; Chan PKS, 2012, INT J CANCER, V131, P692, DOI 10.1002/ijc.26404; Chan PKS, 2009, INT J CANCER, V125, P1671, DOI 10.1002/ijc.24495; Chan PKS, 2006, INT J CANCER, V118, P243, DOI 10.1002/ijc.21299; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483; Ding DC, 2008, EUR J OBSTET GYN R B, V140, P245, DOI 10.1016/j.ejogrb.2008.03.014; Hong SR, 2009, KOREAN J PATHOL, V43, P342, DOI 10.4132/KoreanJPathol.2009.43.4.342; Huang SX, 1997, INT J CANCER, V70, P408, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;408::AID-IJC6&gt;3.0.CO;2-#; Hwang T, 1999, J KOREAN MED SCI, V14, P593, DOI 10.3346/jkms.1999.14.6.593; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Maucort-Boulch D, 2010, INT J CANCER, V126, P684, DOI 10.1002/ijc.24752; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Sherman ME, 1998, CANCER CYTOPATHOL, V84, P273; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Thrall MJ, 2010, AM J CLIN PATHOL, V133, P894, DOI 10.1309/AJCPAZV88VIFZSFD; Wright Thomas C Jr, 2007, J Low Genit Tract Dis, V11, P201, DOI 10.1097/LGT.0b013e3181585870; Wright TC, 2011, AM J CLIN PATHOL, V136, P578, DOI 10.1309/AJCPTUS5EXAS6DKZ; Wu EQ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-202	25	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58678	10.1371/journal.pone.0058678	http://dx.doi.org/10.1371/journal.pone.0058678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505548	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500112
J	Zhang, XZ; Krause, KH; Xenarios, I; Soldati, T; Boeckmann, B				Zhang, Xuezhi; Krause, Karl-Heinz; Xenarios, Ioannis; Soldati, Thierry; Boeckmann, Brigitte			Evolution of the Ferric Reductase Domain (FRD) Superfamily: Modularity, Functional Diversification, and Signature Motifs	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; GENERATING NADPH OXIDASE; HYDROGEN-PEROXIDE; IRON UPTAKE; CHELATE REDUCTASE; DUAL OXIDASE; CELL-DIFFERENTIATION; HEME-BINDING; NOX-FAMILY; ESOPHAGEAL ADENOCARCINOMA	A heme-containing transmembrane ferric reductase domain (FRD) is found in bacterial and eukaryotic protein families, including ferric reductases (FRE), and NADPH oxidases (NOX). The aim of this study was to understand the phylogeny of the FRD superfamily. Bacteria contain FRD proteins consisting only of the ferric reductase domain, such as YedZ and short bFRE proteins. Full length FRE and NOX enzymes are mostly found in eukaryotic cells and all possess a dehydrogenase domain, allowing them to catalyze electron transfer from cytosolic NADPH to extracellular metal ions (FRE) or oxygen (NOX). Metazoa possess YedZ-related STEAP proteins, possibly derived from bacteria through horizontal gene transfer. Phylogenetic analyses suggests that FRE enzymes appeared early in evolution, followed by a transition towards EF-hand containing NOX enzymes (NOX5- and DUOX-like). An ancestral gene of the NOX(1-4) family probably lost the EF-hands and new regulatory mechanisms of increasing complexity evolved in this clade. Two signature motifs were identified: NOX enzymes are distinguished from FRE enzymes through a four amino acid motif spanning from transmembrane domain 3 (TM3) to TM4, and YedZ/STEAP proteins are identified by the replacement of the first canonical heme-spanning histidine by a highly conserved arginine. The FRD superfamily most likely originated in bacteria.	[Zhang, Xuezhi; Soldati, Thierry] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Krause, Karl-Heinz] Univ Geneva, Dept Pathol & Immunol, Cent Med Univ, Geneva, Switzerland; [Xenarios, Ioannis; Boeckmann, Brigitte] Swiss Inst Bioinformat, SwissProt, Geneva, Switzerland; [Xenarios, Ioannis] Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland; [Xenarios, Ioannis] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics; University of Lausanne	Boeckmann, B (corresponding author), Swiss Inst Bioinformat, SwissProt, Geneva, Switzerland.	brigitte.boeckmann@isb-sib.ch	SOLDATI, Thierry/U-6494-2019; Krause, Karl-Heinz/E-8030-2011; Xenarios, Ioannis/ABD-5045-2021; SOLDATI, Thierry/A-2902-2009	SOLDATI, Thierry/0000-0002-2056-7931; Krause, Karl-Heinz/0000-0002-9033-6768; Xenarios, Ioannis/0000-0002-3413-6841; SOLDATI, Thierry/0000-0002-2056-7931	Swiss Federal Government through the Federal Office of Education and Science; Swiss National Science Foundation ProDoc Research Module [PDFMP3_127302]; Swiss Institute of Bioinformatics	Swiss Federal Government through the Federal Office of Education and Science; Swiss National Science Foundation ProDoc Research Module; Swiss Institute of Bioinformatics	This work was supported in part by the Swiss Federal Government through the Federal Office of Education and Science (BB) and by a Swiss National Science Foundation ProDoc Research Module, PDFMP3_127302 (TS and KHK). Funding for open access charge: Swiss Institute of Bioinformatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P524, DOI 10.1016/S0968-0004(01)01924-7; Babior BM, 2000, IUBMB LIFE, V50, P267, DOI 10.1080/15216540051080976; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cardoso LC, 2001, J CLIN ENDOCR METAB, V86, P4339, DOI 10.1210/jc.86.9.4339; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Crichton RR, 2001, BIOMETALS, V14, P99, DOI 10.1023/A:1016710810701; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Donko A, 2010, FREE RADICAL BIO MED, V49, P2040, DOI 10.1016/j.freeradbiomed.2010.09.027; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Einset J, 2008, PHYSIOL PLANTARUM, V134, P334, DOI 10.1111/j.1399-3054.2008.01141.x; Eisenhaber F, 2003, NUCLEIC ACIDS RES, V31, P3631, DOI 10.1093/nar/gkg537; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fagard M, 2007, MOL PLANT MICROBE IN, V20, P794, DOI 10.1094/MPMI-20-7-0794; Feng HZ, 2006, PLANT PHYSIOL, V140, P1345, DOI 10.1104/pp.105.074138; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Grasberger H, 2012, MOL ENDOCRINOL, V26, P481, DOI 10.1210/me.2011-1320; Grissa I, 2010, FUNGAL BIOL-UK, V114, P766, DOI 10.1016/j.funbio.2010.07.002; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Herve C, 2006, CURR GENET, V49, P190, DOI 10.1007/s00294-005-0044-z; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; Hong J, 2010, CANCER RES, V70, P1247, DOI 10.1158/0008-5472.CAN-09-2774; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iyer LM, 2007, BIOINFORMATICS, V23, P2660, DOI 10.1093/bioinformatics/btm411; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jendrysik MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028198; Jeong J, 2008, P NATL ACAD SCI USA, V105, P10619, DOI 10.1073/pnas.0708367105; Jeong J, 2009, PLANT SCI, V176, P709, DOI 10.1016/j.plantsci.2009.02.011; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Juarez MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002424; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kim KS, 2010, J BIOL CHEM, V285, P40294, DOI 10.1074/jbc.M110.126821; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Kosman DJ, 2010, J BIOL CHEM, V285, P26729, DOI 10.1074/jbc.R110.113217; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Kumatori A, 1998, GENOMICS, V53, P123, DOI 10.1006/geno.1998.5510; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Lardy B, 2005, BBA-MOL CELL RES, V1744, P199, DOI 10.1016/j.bbamcr.2005.02.004; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Mayer BJ, 2001, J CELL SCI, V114, P1253; Meitzler JL, 2010, J BIOL CHEM, V285, P40991, DOI 10.1074/jbc.M110.170902; Moreno Jose C., 2007, V10, P99, DOI 10.1159/000106822; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; Nguyen TTA, 2011, J BIOL CHEM, V286, P33244, DOI 10.1074/jbc.M111.263178; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohye H, 2010, EXP BIOL MED, V235, P424, DOI 10.1258/ebm.2009.009241; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; OLSON JS, 1988, NATURE, V336, P265, DOI 10.1038/336265a0; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Paravicini TM, 2004, STROKE, V35, P584, DOI 10.1161/01.STR.0000112974.37028.58; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Rae J, 1998, AM J HUM GENET, V62, P1320, DOI 10.1086/301874; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Ritsick DR, 2007, FREE RADICAL BIO MED, V43, P31, DOI 10.1016/j.freeradbiomed.2007.03.006; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMAN DG, 1993, MOL CELL BIOL, V13, P4342, DOI 10.1128/MCB.13.7.4342; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Song Y, 2007, J CLIN ENDOCR METAB, V92, P3764, DOI 10.1210/jc.2007-0660; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tirone F, 2007, FEBS LETT, V581, P1202, DOI 10.1016/j.febslet.2007.02.047; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Touyz RM, 2011, MOL INTERV, V11, P27, DOI 10.1124/mi.11.1.5; Tripathi S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2928634; Tsuda M, 1998, HUM GENET, V103, P377, DOI 10.1007/s004390050836; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Vasconcelos M, 2006, PLANTA, V224, P1116, DOI 10.1007/s00425-006-0293-1; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Rozycki T, 2004, J MOL MICROB BIOTECH, V8, P129, DOI 10.1159/000085786; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Wu HL, 2005, PLANT CELL PHYSIOL, V46, P1505, DOI 10.1093/pcp/pci163; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Zhou XX, 2011, J PHARMACOL EXP THER, V339, P218, DOI 10.1124/jpet.111.182352	127	51	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58126	10.1371/journal.pone.0058126	http://dx.doi.org/10.1371/journal.pone.0058126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505460	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500052
J	Yeom, J; Shin, JH; Yang, JY; Kim, J; Hwang, GS				Yeom, Jinki; Shin, Ji-Hyun; Yang, Ji-Young; Kim, Jungmin; Hwang, Geum-Sook			H-1 NMR-Based Metabolite Profiling of Planktonic and Biofilm Cells in Acinetobacter baumannii 1656-2	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL BIOFILMS; ANTIBIOTIC-RESISTANCE; METABOLOMICS; FERMENTATION; SURFACES; GROWTH	Acinetobacter baumannii is an aerobic and gram-negative pathogenic bacterium that is resistant to most antibiotics. Recently, A. baumannii 1656-2 exhibited the ability to form biofilms under clinical conditions. In this study, global metabolite profiling of both planktonic and biofilm forms of A. baumannii 1656-2 was performed using high-resolution nuclear magnetic resonance (NMR) spectroscopy and multivariate statistical analysis to investigate the metabolic patterns leading to biofilm formation. Principal components analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA) score plots showed a distinct separation between planktonic and biofilm cells. Metabolites including acetates, pyruvate, succinate, UDP-glucose, AMP, glutamate, and lysine were increasingly involved in the energy metabolism of biofilm formation. In particular, the ratio of N-acetyl-D-glucosamine (GlcNAc) to D-glucosamine (GlcNH(2)) was significantly higher during biofilm formation than under the planktonic condition. This study demonstrates that NMR-based global metabolite profiling of bacterial cells can provide valuable insight into the metabolic changes in multidrug resistant and biofilm-forming bacteria such as A. baumannii 1656-2.	[Yeom, Jinki; Yang, Ji-Young; Hwang, Geum-Sook] Korea Basic Sci Inst, Seoul Ctr, Integrated Metabol Res Grp, Seoul, South Korea; [Shin, Ji-Hyun; Kim, Jungmin] Kyungpook Natl Univ, Dept Microbiol, Sch Med, Taegu, South Korea; [Shin, Ji-Hyun] Dankook Univ, Dept Pharmacol, Coll Med, Cheonan, South Korea; [Yang, Ji-Young; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Korea Basic Science Institute (KBSI); Kyungpook National University; Dankook University; Chungnam National University	Kim, J (corresponding author), Kyungpook Natl Univ, Dept Microbiol, Sch Med, Taegu, South Korea.	minkim@knu.ac.kr; gshwang@kbsi.re.kr	Kim, Jungmin/AAX-6484-2021	Kim, Jungmin/0000-0002-1795-1844; Yeom, Jinki/0000-0002-5332-2658	National Research Foundation [2010-0019394, 2010-0007203]; Ministry of Education, Science and Technology; Korea Basic Science Institute [T32409]	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Basic Science Institute	This study was supported by National Research Foundation Grants, no. 2010-0019394 (to G.S.H) and no.2010-0007203 (to J.K.) funded by the Ministry of Education, Science and Technology and the Korea Basic Science Institute (T32409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereket W, 2012, EUR REV MED PHARMACO, V16, P1039; Booth SC, 2011, J PROTEOME RES, V10, P3190, DOI 10.1021/pr2002353; Cabral MP, 2011, J PROTEOME RES, V10, P3399, DOI 10.1021/pr101299j; Candela T, 2011, J BIOL CHEM, V286, P31250, DOI 10.1074/jbc.M111.249821; Cerqueira GM, 2011, IUBMB LIFE, V63, P1055, DOI 10.1002/iub.533; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Gjersing EL, 2007, ANAL CHEM, V79, P8037, DOI 10.1021/ac070800t; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jung J, 2011, APPL ENVIRON MICROB, V77, P7418, DOI 10.1128/AEM.05231-11; Jung Y, 2010, J AGR FOOD CHEM, V58, P10458, DOI 10.1021/jf102194t; Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320; Kronthaler J, 2012, OMICS, V16, P90, DOI 10.1089/omi.2011.0048; Larsen FH, 2006, J CHEMOMETR, V20, P198, DOI 10.1002/cem.991; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Li J, 2012, J PROTEOME RES, V11, P4654, DOI 10.1021/pr300469v; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Park JY, 2011, J BACTERIOL, V193, P6393, DOI 10.1128/JB.06109-11; Poirel L, 2011, IUBMB LIFE, V63, P1061, DOI 10.1002/iub.532; Pruss BM, 2010, ARCH MICROBIOL, V192, P715, DOI 10.1007/s00203-010-0599-z; Pysz MA, 2004, APPL ENVIRON MICROB, V70, P6098, DOI 10.1128/AEM.70.10.6098-6112.2004; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Son HS, 2009, ANAL CHEM, V81, P1137, DOI 10.1021/ac802305c; Tatarko M, 2001, CURR MICROBIOL, V43, P26, DOI 10.1007/s002840010255; Thomas VL, 1997, CURR MICROBIOL, V35, P249, DOI 10.1007/s002849900248; Thompson FL, 2011, MICROBES ENVIRON, V26, P61, DOI 10.1264/jsme2.ME10152; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Valle J, 2008, J BACTERIOL, V190, P264, DOI 10.1128/JB.01405-07; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h; Yeom J, 2012, RES MICROBIOL, V163, P258, DOI 10.1016/j.resmic.2012.01.008	34	52	53	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57730	10.1371/journal.pone.0057730	http://dx.doi.org/10.1371/journal.pone.0057730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483923	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100039
J	Patel, M; Cai, QF; Ding, DL; Salvi, R; Hu, ZH; Hu, BH				Patel, Minal; Cai, Qunfeng; Ding, Dalian; Salvi, Richard; Hu, Zihua; Hu, Bo Hua			The miR-183/Taok1 Target Pair Is Implicated in Cochlear Responses to Acoustic Trauma	PLOS ONE			English	Article							APOPTOSIS-RELATED GENES; NOISE-INDUCED APOPTOSIS; OUTER HAIR-CELLS; HEARING-LOSS; INNER-EAR; OXIDATIVE STRESS; PROTEIN-KINASE; MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; EXPOSURE	Acoustic trauma, one of the leading causes of sensorineural hearing loss, induces sensory hair cell damage in the cochlea. Identifying the molecular mechanisms involved in regulating sensory hair cell death is critical towards developing effective treatments for preventing hair cell damage. Recently, microRNAs (miRNAs) have been shown to participate in the regulatory mechanisms of inner ear development and homeostasis. However, their involvement in cochlear sensory cell degeneration following acoustic trauma is unknown. Here, we profiled the expression pattern of miRNAs in the cochlear sensory epithelium, defined miRNA responses to acoustic overstimulation, and explored potential mRNA targets of miRNAs that may be responsible for the stress responses of the cochlea. Expression analysis of miRNAs in the cochlear sensory epithelium revealed constitutive expression of 176 miRNAs, many of which have not been previously reported in cochlear tissue. Exposure to intense noise caused significant threshold shift and apoptotic activity in the cochleae. Gene expression analysis of noise-traumatized cochleae revealed time-dependent transcriptional changes in the expression of miRNAs. Target prediction analysis revealed potential target genes of the significantly downregulated miRNAs, many of which had cell death- and apoptosis-related functions. Verification of the predicted targets revealed a significant upregulation of Taok1, a target of miRNA-183. Moreover, inhibition of miR-183 with morpholino antisense oligos in cochlear organotypic cultures revealed a negative correlation between the expression levels of miR-183 and Taok1, suggesting the presence of a miR-183/Taok1 target pair. Together, miRNA profiling as well as the target analysis and validation suggest the involvement of miRNAs in the regulation of the degenerative process of the cochlea following acoustic overstimulation. The miR-183/Taok1 target pair is likely to play a role in this regulatory process.	[Patel, Minal; Cai, Qunfeng; Ding, Dalian; Salvi, Richard; Hu, Bo Hua] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA; [Hu, Zihua] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Ctr Computat Res, Dept Ophthalmol,Dept Biostat,Dept Med, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hu, BH (corresponding author), SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA.	bhu@buffalo.edu			National Institutes of Health [R01DC010154-01A2]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant R01DC010154-01A2 (to BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Ahn JH, 2005, BIOCHEM BIOPH RES CO, V335, P485, DOI 10.1016/j.bbrc.2005.07.114; Akao Y, 2009, LEUKEMIA RES, V33, P1530, DOI 10.1016/j.leukres.2009.04.019; Belleannee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034996; Bohne BA, 2007, HEARING RES, V223, P61, DOI 10.1016/j.heares.2006.10.004; Cai QF, 2012, NEUROBIOL DIS, V45, P723, DOI 10.1016/j.nbd.2011.10.018; Chan DK, 2007, OTOL NEUROTOL, V28, P417, DOI 10.1097/01.mao.0000247826.28893.7a; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Cho YS, 2004, MOL BRAIN RES, V130, P134, DOI 10.1016/j.molbrainres.2004.07.017; Cosulich S, 1996, CURR BIOL, V6, P1586, DOI 10.1016/S0960-9822(02)70779-3; David EA, 2002, J OTOLARYNGOL, V31, P304, DOI 10.2310/7070.2002.34330; Ding DL, 2002, HEARING RES, V164, P115, DOI 10.1016/S0378-5955(01)00417-8; Elkan-Miller T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018195; Eskiizmir G, 2011, ORL-J OTO-RHIN-LARYN, V73, P24, DOI 10.1159/000321116; Feng S, 2011, NUCL ACIDS RES; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frucht CS, 2011, NEUROSCI LETT, V493, P44, DOI 10.1016/j.neulet.2011.02.017; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Habtemichael N, 2010, MOL CELL NEUROSCI, V45, P297, DOI 10.1016/j.mcn.2010.07.003; Han WJ, 2006, HEARING RES, V211, P85, DOI 10.1016/j.heares.2005.10.004; Harding GW, 2005, HEARING RES, V204, P90, DOI 10.1016/j.heares.2005.01.004; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; HENRY KR, 1981, ARCH OTOLARYNGOL, V107, P92; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hsu CJ, 2000, HEARING RES, V142, P203, DOI 10.1016/S0378-5955(00)00020-4; Hu BH, 2009, NEUROSCIENCE, V161, P915, DOI 10.1016/j.neuroscience.2009.03.072; Hu BH, 2000, ACTA OTO-LARYNGOL, V120, P19, DOI 10.1080/000164800760370774; Hu BH, 2002, HEARING RES, V166, P62, DOI 10.1016/S0378-5955(02)00286-1; Hu BH, 2010, J NEUROSCI RES, V88, P1812, DOI 10.1002/jnr.22333; Hu BH, 2008, HEARING RES, V245, P48, DOI 10.1016/j.heares.2008.08.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Jamesdaniel S, 2011, J PROTEOMICS; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Kanitz A, 2010, WIRES SYST BIOL MED, V2, P245, DOI 10.1002/wsbm.55; KONISHI T, 1979, HEARING RES, V1, P325, DOI 10.1016/0378-5955(79)90004-2; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; Li PF, 2010, J CARDIOVASC TRANSL, V3, P219, DOI 10.1007/s12265-010-9175-9; Lu SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040676; Masaki M, 2003, EUR J BIOCHEM, V270, P76, DOI 10.1046/j.1432-1033.2003.03363.x; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200; Motsch N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042193; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Murillo-Cuesta S, 2012, MOL MED, V18, P260, DOI 10.2119/molmed.2011.00328; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Okumura H, 2011, EXP ANIM TOKYO, V60, P355, DOI 10.1538/expanim.60.355; Patel M, 2012, HEARING RES, V287, P6, DOI 10.1016/j.heares.2012.03.008; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Pirvola U, 2000, J NEUROSCI, V20, P43, DOI 10.1523/JNEUROSCI.20-01-00043.2000; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Raman M, 2007, EMBO J, V26, P2005, DOI 10.1038/sj.emboj.7601668; Ross JS, 2007, AM J CLIN PATHOL, V128, P830, DOI 10.1309/2JK279BU2G743MWJ; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003; SAUNDERS JC, 1985, J ACOUST SOC AM, V78, P833, DOI 10.1121/1.392915; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shruti K, 2011, BIOCH BIOPHYS RES CO; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Tadros SF, 2008, APOPTOSIS, V13, P1303, DOI 10.1007/s10495-008-0266-x; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Thulasingam S, 2011, MOL CELL BIOCH; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van De Water TR, 2004, OTOL NEUROTOL, V25, P627, DOI 10.1097/00129492-200407000-00035; Vecchione A, 2010, ENDOCR-RELAT CANCER, V17, pF37, DOI 10.1677/ERC-09-0163; Vlajkovic SM, 2004, NEUROSCIENCE, V126, P763, DOI 10.1016/j.neuroscience.2004.04.023; Wang J, 2003, J NEUROSCI, V23, P8596; Wang J, 2011, GENE THER; Wang XR, 2010, NEUROREPORT, V21, P611, DOI 10.1097/WNR.0b013e328338864b; Wang Z, 2010, BRAIN RES, V1346, P14, DOI 10.1016/j.brainres.2010.05.059; Wei L, 2010, NEUROSCIENCE, V168, P288, DOI 10.1016/j.neuroscience.2010.03.015; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Wojtala RL, 2011, J BIOL CHEM, V286, P30161, DOI 10.1074/jbc.M111.228320; Wu MF, 2008, CELL BIOL INT, V32, P151, DOI 10.1016/j.cellbi.2007.08.006; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yamamoto H, 2009, NEUROSCIENCE, V158, P1691, DOI 10.1016/j.neuroscience.2008.10.063; Yang WP, 2004, HEARING RES, V196, P69, DOI 10.1016/j.heares.2004.04.015; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043741; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034688	93	27	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58471	10.1371/journal.pone.0058471	http://dx.doi.org/10.1371/journal.pone.0058471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472202	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900148
J	Wang, ZW; van Kleunen, M; During, HJ; Werger, MJA				Wang, Zhengwen; van Kleunen, Mark; During, Heinjo J.; Werger, Marinus J. A.			Root Foraging Increases Performance of the Clonal Plant Potentilla reptans in Heterogeneous Nutrient Environments	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; DIVISION-OF-LABOR; MORPHOLOGICAL PLASTICITY; STOLONIFEROUS HERBS; GLECHOMA-HEDERACEA; SOIL HETEROGENEITY; SHADE-AVOIDANCE; ELEVATED CO2; COSTS; INTEGRATION	Background: Plastic root-foraging responses have been widely recognized as an important strategy for plants to explore heterogeneously distributed resources. However, the benefits and costs of root foraging have received little attention. Methodology/Principal Findings: In a greenhouse experiment, we grew pairs of connected ramets of 22 genotypes of the stoloniferous plant Potentilla reptans in paired pots, between which the contrast in nutrient availability was set as null, medium and high, but with the total nutrient amount kept the same. We calculated root-foraging intensity of each individual ramet pair as the difference in root mass between paired ramets divided by the total root mass. For each genotype, we then calculated root-foraging ability as the slope of the regression of root-foraging intensity against patch contrast. For all genotypes, root-foraging intensity increased with patch contrast and the total biomass and number of offspring ramets were lowest at high patch contrast. Among genotypes, root-foraging intensity was positively related to production of offspring ramets and biomass in the high patch-contrast treatment, which indicates an evolutionary benefit of root foraging in heterogeneous environments. However, we found no significant evidence that the ability of plastic foraging imposes costs under homogeneous conditions (i.e. when foraging is not needed). Conclusions/Significance: Our results show that plants of P. reptans adjust their root-foraging intensity according to patch contrast. Moreover, the results show that the root foraging has an evolutionary advantage in heterogeneous environments, while costs of having the ability of plastic root foraging were absent or very small.	[Wang, Zhengwen] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Wang, Zhengwen; During, Heinjo J.; Werger, Marinus J. A.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands; [Wang, Zhengwen] Univ Bern, Inst Plant Sci, Bern, Switzerland; [van Kleunen, Mark] Univ Konstanz, Dept Biol, Constance, Germany	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Utrecht University; University of Bern; University of Konstanz	Wang, ZW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	wangzw@iae.ac.cn	Wang, Zhengwen/A-8292-2011; van Kleunen, Mark/B-3769-2009	van Kleunen, Mark/0000-0002-2861-3701	Natural Science Foundation of China [30370268, 30870422]; Sino-Swiss Science and Technology Cooperation Program [EG14-092009]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Swiss Science and Technology Cooperation Program	This study was supported by Natural Science Foundation of China grant (30370268, 30870422). Analysis and writing were partly done while ZW was funded by the Sino-Swiss Science and Technology Cooperation Program (EG14-092009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P137; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Cahill JF, 1999, ANN BOT-LONDON, V83, P471, DOI 10.1006/anbo.1999.0841; Chen X, 2011, NEW PHYTOL, V190, P409, DOI 10.1111/j.1469-8137.2010.03639.x; D'Hertefeldt T, 1999, J ECOL, V87, P258, DOI 10.1046/j.1365-2745.1999.00345.x; de Kroon H, 2006, TRENDS ECOL EVOL, V21, P113, DOI 10.1016/j.tree.2005.11.021; De Kroon H, 2003, ECOL STU AN, V168, P215; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; EVANS JP, 1991, OECOLOGIA, V86, P268, DOI 10.1007/BF00317540; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; Fransen B, 2001, J ECOL, V89, P711, DOI 10.1046/j.0022-0477.2001.00589.x; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; Garcia-Palacios P, 2011, J ECOL, V99, P551, DOI 10.1111/j.1365-2745.2010.01765.x; Gleeson SK, 1997, OIKOS, V79, P387, DOI 10.2307/3546023; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; Huber H, 1999, PLANT ECOL, V141, P107, DOI 10.1023/A:1009861521047; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Hutchings MJ, 2003, ECOLOGY, V84, P2322, DOI 10.1890/02-0290; Kembel SW, 2005, AM NAT, V166, P216, DOI 10.1086/431287; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Lamb EG, 2004, FUNCT ECOL, V18, P836, DOI 10.1111/j.0269-8463.2004.00893.x; Lande K, 1983, EVOLUTION, V37, P1210; Louapre P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038288; Maestre FT, 2007, OECOLOGIA, V151, P512, DOI 10.1007/s00442-006-0577-y; Maestre FT, 2005, NEW PHYTOL, V168, P637, DOI 10.1111/j.1469-8137.2005.01547.x; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; Matlaga DP, 2009, AM J BOT, V96, P431, DOI 10.3732/ajb.0800164; McNickle GG, 2009, TRENDS ECOL EVOL, V24, P419, DOI 10.1016/j.tree.2009.03.004; McNickle GG, 2009, P NATL ACAD SCI USA, V106, P4747, DOI 10.1073/pnas.0807971106; Rausher D, 1992, EVOLUTION, V46, P616; Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431, DOI 10.1098/rspb.1999.0656; SAS Institute Inc, 2004, SAS 9 1 2 QUAL TOOLS; Shemesh H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010824; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Steinger T, 2003, J EVOLUTION BIOL, V16, P313, DOI 10.1046/j.1420-9101.2003.00518.x; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Stuefer JF, 2002, J EVOLUTION BIOL, V15, P880, DOI 10.1046/j.1420-9101.2002.00435.x; Stuefer Josef F., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P47, DOI 10.1078/1433-8319-00051; Stuefer JF, 2009, J ECOL, V97, P1020, DOI 10.1111/j.1365-2745.2009.01546.x; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; van Kleunen M, 2000, EVOLUTION, V54, P1947, DOI 10.1111/j.0014-3820.2000.tb01239.x; van Kleunen M, 2007, NEW PHYTOL, V176, P727, DOI 10.1111/j.1469-8137.2007.02296.x; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; Wang ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025401; Weijschede J, 2006, NEW PHYTOL, V172, P655, DOI 10.1111/j.1469-8137.2006.01885.x; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; Yu FH, 2002, ACTA BOT SIN, V44, P468	61	27	28	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58602	10.1371/journal.pone.0058602	http://dx.doi.org/10.1371/journal.pone.0058602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472211	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900157
J	Sorhouet-Pereira, C; Efron, A; Gagetti, P; Faccone, D; Regueira, M; Corso, A; Gabastou, JM; Ibarz-Pavon, AB				Sorhouet-Pereira, Cecilia; Efron, Adriana; Gagetti, Paula; Faccone, Diego; Regueira, Mabel; Corso, Alejandra; Gabastou, Jean-Marc; Ibarz-Pavon, Ana Belen		Argentinean SIREVA II Working Grp	Phenotypic and Genotypic Characteristics of Neisseria meningitidis Disease-Causing Strains in Argentina, 2010	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; FLUOROQUINOLONE RESISTANCE; DECREASED SUSCEPTIBILITY; SEROGROUP; CIPROFLOXACIN; VACCINE; EMERGENCE; W135; PREVALENCE; AMERICA	Phenotypic and genotypic characterization of 133 isolates of Neisseria meningitidis obtained from meningococcal disease cases in Argentina during 2010 were performed by the National Reference Laboratory as part of a project coordinated by the PAHO within the SIREVA II network. Serogroup, serotype, serosubtype and MLST characterization were performed. Minimum Inhibitory Concentration to penicillin, ampicillin, ceftriaxone, rifampin, chloramphenicol, tetracycline and ciprofloxacin were determined and interpreted according to CLSI guidelines. Almost 49% of isolates were W135, and two serotype: serosubtype combinations, W135:2a:P1.5,2:ST-11 and W135:2a:P1.2:ST-11 accounted for 78% of all W135 isolates. Serogroup B accounted for 42.1% of isolates, and was both phenotypically and genotypically diverse. Serogroup C isolates represented 5.3% of the dataset, and one isolate belonging to the ST-198 complex was non-groupable. Isolates belonged mainly to the ST-11 complex (48%) and to a lesser extent to the ST-865 (18%), ST-32 (9,8%) and the ST-35 complexes (9%). Intermediate resistance to penicillin and ampicillin was detected in 35.4% and 33.1% of isolates respectively. Two W135: 2a: P1.5,2: ST-11: ST-11 isolates presented resistance to ciprofloxacin associated with a mutation in the QRDR of gyrA gene Thr91-Ile. These data show serogroup W135 was the first cause of disease in Argentina in 2010, and was strongly associated with the W135: 2a: P1.5,2: ST-11 epidemic clone. Serogroup B was the second cause of disease and isolates belonging to this serogroup were phenotypically and genotypically diverse. The presence of isolates with intermediate resistance to penicillin and the presence of fluorquinolone-resistant isolates highlight the necessity and importance of maintaining and strengthening National Surveillance Programs.	[Sorhouet-Pereira, Cecilia; Efron, Adriana; Regueira, Mabel] Minist Hlth, Clin Bacteriol Serv, Dept Bacteriol, Natl Inst Infect Dis ANLIS INEI, Buenos Aires, DF, Argentina; [Gagetti, Paula; Faccone, Diego; Corso, Alejandra] Minist Hlth, Antimicrobial Resistance Serv, Dept Bacteriol, Natl Inst Infect Dis ANLIS INEI, Buenos Aires, DF, Argentina; [Gabastou, Jean-Marc; Ibarz-Pavon, Ana Belen] Pan Amer Hlth Org, Washington, DC USA	Pan American Health Organization	Ibarz-Pavon, AB (corresponding author), Pan Amer Hlth Org, Washington, DC USA.	ibarzpav@paho.org			Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Funding was provided by Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDILLAHI H, 1987, FEMS MICROBIOL LETT, V48, P367, DOI 10.1016/0378-1097(87)90077-2; Alcala B, 2004, J ANTIMICROB CHEMOTH, V53, P409, DOI 10.1093/jac/dkh075; Barroso DE, 2007, MEM I OSWALDO CRUZ, V102, P773, DOI [10.1590/S0074-02762007005000104, 10.1590/S0074-02762007000600019]; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22; Castanheira M, 2012, DIAGN MICR INFEC DIS, V72, P263, DOI 10.1016/j.diagmicrobio.2011.12.001; Chiavetta L., 2007, Rev. argent. microbiol., V39, P21; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; CLSI, 2010, M7A8 CLSI; Corso A, 2005, J ANTIMICROB CHEMOTH, V55, P596, DOI 10.1093/jac/dki048; de Filippis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033016; Efron AM, 2009, J CLIN MICROBIOL, V47, P1979, DOI 10.1128/JCM.02390-08; Enriquez R, 2008, J ANTIMICROB CHEMOTH, V61, P286, DOI 10.1093/jac/dkm452; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; Gabastou JM, 2008, REV PANAM SALUD PUBL, V24, P1, DOI 10.1590/S1020-49892008000700001; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gorla MCO, 2012, ENFERM INFEC MICR CL, V30, P56, DOI 10.1016/j.eimc.2011.07.022; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; Ibarz-Pavon AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044102; Iser BPM, 2012, EPIDEMIOL INFECT, V140, P906, DOI 10.1017/S0950268811001610; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McCaw SE, 2012, INFECT IMMUN; Mehta G, 2007, J ANTIMICROB CHEMOTH, V59, P329, DOI [10.1093/jac/dk1484, 10.1093/jac/dkl484]; Moriel DG, 2008, HUM VACCINES, V4, P184, DOI 10.4161/hv.4.3.6313; OPS, 2012, INF REG SIREVA 2 DAT; OPS, 2011, INF REG SIREVA 2 DAT; Panatto D, 2011, EXPERT REV VACCINES, V10, P1337, DOI [10.1586/ERV.11.103, 10.1586/erv.11.103]; Pereira CS, 2008, J MED MICROBIOL, V57, P338, DOI 10.1099/jmm.0.47631-0; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Rainbow J., 2008, Morbidity and Mortality Weekly Report, V57, P173; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Salisbury D, 2001, J Paediatr Child Health, V37, pS34, DOI 10.1046/j.1440-1754.2001.00738.x; Salisbury D, 2001, J PAEDIATR CHILD H, V37, P37; Singhal S, 2007, EMERG INFECT DIS, V13, P1614, DOI 10.3201/eid1310.060820; Skoczynska A, 2008, EMERG INFECT DIS, V14, P1322, DOI 10.3201/eid1408.080040; Sorhouet Pereira C, 2009, NATL SURVEILLANCE AN; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P27, DOI 10.1111/j.1574-6976.2006.00060.x; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Vazquez JA, 2003, ANTIMICROB AGENTS CH, V47, P3430, DOI 10.1128/AAC.47.11.3430-3434.2003; Vogel U, 2004, J CLIN MICROBIOL, V42, P2898, DOI 10.1128/JCM.42.7.2898-2901.2004; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Wu HM, 2009, NEW ENGL J MED, V360, P886, DOI 10.1056/NEJMoa0806414	48	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58065	10.1371/journal.pone.0058065	http://dx.doi.org/10.1371/journal.pone.0058065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483970	gold, Green Published			2022-12-25	WOS:000315634900067
J	La, P; Yang, G; Dennery, PA				La, Ping; Yang, Guang; Dennery, Phyllis A.			Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation Stabilizes ISCU Protein IMPLICATIONS FOR IRON METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOPROTEOMIC ANALYSIS; MTOR; SUBSTRATE; REVEALS; HYPOXIA	The scaffold protein ISCU facilitates the assembly of iron-sulfur clusters (ISCs), which are essential cofactors for many vital metabolic processes. The mTOR pathways are central to nutrient and energy-sensing networks. Here, we demonstrate that mTORC1 associates with ISCU and phosphorylates ISCU at serine 14. This phosphorylation stabilized ISCU protein. Insufficiency of ISCU triggered by mTORC1 inhibition prevented ISC assembly. Sustained ISCU protein levels enhanced by mTORC1 sensitized TSC2-null cells to iron deprivation due to constitutive ISC biogenesis-triggered iron demand, which outstrips supply. We conclude that the mTORC1 pathway serves to modulate iron metabolism and homeostasis, and we speculate that iron deprivation may be an adjunct in the treatment of cancers characterized by constitutive mTORC1 activation.	[La, Ping; Yang, Guang; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Dennery, Phyllis A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	La, P (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA.	lap@email.chop.edu; dennery@email.chop.edu	Dennery, Phyllis/GQG-9113-2022	Dennery, Phyllis/0000-0001-5745-1855	National Institutes of Health [R01-HL058752]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01-HL058752 (to P.A.D.).	BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Sofroniadou S, 2011, DRUG SAFETY, V34, P97, DOI 10.2165/11585040-000000000-00000; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Ye H., 2010, ADV HEMATOL, V2010, DOI DOI 10.1155/2010/329394; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; YOSHIKURA H, 1974, J VIROL, V13, P1319, DOI 10.1128/JVI.13.6.1319-1325.1974; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhou T, 2012, DALTON T, V41, P6371, DOI 10.1039/c2dt12159j; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12901	12909		10.1074/jbc.M112.424499	http://dx.doi.org/10.1074/jbc.M112.424499			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508953	hybrid, Green Published			2022-12-25	WOS:000318555100044
J	Walsh, AA; Szklarz, GD; Scott, EE				Walsh, Agnes A.; Szklarz, Grazyna D.; Scott, Emily E.			Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; P450 1A1; HUMAN LUNG; CATALYTIC-ACTIVITIES; SUBSTRATE-BINDING; ACTIVATION; EXPRESSION; OXIDATION; CYP1A1; 1B1	Cytochrome P450 (CYP) 1A1 is an extrahepatic monooxygenase involved in the metabolism of endogenous substrates and drugs, as well as the activation of certain toxins and environmental pollutants. CYP1A1 is particularly well known for its ability to biotransform polycyclic aromatic hydrocarbons, such as benzo[a] pyrene in tobacco smoke, into carcinogens. CYP1A1 possesses functional similarities and differences with human CYP1A2 and CYP1B1 enzymes, but the structural basis for this has been unclear. We determined a 2.6 angstrom structure of human CYP1A1 with the inhibitor alpha-naphthoflavone. alpha-Naphthoflavone binds within an enclosed active site, with the planar benzochromen-4-one core packed flat against the I helix that composes one wall of the active site, and the 2-phenyl substituent oriented toward the catalytic heme iron. Comparisons with previously determined structures of the related cytochrome P450 1A2 and 1B1 enzymes reveal distinct features among the active sites that may underlie the functional variability of these enzymes. Finally, docking studies probed the ability of CYP1A structures to assist in understanding their known in vitro interactions with several typical substrates and inhibitors.	[Walsh, Agnes A.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Szklarz, Grazyna D.] W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA	University of Kansas; West Virginia University	Scott, EE (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu			National Institutes of Health [R01 GM076343, GM103393, RR001209, RR017708, GM103420]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420, R01GM076343, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM076343 (to E.E.S.), RR001209 (to the Stanford Synchrotron Radiation Lightsource), GM103393 and RR001209 (to the SSRL Structural Molecular Biology Program), and RR017708 and GM103420 (to the Protein Structure Laboratory at the University of Kansas).	Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; BAUER E, 1995, CHEM RES TOXICOL, V8, P136, DOI 10.1021/tx00043a018; Chi AC, 2009, ORAL ONCOL, V45, P980, DOI 10.1016/j.oraloncology.2009.05.562; Chun YJ, 1999, BIOCHEM BIOPH RES CO, V262, P20, DOI 10.1006/bbrc.1999.1152; Chun YJ, 2001, DRUG METAB DISPOS, V29, P389; De Kerkhof EGV, 2008, DRUG METAB DISPOS, V36, P604, DOI 10.1124/dmd.107.018820; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; Doostdar H, 2000, TOXICOLOGY, V144, P31, DOI 10.1016/S0300-483X(99)00215-2; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericksen SS, 2005, J BIOMOL STRUCT DYN, V23, P243, DOI 10.1080/07391102.2005.10507063; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakkola J, 1996, BIOCHEM PHARMACOL, V52, P379, DOI 10.1016/0006-2952(96)00216-X; Hammons GJ, 1997, CARCINOGENESIS, V18, P851, DOI 10.1093/carcin/18.4.851; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; Honma W, 2005, ARCH BIOCHEM BIOPHYS, V435, P157, DOI 10.1016/j.abb.2004.12.014; Huang QB, 2012, DRUG METAB DISPOS, V40, P2324, DOI 10.1124/dmd.112.047308; Huang QB, 2010, DRUG METAB DISPOS, V38, P1039, DOI 10.1124/dmd.109.030767; Iba MM, 2010, TOXICOLOGY, V273, P35, DOI 10.1016/j.tox.2010.04.012; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; Kim JH, 2004, TOXICOL APPL PHARM, V199, P210, DOI 10.1016/j.taap.2003.11.015; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Lautraite S, 2002, MUTAGENESIS, V17, P45, DOI 10.1093/mutage/17.1.45; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Leong CO, 2003, BRIT J CANCER, V88, P470, DOI 10.1038/sj.bjc.6600719; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu JG, 2004, ARCH BIOCHEM BIOPHYS, V424, P33, DOI 10.1016/j.abb.2003.12.040; Liu JG, 2003, DRUG METAB DISPOS, V31, P412, DOI 10.1124/dmd.31.4.412; Ma XC, 2005, DRUG METAB DISPOS, V33, P489, DOI 10.1124/dmd.104.002410; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; PAULSEN MD, 1992, J COMPUT AID MOL DES, V6, P449, DOI 10.1007/BF00130396; PAULSEN MD, 1991, PROTEINS, V11, P184, DOI 10.1002/prot.340110304; Piver B, 2004, BIOCHEM PHARMACOL, V68, P773, DOI 10.1016/j.bcp.2004.05.008; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Reid JM, 1999, CLIN CANCER RES, V5, P2192; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; SHIMADA T, 1992, MOL PHARMACOL, V41, P856; Shimada T, 1998, ARCH BIOCHEM BIOPHYS, V357, P111, DOI 10.1006/abbi.1998.0808; Shimada T, 1997, DRUG METAB DISPOS, V25, P617; Shimada T, 1996, CANCER RES, V56, P2979; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Shimada T, 2010, CHEM RES TOXICOL, V23, P1921, DOI 10.1021/tx100286d; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Szklarz GD, 2002, J BIOMOL STRUCT DYN, V20, P155, DOI 10.1080/07391102.2002.10506831; Tu Y, 2008, DRUG METAB DISPOS, V36, P2371, DOI 10.1124/dmd.108.022640; Turesky RJ, 1998, CHEM RES TOXICOL, V11, P925, DOI 10.1021/tx980022n; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Willey JC, 1997, AM J RESP CELL MOL, V17, P114, DOI 10.1165/ajrcmb.17.1.2783; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Yengi LG, 2003, ANAL BIOCHEM, V316, P103, DOI 10.1016/S0003-2697(03)00042-3; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y	66	187	193	5	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12932	12943		10.1074/jbc.M113.452953	http://dx.doi.org/10.1074/jbc.M113.452953			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508959	hybrid, Green Published			2022-12-25	WOS:000318555100047
J	Waitkus, MS; Chandrasekharan, UM; Willard, B; Haque, SJ; DiCorleto, PE				Waitkus, Matthew S.; Chandrasekharan, Unni M.; Willard, Belinda; Haque, S. Jaharul; DiCorleto, Paul E.			STAT3-mediated Coincidence Detection Regulates Noncanonical Immediate Early Gene Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3; FACTOR RECEPTOR TRANSACTIVATION; PROTEIN-COUPLED RECEPTORS; MONOCYTIC-CELL-ADHESION; TUMOR ENDOTHELIAL-CELLS; SUBSTRATE-SPECIFICITY; SIGNALING PATHWAYS; TYROSINE KINASE; ACTIVATION	Signaling pathways interact with one another to form dynamic networks in which the cellular response to one stimulus may depend on the presence, intensity, timing, or localization of other signals. In rare cases, two stimuli may be simultaneously required for cells to elicit a significant biological output. This phenomenon, generally termed "coincidence detection," requires a downstream signaling node that functions as a Boolean AND gate to restrict biological output from a network unless multiple stimuli are received within a specific window of time. Simultaneous activation of the EGF receptor (EGFR) and a thrombin receptor (protease-activated receptor-1, PAR-1) increases the expression of multiple immediate early genes (IEGs) associated with growth and angiogenesis. Using a bioinformatic comparison of IEG promoter regions, we identified STAT3 as a critical transcription factor for the detection of coincident EGFR/PAR-1 activation. EGFR activation induces classical STAT3 Tyr(705) phosphorylation but also initiates an inhibitory signal through the PI3K-AKT signaling axis that prevents STAT3 Ser(727) phosphorylation. Coincident PAR-1 signaling resolves these conflicting EGF-activated pathways by blocking AKT activation and permitting GSK-3 alpha/beta-dependent STAT3 Ser(727) phosphorylation and STAT3-dependent gene expression. Functionally, combinatorial EGFR/PAR-1 signaling suppresses EGF-induced proliferation and thrombin-induced leukocyte adhesion and triggers a STAT3-dependent increase in endothelial cell migration. This study reveals a novel signaling role for STAT3 in which the simultaneous presence of extracellular EGF and thrombin is detected at the level of STAT3 post-translational modifications. Collectively, our results describe a novel regulatory mechanism in which combinatorial EGFR/PAR-1 signaling regulates STAT3-dependent IEG induction and endothelial cell migration.	[Waitkus, Matthew S.; Chandrasekharan, Unni M.; DiCorleto, Paul E.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Haque, S. Jaharul] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Waitkus, Matthew S.; DiCorleto, Paul E.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation	DiCorleto, PE (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	dicorlp@ccf.org			National Institutes of Health [HL29582]; Graduate Assistance in Areas of National Need Predoctoral Fellowship; National Center for Advancing Translational Sciences, a component of the National Institutes of Health [UL1TR000439]; Roadmap for Medical Research, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Assistance in Areas of National Need Predoctoral Fellowship; National Center for Advancing Translational Sciences, a component of the National Institutes of Health; Roadmap for Medical Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL29582 (to P. E. D.). This work was also supported by the Graduate Assistance in Areas of National Need Predoctoral Fellowship (to M. S. W.).; We thank Lisa Dechert, Emily Tillmaand, and Chad Braley for cell culture assistance and Joel Boerckel for constructive criticism of the manuscript. Human umbilical vein ECs were harvested by the Clinical and Translational Science Collaborative of Cleveland (supported by Grant UL1TR000439 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health and Roadmap for Medical Research, National Institutes of Health).	Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Al-Ani B, 2010, HYPERTENSION, V55, P689, DOI 10.1161/HYPERTENSIONAHA.109.136333; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; Amin DN, 2008, MICROVASC RES, V76, P15, DOI 10.1016/j.mvr.2008.01.002; Amin DN, 2006, CANCER RES, V66, P2173, DOI 10.1158/0008-5472.CAN-05-3387; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arora S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r166; Baker CH, 2002, AM J PATHOL, V161, P929, DOI 10.1016/S0002-9440(10)64253-8; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Chandrasekharan UM, 2004, J BIOL CHEM, V279, P46678, DOI 10.1074/jbc.M406441200; Chandrasekharan UM, 2010, ARTERIOSCL THROM VAS, V30, P1983, DOI 10.1161/ATVBAHA.110.212399; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Darmoul D, 2004, MOL CANCER RES, V2, P514; DAY ML, 1990, J BIOL CHEM, V265, P15253; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; DICORLETO PE, 1989, BIOCHEM J, V264, P71, DOI 10.1042/bj2640071; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Duan WR, 2002, MOL ENDOCRINOL, V16, P221, DOI 10.1210/me.16.2.221; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gregg Jennifer, 2011, Genes Cancer, V2, P900, DOI 10.1177/1947601911431885; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hirata A, 2004, CANCER SCI, V95, P614, DOI 10.1111/j.1349-7006.2004.tb02496.x; Hirata A, 2002, CANCER RES, V62, P2554; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Kaufmann K., 2002, J CELL BIOCHEM, V391, P15253; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kinney CM, 2008, AM J PHYSIOL-CELL PH, V294, pC241, DOI 10.1152/ajpcell.00187.2007; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Lee S, 2003, FASEB J, V17, pA326, DOI 10.1096/fj.02-0570fje; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Pan JQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1397, DOI 10.1038/npp.2011.24; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; SHANKAR R, 1994, J BIOL CHEM, V269, P13936; Shin SY, 2001, J BIOL CHEM, V276, P7797, DOI 10.1074/jbc.M009465200; Sini P, 2005, CLIN CANCER RES, V11, P4521, DOI 10.1158/1078-0432.CCR-04-1954; Tsai JC, 2001, AM J PHYSIOL-GASTR L, V281, pG1271, DOI 10.1152/ajpgi.2001.281.5.G1271; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	65	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11988	12003		10.1074/jbc.M112.428516	http://dx.doi.org/10.1074/jbc.M112.428516			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504318	Green Published, hybrid			2022-12-25	WOS:000318157600033
J	Kent, R; Levanoni, O; Banker, E; Pe'er, G; Kark, S				Kent, Rafi; Levanoni, Oded; Banker, Eran; Pe'er, Guy; Kark, Salit			Comparing the Response of Birds and Butterflies to Vegetation-Based Mountain Ecotones Using Boundary Detection Approaches	PLOS ONE			English	Article							ELEVATIONAL GRADIENTS; DIVERSITY; LANDSCAPE; RICHNESS; TURNOVER	Mountains provide an opportunity to examine changes in biodiversity across environmental gradients and areas of transition (ecotones). Mountain ecotones separate vegetation belts. Here, we aimed to examine whether transition areas for birds and butterflies spatially correspond with ecotones between three previously described altitudinal vegetation belts on Mt. Hermon, northern Israel. These include the Mediterranean Maquis, xero-montane open forest and Tragacanthic mountain steppe vegetation belts. We sampled the abundance of bird and butterfly species in 34 sampling locations along an elevational gradient between 500 and 2200 m. We applied wombling, a boundary-detection technique, which detects rapid changes in a continuous variable, in order to locate the transition areas for bird and butterfly communities and compare the location of these areas with the location of vegetation belts as described in earlier studies of Mt. Hermon. We found some correspondence between the areas of transition of both bird and butterfly communities and the ecotones between vegetation belts. For birds and butterflies, important transitions occurred at the lower vegetation ecotone between Mediterranean maquis and the xero-montane open forest vegetation belts, and between the xero-montane open forest and the mountain steppe Tragacanthic belts. While patterns of species turnover with elevation were similar for birds and butterflies, the change in species richness and diversity with elevation differed substantially between the two taxa. Birds and butterflies responded quite similarly to the elevational gradient and to the shift between vegetation belts in terms of species turnover rates. While the mechanisms generating these patterns may differ, the resulting areas of peak turnover in species show correspondence among three different taxa (plants, birds and butterflies).	[Kent, Rafi; Levanoni, Oded; Banker, Eran; Pe'er, Guy; Kark, Salit] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Biodivers Res Grp, Jerusalem, Israel; [Kark, Salit] Univ Queensland, ARC Ctr Excellence Environm Decis, Sch Biol Sci, Brisbane, Qld, Australia	Hebrew University of Jerusalem; University of Queensland	Kent, R (corresponding author), Technion Israel Inst Technol, Dept Civil & Environm Engn, Haifa, Israel.	rkent@technion.ac.il	Kark, Salit/C-6795-2016; Kark, Salit/I-7123-2013	Kark, Salit/0000-0002-7183-3988; Kark, Salit/0000-0002-7183-3988; Levanoni, Oded/0000-0003-0257-8693	Israel Science Foundation [740/04]; Raymond and Jenine Bollag post-doctoral fellowship at the Hebrew University of Jerusalem	Israel Science Foundation(Israel Science Foundation); Raymond and Jenine Bollag post-doctoral fellowship at the Hebrew University of Jerusalem	This research was supported by the Israel Science Foundation (grant no. 740/04 to SK). GP was partly supported by a Raymond and Jenine Bollag post-doctoral fellowship at the Hebrew University of Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH M, 1993, J ECOL, V81, P25, DOI 10.2307/2261221; Benyamini D, 2002, FIELD GUIDE BUTTERFL; BioMedware, 2001, BOUNDARYSEER 1 0; Blair RB, 1999, ECOL APPL, V9, P164, DOI 10.1890/1051-0761(1999)009[0164:BABAAU]2.0.CO;2; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Boggs CL, 1997, GLOBAL ECOL BIOGEOGR, V6, P39, DOI 10.2307/2997525; Cavieres LA, 2000, REV CHIL HIST NAT, V73, P331; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Colwell RK, 2006, ESTIMATES ESTIMATION; Debinski DM, 2000, ENVIRON MONIT ASSESS, V64, P213, DOI 10.1023/A:1006432030089; Dennis RLH, 2004, ECOL ENTOMOL, V29, P12, DOI 10.1111/j.1365-2311.2004.00572.x; DOWNEY JC, 1962, SYST ZOOL, V11, P150, DOI 10.2307/2411462; Fitzpatrick MC, 2010, ECOLOGY, V91, P3448, DOI 10.1890/10-0807.1; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Fortin MJ, 1997, CAN J FOREST RES, V27, P1851, DOI 10.1139/cjfr-27-11-1851; Fortin MJ, 2000, LANDSCAPE ECOL, V15, P453, DOI 10.1023/A:1008194205292; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; Grace J, 2002, ANN BOT-LONDON, V90, P537, DOI 10.1093/aob/mcf222; Holtmeier FK, 2005, GLOBAL ECOL BIOGEOGR, V14, P395, DOI 10.1111/j.1466-822x.2005.00168.x; Kark S., 2007, ENCY BIODIVERSITY; Kark S, 2007, GLOBAL ECOLOGY BIOGE, V15; Kark S, 2006, ISR J ECOL EVOL, V52, P29, DOI 10.1560/IJEE.52.1.29; Kent M, 1997, PROG PHYS GEOG, V21, P315, DOI 10.1177/030913339702100301; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Krementz D. G., 1995, USDA FOREST SERVICE, DOI [10.2307/3802161, DOI 10.2307/3802161]; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Levanoni O, 2011, ECOGRAPHY, V34, P372, DOI 10.1111/j.1600-0587.2010.06460.x; Levin N, 2007, DIVERS DISTRIB, V13, P692, DOI 10.1111/j.1472-4642.2007.00372.x; Levin SA, 2000, ECOSYSTEMS, V3, P498, DOI 10.1007/s100210000044; Ma HJ, 2007, BAYESIAN ANAL, V2, P281, DOI 10.1214/07-BA211; Mac Nally R, 2004, J BIOGEOGR, V31, P917, DOI 10.1111/j.1365-2699.2004.01089.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Mena JL, 2005, GLOBAL ECOL BIOGEOGR, V14, P539, DOI 10.1111/j.1466-822x.2005.00189.x; ODUM E P, 1971, P574; Pe'er G, 2004, ANIM BEHAV, V68, P825, DOI 10.1016/j.anbehav.2004.02.006; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Sanchez-Rodriguez J. F., 1995, Journal of the Lepidopterists' Society, V49, P192; SHIELDS O, 1967, Journal of Research on the Lepidoptera, V6, P69; SHMIDA A, 1977, THESIS HEBREW U JERU; Shmida A, 1980, MT HERMON NATURE LAN; TERBORGH J, 1970, ECOLOGY, V52, P23; van Rensburg BJ, 2009, DIVERS DISTRIB, V15, P379, DOI 10.1111/j.1472-4642.2008.00545.x	44	4	4	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58229	10.1371/journal.pone.0058229	http://dx.doi.org/10.1371/journal.pone.0058229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505472	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100038
J	Amaro, SM; Golub, JE; Nuovo, GJ; Cunha, CB; Levi, JE; Villa, LL; Andrade, CV; Russomano, FB; Tristao, A; Pires, A; Nicol, AF				Amaro-Filho, Sergio M.; Golub, Jonathan E.; Nuovo, Gerard J.; Cunha, Cynthia B.; Levi, Jose E.; Villa, Luisa L.; Andrade, Cecilia V.; Russomano, Fabio B.; Tristao, Aparecida; Pires, Andrea; Nicol, Alcina F.			A Comparative Analysis of Clinical and Molecular Factors with the Stage of Cervical Cancer in a Brazilian Cohort	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; P16(INK4A) EXPRESSION; COMPUTED-TOMOGRAPHY; CYCLE REGULATORS; HPV; P53; MARKER; KI-67	Cell cycle protein expression plays an important role in the pathophysiology of cervical cancer. However, few studies have attempted to correlate the use of these biomarkers with the clinical progression of the tumor. Objectives: 1) To analyze the expression of Ki-67, p53 and p16(INK4a) in cervical cancer, 2) to correlate the relative expression of these proteins as well as clinical parameters with the stage of disease, and 3) to determine the HPV DNA prevalence and subtype distribution. Methods: Tissue Micro-Arrays (TMA) from patients with invasive cervical cancer (ICC) and controls were analyzed. HPV DNA detection was done by PCR and in situ hybridization. Ki-67, p53 and p16(INK4a) were analyzed by immunohistochemistry; clinical data was derived from the chart review. Results: Advanced tumor stage (III and IV) was strongly associated (p<0.005) with advanced age (>55 years old), with more than four pregnancies and with the lack of formal education. HPV DNA was found in 94.3% of cases with the most prevalent types being HPV16 (67.5%), followed by HPV33 (12.0%) and HPV35 (3.6%). High expression of Ki-67 and p16 was more common in the advanced FIGO stages (p = 0.023). Women with HPV16 tended to be younger (50.9 years; SE 1.9) compared to women with other types (59.9 years; SE 2.8). Conclusion: We found that Ki-67 and p16 expression were independently associated with the tumor stage. We also noted that about 1/3 of the cervical cancers in this Brazilian cohort were not associated with HPV types directly targeted by the current HPV vaccines.	[Amaro-Filho, Sergio M.; Nicol, Alcina F.] Fiocruz MS, IOC, Lab Interdisciplinary Med Res LIPMED, BR-21045900 Rio De Janeiro, Brazil; [Golub, Jonathan E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol Infect Dis, Baltimore, MD USA; [Nuovo, Gerard J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Cunha, Cynthia B.] Fiocruz MS, IPEC, Evandro Chagas Clin Res Inst, Dept Infect Dis, BR-21045900 Rio De Janeiro, Brazil; [Levi, Jose E.] Univ Sao Paulo, Virol Lab, Inst Trop Med, BR-09500900 Sao Paulo, Brazil; [Villa, Luisa L.] Hosp Alemao Oswaldo Cruz, Ludwig Inst Canc Res, Sao Paulo, Brazil; [Andrade, Cecilia V.; Russomano, Fabio B.; Tristao, Aparecida] Fiocruz MS, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil; [Pires, Andrea] Fonte Med Diagnost Lab, Niteroi, RJ, Brazil; [Pires, Andrea] Univ Fed Fluminense, Niteroi, RJ, Brazil	Fundacao Oswaldo Cruz; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Ludwig Institute for Cancer Research; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Nicol, AF (corresponding author), Fiocruz MS, IOC, Lab Interdisciplinary Med Res LIPMED, BR-21045900 Rio De Janeiro, Brazil.	nicol@ioc.fiocruz.br	VILLA, LUISA/AAH-4761-2019; Papilomavirus, Inct/I-2406-2013; Andrade, Cecilia V/B-5916-2017; USP, Oncologia/F-9053-2014	VILLA, LUISA/0000-0003-4074-2335; Andrade, Cecilia V/0000-0001-7980-4367; Amaro-Filho, Sergio/0000-0002-7374-4081	Fogarty International Center, National Institutes of Health (NIH) [2 D 43 TW000010-23-AITRP]; LIPMED-IOCFiocruz, RJ, Brazil; Lewis Foundation (from Dr Gerard J Nuovo Laboratory); FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); LIPMED-IOCFiocruz, RJ, Brazil; Lewis Foundation (from Dr Gerard J Nuovo Laboratory); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Grant Support: AFN and SAF were scholars in the International AIDS Research and Training Program, supported by the Fogarty International Center, National Institutes of Health (NIH) Research Grant 2 D 43 TW000010-23-AITRP. This work was supported in part by grants from LIPMED-IOCFiocruz, RJ, Brazil, and the Lewis Foundation (from Dr Gerard J Nuovo Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta E, 2009, ROM J MORPHOL EMBRYO, V50, P413; Angeletti PC, 2008, ADV PHARMACOL, V56, P509, DOI 10.1016/S1054-3589(07)56016-3; Bahnassy AA, 2007, BMC CLIN PATHOL, V7, DOI 10.1186/1472-6890-7-4; Bidus MA, 2007, CERVICAL VAGINAL CAN; BUCHWALD C, 1995, LARYNGOSCOPE, V105, P66, DOI 10.1288/00005537-199501000-00015; Cheah PL, 2012, ASIAN PAC J CANCER P, V13, P469, DOI 10.7314/APJCP.2012.13.2.469; Conesa-Zamora P, 2009, AM J CLIN PATHOL, V132, P378, DOI 10.1309/AJCPO0WY1VIFCYDC; Pires ARC, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-14; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DRYJA TP, 1986, AM J HUM GENET, V38, P59; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; FUJITA M, 1992, CANCER RES, V52, P5323; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; Giarnieri E, 2000, CLIN CANCER RES, V6, P3600; Giarre M, 2001, J VIROL, V75, P4705, DOI 10.1128/JVI.75.10.4705-4712.2001; Goel MM, 2005, DIAGN CYTOPATHOL, V33, P15, DOI 10.1002/dc.20218; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gupta N, 2010, DIAGN CYTOPATHOL, V38, P618, DOI 10.1002/dc.21270; Hampl M, 2007, J CANCER RES CLIN, V133, P235, DOI 10.1007/s00432-006-0162-0; Harima Y, 2002, INT J RADIAT ONCOL, V52, P1345, DOI 10.1016/S0360-3016(01)02796-1; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalof AN, 2006, ADV ANAT PATHOL, V13, P190, DOI 10.1097/00125480-200607000-00006; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Ku JL, 1997, INT J CANCER, V72, P313, DOI 10.1002/(SICI)1097-0215(19970717)72:2<313::AID-IJC19>3.0.CO;2-G; Kuo KT, 2006, BRIT J OPHTHALMOL, V90, P894, DOI 10.1136/bjo.2005.086314; Mimica M, 2010, INT J GYNECOL CANCER, V20, P116, DOI 10.1111/IGC.0b013e3181bc8da7; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nicol AF, 2012, MEM I OSWALDO CRUZ, V107, P571, DOI 10.1590/S0074-02762012000500001; Nicol AF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-289; Oka K, 2000, CANCER, V88, P2766, DOI 10.1002/1097-0142(20000615)88:12<2766::AID-CNCR15>3.0.CO;2-G; OMIM, LI FRAUM SYNDR; Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04; Queiroz C, 2006, PATHOL RES PRACT, V202, P77, DOI 10.1016/j.prp.2005.08.012; Rajaram S, 2010, J CANCER RES THER, V6, P267, DOI 10.4103/0973-1482.73342; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; Skomedal H, 1999, GYNECOL ONCOL, V73, P223, DOI 10.1006/gyno.1999.5346; SUBAK LL, 1995, OBSTET GYNECOL, V86, P43, DOI 10.1016/0029-7844(95)00109-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan GC, 2008, ASIAN PAC J CANCER P, V9, P781; Tjalma WA, 2001, EUR J OBSTET GYN R B, V97, P223, DOI 10.1016/S0301-2115(00)00541-8; Tsuda H, 2003, GYNECOL ONCOL, V91, P476, DOI 10.1016/j.ygyno.2003.08.019; Volgareva G, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-58	46	11	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57810	10.1371/journal.pone.0057810	http://dx.doi.org/10.1371/journal.pone.0057810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505442	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500034
J	Bartis, D; Csongei, V; Weich, A; Kiss, E; Barko, S; Kovacs, T; Avdicevic, M; D'Souza, VK; Rapp, J; Kvell, K; Jakab, L; Nyitrai, M; Molnar, TF; Thickett, DR; Laszlo, T; Pongracz, JE				Bartis, Domokos; Csongei, Veronika; Weich, Alexander; Kiss, Edit; Barko, Szilvia; Kovacs, Tamas; Avdicevic, Monika; D'Souza, Vijay K.; Rapp, Judit; Kvell, Krisztian; Jakab, Laszlo; Nyitrai, Miklos; Molnar, Tamas F.; Thickett, David R.; Laszlo, Terezia; Pongracz, Judit E.			Down-Regulation of Canonical and Up-Regulation of Non-Canonical Wnt Signalling in the Carcinogenic Process of Squamous Cell Lung Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN; CANCER; EXPRESSION; PATHWAY; GENE; INHIBITION; ACTIVATION; PROMOTER; ADHESION	The majority of lung cancers (LC) belong to the non-small cell lung carcinoma (NSCLC) type. The two main NSCLC sub-types, namely adenocarcinoma (AC) and squamous cell carcinoma (SCC), respond differently to therapy. Whereas the link between cigarette smoke and lung cancer risk is well established, the relevance of non-canonical Wnt pathway up-regulation detected in SCC remains poorly understood. The present study was undertaken to investigate further the molecular events in canonical and non-canonical Wnt signalling during SCC development. A total of 20 SCC and AC samples with matched non-cancerous controls were obtained after surgery. TaqMan array analysis confirmed up-regulation of non-canonical Wnt5a and Wnt11 and identified down-regulation of canonical Wnt signalling in SCC samples. The molecular changes were tested in primary small airway epithelial cells (SAEC) and various lung cancer cell lines (e. g. A549, H157, etc). Our studies identified Wnt11 and Wnt5a as regulators of cadherin expression and potentiated relocation of beta-catenin to the nucleus as an important step in decreased cellular adhesion. The presented data identifies additional details in the regulation of SCC that can aid identification of therapeutic drug targets in the future.	[Bartis, Domokos; Csongei, Veronika; Weich, Alexander; Kiss, Edit; Kovacs, Tamas; Avdicevic, Monika; Rapp, Judit; Kvell, Krisztian; Pongracz, Judit E.] Univ Pecs, Sch Med, Inst Immunol & Biotechnol, Dept Med Biotechnol, Pecs, Hungary; [Bartis, Domokos; D'Souza, Vijay K.; Nyitrai, Miklos; Thickett, David R.] Univ Birmingham, Sch Med, Dept Med, Birmingham, W Midlands, England; [Barko, Szilvia] Univ Pecs, Sch Med, Dept Biophys, Pecs, Hungary; [Jakab, Laszlo; Molnar, Tamas F.] Univ Pecs, Sch Med, Dept Surg, Pecs, Hungary; [Laszlo, Terezia] Univ Pecs, Sch Med, Dept Pathol, Pecs, Hungary; [Csongei, Veronika; Kiss, Edit; Kovacs, Tamas; Rapp, Judit; Kvell, Krisztian; Nyitrai, Miklos; Pongracz, Judit E.] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Birmingham; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Pongracz, JE (corresponding author), Univ Pecs, Sch Med, Inst Immunol & Biotechnol, Dept Med Biotechnol, Pecs, Hungary.	judit.e.pongracz@aok.pte.hu	Pongracz, Judit E/N-7927-2018; Bartis, Domokos/C-7763-2016; Pongracz, Judit E/J-7517-2019	Pongracz, Judit E/0000-0002-0278-5556; Bartis, Domokos/0000-0003-2301-3704; Pongracz, Judit E/0000-0002-0278-5556; Weich, Alexander/0000-0002-4127-1347; thickett, david/0000-0002-5456-6080; Kvell MD PhD dr. habil., Krisztian/0000-0001-8609-6274; D'Souza, Vijay/0000-0002-9402-7516; Nyitrai, Miklos/0000-0002-6229-4337	Tarsadalmi Megujulas Operativ Program; Tarsadalmi Infrastruktura Operativ Program [TIOP 1.3.1-07/1-2F-2008-0002]; MAG Zrt-NKTH(NFU)-OTKA(Magyar Gazdasagfejlesztesi Kozpont Zrt-Nemzeti Kutatastamogatasi Hivatal (Nemzeti Fejlesztesi Ugynokseg)-Orszagos Tudomanyos Kutatasi Alapprogramok Iroda or Hungarian Scientific Research Fund [K-OTKA_67807_ A_O7 -2-2012-0093328]; K-OTKA [34039/KA-OTKA/11-02];  [TAMOP-4.2.1.B-10/2/KONV-2010-0002]	Tarsadalmi Megujulas Operativ Program; Tarsadalmi Infrastruktura Operativ Program; MAG Zrt-NKTH(NFU)-OTKA(Magyar Gazdasagfejlesztesi Kozpont Zrt-Nemzeti Kutatastamogatasi Hivatal (Nemzeti Fejlesztesi Ugynokseg)-Orszagos Tudomanyos Kutatasi Alapprogramok Iroda or Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); K-OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); 	This work was supported by the TAMOP-4.2.1.B-10/2/KONV-2010-0002; (Tarsadalmi Megujulas Operativ Program); TIOP 1.3.1-07/1-2F-2008-0002 (Tarsadalmi Infrastruktura Operativ Program); K-OTKA_67807_ A_O7 -2-2012-0093328 (MAG Zrt-NKTH(NFU)-OTKA(Magyar Gazdasagfejlesztesi Kozpont Zrt-Nemzeti Kutatastamogatasi Hivatal (Nemzeti Fejlesztesi Ugynokseg)-Orszagos Tudomanyos Kutatasi Alapprogramok Iroda or Hungarian Scientific Research Fund) all to JEP and by the K-OTKA grant 34039/KA-OTKA/11-02 to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Blanco D, 2004, LAB INVEST, V84, P999, DOI 10.1038/labinvest.3700129; Bovia F, 2003, BLOOD, V101, P1727, DOI 10.1182/blood-2001-12-0249; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brandon C, 2000, BLOOD, V96, P4132, DOI 10.1182/blood.V96.13.4132.h8004132_4132_4141; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Danielson KG, 1995, J BIOL CHEM, V270, P31225, DOI 10.1074/jbc.270.52.31225; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025807; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Kang Moon-Il, 2012, Genes Cancer, V3, P37, DOI 10.1177/1947601912448820; Kawakami Y, 2000, DEV GROWTH DIFFER, V42, P561; Kawasaki A, 2007, CELL SIGNAL, V19, P2498, DOI 10.1016/j.cellsig.2007.07.023; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nozaki I, 2001, INT J ONCOL, V19, P117; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Shu WG, 2002, DEVELOPMENT, V129, P4831; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Taki M, 2003, CANCER SCI, V94, P593, DOI 10.1111/j.1349-7006.2003.tb01488.x; Tichelaar JW, 2010, CANCER PREV RES, V3, P1148, DOI 10.1158/1940-6207.CAPR-10-0023; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Yuan G, 2013, ONCOGENE, V32, P375, DOI 10.1038/onc.2012.40	41	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57393	10.1371/journal.pone.0057393	http://dx.doi.org/10.1371/journal.pone.0057393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505429	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500021
J	Caceres, NE; Aerts, M; Marquez, B; Mingeot-Leclercq, MP; Tulkens, PM; Devreese, B; Van Bambeke, F				Caceres, Nancy E.; Aerts, Maarten; Marquez, Beatrice; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.; Devreese, Bart; Van Bambeke, Francoise			Analysis of the Membrane Proteome of Ciprofloxacin-Resistant Macrophages by Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC)	PLOS ONE			English	Article							NF-KAPPA-B; PHOSPHOLIPID-BINDING PROTEINS; GROWTH-FACTOR RECEPTOR; PROSTATE-CANCER; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; MULTIDRUG-RESISTANT; EFFLUX TRANSPORTER; PREVENTS APOPTOSIS; J774 MACROPHAGES	Overexpression of multidrug transporters is a well-established mechanism of resistance to chemotherapy, but other changes may be co-selected upon exposure to drugs that contribute to resistance. Using a model of J774 macrophages made resistant to the fluoroquinolone antibiotic ciprofloxacin and comparing it with the wild-type parent cell line, we performed a quantitative proteomic analysis using the stable isotope labeling with amino acids in cell culture technology coupled with liquid chromatography electrospray ionization Fourier transform tandem mass spectrometry (LC-ESI-FT-MS/MS) on 2 samples enriched in membrane proteins (fractions F1 and F2 collected from discontinuous sucrose gradient). Nine hundred proteins were identified with at least 3 unique peptides in these 2 pooled fractions among which 61 (F1) and 69 (F2) showed a significantly modified abundance among the 2 cell lines. The multidrug resistance associated protein Abcc4, known as the ciprofloxacin efflux transporter in these cells, was the most upregulated, together with Dnajc3, a protein encoded by a gene located downstream of Abcc4. The other modulated proteins are involved in transport functions, cell adhesion and cytoskeleton organization, immune response, signal transduction, and metabolism. This indicates that the antibiotic ciprofloxacin is able to trigger a pleiotropic adaptative response in macrophages that includes the overexpression of its efflux transporter.	[Caceres, Nancy E.; Marquez, Beatrice; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.; Van Bambeke, Francoise] Catholic Univ Louvain, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Aerts, Maarten; Devreese, Bart] Univ Ghent, Lab Eiwitbiochem & Biomol Engn, Ghent, Belgium	Universite Catholique Louvain; Ghent University	Devreese, B (corresponding author), Univ Ghent, Lab Eiwitbiochem & Biomol Engn, Ghent, Belgium.	bart.devreese@ugent.be; francoise.vanbambeke@uclouvain.be	Devreese, Bart/K-2841-2019; Devreese, Bart/B-2011-2009; Van Bambeke, Françoise/H-5934-2019; Aerts, Maarten/O-6194-2014; Tulkens, Paul/B-2087-2015	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Van Bambeke, Françoise/0000-0002-0052-7991; Aerts, Maarten/0000-0003-0125-6721; Tulkens, Paul/0000-0002-7121-3623	Belgian Interuniversity Attraction Poles (Interuniversitaire Attractiepolen/Poles d'attraction interuniversitaires) [P6/19]; IWT-Flanders (SBO) [B/06921/01]; Fonds de la Recherche Scientifique Medicale (FRSM) [3.4.597.06, 3.4.583.08]; French Association Mucoviscidose: ABCF	Belgian Interuniversity Attraction Poles (Interuniversitaire Attractiepolen/Poles d'attraction interuniversitaires); IWT-Flanders (SBO); Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); French Association Mucoviscidose: ABCF	NEC and BM were respectively post-doctoral fellows of the Fonds de la Recherche Scientifique (F.R.S-FNRS) and of the Region Wallonne (programme FIRST post-doc). FVB is Maitre de recherches of the F.R.S.-FNRS. This work was supported by the Belgian Interuniversity Attraction Poles (Interuniversitaire Attractiepolen/Poles d'attraction interuniversitaires) Research project P6/19 [research action P6]), IWT-Flanders (SBO project B/06921/01), the Fonds de la Recherche Scientifique Medicale (FRSM; grants no. 3.4.597.06 and 3.4.583.08) and a grant from the French Association Mucoviscidose: ABCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Biswas G, 2008, J BIOL CHEM, V283, P12586, DOI 10.1074/jbc.M710481200; Borst P, 2007, CELL CYCLE, V6, P2782, DOI 10.4161/cc.6.22.4936; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chavez JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019892; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Conacci -Sorrell M, 2005, CANCER RES, V65, P11605, DOI 10.1158/0008-5472.CAN-05-2647; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dupressoir A, 1997, ONCOGENE, V14, P2951, DOI 10.1038/sj.onc.1201148; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eriksson E, 2003, J LEUKOCYTE BIOL, V74, P456, DOI 10.1189/jlb.0103048; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Girard M, 2008, FEBS LETT, V582, P961, DOI 10.1016/j.febslet.2008.02.042; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Hu SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-30; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Koochekpour S, 2005, GENE CHROMOSOME CANC, V44, P351, DOI 10.1002/gcc.20249; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lee TJ, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-31; LEPAGE P, 1993, MOL CELL BIOL, V13, P7380, DOI 10.1128/MCB.13.12.7380; Lin HH, 1997, GENOMICS, V41, P301, DOI 10.1006/geno.1997.4674; Lin ST, 2012, J PROTEOMICS; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Liu C, 2003, CANCER RES, V63, P2957; Lucki NC, 2012, MOL ENDOCRINOL, V26, P228, DOI 10.1210/me.2011-1150; LUEDERS KK, 1993, MOL CELL BIOL, V13, P7439, DOI 10.1128/MCB.13.12.7439; Mari M, 2001, J BIOL CHEM, V276, P42501, DOI 10.1074/jbc.M104885200; Marquez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028368; Marquez B, 2009, ANTIMICROB AGENTS CH, V53, P2410, DOI 10.1128/AAC.01428-08; Matusan-Ilijas K, 2011, PATHOL RES PRACT, V207, P104, DOI 10.1016/j.prp.2010.11.004; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Michot JM, 2006, ANTIMICROB AGENTS CH, V50, P1689, DOI 10.1128/AAC.50.5.1689-1695.2006; Michot JM, 2004, ANTIMICROB AGENTS CH, V48, P2673, DOI 10.1128/AAC.48.7.2673-2682.2004; Misasi R, 2001, FASEB J, V15, P467, DOI 10.1096/fj.00-0217com; Misasi R, 2004, EXP CELL RES, V298, P38, DOI 10.1016/j.yexcr.2004.04.011; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Naito M, 2008, PATHOL INT, V58, P143, DOI 10.1111/j.1440-1827.2007.02203.x; Nakamura K, 2001, BBA-GENE STRUCT EXPR, V1522, P53, DOI 10.1016/S0167-4781(01)00284-6; Novak N, 2008, DRUG NEWS PERSPECT, V21, P158, DOI 10.1358/dnp.2008.21.3.1203412; O'Connell K, 2012, PROTEOMICS, V12, P2115, DOI 10.1002/pmic.201100489; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Parker PJ, 2004, BIOCHEM SOC T, V32, P893, DOI 10.1042/BST0320893; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; RENARD C, 1987, ANTIMICROB AGENTS CH, V31, P410, DOI 10.1128/AAC.31.3.410; Riesbeck K, 1998, ANTIMICROB AGENTS CH, V42, P1923, DOI 10.1128/AAC.42.8.1923; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; SANGO K, 1995, GENOMICS, V27, P362, DOI 10.1006/geno.1995.1058; Seo KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042960; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; SPILSBURY K, 1995, BLOOD, V85, P1620, DOI 10.1182/blood.V85.6.1620.bloodjournal8561620; Tomsig JL, 2002, CELL MOL LIFE SCI, V59, P1467, DOI 10.1007/s00018-002-8522-7; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Tsou CL, 1998, J EXP MED, V188, P603, DOI 10.1084/jem.188.3.603; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vanrobaeys F, 2005, J PROTEOME RES, V4, P2283, DOI 10.1021/pr050205c; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Zhou CH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3144	90	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58285	10.1371/journal.pone.0058285	http://dx.doi.org/10.1371/journal.pone.0058285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505477	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500063
J	Kalliokoski, O; Jacobsen, KR; Darusman, HS; Henriksen, T; Weimann, A; Poulsen, HE; Hau, J; Abelson, KSP				Kalliokoski, Otto; Jacobsen, Kirsten R.; Darusman, Huda S.; Henriksen, Trine; Weimann, Allan; Poulsen, Henrik E.; Hau, Jann; Abelson, Klas S. P.			Mice Do Not Habituate to Metabolism Cage Housing-A Three Week Study of Male BALB/c Mice	PLOS ONE			English	Article							CHRONIC MILD STRESS; CORTICOSTERONE EXCRETION; OXIDATIVE DAMAGE; LABORATORY RATS; FEMALE MICE; IN-VIVO; DEPRESSION; RESPONSES; URINE; BEHAVIOR	The metabolism cage is a barren, non-enriched, environment, combining a number of recognized environmental stressors. We investigated the ability of male BALB/c mice to acclimatize to this form of housing. For three weeks markers of acute and oxidative stress, as well as clinical signs of abnormality were monitored. Forced swim tests were conducted to determine whether the animals experienced behavioral despair and the serotonergic integrity was tested using an 8-OH-DPAT challenge. The metabolism cage housed mice excreted approximately tenfold higher amounts of corticosterone metabolites in feces throughout the study when compared to controls. Urinary biomarkers confirmed that these mice suffered from elevated levels of oxidative stress, and increased creatinine excretions indicated increased muscle catabolism. Changes in the core body temperature (stress-induced hyperthermia) and the fur state of the mice also indicated impaired well-being in the metabolism cage housed mice. However, monitoring body weight and feed intake was found misleading in assessing the wellbeing of mice over a longer time course, and the forced swim test was found poorly suited for studying chronic stress in mice in the present setup. In conclusion, the mice were found not to acclimatize to the metabolism cages whereby concern for animal welfare would dictate that mice should be housed in this way for as short periods as possible. The elevated degree of HPA axis activity, oxidative stress, and increased overall metabolism warrant caution when interpreting data obtained from metabolism cage housed mice, as their condition cannot be considered representative of a normal physiology.	[Kalliokoski, Otto; Jacobsen, Kirsten R.; Darusman, Huda S.; Hau, Jann; Abelson, Klas S. P.] Univ Copenhagen, Dept Expt Med, Copenhagen, Denmark; [Kalliokoski, Otto; Jacobsen, Kirsten R.; Darusman, Huda S.; Hau, Jann; Abelson, Klas S. P.] Univ Copenhagen Hosp, DK-2100 Copenhagen, Denmark; [Darusman, Huda S.] Bogor Agr Univ, Fac Vet Med, Dept Anat Physiol & Pharmacol, Bogor, Indonesia; [Henriksen, Trine; Weimann, Allan; Poulsen, Henrik E.] Rigshosp, Lab Clin Pharmacol, DK-2100 Copenhagen, Denmark; [Henriksen, Trine; Weimann, Allan; Poulsen, Henrik E.] Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bogor Agricultural University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Kalliokoski, O (corresponding author), Univ Copenhagen, Dept Expt Med, Copenhagen, Denmark.	otto.kalliokoski@gmail.com	Hau, Jann/C-8692-2012; Kalliokoski, Otto/I-3828-2019	Hau, Jann/0000-0001-8586-5705; Kalliokoski, Otto/0000-0001-6531-3487; Rosenmay Jacobsen, Kirsten/0000-0002-3211-7890; Poulsen, Henrik Enghusen/0000-0003-4242-9924	Danish Council for Strategic Research [09-066115]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The present investigation was supported by a generous grant from the Danish Council for Strategic Research (http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research). Grant Journal no.: 09-066115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Baumans V., 2010, COST MANUAL LAB ANIM, P75; Bhatnagar S, 2006, J NEUROENDOCRINOL, V18, P13, DOI 10.1111/j.1365-2826.2005.01375.x; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Broedbaek K, 2011, DIABETES CARE; CORNFIELD LJ, 1991, MOL PHARMACOL, V39, P780; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; CUPPLES LA, 1984, ANN INTERN MED, V100, P122, DOI 10.7326/0003-4819-100-1-122; David DJP, 2003, PSYCHOPHARMACOLOGY, V166, P373, DOI 10.1007/s00213-002-1335-4; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Eriksson E, 2004, EXP PHYSIOL, V89, P427, DOI 10.1113/expphysiol.2004.027656; Fawcett A, 2011, GUIDELINES IN PRESS, P22; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gaskill BN, 2011, J THERM BIOL, V36, P193, DOI 10.1016/j.jtherbio.2011.02.004; Gaskill BN, 2009, APPL ANIM BEHAV SCI, V116, P279, DOI 10.1016/j.applanim.2008.10.002; Gil MC, 1999, CELL MOL NEUROBIOL, V19, P625, DOI 10.1023/A:1006984402291; Gilmore AJ, 2008, LAB ANIM-UK, V42, P140, DOI 10.1258/la.2007.06030e; GOMEZSANCHEZ EP, 1991, STEROIDS, V56, P451, DOI 10.1016/0039-128X(91)90035-T; Gordon CJ, 2004, COMPARATIVE MED, V54, P63; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 2002, FREE RADICAL BIO MED, V32, P968, DOI 10.1016/S0891-5849(02)00808-0; Hau J, 2011, LAB ANIM-UK, V45, P129, DOI 10.1258/la.2010.010125; HENNESSY MB, 1977, PHYSIOL BEHAV, V18, P799, DOI 10.1016/0031-9384(77)90186-X; Henriksen T, 2009, FREE RADICAL BIO MED, V47, P629, DOI 10.1016/j.freeradbiomed.2009.06.002; Hoppe CC, 2009, PHYSIOL RES, V58, P69, DOI 10.33549/physiolres.931390; Ishida H, 2003, BIOL PHARM BULL, V26, P170, DOI 10.1248/bpb.26.170; Joergensen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020795; Kalliokoski O, 2012, IN VIVO, V26, P213; Kalliokoski O, 2010, GEN COMP ENDOCR, V168, P450, DOI 10.1016/j.ygcen.2010.06.003; Kong QM, 2010, CELL MOL LIFE SCI, V67, P1817, DOI 10.1007/s00018-010-0277-y; Kudoh A, 2003, ANESTH ANALG, V97, P275, DOI 10.1213/01.ANE.0000068821.29712.AC; Kurien BT, 2004, LAB ANIM-UK, V38, P333, DOI 10.1258/0023677041958945; Larauche M, 2010, STRESS, V13, P344, DOI 10.3109/10253891003664166; Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078; Lunec J, 2002, FREE RADICAL BIO MED, V33, P875, DOI 10.1016/S0891-5849(02)00882-1; MANSER CE, 1995, LAB ANIM, V29, P353, DOI 10.1258/002367795780740023; Manser CE, 1996, LAB ANIM, V30, P1, DOI 10.1258/002367796780744974; Mineur YS, 2006, BEHAV BRAIN RES, V175, P43, DOI 10.1016/j.bbr.2006.07.029; Mineur YS, 2003, BEHAV GENET, V33, P513, DOI 10.1023/A:1025770616068; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; POLLACK GM, 1991, DRUG METAB DISPOS, V19, P130; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; REBUFFESCRIVE M, 1992, PHYSIOL BEHAV, V52, P583, DOI 10.1016/0031-9384(92)90351-2; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Sheridan J, 2009, BRIT J CANCER, V100, P381, DOI 10.1038/sj.bjc.6604821; Solich J, 2008, PHARMACOL REP, V60, P1008; Stechman MJ, 2010, LAB ANIM-UK, V44, P218, DOI 10.1258/la.2010.009128; Sun L, 2008, P NATL ACAD SCI USA, V105, P3339, DOI 10.1073/pnas.0800165105; Sundbom R, 2011, IN VIVO, V25, P335; Tabata H, 1998, LAB ANIM-UK, V32, P143, DOI 10.1258/002367798780599983; TULI JS, 1995, LAB ANIM, V29, P132, DOI 10.1258/002367795780740249; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; Wang SH, 2009, PSYCHIAT RES, V170, P245, DOI 10.1016/j.psychres.2008.07.006; WEISS JM, 1981, BRAIN RES REV, V3, P167, DOI 10.1016/0165-0173(81)90005-9; Zethof TJJ, 1995, EUR J PHARMACOL, V294, P125, DOI 10.1016/0014-2999(95)00520-X; Zhu SW, 2006, BEHAV BRAIN RES, V169, P10, DOI 10.1016/j.bbr.2005.11.024	59	50	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58460	10.1371/journal.pone.0058460	http://dx.doi.org/10.1371/journal.pone.0058460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505511	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500087
J	Tori, K; Ishino, S; Kiyonari, S; Tahara, S; Ishino, Y				Tori, Kazuo; Ishino, Sonoko; Kiyonari, Shinichi; Tahara, Saki; Ishino, Yoshizumi			A Novel Single-Strand Specific 3 '-5 ' Exonuclease Found in the Hyperthermophilic Archaeon, Pyrococcus furiosus	PLOS ONE			English	Article							IONIZING-RADIATION; THERMOCOCCUS-KODAKARAENSIS; HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; DNA-REPLICATION; SULFOLOBUS-ACIDOCALDARIUS; GAMMA-IRRADIATION; MISMATCH REPAIR; MECHANISMS; MUTANT	Nucleases play important roles in all DNA transactions, including replication, repair, and recombination. Many different nucleases from bacterial and eukaryotic organisms have been identified and functionally characterized. However, our knowledge about the nucleases from Archaea, the third domain of life, is still limited. We searched for 3'-5' exonuclease activity in the hyperthermophilic archaeon, Pyrococcus furiosus, and identified a protein with the target activity. The purified protein, encoded by PF2046, is composed of 229 amino acids with a molecular weight of 25,596, and displayed single-strand specific 3'-5' exonuclease activity. The protein, designated as PfuExo I, forms a stable trimeric complex in solution and excises the DNA at every two nucleotides from the 3' to 5' direction. The amino acid sequence of this protein is conserved only in Thermococci, one of the hyperthermophilic classes in the Euryarchaeota subdomain in Archaea. The newly discovered exonuclease lacks similarity to any other proteins with known function, including hitherto reported 3'-5' exonucleases. This novel nuclease may be involved in a DNA repair pathway conserved in the living organisms as a specific member for some hyperthermophilic archaea.	[Ishino, Sonoko] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan; Kyushu Univ, Fac Agr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Ishino, S (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan.	sonoko@agr.kyushu-u.ac.jp; ishino@agr.kyushu-u.ac.jp	Kiyonari, Shinichi/I-7329-2014	Ishino, Sonoko/0000-0002-1833-1735; Ishino, Yoshizumi/0000-0001-9419-0826	Ministry of Education, Culture, Sports, Science and Technology of Japan [21113005, 23310152]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [grant numbers 21113005 and 23310152 to YI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Cann IKO, 1999, GENETICS, V152, P1249; Capes MD, 2011, PLASMID, V65, P77, DOI 10.1016/j.plasmid.2010.11.005; Constantinesco F, 2002, EMBO REP, V3, P537, DOI 10.1093/embo-reports/kvf112; Crowley David J, 2006, Saline Syst, V2, P11, DOI 10.1186/1746-1448-2-11; DiRuggiero J, 1997, J BACTERIOL, V179, P4643, DOI 10.1128/jb.179.14.4643-4645.1997; Farkas JZ, 2012, J BIOL DYNAM, V6, P1, DOI 10.1080/17513758.2011.615464; Feschenko VV, 2003, P NATL ACAD SCI USA, V100, P1134, DOI 10.1073/pnas.0233122100; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Grogan DW, 2004, CURR ISSUES MOL BIOL, V6, P137; GROGAN DW, 1991, J BACTERIOL, V173, P7725, DOI 10.1128/jb.173.23.7725-7727.1991; HENNER WD, 1983, J BIOL CHEM, V258, P5198; HUTCHINSON F, 1985, PROG NUCLEIC ACID RE, V32, P115, DOI 10.1016/S0079-6603(08)60347-5; Ishino Y, 2006, CHEM REV, V106, P324, DOI 10.1021/cr0404803; Ishino Y, 2012, SCI CHINA, V189, P5652; Ishino Y, 2006, METHOD ENZYMOL, V11, P99; Jacobs KL, 1998, ARCH MICROBIOL, V169, P81; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Kish A, 2008, J BACTERIOL, V190, P5210, DOI 10.1128/JB.00292-08; Komori K, 2000, PROTEIN ENG, V13, P41, DOI 10.1093/protein/13.1.41; Komori K, 1999, P NATL ACAD SCI USA, V96, P8873, DOI 10.1073/pnas.96.16.8873; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nishino T, 2006, CURR OPIN STRUC BIOL, V16, P60, DOI 10.1016/j.sbi.2006.01.009; Olsen GJ, 1997, CELL, V89, P991, DOI 10.1016/S0092-8674(00)80284-6; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Rajman LA, 2000, J BACTERIOL, V182, P607, DOI 10.1128/JB.182.3.607-612.2000; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Uemori T, 1997, GENES CELLS, V2, P499, DOI 10.1046/j.1365-2443.1997.1380336.x; Viswanathan M, 1998, GENETICS, V149, P7; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Watrin L, 1996, CURR MICROBIOL, V33, P377, DOI 10.1007/s002849900131; Williams E, 2007, EXTREMOPHILES, V11, P19, DOI 10.1007/s00792-006-0002-9; Woods WG, 1997, MOL MICROBIOL, V23, P791, DOI 10.1046/j.1365-2958.1997.2651626.x; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zhang CY, 2010, MICROBIOL-SGM, V156, P3386, DOI 10.1099/mic.0.042523-0	44	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58497	10.1371/journal.pone.0058497	http://dx.doi.org/10.1371/journal.pone.0058497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505520	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500093
J	Valverde, JR; Mellado, RP				Valverde, Jose R.; Mellado, Rafael P.			Analysis of Metagenomic Data Containing High Biodiversity Levels	PLOS ONE			English	Article							RIBOSOMAL-RNA; MICROBIAL DIVERSITY; COMMUNITY; BLAST; GENERATION; BIOSPHERE; SEQUENCES; RESOURCE; SEARCH	In this paper we have addressed the problem of analysing Next Generation Sequencing samples with an expected large biodiversity content. We analysed several well-known 16S rRNA datasets from experimental samples, including both large and short sequences, in numbers of tens of thousands, in addition to carefully crafted synthetic datasets containing more than 7000 OTUs. From this data analysis several patterns were identified and used to develop new guidelines for experimentation in conditions of high biodiversity. We analysed the suitability of different clustering packages for these type of situations, the problem of even sampling, the relative effectiveness of Chao1 and ACE estimators as well as their effect on sampling size for a variety of population distributions. As regards practical analysis procedures, we advocated an approach that retains as much high-quality experimental data as possible. By carefully applying selection rules combining the taxonomic assignment with clustering strategies, we derived a set of recommendations for ultra-sequencing data analysis at high biodiversity levels.	[Valverde, Jose R.] CSIC, Ctr Nacl Biotecnol, Sci Comp Serv, Madrid, Spain; [Mellado, Rafael P.] CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Mellado, RP (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, C Darwin 3, Madrid, Spain.	rpmellado@cnb.csic.es	Mellado, Rafael P/D-2680-2009; Valverde, Jose R/K-8853-2014	Valverde, Jose R/0000-0002-6655-7114	Spanish Ministry of Agriculture, Food and Environment [EGO22008]; Spanish Research Council (CSIC) [200420E397]; CYTED [510RT0391]; EU [BM1006]	Spanish Ministry of Agriculture, Food and Environment; Spanish Research Council (CSIC); CYTED; EU(European Commission)	The authors wish to acknowledge the support provided by grant EGO22008 from the Spanish Ministry of Agriculture, Food and Environment for this research, as well as partial support from the Spanish Research Council (CSIC) PIE number 200420E397, and grants 510RT0391 (FreeBIT) from CYTED and BM1006 (SEQAHEAD) from the EU 7FP COST program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barriuso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035481; Barriuso J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-473; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Eells WC, 1926, J AM STAT ASSOC, V21, P119, DOI 10.2307/2277140; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Heidelberg KB, 2010, MICROB BIOTECHNOL, V3, P531, DOI 10.1111/j.1751-7915.2010.00193.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Core Team, 2022, R LANG ENV STAT COMP; Razgour O, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.49; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; TRUDEL L, 1986, CAN J MICROBIOL, V32, P673, DOI 10.1139/m86-124; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wooley JC, 2010, J COMPUT SCI TECH-CH, V25, P71, DOI 10.1007/s11390-010-9306-4	41	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58118	10.1371/journal.pone.0058118	http://dx.doi.org/10.1371/journal.pone.0058118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505458	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500050
J	Hotomi, M; Togawa, A; Kono, M; Ikeda, Y; Takei, S; Hollingshead, SK; Briles, DE; Suzuki, K; Yamanaka, N				Hotomi, Muneki; Togawa, Akihisa; Kono, Masamitsu; Ikeda, Yorihiko; Takei, Shin; Hollingshead, Susan K.; Briles, David E.; Suzuki, Kenji; Yamanaka, Noboru			PspA Family Distribution, Antimicrobial Resistance and Serotype of Streptococcus pneumoniae Isolated from Upper Respiratory Tract Infections in Japan	PLOS ONE			English	Article							SURFACE PROTEIN-A; PNEUMOCOCCAL CONJUGATE VACCINE; ACUTE OTITIS-MEDIA; ANTIBIOTIC-RESISTANCE; GENETIC DIVERSITY; UNITED-STATES; ANTIBACTERIAL SUSCEPTIBILITY; NATIONWIDE SURVEILLANCE; ELICIT PROTECTION; HETEROLOGOUS PSPA	Background: The protection against pneumococcal infections provided by currently available pneumococcal polysaccharide conjugate vaccines are restricted to the limited number of the serotypes included in the vaccine. In the present study, we evaluated the distribution of the pneumococcal capsular type and surface protein A (PspA) family of pneumococcal isolates from upper respiratory tract infections in Japan. Methods: A total of 251 S. pneumoniae isolates from patients seeking treatment for upper respiratory tract infections were characterized for PspA family, antibiotic resistance and capsular type. Results: Among the 251 pneumococci studied, the majority (49.4%) was identified as belonging to PspA family 2, while most of the remaining isolates (44.6%) belonged to family 1. There were no significant differences between the distributions of PspA1 versus PspA2 isolates based on the age or gender of the patient, source of the isolates or the isolates' susceptibilities to penicillin G. In contrast, the frequency of the mefA gene presence and of serotypes 15B and 19F were statistically more common among PspA2 strains. Conclusion: The vast majority of pneumococci isolated from the middle ear fluids, nasal discharges/ sinus aspirates or pharyngeal secretions represented PspA families 1 and 2. Capsular serotypes were generally not exclusively associated with certain PspA families, although some capsular types showed a much higher proportion of either PspA1 or PspA2. A PspA-containing vaccine would potentially provide high coverage against pneumococcal infectious diseases because it would be cross-protective versus invasive disease with the majority of pneumococci infecting children and adults.	[Hotomi, Muneki; Togawa, Akihisa; Kono, Masamitsu; Ikeda, Yorihiko; Takei, Shin; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Hollingshead, Susan K.; Briles, David E.] Univ Birmingham Alabama, Dept Microbiol, Birmingham, AL USA; [Suzuki, Kenji] Fujita Hlth Univ, Sch Med, Hosp 2, Dept Otolaryngol, Toyoake, Aichi 47011, Japan; [Suzuki, Kenji; Yamanaka, Noboru] Japan Soc Infect Dis Otolaryngol, Surveillance Subcomm, Nagoya, Aichi, Japan	Wakayama Medical University; Fujita Health University	Hotomi, M (corresponding author), Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan.	mhotomi@wakayama-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [22791624]; National Institutes of Health (NIH) [R01-AI021458]; Bill & Melinda Gates Foundation Grant [37863]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation Grant	This work was supported by national grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (no. 22791624). The PspA work of David E. Briles and Susan K Hollingshead is supported by a National Institutes of Health (NIH) grant (Grant No. R01-AI021458) and Bill & Melinda Gates Foundation Grant (Grant No. 37863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELBAUM PC, 1992, CLIN INFECT DIS, V15, P77, DOI 10.1093/clinids/15.1.77; Beall B, 2000, J CLIN MICROBIOL, V38, P3663, DOI 10.1128/JCM.38.10.3663-3669.2000; Brandileone MCC, 2004, VACCINE, V22, P3890, DOI 10.1016/j.vaccine.2004.04.009; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; Briles D. E., 2006, Gram-positive pathogens, P289; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Briles DE, 1998, CLIN MICROBIOL REV, V11, P645, DOI 10.1128/CMR.11.4.645; Briles DE, 2000, VACCINE, V19, pS87, DOI 10.1016/S0264-410X(00)00285-1; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; BRILES DE, 1988, REV INFECT DIS, V10, pS372; Brooks-Walter A, 1995, 35 ICAAC; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Coral MCV, 2001, EMERG INFECT DIS, V7, P832; Crain MJ, 1996, MICROB PATHOGENESIS, V21, P265, DOI 10.1006/mpat.1996.0060; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Darrieux M, 2007, INFECT IMMUN, V75, P5930, DOI 10.1128/IAI.00940-07; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Ferreira DM, 2010, MICROB PATHOGENESIS, V48, P205, DOI 10.1016/j.micpath.2010.02.009; Franco CM, 2010, PEDIATR INFECT DIS J, V29, P77, DOI 10.1097/INF.0b013e3181af7e90; Fukuyama Y, 2010, J IMMUNOL, V185, P1755, DOI 10.4049/jimmunol.1000831; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Heeg C, 2007, VACCINE, V25, P1030, DOI 10.1016/j.vaccine.2006.09.061; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hollingshead SK, 2006, J MED MICROBIOL, V55, P215, DOI 10.1099/jmm.0.46268-0; Hollingshead SK, 2001, CURR OPIN MICROBIOL, V4, P71, DOI 10.1016/S1369-5274(00)00167-3; Hotomi M, 2006, ORL-J OTO-RHIN-LARYN, V68, P139, DOI 10.1159/000091276; Hotomi M, 2008, J CLIN MICROBIOL, V46, P3808, DOI 10.1128/JCM.01782-08; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Imai S, 2011, CLIN MICROBIOL INFEC, V17, P1409, DOI 10.1111/j.1469-0691.2010.03446.x; Ito Y, 2007, EUR J CLIN MICROBIOL, V26, P739, DOI 10.1007/s10096-007-0364-7; Jedrzejas MJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P116, DOI 10.1006/abbi.1999.1544; Jedrzejas MJ, 2001, J BIOL CHEM, V276, P33121, DOI 10.1074/jbc.M103304200; Klugman KP, 2009, ADV EXP MED BIOL, V634, P121, DOI 10.1007/978-0-387-79838-7_11; KLUGMAN KP, 1990, CLIN MICROBIOL REV, V3, P171, DOI 10.1128/CMR.3.2.171-196.1990; MCDANIEL LS, 1992, MICROB PATHOGENESIS, V13, P261, DOI 10.1016/0882-4010(92)90036-N; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1555, DOI 10.1128/CVI.00177-08; Mollerach M, 2004, EPIDEMIOL INFECT, V132, P177, DOI 10.1017/S0950268803001626; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; MUSHER DM, 2000, STREPTOCOCCUS PNEUMO, P485; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Niki Y., 2008, Journal of Infection and Chemotherapy, V14, P279, DOI 10.1007/s10156-008-0623-2; Niki Y, 2009, J INFECT CHEMOTHER, V15, P156, DOI 10.1007/s10156-009-0674-z; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; Pimenta FC, 2006, J CLIN MICROBIOL, V44, P2838, DOI 10.1128/JCM.00156-06; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Razzaque R, 2012, INFECT IMMUN UNPUB; Ren B, 2012, CLIN VACCINE IMMUNOL, V19, P1574, DOI 10.1128/CVI.00393-12; Robinson DA, 1999, J INFECT DIS, V179, P414, DOI 10.1086/314589; Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; Sadowy E, 2006, CLIN VACCINE IMMUNOL, V13, P139, DOI 10.1128/CVI.13.1.139-144.2006; Shouval DS, 2009, PEDIATR INFECT DIS J, V28, P277, DOI 10.1097/INF.0b013e31818e0e2e; Tart RC, 1996, J INFECT DIS, V173, P380, DOI 10.1093/infdis/173.2.380; Weinstein MP, 2009, CLIN INFECT DIS, V48, P1596, DOI 10.1086/598975; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Yamanaka Noboru, 2008, Journal of Infection and Chemotherapy, V14, P180, DOI 10.1007/s10156-007-0599-3	59	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58124	10.1371/journal.pone.0058124	http://dx.doi.org/10.1371/journal.pone.0058124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483982	Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100079
J	Larsen, P; Gilbert, J				Larsen, Peter; Gilbert, Jack			Microbial Bebop: Creating Music from Complex Dynamics in Microbial Ecology	PLOS ONE			English	Article								In order for society to make effective policy decisions on complex and far-reaching subjects, such as appropriate responses to global climate change, scientists must effectively communicate complex results to the non-scientifically specialized public. However, there are few ways however to transform highly complicated scientific data into formats that are engaging to the general community. Taking inspiration from patterns observed in nature and from some of the principles of jazz bebop improvisation, we have generated Microbial Bebop, a method by which microbial environmental data are transformed into music. Microbial Bebop uses meter, pitch, duration, and harmony to highlight the relationships between multiple data types in complex biological datasets. We use a comprehensive microbial ecology, time course dataset collected at the L4 marine monitoring station in the Western English Channel as an example of microbial ecological data that can be transformed into music. Four compositions were generated (www.bio.anl.gov/MicrobialBebop.htm.) from L4 Station data using Microbial Bebop. Each composition, though deriving from the same dataset, is created to highlight different relationships between environmental conditions and microbial community structure. The approach presented here can be applied to a wide variety of complex biological datasets.	[Larsen, Peter; Gilbert, Jack] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Gilbert, Jack] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Larsen, P (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	plarsen@anl.gov	Gilbert, Jack/AAF-3270-2019		United States Department of Energy [DE-AC02-06CH11357]; U.S. Department of Energy Office of Science laboratory [DE-AC02-06CH11357]	United States Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy Office of Science laboratory(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The submitted manuscript has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne''). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The U.S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.	Engel A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00083; Gilbert J.A., 2011, ISME J; Keller B, 2011, IMPROVISOR V4 12; Khatib F, 2011, NATURE STRUCTURAL MO; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; National Science Board, 2012, SCI ENG IND 2012; OHNO S, 1986, CHEM SCRIPTA, V26B, P43; Szwed John, 2000, JAZZ 101 COMPLETE GU; Takahashi R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-405; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60	10	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58119	10.1371/journal.pone.0058119	http://dx.doi.org/10.1371/journal.pone.0058119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483981	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100078
J	Votier, SC; Bicknell, A; Cox, SL; Scales, KL; Patrick, SC				Votier, Stephen C.; Bicknell, Anthony; Cox, Samantha L.; Scales, Kylie L.; Patrick, Samantha C.			A Bird's Eye View of Discard Reforms: Bird-Borne Cameras Reveal Seabird/Fishery Interactions	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; COMMERCIAL FISHERIES; FORAGING BEHAVIOR; FINE-SCALE; SEABIRDS; PREDATION; FOOD; AVAILABILITY; RESPONSES; DYNAMICS	Commercial capture fisheries produce huge quantities of offal, as well as undersized and unwanted catch in the form of discards. Declines in global catches and legislation to ban discarding will significantly reduce discards, but this subsidy supports a large scavenger community. Understanding the potential impact of declining discards for scavengers should feature in an eco-system based approach to fisheries management, but requires greater knowledge of scavenger/fishery interactions. Here we use bird-borne cameras, in tandem with GPS loggers, to provide a unique view of seabird/fishery interactions. 20,643 digital images (one min 21) from ten bird-borne cameras deployed on central place northern gannets Morus bassanus revealed that all birds photographed fishing vessels. These were large (>15 m) boats, with no small-scale vessels. Virtually all vessels were trawlers, and gannets were almost always accompanied by other scavenging birds. All individuals exhibited an Area-Restricted Search (ARS) during foraging, but only 42% of ARS were associated with fishing vessels, indicating much 'natural' foraging. The proportion of ARS behaviours associated with fishing boats were higher for males (81%) than females (30%), although the reasons for this are currently unclear. Our study illustrates that fisheries form a very important component of the prey-landscape for foraging gannets and that a discard ban, such as that proposed under reforms of the EU Common Fisheries Policy, may have a significant impact on gannet behaviour, particularly males. However, a continued reliance on 'natural' foraging suggests the ability to switch away from scavenging, but only if there is sufficient food to meet their needs in the absence of a discard subsidy.	[Votier, Stephen C.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Votier, Stephen C.; Bicknell, Anthony; Cox, Samantha L.; Patrick, Samantha C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Scales, Kylie L.] Plymouth Marine Lab, Plymouth, Devon, England; [Patrick, Samantha C.] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	University of Exeter; University of Plymouth; Plymouth Marine Laboratory; Centre National de la Recherche Scientifique (CNRS)	Votier, SC (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	stephen.votier@plymouth.ac.uk	Cox, S L/ABD-5059-2021; Scales, Kylie/L-9318-2018; Bicknell, Anthony/G-6809-2016; Votier, Stephen C/G-2348-2014; Cox, S L/AEX-9613-2022	Cox, S L/0000-0002-5409-4458; Scales, Kylie/0000-0003-0843-0956; Bicknell, Anthony/0000-0002-2817-2010; Votier, Stephen C/0000-0002-0976-0167; Cox, S L/0000-0002-5409-4458	EU INTERREG project CHARM-III; Natural Environment Research Council [NE/G001014/1, NE/H007466/1]; Association for the Study of Animal Behaviour; Natural Environment Research Council [pml010005, 1066095, NE/H007199/1] Funding Source: researchfish; NERC [pml010005, NE/G001014/1, NE/H007199/1, NE/H007466/1] Funding Source: UKRI	EU INTERREG project CHARM-III; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Association for the Study of Animal Behaviour; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by EU INTERREG project CHARM-III, Natural Environment Research Council (NE/G001014/1 & NE/H007466/1) and an Association for the Study of Animal Behaviour research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2011, ECOLOGY, V92, P1948, DOI 10.1890/11-0181.1; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; [Anonymous], 2007, SEC2007380 COMM EUR; [Anonymous], 2005, DISCARDS WORLDS MARI; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Bearhop S, 2001, CONDOR, V103, P802, DOI 10.1650/0010-5422(2001)103[0802:AVIGSD]2.0.CO;2; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Enever R, 2007, FISH RES, V86, P143, DOI 10.1016/j.fishres.2007.05.013; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Garthe S, 2011, LIMNOL OCEANOGR, V56, P802, DOI 10.4319/lo.2011.56.3.0802; Granadeiro JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017467; Gremillet D, 2010, FRONT ECOL ENVIRON, V8, P401, DOI 10.1890/10.WB.020; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; HUDSON AV, 1989, IBIS, V131, P225, DOI 10.1111/j.1474-919X.1989.tb02765.x; Huppop O, 2000, MAR ECOL PROG SER, V194, P241, DOI 10.3354/meps194241; Jackson AL, 2008, BIOL LETTERS, V4, P311, DOI 10.1098/rsbl.2008.0038; Montevecchi WA, 2007, MAR ECOL PROG SER, V352, P213, DOI 10.3354/meps07075; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Oro D, 1996, MAR ECOL PROG SER, V132, P43, DOI 10.3354/meps132043; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; R Development Core Team, 2012, R LANG ENV STAT COMP; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2008, MAR ECOL PROG SER, V367, P223, DOI 10.3354/meps07621; Votier SC, 2008, IBIS, V150, P45, DOI 10.1111/j.1474-919X.2008.00804.x; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x	33	86	90	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57376	10.1371/journal.pone.0057376	http://dx.doi.org/10.1371/journal.pone.0057376			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483906	Green Published, Green Accepted, gold			2022-12-25	WOS:000316936100023
J	Azevedo, AS; Goncalves, AJS; Archer, M; Freire, MS; Galler, R; Alves, AMB				Azevedo, Adriana S.; Goncalves, Antonio J. S.; Archer, Marcia; Freire, Marcos S.; Galler, Ricardo; Alves, Ada M. B.			The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against Dengue	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIBODY-RESPONSES; NEUTRALIZING ANTIBODY; ENVELOPE GLYCOPROTEIN; JAPANESE ENCEPHALITIS; PROTEIN VACCINES; IMMUNE-RESPONSE; SUBUNIT VACCINE; TYPE-2 VIRUS; NS1 GENE	The dengue envelope glycoprotein (E) is the major component of virion surface and its ectodomain is composed of domains I, II and III. This protein is the main target for the development of a dengue vaccine with induction of neutralizing antibodies. In the present work, we tested two different vaccination strategies, with combined immunizations in a prime/booster regimen or simultaneous inoculation with a DNA vaccine (pE1D2) and a chimeric yellow fever/dengue 2 virus (YF17D-D2). The pE1D2 DNA vaccine encodes the ectodomain of the envelope DENV2 protein fused to t-PA signal peptide, while the YF17D-D2 was constructed by replacing the prM and E genes from the 17D yellow fever vaccine virus by those from DENV2. Balb/c mice were inoculated with these two vaccines by different prime/booster or simultaneous immunization protocols and most of them induced a synergistic effect on the elicited immune response, mainly in neutralizing antibody production. Furthermore, combined immunization remarkably increased protection against a lethal dose of DENV2, when compared to each vaccine administered alone. Results also revealed that immunization with the DNA vaccine, regardless of the combination with the chimeric virus, induced a robust cell immune response, with production of IFN-c by CD8+ T lymphocytes.	[Azevedo, Adriana S.; Goncalves, Antonio J. S.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil; [Archer, Marcia; Freire, Marcos S.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Alves, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.	ada@ioc.fiocruz.br	Galler, Ricardo/B-3280-2014	Souza Azevedo, Adriana/0000-0001-7401-5107	Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Apoio a Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ; Instituto Nacional de Ciencia e Tecnologia de Vacinas(INCTV)/CNPq	Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ; Instituto Nacional de Ciencia e Tecnologia de Vacinas(INCTV)/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz (FIOCRUZ), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa de Apoio a Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ and Instituto Nacional de Ciencia e Tecnologia de Vacinas(INCTV)/CNPq grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155; Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528; Biswas S, 2001, HUM GENE THER, V12, P1917, DOI 10.1089/104303401753153965; Boyle JS, 1997, INT IMMUNOL, V9, P1897, DOI 10.1093/intimm/9.12.1897; Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8; Chen L, 2007, J VIROL, V81, P11634, DOI 10.1128/JVI.00996-07; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Galler R, 2005, BRAZ J MED BIOL RES, V38, P1835, DOI 10.1590/S0100-879X2005001200012; George Junu A, 2011, Immune Netw, V11, P268, DOI 10.4110/in.2011.11.5.268; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001; Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Haglund K, 2002, J VIROL, V76, P7506, DOI 10.1128/JVI.76.15.7506-7517.2002; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Imoto J, 2007, VACCINE, V25, P1076, DOI 10.1016/j.vaccine.2006.09.059; Inchauspe G, 1997, DNA CELL BIOL, V16, P185, DOI 10.1089/dna.1997.16.185; Julander Justin G., 2011, Antiviral Chemistry & Chemotherapy, V21, P105, DOI 10.3851/IMP1690; Khanam S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-10; Konishi E, 2006, VACCINE, V24, P2200, DOI 10.1016/j.vaccine.2005.11.002; Konishi E, 2003, VACCINE, V21, P1826, DOI 10.1016/S0264-410X(03)00028-8; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Monath T. P., 1997, CLIN VIROLOGY, P1133; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Porter KR, 1998, ARCH VIROL, V143, P997, DOI 10.1007/s007050050348; Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Simmons M, 2001, AM J TROP MED HYG, V65, P420, DOI 10.4269/ajtmh.2001.65.420; Simmons M, 2006, J VIROL, V80, P9577, DOI 10.1128/JVI.00284-06; Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Valdes I, 2009, VIROLOGY, V394, P249, DOI 10.1016/j.virol.2009.08.029; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Wang Z, 2009, CHINESE MED J-PEKING, V122, P2339, DOI 10.3760/cma.j.issn.0366-6999.2009.19.028; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974	57	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58357	10.1371/journal.pone.0058357	http://dx.doi.org/10.1371/journal.pone.0058357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472186	gold, Green Published, Green Submitted			2022-12-25	WOS:000315637900132
J	Edwards, CB; Copes, N; Brito, AG; Canfield, J; Bradshaw, PC				Edwards, Clare B.; Copes, Neil; Brito, Andres G.; Canfield, John; Bradshaw, Patrick C.			Malate and Fumarate Extend Lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							DIETARY RESTRICTION; C. ELEGANS; MITOCHONDRIAL RESPIRATION; CALORIC RESTRICTION; ENERGY-METABOLISM; OXIDATIVE STRESS; SKELETAL-MUSCLE; LONGEVITY; PROTEIN; LONG	Malate, the tricarboxylic acid (TCA) cycle metabolite, increased lifespan and thermotolerance in the nematode C. elegans. Malate can be synthesized from fumarate by the enzyme fumarase and further oxidized to oxaloacetate by malate dehydrogenase with the accompanying reduction of NAD. Addition of fumarate also extended lifespan, but succinate addition did not, although all three intermediates activated nuclear translocation of the cytoprotective DAF-16/FOXO transcription factor and protected from paraquat-induced oxidative stress. The glyoxylate shunt, an anabolic pathway linked to lifespan extension in C. elegans, reversibly converts isocitrate and acetyl-CoA to succinate, malate, and CoA. The increased longevity provided by malate addition did not occur in fumarase (fum-1), glyoxylate shunt (gei-7), succinate dehydrogenase flavoprotein (sdha-2), or soluble fumarate reductase F48E8.3 RNAi knockdown worms. Therefore, to increase lifespan, malate must be first converted to fumarate, then fumarate must be reduced to succinate by soluble fumarate reductase and the mitochondrial electron transport chain complex II. Reduction of fumarate to succinate is coupled with the oxidation of FADH(2) to FAD. Lifespan extension induced by malate depended upon the longevity regulators DAF-16 and SIR-2.1. Malate supplementation did not extend the lifespan of long-lived eat-2 mutant worms, a model of dietary restriction. Malate and fumarate addition increased oxygen consumption, but decreased ATP levels and mitochondrial membrane potential suggesting a mild uncoupling of oxidative phosphorylation. Malate also increased NADPH, NAD, and the NAD/NADH ratio. Fumarate reduction, glyoxylate shunt activity, and mild mitochondrial uncoupling likely contribute to the lifespan extension induced by malate and fumarate by increasing the amount of oxidized NAD and FAD cofactors.	[Edwards, Clare B.; Copes, Neil; Brito, Andres G.; Canfield, John; Bradshaw, Patrick C.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Bradshaw, PC (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	pbradsha@cas.usf.edu	Bradshaw, Patrick C./AAR-9189-2020	Bradshaw, Patrick C./0000-0002-4591-6798	University of South Florida; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	University of South Florida; NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by start-up funds to the PI from the University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Meera Nanjundan for helpful advice. We would also like to thank Gabriel Pizzano and Lindsay Cash for help in the preparation of the lifespan assays and Joseph Lofti for help with the respiration experiments. The sir-2.1(ok434) C. elegans strain was obtained from Dr. Sandy Westerheide. All other nematode strains were provided by the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN, USA), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; BEYER RE, 1984, MECH AGEING DEV, V24, P309, DOI 10.1016/0047-6374(84)90116-7; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Braeckman B.P., 2009, INTERMEDIARY METABOL, V1-24, DOI DOI 10.1895/WORMBOOK.1.146.1; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Camarasa C, 2007, YEAST, V24, P391, DOI 10.1002/yea.1467; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; Chuang MH, 2009, BIOORGAN MED CHEM, V17, P7831, DOI 10.1016/j.bmc.2009.09.002; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P132, DOI 10.1159/000089642; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; de Jong L, 2004, GENETICS, V168, P845, DOI 10.1534/genetics.104.028605; Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807; Fei YJ, 2003, J BIOL CHEM, V278, P6136, DOI 10.1074/jbc.M208763200; Fitzgerald VK, 2009, BIOTECHNIQUES, V47, pIX, DOI 10.2144/000113277; Gallo M, 2011, MECH AGEING DEV, V132, P515, DOI 10.1016/j.mad.2011.08.004; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Gonzalez-Cabo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008872; GOODRICK CL, 1980, GERONTOLOGY, V26, P22, DOI 10.1159/000212390; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Harman D, 2009, BIOGERONTOLOGY, V10, P773, DOI 10.1007/s10522-009-9234-2; Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3; Hempenstall S, 2012, MECH AGEING DEV, V133, P37, DOI 10.1016/j.mad.2011.12.002; Hipkiss AR, 2010, EXP GERONTOL, V45, P395, DOI 10.1016/j.exger.2010.03.006; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Holt SJ, 2003, MECH AGEING DEV, V124, P779, DOI 10.1016/S0047-6374(03)00132-5; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kamei Y, 2011, BIOCHEM BIOPH RES CO, V407, P185, DOI 10.1016/j.bbrc.2011.02.136; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887; Kirkwood TBL, 2012, BIOESSAYS, V34, P692, DOI 10.1002/bies.201200014; Knauf F, 2006, BIOCHEM J, V397, P25, DOI 10.1042/BJ20060409; LECLERC J, 1981, ANN NUTR METAB, V25, P20, DOI 10.1159/000176475; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Leiser SF, 2011, AGING CELL, V10, P318, DOI 10.1111/j.1474-9726.2011.00672.x; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Link CD, 2002, METHOD ENZYMOL, V353, P497; LIU FZ, 1995, DEV BIOL, V169, P399, DOI 10.1006/dbio.1995.1156; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Perron JT, 2000, NEUROSCI LETT, V281, P91, DOI 10.1016/S0304-3940(00)00825-9; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Regev-Rudzki N, 2009, MOL MICROBIOL, V72, P297, DOI 10.1111/j.1365-2958.2009.06659.x; Ruzanov P, 2007, EXP GERONTOL, V42, P825, DOI 10.1016/j.exger.2007.04.002; Salminen A, 2010, AGEING RES REV, V9, P211, DOI 10.1016/j.arr.2010.04.003; Schaffer S, 2011, BIOGERONTOLOGY, V12, P195, DOI 10.1007/s10522-010-9310-7; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shoyama T, 2009, EXP GERONTOL, V44, P784, DOI 10.1016/j.exger.2009.09.006; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Stiernagle Theresa, 2006, WormBook, P1; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Tahara EB, 2011, J BIOENERG BIOMEMBR, V43, P483, DOI 10.1007/s10863-011-9377-0; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Tomitsuka E, 2010, ANN NY ACAD SCI, V1201, P44, DOI 10.1111/j.1749-6632.2010.05620.x; Wang JQ, 2010, EXP GERONTOL, V45, P621, DOI 10.1016/j.exger.2010.02.008; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Williams DS, 2009, AGING CELL, V8, P765, DOI 10.1111/j.1474-9726.2009.00527.x; Wu JL, 2008, PHYSIOL RES, V57, P261, DOI 10.33549/physiolres.931161; Wu JL, 2007, PHYSIOL RES, V56, P213, DOI 10.33549/physiolres.930937; Wu JL, 2011, PHYSIOL RES, V60, P329, DOI 10.33549/physiolres.931986; Yuan Y, 2012, J BIOL CHEM; Yuan YY, 2012, J BIOL CHEM, V287, P31414, DOI 10.1074/jbc.M112.377275; Zarse K, 2007, FASEB J, V21, P1271, DOI 10.1096/fj.06-6994com; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang MH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000245	82	56	59	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58345	10.1371/journal.pone.0058345	http://dx.doi.org/10.1371/journal.pone.0058345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472183	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900129
J	Oh, ET; Park, MT; Song, MJ; Lee, H; Cho, YU; Kim, SJ; Chu, YC; Choi, EK; Park, HJ				Oh, E-T; Park, M-T; Song, M-J; Lee, H.; Cho, Y. U.; Kim, S. J.; Chu, Y-C; Choi, E. K.; Park, H. J.			Radiation-induced angiogenic signaling pathway in endothelial cells obtained from normal and cancer tissue of human breast	ONCOGENE			English	Article						angiogenesis; cancer endothelial cells; ionizing radiation	MATRIX METALLOPROTEINASE-2 EXPRESSION; IONIZING-RADIATION; TUMOR-GROWTH; IN-VITRO; INTERLEUKIN-6 EXPRESSION; GENE-EXPRESSION; C-JUN; ANGIOSTATIN; RADIOSENSITIVITY; INHIBITOR	Despite strong possibility that endothelial cells (ECs) of tumors and normal tissues may differ in various aspects, most previous studies on ECs have used normal cells. Here, we purified ECs from tumorous and normal human breast tissues, and studied the effect of radiation on angiogenesis and relevant molecular mechanisms in these cells. We found that in normal tissue-derived ECs (NECs), 4 Gy irradiation increased tube formation, matrix metalloproteinase 2 (MMP-2) expression and extracellular signal-regulated kinase (ERK) pathway activation. In cancer-derived ECs (CECs), however, 4Gy irradiation significantly reduced tube formation, increased the production of angiostatin and interleukin-6 (IL-6), and upregulated AKT and c-Jun N-terminal kinase (JNK) pathway activation. Knockdown experiments showed that siMMP-2 efficiently inhibited tube formation by irradiated NECs, whereas siPlasminogen effectively attenuated the radiation-induced suppression of tube formation and the upregulation of angiostatin in CECs. Moreover, silL-6 clearly inhibited the radiation-induced generation of angiostatin in CECs. Inhibition of ERK with a pharmacological inhibitor or small interfering RNAs (siRNAs) markedly suppressed the radiation-induced tube formation and MMP-2 upregulation in NECs, whereas the inhibition of either AKT or JNK with pharmacological inhibitor or siRNA treatment of CECs markedly attenuated the inhibition of tube formation and the upregulation of angiostatin and IL-6 caused by 4 Gy irradiation. These observations collectively demonstrate that there are distinct differences in the radiation responses of NECs and CECs, and might provide important clues for improving the efficacy of radiation therapy.	[Oh, E-T; Park, M-T; Song, M-J; Lee, H.; Park, H. J.] Inha Univ, Coll Med, Dept Microbiol, Ctr Adv Med Educ,Project BK21, Inchon 400712, South Korea; [Cho, Y. U.; Kim, S. J.] Inha Univ, Coll Med, Dept Surg, Inchon 400712, South Korea; [Chu, Y-C] Inha Univ, Coll Med, Dept Pathol, Inchon 400712, South Korea; [Choi, E. K.] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea	Inha University; Inha University; Inha University; University of Ulsan; Asan Medical Center	Park, HJ (corresponding author), Inha Univ, Coll Med, Dept Microbiol, Jungsuck B-D B Dong 3F,7-241,3rd St, Inchon 400712, South Korea.	park001@inha.ac.kr			National Nuclear R&D Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0015230, 2009-0093747]; Korean Health Technology R&D Project, Ministry of Health and Welfare [A062254]	National Nuclear R&D Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology R&D Project, Ministry of Health and Welfare	This research was supported by the National Nuclear R&D Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0015230 and 2009-0093747), and by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare (A062254).	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Ahmad M, 2007, MICROVASC RES, V73, P14, DOI 10.1016/j.mvr.2006.08.005; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Bannach FG, 2004, J THROMB HAEMOST, V2, P2205, DOI 10.1111/j.1538-7836.2004.01022.x; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Brown M, 2003, SCIENCE, V302; Burwick NR, 2005, J BIOL CHEM, V280, P1740, DOI 10.1074/jbc.M405947200; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chen FH, 2011, INT J RADIAT ONCOL, V80, P1512, DOI 10.1016/j.ijrobp.2011.02.055; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Djonov V, 2002, INT J ONCOL, V21, P25; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fee D, 2000, CYTOKINE, V12, P655, DOI 10.1006/cyto.1999.0599; Fokas E, 2012, CANCER METAST REV, V31, P823, DOI 10.1007/s10555-012-9394-4; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gerweck LE, 2006, CANCER RES, V66, P8352, DOI 10.1158/0008-5472.CAN-06-0533; Gorski DH, 1998, CANCER RES, V58, P5686; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haimovitz-Fredman A., 1995, RADIAT ONCOL INVEST, V3, P1; Hatzi E, 2002, ONCOGENE, V21, P3552, DOI 10.1038/sj.onc.1205440; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hida K, 2008, CANCER SCI, V99, P459, DOI 10.1111/j.1349-7006.2007.00704.x; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Karar J, 2009, CANCER BIOL THER, V8, P1994, DOI 10.4161/cbt.8.21.9988; Kim KH, 2011, IMMUNE NETW, V11, P123, DOI DOI 10.4110/IN.2011.11.2.123; Konerding MA, 2001, BRIT J CANCER, V84, P1354, DOI 10.1054/bjoc.2001.1809; Lin HY, 2011, J CELL PHYSIOL, V226, P1573, DOI 10.1002/jcp.22489; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Milliat F, 2006, AM J PATHOL, V169, P1484, DOI 10.2353/ajpath.2006.060116; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nguyen V, 2000, RADIAT RES, V154, P531, DOI 10.1667/0033-7587(2000)154[0531:LEOIRO]2.0.CO;2; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pang XF, 2009, CANCER RES, V69, P5893, DOI 10.1158/0008-5472.CAN-09-0755; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Park HJ, 2003, RADIAT RES, V159, P86, DOI 10.1667/0033-7587(2003)159[0086:IOEPOG]2.0.CO;2; Park MT, 2012, J RADIAT RES, V53, P570, DOI 10.1093/jrr/rrs011; Park MT, 2012, MICROVASC RES, V84, P140, DOI 10.1016/j.mvr.2012.06.002; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158; Soff GA, 2000, CANCER METAST REV, V19, P97, DOI 10.1023/A:1026525121027; Song CW, 1971, CANCER RES, V4, P31; St Croix B, 2000, SCIENCE, V289, P1197; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sweeney NV, 2004, CARDIOVASC RES, V63, P625, DOI 10.1016/j.cardiores.2004.05.008; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; VanderMeeren A, 1997, MEDIAT INFLAMM, V6, P185, DOI 10.1080/09629359791677; Verhoeff JJC, 2009, EUR J CANCER, V45, P3074, DOI 10.1016/j.ejca.2009.08.004; Vincenti S, 2007, MICROVASC RES, V73, P14; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vorotnikova E, 2004, RADIAT RES, V161, P174, DOI 10.1667/RR3107; Wei JW, 2007, ANTICANCER RES, V27, P1415; Wu WT, 2005, ENDOCRINOLOGY, V146, P3387, DOI 10.1210/en.2004-1654; Zhao WL, 2004, RADIAT RES, V161, P418, DOI 10.1667/3155	61	25	26	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1229	1238		10.1038/onc.2013.70	http://dx.doi.org/10.1038/onc.2013.70			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23503466				2022-12-25	WOS:000332631100003
J	Lewis, WG; Robinson, LS; Gilbert, NM; Perry, JC; Lewis, AL				Lewis, Warren G.; Robinson, Lloyd S.; Gilbert, Nicole M.; Perry, Justin C.; Lewis, Amanda L.			Degradation, Foraging, and Depletion of Mucus Sialoglycans by the Vagina-adapted Actinobacterium Gardnerella vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; SIALIC-ACID TRANSPORT; LOW-BIRTH-WEIGHT; DIAGNOSING BACTERIAL VAGINOSIS; INFLAMMATORY-BOWEL-DISEASE; PRETERM DELIVERY; VIBRIO-CHOLERAE; PREGNANT-WOMEN; O-ACETYLATION; HAEMOPHILUS-INFLUENZAE	Bacterial vaginosis (BV) is a polymicrobial imbalance of the vaginal microbiota associated with reproductive infections, preterm birth, and other adverse health outcomes. Sialidase activity in vaginal fluids is diagnostic of BV and sialic acid-rich components of mucus have protective and immunological roles. However, whereas mucus degradation is believed to be important in the etiology and complications associated with BV, the role(s) of sialidases and the participation of individual bacterial species in the degradation of mucus barriers in BV have not been investigated. Here we demonstrate that the BV-associated bacterium Gardnerella vaginalis uses sialidase to break down and deplete sialic acid-containing mucus components in the vagina. Biochemical evidence using purified sialoglycan substrates supports a model in which 1) G. vaginalis extracellular sialidase hydrolyzes mucosal sialoglycans, 2) liberated sialic acid (N-acetylneuraminic acid) is transported into the bacterium, a process inhibited by excess N-glycolylneuraminic acid, and 3) sialic acid catabolism is initiated by an intracellular aldolase/lyase mechanism. G. vaginalis engaged in sialoglycan foraging in vitro, in the presence of human vaginal mucus, and in vivo, in a murine vaginal model, in each case leading to depletion of sialic acids. Comparison of sialic acid levels in human vaginal specimens also demonstrated significant depletion of mucus sialic acids in women with BV compared with women with a "normal" lactobacilli-dominated microbiota. Taken together, these studies show that G. vaginalis utilizes sialidase to support the degradation, foraging, and depletion of protective host mucus barriers, and that this process of mucus barrier degradation and depletion also occurs in the clinical setting of BV.	[Lewis, Warren G.] Washington Univ, Sch Med, Dept Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Robinson, Lloyd S.; Gilbert, Nicole M.; Perry, Justin C.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	allewis@wustl.edu	Lewis, Warren G/W-4369-2019	Lewis, Warren G/0000-0003-1210-6403; Gilbert, Nicole/0000-0003-4830-3257; Lewis, Amanda/0000-0001-6195-3030	National Institutes of Health [P50DK064540-11]; March of Dimes; Barnes-Jewish Hospital Foundation; American Heart Association; NCRR Grant [C06RR012466]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Barnes-Jewish Hospital Foundation; American Heart Association(American Heart Association); NCRR Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant P50DK064540-11, a Basil O' Connor award from the March of Dimes (to A. L. L.), a Translational Research Pilot Grant funded by the Barnes-Jewish Hospital Foundation (to A. L. L. and W. G. L.), and a postdoctoral fellowship from the American Heart Association (to N. M. G.).; We thank Jeffrey Peipert and Jennifer Allsworth for contributions of Contraceptive CHOICE project clinical specimens and confirmatory data. We also gratefully acknowledge Gina Secura and the CHOICE team of nurses and for logistical support in the collection of fresh vaginal specimens subsequently used for anaerobic culture and G. vaginalis isolation. We also thank Jenifer Bick for technical assistance and transport of fresh vaginal specimens from clinic to laboratory. We are grateful to Christy Marrs for helpful suggestions for G. vaginalis freezing media. The animal work described in this article was performed in a facility supported by NCRR Grant C06RR012466.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Bradshaw CS, 2005, J CLIN MICROBIOL, V43, P1304, DOI 10.1128/JCM.43.3.1304-1308.2005; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; BRISELDEN AM, 1990, J CLIN MICROBIOL, V28, P2761, DOI 10.1128/JCM.28.12.2761-2764.1990; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Byers HL, 1999, J MED MICROBIOL, V48, P375, DOI 10.1099/00222615-48-4-375; Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469; Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Chowdhury Suchandra, 2009, Biotechnology Journal, V4, P361, DOI 10.1002/biot.200800253; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Donders GGG, 2000, AM J OBSTET GYNECOL, V182, P872, DOI 10.1016/S0002-9378(00)70338-3; ESCHENBACH DA, 1988, AM J OBSTET GYNECOL, V158, P819, DOI 10.1016/0002-9378(88)90078-6; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2011, ANAEROBE, V17, P191, DOI 10.1016/j.anaerobe.2011.01.001; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; GARDNER HL, 1954, SCIENCE, V120, P853, DOI 10.1126/science.120.3125.853; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hendler I, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.073; Trinh HT, 2011, PLANTA MED, V77, P1996, DOI 10.1055/s-0031-1280094; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hitti J, 2001, OBSTET GYNECOL, V97, P211, DOI 10.1016/S0029-7844(00)01146-7; HOLST E, 1994, J CLIN MICROBIOL, V32, P176, DOI 10.1128/JCM.32.1.176-186.1994; Homer KA, 1996, MICROBIOL-UK, V142, P1221, DOI 10.1099/13500872-142-5-1221; HOSKINS LC, 1981, J CLIN INVEST, V67, P163, DOI 10.1172/JCI110009; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; Jenkins GA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-48; Joo HM, 2011, INT IMMUNOPHARMACOL, V11, P1758, DOI 10.1016/j.intimp.2011.07.002; KROHN MA, 1989, J CLIN MICROBIOL, V27, P1266, DOI 10.1128/JCM.27.6.1266-1271.1989; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Lewis AL, 2011, APPL ENVIRON MICROB, V77, P5782, DOI 10.1128/AEM.00712-11; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Lubin JB, 2012, APPL ENVIRON MICROB, V78, P3407, DOI 10.1128/AEM.07395-11; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Marrs CN, 2012, MICROBES INFECT, V14, P500, DOI 10.1016/j.micinf.2011.12.009; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Mulligan C, 2012, J BIOL CHEM, V287, P3598, DOI 10.1074/jbc.M111.281030; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Myziuk L, 2003, J CLIN MICROBIOL, V41, P1925, DOI 10.1128/JCM.41.5.1925-1928.2003; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Pezzicoli A, 2012, J INFECT DIS, V206, P924, DOI 10.1093/infdis/jis451; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Rafay AM, 1996, J MED MICROBIOL, V44, P409, DOI 10.1099/00222615-44-6-409; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Roy S, 2011, MICROBIOL-SGM, V157, P3195, DOI 10.1099/mic.0.052498-0; Roy S, 2010, J BACTERIOL, V192, P2285, DOI 10.1128/JB.00079-10; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; SILVER HM, 1989, AM J OBSTET GYNECOL, V161, P808, DOI 10.1016/0002-9378(89)90406-7; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Slomiany BL, 1996, GEN PHARMACOL, V27, P761, DOI 10.1016/0306-3623(95)02050-0; Smayevsky J, 2001, Infect Dis Obstet Gynecol, V9, P17, DOI 10.1155/S1064744901000047; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Sumeksri Permsak, 2005, J Med Assoc Thai, V88 Suppl 3, pS7; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Thomas GH, 2011, MICROBIOL-SGM, V157, P3253, DOI 10.1099/mic.0.054692-0; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; VONNICOLAI H, 1984, ZBL BAKT-INT J MED M, V258, P20, DOI 10.1016/S0176-6724(84)80003-6; WATTS DH, 1990, OBSTET GYNECOL, V75, P52; Weiman S, 2009, GLYCOBIOLOGY, V19, P1204, DOI 10.1093/glycob/cwp111; Wiggins R, 2000, J CLIN MICROBIOL, V38, P3096, DOI 10.1128/JCM.38.8.3096-3097.2000; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yoo EM, 2005, CLIN IMMUNOL, V116, P3, DOI 10.1016/j.clim.2005.03.010; Zhang Xin, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P588	93	82	91	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12067	12079		10.1074/jbc.M113.453654	http://dx.doi.org/10.1074/jbc.M113.453654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479734	hybrid, Green Published			2022-12-25	WOS:000318157600040
J	De Souza, CP; Hashmi, SB; Osmani, AH; Andrews, P; Ringelberg, CS; Dunlap, JC; Osmani, SA				De Souza, Colin P.; Hashmi, Shahr B.; Osmani, Aysha H.; Andrews, Peter; Ringelberg, Carol S.; Dunlap, Jay C.; Osmani, Stephen A.			Functional Analysis of the Aspergillus nidulans Kinome	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; SEPTATION INITIATION NETWORK; SPINDLE ASSEMBLY CHECKPOINT; PROTEIN-KINASE FAMILY; POLO-LIKE KINASE; FISSION YEAST; MESSENGER-RNA; CELL MORPHOGENESIS; SEXUAL DEVELOPMENT; NEUROSPORA-CRASSA	The filamentous fungi are an ecologically important group of organisms which also have important industrial applications but devastating effects as pathogens and agents of food spoilage. Protein kinases have been implicated in the regulation of virtually all biological processes but how they regulate filamentous fungal specific processes is not understood. The filamentous fungus Aspergillus nidulans has long been utilized as a powerful molecular genetic system and recent technical advances have made systematic approaches to study large gene sets possible. To enhance A. nidulans functional genomics we have created gene deletion constructs for 9851 genes representing 93.3% of the encoding genome. To illustrate the utility of these constructs, and advance the understanding of fungal kinases, we have systematically generated deletion strains for 128 A. nidulans kinases including expanded groups of 15 histidine kinases, 7 SRPK (serine-arginine protein kinases) kinases and an interesting group of 11 filamentous fungal specific kinases. We defined the terminal phenotype of 23 of the 25 essential kinases by heterokaryon rescue and identified phenotypes for 43 of the 103 non-essential kinases. Uncovered phenotypes ranged from almost no growth for a small number of essential kinases implicated in processes such as ribosomal biosynthesis, to conditional defects in response to cellular stresses. The data provide experimental evidence that previously uncharacterized kinases function in the septation initiation network, the cell wall integrity and the morphogenesis Orb6 kinase signaling pathways, as well as in pathways regulating vesicular trafficking, sexual development and secondary metabolism. Finally, we identify ChkC as a third effector kinase functioning in the cellular response to genotoxic stress. The identification of many previously unknown functions for kinases through the functional analysis of the A. nidulans kinome illustrates the utility of the A. nidulans gene deletion constructs.	[De Souza, Colin P.; Hashmi, Shahr B.; Osmani, Aysha H.; Osmani, Stephen A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Ringelberg, Carol S.; Dunlap, Jay C.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH USA; [Andrews, Peter] Geisel Sch Med Dartmouth, Inst Quantitat Biomed Sci, Hanover, NH USA	University System of Ohio; Ohio State University; Dartmouth College; Dartmouth College	De Souza, CP (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12Th Ave, Columbus, OH 43210 USA.	de-souza.1@osu.edu	Dunlap, Jay/L-6232-2013; Osmani, Stephen A./AAS-3904-2021	Dunlap, Jay/0000-0003-1577-0457; 	National Institutes of Health [P01 GM068087-08S1, GM042564, P01 GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042564, P01GM068087, R01GM083336, R01GM034985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (P01 GM068087-08S1 and GM042564) to SAO and (P01 GM068087) to JCD and SAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya P, 1998, GENE, V211, P323, DOI 10.1016/S0378-1119(98)00115-2; Apostolaki A, 2012, MOL MICROBIOL, V84, P530, DOI 10.1111/j.1365-2958.2012.08042.x; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Bachewich C, 2005, MOL MICROBIOL, V55, P572, DOI 10.1111/j.1365-2958.2004.04404.x; Bayram O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002816; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram O, 2009, MOL MICROBIOL, V71, P1278, DOI 10.1111/j.1365-2958.2009.06606.x; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Boyce KJ, 2011, TRENDS MICROBIOL, V19, P400, DOI 10.1016/j.tim.2011.04.006; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Bruno KS, 2001, MOL MICROBIOL, V42, P3, DOI 10.1046/j.1365-2958.2001.02605.x; Calcagno-Pizarelli AM, 2011, J CELL SCI, V124, P4064, DOI 10.1242/jcs.088344; CID VJ, 1995, MICROBIOL REV, V59, P345, DOI 10.1128/MMBR.59.3.345-386.1995; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; De Souza CP, 2011, EMBO J, V30, P2648, DOI 10.1038/emboj.2011.176; De Souza CPC, 2006, GENETICS, V174, P1881, DOI 10.1534/genetics.106.063438; De Souza CPC, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P63; De Souza CPC, 1999, MOL BIOL CELL, V10, P3661, DOI 10.1091/mbc.10.11.3661; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dementhon K, 2003, EUKARYOT CELL, V2, P238, DOI 10.1128/EC.2.2.238-246.2003; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Doering TL, 2011, PLOS PATHOG, V7; Dominguez-Kelly R, 2011, J CELL BIOL, V194, P567, DOI 10.1083/jcb.201101047; Dou XW, 2003, GENETICS, V165, P1105; Draghetti C, 2009, J BIOL CHEM, V284, P32053, DOI 10.1074/jbc.M109.009324; Dvash E, 2010, EUKARYOT CELL, V9, P502, DOI 10.1128/EC.00230-09; Efimov VP, 1998, GENETICS, V149, P101; Findon H, 2010, FUNGAL GENET BIOL, V47, P647, DOI 10.1016/j.fgb.2010.04.002; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Furukawa K, 2005, MOL MICROBIOL, V56, P1246, DOI 10.1111/j.1365-2958.2005.04605.x; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Goldman G. H., 2008, ASPERGILLI GENOMICS; Goldman GH, 2004, FUNGAL GENET BIOL, V41, P428, DOI 10.1016/j.fgb.2003.12.001; Goldman GH, 2002, FUNGAL GENET BIOL, V35, P183, DOI 10.1006/fgbi.2002.1344; Gorovits R, 2003, EUKARYOT CELL, V2, P699, DOI 10.1128/EC.2.4.699-707.2003; Gupta S, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-19; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P1003, DOI 10.1271/bbb.60665; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; HARRIS SD, 1994, GENETICS, V136, P517; Hofmann AF, 2000, GENETICS, V154, P1577; Holt CL, 1996, GENETICS, V142, P777; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; James SW, 1999, J CELL SCI, V112, P1313; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Jun SC, 2011, J MICROBIOL, V49, P418, DOI 10.1007/s12275-011-0193-3; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; KAFER E, 1965, GENETICS, V52, P217; Kim JM, 2006, GENETICS, V173, P685, DOI 10.1534/genetics.105.054304; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; LaRonde-LeBlanc N, 2005, BBA-PROTEINS PROTEOM, V1754, P14, DOI 10.1016/j.bbapap.2005.07.037; Lee KM, 2005, MOL BIOL CELL, V16, P2734, DOI 10.1091/mbc.E04-11-0982; Liu HL, 2010, EUKARYOT CELL, V9, P831, DOI 10.1128/EC.00032-10; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Malavazi I, 2008, GENETICS, V178, P675, DOI 10.1534/genetics.107.080879; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Martin Y, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-21; Martinez DA, 2012, MBIO, V3, DOI 10.1128/mBio.00259-12; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Mirouse V, 2006, DEVELOPMENT, V133, P4005, DOI 10.1242/dev.02565; Mogilevsky K, 2012, EUKARYOT CELL, V11, P194, DOI 10.1128/EC.05130-11; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; MORRIS NR, 1975, GENET RES, V26, P237, DOI 10.1017/S0016672300016049; Mulder HJ, 2009, EUKARYOT CELL, V8, P665, DOI 10.1128/EC.00131-08; Muthuvijayan Vignesh, 2004, In Silico Biology, V4, P605; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; OSMANI AH, 1994, J CELL SCI, V107, P1519; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Park G, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P50; Park JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006179; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Perez-Martin J, 2009, DNA REPAIR, V8, P720, DOI 10.1016/j.dnarep.2009.01.023; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Rethinaswamy A, 1998, J BIOL CHEM, V273, P5869, DOI 10.1074/jbc.273.10.5869; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Rubin-Bejerano I, 2004, MOL CELL BIOL, V24, P6967, DOI 10.1128/MCB.24.16.6967-6979.2004; Sawin KE, 2009, NATURE, V459, P782, DOI 10.1038/459782a; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schaller GE, 2011, CURR BIOL, V21, pR320, DOI 10.1016/j.cub.2011.02.045; Schwelnus W, 2001, EMBO REP, V2, P35, DOI 10.1093/embo-reports/kve009; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Sgarlata C, 2005, J CELL SCI, V118, P3607, DOI 10.1242/jcs.02499; Shi J, 2008, FUNGAL GENET BIOL, V45, P1570, DOI 10.1016/j.fgb.2008.08.011; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; Son S, 2009, EUKARYOT CELL, V8, P573, DOI 10.1128/EC.00346-08; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Suzuki A, 2008, BIOSCI BIOTECH BIOCH, V72, P428, DOI 10.1271/bbb.70543; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2010, P NATL ACAD SCI USA, V107, P11655, DOI 10.1073/pnas.1006430107; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wakabayashi M, 2008, DNA REPAIR, V7, P1951, DOI 10.1016/j.dnarep.2008.08.004; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Wei HJ, 2003, MOL MICROBIOL, V47, P1577, DOI 10.1046/j.1365-2958.2003.03405.x; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; Ye XS, 1998, MOL BIOL CELL, V9, P3019, DOI 10.1091/mbc.9.11.3019; Ye XS, 1997, EMBO J, V16, P182, DOI 10.1093/emboj/16.1.182; Ye XS, 1996, EMBO J, V15, P3599, DOI 10.1002/j.1460-2075.1996.tb00729.x; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; Ziv C, 2009, MOL MICROBIOL, V74, P974, DOI 10.1111/j.1365-2958.2009.06911.x	124	95	97	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58008	10.1371/journal.pone.0058008	http://dx.doi.org/10.1371/journal.pone.0058008			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505451	Green Submitted, gold, Green Published			2022-12-25	WOS:000318334500043
J	Herman, B; Gudrun, A; Potopalsky, AI; Chroboczek, J; Tcherniuk, SO				Herman, Bastien; Gudrun, Aldrian; Potopalsky, Anatoly I.; Chroboczek, Jadwiga; Tcherniuk, Sergey O.			Amitozyn Impairs Chromosome Segregation and Induces Apoptosis via Mitotic Checkpoint Activation	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; BENZOPHENANTHRIDINE ALKALOIDS; RETINOBLASTOMA PROTEIN; TUBULIN POLYMERIZATION; CHELIDONIUM-MAJUS; DRUG-RESISTANCE; MELANOMA-CELLS; DNA-DAMAGE; SANGUINARINE; PHOSPHORYLATION	Amitozyn (Am) is a semi-synthetic drug produced by the alkylation of major celandine (Chelidonium majus L.) alkaloids with the organophosphorous compound N,N'N'-triethylenethiophosphoramide (ThioTEPA). We show here that the treatment of living cells with Am reversibly perturbs the microtubule cytoskeleton, provoking a dose-dependent cell arrest in the M phase. Am changed the dynamics of tubulin polymerization in vitro, promoted the appearance of aberrant mitotic phenotypes in HeLa cells and induced apoptosis by the activation of caspase-9, caspase-3 and PARP, without inducing DNA breaks. Am treatment of HeLa cells induced changes in the phosphorylation of the growth suppressor pRb that coincided with maximum mitotic index. The dose-dependent and reversible anti-proliferative effect of Am was observed in several transformed cell lines. Importantly, the drug was also efficient against multidrug-resistant, paclitaxel-resistant or p53-deficient cells. Our results thus open the way to further pre-clinical evaluation of Am.	[Herman, Bastien; Chroboczek, Jadwiga; Tcherniuk, Sergey O.] CNRS, Inst Biol Struct, Grenoble, France; [Gudrun, Aldrian; Tcherniuk, Sergey O.] CNRS, Ctr Rech Biochim Macromol, Montpellier, France; [Potopalsky, Anatoly I.] Natl Acad Sci Ukraine NAN Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Chroboczek, Jadwiga] Polish Acad Sci PAN, Inst Biochem & Biophys, Warsaw, Poland; [Chroboczek, Jadwiga] Univ Grenoble 1, CNRS, Therapeut Recombinante Expt Tech Ingn Med & Compl, La Tronche, France; [Tcherniuk, Sergey O.] AYSU, Dept Biol Sci, Kiev, Ukraine	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Tcherniuk, SO (corresponding author), CNRS, Inst Biol Struct, Grenoble, France.	sergey.tcherniuk@crbm.cnrs.fr	Chroboczek, Jadwiga/M-6554-2014	Aldrian, Gudrun/0000-0002-7899-0572	CNRS (France); Gefluc Association (France); Academy of Young Scientists of Ukraine [4791/05]	CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Gefluc Association (France); Academy of Young Scientists of Ukraine	This study was in part supported by CNRS (France), by the Gefluc Association (France) and by the Academy of Young Scientists of Ukraine (Grant 4791/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINEV A M, 1963, Am J Proctol, V14, P25; Bai LP, 2006, BIOORGAN MED CHEM, V14, P5439, DOI 10.1016/j.bmc.2006.05.012; Caballero-George C, 2002, PLANTA MED, V68, P770, DOI 10.1055/s-2002-34406; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chadebech P, 1999, BIOCHEM BIOPH RES CO, V262, P823, DOI 10.1006/bbrc.1999.1291; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Colombo ML, 2001, FARMACO, V56, P403, DOI 10.1016/S0014-827X(01)01121-1; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Drsata J, 1996, J ENZYM INHIB, V10, P231, DOI 10.3109/14756369609036530; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Galmarini CM, 2003, BRIT J CANCER, V88, P1793, DOI 10.1038/sj.bjc.6600960; Gasco M, 2003, DRUG RESIST UPDATE, V6, P323, DOI 10.1016/j.drup.2003.11.001; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hammerova J, 2011, J DERMATOL SCI, V62, P22, DOI 10.1016/j.jdermsci.2011.01.006; Hari M, 2006, MOL CANCER THER, V5, P270, DOI 10.1158/1535-7163.MCT-05-0190; HARKER WG, 1985, CANCER RES, V45, P4091; Haslam G, 2000, CYTOTECHNOLOGY, V32, P63, DOI 10.1023/A:1008121125755; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Joubert A, 2004, BIOMED RES-TOKYO, V25, P27, DOI 10.2220/biomedres.25.27; Kaminskyy V, 2008, TOXICOL LETT, V177, P168, DOI 10.1016/j.toxlet.2008.01.009; Kaminskyy V, 2008, CELL BIOL INT, V32, P271, DOI 10.1016/j.cellbi.2007.09.004; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kemeny-Beke A, 2006, CANCER LETT, V237, P67, DOI 10.1016/j.canlet.2005.05.037; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lee Jun, 2005, Journal of Applied Biological Chemistry, V48, P198; Lee SK, 1998, J BIOL CHEM, V273, P19829, DOI 10.1074/jbc.273.31.19829; Lee SS, 2001, PHYTOTHER RES, V15, P167, DOI 10.1002/ptr.703; LETTRE H., 1942, Naturwissenschaften, V30, P184; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li WQ, 1999, CELL GROWTH DIFFER, V10, P769; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; Lopus M, 2006, FEBS J, V273, P2139, DOI 10.1111/j.1742-4658.2006.05227.x; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; MAITI M, 1982, FEBS LETT, V142, P280, DOI 10.1016/0014-5793(82)80152-X; Martello LA, 2003, CANCER RES, V63, P1207; Matkar SS, 2008, CHEM-BIOL INTERACT, V172, P63, DOI 10.1016/j.cbi.2007.12.006; Nakanishi Y, 1999, ONCOLOGY-BASEL, V57, P318, DOI 10.1159/000012068; Nelson DA, 1997, J BIOL CHEM, V272, P4528, DOI 10.1074/jbc.272.7.4528; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Panzer A, 2001, EUR J CELL BIOL, V80, P111, DOI 10.1078/0171-9335-00135; Park JE, 2011, BIOORG MED CHEM LETT, V21, P6960, DOI 10.1016/j.bmcl.2011.09.128; Paul Avijit, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1025, DOI 10.3736/jcim20120912; Philchenkov A. A., 2006, Ukrainskii Biokhimicheskii Zhurnal, V78, P81; ROSS W, 1984, CANCER RES, V44, P5857; Sarkozi A, 2006, CHROMATOGRAPHIA, V63, pS81, DOI 10.1365/s10337-006-0728-7; SAVCHAK V I, 1976, Vestnik Dermatologii i Venerologii, V3, P77; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Tanabe H, 2006, PHYTOMEDICINE, V13, P334, DOI 10.1016/j.phymed.2005.02.001; TANAKA T, 1993, PLANTA MED, V59, P200, DOI 10.1055/s-2006-959651; Tcherniuk S, 2011, CHEM BIOL, V18, P631, DOI 10.1016/j.chembiol.2011.03.006; Tcherniuk S, 2010, ANGEW CHEM INT EDIT, V49, P8228, DOI 10.1002/anie.201003254; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vasey PA, 1996, MOL PHARMACOL, V50, P1536; Vavreckova C, 1996, PLANTA MED, V62, P397, DOI 10.1055/s-2006-957924; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; WIDMANN H, 1955, Arch Geschwulstforsch, V9, P6; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; WOLFF J, 1993, BIOCHEMISTRY-US, V32, P13334, DOI 10.1021/bi00211a047; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044	66	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57461	10.1371/journal.pone.0057461	http://dx.doi.org/10.1371/journal.pone.0057461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505430	gold, Green Published			2022-12-25	WOS:000318334500022
J	Smagghe, BJ; Stewart, AK; Carter, MG; Shelton, LM; Bernier, KJ; Hartman, EJ; Calhoun, AK; Hatziioannou, VM; Lillacci, G; Kirk, BA; DiNardo, BA; Kosik, KS; Bamdad, C				Smagghe, Benoit J.; Stewart, Andrew K.; Carter, Mark G.; Shelton, Laura M.; Bernier, Kyle J.; Hartman, Eric J.; Calhoun, Amy K.; Hatziioannou, Vasilios M.; Lillacci, Gabriele; Kirk, Brian A.; DiNardo, Brian A.; Kosik, Kenneth S.; Bamdad, Cynthia			MUC1*Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naive State	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; OLIGOMERIC STRUCTURE; SELF-RENEWAL; MATRIX; LINES; DIFFERENTIATION; SUPPORTS; PROLIFERATION; PLURIPOTENCY; DERIVATION	We report that a single growth factor, NM23-H1, enables serial passaging of both human ES and iPS cells in the absence of feeder cells, their conditioned media or bFGF in a fully defined xeno-free media on a novel defined, xeno-free surface. Stem cells cultured in this system show a gene expression pattern indicative of a more "naive" state than stem cells grown in bFGF-based media. NM23-H1 and MUC1* growth factor receptor cooperate to control stem cell self-replication. By manipulating the multimerization state of NM23-H1, we override the stem cell's inherent programming that turns off pluripotency and trick the cells into continuously replicating as pluripotent stem cells. Dimeric NM23-H1 binds to and dimerizes the extra cellular domain of the MUC1* transmembrane receptor which stimulates growth and promotes pluripotency. Inhibition of the NM23-H1/MUC1* interaction accelerates differentiation and causes a spike in miR-145 expression which signals a cell's exit from pluripotency.	[Smagghe, Benoit J.; Stewart, Andrew K.; Carter, Mark G.; Shelton, Laura M.; Bernier, Kyle J.; Hartman, Eric J.; Calhoun, Amy K.; Hatziioannou, Vasilios M.; Kirk, Brian A.; DiNardo, Brian A.; Bamdad, Cynthia] Minerva Biotechnol, Waltham, MA USA; [Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Lillacci, Gabriele] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bamdad, C (corresponding author), Minerva Biotechnol, Waltham, MA USA.	cbamdad@minervabio.com		Lillacci, Gabriele/0000-0002-5162-1750	National Science Foundation [NSF-CDI ECC-0835847]	National Science Foundation(National Science Foundation (NSF))	The work of GL was supported by the National Science Foundation under Grant NSF-CDI ECC-0835847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; [Anonymous], 2007, HUM CELL CULT; Bamdad C, 1998, BIOPHYS J, V75, P1989, DOI 10.1016/S0006-3495(98)77640-4; Bamdad C, 1999, RAPID SENSITIVE DETE; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; CHANG CL, 1994, NATURE, V370, P335, DOI 10.1038/370335a0; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Derda R, 2010, J AM CHEM SOC, V132, P1289, DOI 10.1021/ja906089g; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hikita ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003312; HOZUMI M, 1985, CRC CR REV ONCOL-HEM, V3, P235, DOI 10.1016/S1040-8428(85)80028-7; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Klim JR, 2012, ACS CHEM BIOL; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Lascu I, 1997, J BIOL CHEM, V272, P15599, DOI 10.1074/jbc.272.25.15599; Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732; LIEDBERG B, 1993, SENSOR ACTUAT B-CHEM, V11, P63, DOI 10.1016/0925-4005(93)85239-7; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; Lombardi D, 2000, J CELL PHYSIOL, V182, P144, DOI 10.1002/(SICI)1097-4652(200002)182:2<144::AID-JCP2>3.3.CO;2-Y; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Mesnildrey S, 1997, FEBS LETT, V418, P53, DOI 10.1016/S0014-5793(97)01292-1; Mesnildrey S, 1998, J BIOL CHEM, V273, P4436, DOI 10.1074/jbc.273.8.4436; Nelson TJ, 2010, NAT REV CARDIOL, V7, P700, DOI 10.1038/nrcardio.2010.159; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; OKABEKADO J, 1992, BIOCHEM BIOPH RES CO, V182, P987, DOI 10.1016/0006-291X(92)91829-F; OKABEKADO J, 1995, FEBS LETT, V363, P311, DOI 10.1016/0014-5793(95)00338-A; ORKIN RW, 1977, J EXP MED, V145, P204, DOI 10.1084/jem.145.1.204; Pompe T, 2010, NAT PROTOC, V5, P1042, DOI 10.1038/nprot.2010.70; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Thompson AB, 2011, ACS APPL MATER INTER, V3, P2979, DOI 10.1021/am200459a; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unger C, 2008, HUM MOL GENET, V17, pR48, DOI 10.1093/hmg/ddn079; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Vr Wallet, 1990, DICTYOSTELIUM NUCLEO, P1199; Vuoristo S, 2009, J CELL MOL MED, V13, P2622, DOI 10.1111/j.1582-4934.2008.00643.x; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189	55	20	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58601	10.1371/journal.pone.0058601	http://dx.doi.org/10.1371/journal.pone.0058601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505541	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500106
J	Zhou, J; Zhuang, J; Li, J; Ooi, E; Bloom, J; Poon, C; Lax, D; Rosenbaum, DM; Barone, FC				Zhou, Jin; Zhuang, Jian; Li, Jie; Ooi, Evelyn; Bloom, Jonathan; Poon, Carrie; Lax, Daniel; Rosenbaum, Daniel M.; Barone, Frank C.			Long-Term Post-Stroke Changes Include Myelin Loss, Specific Deficits in Sensory and Motor Behaviors and Complex Cognitive Impairment Detected Using Active Place Avoidance	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; WHITE-MATTER INTEGRITY; DELAYED NEURONAL DEATH; BRAIN-INJURY; OCCLUSION; STROKE; ISCHEMIA; RAT; SENSORIMOTOR; MEMORY	Persistent neurobehavioral deficits and brain changes need validation for brain restoration. Two hours middle cerebral artery occlusion (tMCAO) or sham surgery was performed in male Sprague-Dawley rats. Neurobehavioral and cognitive deficits were measured over 10 weeks included: (1) sensory, motor, beam balance, reflex/abnormal responses, hindlimb placement, forepaw foot fault and cylinder placement tests, and (2) complex active place avoidance learning (APA) and simple passive avoidance retention (PA). Electroretinogram (ERG), hemispheric loss (infarction), hippocampus CA1 neuronal loss and myelin (Luxol Fast Blue) staining in several fiber tracts were also measured. In comparison to Sham surgery, tMCAO surgery produced significant deficits in all behavioral tests except reflex/abnormal responses. Acute, short lived deficits following tMCAO were observed for forelimb foot fault and forelimb cylinder placement. Persistent, sustained deficits for the whole 10 weeks were exhibited for motor (p<0.001), sensory (p<0.001), beam balance performance (p<0.01) and hindlimb placement behavior (p<0.01). tMCAO produced much greater and prolonged cognitive deficits in APA learning (maximum on last trial of 604 +/- 83% change, p<0.05) but only a small, comparative effect on PA retention. Hemispheric loss/atrophy was measured 10 weeks after tMCAO and cross-validated by two methods (e. g., almost identical % ischemic hemispheric loss of 33.4 +/- 3.5% for H&E and of 34.2 +/- 3.5% for TTC staining). No visual dysfunction by ERG and no hippocampus neuronal loss were detected after tMCAO. Fiber tract damage measured by Luxol Fast Blue myelin staining intensity was significant (p<0.01) in the external capsule and striatum but not in corpus callosum and anterior commissure. In summary, persistent neurobehavioral deficits were validated as important endpoints for stroke restorative research in the future. Fiber myelin loss appears to contribute to these long term behavioral dysfunctions and can be important for cognitive behavioral control necessary for complex APA learning.	[Zhou, Jin; Zhuang, Jian; Li, Jie; Ooi, Evelyn; Bloom, Jonathan; Poon, Carrie; Lax, Daniel; Rosenbaum, Daniel M.; Barone, Frank C.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Rosenbaum, Daniel M.; Barone, Frank C.] Suny Downstate Med Ctr, Robert F Furchgott Fdn, Brooklyn, NY 11203 USA; [Barone, Frank C.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Zhou, J (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.	jin.zhou@downstate.edu		Lax, Daniel/0000-0003-1186-3111	States University of New York Downstate Research Foundation; Department of Neurology	States University of New York Downstate Research Foundation; Department of Neurology	This work was supported using basic research funds provided by the States University of New York Downstate Research Foundation and Department of Neurology. Only the persons listed as authors of this manuscript had roles in the study design, the collection and analysis of data, the decision to publish, and/or the preparation of this paper for publication.	Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Barone FC, 2010, NEUROPHARMACOLOGY, V59, P650, DOI 10.1016/j.neuropharm.2010.08.016; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bingham D, 2012, J CEREBR BLOOD F MET, V32, P989, DOI 10.1038/jcbfm.2012.16; Blahna K, 2011, BEHAV BRAIN RES, V216, P207, DOI 10.1016/j.bbr.2010.07.038; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cimadevilla JM, 2000, NEUROSCI LETT, V285, P53, DOI 10.1016/S0304-3940(00)01019-3; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; Das A, 2005, PHARMACOL BIOCHEM BE, V81, P89, DOI 10.1016/j.pbb.2005.02.006; David J, 2011, NEUROREPORT, V22, P633, DOI 10.1097/WNR.0b013e32834959c5; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P11493, DOI 10.1073/pnas.95.19.11493; Ferrucci L, 1996, J AM GERIATR SOC, V44, P237; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; Freret Thomas, 2011, Exp Transl Stroke Med, V3, P6, DOI 10.1186/2040-7378-3-6; Gwag BJ, 2007, J CEREBR BLOOD F MET, V27, P1142, DOI 10.1038/sj.jcbfm.9600418; HIRAKAWA M, 1994, STROKE, V25, P2471, DOI 10.1161/01.STR.25.12.2471; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Kalesnykas G, 2008, NEUROSCIENCE, V155, P937, DOI 10.1016/j.neuroscience.2008.06.038; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; Lee JH, 2011, ANAT CELL BIOL, V44, P25, DOI 10.5115/acb.2011.44.1.25; Lei B, 2004, NEUROSCIENCE, V125, P691, DOI 10.1016/j.neuroscience.2004.02.034; Lenhard SC, 2008, PHARMACOLOGY, V81, P1, DOI 10.1159/000107661; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Lin SY, 2004, BRAIN RES, V1007, P132, DOI 10.1016/j.brainres.2004.01.074; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Ma JY, 2006, J NEUROSCI METH, V156, P76, DOI 10.1016/j.jneumeth.2006.02.006; Merino Jose G, 2002, Curr Atheroscler Rep, V4, P285, DOI 10.1007/s11883-002-0007-5; Pendlebury ST, 1999, STROKE, V30, P956, DOI 10.1161/01.STR.30.5.956; Petito CK, 1997, J CEREBR BLOOD F MET, V17, P967, DOI 10.1097/00004647-199709000-00006; Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Sakai N, 1996, BEHAV BRAIN RES, V77, P181, DOI 10.1016/0166-4328(95)00232-4; Samanez-Larkin GR, 2012, J NEUROSCI, V32, P5333, DOI 10.1523/JNEUROSCI.5756-11.2012; Savva GM, 2010, STROKE, V41, pE41, DOI 10.1161/STROKEAHA.109.559880; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; WAHL F, 1992, STROKE, V23, P267, DOI 10.1161/01.STR.23.2.267; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Willing AE, 2002, INT J NEUROSCI, V112, P503, DOI 10.1080/00207450290025617; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; YAMAGUCHI T, 1995, BRAIN RES, V669, P107, DOI 10.1016/0006-8993(94)01268-M; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zhou J, 2011, J CEREBR BLOOD F MET, V31, P924, DOI 10.1038/jcbfm.2010.171; Zvejniece L, 2012, J NEUROSCI METHODS	57	30	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57503	10.1371/journal.pone.0057503	http://dx.doi.org/10.1371/journal.pone.0057503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505432	gold, Green Submitted, Green Published			2022-12-25	WOS:000318334500024
J	Jansen, OE; Aarts, GM; Reijnders, PJH				Jansen, Okka E.; Aarts, Geert M.; Reijnders, Peter J. H.			Harbour Porpoises Phocoena phocoena in the Eastern Scheldt: A Resident Stock or Trapped by a Storm Surge Barrier?	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; FEEDING ECOLOGY; CARBON ISOTOPES; MARINE MAMMALS; NORTH-SEA; FOOD-WEB; NITROGEN; DELTA-C-13; TISSUES; DIET	Coastal protection measures are planned and executed worldwide to combat the effects of global warming and climate change, in particular the acceleration of sea level rise, higher storm surge flooding and extensive coastal inundation. The extent to which these defensive measures may impact coastal and estuarine ecosystems is still poorly understood. Since the building of a storm surge barrier, movement of harbour porpoises Phocoena phocoena in and out of the Eastern Scheldt tidal bay (SW-Netherlands) may be limited. To measure residency, porpoises stranded along the Dutch North Sea coast between 2006 and 2008 were sampled for muscle (n = 102) and bone tissue (n = 118), of which 9 muscle (8.8 parts per thousand) and 12 bone samples (10.2 parts per thousand) were collected from animals stranded within the Eastern Scheldt. Stable carbon (delta C-13) was analysed to get insight into the habitat use and residency of porpoises in the Eastern Scheldt. Our data showed significantly higher delta C-13 values in the muscle of porpoises stranded within the Eastern Scheldt (mu = -17.7%, SD = 0.4 parts per thousand) compared to animals stranded along the Dutch coast (mu = 218.3 parts per thousand, SD = 0.5 parts per thousand). This suggests that most porpoises stranded in the Eastern Scheldt foraged there for a longer period. The distinct delta C-13 signature of animals from the Eastern Scheldt was not observed in bone tissue, suggesting a relatively recent shift in habitat use rather than life-long residency of porpoises within the Eastern Scheldt. The high number of strandings within the Eastern Scheldt suggests a higher mortality rate compared to the Dutch coastal zone. Our study indicates that along with other changes in the physical environment, the storm surge barrier may play an important role in determining the residency of porpoises in the Eastern Scheldt, and that the area might act as an ecological trap for porpoises entering it.	[Jansen, Okka E.; Aarts, Geert M.; Reijnders, Peter J. H.] Wageningen UR, IMARES, Dept Ecosyst, Den Burg, Netherlands; [Jansen, Okka E.; Aarts, Geert M.; Reijnders, Peter J. H.] Wageningen Univ, Dept Aquat Ecol & Waterqual Management, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Jansen, OE (corresponding author), Wageningen UR, IMARES, Dept Ecosyst, Den Burg, Netherlands.	okka.jansen@wur.nl		Aarts, Geert/0000-0003-3196-4235; reijnders, peter/0000-0002-3783-8283	Dutch Ministry of Agriculture, Nature and Food Quality (LNV), BO Project [4308201019]; NWO-ZKO (The Netherlands Organisation for Scientific Research under the Sea and Coastal Research programme)	Dutch Ministry of Agriculture, Nature and Food Quality (LNV), BO Project; NWO-ZKO (The Netherlands Organisation for Scientific Research under the Sea and Coastal Research programme)	This work was funded by the Dutch Ministry of Agriculture, Nature and Food Quality (LNV), BO Project 4308201019. G. Aarts is funded by the NWO-ZKO (The Netherlands Organisation for Scientific Research under the Sea and Coastal Research programme) grant Effects of underwater noise on fish and marine mammals in the North Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes C, 2009, ESTUAR COAST SHELF S, V81, P368, DOI 10.1016/j.ecss.2008.11.011; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bosello F, 2012, CLIMATIC CHANGE, V112, P63, DOI 10.1007/s10584-011-0340-1; Camphuysen Kees (C. J.), 2011, Lutra, V54, P39; Camphuysen Kees C. J., 2008, Lutra, V51, P87; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Christensen JT, 2008, MAR ECOL PROG SER, V368, P1, DOI 10.3354/meps07635; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Das K, 2003, MAR ECOL PROG SER, V263, P287, DOI 10.3354/meps263287; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Geelhoed S, 2011, C10311 IM; Hallegatte S, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015604; Harrod C, 2005, OECOLOGIA, V144, P673, DOI 10.1007/s00442-005-0161-x; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; IPCC, 1990, STRAT AD SEA LEV RIS; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Jansen OE, 2012, MAR BIOL RES, V8, P829, DOI 10.1080/17451000.2012.692164; Kabat P, 2005, NATURE, V438, P283, DOI 10.1038/438283a; Kurle CM, 2002, MAR ECOL PROG SER, V236, P289, DOI 10.3354/meps236289; McCullagh P, 1989, GEN LINEAR MODELS; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Middelburg JJ, 2007, MAR CHEM, V106, P127, DOI 10.1016/j.marchem.2006.02.007; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; NIENHUIS PH, 1994, HYDROBIOLOGIA, V283, P1; O'Regan HJ, 2008, J HUM EVOL, V55, P617, DOI 10.1016/j.jhevol.2008.05.001; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R Development Core Team, 2009, R FDN STAT COMP; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Reijnders PJH, 2009, MARINE MAMMALS; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Scheidat M, 2012, J SEA RES, V69, P1, DOI 10.1016/j.seares.2011.12.004; SEALY J, 1995, ANTIQUITY, V69, P290, DOI 10.1017/S0003598X00064693; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Zanderink Frank, 2010, Zoogdier, V21, P12	40	2	4	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56932	10.1371/journal.pone.0056932	http://dx.doi.org/10.1371/journal.pone.0056932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483892	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100010
J	Miura, K; Deng, BB; Tullo, G; Diouf, A; Moretz, SE; Locke, E; Morin, M; Fay, MP; Long, CA				Miura, Kazutoyo; Deng, Bingbing; Tullo, Gregory; Diouf, Ababacar; Moretz, Samuel E.; Locke, Emily; Morin, Merribeth; Fay, Michael P.; Long, Carole A.			Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays	PLOS ONE			English	Article							TRANSMISSION-BLOCKING IMMUNITY; GAMETOCYTE INFECTIVITY; VACCINE; ANTIBODIES; AREA; MOSQUITOS; PFS25; PARASITEMIA; POPULATIONS; VALIDATION	Vaccines that interrupt malaria transmission are of increasing interest and a robust functional assay to measure this activity would promote their development by providing a biologically relevant means of evaluating potential vaccine candidates. Therefore, we aimed to qualify the standard membrane-feeding assay (SMFA). The assay measures the transmission-blocking activity of antibodies by feeding cultured P. falciparum gametocytes to Anopheles mosquitoes in the presence of the test antibodies and measuring subsequent mosquito infection. The International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline Q2(R1) details characteristics considered in assay validation. Of these characteristics, we decided to qualify the SMFA for Precision, Linearity, Range and Specificity. The transmission-blocking 4B7 monoclonal antibody was tested over 6 feeding experiments at several concentrations to determine four suitable concentrations that were tested in triplicate in the qualification experiments (3 additional feeds) to evaluate Precision, Linearity and Range. For Specificity, 4B7 was tested in the presence of normal mouse IgG. We determined intra-and inter-assay variability of % inhibition of mean oocyst intensity at each concentration of 4B7 (lower concentrations showed higher variability). We also showed that % inhibition was dependent on 4B7 concentration and the activity is specific to 4B7. Since obtaining empirical data is time-consuming, we generated a model using data from all 9 feeds and simulated the effects of different parameters on final readouts to improve the assay procedure and analytical methods for future studies. For example, we estimated the effect of number of mosquitoes dissected on variability of % inhibition, and simulated the relationship between % inhibition in oocyst intensity and % inhibition of prevalence of infected mosquitos at different mean oocysts in the control. SMFA is one of the few biological assays used in preclinical and early clinical development of transmission-blocking vaccines, and this study strongly supports its further development and application.	[Miura, Kazutoyo; Deng, Bingbing; Tullo, Gregory; Diouf, Ababacar; Moretz, Samuel E.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Locke, Emily; Morin, Merribeth] PATH Malaria Vaccine Initiat, Washington, DC USA; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Miura, K (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	kmiura@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020; Fay, Michael P/A-2974-2008	Miura, Kazutoyo/0000-0003-4455-2432; Fay, Michael P/0000-0002-8643-9625	National Institute of Allergy and Infectious Diseases/National Institutes of Health; PATH Malaria Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PATH Malaria Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the intramural program of the National Institute of Allergy and Infectious Diseases/National Institutes of Health and by the PATH Malaria Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; BILLINGSLEY PF, 1994, AM J TROP MED HYG, V51, P260, DOI 10.4269/ajtmh.1994.51.260; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Bousema T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042821; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Delves MJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-35; Drakeley CJ, 2004, PARASITE IMMUNOL, V26, P159, DOI 10.1111/j.0141-9838.2004.00696.x; Efron B., 1994, INTRO BOOTSTRAP; Fay MP, 2001, BIOMETRICS, V57, P1198, DOI 10.1111/j.0006-341X.2001.01198.x; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Gozar MMG, 2001, EXP PARASITOL, V97, P61, DOI 10.1006/expr.2000.4580; GRAVES PM, 1988, PARASITOLOGY, V96, P251, DOI 10.1017/S003118200005825X; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; ICH(INTERNATIONALCOUNCILFOR HARMONISATION), 2005, VALIDATION ANALYTICA; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; Lee A.J., 1990, U STAT THEORY PRACTI; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; MEDLEY GF, 1993, PARASITOLOGY, V106, P441, DOI 10.1017/S0031182000076721; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Mulder B, 1999, EXP PARASITOL, V92, P81, DOI 10.1006/expr.1999.4398; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ouedraogo AL, 2011, INFECT IMMUN, V79, P4957, DOI 10.1128/IAI.05288-11; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; SATTABONGKOT J, 1991, PARASITOLOGY, V102, P27, DOI 10.1017/S0031182000060303; SKAUG H., 2012, GEN LINEAR MIXED MOD; Stowers AW, 2000, INFECT IMMUN, V68, P5530, DOI 10.1128/IAI.68.10.5530-5538.2000; Toure YT, 1998, AM J TROP MED HYG, V59, P481, DOI 10.4269/ajtmh.1998.59.481; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van der Kolk M, 2006, INT J PARASITOL, V36, P1091, DOI 10.1016/j.ijpara.2006.05.004; Vossen MG, 2010, AM J TROP MED HYG, V82, P398, DOI 10.4269/ajtmh.2010.09-0417; Wu Yu-Huan, 2008, P3	36	90	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57909	10.1371/journal.pone.0057909	http://dx.doi.org/10.1371/journal.pone.0057909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483940	Green Published, gold			2022-12-25	WOS:000316936100053
J	Porcheron, A; Mauger, E; Russell, R				Porcheron, Aurelie; Mauger, Emmanuelle; Russell, Richard			Aspects of Facial Contrast Decrease with Age and Are Cues for Age Perception	PLOS ONE			English	Article							COSMETICS USE; ATTRACTIVENESS; SEX; HEALTH; FACES; IMPACT; YOUNG; SHAPE; OLD	Age is a primary social dimension. We behave differently toward people as a function of how old we perceive them to be. Age perception relies on cues that are correlated with age, such as wrinkles. Here we report that aspects of facial contrast-the contrast between facial features and the surrounding skin-decreased with age in a large sample of adult Caucasian females. These same aspects of facial contrast were also significantly correlated with the perceived age of the faces. Individual faces were perceived as younger when these aspects of facial contrast were artificially increased, but older when these aspects of facial contrast were artificially decreased. These findings show that facial contrast plays a role in age perception, and that faces with greater facial contrast look younger. Because facial contrast is increased by typical cosmetics use, we infer that cosmetics function in part by making the face appear younger.	[Porcheron, Aurelie; Mauger, Emmanuelle] CERIES, Neuilly Sur Seine, France; [Porcheron, Aurelie; Russell, Richard] Gettysburg Coll, Gettysburg, PA 17325 USA	Gettysburg College	Russell, R (corresponding author), Gettysburg Coll, Gettysburg, PA 17325 USA.	rrussell@gettysburg.edu	Russell, Richard/A-1331-2007	Russell, Richard/0000-0002-4007-8596				BERRY DS, 1986, PSYCHOL BULL, V100, P3, DOI 10.1037/0033-2909.100.1.3; Brainard D.H., 2003, SCI COLOR, V2, P191, DOI DOI 10.1016/B978-044451251-2/50006-4; Bruce V., 1998, EYE BEHOLDER SCI FAC; Bulpitt CJ, 2001, POSTGRAD MED J, V77, P578, DOI 10.1136/pmj.77.911.578; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; Christensen K, 2004, EPIDEMIOLOGY, V15, P251, DOI 10.1097/01.ede.0000112211.11416.a6; Christensen K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5262; COX CL, 1986, SEX ROLES, V14, P51, DOI 10.1007/BF00287847; Dakin SC, 2009, J VISION, V9, DOI [10.1167/9.4.2, 10.1167/9.11.28]; Dupuis-Roy N, 2009, J VISION, V9, DOI 10.1167/9.2.10; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Etcoff NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025656; Farage M. A., 2010, TXB AGING SKIN, P983; Farkas LG, 2004, J CRANIOFAC SURG, V15, P288, DOI 10.1097/00001665-200403000-00027; Fink B, 2012, INT J COSMETIC SCI, V34, P307, DOI 10.1111/j.1468-2494.2012.00724.x; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; GEORGE PA, 1995, PERCEPTION, V24, P1059, DOI 10.1068/p241059; George PA, 1998, PERCEPTION, V27, P295, DOI 10.1068/p270295; GRAHAM JA, 1980, INT J COSMETIC SCI, V2, P77, DOI 10.1111/j.1467-2494.1980.tb00237.x; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Gupta MA, 2005, DERMATOL CLIN, V23, P643, DOI 10.1016/j.det.2005.05.012; HENLEY NM, 1973, B PSYCHONOMIC SOC, V2, P91, DOI 10.3758/BF03327726; Hillebrand GG., 2007, ETHNIC SKIN HAIR, P105; Hole G, 2011, VIS COGN, V19, P585, DOI 10.1080/13506285.2011.562076; Huguet P, 2004, J APPL SOC PSYCHOL, V34, P1752, DOI 10.1111/j.1559-1816.2004.tb02796.x; Hwang SW, 2011, J GEN INTERN MED, V26, P136, DOI 10.1007/s11606-010-1537-0; KLIGMAN AM, 1989, CUTIS, V43, P498; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Leong Paul L, 2008, Facial Plast Surg Clin North Am, V16, P277, DOI 10.1016/j.fsc.2008.03.007; MARK LS, 1980, PERCEPT PSYCHOPHYS, V27, P117, DOI 10.3758/BF03204298; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Mayes AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015270; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Nash R, 2006, J APPL SOC PSYCHOL, V36, P493, DOI 10.1111/j.0021-9029.2006.00016.x; Nestor A, 2008, PSYCHOL SCI, V19, P1242, DOI 10.1111/j.1467-9280.2008.02232.x; Nkengne A, 2008, J EUR ACAD DERMATOL, V22, P982, DOI 10.1111/j.1468-3083.2008.02698.x; Porcheron A, 2011, PIGM CELL MELANOMA R, V24, P840; Rexbye H, 2006, AGE AGEING, V35, P110, DOI 10.1093/ageing/afj031; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Russell R, 2010, SCI SOCIAL VISION; Russell R, 2009, PERCEPTION, V38, P1211, DOI 10.1068/p6331; Samson N, 2010, J COSMET DERMATOL-US, V9, P79, DOI 10.1111/j.1473-2165.2010.00489.x; SEDDON JM, 1990, INVEST OPHTH VIS SCI, V31, P1592; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Stephen ID, 2010, PLOS ONE; Swanson E, 2011, J PLAST RECONSTR AES, V64, P1124, DOI 10.1016/j.bjps.2011.04.004; Tschachler E, 2005, SKIN AGING, P23; Verbeke G, 1997, LINEAR MIXED MODELS; Zebrowitz L. A., 1997, READING FACES WINDOW	51	72	73	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57985	10.1371/journal.pone.0057985	http://dx.doi.org/10.1371/journal.pone.0057985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483959	gold, Green Published			2022-12-25	WOS:000316936100064
J	Huai, C; Song, JP; Ma, ZY; Qin, XF; Li, PL; Chen, HY; Zhao, F; Lu, DR; Song, DL; Mao, Y; Song, X; Zhao, Y				Huai, Cong; Song, Jianping; Ma, Zengyi; Qin, Xuanfeng; Li, Peiliang; Chen, Hongyan; Zhao, Fan; Lu, Daru; Song, Donglei; Mao, Ying; Song, Xiao; Zhao, Yao			Allelic Variation of the MMP3 Promoter Affects Transcription Activity through the Transcription Factor C-MYB in Human Brain Arteriovenous Malformations	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INTRACRANIAL HEMORRHAGE; GROWTH-FACTOR; EXPRESSION; POLYMORPHISMS; ONCOGENE; GENE	MMPs comprise a family of proteolytic enzymes that degrade pericellular substances, which may result in the destabilization of vessels and related to the development of brain arteriovenous malformations (BAVM). MMP3 is a key member of this family, overexpressed in BAVM tissues, and a single nucleotide polymorphism within MMP3, -709A>G (rs522616), is significantly associated with the risk of BAVM. In this study, we aimed to investigate the mechanism through which the polymorphism rs522616 regulates the expression of MMP3. Our results showed that -709A led to a over 2-fold higher transcriptional activity compared with the G allele (P<0.05) and this transcriptional activity can be depressed by co-ransfecting cells with competitive DNA fragments containing -709A but not -709G. Bioinformatics analyses suggested that the transcription factor C-MYB might bind to the area around rs522616. Overexpressed C-MYB significantly increased the transcriptional activity of -709A compared with -709G or controls that did not overexpress c-myb (P<0.01) in HEK293 and HUVEC cells. ChIP assays indicated that C-MYB bound to the SNP region in the two cell lines and three BAVM tissue samples. Together, these data indicated that C-MYB can bind to the -709A allele of the MMP3 promoter, activate its transcription and lead to a higher expression of this gene. This novel hypothesis, supported by molecular evidence, explains how this SNP affects MMP3 promoter function and results in a risk of BAVM development.	[Huai, Cong; Chen, Hongyan; Lu, Daru; Song, Xiao] Fudan Univ, State Key Lab Genet Engn, Fudan VARI Genet Epidemiol Ctr, Shanghai 200433, Peoples R China; [Huai, Cong; Chen, Hongyan; Lu, Daru; Song, Xiao] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Huai, Cong; Chen, Hongyan; Lu, Daru; Song, Xiao] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Song, Jianping; Ma, Zengyi; Qin, Xuanfeng; Li, Peiliang; Zhao, Fan; Song, Donglei; Mao, Ying; Zhao, Yao] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Song, X (corresponding author), Fudan Univ, State Key Lab Genet Engn, Fudan VARI Genet Epidemiol Ctr, Shanghai 200433, Peoples R China.	dylansong0207@gmail.com; yao.zhao.hs@gmail.com		Mao, Ying/0000-0001-8055-115X; Song, Jianping/0000-0003-3411-1457	National Natural Science Foundation of China [30500524, 30973103, 81070936]; Key Subjects Innovative Talents Training Program of Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Subjects Innovative Talents Training Program of Fudan University	This work was supported by the National Natural Science Foundation of China (30500524, 30973103, 81070936), the web site url of this foundation is http://www.nsfc.gov.cn/Portal0/default152.htm and the Key Subjects Innovative Talents Training Program of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALITALO K, 1984, P NATL ACAD SCI-BIOL, V81, P4534, DOI 10.1073/pnas.81.14.4534; Berman MF, 2000, NEUROSURGERY, V47, P389, DOI 10.1097/00006123-200008000-00023; Biondi ML, 2000, CLIN CHEM, V46, P2023; Brown RD, 2008, LANCET NEUROL, V7, P195, DOI 10.1016/S1474-4422(08)70027-9; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Dey S, 2012, MOL CARCINOGEN, V51, pE42, DOI 10.1002/mc.21837; Du R, 2007, J NEUROSURG, V106, P470, DOI 10.3171/jns.2007.106.3.470; Fan WW, 2012, MOL CARCINOGEN, V51, pE1, DOI 10.1002/mc.20842; Gang Ouyang, 2011, WORLD CHINESE J DIGE, V19, P3130; Hacein-Bey L, 1999, Interv Neuroradiol, V5 Suppl 1, P177; Halim AX, 2004, STROKE, V35, P1697, DOI 10.1161/01.STR.0000130988.44824.29; Hashimoto T, 2004, NEUROSURGERY, V54, P410, DOI 10.1227/01.NEU.0000103421.35266.71; Hashimoto T, 2003, STROKE, V34, P925, DOI 10.1161/01.STR.0000061888.71524.DF; Jeffree RL, 2009, PEDIATR NEUROSURG, V45, P296, DOI 10.1159/000235604; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Kim H, 2008, ACTA NEUROCHIR SUPPL, V105, P199; Kim H, 2009, STROKE, V40, pS95, DOI 10.1161/STROKEAHA.108.533216; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; Letra A, 2012, J CLIN PERIODONTOL, V39, P707, DOI 10.1111/j.1600-051X.2012.01902.x; Luo J, 2005, CEREBELLUM, V4, P239, DOI 10.1080/14734220500247646; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Pawlikowska L, 2005, STROKE, V36, P2278, DOI 10.1161/01.STR.0000182253.91167.fa; Quick CM, 2001, NEUROL RES, V23, P641, DOI 10.1179/016164101101198938; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; Zhao Y, 2010, J CLIN NEUROSCI, V17, P1568, DOI 10.1016/j.jocn.2010.04.023; Zhu YQ, 2006, NEUROSURGERY, V59, P687, DOI 10.1227/01.NEU.0000228962.68204.CF	30	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57958	10.1371/journal.pone.0057958	http://dx.doi.org/10.1371/journal.pone.0057958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483952	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900059
J	Chung, IYW; Paetzel, M				Chung, Ivy Yeuk Wah; Paetzel, Mark			Crystal Structures of Yellowtail Ascites Virus VP4 Protease TRAPPING AN INTERNAL CLEAVAGE SITE TRANS ACYL-ENZYME COMPLEX IN A NATIVE SER/LYS DYAD ACTIVE SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC NECROSIS VIRUS; SER-LYS DYAD; SULFENIC ACIDS; CATALYTIC DYAD; SELF-CLEAVAGE; BIRNAVIRUS; AQUABIRNAVIRUS; IDENTIFICATION; AVIBIRNAVIRUS; REFINEMENT	Yellowtail ascites virus (YAV) is an aquabirnavirus that causes ascites in yellowtail, a fish often used in sushi. Segment A of the YAV genome codes for a polyprotein (pVP2-VP4-VP3), where processing by its own VP4 protease yields the capsid protein precursor pVP2, the ribonucleoprotein-forming VP3, and free VP4. VP4 protease utilizes the rarely observed serine-lysine catalytic dyad mechanism. Here we have confirmed the existence of an internal cleavage site, preceding the VP4/VP3 cleavage site. The resulting C-terminally truncated enzyme (ending at Ala(716)) is active, as shown by a trans full-length VP4 cleavage assay and a fluorometric peptide cleavage assay. We present a crystal structure of a native active site YAV VP4 with the internal cleavage site trapped as trans product complexes and trans acyl-enzyme complexes. The acyl-enzyme complexes confirm directly the role of Ser(633) as the nucleophile. A crystal structure of the lysine general base mutant (K674A) reveals the acyl-enzyme and empty binding site states of VP4, which allows for the observation of structural changes upon substrate or product binding. These snapshots of three different stages in the VP4 protease reaction mechanism will aid in the design of anti-birnavirus compounds, provide insight into previous site-directed mutagenesis results, and contribute to understanding of the serine-lysine dyad protease mechanism. In addition, we have discovered that this protease contains a channel that leads from the enzyme surface (adjacent to the substrate binding groove) to the active site and the deacylating water.	[Chung, Ivy Yeuk Wah; Paetzel, Mark] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Paetzel, M (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	mpaetzel@sfu.ca		Paetzel, Mark/0000-0002-7408-5487	National Science and Engineering Research Council; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan; National Science and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Canadian Foundation of Innovation	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Foundation of Innovation(Canada Foundation for Innovation)	We thank the staff at beam line 08ID-1 at the Canadian Light Source, Saskatoon, Canada (especially Shaunivan Labiuk) for technical assistance with data collection. The Canadian Light Source is supported by the National Science and Engineering Research Council, National Research Council, Canadian Institutes of Health Research, and University of Saskatchewan. We thank Dr. Syunichirou Oshima for providing the YAV cDNA.; This work was supported in part by the Canadian Institutes of Health Research (to M.P.), the National Science and Engineering Research Council of Canada (to M.P.), the Michael Smith Foundation for Health Research (to M.P.), and the Canadian Foundation of Innovation (to M.P.).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Chung IYW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198812; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Da Costa B, 2003, J VIROL, V77, P719, DOI 10.1128/JVI.77.1.719-725.2003; DeLano WL, 2002, PYMOL USERS MANUAL; Delmas B, 2011, VIRUS TAXONOMY, P499; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engh R. A., 2001, INT TABLES CRYSTALLO, VF, P382; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Granzow H, 1997, J VIROL, V71, P8879, DOI 10.1128/JVI.71.11.8879-8885.1997; Hirayama T, 2007, MICROBIOL IMMUNOL, V51, P397, DOI 10.1111/j.1348-0421.2007.tb03927.x; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Hosono N, 1996, J FISH DIS, V19, P295, DOI 10.1111/j.1365-2761.1996.tb00707.x; Imajoh M, 2007, ARCH VIROL, V152, P1103, DOI 10.1007/s00705-007-0935-z; Immirzi A., 1966, CRYSTALLOGRAPHIC COM, P399; Kamakura M., 1995, AUT M JAP SOC FISH P, P14; Kettenhofen NJ, 2010, CHEM RES TOXICOL, V23, P1633, DOI 10.1021/tx100237w; Kim AC, 2008, J MOL BIOL, V376, P352, DOI 10.1016/j.jmb.2007.11.080; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kusuda R., 1989, Suisan Zoshoku, V37, P115; Kusuda Riichi, 1994, Suisan Zoshoku, V42, P145; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2007, J BIOL CHEM, V282, P24928, DOI 10.1074/jbc.M701551200; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LIEBECQ C, 1992, COMPENDIUM BIOCH NOM; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MURSHUDOV G, 1996, REFINEMENT PROTEIN S; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nobiron I, 2008, VIROLOGY, V371, P350, DOI 10.1016/j.virol.2007.09.022; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Paetzel M, 2002, J BIOL CHEM, V277, P9512, DOI 10.1074/jbc.M110983200; Paetzel M, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3487, DOI 10.1016/B978-0-12-382219-2.00773-0; Petit S, 2000, J VIROL, V74, P2057, DOI 10.1128/JVI.74.5.2057-2066.2000; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rodriguez-Lecompte JC, 2002, VIROLOGY, V292, P241, DOI 10.1006/viro.2001.1260; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Suzuki S, 1997, FISHERIES SCI, V63, P563, DOI 10.2331/fishsci.63.563; Suzuki S, 1998, FISHERIES SCI, V64, P342, DOI 10.2331/fishsci.64.342; Suzuki Satoru, 1998, Bulletin of Marine Sciences and Fisheries Kochi University, V18, P39; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; ZIMMERMAN M, 1977, ANAL BIOCHEM, V78, P47, DOI 10.1016/0003-2697(77)90006-9	61	2	2	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13068	13081		10.1074/jbc.M112.386953	http://dx.doi.org/10.1074/jbc.M112.386953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511637	Green Published, hybrid			2022-12-25	WOS:000318555100058
J	Small, JL; O'Donoghue, AJ; Boritsch, EC; Tsodikov, OV; Knudsen, GM; Vandal, O; Craik, CS; Ehrt, S				Small, Jennifer L.; O'Donoghue, Anthony J.; Boritsch, Eva C.; Tsodikov, Oleg V.; Knudsen, Giselle M.; Vandal, Omar; Craik, Charles S.; Ehrt, Sabine			Substrate Specificity of MarP, a Periplasmic Protease Required for Resistance to Acid and Oxidative Stress in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; QUALITY CONTROL; OUTER-MEMBRANE; CELL-ENVELOPE; HTRA FAMILY; PH; ADAPTATION; PHAGOSOME; IDENTIFICATION	The transmembrane serine protease MarP is important for pH homeostasis in Mycobacterium tuberculosis (Mtb). Previous structural studies revealed that MarP contains a chymotrypsin fold and a disulfide bond that stabilizes the protease active site in the substrate-bound conformation. Here, we determined that MarP is located in the Mtb periplasm and showed that this localization is essential for function. Using the recombinant protease domain of MarP, we identified its substrate specificity using two independent assays: positional-scanning synthetic combinatorial library profiling and multiplex substrate profiling by mass spectrometry. These methods revealed that MarP prefers bulky residues at P4, tryptophan or leucine at P2, arginine or hydrophobic residues at P1, and alanine or asparagine at P1'. Guided by these data, we designed fluorogenic peptide substrates and characterized the kinetic properties of MarP. Finally, we tested the impact of mutating MarP cysteine residues on the peptidolytic activity of recombinant MarP and its ability to complement phenotypes of Mtb Delta MarP. Taken together, our studies provide insight into the enzymatic properties of MarP, its substrate preference, and the importance of its transmembrane helices and disulfide bond.	[Small, Jennifer L.; Boritsch, Eva C.; Vandal, Omar; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [O'Donoghue, Anthony J.; Knudsen, Giselle M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Tsodikov, Oleg V.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA	Cornell University; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	charles.craik@ucsf.edu; sae2004@med.cornell.edu	Ehrt, Sabine/AAU-6449-2020		Biomedical Technology Research Centers program of the NIGMS, National Institutes of Health [8P41GM103481]; National Institutes of Health [AI08172, P50 GM082250]; Sandler Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, P50GM082250, P41GM103481] Funding Source: NIH RePORTER	Biomedical Technology Research Centers program of the NIGMS, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. B. Cravatt (Scripps Research Institute, La Jolla, CA) for fluorophosphonate-rhodamine. Mass spectrometry analysis was performed in the Bio-Organic Biomedical Mass Spectrometry Resource at the University of California, San Francisco (A. L. Burlingame, Director), which is supported by the Biomedical Technology Research Centers program of the NIGMS, National Institutes of Health, Grant 8P41GM103481.; This work was supported, in whole or in part, by National Institutes of Health Grants AI08172 (to S. E.) and P50 GM082250 (to C. S. C.). This work was also supported by the Sandler Center (to C. S. C.).	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; [Anonymous], 2011, GLOB TUB CONTR; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Biswas T, 2010, STRUCTURE, V18, P1353, DOI 10.1016/j.str.2010.06.017; Braunstein M, 2000, J BACTERIOL, V182, P2732, DOI 10.1128/JB.182.10.2732-2740.2000; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Darby N., 1995, DISULFIDE BONDS PROT, P219; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Dutton RJ, 2010, P NATL ACAD SCI USA, V107, P297, DOI 10.1073/pnas.0912952107; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster JW, 1999, CURR OPIN MICROBIOL, V2, P170, DOI 10.1016/S1369-5274(99)80030-7; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Jabaiah AM, 2012, BIOL CHEM, V393, P933, DOI 10.1515/hsz-2012-0162; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Ribeiro-Guimaraes ML, 2007, MICROB PATHOGENESIS, V43, P173, DOI 10.1016/j.micpath.2007.05.010; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Schaible UE, 1998, J IMMUNOL, V160, P1290; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Sklar JG, 2010, MOL MICROBIOL, V77, P605, DOI 10.1111/j.1365-2958.2010.07232.x; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Skorko-Glonek J, 2006, ACTA BIOCHIM POL, V53, P585; Skorko-Glonek J, 2013, CURR PHARM DESIGN, V19, P977, DOI 10.2174/1381612811319060003; Sojka D, 2012, J BIOL CHEM, V287, P21152, DOI 10.1074/jbc.M112.347922; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vandal OH, 2009, J BACTERIOL, V191, P625, DOI 10.1128/JB.00932-08; Via LE, 1998, J CELL SCI, V111, P897; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P7032, DOI 10.1021/bi005111p; White MJ, 2010, J BACTERIOL, V192, P1498, DOI 10.1128/JB.01167-09; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	58	23	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12489	12499		10.1074/jbc.M113.456541	http://dx.doi.org/10.1074/jbc.M113.456541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504313	Green Published, hybrid			2022-12-25	WOS:000318555100008
J	Wu, CJ; Mannan, P; Lu, M; Udey, MC				Wu, Chuan-Jin; Mannan, Poonam; Lu, Michael; Udey, Mark C.			Epithelial Cell Adhesion Molecule (EpCAM) Regulates Claudin Dynamics and Tight Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EP-CAM; BARRIER FUNCTION; COLORECTAL-CARCINOMA; TUMOR PROGRESSION; CANCER; ANTIGEN; PROTEINS; GENE; PERMEABILITY; METASTASIS	Epithelial cell adhesion molecule (EpCAM) (CD326) is a surface glycoprotein expressed by invasive carcinomas and some epithelia. Herein, we report that EpCAM regulates the composition and function of tight junctions (TJ). EpCAM accumulated on the lateral interfaces of human colon carcinoma and normal intestinal epithelial cells but did not co-localize with TJ. Knockdown of EpCAM in T84 and Caco-2 cells using shRNAs led to changes in morphology and adhesiveness. TJ formed readily after EpCAM knockdown; the acquisition of trans-epithelial electroresistance was enhanced, and TJ showed increased resistance to disruption by calcium chelation. Preparative immunoprecipitation demonstrated that EpCAM bound tightly to claudin-7. Co-immunoprecipitation documented associations of EpCAM with claudin-7 and claudin-1 but not claudin-2 or claudin-4. Claudin-1 associated with claudin-7 in co-transfection experiments, and claudin-7 was required for association of claudin-1 with EpCAM. EpCAM knockdown resulted in decreases in claudin-7 and claudin-1 proteins that were reversed with lysosome inhibitors. Immunofluorescence microscopy revealed that claudin-7 and claudin-1 continually trafficked into lysosomes. Although EpCAM knockdown decreased claudin-1 and claudin-7 protein levels overall, accumulations of claudin-1 and claudin-7 in TJ increased. Physical interactions between EpCAM and claudins were required for claudin stabilization. These findings suggest that EpCAM modulates adhesion and TJ function by regulating intracellular localization and degradation of selected claudins.	[Wu, Chuan-Jin; Lu, Michael; Udey, Mark C.] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Mannan, Poonam] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Udey, MC (corresponding author), NCI, Dermatol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	udeym@mail.nih.gov			National Institutes of Health grant from the Intramural Research Program, Center for Cancer Research; National Institutes of Health grant from NCI; NATIONAL CANCER INSTITUTE [ZIABC010956] Funding Source: NIH RePORTER	National Institutes of Health grant from the Intramural Research Program, Center for Cancer Research; National Institutes of Health grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants from the Intramural Research Program, Center for Cancer Research, and NCI.	Akita H, 2011, ONCOGENE, V30, P3468, DOI 10.1038/onc.2011.59; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Balzar M, 1998, MOL CELL BIOL, V18, P4833, DOI 10.1128/MCB.18.8.4833; Basak S, 1998, JNCI-J NATL CANCER I, V90, P691, DOI 10.1093/jnci/90.9.691; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Darido C, 2008, CANCER RES, V68, P4258, DOI 10.1158/0008-5472.CAN-07-5805; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Gelderman KA, 2002, EUR J IMMUNOL, V32, P128; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Guerra E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049302; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Koch S, 2009, ANN NY ACAD SCI, V1165, P220, DOI 10.1111/j.1749-6632.2009.04025.x; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lei ZL, 2012, DEV BIOL, V371, P136, DOI 10.1016/j.ydbio.2012.07.005; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lui WY, 2006, MOL CELL ENDOCRINOL, V250, P25, DOI 10.1016/j.mce.2005.12.021; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2010, J CELL BIOL, V191, P645, DOI 10.1083/jcb.201004074; Martin TA, 2011, FRONT BIOSCI-LANDMRK, V16, P898, DOI 10.2741/3726; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tirumalasetty PP, 2006, J PHARM PHARM SCI, V9, P32; Trzpis M, 2008, FRONT BIOSCI-LANDMRK, V13, P5050, DOI 10.2741/3063; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Utech M, 2006, METH MOL B, V341, P185; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Wilson AJ, 1997, CLIN SCI, V93, P97, DOI 10.1042/cs0930097; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamazaki Y, 2011, MOL BIOL CELL, V22, P1495, DOI 10.1091/mbc.E10-12-1003; Zanna P, 2007, CANCER-AM CANCER SOC, V110, P452, DOI 10.1002/cncr.22785; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	48	87	90	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12253	12268		10.1074/jbc.M113.457499	http://dx.doi.org/10.1074/jbc.M113.457499			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486470	Green Published, hybrid			2022-12-25	WOS:000318157600057
J	Mukundan, B; Ansari, A				Mukundan, Banupriya; Ansari, Athar			Srb5/Med18-mediated Termination of Transcription Is Dependent on Gene Looping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; MEDIATOR HEAD MODULE; PROCESSING FACTORS; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; INTERACTION MAP; ELONGATION; ACTIVATION; BINDING; DOMAIN	We have earlier demonstrated the involvement of Mediator subunit Srb5/Med18 in the termination of transcription for a subset of genes in yeast. Srb5/Med18 could affect termination either indirectly by modulating CTD-Ser(2) phosphorylation near the 3' end of a gene or directly by physically interacting with the cleavage and polyadenylation factor or cleavage factor 1 (CF1) complex and facilitating their recruitment to the terminator region. Here, we show that the CTD-Ser(2) phosphorylation pattern on Srb5/Med18-dependent genes remains unchanged in the absence of Srb5 in cells. Coimmunoprecipitation analysis revealed the physical interaction of Srb5/Med18 with the CF1 complex. No such interaction of Srb5/Med18 with the cleavage and polyadenylation factor complex, however, could be detected. The Srb5/Med18-CF1 interaction was not observed in the looping defective sua7-1 strain. Srb5/Med18 cross-linking to the 3' end of genes was also abolished in the sua7-1 strain. Chromosome conformation capture analysis revealed that the looped architecture of Srb5/Med18-dependent genes was abrogated in srb5(-) cells. Furthermore, Srb5-dependent termination of transcription was compromised in the looping defective sua7-1 cells. The overall conclusion of these results is that gene looping plays a crucial role in Srb5/Med18 facilitated termination of transcription, and the looped gene architecture may have a general role in termination of transcription in budding yeast.	[Mukundan, Banupriya; Ansari, Athar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Ansari, A (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	bb2749@wayne.edu	Ansari, Athar/AEK-0223-2022	Ansari, Athar/0000-0003-2806-421X	National Science Foundation [MCB1020911]; Department of Biology, Wayne State University	National Science Foundation(National Science Foundation (NSF)); Department of Biology, Wayne State University	This work was supported in part by National Science Foundation Grant MCB1020911 (to A. A.).; Supported by National Science Foundation Grant (MCB1020911) (to A. A.) and a graduate research fellowship from the Department of Biology, Wayne State University.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; [Anonymous], [No title captured]; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Ansari SA, 2012, TRANSCR-AUSTIN, V3, P110, DOI 10.4161/trns.19840; Ansari SA, 2009, P NATL ACAD SCI USA, V106, P16734, DOI 10.1073/pnas.0905103106; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cai G, 2012, STRUCTURE, V20, P899, DOI 10.1016/j.str.2012.02.023; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crevillen P, 2013, EMBO J, V32, P140, DOI 10.1038/emboj.2012.324; Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Henriques T, 2012, TRANSCR-AUSTIN, V3, P198, DOI 10.4161/trns.21967; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; Hirose Y, 2000, GENE DEV, V14, P1415; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kremer SB, 2012, GENETICS, V191, P95, DOI 10.1534/genetics.111.135806; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lykke-Andersen S, 2011, CELL CYCLE, V10, P863, DOI 10.4161/cc.10.6.14931; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; Malik S, 2007, P NATL ACAD SCI USA, V104, P6182, DOI 10.1073/pnas.0608717104; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Medler S, 2011, J BIOL CHEM, V286, P33709, DOI 10.1074/jbc.M110.193870; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Moabbi AM, 2012, P NATL ACAD SCI USA, V109, P8505, DOI 10.1073/pnas.1112400109; Mukundan B, 2011, J BIOL CHEM, V286, P37053, DOI 10.1074/jbc.C111.295915; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Proshkina G M, 2009, Bioorg Khim, V35, P572; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Shandilya J, 2012, BBA-GENE REGUL MECH, V1819, P391, DOI 10.1016/j.bbagrm.2012.01.010; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012	68	27	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11384	11394		10.1074/jbc.M112.446773	http://dx.doi.org/10.1074/jbc.M112.446773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23476016	Green Published, hybrid			2022-12-25	WOS:000317915500041
J	Durigutto, P; Macor, P; Ziller, F; De Maso, L; Fischetti, F; Marzari, R; Sblattero, D; Tedesco, F				Durigutto, Paolo; Macor, Paolo; Ziller, Federica; De Maso, Luca; Fischetti, Fabio; Marzari, Roberto; Sblattero, Daniele; Tedesco, Francesco			Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; IMMUNE-SYSTEM; MICE; THERAPY; INFLAMMATION; ETANERCEPT; ACTIVATION; INJECTION; PROTEINS	Treatment of patients suffering from chronic diseases such as rheumatoid arthritis with recombinant antibodies is time consuming and fairly expensive and can be associated with side effects due to generalized depletion of the target molecule. We have addressed these issues by developing an alternative approach consisting of the intraarticular injection of a DNA vector encoding for the anti-C5 neutralizing recombinant miniantibody MB12/22. This method allows local production of the antibody in sufficient amount to be effective in preventing joint inflammation in a rat model of antigen-induced arthritis. Injection of the DNA vector in a right knee of normal rats resulted in the production of the minibody detected in the synovial washes by western blot with a strong signal peaking at 3 days after administration. DNA encoding for the minibody was shown for 14 days in the synovial tissue and was undetectable in the controlateral knee and in other organs. The preventive effect of this approach was evaluated in rats receiving a single injection of the vector 3 days before the induction of antigen-induced arthritis and analyzed 3 days later. The treated rats exhibited a lower increase in swelling, associated with a lower number of PMN in the articular washes and reduced deposition of C9 in synovial tissue compared to control rats. These results suggest that treating the inflamed joints with a vector that induces a local production of a neutralizing anti-C5 antibody may represent a useful strategy to inhibit in situ complement activation and to treat patients with monoarthritis. Moreover, this approach may be adopted as a novel therapeutic strategy to prevent monoarthritis as an alternative to local treatment with antibodies commonly used in this form of arthritis, with the advantages of the lower cost and the longer persistence of antibody production.	[Durigutto, Paolo; Macor, Paolo; Ziller, Federica; De Maso, Luca; Marzari, Roberto; Tedesco, Francesco] Univ Trieste, Dept Life Sci, Trieste, Italy; [Fischetti, Fabio] Univ Trieste, Dipartimento Univ Clin Sci Med Chirurg & Salute, Trieste, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, IRCAD, Novara, Italy	University of Trieste; University of Trieste; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Macor, P (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	pmacor@units.it	Tedesco, Francesco/F-1929-2011	Macor, Paolo/0000-0003-3079-4019; Sblattero, Daniele/0000-0003-4309-242X; Durigutto, Paolo/0000-0003-3862-4970	Italian Ministry of University and Research [MFXE7L_004]; Fondazione SanPaolo; Fondazione Cariplo Bando ricerca biomedica; Fondazione Casali - Trieste	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione SanPaolo(Compagnia di San Paolo); Fondazione Cariplo Bando ricerca biomedica; Fondazione Casali - Trieste	This study has been made possible by research grants from the Italian Ministry of University and Research (PRIN MFXE7L_004); Fondazione SanPaolo, Fondazione Cariplo Bando ricerca biomedica 2009, and Fondazione Casali - Trieste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; Banda NK, 2010, J IMMUNOL, V185, P5598, DOI 10.4049/jimmunol.1001564; Bliddal H, 2006, SCAND J RHEUMATOL, V35, P341, DOI 10.1080/03009740600844530; Boscolo S, 2012, NEW BIOTECHNOL, V29, P477, DOI 10.1016/j.nbt.2011.12.005; Cesco-Gaspere M, 2008, SCAND J IMMUNOL, V68, P58, DOI 10.1111/j.1365-3083.2008.02119.x; Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x; CORVETTA A, 1992, CLIN EXP RHEUMATOL, V10, P433; Di Niro R, 2008, MOL IMMUNOL, V45, P1782, DOI 10.1016/j.molimm.2007.09.025; Dimitrova P, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3926; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Fischetti F, 2007, ARTHRITIS RHEUM-US, V56, P1187, DOI 10.1002/art.22492; Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009; Garmory HS, 2005, ADV DRUG DELIVER REV, V57, P1343, DOI 10.1016/j.addr.2005.01.013; Goodfellow RM, 1997, CLIN EXP IMMUNOL, V110, P45; Hackett NR, 2000, CURR OPIN MOL THER, V2, P376; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hietala MA, 2004, EUR J IMMUNOL, V34, P1208, DOI 10.1002/eji.200424895; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Linton SM, 1999, MOL IMMUNOL, V36, P905, DOI 10.1016/S0161-5890(99)00113-3; Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811; Macor P, 2012, ARTHRITIS RHEUM-US, V64, P2559, DOI 10.1002/art.34430; Marzari R, 2002, EUR J IMMUNOL, V32, P2773, DOI 10.1002/1521-4141(2002010)32:10<2773::AID-IMMU2773>3.0.CO;2-G; Morgan B P, 2000, Methods Mol Biol, V150, P1; Neumann E, 2002, ARTHRITIS RHEUM, V46, P934, DOI 10.1002/art.10183; Nilsson KE, 2009, FASEB J, V23, P2450, DOI 10.1096/fj.08-125849; Ochiya T, 1999, BIOCHEM BIOPH RES CO, V258, P358, DOI 10.1006/bbrc.1999.0590; Roux CH, 2011, J RHEUMATOL, V38, P1009, DOI 10.3899/jrheum.100828; Senolt L, 2009, AUTOIMMUN REV, V9, P102, DOI 10.1016/j.autrev.2009.03.010; Skaricic D, 2008, VIROLOGY, V378, P79, DOI 10.1016/j.virol.2008.04.016; Smolen JS, 2010, ANN RHEUM DIS, V69, P1058, DOI 10.1136/ard.2009.114652; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Thrall JH, 2005, RADIOLOGY, V235, P9, DOI 10.1148/radiol.2351041768; Valenta R, 2011, J ALLERGY CLIN IMMUN, V127, P860, DOI 10.1016/j.jaci.2011.02.016; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Ziller F, 2005, EUR J IMMUNOL, V35, P2175, DOI 10.1002/eji.200425920	37	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58696	10.1371/journal.pone.0058696	http://dx.doi.org/10.1371/journal.pone.0058696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505550	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500115
J	Lv, M; Ye, HG; Zhao, XS; Zhao, XY; Chang, YJ; Liu, DH; Xu, LP; Huang, XJ				Lv, Meng; Ye, Hai-ge; Zhao, Xiao-su; Zhao, Xiang-yu; Chang, Ying-jun; Liu, Dai-hong; Xu, Lan-ping; Huang, Xiao-jun			Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ACUTE-PHASE PROTEINS; MARROW; BLOOD; GVHD; OXIDASE; TRIALS; SERUM	Acute graft-versus-host-disease (aGvHD) is the major cause of non-relapse mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recently, diagnostic biomarkers for aGvHD have been shown to play important roles in evaluating disease status and mortality risk after allo-HSCT. To identify plasma biomarkers for aGvHD with high sensitivity and specificity, a quantitative proteomic approach using 8-plex isobaric tags for relative and absolute quantitation (8-plex iTRAQ) was employed to screen differentially expressed proteins in peripheral blood before and after the onset of aGvHD. Four target proteins, ceruloplasmin (CP), myeloperoxidase (MPO), complement factor H (CFH), and alpha-1-acid glycoprotein (AGP), were chosen for preliminary validation with enzyme linked immunosorbent assay (ELISA) in 20 paired samples at both the time of diagnosis of aGvHD and the time of complete response. The most promising candidate, ceruloplasmin, was further validated at fixed time points after allo-HSCT and during aGvHD. The plasma ceruloplasmin levels were significantly increased during the period of aGvHD onset and were markedly decreased as aGvHD resolved. The plasma ceruloplasmin levels at different time points post-transplant in the aGvHD (+) group were significantly higher than those in the aGvHD (2) group (p<0.001). The elevation of ceruloplasmin level in patients with active aGvHD was independent of infection status. Patients whose ceruloplasmin levels were elevated above 670 mu g/ml at 7, 14 and 21 days after allo-HSCT had a remarkably increased probability of subsequently developing aGvHD. In conclusion, our results suggest that plasma ceruloplasmin is a potential plasma biomarker of aGvHD, and it also has prognostic value for risk-adapted prophylaxis during the consecutive time points monitored in the first month after allo-HSCT.	[Lv, Meng; Ye, Hai-ge; Zhao, Xiao-su; Zhao, Xiang-yu; Chang, Ying-jun; Liu, Dai-hong; Xu, Lan-ping; Huang, Xiao-jun] Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China; [Ye, Hai-ge] Wenzhou Med Coll, Affiliated Hosp 1, Dept Hematol, Wenzhou, Zhejiang, Peoples R China	Peking University; Wenzhou Medical University	Huang, XJ (corresponding author), Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China.	huangxiaojun@bjmu.edu.cn	Chang, Ying-Jun/AAA-1182-2020; Lv, Meng/I-5203-2014	Chang, Ying-Jun/0000-0002-6124-6050; Lv, Meng/0000-0001-6625-9523; Huang, XiaoJun/0000-0002-2145-6643	Key Program of National Natural Science Foundation of China [81230013]; Major State Basic Research Development Program of China (973 Program) [2013CB733700]; Beijing Municipal Science and Technology Program [Z111107067311070]; Natural Science Foundation of Beijing [7122193]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Science and Technology Program; Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This research was supported by the Key Program of National Natural Science Foundation of China (grant no. 81230013), the Major State Basic Research Development Program of China (973 Program No. 2013CB733700), the Beijing Municipal Science and Technology Program (grant no. Z111107067311070), Natural Science Foundation of Beijing (grant no. 7122193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer J, 2007, ANN HEMATOL, V86, P753, DOI 10.1007/s00277-007-0321-7; Chang YJ, 2012, CURR OPIN HEMATOL, V19, P454, DOI 10.1097/MOH.0b013e3283582322; Chen YB, 2012, BONE MARROW TRANSPLA; Chiarla C, 2008, J SURG RES, V144, P107, DOI 10.1016/j.jss.2007.03.024; Choi SW, 2008, BLOOD, V112, P1539, DOI 10.1182/blood-2008-02-138867; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Giurgea N, 2005, MED SCI MONITOR, V11, pRA48; Healy J, 2007, J NEURAL TRANSM, V114, P777, DOI 10.1007/s00702-007-0687-7; Hrycek A, 2007, AUTOIMMUNITY, V40, P217, DOI 10.1080/08916930701306817; Huang XJ, 2012, BLOOD, V119, P5584, DOI 10.1182/blood-2011-11-389809; Huang XJ, 2009, CLIN CANCER RES, V15, P4777, DOI 10.1158/1078-0432.CCR-09-0691; Huang XJ, 2001, LEUKEMIA, V15, P1089, DOI 10.1038/sj.leu.2402151; Koc M, 2003, BIOL PHARM BULL, V26, P1494, DOI 10.1248/bpb.26.1494; Levine JE, 2012, BLOOD, V119, P3854, DOI 10.1182/blood-2012-01-403063; Li TW, 2010, CHINESE MED J-PEKING, V123, P537, DOI 10.3760/cma.j.issn.0366-6999.2010.05.006; MacMillan ML, 2010, BLOOD, V115, P5412, DOI 10.1182/blood-2009-12-258442; Martin PJ, 2008, BEST PRACT RES CL HA, V21, P357, DOI 10.1016/j.beha.2008.03.001; NATESHA RK, 1992, J NATL MED ASSOC, V84, P781; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Paradis M, 2010, FREE RADICAL BIO MED, V49, P2019, DOI 10.1016/j.freeradbiomed.2010.09.030; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Sidhu A, 2011, BIOCHEM BIOPH RES CO, V404, P963, DOI 10.1016/j.bbrc.2010.12.089; Weiss Karl Heinz, 2012, Curr Gastroenterol Rep, V14, P1, DOI 10.1007/s11894-011-0227-3; Ye HG, 2012, INT J HEMATOL, V95, P680, DOI 10.1007/s12185-012-1076-z; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x	28	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58735	10.1371/journal.pone.0058735	http://dx.doi.org/10.1371/journal.pone.0058735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505556	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500121
J	Solinski, HJ; Petermann, F; Rothe, K; Boekhoff, I; Gudermann, T; Breit, A				Solinski, Hans Juergen; Petermann, Franziska; Rothe, Kathrin; Boekhoff, Ingrid; Gudermann, Thomas; Breit, Andreas			Human Mas-Related G Protein-Coupled Receptors-X1 Induce Chemokine Receptor 2 Expression in Rat Dorsal Root Ganglia Neurons and Release of Chemokine Ligand 2 from the Human LAD-2 Mast Cell Line	PLOS ONE			English	Article							SENSORY NEURON; DEPENDENT TRANSCRIPTION; CONSTITUTIVE ACTIVITY; SPECIES-DIFFERENCES; OPIOID RECEPTORS; NUCLEAR FACTOR; SPINAL-CORD; C-FOS; ACTIVATION; BRADYKININ	Primate-specific Mas-related G protein-coupled receptors-X1 (MRGPR-X1) are highly enriched in dorsal root ganglia (DRG) neurons and induce acute pain. Herein, we analyzed effects of MRGPR-X1 on serum response factors (SRF) or nuclear factors of activated T cells (NFAT), which control expression of various markers of chronic pain. Using HEK293, DRG neuron-derived F11 cells and cultured rat DRG neurons recombinantly expressing human MRGPR-X1, we found activation of a SRF reporter gene construct and induction of the early growth response protein-1 via extracellular signal-regulated kinases-1/2 known to play a significant role in the development of inflammatory pain. Furthermore, we observed MRGPR-X1-induced upregulation of the chemokine receptor 2 (CCR2) via NFAT, which is considered as a key event in the onset of neuropathic pain and, so far, has not yet been described for any endogenous neuropeptide. Up-regulation of CCR2 is often associated with increased release of its endogenous agonist chemokine ligand 2 (CCL2). We also found MRGPR-X1-promoted release of CCL2 in a human connective tissue mast cell line endogenously expressing MRGPR-X1. Thus, we provide first evidence to suggest that MRGPR-X1 induce expression of chronic pain markers in DRG neurons and propose a so far unidentified signaling circuit that enhances chemokine signaling by acting on two distinct yet functionally co-operating cell types. Given the important role of chemokine signaling in pain chronification, we propose that interruption of this signaling circuit might be a promising new strategy to alleviate chemokine-promoted pain.	[Solinski, Hans Juergen; Rothe, Kathrin; Boekhoff, Ingrid; Gudermann, Thomas; Breit, Andreas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80539 Munich, Germany; [Petermann, Franziska] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	University of Munich; Technical University of Munich	Breit, A (corresponding author), Univ Munich, Walther Straub Inst Pharmakol & Toxikol, Nussbaumstr 26, D-80539 Munich, Germany.	andreas.breit@lrz.uni-muenchen.de			Deutsche Forschungsgemeinschaft [BR 3346/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the "Deutsche Forschungsgemeinschaft" [grant BR 3346/3-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Andrisani OM, 1999, CRIT REV EUKAR GENE, V9, P19, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.20; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bhangoo S, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-38; Bhangoo SK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-48; BOLAND LM, 1991, J NEUROSCI, V11, P1140; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Brinkmann M, 2002, CYTOTECHNOLOGY, V38, P119, DOI 10.1023/A:1021118501866; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Chen HM, 2004, J NEUROSCI, V24, P5044, DOI 10.1523/JNEUROSCI.0990-04.2004; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Dolan S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-91; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Eijkelkamp N, 2010, J NEUROSCI, V30, P2138, DOI 10.1523/JNEUROSCI.5752-09.2010; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; Fatakia SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027813; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Grazzini E, 2004, P NATL ACAD SCI USA, V101, P7175, DOI 10.1073/pnas.0307185101; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Hao L, 2012, BMC EVOL BIOL, V10, P316; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Jackson JG, 2007, MOL PHARMACOL, V72, P303, DOI 10.1124/mol.107.035048; JAMIESON GA, 1989, J CELL PHYSIOL, V139, P262, DOI 10.1002/jcp.1041390207; Jenkins L, 2012, BIOCHEM J, V432, P451; Jow F, 2006, ASSAY DRUG DEV TECHN, V4, P49, DOI 10.1089/adt.2006.4.49; Jung HT, 2008, MOL CELL NEUROSCI, V37, P170, DOI 10.1016/j.mcn.2007.09.004; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; KATAYAMA N, 1993, J NEUROCHEM, V60, P902, DOI 10.1111/j.1471-4159.1993.tb03235.x; KENDALL G, 1994, MOL BRAIN RES, V25, P73, DOI 10.1016/0169-328X(94)90280-1; Kerr N, 2010, MOL CELL NEUROSCI, V44, P165, DOI 10.1016/j.mcn.2010.03.005; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Ko SW, 2005, J PAIN, V6, P12, DOI 10.1016/j.jpain.2004.10.001; Kunapuli P, 2006, ANAL BIOCHEM, V351, P50, DOI 10.1016/j.ab.2006.01.014; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li J, 2002, MOL PHARMACOL, V61, P73, DOI 10.1124/mol.61.1.73; Li YZ, 2004, J NEUROSCI, V24, P9623, DOI 10.1523/JNEUROSCI.2392-04.2004; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; McIlvain HB, 2006, BRAIN RES, V1077, P16, DOI 10.1016/j.brainres.2005.12.130; MOORE JJ, 1982, PLACENTA, V3, P257, DOI 10.1016/S0143-4004(82)80003-9; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Puttfarcken PS, 1997, J NEUROCHEM, V69, P930; Romero A, 2012, N-S ARCH PHARMACOL, V385, P397, DOI 10.1007/s00210-011-0721-z; Rothe K, 2012, J PHARMACOL EXP THER, V342, P41, DOI 10.1124/jpet.112.192757; Serrano A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-90; Seybold VS, 2006, J NEUROCHEM, V97, P397, DOI 10.1111/j.1471-4159.2006.03744.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Skaper SD, 2012, FASEB J; Solinski HJ, 2010, MOL PHARMACOL, V78, P249, DOI 10.1124/mol.110.063867; Solinski HJ, 2012, J BIOL CHEM; Strasser A, 2013, TRENDS PHARMACOL SCI, V34, P13, DOI 10.1016/j.tips.2012.10.004; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Taylor DA, 2001, J PHARMACOL EXP THER, V297, P11; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Wang CH, 2010, NEUROSCI LETT, V475, P48, DOI 10.1016/j.neulet.2010.03.044; White FA, 2005, NAT REV DRUG DISCOV, V4, P834, DOI 10.1038/nrd1852; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	69	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58756	10.1371/journal.pone.0058756	http://dx.doi.org/10.1371/journal.pone.0058756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505557	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500122
J	Janek, T; Krasowska, A; Radwanska, A; Lukaszewicz, M				Janek, Tomasz; Krasowska, Anna; Radwanska, Agata; Lukaszewicz, Marcin			Lipopeptide Biosurfactant Pseudofactin II Induced Apoptosis of Melanoma A 375 Cells by Specific Interaction with the Plasma Membrane	PLOS ONE			English	Article							LEUKEMIA K562 CELLS; INDUCTION; MITOCHONDRIA; ARREST	In the case of melanoma, advances in therapies are slow, which raises the need to evaluate new therapeutic strategies and natural products with potential cancer cell inhibiting effect. Pseudofactin II (PFII), a novel cyclic lipopeptide biosurfactant has been isolated from the Arctic strain of Pseudomonas fluorescens BD5. The aim of this study was to investigate the effect of PFII on A375 melanoma cells compared with the effect of PFII on Normal Human Dermis Fibroblast (NHDF) cells and elucidate the underlying mechanism of PFII cytotoxic activity. Melanoma A375 cells and NHDF cells were exposed to PFII or staurosporine and apoptotic death was assessed by monitoring caspase 3-like activity and DNA fragmentation. From time-dependent monitoring of lactate dehydrogenase (LDH) release, Ca2+ influx, and a correlation between Critical Micelle Concentration (CMC) we concluded that cell death is the consequence of plasma membrane permeabilisation by micelles. This finding suggests that pro-apoptotic mechanism of PFII is different from previously described cyclic lipopeptides. The mechanism of PFII specificity towards malignant cells remains to be discovered. The results of this study show that PFII could be a new promising anti-melanoma agent.	[Janek, Tomasz; Krasowska, Anna; Lukaszewicz, Marcin] Univ Wroclaw, Fac Biotechnol, Dept Biotransformat, PL-50138 Wroclaw, Poland; [Radwanska, Agata] Univ Wroclaw, Fac Biotechnol, Dept Cell Pathol, PL-50138 Wroclaw, Poland; [Lukaszewicz, Marcin] Univ Wroclaw, Div Chem & Technol Fuels, PL-50138 Wroclaw, Poland	University of Wroclaw; University of Wroclaw; University of Wroclaw	Lukaszewicz, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Biotransformat, PL-50138 Wroclaw, Poland.	marcin.lukaszewicz@uni.wroc.pl	Janek, Tomasz/AAQ-8641-2020; Janek, Tomasz/AAQ-8642-2020; Łukaszewicz, Marcin/K-8441-2013; Janek, Tomasz/E-2059-2017; Krasowska, Anna/I-5054-2019	Janek, Tomasz/0000-0003-1939-5500; Łukaszewicz, Marcin/0000-0002-1453-8376; Janek, Tomasz/0000-0003-1939-5500; Krasowska, Anna/0000-0002-1925-193X; Radwanska, Agata/0000-0002-8424-4648	Polish National Centre for Science [NN302 640940]; Polish National Centre for Research and Development [KB/48/13639/IT1-B/U/08]; EU [POIG.01.01.02-00-016/2008]	Polish National Centre for Science; Polish National Centre for Research and Development; EU(European Commission)	This work was financially supported by a grant from the Polish National Centre for Science NN302 640940, Polish National Centre for Research and Development KB/48/13639/IT1-B/U/08 and EU POIG.01.01.02-00-016/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Eggermont AMM, 2010, ANN ONCOL, V21, P339, DOI 10.1093/annonc/mdq364; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hersey P, 2003, J CELL PHYSIOL, V196, P9, DOI 10.1002/jcp.10256; Hersey P, 2002, EXPERT OPIN INV DRUG, V11, P75, DOI 10.1517/13543784.11.1.75; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; HUH C, 1975, COLLOID POLYM SCI, V253, P566, DOI 10.1007/BF01753960; Igor NS, 2005, J STEROID BIOCHEM, V97, P145; Janek T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-24; Janek T, 2010, BIORESOURCE TECHNOL, V101, P6118, DOI 10.1016/j.biortech.2010.02.109; Kim SY, 2007, FEBS LETT, V581, P865, DOI 10.1016/j.febslet.2007.01.059; Krasowska A, 2011, ACTA SCI POL BIOTECH, V10, P3; Landman D, 2008, CLIN MICROBIOL REV, V21, P449, DOI 10.1128/CMR.00006-08; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Mitchell D, 2012, PIGMENT CELL MELANOM; Nielsen TH, 2003, APPL ENVIRON MICROB, V69, P861, DOI 10.1128/AEM.69.2.861-868.2003; Oakes SA, 2003, BIOCHEM PHARMACOL, V66, P1335, DOI 10.1016/S0006-2952(03)00482-9; Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010; Sudo T, 2000, CYTOTECHNOLOGY, V33, P259, DOI 10.1023/A:1008137817944; Tim M., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4.PMID:6606682; Wang CL, 2007, PEPTIDES, V28, P1344, DOI 10.1016/j.peptides.2007.06.014; Wang CL, 2009, CANCER LETT, V276, P221, DOI 10.1016/j.canlet.2008.11.007; Zaragoza A, 2010, LANGMUIR, V26, P8567, DOI 10.1021/la904637k; Zaragoza A, 2009, LANGMUIR, V25, P7892, DOI 10.1021/la900480q; Zhao XX, 2000, CYTOTECHNOLOGY, V33, P123, DOI 10.1023/A:1008129616127	25	45	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57991	10.1371/journal.pone.0057991	http://dx.doi.org/10.1371/journal.pone.0057991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483962	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100067
J	Wang, P; Song, P; Jin, MM; Zhu, GP				Wang, Peng; Song, Ping; Jin, Mingming; Zhu, Guoping			Isocitrate Dehydrogenase from Streptococcus mutans: Biochemical Properties and Evaluation of a Putative Phosphorylation Site at Ser102	PLOS ONE			English	Article							INDUCED OXIDATIVE DAMAGE; CELLULAR DEFENSE; MOLECULAR CHARACTERIZATION; COFACTOR SPECIFICITY; CRYSTAL-STRUCTURE; ENZYME; MECHANISM; INSIGHTS; REVEALS; STATE	Isocitrate deyhdrogenase (IDH) is a reversible enzyme in the tricarboxylic acid cycle that catalyzes the NAD(P)(+)-dependent oxidative decarboxylation of isocitrate to alpha-ketoglutarate (alpha KG) and the NAD(P)H/CO2-dependent reductive carboxylation of alpha KG to isocitrate. The IDH gene from Streptococcus mutans was fused with the icd gene promoter from Escherichia coli to initiate its expression in the glutamate auxotrophic strain E. coli Delta icd::kan(r) of which the icd gene has been replaced by kanamycin resistance gene. The expression of S. mutans IDH (SmIDH) may restore the wild-type phenotype of the icd-defective strain on minimal medium without glutamate. The molecular weight of SmIDH was estimated to be 70 kDa by gel filtration chromatography, suggesting a homodimeric structure. SmIDH was divalent cation-dependent and Mn2+ was found to be the most effective cation. The optimal pH of SmIDH was 7.8 and the maximum activity was around 45 degrees C. SmIDH was completely NAD(+) dependent and its apparent K-m for NAD(+) was 137 mu M. In order to evaluate the role of the putative phosphorylation site at Ser102 in catalysis, two "stably phosphorylated" mutants were constructed by converting Ser102 into Glu102 or Asp102 in SmIDH to mimick a constitutively phosphorylated state. Meanwhile, the functional roles of another four amino acids (threonine, glycine, alanine and tyrosine) containing variant size of side chains were investigated. The replacement of Asp102 or Glu102 totally inactivated the enzyme, while the S102T, S102G, S102A and S102Y mutants decreased the affinity to isocitrate and only retained 16.0%, 2.8%, 3.3% and 1.1% of the original activity, respectively. These results reveal that Ser102 plays important role in substrate binding and is required for the enzyme function. Also, Ser102 in SmIDH is a potential phosphorylation site, indicating that the ancient NAD-dependent IDHs might be the underlying origin of "phosphorylation mechanism" used by their bacterial NADP-dependent homologs.	[Zhu, Guoping] Anhui Normal Univ, Key Lab Mol Evolut & Biodivers, Coll Life Sci, Wuhu, Anhui, Peoples R China; Anhui Normal Univ, Inst Mol Biol & Biotechnol, Coll Life Sci, Wuhu, Anhui, Peoples R China	Anhui Normal University; Anhui Normal University	Zhu, GP (corresponding author), Anhui Normal Univ, Key Lab Mol Evolut & Biodivers, Coll Life Sci, Wuhu, Anhui, Peoples R China.	gpz1996@yahoo.com	Wang, Peng/I-8770-2018; Wang, Peng/AAW-9052-2020	Wang, Peng/0000-0002-5598-0996; Wang, Peng/0000-0002-5598-0996	National High Technology Research and Development Program ("863" Program) [2012AA02A708]; National Natural Science Foundation of China [31170005, 30870062]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113424110004]; State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (CAS) [GREKF11-07]	National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (CAS)	This research was supported by the National High Technology Research and Development Program ("863" Program: 2012AA02A708), the National Natural Science Foundation of China (31170005; 30870062), Specialized Research Fund for the Doctoral Program of Higher Education of China (20113424110004), and the Fund of State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (CAS) (GREKF11-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshima M, 2004, MOL MICROBIOL, V51, P791, DOI 10.1046/j.1365-2958.2003.03863.x; Aoshima M, 2008, J BACTERIOL, V190, P2050, DOI 10.1128/JB.01799-07; BORTHWICK AC, 1984, BIOCHEM J, V222, P797, DOI 10.1042/bj2220797; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chen RD, 1996, PROTEIN SCI, V5, P287; Cvitkovitch DG, 1997, J BACTERIOL, V179, P650, DOI 10.1128/jb.179.3.650-655.1997; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DEAN AM, 1990, SCIENCE, V249, P1044, DOI 10.1126/science.2204110; DEAN AM, 1989, J BIOL CHEM, V264, P20482; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grodsky NB, 2000, BIOCHEMISTRY-US, V39, P2193, DOI 10.1021/bi9919753; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Hurley JH, 1996, BIOCHEMISTRY-US, V35, P5670, DOI 10.1021/bi953001q; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; Imada K, 2008, PROTEINS, V70, P63, DOI 10.1002/prot.21486; Inoue H, 2002, FEMS MICROBIOL LETT, V214, P127, DOI 10.1111/j.1574-6968.2002.tb11335.x; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kim HJ, 2005, FREE RADICAL RES, V39, P441, DOI 10.1080/10715760500066265; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Matsuno K, 1999, J BACTERIOL, V181, P3382, DOI 10.1128/JB.181.11.3382-3391.1999; MCKEE JS, 1989, BIOCHEM J, V261, P301, DOI 10.1042/bj2610301; MEIXNERMONORI B, 1986, BIOCHEM J, V236, P549, DOI 10.1042/bj2360549; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Singh SK, 2002, J BIOL CHEM, V277, P7567, DOI 10.1074/jbc.M107908200; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Steen IH, 2001, J BIOL CHEM, V276, P43924, DOI 10.1074/jbc.M105999200; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; Stokke R, 2007, ARCH MICROBIOL, V187, P361, DOI 10.1007/s00203-006-0200-y; Taylor AB, 2008, J BIOL CHEM, V283, P10872, DOI 10.1074/jbc.M708719200; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; WALSH K, 1985, J BIOL CHEM, V260, P8430; Wang P, 2012, FEMS MICROBIOL LETT, V327, P134, DOI 10.1111/j.1574-6968.2011.02467.x; Wang P, 2011, BIOCHIMIE, V93, P1470, DOI 10.1016/j.biochi.2011.04.021; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoon JJ, 2003, BIOSCI BIOTECH BIOCH, V67, P114, DOI 10.1271/bbb.67.114; Zaremba-Czogalla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032649; Zhang BB, 2009, BIOCHIMIE, V91, P1405, DOI 10.1016/j.biochi.2009.07.011; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	49	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58918	10.1371/journal.pone.0058918	http://dx.doi.org/10.1371/journal.pone.0058918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484056	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100142
J	Cohen, B; Martinelli, GP; Raphan, T; Schaffner, A; Xiang, YQ; Holstein, GR; Yakushin, SB				Cohen, Bernard; Martinelli, Giorgio P.; Raphan, Theodore; Schaffner, Adam; Xiang, Yongqing; Holstein, Gay R.; Yakushin, Sergei B.			The vasovagal response of the rat: its relation to the vestibulosympathetic reflex and to Mayer waves	FASEB JOURNAL			English	Article						blood pressure; heart rate; sinusoidal galvanic vestibular stimulation; linear acceleration; faints; otolith system	SYMPATHETIC-NERVE ACTIVITY; GALVANIC VESTIBULAR STIMULATION; DIFFERENTIAL-DELAY EQUATION; BLOOD-PRESSURE WAVES; ARTERIAL-PRESSURE; HEART-RATE; LINEAR ACCELERATION; BAROREFLEX CONTROL; SQUIRREL-MONKEY; SYNCOPE	Vasovagal responses (VVRs) are characterized by transient drops in blood pressure (BP) and heart rate (HR) and increased amplitude of low-frequency oscillations in the Mayer wave frequency range. Typical VVRs were induced in anesthetized, male, Long-Evans rats by sinusoidal galvanic vestibular stimulation (sGVS). VVRs were also produced by single sinusoids that transiently increased BP and HR, by 70-90 degrees nose-up tilts, and by 60 degrees tilts of the gravitoinertial acceleration vector using translation while rotating (TWR). The average power of the BP signal in the Mayer wave range increased substantially when tilts were >70 degrees (0.91 g), i.e., when linear accelerations in the x-z plane were 0.9-1.0 g. The standard deviations of the wavelet-filtered BP signals during tilt and TWR overlaid when they were normalized to 1 g. Thus, the amplitudes of the Mayer waves coded the magnitude of the linear acceleration 1 g acting on the head and body, and the average power in this frequency range was associated with the generation of VVRs. These data show that VVRs are a natural outcome of stimulation of the vestibulosympathetic reflex and are not a disease. The results also demonstrate the usefulness of the rat as a small animal model for studying human VVRs.Cohen, B., Martinelli, G. P., Raphan, T., Schaffner, A., Xiang, Y., Holstein, G. R., Yakushin, S. B. The vasovagal response of the rat: its relation to the vestibulosympathetic reflex and to Mayer waves.	[Cohen, Bernard; Martinelli, Giorgio P.; Schaffner, Adam; Holstein, Gay R.; Yakushin, Sergei B.] Icahn Sch Med Mt Sinai, Dept Neurol, Brooklyn, NY USA; [Holstein, Gay R.] Icahn Sch Med Mt Sinai, Dept Neurosci, Brooklyn, NY USA; [Raphan, Theodore; Xiang, Yongqing] CUNY Brooklyn Coll, Dept Comp & Informat Sci, Brooklyn, NY 11210 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Brooklyn College (CUNY)	Yakushin, SB (corresponding author), Mt Sinai Sch Med, Box 1135,1 Gustave Levy Pl, New York, NY 10029 USA.	bernard.cohen@mssm.edu			U.S. National Institutes of Health [DC12573, DC008846, AG035389, DC004996, DC05204]; NATIONAL INSTITUTE ON AGING [R21AG035389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012573, R01DC008846, P30DC005204, R01DC004996] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by U.S. National Institutes of Health grants DC12573, DC008846, AG035389, DC004996, and DC05204. The authors thank Kathleen Crosby for editorial assistance and Dmitri Ogorodnikov for technical assistance.	Abbiw-Jackson RM, 1998, J MATH BIOL, V37, P203, DOI 10.1007/s002850050126; Alboni P, 2000, EUROPACE, V2, P172, DOI 10.1053/eupc.1999.0088; Alboni P, 2007, EUROPACE, V9, P83, DOI 10.1093/europace/eul179; Bent LR, 2006, EXP BRAIN RES, V174, P701, DOI 10.1007/s00221-006-0515-6; Burattini R, 2004, EXP PHYSIOL, V89, P397, DOI 10.1113/expphysiol.2003.027094; Burgess DE, 1997, AM J PHYSIOL-REG I, V273, pR1878, DOI 10.1152/ajpregu.1997.273.6.R1878; Card JP, 2006, J COMP NEUROL, V499, P840, DOI 10.1002/cne.21140; Cavalcanti S, 1996, IEEE T BIO-MED ENG, V43, P982, DOI 10.1109/10.536899; Chapuis B, 2004, J PHYSIOL-LONDON, V559, P639, DOI 10.1113/jphysiol.2004.065474; Cohen Bernard, 2012, Front Neurol, V3, P148, DOI 10.3389/fneur.2012.00148; Cohen Bernard, 2011, Front Neurol, V2, P90, DOI 10.3389/fneur.2011.00090; Cohen B, 2011, EXP BRAIN RES, V210, P45, DOI 10.1007/s00221-011-2604-4; Connolly SJ, 2003, JAMA-J AM MED ASSOC, V289, P2224, DOI 10.1001/jama.289.17.2224; COURJON JH, 1987, EXP BRAIN RES, V66, P41; Cui J, 2001, AM J PHYSIOL-REG I, V281, pR625, DOI 10.1152/ajpregu.2001.281.2.R625; Cui JA, 1999, NEUROSCI LETT, V267, P181, DOI 10.1016/S0304-3940(99)00360-2; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; El Sayed K, 2012, EXP BRAIN RES, V221, P427, DOI 10.1007/s00221-012-3185-6; ELGHOZI JL, 1991, CLIN EXP PHARMACOL P, V18, P735, DOI 10.1111/j.1440-1681.1991.tb01391.x; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GOLDBERG JM, 1982, BRAIN RES, V252, P156, DOI 10.1016/0006-8993(82)90990-8; Grewal T, 2012, EXP BRAIN RES, V220, P101, DOI 10.1007/s00221-012-3118-4; Guild SJ, 2001, AM J PHYSIOL-REG I, V281, pR206, DOI 10.1152/ajpregu.2001.281.1.R206; GUYTON AC, 1952, AM J PHYSIOL, V170, P601, DOI 10.1152/ajplegacy.1952.170.3.601; GUYTON AC, 1951, AM J PHYSIOL, V165, P158, DOI 10.1152/ajplegacy.1951.165.1.158; Hammam E, 2012, EXP BRAIN RES, V219, P441, DOI 10.1007/s00221-012-3090-z; Hammam E, 2011, EXP BRAIN RES, V213, P507, DOI 10.1007/s00221-011-2800-2; Hammer PE, 2005, AM J PHYSIOL-REG I, V288, pR1637, DOI 10.1152/ajpregu.00050.2004; Holstein Gay R, 2012, Front Neurol, V3, P4, DOI 10.3389/fneur.2012.00004; James C, 2010, AUTON NEUROSCI-BASIC, V158, P127, DOI 10.1016/j.autneu.2010.07.005; James C, 2010, EXP BRAIN RES, V202, P291, DOI 10.1007/s00221-009-2131-8; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; KAMINSKI RJ, 1970, AM J PHYSIOL, V219, P1768, DOI 10.1152/ajplegacy.1970.219.6.1768; Kitney R I, 1979, J Biomed Eng, V1, P89, DOI 10.1016/0141-5425(79)90063-3; LEVISON WH, 1966, CIRC RES, V18, P673, DOI 10.1161/01.RES.18.6.673; Lewis T, 1932, BRIT MED J, V1932, P873, DOI 10.1136/bmj.1.3723.873; MADWED JB, 1989, AM J PHYSIOL, V256, pH1573, DOI 10.1152/ajpheart.1989.256.6.H1573; Malpas SC, 1999, AM J PHYSIOL-REG I, V276, pR1311, DOI 10.1152/ajpregu.1999.276.5.R1311; Malpas SC, 1998, AM J PHYSIOL-REG I, V274, pR1283, DOI 10.1152/ajpregu.1998.274.5.R1283; MANOLIS AS, 1990, ANN INTERN MED, V112, P850, DOI 10.7326/0003-4819-112-11-850; Marrone A, 1999, PHYSICA A, V271, P458, DOI 10.1016/S0378-4371(99)00243-5; Maruta J, 2005, EXP BRAIN RES, V163, P273, DOI 10.1007/s00221-004-2178-5; Mayer S, 1876, SITZUNGSBERICHT MATH, V74, P281; Myers CW, 2001, AUTON NEUROSCI-BASIC, V91, P62, DOI 10.1016/S1566-0702(01)00289-2; Nowak JA, 2009, AM J PHYSIOL-HEART C, V296, pH171, DOI 10.1152/ajpheart.00963.2008; Ottesen JT, 1997, J MATH BIOL, V36, P41, DOI 10.1007/s002850050089; PREISS G, 1974, AM J PHYSIOL, V226, P724, DOI 10.1152/ajplegacy.1974.226.3.724; Prudham D, 1981, Age Ageing, V10, P141; Ringwood JV, 2001, AM J PHYSIOL-REG I, V280, pR1105, DOI 10.1152/ajpregu.2001.280.4.R1105; Seydnejad SR, 2001, IEEE ENG MED BIOL, V20, P92, DOI 10.1109/51.917729; Strang G., 1996, WAVELETS FILTER BANK; Sumner GL, 2010, J CARDIOVASC ELECTR, V21, P1375, DOI 10.1111/j.1540-8167.2010.01848.x; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; Traube, 1865, CENTRALBL MED WISS B, V3, P881; Vielle B, 2005, J MATH BIOL, V50, P595, DOI 10.1007/s00285-004-0305-3; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; Yates BJ, 2000, EXP BRAIN RES, V130, P151, DOI 10.1007/s002219900238	57	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2564	2572		10.1096/fj.12-226381	http://dx.doi.org/10.1096/fj.12-226381			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23504712	Green Published, Bronze			2022-12-25	WOS:000328841000006
J	Capraro, BR; Shi, Z; Wu, TT; Chen, ZM; Dunn, JM; Rhoades, E; Baumgart, T				Capraro, Benjamin R.; Shi, Zheng; Wu, Tingting; Chen, Zhiming; Dunn, Joanna M.; Rhoades, Elizabeth; Baumgart, Tobias			Kinetics of Endophilin N-BAR Domain Dimerization and Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CURVATURE GENERATION; AMPHIPATHIC HELICES; BINDING; MECHANISM; DYNAMIN; SYNAPTOJANIN; VESICLES; MOLECULE; LIPIDS	The recruitment to plasma membrane invaginations of the protein endophilin is a temporally regulated step in clathrin-mediated endocytosis. Endophilin is believed to sense or stabilize membrane curvature, which in turn likely depends on the dimeric structure of the protein. The dynamic nature of the membrane association and dimerization of endophilin is thus functionally important and is illuminated herein. Using subunit exchange Forster resonance energy transfer (FRET), we determine dimer dissociation kinetics and find a dimerization equilibrium constant orders of magnitude lower than previously published values. We characterize N-BAR domain membrane association kinetics under conditions where the dimeric species predominates, by stopped flow, observing prominent electrostatic sensitivity of membrane interaction kinetics. Relative to membrane binding, we find that protein monomer/dimer species equilibrate with far slower kinetics. Complementary optical microscopy studies reveal strikingly slow membrane dissociation and an increase of dissociation rate constant for a construct lacking the amphipathic segment helix 0 (H0). We attribute the slow dissociation kinetics to higher-order protein oligomerization on the membrane. We incorporate our findings into a kinetic scheme for endophilin N-BAR membrane binding and find a significant separation of time scales for endophilin membrane binding and subsequent oligomerization. This separation may facilitate the regulation of membrane trafficking phenomena.	[Capraro, Benjamin R.; Shi, Zheng; Wu, Tingting; Chen, Zhiming; Baumgart, Tobias] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Dunn, Joanna M.; Rhoades, Elizabeth] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA	University of Pennsylvania; Yale University	Baumgart, T (corresponding author), Univ Penn, Dept Chem, 231 S 34th St, Philadelphia, PA 19104 USA.	baumgart@sas.upenn.edu	Capraro, Benjamin R/C-6090-2009	Shi, Zheng/0000-0002-5214-1871; Chen, Zhiming/0000-0002-2423-101X	National Institutes of Health/NIGMS [9P41GM104605]; National Institutes of Health [T32 GM08275, R01 GM097552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552, T32GM008275, P41GM104605, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. E. M. Ostap for generously providing access to the stopped-flow instrument. We thank Ken Chang for assisting with fluorescence measurements and for reading the manuscript. We thank Drs. J. Saven, P. Janmey, and T. Svitkina for additional access to instrumentation, Dr. T. Troxler for guidance with time-correlated single photon counting/lifetime measurements, and Drs. N. Mochizuki, P. De Camilli, and R. Langen for supplying plasmids. Time-correlated single photon counting measurements were collected at the Ultrafast Optical Processes Laboratory at the University of Pennsylvania supported through National Institutes of Health/NIGMS Grant 9P41GM104605.; Supported by National Institutes of Health Training Grant T32 GM08275.; This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM097552 (to T. B.).	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Arbuzova A, 1997, J BIOL CHEM, V272, P27167, DOI 10.1074/jbc.272.43.27167; Ayton GS, 2009, BIOPHYS J, V97, P1616, DOI 10.1016/j.bpj.2009.06.036; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; BERG OG, 1978, BIOPHYS CHEM, V8, P271, DOI 10.1016/0301-4622(78)80010-6; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Cui HS, 2013, BIOPHYS J, V104, P404, DOI 10.1016/j.bpj.2012.12.006; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Cui HS, 2009, BIOPHYS J, V97, P2746, DOI 10.1016/j.bpj.2009.08.043; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dries DR, 2008, J BIOL CHEM, V283, P7885, DOI 10.1074/jbc.M709943200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Feeser EA, 2010, BIOCHEMISTRY-US, V49, P9353, DOI 10.1021/bi1012657; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frost A., 2009, POMBE CDC15 HOMOLOGY, P1; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Goldberg JM, 2012, J AM CHEM SOC, V134, P6088, DOI 10.1021/ja3005094; Gortat A, 2012, J BIOL CHEM, V287, P4232, DOI 10.1074/jbc.M111.325837; Gregory SM, 2008, BIOPHYS J, V94, P1667, DOI 10.1529/biophysj.107.118760; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Jia HF, 2005, J MOL BIOL, V350, P919, DOI 10.1016/j.jmb.2005.05.054; Jonsson T, 1996, BIOCHEMISTRY-US, V35, P4795, DOI 10.1021/bi953056s; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9; KINGSLEY PB, 1979, CHEM PHYS LIPIDS, V24, P135, DOI 10.1016/0009-3084(79)90083-5; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Kreutzberger AJ, 2012, J PHYS CHEM B, V116, P951, DOI 10.1021/jp209080m; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; LOHMAN TM, 1978, BIOPHYS CHEM, V8, P281, DOI 10.1016/0301-4622(78)80011-8; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; McKenna JMD, 2009, J BIOL CHEM, V284, P28650, DOI 10.1074/jbc.M109.049791; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Merzlyakov M, 2007, J MEMBRANE BIOL, V215, P93, DOI 10.1007/s00232-007-9009-0; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Ross JA, 2011, BIOPHYS J, V100, P729, DOI 10.1016/j.bpj.2010.12.3717; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; SCHWARZ G, 1987, BIOPHYS CHEM, V26, P163, DOI 10.1016/0301-4622(87)80019-4; Sevcsik E, 2011, J AM CHEM SOC, V133, P7152, DOI 10.1021/ja2009554; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Subramanian M, 1998, BIOCHEMISTRY-US, V37, P1394, DOI 10.1021/bi9716581; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Suresh S, 2010, BIOCHEMISTRY-US, V49, P5766, DOI 10.1021/bi100760e; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang J, 2007, BIOCHEMISTRY-US, V46, P13856, DOI 10.1021/bi7018404; Tang J, 2009, J AM CHEM SOC, V131, P3816, DOI 10.1021/ja809007f; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; WENDT H, 1995, BIOCHEMISTRY-US, V34, P4097, DOI 10.1021/bi00012a028; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Yoon YD, 2012, J BIOL CHEM, V287, P34078, DOI 10.1074/jbc.M112.372789; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zhu C, 2012, BIOPHYS J, V102, P1837, DOI 10.1016/j.bpj.2012.03.039	89	31	31	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12533	12543		10.1074/jbc.M112.435511	http://dx.doi.org/10.1074/jbc.M112.435511			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23482561	Green Published, hybrid			2022-12-25	WOS:000318555100012
J	Kim, JB; Kim, SY; Kim, BM; Lee, H; Kim, I; Yun, J; Jo, Y; Oh, T; Jo, Y; Chae, HD; Shin, DY				Kim, Jung-bin; Kim, So Youn; Kim, Byeong Mo; Lee, Hunjin; Kim, Insook; Yun, Jeanho; Jo, Yejin; Oh, Taeheun; Jo, Yongsam; Chae, Hee-Don; Shin, Deug Y.			Identification of a Novel Anti-apoptotic E3 Ubiquitin Ligase That Ubiquitinates Antagonists of Inhibitor of Apoptosis Proteins SMAC, HtrA2, and ARTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; PROMOTES APOPTOSIS; CASPASE ACTIVITY; ACTIN DAMAGE; CELL-DEATH; XIAP; IAP; FAMILY; MITOCHONDRIA; ACTIVATION	Identification of new anti-apoptotic genes is important for understanding the molecular mechanisms underlying apoptosis and tumorigenesis. The present study identified a novel anti-apoptotic gene named AREL1, which encodes a HECT(homologous to E6-AP carboxyl terminus) family E3 ubiquitin ligase. AREL1 interacted with and ubiquitinated IAP antagonists such as SMAC, HtrA2, and ARTS. However, AREL1 was cytosolic and did not localize to nuclei or mitochondria. The interactions between AREL1 and the IAP antagonists were specific for apoptosis-stimulated cells, in which the IAP antagonists were released into the cytosol from mitochondria. Furthermore, the ubiquitination and degradation of SMAC, HtrA2, and ARTS were significantly enhanced in AREL1-expressing cells following apoptotic stimulation, indicating that AREL1 binds to and ubiquitinates cytosolic but not mitochondria-associated forms of IAP antagonists. Furthermore, the anti-apoptotic role of AREL1-mediated degradation of SMAC, HtrA2, and ARTS was shown by simultaneous knockdown of three IAP antagonists, which caused the inhibition of caspase-3 cleavage, XIAP degradation, and induction of apoptosis. Therefore, the present study suggests that AREL1-mediated ubiquitination and degradation of cytosolic forms of three IAP antagonists plays an important role in the regulation of apoptosis.	[Kim, Jung-bin; Kim, So Youn; Kim, Byeong Mo; Lee, Hunjin; Kim, Insook; Yun, Jeanho; Jo, Yejin; Oh, Taeheun; Jo, Yongsam; Chae, Hee-Don; Shin, Deug Y.] Dankook Univ, Coll Med, Dept Microbiol & Immunol, Cheonan 330714, South Korea; [Kim, So Youn; Kim, Byeong Mo; Kim, Insook; Chae, Hee-Don; Shin, Deug Y.] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea	Dankook University; Seoul National University (SNU)	Shin, DY (corresponding author), Dankook Univ, Coll Med, Dept Microbiol & Immunol, Cheonan 330714, South Korea.	dyshin@dankook.ac.kr	Chae, Hee-Don/D-2620-2011		21C Frontier Functional Human Genome Project; Research Program for Regulation of Aging and Cancer; Basic Research Promotion Fund, Korean Research Foundation [KRF-2008-359-C00030, NRF-2009-353-C00070, 2012R1A1A3002027]; Korean Ministry of Education, Science, and Technology	21C Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Research Program for Regulation of Aging and Cancer; Basic Research Promotion Fund, Korean Research Foundation; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the 21C Frontier Functional Human Genome Project, the Research Program for Regulation of Aging and Cancer, and the Basic Research Promotion Fund (KRF-2008-359-C00030, NRF-2009-353-C00070, and 2012R1A1A3002027) from the Korean Research Foundation, which was funded by the Korean Ministry of Education, Science, and Technology.	Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Chae HD, 2008, ONCOGENE, V27, P4115, DOI 10.1038/onc.2008.46; Chae HD, 2012, EXP MOL MED, V44, P236, DOI 10.3858/emm.2012.44.3.018; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; LORENZI MV, 1995, ONCOGENE, V10, P2051; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Yoon K, 2004, BIOCHEM BIOPH RES CO, V319, P649, DOI 10.1016/j.bbrc.2004.05.043	30	32	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12014	12021		10.1074/jbc.M112.436113	http://dx.doi.org/10.1074/jbc.M112.436113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479728	hybrid, Green Published			2022-12-25	WOS:000318157600035
J	Arora, K; Alfulaij, N; Higa, JK; Panee, J; Nichols, RA				Arora, Komal; Alfulaij, Naghum; Higa, Jason K.; Panee, Jun; Nichols, Robert A.			Impact of Sustained Exposure to beta-Amyloid on Calcium Homeostasis and Neuronal Integrity in Model Nerve Cell System Expressing alpha 4 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT BASAL FOREBRAIN; A-BETA; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; UP-REGULATION; BINDING; HIPPOCAMPUS; DOPAMINE; SMOKERS; TAU	Although the interaction between beta-amyloid (A beta) and nicotinic acetylcholine receptors has been widely studied, the impact of prolonged exposure to A beta on nAChR expression and signaling is not known. In this study, we employed a neuronal culture model to better understand the impact of sustained exposure of A beta on the regulation of cellular and synaptic function. The differentiated rodent neuroblastoma cell line NG108-15 expressing exogenous high-affinity alpha 4 beta 2 nAChRs was exposed to soluble oligomeric A beta for several days. Ca2+ responses, expression levels of alpha 4 beta 2 nAChRs, rate of mitochondrial movement, mitochondrial fission, levels of reactive oxygen species, and nuclear integrity were compared between A beta-treated and untreated cells, transfected or not (mock-transfected) with alpha 4 beta 2 nAChRs. Sustained exposure of A beta(1-42) to alpha 4 beta 2 nAChR-transfected cells for several days led to increased Ca2+ responses on subsequent acute stimulation with A beta(1-42) or nicotine, paralleled by increased expression levels of alpha 4 beta 2 nAChRs, likely the result of enhanced receptor recycling. The rate of mitochondrial movement was sharply reduced, whereas the mitochondrial fission protein pDrp-1 was increased in alpha 4 beta 2 nAChR-transfected cells treated with A beta(1-42). In addition, the presence of alpha 4 beta 2 nAChRs dramatically enhanced A beta(1-42)-mediated increases in reactive oxygen species and nuclear fragmentation, eventually leading to apoptosis. Our data thus show disturbed calcium homeostasis coupled with mitochondrial dysfunction and loss of neuronal integrity on prolonged exposure of A beta in cells transfected with alpha 4 beta 2 nAChRs. Together, the results suggest that the presence of nAChRs sensitizes neurons to the toxic actions of soluble oligomeric A beta, perhaps contributing to the cholinergic deficit in Alzheimer disease.	[Arora, Komal; Alfulaij, Naghum; Higa, Jason K.; Panee, Jun; Nichols, Robert A.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa	Nichols, RA (corresponding author), 651 Ilalo St, Honolulu, HI 96813 USA.	robert.nichols@hawaii.edu		Higa, Jason Kenji/0000-0002-0429-6254	National Institutes of Health from the NIA [AG21586]; American Health Assistance Foundation [AHAF-A2007-409]; Hawaii Community Foundation [09ADVC-45413]; IDeA Networks of Biomedical Research Excellence II Grant from the National Center for Research Resources [P20RR016467]; National Center for Research Resources [G12RR003061]; National Institute on Minority Health and Health Disparities [G12MD007601]; COBRE Grant [P20RR016453]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453, P20RR016467, G12RR003061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021586] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institutes of Health from the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation(BrightFocus Foundation); Hawaii Community Foundation; IDeA Networks of Biomedical Research Excellence II Grant from the National Center for Research Resources; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); COBRE Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant AG21586 from the NIA, American Health Assistance Foundation Grant AHAF-A2007-409, and Hawaii Community Foundation Grant 09ADVC-45413 (to R. A. N.).; Supported by IDeA Networks of Biomedical Research Excellence II Grant P20RR016467 from the National Center for Research Resources.; We thank Dr. Jerry Stitzel, University of Colorado, for kindly providing the mouse alpha 4 and beta 2 nAChR subunit sequences. We also thank Drs. Ghous Khan and Mei Tong for help with preliminary experiments examining expression of alpha 4 beta 2-nAChRs in differentiated NG108-15 cells. We thank Dr. Joe Ramos for advice on the endocytosis/recycling experiments and for providing anti-Rab5 antibody for preliminary experiments. We thank Dr. Marla Berry for valuable input. We also thank Drs. Peter Hoffmann and Frederick Bellinger for insightful comments on the manuscript. Additional support for the microscopy core at the University of Hawaii was provided by Research Center for Minority Institutions grants from the National Center for Research Resources (G12RR003061) and the National Institute on Minority Health and Health Disparities (G12MD007601), with additional funding from COBRE Grant P20RR016453.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BENCHERIF M, 1995, J PHARMACOL EXP THER, V275, P987; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Buisson B, 2002, TRENDS PHARMACOL SCI, V23, P130, DOI 10.1016/S0165-6147(00)01979-9; Chin JH, 2007, J NEUROSCI, V27, P9262, DOI 10.1523/JNEUROSCI.1843-07.2007; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Court JA, 1998, NEUROSCIENCE, V87, P63, DOI 10.1016/S0306-4522(98)00088-8; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; Dougherty JJ, 2008, NEUROCHEM RES, V33, P1106, DOI 10.1007/s11064-007-9557-9; FLORES CM, 1992, MOL PHARMACOL, V41, P31; FRIED G, 1995, SYNAPSE, V20, P44, DOI 10.1002/syn.890200108; Fu W, 2003, J NEUROPHYSIOL, V90, P3130, DOI 10.1152/jn.00616.2003; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hsu YN, 1996, J NEUROCHEM, V66, P667; Iijima-Ando K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008310; Khan GM, 2010, EUR J NEUROSCI, V31, P788, DOI 10.1111/j.1460-9568.2010.07116.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lukyanetz EA, 1998, NEUROSCIENCE, V87, P265, DOI 10.1016/S0306-4522(98)00057-8; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Valenzuela IMPY, 2010, J NEUROSCI, V30, P12455, DOI 10.1523/JNEUROSCI.3309-10.2010; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Mehta TK, 2009, J NEUROCHEM, V109, P1452, DOI 10.1111/j.1471-4159.2009.06070.x; Mohamed Amany, 2011, Int J Alzheimers Dis, V2011, P127984, DOI 10.4061/2011/127984; Mukhin AG, 2008, J NUCL MED, V49, P1628, DOI 10.2967/jnumed.108.050716; Nashmi R, 2003, J NEUROSCI, V23, P11554; NELSON P, 1976, P NATL ACAD SCI USA, V73, P123, DOI 10.1073/pnas.73.1.123; Nichols RA, 2007, J BIOL CHEM, V282, P36102, DOI 10.1074/jbc.M706002200; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Patel AN, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002134; PENG X, 1994, MOL PHARMACOL, V46, P523; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Religa D, 2003, AM J PSYCHIAT, V160, P867, DOI 10.1176/appi.ajp.160.5.867; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Staley JK, 2006, J NEUROSCI, V26, P8707, DOI 10.1523/JNEUROSCI.0546-06.2006; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Tong M, 2011, J BIOL CHEM, V286, P34373, DOI 10.1074/jbc.M111.241299; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wu JL, 2007, BRAIN RES, V1182, P82, DOI 10.1016/j.brainres.2007.08.079; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; ZHANG X, 1994, BRAIN RES, V644, P32, DOI 10.1016/0006-8993(94)90343-3; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010	57	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11175	11190		10.1074/jbc.M113.453746	http://dx.doi.org/10.1074/jbc.M113.453746			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479730	hybrid, Green Published			2022-12-25	WOS:000317915500022
J	Li, Y; Wang, YQ				Li, Yang; Wang, Yuqi			Ras Protein/cAMP-dependent Protein Kinase Signaling Is Negatively Regulated by a Deubiquitinating Enzyme, Ubp3, in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; RAS/CAMP PATHWAY; UBIQUITIN; BINDING; METABOLISM; STARVATION; RESISTANCE; RECEPTOR; ELEMENTS	Ras proteins and cAMP-dependent protein kinase (protein kinase A, PKA) are important components of a nutrient signaling pathway that mediates cellular responses to glucose in yeast. The molecular mechanisms that regulate Ras/PKA-mediated signaling remain to be fully understood. Here, we provide evidence that Ras/PKA signaling is negatively regulated by a deubiquitinating enzyme, Ubp3. Disrupting the activity of Ubp3 leads to hyperactivation of PKA, as evidenced by much enhanced phosphorylation of PKA substrates, decreased accumulation of glycogen, larger cell size, and increased sensitivity to heat shock. Levels of intracellular cAMP and the active forms of Ras proteins are also elevated in the ubp3 Delta mutant. Consistent with a possibility that the increased cAMP is responsible for the abnormal signaling behavior of the ubp3 Delta mutant, overexpressing PDE2, which encodes a phosphodiesterase that hydrolyzes cAMP, significantly relieves the cell size increase and heat shock sensitivity of the mutant. Further analysis reveals that Ubp3 interacts with a Ras GTPase-accelerating protein, Ira2, and regulates its level of ubiquitination. Together, our data indicate that Ubp3 is a new regulator of the Ras/PKA signaling pathway and suggest that Ubp3 regulates this pathway by controlling the ubiquitination of Ras GTPase-accelerating protein Ira2.	[Li, Yang; Wang, Yuqi] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA.	ywang8@slu.edu		Li, Yang/0000-0001-5714-0416	National Institutes of Health [R15GM093313-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM093313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15GM093313-01 (to Y. W.).	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Broach JR, 1991, CURR OPIN GENET DEV, V1, P370, DOI 10.1016/S0959-437X(05)80302-8; BROSTROM CO, 1971, P NATL ACAD SCI USA, V68, P2444, DOI 10.1073/pnas.68.10.2444; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Burrows JF, 2012, FRONT BIOSCI-LANDMRK, V17, P1184, DOI 10.2741/3980; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Chautard H, 2004, EUKARYOT CELL, V3, P459, DOI 10.1128/EC.3.2.459-470.2004; Cherkasova VA, 2003, CURR BIOL, V13, P1220, DOI 10.1016/S0960-9822(03)00490-1; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Esch RK, 2006, EUKARYOT CELL, V5, P2147, DOI 10.1128/EC.00270-06; Feldkamp MM, 1999, SURG NEUROL, V51, P211, DOI 10.1016/S0090-3019(97)00356-X; Grewal Thomas, 2011, Genes Cancer, V2, P288, DOI 10.1177/1947601911407330; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Petkova MI, 2010, J BIOL CHEM, V285, P19521, DOI 10.1074/jbc.M109.085282; JOHNSTON C, 1991, BIOCHEM SOC T, V19, P296, DOI 10.1042/bst0190296; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kvint K, 2008, MOL CELL, V30, P498, DOI 10.1016/j.molcel.2008.04.018; Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Phan VT, 2010, MOL CELL BIOL, V30, P2264, DOI 10.1128/MCB.01450-08; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Powers S, 1992, Semin Cancer Biol, V3, P209; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Riccardi V M, 1992, Curr Probl Pediatr, V22, P66, DOI 10.1016/0045-9380(92)90053-2; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Rudoni S, 2001, BBA-MOL CELL RES, V1538, P181, DOI 10.1016/S0167-4889(01)00067-2; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sole C, 2011, EMBO J, V30, P3274, DOI 10.1038/emboj.2011.227; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; THEVELEIN JM, 1992, ANTON LEEUW INT J G, V62, P109, DOI 10.1007/BF00584466; Thevelein JM, 2000, ENZYME MICROB TECH, V26, P819, DOI 10.1016/S0141-0229(00)00177-0; Toda T, 1986, Princess Takamatsu Symp, V17, P253; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zhu M, 2011, J BIOL CHEM, V286, P27147, DOI 10.1074/jbc.M111.254193	60	20	21	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11358	11365		10.1074/jbc.M112.449751	http://dx.doi.org/10.1074/jbc.M112.449751			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23476013	Green Published, hybrid			2022-12-25	WOS:000317915500038
J	Lin, HL; Trejo, J				Lin, Huilan; Trejo, JoAnn			Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits beta-Arrestin-mediated Endosomal Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; HUMAN ENDOTHELIAL-CELLS; OPIOID RECEPTOR; DEPENDENT INTERNALIZATION; DOWN-REGULATION; TRAFFICKING; PAR1; RESENSITIZATION; COMPLEX; GPCR	Thrombin cleaves the N terminus of PAR1, generating a new N-terminal domain that functions as a tethered ligand that binds intermolecularly to activate PAR2 in trans. The mechanisms that regulate PAR1-PAR2 heterodimer signaling and trafficking are not known. We now report that PAR1 and PAR2 form a heterodimer that exhibits unique trafficking and signaling behaviors compared with receptor protomers. Using bioluminescence resonance energy transfer, immunofluorescence microscopy, co-immunoprecipitation, and cells expressing receptors exogenously and endogenously, we show that PAR1 and PAR2 specifically interact and form stable dimers. Intriguingly, the PAR1-PAR2 heterodimer displays constitutive internalization that is driven by PAR1 C-terminal tail sorting motifs and is a process that enhances dimer formation. Upon thrombin activation, PAR1-PAR2 dimers co-internalize and recruit beta-arrestins to endosomes. Remarkably, PAR1-PAR2 heterodimers appear to utilize a distinct interface for beta-arrestin interaction compared with receptor protomers. Moreover, thrombin-activated PAR1-PAR2 heterodimers enhance beta-arrestin-mediated ERK1/2 activation in the cytoplasm, whereas activated ERK1/2 induced by the thrombin-activated PAR1 protomer redistributes to the nucleus. Thus, the formation of PAR1-PAR2 heterodimers provides additional modes of thrombin-stimulated signaling responses that appear to be distinctly regulated compared with the receptor protomer.	[Lin, Huilan; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Sch Med, BSB Rm 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Lin, Huilan/B-7671-2013	TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [GM090689]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090689 (to J. T.).	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lidington EA, 2005, AM J PHYSIOL-CELL PH, V289, pC1437, DOI 10.1152/ajpcell.00502.2004; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Sambrano GR, 1999, J BIOL CHEM, V274, P20178, DOI 10.1074/jbc.274.29.20178; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Suzuki H, 2009, HYPERTENSION, V53, P182, DOI 10.1161/HYPERTENSIONAHA.108.125229; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1996, J BIOL CHEM, V271, P21536, DOI 10.1074/jbc.271.35.21536; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	47	67	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11203	11215		10.1074/jbc.M112.439950	http://dx.doi.org/10.1074/jbc.M112.439950			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23476015	Green Published, hybrid			2022-12-25	WOS:000317915500024
J	Yu, JW; Farias, A; Hwang, I; Fernandes-Alnemri, T; Alnemri, ES				Yu, Je-Wook; Farias, Andrew; Hwang, Inhwa; Fernandes-Alnemri, Teresa; Alnemri, Emad S.			Ribotoxic Stress through p38 Mitogen-activated Protein Kinase Activates in Vitro the Human Pyrin Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL MEDITERRANEAN FEVER; NLRP3 INFLAMMASOME; CELL-DEATH; CASPASE-1; PYROPTOSOME; INHIBITORS; DISEASES	Human pyrin with gain-of-function mutations in its B30.2/SPRY domain causes the autoinflammatory disease familial Mediterranean fever by assembling an ASC-dependent inflammasome that activates caspase-1. Wild-type human pyrin can also form an inflammasome complex with ASC after engagement by autoinflammatory PSTPIP1 mutants. How the pyrin inflammasome is activated in the absence of disease-associated mutations is not yet known. We report here that ribotoxic stress triggers the assembly of the human pyrin inflammasome, leading to ASC oligomerization and caspase-1 activation in THP-1 macrophages and in a 293T cell line stably reconstituted with components of the pyrin inflammasome. Knockdown of pyrin and selective inhibition of p38 MAPK greatly attenuated caspase-1 activation by ribotoxic stress, whereas expression of the conditional mutant Delta MEKK3:ER* allowed the activation of caspase-1 without ribotoxic stress. Disruption of microtubules by colchicine also inhibited pyrin inflammasome activation by ribotoxic stress. Together, our results indicate that ribotoxic stress activates the human pyrin inflammasome through a mechanism that requires p38 MAPK signaling and microtubule stability.	[Yu, Je-Wook; Farias, Andrew; Fernandes-Alnemri, Teresa; Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Yu, Je-Wook; Farias, Andrew; Fernandes-Alnemri, Teresa; Alnemri, Emad S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Yu, Je-Wook; Hwang, Inhwa] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul 120752, South Korea	Jefferson University; Jefferson University; Yonsei University; Yonsei University Health System	Yu, JW (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul 120752, South Korea.	jewookyu@yuhs.ac; emad.alnemri@jefferson.edu		Yu, Je-Wook/0000-0001-5943-4071	National Research Foundation Basic Science Research Program Grant from the Ministry of Education, Science and Technology (MEST) [2010-10849]; National R&D Program for Cancer Control Grant from the Ministry of Health, Welfare and Family Affairs, Korea [1020190]; National Institutes of Health [AG14357, AR055398]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	National Research Foundation Basic Science Research Program Grant from the Ministry of Education, Science and Technology (MEST); National R&D Program for Cancer Control Grant from the Ministry of Health, Welfare and Family Affairs, Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG14357 and AR055398 (to E. S. A).; Supported by National Research Foundation Basic Science Research Program Grant 2010-10849 from the Ministry of Education, Science and Technology (MEST) and National R&D Program for Cancer Control Grant 1020190 from the Ministry of Health, Welfare and Family Affairs, Korea. To whom correspondence may be addressed: Dept. of Microbiology and Immunology, Yonsei University College of Medicine, Seoul 120-752, Korea. E-mail: jewookyu@yuhs.ac.	Aksentijevich I, 1997, CELL, V90, P797; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bernot A, 1997, NAT GENET, V17, P25; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Garner AP, 2002, ONCOGENE, V21, P8089, DOI 10.1038/sj.onc.1206000; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kataoka T, 2012, EUR J PHARMACOL, V676, P1, DOI 10.1016/j.ejphar.2011.11.044; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Laskin JD, 2002, TOXICOL SCI, V69, P289, DOI 10.1093/toxsci/69.2.289; Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Ozturk MA, 2011, CLIN EXP RHEUMATOL, V29, pS77; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Wang DH, 2013, J BIOL CHEM, V288, P4594, DOI 10.1074/jbc.M112.443077; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	31	25	27	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11378	11383		10.1074/jbc.M112.448795	http://dx.doi.org/10.1074/jbc.M112.448795			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479736	Green Published, hybrid			2022-12-25	WOS:000317915500040
J	Zhang, YG; Wu, SP; Xia, YL; Sun, J				Zhang, Yong-guo; Wu, Shaoping; Xia, Yinglin; Sun, Jun			Salmonella Infection Upregulates the Leaky Protein Claudin-2 in Intestinal Epithelial Cells	PLOS ONE			English	Article							TIGHT JUNCTIONS; BARRIER DYSFUNCTION; CANCER-CELLS; EXPRESSION; RECEPTOR; TUMORIGENICITY; INFLAMMATION; ACTIVATION; DISEASE	Background: Tight junctions seal the space between adjacent epithelial cells. Mounting evidence suggests that tight junction proteins play a key role in the pathogenesis of human disease. Claudin is a member of the tight junction protein family, which has 24 members in humans. To regulate cellular function, claudins interact structurally and functionally with membrane and scaffolding proteins via their cytoplasmic domain. In particular, claudin-2 is known to be a leaky protein that contributes to inflammatory bowel disease and colon cancer. However, the involvement of claudin-2 in bacterial infection in the intestine remains unknown. Methods/Principal Findings: We hypothesized that Salmonella elevates the leaky protein claudin-2 for its own benefit to facilitate bacterial invasion in the colon. Using a Salmonella-colitis mouse model and cultured colonic epithelial cells, we found that pathogenic Salmonella colonization significantly increases the levels of claudin-2 protein and mRNA in the intestine, but not that of claudin-3 or claudin-7 in the colon, in a time-dependent manner. Immunostaining studies showed that the claudin-2 expression along the crypt-villous axis postinfection. In vitro, Salmonella stimulated claudin-2 expression in the human intestinal epithelial cell lines SKCO15 and HT29C19A. Further analysis by siRNA knockdown revealed that claudin-2 is associated with the Salmonella-induced elevation of cell permeability. Epithelial cells with claudin-2 knockdown had significantly less internalized Salmonella than control cells with normal claudin-2 expression. Inhibitor assays demonstrated that this regulation is mediated through activation of the EGFR pathway and the downstream protein JNK. Conclusion/Significance: We have shown that Salmonella targets the tight junction protein claudin-2 to facilitate bacterial invasion. We speculate that this disruption of barrier function contributes to a new mechanism by which bacteria interact with their host cells and suggests the possibility of blocking claudin-2 as a potential therapeutic strategy to prevent bacterial invasion.	[Zhang, Yong-guo; Wu, Shaoping; Sun, Jun] Rush Univ, Dept Biochem, Chicago, IL 60612 USA; [Xia, Yinglin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA; [Sun, Jun] Univ Rochester, Dept Med, Div Gastroenterol & Hepatol, Rochester, NY USA	Rush University; University of Rochester; University of Rochester	Sun, J (corresponding author), Rush Univ, Dept Biochem, Chicago, IL 60612 USA.	jun_sun@rush.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	National Institute of Diabetes and Digestive and Kidney Diseases [KO1 DK075386, 1R03DK089010-01]; American Cancer Society [RSG-09-075-01-MBC]; Swim Across America Cancer Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089010, K01DK075386] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); Swim Across America Cancer Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (KO1 DK075386 and 1R03DK089010-01), the American Cancer Society (RSG-09-075-01-MBC), and Swim Across America Cancer Research Award to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott IDR, 2000, SCAND J GASTROENTERO, V35, P1163; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Capaldo CT, 2011, MOL BIOL CELL, V22, P1677, DOI 10.1091/mbc.E10-08-0677; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Christakos S, 2010, J STEROID BIOCHEM, V121, P183, DOI 10.1016/j.jsbmb.2010.03.005; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; HOLLANDER D, 1988, GUT, V29, P1621, DOI 10.1136/gut.29.12.1621; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Ivanov AI, 2004, NOVART FDN SYMP, V263, P124; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P1, DOI 10.1111/j.1749-6632.2009.04925.x; Severson EA, 2010, BIOCHEM BIOPH RES CO, V397, P592, DOI 10.1016/j.bbrc.2010.05.164; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Smith AJ, 2010, JAIDS-J ACQ IMM DEF, V55, P306, DOI 10.1097/QAI.0b013e3181ecfeca; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Takeuchi K, 2009, FEBS J, V276, P1255, DOI 10.1111/j.1742-4658.2008.06861.x; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Turner JR, 2000, AM J PHYSIOL-CELL PH, V279, pC1918, DOI 10.1152/ajpcell.2000.279.6.C1918; Van Itallie CM, 2009, ANN NY ACAD SCI, V1165, P82, DOI 10.1111/j.1749-6632.2009.04052.x; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	32	53	53	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58606	10.1371/journal.pone.0058606	http://dx.doi.org/10.1371/journal.pone.0058606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505542	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100070
J	Deng, C; Sun, ZC; Tong, G; Yi, W; Ma, L; Zhao, BJ; Cheng, L; Zhang, JZ; Cao, F; Yi, DH				Deng, Chao; Sun, Zhongchan; Tong, Guang; Yi, Wei; Ma, Li; Zhao, Bijun; Cheng, Liang; Zhang, Jinzhou; Cao, Feng; Yi, Dinghua			alpha-Lipoic Acid Reduces Infarct Size and Preserves Cardiac Function in Rat Myocardial Ischemia/Reperfusion Injury through Activation of PI3K/Akt/Nrf2 Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ERYTHROID 2-RELATED FACTOR-2; HEME OXYGENASE-1 EXPRESSION; PROTEIN-KINASE; OXIDATIVE STRESS; CELLS; NRF2; ANTIOXIDANT; PHOSPHORYLATION; TRANSCRIPTION	Background: The present study investigates the effects and mechanisms of alpha-Lipoic acid (LA) on myocardial infarct size, cardiac function and cardiomyocyte apoptosis in rat hearts subjected to in vivo myocardial ischemia/reperfusion (MI/R) injury. Methodology/Principal Findings: Male adult rats underwent 30 minutes of ischemia followed by 3, 24, or 72 h of reperfusion. Animals were pretreated with LA or vehicle before coronary artery ligation. The level of MI/R-induced LDH and CK release, infarct size, cardiomyocyte apoptosis and cardiac functional impairment were examined and compared. Western blot analysis was performed to elucidate the mechanism of LA pretreatment. The level of inflammatory cytokine TNF-alpha released to serum and accumulated in injured myocardium as well as neutrophil accumulation in injured myocardium were also examined after MI/R injury. Our results reveal that LA administration significantly reduced LDH and CK release, attenuated myocardial infarct size, decreased cardiomyocytes apoptosis, and partially preserved heart function. Western blot analysis showed that LA pretreatment up-regulated Akt phosphorylation and Nrf2 nuclear translocation while producing no impact on p38MAPK activation or nitric oxide (NO) production. LA pretreatment also increased expression of HO-1, a major target of Nrf2. LA treatment inhibited neutrophil accumulation and release of TNF-alpha. Moreover, PI3K inhibition abolished the beneficial effects of LA. Conclusions/Significance: This study indicates that LA attenuates cardiac dysfunction by reducing cardiomyoctyes necrosis, apoptosis and inflammation after MI/R. LA exerts its action by activating the PI3K/Akt pathway as well as subsequent Nrf2 nuclear translocation and induction of cytoprotective genes such as HO-1.	[Deng, Chao; Tong, Guang; Yi, Wei; Zhao, Bijun; Cheng, Liang; Zhang, Jinzhou; Yi, Dinghua] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Sun, Zhongchan; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Ma, Li] Navy Gen Hosp, Dept Anesthesia, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital	Cao, F (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China.	wind8828@gmail.com; dinghuayi210@126.com		Yi, Wei/0000-0002-4349-910X	National Natural Science Foundation, People's Republic of China [81102687]	National Natural Science Foundation, People's Republic of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants (No. 81102687) from National Natural Science Foundation, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Bitar MS, 2010, LIFE SCI, V86, P844, DOI 10.1016/j.lfs.2010.03.019; Black SC, 1996, J PHARMACOL TOX MET, V35, P179, DOI 10.1016/1056-8719(96)00051-2; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cheng PY, 2006, FREE RADICAL BIO MED, V40, P1313, DOI 10.1016/j.freeradbiomed.2005.11.024; Coleman MD, 2001, ENVIRON TOXICOL PHAR, V10, P167, DOI 10.1016/S1382-6689(01)00080-1; DeMarco VG, 2004, FREE RADICAL RES, V38, P675, DOI 10.1080/10715760410001702503; Dudek M, 2008, EUR J PHARMACOL, V591, P203, DOI 10.1016/j.ejphar.2008.06.073; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Ghibu S, 2009, J CARDIOVASC PHARM, V54, P391, DOI 10.1097/FJC.0b013e3181be7554; Goraca A, 2011, PHARMACOL REP, V63, P849; GRACE PA, 1994, BRIT J SURG, V81, P637, DOI 10.1002/bjs.1800810504; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; He L, 2012, EUR J PHARMACOL, V678, P32, DOI 10.1016/j.ejphar.2011.12.042; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Konrad D, 2001, DIABETES, V50, P1464, DOI 10.2337/diabetes.50.6.1464; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Muller C, 2003, AM J PHYSIOL-GASTR L, V285, pG769, DOI 10.1152/ajpgi.00009.2003; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; Oh Seok Kyu, 2009, Korean Circ J, V39, P359, DOI 10.4070/kcj.2009.39.9.359; Packer L, 1998, DRUG METAB REV, V30, P245, DOI 10.3109/03602539808996311; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Pugazhenthi S, 2007, AM J PHYSIOL-ENDOC M, V293, pE645, DOI 10.1152/ajpendo.00111.2007; Richard MJP, 2011, NEUROSCI RES, V69, P299, DOI 10.1016/j.neures.2010.12.011; Rojo AI, 2008, J NEUROCHEM, V105, P192, DOI 10.1111/j.1471-4159.2007.05124.x; Shaafi S, 2011, MED PRIN PRACT, V20, P19, DOI 10.1159/000319772; Shay KP, 2012, BBA-MOL CELL RES, V1823, P1102, DOI 10.1016/j.bbamcr.2012.04.002; Steffens S, 2009, THROMB HAEMOSTASIS, V102, P240, DOI 10.1160/TH08-12-0837; Sun ZC, 2011, HISTOCHEM CELL BIOL, V135, P27, DOI 10.1007/s00418-010-0776-9; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tong GA, 2011, LIFE SCI, V88, P31, DOI 10.1016/j.lfs.2010.10.018; Visioli F, 2002, REDOX REP, V7, P223, DOI 10.1179/135100002125000604; Wildhirt SM, 1999, CARDIOVASC RES, V43, P698, DOI 10.1016/S0008-6363(99)00080-2; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Yamada M, 2012, DIGEST DIS SCI, V57, P943, DOI 10.1007/s10620-011-2012-4; Yan Guang-tao, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P345	43	122	128	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58371	10.1371/journal.pone.0058371	http://dx.doi.org/10.1371/journal.pone.0058371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505496	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500074
J	Melton, AC; Melrose, J; Alajoki, L; Privat, S; Cho, H; Brown, N; Plavec, AM; Nguyen, D; Johnston, ED; Yang, J; Polokoff, MA; Plavec, I; Berg, EL; O'Mahony, A				Melton, Andrew C.; Melrose, Jennifer; Alajoki, Liisa; Privat, Sylvie; Cho, Hannah; Brown, Naomi; Plavec, Ana Marija; Dat Nguyen; Johnston, Elijah D.; Yang, Jian; Polokoff, Mark A.; Plavec, Ivan; Berg, Ellen L.; O'Mahony, Alison			Regulation of IL-17A Production Is Distinct from IL-17F in a Primary Human Cell Co-culture Model of T Cell-Mediated B Cell Activation	PLOS ONE			English	Article							IL-17-DEFICIENT MICE; CD40 LIGAND; EXPRESSION; DIFFERENTIATION; TH17; RESPONSES; RECEPTOR; INTERLEUKIN-17; IDENTIFICATION; INFLAMMATION	Improper regulation of B cell responses leads to excessive production of antibodies and contributes to the development of autoimmune disease. T helper 17 (Th17) cells also drive the development of autoimmune disease, but the role of B cells in shaping Th17 cell-mediated immune responses, as well as the reciprocal regulation of B cell responses by IL-17 family cytokines, remains unclear. The aim of this study was to characterize the regulation of IL-17A and IL-17F in a model of T cell-dependent B cell activation. Stimulation of primary human B cell and peripheral blood mononuclear cell (BT) co-cultures with alpha-IgM and a non-mitogenic concentration of superantigens for three days promoted a Th17 cell response as evidenced by increased expression of Th17-related gene transcripts, including Il17f, Il21, Il22, and Il23r, in CD4 T cells, as well as the secretion of IL-17A and IL-17F protein. We tested the ability of 144 pharmacologic modulators representing 91 different targets or pathways to regulate IL-17A and IL-17F production in these stimulated BT co-cultures. IL-17A production was found to be preferentially sensitive to inhibition of the PI3K/mTOR pathway, while prostaglandin EP receptor agonists, including PGE2, increased IL-17A concentrations. In contrast, the production of IL-17F was inhibited by PGE2, but selectively increased by TLR2 and TLR5 agonists. These results indicate that IL-17A regulation is distinct from IL-17F in stimulated BT co-cultures and that this co-culture approach can be used to identify pathway mechanisms and novel agents that selectively inhibit production of IL-17A or IL-17F.	[Melton, Andrew C.; Melrose, Jennifer; Alajoki, Liisa; Privat, Sylvie; Cho, Hannah; Brown, Naomi; Plavec, Ana Marija; Dat Nguyen; Johnston, Elijah D.; Yang, Jian; Polokoff, Mark A.; Plavec, Ivan; Berg, Ellen L.; O'Mahony, Alison] BioSeek, San Francisco, CA USA		O'Mahony, A (corresponding author), BioSeek, San Francisco, CA USA.	aomahony@bioseekinc.com	Berg, Ellen/D-9076-2014; Berg, Ellen/T-8827-2019	Berg, Ellen/0000-0001-5149-6665; 	BioSeek, a division of DiscoveRx, Corp.	BioSeek, a division of DiscoveRx, Corp.	The authors have the following interests. BioSeek, a division of DiscoveRx, Corp., provided the financial support for this research and is the employer of all authors. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Aoki Y, 1999, ANTIMICROB AGENTS CH, V43, P2678, DOI 10.1128/AAC.43.11.2678; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Galimberti D, 2008, MULT SCLER, V14, P547, DOI 10.1177/1352458507084268; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Hebel K, 2011, J IMMUNOL, V187, P5627, DOI 10.4049/jimmunol.1003998; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Johnson-Leger C, 1998, INT IMMUNOL, V10, P1083, DOI 10.1093/intimm/10.8.1083; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y; Kunkel EJ, 2004, FASEB J, V18, P1279, DOI 10.1096/fj.04-1538fje; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Plavec I, 2004, P NATL ACAD SCI USA, V101, P1223, DOI 10.1073/pnas.0308221100; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; ROY M, 1993, J IMMUNOL, V151, P2497; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; STOHL W, 1994, J IMMUNOL, V153, P117; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; van de Veerdonk FL, 2011, ARTHRITIS RHEUM-US, V63, P1507, DOI 10.1002/art.30314; Vazquez-Tello A, 2012, INT ARCH ALLERGY IMM, V157, P406, DOI 10.1159/000329527; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	43	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58966	10.1371/journal.pone.0058966	http://dx.doi.org/10.1371/journal.pone.0058966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505568	gold, Green Submitted, Green Published			2022-12-25	WOS:000318334500133
J	Whitty, JA; Stewart, S; Carrington, MJ; Calderone, A; Marwick, T; Horowitz, JD; Krum, H; Davidson, PM; Macdonald, PS; Reid, C; Scuffham, PA				Whitty, Jennifer A.; Stewart, Simon; Carrington, Melinda J.; Calderone, Alicia; Marwick, Thomas; Horowitz, John D.; Krum, Henry; Davidson, Patricia M.; Macdonald, Peter S.; Reid, Christopher; Scuffham, Paul A.			Patient Preferences and Willingness-To-Pay for a Home or Clinic Based Program of Chronic Heart Failure Management: Findings from the Which? Trial	PLOS ONE			English	Article							DISCRETE-CHOICE EXPERIMENTS; BURDEN; CARE; HETEROGENEITY; POPULATION; ATTRIBUTES; DESIGN; IMPACT	Background: Beyond examining their overall cost-effectiveness and mechanisms of effect, it is important to understand patient preferences for the delivery of different modes of chronic heart failure management programs (CHF-MPs). We elicited patient preferences around the characteristics and willingness-to-pay (WTP) for a clinic or home-based CHF-MP. Methodology/Principal Findings: A Discrete Choice Experiment was completed by a sub-set of patients (n = 91) enrolled in the WHICH? trial comparing home versus clinic-based CHF-MP. Participants provided 5 choices between hypothetical clinic and home-based programs varying by frequency of nurse consultations, nurse continuity, patient costs, and availability of telephone or education support. Participants (aged 71 +/- 13 yrs, 72.5% male, 25.3% NYHA class III/IV) displayed two distinct preference classes. A latent class model of the choice data indicated 56% of participants preferred clinic delivery, access to group CHF education classes, and lower cost programs (p<0.05). The remainder preferred home-based CHF-MPs, monthly rather than weekly visits, and access to a phone advice service (p<0.05). Continuity of nurse contact was consistently important. No significant association was observed between program preference and participant allocation in the parent trial. WTP was estimated from the model and a dichotomous bidding technique. For those preferring clinic, estimated WTP was approximate to AU$9-20 per visit; however for those preferring home-based programs, WTP varied widely (AU$ 15-105). Conclusions/Significance: Patient preferences for CHF-MPs were dichotomised between a home-based model which is more likely to suit older patients, those who live alone, and those with a lower household income; and a clinic-based model which is more likely to suit those who are more socially active and wealthier. To optimise the delivery of CHF-MPs, health care services should consider their patients' preferences when designing CHF-MPs.	[Whitty, Jennifer A.; Scuffham, Paul A.] Griffith Univ, Ctr Appl Hlth Econ, Sch Med, Griffith Hlth Inst, Meadowbrook, Qld 4131, Australia; [Stewart, Simon; Carrington, Melinda J.; Calderone, Alicia] Baker IDI Heart & Diabet Inst, NHMRC Ctr Res Excellence Reduce Inequal Heart Dis, Melbourne, Vic, Australia; [Marwick, Thomas] Cleveland Clin, Cleveland, OH 44106 USA; [Horowitz, John D.] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Horowitz, John D.] Univ Adelaide, Adelaide, SA, Australia; [Krum, Henry; Reid, Christopher] Monash Univ, Sch Publ Hlth & Preventat Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Davidson, Patricia M.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Davidson, Patricia M.; Macdonald, Peter S.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Macdonald, Peter S.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Macdonald, Peter S.] Univ New S Wales, Sydney, NSW, Australia	Griffith University; Menzies Health Institute Queensland; Baker Heart and Diabetes Institute; Cleveland Clinic Foundation; University of Adelaide; Monash University; University of Technology Sydney; St Vincents Hospital Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Whitty, JA (corresponding author), Griffith Univ, Ctr Appl Hlth Econ, Sch Med, Griffith Hlth Inst, Meadowbrook, Qld 4131, Australia.	j.whitty@griffith.edu.au	Reid, Christopher M/AAP-8135-2021; Stewart, Simon/M-3316-2016; Whitty, Jennifer A/N-6434-2013; Macdonald, Peter/Q-3188-2019; Marwick, Thomas/AAK-3869-2021; Scuffham, Paul/B-3066-2014; Scuffham, Paul/AAS-8084-2021	Stewart, Simon/0000-0001-9032-8998; Whitty, Jennifer A/0000-0002-5886-1933; Marwick, Thomas/0000-0001-9065-0899; Scuffham, Paul/0000-0001-5931-642X; Scuffham, Paul/0000-0001-5931-642X; Reid, Christopher/0000-0001-9173-3944; Davidson, Patricia M./0000-0003-2050-1534; Horowitz, John/0000-0001-6883-0703; Carrington, Melinda J/0000-0003-3865-1645	Health Services Research grant from National Health and Medical Research Council of Australia [418967]; Program grant from the National Health and Medical Research Council of Australia [519823]; Queensland Government Department of Employment, Economic Development and Innovation, Queensland Health; Griffith University; National Health and Medical Research Council of Australia; Victorian Government's Operational Infrastructure Support Program	Health Services Research grant from National Health and Medical Research Council of Australia; Program grant from the National Health and Medical Research Council of Australia; Queensland Government Department of Employment, Economic Development and Innovation, Queensland Health; Griffith University(Griffith University); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by a Health Services Research grant [grant #418967] and a Program grant [grant #519823], both from the National Health and Medical Research Council of Australia. JW is supported by a research fellowship from the Queensland Government Department of Employment, Economic Development and Innovation, Queensland Health and Griffith University. MC & SS are supported by the National Health and Medical Research Council of Australia. The WHICH? trial was supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2004, NAT HLTH SURV; Bauman AE, 2003, MED J AUSTRALIA, V179, P253, DOI 10.5694/j.1326-5377.2003.tb05532.x; Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Campbell D, 2011, J ENVIRON PLANN MAN, V54, P1061, DOI 10.1080/09640568.2010.549367; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; Davidson P, 2010, MULTIDISCIPLINARY CA; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Driscoll Andrea, 2006, Eur J Cardiovasc Nurs, V5, P75, DOI 10.1016/j.ejcnurse.2005.08.001; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hole AR, 2008, J HEALTH ECON, V27, P1078, DOI 10.1016/j.jhealeco.2007.11.006; Kim Edward, 2010, J Med Econ, V13, P185, DOI 10.3111/13696991003723023; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2004, HEALTH ECON, V13, P901, DOI 10.1002/hec.870; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McFadden D., 1981, STRUCTURAL ANAL DISC; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mentzakis E, 2011, HEALTH ECON, V20, P930, DOI 10.1002/hec.1656; Mitchell R.C., 1989, USING SURVEYS VALUE; Stewart S, 2003, HEART, V89, P49, DOI 10.1136/heart.89.1.49; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stewart S, 2012, J AM COLL CARDIOL, V60, P1239, DOI 10.1016/j.jacc.2012.06.025; Stewart S, 2011, EUR J HEART FAIL, V13, P909, DOI 10.1093/eurjhf/hfr048; Stewart S, 2010, CIRC-CARDIOVASC QUAL, V3, P573, DOI 10.1161/CIRCOUTCOMES.110.957571; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Vijan S, 2005, J GEN INTERN MED, V20, P479, DOI 10.1111/j.1525-1497.2005.0117.x; Whitty JA, 2012, J CARDIOVASC NURS, V27, P201, DOI 10.1097/JCN.0b013e31821abf22	27	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58347	10.1371/journal.pone.0058347	http://dx.doi.org/10.1371/journal.pone.0058347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505491	Green Published, gold, Green Accepted			2022-12-25	WOS:000318334500071
J	Hsiao, HM; Sapinoro, RE; Thatcher, TH; Croasdell, A; Levy, EP; Fulton, RA; Olsen, KC; Pollock, SJ; Serhan, CN; Phipps, RP; Sime, PJ				Hsiao, Hsi-Min; Sapinoro, Ramil E.; Thatcher, Thomas H.; Croasdell, Amanda; Levy, Elizabeth P.; Fulton, Robert A.; Olsen, Keith C.; Pollock, Stephen J.; Serhan, Charles N.; Phipps, Richard P.; Sime, Patricia J.			A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARYL-HYDROCARBON RECEPTOR; AIRWAY INFLAMMATION; DOCOSAHEXAENOIC ACID; PROMOTE RESOLUTION; CYTOKINE RELEASE; BRONCHIAL-ASTHMA; APOPTOTIC CELLS; KAPPA-B; MACROPHAGES	Introduction: Cigarette smoke is a profound pro-inflammatory stimulus that contributes to acute lung injuries and to chronic lung disease including COPD (emphysema and chronic bronchitis). Until recently, it was assumed that resolution of inflammation was a passive process that occurred once the inflammatory stimulus was removed. It is now recognized that resolution of inflammation is a bioactive process, mediated by specialized lipid mediators, and that normal homeostasis is maintained by a balance between pro-inflammatory and pro-resolving pathways. These novel small lipid mediators, including the resolvins, protectins and maresins, are bioactive products mainly derived from dietary omega-3 and omega-6 polyunsaturated fatty acids (PUFA). We hypothesize that resolvin D1 (RvD1) has potent anti-inflammatory and pro-resolving effects in a model of cigarette smoke-induced lung inflammation. Methods: Primary human lung fibroblasts, small airway epithelial cells and blood monocytes were treated with IL-1 beta or cigarette smoke extract in combination with RvD1 in vitro, production of pro-inflammatory mediators was measured. Mice were exposed to dilute mainstream cigarette smoke and treated with RvD1 either concurrently with smoke or after smoking cessation. The effects on lung inflammation and lung macrophage populations were assessed. Results: RvD1 suppressed production of pro-inflammatory mediators by primary human cells in a dose-dependent manner. Treatment of mice with RvD1 concurrently with cigarette smoke exposure significantly reduced neutrophilic lung inflammation and production of pro-inflammatory cytokines, while upregulating the anti-inflammatory cytokine IL-10. RvD1 promoted differentiation of alternatively activated (M2) macrophages and neutrophil efferocytosis. RvD1 also accelerated the resolution of lung inflammation when given after the final smoke exposure. Conclusions: RvD1 has potent anti-inflammatory and pro-resolving effects in cells and mice exposed to cigarette smoke. Resolvins have strong potential as a novel therapeutic approach to resolve lung injury caused by smoke and pulmonary toxicants.	[Hsiao, Hsi-Min] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY USA; [Sapinoro, Ramil E.; Thatcher, Thomas H.; Croasdell, Amanda; Levy, Elizabeth P.; Fulton, Robert A.; Olsen, Keith C.; Pollock, Stephen J.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Lung Biol & Dis Program, Rochester, NY 14627 USA; [Sapinoro, Ramil E.; Thatcher, Thomas H.; Levy, Elizabeth P.; Fulton, Robert A.; Sime, Patricia J.] Univ Rochester, Div Pulm & Crit Care Med, Rochester, NY USA; [Croasdell, Amanda; Pollock, Stephen J.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Dept Environm Med, Rochester, NY USA; [Olsen, Keith C.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Serhan, Charles N.] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Sime, PJ (corresponding author), Univ Rochester, Lung Biol & Dis Program, Rochester, NY 14627 USA.	Patricia_Sime@urmc.rochester.edu		Hsiao, Hsi-Min Jim/0000-0003-1918-7381; Pollock, Stephen/0000-0002-2091-1675; Thatcher, Thomas/0000-0001-7177-3041; , Ramil/0000-0003-4907-6340	National Institutes of Health [R01 HL088325, HL088325-02S1, HL66988, ES07026, 8UL1TR000042, ES01247]; The PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, R01HL088325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026, P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01 HL088325, HL088325-02S1, HL66988, ES07026, 8UL1TR000042 and ES01247. AC is supported by a pre-doctoral fellowship from The PhRMA Foundation. The funders had no role in study design, data collection; and analysis, decision to publish, or preparation of the manuscript.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; ARM JP, 1989, AM REV RESPIR DIS, V139, P1395, DOI 10.1164/ajrccm/139.6.1395; Baines KJ, 2011, PLOS ONE, V6, P18426; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Burgess JL, 2002, INHAL TOXICOL, V14, P133, DOI 10.1080/089583701753403953; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; Chen Ya-feng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P1039; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Eickmeier O, 2012, MUCOSAL IMMUNOL; El Kebir D, 2012, P NATL ACAD SCI US; FRIES KM, 1995, CLIN IMMUNOL IMMUNOP, V77, P42, DOI 10.1016/0090-1229(95)90135-3; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Invernizzi G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-48; Joo MJ, 2010, RESP MED, V104, P246, DOI 10.1016/j.rmed.2009.10.002; Kent LM, 2010, INT IMMUNOPHARMACOL, V10, P57, DOI 10.1016/j.intimp.2009.09.021; Koumas L, 2002, EUR J IMMUNOL, V32, P477, DOI 10.1002/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Minematsu N, 2011, AM J RESP CELL MOL, V44, P474, DOI 10.1165/rcmb.2009-0463OC; Ogawa Y, 2008, CURR MOL MED, V8, P437, DOI 10.2174/156652408785160907; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Seki H, 2010, J IMMUNOL, V184, P836, DOI 10.4049/jimmunol.0901809; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; SHAHAR E, 1994, NEW ENGL J MED, V331, P228, DOI 10.1056/NEJM199407283310403; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Takanashi S, 1999, EUR RESPIR J, V14, P309, DOI 10.1034/j.1399-3003.1999.14b12.x; Tanaka T, 2010, BIOCHEM BIOPH RES CO, V399, P677, DOI 10.1016/j.bbrc.2010.07.141; Thatcher TH, 2005, AM J PHYSIOL-LUNG C, V289, pL322, DOI 10.1152/ajplung.00039.2005; Thatcher TH, 2008, AM J PHYSIOL-LUNG C, V295, pL412, DOI 10.1152/ajplung.00392.2007; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Uddin M, 2011, PROG LIPID RES, V50, P75, DOI 10.1016/j.plipres.2010.09.002; Vachier I, 2002, BIOCHEM BIOPH RES CO, V290, P219, DOI 10.1006/bbrc.2001.6155; Xu J, 2008, AM J PHYSIOL-LUNG C, V295, pL162, DOI 10.1152/ajplung.00282.2007; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626	54	134	137	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58258	10.1371/journal.pone.0058258	http://dx.doi.org/10.1371/journal.pone.0058258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484005	Green Published, gold			2022-12-25	WOS:000316936100097
J	Araujo, SBL; Rorato, AC; Perez, DM; Pie, MR				Lino Araujo, Sabrina Borges; Rorato, Ana C.; Perez, Daniela M.; Pie, Marcio R.			A Spatially Explicit Model of Synchronization in Fiddler Crab Waving Displays	PLOS ONE			English	Article							COUPLED LOGISTIC MAP; REPRODUCTIVE-CYCLES; POPULATION-DYNAMICS; VISUAL CONTROL; FEMALE CHOICE; COURTSHIP; EVOLUTION; BRACHYURA; SIGNAL; HETEROGENEITY	Fiddler crabs (Uca spp., Decapoda: Ocypodidae) are commonly found forming large aggregations in intertidal zones, where they perform rhythmic waving displays with their greatly enlarged claws. While performing these displays, fiddler crabs often synchronize their behavior with neighboring males, forming the only known synchronized visual courtship displays involving reflected light and moving body parts. Despite being one of the most conspicuous aspects of fiddler crab behavior, little is known about the mechanisms underlying synchronization of male displays. In this study we develop a spatially explicit model of fiddler crab waving displays using coupled logistic map equations. We explored two alternative models in which males either direct their attention at random angles or preferentially toward neighbors. Our results indicate that synchronization is possible over a fairly large region of parameter space. Moreover, our model was capable of generating local synchronization neighborhoods, as commonly observed in fiddler crabs under natural conditions.	[Lino Araujo, Sabrina Borges; Rorato, Ana C.; Pie, Marcio R.] Univ Fed Parana, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil; [Rorato, Ana C.; Perez, Daniela M.; Pie, Marcio R.] Univ Fed Parana, Lab Dinam Evolut & Sistemas Complexos, Dept Zool, BR-80060000 Curitiba, Parana, Brazil; [Perez, Daniela M.; Pie, Marcio R.] Univ Fed Parana, Programa Posgrad Zool, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana	Araujo, SBL (corresponding author), Univ Fed Parana, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil.	araujosbl@gmail.com	Pie, Marcio/B-7684-2008; Araujo, Sabrina Borges Lino/I-9274-2012	Araujo, Sabrina Borges Lino/0000-0002-8759-8310; Rorato Vitor, Ana Claudia/0000-0002-1532-2016; M. Perez, Daniela/0000-0002-8560-0368	CAPES [0004428/2010]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SBLA thanks CAPES for PRODOC No 0004428/2010 grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Aizawa N, 1998, MAR BIOL, V131, P523, DOI 10.1007/s002270050344; Allen BJ, 2007, FUNCT ECOL, V21, P154, DOI 10.1111/j.1365-2435.2006.01219.x; Anteneodo C, 2006, PHYSICA D, V223, P270, DOI 10.1016/j.physd.2006.10.001; Araujo SBL, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.022903; Araujo SBL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061908; Backwell P, 1998, NATURE, V391, P31, DOI 10.1038/34076; Backwell P, 2006, ACTA ETHOL, V9, P22, DOI 10.1007/s10211-005-0009-8; Backwell PRY, 1999, ETHOLOGY, V105, P415, DOI 10.1046/j.1439-0310.1999.00387.x; Bascompte J., 1998, MODELING SPATIOTEMPO; BUCK J, 1978, AM NAT, V112, P471, DOI 10.1086/283291; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; CHRISTY JH, 1984, BIOL REV, V59, P483, DOI 10.1111/j.1469-185X.1984.tb00412.x; CHRISTY JH, 1978, SCIENCE, V199, P453, DOI 10.1126/science.199.4327.453; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; DOHERTY JA, 1982, ANIM BEHAV, V30, P352, DOI 10.1016/S0003-3472(82)80046-8; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; GORDON H. R. S., 1958, ANIMAL BEHAVIOUR, V6, P238, DOI 10.1016/0003-3472(58)90057-5; Greenfield MD, 1997, P ROY SOC B-BIOL SCI, V264, P1355, DOI 10.1098/rspb.1997.0188; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; GREENFIELD MD, 1993, NATURE, V364, P618, DOI 10.1038/364618a0; GREENFIELD MD, 1994, AM ZOOL, V34, P605; GYLLENBERG M, 1993, MATH BIOSCI, V118, P25, DOI 10.1016/0025-5564(93)90032-6; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Hemmi JM, 2003, NATURE, V421, P160, DOI 10.1038/nature01247; How MJ, 2009, J COMP PHYSIOL A, V195, P55, DOI 10.1007/s00359-008-0382-7; Kendall BE, 1998, THEOR POPUL BIOL, V54, P11, DOI 10.1006/tpbi.1998.1365; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Knell RJ, 2004, P ROY SOC B-BIOL SCI, V271, P523, DOI 10.1098/rspb.2003.2641; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; LAND M, 1995, J COMP PHYSIOL A, V177, P91, DOI 10.1007/BF00243401; LAND M, 1995, J COMP PHYSIOL A, V177, P81, DOI 10.1007/BF00243400; LANGDON JW, 1985, MAR BEHAV PHYSIOL, V11, P315, DOI 10.1080/10236248509387056; Layne JE, 1998, J EXP BIOL, V201, P2253; LLOYD AL, 1995, J THEOR BIOL, V173, P217, DOI 10.1006/jtbi.1995.0058; Matsumasa M, 2005, ANIM BEHAV, V69, P569, DOI 10.1016/j.anbehav.2004.06.017; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Milner RNC, 2012, BIOL LETTERS, V8, P176, DOI 10.1098/rsbl.2011.0926; Milner RNC, 2010, BIOL LETTERS, V6, P755, DOI 10.1098/rsbl.2010.0384; Murai M, 2006, BEHAV ECOL SOCIOBIOL, V60, P736, DOI 10.1007/s00265-006-0217-x; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Neda Z, 2000, PHYS REV E, V61, P6987, DOI 10.1103/PhysRevE.61.6987; Ott E., 1993, CHAOS DYNAMICAL SYST; Perez DM, 2012, BIOL J LINN SOC, V106, P307, DOI 10.1111/j.1095-8312.2012.01860.x; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Pope Denise S., 2005, P252, DOI 10.1017/CBO9780511610363.016; Pope DS, 2000, BEHAV ECOL SOCIOBIOL, V47, P432, DOI 10.1007/s002650050687; Reaney LT, 2008, CURR BIOL, V18, pR62, DOI 10.1016/j.cub.2007.11.047; Rosenberg MS, 2002, BIOL J LINN SOC, V75, P147, DOI 10.1046/j.1095-8312.2002.00012.x; Rosenberg MS, 2001, J CRUSTACEAN BIOL, V21, P839, DOI 10.1651/0278-0372(2001)021[0839:TSATOF]2.0.CO;2; SALMON M, 1978, Z TIERPSYCHOL, V48, P251; SALMON M, 1968, AM ZOOL, V8, P623; Smolka J, 2009, J EXP BIOL, V212, P3522, DOI 10.1242/jeb.032359; Sole R, 2000, SIGNS LIFE COMPLEXIT; Strogatz S.H., 2003, SYNC EMERGING SCI SP; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Viscido SV, 2002, ANIM BEHAV, V63, P735, DOI 10.1006/anbe.2001.1935; Zeil J, 2006, J COMP PHYSIOL A, V192, P1, DOI 10.1007/s00359-005-0048-7; Zeil J, 1997, VISION RES, V37, P3417, DOI 10.1016/S0042-6989(97)00106-5; Zeil J, 2001, J EXP BIOL, V204, P2561; ZEIL J, 1986, J COMP PHYSIOL A, V159, P801, DOI 10.1007/BF00603733; Zeil J, 1996, J EXP BIOL, V199, P1569; Zhang QB, 2003, OIKOS, V102, P146, DOI 10.1034/j.1600-0706.2003.12169.x; ZUCKER N, 1978, BIOL BULL, V155, P410, DOI 10.2307/1540961	67	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57362	10.1371/journal.pone.0057362	http://dx.doi.org/10.1371/journal.pone.0057362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483905	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100022
J	Tredennick, AT; Bentley, LP; Hanan, NP				Tredennick, Andrew T.; Bentley, Lisa Patrick; Hanan, Niall P.			Allometric Convergence in Savanna Trees and Implications for the Use of Plant Scaling Models in Variable Ecosystems	PLOS ONE			English	Article							SPECIES-LEVEL MODEL; METABOLIC THEORY; MATHEMATICALLY CORRECT; BIOLOGICALLY RELEVANT; BRANCHING PATTERNS; MECHANICAL DESIGN; GENERAL-MODEL; GROWTH; FIRE; FOREST	Theoretical models of allometric scaling provide frameworks for understanding and predicting how and why the morphology and function of organisms vary with scale. It remains unclear, however, if the predictions of 'universal' scaling models for vascular plants hold across diverse species in variable environments. Phenomena such as competition and disturbance may drive allometric scaling relationships away from theoretical predictions based on an optimized tree. Here, we use a hierarchical Bayesian approach to calculate tree-specific, species-specific, and 'global' (i.e. interspecific) scaling exponents for several allometric relationships using tree- and branch-level data harvested from three savanna sites across a rainfall gradient in Mali, West Africa. We use these exponents to provide a rigorous test of three plant scaling models (Metabolic Scaling Theory (MST), Geometric Similarity, and Stress Similarity) in savanna systems. For the allometric relationships we evaluated (diameter vs. length, aboveground mass, stem mass, and leaf mass) the empirically calculated exponents broadly overlapped among species from diverse environments, except for the scaling exponents for length, which increased with tree cover and density. When we compare empirical scaling exponents to the theoretical predictions from the three models we find MST predictions are most consistent with our observed allometries. In those situations where observations are inconsistent with MST we find that departure from theory corresponds with expected tradeoffs related to disturbance and competitive interactions. We hypothesize savanna trees have greater length-scaling exponents than predicted by MST due to an evolutionary tradeoff between fire escape and optimization of mechanical stability and internal resource transport. Future research on the drivers of systematic allometric variation could reconcile the differences between observed scaling relationships in variable ecosystems and those predicted by ideal models such as MST.	[Tredennick, Andrew T.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Tredennick, Andrew T.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Bentley, Lisa Patrick] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Hanan, Niall P.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA	Colorado State University; Colorado State University; University of Arizona; South Dakota State University	Tredennick, AT (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	Andrew.Tredennick@colostate.edu		Tredennick, Andrew/0000-0003-1254-3339; Hanan, Niall/0000-0002-9130-5306	National Science Foundation [DEB-1139096]; NASA Headquarters under the Earth and Space Science Fellowship Program [NNX11AL43H]; NSF Postdoctoral Fellowship in Bioinformatics [DBI-0905868]; Direct For Biological Sciences [1139096] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NASA Headquarters under the Earth and Space Science Fellowship Program(National Aeronautics & Space Administration (NASA)); NSF Postdoctoral Fellowship in Bioinformatics; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	A National Science Foundation (http://www.nsf.gov/) award (DEB-1139096) to NPH provided funding for this work. ATT was supported by NASA Headquarters (http://science.nasa.gov/) under the Earth and Space Science Fellowship Program (NNX11AL43H). LPB was supported by a NSF Postdoctoral Fellowship in Bioinformatics (DBI-0905868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyamba A, 2005, J ARID ENVIRON, V63, P596, DOI 10.1016/j.jaridenv.2005.03.007; Archibald S, 2003, OIKOS, V102, P3, DOI 10.1034/j.1600-0706.2003.12181.x; BARKER SB, 1973, J THEOR BIOL, V40, P33, DOI 10.1016/0022-5193(73)90163-X; Bertram JEA, 1989, TREES-STRUCT FUNCT, V3, P241, DOI 10.1007/BF00225358; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Brown JH, 2005, FUNCT ECOL, V19, P735, DOI 10.1111/j.1365-2435.2005.01022.x; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Coomes DA, 2009, J ECOL, V97, P1369, DOI 10.1111/j.1365-2745.2009.01571.x; Costes E, 2012, TREES-STRUCT FUNCT, V26, P865, DOI 10.1007/s00468-011-0661-8; Dahle GA, 2010, TREES-STRUCT FUNCT, V24, P321, DOI 10.1007/s00468-009-0401-5; Day JS, 1997, ANN BOT-LONDON, V79, P607, DOI 10.1006/anbo.1996.0368; DELLAPORTAS P, 1995, BIOMETRICS, V51, P1085, DOI 10.2307/2533007; Dietze MC, 2008, FOREST ECOL MANAG, V256, P1939, DOI 10.1016/j.foreco.2008.07.034; Dodonov P, 2011, BRAZ J BIOL, V71, P527, DOI 10.1590/S1519-69842011000300025; ELLIS JE, 1988, J RANGE MANAGE, V41, P450, DOI 10.2307/3899515; Enquist B.J., 2012, METAB ECOL SCALING A, P164, DOI [10.1002/, DOI 10.1002/9781119968535.CH14]; Enquist BJ, 2002, TREE PHYSIOL, V22, P1045, DOI 10.1093/treephys/22.15-16.1045; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A, 2009, DATA ANAL USING REGR; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gignoux J, 1997, OECOLOGIA, V110, P576, DOI 10.1007/s004420050198; Hanan NP, 2008, AM NAT, V171, P851, DOI 10.1086/587527; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; Hobbs NT, 2012, ECOL APPL, V22, P1640, DOI 10.1890/11-1309.1; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Hoffmann WA, 2009, ECOLOGY, V90, P1326, DOI 10.1890/08-0741.1; Horn HS, 2000, SCALING BIOL; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Kozlowski J, 2004, FUNCT ECOL, V18, P283, DOI 10.1111/j.0269-8463.2004.00830.x; Lawes MJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00204.1; LEOPOLD LB, 1971, J THEOR BIOL, V31, P339, DOI 10.1016/0022-5193(71)90192-5; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; Moncrieff GR, 2011, ECOLOGY, V92, P2310, DOI 10.1890/11-0230.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2004, P NATL ACAD SCI USA, V101, P15661, DOI 10.1073/pnas.0405857101; Osada N, 2001, J ECOL, V89, P774, DOI 10.1046/j.0022-0477.2001.00590.x; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M., 2015, PACKAGE CODA; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Price CA, 2012, ECOL LETT, V15, P1465, DOI 10.1111/j.1461-0248.2012.01860.x; Price CA, 2012, NEW PHYTOL, V193, P882, DOI 10.1111/j.1469-8137.2011.04022.x; Price CA, 2010, NEW PHYTOL, V188, P696, DOI 10.1111/j.1469-8137.2010.03442.x; Price CA, 2009, ECOL LETT, V12, P641, DOI 10.1111/j.1461-0248.2009.01316.x; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Renton M, 2006, J EXP BOT, V57, P3131, DOI 10.1093/jxb/erl075; Rinnan R, 2009, J ECOL, V97, P788, DOI 10.1111/j.1365-2745.2009.01506.x; Ruger N, 2012, FUNCT ECOL, V26, P759, DOI 10.1111/j.1365-2435.2012.01981.x; Russo SE, 2007, ECOL LETT, V10, P889, DOI 10.1111/j.1461-0248.2007.01079.x; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Sone K, 2005, TREE PHYSIOL, V25, P39, DOI 10.1093/treephys/25.1.39; Sperry JS, 2012, FUNCT ECOL, V26, P1054, DOI 10.1111/j.1365-2435.2012.02022.x; Staver AC, 2012, ECOL LETT, V15, P673, DOI 10.1111/j.1461-0248.2012.01784.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Team RDC, 2012, R LANG ENV STAT COMP; Tilman D, 2004, ECOLOGY, V85, P1797, DOI 10.1890/03-0725; von Allmen EI, 2012, FUNCT ECOL, V26, P1066, DOI 10.1111/j.1365-2435.2012.02021.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1	73	16	16	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58241	10.1371/journal.pone.0058241	http://dx.doi.org/10.1371/journal.pone.0058241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484003	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100094
J	Fu, RH; Wang, YC; Liu, SP; Chu, CL; Tsai, RT; Ho, YC; Chang, WL; Chiu, SC; Harn, HJ; Shyu, WC; Lin, SZ				Fu, Ru-Huei; Wang, Yu-Chi; Liu, Shih-Ping; Chu, Ching-Liang; Tsai, Rong-Tzong; Ho, Yu-Chen; Chang, Wen-Lin; Chiu, Shao-Chih; Harn, Horng-Jyh; Shyu, Woei-Cherng; Lin, Shinn-Zong			Acetylcorynoline Impairs the Maturation of Mouse Bone Marrow-Derived Dendritic Cells via Suppression of I kappa B Kinase and Mitogen-Activated Protein Kinase Activities	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; GENE-EXPRESSION; HERBAL MEDICINE; LPS; SURVIVAL; BIOLOGY; ENDOCYTOSIS; INDUCTION; ALKALOIDS; CCR7	Background: Dendritic cells (DCs) are major modulators in the immune system. One active field of research is the manipulation of DCs as pharmacological targets to screen novel biological modifiers for the treatment of inflammatory and autoimmune disorders. Acetylcorynoline is the major alkaloid component derived from Corydalis bungeana herbs. We assessed the capability of acetylcorynoline to regulate lipopolysaccharide (LPS)-stimulated activation of mouse bone marrow-derived DCs. Methodology/Principal Findings: Our experimental data showed that treatment with up to 20 mu M acetylcorynoline does not cause cytotoxicity in cells. Acetylcorynoline significantly inhibited the secretion of tumor necrosis factor-alpha, interleukin-6, and interleukin-12p70 by LPS-stimulated DCs. The expression of LPS-induced major histocompatibility complex class II, CD40, and CD86 on DCs was also decreased by acetylcorynoline, and the endocytic capacity of LPS-stimulated DCs was restored by acetylcorynoline. In addition, LPS-stimulated DC-elicited allogeneic T-cell proliferation was blocked by acetylcorynoline, and the migratory ability of LPS-stimulated DCs was reduced by acetylcorynoline. Moreover, acetylcorynoline significantly inhibits LPS-induced activation of IkB kinase and mitogen-activated protein kinase. Importantly, administration of acetylcorynoline significantly attenuates 2,4-dinitro-1-fluorobenzene-induced delayed-type hypersensitivity. Conclusions/Significance: Acetylcorynoline may be one of the potent immunosuppressive agents through the blockage of DC maturation and function.	[Fu, Ru-Huei; Ho, Yu-Chen; Chang, Wen-Lin; Chiu, Shao-Chih; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Fu, Ru-Huei; Liu, Shih-Ping; Chiu, Shao-Chih; Harn, Horng-Jyh; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Wang, Yu-Chi] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Liu, Shih-Ping] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chu, Ching-Liang] Natl Taiwan Univ, Grad Inst Immunol, Taipei 10764, Taiwan; [Tsai, Rong-Tzong] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Yunlin, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Industrial Technology Research Institute - Taiwan; China Medical University Taiwan; National Taiwan University; Chung Shan Medical University; China Medical University Taiwan	Fu, RH (corresponding author), China Med Univ, Grad Inst Immunol, Taichung, Taiwan.	rhfu@mail.cmu.edu.tw; shinnzong@yahoo.com.tw	Lin, Shinn-Zong/AAX-2379-2020	Chu, Ching-Liang/0000-0002-8463-526X; Fu, Ru-Huei/0000-0001-9367-1759; Liu, Shih-Ping/0000-0002-5803-4460	National Science Council (Taiwan) [NSC 98-2320-B-039-043-MY2]; China Medical University [CMU98-CT-31]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Taiwan Department of Health Clinical Trial and Research Center of Excellence	This work was supported in part by the National Science Council (Taiwan) (NSC 98-2320-B-039-043-MY2), China Medical University (CMU98-CT-31), and the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 1999, J IMMUNOL, V163, P5786; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Chen YW, 2007, INT IMMUNOPHARMACOL, V7, P1102, DOI 10.1016/j.intimp.2007.04.007; Chen Y, 2010, PLANTA MED, V76, P1424, DOI 10.1055/s-0029-1240909; deLuca LS, 2012, NAT REV IMMUNOL, V12, P339, DOI 10.1038/nri3193; Fang F, 2010, J IMMUNOL, V184, P6084, DOI 10.4049/jimmunol.0902561; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fu RH, 2013, J SCI FOOD AGR, V93, P76, DOI 10.1002/jsfa.5733; Fu RH, 2011, BIOTECHNOL LETT, V33, P903, DOI 10.1007/s10529-011-0528-5; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gommerman JL, 2011, IMMUNOL REV, V244, P85, DOI 10.1111/j.1600-065X.2011.01056.x; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Huang RY, 2010, J IMMUNOL, V184, P6815, DOI 10.4049/jimmunol.0903991; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Kim JS, 2005, IMMUNOLOGY, V115, P375, DOI 10.1111/j.1365-2567.2005.02156.x; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li CY, 2011, J CELL PHYSIOL, V226, P2338, DOI 10.1002/jcp.22576; Lin MK, 2011, IMMUNOBIOLOGY, V216, P1103, DOI 10.1016/j.imbio.2011.05.002; Liu C, 2011, INT J BIOL SCI, V7, P168, DOI 10.7150/ijbs.7.168; Liu Y, 2007, TRANSPLANTATION, V84, P1517, DOI 10.1097/01.tp.0000289990.55668.0d; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mitsui S, 2010, J PHARMACOL EXP THER, V333, P954, DOI 10.1124/jpet.109.162305; Murakami M, 2011, CURR OPIN RHEUMATOL, V23, P273, DOI 10.1097/BOR.0b013e3283456797; Nhiem NX, 2011, ARCH PHARM RES, V34, P1593, DOI 10.1007/s12272-011-1002-6; Niu LL, 2011, J SEP SCI, V34, P987, DOI 10.1002/jssc.201000785; Nouri-Shirazi M, 2003, IMMUNOLOGY, V109, P365, DOI 10.1046/j.1365-2567.2003.01655.x; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Thobe BM, 2007, J CELL PHYSIOL, V210, P667, DOI 10.1002/jcp.20860; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uto T, 2011, INT IMMUNOPHARMACOL, V11, P1932, DOI 10.1016/j.intimp.2011.08.003; Wei H. L., 1997, Yaoxue Xuebao, V32, P331; Xie C, 2004, PHYTOCHEMISTRY, V65, P3041, DOI 10.1016/j.phytochem.2004.09.009; Yoon MS, 2006, MOL PHARMACOL, V70, P1033, DOI 10.1124/mol.106.024547; Yu QG, 2004, J IMMUNOL, V172, P6047, DOI 10.4049/jimmunol.172.10.6047; Yu YL, 2009, EUR J IMMUNOL, V39, P2482, DOI 10.1002/eji.200839039	42	21	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58398	10.1371/journal.pone.0058398	http://dx.doi.org/10.1371/journal.pone.0058398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472193	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900139
J	Hu, H; Gao, J; He, J; Yu, B; Zheng, P; Huang, ZQ; Mao, XB; Yu, J; Han, GQ; Chen, DW				Hu, Hong; Gao, Jie; He, Jun; Yu, Bing; Zheng, Ping; Huang, Zhiqing; Mao, Xiangbing; Yu, Jie; Han, Guoquan; Chen, Daiwen			Codon Optimization Significantly Improves the Expression Level of a Keratinase Gene in Pichia pastoris	PLOS ONE			English	Article							BACILLUS-LICHENIFORMIS; ESCHERICHIA-COLI; KERA GENE; YEAST; PROTEIN; SEQUENCE; FERMENTATION; PURIFICATION; CHICKENS; PROMOTER	The main keratinase (kerA) gene from the Bacillus licheniformis S90 was optimized by two codon optimization strategies and expressed in Pichia pastoris in order to improve the enzyme production compared to the preparations with the native kerA gene. The results showed that the corresponding mutations (synonymous codons) according to the codon bias in Pichia pastoris were successfully introduced into keratinase gene. The highest keratinase activity produced by P. pastoris pPICZ alpha A-kerAwt, pPICZ alpha A-kerAopti1 and pPICZ alpha A-kerAopti2 was 195 U/ml, 324 U/ml and 293 U/ml respectively. In addition, there was no significant difference in biomass concentration, target gene copy numbers and relative mRNA expression levels of every positive strain. The molecular weight of keratinase secreted by recombinant P. pastori was approx. 39 kDa. It was optimally active at pH 7.5 and 50 degrees C. The recombinant keratinase could efficiently degrade both alpha-keratin (keratin azure) and beta-keratin (chicken feather meal). These properties make the P. pastoris pPICZ alpha A-kerAopti1 a suitable candidate for industrial production of keratinases.	[Hu, Hong; Gao, Jie; He, Jun; Yu, Bing; Zheng, Ping; Huang, Zhiqing; Mao, Xiangbing; Yu, Jie; Han, Guoquan; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University	Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	dwchen@sicau.edu.cn			Feed Biotechnology Project of Sichuan Province of China [2010GZ0193]	Feed Biotechnology Project of Sichuan Province of China	This research was granted by Feed Biotechnology Project of Sichuan Province of China with grant number 2010GZ0193. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON SGE, 1991, MOL BIOL EVOL, V8, P530; Bai JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022577; Boettner M, 2007, J BIOTECHNOL, V130, P1, DOI 10.1016/j.jbiotec.2007.02.019; [陈惠 Chen Hui], 2005, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V21, P171; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Hu H, 2013, BIOTECHNOL LETT, V35, P239, DOI 10.1007/s10529-012-1064-7; Hu XY, 1996, PROTEIN EXPRES PURIF, V7, P289, DOI 10.1006/prep.1996.0041; Huang H, 2008, APPL MICROBIOL BIOT, V78, P95, DOI 10.1007/s00253-007-1290-4; Jia HY, 2012, J MOL CATAL B-ENZYM, V78, P72, DOI 10.1016/j.molcatb.2012.02.009; Kublanov IV, 2009, APPL ENVIRON MICROB, V75, P286, DOI 10.1128/AEM.00607-08; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; Li K, 2012, VACCINE, V30, P2273, DOI 10.1016/j.vaccine.2012.01.075; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; LIN XA, 1995, APPL ENVIRON MICROB, V61, P1469, DOI 10.1128/AEM.61.4.1469-1474.1995; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Macedo AJ, 2005, APPL ENVIRON MICROB, V71, P594, DOI 10.1128/AEM.71.1.594-596.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porres JM, 2002, BIOTECHNOL LETT, V24, P631, DOI 10.1023/A:1015083007746; Potvin G, 2012, BIOCHEM ENG J, V64, P91, DOI 10.1016/j.bej.2010.07.017; Radha S, 2007, J APPL MICROBIOL, V103, P1301, DOI 10.1111/j.1365-2672.2007.03372.x; Radha S, 2009, PROTEIN EXPRES PURIF, V64, P24, DOI 10.1016/j.pep.2008.10.008; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Son HJ, 2008, BIOTECHNOL LETT, V30, P461, DOI 10.1007/s10529-007-9567-3; SPANJAARD RA, 1988, P NATL ACAD SCI USA, V85, P7967, DOI 10.1073/pnas.85.21.7967; Stark CR, 2009, J APPL POULTRY RES, V18, P30, DOI 10.3382/japr.2008-00038; Wang JJ, 2006, J APPL POULTRY RES, V15, P544, DOI 10.1093/japr/15.4.544; Waterham HR, 1997, GENE, V186, P37, DOI 10.1016/S0378-1119(96)00675-0; WILLIAMS CM, 1990, APPL ENVIRON MICROB, V56, P1509, DOI 10.1128/AEM.56.6.1509-1515.1990; Yao B, 1998, SCI CHINA SER C, V28, P237; ZHANG SP, 1991, GENE, V105, P61, DOI 10.1016/0378-1119(91)90514-C; Zhu T, 2009, J APPL MICROBIOL, V107, P954, DOI 10.1111/j.1365-2672.2009.04279.x	38	50	57	6	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58393	10.1371/journal.pone.0058393	http://dx.doi.org/10.1371/journal.pone.0058393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472192	Green Submitted, Green Published, gold			2022-12-25	WOS:000315637900138
J	Saraiva, N; Prole, DL; Carrara, G; de Motes, CM; Johnson, BF; Byrne, B; Taylor, CW; Smith, GL				Saraiva, Nuno; Prole, David L.; Carrara, Guia; de Motes, Carlos Maluquer; Johnson, Benjamin F.; Byrne, Bernadette; Taylor, Colin W.; Smith, Geoffrey L.			Human and Viral Golgi Anti-apoptotic Proteins (GAAPs) Oligomerize via Different Mechanisms and Monomeric GAAP Inhibits Apoptosis and Modulates Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BAX INHIBITOR-1; ENDOPLASMIC-RETICULUM; VACCINIA VIRUS; CROSS-LINKING; PH REGULATION; FAMILY; CHANNEL; GENE; TRAFFICKING; HOMEOSTASIS	Golgi anti-apoptotic proteins (GAAPs) are hydrophobic proteins resident in membranes of the Golgi complex. They protect cells from a range of apoptotic stimuli, reduce the Ca2+ content of intracellular stores, and regulate Ca2+ fluxes. GAAP was discovered in camelpox virus, but it is highly conserved throughout evolution and encoded by all eukaryote genomes examined. GAAPs are part of the transmembrane Bax inhibitor-containing motif (TMBIM) family that also includes other anti-apoptotic and Ca2+-modulating membrane proteins. Most TMBIM members show multiple bands when analyzed by SDS-PAGE, suggesting that they may be oligomeric. However, the molecular mechanisms of oligomerization, the native state of GAAPs in living cells and the functional significance of oligomerization have not been addressed. TMBIM members are thought to have evolved from an ancestral GAAP. Two different GAAPs, human (h) and viral (v) GAAP were therefore selected as models to examine oligomerization of TMBIM family members. We show that both hGAAP and vGAAP in their native states form oligomers and that oligomerization is pH-dependent. Surprisingly, hGAAP and vGAAP do not share the same oligomerization mechanism. Oligomerization of hGAAP is independent of cysteines, but oligomerization of vGAAP depends on cysteines 9 and 60. Amutant vGAAP that is unable to oligomerize revealed that monomeric vGAAP retains both its anti-apoptotic function and its effect on intracellular Ca2+ stores. In conclusion, GAAP can oligomerize in a pH-regulated manner, and monomeric GAAP is functional.	[Saraiva, Nuno; Carrara, Guia; de Motes, Carlos Maluquer; Smith, Geoffrey L.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Saraiva, Nuno; Carrara, Guia; de Motes, Carlos Maluquer; Johnson, Benjamin F.; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, London W2 1PG, England; [Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Byrne, Bernadette] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	University of Cambridge; Imperial College London; University of Cambridge; Imperial College London	Smith, GL (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	gls37@cam.ac.uk	Smith, Geoffrey L/G-2894-2012; de Motes, Carlos Maluquer/AAF-8092-2021; Saraiva, Nuno/I-9299-2019; Taylor, Colin/G-2447-2010	de Motes, Carlos Maluquer/0000-0003-4712-4601; Saraiva, Nuno/0000-0003-1333-9137; Johnson, Benjamin/0000-0001-5991-7612; Prole, David/0000-0003-2782-6665; Taylor, Colin/0000-0001-7771-1044; Byrne, Bernadette/0000-0001-9598-9832; Smith, Geoffrey L/0000-0002-3730-9955	UK Medical Research Council [G0900224]; Wellcome Trust [085295]; Portuguese Foundation for Science and Technology; St. John's College (Cambridge, UK); Medical Research Council [G0900224] Funding Source: researchfish; MRC [G0900224] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); St. John's College (Cambridge, UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the UK Medical Research Council (G0900224) and The Wellcome Trust (085295).; Supported by the Portuguese Foundation for Science and Technology.; Supported in part by a Meres Research associateship from St. John's College (Cambridge, UK).	Ahn T, 2010, CELL CALCIUM, V47, P387, DOI 10.1016/j.ceca.2010.02.003; Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Capasso M, 2011, TRENDS CELL BIOL, V21, P20, DOI 10.1016/j.tcb.2010.09.006; Carrara G, 2012, J BIOL CHEM, V287, P15896, DOI 10.1074/jbc.M111.336149; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Fatmi MQ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000994; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; GRODEN DL, 1991, CELL CALCIUM, V12, P279, DOI 10.1016/0143-4160(91)90002-V; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Karasawa A, 2010, BIOCHEM J, V426, P99, DOI 10.1042/BJ20091339; Kew J. N., 2010, ION CHANNELS STRUCTU, P172; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; KORNBLATT JA, 1980, CAN J BIOCHEM CELL B, V58, P219, DOI 10.1139/o80-030; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Reimers K, 2008, CURR MOL MED, V8, P148, DOI 10.2174/156652408783769562; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zhou JH, 2008, COMPUT BIOL CHEM, V32, P159, DOI 10.1016/j.compbiolchem.2008.01.002	35	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13057	13067		10.1074/jbc.M112.414367	http://dx.doi.org/10.1074/jbc.M112.414367			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508950	hybrid, Green Published			2022-12-25	WOS:000318555100057
J	Fujimoto, Z; Jackson, A; Michikawa, M; Maehara, T; Momma, M; Henrissat, B; Gilbert, HJ; Kaneko, S				Fujimoto, Zui; Jackson, Adam; Michikawa, Mari; Maehara, Tomoko; Momma, Mitsuru; Henrissat, Bernard; Gilbert, Harry J.; Kaneko, Satoshi			The Structure of a Streptomyces avermitilis alpha-L-Rhamnosidase Reveals a Novel Carbohydrate-binding Module CBM67 within the Six-domain Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HYDROLASE; FAMILY; HYDROLYSIS; MECHANISM; LECTIN; DEGRADATION	alpha-L-Rhamnosidases hydrolyze alpha-linked L-rhamnosides from oligosaccharides or polysaccharides. We determined the crystal structure of the glycoside hydrolase family 78 Streptomyces avermitilis alpha-L-rhamnosidase (SaRha78A) in its free and L-rhamnose complexed forms, which revealed the presence of six domains N, D, E, F, A, and C. In the ligand complex, L-rhamnose was bound in the proposed active site of the catalytic module, revealing the likely catalytic mechanism of SaRha78A. Glu(636) is predicted to donate protons to the glycosidic oxygen, and Glu(895) is the likely catalytic general base, activating the nucleophilic water, indicating that the enzyme operates through an inverting mechanism. Replacement of Glu(636) and Glu(895) resulted in significant loss of alpha-rhamnosidase activity. Domain D also bound L-rhamnose in a calcium-dependent manner, with a K-D of 135 mu M. Domain D is thus a non-catalytic carbohydrate binding module (designated SaCBM67). Mutagenesis and structural data identified the amino acids in SaCBM67 that target the features of L-rhamnose that distinguishes it from the other major sugars present in plant cell walls. Inactivation of SaCBM67 caused a substantial reduction in the activity of SaRha78A against the polysaccharide composite gum arabic, but not against aryl rhamnosides, indicating that SaCBM67 contributes to enzyme function against insoluble substrates.	[Fujimoto, Zui; Momma, Mitsuru] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Jackson, Adam; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Michikawa, Mari; Maehara, Tomoko; Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR 7257, Lab Architecture & Fonct Macromol Biol, F-13288 Marseille 9, France	National Institute of Agrobiological Sciences - Japan; Newcastle University - UK; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Fujimoto, Z (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	zui@affrc.go.jp; harry.gilbert@newcastle.ac.uk; sakaneko@affrc.go.jp	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Fujimoto, Zui/0000-0002-3551-6854	JSPS KAKENHI [22580110]; Grants-in-Aid for Scientific Research [22580110] Funding Source: KAKEN; BBSRC [BB/G016224/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016224/1] Funding Source: researchfish	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in part, by JSPS KAKENHI Grant 22580110.	Barker IJ, 2010, J PHYS CHEM B, V114, P15389, DOI 10.1021/jp107886e; Bonanno Jeffrey B., 2005, Journal of Structural and Functional Genomics, V6, P225, DOI 10.1007/s10969-005-6827-0; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cui Z, 2007, J MOL BIOL, V374, P384, DOI 10.1016/j.jmb.2007.09.003; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; DEFAYE J, 1986, CARBOHYD RES, V150, P221, DOI 10.1016/0008-6215(86)80018-0; Drewnowski A, 1997, AM J CLIN NUTR, V66, P391, DOI 10.1093/ajcn/66.2.391; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Ichinose H, 2013, BIOSCI BIOTECH BIOCH, V77, P213, DOI 10.1271/bbb.120735; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Montanier C, 2010, J BIOL CHEM, V285, P31742, DOI 10.1074/jbc.M110.142133; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mutter M, 1998, CARBOHYD RES, V311, P155, DOI 10.1016/S0008-6215(98)00188-8; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; Oguri S, 1996, J BACTERIOL, V178, P5692, DOI 10.1128/jb.178.19.5692-5698.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Shirai T, 2009, J MOL BIOL, V391, P390, DOI 10.1016/j.jmb.2009.06.027; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; Sumisa F, 2004, J BIOSCI BIOENG, V98, P257, DOI 10.1016/S1389-1723(04)00278-6; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vila-Real Helder, 2011, Enzyme Res, V2011, P692618, DOI 10.4061/2011/692618; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang H, 2006, FOOD SCI TECHNOL RES, V12, P43, DOI 10.3136/fstr.12.43; Yazawa R, 2011, BIOSCI BIOTECH BIOCH, V75, P379, DOI 10.1271/bbb.100730; Zverlov VV, 2000, MOL MICROBIOL, V35, P173, DOI 10.1046/j.1365-2958.2000.01691.x	43	48	56	6	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12376	12385		10.1074/jbc.M113.460097	http://dx.doi.org/10.1074/jbc.M113.460097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486481	hybrid, Green Published			2022-12-25	WOS:000318157600068
J	Matsen, FA; Evans, SN				Matsen, Frederick A.; Evans, Steven N.			Edge Principal Components and Squash Clustering: Using the Special Structure of Phylogenetic Placement Data for Sample Comparison	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SPACE	Principal components analysis (PCA) and hierarchical clustering are two of the most heavily used techniques for analyzing the differences between nucleic acid sequence samples taken from a given environment. They have led to many insights regarding the structure of microbial communities. We have developed two new complementary methods that leverage how this microbial community data sits on a phylogenetic tree. Edge principal components analysis enables the detection of important differences between samples that contain closely related taxa. Each principal component axis is a collection of signed weights on the edges of the phylogenetic tree, and these weights are easily visualized by a suitable thickening and coloring of the edges. Squash clustering outputs a (rooted) clustering tree in which each internal node corresponds to an appropriate "average" of the original samples at the leaves below the node. Moreover, the length of an edge is a suitably defined distance between the averaged samples associated with the two incident nodes, rather than the less interpretable average of distances produced by UPGMA, the most widely used hierarchical clustering method in this context. We present these methods and illustrate their use with data from the human microbiome.	[Matsen, Frederick A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Evans, Steven N.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Fred Hutchinson Cancer Center; University of California System; University of California Berkeley	Matsen, FA (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	matsen@fhcrc.org			National Institutes of Health [HG005966-01]; National Science Foundation [DMS-09-07630]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The first author was supported in part by National Institutes of Health grant HG005966-01, and the second author was supported in part by National Science Foundation grant DMS-09-07630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Matsen FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031009; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mitra S, 2009, BIOINFORMATICS, V25, P1849, DOI 10.1093/bioinformatics/btp341; Morgan JL, 2010, PLOS ONE, V5; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Nye TMW, 2011, ANN STAT, V39, P2716, DOI 10.1214/11-AOS915; Purdom E., 2008, UC BERKELEY STAT TEC, V766, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wang H, 2007, ANN STAT, V35, P1849, DOI 10.1214/009053607000000217; White JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-152; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07	32	50	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e56859	10.1371/journal.pone.0056859	http://dx.doi.org/10.1371/journal.pone.0056859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505415	Green Submitted, Green Published, gold			2022-12-25	WOS:000316251100004
J	Neely, KA; Planetta, PJ; Prodoehl, J; Corcos, DM; Comella, CL; Goetz, CG; Shannon, KL; Vaillancourt, DE				Neely, Kristina A.; Planetta, Peggy J.; Prodoehl, Janey; Corcos, Daniel M.; Comella, Cynthia L.; Goetz, Christopher G.; Shannon, Kathleen L.; Vaillancourt, David E.			Force Control Deficits in Individuals with Parkinson's Disease, Multiple Systems Atrophy, and Progressive Supranuclear Palsy	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; VOXEL-WISE ANALYSIS; ISOMETRIC FORCE; APPLAUSE SIGN; PRECISION GRIP; FOLLOW-UP; DEGENERATION; VARIABILITY; MILESTONES; GENERATION	Objective: This study examined grip force and cognition in Parkinson's disease (PD), Parkinsonian variant of multiple system atrophy (MSAp), progressive supranuclear palsy (PSP), and healthy controls. PD is characterized by a slower rate of force increase and decrease and the production of abnormally large grip forces. Early-stage PD has difficulty with the rapid contraction and relaxation of hand muscles required for precision gripping. The first goal was to determine which features of grip force are abnormal in MSAp and PSP. The second goal was to determine whether a single variable or a combination of motor and cognitive measures would distinguish patient groups. Since PSP is more cognitively impaired relative to PD and MSAp, we expected that combining motor and cognitive measures would further distinguish PSP from PD and MSAp. Methods: We studied 44 participants: 12 PD, 12 MSAp, 8 PSP, and 12 controls. Patients were diagnosed by a movement disorders neurologist and were tested off anti-Parkinsonian medication. Participants completed a visually guided grip force task wherein force pulses were produced for 2 s, followed by 1 s of rest. We also conducted four cognitive tests. Results: PD, MSAp, and PSP were slower at contracting and relaxing force and produced longer pulse durations compared to controls. PSP produced additional force pulses during the task and were more cognitively impaired relative to other groups. A receiver operator characteristic analysis revealed that the combination of number of pulses and Brief Test of Attention (BTA) discriminated PSP from PD, MSAp, and controls with a high degree of sensitivity and specificity. Conclusions: Slowness in contracting and relaxing force represent general features of PD, MSAp, and PSP, whereas producing additional force pulses was specific to PSP. Combining motor and cognitive measures provides a robust method for characterizing behavioral features of PSP compared to MSAp and PD.	[Neely, Kristina A.; Planetta, Peggy J.; Vaillancourt, David E.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA; [Prodoehl, Janey] Midwestern Univ, Phys Therapy Program, Downers Grove, IL 60515 USA; [Corcos, Daniel M.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Corcos, Daniel M.] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Corcos, Daniel M.] Univ Illinois, Dept Phys Therapy, Chicago, IL USA; [Corcos, Daniel M.] Univ Illinois, Dept Neurol Sci, Chicago, IL USA; [Comella, Cynthia L.; Goetz, Christopher G.; Shannon, Kathleen L.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Vaillancourt, David E.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Vaillancourt, David E.] Univ Florida, Dept Biomed Engn, Gainesville, FL USA	State University System of Florida; University of Florida; Midwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vaillancourt, DE (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	vcourt@ufl.edu	Corcos, Daniel/AAX-9971-2021; Neely, Kristina A./GQH-9601-2022; Prodoehl, Janey/AAS-4875-2021; Neely, Kristina A./H-7117-2019	Neely, Kristina A./0000-0002-3008-8707	National Institutes of Health (NIH) [R01 NS52318, R01 NS58487, R01 NS75012, R01 NS028127]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058487, R01NS028127, R01NS075012, R01NS052318] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant numbers: R01 NS52318, R01 NS58487, R01 NS75012, and R01 NS028127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini A, 2010, LANCET NEUROL, V9, P130, DOI 10.1016/S1474-4422(09)70360-6; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Berendse HW, 2009, PARKINSONISM RELAT D, V15, pS26, DOI 10.1016/S1353-8020(09)70774-6; Brooks DJ, 2008, NAT CLIN PRACT NEURO, V4, P267, DOI 10.1038/ncpneuro0773; Corcos DM, 1996, ANN NEUROL, V39, P79, DOI 10.1002/ana.410390112; Dodel RC, 2003, MOVEMENT DISORD, V18, pS52, DOI 10.1002/mds.10580; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dubois B, 2005, NEUROLOGY, V64, P2132, DOI 10.1212/01.WNL.0000165977.38272.15; DUTTA C, 1995, J GERONTOL A-BIOL, V50, P1, DOI 10.1093/gerona/50A.Special_Issue.1; Fellows SJ, 2006, PARKINSONISM RELAT D, V12, P149, DOI 10.1016/j.parkreldis.2005.12.001; Fellows SJ, 2004, MOVEMENT DISORD, V19, P560, DOI 10.1002/mds.10710; Fellows SJ, 1998, BRAIN, V121, P1771, DOI 10.1093/brain/121.9.1771; FREUND HJ, 1978, EXP BRAIN RES, V31, P1; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; GORDON J, 1987, EXP BRAIN RES, V67, P241, DOI 10.1007/BF00248546; Hallett M, 2011, MOVEMENT DISORD, V26, P958, DOI 10.1002/mds.23572; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hughes AJ, 2001, NEUROLOGY, V57, pS34; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; JORDAN N, 1992, J NEUROL NEUROSUR PS, V55, P572, DOI 10.1136/jnnp.55.7.572; Ling H, 2012, BRAIN, V135, P1141, DOI 10.1093/brain/aws038; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Luzzi S, 2011, J NEUROL NEUROSUR PS, V82, P830, DOI 10.1136/jnnp.2010.224394; Luzzi S, 2013, J NEUROL, V260, P172, DOI 10.1007/s00415-012-6608-1; Marras C, 2005, NEUROLOGY, V64, P87, DOI 10.1212/01.WNL.0000148603.44618.19; Menke RA, 2009, NEUROIMAGE, V47, P435, DOI 10.1016/j.neuroimage.2009.05.017; Muratori LM, 2003, NEUROPSYCHOLOGIA, V41, P1498, DOI 10.1016/S0028-3932(03)00092-7; Nowak DA, 2005, EXP NEUROL, V193, P427, DOI 10.1016/j.expneurol.2005.01.003; Park JH, 2007, NEUROSCI LETT, V412, P173, DOI 10.1016/j.neulet.2006.11.009; PILLON B, 1995, NEUROLOGY, V45, P1477, DOI 10.1212/WNL.45.8.1477; Prodoehl J, 2010, MOVEMENT DISORD, V25, P2035, DOI 10.1002/mds.23360; Robichaud JA, 2005, MOVEMENT DISORD, V20, P441, DOI 10.1002/mds.20350; Scherfler C, 2006, BRAIN, V129, P538, DOI 10.1093/brain/awh674; Scherfler C, 2005, BRAIN, V128, P1605, DOI 10.1093/brain/awh485; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Slifkin AB, 2000, J MOTOR BEHAV, V32, P141, DOI 10.1080/00222890009601366; Soliveri P, 2000, J NEUROL NEUROSUR PS, V69, P313, DOI 10.1136/jnnp.69.3.313; Sosnov JJ, 2006, EXP BRAIN RES, V174, P86, DOI 10.1007/s00221-006-0422-x; Spraker MB, 2009, CEREB CORTEX, V19, P2640, DOI 10.1093/cercor/bhp015; STELMACH GE, 1988, NEUROPSYCHOLOGIA, V26, P93, DOI 10.1016/0028-3932(88)90033-4; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Tracy BL, 2005, MUSCLE NERVE, V32, P533, DOI 10.1002/mus.20392; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Vaillancourt DE, 2004, BRAIN, V127, P491, DOI 10.1093/brain/awh057; Vaillancourt DE, 2003, J NEUROPHYSIOL, V90, P3330, DOI 10.1152/jn.00394.2003; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; WENNING GK, 1995, ACTA NEUROL SCAND, V91, P247, DOI 10.1111/j.1600-0404.1995.tb06998.x; Wenning GK, 2011, MOVEMENT DISORD, V26, P1083, DOI 10.1002/mds.23713; Wichmann T, 2011, NEUROSCIENCE, V198, P232, DOI 10.1016/j.neuroscience.2011.06.048; Wichmann T, 2011, MOVEMENT DISORD, V26, P1032, DOI 10.1002/mds.23695; Wu LJC, 2008, MOVEMENT DISORD, V23, P2307, DOI 10.1002/mds.22090	53	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58403	10.1371/journal.pone.0058403	http://dx.doi.org/10.1371/journal.pone.0058403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505500	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100049
J	Lamash, NE; Dolmatov, IY				Lamash, Nina E.; Dolmatov, Igor Yu			Proteases from the Regenerating Gut of the Holothurian Eupentacta fraudatrix	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; SEA-URCHIN; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; INTESTINE REGENERATION; HATCHING ENZYME; EXPRESSION; CUCUMBER; INHIBITION; PROTEIN	Four proteases with molecular masses of 132, 58, 53, and 47 kDa were detected in the digestive system of the holothurian Eupentacta fraudatrix. These proteases displayed the gelatinase activity and characteristics of zinc metalloproteinases. The 58 kDa protease had similar protease inhibitor sensitivity to that of mammalian matrix metalloproteinases. Zymographic assay revealed different lytic activities of all four proteases during intestine regeneration in the holothurian. The 132 kDa protease showed the highest activity at the first stage. During morphogenesis (stages 2-4 of regeneration), the highest activity was measured for the 53 and 58 kDa proteases. Inhibition of protease activity exerts a marked effect on regeneration, which was dependent on the time when 1,10-phenanthroline injections commenced. When metalloproteinases were inhibited at the second stage of regeneration, the restoration rates were decreased. However, such an effect proved to be reversible, and when inhibition ceased, the previous rate of regeneration was recovered. When protease activity is inhibited at the first stage, regeneration is completely abolished, and the animals die, suggesting that early activation of the proteases is crucial for triggering the regenerative process in holothurians. The role of the detected proteases in the regeneration processes of holothurians is discussed.	[Lamash, Nina E.; Dolmatov, Igor Yu] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia; [Lamash, Nina E.; Dolmatov, Igor Yu] Far Eastern Fed Univ, Sch Nat Sci, Vladivostok, Russia	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Far Eastern Federal University	Dolmatov, IY (corresponding author), Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia.	idolmatov@mail.ru	Dolmatov, Igor Yu/A-7704-2014; Lamash, Nina E/Q-1040-2015	Dolmatov, Igor Yu/0000-0003-3923-8131; Lamash, Nina E/0000-0003-4923-4580	Russian Foundation for Basic Research [11-04-00408]; Far Eastern Branch of the Russian Academy of Sciences [12-I-P6-06]; Government of the Russian Federation [11.G34.31.0010]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Government of the Russian Federation	This work was supported by the Russian Foundation for Basic Research (grant number 11-04-00408) and the Far Eastern Branch of the Russian Academy of Sciences (grant number 12-I-P6-06) to ID and the Government of the Russian Federation (grant number 11.G34.31.0010) to NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Atzori L, 2009, AM J RESP CELL MOL, V41, P680, DOI 10.1165/rcmb.2007-0386OC; BYRNE M, 1986, J MORPHOL, V188, P179, DOI 10.1002/jmor.1051880205; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Coraux C, 2005, AM J RESP CELL MOL, V32, P87, DOI 10.1165/rcmb.2004-0079RC; Dawbin W. H., 1949, Transactions and Proceedings of the Royal Society of New Zealand, V77, P497; Dolmatov I. Y., 2007, REGENERATSIYA GOLOTU; Dolmatov I.Yu., 1992, Monographs in Developmental Biology, V23, P40; Dolmatov I. Yu, 1996, Ontogenez, V27, P256; Dolmatov IY, 2009, ZH OBSHCH BIOL, V70, P316; Dolmatov IY, 2001, MICROSC RES TECHNIQ, V55, P452, DOI 10.1002/jemt.1190.abs; Dolmatov IY, 1995, BIOL BULL, V4, P490; Dragutinovic VV, 2006, WORLD J GASTROENTERO, V12, P105, DOI 10.3748/wjg.v12.i1.105; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; ELISEIKINA MG, 2002, RUSSIAN J MARINE BIO, V28, P197, DOI DOI 10.1023/A:1016801521216; Flood J, 2000, BIOCHEM CELL BIOL, V78, P455, DOI 10.1139/bcb-78-4-455; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Garcia-Arraras JE, 1998, J EXP ZOOL, V281, P288, DOI 10.1002/(SICI)1097-010X(19980701)281:4<288::AID-JEZ5>3.0.CO;2-K; Garcia-Arraras JE, 2010, CURR PHARM DESIGN, V16, P942, DOI 10.2174/138161210790883426; Garcia-Arraras JE, 2006, DEV DYNAM, V235, P3259, DOI 10.1002/dvdy.20983; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Humason G.L., 1962, ANIMAL TISSUE TECHNI; Hyman LH, 1955, INVERTEBRATED ECHINO; Ingersoll EP, 1998, DEV BIOL, V196, P95, DOI 10.1006/dbio.1998.8857; Jourdan-LeSaux C, 2010, LIFE SCI, V87, P391, DOI 10.1016/j.lfs.2010.07.010; Kato T, 2003, DEV DYNAM, V226, P366, DOI 10.1002/dvdy.10247; Kille FR, 1935, BIOL BULL-US, V69, P82, DOI 10.2307/1537360; Lee H, 2011, TOXICON, V58, P277, DOI 10.1016/j.toxicon.2011.06.007; LEIBSON NL, 1992, MG DEVEL B, V23, P51; LEIBSON NL, 1989, ZOOL ZH, V68, P67; Makanae A, 2012, ANAT REC, V295, P1566, DOI 10.1002/ar.22529; Mannello F, 2003, CLIN CHEM, V49, P1546, DOI 10.1373/49.9.1546; Mashanov VS, 2011, BIOL BULL-US, V221, P93, DOI 10.1086/BBLv221n1p93; Mashanov VS, 2005, BIOL BULL-US, V209, P184, DOI 10.2307/3593108; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Mayne J, 2002, J CELL BIOCHEM, V84, P567; Mayne J, 2002, DEV GROWTH DIFFER, V44, P345; Mayne J, 1998, J CELL BIOCHEM, V71, P546, DOI 10.1002/(SICI)1097-4644(19981215)71:4<546::AID-JCB9>3.0.CO;2-Y; Mitten EK, 2012, INSECT BIOC IN PRESS; Miyazaki K, 1996, P NATL ACAD SCI USA, V93, P6819, DOI 10.1073/pnas.93.13.6819; MOSHER CAROL, 1956, ZOOLOGICA [NEW YORK], V41, P17; Mukhi S, 2011, DEV BIOL, V351, P311, DOI 10.1016/j.ydbio.2010.12.020; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakajima M, 1991, Semin Cancer Biol, V2, P115; NOMURA K, 1993, FEBS LETT, V321, P84, DOI 10.1016/0014-5793(93)80626-6; NOMURA K, 1991, BIOCHEMISTRY-US, V30, P6115, DOI 10.1021/bi00239a005; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Ortiz-Pineda PA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-262; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Pilcher BK, 1999, ANN NY ACAD SCI, V878, P12, DOI 10.1111/j.1749-6632.1999.tb07671.x; Qin L, 2010, AM J PATHOL, V177, P1915, DOI 10.2353/ajpath.2010.100011; QUIGLEY JP, 1993, DIFFERENTIATION, V54, P19, DOI 10.1111/j.1432-0436.1993.tb00655.x; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Ranganathan L, 2004, J CELL BIOCHEM, V93, P1075, DOI 10.1002/jcb.20268; Robinson JJ, 2006, J CELL BIOCHEM, V99, P816, DOI 10.1002/jcb.20975; Santosh N, 2011, DEV DYNAM, V240, P1127, DOI 10.1002/dvdy.22503; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; SEKAR V, 1979, BIOCHEM BIOPH RES CO, V89, P474, DOI 10.1016/0006-291X(79)90653-3; Shamshurina EV, 2010, RUSS J MAR BIOL+, V36, P293, DOI 10.1134/S1063074010040073; Sharpe C, 2001, BIOCHEM CELL BIOL, V79, P461; Smiley Scott, 1994, P401; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Steffensen B, 2011, MATRIX BIOL, V30, P34, DOI 10.1016/j.matbio.2010.09.004; Stevens LJ, 2012, MOL BIOL CELL, V23, P1068, DOI 10.1091/mbc.E11-09-0745; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Sun L, 2011, COMP BIOCHEM PHYS D, V6, P195, DOI 10.1016/j.cbd.2011.03.002; Turner NA, 2012, IUBMB LIFE, V64, P143, DOI 10.1002/iub.594; Vafa O, 1996, DIFFERENTIATION, V60, P129, DOI 10.1007/s002580050143; Vanderheyden PML, 2006, FUND CLIN PHARMACOL, V20, P613, DOI 10.1111/j.1472-8206.2006.00444.x; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wojcik-Stanaszek L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022465	78	16	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58433	10.1371/journal.pone.0058433	http://dx.doi.org/10.1371/journal.pone.0058433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505505	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500082
J	Lemkau, LR; Comellas, G; Lee, SW; Rikardsen, LK; Woods, WS; George, JM; Rienstra, CM				Lemkau, Luisel R.; Comellas, Gemma; Lee, Shin W.; Rikardsen, Lars K.; Woods, Wendy S.; George, Julia M.; Rienstra, Chad M.			Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K	PLOS ONE			English	Article							SOLID-STATE NMR; PROTEIN SECONDARY STRUCTURE; ANGLE-SPINNING NMR; CHEMICAL-SHIFT; WILD-TYPE; AMYLOID FIBRILS; PHOSPHOLIPID-BINDING; CROSS-POLARIZATION; SPECTROSCOPY; RESOLUTION	Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded alpha-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mutations in AS are associated with rare, early-onset forms of PD, although aggregation of the wild-type (WT) protein is observed in the more common sporadic forms of the disease. Here, we employed multidimensional solid-state NMR experiments to assess A53T and E46K mutant fibrils, in comparison to our recent description of WT AS fibrils. We made de novo chemical shift assignments for the mutants, and used these chemical shifts to empirically determine secondary structures. We observe significant perturbations in secondary structure throughout the fibril core for the E46K fibril, while the A53T fibril exhibits more localized perturbations near the mutation site. Overall, these results demonstrate that the secondary structure of A53T has some small differences from the WT and the secondary structure of E46K has significant differences, which may alter the overall structural arrangement of the fibrils.	[Lemkau, Luisel R.; Lee, Shin W.; Rikardsen, Lars K.; Rienstra, Chad M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Comellas, Gemma; Rienstra, Chad M.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Woods, Wendy S.; George, Julia M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Rienstra, Chad M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rienstra, CM (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	rienstra@illinois.edu	George, Julia M/B-2169-2008	George, Julia M/0000-0001-6194-6914	National Institutes of Health [R01-GM073770, S10RR025037-01]; Novartis Predoctoral Fellowship; Caja Madrid Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Predoctoral Fellowship; Caja Madrid Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health R01-GM073770; National Institutes of Health S10RR025037-01; Novartis Predoctoral Fellowship to LRL; Caja Madrid Fellowship to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Comellas G, 2011, J MAGN RESON, V209, P131, DOI 10.1016/j.jmr.2010.12.011; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Johnson B, 2007, NMRVIEWJ; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lemkau LR, 2012, J BIOL CHEM, V287, P11526, DOI 10.1074/jbc.M111.306902; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Loquet A, 2010, J AM CHEM SOC, V132, P15164, DOI 10.1021/ja107460j; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	44	42	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e49750	10.1371/journal.pone.0049750	http://dx.doi.org/10.1371/journal.pone.0049750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505409	Green Published, gold, Green Submitted			2022-12-25	WOS:000318334500001
J	Matic, AI; Robinson, AM; Young, HK; Badofsky, B; Rajguru, SM; Stock, S; Richter, CP				Matic, Agnella Izzo; Robinson, Alan M.; Young, Hunter K.; Badofsky, Ben; Rajguru, Suhrud M.; Stock, Stuart; Richter, Claus-Peter			Behavioral and Electrophysiological Responses Evoked by Chronic Infrared Neural Stimulation of the Cochlea	PLOS ONE			English	Article							OPTICAL STIMULATION; AUDITORY NEURONS; LASER STIMULATION; SPEECH-PERCEPTION; PULSE DURATION; NERVE; RECOGNITION; PROSTHESIS; DEPENDENCE; MONOPOLAR	Infrared neural stimulation (INS) has been proposed as a novel method for neural stimulation. In order for INS to translate to clinical use, which would involve the use of implanted devices over years or decades, the efficacy and safety of chronic INS needs to be determined. We examined a population of cats that were chronically implanted with an optical fiber to stimulate the cochlea with infrared radiation, the first known chronic application of INS. Through behavioral responses, the cats demonstrate that stimulation occurs and a perceptual event results. Long-term stimulation did not result in a change in the electrophysiological responses, either optically-evoked or acoustically-evoked. Spiral ganglion neuron counts and post implantation tissue growth, which was localized at the optical fiber, were similar in chronically stimulated and sham implanted cochleae. Results from chronic INS experiments in the cat cochlea support future work toward INS-based neuroprostheses for humans.	[Matic, Agnella Izzo; Robinson, Alan M.; Young, Hunter K.; Badofsky, Ben; Richter, Claus-Peter] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, Chicago, IL 60611 USA; [Rajguru, Suhrud M.] Univ Miami, Dept Biomed Engn, Miami, FL USA; [Rajguru, Suhrud M.] Univ Miami, Dept Otolaryngol, Miami, FL USA; [Stock, Stuart] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60611 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Miami; University of Miami; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Matic, AI (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, Chicago, IL 60611 USA.	agnella.matic@gmail.com		Stock, Stuart R./0000-0002-8886-4035	US Army Medical Research and Materiel Command [W81XWH-10-C-0208]	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This project has been funded by the US Army Medical Research and Materiel Command under Contract No. W81XWH-10-C-0208 to Lockheed Martin Aculight. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ES, 2012, J NEUROPHYSIOL, V107, P3227, DOI 10.1152/jn.00424.2011; Berenstein CK, 2008, EAR HEARING, V29, P250, DOI 10.1097/AUD.0b013e3181645336; Bierer JA, 2002, J NEUROPHYSIOL, V87, P478, DOI 10.1152/jn.00212.2001; Bohne BA, 2000, AM J OTOL, V21, P505; BOWMAN BR, 1985, ANN BIOMED ENG, V13, P75, DOI 10.1007/BF02371251; Carvalho GJ, 1999, AM J OTOL, V20, P87; DORMAN M, 1989, EAR HEARING, V10, P288, DOI 10.1097/00003446-198910000-00003; Dorman MF, 1998, J ACOUST SOC AM, V104, P3583, DOI 10.1121/1.423940; DOWELL RC, 1987, ACTA OTO-LARYNGOL, V104, P439, DOI 10.3109/00016488709128272; FALK M, 1966, CAN J CHEMISTRY, V44, P1699, DOI 10.1139/v66-255; Goyal V, 2012, ANAT REC, V295, P1987, DOI 10.1002/ar.22583; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; IGARASHI M, 1968, J SPEECH HEAR RES, V11, P229, DOI 10.1044/jshr.1102.229; Izzo AD, 2008, BIOPHYS J, V94, P3159, DOI 10.1529/biophysj.107.117150; Izzo AD, 2007, IEEE T BIO-MED ENG, V54, P1108, DOI 10.1109/TBME.2007.892925; Izzo AD, 2006, LASER SURG MED, V38, P745, DOI 10.1002/lsm.20358; Izzo AD, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714296; JACQUES SL, 1992, SURG CLIN N AM, V72, P531; JANSEN ED, 1994, LASER SURG MED, V14, P258, DOI 10.1002/lsm.1900140308; Jenkins MW, 2010, NAT PHOTONICS, V4, P623, DOI 10.1038/NPHOTON.2010.166; JERGER JF, 1957, J ACOUST SOC AM, V29, P357, DOI 10.1121/1.1908889; KAHANA L, 1950, AM J PHYSIOL, V163, P213, DOI 10.1152/ajplegacy.1950.163.2.213; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; LEFURGE T, 1991, ANN BIOMED ENG, V19, P197, DOI 10.1007/BF02368469; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Matic AI, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655590; McIntire CL, 1968, ARCH OTOLARYNGOL, V88, P56; Mens LHM, 2005, OTOL NEUROTOL, V26, P957, DOI 10.1097/01.mao.0000185060.74339.9d; Middlebrooks JC, 2007, JARO-J ASSOC RES OTO, V8, P258, DOI 10.1007/s10162-007-0070-2; Moreno LE, 2011, HEARING RES, V282, P289, DOI 10.1016/j.heares.2011.06.006; OHLEMILLER KK, 1994, HEARING RES, V80, P174, DOI 10.1016/0378-5955(94)90109-0; Rajguru SM, 2011, J PHYSIOL-LONDON, V589, P1283, DOI 10.1113/jphysiol.2010.198333; Rajguru SM, 2010, HEARING RES, V269, P102, DOI 10.1016/j.heares.2010.06.021; Richter CP, 2011, HEARING RES, V278, P43, DOI 10.1016/j.heares.2011.02.003; Richter CP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056006; Richter CP, 2008, HEARING RES, V242, P42, DOI 10.1016/j.heares.2008.01.011; Richter CP, 2011, LASER PHOTONICS REV, V5, P68, DOI 10.1002/lpor.200900044; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Snyder RL, 2004, JARO-J ASSOC RES OTO, V5, P305, DOI 10.1007/s10162-004-4026-5; SPOENDLIN H, 1971, ACTA OTO-LARYNGOL, V71, P166, DOI 10.3109/00016487109125346; Teudt IU, 2007, LARYNGOSCOPE, V117, P1641, DOI 10.1097/MLG.0b013e318074ec00; Teudt IU, 2011, IEEE T BIO-MED ENG, V58, P1648, DOI 10.1109/TBME.2011.2108297; THOMPSON G, 1974, J SPEECH HEAR DISORD, V39, P140, DOI 10.1044/jshd.3902.140; THOMSEN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P825, DOI 10.1111/j.1751-1097.1991.tb09897.x; WALSH JT, 1994, LASER SURG MED, V15, P295, DOI 10.1002/lsm.1900150310; Wells J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2121772; Wells J, 2007, BIOPHYS J, V93, P2567, DOI 10.1529/biophysj.107.104786; Wells J, 2007, J NEUROSCI METH, V163, P326, DOI 10.1016/j.jneumeth.2007.03.016; Wells JD, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P915, DOI 10.1007/978-90-481-8831-4_24; Whitlon DS, 2006, NEUROSCIENCE, V138, P653, DOI 10.1016/j.neuroscience.2005.11.030	50	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58189	10.1371/journal.pone.0058189	http://dx.doi.org/10.1371/journal.pone.0058189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505466	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500057
J	Mordel, J; Karnas, D; Pevet, P; Isope, P; Challet, E; Meissl, H				Mordel, Jerome; Karnas, Diana; Pevet, Paul; Isope, Philippe; Challet, Etienne; Meissl, Hilmar			The Output Signal of Purkinje Cells of the Cerebellum and Circadian Rhythmicity	PLOS ONE			English	Article							MOUSE SUPRACHIASMATIC NUCLEUS; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; FOOD-ANTICIPATORY ACTIVITY; SLICE CULTURES; NEURONAL-ACTIVITY; PHASE-SHIFTS; RAT-BRAIN; CORTEX; TIME; INTEGRATION	Measurement of clock gene expression has recently provided evidence that the cerebellum, like the master clock in the SCN, contains a circadian oscillator. The cerebellar oscillator is involved in anticipation of mealtime and possibly resides in Purkinje cells. However, the rhythmic gene expression is likely transduced into a circadian cerebellar output signal to exert an effective control of neuronal brain circuits that are responsible for feeding behavior. Using electrophysiological recordings from acute and organotypic cerebellar slices, we tested the hypothesis whether Purkinje cells transmit a circadian modulated signal to their targets in the brain. Extracellular recordings from brain slices revealed the typical discharge pattern previously described in vivo in single cell recordings showing basically a tonic or a trimodal-like firing pattern. However, in acute sagittal cerebellar slices the average spike rate of randomly selected Purkinje cells did not exhibit significant circadian variations, irrespective of their specific firing pattern. Also, frequency and amplitude of spontaneous inhibitory postsynaptic currents and the amplitude of GABA- and glutamate-evoked currents did not vary with circadian time. Long-term recordings using multielectrode arrays (MEA) allowed to monitor neuronal activity at multiple sites in organotypic cerebellar slices for several days to weeks. With this recording technique we observed oscillations of the firing rate of cerebellar neurons, presumably of Purkinje cells, with a period of about 24 hours which were stable for periods up to three days. The daily renewal of culture medium could induce circadian oscillations of the firing rate of Purkinje cells, a feature that is compatible with the behavior of slave oscillators. However, from the present results it appears that the circadian expression of cerebellar clock genes exerts only a weak influence on the electrical output of cerebellar neurons.	[Mordel, Jerome; Karnas, Diana; Meissl, Hilmar] Max Planck Inst Brain Res, Neuroanat Dept, Frankfurt, Germany; [Mordel, Jerome; Karnas, Diana; Pevet, Paul; Isope, Philippe; Challet, Etienne] CNRS, Inst Cellular & Integrat Neurosci, UPR3212, Strasbourg, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Meissl, H (corresponding author), Max Planck Inst Brain Res, Neuroanat Dept, Frankfurt, Germany.	hilmar.meissl@brain.mpg.de	Challet, Etienne/ABF-7553-2020	Challet, Etienne/0000-0001-9416-9496; Isope, Philippe/0000-0002-0630-5935	Max Planck Society, Munchen; CNRS, Paris; University of Strasbourg; Centre National pour la Recherche Scientifique, Universite de Strasbourg, Agence Nationale pour la Recherche [ANR-09-MNPS-038, ANR-2010-JCJC-1403-1]	Max Planck Society, Munchen(Max Planck Society); CNRS, Paris(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; Centre National pour la Recherche Scientifique, Universite de Strasbourg, Agence Nationale pour la Recherche(French National Research Agency (ANR))	Research carried out within the scope of the Associated European Laboratory "European Laboratory for Circadian Research", LEA CNRS-ULP-MPG (LEA No 367), Strasbourg and Frankfurt/M supported by the Max Planck Society, Munchen, the CNRS, Paris and the University of Strasbourg. The work was also supported by the Centre National pour la Recherche Scientifique, Universite de Strasbourg, Agence Nationale pour la Recherche, Grants ANR-09-MNPS-038 and ANR-2010-JCJC-1403-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Akiyama M, 2001, J NEUROCHEM, V78, P499, DOI 10.1046/j.1471-4159.2001.00452.x; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; Challet E, 1996, NEUROSCI LETT, V211, P1, DOI 10.1016/0304-3940(96)12715-4; Choeiri C, 2002, NEUROSCIENCE, V111, P19, DOI 10.1016/S0306-4522(01)00619-4; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; De Vasconcelos AP, 2006, NEUROSCIENCE, V139, P741, DOI 10.1016/j.neuroscience.2005.12.045; Diaz-Munoz M, 2000, AM J PHYSIOL-REG I, V279, pR2048, DOI 10.1152/ajpregu.2000.279.6.R2048; DIETRICHS E, 1994, HISTOL HISTOPATHOL, V9, P603; Dugue GP, 2005, J NEUROSCI, V25, P6490, DOI 10.1523/JNEUROSCI.1500-05.2005; Dupont JL, 2006, CEREBELLUM, V5, P243, DOI 10.1080/14734220600905317; Ebner TJ, 2012, CEREBELLUM, V11, P418, DOI 10.1007/s12311-011-0347-1; Egert U, 2002, EXP BRAIN RES, V142, P268, DOI 10.1007/s00221-001-0932-5; FAUTECK JD, 1994, NEUROSCI LETT, V179, P60, DOI 10.1016/0304-3940(94)90935-0; GAHWILER BH, 1984, EXPERIENTIA, V40, P235, DOI 10.1007/BF01947561; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; HAWKES R, 1989, BRAIN RES, V476, P279, DOI 10.1016/0006-8993(89)91248-1; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Ito M, 1984, CEREBELLUM NEURAL CO; Itri J, 2004, J NEUROPHYSIOL, V92, P311, DOI 10.1152/jn.01078.2003; Kessler M, 2008, BRAIN RES, V1218, P54, DOI 10.1016/j.brainres.2008.04.063; Klisch C, 2009, EUR J NEUROSCI, V30, P65, DOI 10.1111/j.1460-9568.2009.06794.x; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mordel J, 2011, J PHYSIOL-LONDON, V589, P2287, DOI 10.1113/jphysiol.2010.204693; Pekary AE, 2006, BRAIN RES, V1125, P67, DOI 10.1016/j.brainres.2006.10.003; Persengiev SP, 2001, J STEROID BIOCHEM, V77, P151, DOI 10.1016/S0960-0760(01)00037-1; Rath MF, 2012, CHRONOBIOL INT, V29, P1289, DOI 10.3109/07420528.2012.728660; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Carneiro BTS, 2009, CHRONOBIOL INT, V26, P1273, DOI 10.3109/07420520903404480; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Tousson E, 2004, J NEUROSCI, V24, P2983, DOI 10.1523/JNEUROSCI.5044-03.2004; van Welie I, 2011, CURR OPIN NEUROBIOL, V21, P245, DOI 10.1016/j.conb.2011.01.009; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Zhu JN, 2006, BRAIN RES REV, V52, P93, DOI 10.1016/j.brainresrev.2006.01.003	57	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58457	10.1371/journal.pone.0058457	http://dx.doi.org/10.1371/journal.pone.0058457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505510	Green Published, gold			2022-12-25	WOS:000318334500086
J	Yu, RJ; Hsieh, MH; Wang, HLS; Liu, CM; Liu, CC; Hwang, TJ; Chien, YL; Hwu, HG; Tseng, WYI				Yu, Rongjun; Hsieh, Ming H.; Wang, Hsiao-Lan Sharon; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Chien, Yi-Ling; Hwu, Hai-Gwo; Tseng, Wen-Yih Isaac			Frequency Dependent Alterations in Regional Homogeneity of Baseline Brain Activity in Schizophrenia	PLOS ONE			English	Article							RESTING-STATE FMRI; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; PREFRONTAL CORTEX; BOLD SIGNAL; PHYSIOLOGICAL CONDITION; VOLUME REDUCTION; WORKING-MEMORY; HYPOFRONTALITY	Low frequency oscillations are essential in cognitive function impairment in schizophrenia. While functional connectivity can reveal the synchronization between distant brain regions, the regional abnormalities in task-independent baseline brain activity are less clear, especially in specific frequency bands. Here, we used a regional homogeneity (ReHo) method combined with resting-state functional magnetic resonance imaging to investigate low frequency spontaneous neural activity in the three different frequency bands (slow-5: 0.01-0.027 Hz; slow-4: 0.027-0.08 Hz; and typical band: 0.01-0.08 Hz) in 69 patients with schizophrenia and 62 healthy controls. Compared with controls, schizophrenia patients exhibited decreased ReHo in the precentral gyrus, middle occipital gyrus, and posterior insula, whereas increased ReHo in the medial prefrontal cortex and anterior insula. Significant differences in ReHo between the two bands were found in fusiform gyrus and superior frontal gyrus (slow-4> slow-5), and in basal ganglia, parahippocampus, and dorsal middle prefrontal gyrus (slow-5> slow-4). Importantly, we identified significant interaction between frequency bands and groups in the inferior occipital gyrus and caudate body. This study demonstrates that ReHo changes in schizophrenia are widespread and frequency dependent.	[Yu, Rongjun] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Hsieh, Ming H.; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Chien, Yi-Ling; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Hsieh, Ming H.; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Chien, Yi-Ling; Hwu, Hai-Gwo] Coll Med, Taipei, Taiwan; [Hsieh, Ming H.; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Chien, Yi-Ling; Hwu, Hai-Gwo] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Wang, Hsiao-Lan Sharon; Tseng, Wen-Yih Isaac] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan; [Hwu, Hai-Gwo; Tseng, Wen-Yih Isaac] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Tseng, Wen-Yih Isaac] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan	California Institute of Technology; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hwu, HG (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan.	haigohwu@ntu.edu.tw; wytseng@ntu.edu.tw	Hwang, TJ/K-4768-2019; Yu, Rongjun/AAV-2615-2020; Hsieh, Ming H./B-2970-2010	Yu, Rongjun/0000-0003-0123-1524; Tseng, Wen-Yih Isaac/0000-0002-2314-6868; LIU, CHIH-MIN/0000-0001-7016-8990; HWU, HAI-GWO/0000-0002-2582-2807; LIU, CHEN-CHUNG/0000-0002-9290-110X; Hsieh, Ming H./0000-0002-3585-7843; CHIEN, YI-LING/0000-0002-3477-3015; Hwang, Tzung-Jeng/0000-0001-7894-9484	National Health Research Institute, Taiwan [NHRI-EX101-10145NI]; National Science Council, Taiwan [NSC100-3112-B-002-016]; National Taiwan University [97HM00273]	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was supported in part by the National Health Research Institute, Taiwan (NHRI-EX101-10145NI), National Science Council, Taiwan (NSC100-3112-B-002-016), and National Taiwan University (97HM00273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth H, 2002, AM J PSYCHIAT, V159, P1497, DOI 10.1176/appi.ajp.159.9.1497; Bermann KF, 1998, BIOL PSYCHIAT, V43, p67S, DOI 10.1016/S0006-3223(98)90674-6; Bhugra D, 2005, PLOS MED, V2, P372, DOI 10.1371/journal.pmed.0020151; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blow N, 2008, NAT METHODS, V5, P981, DOI 10.1038/nmeth1108-981; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Brown GG, 2010, CURR TOP BEHAV NEURO, V4, P181, DOI 10.1007/7854_2010_54; BUCHSBAUM MS, 1987, AM J PSYCHIAT, V144, P122, DOI 10.1176/ajp.144.1.122; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; Cao Qing-jiu, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P261; Carter CS, 1998, AM J PSYCHIAT, V155, P1285, DOI 10.1176/ajp.155.9.1285; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Cochran S, 2005, SCHIZOPHRENIA BULL, V31, P296; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FRITH CD, 1995, BRIT J PSYCHIAT, V167, P343, DOI 10.1192/bjp.167.3.343; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; Hill KE, 2002, SCHIZOPHR RES, V53, P112; Honey GD, 2004, SCHIZOPHRENIA NEUROI, P237; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Kane JM, 1996, NEW ENGL J MED, V334, P34, DOI 10.1056/NEJM199601043340109; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Mitchell RLC, 2004, BRIT J PSYCHIAT, V184, P223, DOI 10.1192/bjp.184.3.223; Moran LV, 2011, SCHIZOPHRENIA BULL, V37, P659, DOI 10.1093/schbul/sbr056; Narr KL, 2005, BIOL PSYCHIAT, V58, P32, DOI 10.1016/j.biopsych.2005.03.043; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onitsuka T, 2007, SCHIZOPHR RES, V92, P197, DOI 10.1016/j.schres.2007.01.027; PAULMAN RG, 1990, BIOL PSYCHIAT, V27, P377, DOI 10.1016/0006-3223(90)90549-H; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Saze T, 2007, EUR ARCH PSY CLIN N, V257, P473, DOI 10.1007/s00406-007-0750-2; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sun YM, 2011, BRAIN RES, V1413, P98, DOI 10.1016/j.brainres.2011.06.065; Takahashi T, 2004, PSYCHIAT RES-NEUROIM, V131, P185, DOI 10.1016/j.pscychresns.2004.05.006; Takahashi T, 2009, SCHIZOPHR RES, V108, P49, DOI 10.1016/j.schres.2008.12.029; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI [10.1093/cercor/bhm069, 10.1093/cercor/hhm069]; Tan HY, 2006, AM J PSYCHIAT, V163, P1969, DOI 10.1176/appi.ajp.163.11.1969; TAYLOR MA, 1984, AM J PSYCHIAT, V141, P196; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Vercammen A, 2010, BIOL PSYCHIAT, V67, P912, DOI 10.1016/j.biopsych.2009.11.017; Whalley HC, 2008, J AFFECT DISORDERS, V109, P99, DOI 10.1016/j.jad.2007.11.009; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Wynn JK, 2008, PSYCHIAT RES-NEUROIM, V164, P97, DOI 10.1016/j.pscychresns.2008.01.005; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou SY, 2005, PSYCHIAT RES-NEUROIM, V139, P127, DOI 10.1016/j.pscychresns.2005.05.005; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	73	55	61	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57516	10.1371/journal.pone.0057516	http://dx.doi.org/10.1371/journal.pone.0057516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483911	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000316936100027
J	Bartolommei, G; Moncelli, MR; Tadini-Buoninsegni, F				Bartolommei, Gianluca; Moncelli, Maria Rosa; Tadini-Buoninsegni, Francesco			A Method to Measure Hydrolytic Activity of Adenosinetriphosphatases (ATPases)	PLOS ONE			English	Article							RETICULUM CA-ATPASE; SARCOPLASMIC-RETICULUM; INORGANIC-PHOSPHATE; PUMP CYCLE; PHOSPHORUS; NA,K-ATPASE; CA2+-ATPASE; TRANSPORT; STATE; NA+,K+-ATPASE	The detection of small amounts (nanomoles) of inorganic phosphate has a great interest in biochemistry. In particular, phosphate detection is useful to evaluate the rate of hydrolysis of phosphatases, that are enzymes able to remove phosphate from their substrate by hydrolytic cleavage. The hydrolysis rate is correlated to enzyme activity, an extremely important functional parameter. Among phosphatases there are the cation transporting adenosinetriphosphatases (ATPases), that produce inorganic phosphate by cleavage of the gamma-phosphate of ATP. These membrane transporters have many fundamental physiological roles and are emerging as potential drug targets. ATPase hydrolytic activity is measured to test enzyme functionality, but it also provides useful information on possible inhibitory effects of molecules that interfere with the hydrolytic process. We have optimized a molybdenum-based protocol that makes use of potassium antimony (III) oxide tartrate (originally employed for phosphate detection in environmental analysis) to allow its use with phosphatase enzymes. In particular, the method was successfully applied to native and recombinant ATPases to demonstrate its reliability, validity, sensitivity and versatility. Our method introduces significant improvements to well-established experimental assays, which are currently employed for ATPase activity measurements. Therefore, it may be valuable in biochemical and biomedical investigations of ATPase enzymes, in combination with more specific tests, as well as in high throughput drug screening.	[Bartolommei, Gianluca; Moncelli, Maria Rosa; Tadini-Buoninsegni, Francesco] Univ Florence, Dept Chem Ugo Schiff, Sesto Fiorentino, Italy	University of Florence	Bartolommei, G (corresponding author), Univ Florence, Dept Chem Ugo Schiff, Sesto Fiorentino, Italy.	gianluca.bartolommei@unifi.it	Tadini-Buoninsegni, Francesco/CAJ-5745-2022	TADINI-BUONINSEGNI, Francesco/0000-0001-5594-2554	Ente Cassa di Risparmio di Firenze [2009.0749]; Italian Ministry of Education, University and Research [20083YM37E]	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ente Cassa di Risparmio di Firenze (2009.0749) (http://www.entecarifirenze.it) and the Italian Ministry of Education, University and Research (PRIN Project 20083YM37E) (http://hubmiur.pubblica.istruzione.it/web/ricerca/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGINSKI E S, 1975, Annals of Clinical and Laboratory Science, V5, P399; Bartolommei G, 2008, BIOPHYS J, V95, P1813, DOI 10.1529/biophysj.108.133546; Bartolommei G, 2011, J BIOL CHEM, V286, P38383, DOI 10.1074/jbc.M111.287276; Bartolommei G, 2010, BIOPHYS J, V99, P2087, DOI 10.1016/j.bpj.2010.07.050; Billington RA, 2004, BIOCHEM J, V378, P275, DOI 10.1042/BJ20031284; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; D'Angelo E, 2001, J ENVIRON QUAL, V30, P2206, DOI 10.2134/jeq2001.2206; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DRYER RL, 1957, J BIOL CHEM, V225, P177; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; ERNSTER L, 1956, Methods Biochem Anal, V3, P1; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORBUSH B, 1988, J BIOL CHEM, V263, P7961; Gemma S, 2012, J MED CHEM, V55, P10387, DOI 10.1021/jm300831b; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Jorgensen P L, 1974, Methods Enzymol, V32, P277; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan J.H., 2004, HDB ATPASES BIOCH CE, P63; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Katewa SD, 2003, ANAL BIOCHEM, V323, P180, DOI 10.1016/j.ab.2003.08.024; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lin SH, 2000, ANAL BIOCHEM, V287, P303, DOI 10.1006/abio.2000.4828; Liu YY, 2009, J MOL BIOL, V391, P858, DOI 10.1016/j.jmb.2009.06.044; LOWRY OH, 1946, J BIOL CHEM, V162, P421; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lupfert C, 2001, BIOPHYS J, V81, P2069, DOI 10.1016/S0006-3495(01)75856-0; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matula J, 2011, PLANT SOIL ENVIRON, V57, P1, DOI 10.17221/185/2010-PSE; Mesquita RBR, 2011, ANAL CHIM ACTA, V701, P15, DOI 10.1016/j.aca.2011.06.002; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Noske R, 2010, BBA-BIOENERGETICS, V1797, P1540, DOI 10.1016/j.bbabio.2010.03.021; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Osmond, 1887, B SOC CHIM FR, V47, P745; Peinelt C, 2004, BIOPHYS J, V86, P815, DOI 10.1016/S0006-3495(04)74157-0; Power MH, 1953, STANDARD METHODS CLI; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SCHWARTZ A, 1971, METHOD PHARMACOL, V1, P368; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Taylor AE, 1914, J BIOL CHEM, V18, P215; U.S. Environmental Protection Agency, 2005, STAND OP PROC PART P; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019	46	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58615	10.1371/journal.pone.0058615	http://dx.doi.org/10.1371/journal.pone.0058615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472215	Green Submitted, gold, Green Published			2022-12-25	WOS:000315637900161
J	Skeeles, LE; Fleming, JL; Mahler, KL; Toland, AE				Skeeles, Laura E.; Fleming, Jessica L.; Mahler, Kimberly L.; Toland, Amanda Ewart			The Impact of 3 ' UTR Variants on Differential Expression of Candidate Cancer Susceptibility Genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BINDING-SITES; WEB TOOL; GENOME; LOCI; IDENTIFICATION; PREDICTION	Variants in regulatory regions are predicted to play an important role in disease susceptibility of common diseases. Polymorphisms mapping to microRNA (miRNA) binding sites have been shown to disrupt the ability of miRNAs to target genes resulting in differential mRNA and protein expression. Skin tumor susceptibility 5 (Skts5) was identified as a locus conferring susceptibility to chemically-induced skin cancer in NIH/Ola by SPRET/Outbred F1 backcrosses. To determine if polymorphisms between the strains which mapped to putative miRNA binding sites in the 3' untranslated region (3'UTR) of genes at Skts5 influenced expression, we conducted a systematic evaluation of 3'UTRs of candidate genes across this locus. Nine genes had polymorphisms in their 3'UTRs which fit the linkage data and eight of these contained polymorphisms suspected to interfere with or introduce miRNA binding. 3'UTRs of six genes, Bcap29, Dgkb, Hbp1, Pik3cg, Twistnb, and Tspan13 differentially affected luciferase expression, but did not appear to be differentially regulated by the evaluated miRNAs predicted to bind to only one of the two isoforms. 3'UTRs from four additional genes chosen from the locus that fit less stringent criteria were evaluated. Ifrd1 and Etv1 showed differences and contained polymorphisms predicted to disrupt or create miRNA binding sites but showed no difference in regulation by the miRNAs tested. In summary, multiple 3'UTRs with putative functional variants between susceptible and resistant strains of mice influenced differential expression independent of predicted miRNA binding.	[Skeeles, Laura E.; Fleming, Jessica L.; Mahler, Kimberly L.; Toland, Amanda Ewart] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Toland, Amanda Ewart] Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Toland, AE (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	Amanda.toland@osumc.edu	Toland, Amanda Ewart/E-4202-2011	Toland, Amanda/0000-0002-0271-1792	American Cancer Society [MGO RSG-07-083]; National Cancer Institute [CA134461]; OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA134461] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part from MGO RSG-07-083 from the American Cancer Society, CA134461 from the National Cancer Institute and the OSU Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036694; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chin L, 2008, CANCER RES, V69, P5970; Emerson JJ, 2010, PHILOS T R SOC B, V365, P2581, DOI 10.1098/rstb.2010.0005; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Knight JC, 2012, J INTERN MED, V271, P379, DOI 10.1111/j.1365-2796.2011.02508.x; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Landi D, 2012, MUTAGENESIS, V27, P205, DOI 10.1093/mutage/ger055; Liu XG, 2010, THROMB RES, V126, P130, DOI 10.1016/j.thromres.2010.04.010; Mahler KL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-626; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Nagase H, 2003, CANCER RES, V63, P4849; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 2001, CANCER RES, V61, P1305; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sotiriou S, 2009, NEUROSCI LETT, V461, P196, DOI 10.1016/j.neulet.2009.06.034; Tsao D, 2011, NUCLEIC ACIDS RES, V39, P6201, DOI 10.1093/nar/gkr165	30	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58609	10.1371/journal.pone.0058609	http://dx.doi.org/10.1371/journal.pone.0058609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472213	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900159
J	Brox, D; Kiel, A; Worner, SJ; Pernpointner, M; Comba, P; Martin, B; Herten, DP				Brox, Dominik; Kiel, Alexander; Woerner, Svenja Johanna; Pernpointner, Markus; Comba, Peter; Martin, Bodo; Herten, Dirk-Peter			Ensemble and Single-Molecule Studies on Fluorescence Quenching in Transition Metal Bipyridine-Complexes	PLOS ONE			English	Article							SENSORS	Beyond their use in analytical chemistry fluorescent probes continuously gain importance because of recent applications of single-molecule fluorescence spectroscopy to monitor elementary reaction steps. In this context, we characterized quenching of a fluorescent probe by different metal ions with fluorescence spectroscopy in the bulk and at the single-molecule level. We apply a quantitative model to explain deviations from existing standard models for fluorescence quenching. The model is based on a reversible transition from a bright to a dim state upon binding of the metal ion. We use the model to estimate the stability constants of complexes with different metal ions and the change of the relative quantum yield of different reporter dye labels. We found ensemble data to agree widely with results from single-molecule experiments. Our data indicates a mechanism involving close molecular contact of dye and quenching moiety which we also found in molecular dynamics simulations. We close the manuscript with a discussion of possible mechanisms based on Forster distances and electrochemical potentials which renders photo-induced electron transfer to be more likely than Forster resonance energy transfer.	[Brox, Dominik; Kiel, Alexander; Herten, Dirk-Peter] Heidelberg Univ, Heidelberg, Germany; [Brox, Dominik; Kiel, Alexander; Woerner, Svenja Johanna; Pernpointner, Markus; Herten, Dirk-Peter] Heidelberg Univ, Inst Phys Chem, Heidelberg, Germany; [Comba, Peter; Martin, Bodo] Heidelberg Univ, Inst Inorgan Chem, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Herten, DP (corresponding author), Heidelberg Univ, Heidelberg, Germany.	dirk-peter.herten@urz.uni-hd.de	Herten, Dirk-Peter/P-4836-2016; Sauer, Markus/C-4378-2017; Herten, Dirk-Peter/AAT-1458-2020; Comba, Peter/A-2855-2008; Martin, Bodo/C-3507-2014	Herten, Dirk-Peter/0000-0002-3884-0262; Sauer, Markus/0000-0002-1692-3219; Herten, Dirk-Peter/0000-0002-3884-0262; Comba, Peter/0000-0001-7796-3532; 	Deutsche Forschungsgemeinschaft [EXC81, SFB623]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was given by the Deutsche Forschungsgemeinschaft (www.dfg.de) under the grant numbers EXC81 and SFB623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WEB KNOWLEDGE V 5 3; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; BOAZ H, 1950, J AM CHEM SOC, V72, P3435, DOI 10.1021/ja01164a032; Callan JF, 2005, TETRAHEDRON, V61, P8551, DOI 10.1016/j.tet.2005.05.043; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; HO CN, 1986, TRAC-TREND ANAL CHEM, V5, P37; Jager M, 2009, CHEMPHYSCHEM, V10, P2486, DOI 10.1002/cphc.200900331; Kiel A, 2007, ANGEW CHEM INT EDIT, V46, P3363, DOI 10.1002/anie.200604965; Kovacs J, 2007, SPIE P; PATONAY G, 1986, J PHYS CHEM-US, V90, P1963, DOI 10.1021/j100400a045; Prodi L, 2000, COORDIN CHEM REV, V205, P59, DOI 10.1016/S0010-8545(00)00242-3; RYAN DK, 1982, ANAL CHEM, V54, P986, DOI 10.1021/ac00243a033; Schwering M, 2011, ANGEW CHEM INT EDIT, V50, P2940, DOI 10.1002/anie.201006013; Thomas SW, 2007, CHEM REV, V107, P1339, DOI 10.1021/cr0501339; Valeur B, 2000, COORDIN CHEM REV, V205, P3, DOI 10.1016/S0010-8545(00)00246-0	15	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58049	10.1371/journal.pone.0058049	http://dx.doi.org/10.1371/journal.pone.0058049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483966	Green Published, gold, Green Submitted			2022-12-25	WOS:000315634900064
J	Clambey, ET; Collins, B; Young, MH; Eberlein, J; David, A; Kappler, JW; Marrack, P				Clambey, Eric T.; Collins, Bernard; Young, Mary H.; Eberlein, Jens; David, Alexandria; Kappler, John W.; Marrack, Philippa			The Ikaros Transcription Factor Regulates Responsiveness to IL-12 and Expression of IL-2 Receptor Alpha in Mature, Activated CD8 T Cells	PLOS ONE			English	Article							FATE DECISIONS; MEMORY; EFFECTOR; GENE; DIFFERENTIATION; GENERATION; MICE; BET; INTERLEUKIN-12; LYMPHOCYTE	The Ikaros family of transcription factors is critical for normal T cell development while limiting malignant transformation. Mature CD8 T cells express multiple Ikaros family members, yet little is known about their function in this context. To test the functions of this gene family, we used retroviral transduction to express a naturally occurring, dominant negative (DN) isoform of Ikaros in activated CD8 T cells. Notably, expression of DN Ikaros profoundly enhanced the competitive advantage of activated CD8 T cells cultured in IL-12, such that by 6 days of culture, DN Ikaros-transduced cells were 100-fold more abundant than control cells. Expression of a DN isoform of Helios, a related Ikaros-family transcription factor, conferred a similar advantage to transduced cells in IL-12. While DN Ikaros-transduced cells had higher expression of the IL-2 receptor alpha chain, DN Ikaros-transduced cells achieved their competitive advantage through an IL-2 independent mechanism. Finally, the competitive advantage of DN Ikaros-transduced cells was manifested in vivo, following adoptive transfer of transduced cells. These data identify the Ikaros family of transcription factors as regulators of cytokine responsiveness in activated CD8 T cells, and suggest a role for this family in influencing effector and memory CD8 T cell differentiation.	[Clambey, Eric T.; Young, Mary H.; Eberlein, Jens; David, Alexandria; Kappler, John W.; Marrack, Philippa] Univ Colorado, Integrated Dept Immunol, Aurora, CO USA; [Clambey, Eric T.; Collins, Bernard; Young, Mary H.; David, Alexandria; Kappler, John W.; Marrack, Philippa] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO USA; [Clambey, Eric T.; Eberlein, Jens] Univ Colorado, Dept Anesthesiol, Aurora, CO USA; [Clambey, Eric T.] Univ Colorado, Mucosal Inflammat Program, Aurora, CO USA; [Collins, Bernard; Marrack, Philippa] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO USA; [Eberlein, Jens] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado, Dept Med, Aurora, CO USA; [Kappler, John W.] Univ Colorado, Dept Pharmacol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Clambey, ET (corresponding author), Univ Colorado, Integrated Dept Immunol, Anschutz Med Campus, Aurora, CO USA.	eric.clambey@ucdenver.edu	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	National Institutes of Health [AI-17134, AI-18785, AI-22295, AI-52225]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI018785, R56AI017134, R01AI018785, R37AI017134, R37AI018785, R01AI017134, R01AI052225, P01AI022295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work supported by National Institutes of Health grants AI-17134, AI-18785, AI-22295 and AI-52225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinheiro AAD, 2007, J LEUKOCYTE BIOL, V81, P1102, DOI 10.1189/jlb.0906583; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Berg RE, 2002, EUR J IMMUNOL, V32, P2807, DOI 10.1002/1521-4141(2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fallarino F, 1996, J IMMUNOL, V156, P1095; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Grossel MJ, 1999, J BIOL CHEM, V274, P29960, DOI 10.1074/jbc.274.42.29960; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Manders PM, 2005, P NATL ACAD SCI USA, V102, P7418, DOI 10.1073/pnas.0501585102; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Quintana FJ, 2012, NAT IMMUNOL; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Rao JB, 1996, J IMMUNOL, V156, P3357; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Roberts KG, 2011, CURR OPIN PEDIATR, V23, P34, DOI 10.1097/MOP.0b013e3283426260; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schmidt CS, 2002, J IMMUNOL, V168, P5521, DOI 10.4049/jimmunol.168.11.5521; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Thaventhiran JE, 2012, P NATL ACAD SCI US; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thomas RM, 2010, J BIOL CHEM, V285, P2545, DOI 10.1074/jbc.M109.038794; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Umetsu SE, 2009, J IMMUNOL, V183, P5518, DOI 10.4049/jimmunol.0901284; Urban JA, 2004, J IMMUNOL, V173, P4470, DOI 10.4049/jimmunol.173.7.4470; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Welsh RM, 2009, IMMUNITY, V31, P178, DOI 10.1016/j.immuni.2009.08.005; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Yap WH, 2005, FEBS LETT, V579, P4470, DOI 10.1016/j.febslet.2005.07.018; Zhang L, 2011, MOL THER, V19, P751, DOI 10.1038/mt.2010.313; Zhang Z, 2007, BLOOD, V109, P2190, DOI 10.1182/blood-2005-01-031930; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	70	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57435	10.1371/journal.pone.0057435	http://dx.doi.org/10.1371/journal.pone.0057435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23483882	gold, Green Submitted, Green Published			2022-12-25	WOS:000315561400042
J	Crevenna, AH; Naredi-Rainer, N; Schonichen, A; Dzubiella, J; Barber, DL; Lamb, DC; Wedlich-Soldner, R				Crevenna, Alvaro H.; Naredi-Rainer, Nikolaus; Schoenichen, Andre; Dzubiella, Joachim; Barber, Diane L.; Lamb, Don C.; Wedlich-Soeldner, Roland			Electrostatics Control Actin Filament Nucleation and Elongation Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; NA+/H+ EXCHANGER; BARBED END; PH; POLYMERIZATION; IDENTIFICATION; CYTOSKELETON; ASSOCIATION; ACTIVATION; MECHANISM	The actin cytoskeleton is a central mediator of cellular morphogenesis, and rapid actin reorganization drives essential processes such as cell migration and cell division. Whereas several actin-binding proteins are known to be regulated by changes in intracellular pH, detailed information regarding the effect of pH on the actin dynamics itself is still lacking. Here, we combine bulk assays, total internal reflection fluorescence microscopy, fluorescence fluctuation spectroscopy techniques, and theory to comprehensively characterize the effect of pH on actin polymerization. We show that both nucleation and elongation are strongly enhanced at acidic pH, with a maximum close to the pI of actin. Monomer association rates are similarly affected by pH at both ends, although dissociation rates are differentially affected. This indicates that electrostatics control the diffusional encounter but not the dissociation rate, which is critical for the establishment of actin filament asymmetry. A generic model of protein-protein interaction, including electrostatics, explains the observed pH sensitivity as a consequence of charge repulsion. The observed pH effect on actin in vitro agrees with measurements of Listeria propulsion in pH-controlled cells. pH regulation should therefore be considered as a modulator of actin dynamics in a cellular environment.	[Crevenna, Alvaro H.; Wedlich-Soeldner, Roland] Max Planck Inst Biochem, AG Cellular Dynam & Cell Patterning, D-82152 Martinsried, Germany; [Crevenna, Alvaro H.; Naredi-Rainer, Nikolaus; Lamb, Don C.] Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; [Crevenna, Alvaro H.; Naredi-Rainer, Nikolaus; Lamb, Don C.] Univ Munich, Ctr Nanosci, D-81377 Munich, Germany; [Schoenichen, Andre; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Dzubiella, Joachim] Helmholtz Zentrum Berlin, D-14109 Berlin, Germany; [Dzubiella, Joachim] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Lamb, Don C.] Univ Munich, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Lamb, Don C.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Max Planck Society; University of Munich; University of Munich; University of California System; University of California San Francisco; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Humboldt University of Berlin; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign	Crevenna, AH (corresponding author), Univ Munich, Dept Chem & Biochem, Butenandtstr 5-13,Haus E, D-81377 Munich, Germany.	alvaro.crevenna@cup.uni-muenchen.de; don.lamb@cup.uni-muenchen.de; wedlich@biochem.mpg.de	Dzubiella, Joachim/K-8886-2012; Lamb, Don C/G-9501-2014; Crevenna, Alvaro/Q-4476-2019; Crevenna, Alvaro/E-9125-2016	Lamb, Don C/0000-0002-0232-1903; Crevenna, Alvaro/0000-0002-5580-3711; Crevenna, Alvaro/0000-0002-5580-3711	National Institutes of Health [GM58642]; Deutsche Forschungsgemeinschaft [SFB 863, SPP 1464]; Emmy-Noether Programm; Ludwig-Maximilians-Universitat Munchen (LMUInnovativBio-Imaging Network); Nanosystems Initiative Munich; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy-Noether Programm(German Research Foundation (DFG)); Ludwig-Maximilians-Universitat Munchen (LMUInnovativBio-Imaging Network); Nanosystems Initiative Munich; Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58642. This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB 863 and SPP 1464 and Emmy-Noether Programm (to J. D.), the Ludwig-Maximilians-Universitat Munchen (LMUInnovativBio-Imaging Network), the Nanosystems Initiative Munich, and the Max Planck Society.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Barrat J.-L., 2003, BASIC CONCEPTS SIMPL; BEGG DA, 1979, J CELL BIOL, V83, P241, DOI 10.1083/jcb.83.1.241; Breitsprecher D, 2009, METHODS MOL BIOL, V571, P401, DOI 10.1007/978-1-60761-198-1_27; Brooks C, 2005, AM J PHYSIOL-RENAL, V289, pF410, DOI 10.1152/ajprenal.00440.2004; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Debye P., 1942, T ELECTROCHEM SOC, V82, P265, DOI [10.1149/1.3071413, DOI 10.1149/1.3071413]; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; FEI W, 1989, BIOPHYS J, V55, P293, DOI 10.1016/S0006-3495(89)82804-8; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; FRIEDEN C, 1983, P NATL ACAD SCI-BIOL, V80, P6513, DOI 10.1073/pnas.80.21.6513; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Ivanchenko S, 2011, SUPRAMOLECULAR STRUCTURE AND FUNCTION 10, P1, DOI 10.1007/978-94-007-0893-8_1; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Kang HR, 2012, P NATL ACAD SCI USA, V109, P16923, DOI 10.1073/pnas.1211078109; Kohler S, 2012, CELL REP, V2, P433, DOI 10.1016/j.celrep.2012.08.014; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Narita A, 2011, EMBO J, V30, P1230, DOI 10.1038/emboj.2011.48; Niedermayer T, 2012, P NATL ACAD SCI USA, V109, P10769, DOI 10.1073/pnas.1121381109; Oda T, 2001, BIOPHYS J, V80, P841, DOI 10.1016/S0006-3495(01)76063-8; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; OOSAWA F, 1959, J POLYM SCI, V37, P323, DOI 10.1002/pol.1959.1203713202; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Qin S, 2011, STRUCTURE, V19, P1744, DOI 10.1016/j.str.2011.10.015; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Schmoller KM, 2012, SOFT MATTER, V8, P9685, DOI 10.1039/c2sm25969a; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Sept D, 1999, J MOL BIOL, V294, P1181, DOI 10.1006/jmbi.1999.3332; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; STEINER RF, 1952, J POLYM SCI, V8, P23, DOI 10.1002/pol.1952.120080102; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; TILNEY LG, 1978, J CELL BIOL, V77, P536, DOI 10.1083/jcb.77.2.536; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; von Smoluchowski M, 1916, PHYS Z, V17, P557; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Zhou HX, 2010, Q REV BIOPHYS, V43, P219, DOI 10.1017/S0033583510000120; ZIMMERLE CT, 1988, BIOCHEMISTRY-US, V27, P7766, DOI 10.1021/bi00420a027	57	34	35	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12102	12113		10.1074/jbc.M113.456327	http://dx.doi.org/10.1074/jbc.M113.456327			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486468	Green Published, hybrid			2022-12-25	WOS:000318157600043
J	Slupe, AM; Merrill, RA; Flippo, KH; Lobas, MA; Houtman, JCD; Strack, S				Slupe, Andrew M.; Merrill, Ronald A.; Flippo, Kyle H.; Lobas, Mark A.; Houtman, Jon C. D.; Strack, Stefan			A Calcineurin Docking Motif (LXVP) in Dynamin-related Protein 1 Contributes to Mitochondrial Fragmentation and Ischemic Neuronal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC TIME WINDOW; CEREBRAL-ISCHEMIA; REGULATES TRANSLOCATION; TACROLIMUS FK506; PLASMA-MEMBRANE; DRP1; FISSION; DEPHOSPHORYLATION; PHOSPHORYLATION; PHOSPHATASE	Fission and fusion events dynamically control the shape and function of mitochondria. The activity of the mitochondrial fission enzyme dynamin-related protein 1 (Drp1) is finely tuned by several post-translational modifications. Phosphorylation of Ser-656 by cAMP-dependent protein kinase (PKA) inhibits Drp1, whereas dephosphorylation by a mitochondrial protein phosphatase 2A isoform and the calcium-calmodulin-dependent phosphatase calcineurin (CaN) activates Drp1. Here, we identify a conserved CaN docking site on Drp1, an LXVP motif, which mediates the interaction between the phosphatase and mechanoenzyme. We mutated the LXVP motif in Drp1 to either increase or decrease similarity to the prototypical LXVP motif in the transcription factor NFAT, and assessed stability of the mutant Drp1-CaN complexes by affinity precipitation and isothermal titration calorimetry. Furthermore, we quantified effects of LXVP mutations on Drp1 dephosphorylation kinetics in vitro and in intact cells. With tools for bidirectional control of the CaN-Drp1 signaling axis in hand, we demonstrate that the Drp1 LXVP motif shapes mitochondria in neuronal and non-neuronal cells, and that CaN-mediated Drp1 dephosphorylation promotes neuronal death following oxygen-glucose deprivation. These results point to the CaN-Drp1 complex as a potential target for neuroprotective therapy of ischemic stroke.	[Slupe, Andrew M.; Merrill, Ronald A.; Flippo, Kyle H.; Strack, Stefan] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Lobas, Mark A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Strack, S (corresponding author), 2-432 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu		Flippo, Kyle/0000-0001-9667-7056; Houtman, Jon/0000-0002-5307-9854; Strack, Stefan/0000-0002-6175-7280; Merrill, Ronald/0000-0002-5276-4163	National Institutes of Health [NS056244, NS057714, CA136729, F31 NS077563]; NATIONAL CANCER INSTITUTE [R01CA136729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795, T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS056244, R01NS056244, R01NS057714, T32NS045549, F31NS077563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS056244 and NS057714 (to S. S.) and CA136729 (to J. C. D. H.) and Predoctoral Fellowship F31 NS077563 (to A. M. S.).	Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7; Dagda RK, 2008, J BIOL CHEM, V283, P36241, DOI 10.1074/jbc.M800989200; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Furuichi Y, 2003, J CEREBR BLOOD F MET, V23, P1183, DOI 10.1097/01.WCB.0000088761.02615.EB; Furuichi Y, 2003, BRAIN RES, V965, P137, DOI 10.1016/S0006-8993(02)04151-3; Furuichi Y, 2007, EXP NEUROL, V204, P138, DOI 10.1016/j.expneurol.2006.10.003; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Jahani-Asl A, 2011, J BIOL CHEM, V286, P4772, DOI 10.1074/jbc.M110.167155; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu WT, 2012, J NEUROSCI RES, V90, P1183, DOI 10.1002/jnr.23016; Martin BL, 1999, BIOCHEMISTRY-US, V38, P3386, DOI 10.1021/bi981748l; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; McAvoy T., 2010, CURR PROTOC MOL BOL, V92; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Merrill RA, 2013, FEBS J, V280, P662, DOI 10.1111/j.1742-4658.2012.08631.x; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; O'Donnell SE, 2011, PROTEINS, V79, P765, DOI 10.1002/prot.22917; Ogata T, 2009, MECH AGEING DEV, V130, P328, DOI 10.1016/j.mad.2009.02.001; Oliveria SF, 2012, J NEUROSCI, V32, P15328, DOI 10.1523/JNEUROSCI.2302-12.2012; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; PEDIGO S, 1995, BIOCHEMISTRY-US, V34, P1179, DOI 10.1021/bi00004a011; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rintoul GL, 2003, J NEUROSCI, V23, P7881; RODBARD D, 1974, CLIN CHEM, V20, P1255; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; Sharifi ZN, 2012, STROKE RES TREAT, V2012, DOI DOI 10.1155/2012/809417; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Strack S., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/398751; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wilson TJ, 2013, NEUROBIOL DIS, V51, P13, DOI 10.1016/j.nbd.2012.01.009; Wood AM, 1998, J NEUROCHEM, V70, P677; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343	73	53	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12353	12365		10.1074/jbc.M113.459677	http://dx.doi.org/10.1074/jbc.M113.459677			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486469	Green Published, hybrid			2022-12-25	WOS:000318157600066
J	Wei, H; Bera, TK; Wayne, AS; Xiang, LM; Colantonio, S; Chertov, O; Pastan, I				Wei, Hui; Bera, Tapan K.; Wayne, Alan S.; Xiang, Laiman; Colantonio, Simona; Chertov, Oleg; Pastan, Ira			A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOLOGIC MALIGNANCIES; RECOMBINANT IMMUNOTOXIN; OVCA1; BIOSYNTHESIS	HA22 is a recombinant immunotoxin that kills CD22-expressing cells by ADP-ribosylating and inactivating elongation factor-2 (EF2). HA22 is composed of an Fv that binds to CD22 fused to a portion of Pseudomonas exotoxin A. HA22 is very active in drug-resistant hairy cell leukemia but is less active in children with acute lymphoblastic leukemia. To understand why some patients do not respond to HA22, we isolated an HA22-resistant lymphoma cell line and showed that resistance was due to the inability of HA22 to ADP-ribosylate and inactivate EF2. We analyzed the diphthamide synthesis genes and found that the WDR85 gene was deleted. We show that WDR85 knockdown conferred HA22 resistance to sensitive cells and that sensitivity was restored by introduction of a WDR85 cDNA into resistant cells. Analysis of EF2 in the mutant cells revealed a novel form of diphthamide with an additional methyl group that prevented ADP-ribosylation and inactivation of EF2. The abnormal methylation appeared to be catalyzed by DPH5. Inactivation of the WDR85 gene could be a mechanism of immunotoxin resistance in patients undergoing immunotoxin therapy.	[Wei, Hui; Bera, Tapan K.; Wayne, Alan S.; Xiang, Laiman; Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wayne, Alan S.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Colantonio, Simona; Chertov, Oleg] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Adv Technol Program, Prot Chem Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Pastan, I (corresponding author), NCI, Mol Biol Lab, Rm 5106,37 Convent Dr, Bethesda, MD 20892 USA.	pastani@mail.nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Chertov, Oleg/0000-0002-0426-2521	Center for Cancer Research, NCI, National Institutes of Health; NCI, National Institutes of Health [HHSN261200800001E]; MedImmune, LLC.; NATIONAL CANCER INSTITUTE [ZIABC008753] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MedImmune, LLC.(AstraZenecaMedimmune); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health, in part with federal funds from NCI, National Institutes of Health, under Contract HHSN261200800001E and under a Cooperative Research and Development Agreement with MedImmune, LLC. Dr. Pastan is an inventor of patents on immunotoxins that have all been assigned to the National Institutes of Health.	Bachner D, 2002, FEBS LETT, V526, P124, DOI 10.1016/S0014-5793(02)03115-0; Baylin SB, 2011, NAT MED, V17, P288, DOI 10.1038/nm0311-288; Bruening W, 1999, CANCER RES, V59, P4973; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Du X, 2008, CANCER RES, V68, P6300, DOI 10.1158/0008-5472.CAN-08-0461; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Fei ZL, 2011, J BIOL CHEM, V286, P27761, DOI 10.1074/jbc.M111.248435; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Francke F, 2005, BIOCHEM BIOPH RES CO, V334, P1292, DOI 10.1016/j.bbrc.2005.07.027; Greganova E, 2011, FEBS J, V278, P2613, DOI 10.1111/j.1742-4658.2011.08199.x; Howlader N, 2011, SEER CANC STAT REV 1; Jensen MR, 2004, GENE DEV, V18, P245, DOI 10.1101/gad.1184004; Kreitman RJ, 2012, J CLIN ONCOL, V30, P1822, DOI 10.1200/JCO.2011.38.1756; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; MAGRATH IT, 1980, J NATL CANCER I, V64, P477; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; Nowak NJ, 2010, CANCER GENET CYTOGEN, V199, P15, DOI 10.1016/j.cancergencyto.2010.01.014; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pastan Ira, 2004, Methods Mol Biol, V248, P503; PHILLIPS N, 1993, INT J CANCER, V54, P85, DOI 10.1002/ijc.2910540115; Phillips NJ, 1996, CANCER LETT, V102, P85, DOI 10.1016/0304-3835(96)04169-9; Ries L. A. G., 1999, NIH PUB, V99-4649, P1; Salvatore G, 2002, CLIN CANCER RES, V8, P995; Stewart DR, 2007, AM J MED GENET C, V145C, P383, DOI 10.1002/ajmg.c.30148; Su XY, 2012, J AM CHEM SOC, V134, P773, DOI 10.1021/ja208870a; Wayne AS, 2008, JNCI-J NATL CANCER I, V100, P1271, DOI 10.1093/jnci/djn306; Wayne AS, 2011, BLOOD, V118, P113, DOI 10.1182/blood.V118.21.248.248; Wayne AS, 2010, CLIN CANCER RES, V16, P1894, DOI 10.1158/1078-0432.CCR-09-2980; Wei H, 2012, P NATL ACAD SCI USA, V109, P6898, DOI 10.1073/pnas.1204523109; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138; Zhang YJ, 2010, CANCER RES, V70, P1082, DOI 10.1158/0008-5472.CAN-09-2405	34	25	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12305	12312		10.1074/jbc.M113.461343	http://dx.doi.org/10.1074/jbc.M113.461343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486472	Green Published, hybrid			2022-12-25	WOS:000318157600061
J	Zhang, YH; Wang, NN; Raab, RW; McKown, RL; Irwin, JA; Kwon, I; van Kuppevelt, TH; Laurie, GW				Zhang, Yinghui; Wang, Ningning; Raab, Ronald W.; McKown, Robert L.; Irwin, Jacob A.; Kwon, Inchan; van Kuppevelt, Toin H.; Laurie, Gordon W.			Targeting of Heparanase-modified Syndecan-1 by Prosecretory Mitogen Lacritin Requires Conserved Core GAGAL plus Heparan and Chondroitin Sulfate as a Novel Hybrid Binding Site That Enhances Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; DRY EYE; EXTRACELLULAR DOMAIN; INTEGRIN ACTIVATION; CRYSTAL-STRUCTURE; LACRIMAL GLAND; EXPRESSION; GROWTH; IDENTIFICATION; PROTEOGLYCANS	Cell surface heparan sulfate (HS) proteoglycans shape organogenesis and homeostasis by capture and release of morphogens through mechanisms largely thought to exclude the core protein domain. Nevertheless, heparanase deglycanation of the N-terminal HS-rich domain of syndecan-1 (SDC1), but not SDC2 or -4, is a prerequisite for binding of the prosecretory mitogen lacritin (Ma, P., Beck, S. L., Raab, R. W., McKown, R. L., Coffman, G. L., Utani, A., Chirico, W. J., Rapraeger, A. C., and Laurie, G. W. (2006) Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin. J. Cell Biol. 174, 1097-1106). We now report that the conserved and hydrophobic GAGAL domain in SDC1, adjacent to predicted HS substitution sites, is necessary to ligate and substantially enhance the alpha-helicity of the amphipathic C terminus of lacritin. Swapping out GAGAL for GADED in SDC2 or for GDLDD in SDC4 (both less hydrophobic) abrogated binding. HS and chondroitin sulfate are also essential. Both are detected in the N terminus, and when incubated with antibodies HS4C3 (anti-HS) or IO3H10 (anti-chondroitin sulfate), binding was absent, as occurred when all three N-terminal glycosaminoglycan substitution sites were mutated to alanine or when cells were treated with 4-methylumbelliferyl-beta-D-xylopyranoside or chlorate to suppress glycosaminoglycan substitution or sulfation, respectively. SDC1 interacts with the hydrophobic face of lacritin via Leu-108/Leu-109/Phe-112 as well as with Glu-103/Lys-107 and Lys-111 of the largely cationic face. Carving a hybrid hydrophobic/electrostatic docking site out of SDC1 in a manner dependent on endogenous heparanase is a dynamic process appropriate for subtle or broad epithelial regulation in morphogenesis, health, and disease.	[Zhang, Yinghui; Wang, Ningning; Laurie, Gordon W.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Irwin, Jacob A.; Kwon, Inchan] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22908 USA; [Raab, Ronald W.; McKown, Robert L.] James Madison Univ, Dept Integrated Sci & Technol, Harrisonburg, VA 22807 USA; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	University of Virginia; University of Virginia; University of Virginia; James Madison University; Radboud University Nijmegen	Laurie, GW (corresponding author), Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	glaurie@virginia.edu	van Kuppevelt, A.H.M.S.M./L-4463-2015; Laurie, Gordon W/A-5244-2008	Laurie, Gordon W/0000-0002-5311-2650	National Institutes of Health [RO1 EY013143, EY018222]; NATIONAL EYE INSTITUTE [R01EY013143, R01EY018222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY013143 and EY018222 (to G. W. L.).	Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; Barden JA, 1997, J BIOL CHEM, V272, P29572, DOI 10.1074/jbc.272.47.29572; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dore JM, 1998, FEBS LETT, V426, P67, DOI 10.1016/S0014-5793(98)00310-X; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Khan S, 2011, J BIOL CHEM, V286, P24842, DOI 10.1074/jbc.M111.226027; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lin PY, 2005, INVEST OPHTH VIS SCI, V46, P1593, DOI 10.1167/iovs.04-0864; LOHMANDER LS, 1979, J BIOL CHEM, V254, P551; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Mantelli F, 2009, INVEST OPHTH VIS SCI, V50, P2666, DOI 10.1167/iovs.08-2734; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; McKown RL, 2013, INVEST OPHTH VIS SCI, V54, P1979, DOI 10.1167/iovs.12-10740; McKown RL, 2009, EXP EYE RES, V88, P848, DOI 10.1016/j.exer.2008.09.002; Nichols JJ, 2009, CORNEA, V28, P1109, DOI 10.1097/ICO.0b013e3181a2ad81; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; PARALKAR VM, 1991, P NATL ACAD SCI USA, V88, P3397, DOI 10.1073/pnas.88.8.3397; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Peterson SB, 2010, J BIOL CHEM, V285, P14504, DOI 10.1074/jbc.M110.104166; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rawson JM, 2005, CURR BIOL, V15, P833, DOI 10.1016/j.cub.2005.03.039; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Shafat I, 2006, J BIOL CHEM, V281, P23804, DOI 10.1074/jbc.M602762200; Srinivasan S, 2012, INVEST OPHTH VIS SCI, V53, P5052, DOI 10.1167/iovs.11-9022; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; TSUTSUI J, 1991, BIOCHEM BIOPH RES CO, V176, P792, DOI 10.1016/S0006-291X(05)80255-4; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Velez VF, 2013, INVEST OPHTH VIS SCI, V54, P2123, DOI 10.1167/iovs.12-11488; Wang JH, 2006, J CELL BIOL, V174, P689, DOI 10.1083/jcb.200605140; Weigelt B, 2003, J CANCER RES CLIN, V129, P735, DOI 10.1007/s00432-003-0514-y; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Zhong M, 2004, BIOCHEMISTRY-US, V43, P3490, DOI 10.1021/bi035899m; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	62	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12090	12101		10.1074/jbc.M112.422717	http://dx.doi.org/10.1074/jbc.M112.422717			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504321	Green Published, hybrid			2022-12-25	WOS:000318157600042
J	Alzayady, KJ; Chandrasekhar, R; Yule, DI				Alzayady, Kamil J.; Chandrasekhar, Rahul; Yule, David I.			Fragmented Inositol 1,4,5-Trisphosphate Receptors Retain Tetrameric Architecture and Form Functional Ca2+ Release Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; TRISPHOSPHATE RECEPTOR; SIGNAL-TRANSDUCTION; IP3 RECEPTORS; TYPE-1; APOPTOSIS; CLEAVAGE; DOMAIN; CALCINEURIN; ACTIVATION	Inositol 1,4,5-trisphosphate receptor isoforms are a family of ubiquitously expressed ligand-gated channels encoded by three individual genes. The proteins are localized to membranes of intracellular Ca2+ stores and play pivotal roles in Ca2+ homeostasis. Previous studies have demonstrated that IP(3)R1 is cleaved by the intracellular proteases calpain and caspase both in vivo and in vitro. However, the resultant cleavage products are poorly defined, and the functional consequences of these proteolytic events are not fully understood. We demonstrate that IP(3)R1 is cleaved during staurosporine-induced apoptosis, yielding N-terminal fragments encompassing the ligand-binding domain and the majority of the central modulatory domain together with a C-terminal fragment containing the channel domain and cytosolic tail. Notably, these fragments remain associated with the membrane after initiation of apoptotic cleavage. Furthermore, when recombinant IP(3)R1 fragments, corresponding to those predicted to be generated by caspase or calpain cleavage, are stably coexpressed in cells, they physically associate and form functional channels. These data provide novel insights regarding the regulation of I(P)3R1 during proteolysis and provide direct evidence that polypeptide continuity is not required for IP3R activation and Ca2+ release.	[Alzayady, Kamil J.; Chandrasekhar, Rahul; Yule, David I.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Yule, DI (corresponding author), Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	david_Yule@urmc.rochester.edu			National Institutes of Health [R01 DE014756, DK54568]; NIDCR, National Institutes of Health [T90 DE021985-02]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756, T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568, R56DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE014756 and DK54568 (to D. I. Y.) and by NIDCR, National Institutes of Health Training Grant T90 DE021985-02 (to K. J. A.).	Akimzhanov AM, 2013, CELL CALCIUM, V53, P152, DOI 10.1016/j.ceca.2012.10.002; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bhanumathy C, 2012, J BIOL CHEM, V287, P43674, DOI 10.1074/jbc.M112.415786; Blackshaw S, 2000, FASEB J, V14, P1375, DOI 10.1096/fj.14.10.1375; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; Elkoreh G, 2012, J CELL BIOCHEM, V113, P2775, DOI 10.1002/jcb.24155; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Hang LS, 2000, J NEUROCHEM, V75, P1852; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; How PC, 2011, J BIOL CHEM, V286, P8565, DOI 10.1074/jbc.M110.175174; Igwe OJ, 1997, MOL BRAIN RES, V46, P39, DOI 10.1016/S0169-328X(96)00269-0; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Kopil CM, 2012, J NEUROCHEM, V123, P147, DOI 10.1111/j.1471-4159.2012.07859.x; Kopil CM, 2011, J BIOL CHEM, V286, P35998, DOI 10.1074/jbc.M111.254177; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; MAGNUSSON A, 1993, FEBS LETT, V323, P229, DOI 10.1016/0014-5793(93)81345-Z; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mukerjee N, 2000, ARCH BIOCHEM BIOPHYS, V379, P337, DOI 10.1006/abbi.2000.1889; Mukerjee N, 2001, BIOCHEM BIOPH RES CO, V285, P1192, DOI 10.1006/bbrc.2001.5278; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Orrenius S, 1991, Adv Exp Med Biol, V283, P419; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Shimbo K, 2012, P NATL ACAD SCI USA, V109, P12432, DOI 10.1073/pnas.1208616109; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szlufcik K, 2006, BIOL CELL, V98, P1, DOI 10.1042/BC20050031; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Verbert L, 2008, BIOL CELL, V100, P39, DOI 10.1042/BC20070086; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yim H, 2003, MOL BIOL CELL, V14, P4250, DOI 10.1091/mbc.E03-01-0029; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	54	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11122	11134		10.1074/jbc.M113.453241	http://dx.doi.org/10.1074/jbc.M113.453241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479737	Green Published, hybrid			2022-12-25	WOS:000317915500017
J	Bertsch, J; Parthasarathy, A; Buckel, W; Muller, V				Bertsch, Johannes; Parthasarathy, Anutthaman; Buckel, Wolfgang; Mueller, Volker			An Electron-bifurcating Caffeyl-CoA Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETOBACTERIUM-WOODII; TRANSFER FLAVOPROTEIN; COENZYME-A; TRANSFERRING FLAVOPROTEIN; ENERGY-CONSERVATION; INTERMEDIATE STEP; CRYSTAL-STRUCTURE; ENZYME COMPLEX; FERREDOXIN; IRON	A low potential electron carrier ferredoxin (E-0' approximate to -500 mV) is used to fuel the only bioenergetic coupling site, a sodium-motive ferredoxin: NAD(+) oxidoreductase (Rnf) in the acetogenic bacterium Acetobacterium woodii. Because ferredoxin reduction with physiological electron donors is highly endergonic, it must be coupled to an exergonic reaction. One candidate is NADH-dependent caffeyl-CoA reduction. We have purified a complex from A. woodii that contains a caffeyl-CoA reductase and an electron transfer flavoprotein. The enzyme contains three subunits encoded by the carCDE genes and is predicted to have, in addition to FAD, two [4Fe-4S] clusters as cofactor, which is consistent with the experimental determination of 4 mol of FAD, 9 mol of iron, and 9 mol of acid-labile sulfur. The enzyme complex catalyzed caffeyl-CoA-dependent oxidation of reduced methyl viologen. With NADH as donor, it catalyzed caffeyl-CoA reduction, but this reaction was highly stimulated by the addition of ferredoxin. Spectroscopic analyses revealed that ferredoxin and caffeyl-CoA were reduced simultaneously, and a stoichiometry of 1.3:1 was determined. Apparently, the caffeyl-CoA reductase-Etf complex of A. woodii uses the novel mechanism of flavin-dependent electron bifurcation to drive the endergonic ferredoxin reduction with NADH as reductant by coupling it to the exergonic NADH-dependent reduction of caffeyl-CoA.	[Bertsch, Johannes; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60438 Frankfurt, Germany; [Parthasarathy, Anutthaman; Buckel, Wolfgang] Univ Marburg, Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany; [Buckel, Wolfgang] Univ Marburg, Fachbereich Biol, D-35043 Marburg, Germany	Goethe University Frankfurt; Max Planck Society; Philipps University Marburg; Philipps University Marburg	Muller, V (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Parthasarathy, Anutthaman/L-5490-2019; Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508; Parthasarathy, Anutthaman/0000-0003-1830-5948; Parthasarathy, Anutthaman/0000-0003-4750-6335	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	Aufurth S, 2000, J BIOL CHEM, V275, P33297, DOI 10.1074/jbc.M005134200; BACHE R, 1981, ARCH MICROBIOL, V130, P255, DOI 10.1007/BF00459530; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BERTINI I, 1995, EUR J BIOCHEM, V232, P192, DOI 10.1111/j.1432-1033.1995.tb20799.x; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; Boiangiu CD, 2005, J MOL MICROB BIOTECH, V10, P105, DOI 10.1159/000091558; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt K, 2013, J BIOENERG BIOMEMBR, V45, P15, DOI 10.1007/s10863-012-9474-8; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; CRANE FL, 1956, J BIOL CHEM, V218, P717; Dimroth Peter, 2008, V45, P153, DOI 10.1007/400_2007_045; DUEE ED, 1994, J MOL BIOL, V243, P683, DOI 10.1016/0022-2836(94)90041-8; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fritz M, 2008, FEBS J, V275, P1999, DOI 10.1111/j.1742-4658.2008.06354.x; Fritz M, 2007, FEBS J, V274, P3421, DOI 10.1111/j.1742-4658.2007.05874.x; Gottschalk G, 2001, BBA-BIOENERGETICS, V1505, P28, DOI 10.1016/S0005-2728(00)00274-7; HEISE R, 1991, FEBS LETT, V295, P119, DOI 10.1016/0014-5793(91)81400-3; HEISE R, 1989, J BACTERIOL, V171, P5473, DOI 10.1128/jb.171.10.5473-5478.1989; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hess V, 2013, APPL ENVIRON MICROB, V79, P1942, DOI 10.1128/AEM.03604-12; Hess V, 2011, J BACTERIOL, V193, P971, DOI 10.1128/JB.01126-10; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Huang HY, 2012, J BACTERIOL, V194, P3689, DOI 10.1128/JB.00385-12; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Mueller V., 2008, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0001415.pub2, DOI 10.1002/9780470015902.A0001415.PUB2]; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; REIDLINGER J, 1994, FEBS LETT, V356, P17, DOI 10.1016/0014-5793(94)01222-9; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Schlegel K, 2012, FEBS J, V279, P4444, DOI 10.1111/febs.12031; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Schmitz RA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P86, DOI 10.1007/0-387-30742-7_4; SCHONHEIT P, 1978, FEBS LETT, V89, P219, DOI 10.1016/0014-5793(78)80221-X; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Swanson MA, 2008, BIOCHEMISTRY-US, V47, P8894, DOI 10.1021/bi800507p; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; TSAI MH, 1995, RES MICROBIOL, V146, P397, DOI 10.1016/0923-2508(96)80285-3; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007	51	55	59	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11304	11311		10.1074/jbc.M112.444919	http://dx.doi.org/10.1074/jbc.M112.444919			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479729	Green Published, hybrid			2022-12-25	WOS:000317915500033
J	Soderstjerna, E; Johansson, F; Klefbohm, B; Johansson, UE				Soderstjerna, Erika; Johansson, Fredrik; Klefbohm, Birgitta; Johansson, Ulrica Englund			Gold- and Silver Nanoparticles Affect the Growth Characteristics of Human Embryonic Neural Precursor Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; STEM-CELLS; IN-VITRO; PROGENITOR CELLS; COLLOIDAL GOLD; DRUG-DELIVERY; TOXICITY; PROTEIN; BRAIN; SIZE	Rapid development of nanotechnologies and their applications in clinical research have raised concerns about the adverse effects of nanoparticles (NPs) on human health and environment. NPs can be directly taken up by organs exposed, but also translocated to secondary organs, such as the central nervous system (CNS) after systemic-or subcutaneous administration, or via the olfactory system. The CNS is particularly vulnerable during development and recent reports describe transport of NPs across the placenta and even into brain tissue using in vitro and in vivo experimental systems. Here, we investigated whether well-characterized commercial 20 and 80 nm Au- and AgNPs have an effect on human embryonic neural precursor cell (HNPC) growth. After two weeks of NP exposure, uptake of NPs, morphological features and the amount of viable and dead cells, proliferative cells (Ki67 immunostaining) and apoptotic cells (TUNEL assay), respectively, were studied. We demonstrate uptake of both 20 and 80 nm Au- and AgNPs respectively, by HNPCs during proliferation. A significant effect on the sphere size-and morphology was found for all cultures exposed to Au- and AgNPs. AgNPs of both sizes caused a significant increase in numbers of proliferating and apoptotic HNPCs. In contrast, only the highest dose of 20 nm AuNPs significantly affected proliferation, whereas no effect was seen on apoptotic cell death. Our data demonstrates that both Au- and AgNPs interfere with the growth profile of HNPCs, indicating the need of further detailed studies on the adverse effects of NPs on the developing CNS.	[Soderstjerna, Erika; Klefbohm, Birgitta; Johansson, Ulrica Englund] Lund Univ, Dept Ophthalmol, Inst Clin Sci, Lund, Sweden; [Johansson, Fredrik] Lund Univ, Sect Funct Zool, Dept Biol, Lund, Sweden	Lund University; Lund University	Johansson, UE (corresponding author), Lund Univ, Dept Ophthalmol, Inst Clin Sci, Lund, Sweden.	ulrica.englund_johansson@med.lu.se	Johansson, Fredrik/M-4554-2014	Johansson, Fredrik/0000-0002-7813-8822	Faculties of Medicine and Science, Lund University; Crafoord Foundation; Per Westling Foundation; Crown Princess Margaretas Foundation	Faculties of Medicine and Science, Lund University; Crafoord Foundation; Per Westling Foundation; Crown Princess Margaretas Foundation	This work was supported by the Faculties of Medicine and Science, Lund University and the Crafoord-, Per Westling- Crown Princess Margaretas Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Blum JL, 2012, TOXICOL SCI, V126, P478, DOI 10.1093/toxsci/kfs008; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Chen DF, 2007, BIOMED MATER, V2, pS126, DOI 10.1088/1748-6041/2/3/S08; Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cortese-Krott MM, 2009, FREE RADICAL BIO MED, V47, P1570, DOI 10.1016/j.freeradbiomed.2009.08.023; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Dziendzikowska K, 2012, J APPL TOXICOL, V32, P920, DOI 10.1002/jat.2758; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Ema M, 2010, REPROD TOXICOL, V30, P343, DOI 10.1016/j.reprotox.2010.06.002; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; FITZGERALD WF, 1991, ENVIRON HEALTH PERSP, V96, P159, DOI 10.2307/3431225; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gramowski A, 2010, ENVIRON HEALTH PERSP, V118, P1363, DOI 10.1289/ehp.0901661; Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1; Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; HORISBERGER M, 1977, J HISTOCHEM CYTOCHEM, V25, P295, DOI 10.1177/25.4.323352; Hussain SM, 2006, TOXICOL SCI, V92, P456, DOI 10.1093/toxsci/kfl020; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Jain KK, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-83; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Ji JH, 2007, INHAL TOXICOL, V19, P857, DOI 10.1080/08958370701432108; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Kim JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/50/505101; Kreyling WG, 2006, J AEROSOL MED, V19, P74, DOI 10.1089/jam.2006.19.74; Kreyling Wolfgang G, 2009, Inhal Toxicol, V21 Suppl 1, P55, DOI 10.1080/08958370902942517; Lima FB, 2010, MOL PSYCHIATR, V15, P657, DOI 10.1038/mp.2009.97; Liu ZW, 2011, ENVIRON TOXICOL, V26, P552, DOI 10.1002/tox.20586; Liu ZW, 2009, TOXICOLOGY, V264, P179, DOI 10.1016/j.tox.2009.08.005; Liu ZP, 2001, J HISTOCHEM CYTOCHEM, V49, P957, DOI 10.1177/002215540104900804; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Menezes V, 2011, CURR PHARM BIOTECHNO, V12, P731, DOI 10.2174/138920111795471010; Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Oberdorster G, 2009, J NANOSCI NANOTECHNO, V9, P4996, DOI 10.1166/jnn.2009.GR02; Park MVDZ, 2009, TOXICOL APPL PHARM, V240, P108, DOI 10.1016/j.taap.2009.07.019; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Pernodet N, 2006, SMALL, V2, P766, DOI 10.1002/smll.200500492; Prediger RDS, 2012, NEUROTOX RES, V21, P90, DOI 10.1007/s12640-011-9281-8; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rahman MF, 2009, TOXICOL LETT, V187, P15, DOI 10.1016/j.toxlet.2009.01.020; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10; Saunders M, 2009, WIRES NANOMED NANOBI, V1, P671, DOI 10.1002/wnan.53; Schleh C, 2012, NANOTOXICOLOGY, V6, P36, DOI 10.3109/17435390.2011.552811; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sen E, 2011, ASN NEURO, V3, DOI 10.1042/AN20100029; Sintubin L, 2012, BIOTECHNOL BIOENG, V109, P2422, DOI 10.1002/bit.24570; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Tang JL, 2009, J NANOSCI NANOTECHNO, V9, P4924, DOI 10.1166/jnn.2009.1269; Tarantola M, 2011, NANOTOXICOLOGY, V5, P254, DOI 10.3109/17435390.2010.528847; Teow Y, 2011, CHEM COMMUN, V47, P7025, DOI 10.1039/c0cc05271j; Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005; Wick P, 2010, ENVIRON HEALTH PERSP, V118, P432, DOI 10.1289/ehp.0901200; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yamashita K, 2011, NAT NANOTECHNOL, V6, P321, DOI [10.1038/nnano.2011.41, 10.1038/NNANO.2011.41]; Zhang XD, 2010, INT J NANOMED, V5, P771, DOI 10.2147/IJN.S8428; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	80	62	63	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58211	10.1371/journal.pone.0058211	http://dx.doi.org/10.1371/journal.pone.0058211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505470	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100035
J	Castillo, V; Chiti, F; Ventura, S				Castillo, Virginia; Chiti, Fabrizio; Ventura, Salvador			The N-terminal Helix Controls the Transition between the Soluble and Amyloid States of an FF Domain	PLOS ONE			English	Article							ON-PATHWAY INTERMEDIATE; PROTEIN AGGREGATION; RELAXATION DISPERSION; FOLDING INTERMEDIATE; SEQUENCE DETERMINANTS; ATOMIC-RESOLUTION; C-PEPTIDE; PREDICTION; FIBRILS; PROPENSITY	Background: Protein aggregation is linked to the onset of an increasing number of human nonneuropathic (either localized or systemic) and neurodegenerative disorders. In particular, misfolding of native alpha-helical structures and their self-assembly into nonnative intermolecular beta-sheets has been proposed to trigger amyloid fibril formation in Alzheimer's and Parkinson's diseases. Methods: Here, we use a battery of biophysical techniques to elucidate the conformational conversion of native alpha-helices into amyloid fibrils using an all-alpha FF domain as a model system. Results: We show that under mild denaturing conditions at low pH this FF domain self-assembles into amyloid fibrils. Theoretical and experimental dissection of the secondary structure elements in this domain indicates that the helix 1 at the N-terminus has both the highest alpha-helical and amyloid propensities, controlling the transition between soluble and aggregated states of the protein. Conclusions: The data illustrates the overlap between the propensity to form native alpha-helices and amyloid structures in protein segments. Significance: The results presented contribute to explain why proteins cannot avoid the presence of aggregation-prone regions and indeed use stable alpha-helices as a strategy to neutralize such potentially deleterious stretches.	[Castillo, Virginia; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol Biomed, Bellaterra, Spain; [Castillo, Virginia; Ventura, Salvador] Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim Biol Mol, Bellaterra, Spain; [Chiti, Fabrizio] Univ Florence, Dipartimento Sci Biochim, Florence, Italy	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Florence	Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol Biomed, Bellaterra, Spain.	salvador.ventura@uab.es	Ventura, Salvador/C-7021-2008; Ventura, Salvador/AAY-3170-2021	Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351	Ministerio de Ciencia e Innovacion (MCISpain) [BFU2010-14901]; AGAUR (Generalitat de Catalunya) [2009-SGR 760]; Ministerio de Educacion-Spain [FPU AP 2007-02849]; ICREA ACADEMIA award	Ministerio de Ciencia e Innovacion (MCISpain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ministerio de Educacion-Spain; ICREA ACADEMIA award(ICREA)	This work was supported by BFU2010-14901 from Ministerio de Ciencia e Innovacion (MCISpain) and 2009-SGR 760 from AGAUR (Generalitat de Catalunya). V.C. is beneficiary of predoctoral FPU AP 2007-02849 fellowship from the Ministerio de Educacion-Spain. S.V. has been granted an ICREA ACADEMIA award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JS, 1995, BIOCHEMISTRY-US, V34, P984, DOI 10.1021/bi00003a033; Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Baldwin RL, 2012, CURR OPIN STRUCT BIO; Barette J, 2012, J PHYS CHEM B, V116, P6637, DOI 10.1021/jp209974f; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Belli M, 2011, EMBO REP, V12, P657, DOI 10.1038/embor.2011.116; BIERZYNSKI A, 1982, P NATL ACAD SCI-BIOL, V79, P2470, DOI 10.1073/pnas.79.8.2470; Bonet R, 2008, PROTEINS, V73, P1001, DOI 10.1002/prot.22127; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768; Castillo V, 2011, BIOTECHNOL J, V6, P674, DOI 10.1002/biot.201000331; Castillo V, 2010, PROTEOMICS, V10, P4172, DOI 10.1002/pmic.201000260; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Daggett V, 2009, CURR OPIN STRUC BIOL, V19, P1, DOI 10.1016/j.sbi.2009.01.006; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gasch A, 2006, J BIOL CHEM, V281, P356, DOI 10.1074/jbc.M508047200; HAMADA D, 1995, J MOL BIOL, V254, P737, DOI 10.1006/jmbi.1995.0651; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jemth P, 2005, J MOL BIOL, V350, P363, DOI 10.1016/j.jmb.2005.04.067; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Jemth P, 2008, PROTEIN ENG DES SEL, V21, P207, DOI 10.1093/protein/gzm091; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Korzhnev DM, 2012, P NATL ACAD SCI US; Korzhnev DM, 2007, J MOL BIOL, V372, P497, DOI 10.1016/j.jmb.2007.06.012; Korzhnev DM, 2011, J AM CHEM SOC, V133, P10974, DOI 10.1021/ja203686t; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Niraula TN, 2002, J MOL BIOL, V320, P333, DOI 10.1016/S0022-2836(02)00425-4; SEGAWA S, 1991, BIOPOLYMERS, V31, P497, DOI 10.1002/bip.360310505; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; Sirangelo I, 2002, J BIOL CHEM, V277, P45887, DOI 10.1074/jbc.M207659200; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Taddei N, 2001, J BIOL CHEM, V276, P37149, DOI 10.1074/jbc.M105720200; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tzotzos S, 2010, PROTEIN SCI, V19, P327, DOI 10.1002/pro.314; Ventura S, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-11; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858	55	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58297	10.1371/journal.pone.0058297	http://dx.doi.org/10.1371/journal.pone.0058297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505482	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500066
J	Griffiths, JR; Schindler, DE; Seeb, LW				Griffiths, Jennifer R.; Schindler, Daniel E.; Seeb, Lisa W.			How Stock of Origin Affects Performance of Individuals across a Meta-Ecosystem: An Example from Sockeye Salmon	PLOS ONE			English	Article							POPULATION DIVERSITY; JUVENILE MIGRATION; ECOLOGY; HABITAT; MOVEMENT; PRODUCTIVITY; TEMPERATURE; EVOLUTION; PATTERNS; GENETICS	Connectivity among diverse habitats can buffer populations from adverse environmental conditions, influence the functioning of meta-ecosystems, and ultimately affect the reliability of ecosystem services. This stabilizing effect on populations is proposed to derive from complementarity in growth and survival conditions experienced by individuals in the different habitats that comprise meta-ecosystems. Here we use the fine scale differentiation of salmon populations between diverse lake habitats to assess how rearing habitat and stock of origin affect the body condition of juvenile sockeye salmon. We use genetic markers (single nucleotide polymorphisms) to assign individuals of unknown origin to stock group and in turn characterize ecologically relevant attributes across habitats and stocks. Our analyses show that the body condition of juvenile salmon is related to the productivity of alternative habitats across the watershed, irrespective of their stock of origin. Emigrants and residents with genetic origins in the high productivity lake were also differentiated by their body condition, poor and high respectively. These emigrants represented a substantial proportion of juvenile sockeye salmon rearing in the lower productivity lake habitat. Despite emigrants originating from the more productive lake, they did not differ in body condition from the individuals spawned in the lower productivity, recipient habitat. Genetic tools allowed us to assess the performance of different stocks groups across the diverse habitats comprising their meta-ecosystem. The ability to characterize the ecological consequences of meta-ecosystem connectivity can help develop strategies to protect and restore ecosystems and the services they provide to humans.	[Griffiths, Jennifer R.; Schindler, Daniel E.; Seeb, Lisa W.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Griffiths, JR (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	jeng@uw.edu	Seeb, Lisa W/GSN-3076-2022		US Army Corps of Engineers [WC1JIW01419268]; National Science Foundation; Gordon and Betty Moore Foundation; Chignik Regional Aquaculture Association	US Army Corps of Engineers(United States Department of DefenseUnited States Army); National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Chignik Regional Aquaculture Association	Funding was provided by the US Army Corps of Engineers (contract no. WC1JIW01419268; http://www.usace.army.mil/), National Science Foundation (www.nsf.gov/), Gordon and Betty Moore Foundation (http://www.moore.org/), and the Chignik Regional Aquaculture Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Armstrong JB, DIEL HORIZO IN PRESS; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Biro PA, 2005, P ROY SOC B-BIOL SCI, V272, P1443, DOI 10.1098/rspb.2005.3096; BRETT JR, 1971, AM ZOOL, V11, P99; Brodersen J, 2011, OIKOS, V120, P1838, DOI 10.1111/j.1600-0706.2011.19433.x; Burgner R.L., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P129; CARVALHO GR, 1994, REV FISH BIOL FISHER, V4, P326, DOI 10.1007/BF00042908; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK CW, 1988, AM NAT, V131, P271, DOI 10.1086/284789; CONE RS, 1989, T AM FISH SOC, V118, P510, DOI 10.1577/1548-8659(1989)118<0511:TNTRTU>2.3.CO;2; Creelman EK, 2011, T AM FISH SOC, V140, P749, DOI 10.1080/00028487.2011.584494; Crooks K. R., 2006, CONNECTIVITY CONSERV; Dann TH, 2012, SOCKEYE SALMON BASEL; Dingle Hugh, 1996, P1; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Griffiths JR, 2012, ECOL FRESHW FISH, V21, P349, DOI 10.1111/j.1600-0633.2012.00555.x; Griffiths JR, 2011, LIMNOL OCEANOGR, V56, P193, DOI 10.4319/lo.2011.56.1.0193; Habicht C, 2010, T AM FISH SOC, V139, P1171, DOI 10.1577/T09-149.1; Hamann EJ, 2012, ECOLOGY, V93, P733, DOI 10.1890/11-1009.1; Hayes SA, 2011, CAN J FISH AQUAT SCI, V68, P1341, DOI 10.1139/F2011-062; Hendry Andrew P., 2004, P52; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Kahler TH, 2001, CAN J FISH AQUAT SCI, V58, P1947, DOI 10.1139/cjfas-58-10-1947; Koski KV, 2009, ECOL SOC, V14; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mazerolle M. J., 2010, AICCMODAVG MODEL SEL; McGlauflin MT, 2011, T AM FISH SOC, V140, P763, DOI 10.1080/00028487.2011.584495; Narum SR, 2008, MOL ECOL, V17, P3464, DOI 10.1111/j.1365-294X.2008.03851.x; Narver DW, 1966, PELAGIAL ECOLOGY CAR; NASLUND I, 1993, OIKOS, V66, P538, DOI 10.2307/3544950; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Pella J, 2001, FISH B-NOAA, V99, P151; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinn TP, 2006, ANIM BEHAV, V72, P941, DOI 10.1016/j.anbehav.2006.03.003; Raftery AE, 1996, MARKOV CHAIN MONTE C; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ringsby TH, 2002, ECOLOGY, V83, P561, DOI 10.1890/0012-9658(2002)083[0561:ASDOAH]2.0.CO;2; Rogers LA, 2008, OIKOS, V117, P1578, DOI 10.1111/j.0030-1299.2008.16758.x; RUGGERONE G T, 1992, North American Journal of Fisheries Management, V12, P87, DOI 10.1577/1548-8675(1992)012<0087:POSSFB>2.3.CO;2; Ruggerone G. T., 2003, RAPID NATURAL HABITA; Ruggerone GT, 1994, INVESTIGATIONS SALMO; Scheuerell MD, 2003, ECOLOGY, V84, P1713, DOI 10.1890/0012-9658(2003)084[1713:DVMBJS]2.0.CO;2; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SCHLOSSER IJ, 1991, BIOSCIENCE, V41, P704, DOI 10.2307/1311765; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Seeb JE, 2009, METHODS MOL BIOL, V578, P277, DOI 10.1007/978-1-60327-411-1_18; Seeb LW, 2011, T AM FISH SOC, V140, P734, DOI 10.1080/00028487.2011.584493; Simmons RK, 2012, CANADIAN J FISHERIES; Smith MJ, 2011, MOL ECOL RESOUR, V11, P268, DOI 10.1111/j.1755-0998.2010.02965.x; Stanford JA, 2005, INT VER THEOR ANGEW, V29, P123; STENSETH NC, 1980, OIKOS, V35, P165, DOI 10.2307/3544425; Team RDC, 2010, R LANG ENV STAT COMP; UTTER F, 1993, FISHERIES, V18, P11, DOI 10.1577/1548-8446(1993)018&lt;0011:GMAMSF&gt;2.0.CO;2; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Westley PAH, 2008, ECOL FRESHW FISH, V17, P443, DOI 10.1111/j.1600-0633.2008.00296.x; Westley PA, 2007, BIOCOMPLEXITY RAPID; Westley PAH, 2010, OECOLOGIA, V163, P471, DOI 10.1007/s00442-009-1534-3; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zar JH, 1999, BIOSTATISTICAL ANAL	64	10	12	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58584	10.1371/journal.pone.0058584	http://dx.doi.org/10.1371/journal.pone.0058584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505539	gold, Green Published, Green Submitted			2022-12-25	WOS:000318334500104
J	Liu, SP; Lin, CC; Lin, HC; Chen, YH; Yu, HJ				Liu, Shih-Ping; Lin, Ching-Chun; Lin, Herng-Ching; Chen, Yi-Hua; Yu, Hong-Jeng			Association between Schizophrenia and Urinary Calculi: A Population-Based Case-Control Study	PLOS ONE			English	Article							KIDNEY-STONES; MEDICAL COMORBIDITY; NEPHROLITHIASIS; RISK; EPIDEMIOLOGY; MORTALITY; PREVALENCE; DISEASE; TIME	Background: People with schizophrenia have been demonstrated to have higher overall morbidity and all-cause mortality rates from general medical conditions. However, little attention has been given to the urinary system of people with schizophrenia. As no direct evidence has been reported demonstrating a link between schizophrenia and urinary calculi, this study utilized a population-based case-control study design to investigate the possibility of an association between schizophrenia and the occurrence of urinary calculi. Method: This study used data from the Taiwan Longitudinal Health Insurance Database. Cases consisted of 53,965 urinary calculi patients newly diagnosed between 2002 and 2008. In total, 269,825 controls were randomly selected and matched with the cases in terms of age and sex. Each person was traced to discern whether he had previously received a diagnosis of schizophrenia. Conditional logistic regression models were performed for the analysis. Results: A total of 3,119 (1.0%) subjects had been diagnosed with schizophrenia prior to the index date. This included 0.7% of the patients with urinary calculi, and 1.0% of the controls. A prior diagnosis of schizophrenia was independently associated with a 30% decrease (95% CI = 0.62-0.76) in the occurrence of urinary calculi. The reduction was even more remarkable in males (38%, 95% CI = 0.55-0.71) and in elder individuals independent of gender (48% in those aged >69,95% CI = 0.36-0.77). Conclusion: Our findings suggest that there is an inverse association between schizophrenia and urinary calculi. Future studies are needed to elucidate the mechanisms by which schizophrenia negatively associates with urinary calculi.	[Liu, Shih-Ping; Yu, Hong-Jeng] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Lin, Ching-Chun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Hlth Care Adm, Taipei, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Yu, Hong-Jeng] Far Eastern Mem Hosital, Dept Surg, Div Urol, New Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Far Eastern Memorial Hospital	Yu, HJ (corresponding author), Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan.	yhj5251@ntu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695; YU, HONG-JENG/0000-0003-3287-5736				Amato M, 2004, UROL INT, V72, P1, DOI 10.1159/000076582; Barak Y, 2005, CANCER-AM CANCER SOC, V104, P2817, DOI 10.1002/cncr.21574; Bonney WW, 1997, SCHIZOPHR RES, V25, P243, DOI 10.1016/S0920-9964(97)00021-2; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Carney CP, 2006, J GEN INTERN MED, V21, P1133, DOI 10.1111/j.1525-1497.2006.00563.x; Carra G, 2012, EUR ARCH PSY CLIN N, V262, P607, DOI 10.1007/s00406-012-0305-z; Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; Curhan GC, 1996, AM J EPIDEMIOL, V143, P240, DOI 10.1093/oxfordjournals.aje.a008734; Curhan GC, 1997, J AM SOC NEPHROL, V8, P1568; DAngelo A, 1997, MINER ELECTROL METAB, V23, P269; DELEON J, 1994, BIOL PSYCHIAT, V35, P408, DOI 10.1016/0006-3223(94)90008-6; Dundas Brian, 2007, Curr Psychiatry Rep, V9, P236, DOI 10.1007/s11920-007-0025-7; EATON WW, 1992, SCHIZOPHR RES, V6, P181, DOI 10.1016/0920-9964(92)90001-L; Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2; Green AI, 2003, PSYCHIAT CLIN N AM, V26, P115, DOI 10.1016/S0193-953X(02)00014-X; HARRIS AE, 1988, SCHIZOPHRENIA BULL, V14, P85, DOI 10.1093/schbul/14.1.85; Jeste DV, 1996, SCHIZOPHRENIA BULL, V22, P413, DOI 10.1093/schbul/22.3.413; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Kato Y, 2005, UROL RES, V33, P476, DOI 10.1007/s00240-005-0511-5; KOHRI K, 1990, BONE MINER, V8, P59, DOI 10.1016/0169-6009(91)90141-L; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shiloh R, 2001, EUR PSYCHIAT, V16, P497, DOI 10.1016/S0924-9338(01)00612-5; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Terao T, 1999, AUST NZ J PSYCHIAT, V33, P769; Walker D, 1971, J UROLOGY, V1054, P868; Weber NS, 2009, PSYCHIAT SERV, V60, P1059, DOI 10.1176/appi.ps.60.8.1059; YODER V, 1984, AM J PSYCHIAT, V141, P617, DOI 10.1176/ajp.141.4.617	32	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e56942	10.1371/journal.pone.0056942	http://dx.doi.org/10.1371/journal.pone.0056942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505416	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500008
J	Wilson, N; Nghiem, N; Foster, RH				Wilson, Nick; Nghiem, Nhung; Foster, Rachel H.			The Feasibility of Achieving Low-Sodium Intake in Diets That Are Also Nutritious, Low-Cost, and Have Familiar Meal Components	PLOS ONE			English	Article							SALT INTAKE; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; COLORECTAL-CANCER; METAANALYSIS; HEALTH; REDUCTION; PATTERNS; RISK; CONSUMPTION	Objective: Given the importance of high sodium diets as a risk factor for disease burden (ranked 11th in importance in the Global Burden of Disease Study 2010), we aimed to determine the feasibility of low-sodium diets that were also low-cost, nutritious and (for some scenarios) included familiar meals. Methods: The mathematical technique of "linear programming" was used to model eight optimized daily diets (some with uncertainty), including some diets that contained "familiar meals" for New Zealanders or were Mediterranean-, Asian- and Pacific-style diets. Data inputs included nutrients in foods, food prices and food wastage. Findings: Using nutrient recommendations for men and a cost constraint of <NZ$9/d (US$6.84), the sodium intake levels in the eight optimized daily diets were all well below the 2300 mg/d (5.8 g salt/d) recommended maximum. The only diet to not consistently fall below the recommended "target" upper limit of 1600 mg/d included an evening meal with sausages (median = 1640 mg/d, 95% simulation interval: 1551-1735 mg/d). Many additional nutritional aspects of these optimized low-sodium diets suggest that they would reduce cardiovascular disease risk in other ways (e.g., improved polyunsaturated to saturated fat ratio) and also reduce risk of cancer and other chronic diseases (e.g., via higher intakes of vegetables, fruits and dietary fiber). Even healthier diets (e.g., with higher intakes of fruit) occurred when the cost constraint was relaxed to $NZ15/d (US$11.40). Similar results were obtained when the modeling considered diets for women. Conclusions: These results provide some reassurance for the feasibility of substantially reducing population sodium intake given currently available low-cost foods and while maintaining some level of familiar meals. Policy makers could consider ways to promote such optimized diets and foods, including regulations on maximum salt levels in processed foods, and taxes on alternative foods that are high in salt, sugar and saturated fat.	[Wilson, Nick; Nghiem, Nhung; Foster, Rachel H.] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Otago	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	nick.wilson@otago.ac.nz		Nghiem, Nhung/0000-0003-0078-4549	Health Research Council of New Zealand [10/248]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This project was part of the BODE3 Program, which receives funding support from the Health Research Council of New Zealand (Project number 10/248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 2009 NZ TOT DIET STU; Appel LJ, 2012, ANN EPIDEMIOL, V22, P417, DOI 10.1016/j.annepidem.2012.04.003; Arcand J, 2012, AM J HYPERTENS, V25, P19, DOI 10.1038/ajh.2011.187; Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Faber J, 2012, BEHAV CLIMATE CHANGE; Fahimi S, 2012, AM J HYPERTENS, V25, P17, DOI 10.1038/ajh.2011.183; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; Hawkes C, 2009, NUTR REV, V67, P333, DOI 10.1111/j.1753-4887.2009.00206.x; He FJ, 2012, ANN MED, V44, pS127, DOI 10.3109/07853890.2012.660495; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Holt E, 2011, LANCET, V378, P755, DOI 10.1016/S0140-6736(11)61359-7; Human Nutrition University of Otago, FOOD COST SURV; Institute of Medicine (US) Committee on Strategies to Reduce Sodium Intake, 2010, STRAT RED COD INT US; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Maillot M, 2012, AM J PREV MED, V42, P174, DOI 10.1016/j.amepre.2011.10.009; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; McLean R, 2011, JOINT ANN SCI M AUST; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; NHMRC (National Health and Medical Research Council), 2006, NUTR REF VAL AUSTR N; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Sherzai A, 2012, NUTR REV, V70, P423, DOI 10.1111/j.1753-4887.2012.00490.x; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Statistics New Zealand, 2011, FOOD PRIC IND 2011; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Thomson BM, 2009, BRIT J NUTR, V102, P757, DOI 10.1017/S000711450928901X; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; University of Otago, 2011, FOC NUTR KEY FIND 20; Villanueva T, 2011, CAN MED ASSOC J, V183, pE1229, DOI 10.1503/cmaj.109-4031; WHO, 2012, GUID SOD INT AD CHIL; Wilson Nick, 2007, N Z Med J, V120, pU2665; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; WRAP (The Waste and Resources Action Programme), 2009, HOUS FOOD DRINK WAST; Yusof AS, 2012, ASIAN PAC J CANCER P, V13, P4713, DOI 10.7314/APJCP.2012.13.9.4713	43	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58539	10.1371/journal.pone.0058539	http://dx.doi.org/10.1371/journal.pone.0058539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505532	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500099
J	Collino, S; Montoliu, I; Martin, FPJ; Scherer, M; Mari, D; Salvioli, S; Bucci, L; Ostan, R; Monti, D; Biagi, E; Brigidi, P; Franceschi, C; Rezzi, S				Collino, Sebastiano; Montoliu, Ivan; Martin, Francois-Pierre J.; Scherer, Max; Mari, Daniela; Salvioli, Stefano; Bucci, Laura; Ostan, Rita; Monti, Daniela; Biagi, Elena; Brigidi, Patrizia; Franceschi, Claudio; Rezzi, Serge			Metabolic Signatures of Extreme Longevity in Northern Italian Centenarians Reveal a Complex Remodeling of Lipids, Amino Acids, and Gut Microbiota Metabolism	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; EPOXYEICOSATRIENOIC ACIDS; RHEUMATOID-ARTHRITIS; CALORIC RESTRICTION; CROHNS-DISEASE; FATTY-ACIDS; PLASMA; SPECTROSCOPY; POPULATION; IDENTIFICATION	The aging phenotype in humans has been thoroughly studied but a detailed metabolic profiling capable of shading light on the underpinning biological processes of longevity is still missing. Here using a combined metabonomics approach compromising holistic 1 H-NMR profiling and targeted MS approaches, we report for the first time the metabolic phenotype of longevity in a well characterized human aging cohort compromising mostly female centenarians, elderly, and young individuals. With increasing age, targeted MS profiling of blood serum displayed a marked decrease in tryptophan concentration, while an unique alteration of specific glycerophospholipids and sphingolipids are seen in the longevity phenotype. We hypothesized that the overall lipidome changes specific to longevity putatively reflect centenarians' unique capacity to adapt/respond to the accumulating oxidative and chronic inflammatory conditions characteristic of their extreme aging phenotype. Our data in centenarians support promotion of cellular detoxification mechanisms through specific modulation of the arachidonic acid metabolic cascade as we underpinned increased concentration of 8,9-EpETrE, suggesting enhanced cytochrome P450 (CYP) enzyme activity. Such effective mechanism might result in the activation of an anti-oxidative response, as displayed by decreased circulating levels of 9-HODE and 9-oxoODE, markers of lipid peroxidation and oxidative products of linoleic acid. Lastly, we also revealed that the longevity process deeply affects the structure and composition of the human gut microbiota as shown by the increased extrection of phenylacetylglutamine (PAG) and p-cresol sulfate (PCS) in urine of centenarians. Together, our novel approach in this representative Italian longevity cohort support the hypothesis that a complex remodeling of lipid, amino acid metabolism, and of gut microbiota functionality are key regulatory processes marking exceptional longevity in humans.	[Collino, Sebastiano; Martin, Francois-Pierre J.; Scherer, Max; Rezzi, Serge] Nestle Inst Hlth Sci SA, Prote & Metabon, Lausanne, Switzerland; [Montoliu, Ivan] Nestec Ltd, Appl Math, Nestle Res Ctr, Lausanne, Switzerland; [Mari, Daniela] Univ Milan, Dept Med Sci, Milan, Italy; [Mari, Daniela] Geriatr Unit Ca Grande Fdn Maggiore Policlin Hosp, Milan, Italy; [Salvioli, Stefano; Bucci, Laura; Ostan, Rita; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Salvioli, Stefano; Bucci, Laura; Ostan, Rita; Franceschi, Claudio] Univ Bologna, Interdept Ctr L Galvani, Bologna, Italy; [Monti, Daniela] Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy; [Biagi, Elena; Brigidi, Patrizia] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy	Nestle SA; Nestle SA; University of Milan; University of Bologna; University of Bologna; University of Florence; University of Bologna	Collino, S (corresponding author), Nestle Inst Hlth Sci SA, Prote & Metabon, Campus EPFL, Lausanne, Switzerland.	sebastiano.collino@rd.nestle.com	Salvioli, Stefano/K-6663-2016; Franceschi, Claudio/L-4484-2017; Monti, Daniela/G-9556-2012; Ostan, Rita/K-3074-2018; Mari, Daniela/K-5663-2016	Salvioli, Stefano/0000-0002-6191-1225; Franceschi, Claudio/0000-0001-9841-6386; Monti, Daniela/0000-0001-8651-8123; Ostan, Rita/0000-0002-0299-2811; Mari, Daniela/0000-0002-6950-0789; Martin, Francois-Pierre/0000-0003-1373-5367; Brigidi, Patrizia/0000-0001-8375-6150; Collins, Steve/0000-0002-3997-3374	University of Florence; MIUR	University of Florence; MIUR(Ministry of Education, Universities and Research (MIUR))	The authors are grateful to CEPS and ANNFAS no-profit associations and to Dr. Daniela Follo and Alessandro Ghezzo for the recruitment of DS persons. This research was funded by University of Florence to D. Monti and MIUR (PRIN2006) to D. Monti, CF, and D. Mari. The funding sources have not been involved in the design, analysis or interpretation of the results.	Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Atmon G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/j.mad.2004.08.026; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Baur P, 2011, J PROTEOME RES; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burkle Alexander, 2007, Immun Ageing, V4, P4, DOI 10.1186/1742-4933-4-4; BYRNE GI, 1986, J INTERFERON RES, V6, P389, DOI 10.1089/jir.1986.6.389; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Campbell WB, 2000, TRENDS PHARMACOL SCI, V21, P125, DOI 10.1016/S0165-6147(00)01472-3; Cevenini E, 2008, EXPERT OPIN BIOL TH, V8, P1393, DOI 10.1517/14712598.8.9.1393 ; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Davinelli S, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-9; De Benedictis G, 1998, EUR J HUM GENET, V6, P534, DOI 10.1038/sj.ejhg.5200222; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Dillon EL, 2009, J CLIN ENDOCR METAB, V94, P1630, DOI 10.1210/jc.2008-1564; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Fuchs B, 2005, CLIN BIOCHEM, V38, P925, DOI 10.1016/j.clinbiochem.2005.06.006; Gaskins AJ, 2010, AM J CLIN NUTR, V92, P1461, DOI 10.3945/ajcn.110.000026; Guigoz Y, 2008, CURR OPIN CLIN NUTR, V11, P13, DOI 10.1097/MCO.0b013e3282f2bfdf; GUPTA N, 2011, INFLAMM BOWEL DIS; Hsieh CC, 2004, MECH AGEING DEV, V125, P785, DOI 10.1016/j.mad.2004.07.008; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; Jira W, 1997, CHEM PHYS LIPIDS, V87, P81, DOI 10.1016/S0009-3084(97)00030-3; Jira W, 1998, CHEM PHYS LIPIDS, V91, P1, DOI 10.1016/S0009-3084(97)00095-9; Kummerow FA, 2001, J NUTR BIOCHEM, V12, P602, DOI 10.1016/S0955-2863(01)00181-4; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Maeba R, 2007, J ATHEROSCLER THROMB, V14, P12, DOI 10.5551/jat.14.12; Magni E, 1996, EUR J NEUROL, V3, P198, DOI 10.1111/j.1468-1331.1996.tb00423.x; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Oostendorp M, 2006, CLIN CHEM, V52, P1395, DOI 10.1373/clinchem.2006.069112; Passarino G, 2002, EXP GERONTOL, V37, P1283, DOI 10.1016/S0531-5565(02)00140-7; Patterson D, 2011, MECH AGEING DEV; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pereira SP, 1996, CLIN SCI, V91, P509, DOI 10.1042/cs0910509; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Radmark O, 2003, ARTERIOSCL THROM VAS, V23, P1140, DOI 10.1161/01.ATV.0000082460.58448.01; Rezzi S, 2007, J PROTEOME RES, V6, P4469, DOI 10.1021/pr070431h; Rezzi S, 2009, EXP GERONTOL, V44, P356, DOI 10.1016/j.exger.2009.02.008; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Schieke SM, 2007, CELL METAB, V5, P233, DOI 10.1016/j.cmet.2007.03.005; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212; Siddiqui N, 2003, J LIPID RES, V44, P2406, DOI 10.1194/jlr.D300017-JLR200; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Suliman ME, 2005, AM J CLIN NUTR, V82, P342, DOI 10.1093/ajcn/82.2.342; TAKATA S, 1994, AM J PATHOL, V145, P541; Wang YL, 2007, J PROTEOME RES, V6, P1846, DOI 10.1021/pr060685n; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Wijeyesekera A, 2012, J PROTEOME RES, V11, P2224, DOI 10.1021/pr2010154; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yeboah J, 2010, ARTERIOSCL THROM VAS, V30, P628, DOI 10.1161/ATVBAHA.109.199281	59	175	176	4	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56564	10.1371/journal.pone.0056564	http://dx.doi.org/10.1371/journal.pone.0056564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483888	Green Published, gold			2022-12-25	WOS:000316936100006
J	Ibrahim, AI; El Hassan, AM; Fahal, A; van de Sande, WW				Ibrahim, Anahid Izzat; El Hassan, Ahmed Mohammed; Fahal, Ahmed; van de Sande, Wendy W.			A Histopathological Exploration of the Madurella mycetomatis Grain	PLOS ONE			English	Article							FUNGAL MELANINS; PATHOGENIC FUNGI; ATOMIC-ABSORPTION; METAL-IONS; SPECTROPHOTOMETRY; BIOSYNTHESIS	Although the Madurella mycetomatis grains seem to interfere with the host defense mechanisms and impede the antifungal drugs penetration, yet their histological features are not fully known and hence this study was set out to determine that. The study included 80 patients with confirmed M. mycetomatis eumycetoma. After informed written consent, surgical biopsies were obtained from the excised tissues during the patients' surgical treatment. All sections were stained with haematoxylin and eosin, Grocott's hexamine silver, Periodic Acid-Schiff's, Masson-Fontana, Perl's Prussian Blue, Von-kossa's, Formalin Inducing Fluorescence and Schmorl's stains. Modified bleaching technique was used. The concentrations of Zinc, Copper, Calcium, Iron, Lead, Cobalt and Nickel were determined by Atomic Absorption Spectrophotometer. The M. Mycetomatis grains appeared to consist of lipid, protein and melanin. The melanin was located on the hyphal wall as thick layers. The Zinc, Copper and Calcium concentrations in the grains were four, six, and sixteen folds higher than in normal tissue respectively, the other metals were found in the same concentrations as in normal tissue. In the grains, calcium was located in the melanin vicinity. From this study, it can be concluded that, the grains contain melanin, heavy metals, proteins, lipids and they contribute in the formation of the grain cement matrix. These elements seem to contribute in the organism pathogenicity and might impede the penetration of various anti-fungal agents.	[Ibrahim, Anahid Izzat] Univ Khartoum, Fac Med Lab Sci, Khartoum, Sudan; [El Hassan, Ahmed Mohammed; Fahal, Ahmed] Univ Khartoum, Mycetoma Res Ctr, Khartoum, Sudan; [van de Sande, Wendy W.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	University of Khartoum; University of Khartoum; Erasmus University Rotterdam; Erasmus MC	Fahal, A (corresponding author), Univ Khartoum, Mycetoma Res Ctr, Khartoum, Sudan.	ahfahal@hotmail.com	Fahal, Ahmed H/H-9573-2012; van de Sande, Wendy/AAS-4545-2021	Fahal, Ahmed H/0000-0003-4922-7321; van de Sande, Wendy/0000-0002-8652-8783; Mohamed Elhassan, Ahmed/0000-0003-0740-0499				Ahmed AOA, 2004, LANCET INFECT DIS, V4, P566, DOI 10.1016/S1473-3099(04)01131-4; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; CAESARTONTHAT TC, 1995, APPL ENVIRON MICROB, V61, P1968, DOI 10.1128/AEM.61.5.1968-1975.1995; EL Hassan AM, 1994, SUDAN MED J, V32, P23; ELINOV NP, 1984, ZBL BAKT-INT J MED M, V257, P246, DOI 10.1016/S0174-3031(84)80079-7; Erb-Downward JR, 2006, FUTURE MICROBIOL, V1, P219, DOI 10.2217/17460913.1.2.219; Fahal AH, 2004, T ROY SOC TROP MED H, V98, P3, DOI 10.1016/S0035-9203(03)00009-9; Fahal AH, 2011, KHARTOUM MED J, Vthird, P565; FINDLAY GH, 1980, MYCOPATHOLOGIA, V70, P61, DOI 10.1007/BF00704324; FINDLAY GH, 1977, BRIT J DERMATOL, V97, P497, DOI 10.1111/j.1365-2133.1977.tb14125.x; Fogarty RV, 1996, ENZYME MICROB TECH, V19, P311, DOI 10.1016/0141-0229(96)00002-6; Hamilton AJ, 2000, J MED MICROBIOL, V51, P89; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; Hong L, 2004, PHOTOCHEM PHOTOBIOL, V80, P477, DOI 10.1562/0031-8655(2004)080<0477:BOMITM>2.0.CO;2; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Roderick NM, 1992, MICROBIAL INFECT MUI, P333; Ropek D, 2002, J INVERTEBR PATHOL, V79, P123, DOI 10.1016/S0022-2011(02)00013-7; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Steven A, 1996, THEORY PRACTICE HIST, P250; Turan S, 2001, J TROP PEDIATRICS, V47, P81, DOI 10.1093/tropej/47.2.81; van de Sande WWJ, 2007, MICROBES INFECT, V9, P1114, DOI 10.1016/j.micinf.2007.05.015; WETHERED DB, 1987, J MED VET MYCOL, V25, P39	24	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57774	10.1371/journal.pone.0057774	http://dx.doi.org/10.1371/journal.pone.0057774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483927	Green Published, gold			2022-12-25	WOS:000316936100043
J	Jensen, TJ; Zwiefelhofer, T; Tim, RC; Dzakula, Z; Kim, SK; Mazloom, AR; Zhu, ZY; Tynan, J; Lu, T; McLennan, G; Palomaki, GE; Canick, JA; Oeth, P; Deciu, C; van den Boom, D; Ehrich, M				Jensen, Taylor J.; Zwiefelhofer, Tricia; Tim, Roger C.; Dzakula, Zeljko; Kim, Sung K.; Mazloom, Amin R.; Zhu, Zhanyang; Tynan, John; Lu, Tim; McLennan, Graham; Palomaki, Glenn E.; Canick, Jacob A.; Oeth, Paul; Deciu, Cosmin; van den Boom, Dirk; Ehrich, Mathias			High-Throughput Massively Parallel Sequencing for Fetal Aneuploidy Detection from Maternal Plasma	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; DOWN-SYNDROME; DNA METHYLATION; LIGATION	Background: Circulating cell-free (ccf) fetal DNA comprises 3-20% of all the cell-free DNA present in maternal plasma. Numerous research and clinical studies have described the analysis of ccf DNA using next generation sequencing for the detection of fetal aneuploidies with high sensitivity and specificity. We sought to extend the utility of this approach by assessing semi-automated library preparation, higher sample multiplexing during sequencing, and improved bioinformatic tools to enable a higher throughput, more efficient assay while maintaining or improving clinical performance. Methods: Whole blood (10mL) was collected from pregnant female donors and plasma separated using centrifugation. Ccf DNA was extracted using column-based methods. Libraries were prepared using an optimized semi-automated library preparation method and sequenced on an Illumina HiSeq2000 sequencer in a 12-plex format. Z-scores were calculated for affected chromosomes using a robust method after normalization and genomic segment filtering. Classification was based upon a standard normal transformed cutoff value of z = 3 for chromosome 21 and z = 3.95 for chromosomes 18 and 13. Results: Two parallel assay development studies using a total of more than 1900 ccf DNA samples were performed to evaluate the technical feasibility of automating library preparation and increasing the sample multiplexing level. These processes were subsequently combined and a study of 1587 samples was completed to verify the stability of the process-optimized assay. Finally, an unblinded clinical evaluation of 1269 euploid and aneuploid samples utilizing this high-throughput assay coupled to improved bioinformatic procedures was performed. We were able to correctly detect all aneuploid cases with extremely low false positive rates of 0.09%, <0.01%, and 0.08% for trisomies 21, 18, and 13, respectively. Conclusions: These data suggest that the developed laboratory methods in concert with improved bioinformatic approaches enable higher sample throughput while maintaining high classification accuracy.	[Jensen, Taylor J.; Zwiefelhofer, Tricia; Tim, Roger C.; Dzakula, Zeljko; Kim, Sung K.; Mazloom, Amin R.; Zhu, Zhanyang; Tynan, John; Lu, Tim; Oeth, Paul; Deciu, Cosmin] Sequenom Inc, Res & Dev, Ctr Mol Med, San Diego, CA USA; [McLennan, Graham; van den Boom, Dirk; Ehrich, Mathias] Sequenom Inc, Res & Dev, San Diego, CA USA; [Palomaki, Glenn E.; Canick, Jacob A.] Brown Univ, Women & Infants Hosp, Alpert Med Sch, Providence, RI USA	Sequenom; Sequenom; Brown University; Women & Infants Hospital Rhode Island	Ehrich, M (corresponding author), Sequenom Inc, Res & Dev, San Diego, CA USA.	mehrich@sequenom.com			Sequenom, Inc.	Sequenom, Inc.	This study was funded by Sequenom, Inc. The funding organization had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Canick JA, 2012, PRENATAL DIAG, V32, P730, DOI 10.1002/pd.3892; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Della Ragione F, 2010, J MOL DIAGN, V12, P797, DOI 10.2353/jmoldx.2010.090199; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Faas BHW, 2012, EXPERT OPIN BIOL TH, V12, pS19, DOI 10.1517/14712598.2012.670632; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Patsalis PC, 2012, EXPERT OPIN BIOL TH, V12, pS155, DOI 10.1517/14712598.2012.674108; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922	27	77	116	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57381	10.1371/journal.pone.0057381	http://dx.doi.org/10.1371/journal.pone.0057381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483908	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100025
J	Sartori, A; Mano, CM; Mantovani, MC; Dyszy, FH; Massari, J; Tokikawa, R; Nascimento, OR; Nantes, IL; Bechara, EJH				Sartori, Adriano; Mano, Camila M.; Mantovani, Mariana C.; Dyszy, Fabio H.; Massari, Julio; Tokikawa, Rita; Nascimento, Otaciro R.; Nantes, Iseli L.; Bechara, Etelvino J. H.			Ferricytochrome c Directly Oxidizes Aminoacetone to Methylglyoxal, a Catabolite Accumulated in Carbonyl Stress	PLOS ONE			English	Article							HYDROXYL-RADICAL GENERATION; ADVANCED GLYCATION ENDPRODUCTS; SENSITIVE AMINE OXIDASE; RAT-LIVER MITOCHONDRIA; CYTOCHROME-C; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; DIABETES-MELLITUS; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM	Age-related diseases are associated with increased production of reactive oxygen and carbonyl species such as methylglyoxal. Aminoacetone, a putative threonine catabolite, is reportedly known to undergo metal-catalyzed oxidation to methylglyoxal, NH4+ ion, and H2O2 coupled with (i) permeabilization of rat liver mitochondria, and (ii) apoptosis of insulin-producing cells. Oxidation of aminoacetone to methylglyoxal is now shown to be accelerated by ferricytochrome c, a reaction initiated by one-electron reduction of ferricytochrome c by aminoacetone without amino acid modifications. The participation of O-2(center dot-) and HO center dot radical intermediates is demonstrated by the inhibitory effect of added superoxide dismutase and Electron Paramagnetic Resonance spin-trapping experiments with 5,5'-dimethyl-1-pyrroline-N-oxide. We hypothesize that two consecutive one-electron transfers from aminoacetone (E-0 values = -0.51 and -1.0 V) to ferricytochrome c (E-0 = 0.26 V) may lead to aminoacetone enoyl radical and, subsequently, imine aminoacetone, whose hydrolysis yields methylglyoxal and NH4+ ion. In the presence of oxygen, aminoacetone enoyl and O-2(center dot-) radicals propagate aminoacetone oxidation to methylglyoxal and H2O2. These data endorse the hypothesis that aminoacetone, putatively accumulated in diabetes, may directly reduce ferricyt c yielding methylglyoxal and free radicals, thereby triggering redox imbalance and adverse mitochondrial responses.	[Sartori, Adriano; Mano, Camila M.; Massari, Julio; Tokikawa, Rita; Bechara, Etelvino J. H.] Univ Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Sartori, Adriano] Univ Fed Sao Paulo, Dept Bioquim & Biol Mol, Sao Paulo, Brazil; [Mantovani, Mariana C.; Bechara, Etelvino J. H.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Sao Paulo, Brazil; [Dyszy, Fabio H.; Nascimento, Otaciro R.] Univ Sao Paulo, Dept Fis & Informat, Sao Paulo, Brazil; [Nantes, Iseli L.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Bechara, EJH (corresponding author), Univ Sao Paulo, Dept Bioquim, Sao Paulo, Brazil.	ejhbechara@gmail.com	Nantes, Iseli Lourenço/B-9517-2012; Bechara, Etelvino JH/AAN-1136-2021; Bechara, Etelvino JH/M-6251-2013	Nantes, Iseli Lourenço/0000-0003-1434-3154; Bechara, Etelvino JH/0000-0001-9526-2529; Bechara, Etelvino JH/0000-0001-9526-2529	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT Processos Redox em Biomedicina (Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT Processos Redox em Biomedicina (Brazil)	This work was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and the INCT Processos Redox em Biomedicina (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, DIABETES OBES METAB, V9, P233, DOI 10.1111/j.1463-1326.2006.00595.x; Ahmed N, 2002, BIOCHEM J, V364, P1; BAADER WJ, 1985, J BIOL CHEM, V260, P217; Banach MS, 2009, CHEM-BIOL INTERACT, V178, P324, DOI 10.1016/j.cbi.2008.10.003; Bechara EJH, 2007, COMP BIOCHEM PHYS C, V146, P88, DOI 10.1016/j.cbpc.2006.07.004; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Best L, 1999, J MEMBRANE BIOL, V167, P65, DOI 10.1007/s002329900472; BIRD MI, 1984, BIOCHIM BIOPHYS ACTA, V802, P229, DOI 10.1016/0304-4165(84)90166-1; Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d; BRITIGAN BE, 1991, BIOCHIM BIOPHYS ACTA, V1075, P213, DOI 10.1016/0304-4165(91)90269-M; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; BURKITT MJ, 1991, P NATL ACAD SCI USA, V88, P8440, DOI 10.1073/pnas.88.19.8440; CASTRO CE, 1986, J AM CHEM SOC, V108, P4179, DOI 10.1021/ja00274a055; Chan WH, 2008, J CELL BIOCHEM, V103, P1144, DOI 10.1002/jcb.21489; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; CILENTO G, 1995, FREE RADICAL BIO MED, V19, P103, DOI 10.1016/0891-5849(95)00002-F; DAVISON AJ, 1984, ARCH BIOCHEM BIOPHYS, V233, P761, DOI 10.1016/0003-9861(84)90504-6; Deng YL, 1999, ANAL BIOCHEM, V270, P97, DOI 10.1006/abio.1999.4058; Duran-Jimenez B, 2009, DIABETES, V58, P2893, DOI 10.2337/db09-0320; Dutra F, 2005, CHEM RES TOXICOL, V18, P755, DOI 10.1021/tx049655u; Dutra F, 2004, ARCH BIOCHEM BIOPHYS, V430, P284, DOI 10.1016/j.abb.2004.06.029; Dutra F, 2003, FREE RADICAL RES, V37, P1113, DOI 10.1080/10715760310001604116; Dutra F, 2001, CHEM RES TOXICOL, V14, P1323, DOI 10.1021/tx015526r; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Estevam ML, 2004, J BIOL CHEM, V279, P39214, DOI 10.1074/jbc.M402093200; Fleming T, 2012, DIABETOLOGIA, V55, P1151, DOI 10.1007/s00125-012-2452-1; Garcia-Roves Pablo M., 2011, Archives of Physiology and Biochemistry, V117, P177, DOI 10.3109/13813455.2011.584538; GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122; Gokturk C, 2003, BBA-PROTEINS PROTEOM, V1647, P88, DOI 10.1016/S1570-9639(03)00064-5; Guerranti R, 2001, BBA-GEN SUBJECTS, V1568, P45, DOI 10.1016/S0304-4165(01)00197-0; HANNA PM, 1992, CHEM RES TOXICOL, V5, P109, DOI 10.1021/tx00025a019; Hepworth JD, 1976, ORG SYNTH, V45, P1; Hiraku Y, 1999, FREE RADICAL RES, V31, P389, DOI 10.1080/10715769900300961; House JD, 2001, AM J PHYSIOL-ENDOC M, V281, pE1300, DOI 10.1152/ajpendo.2001.281.6.E1300; Kalapos Miklos Peter, 2008, Drug Metabolism and Drug Interactions, V23, P69; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; KALAPOS MP, 1991, BIOCHIM BIOPHYS ACTA, V1092, P284, DOI 10.1016/S0167-4889(97)90002-1; KALAPOS MP, 1992, BIOCHEM EDUC, V20, P27, DOI 10.1016/0307-4412(92)90012-B; Kalapos MP, 2012, DIABETES RES CLIN PR, DOI S0168-8227(12)00426-3.10.1016; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Krautwald M, 2010, EXP GERONTOL, V45, P744, DOI 10.1016/j.exger.2010.03.001; Lee C, 1998, J BIOL CHEM, V273, P25272, DOI 10.1074/jbc.273.39.25272; LEONCINI G, 1980, FEBS LETT, V117, P17, DOI 10.1016/0014-5793(80)80903-3; LIOTTI FS, 1989, INT J CANCER, V43, P1145, DOI 10.1002/ijc.2910430630; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V254, P547, DOI 10.1016/0003-9861(87)90136-6; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MONTEIRO HP, 1989, ARCH BIOCHEM BIOPHYS, V271, P206, DOI 10.1016/0003-9861(89)90271-3; Mugnol KCU, 2008, BIOPHYS J, V94, P4066, DOI 10.1529/biophysj.107.116483; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Nantes IL, 2000, FREE RADICAL BIO MED, V28, P786, DOI 10.1016/S0891-5849(00)00170-2; Nohara Y, 2002, CHEM PHARM BULL, V50, P179, DOI 10.1248/cpb.50.179; O'Sullivan J, 2004, NEUROTOXICOLOGY, V25, P303, DOI 10.1016/S0161-813X(03)00117-7; Park YS, 2003, FREE RADICAL RES, V37, P205, DOI 10.1080/1071576021000041005; Rebelato E, 2010, METABOLISM, V59, P409, DOI 10.1016/j.metabol.2009.08.010; Rinaldi TA, 2004, FREE RADICAL BIO MED, V36, P802, DOI 10.1016/j.freeradbiomed.2003.12.002; Rocha MEM, 2000, FREE RADICAL BIO MED, V29, P1272, DOI 10.1016/S0891-5849(00)00437-8; Rodrigues T, 2007, J BIOL CHEM, V282, P25577, DOI 10.1074/jbc.M700009200; Sartori A, 2008, CHEM RES TOXICOL, V21, P1841, DOI 10.1021/tx8001753; Shang Y, 2012, ENVIRON SCI TECHNOL, V46, P2935, DOI 10.1021/es203032v; Sheader EA, 2001, BIOCHEM PHARMACOL, V61, P1381, DOI 10.1016/S0006-2952(01)00603-7; Singh M, 2010, J ALZHEIMERS DIS, V21, P229, DOI 10.3233/JAD-2010-091729; Soares CO, 2012, ARCH BIOCHEM BIOPHYS, V528, P103, DOI 10.1016/j.abb.2012.09.005; Soares CO, 2011, FREE RADICAL BIO MED, V50, P1760, DOI 10.1016/j.freeradbiomed.2011.03.033; Stoll S, 2007, BIOL MAGN RESON, V27, P299; Toledo JC, 2012, CHEM RES TOXICOL, V25, P975, DOI 10.1021/tx300042g; VanderJagt DL, 1997, BIOCHEM PHARMACOL, V53, P1133, DOI 10.1016/S0006-2952(97)00090-7; Wallace JW, 1982, J BIOL CHEM, V257, P4966; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Yamazaki I, 1993, QUIM NOVA, V16, P365; YIM HS, 1995, J BIOL CHEM, V270, P28228	73	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57790	10.1371/journal.pone.0057790	http://dx.doi.org/10.1371/journal.pone.0057790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483930	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100046
J	Stoll, SJ; Bartsch, S; Kroll, J				Stoll, Sandra J.; Bartsch, Susanne; Kroll, Jens			HOXC9 Regulates Formation of Parachordal Lymphangioplasts and the Thoracic Duct in Zebrafish via Stabilin 2	PLOS ONE			English	Article							ENDOTHELIAL-CELL QUIESCENCE; VASCULAR MORPHOGENESIS; LYMPHATIC DEVELOPMENT; TRANSCRIPTION FACTOR; ANGIOGENESIS; RECEPTOR; GENES; LYMPHANGIOGENESIS; IDENTIFICATION; INHIBITION	HOXC9 belongs to the family of homeobox transcription factors, which are regulators of body patterning and development. HOXC9 acts as a negative regulator on blood endothelial cells but its function on lymphatic vessel development has not been studied. The hyaluronan receptor homologs stabilin 1 and stabilin 2 are expressed in endothelial cells but their role in vascular development is poorly understood. This study was aimed at investigating the function of HOXC9, stabilin 2 and stabilin 1 in lymphatic vessel development in zebrafish and in endothelial cells. Morpholino-based expression silencing of HOXC9 repressed parachordal lymphangioblast assembly and thoracic duct formation in zebrafish. HOXC9 positively regulated stabilin 2 expression in zebrafish and in HUVECs and expression silencing of stabilin 2 phenocopied the HOXC9 morphant vascular phenotype. This effect could be compensated by HOXC9 mRNA injection in stabilin 2 morphant zebrafish embryos. Stabilin 1 also regulated parachordal lymphangioblast and thoracic duct formation in zebrafish but acts independently of HOXC9. On a cellular level stabilin 1 and stabilin 2 regulated endothelial cell migration and in-gel sprouting angiogenesis in endothelial cells. HOXC9 was identified as novel transcriptional regulator of parachordal lymphangioblast assembly and thoracic duct formation in zebrafish that acts via stabilin 2. Stabilin 1, which acts independently of HOXC9, has a similar function in zebrafish and both receptors control important cellular processes in endothelial cells.	[Stoll, Sandra J.; Bartsch, Susanne; Kroll, Jens] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, Mannheim, Germany; [Kroll, Jens] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Kroll, J (corresponding author), Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, Mannheim, Germany.	jens.kroll@medma.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB/TR23, KR1887/5-1]; German Cardiac Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cardiac Society	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de) (SFB/TR23, project Z5, to J.K.) and by the German Cardiac Society (http://dgk.org/)( to S.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.KR1887/5-1	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Butler MG, 2009, BIRTH DEFECTS RES C, V87, P222, DOI 10.1002/bdrc.20155; Cantile M, 2008, NUTR METAB CARDIOVAS, V18, P651, DOI 10.1016/j.numecd.2008.08.001; Choi I, 2012, ANGIOGENESIS; ELGJO RF, 1975, CELL TISSUE RES, V162, P49; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Hirose Y, 2012, P NATL ACAD SCI USA, V109, P4263, DOI 10.1073/pnas.1117560109; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jorgens K, 2011, DEUT MED WOCHENSCHR, V136, P1865, DOI 10.1055/s-0031-1286357; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; Karikoski M, 2009, EUR J IMMUNOL, V39, P3477, DOI 10.1002/eji.200939896; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kzhyshkowska J, 2010, THESCIENTIFICWORLDJO, V10, P2039, DOI 10.1100/tsw.2010.189; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee GY, 2011, J CONTROL RELEASE, V155, P211, DOI 10.1016/j.jconrel.2011.07.010; Nacak TG, 2007, CIRC RES, V100, P1155, DOI 10.1161/01.RES.0000265844.56493.ac; Park SY, 2009, FEBS LETT, V583, P1375, DOI 10.1016/j.febslet.2009.03.046; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Pruett ND, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-93; Salmi M, 2004, BLOOD, V104, P3849, DOI 10.1182/blood-2004-01-0222; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Stoll SJ, 2011, CIRC RES, V108, P1367, DOI 10.1161/CIRCRESAHA.111.244095; Stoll SJ, 2012, TRENDS CARDIOVAS MED, V22, P7, DOI 10.1016/j.tcm.2012.06.002; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wong KS, 2009, DEV DYNAM, V238, P1836, DOI 10.1002/dvdy.21990; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58311	10.1371/journal.pone.0058311	http://dx.doi.org/10.1371/journal.pone.0058311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484014	gold, Green Published, Green Submitted			2022-12-25	WOS:000316936100104
J	Weber, M; Lupp, C; Stein, P; Kreft, A; Bopp, T; Wehler, TC; Schmitt, E; Schild, H; Radsak, MP				Weber, Michael; Lupp, Corinna; Stein, Pamela; Kreft, Andreas; Bopp, Tobias; Wehler, Thomas C.; Schmitt, Edgar; Schild, Hansjoerg; Radsak, Markus P.			Mechanisms of Cyclic Nucleotide Phosphodiesterases in Modulating T Cell Responses in Murine Graft-versus-Host Disease	PLOS ONE			English	Article							DENDRITIC CELLS; ADENOSINE-MONOPHOSPHATE; REGULATORY CELLS; SUPPRESSION; TOLERANCE; INHIBITION; EXPRESSION; RECIPIENTS; INDUCTION; DELETION	Graft-versus-host disease (GvHD) is a key contributor to the morbidity and mortality after allogeneic hematopoetic stem cell transplantation (HSCT). Regulatory Foxp3(+)CD4(+) T cells (T-reg) suppress conventional T cell activation and can control GvHD. In our previous work, we demonstrate that a basic mechanism of T-reg mediated suppression occurs by the transfer of cyclic adenosine monophosphate (cAMP) to responder cells. Whether this mechanism is relevant for T-reg mediated suppression of GvHD is currently unknown. To address this question, bone marrow and T cells from C57BL/6 mice were transferred into lethally irradiated BALB/c recipients, and the course of GvHD and survival were monitored. Transplanted recipients developed severe GvHD that was strongly ameliorated by the transfer of donor T-reg cells. Towards the underlying mechanisms, in vitro studies revealed that T-reg communicated with DCs via gap junctions, resulting in functional inactivation of DC by a metabolic pathway involving cAMP that is modulated by the phosphodiesterase (PDE) 4 inhibitor rolipram. PDE2 or PDE3 inhibitors as well as rolipram suppressed allogeneic T cell activation, indirectly by enhancing T-reg mediated suppression of DC activation and directly by inhibiting responder T cell proliferation. In line with this, we observed a cooperative suppression of GvHD upon T-reg transfer and additional rolipram treatment. In conclusion, we propose that an important pathway of T-reg mediated control of GvHD is based on a cAMP dependent mechanism. These data provide the basis for future concepts to manipulate allogeneic T cell responses to prevent GvHD.	[Weber, Michael; Lupp, Corinna; Stein, Pamela; Bopp, Tobias; Schmitt, Edgar; Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Immunol, D-55122 Mainz, Germany; [Kreft, Andreas; Wehler, Thomas C.] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Pathol, D-55122 Mainz, Germany; [Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 3, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Radsak, MP (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 3, D-55122 Mainz, Germany.	radsak@uni-mainz.de	Wehler, Thomas Christian/AAY-6362-2020; Bopp, Tobias/A-4328-2018; Radsak, Markus P/L-3651-2013	Bopp, Tobias/0000-0002-3232-8065; Radsak, Markus P/0000-0002-3991-5721	Deutsche Forschungsgemeinschaft [Ra988/4-2]; International Graduate School of Immunotherapy [GRK 1043]; "Forschungszentrum Immunologie (FZI)'' of the University medical center;  [SFB TR52 TPA1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School of Immunotherapy; "Forschungszentrum Immunologie (FZI)'' of the University medical center; 	This work was supported by grants from the Deutsche Forschungsgemeinschaft to M. P. R. and H. S. (Ra988/4-2), SFB TR52 TPA1 (T. B. and E. S.), the GRK 1043 International Graduate School of Immunotherapy (E. S. and T. B.), "Forschungszentrum Immunologie (FZI)'' of the University medical center (H. S., E. S. and T. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Bopp T, 2009, J IMMUNOL, V182, P4017, DOI 10.4049/jimmunol.0803310; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fassbender M, 2010, CELL IMMUNOL, V265, P91, DOI 10.1016/j.cellimm.2010.07.007; Fehr T, 2005, EUR J IMMUNOL, V35, P2679, DOI 10.1002/eji.200526190; Feng G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002099; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Kurtz J, 2004, BLOOD, V103, P4336, DOI 10.1182/blood-2003-08-2642; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; O'Shaughnessy MJ, 2007, BIOL BLOOD MARROW TR, V13, P530, DOI 10.1016/j.bbmt.2007.01.071; Onizuka S, 1999, CANCER RES, V59, P3128; Ring S, 2010, J ALLERGY CLIN IMMUN, V125, P237, DOI 10.1016/j.jaci.2009.10.025; Rowe V, 2006, BLOOD, V108, P2485, DOI 10.1182/blood-2006-04-016063; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sela U, 2011, J EXP MED, V208, P2489, DOI 10.1084/jem.20110466; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Tawara I, 2010, J IMMUNOL, V185, P3866, DOI 10.4049/jimmunol.1001625; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; Vela-Ojeda J, 2010, STEM CELLS DEV, V19, P333, DOI 10.1089/scd.2009.0216; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yi TS, 2011, J IMMUNOL, V186, P2739, DOI 10.4049/jimmunol.1002939; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zhai YA, 2006, J IMMUNOL, V176, P5988, DOI 10.4049/jimmunol.176.10.5988	41	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58110	10.1371/journal.pone.0058110	http://dx.doi.org/10.1371/journal.pone.0058110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483980	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100077
J	Rotem-Bamberger, S; Katz, C; Friedler, A				Rotem-Bamberger, Shahar; Katz, Chen; Friedler, Assaf			Regulation of ASPP2 Interaction with p53 Core Domain by an Intramolecular Autoinhibitory Mechanism	PLOS ONE			English	Article							NF-KAPPA-B; BCL-2 FAMILY PROTEINS; DESIGNED PEPTIDE; SH3 DOMAINS; CELL-DEATH; RESCUE; CANCER; 53BP2; MUTANTS; PROLINE	ASPP2 is a key protein in regulating apoptosis both in p53-dependent and-independent pathways. The C-terminal part of ASPP2 contains four ankyrin repeats and an SH3 domain (Ank-SH3) that mediate the interactions of ASPP2 with apoptosis related proteins such as p53, Bcl-2 and the p65 subunit of NF kappa B. p53 core domain (p53CD) binds the n-src loop and the RT loop of ASPP2 SH3. ASPP2 contains a disordered proline rich domain (ASPP2 Pro) that forms an intramolecular autoinhibitory interaction with the Ank-SH3 domains. Here we show how this intramolecular interaction affects the intermolecular interactions of ASPP2 with p53, Bcl-2 and NFkB. We used biophysical methods to obtain better understanding of the relationship between ASPP2 and its partners for getting a comprehensive view on ASPP2 pathways. Fluorescence anisotropy competition experiments revealed that both ASPP2 Pro and p53CD competed for binding the n-src loop of the ASPP2 SH3, indicating regulation of p53CD binding to this loop by ASPP2 Pro. Peptides derived from the ASPP2-binding interface of Bcl-2 did not compete with p53CD or NFkB peptides for binding the ASPP2 n-src loop. However, p53CD displaced the NF kappa B peptide (residues 303-332) from its complex with ASPP2 Ank-SH3, indicating that NF kappa B 303-332 and p53CD bind a partly overlapping site in ASPP2 SH3, mostly in the RT loop. These results are in agreement with previous docking studies, which showed that ASPP2 Ank-SH3 binds Bcl-2 and NF kappa B mostly via distinct sites from p53. However they show some overlap between the binding sites of p53CD and NF kappa B in ASPP2 Ank-SH3. Our results provide experimental evidence that the intramolecular interaction in ASPP2 regulates its binding to p53CD and that ASPP2 Ank-SH3 binds Bcl-2 and NF kappa B via distinct sites.	[Rotem-Bamberger, Shahar; Katz, Chen; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Friedler, A (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	assaf.friedler@mail.huji.ac.il			Israeli Ministry of Health; European Research Council under the European Community/ERC [203413]	Israeli Ministry of Health; European Research Council under the European Community/ERC(European Research Council (ERC))	AF was supported by a grant from the Israeli Ministry of Health and by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement nu 203413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Benyamini H, 2011, J MOL RECOGNIT, V24, P266, DOI 10.1002/jmr.1048; Benyamini H, 2009, PROTEINS, V77, P602, DOI 10.1002/prot.22473; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bouchet BP, 2006, CRIT REV ONCOL HEMAT, V58, P190, DOI 10.1016/j.critrevonc.2005.10.005; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Friedler A, 2004, J MOL BIOL, V336, P187, DOI 10.1016/j.jmb.2003.12.005; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Kampa KM, 2009, CELL CYCLE, V8, P2871, DOI 10.4161/cc.8.18.9474; Katz C, 2008, P NATL ACAD SCI USA, V105, P12277, DOI 10.1073/pnas.0711269105; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu WK, 2010, ONKOLOGIE, V33, P500, DOI 10.1159/000319692; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Rotem S, 2007, BIOCHEM SOC T, V35, P966, DOI 10.1042/BST0350966; Rotem S, 2008, J BIOL CHEM, V283, P18990, DOI 10.1074/jbc.M708717200; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Saksela K, 2012, FEBS LETT; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Takahashi N, 2005, GENES CELLS, V10, P803, DOI 10.1111/j.1365-2443.2005.00878.x; Tidow H, 2007, J MOL BIOL, V371, P948, DOI 10.1016/j.jmb.2007.05.024; Tidow H, 2006, J BIOL CHEM, V281, P32526, DOI 10.1074/jbc.M604725200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yang JP, 1999, ONCOGENE, V18, P5177, DOI 10.1038/sj.onc.1202904; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhao J, 2010, HEPATOLOGY, V51, P142, DOI 10.1002/hep.23247	39	15	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58470	10.1371/journal.pone.0058470	http://dx.doi.org/10.1371/journal.pone.0058470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472201	gold, Green Published, Green Submitted			2022-12-25	WOS:000315637900147
J	Yang, HY; Lu, KC; Lee, HS; Huang, SM; Lin, YF; Wu, CC; Salter, DM; Su, SL				Yang, Hsin-Yi; Lu, Kuo-Cheng; Lee, Herng-Sheng; Huang, Shih-Ming; Lin, Yuh-Feng; Wu, Chia-Chao; Salter, Donald M.; Su, Sui-Lung			Role of the Functional Toll-Like Receptor-9 Promoter Polymorphism (-1237T/C) in Increased Risk of End-Stage Renal Disease: A Case-Control Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; NUTRITIONAL-STATUS; PROSPECTIVE COHORT; HUMAN TLR9; GENE; TOLL-LIKE-RECEPTOR-9; MORTALITY; CPG; INTERLEUKIN-6	Inflammation induced by infectious and noninfectious triggers in the kidney may lead to end stage renal disease (ESRD). Toll-like receptor 9 (TLR-9) a receptor for CpG DNA is involved in activation of immune cells in renal disease and may contribute to chronic inflammatory disease progression through an interleukin-6 (IL-6) dependent pathway. Previous studies indicate that -1237T/C confers regulatory effects on TLR-9 transcription. To date the effect of TLR-9 polymorphisms on ESRD remains unknown. We performed a case-control study and genotyped 630 ESRD patients and 415 controls for -1237T/C, -1486T/C and 1635G/A by real-time PCR assays and assessed plasma concentration of IL-6 by ELISA. Haplotype association analysis was performed using the Haploview package. A luciferase reporter assay and real-time PCR were used to test the function of the -1237T/C promoter polymorphism. A significant association between -1237T/C in TLR-9 and ESRD was identified. The TCA, TTA and CCA haplotype of TLR-9 were associated with ESRD. ESRD patients carrying -1237TC had a higher mean plasma IL-6 level when compared with -1237TT. The TLR-9 transcriptional activity of the variant -1237CC allele is higher than the -1237TT allele. The results indicate that in a Han Chinese population the presence of the C allele of 1237T/C in the TLR-9 gene increases susceptibility towards development of ESRD. In vitro studies demonstrate that -1237T/C may be involved in the development of ESRD through transcriptional modulation of TLR-9.	[Yang, Hsin-Yi; Su, Sui-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lu, Kuo-Cheng] Fu Jen Catholic Univ, Sch Med, Cardinal Tien Hosp, Div Nephrol,Dept Med, New Taipei City, Taiwan; [Lee, Herng-Sheng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Lin, Yuh-Feng] Taipei Med Univ, Grad Inst Clin Med, Shuang Ho Hosp, Div Nephrol,Dept Med, New Taipei City, Taiwan; [Lin, Yuh-Feng; Wu, Chia-Chao] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Salter, Donald M.] Univ Edinburgh, Ctr Mol Med, MRC IGMM, Edinburgh, Midlothian, Scotland	National Defense Medical Center; Cardinal Tien Hospital; Fu Jen Catholic University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; University of Edinburgh	Su, SL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	a131419@gmail.com		Wu, Chia-Chao/0000-0002-8772-011X; Su, Sui-Lung/0000-0003-3122-1116	National Science Council; National Defense Medical Center; Tri-Service General Hospital; Cardinal Tien Hospital, Taiwan, ROC [NSC99-2314-B-016-001, NSC 99-2815-C-016-002-B, TSGH-C100-007-009-10-S03, CTH- NC10007, MAB101-29]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Center; Tri-Service General Hospital; Cardinal Tien Hospital, Taiwan, ROC	This study was supported by grants from the National Science Council, National Defense Medical Center, Tri-Service General Hospital and Cardinal Tien Hospital, Taiwan, ROC (NSC99-2314-B-016-001, NSC 99-2815-C-016-002-B, TSGH-C100-007-009-10-S03, CTH- NC10007, MAB101-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler S, 2006, ETHNIC DIS, V16; Anders HJ, 2004, FASEB J, V18, P534, DOI 10.1096/fj.03-0646fje; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028256; Dalpke A, 2002, BIODRUGS, V16, P419, DOI 10.2165/00063030-200216060-00003; De Jager PL, 2006, ARTHRITIS RHEUM, V54, P1279, DOI 10.1002/art.21755; Eleftheriadis Theodoros, 2009, Inflammation & Allergy Drug Targets, V8, P191; Faresjo T, 2010, INT J ENV RES PUB HE, V7, P325, DOI 10.3390/ijerph7010325; Gama-Axelsson T, 2012, CLIN J AM SOC NEPHRO, V7, P1446, DOI 10.2215/CJN.10251011; Giachelia M, 2012, LEUKEMIA LYMPHOMA, V53, P411, DOI 10.3109/10428194.2011.621566; Hamann L, 2004, J IMMUNOL METHODS, V285, P281, DOI 10.1016/j.jim.2003.12.005; Hasuike Y, 2009, AM J NEPHROL, V30, P389, DOI 10.1159/000235687; Holla LI, 2010, J CLIN PERIODONTOL, V37, P152, DOI 10.1111/j.1600-051X.2009.01523.x; Jansen MAM, 2001, J AM SOC NEPHROL, V12, P157, DOI 10.1681/ASN.V121157; Kikuchi K, 2005, J AUTOIMMUN, V24, P347, DOI 10.1016/j.jaut.2005.03.002; Koc M, 2011, NEPHROL DIAL TRANSPL, V26, P955, DOI 10.1093/ndt/gfq500; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Krayenbuehl PA, 2010, EUR J GASTROEN HEPAT, V22, P835, DOI 10.1097/MEG.0b013e3283322067; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Lange NE, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-26; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Ljungman P, 2009, THROMB RES, V124, P57, DOI 10.1016/j.thromres.2008.10.009; Lu KC, 2011, TOHOKU J EXP MED, V225, P109, DOI 10.1620/tjem.225.109; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Ng MW, 2005, RHEUMATOLOGY, V44, P1456, DOI 10.1093/rheumatology/kei120; Novak N, 2007, ALLERGY, V62, P766, DOI 10.1111/j.1398-9995.2007.01358.x; Pahl MV, 2010, NEPHROL DIAL TRANSPL, V25, P205, DOI 10.1093/ndt/gfp397; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Schwartz DA, 2005, CLIN INFECT DIS, V41, pS403, DOI 10.1086/431985; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Smith KD, 2009, CURR OPIN NEPHROL HY, V18, P189, DOI 10.1097/MNH.0b013e32832a1d5f; Soriano-Sarabia N, 2008, JAIDS-J ACQ IMM DEF, V49, P128, DOI 10.1097/QAI.0b013e318184fb41; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Summers SA, 2010, AM J PATHOL, V177, P2234, DOI 10.2353/ajpath.2010.100153; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wu JF, 2012, J INFECT DIS, V206, P662, DOI 10.1093/infdis/jis420; Xu CJ, 2009, MOL BIOL REP, V36, P2245, DOI 10.1007/s11033-008-9440-z; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS169, DOI 10.1681/ASN.2006080910	46	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58444	10.1371/journal.pone.0058444	http://dx.doi.org/10.1371/journal.pone.0058444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472199	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900145
J	Besser, MJ; Shoham, T; Harari-Steinberg, O; Zabari, N; Ortenberg, R; Yakirevitch, A; Nagler, A; Loewenthal, R; Schachter, J; Markel, G				Besser, Michal J.; Shoham, Tsipi; Harari-Steinberg, Orit; Zabari, Naama; Ortenberg, Rona; Yakirevitch, Arkadi; Nagler, Arnon; Loewenthal, Ron; Schachter, Jacob; Markel, Gal			Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RECEPTOR; LYSIS; CYTOTOXICITY; NKG2D; HEMAGGLUTININS; ALLOREACTIVITY; POLYMORPHISMS; RECOGNITION; ACTIVATION	Natural killer (NK) cells have long been considered as potential agents for adoptive cell therapy for solid cancer patients. Until today most studies utilized autologous NK cells and yielded disappointing results. Here we analyze various modular strategies to employ allogeneic NK cells for adoptive cell transfer, including donor-recipient HLA-C mismatching, selective activation and induction of melanoma-recognizing lysis receptors, and co-administration of antibodies to elicit antibody-dependent cell cytotoxicity (ADCC). We show that NK cell activation and induction of the relevant lysis receptors, as well as co-administration of antibodies yield substantial anti-cancer effects, which are functionally superior to HLA-C mismatching. Combination of the various strategies yielded improved effects. In addition, we developed various clinically-compatible ex vivo expansion protocols that were optimized according to fold expansion, purity and expression of lysis receptors. The main advantages of employing allogeneic NK cells are accessibility, the ability to use a single donor for many patients, combination with various strategies associated with the mechanism of action, e. g. antibodies and specific activation, as well as donor selection according to HLA or CD16 genotypes. This study rationalizes a clinical trial that combines adoptive transfer of highly potent allogeneic NK cells and antibody therapy.	[Besser, Michal J.; Harari-Steinberg, Orit; Zabari, Naama; Ortenberg, Rona; Schachter, Jacob; Markel, Gal] Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel; [Besser, Michal J.; Zabari, Naama; Ortenberg, Rona; Markel, Gal] Tel Aviv Univ, Dept Clin Microbiol & Immunol, Sackler Fac Med, GreenOnyx, Tel Aviv, Israel; [Shoham, Tsipi] GreenOnyx, Tel Aviv, Israel; [Harari-Steinberg, Orit] Chaim Sheba Med Ctr, Pediat Stem Cell Res Inst, IL-52621 Tel Hashomer, Israel; [Yakirevitch, Arkadi] Chaim Sheba Med Ctr, Dept Otolaryngol & Head & Neck Surg, IL-52621 Tel Hashomer, Israel; [Nagler, Arnon] Chaim Sheba Med Ctr, Div Hematol, IL-52621 Tel Hashomer, Israel; [Loewenthal, Ron] Chaim Sheba Med Ctr, Tissue Typing Lab, IL-52621 Tel Hashomer, Israel; [Markel, Gal] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Markel, G (corresponding author), Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel.	markel@post.tau.ac.il		Yakirevitch, Arkadi/0000-0002-2540-3549				Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Bachanova V, 2010, CANCER IMMUNOL IMMUN, V59, P1739, DOI 10.1007/s00262-010-0896-z; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2011, NAT REV DRUG DISCOV, V10, P811, DOI 10.1038/nrd3579; Frohn C, 2000, J IMMUNOTHER, V23, P499, DOI 10.1097/00002371-200007000-00014; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Hatjiharissi E, 2007, BLOOD, V110, P2561, DOI 10.1182/blood-2007-01-070656; Hodi MS, 2012, J CLIN ONCOL S, V30; Igarashi T, 2004, BLOOD, V104, P170, DOI 10.1182/blood-2003-12-4438; Kono K, 2002, CANCER RES, V62, P5813; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Ledford H, 2011, NATURE, V471, P561, DOI 10.1038/471561a; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Markel G, 2010, CANCER IMMUNOL IMMUN, V59, P215, DOI 10.1007/s00262-009-0740-5; Markel G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005597; Markel G, 2009, IMMUNOLOGY, V126, P186, DOI 10.1111/j.1365-2567.2008.02888.x; McKenna David H, 2012, Methods Mol Biol, V882, P491, DOI 10.1007/978-1-61779-842-9_28; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moretta A, 2008, IMMUNOL REV, V224, P58, DOI 10.1111/j.1600-065X.2008.00651.x; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Murphy WJ, 2012, BIOL BLOOD MARROW TR, V18, pS2, DOI 10.1016/j.bbmt.2011.10.033; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Parham P, 2006, IMMUNOL REV, V214, P155, DOI 10.1111/j.1600-065X.2006.00462.x; Parkhurst MR, 2011, CLIN CANCER RES, V17, P6287, DOI 10.1158/1078-0432.CCR-11-1347; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Roda-Navarro P, 2006, P NATL ACAD SCI USA, V103, P11258, DOI 10.1073/pnas.0600721103; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Scott Andrew M, 2005, Cancer Immun, V5, P3; VANDEGRIEND RJ, 1987, J IMMUNOL, V138, P3137; Weisdorf D, 2012, BIOL BLOOD MARROW TR, V18, P937, DOI 10.1016/j.bbmt.2011.11.024; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402	52	22	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57922	10.1371/journal.pone.0057922	http://dx.doi.org/10.1371/journal.pone.0057922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483943	Green Published, Green Submitted, gold			2022-12-25	WOS:000315634900055
J	Yu, JH; Peng, Y; Wu, LC; Xie, ZL; Deng, YC; Hughes, T; He, S; Mo, XK; Chiu, M; Wang, QE; He, XM; Liu, SJ; Grever, MR; Chan, KK; Liu, ZF				Yu, Jianhua; Peng, Yong; Wu, Lai-Chu; Xie, Zhiliang; Deng, Youcai; Hughes, Tiffany; He, Shun; Mo, XiaoKui; Chiu, Ming; Wang, Qi-En; He, Xiaoming; Liu, Shujun; Grever, Michael R.; Chan, Kenneth K.; Liu, Zhongfa			Curcumin Down-Regulates DNA Methyltransferase 1 and Plays an Anti-Leukemic Role in Acute Myeloid Leukemia	PLOS ONE			English	Article							CANCER-THERAPY; METHYLATION; TRANSCRIPTION; INHIBITORS; ACETYLTRANSFERASE; HYPOMETHYLATION; DECITABINE; DELIVERY; TARGET; GENES	Bioactive components from dietary supplements such as curcumin may represent attractive agents for cancer prevention or treatment. DNA methylation plays a critical role in acute myeloid leukemia (AML) development, and presents an excellent target for treatment of this disease. However, it remains largely unknown how curcumin, a component of the popular Indian spice turmeric, plays a role in DNA hypomethylation to reactivate silenced tumor suppressor genes and to present a potential treatment option for AML. Here we show that curcumin down-regulates DNMT1 expression in AML cell lines, both in vitro and in vivo, and in primary AML cells ex vivo. Mechanistically, curcumin reduced the expression of positive regulators of DNMT1, p65 and Sp1, which correlated with a reduction in binding of these transcription factors to the DNMT1 promoter in AML cell lines. This curcumin-mediated down-regulation of DNMT1 expression was concomitant with p15(INK4B) tumor suppressor gene reactivation, hypomethylation of the p15(INK4B) promoter, G1 cell cycle arrest, and induction of tumor cell apoptosis in vitro. In mice implanted with the human AML MV4-11 cell line, administration of curcumin resulted in remarkable suppression of AML tumor growth. Collectively, our data indicate that curcumin shows promise as a potential treatment for AML, and our findings provide a basis for future studies to test the clinical efficacy of curcumin - whether used as a single agent or as an adjuvant - for AML treatment.	[Yu, Jianhua; Grever, Michael R.] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Yu, Jianhua; Peng, Yong; Wu, Lai-Chu; Deng, Youcai; Hughes, Tiffany; He, Shun; Wang, Qi-En; He, Xiaoming; Grever, Michael R.; Chan, Kenneth K.; Liu, Zhongfa] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wu, Lai-Chu] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Xie, Zhiliang; Chiu, Ming; Chan, Kenneth K.; Liu, Zhongfa] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Deng, Youcai] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Mo, XiaoKui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Liu, Shujun] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Army Medical University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System	Yu, JH (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.	Jianhua.yu@osumc.edu; liu.550@osu.edu	Wu, Lai-Chu/E-4328-2011; Liu, Zhongfa/G-8549-2013; He, Xiaoming/C-5499-2008; Deng, Youcai/GZK-9548-2022; He, Shun/K-7448-2014	Wu, Lai-Chu/0000-0002-1348-269X; He, Xiaoming/0000-0003-0125-6086; Deng, Youcai/0000-0001-5488-8576; Ye, Xiaojian/0000-0003-2402-5782; He, Dannong/0000-0003-4921-1063; Li, Kai/0000-0001-5436-4836; Wang, Meiyan/0000-0002-2118-6647	U.S. National Institutes of Health (NIH) [CA155521, CA135478]; Experimental Therapeutic Program seed grant; Biomedical Mass Spectrometric Laboratory at The Ohio State University; American Cancer Society [IRG-67-003-47]; National Blood Foundation Scientific Research Grant; NATIONAL CANCER INSTITUTE [R01CA151248, R01CA155521, P30CA016058, R21CA135478] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Experimental Therapeutic Program seed grant; Biomedical Mass Spectrometric Laboratory at The Ohio State University; American Cancer Society(American Cancer Society); National Blood Foundation Scientific Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the U.S. National Institutes of Health (NIH) grants CA155521 (to JY) and CA135478 (to ZL), the Experimental Therapeutic Program seed grant (to ZL), and the Biomedical Mass Spectrometric Laboratory (KKC and ZL) at The Ohio State University. It was also supported in part by Grant # IRG-67-003-47 from the American Cancer Society and by a National Blood Foundation Scientific Research Grant (both to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Blum William, 2005, Clin Adv Hematol Oncol, V3, P855; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chim CS, 2006, LEUKEMIA LYMPHOMA, V47, P815, DOI 10.1080/10428190500513827; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; de Vos D, 2005, ANN HEMATOL, V84, P3, DOI 10.1007/s00277-005-0008-x; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Fu SQ, 2010, CANCER-AM CANCER SOC, V116, P4670, DOI 10.1002/cncr.25414; Grovdal M, 2007, CLIN CANCER RES, V13, P7107, DOI 10.1158/1078-0432.CCR-07-1193; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Li Xin-gang, 2005, Zhonghua Xue Ye Xue Za Zhi, V26, P551; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu Z, 2009, ANAL BIOCH; Liu ZF, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1156; Liu ZF, 2012, CANCER CHEMOTH PHARM, V69, P679, DOI 10.1007/s00280-011-1749-y; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Moiseeva EP, 2007, MOL CANCER THER, V6, P3071, DOI 10.1158/1535-7163.MCT-07-0117; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Pouton CW, 2000, EUR J PHARM SCI, V11, pS93, DOI 10.1016/S0928-0987(00)00167-6; Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shishodia S, 2007, ADV EXP MED BIOL, V595, P127; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; vanIersel MLPS, 1996, CHEM-BIOL INTERACT, V102, P117, DOI 10.1016/S0009-2797(96)03739-8; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2007, CANCER RES, V67, P6400, DOI 10.1158/0008-5472.CAN-07-0251	36	104	111	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55934	10.1371/journal.pone.0055934	http://dx.doi.org/10.1371/journal.pone.0055934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23483914	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300068
J	Goblirsch, M; Huang, ZY; Spivak, M				Goblirsch, Mike; Huang, Zachary Y.; Spivak, Marla			Physiological and Behavioral Changes in Honey Bees (Apis mellifera) Induced by Nosema ceranae Infection	PLOS ONE			English	Article							DIVISION-OF-LABOR; JUVENILE-HORMONE; HYPOPHARYNGEAL GLANDS; WORKER HONEYBEES; EUSOCIAL INSECT; LIFE-SPAN; COLONIES; MICROSPORIDIA; VITELLOGENIN; PHEROMONE	Persistent exposure to mite pests, poor nutrition, pesticides, and pathogens threaten honey bee survival. In healthy colonies, the interaction of the yolk precursor protein, vitellogenin (Vg), and endocrine factor, juvenile hormone (JH), functions as a pacemaker driving the sequence of behaviors that workers perform throughout their lives. Young bees perform nursing duties within the hive and have high Vg and low JH; as older bees transition to foraging, this trend reverses. Pathogens and parasites can alter this regulatory network. For example, infection with the microsporidian, Nosema apis, has been shown to advance behavioral maturation in workers. We investigated the effects of infection with a recent honey bee pathogen on physiological factors underlying the division of labor in workers. Bees infected with N. ceranae were nearly twice as likely to engage in precocious foraging and lived 9 days less, on average, compared to controls. We also show that Vg transcript was low, while JH titer spiked, in infected nurse-aged bees in cages. This pattern of expression is atypical and the reverse of what would be expected for healthy, non-infected bees. Disruption of the basic underpinnings of temporal polyethism due to infection may be a contributing factor to recent high colony mortality, as workers may lose flexibility in their response to colony demands.	[Goblirsch, Mike; Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	University of Minnesota System; University of Minnesota Twin Cities; Michigan State University	Goblirsch, M (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	goblirmj@umn.edu	Huang, Zachary/D-5485-2011; Spivak, Marla/AAI-5088-2020	Huang, Zachary/0000-0001-5354-5547; 	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP); North Central Region Sustainable Agriculture Research and Education (NCR-SARE); Eastern Apicultural Society	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP); North Central Region Sustainable Agriculture Research and Education (NCR-SARE); Eastern Apicultural Society	This research was supported by a United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP) grant awarded to MS and ZH and research grants from North Central Region Sustainable Agriculture Research and Education (NCR-SARE) and the Eastern Apicultural Society awarded to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amdam GV, 2011, NEUROBIOLOGY BEHAV H, P17; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Ares AM, 2012, J CHROMATOGR B, V899, P146, DOI 10.1016/j.jchromb.2012.05.016; Aronstein KA, 2011, J APICULT RES, V50, P145, DOI 10.3896/IBRA.1.50.2.06; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Blaser M, 2005, J INVERTEBR PATHOL, V89, P251, DOI 10.1016/j.jip.2005.04.004; Botias C, 2012, J INVERTEBR PATHOL, V110, P108, DOI 10.1016/j.jip.2012.02.014; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; HASSANEIN MH, 1953, ANN APPL BIOL, V40, P418, DOI 10.1111/j.1744-7348.1953.tb01093.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Hurd H, 2001, P ROY SOC B-BIOL SCI, V268, P1749, DOI 10.1098/rspb.2001.1729; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Medici SK, 2012, PARASITOL RES, V110, P859, DOI 10.1007/s00436-011-2566-2; LIU TP, 1990, TISSUE CELL, V22, P533, DOI 10.1016/0040-8166(90)90081-J; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; PAGE RE, 1992, BEHAV ECOL, V3, P173, DOI 10.1093/beheco/3.2.173; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sakagami SF, 1968, RES POPUL ECOL, V10; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; SOLTER LF, 1990, J INVERTEBR PATHOL, V55, P337, DOI 10.1016/0022-2011(90)90076-I; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Traver BE, 2012, J INVERTEBR PATHOL, V109, P187, DOI 10.1016/j.jip.2011.11.001; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; WANG DI, 1970, J ECON ENTOMOL, V63, P1539, DOI 10.1093/jee/63.5.1539; WANG DI, 1969, J INVERTEBR PATHOL, V14, P135, DOI 10.1016/0022-2011(69)90098-6; WINSTON ML, 1987, BIOL HONEY BEE, P89; Woyciechowski M, 2009, INSECT SOC, V56, P193, DOI 10.1007/s00040-009-0012-6	53	194	201	4	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58165	10.1371/journal.pone.0058165	http://dx.doi.org/10.1371/journal.pone.0058165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483987	Green Published, gold			2022-12-25	WOS:000316936100082
J	Anderson, KE; Kielkowska, A; Durrant, TN; Juvin, V; Clark, J; Stephens, LR; Hawkins, PT				Anderson, Karen E.; Kielkowska, Anna; Durrant, Tom N.; Juvin, Veronique; Clark, Jonathan; Stephens, Len R.; Hawkins, Phillip T.			Lysophosphatidylinositol-Acyltransferase-1 (LPIAT1) Is Required to Maintain Physiological Levels of PtdIns and PtdInsP(2) in the Mouse	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LYSOPHOSPHOLIPID ACYLTRANSFERASES; CAENORHABDITIS-ELEGANS; PHOSPHATIDYLINOSITOL; MEMBRANE; PHOSPHOINOSITIDES; TISSUES; MBOA-7; MICE	We disrupted the gene encoding lysophosphatidylinositol-acyltransferase-1 (LPIAT1) in the mouse with the aim of understanding its role in determining cellular phosphoinositide content. LPIAT1(-/-) mice were born at lower than Mendelian ratios and exhibited a severe developmental brain defect. We compared the phospholipid content of livers and brains from LPIAT1(-/-) and LPIAT1(+/+) littermates by LC-ESI/MS. In accord with previous studies, the most abundant molecular species of each phosphoinositide class (PtdIns, PtdInsP, PtdInsP(2) and PtdInsP(3)) possessed a C38:4 complement of fatty-acyl esters (C18:0 and C20:4 are usually assigned to the sn-1 and sn-2 positions, respectively). LPIAT1(-/-) liver and brain contained relatively less of the C38:4 species of PtdIns, PtdInsP and PtdInsP(2) (dropping from 95-97% to 75-85% of the total species measured for each lipid class) and relatively more of the less abundant species (PtdInsP(3) less abundant species were below our quantification levels). The increases in the less abundant PtdIns and PtdInsP(2) species did not compensate for the loss in C38:4 species, resulting in a 26-44% reduction in total PtdIns and PtdInsP(2) levels in both brain and liver. LPIAT1(-/-) brain and liver also contained increased levels of C18:0 lyso-PtdIns (300% and 525% respectively) indicating a defect in the reacylation of this molecule. LPIAT1(-/-) brain additionally contained significantly reduced C38:4 PC and PE levels (by 47% and 55% respectively), possibly contributing to the phenotype in this organ. The levels of all other molecular species of PC, PE, PS and PA measured in the brain and liver were very similar between LPIAT1(-/-) and LPIAT1(+/+) samples. These results suggest LPIAT1 activity plays a non-redundant role in maintaining physiological levels of PtdIns within an active deacylation/reacylation cycle in mouse tissues. They also suggest that this pathway must act in concert with other, as yet unidentified, mechanisms to achieve the enrichment observed in C38:4 molecular species of phosphoinositides.	[Anderson, Karen E.; Durrant, Tom N.; Juvin, Veronique; Stephens, Len R.; Hawkins, Phillip T.] Babraham Inst, Inositide Lab, Cambridge, England; [Kielkowska, Anna; Clark, Jonathan] Babraham Biosci Technol Ltd, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Stephens, LR (corresponding author), Babraham Inst, Inositide Lab, Babraham Res Campus, Cambridge, England.	len.stephens@babraham.ac.uk; phillip.hawkins@babraham.ac.uk	Walton, Alexander/W-5786-2019; Jones, Beryl/N-5842-2019	Walton, Alexander/0000-0001-8635-873X; Jones, Beryl/0000-0003-2925-0807; Hawkins, Phillip/0000-0002-6979-0464; stephens, len/0000-0002-2771-3487; Durrant, Tom N/0000-0002-0503-9364; Anderson, Karen/0000-0002-7394-6660; Corby-Harris, Vanessa/0000-0001-7680-0328	Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG [BB/J004456/1]; Biotechnology and Biological Sciences Research Council [BB/I003916/1, BBS/E/B/000C0415, BBS/E/B/000C0413] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by the Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG BB/J004456/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER A, 1990, LIPIDS, V25, P473, DOI 10.1007/BF02538091; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fan YY, 2012, J LIPID RES, V53, P1287, DOI 10.1194/jlr.M024216; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Lee HC, 2012, GENES CELLS, V17, P748, DOI 10.1111/j.1365-2443.2012.01624.x; Lung M, 2009, J BIOL CHEM, V284, P31062, DOI 10.1074/jbc.M109.050617; Milne SB, 2005, J LIPID RES, V46, P1796, DOI 10.1194/jlr.D500010-JLR200; PALMER FBS, 1986, BIOCHEM CELL BIOL, V64, P117, DOI 10.1139/o86-019; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shulga YV, 2010, BIOCHEMISTRY-US, V49, P312, DOI 10.1021/bi901551e; Steinhauer J, 2009, MOL BIOL CELL, V20, P5224, DOI 10.1091/mbc.E09-05-0382; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; VADNAL RE, 1989, BIOCHEM BIOPH RES CO, V163, P995, DOI 10.1016/0006-291X(89)92320-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708	27	215	222	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58425	10.1371/journal.pone.0058425	http://dx.doi.org/10.1371/journal.pone.0058425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	24358254	Green Published, gold			2022-12-25	WOS:000315637900141
J	Kang, HS; Liao, G; DeGraff, LM; Gerrish, K; Bortner, CD; Garantziotis, S; Jetten, AM				Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Gerrish, Kevin; Bortner, Carl D.; Garantziotis, Stavros; Jetten, Anton M.			CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance	PLOS ONE			English	Article							GENE-EXPRESSION; MACROPHAGE ACCUMULATION; PROFILING REVEALS; LIVER STEATOSIS; ROR-ALPHA; OBESITY; OSTEOPONTIN; TISSUE; RECRUITMENT; HYALURONAN	CD44 is a multifunctional membrane receptor implicated in the regulation of several biological processes, including inflammation. CD44 expression is elevated in liver and white adipose tissue (WAT) during obesity suggesting a possible regulatory role for CD44 in metabolic syndrome. To study this hypothesis, we examined the effect of the loss of CD44 expression on the development of various features of metabolic syndrome using CD44 null mice. Our study demonstrates that CD44-deficient mice (CD44KO) exhibit a significantly reduced susceptibility to the development of high fat-diet (HFD)-induced hepatic steatosis, WAT-associated inflammation, and insulin resistance. The decreased expression of genes involved in fatty acid synthesis and transport (Fasn and Cd36), de novo triglyceride synthesis (Mogat1), and triglyceride accumulation (Cidea, Cidec) appears in part responsible for the reduced hepatic lipid accumulation in CD44KO(HFD) mice. In addition, the expression of various inflammatory and cell matrix genes, including several chemokines and its receptors, osteopontin, and several matrix metalloproteinases and collagen genes was greatly diminished in CD44KO(HFD) liver consistent with reduced inflammation and fibrogenesis. In contrast, lipid accumulation was significantly increased in CD44KO(HFD) WAT, whereas inflammation as indicated by the reduced infiltration of macrophages and expression of macrophage marker genes, was significantly diminished in WAT of CD44KO(HFD) mice compared to WT(HFD) mice. CD44KO(HFD) mice remained considerably more insulin sensitive and glucose tolerant than WT(HFD) mice and exhibited lower blood insulin levels. Our study indicates that CD44 plays a critical role in regulating several aspects of metabolic syndrome and may provide a new therapeutic target in the management of insulin resistance.	[Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Jetten, Anton M.] NIH, Cell Biol Sect, Res Triangle Pk, NC USA; [Gerrish, Kevin] NIH, Microarray Grp, Res Triangle Pk, NC USA; [Bortner, Carl D.] NIEHS, Lab Signal Transduct, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Garantziotis, Stavros] NIH, Matrix Biol Sect, LRB, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA	Jetten, AM (corresponding author), NIH, Cell Biol Sect, Res Triangle Pk, NC USA.	jetten@niehs.nih.gov	yu, qing/HGC-4611-2022; Jetten, Anton/C-3736-2019; Yu, Qinghua/T-3261-2019; Garantziotis, Stavros/A-6903-2009	Jetten, Anton/0000-0003-0954-4445; Garantziotis, Stavros/0000-0003-4007-375X	Intramural Research Program of the NIEHS, NIH [Z01-ES-101586]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, ZICES102445, ZIAES102605, ZICES102486, Z01ES101586] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIEHS, NIH (Z01-ES-101586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Consolo M, 2009, INT J MOL MED, V24, P143, DOI 10.3892/ijmm_00000217; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kitade H, 2012, DIABETES; Kodama K, 2012, P NATL ACAD SCI US; Li L, 2012, VITAM HORM, V90, P375, DOI 10.1016/B978-0-12-398313-8.00014-2; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Morimoto J, 2010, CURR DRUG TARGETS, V11, P494, DOI 10.2174/138945010790980321; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nakamachi T, 2007, DIABETES, V56, P1662, DOI 10.2337/db06-1177; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; Nio Y, 2012, DIABETOLOGIA; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Solis MA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/346972; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wan ZX, 2012, OBESITY, V20, P453, DOI 10.1038/oby.2011.252; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	61	75	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58417	10.1371/journal.pone.0058417	http://dx.doi.org/10.1371/journal.pone.0058417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	24391892	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500081
J	Yao, XL; Fu, BJ; Lu, YH; Sun, FX; Wang, S; Liu, M				Yao, Xueling; Fu, Bojie; Lu, Yihe; Sun, Feixiang; Wang, Shuai; Liu, Min			Comparison of Four Spatial Interpolation Methods for Estimating Soil Moisture in a Complex Terrain Catchment	PLOS ONE			English	Article							SEMIARID LOESS PLATEAU; LINEAR-REGRESSION; VARIABILITY; WATER; PREDICTION; SURFACE; MODEL; SCALE; SCATTEROMETER; INFORMATION	Many spatial interpolation methods perform well for gentle terrains when producing spatially continuous surfaces based on ground point data. However, few interpolation methods perform satisfactorily for complex terrains. Our objective in the present study was to analyze the suitability of several popular interpolation methods for complex terrains and propose an optimal method. A data set of 153 soil water profiles (1 m) from the semiarid hilly gully Loess Plateau of China was used, generated under a wide range of land use types, vegetation types and topographic positions. Four spatial interpolation methods, including ordinary kriging, inverse distance weighting, linear regression and regression kriging were used for modeling, randomly partitioning the data set into 2/3 for model fit and 1/3 for independent testing. The performance of each method was assessed quantitatively in terms of mean-absolute-percentage-error, root-mean-square-error, and goodness-of-prediction statistic. The results showed that the prediction accuracy differed significantly between each method in complex terrain. The ordinary kriging and inverse distance weighted methods performed poorly due to the poor spatial autocorrelation of soil moisture at small catchment scale with complex terrain, where the environmental impact factors were discontinuous in space. The linear regression model was much more suitable to the complex terrain than the former two distance-based methods, but the predicted soil moisture changed too sharply near the boundary of the land use types and junction of the sunny (southern) and shady (northern) slopes, which was inconsistent with reality because soil moisture should change gradually in short distance due to its mobility in soil. The most optimal interpolation method in this study for the complex terrain was the hybrid regression kriging, which produced a detailed, reasonable prediction map with better accuracy and prediction effectiveness.	[Yao, Xueling; Fu, Bojie; Lu, Yihe; Sun, Feixiang; Wang, Shuai; Liu, Min] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Fu, BJ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bfu@rcees.ac.cn	Fu, Bojie/B-1493-2009; Wang, Shuai/B-2334-2017	Wang, Shuai/0000-0003-1595-9858; Feng, Haiyang/0000-0002-2169-2347; Shen, Wen-Hui/0000-0001-7988-6382	National Natural Science Foundation of China [40930528]; State Forestry Administration [201004058]; CAS/SAFEA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration; CAS/SAFEA(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (No. 40930528), State Forestry Administration (No. 201004058) and the CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergel C, 2008, HYDROL EARTH SYST SC, V12, P1323, DOI 10.5194/hess-12-1323-2008; Bai Tian-lu, 2009, Shengtaixue Zazhi, V28, P2508; Baskan O, 2009, CLAY MINER, V44, P181, DOI 10.1180/claymin.2009.044.2.181; Bi HX, 2008, J AM WATER RESOUR AS, V44, P1121, DOI 10.1111/j.1752-1688.2008.00236.x; Bi HX, 2009, INT J SEDIMENT RES, V24, P63, DOI 10.1016/S1001-6279(09)60016-0; Carre F, 2002, GEODERMA, V110, P241, DOI 10.1016/S0016-7061(02)00233-1; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; Dorigo WA, 2011, HYDROL EARTH SYST SC, V15, P1675, DOI 10.5194/hess-15-1675-2011; Dripps WR, 2007, HYDROGEOL J, V15, P433, DOI 10.1007/s10040-007-0160-6; Fritsch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020682; Gilbert B, 1997, LANDSCAPE URBAN PLAN, V37, P235, DOI 10.1016/S0169-2046(97)80007-2; Govaerts A, 2010, QUANT GEO G, V16, P219, DOI 10.1007/978-90-481-2322-3_20; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Kravchenko A, 1999, AGRON J, V91, P393, DOI 10.2134/agronj1999.00021962009100030007x; Lesch SM, 2008, GEODERMA, V148, P130, DOI 10.1016/j.geoderma.2008.09.014; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Li Y, 2010, GEODERMA, V159, P63, DOI 10.1016/j.geoderma.2010.06.017; Lin GF, 2004, J HYDROL, V288, P288, DOI 10.1016/j.jhydrol.2003.10.008; Liu W, 2010, AGR WATER MANAGE, V97, P1133, DOI 10.1016/j.agwat.2010.01.001; Liu Y, 2012, GEOMORPHOLOGY, V138, P404, DOI 10.1016/j.geomorph.2011.10.009; Minasny B, 2007, GEODERMA, V140, P324, DOI 10.1016/j.geoderma.2007.04.028; Minet J, 2011, HYDROL EARTH SYST SC, V15, P1323, DOI 10.5194/hess-15-1323-2011; Moran MS, 2004, CAN J REMOTE SENS, V30, P805, DOI 10.5589/m04-043; Perry MA, 2008, HYDROL EARTH SYST SC, V12, P39, DOI 10.5194/hess-12-39-2008; Qiu Y, 2003, CATENA, V54, P173, DOI 10.1016/S0341-8162(03)00064-X; Sigua GC, 2008, J SOIL SEDIMENT, V8, P193, DOI 10.1007/s11368-008-0003-7; Stacey KF, 2006, GEODERMA, V135, P107, DOI 10.1016/j.geoderma.2005.11.008; Sun W, 2012, J PLANT NUTR SOIL SC, V175, P212, DOI 10.1002/jpln.201100005; Tabari H, 2011, METEOROL ATMOS PHYS, V110, P135, DOI 10.1007/s00703-010-0110-z; Tischler M, 2007, ENVIRON MODELL SOFTW, V22, P891, DOI 10.1016/j.envsoft.2006.05.022; Toth E, 2008, CEREAL RES COMMUN, V36, P307; Tramblay Y, 2010, J HYDROL, V387, P176, DOI 10.1016/j.jhydrol.2010.04.006; Vanita Pandey, 2010, International Journal of Geosciences, V1, P87; Wagner W, 1999, REMOTE SENS ENVIRON, V70, P191, DOI 10.1016/S0034-4257(99)00036-X; Wang M, 2012, PLOS ONE, V7; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang ZQ, 2009, J GEOGR SCI, V19, P707, DOI 10.1007/s11442-009-0707-7; Wu J, 2006, GEODERMA, V134, P187, DOI 10.1016/j.geoderma.2005.11.002; Yao XL, 2012, J SOIL SEDIMENT, V12, P694, DOI 10.1007/s11368-012-0481-5; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Zeng C, 2011, ACTA AGR SCAND B-S P, V61, P1, DOI 10.1080/09064710903352589; Zhang CL, 2008, INT FED INFO PROC, V258, P719; Zhang CL, 2009, INT FED INFO PROC, V293, P285; Zhao PP, 2010, ACTA AGR SCAND B-S P, V60, P117, DOI 10.1080/09064710802676377; Zhu Q, 2010, PEDOSPHERE, V20, P594, DOI 10.1016/S1002-0160(10)60049-5; Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433; Zribi M, 2003, REMOTE SENS ENVIRON, V86, P30, DOI 10.1016/S0034-4257(03)00065-8	48	126	136	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54660	10.1371/journal.pone.0054660	http://dx.doi.org/10.1371/journal.pone.0054660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23483879	Green Submitted, gold, Green Published			2022-12-25	WOS:000314021500101
J	Kang, HH; Yan, MF; Yu, QH; Yang, Q				Kang, Haihong; Yan, Mengfei; Yu, Qinghua; Yang, Qian			Characteristics of Nasal-Associated Lymphoid Tissue (NALT) and Nasal Absorption Capacity in Chicken	PLOS ONE			English	Article							OVIDUCTAL EPITHELIAL-CELLS; IMMUNE-SYSTEM; MUCOSAL IMMUNITY; INFLUENZA-VIRUS; FALLOPIAN-TUBE; PARTICLES; ANTIGENS; ORGAN; SITE	As the main mucosal immune inductive site of nasal cavity, nasal-associated lymphoid tissue (NALT) plays an important role in both antigen recognition and immune activation after intranasal immunization. However, the efficiency of intranasal vaccines is commonly restricted by the insufficient intake of antigen by the nasal mucosa, resulting from the nasal mucosal barrier and the nasal mucociliary clearance. The distribution of NALT and the characteristic of nasal cavity have already been described in humans and many laboratory rodents, while data about poultry are scarce. For this purpose, histological sections of the chicken nasal cavities were used to examine the anatomical structure and histological characteristics of nasal cavity. Besides, the absorptive capacity of chicken nasal mucosa was also studied using the materials with different particle size. Results showed that the NALT of chicken was located on the bottom of nasal septum and both sides of choanal cleft, which mainly consisted of second lymphoid follicle. A large number of lymphocytes were distributed under the mucosal epithelium of inferior nasal meatus. In addition, there were also diffuse lymphoid tissues located under the epithelium of the concha nasalis media and the walls of nasal cavity. The results of absorption experiment showed that the chicken nasal mucosa was capable to absorb trypan blue, OVA, and fluorescent latex particles. Inactivated avian influenza virus (IAIV) could be taken up by chicken nasal mucosa except for the stratified squamous epithelium sites located on the forepart of nasal cavity. The intake of IAIV by NALT was greater than that of the nasal mucosa covering on non-lymphoid tissue, which could be further enhanced after intranasal inoculation combined with sodium cholate or CpG DNA. The study on NALT and nasal absorptive capacity will be benefit for further understanding of immune mechanisms after nasal vaccination and development of nasal vaccines for poultry.	[Kang, Haihong; Yan, Mengfei; Yu, Qinghua; Yang, Qian] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn	yu, qing/HGC-4611-2022; Jetten, Anton/C-3736-2019; Yu, Qinghua/T-3261-2019; Garantziotis, Stavros/A-6903-2009	Jetten, Anton/0000-0003-0954-4445; Garantziotis, Stavros/0000-0003-4007-375X	National Science Grant of China [31172302]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, ZICES102445, ZIAES102605, ZICES102486, Z01ES101586] Funding Source: NIH RePORTER	National Science Grant of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Grant of China (31172302, http://www.nsfc.gov.cn/), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://www.ec.js.edu.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI N, 1988, JPN J VET SCI, V50, P183; BANG BG, 1968, AM J PATHOL, V53, P735; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brayden DJ, 2001, EUR J PHARM SCI, V14, P183, DOI 10.1016/S0928-0987(01)00175-0; Casteleyn C, 2010, VET IMMUNOL IMMUNOP, V133, P212, DOI 10.1016/j.vetimm.2009.08.011; FAGERLAND JA, 1993, AVIAN DIS, V37, P10, DOI 10.2307/1591451; FAGERLAND JA, 1990, AM J ANAT, V189, P24, DOI 10.1002/aja.1001890104; Fagerland Jane A., 1993, Regional Immunology, V5, P28; Fujimura Y, 2000, VIRCHOWS ARCH, V436, P560, DOI 10.1007/s004289900177; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; HAMELEERS DMH, 1989, CELL TISSUE RES, V256, P431, DOI 10.1007/BF00218901; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Hiller AS, 1998, SCAND J IMMUNOL, V47, P159; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Itoh H, 2006, AM J REPROD IMMUNOL, V56, P91, DOI 10.1111/j.1600-0897.2006.00389.x; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; KUPER CF, 1992, IMMUNOL TODAY, V13, P219; Lathers DMR, 1998, INVEST OPHTH VIS SCI, V39, P1005; Lee HJ, 2005, EXP MOL MED, V37, P297, DOI 10.1038/emm.2005.40; Liu GY, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-36; Liu HS, 2005, INVEST OPHTH VIS SCI, V46, P4217, DOI 10.1167/iovs.05-0280; LOO SK, 1974, J ANAT, V117, P249; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; MAIR TS, 1987, J COMP PATHOL, V97, P575, DOI 10.1016/0021-9975(87)90008-9; MAIR TS, 1988, J COMP PATHOL, V99, P159, DOI 10.1016/0021-9975(88)90069-2; Maldonado-Contreras AL, 2011, CELL TISSUE RES, V343, P5, DOI 10.1007/s00441-010-1082-5; Nasu K, 2007, HUM REPROD, V22, P356, DOI 10.1093/humrep/del385; Ohshima K, 2000, HISTOL HISTOPATHOL, V15, P713, DOI 10.14670/HH-15.713; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; Pawar D, 2010, AAPS J, V12, P130, DOI 10.1208/s12248-009-9169-1; Qian L, 2002, ACTA BIOCH BIOPH SIN, V34, P719; Quinteiro P, 2005, ANATOMIA HISTOLOGIA, V34, P41; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Sato S, 2012, CURR OPIN VIROL, V2, P225, DOI 10.1016/j.coviro.2012.03.009; Smialek M, 2011, POL J VET SCI, V14, P291, DOI 10.2478/v10181-011-0047-2; SPIT BJ, 1989, CELL TISSUE RES, V255, P193; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tamura S, 1998, J GEN VIROL, V79, P291, DOI 10.1099/0022-1317-79-2-291; TlaskalovaHogenova H, 1995, FOLIA MICROBIOL, V40, P385, DOI 10.1007/BF02814746; Yuanji G, 1997, INFLUENZA VIRUS EXPT; Zhang XW, 2009, VACCINE, V27, P5628, DOI 10.1016/j.vaccine.2009.07.023; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	46	75	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84097	10.1371/journal.pone.0084097	http://dx.doi.org/10.1371/journal.pone.0084097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391892	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900035
J	Anderson, KE; Sheehan, TH; Mott, BM; Maes, P; Snyder, L; Schwan, MR; Walton, A; Jones, BM; Corby-Harris, V				Anderson, Kirk E.; Sheehan, Timothy H.; Mott, Brendon M.; Maes, Patrick; Snyder, Lucy; Schwan, Melissa R.; Walton, Alexander; Jones, Beryl M.; Corby-Harris, Vanessa			Microbial Ecology of the Hive and Pollination Landscape: Bacterial Associates from Floral Nectar, the Alimentary Tract and Stored Food of Honey Bees (Apis mellifera)	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GUT BACTERIA; SYMBIONTS; COMMUNITIES; EVOLUTION; MICROFLORA; DIVERSITY; POLLEN; ANTS; MICROORGANISMS	Nearly all eukaryotes are host to beneficial or benign bacteria in their gut lumen, either vertically inherited, or acquired from the environment. While bacteria core to the honey bee gut are becoming evident, the influence of the hive and pollination environment on honey bee microbial health is largely unexplored. Here we compare bacteria from floral nectar in the immediate pollination environment, different segments of the honey bee (Apis mellifera) alimentary tract, and food stored in the hive (honey and packed pollen or "beebread''). We used cultivation and sequencing to explore bacterial communities in all sample types, coupled with culture-independent analysis of beebread. We compare our results from the alimentary tract with both culture-dependent and culture-independent analyses from previous studies. Culturing the foregut (crop), midgut and hindgut with standard media produced many identical or highly similar 16S rDNA sequences found with 16S rDNA clone libraries and next generation sequencing of 16S rDNA amplicons. Despite extensive culturing with identical media, our results do not support the core crop bacterial community hypothesized by recent studies. We cultured a wide variety of bacterial strains from 6 of 7 phylogenetic groups considered core to the honey bee hindgut. Our results reveal that many bacteria prevalent in beebread and the crop are also found in floral nectar, suggesting frequent horizontal transmission. From beebread we uncovered a variety of bacterial phylotypes, including many possible pathogens and food spoilage organisms, and potentially beneficial bacteria including Lactobacillus kunkeei, Acetobacteraceae and many different groups of Actinobacteria. Contributions of these bacteria to colony health may include general hygiene, fungal and pathogen inhibition and beebread preservation. Our results are important for understanding the contribution to pollinator health of both environmentally vectored and core microbiota, and the identification of factors that may affect bacterial detection and transmission, colony food storage and disease susceptibility.	[Anderson, Kirk E.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Anderson, Kirk E.; Sheehan, Timothy H.; Mott, Brendon M.; Maes, Patrick; Snyder, Lucy; Schwan, Melissa R.; Walton, Alexander; Jones, Beryl M.; Corby-Harris, Vanessa] USDA ARS Carl Hayden Bee Res Ctr, Tucson, AZ USA; [Sheehan, Timothy H.; Maes, Patrick] Univ Arizona, Dept Microbiol, Tucson, AZ USA; [Mott, Brendon M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Walton, Alexander] Iowa State Univ, Dept Ecol & Evolut, Ames, IA USA; [Jones, Beryl M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	University of Arizona; University of Arizona; Arizona State University; Arizona State University-Tempe; Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Anderson, KE (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.	kirk.anderson@ars.usda.gov	Walton, Alexander/W-5786-2019; Jones, Beryl/N-5842-2019	Walton, Alexander/0000-0001-8635-873X; Jones, Beryl/0000-0003-2925-0807; Hawkins, Phillip/0000-0002-6979-0464; stephens, len/0000-0002-2771-3487; Durrant, Tom N/0000-0002-0503-9364; Anderson, Karen/0000-0002-7394-6660; Corby-Harris, Vanessa/0000-0001-7680-0328	Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ; Biotechnology and Biological Sciences Research Council [BB/I003916/1, BBS/E/B/000C0415, BBS/E/B/000C0413] Funding Source: researchfish	Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided entirely by the USA tax-payer supported operating budget of the Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ. There were no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Aween MM, 2012, J FOOD SCI, V77, pM364, DOI 10.1111/j.1750-3841.2012.02776.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Bottacini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044229; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Bution ML, 2008, MICRON, V39, P897, DOI 10.1016/j.micron.2007.11.008; Chen YP, 2010, APIDOLOGIE, V41, P364, DOI 10.1051/apido/2010021; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1988, J INSECT PHYSIOL, V34, P85, DOI 10.1016/0022-1910(88)90158-8; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; DAESCHEL MA, 1987, FEMS MICROBIOL LETT, V46, P357, DOI 10.1111/j.1574-6968.1987.tb02472.x; Dawkins R, 2004, BIOL PHILOS, V19, P377, DOI 10.1023/B:BIPH.0000036180.14904.96; DeSantis TZ, 2006, APPL ENV MICROBIOL; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Endo A, 2011, INT J SYST EVOL MICR; Endo A, 2009, SYST APPL MICROBIOL, V32, P593, DOI 10.1016/j.syapm.2009.08.002; Engel, 2013, INT J SYST EVOL MICR, DOI 10.109.; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Feldhaar Heike, 2009, Journal of Biology (London), V8, P31, DOI 10.1186/jbiol129; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1983, J INVERTEBR PATHOL, V42, P187, DOI 10.1016/0022-2011(83)90061-7; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gordon DM, 2001, MICROBIOL-SGM, V147, P1079, DOI 10.1099/00221287-147-5-1079; GOTELLI NJ, 2002, ECOSIM NULL MODELS S; Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hendriksma HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059589; Garcia AH, 2011, J BIOSCIENCES, V36, P939, DOI 10.1007/s12038-011-9107-0; Holldobler B, 2008, SUPERORGANISM BEAUTY; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; INGLIS GD, 1993, MICROBIAL ECOL, V26, P125, DOI 10.1007/BF00177048; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jojima Y, 2004, INT J SYST EVOL MICR, V54, P2263, DOI 10.1099/ijs.0.02911-0; Judd T. M., 2011, SOCIAL INSECTS STRUC; Kacaniova M, 2004, FOLIA MICROBIOL, V49, P169, DOI 10.1007/BF02931394; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOPER GM, 1980, APIDOLOGIE, V11, P63, DOI 10.1051/apido:19800108; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; Microbiome F, 2013, UNEXPECTED DIVERSITY, DOI [10.1128/mBio.00602-12, DOI 10.1128/MBI0.00602-12.EDIT0R]; Millet V, 2000, LETT APPL MICROBIOL, V30, P136, DOI 10.1046/j.1472-765X.2000.00684.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neveling DP, 2012, CURR MICROBIOL; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Ohkuma M., 2001, RIKEN REV, V41, P69; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2009, J APICULT RES, V48, P233, DOI 10.3896/IBRA.1.48.4.02; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P209, DOI 10.1051/apido:19660302; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Promnuan Y, 2009, WORLD J MICROB BIOT, V25, P1685, DOI 10.1007/s11274-009-0051-1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Rangberg A, 2012, INTEGR COMP BIOL, V52, P89, DOI 10.1093/icb/ics089; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rosengaus RB, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.31; RUIZARGU.T, 1973, J GEN MICROBIOL, V76, P211, DOI 10.1099/00221287-76-1-211; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Shamala TR, 2000, LETT APPL MICROBIOL, V30, P453, DOI 10.1046/j.1472-765X.2000.00746.x; SUZUKI I, 1991, MILCHWISSENSCHAFT, V46, P635; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Turner J. Scott, 2005, American Entomologist, V51, P36; Turner JS, 2004, BIOL PHILOS, V19, P327, DOI 10.1023/B:BIPH.0000036115.65522.a1; Vasquez A, 2011, MICROBIOLOGY TODAY, V38, P226; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; VIDAVER AK, 1982, ANNU REV MICROBIOL, V36, P495, DOI 10.1146/annurev.mi.36.100182.002431; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	106	215	222	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83125	10.1371/journal.pone.0083125	http://dx.doi.org/10.1371/journal.pone.0083125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358254	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700049
